[["Eye and mouth dryness are the most common symptoms reported during ophthalmological and dental examinations, and their frequency increases with age.", {"entities": []}], ["In connection with population aging and the huge variety of factors and conditions that can induce this condition, it is becoming a serious and growing problem.", {"entities": []}], ["The purpose of the present study was to determine whether ocular dryness and concomitant xerostomia is associated with particular systemic diseases.", {"entities": []}], ["We enrolled 642 non-Sj\u00f6gren patients referred for examination to the ophthalmology or dental clinic of Lublin region, Poland.", {"entities": []}], ["The research was conducted using a standardized interview: The Interview and Examination Questionnaire.", {"entities": []}], ["All patients responded to the survey questions, which concerned systemic diseases, lifestyle, with special emphasis on computer work, spending time in polluted and air-conditioned rooms, and subsequent questions about the subjective symptoms of ocular and mouth dryness.", {"entities": []}], ["There were 424 patients who presented signs and symptoms of both ocular and mouth dryness.", {"entities": []}], ["Our study showed a statistically significant association between this condition and the age and sex of the patients and systemic diseases such as hypertension (p=0.0000), cardiovascular disease (p=0.057), and stress (p=0.036), and time spent at the computer (p=0.00015).", {"entities": [[146, 158, "DISEASE"]]}], ["Ocular dryness and concomitant xerostomia may occur in apparently healthy individuals, but is more frequent in patients with systemic disorders.", {"entities": []}], ["The lack of dry eye and dry mouth symptoms does not exclude insufficient tearing and salivation; thus, the disorders are usually underestimated.", {"entities": []}], ["Our study indicates that ocular and mouth dryness are the most common conditions seen in out-patients, due to increased use of medications, computers, and air conditioning.", {"entities": []}], ["Synthetic oligodeoxynucleotides containing unmethylated CpG motifs activate Toll-Like Receptor 9 (TLR9).", {"entities": [[98, 102, "GENE"]]}], ["Our previous studies have shown the role of hydrogen-bond donor and acceptor groups of cytosine and guanine in the CpG motif and identified synthetic immunostimulatory motifs.", {"entities": []}], ["In the present study to elucidate the significance of N3-position of cytosine and N1-position of guanine in the CpG motif, we substituted C or G of a CpG dinucleotide with N in vivo in mice, and in human cell cultures.", {"entities": []}], ["In addition, IMOs containing N-Me-substitutions reversed antigen-induced Th2 immune responses towards a Th1-type in OVA-sensitized mouse spleen cell cultures.", {"entities": []}], ["These studies suggest that TLR9 tolerates a methyl group at N1-position of G and a methyl group at N3-position of C may interfere with TLR9 activation to some extent.", {"entities": [[27, 31, "GENE"], [135, 139, "GENE"], [27, 31, "GENE"], [135, 139, "GENE"]]}], ["These are the first studies elucidating the role of N3-position of cytosine and N1-position of guanine in a CpG motif for TLR9 activation and immune stimulation.", {"entities": [[122, 126, "GENE"]]}], ["Chronic hepatitis C virus (HCV) infection affects nearly 170 million individuals worldwide.", {"entities": [[8, 17, "DISEASE"]]}], ["Treatment of HCV with pegylated interferon-\u03b1-2a is successful in eradicating virus from only 30%\u201380% of those treated.", {"entities": []}], ["Interleukin-6 (IL-6) is an important cytokine involved in the immune response to infectious agents and in vitro studies suggest that host genetic variation, particularly haplotypes, may affect IL-6 expression.", {"entities": []}], ["We examined the contribution of haplotypes in the IL-6 gene on sustained viral response (SVR) to therapy for chronic HCV infection.", {"entities": []}], ["We observed the IL-6 T-T-G-G-G-G-C-A-G-A haplotype to be associated with a lower risk of achieving SVR among Caucasian Americans (CAs) (RR=0.80; 95%C.I.", {"entities": []}], [": 0.66\u2013 0.98; p=0.0261).", {"entities": []}], ["Using a sliding window approach, the rs1800797-(G)-rs1800796-(G)-rs1800795-(G ) haplotype was associated with a reduced chance of SVR (RR=0.79; 95%C.I.", {"entities": []}], [": 0.66\u20130.94; p=0.0081), as was the rs1800796-(G)-rs1800795-(G)-rs2069830-(C ) haplotype (RR=0.78; 95%C.I.", {"entities": []}], [": 0.66\u20130.94; p=0.0065) among CAs.", {"entities": []}], ["Overall, the rs1800797-(G)-rs1800796-(G)-rs1800795-(G ) haplotype was independently associated with a reduced chance of SVR (RR=0.78; 95% C.I.", {"entities": []}], [": 0.62\u20131.0; p=0.0489) after adjustment for potential confounding factors.", {"entities": []}], ["Our findings further illustrate the complexity of IL-6 genetic regulation and the potential importance of haplotypes on IL-6 expression.", {"entities": []}], ["Our findings provide additional support for the potential importance of genetic variation in the IL-6 gene and the response to HCV therapy.", {"entities": []}], ["CC chemokines constitute a novel class of cytokines that attract and activate monocytes and lymphocytes, as well as basophil and eosinophil leukocytes, with distinct target cell profiles, and are believed to be involved in the regulation of different types of inflammation.", {"entities": []}], ["The action of the recently identified monocyte chemotactic protein 3 (MCP- 3) on human basophil and eosinophil function was studied and compared with that of other CC chemokines.", {"entities": []}], ["In basophils, MCP-3, MCP-1, RANTES, and macrophage inflammatory protein (MIP)-1 alpha all induced cytosolic- free calcium concentration ([Ca2+]i) changes and, with different efficacies, chemotaxis (RANTES = MCP-3 >> MCP-1 > MIP-1 alpha), histamine release (MCP-1 = MCP-3 >> RANTES > MIP-1 alpha), and leukotriene C4 formation, after IL-3 pretreatment (MCP-1 = MCP-3 >> RANTES > MIP-1 alpha).", {"entities": [[73, 76, "GENE"], [224, 227, "GENE"], [283, 286, "GENE"], [378, 381, "GENE"]]}], ["Thus, MCP-3 was as effective as MCP-1 as an inducer of mediator release, and as effective as RANTES as a stimulus of basophil migration.", {"entities": []}], ["In contrast to MCP-1, MCP-3 was also a stimulus for eosinophils, and induced [Ca2+]i changes and chemotaxis as effectively as RANTES, which is the most potent chemotactic cytokine for these cells.", {"entities": []}], ["Desensitization of the transient changes in [Ca2+]i was used to assess receptor usage.", {"entities": []}], ["In basophils, stimulation with MCP-3 prevented responsiveness to MCP-1 and RANTES, but not to MIP-1 alpha.", {"entities": []}], ["No single CC chemokine (except for MCP-3 itself) affected the response to MCP-3, however, which was prevented only when the cells were prestimulated with both MCP-1 and RANTES.", {"entities": []}], ["In eosinophils, by contrast, cross-desensitization between RANTES and MCP-3 was obtained.", {"entities": []}], ["RANTES and to a lesser extent MCP-3 also desensitized eosinophils toward MIP-1 alpha.", {"entities": []}], ["The desensitization data suggest the existence of three chemokine receptors: (a) a MCP-1 receptor expressed on basophils but not eosinophils that is activated by MCP-1 and MCP-3; (b) a RANTES receptor in basophils and eosinophils that is activated by RANTES and MCP-3; and (c) a MIP-1 alpha receptor that is activated by MIP-1 alpha, RANTES and, more weakly, by MCP-3.", {"entities": []}], ["This study shows that MCP-3 combines the properties of RANTES, a powerful chemoattractant, and MCP-1, a highly effective stimulus of mediator release, and thus has a particularly broad range of activities toward both human basophil and eosinophil leukocytes.", {"entities": []}], ["The population of Han Chinese is \u223c1.226 billion people.", {"entities": []}], ["Genetic heterogeneity between northern Han Chinese (N-Han) and southern Han Chinese (S-Han) has been demonstrated by recent genome-wide studies.", {"entities": []}], ["As an initial step toward health disparities and personalized medicine in Chinese population, this study developed a set of ancestry informative markers (AIM) for Han Chinese population.", {"entities": []}], ["Nasal obstruction is a common problem in continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea and limits treatment compliance.", {"entities": []}], ["The purpose of this study is to model the effects of nasal obstruction on airflow parameters under CPAP using computational fluid dynamics (CFD), and to clarify quantitatively the relation between airflow velocity and pressure loss coefficient in subjects with and without nasal obstruction.", {"entities": [[140, 143, "GENE"]]}], ["We conducted an observational cross-sectional study of 16 Japanese adult subjects, of whom 9 had nasal obstruction and 7 did not (control group).", {"entities": []}], ["Three-dimensional reconstructed models of the nasal cavity and nasopharynx with a CPAP mask fitted to the nostrils were created from each subject\u2019s CT scans.", {"entities": []}], ["The digital models were meshed with tetrahedral cells and stereolithography formats were created.", {"entities": []}], ["CPAP airflow simulations were conducted using CFD software.", {"entities": [[46, 49, "GENE"]]}], ["Airflow streamlines and velocity contours in the nasal cavities and nasopharynx were compared between groups.", {"entities": []}], ["Simulation models were confirmed to agree with actual measurements of nasal flow rate and with pressure and flow rate in the CPAP machine.", {"entities": []}], ["Under 10 cmH 2 O CPAP, average maximum airflow velocity during inspiration was 17.6 \u00b1 5.6 m/s in the nasal obstruction group but only 11.8 \u00b1 1.4 m/s in the control group.", {"entities": []}], ["The average pressure drop in the nasopharynx relative to inlet static pressure was 2.44 \u00b1 1.41 cmH 2 O in the nasal obstruction group but only 1.17 \u00b1 0.29 cmH 2 O in the control group.", {"entities": []}], ["The nasal obstruction and control groups were clearly separated by a velocity threshold of 13.5 m/s, and pressure loss coefficient threshold of approximately 10.0.", {"entities": []}], ["In contrast, there was no significant difference in expiratory pressure in the nasopharynx between the groups.", {"entities": []}], ["This is the first CFD analysis of the effect of nasal obstruction on CPAP treatment.", {"entities": [[18, 21, "GENE"]]}], ["A strong correlation between the inspiratory pressure loss coefficient and maximum airflow velocity was found.", {"entities": []}], ["Non-acetylated salicylates have been recommended for use as alternatives to nonsteroidal anti-inflammatory drugs (NSAIDs) in aspirin and/or tartrazine-sensitive patients.", {"entities": []}], ["We experienced a case of an aspirin-sensitive asthmatic patient who developed a broncho-obstructive reaction after taking 100 mg of sodium salicylate.", {"entities": []}], ["The result of this study suggests that sodium salicylate may cross-react with aspirin in aspirin-and tartrazine-sensitive patients.", {"entities": []}], ["To assess the importance of inflammation in chronic obstructive pulmonary disease (COPD) by measuring airway and systemic inflammatory biomarkers in Japanese patients with the disease and relevant control groups.", {"entities": [[44, 81, "DISEASE"]]}], ["This was the first study of its type in Japanese COPD patients.", {"entities": []}], ["It was a non-treatment study in which 100 participants were enrolled into one of three groups: nonsmoking controls, current or ex-smoking controls, and COPD patients.", {"entities": []}], ["All participants underwent standard lung function assessments and provided sputum and blood samples from which the numbers of inflammatory cells and concentrations of biomarkers were measured, using standard procedures.", {"entities": []}], ["The overall trends observed in levels of inflammatory cells and biomarkers in sputum and blood in COPD were consistent with previous reports in Western studies.", {"entities": []}], ["Increasing levels of neutrophils, interleukin 8 (IL-8), surfactant protein D (SP-D), and Krebs von den Lungen 6 (KL-6) in sputum and clara cell 16 (CC-16), high-sensitivity C-reactive protein (hs-CRP), and KL-6 in serum and plasma fibrinogen were seen in the Japanese COPD patients compared with the non-COPD control participants.", {"entities": []}], ["In sputum, significant correlations were seen between total cell count and matrix metalloproteinase 9 (MMP-9; P <0.001), neutrophils and MMP-9 ( P <0.001), macrophages and KL-6 ( P <0.01), total cell count and IL-8 ( P <0.05), neutrophils and IL-8 ( P <0.05), and macrophages and MMP-9 ( P <0.05).", {"entities": []}], ["Significant correlations were also observed between some inflammatory cells in sputum and biomarkers in serum, with the most significant between serum CC-16 and both total cell count ( P <0.005) and neutrophils ( P <0.005) in sputum.", {"entities": []}], ["These results provide evidence for the first time that COPD in Japanese patients is a multicomponent disease, involving both airway and systemic inflammation, in addition to airway obstruction.", {"entities": []}], ["Therefore, intervention with anti-inflammatory therapy may provide additional benefit in disease management of COPD in Japan.", {"entities": []}], ["Silica inhalation can induce chronic lung inflammation and fibrosis.", {"entities": []}], ["Upon silica stimulation, activated macrophages trigger the T-lymphocyte which can differentiate into many different types of Th cells, including the recently discovered Th17 cells.", {"entities": []}], ["IL-17A, the typical Th17 cytokine, is reported in some inflammatory diseases.", {"entities": []}], ["However, the role of IL-17A in silica-induced inflammatory response is still not clear.", {"entities": []}], ["The regulatory mechanism of silica-induced Th17 response also needs to be investigated.", {"entities": []}], ["So we established a mice primary cell coculture system (macrophage and lymphocyte) to investigate the role of IL-17A in silica-induced inflammatory response in vitro , by using anti-IL-17A mAb and IL-1Ra.", {"entities": []}], ["Both anti-IL-17A mAb and IL-1Ra decreased the level of IL-17A and increased the function of Treg cells.", {"entities": []}], ["The Th1 response was suppressed and the Th2 response was promoted by the addition of anti-IL-17A mAb or IL-1Ra.", {"entities": []}], ["IL-1Ra treatment decreased the level of IL-6, whereas the levels of IL-23 and ROR- \u03b3 t were increased.", {"entities": []}], ["Our study demonstrated that IL-17A reduction altered the pattern of silica-induced Th responses by boosting the function of Treg cells in vitro .", {"entities": []}], ["Blocking the function of IL-1 signal pathway could suppress the level of IL-17A, which played the major role in modulating silica-induced Th responses in vitro .", {"entities": []}], ["Understanding social disparities in obesity are presently an essential element in establishing public health priorities.", {"entities": [[36, 43, "DISEASE"]]}], ["However, the association between socioeconomic status (SES) and obesity has not been assessed in rural Northwest China.", {"entities": [[64, 71, "DISEASE"]]}], ["This study aims to explore the effect of SES on overweight/obesity and abdominal obesity by gender and age in rural Northwest China.", {"entities": [[59, 66, "DISEASE"], [81, 88, "DISEASE"]]}], ["A total of 3030 participants between the ages of 18 to 80\u00a0years from rural Hanzhong, Shaanxi province, Northwest China were enrolled in our study using a two-level stratified random cluster sampling technique.", {"entities": []}], ["Adjusted odds ratio (AOR) were used to assess the relationship between socioeconomic status and obesity after controlling for confounding factors using logistic regression.", {"entities": [[96, 103, "DISEASE"]]}], ["Our results indicated that the prevalence of abdominal obesity (38.8%) was the highest in rural Northwest China when compared with overweight (27.8%) and obesity (5.7%).", {"entities": [[55, 62, "DISEASE"], [154, 161, "DISEASE"]]}], ["When adjusting for possible risk factors, there were significant gender disparities in SES-obesity association.", {"entities": [[91, 98, "DISEASE"]]}], ["In men, the likelihoods of overweight/obesity and abdominal obesity were higher in the high SES groups when compared to the low SES groups.", {"entities": [[38, 45, "DISEASE"], [60, 67, "DISEASE"]]}], ["However, women with a high level of education were less likely to have overweight/obesity (AOR:0.78, 95% CI: 0.62, 0.98) than their counterparts with a low level of education.", {"entities": [[82, 89, "DISEASE"]]}], ["After the inclusion of multiple lifestyle factors, we still observed a strong positive association between age and obesity in the population.", {"entities": [[115, 122, "DISEASE"]]}], ["Both gender and age differences in SES-obesity association were clearly observed in our study.", {"entities": [[39, 46, "DISEASE"]]}], ["Therefore, interventional measures should be employed in rural Northwest China to reduce the obesity epidemic that specifically takes into account gender and age differences.", {"entities": [[93, 100, "DISEASE"]]}], ["The vast majority of deaths in the Kilifi study area are not recorded through official systems of vital registration.", {"entities": []}], ["As a result, few data are available regarding causes of death in this population.", {"entities": []}], ["To describe the causes of death (CODs) among residents of all ages within the Kilifi Health and Demographic Surveillance System (KHDSS) on the coast of Kenya.", {"entities": []}], ["Verbal autopsies (VAs) were conducted using the 2007 World Health Organization (WHO) standard VA questionnaires, and VA data further transformed to align with the 2012 WHO VA instrument.", {"entities": []}], ["CODs were then determined using the InterVA-4 computer-based probabilistic model.", {"entities": []}], ["Five thousand one hundred and eighty seven deaths were recorded between January 2008 and December 2011.", {"entities": []}], ["VA interviews were completed for 4,460 (86%) deaths.", {"entities": []}], ["Neonatal pneumonia and birth asphyxia were the main CODs in neonates; pneumonia and malaria were the main CODs among infants and children aged 1\u20134, respectively, while HIV/AIDS was the main COD for adult women of reproductive age.", {"entities": [[9, 18, "DISEASE"], [70, 79, "DISEASE"], [84, 91, "DISEASE"]]}], ["Road traffic accidents were more commonly observed among men than women.", {"entities": []}], ["Stroke and neoplasms were common CODs among the elderly over the age of 65.", {"entities": []}], ["We have established the main CODs among people of all ages within the area served by the KHDSS on the coast of Kenya using the 2007 WHO VA questionnaire coded using InterVA-4.", {"entities": []}], ["We hope that our data will allow local health planners to estimate the burden of various diseases and to allocate their limited resources more appropriately.", {"entities": []}], ["At a time of increasing disconnectedness from nature, scientific interest in the potential health benefits of nature contact has grown.", {"entities": []}], ["Research in recent decades has yielded substantial evidence, but large gaps remain in our understanding.", {"entities": []}], ["We propose a research agenda on nature contact and health, identifying principal domains of research and key questions that, if answered, would provide the basis for evidence-based public health interventions.", {"entities": []}], ["We identify research questions in seven domains: a ) mechanistic biomedical studies; b ) exposure science; c ) epidemiology of health benefits; d ) diversity and equity considerations; e ) technological nature; f ) economic and policy studies; and g ) implementation science.", {"entities": []}], ["Nature contact may offer a range of human health benefits.", {"entities": []}], ["Although much evidence is already available, much remains unknown.", {"entities": []}], ["A robust research effort, guided by a focus on key unanswered questions, has the potential to yield high-impact, consequential public health insights.", {"entities": []}], ["https://doi.org/10.1289/EHP1663", {"entities": []}], ["Monoclonal antibodies are one of the fastest growing classes of pharmaceutical products, however, their potential is limited by the high cost of development and manufacturing.", {"entities": []}], ["Here we present a safe and cost-effective platform for in vivo expression of therapeutic antibodies using nucleoside-modified mRNA.", {"entities": []}], ["To demonstrate feasibility and protective efficacy, nucleoside-modified mRNAs encoding the light and heavy chains of the broadly neutralizing anti-HIV-1 antibody VRC01 are generated and encapsulated into lipid nanoparticles.", {"entities": []}], ["Systemic administration of 1.4\u2009mg\u2009kg Monoclonal antibodies are highly effective therapeutics that can be delivered as proteins or encoded DNA or mRNA.", {"entities": []}], ["Here the authors develop lipid nanoparticle-formulated nucleoside-modified mRNA encoding an HIV-1 neutralizing antibody and see sustained and protective antibody levels in treated mice.", {"entities": []}], ["Epidemiologic studies suggest a temporal trend of earlier onset and longer duration of puberty, raising concerns regarding the potential impact of environmental factors on pubertal development.", {"entities": []}], ["Lead exposure has been associated with delayed pubertal onset in girls; however, epidemiologic data in boys are limited.", {"entities": []}], ["We used multivariable logistic regression models to explore the cross-sectional association of blood lead levels with growth and pubertal onset based on physician-assessed testicular volume (TV) and pubertal staging in 489 boys 8\u20139 years of age from Chapaevsk, Russia.", {"entities": []}], ["We used multivariable linear regression models to assess associations of blood lead levels with somatic growth at the study entry visit.", {"entities": []}], ["The median (25th\u201375th percentile) blood lead level was 3 \u03bcg/dL (2\u20135 \u03bcg/dL).", {"entities": []}], ["Height, weight, body mass index, birth weight, and gestational age were predictive of the onset of puberty as assessed either by TV (> 3 mL), genitalia stage (G2), or both.", {"entities": []}], ["Blood lead level was inversely associated with height ( p < 0.001) and weight ( p = 0.06) after adjustment for birth weight, gestational age, and age at examination.", {"entities": []}], ["In multivariable adjusted analyses, boys with blood lead levels \u2265 5 \u03bcg/dL had 43% reduced odds of having entered G2 compared with those with lower levels (odds ratio = 0.57; 95% confidence interval, 0.34\u20130.95, p = 0.03).", {"entities": []}], ["Relatively low environmental blood lead levels were associated with decreased growth and differences in pubertal onset in periadolescent Russian boys.", {"entities": []}], ["Future analyses of this prospective cohort will address pubertal onset and progression in relation to lead and other environmental chemicals.", {"entities": []}], ["Celery ( Apium graveolens ) represents a relevant allergen source that can elicit severe reactions in the adult population.", {"entities": []}], ["To investigate the sensitization prevalence and cross-reactivity of Api g 2 from celery stalks in a Mediterranean population and in a mouse model.", {"entities": []}], ["786 non-randomized subjects from Italy were screened for IgE reactivity to rApi g 2, rArt v 3 (mugwort pollen LTP) and nPru p 3 (peach LTP) using an allergen microarray.", {"entities": []}], ["Clinical data of 32 selected patients with reactivity to LTP under investigation were evaluated.", {"entities": []}], ["Specific IgE titers and cross-inhibitions were performed in ELISA and allergen microarray.", {"entities": []}], ["Balb/c mice were immunized with purified LTPs; IgG titers were determined in ELISA and mediator release was examined using RBL-2H3 cells.", {"entities": []}], ["Simulated endolysosomal digestion was performed using microsomes obtained from human DCs.", {"entities": []}], ["IgE testing showed a sensitization prevalence of 25.6% to Api g 2, 18.6% to Art v 3, and 28.6% to Pru p 3 and frequent co-sensitization and correlating IgE-reactivity was observed.", {"entities": []}], ["10/32 patients suffering from LTP-related allergy reported symptoms upon consumption of celery stalks which mainly presented as OAS.", {"entities": []}], ["Considerable IgE cross-reactivity was observed between Api g 2, Art v 3, and Pru p 3 with varying inhibition degrees of individual patients' sera.", {"entities": []}], ["Simulating LTP mono-sensitization in a mouse model showed development of more congruent antibody specificities between Api g 2 and Art v 3.", {"entities": []}], ["Notably, biologically relevant murine IgE cross-reactivity was restricted to the latter and diverse from Pru p 3 epitopes.", {"entities": []}], ["Endolysosomal processing of LTP showed generation of similar clusters, which presumably represent T-cell peptides.", {"entities": []}], ["Api g 2 represents a relevant celery stalk allergen in the LTP-sensitized population.", {"entities": []}], ["The molecule displays common B cell epitopes and endolysosomal peptides that encompass T cell epitopes with pollen and plant-food derived LTP.", {"entities": []}], ["The aim of the present study was to screen the differentially expressed genes (DEGs) associated with familial combined hyperlipidemia (FCHL) and examine the changing patterns.", {"entities": [[101, 133, "DISEASE"]]}], ["The transcription profile of GSE18965 was obtained from the NCBI Gene Expression Omnibus database, including 12 FCHL samples and 12 control specimens.", {"entities": []}], ["The DEGs were identified using a linear models for microarray data package in the R programming language.", {"entities": []}], ["Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was also performed.", {"entities": []}], ["Protein-protein interaction (PPI) networks of the DEGs were constructed using the EnrichNet online tool.", {"entities": []}], ["In addition, cluster analysis of the genes in networks was performed using ClusterONE.", {"entities": []}], ["A total of 879 DEGs were screened, including 394 upregulated and 485 downregulated genes.", {"entities": []}], ["Enrichment analysis identified four important KEGG pathways associated with FCHL: One carbon pool by folate, \u03b1-linolenic acid metabolism, asthma and the glycosphingolipid biosynthesis-globo series.", {"entities": [[138, 144, "DISEASE"]]}], ["GO annotation identified 12 enriched biological processes, including one associated with hematopoiesis and four associated with bone cell differentiation.", {"entities": []}], ["This identification was in accordance with clinical data and experiments into hyperlipidemia and bone lesions.", {"entities": []}], ["Based on PPI networks, these DEGs had a close association with immune responses, hormone responses and cytokine-cytokine receptors.", {"entities": []}], ["In conclusion, these DEGs may be used as specific therapeutic molecular targets in the treatment of FCHL.", {"entities": []}], ["The present findings may provide the basis for understanding the pathogenesis of FCHL in future studies.", {"entities": []}], ["However, further experiments are required to confirm these results.", {"entities": []}], ["Human Rhinovirus (HRV) is associated with acute exacerbations of chronic respiratory disease.", {"entities": []}], ["In healthy individuals, innate viral recognition pathways trigger release of molecules with direct anti-viral activities and pro-inflammatory mediators which recruit immune cells to support viral clearance.", {"entities": []}], ["Interleukin-1alpha (IL-1\u03b1), interleukin-1beta (IL-1\u03b2) and interleukin-18 (IL-18) have critical roles in the establishment of neutrophilic inflammation, which is commonly seen in airways viral infection and thought to be detrimental in respiratory disease.", {"entities": []}], ["We therefore investigated the roles of these molecules in HRV infection of primary human epithelial cells.", {"entities": []}], ["We found that all three cytokines were released from infected epithelia.", {"entities": []}], ["Release of these cytokines was not dependent on cell death, and only IL-1\u03b2 and IL-18 release was dependent on caspase-1 catalytic activity.", {"entities": []}], ["Blockade of IL-1 but not IL-18 signaling inhibited up-regulation of pro-inflammatory mediators and neutrophil chemoattractants but had no effect on virus induced production of interferons and interferon-inducible genes, measured at both mRNA and protein level.", {"entities": []}], ["Similar level of virus mRNA was detected with and without IL-1RI blockade.", {"entities": []}], ["Hence IL-1 signaling, potentially involving both IL-1\u03b2 and IL-1\u03b1, downstream of viral recognition plays a key role in induction of pro-inflammatory signals and potentially in recruitment and activation of immune cells in response to viral infection instigated by the epithelial cells, whilst not participating in direct anti-viral responses.", {"entities": []}], ["Immunological homeostasis in the respiratory tract is thought to require balanced interactions between networks of dendritic cell (DC) subsets in lung microenvironments in order to regulate tolerance or immunity to inhaled antigens and pathogens.", {"entities": []}], ["Influenza A virus (IAV) poses a serious threat of long-term disruption to this balance through its potent pro-inflammatory activities.", {"entities": []}], ["In this study, we have used a BALB/c mouse model of A/PR8/34 H1N1 Influenza Type A Virus infection to examine the effects of IAV on respiratory tissue DC subsets during the recovery phase following clearance of the virus.", {"entities": []}], ["In adult mice, we found differences in the kinetics and activation states of DC residing in the airway mucosa (AMDC) compared to those in the parenchymal lung (PLDC) compartments.", {"entities": []}], ["A significant depletion in the percentage of AMDC was observed at day 4 post-infection that was associated with a change in steady-state CD11b", {"entities": []}], ["Approximately 60% to 87% of patients with heart failure (HF) report sexual problems, and numbers as low as 31% of HF patients younger than 70 have normal sexual function.", {"entities": []}], ["When compared with healthy elders, the amount of perceived sexual dysfunction might be similar (around 56%), but patients with HF are reporting more erectile dysfunction (ED) and also perceive that their HF symptoms (20%) or HF medication (10%) is the cause for their problems.", {"entities": [[59, 77, "DISEASE"]]}], ["The prevalence of ED is highly prevalent in men with cardiac disease and reported in up to 81% of cardiac patients, compared with 50% in the general older population.", {"entities": []}], ["In total 25\u201376% of women with HF report sexual problems or concerns.", {"entities": []}], ["The physical effort related to sexual activity in cardiac patients can be compared to mild to moderate physical activity.", {"entities": []}], ["The related energy expenditure of sexual activity falls in the range of three to five metabolic units (METs), which can be compared to the energy needed to climb three flights of stairs, general housework, or gardening.", {"entities": []}], ["Information about sexual activity is often overlooked by health care professionals treating HF patients.", {"entities": []}], ["Advice and counselling about this subject are needed to decrease worries of patients and partners, avoid skipping medication because of fear for side effects, or prevent inappropriate use of potency enhancing drugs or herbs.", {"entities": []}], ["Patients with rheumatoid arthritis (RA), including those treated with biologics, are at increased risk of some vaccine-preventable infections.", {"entities": [[14, 34, "DISEASE"], [25, 34, "DISEASE"]]}], ["We evaluated the antibody response to standard 23-valent pneumococcal polysaccharide vaccine (PPSV23) and the 2011\u20132012 trivalent seasonal influenza vaccine in adults with RA receiving subcutaneous (SC) abatacept and background disease-modifying anti-rheumatic drugs (DMARDs).", {"entities": [[139, 148, "DISEASE"]]}], ["Two multicenter, open-label sub-studies enrolled patients from the ACQUIRE (pneumococcal and influenza) and ATTUNE (pneumococcal) studies at any point during their SC abatacept treatment cycle following completion of \u22653\u00a0months\u2019 SC abatacept.", {"entities": [[93, 102, "DISEASE"]]}], ["All patients received fixed-dose abatacept 125\u00a0mg/week with background DMARDs.", {"entities": []}], ["A pre-vaccination blood sample was taken, and after 28\u2009\u00b1\u20093\u00a0days a final post-vaccination sample was collected.", {"entities": []}], ["The primary endpoint was the proportion of patients achieving an immunologic response to the vaccine at Day 28 among patients without a protective antibody level to the vaccine antigens at baseline (pneumococcal: defined as \u22652-fold increase in post-vaccination titers to \u22653 of 5 antigens and protective antibody level of \u22651.6\u00a0\u03bcg/mL to \u22653 of 5 antigens; influenza: defined as \u22654-fold increase in post-vaccination titers to \u22652 of 3 antigens and protective antibody level of \u22651:40 to \u22652 of 3 antigens).", {"entities": [[353, 362, "DISEASE"]]}], ["Safety and tolerability were evaluated throughout the sub-studies.", {"entities": []}], ["Pre- and post-vaccination titers were available for 113/125 and 186/191 enrolled patients receiving the PPSV23 and influenza vaccine, respectively.", {"entities": [[115, 124, "DISEASE"]]}], ["Among vaccinated patients, 47/113 pneumococcal and 121/186 influenza patients were without protective antibody levels at baseline.", {"entities": [[59, 68, "DISEASE"]]}], ["Among patients with available data, 73.9\u00a0% (34/46) and 61.3\u00a0% (73/119) met the primary endpoint and achieved an immunologic response to PPSV23 or influenza vaccine, respectively.", {"entities": [[146, 155, "DISEASE"]]}], ["In patients with pre- and post-vaccination data available, 83.9\u00a0% in the pneumococcal study demonstrated protective antibody levels with PPSV23 (titer \u22651.6\u00a0\u03bcg/mL to \u22653 of 5 antigens), and 81.2\u00a0% in the influenza study achieved protective antibody levels (titer \u22651:40 to \u22652 of 3 antigens) at Day 28 post-vaccination.", {"entities": [[202, 211, "DISEASE"]]}], ["Vaccines were well tolerated with SC abatacept with background DMARDs.", {"entities": []}], ["In these sub-studies, patients with RA receiving SC abatacept and background DMARDs were able to mount an appropriate immune response to pneumococcal and influenza vaccines.", {"entities": [[154, 163, "DISEASE"]]}], ["NCT00559585 (registered 15 November 2007) and NCT00663702 (registered 18 April 2008).", {"entities": []}], ["The online version of this article (doi:10.1186/s12891-016-1082-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background: The role of the Nlrp3 inflammasome in nonallergic airway hyperresponsiveness (AHR) has not previously been reported.", {"entities": [[28, 33, "GENE"], [90, 93, "GENE"]]}], ["Recent evidence supports both interleukin (IL) 1\u03b2 and short fragments of hyaluronan (HA) as contributors to the biological response to inhaled ozone.", {"entities": []}], ["Objective: Because extracellular secretion of IL-1\u03b2 requires activation of the inflammasome, we investigated the role of the inflammasome proteins ASC, caspase1, and Nlrp3 in the biological response to ozone and HA.", {"entities": [[166, 171, "GENE"]]}], ["Methods: C57BL/6J wild-type mice and mice deficient in ASC, caspase1, or Nlrp3 were exposed to ozone (1 ppm for 3 hr) or HA followed by analysis of airway resistance, cellular inflammation, and total protein and cytokines in bronchoalveolar lavage fluid (BALF).", {"entities": [[73, 78, "GENE"], [114, 116, "GENE"]]}], ["Transcription levels of IL-1 \u03b2 and IL-18 were determined in two populations of lung macrophages.", {"entities": []}], ["In addition, we examined levels of cleaved caspase1 and cleaved IL-1\u03b2 as markers of inflammasome activation in isolated alveolar macrophages harvested from BALF from HA-treated mice.", {"entities": []}], ["Results: We observed that genes of the Nlrp3 inflammasome were required for development of AHR following exposure to either ozone or HA fragments.", {"entities": [[39, 44, "GENE"], [91, 94, "GENE"]]}], ["These genes are partially required for the cellular inflammatory response to ozone.", {"entities": []}], ["The expression of IL-1 \u03b2 mRNA in alveolar macrophages was up-regulated after either ozone or HA challenge and was not dependent on the Nlrp3 inflammasome.", {"entities": [[135, 140, "GENE"]]}], ["However, soluble levels of IL-1\u03b2 protein were dependent on the inflammasome after challenge with either ozone or HA.", {"entities": []}], ["HA challenge resulted in cleavage of macrophage-derived caspase1 and IL-1\u03b2, suggesting a role for alveolar macrophages in Nlrp3-dependent AHR.", {"entities": [[138, 141, "GENE"]]}], ["Conclusions: The Nlrp3 inflammasome is required for the development of ozone-induced reactive airways disease.", {"entities": [[17, 22, "GENE"]]}], ["Patients with chronic obstructive pulmonary disease (COPD) often have organ dysfunction and resulting poor quality of life; however, in China little information is available regarding factors that affect their health.", {"entities": [[14, 51, "DISEASE"]]}], ["Here, the relationship between risk factors, activities and psychological disorders and health of patients with COPD in rural areas of Xuzhou, China was assessed.", {"entities": []}], ["A cross-sectional study of 7597 COPD patients randomly selected by place of residence from 24,641 COPD patients who had been identified by screening of the 1.10 million health records of all residents of the target area was carried out to evaluate the relationships between risk factors, activities, psychological disorders and the ADO index (age, dyspnea, and airflow obstruction).", {"entities": []}], ["The participants were assessed by spirometry and by administering a newly designed face-to-face questionnaire, which included items on general factors, risk factors, activities and psychological disorders.", {"entities": []}], ["Correlations between the ADO index and the items addressed by the questionnaire were calculated.", {"entities": []}], ["The mean score of the ADO index was 3.7\u2009\u00b1\u20091.6.", {"entities": []}], ["The ADO indices of current smokers, ex-smokers, and non-smokers were 3.9\u2009\u00b1\u20092.1, 3.7\u2009\u00b1\u20091.9, and 3.2\u2009\u00b1\u20091.5, respectively ( P \u2009<\u20090.001).", {"entities": []}], ["The ADO indices of cooks and non-cooks were 4.0\u2009\u00b1\u20092.2 and 3.5\u2009\u00b1\u20091.7, respectively ( P \u2009<\u20090.001).", {"entities": []}], ["The correlation coefficient between self-assessment of health status and ADO index was 0.976 ( P \u2009<\u20090.001).", {"entities": []}], ["Only 5.7% of patients reported no limitation of their daily living activities.", {"entities": []}], ["The correlation coefficient between daily living activities and ADO index was 0.981 ( P \u2009<\u20090.001).", {"entities": []}], ["Only 5.5% of patients reported no limitation of social activities.", {"entities": []}], ["The correlation coefficient between social activities and ADO index was 0.989 ( P \u2009<\u20090.001), between the assessed anxiety score and ADO index 0.972 ( P \u2009<\u20090.001), and between the assessed depression score and ADO index 0.989 ( P \u2009<\u20090.001).", {"entities": []}], ["COPD severity was significantly correlated with behavior (especially regarding smoking and cooking with biofuel in confined spaces), physical strength, daily living activities, social activities, anxiety and depression.", {"entities": []}], ["Comprehensive approaches are required for the prevention and treatment of COPD.", {"entities": []}], ["Objectives To develop a predictive model for pre-eclampsia based on clinical risk factors for nulliparous women and to identify a subgroup at increased risk, in whom specialist referral might be indicated.", {"entities": [[49, 58, "DISEASE"], [45, 58, "DISEASE"]]}], ["Design Prospective multicentre cohort.", {"entities": []}], ["Setting Five centres in Auckland, New Zealand; Adelaide, Australia; Manchester and London, United Kingdom; and Cork, Republic of Ireland.", {"entities": []}], ["Participants 3572 \u201chealthy\u201d nulliparous women with a singleton pregnancy from a large international study; data on pregnancy outcome were available for 3529 (99%).", {"entities": []}], ["Main outcome measure Pre-eclampsia defined as \u2265140 mm Hg or diastolic blood pressure \u226590 mm Hg, or both, on at least two occasions four hours apart after 20 weeks\u2019 gestation but before the onset of labour, or postpartum, with either proteinuria or any multisystem complication.", {"entities": [[25, 34, "DISEASE"], [233, 244, "DISEASE"], [21, 34, "DISEASE"]]}], ["Preterm pre-eclampsia was defined as women with pre-eclampsia delivered before 37 Results Of the 3529 women, 186 (5.3%) developed pre-eclampsia, including 47 (1.3%) with preterm pre-eclampsia.", {"entities": [[12, 21, "DISEASE"], [52, 61, "DISEASE"], [134, 143, "DISEASE"], [182, 191, "DISEASE"], [8, 21, "DISEASE"], [48, 61, "DISEASE"], [130, 143, "DISEASE"], [178, 191, "DISEASE"]]}], ["Clinical risk factors at 14-16 weeks\u2019 gestation were age, mean arterial blood pressure, body mass index (BMI), family history of pre-eclampsia, family history of coronary heart disease, maternal birth weight, and vaginal bleeding for at least five days.", {"entities": [[133, 142, "DISEASE"], [171, 184, "DISEASE"], [162, 184, "DISEASE"], [129, 142, "DISEASE"]]}], ["Factors associated with reduced risk were a previous single miscarriage with the same partner, taking at least 12 months to conceive, high intake of fruit, cigarette smoking, and alcohol use in the first trimester.", {"entities": []}], ["The area under the receiver operating characteristics curve (AUC), under internal validation, was 0.71.", {"entities": []}], ["Addition of uterine artery Doppler indices did not improve performance (internal validation AUC 0.71).", {"entities": []}], ["A framework for specialist referral was developed based on a probability of pre-eclampsia generated by the model of at least 15% or an abnormal uterine artery Doppler waveform in a subset of women with single risk factors.", {"entities": [[80, 89, "DISEASE"], [76, 89, "DISEASE"]]}], ["Nine per cent of nulliparous women would be referred for a specialist opinion, of whom 21% would develop pre-eclampsia.", {"entities": [[109, 118, "DISEASE"], [105, 118, "DISEASE"]]}], ["The relative risk for developing pre-eclampsia and preterm pre-eclampsia in women referred to a specialist compared with standard care was 5.5 and 12.2, respectively.", {"entities": [[37, 46, "DISEASE"], [63, 72, "DISEASE"], [33, 46, "DISEASE"], [59, 72, "DISEASE"]]}], ["Conclusions The ability to predict pre-eclampsia in healthy nulliparous women using clinical phenotype is modest and requires external validation in other populations.", {"entities": [[39, 48, "DISEASE"], [35, 48, "DISEASE"]]}], ["If validated, it could provide a personalised clinical risk profile for nulliparous women to which biomarkers could be added.", {"entities": []}], ["Trial registration ACTRN12607000551493.", {"entities": []}], ["The isolation of circulating tumor cells (CTCs) from the blood of patients afflicted with solid malignant tumors becomes increasingly important as it may serve as a \u2018liquid biopsy\u2019 with the potential of monitoring the course of the cancer disease and its response to cancer therapy, with subsequent molecular characterization.", {"entities": [[232, 238, "DISEASE"], [267, 273, "DISEASE"]]}], ["For this purpose, we functionalized a structured medical Seldinger guidewire (FSMW), normally used to obtain safe access to blood vessels and other organ cavities, with a chimeric monoclonal antibody directed to the cell surface expressed epithelial cell surface adhesion molecule (EpCAM).", {"entities": [[282, 287, "GENE"]]}], ["This medical device was optimized in vitro and its biocompatibility was tested according to the regulations for medical devices and found to be safe with no noteworthy side effects.", {"entities": []}], ["Suitability, specificity and sensitivity of the FSMW to catch and enrich CTCs in vivo from circulating peripheral blood were tested in 24 breast cancer or non-small cell lung cancer (NSCLC) patients and in 29 healthy volunteers.", {"entities": [[170, 181, "DISEASE"], [138, 151, "DISEASE"], [145, 151, "DISEASE"], [175, 181, "DISEASE"]]}], ["For this, the FSMW was inserted through a standard venous cannula into the cubital veins of healthy volunteers or cancer patients for the duration of 30 min.", {"entities": [[114, 120, "DISEASE"]]}], ["After removal, CTCs were identified by immunocytochemical staining of EpCAM and/or cytokeratins and staining of their nuclei and counted.", {"entities": [[70, 75, "GENE"]]}], ["The FSMW successfully enriched EpCAM-positive CTCs from 22 of the 24 patients, with a median of 5.5 (0\u201350) CTCs in breast cancer (n=12) and 16 (2\u2013515) CTCs in NSCLC (n=12).", {"entities": [[115, 128, "DISEASE"], [122, 128, "DISEASE"]]}], ["CTCs could be isolated across all tumor stages, including early stage cancer, in which distant metastases were not yet diagnosed, while no CTCs could be detected in healthy volunteers.", {"entities": [[70, 76, "DISEASE"]]}], ["In this observatory study, no adverse effects were noted.", {"entities": []}], ["Evidently, the FSMW has the potential to become an important device to enrich CTCs in vivo for monitoring the course of the cancer disease and the efficacy of anticancer treatment.", {"entities": [[124, 130, "DISEASE"]]}], ["Community-based participatory research (CBPR) increasingly is seen as a potent tool for studying and addressing urban environmental health problems by linking place-based work with efforts to help effect policy-level change.", {"entities": []}], ["This paper explores a successful CBPR and organizing effort, the Toxic Free Neighborhoods Campaign, in Old Town National City (OTNC), CA, United States, and its contributions to both local policy outcomes and changes in the broader policy environment, laying the groundwork for a Specific Plan to address a host of interlocking community concerns.", {"entities": []}], ["After briefly describing the broader research of which the OTNC case study was a part, we provide background on the Environmental Health Coalition (EHC) partnership and the setting in which it took place, including the problems posed for residents in this light industrial/residential neighborhood.", {"entities": []}], ["EHC\u2019s strong in-house research, and its training and active engagement of promotoras de salud (lay health promoters) as co-researchers and policy change advocates, are described.", {"entities": []}], ["We explore in particular the translation of research findings as part of a policy advocacy campaign, interweaving challenges faced and success factors and multi-level outcomes to which these efforts contributed.", {"entities": []}], ["The EHC partnership's experience then is compared with that of other policy-focused CBPR efforts in urban environmental health, emphasizing common success factors and challenges faced, as these may assist other partnerships wishing to pursue CBPR in urban communities .", {"entities": []}], ["This study investigated the feasibility of using polycaprolactone (PCL) nanofiber-based air filters to capture PM2.5 particles emitted from fused deposition modeling (FDM) 3D printing.", {"entities": []}], ["Generation and aggregation of emitted particles were investigated under different testing environments.", {"entities": []}], ["The results show that: (1) the PCL nanofiber membranes are capable of capturing particle emissions from 3D printing, (2) relative humidity plays a signification role in aggregation of the captured particles, (3) generation and aggregation of particles from 3D printing can be divided into four stages: the PM2.5 concentration and particles size increase slowly (first stage), small particles are continuously generated and their concentration increases rapidly (second stage), small particles aggregate into more large particles and the growth of concentration slows down (third stage), the PM2.5 concentration and particle aggregation sizes increase rapidly (fourth stage), and (4) the ultrafine particles denoted as \u201cbuilding unit\u201d act as the fundamentals of the aggregated particles.", {"entities": []}], ["This work has tremendous implications in providing measures for controlling the particle emissions from 3D printing, which would facilitate the extensive application of 3D printing.", {"entities": []}], ["In addition, this study provides a potential application scenario for nanofiber-based air filters other than laboratory theoretical investigation.", {"entities": []}], ["We examined the association between particulate matter [less than/equal to] 10 microm; (PM(10)) and hospital admission for heart and lung disease in ten U.S. cities.", {"entities": [[133, 145, "DISEASE"]]}], ["Our three goals were to determine whether there was an association, to estimate how the association was distributed across various lags between exposure and response, and to examine socioeconomic factors and copollutants as effect modifiers and confounders.", {"entities": []}], ["We fit a Poisson regression model in each city to allow for city-specific differences and then combined the city-specific results.", {"entities": []}], ["We examined potential confounding by a meta-regression of the city-specific results.", {"entities": []}], ["Using a model that considered simultaneously the effects of PM(10) up to lags of 5 days, we found a 2.5% [95% confidence interval (CI), 1.8-3.", {"entities": []}], ["3] increase in chronic obstructive pulmonary disease, a 1.95% (CI, 1.", {"entities": [[15, 52, "DISEASE"]]}], ["5-2.4) increase in pneumonia, and a 1.27% increase (CI, 1-1.5) in CVD for a 10 microg/m(3) increase in PM(10).", {"entities": [[19, 28, "DISEASE"]]}], ["We found similar effect estimates using the mean of PM(10) on the same and previous day, but lower estimates using only PM(10) for a single day.", {"entities": []}], ["When using only days with PM(10) < 50 mg/m(3), the effect size increased by [greater/equal to] 20% for all three outcomes.", {"entities": []}], ["These effects are not modified by poverty rates or minority status.", {"entities": []}], ["The results were stable when controlling for confounding by sulfur dioxide, ozone, and carbon monoxide.", {"entities": []}], ["These results are consistent with previous epidemiology and recent mechanistic studies in animals and humans.", {"entities": []}], ["Common genetic variants have been identified for adult height, but not much is known about the genetics of skeletal growth in early life.", {"entities": []}], ["To identify common genetic variants that influence fetal skeletal growth, we meta-analyzed 22 genome-wide association studies (Stage 1; N = 28 459).", {"entities": []}], ["We identified seven independent top single nucleotide polymorphisms (SNPs) ( P < 1 \u00d7 10 LCORL , PTCH1 , GPR126 and HMGA2 ).", {"entities": [[88, 93, "GENE"], [96, 101, "GENE"], [104, 110, "GENE"], [115, 120, "GENE"]]}], ["The three novel SNPs were followed-up in nine replication studies (Stage 2; N = 11 995), with rs905938 in DC-STAMP domain containing 2 ( DCST2 ) genome-wide significantly associated with birth length in a joint analysis (Stages 1 + 2; \u03b2 = 0.046, SE = 0.008, P = 2.46 \u00d7 10 N = 28 228; P = 5.54 \u00d7 10 N = 127 513; P = 1.45 \u00d7 10 SF3B4 , LCORL , SPAG17 , C6orf173 , PTCH1 , GDF5 , ZNFX1 , HHIP , ACAN , HLA locus and HMGA2 ).", {"entities": [[325, 330, "GENE"], [333, 338, "GENE"], [341, 347, "GENE"], [361, 366, "GENE"], [369, 373, "GENE"], [376, 381, "GENE"], [384, 388, "GENE"], [391, 395, "GENE"], [398, 401, "GENE"], [412, 417, "GENE"]]}], ["This study highlights that common variation in DCST2 influences variation in early growth and adult height.", {"entities": []}], ["The Child Health and Illness Profile (CHIP) has separate child (6\u201311\u00a0years) and adolescent (12\u201321\u00a0years) editions that measure youth\u2019s self-assessed health, illness, and well-being.", {"entities": []}], ["The purpose of this study was to revise the CHIP by combining the two editions to create the Healthy Pathways Child-Report Scales.", {"entities": []}], ["We modified the original CHIP domains of Comfort, Risk Avoidance, Satisfaction, and Resilience to reflect advances in child health conceptualization.", {"entities": []}], ["Classical test and item response theory psychometric analyses were conducted using data collected from 2,095 children (49% boys, 80% White, 17% African-American, 3% Hispanic, Age: M \u00a0=\u00a010.6, SD\u00a0=\u00a01.0) in grades 4\u20136 at 34 schools.", {"entities": []}], ["After minor revisions, 16 of the 17 scales were found to measure unidimensional self-assessed health, illness, and well-being constructs comprehensively, but with a minimal number of items.", {"entities": []}], ["Scales were unbiased by age, gender, survey modality, and geographic location.", {"entities": []}], ["Construct validity was demonstrated by the instrument\u2019s capacity to differentiate among children with and without chronic illnesses and to detect expected age and gender differences.", {"entities": []}], ["The Healthy Pathways Child-Report Scales may be used to reliably and accurately assess unidimensional aspects of health, illness, and well-being in clinical and population-based research studies involving youth in transition from childhood to adolescence.", {"entities": []}], ["Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE).", {"entities": []}], ["The US FDA has approved this molecule for chronic urticaria.", {"entities": [[50, 59, "DISEASE"]]}], ["iNKT cells are CD1d-restricted lipid-sensing innate T cells that express the transcription factor PLZF.", {"entities": []}], ["iNKT cells accumulate in adipose tissue, where they are anti-inflammatory, but the factors that contribute to their anti-inflammatory nature, and their targets in adipose tissue are unknown.", {"entities": []}], ["Here we report that adipose tissue iNKT cells have a unique transcriptional program and produce interleukin 2 (IL-2) and IL-10.", {"entities": []}], ["Unlike other iNKT cells, they lack PLZF, but express the transcription factor E4BP4, which controls their IL-10 production.", {"entities": []}], ["Adipose iNKT cells are a tissue resident population that induces an anti-inflammatory phenotype in macrophages and, through production of IL-2, controls the number, proliferation and suppressor function of adipose regulatory T (T reg ) cells.", {"entities": []}], ["Thus, adipose tissue iNKT cells are unique regulators of immune homeostasis in this tissue.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis and emphysema.", {"entities": [[62, 72, "DISEASE"]]}], ["Environmental exposure, primarily cigarette smoking, can cause high oxidative stress and is the main factor of COPD development.", {"entities": []}], ["Cigarette smoke also contributes to the imbalance of oxidant/antioxidant due to exogenous reactive oxygen species (ROS).", {"entities": []}], ["Moreover, endogenously released ROS during the inflammatory process and mitochondrial dysfunction may contribute to this disease progression.", {"entities": []}], ["ROS and reactive nitrogen species (RNS) can oxidize different biomolecules such as DNA, proteins, and lipids leading to epithelial cell injury and death.", {"entities": []}], ["Various detoxifying enzymes and antioxidant defense systems can be involved in ROS removal.", {"entities": []}], ["In this review, we summarize the main findings regarding the biological role of ROS, which may contribute to COPD development, and cytoprotective mechanisms against this disease progression.", {"entities": []}], ["Asthma and chronic obstructive pulmonary disease (COPD) exacerbations are commonly associated with respiratory syncytial virus (RSV), rhinovirus (RV) and influenza A virus (IAV) infection.", {"entities": [[154, 163, "DISEASE"], [11, 48, "DISEASE"], [0, 6, "DISEASE"]]}], ["The ensuing airway inflammation is resistant to the anti-inflammatory actions of glucocorticoids (GCs).", {"entities": []}], ["Viral infection elicits transforming growth factor-\u03b2 (TGF-\u03b2) activity, a growth factor we have previously shown to impair GC action in human airway epithelial cells through the activation of activin-like kinase 5 (ALK5), the type 1 receptor of TGF-\u03b2.", {"entities": [[122, 124, "GENE"]]}], ["In the current study, we examine the contribution of TGF-\u03b2 activity to the GC-resistance caused by viral infection.", {"entities": []}], ["We demonstrate that viral infection of human bronchial epithelial cells with RSV, RV or IAV impairs GC anti-inflammatory action.", {"entities": [[100, 102, "GENE"]]}], ["Poly(I:C), a synthetic analog of double-stranded RNA, also impairs GC activity.", {"entities": [[67, 69, "GENE"]]}], ["Both viral infection and poly(I:C) increase TGF-\u03b2 expression and activity.", {"entities": []}], ["Importantly, the GC impairment was attenuated by the selective ALK5 (TGF\u03b2RI) inhibitor, SB431542 and prevented by the therapeutic agent, tranilast, which reduced TGF-\u03b2 activity associated with viral infection.", {"entities": [[17, 19, "GENE"]]}], ["This study shows for the first time that viral-induced glucocorticoid-insensitivity is partially mediated by activation of endogenous TGF-\u03b2.", {"entities": []}], ["In this study, we investigate how respiratory viral infection interferes with the anti-inflammatory actions of glucocorticoid (GC) drugs, which are a highly effective group of anti-inflammatory agents widely used in the treatment of chronic inflammatory airway diseases, including asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[292, 329, "DISEASE"], [281, 287, "DISEASE"], [127, 129, "GENE"]]}], ["Exacerbations of both asthma (\u201casthma attacks\u201d) and COPD are often caused by viral infection, which does not respond well to GC therapy.", {"entities": [[22, 28, "DISEASE"], [31, 37, "DISEASE"], [125, 127, "GENE"]]}], ["Patients are often hospitalized placing a large burden on healthcare systems around the world, with the young, elderly, and those with a poor immune system particularly at risk.", {"entities": []}], ["We show that viral infection of airway epithelial cells causes increased expression and activity of transforming growth factor-beta (TGF-\u03b2), which interferes with GC drug action.", {"entities": [[163, 165, "GENE"]]}], ["Importantly, we have shown for the first time that inhibiting TGF-\u03b2 activity in the airways could serve as a new strategy to prevent and/or treat viral exacerbations of chronic airway diseases.", {"entities": []}], ["In clinical trials in childhood asthma, outcomes reflecting short-term disease activity are frequently measured, whilst functional status, quality of life (QoL), and long-term treatment effects are rarely assessed.", {"entities": [[32, 38, "DISEASE"]]}], ["There is also non-uniformity across studies in the selection and measurement of outcomes within these domains.", {"entities": []}], ["The development of a core outcome set has the potential to reduce heterogeneity between trials, lead to research that is more likely to have measured relevant outcomes, and enhance the value of evidence synthesis by reducing the risk of outcome reporting bias and ensuring that all trials contribute usable information.", {"entities": []}], ["Paediatricians and specialist nurses, identified through the British Paediatric Respiratory Society, completed a two-round Delphi survey.", {"entities": []}], ["Separate cohorts of parents of children younger than 18\u2009years, recruited in clinics, participated in each round.", {"entities": []}], ["Young people with asthma, aged at least 13\u2009years, participated in the first round.", {"entities": [[18, 24, "DISEASE"]]}], ["Outcomes were identified separately for preschool and school-aged children.", {"entities": []}], ["We identified outcomes considered important in routine clinical assessment by clinicians and parents/young people.", {"entities": []}], ["In round 1, 46 clinicians suggested outcomes they considered important when deciding whether to adjust a child\u2019s asthma therapy regime, and 49 parents/young people were asked, using open questions, how they judged whether their child\u2019s (for young people, their own) asthma therapy was appropriate.", {"entities": [[113, 119, "DISEASE"], [266, 272, "DISEASE"]]}], ["Two researchers independently classified responses into appropriate, corresponding outcomes.", {"entities": []}], ["In round 2, 43 clinicians and 50 parents scored, from 0\u20134, the importance of each outcome suggested by at least 10\u2009% of round 1 responders and selected the three most important.", {"entities": []}], ["The most important outcomes, when making shared decisions about regular therapies for school-aged and preschool children with asthma, were daytime and nocturnal symptoms, exacerbations, QoL, and mortality.", {"entities": [[126, 132, "DISEASE"]]}], ["Results from parents and clinicians were generally concordant, but parents placed more emphasis on long-term treatment effects.", {"entities": []}], ["We have developed a methodology to identify outcomes of most relevance to clinicians, parents, and young people when evaluating regularly administered therapies for asthma.", {"entities": [[165, 171, "DISEASE"]]}], ["Daytime and nocturnal symptoms, exacerbations, QoL, and mortality are particularly important outcomes that should be measured and reported in all clinical trials of regular therapies for children with asthma.", {"entities": [[201, 207, "DISEASE"]]}], ["Inhaled, long-acting beta-2-adrenoceptor agonists (LABA) have well-established roles in asthma and/or COPD treatment.", {"entities": [[88, 94, "DISEASE"]]}], ["Drug utilisation patterns for LABA have been described, but few studies have directly compared LABA use in different countries.", {"entities": []}], ["We aimed to compare the prevalence of LABA-containing prescriptions in five European countries using a standardised methodology.", {"entities": []}], ["A common study protocol was applied to seven European healthcare record databases (Denmark, Germany, Spain, the Netherlands (2), and the UK (2)) to calculate crude and age- and sex-standardised annual period prevalence rates (PPRs) of LABA-containing prescriptions from 2002\u20132009.", {"entities": []}], ["Annual PPRs were stratified by sex, age, and indication (asthma, COPD, asthma and COPD).", {"entities": [[57, 63, "DISEASE"], [71, 77, "DISEASE"]]}], ["From 2002\u20132009, age- and sex-standardised PPRs of patients with LABA-containing medications increased in all databases (58.2%\u2013185.1%).", {"entities": []}], ["Highest PPRs were found in men \u2265 80 years old and women 70\u201379 years old.", {"entities": []}], ["Regarding the three indications, the highest age- and sex-standardised PPRs in all databases were found in patients with \u201casthma and COPD\u201d but with large inter-country variation.", {"entities": [[122, 128, "DISEASE"]]}], ["In those with asthma or COPD, lower PPRs and smaller inter-country variations were found.", {"entities": [[14, 20, "DISEASE"]]}], ["For all three indications, PPRs for LABA-containing prescriptions increased with age.", {"entities": []}], ["Using a standardised protocol that allowed direct inter-country comparisons, we found highest rates of LABA-containing prescriptions in elderly patients and distinct differences in the increased utilisation of LABA-containing prescriptions within the study period throughout the five European countries.", {"entities": []}], ["Limited data are available regarding the use of golimumab (100\u00a0mg) every 4\u00a0weeks, with or without methotrexate (MTX).", {"entities": []}], ["The aim of this retrospective analysis was to evaluate the effectiveness and safety of golimumab following usual clinical practice in Japanese patients with rheumatoid arthritis (RA) according to the recommendations given in the Japanese package insert.", {"entities": [[157, 177, "DISEASE"], [168, 177, "DISEASE"]]}], ["Japanese RA patients with moderate-to-high disease activity, according to the 28-joint disease activity score based on C-reactive protein (DAS28-CRP) criteria, despite treatment with MTX or another biological agent, were enrolled.", {"entities": []}], ["Patients were assigned to 50 mg golimumab plus MTX or 100 mg golimumab monotherapy every 4\u00a0weeks for 24\u00a0weeks.", {"entities": []}], ["All patients were given MTX if it was not contraindicated.", {"entities": []}], ["The primary endpoint was the proportion of patients achieving clinical remission (defined as a DAS28-CRP <2.3 or a simplified disease activity index [SDAI] score <3.3) at 24\u00a0weeks.", {"entities": []}], ["Most patients received combined 50 mg golimumab plus MTX (41/43).", {"entities": []}], ["In these patients, the primary endpoint, clinical remission, was attained in 83\u00a0% of patients according to DAS28-CRP criteria ( p \u00a0<\u00a00.001) and 69\u00a0% according to SDAI criteria ( p \u00a0<\u00a00.001) by week 24.", {"entities": []}], ["Adverse events were reported in 11.6\u00a0% of patients receiving golimumab.", {"entities": []}], ["Golimumab (50\u00a0mg) plus MTX effectively reduced the signs and symptoms of RA and was generally well tolerated in patients with an inadequate response to MTX and other biological agents.", {"entities": []}], ["Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate.", {"entities": [[67, 85, "DISEASE"]]}], ["Mast cells actively participate in the pathogenesis of MS, in part because they release large amounts of various mediators that sustain the inflammatory network.", {"entities": []}], ["Masitinib, a selective oral tyrosine kinase inhibitor, effectively inhibits the survival, migration and activity of mast cells.", {"entities": []}], ["This exploratory study assessed the safety and clinical benefit of masitinib in the treatment of primary progressive MS (PPMS) or relapse-free secondary progressive MS (rfSPMS).", {"entities": []}], ["Multicenter, randomized, placebo-controlled, proof-of-concept trial.", {"entities": []}], ["Masitinib was administered orally at 3 to 6\u2009mg/kg/day for at least 12\u2009months, with dose adjustment permitted in event of insufficient response with no toxicity.", {"entities": []}], ["The primary response endpoint was the change relative to baseline in the multiple sclerosis functional composite score (MSFC).", {"entities": [[73, 91, "DISEASE"]]}], ["Clinical response was defined as an increase in MSFC score relative to baseline of\u2009>\u2009100%.", {"entities": []}], ["Thirty-five patients were randomized to receive masitinib (N\u2009=\u200927) or placebo (N\u2009=\u20098).", {"entities": []}], ["Masitinib was relatively well tolerated with the most common adverse events being asthenia, rash, nausea, edema, and diarrhea.", {"entities": [[117, 125, "DISEASE"]]}], ["The overall frequency of adverse events was similar to the placebo group, however, a higher incidence of severe and serious events was associated with masitinib treatment.", {"entities": []}], ["Masitinib appeared to have a positive effect on MS-related impairment for PPMS and rfSPMS patients, as evidenced by an improvement in MSFC scores relative to baseline, compared with a worsening MSFC score in patients receiving placebo; +103%\u2009\u00b1\u2009189 versus -60%\u2009\u00b1\u2009190 at month-12, respectively.", {"entities": []}], ["This positive, albeit non-statistically significant response was observed as early as month-3 and sustained through to month-18, with similar trends seen in the PPMS and rfSPMS subpopulations.", {"entities": []}], ["A total of 7/22 (32%) assessable masitinib patients reported clinical response following 12\u2009months of treatment (according to the modified intent-to-treat population, observed cases) compared with none in the placebo group.", {"entities": []}], ["The Expanded Disability Status Scale remained stable for both treatment groups.", {"entities": []}], ["These data suggest that masitinib is of therapeutic benefit to PPMS and rfSPMS patients and could therefore represent an innovative avenue of treatment for this disease.", {"entities": []}], ["This exploratory trial provides evidence that may support a larger placebo-controlled investigation.", {"entities": []}], ["Currently, limited information is available to clinicians regarding the long-term efficacy of omalizumab treatment for allergic asthma.", {"entities": [[119, 134, "DISEASE"], [128, 134, "DISEASE"]]}], ["In this report, we aimed to (i) systematically review the evidence regarding the long-term efficacy of omalizumab in patients with persistent uncontrolled allergic asthma, and to (ii) discuss the cost-effectiveness evidence published for omalizumab in this patient population.", {"entities": [[155, 170, "DISEASE"], [164, 170, "DISEASE"]]}], ["A comprehensive search for randomized controlled trials (RCTs; \u226552 weeks) was performed, and six studies met our final inclusion criteria (n = 2,749).", {"entities": []}], ["Omalizumab was associated with significant improvements in quality of life and the Global Evaluation of Treatment Effectiveness.", {"entities": []}], ["Omalizumab also allowed patients to completely withdraw from inhaled corticosteroid therapy and did not increase the overall incidence of adverse events.", {"entities": []}], ["However, there was insufficient evidence that omalizumab reduced the incidence of exacerbations, and the cost-effectiveness of omalizumab varied across studies.", {"entities": []}], ["Our data indicated that omalizumab use for at least 52 weeks in patients with persistent uncontrolled allergic asthma was accompanied by an acceptable safety profile, but it lacked effect on the asthma exacerbations.", {"entities": [[102, 117, "DISEASE"], [111, 117, "DISEASE"], [195, 201, "DISEASE"]]}], ["Use of omalizumab was associated with a higher cost than conventional therapy, but these increases may be cost-effective if the medication is used in patients with severe allergic asthma.", {"entities": [[171, 186, "DISEASE"], [180, 186, "DISEASE"]]}], ["Continuity of care (COC) has a proven relationship with health care outcomes.", {"entities": []}], ["However, evidence regarding an association between COC and avoidable hospitalization for elderly patients with asthma is insufficient.", {"entities": [[111, 117, "DISEASE"]]}], ["A retrospective cohort study was performed using Taiwanese National Health Insurance claim data from 2004 to 2013.", {"entities": []}], ["Patients were retrospectively followed for 2 years; the COC index (COCI) for asthma was measured in the 1st year, and avoidable hospitalization for asthma and follow-up time were determined in the subsequent year.", {"entities": [[77, 83, "DISEASE"], [148, 154, "DISEASE"]]}], ["Cox proportional hazards regression was employed to examine hazard ratios (HRs) between COC and avoidable hospitalization for asthma after adjustment for confounding factors.", {"entities": [[126, 132, "DISEASE"]]}], ["Adjusted HR (aHR) was also calculated by stratifying each variable to investigate whether the effect of COC on hospitalization for asthma was avoidable and how this varied across levels of COCI.", {"entities": [[131, 137, "DISEASE"], [9, 11, "GENE"], [13, 16, "GENE"]]}], ["Of 3356 patients included in this study, 1648 patients (49%) had a COCI of 1, and the average COCI was 0.73.", {"entities": []}], ["Compared with patients with high COC (COCI = 1), those with low COC (COCI\u200a<\u200a0.5) had a significantly higher risk of avoidable hospitalization for asthma (aHR = 2.68; 95% confidence interval [CI]: 1.55\u20134.63).", {"entities": [[146, 152, "DISEASE"], [154, 157, "GENE"]]}], ["In addition, after stratified analysis, we determined that COC plays a much more important role for patients who were women, had low insurance premiums, and had no comorbidities.", {"entities": []}], ["High continuity of ambulatory asthma care is linked to a reduced risk of avoidable hospitalization for asthma in elderly asthmatic patients.", {"entities": [[30, 36, "DISEASE"], [103, 109, "DISEASE"]]}], ["We evaluated the efficacy and safety of oral immunotherapy (OIT) combined with 24 weeks of omalizumab (OMB) at inducing desensitization in children with cow\u2019s milk allergy (CM) compared with an untreated group.", {"entities": []}], ["The present study was a prospective randomized controlled trial.", {"entities": []}], ["Sixteen patients (age, 6\u201314 years) with high IgE levels to CM were enrolled in the present study.", {"entities": []}], ["Patients were randomized 1:1 to receive OMB-OIT group or untreated group.", {"entities": []}], ["The primary outcome was the induction of desensitization at 8 weeks after OMB was discontinued in OMB-OIT treated group and at 32 weeks after study entry.", {"entities": []}], ["None of the 6 children in the untreated group developed desensitization to CM while all of the 10 children in the OIT-OMB treated group achieved desensitization (P\u2009<\u20090.001).", {"entities": []}], ["A significantly decreased wheal diameter in response to a skin prick test using CM was found in the OMB-OIT treated group (P\u2009<\u20090.05).", {"entities": []}], ["These data suggest that OIT combined with OMB using microwave heated CM may help to induce desensitization for children with high-risk CM allergy.", {"entities": []}], ["This prospective randomized controlled trial was intended for 50 participants but was prematurely discontinued due to overwhelming superiority of OMB combined with microwave heated OIT over CM avoidance.", {"entities": []}], ["Food allergies are increasing in prevalence but no treatment strategies are currently available to cure dogs with food allergy.", {"entities": [[114, 126, "DISEASE"]]}], ["Over the past decade, experimental food allergen-specific sublingual immunotherapy (FA-SLIT) has emerged as a potential treatment for food allergies in human medicine.", {"entities": []}], ["However, FA-SLIT has not been investigated in dogs.", {"entities": []}], ["Therefore, the objective of this study was to prospectively evaluate the safety, tolerability and dispenser sterility of FA-SLIT in healthy dogs before testing it in food allergic dogs.", {"entities": []}], ["Eight experimental healthy beagle dogs, never orally exposed to peanut, were randomized in two groups to receive SLIT with peanut or placebo for 4\u00a0months.", {"entities": []}], ["Subjects were monitored daily for local and systemic adverse effects.", {"entities": []}], ["Blood samples for complete blood count and serum biochemistry, and urine for urinalysis were collected and the dogs\u2019 body weight was recorded at day 0, 35 and 119 of the SLIT treatment.", {"entities": []}], ["Sera for the determination of peanut-specific IgG and IgE were collected at day 0, 35, 49, 70, 91, 105 and 119.", {"entities": []}], ["Intradermal tests were performed before (day 0) and after (day 119) the experiment.", {"entities": []}], ["The content of each dispenser used to administer treatment or placebo was tested for sterility after usage.", {"entities": []}], ["In order to assess the presence or absence of sensitization, dogs were challenged 6\u00a0months after the end of the study with 2000\u00a0\u03bcg of peanut extract daily for 7 to 14\u00a0days.", {"entities": []}], ["All dogs completed the study.", {"entities": []}], ["The treatment did not provoke either local or systemic side-effects.", {"entities": []}], ["Peanut-specific IgG significantly increased in treatment group.", {"entities": []}], ["Even though a significant increase in peanut-specific IgE was also seen, intradermal tests were negative in all dogs before and after the experiment, and the challenge test did not trigger any adverse reactions in the treated dogs, which shows the protocol did not cause sensitization to peanut, but nevertheless primed the immune system as indicated by the humoral immune response.", {"entities": []}], ["All dispenser solutions were sterile.", {"entities": []}], ["Our results demonstrate that the used peanut-SLIT protocol is well tolerated and safe in healthy dogs.", {"entities": []}], ["Further studies should evaluate tolerability, safety and efficacy in dogs with food allergy.", {"entities": [[79, 91, "DISEASE"]]}], ["Conflicting data have been reported on the association between Toll-like receptor 4 (TLR4) +896A/G and +1196C/T polymorphisms and the risk of asthma.", {"entities": [[142, 148, "DISEASE"], [85, 89, "GENE"]]}], ["Therefore, we conducted this meta-analysis to clarify the effect of TLR4 +896A/G and +1196C/T polymorphisms on the risk of asthma.", {"entities": [[123, 129, "DISEASE"], [68, 72, "GENE"]]}], ["An electronic literature search was performed using PubMed, Embase, Web of Science, Chinese National Knowledge Infrastructure (CNKI), and Wanfang Data to find relevant studies.", {"entities": []}], ["Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the associations.", {"entities": []}], ["All statistical analyses were conducted using STATA software version 12.0.", {"entities": []}], ["A total of 14 studies with 2873 asthma cases and 3110 controls were included.", {"entities": [[32, 38, "DISEASE"]]}], ["The pooled results indicated a significant association between TLR4 +1196C/T polymorphism and the risk of asthma (T vs. C: OR=0.79, 95%CI=0.63\u20130.99, P=0.04; TT+CT vs. CC: OR=0.76, 95%CI=0.59\u20130.96, P=0.03; CT vs. CC: OR=0.74, 95%CI=0.58\u20130.95, P=0.02).", {"entities": [[106, 112, "DISEASE"], [63, 67, "GENE"]]}], ["In subgroup analysis by ethnicity, TLR4 +1196C/T polymorphism was significantly associated with asthma risk in Asians (T vs. C: OR=0.73, 95%CI=0.54\u20130.98, P=0.04; TT+CT vs. CC: OR=0.70, 95%CI=0.51\u20130.96, P=0.03; CT vs. CC: OR=0.69, 95%CI=0.50\u20130.96, P=0.03), but not in whites.", {"entities": [[96, 102, "DISEASE"], [35, 39, "GENE"]]}], ["For TLR4 +896A/G polymorphism, no significant association was found between TLR4 +896A/G polymorphism and asthma risk under any genetic models.", {"entities": [[106, 112, "DISEASE"], [4, 8, "GENE"], [76, 80, "GENE"], [4, 8, "GENE"], [76, 80, "GENE"]]}], ["The results of this meta-analysis suggest that T allele of the TLR4 +1196C/T might act as a protective factor against the development of asthma.", {"entities": [[137, 143, "DISEASE"], [63, 67, "GENE"]]}], ["Given the complex nature of the responses that can occur in host-pathogen interactions, dual transcriptomics offers a powerful method of elucidating these interactions during infection.", {"entities": []}], ["The gene expression patterns of Aspergillus fumigatus conidia or host cells have been reported in a number of previous studies, but each focused on only one of the interacting organisms.", {"entities": []}], ["In the present study, we profiled simultaneously the transcriptional response of both A. fumigatus and human airway epithelial cells (AECs).", {"entities": []}], ["16HBE14o- transformed bronchial epithelial cells were incubated with A. fumigatus conidia at 37\u00b0C for 6 hours, followed by genome-wide transcriptome analysis using human and fungal microarrays.", {"entities": []}], ["Differentially expressed gene lists were generated from the microarrays, from which biologically relevant themes were identified.", {"entities": []}], ["Human and fungal candidate genes were selected for validation, using RT-qPCR, in both 16HBE14o- cells and primary AECs co-cultured with conidia.", {"entities": []}], ["We report that ontologies related to the innate immune response are activated by co-incubation with A. fumigatus condia, and interleukin-6 (IL-6) was confirmed to be up-regulated in primary AECs via RT-qPCR.", {"entities": []}], ["Concomitantly, A. fumigatus was found to up-regulate fungal pathways involved in iron acquisition, vacuolar acidification, and formate dehydrogenase activity.", {"entities": []}], ["To our knowledge, this is the first study to apply a dual organism transcriptomics approach to interactions of A. fumigatus conidia and human airway epithelial cells.", {"entities": []}], ["The up-regulation of IL-6 by epithelia and simultaneous activation of several pathways by fungal conidia warrants further investigation as we seek to better understand this interaction in both health and disease.", {"entities": []}], ["The cellular response of the airway epithelium to A. fumigatus is important to understand if we are to improve host-pathogen outcomes.", {"entities": []}], ["Human respiratory syncytial virus (RSV) sometimes causes acute and severe lower respiratory tract illness in infants and young children.", {"entities": []}], ["RSV strongly upregulates proinflammatory cytokines and the platelet-activating factor (PAF) receptor, which is a receptor for Streptococcus pneumoniae , in the pulmonary epithelial cell line A549.", {"entities": []}], ["Clarithromycin (CAM), which is an antimicrobial agent and is also known as an immunomodulator, significantly suppressed RSV-induced production of interleukin-6, interleukin-8, and regulated on activation, normal T-cell expressed and secreted (RANTES).", {"entities": []}], ["CAM also suppressed RSV-induced PAF receptor expression and adhesion of fluorescein-labeled S. pneumoniae cells to A549 cells.", {"entities": []}], ["The RSV-induced S. pneumoniae adhesion was thought to be mediated by the host cell's PAF receptor.", {"entities": []}], ["CAM, which exhibits antimicrobial and immunomodulatory activities, was found in this study to suppress the RSV-induced adhesion of respiratory disease-causing bacteria, S. pneumoniae , to host cells.", {"entities": []}], ["Thus, CAM might suppress immunological disorders and prevent secondary bacterial infections during RSV infection.", {"entities": []}], ["Even in developed economies infectious diseases remain the most common cause of illness in early childhood.", {"entities": []}], ["Our current understanding of the epidemiology of these infections is limited by reliance on data from decades ago performed using low-sensitivity laboratory methods, and recent studies reporting severe, hospital-managed disease.", {"entities": []}], ["The Observational Research in Childhood Infectious Diseases (ORChID) study is an ongoing study enrolling a dynamic birth cohort to document the community-based epidemiology of viral respiratory and gastrointestinal infections in early childhood.", {"entities": []}], ["Women are recruited antenatally, and their healthy newborn is followed for the first 2\u2005years of life.", {"entities": []}], ["Parents keep a daily symptom diary for the study child, collect a weekly anterior nose swab and dirty nappy swab and complete a burden diary when a child meets pre-defined illness criteria.", {"entities": []}], ["Specimens will be tested for a wide range of viruses by real-time PCR assays.", {"entities": []}], ["Primary analyses involves calculating incidence rates for acute respiratory illness (ARI) and acute gastroenteritis (AGE) for the cohort by age and seasonality.", {"entities": [[100, 115, "DISEASE"]]}], ["Control material from children when they are without symptoms will allow us to determine what proportion of ARIs and AGE can be attributed to specific pathogens.", {"entities": []}], ["Secondary analyses will assess the incidence and shedding duration of specific respiratory and gastrointestinal pathogens.", {"entities": []}], ["This study is approved by The Human Research Ethics Committees of the Children's Health Queensland Hospital and Health Service, the Royal Brisbane and Women's Hospital and The University of Queensland.", {"entities": []}], ["clinicaltrials.gov NCT01304914.", {"entities": []}], ["Previous studies have suggested an important role for IL-17, mainly secreted by Th17 cells, in the development of systemic inflammation in preeclampsia (PE).", {"entities": []}], ["This study therefore investigated the association between genetic variants in IL-17A , IL-17F , and IL-17RA and susceptibility to PE in Chinese Han women.", {"entities": []}], ["We recruited 1,031 PE patients and 1,298 controls of later pregnant women, and used TaqMan allelic discrimination real-time PCR to genotype the polymorphisms of IL17A rs2275913, IL-17F rs763780, and IL-17RA rs4819554.", {"entities": [[161, 166, "GENE"]]}], ["No significant differences in genotypic or allelic frequencies were found at all three polymorphic sites between PE patients and controls (rs2275913: genotype \u03c7 p = 0.897 and allele \u03c7 p = 0.692, OR = 1.024, 95%CI 0.911\u20131.152; rs763780: genotype \u03c7 p = 0.377 and allele \u03c7 p = 0.265, OR = 0.897, 95%CI 0.741\u20131.086; rs4819554: genotype \u03c7 p = 0.729 and allele \u03c7 p = 0.735, OR = 1.020, 95%CI 0.908\u20131.146).", {"entities": []}], ["There were also no significant differences in genetic distributions between mild/severe PE or early/late-onset PE and control subgroups.", {"entities": []}], ["Our data indicate that the genetic variants of rs2275913 in IL-17A , rs763780 in IL-17F , and rs4819554 in IL-17RA may not play a role in the pathogenesis of PE in Chinese Han women.", {"entities": []}], ["However, these findings should be confirmed in other ethnic populations.", {"entities": []}], ["To test whether high levels of reported pride are associated with subsequent falls.", {"entities": []}], ["Secondary analysis of the English Longitudinal Study of Ageing (ELSA) dataset.", {"entities": []}], ["Multi-wave longitudinal sample of non-institutionalised older English adults.", {"entities": []}], ["ELSA cohort of 6415 participants at wave 5 (baseline, 2010/11), of whom 4964 were available for follow-up at wave 7 (follow-up, 2014/15).", {"entities": []}], ["Self reported pride at baseline (low/moderate/high) and whether the participant had reported having fallen during the two years before follow-up.", {"entities": []}], ["The findings did not support the contention that \u201cpride comes before a fall.\u201d Unadjusted estimates indicate that the odds of reported falls were significantly lower for people with high pride levels compared with those who had low pride (odds ratio 0.69, 95% confidence interval 0.58 to 0.81, P<0.001).", {"entities": []}], ["This association remained after adjustment for age, sex, household wealth, and history of falls (odds ratio 0.81, 0.68 to 0.97, P<0.05).", {"entities": []}], ["It was partially attenuated after further adjustment for mobility problems, eyesight problems, the presence of a limiting long term illness, a diagnosis of arthritis or osteoporosis, medication use, cognitive function, and pain and depression (odds ratio 0.86, 0.72 to 1.03, P<0.1).", {"entities": [[169, 181, "DISEASE"], [156, 165, "DISEASE"]]}], ["Because the confidence interval exceeded 1 in the final model, it remains possible that pride may not be an independent predictor of falls when known risk factors are considered.", {"entities": []}], ["People with moderate pride did not have lower odds of having fallen than those with low pride in adjusted models.", {"entities": []}], ["Participants lost to follow-up did not differ from those retained in terms of key variables, and weighting the analyses to account for selective attrition did not produce different results.", {"entities": []}], ["Contrary to the well known saying \u201cpride comes before a fall,\u201d these findings suggest that pride may actually be a protective factor against falling in older adults.", {"entities": []}], ["Future studies may seek to investigate the mechanisms underpinning this relation.", {"entities": []}], ["Exposure to particulate matter (PM) is recognized as a major health hazard, but molecular responses are still insufficiently described.", {"entities": []}], ["We analyzed the epigenetic impact of ambient PM 2.5 from biomass combustion on the methylome of primary human bronchial epithelial BEAS-2B cells using the Illumina HumanMethylation450 BeadChip.", {"entities": []}], ["The transcriptome was determined by the Affymetrix HG-U133 Plus 2.0 Array.", {"entities": []}], ["PM 2.5 induced genome wide alterations of the DNA methylation pattern, including differentially methylated CpGs in the promoter region associated with CpG islands.", {"entities": []}], ["Gene ontology analysis revealed that differentially methylated genes were significantly clustered in pathways associated with the extracellular matrix, cellular adhesion, function of GTPases, and responses to extracellular stimuli, or were involved in ion binding and shuttling.", {"entities": []}], ["Differential methylations also affected tandem repeats.", {"entities": []}], ["Additionally, 45 different miRNA CpG loci showed differential DNA methylation, most of them proximal to their promoter.", {"entities": []}], ["These miRNAs are functionally relevant for lung cancer, inflammation, asthma, and other PM-associated diseases.", {"entities": [[43, 54, "DISEASE"], [70, 76, "DISEASE"], [48, 54, "DISEASE"]]}], ["Correlation of the methylome and transcriptome demonstrated a clear bias toward transcriptional activation by hypomethylation.", {"entities": []}], ["Genes that exhibited both differential methylation and expression were functionally linked to cytokine and immune responses, cellular motility, angiogenesis, inflammation, wound healing, cell growth, differentiation and development, or responses to exogenous matter.", {"entities": []}], ["Disease ontology of differentially methylated and expressed genes indicated their prominent role in lung cancer and their participation in dominant cancer related signaling pathways.", {"entities": [[100, 111, "DISEASE"], [105, 111, "DISEASE"], [148, 154, "DISEASE"]]}], ["Thus, in lung epithelial cells, PM 2.5 alters the methylome of genes and noncoding transcripts or elements that might be relevant for PM- and lung-associated diseases.", {"entities": []}], ["Experiences from nations with population diversity show extensive evidence on the need for cultural and linguistic competence in health care.", {"entities": []}], ["In Sweden, despite the increasing diversity, only few studies have focused on challenges in cross-cultural care.", {"entities": []}], ["The aim of this study was to explore the perspectives and experiences of caregivers in caring for migrant patients in Northern Sweden in order to understand the challenges they face and generate knowledge that could inform clinical practice.", {"entities": []}], ["We used an interpretive description approach, combining semi-structured interviews with 10 caregivers purposively selected and participant observation of patient-provider interactions in caring encounters.", {"entities": []}], ["The interviews were transcribed and analyzed using thematic analysis approach.", {"entities": []}], ["Field notes were also used to orient data collection and confirm or challenge the analysis.", {"entities": []}], ["We found complex and intertwined challenges as indicated in the three themes we present including: the sociocultural diversity, the language barrier and the challenges migrants face in navigating through the Swedish health care system.", {"entities": []}], ["The caregivers described migrants as a heterogeneous group coming from different geographical areas with varied social, cultural and religious affiliations, migration histories and statuses, all of which influenced the health care encounter, whether providing or receiving.", {"entities": []}], ["Participants also described language as a major barrier to effective provision and use of health services.", {"entities": []}], ["Meanwhile, they expressed concern over the use of interpreters in the triad communication and over the difficulties encountered by migrants in navigating through the Swedish health care system.", {"entities": []}], ["The study illuminates complex challenges facing health care providers caring for migrant populations and highlights the need for multifaceted approaches to improve the delivery and receipt of care.", {"entities": []}], ["The policy implications of these challenges are discussed in relation to the need to (a) adapt care to the individual needs, (b) translate key documents and messages in formats and languages accessible and acceptable to migrants, (c) train interpreters and enhance caregivers\u2019 contextual understanding of migrant groups and their needs, (d) and improve migrants\u2019 health literacy through strategies such as community based educational outreach.", {"entities": []}], ["Mycoplasma pneumoniae causes acute and chronic respiratory infections, including tracheobronchitis and community acquired pneumonia, and is linked to asthma and an array of extra-pulmonary disorders.", {"entities": [[122, 131, "DISEASE"], [150, 156, "DISEASE"]]}], ["Recently, we identified an ADP-ribosylating and vacuolating toxin of M. pneumoniae , designated Community Acquired Respiratory Distress Syndrome (CARDS) toxin.", {"entities": []}], ["In this study we analysed CARDS toxin gene (annotated mpn372 ) transcription and identified its promoter.", {"entities": []}], ["We also compared CARDS toxin mRNA and protein profiles in M. pneumoniae during distinct in vitro growth phases.", {"entities": []}], ["CARDS toxin mRNA expression was maximal, but at low levels, during early exponential growth and declined sharply during mid-to-late log growth phases, which was in direct contrast to other mycoplasma genes examined.", {"entities": []}], ["Between 7% and 10% of CARDS toxin was localized to the mycoplasma membrane at mid-exponential growth, which was reinforced by immunogold electron microscopy.", {"entities": []}], ["No CARDS toxin was released into the medium.", {"entities": []}], ["Upon M. pneumoniae infection of mammalian cells, increased expression of CARDS toxin mRNA was observed when compared with SP-4 broth-grown cultures.", {"entities": []}], ["Further, confocal immunofluorescence microscopy revealed that M. pneumoniae readily expressed CARDS toxin during infection of differentiated normal human bronchial epithelial cells.", {"entities": []}], ["Analysis of M. pneumoniae -infected mouse lung tissue revealed high expression of CARDS toxin per mycoplasma cell when compared with M. pneumoniae cells grown in SP-4 medium alone.", {"entities": []}], ["Taken together, these studies indicate that CARDS toxin expression is carefully controlled by environmental cues that influence its transcription and translation.", {"entities": []}], ["Further, the acceleration of CARDS toxin synthesis and accumulation in vivo is consistent with its role as a bona fide virulence determinant.", {"entities": []}], ["Cisplatin (CP) drug is platinum compounds used for the treatment of various human malignancies.", {"entities": [[11, 13, "GENE"]]}], ["However, adverse outcomes related to CP restrict its usage.", {"entities": [[37, 39, "GENE"]]}], ["Acacia hydaspica is a natural shrub with various pharmacological properties.", {"entities": []}], ["The current investigation aimed to assess the protective potential of A. hydaspica polyphenol rich ethyl acetate extract (AHE) against cisplatin (CP) induced pulmonary toxicity.", {"entities": [[146, 148, "GENE"]]}], ["Rats were divided into six groups.", {"entities": []}], ["Group 1 served as control (saline); Group 2 (drug control) recieved single dose of CP (7.5\u00a0mg/kg i.p.)", {"entities": [[83, 85, "GENE"]]}], ["on 1st day; Group 3 (extract control) (400\u00a0mg/kg bw, p.o.)", {"entities": []}], ["received AHE for one week; Group 4 (Post-treated) and Group 5 (pretreated) received AHE (400\u00a0mg/kg bw/day, p.o) for 7\u00a0days after and before CP (7.5\u00a0mg/kg b.w., i.p.)", {"entities": [[140, 142, "GENE"]]}], ["respectively; Group 6 (Standard control) received silymarin (100\u00a0mg/kg b.w/7\u00a0days) before CP.", {"entities": [[90, 92, "GENE"]]}], ["At the end of dosing rats were sacrificed and pulmonary tissue samples were processed for the evaluation of antioxidant enzymes, oxidative stress markers, genotoxicity and histopathological alterations.", {"entities": []}], ["CP caused body weights loss and increase pulmonary tissue weight.", {"entities": [[0, 2, "GENE"]]}], ["The CP significantly increases oxidative stress markers and decreases tissue antioxidant enzyme levels.", {"entities": [[4, 6, "GENE"]]}], ["Furthermore, CP induced deleterious changes in the microanatomy of pulmonary tissue by rupturing the alveolar septa, thickening of alveolar walls, and injuring the cells with subsequent collapse of blood vessels.", {"entities": [[13, 15, "GENE"]]}], ["AHE pretreatment returned MDA, NO, H 2 O 2 production and improved tissue antioxidant enzyme levels to near normalcy.", {"entities": []}], ["The histological observations evidenced that AHE effectively rescues the lungs from CP-mediated oxidative damage.", {"entities": []}], ["CP induction in rats also caused DNA fragmentation which was restored by AHE treatment.", {"entities": [[0, 2, "GENE"]]}], ["Our results suggest that pretreatment more significantly improve CP induced deleterious effects compared with post treatment indicating protective effect.", {"entities": [[65, 67, "GENE"]]}], ["Potency of AHE pretreatment is similar to silymarin.", {"entities": []}], ["These findings demonstrated that A. hydaspica AHE extract might serve as potential adjuvant that prevents CP persuaded pulmonary toxicity due to its intrinsic antioxidant potential and polyphenolic constituents.", {"entities": [[106, 108, "GENE"]]}], ["Asthma and allergic rhinitis are respiratory diseases with a significant global burden.", {"entities": [[11, 28, "DISEASE"], [20, 28, "DISEASE"], [0, 6, "DISEASE"]]}], ["Forkhead box O3 ( FOXO3 ) is a gene involved in the etiology of a number of respiratory diseases.", {"entities": [[18, 23, "GENE"]]}], ["The objective of this study is to assess the association of rs13217795, an intronic FOXO3 single-nucleotide polymorphism, with asthma and allergic rhinitis.", {"entities": [[138, 155, "DISEASE"], [147, 155, "DISEASE"], [127, 133, "DISEASE"], [84, 89, "GENE"]]}], ["In this case\u2013case\u2013control genetic association study, genotyping was conducted using the PCR\u2013RFLP method.", {"entities": []}], ["Genotype-based associations were investigated under the general, recessive, and dominant models of disease penetrance using binomial logistic regression; and, allele-based associations were tested using Pearson\u2019s chi-squared test.", {"entities": []}], ["The final study population consisted of 94 controls, 124 asthmatics, and 110 allergic rhinitis patients.", {"entities": [[77, 94, "DISEASE"], [86, 94, "DISEASE"]]}], ["The general and recessive models of disease penetrance were statistically significant for both case\u2013control comparisons.", {"entities": []}], ["Under the general model, the odds of the asthma phenotype were 1.46 (0.64 to 3.34) and 3.42 (1.37 to 8.57) times higher in heterozygotes and derived allele homozygotes, respectively, compared to ancestral allele homozygotes.", {"entities": [[41, 47, "DISEASE"]]}], ["The corresponding odds ratios for the allergic rhinitis phenotype were 1.05 (0.46 to 2.40) and 2.35 (0.96 to 5.73), respectively.", {"entities": [[38, 55, "DISEASE"], [47, 55, "DISEASE"]]}], ["The dominant model of disease penetrance was not statistically significant.", {"entities": []}], ["The minor allele in all study groups was the ancestral allele, with a frequency of 0.49 in controls.", {"entities": []}], ["There was no deviation from Hardy\u2013Weinberg equilibrium in controls.", {"entities": []}], ["Both case\u2013control allele-based associations were statistically significant.", {"entities": []}], ["Herein we present the first report of the association between rs13217795 and allergic rhinitis, and the first independent verification of the association between rs13217795 and asthma.", {"entities": [[77, 94, "DISEASE"], [86, 94, "DISEASE"], [177, 183, "DISEASE"]]}], ["Marker selection in future genetic association studies of asthma and allergic rhinitis should include functional polymorphisms in linkage disequilibrium with rs13217795.", {"entities": [[69, 86, "DISEASE"], [78, 86, "DISEASE"], [58, 64, "DISEASE"]]}], ["The online version of this article (10.1186/s12881-017-0494-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mucin hypersecretion and mucus plugging in the airways are characteristic features of chronic respiratory diseases like cystic fibrosis (CF) and contribute to morbidity and mortality.", {"entities": [[120, 135, "DISEASE"]]}], ["In CF, Pseudomonas aeruginosa superinfections in the lung exacerbate inflammation and alter mucus properties.", {"entities": []}], ["There is increasing evidence that n-3 polyunsaturated fatty acids (PUFAs) exhibit anti-inflammatory properties in many inflammatory diseases while n-6 PUFA arachidonic acid (AA) favors inflammatory mediators such as eicosanoids prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) that may enhance inflammatory reactions.", {"entities": []}], ["This suggests that n-3 PUFAs may have a protective effect against mucus over-production in airway diseases.", {"entities": []}], ["Therefore, we hypothesized that n-3 PUFAs may downregulate mucins expression.", {"entities": []}], ["We designed an absolute real-time PCR assay to assess the effect of a 5-week diet enriched either with n-3 or n-6 PUFAs on the expression of large mucins in the lungs of mice infected by P. aeruginosa .", {"entities": []}], ["Dietary fatty acids did not influence mucin gene expression in healthy mice.", {"entities": []}], ["Lung infection induced an increase of the secreted gel-forming mucin Muc5b and a decrease of the membrane bound mucin Muc4 .", {"entities": [[69, 74, "GENE"], [118, 122, "GENE"]]}], ["These deregulations are modulated by dietary fatty acids with a suppressive effect of n-3 PUFAs on mucin (increase of Muc5b from 19-fold up to 3.6 \u00d7 10 Muc4 from 15-fold up to 3.2 \u00d7 10 Our data suggest that n-3 PUFAs enriched diet represents an inexpensive strategy to prevent or treat mucin overproduction in pulmonary bacterial colonization.", {"entities": [[118, 123, "GENE"], [152, 156, "GENE"]]}], ["Healthcare providers in emergency departments should wear respirators for infection protection.", {"entities": []}], ["However, the wearer's vigorous movements during cardiopulmonary resuscitation may affect the protective performance of the respirator.", {"entities": []}], ["Herein, we aimed to assess the effects of chest compressions (CCs) on the protective performance of respirators.", {"entities": [[62, 65, "GENE"]]}], ["This crossover study evaluated 30 healthcare providers from 1 emergency department who performed CC with real-time feedback.", {"entities": []}], ["The first, second, and third groups started with a cup-type, fold-type, and valve-type respirator, respectively, after which the respirators were randomized for each group.", {"entities": []}], ["The fit factors were measured using a quantitative fit testing device before and during the CC in each experiment.", {"entities": []}], ["The protection rate was defined as the proportion of respirators achieving a fit factor \u2265100.", {"entities": []}], ["The fold-type respirator had a significantly greater protection rate at baseline (100.0%\u200a\u00b1\u200a0.0%) compared to the cup-type (73.6%\u200a\u00b1\u200a39.6%, P \u200a=\u200a.003) and valve-type respirators (87.5%\u200a\u00b1\u200a30.3%, P \u200a=\u200a.012).", {"entities": []}], ["During the CC, the fit factor values significantly decreased for the cup-type (44.9%\u200a\u00b1\u200a42.8%, P \u200a<\u200a.001) and valve-type respirators (59.5%\u200a\u00b1\u200a41.7%, P \u200a=\u200a.002), but not for the fold-type respirator (93.2%\u200a\u00b1\u200a21.7%, P \u200a=\u200a.095).", {"entities": []}], ["The protective performances of respirators may be influenced by CC.", {"entities": []}], ["Healthcare providers should identify the respirator that provides the best fit for their intended tasks.", {"entities": []}], ["The effects of beverage alcohol (ethanol) on the body are determined largely by the rate at which it and its main breakdown product, acetaldehyde, are metabolized after consumption.", {"entities": []}], ["The main metabolic pathway for ethanol involves the enzymes alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH).", {"entities": []}], ["Seven different ADHs and three different ALDHs that metabolize ethanol have been identified.", {"entities": []}], ["The genes encoding these enzymes exist in different variants (i.e., alleles), many of which differ by a single DNA building block (i.e., single nucleotide polymorphisms [SNPs]).", {"entities": []}], ["Some of these SNPs result in enzymes with altered kinetic properties.", {"entities": []}], ["For example, certain ADH1B and ADH1C variants that are commonly found in East Asian populations lead to more rapid ethanol breakdown and acetaldehyde accumulation in the body.", {"entities": [[21, 26, "GENE"]]}], ["Because acetaldehyde has harmful effects on the body, people carrying these alleles are less likely to drink and have a lower risk of alcohol dependence.", {"entities": [[134, 152, "DISEASE"]]}], ["Likewise, an ALDH2 variant with reduced activity results in acetaldehyde buildup and also has a protective effect against alcoholism.", {"entities": [[13, 18, "GENE"]]}], ["In addition to affecting drinking behaviors and risk for alcoholism, ADH and ALDH alleles impact the risk for esophageal cancer.", {"entities": [[110, 127, "DISEASE"], [121, 127, "DISEASE"]]}], ["Proteases, enzymes catalyzing the hydrolysis of peptide bonds, are present at high concentrations in the gastrointestinal tract.", {"entities": []}], ["Besides their well-known role in the digestive process, they also function as signaling molecules through the activation of protease-activated receptors (PARs).", {"entities": []}], ["Based on their chemical mechanism for catalysis, proteases can be classified into several classes: serine, cysteine, aspartic, metallo- and threonine proteases represent the mammalian protease families.", {"entities": []}], ["In particular, the class of serine proteases will play a significant role in this review.", {"entities": []}], ["In the last decades, proteases have been suggested to play a key role in the pathogenesis of visceral hypersensitivity, which is a major factor contributing to abdominal pain in patients with inflammatory bowel diseases and/or irritable bowel syndrome.", {"entities": [[227, 251, "DISEASE"], [243, 251, "DISEASE"]]}], ["So far, only a few preclinical animal studies have investigated the effect of protease inhibitors specifically on visceral sensitivity while their effect on inflammation is described in more detail.", {"entities": []}], ["In our accompanying review we describe their effect on gastrointestinal permeability.", {"entities": []}], ["On account of their promising results in the field of visceral hypersensitivity, further research is warranted.", {"entities": []}], ["The aim of this review is to give an overview on the concept of visceral hypersensitivity as well as on the physiological and pathophysiological functions of proteases herein.", {"entities": []}], ["Maternal obesity and gestational diabetes mellitus (GDM) are two increasingly common and important obstetric complications that are associated with severe long-term health risks to mothers and babies.", {"entities": [[21, 41, "DISEASE"], [9, 16, "DISEASE"], [33, 50, "DISEASE"]]}], ["IL-1\u03b2, which is increased in obese and GDM pregnancies, plays an important role in the pathophysiology of these two pregnancy complications.", {"entities": []}], ["In non-pregnant tissues, endoplasmic (ER) stress is increased in diabetes and can induce IL-1\u03b2 via inflammasome activation.", {"entities": []}], ["The aim of this study was to determine whether ER stress is increased in omental adipose tissue of women with GDM, and if ER stress can also upregulate inflammasome-dependent secretion of IL-1\u03b2.", {"entities": []}], ["ER stress markers IRE1\u03b1, GRP78 and XBP-1s were significantly increased in adipose tissue of obese compared to lean pregnant women.", {"entities": []}], ["ER stress was also increased in adipose tissue of women with GDM compared to BMI-matched normal glucose tolerant (NGT) women.", {"entities": []}], ["Thapsigargin, an ER stress activator, induced upregulated secretion of mature IL-1\u03b1 and IL-1\u03b2 in human omental adipose tissue explants primed with bacterial endotoxin LPS, the viral dsRNA analogue poly(I:C) or the pro-inflammatory cytokine TNF-\u03b1.", {"entities": []}], ["Inhibition of capase-1 with Ac-YVAD-CHO resulted in decreased IL-1\u03b1 and IL-1\u03b2 secretion, whereas inhibition of pannexin-1 with carbenoxolone suppressed IL-1\u03b2 secretion only.", {"entities": []}], ["Treatment with anti-diabetic drugs metformin and glibenclamide also reduced IL-1\u03b1 and IL-1\u03b2 secretion in infection and cytokine-primed adipose tissue.", {"entities": []}], ["In conclusion, this study has demonstrated ER stress to activate the inflammasome in pregnant adipose tissue.", {"entities": []}], ["Therefore, increased ER stress may contribute towards the pathophysiology of obesity in pregnancy and GDM.", {"entities": [[77, 84, "DISEASE"]]}], ["The changes in lymphocyte subpopulations in atopic dermatitis (AD) concern also T-regulatory cells.", {"entities": [[44, 61, "DISEASE"], [51, 61, "DISEASE"]]}], ["We investigated the expression of various surface receptors on CD3 r \u00a0=\u00a00.55, p \u00a0=\u00a00.03).", {"entities": []}], ["The concentrations of IL-10 in the CD4 p \u00a0<\u00a00.01, r \u00a0=\u00a0\u22120.63; p \u00a0<\u00a00.02, r \u00a0=\u00a0\u22120.64 and p \u00a0<\u00a00.03, r \u00a0=\u00a0\u22120.58, respectively), whereas the serum concentration of IL-6 correlated positively ( p \u00a0<\u00a00.003, r \u00a0=\u00a00.71).", {"entities": [[35, 38, "GENE"]]}], ["The regulatory cells expressed more CD62L and CD134 surface markers but less CD95.", {"entities": []}], ["Reduced expression of the apoptotic CD95 receptor suggests that survival time of these cells is prolonged.", {"entities": []}], ["Since CD62L and CD134 were upregulated, the enhanced modulatory effect of CD4", {"entities": [[74, 77, "GENE"]]}], ["Human bocavirus is a newly discovered parvovirus.", {"entities": []}], ["Multiple studies have confirmed the presence of human bocavirus1 (HBoV1) in respiratory tract samples of children.", {"entities": []}], ["The viral load, presentation of single detection and its role as a causative agent of severe respiratory tract infections have not been thoroughly elucidated.", {"entities": []}], ["We investigated the presence of HBoV1 by quantitative polymerase chain reaction (PCR) of nasopharyngeal aspirate specimens from 1229 children hospitalized for respiratory tract infections.", {"entities": []}], ["The samples were analyzed for 15 respiratory viruses by PCR and 7 respiratory viruses by viral culture.", {"entities": []}], ["At least one virus was detected in 652 (53.1%) of 1229 children, and two or more viruses were detected in 266 (21.6%) children.", {"entities": []}], ["HBoV1 was detected in 127 children (10.3%), in which 66/127 (52%) of the cases were the only HBoV1 virus detected.", {"entities": []}], ["Seasonal variation was observed with a high HBoV1 infection rate in summer.", {"entities": []}], ["A cutoff value of 10 HBoV1 at a high viral load is not frequently found in co-detection with other respiratory viruses, and a single detection with a high viral load could be an etiological agent of severe respiratory tract infections.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2334-14-424) contains supplementary material, which is available to authorized users.", {"entities": []}], ["General control non-repressible 5 (GCN5)-related N -acetyltransferases (GNAT) catalyze the transfer of an acyl moiety from acyl coenzyme A (acyl-CoA) to a diverse group of substrates and are widely distributed in all domains of life.", {"entities": []}], ["This review of the currently available data acquired on GNAT enzymes by a combination of structural, mutagenesis and kinetic methods summarizes the key similarities and differences between several distinctly different families within the GNAT superfamily, with an emphasis on the mechanistic insights obtained from the analysis of the complexes with substrates or inhibitors.", {"entities": []}], ["It discusses the structural basis for the common acetyltransferase mechanism, outlines the factors important for the substrate recognition, and describes the mechanism of action of inhibitors of these enzymes.", {"entities": []}], ["It is anticipated that understanding of the structural basis behind the reaction and substrate specificity of the enzymes from this superfamily can be exploited in the development of novel therapeutics to treat human diseases and combat emerging multidrug-resistant microbial infections.", {"entities": []}], ["Shisha (waterpipe) smoking is becoming a more prevalent form of tobacco consumption, and is growing worldwide, particularly among the young generation in the Middle East.", {"entities": []}], ["This cross-sectional study aimed to determine the effects of shisha smoking on lung functions and Fractional Exhaled Nitric Oxide (FeNO) among Saudi young adults.", {"entities": []}], ["We recruited 146 apparently healthy male subjects (73 control and 73 shisha smokers).", {"entities": []}], ["The exposed group consisted of male shisha smokers, with mean age 21.54 \u00b1 0.41 (mean \u00b1 SEM) range 17\u201333 years.", {"entities": []}], ["The control group consisted of similar number (73) of non-smokers with mean age 21.36 \u00b1 0.19 (mean \u00b1 SEM) range 18\u201328 years.", {"entities": []}], ["Between the groups we considered the factors like age, height, weight, gender, ethnicity and socioeconomic status to estimate the impact of shisha smoking on lung function and fractional exhaled nitric oxide.", {"entities": []}], ["Lung function test was performed by using an Spirovit-SP-1 Electronic Spirometer.", {"entities": []}], ["Fractional Exhaled Nitric Oxide (FeNO) was measured by using Niox Mino.", {"entities": []}], ["A significant decrease in lung function parameters FEV1, FEV1/FVC Ratio, FEF-25%, FEF-50%, FEF-75% and FEF-75-85% was found among shisha smokers relative to their control group.", {"entities": []}], ["There was also a significant reduction in the Fractional Exhaled Nitric Oxide among Shisha smokers compared to control group.", {"entities": []}], ["Sickle cell disease (SCD) patients have impaired domains of health-related quality of life (HRQOL).", {"entities": [[21, 24, "GENE"]]}], ["Hydroxyurea is safe and efficacious in SCD; however, adherence is suboptimal, and patients\u2019 perceptions are poorly understood amongst adolescents and young adults (AYA).", {"entities": [[39, 42, "GENE"]]}], ["Study objectives were to: (1) examine patients\u2019 perceptions of SCD and hydroxyurea; and (2) explore the relationship of their perceptions to clinical characteristics, HRQOL domains and hydroxyurea adherence.", {"entities": [[63, 66, "GENE"]]}], ["Thirty-four SCD patients on hydroxyurea (\u22656\u00a0months) participated in a single-institution study.", {"entities": [[12, 15, "GENE"]]}], ["Study measures included Brief-Illness Perceptions Questionnaire, \u00a9 Modified Morisky Adherence Scale 8-items, and Patient Reported Outcomes Measurement Information System (PROMIS\u00ae).", {"entities": []}], ["We assessed the relationship of patients\u2019 perceptions to hydroxyurea adherence using Wilcoxon rank-sum test, the number of hospitalizations using Kruskal-Wallis test, and the number of ED visits, adherence level, HRQOL domain scores using Spearman\u2019s rho correlations.", {"entities": []}], ["We conducted a sub-analysis in HbSS patients to evaluate the relationship of patients\u2019 perceptions to laboratory markers of hydroxyurea adherence.", {"entities": []}], ["Participants were 59% male and 91% Black, and had a median age of 13.5 (range 12\u201318) years.", {"entities": []}], ["Participants with \u22654 hospitalizations over 1-year prior (using electronic medical chart review) reported more negative perceptions of SCD-related symptoms and emotional response, and perceived hydroxyurea as less beneficial; all p -values \u22640.01.", {"entities": []}], ["Most participants (74%) reported low hydroxyurea adherence.", {"entities": []}], ["Participants with higher hydroxyurea adherence perceived more hydroxyurea benefits ( r s \u00a0=\u00a00.44, p \u00a0<\u00a00.01) and had better emotional response to SCD ( r s \u00a0=\u00a0\u22120.44, p \u00a0=\u00a00.01).", {"entities": [[146, 149, "GENE"]]}], ["In a sub-analysis of HbSS patients, perceived benefits of hydroxyurea positively correlated with HbF ( r s \u00a0=\u00a00.37, p \u00a0=\u00a00.05) and MCV values ( r s \u00a0=\u00a00.35, p \u00a0=\u00a00.05).", {"entities": []}], ["Participants with more negative perceptions of SCD-related consequences, concerns, and emotional response, and fewer perceived hydroxyurea benefits reported worse fatigue ( r s \u00a0=\u00a00.68; r s \u00a0=\u00a00.44; r s \u00a0=\u00a00.74; r s \u00a0=\u00a0\u22120.60), pain ( r s \u00a0=\u00a00.56; r s \u00a0=\u00a00.54; r s \u00a0=\u00a00.63; r s \u00a0=\u00a0\u22120.39), anxiety ( r s \u00a0=\u00a00.55; r s \u00a0=\u00a00.58; r s \u00a0=\u00a00.56; r s \u00a0=\u00a0\u22120.47), and depression ( r s \u00a0=\u00a00.64; r s \u00a0=\u00a00.49; r s \u00a0=\u00a00.70; r s \u00a0=\u00a0\u22120.62), respectively, all p -values <0.05.", {"entities": []}], ["Dynamics influencing hydroxyurea adherence are multifactorial, and understanding patients\u2019 perceptions is critical to overcoming adherence barriers.", {"entities": []}], ["Patients\u2019 favorable perceptions correlated with greater adherence and better HRQOL domain scores.", {"entities": []}], ["Prospective evaluation of patients\u2019 perceptions of SCD and hydroxyurea in relation adherence, HRQOL domains and clinical outcomes is warranted.", {"entities": [[51, 54, "GENE"]]}], ["Genetic and epidemiologic evidence suggests that in horses, as in other species, different manifestations of hypersensitivity may occur together.", {"entities": []}], ["Horses affected with insect bite hypersensitivity ( IBH ) show airway hyperreactivity ( AH ) to inhaled histamine, even in the absence of overt clinical signs of equine asthma ( EA ).", {"entities": [[169, 175, "DISEASE"]]}], ["Twenty\u2010two healthy controls (group C), 24 horses suffering from IBH alone (group IBH ), and 23 horses suffering from IBH and EA (group IBH / EA ).", {"entities": []}], ["The clinical histories were assessed using 2 standardized questionnaires, the Horse Owner Assessed Respiratory Signs Index ( HOARSI ), and IBH scoring.", {"entities": []}], ["Horses were classified as EA \u2010affected if their HOARSI was >1 and as IBH \u2010affected if IBH score was >0.", {"entities": []}], ["Confounding disorders were excluded by clinical examination.", {"entities": []}], ["The arterial partial pressure of oxygen (PaO 2 ) was measured and flowmetric plethysmography used to assess airway reactivity to increasing doses of inhaled histamine.", {"entities": []}], ["The median histamine provocation concentration ( PC ) when \u2206 flow values increased by 35% ( PC 35) was significantly higher in group C (5.94 [1.11\u201326.33] mg/mL) compared to group IBH (2.95 [0.23\u201310.13] mg/mL) and group IBH / EA (2.03 [0.43\u201310.94] mg/mL; P\u00a0 < \u00a0 0.01).", {"entities": [[49, 51, "GENE"], [92, 94, "GENE"], [49, 51, "GENE"], [92, 94, "GENE"]]}], ["The PC 50 and PC 75 showed very similar differences between groups.", {"entities": [[4, 6, "GENE"], [14, 16, "GENE"], [4, 6, "GENE"], [14, 16, "GENE"]]}], ["Furthermore, PaO 2 was significantly lower in group IBH (84\u00a0\u00b1\u00a08\u00a0mmHg) and group IBH / EA (78\u00a0\u00b1\u00a011\u00a0mmHg) compared to group C (89\u00a0\u00b1\u00a06\u00a0mmHg; P\u00a0 < \u00a0 0.01).", {"entities": []}], ["IBH is associated with AH and decreased PaO 2 , even in the absence of overt respiratory clinical signs.", {"entities": []}], ["Lipoxins and resolvins have anti-inflammatory and pro-resolving actions and accumulating evidence indicates that these lipid mediators also attenuate pain-like behavior in a number of experimental models of inflammation and tissue injury-induced pain.", {"entities": []}], ["The present study was undertaken to assess if spinal administration of lipoxin A 4 (LXA4) or 17 (R)-resolvin D1 (17(R)-RvD1) attenuates mechanical hypersensitivity in the carrageenan model of peripheral inflammation in the rat.", {"entities": []}], ["Given the emerging role of spinal cytokines in the generation and maintenance of inflammatory pain we measured cytokine levels in the cerebrospinal fluid (CSF) after LXA4 or 17(R)-RvD1 administration, and the ability of these lipid metabolites to prevent stimuli-induced release of cytokines from cultured primary spinal astrocytes.", {"entities": []}], ["We found that intrathecal bolus injection of LXA4 and17(R)-RvD1 attenuated inflammation-induced mechanical hypersensitivity without reducing the local inflammation.", {"entities": []}], ["Furthermore, both LXA4 and 17(R)-RvD1 reduced carrageenan-induced tumor necrosis factor (TNF) release in the CSF, while only 17(R)-RvD1attenuated LPS and IFN-\u03b3-induced TNF release in astrocyte cell culture.", {"entities": [[89, 92, "GENE"], [168, 171, "GENE"], [89, 92, "GENE"], [168, 171, "GENE"]]}], ["In conclusion, this study demonstrates that lipoxins and resolvins potently suppress inflammation-induced mechanical hypersensitivity, possibly by attenuating cytokine release from spinal astrocytes.", {"entities": []}], ["The inhibitory effect of lipoxins and resolvins on spinal nociceptive processing puts them in an intriguing position in the search for novel pain therapeutics.", {"entities": []}], ["The relationship between polymorphism of the angiotensin I converting enzyme ( ACE ) gene and chronic obstructive pulmonary disease (COPD) has been examined in many previous studies.", {"entities": [[94, 131, "DISEASE"]]}], ["However, their results were controversial.", {"entities": []}], ["Therefore, we performed a meta-analysis to evaluate the relationship between the ACE gene and the risk of COPD.", {"entities": []}], ["Fourteen case-control studies were included in this meta-analysis.", {"entities": []}], ["The pooled p value, odds ratio (OR), and 95% confidence interval (95% CI) were used to investigate the strength of the association.", {"entities": []}], ["The meta-analysis was performed using comprehensive meta-analysis software.", {"entities": []}], ["Our meta-analysis results revealed that ACE polymorphisms were not related to the risk of COPD ( p > 0.05 in each model).", {"entities": []}], ["In further analyses based on ethnicity, we observed an association between insertion/deletion polymorphism of the ACE gene and risk of COPD in the Asian population (codominant 2, OR = 3.126, 95% CI = 1.919\u20135.093, p < 0.001; recessive, OR = 3.326, 95% CI = 2.190\u20135.050, p < 0.001) but not in the Caucasian population ( p > 0.05 in each model).", {"entities": []}], ["In conclusion, the present meta-analysis indicated that the insertion/deletion polymorphism of the ACE gene may be associated with susceptibility to COPD in the Asian population but not in the Caucasian population.", {"entities": []}], ["However, the results of the present meta-analysis need to be confirmed in a larger sample.", {"entities": []}], ["Glibenclamide is the most widely used sulfonylurea drug for the treatment of type 2 diabetes mellitus (DM).", {"entities": [[84, 101, "DISEASE"], [77, 101, "DISEASE"]]}], ["Recent studies have suggested that glibenclamide reduced adverse neuroinflammation and improved behavioral outcomes following central nervous system (CNS) injury.", {"entities": []}], ["We reviewed glibenclamide's anti-inflammatory effects: abundant evidences have shown that glibenclamide exerted an anti-inflammatory effect in respiratory, digestive, urological, cardiological, and CNS diseases, as well as in ischemia-reperfusion injury.", {"entities": [[226, 234, "DISEASE"]]}], ["Glibenclamide might block K ATP channel, Sur1-Trpm4 channel, and NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome activation, decrease the production of proinflammatory mediators (TNF- \u03b1 , IL-1 \u03b2 , and reactive oxygen species), and suppress the accumulation of inflammatory cells.", {"entities": [[110, 115, "GENE"]]}], ["Glibenclamide's anti-inflammation warrants further investigation.", {"entities": []}], ["The gene encoding IL-1 was sequenced more than 30 years ago, and many related cytokines, such as IL-18, IL-33, IL-36, IL-37, IL-38, IL-1 receptor antagonist (IL-1Ra), and IL-36Ra, have since been identified.", {"entities": []}], ["IL-1 is a potent proinflammatory cytokine and is involved in various inflammatory diseases.", {"entities": []}], ["Other IL-1 family ligands are critical for the development of diverse diseases, including inflammatory and allergic diseases.", {"entities": []}], ["Only IL-1Ra possesses the leader peptide required for secretion from cells, and many ligands require posttranslational processing for activation.", {"entities": []}], ["Some require inflammasome-mediated processing for activation and release, whereas others serve as alarmins and are released following cell membrane rupture, for example, by pyroptosis or necroptosis.", {"entities": []}], ["Thus, each ligand has the proper molecular process to exert its own biological functions.", {"entities": []}], ["In this review, we will give a brief introduction to the IL-1 family cytokines and discuss their pivotal roles in the development of various liver diseases in association with immune responses.", {"entities": []}], ["For example, an excess of IL-33 causes liver fibrosis in mice via activation and expansion of group 2 innate lymphoid cells to produce type 2 cytokines, resulting in cell conversion into pro-fibrotic M2 macrophages.", {"entities": []}], ["Finally, we will discuss the importance of IL-1 family cytokine-mediated molecular and cellular networks in the development of acute and chronic liver diseases.", {"entities": []}], ["Obesity and obesity-associated phenotypes are linked to the chromosome12q24 locus, the non-insulin-dependent-diabetes 2 (NIDDM2) locus.", {"entities": [[0, 7, "DISEASE"], [12, 19, "DISEASE"]]}], ["The gene of proteasome modulator 9 ( PSMD9) lies in the NIDDM2 region and is linked to type 2 diabetes (T2D), microvascular and macrovascular complications of T2D.", {"entities": [[37, 42, "GENE"]]}], ["We aimed at studying whether the PSMD9 T2D risk single nucleotide polymorphisms (SNPs) IVS3+nt460 , IVS3+nt437 , and 197G are linked to obesity, overweight status and waist circumference in Italian T2D families.", {"entities": [[136, 143, "DISEASE"], [33, 38, "GENE"]]}], ["We screened 200 Italians T2D siblings/families for PSMD9 variants.", {"entities": [[51, 56, "GENE"]]}], ["Using Merlin software, we performed non-parametric linkage analysis to test for linkage with obesity and overweight condition and variance component analysis to test for linkage with waist circumference in our T2D siblings/families dataset.", {"entities": [[93, 100, "DISEASE"]]}], ["Our study shows that the PSMD9 SNPs IVS3+nt460 , IVS3+nt437 , and 197G are in linkage with overweight condition and waist circumference in Italians.", {"entities": [[25, 30, "GENE"]]}], ["The statistical power tests performed via simulations on real data confirm that the results are not due to random chance.", {"entities": []}], ["In summary, the linkage strategy using a homogeneous family/subject dataset can identify a gene contributing to a complex trait.", {"entities": []}], ["PMSD9 may be at least one of the genes responsible for the linkage to obesity and obesity-associated phenotypes at the locus 12q24 in other populations.", {"entities": [[70, 77, "DISEASE"], [82, 89, "DISEASE"]]}], ["The catecholamines norepinephrine and epinephrine regulate important physiological functions in vertebrates.", {"entities": []}], ["In insects; these neuroactive substances are functionally replaced by the phenolamines octopamine and tyramine.", {"entities": []}], ["Phenolamines activate specific guanine nucleotide-binding (G) protein-coupled receptors (GPCRs).", {"entities": []}], ["Type 1 tyramine receptors are better activated by tyramine than by octopamine.", {"entities": []}], ["In contrast; type 2 tyramine receptors are almost exclusively activated by tyramine.", {"entities": []}], ["Functionally; activation of type 1 tyramine receptors leads to a decrease in the intracellular concentration of cAMP ([cAMP] i ) whereas type 2 tyramine receptors can mediate Ca i .", {"entities": []}], ["Here; we report that the American cockroach ( Periplaneta americana ) expresses a second type 1 tyramine receptor (PeaTAR1B) in addition to PeaTAR1A (previously called PeaTYR1).", {"entities": []}], ["When heterologously expressed in flpTM cells; activation of PeaTAR1B by tyramine leads to a concentration-dependent decrease in [cAMP] i .", {"entities": []}], ["Its activity can be blocked by a series of established antagonists.", {"entities": []}], ["The functional characterization of two type 1 tyramine receptors from P. americana ; PeaTAR1A and PeaTAR1B; which respond to tyramine by changing cAMP levels; is a major step towards understanding the actions of tyramine in cockroach physiology and behavior; particularly in comparison to the effects of octopamine.", {"entities": []}], ["Modification of the histone proteins associated with DNA is an important process in the epigenetic regulation of DNA structure and function.", {"entities": []}], ["There are several known modifications to histones, including methylation, acetylation, and phosphorylation, and a range of factors influence each of these.", {"entities": []}], ["Histone deacetylases (HDACs) remove the acetyl group from lysine residues within a range of proteins, including transcription factors and histones.", {"entities": []}], ["Whilst this means that their influence on cellular processes is more complex and far-reaching than histone modifications alone, their predominant function appears to relate to histones; through deacetylation of lysine residues they can influence expression of genes encoded by DNA linked to the histone molecule.", {"entities": []}], ["HDAC inhibitors in turn regulate the activity of HDACs, and have been widely used as therapeutics in psychiatry and neurology, in which a number of adverse outcomes are associated with aberrant HDAC function.", {"entities": []}], ["More recently, dietary HDAC inhibitors have been shown to have a regulatory effect similar to that of pharmacological HDAC inhibitors without the possible side-effects.", {"entities": []}], ["Here, we discuss a number of dietary HDAC inhibitors, and how they may have therapeutic potential in the context of a whole food.", {"entities": []}], ["To assess the effectiveness of citalopram for major depressive disorder (MDD) in adults, in a systematic review of all published, randomised, double-blind studies comparing it with a placebo.", {"entities": [[46, 71, "DISEASE"]]}], ["Cochrane Central Register of Controlled Trials, Medline, PsychINFO and Embase.", {"entities": []}], ["Randomised, double-blind, placebo-controlled studies of citalopram in adults with MDD were included.", {"entities": []}], ["Studies with medically ill or treatment resistant subjects were excluded, as were studies of relapse prevention.", {"entities": []}], ["Remission of MDD was defined as a primary outcome, and response or change from baseline scores were defined as secondary.", {"entities": []}], ["Remission, response and symptom improvement scores on the Hamilton Depression Scale, Montgomery\u2013Asberg Depression Rating Scale and Clinical Global Impressions-Severity scales were extracted.", {"entities": []}], ["A random-effects meta-analysis was carried out on the response rates and symptom improvement scores.", {"entities": []}], ["Included studies were examined for the presence of bias and small study effects.", {"entities": []}], ["Eight studies (n=2025) met the inclusion criteria.", {"entities": []}], ["Two studies provided data on remission, but only one of these showed a significant difference between citalopram and placebo (RR=1.59, 95% CI 1.10 to 2.31).", {"entities": []}], ["Meta-analysis of response rates in five studies (n=1010) revealed significant superiority of citalopram (RR=1.42, 95% CI 1.17 to 1.73).", {"entities": []}], ["Meta-analysis of change from baseline scores in five studies (n=1541) gave a standardised mean difference (Hedges' g) of \u22120.27 (95% CI \u22120.38 to to \u22120.16), showing a reduction in MDD symptoms to be significant for citalopram relative to placebo.", {"entities": []}], ["There was no evidence of any significant small study effects.", {"entities": []}], ["The overall quality of reporting was poor, with insufficient information on the methodology or outcomes.", {"entities": []}], ["Seven studies received industry sponsorship.", {"entities": []}], ["Data concerning remission rates for citalopram, relative to placebo, are inconclusive.", {"entities": []}], ["Response rates and symptom reduction scores in citalopram-treated patients with MDD are significantly better relative to placebo treatment, according to a meta-analysis of published reports.", {"entities": []}], ["Evaluation of unpublished data is necessary to assess more definitively the effectiveness of citalopram for MDD.", {"entities": []}], ["Systematic review and meta-analysis of published randomised double-blind studies comparing citalopram with placebo in adults with major depressive disorder (MDD).", {"entities": [[130, 155, "DISEASE"]]}], ["Evaluation of the quality of published studies and the risk of bias.", {"entities": []}], ["Data on remission rates for citalopram in MDD, relative to placebo, are inconclusive Response rates and symptom improvement scores are significantly better in citalopram-treated patients than in those taking placebo.", {"entities": []}], ["The quality of reporting in published studies is poor.", {"entities": []}], ["Further evaluation of citalopram is necessary, incorporating unpublished research.", {"entities": []}], ["This review is based on a thorough search for published placebo-controlled studies of citalopram for adults with MDD, using a broad search strategy.", {"entities": []}], ["In a departure from previously published reviews, this study assesses the risk of bias and includes remission as a primary outcome.", {"entities": []}], ["This study would have been enhanced if the missing data were available for a more complete analysis, and unpublished studies satisfying inclusion criteria were incorporated into this review.", {"entities": []}], ["This review was carried out by a single author.", {"entities": []}], ["Asthma is a disease characterized by intermittent bronchoconstriction due to increased airway reactivity to both allergic and nonallergic stimuli.", {"entities": [[0, 6, "DISEASE"]]}], ["Most asthma exacerbations that result in hospitalization are associated with viral upper respiratory tract infections.", {"entities": [[5, 11, "DISEASE"]]}], ["Such infections typically induce T-helper type 1 (T(H)1) responses in the airway, involving activation of nuclear factor-kappaB (NF-Kappa B).", {"entities": []}], ["However, a more recently appreciated cause of asthma exacerbation is exposure to pollutants, including ozone and various components of particulate matter (PM), including transition metals, diesel exhaust, and biologicals such as endotoxin.", {"entities": [[46, 52, "DISEASE"]]}], ["Although the role of air toxics in asthma pathogenesis remains incompletely examined, many components of PM that are active exacerbants of asthma are also prominent air toxics (metal ions and organic residues).", {"entities": [[35, 41, "DISEASE"], [139, 145, "DISEASE"]]}], ["These agents have been observed to activate NF-Kappa B.", {"entities": []}], ["Reviewed in this article are the actions of specific air pollutants on airway inflammation in humans and potential common response pathways for ozone, PM, and several air toxics.", {"entities": []}], ["Non-human primates are the animals closest to humans for use in influenza A virus challenge studies, in terms of their phylogenetic relatedness, physiology and immune systems.", {"entities": [[64, 73, "DISEASE"]]}], ["Previous studies have shown that cynomolgus macaques ( Macaca fascicularis ) are permissive for infection with H1N1pdm influenza virus.", {"entities": [[119, 128, "DISEASE"]]}], ["These studies have typically used combined challenge routes, with the majority being intra-tracheal delivery, and high doses of virus (> 10", {"entities": []}], ["Resolution of inflammation is an active process mediated by pro-resolution lipid mediators.", {"entities": []}], ["Since resolvin (Rv) D1 is produced in the cornea, pro-resolution mediators could be effective in regulating inflammatory responses to histamine in allergic conjunctivitis.", {"entities": [[147, 170, "DISEASE"], [156, 170, "DISEASE"]]}], ["Two key mediators of resolution are the D-series resolvins RvD1 or aspirin-triggered RvD1 (AT-RvD1).", {"entities": []}], ["We used cultured conjunctival goblet cells to determine whether histamine actions can be terminated during allergic responses.", {"entities": []}], ["We found cross-talk between two types of G protein-coupled receptors, as RvD1 interacts with its receptor GPR32 to block histamine-stimulated H 1 receptor increases in intracellular [Ca i ) preventing H 1 receptor-mediated responses.", {"entities": [[106, 111, "GENE"]]}], ["In human and rat conjunctival goblet cells RvD1 and AT-RvD1 each block histamine-stimulated secretion by preventing its increase in [Ca i and activation of extracellular regulated protein kinase (ERK)1/2.", {"entities": []}], ["We suggest that D-series resolvins regulate histamine responses in the eye and offer new treatment approaches for allergic conjunctivitis or other histamine-dependent pathologies.", {"entities": [[114, 137, "DISEASE"], [123, 137, "DISEASE"]]}], ["Conditional knockout mice are a useful tool to study the function of gene products in a tissue-specific or inducible manner.", {"entities": []}], ["Classical approaches to generate targeting vectors for conditional alleles are often limited by the availability of suitable restriction sites.", {"entities": []}], ["Furthermore, plasmid-based targeting vectors can only cover a few kB of DNA which precludes the generation of targeting vectors where the two lox P sites are placed far apart.", {"entities": []}], ["These limitations have been overcome in the recent past by using homologous recombination of bacterial artificial chromosomes (BACs) in Escherichia coli to produce large targeting vector containing two different lox P-flanked selection cassettes so that a single targeting event is sufficient to introduce lox P-sites a great distances into the mouse genome.", {"entities": []}], ["However, the final targeted allele should be free of selection cassettes and screening for correct removal of selection cassettes can be a laborious task.", {"entities": []}], ["Therefore, we developed a new strategy to rapidly identify ES cells containing the desired allele.", {"entities": []}], ["Using BAC recombineering we generated a single targeting vector which contained two different selection cassettes that were flanked by lox P- lox P sites or by FRT-FRT/ lox P sites so that they could be deleted sequentially by Cre- and FLPe-recombinases, respectively.", {"entities": []}], ["Transfected ES cells were first selected in the presence of both antibiotics in vitro before correctly targeted clones were identified by Southern blot.", {"entities": []}], ["After transfection of a Cre recombinase expression plasmid ES cell clones were selected on replicate plates to identify those clones which maintained the FRT-FRT/ lox P flanked cassette and lost the lox P- lox P flanked cassette.", {"entities": []}], ["Using this strategy facilitated the identification of ES cell clones containing the desired allele before blastocyst injection.", {"entities": []}], ["The strategy of ES cell cultures in replicate plates proved to be very efficient in identifying ES cells that had undergone the correct recombination event.", {"entities": []}], ["This approach facilitates the generation of conditional knock-out mice when large parts of the genome are intended to be flanked by lox P sites.", {"entities": []}], ["Clinical decision support systems (DSS) aimed at supporting diagnosis are not widely used.", {"entities": []}], ["This is mainly due to usability issues and lack of integration into clinical work and the electronic health record (EHR).", {"entities": []}], ["In this study we examined the usability and acceptability of a diagnostic DSS prototype integrated with the EHR and in comparison with the EHR alone.", {"entities": []}], ["Thirty-four General Practitioners (GPs) consulted with 6 standardised patients (SPs) using only their EHR system (baseline session); on another day, they consulted with 6 different but matched for difficulty SPs, using the EHR with the integrated DSS prototype (DSS session).", {"entities": []}], ["GPs were interviewed twice (at the end of each session), and completed the Post-Study System Usability Questionnaire at the end of the DSS session.", {"entities": []}], ["The SPs completed the Consultation Satisfaction Questionnaire after each consultation.", {"entities": []}], ["The majority of GPs (74%) found the DSS useful: it helped them consider more diagnoses and ask more targeted questions.", {"entities": []}], ["They considered three user interface features to be the most useful: (1) integration with the EHR; (2) suggested diagnoses to consider at the start of the consultation and; (3) the checklist of symptoms and signs in relation to each suggested diagnosis.", {"entities": []}], ["There were also criticisms: half of the GPs felt that the DSS changed their consultation style, by requiring them to code symptoms and signs while interacting with the patient.", {"entities": []}], ["SPs sometimes commented that GPs were looking at their computer more than at them; this comment was made more often in the DSS session (15%) than in the baseline session (3%).", {"entities": []}], ["Nevertheless, SP ratings on the satisfaction questionnaire did not differ between the two sessions.", {"entities": []}], ["To use the DSS effectively, GPs would need to adapt their consultation style, so that they code more information during rather than at the end of the consultation.", {"entities": []}], ["This presents a potential barrier to adoption.", {"entities": []}], ["Training GPs to use the system in a patient-centred way, as well as improvement of the DSS interface itself, could facilitate coding.", {"entities": []}], ["To enhance patient acceptability, patients should be informed about the potential of the DSS to improve diagnostic accuracy.", {"entities": []}], ["The online version of this article (doi:10.1186/s12911-017-0477-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Our knowledge and understanding of the tumor microenvironment (TME) have been recently expanded with the recognition of the important role of innate lymphoid cells (ILC).", {"entities": []}], ["Three different groups of ILC have been described based on their ability to produce cytokines that mediate the interactions between innate and adaptive immune cells in a variety of immune responses in infection, allergy, and autoimmunity.", {"entities": []}], ["However, recent evidence from experimental models and clinical studies has demonstrated that ILC contribute to the mechanisms that generate suppressive or tolerant environments that allow tumor regression or progression.", {"entities": []}], ["Defining the complex network of interactions and crosstalk of ILC with other immune cells and understanding the specific contributions of each type of ILC leading to tumor development will allow the manipulation of their function and will be important to develop new interventions and therapeutic strategies.", {"entities": []}], ["Age-associated disability reduces quality of life in older populations and leads to wide-range implications for social and health policy.", {"entities": []}], ["The identification of diseases that contribute to the disability burden is crucial to the development of prevention and intervention strategies to reduce disability.", {"entities": []}], ["In this study, we assessed the contribution of chronic diseases to the prevalence of disability in Belgium.", {"entities": []}], ["Data from 35,837 individuals aged 15\u00a0years or older who participated in the 1997, 2001, 2004, or 2008 Belgian Health Interview Surveys were used.", {"entities": []}], ["Disability was defined as difficulties in doing at least one of six activities of daily living (transfer in and out of bed, transfer in and out of chair, dressing, washing hands and face, feeding, and going to the toilet) and/or mobility limitations (ability to walk without stopping less than 200\u00a0m).", {"entities": []}], ["Multiple additive regression models were fitted separately for men and women to estimate the age-specific background disability rate (experienced by everyone, independent of the presence of specific diseases) and disease-specific disability rates (disability rate in subjects who reported selected chronic diseases).", {"entities": []}], ["Musculoskeletal, cardiovascular, and respiratory diseases were the main contributors to the disability burden in Belgium.", {"entities": []}], ["Musculoskeletal diseases were the most prevalent diseases in men and women in all age groups.", {"entities": []}], ["Neurological diseases and stroke were the most disabling diseases, i.e.", {"entities": []}], ["caused the highest level of disability among the diseased individuals, in all age groups for men and women, respectively.", {"entities": []}], ["Back pain was the main cause of disability in men aged 15 to 64\u00a0years, while heart attack was the major contributor to the disability prevalence in men aged 65 or older.", {"entities": []}], ["Likewise, arthritis was the main cause of disability among women across all age groups.", {"entities": [[10, 19, "DISEASE"]]}], ["Depression was also an important contributor in young subjects (15\u201354 years).", {"entities": []}], ["Cancer was not an important contributor to the disability prevalence in Belgium.", {"entities": []}], ["To reduce the burden of disability in Belgium, interventions should target musculoskeletal, cardiovascular and respiratory diseases especially among elderly.", {"entities": []}], ["Furthermore, attention should also be given to depression in young individuals.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-1574-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Piperlongumine, a natural alkaloid isolated from the long pepper, selectively increases reactive oxygen species production and apoptotic cell death in cancer cells but not in normal cells.", {"entities": [[151, 157, "DISEASE"]]}], ["However, the molecular mechanism underlying piperlongumine-induced selective killing of cancer cells remains unclear.", {"entities": [[88, 94, "DISEASE"]]}], ["In the present study, we observed that human breast cancer MCF-7 cells are sensitive to piperlongumine-induced apoptosis relative to human MCF-10A breast epithelial cells.", {"entities": [[45, 58, "DISEASE"], [52, 58, "DISEASE"]]}], ["Interestingly, this opposing effect of piperlongumine appears to be mediated by heme oxygenase-1 (HO-1).", {"entities": []}], ["Piperlongumine upregulated HO-1 expression through the activation of nuclear factor-erythroid-2-related factor-2 (Nrf2) signaling in both MCF-7 and MCF-10A cells.", {"entities": []}], ["However, knockdown of HO-1 expression and pharmacological inhibition of its activity abolished the ability of piperlongumine to induce apoptosis in MCF-7 cells, whereas those promoted apoptosis in MCF-10A cells, indicating that HO-1 has anti-tumor functions in cancer cells but cytoprotective functions in normal cells.", {"entities": [[261, 267, "DISEASE"]]}], ["Moreover, it was found that piperlongumine-induced Nrf2 activation, HO-1 expression and cancer cell apoptosis are not dependent on the generation of reactive oxygen species.", {"entities": [[88, 94, "DISEASE"]]}], ["Instead, piperlongumine, which bears electrophilic \u03b1,\u03b2-unsaturated carbonyl groups, appears to inactivate Kelch-like ECH-associated protein-1 (Keap1) through thiol modification, thereby activating the Nrf2/HO-1 pathway and subsequently upregulating HO-1 expression, which accounts for piperlongumine-induced apoptosis in cancer cells.", {"entities": [[321, 327, "DISEASE"], [143, 148, "GENE"]]}], ["Taken together, these findings suggest that direct interaction of piperlongumine with Keap1 leads to the upregulation of Nrf2-mediated HO-1 expression, and HO-1 determines the differential response of breast normal cells and cancer cells to piperlongumine.", {"entities": [[225, 231, "DISEASE"], [86, 91, "GENE"]]}], ["The imidazoquinoline derivate imiquimod induces inflammatory responses and protection against transplanted tumors when applied to the skin in combination with a cognate peptide epitope (transcutaneous immunization, TCI).", {"entities": []}], ["Here we investigated the role of regulatory T cells (T reg ) and the suppressive cytokine IL-10 in restricting TCI-induced cytotoxic T lymphocyte (CTL) responses.", {"entities": []}], ["TCI was performed with an ointment containing the TLR7 agonist imiquimod and a CTL epitope was applied to the depilated back skin of C57BL/6 mice.", {"entities": [[50, 54, "GENE"]]}], ["Using specific antibodies and FoxP3-diphteria toxin receptor transgenic (DEREG) mice, we interrogated inhibiting factors after TCI: by depleting FoxP3 reg in IL-10 reg and B cells as source of IL-10 in the setting of TCI.", {"entities": [[30, 35, "GENE"], [145, 150, "GENE"]]}], ["We identify T reg and IL-10 as two important and independently acting suppressors of CTL-responses induced by transcutaneous immunization.", {"entities": []}], ["Advanced vaccination strategies inhibiting T reg function and IL-10 release may lead the development of effective vaccination protocols aiming at the induction of T cell responses suitable for the prophylaxis or treatment of persistent infections or tumors.", {"entities": []}], ["A review of the health effects of relative humidity in indoor environments suggests that relative humidity can affect the incidence of respiratory infections and allergies.", {"entities": []}], ["Experimental studies on airborne-transmitted infectious bacteria and viruses have shown that the survival or infectivity of these organisms is minimized by exposure to relative humidities between 40 and 70%.", {"entities": []}], ["Nine epidemiological studies examined the relationship between the number of respiratory infections or absenteeism and the relative humidity of the office, residence, or school.", {"entities": []}], ["The incidence of absenteeism or respiratory infections was found to be lower among people working or living in environments with mid-range versus low or high relative humidities.", {"entities": []}], ["The indoor size of allergenic mite and fungal populations is directly dependent upon the relative humidity.", {"entities": []}], ["Mite populations are minimized when the relative humidity is below 50% and reach a maximum size at 80% relative humidity.", {"entities": []}], ["Most species of fungi cannot grow unless the relative humidity exceeds 60%.", {"entities": []}], ["Relative humidity also affects the rate of offgassing of formaldehyde from indoor building materials, the rate of formation of acids and salts from sulfur and nitrogen dioxide, and the rate of formation of ozone.", {"entities": []}], ["The influence of relative humidity on the abundance of allergens, pathogens, and noxious chemicals suggests that indoor relative humidity levels should be considered as a factor of indoor air quality.", {"entities": []}], ["The majority of adverse health effects caused by relative humidity would be minimized by maintaining indoor levels between 40 and 60%.", {"entities": []}], ["This would require humidification during winter in areas with cold winter climates.", {"entities": []}], ["Humidification should preferably use evaporative or steam humidifiers, as cool mist humidifiers can disseminate aerosols contaminated with allergens.", {"entities": []}], ["We observed a panel of 133 children (5-13 years of age) with asthma residing in the greater Seattle, Washington, area for an average of 58 days (range 28-112 days) during screening for enrollment in the Childhood Asthma Management Program (CAMP) study.", {"entities": [[61, 67, "DISEASE"], [213, 219, "DISEASE"]]}], ["Daily self-reports of asthma symptoms were obtained from study diaries and compared with ambient air pollution levels in marginal repeated measures logistic regression models.", {"entities": [[22, 28, "DISEASE"]]}], ["We defined days with asthma symptoms as any day a child reported at least one mild asthma episode.", {"entities": [[21, 27, "DISEASE"], [83, 89, "DISEASE"]]}], ["All analyses were controlled for subject-specific variables [age, race, sex, baseline height, and FEV(1) PC(20) concentration (methacholine provocative concentration required to produce a 20% decrease in forced expiratory volume in 1 sec)] and potential time-dependent confounders (day of week, season, and temperature).", {"entities": [[98, 101, "GENE"], [105, 107, "GENE"]]}], ["Because of variable observation periods for participants, we estimated both between- and within-subject air pollutant effects.", {"entities": []}], ["Our primary interest was in the within-subject effects: the effect of air pollutant excursions from typical levels in each child's observation period on the odds of asthma symptoms.", {"entities": [[165, 171, "DISEASE"]]}], ["In single-pollutant models, the population average estimates indicated a 30% [95% confidence interval (CI), 11-52%] increase for a 1-ppm increment in carbon monoxide lagged 1 day, an 18% (95% CI, 5-33%) increase for a 10-microg/m(3) increment in same-day particulate matter < 1.0 microm (PM(1.0)), and an 11% (95% CI, 3-20%) increase for a 10-microg/m(3) increment in particulate matter < 10 microm (PM(10)) lagged 1 day.", {"entities": []}], ["Conditional on the previous day's asthma symptoms, we estimated 25% (95% CI, 10-42%), 14% (95% CI, 4-26%), and 10% (95% CI, 3-16%) increases in the odds of asthma symptoms associated with increases in CO, PM(1.0), and PM(10), respectively.", {"entities": [[34, 40, "DISEASE"], [156, 162, "DISEASE"]]}], ["We did not find any association between sulfur dioxide (SO(2)) and the odds of asthma symptoms.", {"entities": [[79, 85, "DISEASE"]]}], ["In multipollutant models, the separate pollutant effects were smaller.", {"entities": []}], ["The overall effect of an increase in both CO and PM(1.", {"entities": []}], ["0) was a 31% (95% CI, 11-55%) increase in the odds of symptoms of asthma.", {"entities": [[66, 72, "DISEASE"]]}], ["We conclude that there is an association between change in short-term air pollution levels, as indexed by PM and CO, and the occurrence of asthma symptoms among children in Seattle.", {"entities": [[139, 145, "DISEASE"]]}], ["Although PM effects on asthma have been found in other studies, it is likely that CO is a marker for vehicle exhaust and other combustion by-products that aggravate asthma.", {"entities": [[23, 29, "DISEASE"], [165, 171, "DISEASE"]]}], ["In observational research, evidence is usually derived from multiple studies, and any single result is rarely considered sufficient for public health decision making.", {"entities": []}], ["Despite more than five decades of research and thousands of studies published, the ability to draw robust conclusions regarding the presence or absence of causal links between specific environmental exposures and human health remains limited.", {"entities": []}], ["To develop policies that are protective of public health and can withstand scrutiny, agencies need to rely on investigations of satisfactory quality that follow sufficiently concordant protocols in terms of exposure assessment, outcome ascertainment, data analysis, and reporting of results.", {"entities": []}], ["Absent such concordance, the ability of environmental epidemiology studies to inform decision making is greatly diminished.", {"entities": []}], ["Systems and tools are proposed here to improve concordance among environmental epidemiology studies.", {"entities": []}], ["Specifically, working systems in place in other fields of research are critically examined and used as guidelines to develop analogous policies and procedures for environmental epidemiology.", {"entities": []}], ["A three-part path forward toward more concordant, transparent, and readily accessible environmental epidemiology evidence that parallels ongoing efforts in medical research is proposed.", {"entities": []}], ["The three parts address methods for improving quality and accessibility of systematic reviews, access to information on ongoing and completed studies, and principles for reporting.", {"entities": []}], ["The goals are to increase the value of epidemiological research in public health decision making and to stimulate discussions around solutions proposed herein.", {"entities": []}], ["Despite the fact that numerous researches were performed on prevention and treatment of inflammation related diseases, the overall incidence has not changed remarkably.", {"entities": []}], ["This requires new approaches to overcome inflammation mediated diseases, and thus traditional medicine could be an efficacious source for prevention and treatment of these diseases.", {"entities": []}], ["In this review, we discuss the contribution of traditional medicine, especially Rhus verniciflua Stokes, to modern medicine against diverse inflammation mediated diseases.", {"entities": []}], ["Traditionally, this remedy has been used in Eastern Asia for the treatment of gastric problems, hepatic disorders, infectious diseases, and blood disorders.", {"entities": []}], ["Modern science has provided the scientific basis for the use of Rhus verniciflua Stokes against such disorders and diseases.", {"entities": []}], ["Various chemical constituents have been identified from this plant, including phenolic acid, and flavonoids.", {"entities": []}], ["Cell-based studies have exhibited the potential of this as antibacterial, antioxidant, neuroprotective, anti-inflammatory, growth inhibitory, and anticancer activities.", {"entities": []}], ["Enormous animal studies have shown the potential of this against proinflammatory diseases, neurodegenerative diseases, diabetes, liver diseases, and chemical insults.", {"entities": []}], ["At the molecular level, this medicinal plant has been shown to modulate diverse cell-signaling pathways.", {"entities": []}], ["In clinical studies, Rhus verniciflua Stokes has shown efficacy against various cancer patients such as colorectal, gastric, hepatic, renal, pancreatic, and pulmonary cancers.", {"entities": [[80, 86, "DISEASE"]]}], ["Thus, this remedy is now exhibiting activities in the clinic.", {"entities": []}], ["Extracts of Salacia reticulata Wight (Hypocrataceae) roots, stems, and leaves have been used in Asia for hundreds of years for the folkloric treatment of diabetes and other health problems.", {"entities": []}], ["Constituents that have been identified as exhibiting anti\u2010diabetic effects include salacinol, kotalanol, ponkorinol, salaprinol, and their corresponding de\u20100\u2010sulfonated compounds.", {"entities": []}], ["Mangiferin, kotalagenin 16\u2010acetate and various proanthocyanidin oligomers have also been isolated.", {"entities": []}], ["Studies indicate that Salacia extracts modulate multiple targets that influence carbohydrate and lipid metabolism including \u03b1\u2010glucosidase, aldose reductase, pancreatic lipase, peroxisomal proliferator\u2010activated receptor\u2010\u03b1, glucose transporter\u20104 mediated glucose uptake, and angiotensin II type 1 receptor.", {"entities": []}], ["Furthermore, Salacia extracts exhibit free radical scavenging, antioxidant and hepatoprotectant activities.", {"entities": []}], ["In human studies, Salacia extracts have been shown to decrease plasma glucose and insulin levels, decrease HbA1c, and modulate serum lipid levels with no adverse effects being reported.", {"entities": []}], ["Similar results have been demonstrated in rat and mouse models as well as in vitro systems.", {"entities": []}], ["Safety of S.\u2009reticulata and other Salacia species as S.\u2009oblonga and S.\u2009chinensis in rats and mice indicate that extracts are exceedingly safe.", {"entities": []}], ["No clinical studies have examined the effects of Salacia extracts on human weight loss, although weight loss and decreases in weight gain have been demonstrated in animal models.", {"entities": []}], ["Because of the large number of pharmacologically active compounds, it is difficult to establish standards for extracts.", {"entities": []}], ["\u00a9 2015 The Authors.", {"entities": []}], ["Phytotheraphy Research published by John Wiley & Sons Ltd.", {"entities": []}], ["Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is a powerful method for the analysis of gene expression.", {"entities": []}], ["Target gene expression levels are usually normalized to a consistently expressed reference gene also known as internal standard, in the same sample.", {"entities": []}], ["However, much effort has not been expended thus far in the search for reference genes suitable for the study of stomach cancer using RT-qPCR, although selection of optimal reference genes is critical for interpretation of results.", {"entities": [[112, 126, "DISEASE"], [120, 126, "DISEASE"]]}], ["We assessed the suitability of six possible reference genes, beta-actin (ACTB), glyceraldehydes-3-phosphate dehydrogenase (GAPDH), hypoxanthine phosphoribosyl transferase 1 (HPRT1), beta-2-microglobulin (B2M), ribosomal subunit L29 (RPL29) and 18S ribosomal RNA (18S rRNA) in 20 normal and tumor stomach tissue pairs of stomach cancer patients and 6 stomach cancer cell lines, by RT-qPCR.", {"entities": [[320, 334, "DISEASE"], [350, 364, "DISEASE"], [328, 334, "DISEASE"], [358, 364, "DISEASE"], [73, 77, "GENE"], [123, 128, "GENE"], [174, 179, "GENE"], [204, 207, "GENE"], [233, 238, "GENE"]]}], ["Employing expression stability analyses using NormFinder and geNorm algorithms we determined the order of performance of these reference genes and their variation values.", {"entities": []}], ["This RT-qPCR study showed that there are statistically significant ( p < 0.05) differences in the expression levels of HPRT1 and 18S rRNA in 'normal-' versus 'tumor stomach tissues'.", {"entities": [[119, 124, "GENE"]]}], ["The stability analyses by geNorm suggest B2M-GAPDH, as best reference gene combination for 'stomach cancer cell lines'; RPL29-HPRT1, for 'all stomach tissues'; and ACTB-18S rRNA, for 'all stomach cell lines and tissues'.", {"entities": [[92, 106, "DISEASE"], [100, 106, "DISEASE"]]}], ["NormFinder also identified B2M as the best reference gene for 'stomach cancer cell lines', RPL29-B2M for 'all stomach tissues', and 18S rRNA-ACTB for 'all stomach cell lines and tissues'.", {"entities": [[63, 77, "DISEASE"], [71, 77, "DISEASE"], [27, 30, "GENE"], [97, 100, "GENE"]]}], ["The comparisons of normalized expression of the target gene, GPNMB, showed different interpretation of target gene expression depend on best single reference gene or combination.", {"entities": [[61, 66, "GENE"]]}], ["This study validated RPL29 and RPL29-B2M as the best single reference genes and combination, for RT-qPCR analysis of 'all stomach tissues', and B2M and B2M-GAPDH as the best single reference gene and combination, for 'stomach cancer cell lines'.", {"entities": [[218, 232, "DISEASE"], [226, 232, "DISEASE"], [21, 26, "GENE"], [31, 36, "GENE"], [37, 40, "GENE"], [144, 147, "GENE"], [152, 155, "GENE"]]}], ["Use of these validated reference genes should provide more exact interpretation of differential gene expressions at transcription level in stomach cancer.", {"entities": [[139, 153, "DISEASE"], [147, 153, "DISEASE"]]}], ["The abundance of health information available online provides consumers with greater access to information pertinent to the management of health conditions.", {"entities": []}], ["This is particularly important given an increasing drive for consumer-focused health care models globally, especially in the management of chronic health conditions, and in recognition of challenges faced by lay consumers with finding, understanding, and acting on health information sourced online.", {"entities": []}], ["There is a paucity of literature exploring the navigational needs of consumers with regards to accessing online health information.", {"entities": []}], ["Further, existing interventions appear to be didactic in nature, and it is unclear whether such interventions appeal to consumers\u2019 needs.", {"entities": []}], ["Our goal was to explore the navigational needs of consumers with chronic health conditions in finding online health information within the broader context of consumers\u2019 online health information-seeking behaviors.", {"entities": []}], ["Potential barriers to online navigation were also identified.", {"entities": []}], ["Semistructured interviews were conducted with adult consumers who reported using the Internet for health information and had at least one chronic health condition.", {"entities": []}], ["Participants were recruited from nine metropolitan community pharmacies within Western Australia, as well as through various media channels.", {"entities": []}], ["Interviews were audio-recorded, transcribed verbatim, and then imported into QSR NVivo 10.", {"entities": []}], ["Two established approaches to thematic analysis were adopted.", {"entities": []}], ["First, a data-driven approach was used to minimize potential bias in analysis and improve construct and criterion validity.", {"entities": []}], ["A theory-driven approach was subsequently used to confirm themes identified by the former approach and to ensure identified themes were relevant to the objectives.", {"entities": []}], ["Two levels of analysis were conducted for both data-driven and theory-driven approaches: manifest-level analysis, whereby face-value themes were identified, and latent-level analysis, whereby underlying concepts were identified.", {"entities": []}], ["We conducted 17 interviews, with data saturation achieved by the 14th interview.", {"entities": []}], ["While we identified a broad range of online health information-seeking behaviors, most related to information discussed during consumer-health professional consultations such as looking for information about medication side effects.", {"entities": []}], ["The barriers we identified included intrinsic barriers, such as limited eHealth literacy, and extrinsic barriers, such as the inconsistency of information between different online sources.", {"entities": []}], ["The navigational needs of our participants were extrinsic in nature and included health professionals directing consumers to appropriate online resources and better filtering of online health information.", {"entities": []}], ["Our participants\u2019 online health information-seeking behaviors, reported barriers, and navigational needs were underpinned by the themes of trust, patient activation, and relevance.", {"entities": []}], ["This study suggests that existing interventions aimed to assist consumers with navigating online health information may not be what consumers want or perceive they need.", {"entities": []}], ["eHealth literacy and patient activation appear to be prevalent concepts in the context of consumers\u2019 online health information-seeking behaviors.", {"entities": []}], ["Furthermore, the role for health professionals in guiding consumers to quality online health information is highlighted.", {"entities": []}], ["To describe the clinical picture, test results, and clinical evolution of patients with cerebral palsy associated with diagnosis of eosinophilic esophagitis, monitored at tertiary centre.", {"entities": [[145, 156, "DISEASE"], [88, 102, "DISEASE"], [132, 156, "DISEASE"]]}], ["Cross-sectional, retrospective and descriptive study that evaluated the medical records data of pediatric patients with diagnosis of cerebral palsy and eosinophilic esophagitis in a tertiary center of pediatric gastroenterology between August 2005 and August 2013.", {"entities": [[165, 176, "DISEASE"], [133, 147, "DISEASE"], [152, 176, "DISEASE"]]}], ["Seven out of 131 patients with cerebral palsy had the diagnosis of eosinophilic esophagitis.", {"entities": [[80, 91, "DISEASE"], [31, 45, "DISEASE"], [67, 91, "DISEASE"]]}], ["The mean age at diagnosis of eosinophilic esophagitis was 52.3 months and the mean number of eosinophils in esophagus was 35 per high-power field.", {"entities": [[42, 53, "DISEASE"], [29, 53, "DISEASE"]]}], ["Symptoms more frequent were recurrent vomiting and disphagia.", {"entities": []}], ["Endoscopic alterations found were mucosal thickening, vertical lines, mucosal opacificacion and white plaques.", {"entities": []}], ["The frequency of eosinophilic esophagitis found was higher than in general pediatric population.", {"entities": [[30, 41, "DISEASE"], [17, 41, "DISEASE"]]}], ["The investigation of eosinophilic esophagitis should be done regularly in those patients, once this entity could overlap other gastrointestinal diseases.", {"entities": [[34, 45, "DISEASE"], [21, 45, "DISEASE"]]}], ["Descrever quadro cl\u00ednico, resultados dos exames e evolu\u00e7\u00e3o cl\u00ednica de pacientes com paralisia cerebral associada ao diagn\u00f3stico de esofagite eosinof\u00edlica, monitorados em um centro terci\u00e1rio.", {"entities": []}], ["Estudo transversal, retrospectivo e descritivo, que avaliou os prontu\u00e1rios m\u00e9dicos de pacientes pedi\u00e1tricos com diagn\u00f3stico de paralisia cerebral e esofagite eosinof\u00edlica, atendidos em um centro terci\u00e1rio de gastrenterologia pedi\u00e1trica, entre agosto de 2005 e agosto de 2013.", {"entities": []}], ["Dos 131 pacientes com paralisia cerebral, 7 tiveram o diagn\u00f3stico de esofagite eosinof\u00edlica no per\u00edodo estudado.", {"entities": []}], ["A idade m\u00e9dia no momento do diagn\u00f3stico de esofagite eosinof\u00edlica foi 52,3 meses, e o n\u00famero m\u00e9dio de eosin\u00f3filos no es\u00f4fago foi de 35 por campo de grande aumento.", {"entities": [[135, 138, "GENE"]]}], ["Os sintomas mais frequentes associados foram v\u00f4mitos recorrentes e disfagia.", {"entities": []}], ["As altera\u00e7\u00f5es endosc\u00f3picas encontradas foram espessamento da mucosa, linhas verticais, opacifica\u00e7\u00e3o da mucosa e as placas esbranqui\u00e7adas.", {"entities": []}], ["A frequ\u00eancia de esofagite eosinof\u00edlica encontrada foi maior que na popula\u00e7\u00e3o pedi\u00e1trica em geral.", {"entities": []}], ["A investiga\u00e7\u00e3o de esofagite eosinof\u00edlica deve ser realizada regularmente nos pacientes com paralisia cerebral, pois pode haver uma sobreposi\u00e7\u00e3o de sintomas de outras doen\u00e7as gastrintestinais.", {"entities": []}], ["A recent upsurge of malaria in endemic-disease areas with explosive epidemics in many parts of Africa is probably caused by many factors, including rapidly spreading resistance to antimalarial drugs, climatic changes, and population movements.", {"entities": [[20, 27, "DISEASE"]]}], ["In Africa, malaria is caused by Plasmodium falciparum and is transmitted by Anopheles gambiae complex.", {"entities": [[11, 18, "DISEASE"]]}], ["Control efforts have been piecemeal and not coordinated.", {"entities": []}], ["Strategies for control should have a solid research base both for developing antimalarial drugs and vaccines and for better understanding the pathogenesis, vector dynamics, epidemiology, and socioeconomic aspects of the disease.", {"entities": []}], ["An international collaborative approach is needed to build appropriate research in a national context and to effectively translate research results into practical applications in the field.", {"entities": []}], ["The Multilateral Initiative for Malaria in Africa can combine all of the above strategies to plan and coordinate partnerships, networking, and innovative approaches between African scientists and their Northern partners.", {"entities": [[32, 39, "DISEASE"]]}], ["Mast cell numbers and allergen specific IgE are increased in the lungs of patients with allergic asthma and this can be reproduced in mouse models.", {"entities": [[88, 103, "DISEASE"], [97, 103, "DISEASE"]]}], ["The increased number of mast cells is likely due to recruitment of mast cell progenitors that mature in situ .", {"entities": []}], ["We hypothesized that formation of IgE immune complexes in the lungs of sensitized mice increase the migration of mast cell progenitors to this organ.", {"entities": []}], ["To study this, a model of allergic airway inflammation where mice were immunized with ovalbumin (OVA) in alum twice followed by three daily intranasal challenges of either OVA coupled to trinitrophenyl (TNP) alone or as immune complexes with IgE-anti-TNP, was used.", {"entities": []}], ["Mast cell progenitors were quantified by a limiting dilution assay.", {"entities": []}], ["IgE immune complex challenge of sensitized mice elicited three times more mast cell progenitors per lung than challenge with the same dose of antigen alone.", {"entities": []}], ["This dose of antigen challenge alone did not increase the levels of mast cell progenitors compared to unchallenged mice.", {"entities": []}], ["IgE immune complex challenge of sensitized mice also enhanced the frequency of mast cell progenitors per 10", {"entities": []}], ["We describe a patient with Churg-Strauss syndrome who developed unilateral anterior ischemic optic neuropathy.", {"entities": [[99, 109, "DISEASE"], [41, 49, "DISEASE"], [84, 109, "DISEASE"]]}], ["A 54-year-old man with a history of bronchial asthma, allergic rhinitis, and sinusitis presented with sudden decreased visual acuity in his right eye that had begun 2 weeks previously.", {"entities": [[54, 71, "DISEASE"], [63, 71, "DISEASE"], [77, 86, "DISEASE"], [46, 52, "DISEASE"]]}], ["The visual acuity of his right eye was 20 / 50.", {"entities": []}], ["Ophthalmoscopic examination revealed a diffusely swollen right optic disc and splinter hemorrhages at its margin.", {"entities": []}], ["Goldmann perimetry showed central scotomas in the right eye and fluorescein angiography showed remarkable hyperfluorescence of the right optic nerve head.", {"entities": []}], ["Marked peripheral eosinphilia, extravascular eosinophils in a bronchial biopsy specimen, and an increased sedimentation rate supported the diagnosis of Churg-Strauss syndrome.", {"entities": [[166, 174, "DISEASE"]]}], ["Therapy with methylprednisolone corrected the laboratory abnormalities, improved clinical features, and preserved vision, except for the right central visual field defect.", {"entities": []}], ["Early recognition of this systemic disease by ophthalmologists may help in preventing severe ocular complications.", {"entities": []}], ["Cancer cells are characterized by massive dysegulation of physiological cell functions with considerable disruption of transcriptional regulation.", {"entities": [[0, 6, "DISEASE"]]}], ["Genome-wide transcriptome profiling can be utilized for early detection and molecular classification of cancers.", {"entities": []}], ["Accurate discrimination of functionally different tumor types may help to guide selection of targeted therapy in translational research.", {"entities": []}], ["Concise grouping of tumor types in cancer maps according to their molecular profile may further be helpful for the development of new therapeutic modalities or open new avenues for already established therapies.", {"entities": [[35, 41, "DISEASE"]]}], ["Complete available human tumor data of the Stanford Microarray Database was downloaded and filtered for relevance, adequacy and reliability.", {"entities": []}], ["A total of 649 tumor samples from more than 1400 experiments and 58 different tissues were analyzed.", {"entities": []}], ["Next, a method to score deregulation of KEGG pathway maps in different tumor entities was established, which was then used to convert hundreds of gene expression profiles into corresponding tumor-specific pathway activity profiles.", {"entities": []}], ["Based on the latter, we defined a measure for functional similarity between tumor entities, which yielded to phylogeny of tumors.", {"entities": []}], ["We provide a comprehensive, easy-to-interpret functional cancer map that characterizes tumor types with respect to their biological and functional behavior.", {"entities": [[57, 63, "DISEASE"]]}], ["Consistently, multiple pathways commonly associated with tumor progression were revealed as common features in the majority of the tumors.", {"entities": []}], ["However, several pathways previously not linked to carcinogenesis were identified in multiple cancers suggesting an essential role of these pathways in cancer biology.", {"entities": [[152, 158, "DISEASE"]]}], ["Among these pathways were 'ECM-receptor interaction', 'Complement and Coagulation cascades', and 'PPAR signaling pathway'.", {"entities": []}], ["The functional cancer map provides a systematic view on molecular similarities across different cancers by comparing tumors on the level of pathway activity.", {"entities": [[15, 21, "DISEASE"]]}], ["This work resulted in identification of novel superimposed functional pathways potentially linked to cancer biology.", {"entities": [[101, 107, "DISEASE"]]}], ["Therefore, our work may serve as a starting point for rationalizing combination of tumor therapeutics as well as for expanding the application of well-established targeted tumor therapies.", {"entities": []}], ["Psoriasis is a genetically complex, chronic inflammatory skin disease.", {"entities": [[0, 9, "DISEASE"], [57, 69, "DISEASE"]]}], ["The authors have previously identified a susceptibility locus on chromosome 19p13 (PSORS6).", {"entities": []}], ["In a follow-up linkage disequilibrium (LD) study in an independent family based cohort, the authors found evidence for association to a newly discovered microsatellite at this locus (D19SPS21, p<5.3\u00d710 HLA-C locus, evidence for association became much stronger at single SNP and haplotype levels (p values between 1.0\u00d710 MUC16 , coding for a large glycosylated protein expressed in epithelia and of unknown function, could be shown to be also expressed in tissues relevant for pathogenesis of psoriasis such as skin and thymus.", {"entities": [[493, 502, "DISEASE"], [202, 207, "GENE"], [321, 326, "GENE"]]}], ["Immunohistochemical analyses of skin revealed focal staining for MUC16 in suprabasal epidermal cells.", {"entities": [[65, 70, "GENE"]]}], ["Further functional studies are required to clarify its potential role in psoriasis and identify the causal variant(s) at this locus.", {"entities": [[73, 82, "DISEASE"]]}], ["The data establish PSORS6 as a confirmed psoriasis susceptibility locus showing interaction with PSORS1.", {"entities": [[41, 50, "DISEASE"]]}], ["Disturbances of heart rate variability (HRV) may represent one pathway by which second-hand smoke (SHS) and air pollutants affect cardiovascular morbidity and mortality.", {"entities": []}], ["The mechanisms are poorly understood.", {"entities": []}], ["We investigated the hypothesis that oxidative stress alters cardiac autonomic control.", {"entities": []}], ["We studied the association of polymorphisms in oxidant-scavenging glutathione S -transferase ( GST ) genes and their interactions with SHS and obesity with HRV.", {"entities": [[143, 150, "DISEASE"]]}], ["A total of 1,133 nonsmokers > 50 years of age from a population-based Swiss cohort underwent ambulatory 24-hr electrocardiogram monitoring and reported on lifestyle and medical history.", {"entities": []}], ["We genotyped GSTM1 and GSTT1 gene deletions and a GSTP1 (Ile105Val) single nucleotide polymorphism and analyzed genotype\u2013HRV associations by multiple linear regressions.", {"entities": [[13, 18, "GENE"], [23, 28, "GENE"], [50, 55, "GENE"]]}], ["Homozygous GSTT1 null genotypes exhibited an average 10% decrease in total power (TP) and low-frequency-domain HRV parameters.", {"entities": [[11, 16, "GENE"]]}], ["All three polymorphisms modified the cross-sectional associations of HRV with SHS and obesity.", {"entities": [[86, 93, "DISEASE"]]}], ["Homozygous GSTM1 null genotypes with > 2 hr/day of SHS exposure exhibited a 26% lower TP [95% confidence interval (CI), 11 to 39%], versus a reduction of \u22125% (95% CI, \u221222 to 17%) in subjects with the gene and the same SHS exposure compared with GSTM1 carriers without SHS exposure.", {"entities": [[11, 16, "GENE"], [245, 250, "GENE"], [11, 16, "GENE"], [245, 250, "GENE"]]}], ["Similarly, obese GSTM1 null genotypes had, on average, a 22% (95% CI, 12 to 31%) lower TP, whereas with the gene present obesity was associated with only a 3% decline (95% CI, \u221215% to 10%) compared with nonobese GSTM1 carriers.", {"entities": [[121, 128, "DISEASE"], [17, 22, "GENE"], [212, 217, "GENE"], [17, 22, "GENE"], [212, 217, "GENE"]]}], ["GST deficiency is associated with significant HRV alterations in the general population.", {"entities": []}], ["Its interaction with SHS and obesity in reducing HRV is consistent with an impact of oxidative stress on the autonomous nervous system.", {"entities": [[29, 36, "DISEASE"]]}], ["Over the last few years, a significant progress has been made in understanding the role of a disintegrin and metalloproteinase 33 (ADAM33) in asthma.", {"entities": [[142, 148, "DISEASE"], [131, 137, "GENE"]]}], ["The previous observations for the association with asthma have been replicated in over 33 different population samples worldwide.", {"entities": [[51, 57, "DISEASE"]]}], ["We and others have performed association analysis and meta-analysis and provided further evidence that several polymorphisms in the ADAM33 are risk factors for asthma, especially in the Asian population.", {"entities": [[160, 166, "DISEASE"], [132, 138, "GENE"]]}], ["Further, several studies have suggested that alterations in epigenetic marks alter the patterns of DNA methylation of ADAM33 and result in potentially adverse biological effects.", {"entities": [[118, 124, "GENE"]]}], ["Finally, while the biological activities of ADAM33 are as yet unknown, ADAM33 may play a possible role in airway remodeling because of its high expression in epithelium, myo/fibroblasts, and airway smooth muscle cells (ASMCs) and its role in promoting angiogenesis and stimulating cell proliferation and differentiation.", {"entities": [[44, 50, "GENE"], [71, 77, "GENE"], [44, 50, "GENE"], [71, 77, "GENE"]]}], ["Thus, ADAM33 represents a promising target for asthma.", {"entities": [[47, 53, "DISEASE"], [6, 12, "GENE"]]}], ["However, further investigations are clearly needed to discover functional ADAM33 gene polymorphisms and the role of genetic/epigenetic factors in conferring genetic susceptibility to environmental exposure induced asthma as well as biological function in asthma.", {"entities": [[214, 220, "DISEASE"], [255, 261, "DISEASE"], [74, 80, "GENE"]]}], ["This, in turn, will unlock the possibility of ADAM33 as a target for asthma therapy.", {"entities": [[69, 75, "DISEASE"], [46, 52, "GENE"]]}], ["Aggressive treatment with disease-modifying antirheumatic drugs (DMARDs) plays a major role in improving early rheumatoid arthritis (RA) patient outcomes.", {"entities": [[111, 131, "DISEASE"], [122, 131, "DISEASE"]]}], ["Persistence and adherence with medication occurs variably (20% to 70%).", {"entities": []}], ["The objectives of the study were to determine medication persistence (MP) in early RA patients over 13 consecutive visits each 2 months apart, to investigate the relationship between MP and disease activity, disability and structural damage, and to identify baseline prognosticators.", {"entities": []}], ["Charts from 75 patients of an early RA cohort were reviewed.", {"entities": []}], ["At each visit, a rheumatologist interviewed patients regarding therapy, scored disease activity with the 28-joint disease activity score (DAS28) and disability with the health assessment questionnaire (HAQ), and recorded comorbidities and treatment.", {"entities": []}], ["A complete medical history was obtained at baseline.", {"entities": []}], ["MP was defined as the duration of time from initiation to discontinuation of at least one DMARD and/or corticosteroids for at least 1 week and was reported as a dichotomous variable at consecutive evaluations.", {"entities": []}], ["Structural damage was defined by detection of new erosions on radiography.", {"entities": []}], ["Descriptive statistics, Student's t test, the chi-squared test, and logistic regression analyses were used.", {"entities": []}], ["The proportion of MP patients decreased from 98% at 2 months to 34% at 2 years.", {"entities": []}], ["MP patients (n = 32) had similar DAS28 to non-MP patients (n = 53) at initial visits, lower DAS28 and greater DAS28 improvements at follow-ups ( P \u2264 0.05 at visits 4, 6, 7 and 9) and reached sustained remission (\u2265 3 consecutive visits with DAS28 < 2.6) more frequently (82.8% versus 46.5%, P = 0.003) and earlier (7.7 \u00b1 4.6 versus 13.6 \u00b1 5.7 months, P = 0.001) than non-MP patients.", {"entities": []}], ["MP patients had similar baseline HAQ scores, but lower HAQ scores at follow-up ( P \u2264 0.05 at visits 3, 5, 6, 7, 9, 10 and 13).", {"entities": []}], ["More non-MP patients developed erosive disease than MP patients (26.8% versus 17.9%, P = 0.56).", {"entities": []}], ["Older age at baseline was associated with therapy discontinuation (odds ratio = 1.1, 95% confidence interval = 1.007 to 1.103, P = 0.02).", {"entities": []}], ["Discontinuation of DMARDs was frequent and progressive in an early RA cohort.", {"entities": []}], ["Patients with persistence on therapy were younger, had lower disease activity and disability during follow-up, and reached sustained remission more frequently and earlier than patients without it.", {"entities": []}], ["MP should intentionally be evaluated during follow-up of early RA patients, as it seems to play a major role in outcome.", {"entities": []}], ["Currently, a comprehensive assessment between mitochondrial DNA (mtDNA) content and cancer risk is lacking.", {"entities": [[84, 90, "DISEASE"]]}], ["We designed this meta-analysis to test the hypothesis that altered mtDNA copy number might influence genetic susceptibility to some specific types of cancer.", {"entities": [[150, 156, "DISEASE"]]}], ["The processes of literature search, eligibility appraisal and data retrieval were independently completed in duplicate.", {"entities": []}], ["The mtDNA copy number which was dichotomized or classified into tertiles was compared between cancer cases and controls.", {"entities": [[94, 100, "DISEASE"]]}], ["Twenty-six articles with 38 study groups were analyzed among 6682 cases and 9923 controls.", {"entities": []}], ["When dichotomizing mtDNA copy number at the median value, there was an 11% increased cancer risk for carriers of high mtDNA content (P\u2009=\u20090.320).", {"entities": [[85, 91, "DISEASE"]]}], ["By cancer type, high mtDNA content was associated with an increased risk for lymphoma (OR\u2009=\u20091.76; P\u2009=\u20090.023) but a reduced risk for skeleton cancer (OR\u2009=\u20090.39; P\u2009=\u20090.001).", {"entities": [[77, 85, "DISEASE"], [3, 9, "DISEASE"], [141, 147, "DISEASE"]]}], ["Carriers of the 2", {"entities": []}], ["Data for this study were obtained from a population-based follow-up study in 25 Italian Local Health Units (LHUs) to evaluate pregnancy, delivery, and postpartum care in Italy.", {"entities": []}], ["A sample of 3534 women was recruited and interviewed within a few days of their giving birth and at 3, 6, and 12 months after delivery, by trained interviewers using questionnaires.", {"entities": []}], ["The objective of the study was to evaluate changes in smoking behaviour from one interview to the next.", {"entities": []}], ["Of 2546 women who completed the follow-up, smoking prevalences before and during pregnancy were 21.6% and 6.7%; smoking prevalences and smoking relapse at 3, 6, and 12 months were 8.1% and 18.5%, 10.3% and 30.3%, and 10.9% and 32.3%, respectively.", {"entities": []}], ["Smoking during and after pregnancy was more likely among women who were less educated, single, not attending antenatal classes, employed, and not breastfeeding.", {"entities": []}], ["The results show that women who are breastfeeding smoke less than not breastfeeding women, even after controlling for other predictors (i.e.,\u2009\u2009smoking relapse at 12 months: OR = 0.43, 95%\u2009\u2009CI:\u2009\u20090.19, 0.94).", {"entities": []}], ["A low maternal mood increases the risk of smoking relapse within 6 months of about 73%.", {"entities": []}], ["This study also suggests that prolonged breastfeeding reduces the risk of smoking relapse and that this reduction may be persistent in time.", {"entities": []}], ["Interventions targeting breastfeeding promotion may also indirectly support smoking cessation, even in absence of specific interventions.", {"entities": []}], ["Viral infections are a common cause of asthma exacerbation.", {"entities": [[39, 45, "DISEASE"]]}], ["These maladies are sometimes complicated by bacterial infections.", {"entities": []}], ["Toll-like receptors (TLRs) are in the forefront of our microbial defence, with TLR3 responding to viral and TLR4 to bacterial stimulation.", {"entities": [[79, 83, "GENE"], [108, 112, "GENE"]]}], ["The present study was designed to evaluate the effect of concomitant TLR3 and TLR4 stimulation in a murine model of allergic asthma.", {"entities": [[116, 131, "DISEASE"], [125, 131, "DISEASE"], [69, 73, "GENE"], [78, 82, "GENE"]]}], ["BALB/c mice were stimulated intranasally with a combination of poly(I:C) and LPS activating TLR3 and TLR4, respectively.", {"entities": [[92, 96, "GENE"], [101, 105, "GENE"]]}], ["This resulted in the development of airway hyperresponsiveness (AHR) in the proximal part of the lung, along with signs of neutrophilic inflammation.", {"entities": [[64, 67, "GENE"]]}], ["Analysis of the bronchioalveolar lavage fluid (BALF) revealed a marked increase in TNF\u03b1.", {"entities": []}], ["In contrast, the allergic airway inflammation induced by ovalbumin administration to sensitized mice caused AHR in the whole lung along with an increase in eosinophils and lymphocytes in the BALF and lung.", {"entities": [[108, 111, "GENE"]]}], ["When poly(I:C)\u2009+\u2009LPS were given to mice with an ongoing allergic airway inflammation induced by ovalbumin, the AHR was further increased in the peripheral lung and neutrophils appeared together with eosinophils and lymphocytes in the BALF and lung.", {"entities": [[111, 114, "GENE"]]}], ["Treatment with the TNF\u03b1-blocking antibody infliximab blunted the AHR increase, without affecting the cells influx in BALF.", {"entities": [[65, 68, "GENE"]]}], ["To conclude; a combined TLR3- and TLR4-stimulation, representing a concomitant viral and bacterial infection, causes an AHR that is further exaggerated during an ongoing allergic inflammation.", {"entities": [[120, 123, "GENE"]]}], ["The airway stabilizing effect of infliximab indicates the possible future use of TNF\u03b1 blockade in treatment of microbial induced exacerbations of allergic asthma.", {"entities": [[146, 161, "DISEASE"], [155, 161, "DISEASE"]]}], ["Fungi cause more than a billion skin infections, more than 100 million mucosal infections, 10 million serious allergies and more than a million deaths each year.", {"entities": []}], ["Global mortality owing to fungal infections is greater than for malaria and breast cancer and is equivalent to that owing to tuberculosis (TB) and HIV.", {"entities": [[125, 137, "DISEASE"], [76, 89, "DISEASE"], [64, 71, "DISEASE"], [83, 89, "DISEASE"]]}], ["These statistics evidence fungal infections as a major threat to human health and a major burden to healthcare budgets worldwide.", {"entities": []}], ["Those patients who are at greatest risk of life-threatening fungal infections include those who have weakened immunity or have suffered trauma or other predisposing infections such as HIV.", {"entities": []}], ["To address these global threats to human health, more research is urgently needed to understand the immunopathology of fungal disease and human disease susceptibility in order to augment the advances being made in fungal diagnostics and drug development.", {"entities": []}], ["Here, we highlight some recent advances in basic research in medical mycology and fungal immunology that are beginning to inform clinical decisions and options for personalized medicine, vaccine development and adjunct immunotherapies.", {"entities": []}], ["This article is part of the themed issue \u2018Tackling emerging fungal threats to animal health, food security and ecosystem resilience\u2019.", {"entities": []}], ["Managed care organizations use a variety of strategies to reduce the cost and improve the quality of medication use.", {"entities": []}], ["The effectiveness of such policies is not well understood.", {"entities": []}], ["The objective of this research was to update a previous systematic review of interventions, published between 1966 and 2001, to improve the quality and efficiency of medication use in the US managed care setting.", {"entities": []}], ["We searched MEDLINE and EMBASE for publications from July 2001 to January 2007 describing interventions targeting drug use conducted in the US managed care setting.", {"entities": []}], ["We categorized studies by intervention type and adequacy of research design using commonly accepted criteria.", {"entities": []}], ["We summarized the outcomes of well-controlled strategies and documented the significance and magnitude of effects for key study outcomes.", {"entities": []}], ["We identified 164 papers published during the six-year period.", {"entities": []}], ["Predominant strategies were: educational interventions (n = 20, including dissemination of educational materials, and group or one-to-one educational outreach); monitoring and feedback (n = 22, including audit/feedback and computerized monitoring); formulary interventions (n = 66, including tiered formulary and patient copayment); collaborative care involving pharmacists (n = 15); and disease management with pharmacotherapy as a primary focus (n = 41, including care for depression, asthma, and peptic ulcer disease).", {"entities": [[499, 511, "DISEASE"], [487, 493, "DISEASE"]]}], ["Overall, 51 studies met minimum criteria for methodological adequacy.", {"entities": []}], ["Effective interventions included one-to-one academic detailing, computerized alerts and reminders, pharmacist-led collaborative care, and multifaceted disease management.", {"entities": []}], ["Further, changes in formulary tier-design and related increases in copayments were associated with reductions in medication use and increased out-of-pocket spending by patients.", {"entities": []}], ["The dissemination of educational materials alone had little or no impact, while the impact of group education was inconclusive.", {"entities": []}], ["There is good evidence for the effectiveness of several strategies in changing drug use in the managed care environment.", {"entities": []}], ["However, little is known about the cost-effectiveness of these interventions.", {"entities": []}], ["Computerized alerts showed promise in improving short-term outcomes but little is known about longer-term outcomes.", {"entities": []}], ["Few well-designed, published studies have assessed the potential negative clinical effects of formulary-related interventions despite their widespread use.", {"entities": []}], ["However, some evidence suggests increases in cost sharing reduce access to essential medicines for chronic illness.", {"entities": []}], ["Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics and the eventual integration of this information in the practice of medicine and public health.", {"entities": []}], ["Assessment of the strengths and weaknesses of this evidence, and hence the ability to synthesize it, has been limited by inadequate reporting of results.", {"entities": []}], ["The STrengthening the REporting of Genetic Association studies (STREGA) initiative builds on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement and provides additions to 12 of the 22 items on the STROBE checklist.", {"entities": []}], ["The additions concern population stratification, genotyping errors, modeling haplotype variation, Hardy\u2013Weinberg equilibrium, replication, selection of participants, rationale for choice of genes and variants, treatment effects in studying quantitative traits, statistical methods, relatedness, reporting of descriptive and outcome data, and the volume of data issues that are important to consider in genetic association studies.", {"entities": []}], ["The STREGA recommendations do not prescribe or dictate how a genetic association study should be designed but seek to enhance the transparency of its reporting, regardless of choices made during design, conduct, or analysis.", {"entities": []}], ["To evaluate respiratory muscle strength and six-minute walk test (6MWT) variables in patients with uncontrolled severe asthma (UCSA).", {"entities": [[119, 125, "DISEASE"]]}], ["This was a cross-sectional study involving UCSA patients followed at a university hospital.", {"entities": []}], ["The patients underwent 6MWT, spirometry, and measurements of respiratory muscle strength, as well as completing the Asthma Control Test (ACT).", {"entities": [[116, 122, "DISEASE"]]}], ["The Mann-Whitney test was used in order to analyze 6MWT variables, whereas the Kruskal-Wallis test was used to determine whether there was an association between the use of oral corticosteroids and respiratory muscle strength.", {"entities": []}], ["We included 25 patients.", {"entities": []}], ["Mean FEV 1 was 58.8 \u00b1 21.8% of predicted, and mean ACT score was 14.0 \u00b1 3.9 points.", {"entities": [[5, 8, "GENE"]]}], ["No significant difference was found between the median six-minute walk distance recorded for the UCSA patients and that predicted for healthy Brazilians (512 m and 534 m, respectively; p = 0.14).", {"entities": []}], ["During the 6MWT, there was no significant drop in SpO 2 .", {"entities": []}], ["Mean MIP and MEP were normal (72.9 \u00b1 15.2% and 67.6 \u00b1 22.2%, respectively).", {"entities": [[5, 8, "GENE"]]}], ["Comparing the patients treated with at least four courses of oral corticosteroids per year and those treated with three or fewer, we found no significant differences in MIP (p = 0.15) or MEP (p = 0.45).", {"entities": [[169, 172, "GENE"]]}], ["Our findings suggest that UCSA patients are similar to normal subjects in terms of 6MWT variables and respiratory muscle strength.", {"entities": []}], ["The use of oral corticosteroids has no apparent impact on respiratory muscle strength.", {"entities": []}], ["Avaliar a for\u00e7a muscular respirat\u00f3ria e vari\u00e1veis obtidas no teste de caminhada de seis minutos (TC6) em pacientes com asma grave n\u00e3o controlada (AGNC).", {"entities": []}], ["Estudo transversal, envolvendo pacientes com AGNC acompanhados em um hospital universit\u00e1rio.", {"entities": []}], ["Os pacientes foram submetidos a TC6, espirometria e medidas da for\u00e7a muscular respirat\u00f3ria e responderam o Asthma Control Test (ACT, Teste de Controle da Asma).", {"entities": [[107, 113, "DISEASE"]]}], ["O teste de Mann-Whitney foi utilizado na an\u00e1lise das vari\u00e1veis do TC6, e o teste de Kruskal-Wallis foi utilizado na verifica\u00e7\u00e3o de uma poss\u00edvel associa\u00e7\u00e3o do uso de corticoide oral com a for\u00e7a muscular respirat\u00f3ria.", {"entities": []}], ["Foram inclu\u00eddos 25 pacientes, com m\u00e9dias de VEF 1 de 58,8 \u00b1 21,8% do previsto e escore do ACT de 14,0 \u00b1 3,9 pontos.", {"entities": []}], ["N\u00e3o houve diferen\u00e7a significativa entre a mediana da dist\u00e2ncia percorrida no TC6 dos pacientes com AGNC e aquela prevista para brasileiros saud\u00e1veis (512 m e 534 m, respectivamente; p = 0,14).", {"entities": []}], ["Durante o TC6, n\u00e3o houve queda significativa da SpO 2 .", {"entities": []}], ["As m\u00e9dias de PIm\u00e1x e PEm\u00e1x foram normais (72,9 \u00b1 15,2% e 67,6 \u00b1 22,2%, respectivamente).", {"entities": []}], ["N\u00e3o houve diferen\u00e7as significativas nas medidas de PIm\u00e1x (p = 0,15) e PEm\u00e1x (p = 0,45) entre os pacientes que usavam ao menos quatro ciclos de corticoide oral por ano e os que o usavam por tr\u00eas ou menos ciclos por ano.", {"entities": [[159, 162, "GENE"], [185, 188, "GENE"], [210, 213, "GENE"], [159, 162, "GENE"], [185, 188, "GENE"], [210, 213, "GENE"], [159, 162, "GENE"], [185, 188, "GENE"], [210, 213, "GENE"]]}], ["Nossos achados sugerem que os pacientes com AGNC s\u00e3o semelhantes a indiv\u00edduos normais em termos das vari\u00e1veis do TC6 e da for\u00e7a muscular respirat\u00f3ria.", {"entities": []}], ["N\u00e3o se observou um impacto do uso de corticoide oral na for\u00e7a muscular respirat\u00f3ria.", {"entities": []}], ["The association between antipsychotic use and the risk of stroke in schizophrenic patients is controversial.", {"entities": []}], ["We sought to study the association in a nationwide cohort with schizophrenia.", {"entities": [[63, 76, "DISEASE"]]}], ["Using a retrospective cohort of patients with schizophrenia (N = 31,976) derived from the Taiwan National Health Insurance Research Database, 802 new-onset cases of stroke were identified within 10 years of follow-up (from 2000 through 2010).", {"entities": [[46, 59, "DISEASE"]]}], ["We designed a case-crossover study using 14-day windows to explore the risk factors of stroke and the association between antipsychotic drugs and the risk of stroke.", {"entities": []}], ["We analyzed the risks of individual antipsychotics on various subgroups of stroke including ischemic, hemorrhagic, and other strokes, and the risks based on the antipsychotic receptor-binding profile of each drug.", {"entities": []}], ["Use of any second-generation antipsychotic was associated with an increased risk of stroke (adjusted risk ratio = 1.45, P = .009) within 14 days while the use of any first-generation antipsychotic was not.", {"entities": []}], ["Intriguingly, the use of any second-generation antipsychotic was associated with ischemic stroke but not hemorrhagic stroke.", {"entities": []}], ["The antipsychotic receptor-binding profile analysis showed that the antihistamine 1 receptor was significantly associated with ischemic stroke (adjusted risk ratio = 1.72, P = .037), and the sensitivity analysis based on the 7-day window of exposure validated the association (adjusted risk ratio = 1.87, P = .015).", {"entities": []}], ["Use of second-generation antipsychotic drugs appeared to be associated with an increased risk of ischemic stroke in the patients studied, possibly mediated by high affinity for histamine-1 receptor blockade.", {"entities": []}], ["Further research regarding the underlying biological mechanism and drug safety is suggested.", {"entities": []}], ["The address considers the regression that has taken place in American psychiatry during the second half of this century, one which has resulted from attempts to locate the origins of many psychiatric disorders in the brain, and particularly from the misguided attempt to revitalize the nineteenth-century conviction that schizophrenia is a clear-cut disease entity that is chronic and incurable.", {"entities": [[321, 334, "DISEASE"]]}], ["The orientation has again become self-fulfilling because of the relative neglect of psychosocial therapies.", {"entities": []}], ["A basic reason for the regression lies in a misunderstanding of the nature of human adaptation that rests greatly on the capacities for language, which has led to the need for children to acquire a culture in order to survive and become integrated individuals-an acquisition that depends largely on the parental persons, and inevitably creates some emotional conflicts and adaptive shortcomings; and, when extreme, leads to the escape into a fantasy life and a breaking through confines imposed by the meaning system and logic of the culture that we term schizophrenia.", {"entities": [[555, 568, "DISEASE"]]}], ["Myofibroblast accumulation, subepithelial fibrosis, and vascular remodeling are complicating features of chronic asthma, but the mechanisms are not clear.", {"entities": [[113, 119, "DISEASE"]]}], ["Platelet-derived growth factors (PDGFs) regulate the fate and function of various mesenchymal cells and have been implicated as mediators of lung fibrosis.", {"entities": []}], ["However, it is not known whether PDGF-BB signaling via PDGFR\u03b2, which is critical for the recruitment of pericytes to blood vessels, plays a role in airway remodeling in chronic asthma.", {"entities": [[177, 183, "DISEASE"]]}], ["In the present study, we used a selective PDGFR\u03b2 inhibitor (CP-673451) to investigate the role of PDGFR\u03b2 signaling in the development of airway remodeling and lung dysfunction in an established mouse model of house dust mite-induced chronic allergic asthma.", {"entities": [[241, 256, "DISEASE"], [250, 256, "DISEASE"]]}], ["Unexpectedly, we found that pharmacological inhibition of PDGFR\u03b2 signaling in the context of chronic aeroallergen exposure led to exacerbated lung dysfunction and airway smooth muscle thickening.", {"entities": []}], ["Further studies revealed that the inflammatory response to aeroallergen challenge in mice was associated with decreased PDGF-BB expression and the loss of pericytes from the airway microvasculature.", {"entities": []}], ["In parallel, cells positive for pericyte markers accumulated in the subepithelial region of chronically inflamed airways.", {"entities": []}], ["This process was exacerbated in animals treated with CP-673451.", {"entities": []}], ["The results indicate that perturbed PDGF-BB/PDGFR\u03b2 signaling and pericyte accumulation in the airway wall may contribute to airway remodeling in chronic allergic asthma.", {"entities": [[153, 168, "DISEASE"], [162, 168, "DISEASE"]]}], ["We collected Ectobiidae cockroach specimens from 44 locations in the south of the Yangtze valley.", {"entities": []}], ["We obtained 297 COI sequences specimens and carried out phylogenetic and divergence dating analyses, as well as species delimitation analysis using a General Mixed Yule Coalescent (GMYC) framework.", {"entities": []}], ["The intraspecific and interspecific sequence divergence in Ectobiidae cockroaches ranged from 0.0 to 7.0% and 4.6 to 30.8%, respectively.", {"entities": []}], ["GMYC analysis resulted in 53 (confidence interval: 37\u201365) entities (likelihood ratio = 103.63) including 14 downloaded species.", {"entities": []}], ["The COI GMYC groups partly corresponded to the ectobiid species and 52 ectobiid species were delimited successfully based on the combination of GMYC result with morphological information.", {"entities": []}], ["We used the molecular data and 6 cockroach fossil calibrations to obtain a preliminary estimate of the timescale of ectobiid evolution.", {"entities": []}], ["The major subfamilies in the group were found to have diverged between ~125\u2013110 Ma, and morphospecies pairs were found to have diverged ~10 or more Ma.", {"entities": []}], ["The Lipid A moiety of endotoxin potently activates TLR-4 dependent host innate immune responses.", {"entities": []}], ["We demonstrate that Lipid-A mediated leukotriene biosynthesis regulates pathogen-associated molecular patterns (PAMP)-dependent macrophage activation.", {"entities": []}], ["Stimulation of murine macrophages (RAW264.7) with E. coli 0111:B4 endotoxin (LPS) or Kdo2-lipid A (Lipid A) induced inflammation and Lipid A was sufficient to induce TLR-4 mediated macrophage inflammation and rapid ERK activation.", {"entities": []}], ["The contribution of leukotriene biosynthesis was evaluated with a 5-lipoxygenase activating protein (FLAP) inhibitor, MK591.", {"entities": []}], ["MK591 pre-treatment not only enhanced but also sustained ERK activation for up to 4 hours after LPS and Lipid A stimulation while inhibiting cell proliferation and enhancing cellular apoptosis.", {"entities": []}], ["Leukotriene biosynthesis inhibition attenuated inflammation induced by either whole LPS or the Lipid A fraction.", {"entities": []}], ["These responses were regulated by inhibition of the key biosynthesis enzymes for the proinflammatory eicosanoids, 5-lipoxygenase (5-LO), and cyclooxygenase-2 (COX-2) quantified by immunoblotting.", {"entities": []}], ["Inhibition of leukotriene biosynthesis differentially regulated TLR-2 and TLR-4 cell surface expression assessed by flow cytometry, suggesting a close mechanistic association between TLR expression and 5-LO associated eicosanoid activity in activated macrophages.", {"entities": []}], ["Furthermore, MK591 pre-treatment enhanced ERK activation and inhibited cell proliferation after LPS or Lipid A stimulation.", {"entities": []}], ["These effects were regulated in part by increased apoptosis and modulation of cell surface TLR expression.", {"entities": []}], ["Together, these data clarify the mechanistic association between 5-lipoxygenase activating protein-mediated leukotriene biosynthesis and 5-LO dependent eicosanoid metabolites in mediating the TLR-dependent inflammatory response after endotoxin exposure typical of bacterial sepsis.", {"entities": []}], ["This editorial comments on a meta-analysis of the use of noninvasive positive pressure ventilation to treat patients with acute respiratory failure caused by chronic obstructive pulmonary disease (COPD) exacerbations published in the British Medical Journal earlier this year.", {"entities": [[128, 147, "DISEASE"], [158, 195, "DISEASE"]]}], ["Based on its analysis of seven randomized controlled trials that met pre-specified criteria, the meta-analysis demonstrated highly significant benefits of noninvasive positive pressure ventilation in COPD patients, including a reduction in a combined end-point consisting of death and endotracheal intubation.", {"entities": []}], ["The editorial argues that, based on the strength of this and other evidence, noninvasive positive pressure ventilation to treat selected patients with acute respiratory failure due to COPD exacerbations should now be considered a standard of care.", {"entities": [[157, 176, "DISEASE"]]}], ["Previous pharmacokinetic studies of the inhaled corticosteroid, fluticasone furoate (FF), and the long-acting, beta2-receptor agonist, vilanterol (VI) have been performed in relatively small populations using non-compartmental pharmacokinetic methods and censored data (due to low drug exposure relative to assay sensitivity).", {"entities": []}], ["This paper presents a population pharmacokinetic analysis, utilizing pooled concentration\u2013time data from clinical studies in healthy subjects and from global trials in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[182, 219, "DISEASE"]]}], ["The objective of this analysis was to characterize the population pharmacokinetics of FF and VI following once-daily inhalation dosing of FF/VI or the individual components (FF and VI) and to identify significant covariates that impact systemic exposure to FF and VI in this population.", {"entities": []}], ["Population pharmacokinetic methods that maximize the likelihood of all data were developed to describe systemic exposure to FF and VI following once-daily FF/VI, FF, or VI, and to identify significant covariates that impact the pharmacokinetics.", {"entities": []}], ["COPD patients ( N \u00a0=\u00a01225 for the FF analysis and N \u00a0=\u00a01091 for the VI analysis; 94 and 93\u00a0% of total data, respectively) and healthy subjects contributed to the analysis.", {"entities": []}], ["FF data were described by a two-compartment model with first-order absorption and elimination.", {"entities": []}], ["The population grouping \u201crace\u201d was a significant covariate on inhaled clearance (CL/ F ).", {"entities": []}], ["The area under the curve over 24\u00a0h (AUC 0\u201324 ) for FF was higher for East Asian, Japanese, and South East Asian (average 23\u201330\u00a0%) and Asian Central, White Arabic, American Indian/Native Alaskan, and \u2018other\u2019 (10\u201326\u00a0%) subjects compared with White/Caucasians.", {"entities": []}], ["VI pharmacokinetics were described by a three-compartment model with zero-order absorption and first-order elimination.", {"entities": []}], ["Significant demographic covariates identified to affect pharmacokinetics of VI were age [on CL/ F and central volume ( V 1 / F )], bodyweight (on CL/ F ), sex and smoking (on V 1 / F ).", {"entities": []}], ["While significant effects of the covariates were observed in this study, the magnitude of these effects on systemic exposure is not large enough to warrant FF/VI dosage adjustment in patients with COPD.", {"entities": []}], ["The online version of this article (doi:10.1007/s13318-015-0303-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Antibiotic treatment is common practice in the neonatal ward for the prevention and treatment of sepsis, which is one of the leading causes of mortality and morbidity in preterm infants.", {"entities": []}], ["Although the effect of antibiotic treatment on microbiota development is well recognised, little attention has been paid to treatment duration.", {"entities": []}], ["We studied the effect of short and long intravenous antibiotic administration on intestinal microbiota development in preterm infants.", {"entities": []}], ["Faecal samples from 15 preterm infants (35\u2009\u00b1\u20091\u00a0weeks gestation and 2871\u2009\u00b1\u2009260\u00a0g birth weight) exposed to no, short (\u2264\u00a03\u00a0days) or long (\u2265\u00a05\u00a0days) treatment with amoxicillin/ceftazidime were collected during the first six postnatal weeks.", {"entities": []}], ["Microbiota composition was determined through 16S rRNA gene sequencing and by quantitative polymerase chain reaction (qPCR).", {"entities": []}], ["Short and long antibiotic treat ment significantly lowered the abundance of Bifidobacterium right after treatment ( p \u2009=\u20090.027) till postnatal week three ( p \u2009=\u20090.028).", {"entities": []}], ["Long treatment caused Bifidobacterium abundance to remain decreased till postnatal week six ( p \u2009=\u20090.009).", {"entities": []}], ["Antibiotic treatment was effective against members of the Enterobacteriaceae family, but allowed Enterococcus to thrive and remain dominant for up to two weeks after antibiotic treatment discontinuation.", {"entities": []}], ["Community richness and diversity were not affected by antibiotic treatment, but were positively associated with postnatal age ( p \u2009<\u20090.023) and with abundance of Bifidobacterium ( p \u2009=\u20090.003).", {"entities": []}], ["Intravenous antibiotic administration during the first postnatal week greatly affects the infant\u2019s gastrointestinal microbiota.", {"entities": []}], ["However, quick antibiotic treatment cessation allows for its recovery.", {"entities": []}], ["Disturbances in microbiota development caused by short and, more extensively, by long antibiotic treatment could affect healthy development of the infant via interference with maturation of the immune system and gastrointestinal tract.", {"entities": []}], ["The online version of this article (10.1007/s10096-018-3193-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Smooth muscle is present in a wide variety of anatomical locations, such as blood vessels, various visceral organs, and hair follicles.", {"entities": []}], ["Contraction of smooth muscle is central to functions as diverse as peristalsis, urination, respiration, and the maintenance of vascular tone.", {"entities": []}], ["Despite the varied physiological roles of smooth muscle cells (SMCs), we possess only a limited knowledge of the heterogeneity underlying their functional and anatomic specializations.", {"entities": []}], ["As a step toward understanding the intrinsic differences between SMCs from different anatomical locations, we used DNA microarrays to profile global gene expression patterns in 36 SMC samples from various tissues after propagation under defined conditions in cell culture.", {"entities": []}], ["Significant variations were found between the cells isolated from blood vessels, bronchi, and visceral organs.", {"entities": []}], ["Furthermore, pervasive differences were noted within the visceral organ subgroups that appear to reflect the distinct molecular pathways essential for organogenesis as well as those involved in organ-specific contractile and physiological properties.", {"entities": []}], ["Finally, we sought to understand how this diversity may contribute to SMC-involving pathology.", {"entities": []}], ["We found that a gene expression signature of the responses of vascular SMCs to serum exposure is associated with a significantly poorer prognosis in human cancers, potentially linking vascular injury response to tumor progression.", {"entities": []}], ["It has been estimated that the human body contains approximately 200\u2013400 distinct cell types.", {"entities": []}], ["These estimates are largely based on the morphological characteristics of cells and have yielded, among many others, the category of smooth muscle cells, which have a distinct appearance and are present in a wide variety of tissues.", {"entities": []}], ["By using DNA microarrays to interrogate the gene expression of anatomically varying smooth muscle cells, we were able to accurately tease apart many of the distinct cell subtypes that are classically categorized as smooth muscle cells.", {"entities": []}], ["Remarkably, genes expressed by these newly identified, distinct subtypes corroborate many of their known biological properties and give clues about their susceptibility to specific disease states, retained developmental programs, and potential drugable targets.", {"entities": []}], ["Additionally, from a smooth muscle cell model of vascular injury, we were able to extract a gene expression signature that provides prognostic information for human breast cancers.", {"entities": []}], ["Of particular interest for modeling tumor progression was the finding that this gene expression signature was associated with tumor hypoxia.", {"entities": []}], ["This study adds much to our ever-growing depth of understanding of cellular diversity and the contributions of this diversity to normal physiology and disease.", {"entities": []}], ["To investigate whether the integrity (completeness) of pulmonary fissures affects pulmonary function in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[118, 155, "DISEASE"]]}], ["A dataset consisting of 573 CT exams acquired on different subjects was collected from a COPD study.", {"entities": []}], ["According to the global initiative for chronic obstructive lung disease (GOLD) criteria, these subjects (examinations) were classified into five different subgroups, namely non-COPD (222 subjects), GOLD-I (83 subjects), GOLD-II (141 subjects), GOLD-III (63 subjects), and GOLD-IV (64 subjects), in terms of disease severity.", {"entities": [[47, 71, "DISEASE"], [59, 71, "DISEASE"]]}], ["An available computer tool was used to aid in an objective and efficient quantification of fissure integrity.", {"entities": []}], ["The correlations between fissure integrity, and pulmonary functions (e.g., FEV1, and FEV1/FVC) and COPD severity were assessed using Pearson and Spearman's correlation coefficients, respectively.", {"entities": []}], ["For the five sub-groups ranging from non-COPD to GOLD-IV, the average integrities of the right oblique fissure (ROF) were 81.8%, 82.4%, 81.8%, 82.8%, and 80.2%, respectively; the average integrities of the right horizontal fissure (RHF) were 62.6%, 61.8%, 62.1%, 62.2%, and 62.3%, respectively; the average integrities of the left oblique fissure (LOF) were 82.0%, 83.2%, 81.7%, 82.0%, and 78.4%, respectively; and the average integrities of all fissures in the entire lung were 78.0%, 78.6%, 78.1%, 78.5%, and 76.4%, respectively.", {"entities": []}], ["Their Pearson correlation coefficients with FEV1 and FE1/FVC range from 0.027 to 0.248 with p values larger than 0.05.", {"entities": []}], ["Their Spearman correlation coefficients with COPD severity except GOLD-IV range from \u22120.013 to \u22120.073 with p values larger than 0.08.", {"entities": []}], ["There is no significant difference in fissure integrity for patients with different levels of disease severity, suggesting that the development of COPD does not change the completeness of pulmonary fissures and incomplete fissures alone may not contribute to the collateral ventilation.", {"entities": []}], ["The term \u201closs-of-only-child family\u201d means that the only child in a family passed away or is disabled due to an accident or other events.", {"entities": []}], ["The parents who cannot conceive or do not adopt another child, are known as Shidu parents in China.", {"entities": []}], ["This study compares the physical and mental health of Shidu parents with those parents who have not experienced such loss.", {"entities": []}], ["The target group is comprised of parents being Shidu for more than 1 year ( N \u2009=\u200995) and the control group is comprised of parents with a living child ( N \u2009=\u200997) from the same area as the Shidu parents.", {"entities": []}], ["Socio-demographic information and physical health outcomes were collected by the adapted questionnaires.", {"entities": []}], ["PCL-C (PTSD Checklist-Civilian Version), CES-D (Center for Epidemiological Studies Depression Scale) and GHQ-12 (General Health Questionnaire) were applied to evaluate the parents\u2019 physical and mental status.", {"entities": []}], ["Shidu parents have a higher risk of developing PTSD and depression, and suffer more severe psychiatric disorders compared to parents with a living child.", {"entities": []}], ["The rate of PTSD in the Shidu group was up to 32.6% and the scores of PCL-C are much higher than the control group.", {"entities": []}], ["The physical status of Shidu parents were much worse than that of the control group, characterized by higher morbidity of chronic diseases and more hospital visits.", {"entities": []}], ["Shidu parents have more severe mental health problems and a higher rate of chronic diseases than parents who have a living child.", {"entities": []}], ["Loss of the only child is the most traumatic event for the parents, which is a serious and unique problem in Chinese society that deserves attention.", {"entities": []}], ["More studies and support are desired to improve the physical and mental health of Shidu parents.", {"entities": []}], ["Plant-derived molecules (PDMs) are known to be a rich source of diverse scaffolds that could serve as the basis for rational drug design.", {"entities": []}], ["Structured compilation of phytochemicals from traditional medicinal plants can facilitate prospection for novel PDMs and their analogs as therapeutic agents.", {"entities": []}], ["Atropa belladonna , Catharanthus roseus, Heliotropium indicum , Picrorhiza kurroa and Podophyllum hexandrum are important Himalayan medicinal plants, reported to have immense therapeutic properties against various diseases.", {"entities": []}], ["We present Phytochemica, a structured compilation of 963 PDMs from these plants, inclusive of their plant part source, chemical classification, IUPAC names, SMILES notations, physicochemical properties and 3-dimensional structures with associated references.", {"entities": []}], ["Phytochemica is an exhaustive resource of natural molecules facilitating prospection for therapeutic molecules from medicinally important plants.", {"entities": []}], ["It also offers refined search option to explore the neighbourhood of chemical space against ZINC database to identify analogs of natural molecules at user-defined cut-off.", {"entities": []}], ["Availability of phytochemical structured dataset may enable their direct use in in silico drug discovery which will hasten the process of lead identification from natural products under proposed hypothesis, and may overcome urgent need for phytomedicines.", {"entities": []}], ["Compilation and accessibility of indigenous phytochemicals and their derivatives can be a source of considerable advantage to research institutes as well as industries.", {"entities": []}], ["Database URL : home.iitj.ac.in/\u223cbagler/webservers/Phytochemica", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown etiology.", {"entities": [[11, 29, "DISEASE"]]}], ["The pathogenic mechanisms are unclear, but evidence indicates that aberrantly activated alveolar epithelial cells secrete a variety of mediators which induce the migration, proliferation and activation of fibroblasts and finally the excessive accumulation of extracellular matrix with the consequent destruction of the lung parenchyma.", {"entities": []}], ["CC16 (approved symbol SCGB1A1), a putative anti-inflammatory protein produced by \u201cclub\u201d cells in the distal airways, has not been evaluated in IPF lungs.", {"entities": [[22, 29, "GENE"]]}], ["In this study, we determined the serum and bronchoalveolar lavage (BAL) levels as well as the lung cell localization of this protein.", {"entities": []}], ["Also, we explored the usefulness of serum levels of CC16 for the differential diagnosis of IPF (n = 85), compared with non-IPF interstitial lung diseases [chronic hypersensitivity pneumonitis (cHP; n = 85) and connective tissue diseases (CTD-ILD; n = 85)].", {"entities": [[193, 196, "GENE"]]}], ["CC16 was significantly increased in serum and BAL fluids of IPF patients and was found not only in club cells but also in alveolar epithelial cells.", {"entities": []}], ["When compared with non-IPF patients and controls, serum levels were significantly increased (p<0.0001).", {"entities": []}], ["Sensitivity and specificity for CC16 (cut-off 41ng/mL) were 24% and 90%, positive predictive value 56% and negative predictive value 69%.", {"entities": []}], ["These findings demonstrate that CC16 is upregulated in IPF patients suggesting that may participate in its pathogenesis.", {"entities": []}], ["Although higher than the serum levels of non-IPF patients it shows modest sensitivity to be useful as a potential biomarker for the differential diagnosis.", {"entities": []}], ["The human T-lymphotropic virus type 1 (HTLV-1) is efficiently transmitted through cellular contacts.", {"entities": []}], ["While the molecular mechanisms of viral cell-to-cell propagation have been extensively studied in vitro , those facilitating the encounter between infected and target cells remain unknown.", {"entities": []}], ["In this study, we demonstrate that HTLV-1-infected CD4 T cells secrete a potent chemoattractant, leukotriene B4 (LTB4).", {"entities": [[51, 54, "GENE"]]}], ["LTB4 secretion is dependent on Tax-induced transactivation of the pla2g4c gene, which encodes the cytosolic phospholipase A2 gamma.", {"entities": [[66, 73, "GENE"]]}], ["Inhibition of LTB4 secretion or LTB4 receptor knockdown on target cells reduces T-cell recruitment, cellular contact formation and virus propagation in vitro .", {"entities": []}], ["Finally, blocking the synthesis of LTB4 in a humanized mouse model of HTLV-1 infection significantly reduces proviral load.", {"entities": []}], ["This results from a decrease in the number of infected clones while their expansion is not impaired.", {"entities": []}], ["This study shows the critical role of LTB4 secretion in HTLV-1 transmission both in vitro and in vivo .", {"entities": []}], ["HTLV-1 predominantly spreads through direct cell-cell contacts, but mechanisms of target cell recruitment are unclear.", {"entities": []}], ["Here, the authors show that HTLV-1 infected T-cells secrete leukotriene B4, which recruits T-cells, facilitates HTLV-1 transmission in vitro , and increases the number of infected clones in mice.", {"entities": []}], ["A split plot 3 by 4 experiment was designed to characterize the relationship between production of gluthatione (GSH), oxidized gluthatione (GSSG), total flavonoid, anthocyanin, ascorbic acid and antioxidant activities (FRAP and DPPH) in three varieties of Labisia pumila Blume, namely the varieties alata , pumila and lanceolata , under four levels of nitrogen fertilization (0, 90, 180 and 270 kg N/ha) for 15 weeks.", {"entities": []}], ["The treatment effects were solely contributed by nitrogen application; there was neither varietal nor interaction effects observed.", {"entities": []}], ["As the nitrogen levels decreased from 270 to 0 kg N/ha, the production of GSH and GSSG, anthocyanin, total flavonoid and ascorbic acid increased steadily.", {"entities": []}], ["At the highest nitrogen treatment level, L. pumila exhibited significantly lower antioxidant activities (DPPH and FRAP) than those exposed to limited nitrogen growing conditions.", {"entities": []}], ["Significant positive correlation was obtained between antioxidant activities (DPPH and FRAP), total flavonoid, GSH, GSSG, anthocyanin and ascorbic acid suggesting that an increase in the antioxidative activities in L. pumila under low nitrogen fertilization could be attributed to higher contents of these compounds.", {"entities": []}], ["From this observation, it could be concluded that in order to avoid negative effects on the quality of L. pumila , it is advisable to avoid excessive application of nitrogen fertilizer when cultivating the herb for its medicinal use.", {"entities": []}], ["This review will provide new information related to pathophysiology and management of specific diseases that have been addressed by selected articles published in the Italian Journal of Pediatrics in 2013, focusing on allergology, endocrinology, gastroenterology, hypertension, infectious diseases, neonatology, neurology, nutrition and respiratory tract illnesses in children.", {"entities": [[264, 276, "DISEASE"]]}], ["Recommendations for interpretation of skin prick test to foods in atopic eczema, management of allergic conjunctivitis, hypertension and breastfeeding in women treated with antiepileptic drugs and healthy breakfast have been reported.", {"entities": [[120, 132, "DISEASE"], [95, 118, "DISEASE"], [104, 118, "DISEASE"]]}], ["Epidemiological studies have given emphasis to high incidence of autoimmune disorders in patients with Turner syndrome, increasing prevalence of celiac disease, frequency of hypertension in adolescents, incidence and risk factor for retinopathy of prematurity.", {"entities": [[174, 186, "DISEASE"], [145, 159, "DISEASE"], [110, 118, "DISEASE"], [233, 259, "DISEASE"]]}], ["Advances in prevention include elucidation of the role of probiotics in reducing occurrence of allergies and feeding intolerance, and events of foetal life that influence later onset of diseases.", {"entities": []}], ["Mechanistic studies suggested a role for vitamin D deficiency in asthma and type 1 diabetes and for reactivation of Varicella-Zoster virus in aseptic meningitis.", {"entities": [[142, 160, "DISEASE"], [150, 160, "DISEASE"], [65, 71, "DISEASE"]]}], ["Regarding diagnosis, a new mean for the diagnosis of hyperbilirubinaemia in newborns, a score for recognition of impaired nutritional status and growth and criteria for early Dyke-Davidoff-Masson Syndrome have been suggested.", {"entities": [[196, 204, "DISEASE"]]}], ["New therapeutic approaches consist of use of etanercept for reducing insulin dose in type 1 diabetes, probiotics in atopic eczema, and melatonin in viral infections.", {"entities": []}], ["NOD1 {nucleotide-binding oligomerization domain 1; NLRC [NOD-LRR (leucine-rich repeat) family with CARD (caspase recruitment domain) 1]} and NOD2 (NLRC2) are among the most prominent members of the NLR (NOD-LRR) family \u2013proteins that contain nucleotide-binding NACHT domains and receptor-like LRR domains.", {"entities": [[0, 4, "GENE"], [141, 145, "GENE"]]}], ["With over 20 members identified in humans, NLRs represent important components of the mammalian innate immune system, serving as intracellular receptors for pathogens and for endogenous molecules elaborated by tissue injury.", {"entities": []}], ["NOD1 and NOD2 proteins operate as microbial sensors through the recognition of specific PG (peptidoglycan) constituents of bacteria.", {"entities": [[0, 4, "GENE"], [9, 13, "GENE"]]}], ["Upon activation, these NLR family members initiate signal transduction mechanisms that include stimulation of NF-\u03baB (nuclear factor-\u03baB), stress kinases, IRFs (interferon regulatory factors) and autophagy.", {"entities": []}], ["Hereditary polymorphisms in the genes encoding NOD1 and NOD2 have been associated with an increasing number of chronic inflammatory diseases.", {"entities": [[47, 51, "GENE"], [56, 60, "GENE"]]}], ["In fact, potential roles for NOD1 and NOD2\u00a0in inflammatory disorders have been revealed by investigations using a series of animal models.", {"entities": [[29, 33, "GENE"], [38, 42, "GENE"]]}], ["In the present review, we describe recent experimental findings associating NOD1 and NOD2 with various autoimmune and chronic inflammatory disorders, and we discuss prospects for development of novel therapeutics targeting these NLR family proteins.", {"entities": [[76, 80, "GENE"], [85, 89, "GENE"]]}], ["Oenothera paradoxa (EP) preparations are commonly used in folk medicine to treat skin diseases, neuralgia, and gastrointestinal (GI) disorders.", {"entities": []}], ["Several reports suggested that EP preparations exhibit potent anti-inflammatory and antioxidant activities both in vitro and in vivo.", {"entities": []}], ["Here, we aimed to characterize the action of EP pomace polyphenol extract in mouse model of colitis.", {"entities": []}], ["We analyzed the composition of EP pomace polyphenol extract using reversed phase HPLC system and ultra-performance liquid chromatography (UPLC) system coupled with a quadrupole-time of flight (Q-TOF) MS instrument.", {"entities": []}], ["Then, we used a well-established animal model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis to determine the anti-inflammatory action of EP pomace polyphenol extract.", {"entities": []}], ["We also investigated the effect of the EP pomace polyphenol extract on pro-inflammatory (IL-1\u03b2 and TNF-\u03b1) cytokine mRNA levels and hydrogen peroxide concentration in the inflamed colon.", {"entities": []}], ["Administration of EP pomace polyphenol extract significantly improved macroscopic and microscopic damage scores, as well as myeloperoxidase (MPO) activity in TNBS-treated mice.", {"entities": [[141, 144, "GENE"]]}], ["The anti-inflammatory effect of the extract was observed after intracolonic and oral administration and was dose-dependent.", {"entities": []}], ["Significant reduction of tissue hydrogen peroxide level after treatment with EP pomace polyphenol extract suggests that its therapeutic effect is a result of free radical scavenging.", {"entities": []}], ["This novel finding indicates that the application of the EP pomace polyphenol extract in patients with inflammatory bowel diseases (IBDs) may become an attractive supplementary treatment for conventional anti-inflammatory therapy.", {"entities": []}], ["The topical application of minoxidil may achieve millimolar concentrations in the skin.", {"entities": []}], ["We investigated whether millimolar minoxidil could induce vascular endothelial growth factor (VEGF), a possible effector for minoxidil-mediated hair growth, and how it occurred at the molecular level.", {"entities": []}], ["Cell-based experiments were performed to investigate a molecular mechanism underlying the millimolar minoxidil induction of VEGF.", {"entities": []}], ["The inhibitory effect of minoxidil on hypoxia-inducible factor (HIF) prolyl hydroxylase-2 (PHD-2) was tested by an in vitro von Hippel\u2013Lindau protein (VHL) binding assay.", {"entities": [[151, 154, "GENE"]]}], ["To examine the angiogenic potential of millimolar minoxidil, a chorioallantoic membrane (CAM) assay was used.", {"entities": []}], ["In human keratinocytes and dermal papilla cells, millimolar minoxidil increased the secretion of VEGF, which was not attenuated by a specific adenosine receptor antagonist that inhibits the micromolar minoxidil induction of VEGF.", {"entities": []}], ["Millimolar minoxidil induced hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1), and the induction of VEGF was dependent on HIF-1.", {"entities": []}], ["Moreover, minoxidil applied to the dorsal area of mice increased HIF-1\u03b1 and VEGF in the skin.", {"entities": []}], ["In an in vitro VHL binding assay, minoxidil directly inhibited PHD-2, thus preventing the hydroxylation of cellular HIF-1\u03b1 and VHL-dependent proteasome degradation and resulting in the stabilization of HIF-1\u03b1 protein.", {"entities": [[15, 18, "GENE"], [127, 130, "GENE"]]}], ["Minoxidil inhibition of PHD-2 was reversed by ascorbate, a cofactor of PHD-2, and the minoxidil induction of cellular HIF-1\u03b1 was abrogated by the cofactor.", {"entities": []}], ["Millimolar minoxidil promoted angiogenesis in the CAM assay, an in vivo angiogenic test, and this was nullified by the specific inhibition of VEGF.", {"entities": []}], ["Our data demonstrate that PHD may be the molecular target for millimolar minoxidil-mediated VEGF induction via HIF-1.", {"entities": []}], ["Human alveolar macrophages are critical components of the innate immune system.", {"entities": []}], ["Cigarette smoking-induced changes in alveolar macrophage gene expression are linked to reduced resistance to pulmonary infections and to the development of emphysema/COPD.", {"entities": []}], ["We hypothesized that microRNAs (miRNAs) could control, in part, the unique messenger RNA (mRNA) expression profiles found in alveolar macrophages of cigarette smokers.", {"entities": []}], ["Activation of macrophages with different stimuli in vitro leads to a diverse range of M1 (inflammatory) and M2 (anti-inflammatory) polarized phenotypes that are thought to mimic activated macrophages in distinct tissue environments.", {"entities": []}], ["Microarray mRNA data indicated that smoking promoted an \u201cinverse\u201d M1 mRNA expression program, defined by decreased expression of M1-induced transcripts and increased expression of M1-repressed transcripts with few changes in M2-regulated transcripts.", {"entities": []}], ["RT-PCR arrays identified altered expression of many miRNAs in alveolar macrophages of smokers and a decrease in global miRNA abundance.", {"entities": []}], ["Stratification of human subjects suggested that the magnitude of the global decrease in miRNA abundance was associated with smoking history.", {"entities": []}], ["We found that many of the miRNAs with reduced expression in alveolar macrophages of smokers were predicted to target mRNAs upregulated in alveolar macrophages of smokers.", {"entities": []}], ["For example, miR-452 is predicted to target the transcript encoding MMP12, an important effector of smoking-related diseases.", {"entities": [[68, 73, "GENE"]]}], ["Experimental antagonism of miR-452 in differentiated monocytic cells resulted in increased expression of MMP12.", {"entities": [[105, 110, "GENE"]]}], ["The comprehensive mRNA and miRNA expression profiles described here provide insight into gene expression regulation that may underlie the adverse effects cigarette smoking has on alveolar macrophages.", {"entities": []}], ["There is ample epidemiologic and toxicologic evidence that exposure to fine particulate matter (PM) air pollution [aerodynamic diameter \u2264 2.5 \u03bcm (PM 2.5 )], which derives primarily from combustion processes, can result in increased mortality and morbidity.", {"entities": []}], ["There is less certainty as to the contribution of coarse PM (PM 2.5\u201310 ), which derives from crustal materials and from mechanical processes, to mortality and morbidity.", {"entities": []}], ["To determine whether coarse PM causes cardiopulmonary effects, we exposed 14 healthy young volunteers to coarse concentrated ambient particles (CAPs) and filtered air.", {"entities": [[144, 148, "GENE"]]}], ["Coarse PM concentration averaged 89.0 \u03bcg/m Compared with filtered air exposure, coarse CAP exposure produced a small increase in polymorphonuclear neutrophils in the bronchoalveolar lavage fluid 20 hr postexposure, indicating mild pulmonary inflammation.", {"entities": [[198, 200, "GENE"]]}], ["We observed no changes in pulmonary function.", {"entities": []}], ["Blood tissue plasminogen activator, which is involved in fibrinolysis, was decreased 20 hr after exposure.", {"entities": [[88, 90, "GENE"]]}], ["The standard deviation of normal-to-normal intervals (SDNN), a measure of overall heart rate variability, also decreased 20 hr after exposure to CAPs.", {"entities": [[124, 126, "GENE"], [145, 149, "GENE"]]}], ["Coarse CAP exposure produces a mild physiologic response in healthy young volunteers approximately 20 hr postexposure.", {"entities": [[102, 104, "GENE"]]}], ["These changes are similar in scope and magnitude to changes we and others have previously reported for volunteers exposed to fine CAPs, suggesting that both size fractions are comparable at inducing cardiopulmonary changes in acute exposure settings.", {"entities": [[130, 134, "GENE"]]}], ["The activity of protein kinases IKK-\u03b5 and TANK-binding kinase 1 (TBK1) has been shown to be associated with inflammatory diseases.", {"entities": [[65, 69, "GENE"]]}], ["As an inhibitor of IKK-\u03b5 and TBK1, amlexanox is an anti-inflammatory, anti-allergic, immunomodulator and used for treatment of ulcer, allergic rhinitis and asthma in clinic.", {"entities": [[134, 151, "DISEASE"], [143, 151, "DISEASE"], [156, 162, "DISEASE"], [29, 33, "GENE"]]}], ["We hypothesized that amlexanox may be used for treatment of osteoclast-related diseases which frequently associated with a low grade of systemic inflammation.", {"entities": []}], ["In this study, we investigated the effects of amlexanox on RANKL-induced osteoclastogenesis in vitro and ovariectomy-mediated bone loss in vivo .", {"entities": []}], ["In primary bone marrow derived macrophages (BMMs), amlexanox inhibited osteoclast formation and bone resorption.", {"entities": []}], ["At the molecular level, amlexanox suppressed RANKL-induced activation of nuclear factor-\u03baB (NF-\u03baB), mitogen-activated protein kinase (MAPKs), c-Fos and NFATc1.", {"entities": [[152, 158, "GENE"]]}], ["Amlexanox decreased the expression of osteoclast-specific genes, including TRAP, MMP9, Cathepsin K and NFATc1.", {"entities": [[81, 85, "GENE"], [103, 109, "GENE"]]}], ["Moreover, amlexanox enhanced osteoblast differentiation of BMSCs.", {"entities": []}], ["In ovariectomized (OVX) mouse model, amlexanox prevented OVX-induced bone loss by suppressing osteoclast activity.", {"entities": []}], ["Taken together, our results demonstrate that amlexanox suppresses osteoclastogenesis and prevents OVX-induced bone loss.", {"entities": []}], ["Therefore, amlexanox may be considered as a new therapeutic candidate for osteoclast-related diseases, such as osteoporosis and rheumatoid arthritis.", {"entities": [[128, 148, "DISEASE"], [111, 123, "DISEASE"], [139, 148, "DISEASE"]]}], ["Tracheal sounds have received a lot of attention for estimating ventilation parameters in a non-invasive way.", {"entities": []}], ["The aim of this work was to examine the feasibility of extracting accurate airflow, and automating the detection of breath-phase onset and respiratory rates all directly from tracheal sounds acquired from an acoustic microphone connected to a smartphone.", {"entities": []}], ["We employed the Samsung Galaxy S4 and iPhone 4s smartphones to acquire tracheal sounds from N = 9 healthy volunteers at airflows ranging from 0.5 to 2.5 L/s.", {"entities": []}], ["We found that the amplitude of the smartphone-acquired sounds was highly correlated with the airflow from a spirometer, and similar to previously-published studies, we found that the increasing tracheal sounds' amplitude as flow increases follows a power law relationship.", {"entities": []}], ["Acquired tracheal sounds were used for breath-phase onset detection and their onsets differed by only 52 \u00b1 51 ms (mean \u00b1 SD) for Galaxy S4, and 51 \u00b1 48 ms for iPhone 4s, when compared to those detected from the reference signal via the spirometer.", {"entities": []}], ["Moreover, it was found that accurate respiratory rates (RR) can be obtained from tracheal sounds.", {"entities": []}], ["The correlation index, bias and limits of agreement were r = 0.9693, 0.11 (\u22121.41 to 1.63) breaths-per-minute (bpm) for Galaxy S4, and r = 0.9672, 0.097 (\u20131.38 to 1.57) bpm for iPhone 4s, when compared to RR estimated from spirometry.", {"entities": []}], ["Both smartphone devices performed similarly, as no statistically-significant differences were found.", {"entities": []}], ["Background: Environmental health research involving community participation has increased substantially since the National Institute of Environmental Health Sciences (NIEHS) environmental justice and community-based participatory research (CBPR) partnerships began in the mid-1990s.", {"entities": []}], ["The goals of these partnerships are to inform and empower better decisions about exposures, foster trust, and generate scientific knowledge to reduce environmental health disparities in low-income, minority communities.", {"entities": []}], ["Peer-reviewed publication and clinical health outcomes alone are inadequate criteria to judge the success of projects in meeting these goals; therefore, new strategies for evaluating success are needed.", {"entities": []}], ["Objectives: We reviewed the methods used to evaluate our project, \u201cLinking Breast Cancer Advocacy and Environmental Justice,\u201d to help identify successful CBPR methods and to assist other teams in documenting effectiveness.", {"entities": []}], ["Although our project precedes the development of the NIEHS Evaluation Metrics Manual, a schema to evaluate the success of projects funded through the Partnerships in Environmental Public Health (PEPH), our work reported here illustrates the record keeping and self-reflection anticipated in NIEHS\u2019s PEPH.", {"entities": []}], ["Discussion: Evaluation strategies should assess how CBPR partnerships meet the goals of all partners.", {"entities": []}], ["Our partnership, which included two strong community-based organizations, produced a team that helped all partners gain organizational capacity.", {"entities": []}], ["Environmental sampling in homes and reporting the results of that effort had community education and constituency-building benefits.", {"entities": []}], ["Scientific results contributed to a court decision that required cumulative impact assessment for an oil refinery and to new policies for chemicals used in consumer products.", {"entities": []}], ["All partners leveraged additional funding to extend their work.", {"entities": []}], ["Conclusions: An appropriate evaluation strategy can demonstrate how CBPR projects can advance science, support community empowerment, increase environmental health literacy, and generate individual and policy action to protect health.", {"entities": []}], ["We previously localized type 2 diabetes (T2D) susceptibility genes to five chromosomal regions through a genome-wide linkage scan of T2D and age of diagnosis (AOD) in the African American subset of the GENNID sample.", {"entities": []}], ["To follow up these findings, we repeated the linkage and association analysis using genotypes on an additional 9,203 fine-mapping SNPs selected to tag genes under the linkage peaks.", {"entities": []}], ["In each of the five regions, we confirmed linkage and inferred the presence two or more susceptibility genes.", {"entities": []}], ["The evidence of multiple susceptibility genes comprised: 1) multiple linkage peaks in four of the five regions; 2) association of T2D and AOD with SNPs within 2 or more genes in every region.", {"entities": []}], ["The associated genes included 3 previously reported to associate with T2D or related traits ( GRB10, NEDD4L, LIPG ), and 24 novel candidate genes including genes in lipid metabolism ( ACOXL ) and cell-cell and cell-matrix adhesion ( MAGI2, CLDN4, CTNNA2 ).", {"entities": [[94, 99, "GENE"], [101, 107, "GENE"], [109, 113, "GENE"], [184, 189, "GENE"], [233, 238, "GENE"], [240, 245, "GENE"], [247, 253, "GENE"]]}], ["Radiofrequency radiations constitute a new form of environmental pollution.", {"entities": []}], ["Among them, millimeter waves (MMW) will be widely used in the near future for high speed communication systems.", {"entities": []}], ["This study aimed therefore to evaluate the biocompatibility of MMW at 60 GHz.", {"entities": []}], ["For this purpose, we used a whole gene expression approach to assess the effect of acute 60 GHz exposure on primary cultures of human keratinocytes.", {"entities": []}], ["Controls were performed to dissociate the electromagnetic from the thermal effect of MMW.", {"entities": []}], ["Microarray data were validated by RT-PCR, in order to ensure the reproducibility of the results.", {"entities": []}], ["MMW exposure at 20 mW/cm ADAMTS6, NOG, IL7R, FADD, JUNB, SNAI2 and HIST1H1A .", {"entities": [[39, 43, "GENE"], [45, 49, "GENE"], [51, 55, "GENE"], [57, 62, "GENE"], [67, 75, "GENE"]]}], ["Our data evidenced a specific electromagnetic effect of MMW, which is associated to the cellular response to hyperthermia.", {"entities": []}], ["This study raises the question of co-exposures associating radiofrequencies and other environmental sources of cellular stress.", {"entities": []}], ["Anti-M\u00fcllerian hormone (AMH) is a paracrine regulator of ovarian follicles.", {"entities": [[24, 27, "GENE"]]}], ["Vitamin D (Vit D) regulates AMH production in vitro, but its role as a regulator of ovarian AMH production is contentious.", {"entities": [[11, 14, "GENE"], [28, 31, "GENE"], [92, 95, "GENE"], [28, 31, "GENE"], [92, 95, "GENE"]]}], ["If Vit D influences ovarian AMH production, then an acute rise in Vit D level should lead to an acute rise in circulating AMH levels.", {"entities": [[3, 6, "GENE"], [66, 69, "GENE"], [28, 31, "GENE"], [122, 125, "GENE"], [3, 6, "GENE"], [66, 69, "GENE"], [28, 31, "GENE"], [122, 125, "GENE"]]}], ["This hypothesis was tested with a randomized double-blind design, with 18\u201325-year-old women recruited from the community.", {"entities": []}], ["The study was conducted in early spring, when the marker of Vit D level (25-hydroxyvitamin D, 25(OH)D) tends to be at its nadir.", {"entities": [[60, 63, "GENE"]]}], ["The women consumed either an oral dose of 50,000 IU of Vit D3 ( n = 27) or placebo ( n = 22).", {"entities": [[55, 58, "GENE"]]}], ["The initial 25(OH)D \u00b1 SD value was 53.6 \u00b1 23.3 nmol/L, with 42 of the 49 women having a value below 75 nmol/L, consistent with seasonal nadir.", {"entities": []}], ["All women receiving Vit D3 treatment exhibited a robust increase in serum 25(OH)D within 1 day (15.8 \u00b1 1.1 nmol/L ( n = 27), p < 0.0001), with the increase sustained over the study week.", {"entities": [[20, 23, "GENE"]]}], ["Circulating levels of AMH in the women receiving Vit D3 progressively rose during the following week, with a mean increase of 12.9 \u00b1 3.7% ( n = 24, p = 0.001).", {"entities": [[22, 25, "GENE"], [49, 52, "GENE"]]}], ["The study supports the hypothesis that Vit D\u2019s positive effects on the fertility of woman may involve the regulation of ovarian AMH levels.", {"entities": [[39, 42, "GENE"], [128, 131, "GENE"]]}], ["Genomics and proteomics have emerged as key technologies in biomedical research, resulting in a surge of interest in training by investigators keen to incorporate these technologies into their research.", {"entities": []}], ["At least two types of training can be envisioned in order to produce meaningful results, quality publications and successful grant applications: (1) immediate short-term training workshops and (2) long-term graduate education or visiting scientist programs.", {"entities": []}], ["We aimed to fill the former need by providing a comprehensive hands-on training course in genomics, proteomics and informatics in a coherent, experimentally-based framework.", {"entities": []}], ["This was accomplished through a National Heart, Lung, and Blood Institute (NHLBI)-sponsored 10-day Genomics and Proteomics Hands-on Workshop held at National Jewish Health (NJH) and the University of Colorado School of Medicine (UCD).", {"entities": []}], ["The course content included comprehensive lectures and laboratories in mass spectrometry and genomics technologies, extensive hands-on experience with instrumentation and software, video demonstrations, optional workshops, online sessions, invited keynote speakers, and local and national guest faculty.", {"entities": []}], ["Here we describe the detailed curriculum and present the results of short- and long-term evaluations from course attendees.", {"entities": []}], ["Our educational program consistently received positive reviews from participants and had a substantial impact on grant writing and review, manuscript submissions and publications.", {"entities": []}], ["Health economic analysis aimed at informing policy makers and supporting resource allocation decisions has to evaluate not only improvements in health but also avoided decline.", {"entities": []}], ["Little is known however, whether the \"direction\" in which changes in health are experienced is important for the public in prioritizing among patients.", {"entities": []}], ["This experimental study investigates the social value people place on avoiding (further) health decline when directly compared to curative treatments in resource allocation decisions.", {"entities": []}], ["127 individuals completed an interactive survey that was published in the World Wide Web.", {"entities": []}], ["They were confronted with a standard gamble (SG) and three person trade-off tasks, either comparing improvements in health (PTO-Up), avoided decline (PTO-Down), or both, contrasting health changes of equal magnitude differing in the direction in which they are experienced (PTO-WAD).", {"entities": []}], ["Finally, a direct priority ranking of various interventions was obtained.", {"entities": []}], ["Participants strongly prioritized improving patients' health rather than avoiding decline.", {"entities": []}], ["The mean substitution rate between health improvements and avoided decline (WAD) ranged between 0.47 and 0.64 dependent on the intervention.", {"entities": []}], ["Weighting PTO values according to the direction in which changes in health are experienced improved their accuracy in predicting a direct prioritization ranking.", {"entities": []}], ["Health state utilities obtained by the standard gamble method seem not to reflect social values in resource allocation contexts.", {"entities": []}], ["Results suggest that the utility of being cured of a given health state might not be a good approximation for the societal value of avoiding this health state, especially in cases of competition between preventive and curative interventions.", {"entities": []}], ["To compare the similarities among the multimorbidity patterns identified in primary care patients from two European regions (Spain and the Netherlands) with similar organisational features of their primary care systems, using validated methodologies.", {"entities": []}], ["This observational, retrospective, multicentre study analysed information from primary care electronic medical records.", {"entities": []}], ["Multimorbidity patterns were assessed using exploratory factor analysis of the diagnostic information of patients over 14 years of age.", {"entities": []}], ["The analysis was stratified by age groups and sex.", {"entities": []}], ["The analysis of Dutch data revealed a higher prevalence of multimorbidity which corresponds with the clustering of a higher number of diseases in each of the patterns.", {"entities": []}], ["Relevant clinical similarities were found between both countries for three multimorbidity patterns that were previously identified in the original Spanish study: cardiometabolic, mechanical and psychiatric-substance abuse.", {"entities": [[206, 221, "DISEASE"]]}], ["In addition, the clinical evolution towards complexity of the cardiometabolic pattern with advancing age -already demonstrated in the original study- was corroborated in the Dutch context.", {"entities": []}], ["A clear association between mechanical and psychosocial disorders was unique to the Dutch population, as well as the recurrent presentation of the psychiatric-substance abuse pattern in all age and sex groups.", {"entities": [[159, 174, "DISEASE"]]}], ["The similarities found for the cardiometabolic, mechanical and psychiatric-substance abuse patterns in primary care patients from two different European countries could offer initial clues for the elaboration of clinical practice guidelines, if further evidenced in other contexts.", {"entities": [[75, 90, "DISEASE"]]}], ["This study also endorses the use of primary care electronic medical records for the epidemiologic characterization of multimorbidity.", {"entities": []}], ["Antigen selection of B cells within the germinal center reaction generally leads to the accumulation of replacement mutations in the complementarity-determining regions (CDRs) of immunoglobulin genes.", {"entities": []}], ["Studies of mutations in IgE-associated VDJ gene sequences have cast doubt on the role of antigen selection in the evolution of the human IgE response, and it may be that selection for high affinity antibodies is a feature of some but not all allergic diseases.", {"entities": []}], ["The severity of IgE-mediated anaphylaxis is such that it could result from higher affinity IgE antibodies.", {"entities": []}], ["We therefore investigated IGHV mutations in IgE-associated sequences derived from ten individuals with a history of anaphylactic reactions to bee or wasp venom or peanut allergens.", {"entities": []}], ["IgG sequences, which more certainly experience antigen selection, served as a control dataset.", {"entities": []}], ["A total of 6025 unique IgE and 5396 unique IgG sequences were generated using high throughput 454 pyrosequencing.", {"entities": []}], ["The proportion of replacement mutations seen in the CDRs of the IgG dataset was significantly higher than that of the IgE dataset, and the IgE sequences showed little evidence of antigen selection.", {"entities": []}], ["To exclude the possibility that 454 errors had compromised analysis, rigorous filtering of the datasets led to datasets of 90 core IgE sequences and 411 IgG sequences.", {"entities": []}], ["These sequences were present as both forward and reverse reads, and so were most unlikely to include sequencing errors.", {"entities": []}], ["The filtered datasets confirmed that antigen selection plays a greater role in the evolution of IgG sequences than of IgE sequences derived from the study participants.", {"entities": []}], ["Walking speed is a meaningful marker of physical function in the aging population.", {"entities": []}], ["While it is a primarily physical measure, experimental studies have shown that merely priming older adults with negative stereotypes about aging results in immediate declines in objective walking speed.", {"entities": []}], ["What is not clear is whether this is a temporary experimental effect or whether negative aging stereotypes have detrimental effects on long term objective health.", {"entities": []}], ["We sought to explore the association between baseline negative perceptions of aging in the general population and objective walking speed 2 years later.", {"entities": []}], ["4,803 participations were assessed over 2 waves of The Irish Longitudinal Study on Ageing (TILDA), a prospective, population representative study of adults aged 50+ in the Republic of Ireland.", {"entities": []}], ["Wave 1 measures \u2013 which included the Aging Perceptions Questionnaire, walking speed and all covariates - were taken between 2009 and 2011.", {"entities": []}], ["Wave 2 measures \u2013 which included a second measurement of walking speed and covariates - were collected 2 years later between March and December 2012.", {"entities": []}], ["Walking speed was measured as the number of seconds to complete the Timed Up-And-Go (TUG) task.", {"entities": []}], ["Participations with a history of stroke, Parkinson\u2019s disease or an MMSE < 18 were excluded.", {"entities": []}], ["After full adjustment for all covariates (age, gender, level of education, disability, chronic conditions, medications, global cognition and baseline TUG) negative perceptions of aging at baseline were associated with slower TUG speed 2 years later (B=.03, 95% CI = .01 to 05, p< .05).", {"entities": []}], ["Walking speed has previously been considered to be a consequence of physical decline but these results highlight the direct role of psychological state in predicting an objective aging outcome.", {"entities": []}], ["Negative perceptions about aging are a potentially modifiable risk factor of some elements of physical decline in aging.", {"entities": []}], ["Contact hypersensitivity (CHS) is thought to be mainly associated with the activation of T helper type 1 (Th1) cells.", {"entities": []}], ["However, there is also evidence that Th2 cells or Th2 cytokines play a role in the development of CHS.", {"entities": []}], ["To analyze the functional contribution of Th2 cytokines interleukin (IL)-4 and IL-13, signal transducer and activator of transcription 6 (STAT6)-deficient (STAT6 A histological analysis revealed that the infiltration of both eosinophils and neutrophils in the skin challenged after 24 h in STAT6", {"entities": [[138, 143, "GENE"], [156, 161, "GENE"], [290, 295, "GENE"], [138, 143, "GENE"], [156, 161, "GENE"], [290, 295, "GENE"], [138, 143, "GENE"], [156, 161, "GENE"], [290, 295, "GENE"]]}], ["Heparan sulfate (HS), a glycosaminoglycan present on the surface of cells, has been postulated to have important roles in driving both normal and pathological physiologies.", {"entities": []}], ["The chemical structure and sulfation pattern (domain structure) of HS is believed to determine its biological function, to vary across tissue types, and to be modified in the context of disease.", {"entities": []}], ["Characterization of HS requires isolation and purification of cell surface HS as a complex mixture.", {"entities": []}], ["This process may introduce additional chemical modification of the native residues.", {"entities": []}], ["In this study, we describe an approach towards thorough characterization of bovine kidney heparan sulfate (BKHS) that utilizes a variety of orthogonal analytical techniques ( e.g.", {"entities": []}], ["NMR, IP-RPHPLC, LC-MS).", {"entities": []}], ["These techniques are applied to characterize this mixture at various levels including composition, fragment level, and overall chain properties.", {"entities": []}], ["The combination of these techniques in many instances provides orthogonal views into the fine structure of HS, and in other instances provides overlapping / confirmatory information from different perspectives.", {"entities": []}], ["Specifically, this approach enables quantitative determination of natural and modified saccharide residues in the HS chains, and identifies unusual structures.", {"entities": []}], ["Analysis of partially digested HS chains allows for a better understanding of the domain structures within this mixture, and yields specific insights into the non-reducing end and reducing end structures of the chains.", {"entities": []}], ["This approach outlines a useful framework that can be applied to elucidate HS structure and thereby provides means to advance understanding of its biological role and potential involvement in disease progression.", {"entities": []}], ["In addition, the techniques described here can be applied to characterization of heparin from different sources.", {"entities": []}], ["The online version of this article (doi:10.1007/s10719-016-9734-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["African Americans (AA) with systemic sclerosis (SSc) have a worse prognosis compared to Americans of European descent (EA).", {"entities": []}], ["We conducted the current study to test the hypothesis that AA patients with SSc have more severe disease and poorer outcomes compared to EA patients when afflicted with pulmonary arterial hypertension (PAH).", {"entities": [[188, 200, "DISEASE"]]}], ["We studied 160 consecutive SSc patients with PAH diagnosed by right heart catheterization, comparing demographics, hemodynamics, and outcomes between AA and EA patients.", {"entities": []}], ["The cohort included 29 AA and 131 EA patients with similar baseline characteristics except for increased prevalence of diffuse SSc in AA.", {"entities": []}], ["AA patients had worse functional class (FC) (80% FC III-IV vs 53%; p\u200a=\u200a0.02), higher brain natriuretic peptide (NT-pro-BNP) (5729 \u00b1 9730\u200apg/mL vs 1892 \u00b1 2417\u200apg/mL; p\u200a=\u200a0.02), more depressed right ventricular function, a trend toward lower 6-minute walk distance (263 \u00b1 111\u200a\u200am vs 333 \u00b1 110\u200a\u200am; p\u200a=\u200a0.07), and worse hemodynamics (cardiac index 1.95 \u00b1 0.58\u200aL/min/m In conclusion, AA patients with SSc-PAH are more likely to have diffuse SSc and to present with significantly more severe PAH compared with EA patients.", {"entities": []}], ["AA patients also appear to have poorer survival, though larger studies are needed to investigate this association definitively.", {"entities": []}], ["Interleukin-18 ( IL-18 ) is a pleiotropic, pro-inflammatory cytokine that is capable of promoting the Th1 response.", {"entities": []}], ["A predominant Th1 response induces chronic and persistent inflammatory changes in the gastric mucosa in response to Helicobacter pylori ( H. pylori ) infection.", {"entities": []}], ["The aim of this study was to investigate the potential association between IL-18 gene polymorphisms and susceptibility to H. pylori infection in the Korean population.", {"entities": []}], ["A total of 678 subjects who underwent a routine health check-up were enrolled.", {"entities": []}], ["The IL-18 gene polymorphisms at positions \u2212656, \u2212607, \u2212137,\u2009+113, and\u2009+127 were genotyped.", {"entities": []}], ["H. pylori positivity was demonstrated in 456 subjects (67.3%).", {"entities": []}], ["The allele frequencies of IL-18 gene polymorphisms at position \u2212137 (rs187238) were different based on the status of H. pylori infection (G vs. C, adjusted OR 0.64 CI: 0.47\u20130.87, P\u2009=\u20090.005).", {"entities": []}], ["The results indicate that the genetic variants in the IL-18 gene may be associated with susceptibility to H. pylori infection in the Korean population, suggesting that IL-18 plays a role in the pathogenesis of H. pylori -associated diseases.", {"entities": []}], ["However, this finding requires further replication and validation.", {"entities": []}], ["South Africa faces a complex dual burden of chronic communicable and non-communicable diseases (NCDs).", {"entities": []}], ["In response, the Integrated Chronic Disease Management (ICDM) model was initiated in primary health care (PHC) facilities in 2011 to leverage the HIV/ART programme to scale-up services for NCDs, achieve optimal patient health outcomes and improve the quality of medical care.", {"entities": []}], ["However, little is known about the quality of care in the ICDM model.", {"entities": []}], ["The objectives of this study were to: i) assess patients\u2019 and operational managers\u2019 satisfaction with the dimensions of ICDM services; and ii) evaluate the quality of care in the ICDM model using Avedis Donabedian\u2019s theory of relationships between structure (resources), process (clinical activities) and outcome (desired result of healthcare) constructs as a measure of quality of care.", {"entities": []}], ["A cross-sectional study was conducted in 2013 in seven PHC facilities in the Bushbuckridge municipality of Mpumalanga Province, north-east South Africa - an area underpinned by a robust Health and Demographic Surveillance System (HDSS).", {"entities": []}], ["The patient satisfaction questionnaire (PSQ-18), with measures reflecting structure/process/outcome (SPO) constructs, was adapted and administered to 435 chronic disease patients and the operational managers of all seven PHC facilities.", {"entities": []}], ["The adapted questionnaire contained 17 dimensions of care, including eight dimensions identified as priority areas in the ICDM model - critical drugs, equipment, referral, defaulter tracing, prepacking of medicines, clinic appointments, waiting time, and coherence.", {"entities": []}], ["A structural equation model was fit to operationalise Donabedian\u2019s theory, using unidirectional, mediation, and reciprocal pathways.", {"entities": []}], ["The mediation pathway showed that the relationships between structure, process and outcome represented quality systems in the ICDM model.", {"entities": []}], ["Structure correlated with process (0.40) and outcome (0.75).", {"entities": []}], ["Given structure, process correlated with outcome (0.88).", {"entities": []}], ["Of the 17 dimensions of care in the ICDM model, three structure (equipment, critical drugs, accessibility), three process (professionalism, friendliness and attendance to patients) and three outcome (competence, confidence and coherence) dimensions reflected their intended constructs.", {"entities": []}], ["Of the priority dimensions, referrals, defaulter tracing, prepacking of medicines, appointments, and patient waiting time did not reflect their intended constructs.", {"entities": []}], ["Donabedian\u2019s theoretical framework can be used to provide evidence of quality systems in the ICDM model.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-017-2177-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Air pollution has consistently been associated with increased morbidity and mortality due to respiratory and cardiovascular disease.", {"entities": []}], ["Underlying biological mechanisms are not entirely clear, and hemostasis and inflammation are suggested to be involved.", {"entities": []}], ["Our aim was to study the association of the variation in local concentrations of airborne particulate matter (PM) with aerodynamic diameter < 10 \u03bcm, carbon monoxide, nitrogen monoxide, nitrogen dioxide, and ozone with platelet aggregation, thrombin generation, fibrinogen, and C-reactive protein (CRP) levels in healthy individuals.", {"entities": [[297, 300, "GENE"]]}], ["From 40 healthy volunteers, we collected 13 consecutive blood samples within a 1-year period and measured light-transmittance platelet aggregometry, thrombin generation, fibrinogen, and CRP.", {"entities": [[186, 189, "GENE"]]}], ["We performed regression analysis using generalized additive models to study the association between the hemostatic and inflammatory variables, and local environmental concentrations of air pollutants for time lags within 24 hr before blood sampling or 24\u201396 hr before blood sampling.", {"entities": [[224, 226, "GENE"], [258, 260, "GENE"], [224, 226, "GENE"], [258, 260, "GENE"]]}], ["In general, air pollutants were associated with platelet aggregation [average, +8% per interquartile range (IQR), p < 0.01] and thrombin generation (average, +1% per IQR, p < 0.05).", {"entities": []}], ["Platelet aggregation was not affected by in vitro incubation of plasma with PM.", {"entities": []}], ["We observed no relationship between any of the air pollutants and fibrinogen or CRP levels.", {"entities": [[80, 83, "GENE"]]}], ["Air pollution increased platelet aggregation as well as coagulation activity but had no clear effect on systemic inflammation.", {"entities": []}], ["These prothrombotic effects may partly explain the relationship between air pollution and the risk of ischemic cardiovascular disease.", {"entities": []}], ["Supplemental Digital Content is available in the text Peritoneal dialysis (PD) is one type of renal replacement therapy, but potential peritoneal damage and gastrointestinal (GI) tract adverse effects during long-term exposure to bio-incompatible dialysate remain a concern.", {"entities": []}], ["Although GI disease frequently occurs in dialysis patients, whether the risk of GI diseases differs among PD and hemodialysis (HD) or non-uremic groups is still uncertain.", {"entities": []}], ["In this retrospective cohort study, data were obtained from the National Health Insurance Research Database, which includes almost all dialysis patients in Taiwan.", {"entities": []}], ["Between 2000 and 2009, a total of 1791 PD and 8955 HD incident patients were enrolled and matched for age and sex or for propensity score.", {"entities": []}], ["In addition, a comparison cohort of 8955 non-uremic patients was also selected.", {"entities": []}], ["Individuals were monitored for the occurrence of common GI diseases until 2010, and data were analyzed using several different models.", {"entities": []}], ["Generally speaking, the results showed that the risk of gastroesophageal reflux, intestinal obstruction or adhesions, and abdominal hernia was significantly higher in the PD group, whereas the risk of peptic ulcer disease and lower GI diverticula and bleeding was significantly greater in the HD group.", {"entities": [[81, 103, "DISEASE"], [201, 213, "DISEASE"]]}], ["Meanwhile, the risk of mesenteric ischemia, liver cirrhosis, and acute pancreatitis was higher in dialysis patients, but was not significantly different between the PD and HD groups; moreover, the risk of appendicitis in the PD group appeared to be lower than that in the HD group.", {"entities": [[205, 217, "DISEASE"], [34, 42, "DISEASE"], [44, 59, "DISEASE"], [71, 83, "DISEASE"], [65, 83, "DISEASE"]]}], ["In conclusion, dialysis patients have a higher risk of most common GI diseases, and PD and HD modalities are associated with different GI diseases.", {"entities": []}], ["Vascular dementia (VaD) is one of the most common forms of dementia, and second only to Alzheimer's disease.", {"entities": [[9, 17, "DISEASE"], [59, 67, "DISEASE"]]}], ["The purpose of this study was to evaluate the potential diagnostic value of Framingham risk score (FRS) in VaD by investigating the relationship among cardiovascular risks, FRS, and VaD.", {"entities": []}], ["Data were collected from patients (n\u200a=\u200a130) at Tongji Hospital in Wuhan, China.", {"entities": []}], ["They were divided into 2 groups, including the control group (n\u200a=\u200a70) and the VaD group (n\u200a=\u200a60).", {"entities": []}], ["Statistical methods including t- test, logistic regression model, multiple linear regression model, and receiver-operating characteristic (ROC) curve were adopted for the assessment.", {"entities": []}], ["A significant difference (all P \u200a<\u200a.05) was observed in systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure, total cholesterol (TC), homosysteine (HCY), glycosylated hemoglobin A1c (HbA1c), FRS, and cerebral white matter lesions (WMLs) between the 2 groups, even after adjusting for age (both P \u200a<\u200a.05).", {"entities": [[113, 116, "GENE"]]}], ["Age [odds ratio (OR)\u200a=\u200a1.20; P \u200a=\u200a.002], FRS (OR\u200a=\u200a1.55; P \u200a=\u200a.006), and WMLs (OR\u200a=\u200a10.17; P \u200a=\u200a.011) were independent prognostic factors for VaD.", {"entities": []}], ["The area under the ROC curve (AUC) of FRS for VaD diagnosis prediction was 0.830 (95% confidence interval, 95% CI: 0.730\u223c 0.929).", {"entities": []}], ["There was a significant difference in the AUC between WMLs and WMLs combined with FRS (0.788 (95% CI: 0.667 \u223c 0.880) versus 0.863 (95% CI: 0.754 \u223c 0.936, P \u200a=\u200a.049).", {"entities": []}], ["Age, HbA1c, and FRS were negatively correlated with the mini-mental state examination (MMSE) scores (all P \u200a<\u200a.05) in the VaD group.", {"entities": []}], ["Moreover, multiple stepwise linear regression analysis showed that the age and FRS were independent predictors of MMSE scores.", {"entities": []}], ["FRS has a moderate predictive value for the VaD diagnosis, and also increases the risk of cognitive decline.", {"entities": []}], ["Despite the success of cART, greater than 50% of HIV infected people develop cognitive and motor deficits termed HIV-associated neurocognitive disorders (HAND).", {"entities": []}], ["Macrophages are the major cell type infected in the CNS.", {"entities": []}], ["Unlike for T cells, the virus does not kill macrophages and these long-lived cells may become HIV reservoirs in the brain.", {"entities": []}], ["They produce cytokines/chemokines and viral proteins that promote inflammation and neuronal damage, playing a key role in HIV neuropathogenesis.", {"entities": []}], ["HIV Tat is the transactivator of transcription that is essential for replication and transcriptional regulation of the virus and is the first protein to be produced after HIV infection.", {"entities": []}], ["Even with successful cART, Tat is produced by infected cells.", {"entities": []}], ["In this study we examined the role of the HIV Tat protein in the regulation of gene expression in human macrophages.", {"entities": []}], ["Using THP-1 cells, a human monocyte/macrophage cell line, and their infection with lentivirus, we generated stable cell lines that express Tat-Flag.", {"entities": []}], ["We performed ChIP-seq analysis of these cells and found 66 association sites of Tat in promoter or coding regions.", {"entities": []}], ["Among these are C5, CRLF2/TSLPR, BDNF, and APBA1/Mint1, genes associated with inflammation/damage.", {"entities": [[16, 18, "GENE"], [33, 37, "GENE"]]}], ["We confirmed the association of Tat with these sequences by ChIP assay and expression of these genes in our THP-1 cell lines by qRT-PCR.", {"entities": []}], ["We found that HIV Tat increased expression of C5, APBA1, and BDNF, and decreased CRLF2.", {"entities": [[46, 48, "GENE"], [50, 55, "GENE"], [61, 65, "GENE"], [81, 86, "GENE"]]}], ["The K50A Tat-mutation dysregulated expression of these genes without affecting the binding of the Tat complex to their gene sequences.", {"entities": []}], ["Our data suggest that HIV Tat, produced by macrophage HIV reservoirs in the brain despite successful cART, contributes to neuropathogenesis in HIV-infected people.", {"entities": []}], ["Human rhinoviruses (HRV) are known to cause common cold as well as more complicated respiratory infections.", {"entities": [[44, 55, "DISEASE"]]}], ["HRV species -A, -B and -C have all been associated with lower respiratory infections and exacerbations of asthma.", {"entities": [[106, 112, "DISEASE"]]}], ["However, the type distribution of strains connected to different kinds of lower respiratory conditions is not clearly known.", {"entities": []}], ["We have analysed the presence of HRV in sputum specimens derived from military recruits with and without pre-diagnosed asthma at times of acute respiratory infection (CIAS Study, 2004\u20132005).", {"entities": [[119, 125, "DISEASE"]]}], ["The analysis was performed with HRV and HEV real-time RT-PCR assays.", {"entities": []}], ["Subsequently we studied type distribution of HRV strains by genetic typing in the VP4/VP2 genomic region.", {"entities": []}], ["In total 146 (38.8%) specimens were HRV-positive and 36 (9.3%) HEV-positive.", {"entities": []}], ["No difference was found in HRV detection between the asthmatic vs .", {"entities": []}], ["non-asthmatic patients.", {"entities": []}], ["Most of the genetically typed strains, 18 (62.1%), belonged to HRV-A, while HRV-B strains constituted five (17.2%) of the HRV-positive strains.", {"entities": []}], ["HRV-C strain was typed four times from the HRV-positive cases and a HEV-D strain twice.", {"entities": []}], ["We further typed six HEV positive strains in the partial VP1 region.", {"entities": []}], ["Three of these belonged to HRV-A and three to HEV-D. HRV-A strains were discovered throughout the study period, while HRV-C strains originated from winter and spring specimens.", {"entities": []}], ["Interestingly, four out of five typed HRV-B strains originated from the summer season specimens.", {"entities": []}], ["Asthma exacerbations are important events that affect disease control, but predictive factors for severe or moderate exacerbations are not known.", {"entities": [[0, 6, "DISEASE"]]}], ["The objective was to study the predictive factors for moderate (ME) and severe (SE) exacerbations in asthma patients receiving outpatient care.", {"entities": [[101, 107, "DISEASE"]]}], ["Patients aged\u2009>\u200912\u00a0years with asthma were included in the study and followed-up at 4-monthly intervals over a 12-month period.", {"entities": [[30, 36, "DISEASE"]]}], ["Clinical (severity, level of control, asthma control test [ACT]), atopic, functional, inflammatory, SE and ME parameters were recorded.", {"entities": [[38, 44, "DISEASE"]]}], ["Univariate analysis was used to compare data from patients presenting at least 1 SE or ME during the follow-up period vs no exacerbations.", {"entities": []}], ["Statistically significant ( p \u2009<0.1) factors were then subjected to multiple analysis by binary logistic regression.", {"entities": []}], ["A total of 330 patients completed the study, most of whom were atopic (76%), women (nearly 70%), with moderate and mild persistent asthma (>80%).", {"entities": [[131, 137, "DISEASE"]]}], ["Twenty-seven patients (8%) had a SE and 183 had a ME (58.5%) during follow-up.", {"entities": []}], ["In the case of SEs, the only predictive factor identified in the multiple analysis was previous SE (baseline visit OR 4.218 95% CI 1.53-11.58, 4-month follow-up OR 6.88 95% CI 2.018-23.51) and inhalation technique (OR 3.572 95% CI 1.324-9.638).", {"entities": []}], ["In the case of MEs, the only predictive factor found in the multiple analysis were previous ME (baseline visit OR 2.90 95% CI 1.54-5.48, 4-month follow- up OR 1.702 95% CI 1.146-2.529).", {"entities": []}], ["The primary predictive factor for SE or ME is prior SE or ME, respectively.", {"entities": []}], ["SEs seem to constitute a specific patient \"phenotype\", in which the sole predictive factor is prior SEs.", {"entities": []}], ["Pollutant emissions and their contribution to local and regional air quality at the industrial area of Tula were studied during a four-week period as part of the MILAGRO initiative.", {"entities": []}], ["A recurrent shallow stable layer was observed in the morning favoring air pollutants accumulation in the lower 100\u2009m atmospheric layer.", {"entities": []}], ["In the afternoon the mixing layer height reached 3000\u2009m, along with a featuring low level jet which was responsible of transporting air pollutants at regional scales.", {"entities": []}], ["Average PM 10 at Jasso (JAS) and Tepeji (TEP) was 75.1 and 36.8\u2009 \u03bc g/m 2.5 was 31.0 and 25.7\u2009 \u03bc g/m 10 constituted by PM 2.5 .", {"entities": []}], ["Average hourly aerosol light absorption was 22\u2009Mm \u03b4 Tillandsia recurvata show that the emission plume directly affects the SW sector of Mezquital Valley and is then constrained by a mountain range preventing its dispersion.", {"entities": []}], ["Air pollutants may exacerbate acute and chronic adverse health effects in this region.", {"entities": []}], ["Obesity is associated with increased risks for mental disorders.", {"entities": [[0, 7, "DISEASE"]]}], ["This study examined associations of obesity indicators including body mass index (BMI), waist circumference, and waist-height ratio with suicidal ideation among U.S. women.", {"entities": [[36, 43, "DISEASE"]]}], ["We analyzed data from 3,732 nonpregnant women aged \u226520 years who participated in the 2005\u20132008 National Health and Nutrition Examination Survey.", {"entities": []}], ["We used anthropometric measures of weight, height, and waist circumference to calculate BMI and waist-height ratio.", {"entities": []}], ["Suicidal ideation was assessed using the Item 9 of the Patient Health Questionnaire-9.", {"entities": []}], ["Odds ratios with 95% conference intervals were estimated using logistic regression analyses after controlling for potential confounders.", {"entities": []}], ["The age-adjusted prevalence of suicidal ideation was 3.0%; the prevalence increased linearly across quartiles of BMI, waist circumference, and waist-height ratio ( P for linear trend <0.01 for all).", {"entities": []}], ["The positive associations of waist circumference and waist-height ratio with suicidal ideation remained significant ( P < 0.05) after adjustment for sociodemographics, lifestyle-related behavioral factors, and having either chronic conditions or current depression.", {"entities": []}], ["However, these associations were attenuated after both chronic conditions and depression were entered into the models.", {"entities": []}], ["Thus, the previously reported association between obesity and suicidal ideation appears to be confounded by coexistence of chronic conditions and current depression among women of the United States.", {"entities": [[50, 57, "DISEASE"]]}], ["Among babies born by ART, do singleton survivors of a vanishing twin have lower birth weight than other singletons?", {"entities": []}], ["Vanishing twin syndrome (VTS) was associated with lower birth weight among ART singletons; a sibship analysis indicated that the association was not confounded by maternal characteristics that remain stable between deliveries.", {"entities": [[15, 23, "DISEASE"]]}], ["Previous studies indicate that ART singletons with VTS have increased risk of adverse pregnancy outcomes, compared with other ART singletons.", {"entities": []}], ["The potential contribution of unmeasured maternal background characteristics has been unclear.", {"entities": []}], ["This was a Norwegian population-based registry study, including 17 368 mothers with 20 410 ART singleton deliveries between January 1984 and December 2013.", {"entities": []}], ["The study population included 17 291 ART singletons without VTS, 638 ART singletons with VTS and 2418 ART singletons with uncertain vanishing twin status.", {"entities": []}], ["We estimated differences in birth weight and gestational age comparing ART singletons with VTS first to all ART singletons without VTS, and subsequently to their ART siblings without VTS, using random- and fixed-effects linear regression, respectively.", {"entities": []}], ["The corresponding comparisons for the associations with preterm birth and small for gestational age (SGA) were conducted using random-and fixed-effects logistic regression.", {"entities": []}], ["The sibling analysis of preterm birth included 587 discordant siblings, while the sibling analysis of SGA included 674 discordant siblings.", {"entities": []}], ["ART singletons with VTS had lower birth weight when compared to all ART singletons without VTS, with an adjusted mean difference (95% CI) of \u2212116 g (\u2212165, \u221267).", {"entities": []}], ["When we compared ART singletons with VTS to their ART singletons sibling without VTS, the adjusted mean difference was \u2212112 g (\u2212209, \u221215).", {"entities": []}], ["ART singletons with VTS also had increased risk of being born SGA, with an adjusted odds ratio (OR) (95% CI) of 1.48 (1.07, 2.03) compared to all ART singletons without VTS, and 2.79 (1.12, 6.91) in the sibship analyses.", {"entities": []}], ["ART singletons with VTS were also more likely to be born preterm, although this difference did not reach statistical significance.", {"entities": []}], ["We did not have information on maternal socio-economic status, but this factor is accounted for in the sibship analyses.", {"entities": []}], ["We also had no information on whether fresh or frozen embryos were replaced.", {"entities": []}], ["The reduction in birth weight and increased risk of SGA in ART singletons with VTS may suggest the presence of harmful intrauterine factors with long-term health impact.", {"entities": []}], ["While vanishing twins are not routinely observed in naturally conceived pregnancies, loss of a twin is potentially a risk factor for the surviving foetus in any pregnancy.", {"entities": []}], ["This could be further explored in large samples of naturally conceived pregnancies with the necessary information.", {"entities": []}], ["The authors of this study are supported in part by the UK Medical Research Council, US National Institute of Environmental Health Sciences and the Norwegian Research Council.", {"entities": []}], ["The authors have no conflicts of interest.", {"entities": []}], ["The aim of this study was to determine if an interactive web-based pulmonary rehabilitation (PR) programme is a feasible alternative to conventional PR.", {"entities": []}], ["Randomised controlled feasibility trial.", {"entities": []}], ["Participants with a diagnosis of chronic obstructive pulmonary disease were recruited from PR assessments, primary care and community rehabilitation programmes.", {"entities": [[33, 70, "DISEASE"]]}], ["Patients randomised to conventional rehabilitation started the programme according to the standard care at their referred site on the next available date.", {"entities": []}], ["103 patients were recruited to the study and randomised: 52 to conventional rehabilitation (mean (\u00b1SD) age 66 (\u00b18) years, Medical Research Council (MRC) 3 (IQR2\u20134)); 51 to the web arm (mean (\u00b1SD) age 66 (\u00b110) years, MRC 3 (IQR2\u20134)).", {"entities": []}], ["Participants had to be willing to participate in either arm of the trial, have internet access and be web literate.", {"entities": []}], ["Patients randomised to the web-based programme worked through the website, exercising and recording their progress as well as reading educational material.", {"entities": []}], ["Conventional PR consisted of twice weekly, 2 hourly sessions (an hour for exercise training and an hour for education).", {"entities": []}], ["Recruitment rates, eligibility, patient preference and dropout and completion rates for both programmes were collected.", {"entities": []}], ["Standard outcomes for a PR assessment including measures of exercise capacity and quality of life questionnaires were also evaluated.", {"entities": []}], ["A statistically significant improvement (p\u22640.01) was observed within each group in the endurance shuttle walk test (WEB: mean change 189\u00b1211.1; PR classes: mean change 184.5\u00b1247.4\u2005s) and Chronic Respiratory disease Questionnaire-Dyspnoea (CRQ-D; WEB: mean change 0.7\u00b11.2; PR classes: mean change 0.8\u00b11.0).", {"entities": []}], ["However, there were no significant differences between the groups in any outcome.", {"entities": []}], ["Dropout rates were higher in the web-based programme (57% vs 23%).", {"entities": []}], ["An interactive web-based PR programme is feasible and acceptable when compared with conventional PR.", {"entities": []}], ["Future trials maybe around choice-based PR programmes for select patients enabling stratification of patient care.", {"entities": []}], ["ISRCTN03142263 ; Results.", {"entities": []}], ["The prevalence of asthma in our society is rising and there is need for better understanding of the asthma patients\u2019 perception and treatment practice of physicians.", {"entities": [[18, 24, "DISEASE"], [100, 106, "DISEASE"]]}], ["The study was aimed at determining asthma attitudes and treatment practices among adult physicians and patients in Nigeria, with the goal of identifying barriers to optimal management.", {"entities": [[35, 41, "DISEASE"]]}], ["To assess asthma attitudes, treatment practices and limitations among adult physicians and patients in Nigeria, a questionnaire survey was conducted among 150 patients and 70 physicians.", {"entities": [[10, 16, "DISEASE"]]}], ["Majority (66.7%) of the patients reported their asthma as moderate to severe, 42.7% had emergency room visit and 32% had admission due to asthma in the previous 12 months.", {"entities": [[48, 54, "DISEASE"], [138, 144, "DISEASE"]]}], ["Physicians and patients perceptions significantly differed in the time devoted to educational issues (31.4% vs.18.7%) and its contents: individual management plan (64.3% vs.33.3%), correct inhaler technique (84.0% vs.71.0%), medication side effects (80.0% vs.60.0%) and compliance 100% of time (5.7% vs. 18.7%).", {"entities": []}], ["Patients reported that non-compliance with medication causes increased symptoms (67.0%), exacerbations (60.0%), bronchodilator use (56.0%), urgent physician visit (52.0%) and hospitalizations /ER visits (38.7%).", {"entities": []}], ["Asthma medication in patients caused short term (10.7%) and long term side effects (20.0%).", {"entities": [[0, 6, "DISEASE"]]}], ["Due to side effects, 28.0% skipped and stopped their medications.", {"entities": []}], ["Most physicians (85.7%) and patients (56.0%) agreed on the need for new medication options.", {"entities": []}], ["The need for new medication in patients was strongly related to asthma severity, limitation of activities, side effects, cost and lack of satisfaction with current medication.", {"entities": [[64, 70, "DISEASE"]]}], ["With the exception of pulmonologists, physicians did not readily prescribe ICS and their prescriptions were not in line with treatment guidelines.", {"entities": []}], ["This study has highlighted the gaps and barriers to asthma treatment which need to be addressed to improve the quality of care in Nigeria.", {"entities": [[52, 58, "DISEASE"]]}], ["Smoking is a major modifiable risk factor for premature mortality.", {"entities": []}], ["Estimating the smoking-attributable burden is important for public health policy.", {"entities": []}], ["Typically, prevalence- or smoking impact ratio (SIR)-based methods are used to derive estimates, but there is controversy over which method is more appropriate for country-specific estimates.", {"entities": []}], ["We compared smoking-attributable fractions (SAFs) of deaths estimated by these two methods.", {"entities": []}], ["To estimate SAFs in 2012, we used several different prevalence-based approaches using no lag and 10- and 20-year lags.", {"entities": []}], ["For the SIR-based method, we obtained lung cancer mortality rates from the Korean Cancer Prevention Study (KCPS) and from the United States-based Cancer Prevention Study-II (CPS-II).", {"entities": [[38, 49, "DISEASE"], [43, 49, "DISEASE"], [82, 88, "DISEASE"], [146, 152, "DISEASE"]]}], ["The relative risks for the diseases associated with smoking were also obtained from these cohort studies.", {"entities": []}], ["For males, SAFs obtained using KCPS-derived SIRs were similar to those obtained using prevalence-based methods.", {"entities": []}], ["For females, SAFs obtained using KCPS-derived SIRs were markedly greater than all prevalence-based SAFs.", {"entities": []}], ["Differences in prevalence-based SAFs by time-lag period were minimal among males, but SAFs obtained using longer-lagged prevalence periods were significantly larger among females.", {"entities": []}], ["SAFs obtained using CPS-II-based SIRs were lower than KCPS-based SAFs by >15 percentage points for most diseases, with the exceptions of lung cancer and chronic obstructive pulmonary disease.", {"entities": [[137, 148, "DISEASE"], [153, 190, "DISEASE"], [142, 148, "DISEASE"]]}], ["SAFs obtained using prevalence- and SIR-based methods were similar for males.", {"entities": []}], ["However, neither prevalence-based nor SIR-based methods resulted in precise SAFs among females.", {"entities": []}], ["The characteristics of the study population should be carefully considered when choosing a method to estimate SAF.", {"entities": []}], ["Hand disinfection with alcohols-based hand rubs (ABHRs) are known to be the most effective measure to prevent nosocomial infections in healthcare.", {"entities": []}], ["ABHRs contain on average 70% by weight of one or more alcohols.", {"entities": []}], ["During the hand rubbing procedure, users are exposed to these alcohols not only through dermal contact, but also via inhalation, due to the physical and chemical properties of alcohols volatilizing from alcoholic solutions or gels into the air.", {"entities": []}], ["Ethanol ingestion is well known to increase risks of several diseases (affecting the pancreas, liver, cardiovascular system\u2026), but there is a lack of knowledge about the effects of exposure to other alcohols (including n - or isopropanol) via inhalation and dermal contact, despite the worldwide use of ABHRs.", {"entities": []}], ["This work aims at discussing possible health effects related to unintentional alcoholization (via inhalation and dermal contact) from professional ABHR usage to suggest the need for more research in this area (but not to question the value of ABHRs).", {"entities": []}], ["Based upon an average of 30 hand rubbings per healthcare professional per day, it can be assumed that a healthcare worker may be exposed to a maximum 5,500 mg/m", {"entities": []}], ["Mast cells, best known as effector cells in pathogenic immunoglobulin-mediated responses, can sense a variety of \u201cdanger\u201d signals; if manipulated to enhance their resulting inflammatory responses, they also exacerbate inflammatory diseases such as arthritis and lung inflammation.", {"entities": [[248, 257, "DISEASE"]]}], ["Mast cells are implicated in the pathogenesis of inflammatory and autoimmune diseases.", {"entities": []}], ["However, this notion based on studies in mast cell-deficient mice is controversial.", {"entities": []}], ["We therefore established an in vivo model for hyperactive mast cells by specifically ablating the NF-\u03baB negative feedback regulator A20.", {"entities": []}], ["While A20 deficiency did not affect mast cell degranulation, it resulted in amplified pro-inflammatory responses downstream of IgE/Fc\u03b5RI, TLRs, IL-1R, and IL-33R.", {"entities": []}], ["As a consequence house dust mite- and IL-33-driven lung inflammation, late phase cutaneous anaphylaxis, and collagen-induced arthritis were aggravated, in contrast to experimental autoimmune encephalomyelitis and immediate anaphylaxis.", {"entities": [[125, 134, "DISEASE"], [191, 208, "DISEASE"]]}], ["Our results provide in vivo evidence that hyperactive mast cells can exacerbate inflammatory disorders and define diseases that might benefit from therapeutic intervention with mast cell function.", {"entities": []}], ["Mast cells mediate allergic and anaphylactic immune reactions.", {"entities": []}], ["They are also equipped with innate pattern recognition, cytokine, and alarmin receptors, which induce inflammatory responses.", {"entities": []}], ["Correlative studies in human patients hinted at roles for mast cells in autoimmune and inflammatory diseases.", {"entities": []}], ["However, studies using mast cell-deficient mice have yielded contradictory results in this context.", {"entities": []}], ["In this study we determined that A20, the negative feedback regulator, restricts inflammation downstream of the mast cell antigen (allergen) receptor module, innate pattern recognition receptors, and the alarmin receptor IL-33R.", {"entities": []}], ["By mast cell\u2013specific ablation of A20 we established a mouse model for exaggerated inflammatory but normal anaphylactic mast cell signaling.", {"entities": []}], ["With these mice we evaluated the impact of increased mast cell-mediated inflammation under experimental conditions aimed at mimicking several inflammatory human diseases.", {"entities": []}], ["Our results demonstrated that the lack of A20 from mast cells exacerbated disease in mouse models for rheumatoid arthritis and innate forms of asthma, but did not impact disease progression in a mouse model for multiple sclerosis.", {"entities": [[211, 229, "DISEASE"], [102, 122, "DISEASE"], [113, 122, "DISEASE"], [143, 149, "DISEASE"]]}], ["Our data provide direct evidence that enhanced inflammatory mast cell responses can contribute to disease pathology and do so via sensing and amplifying local inflammatory reactions driven by \u201cdanger\u201d stimuli and/or tissue damage that leads to the release of alarmins.", {"entities": []}], ["Subsequent to the first report in the 1940s on incubation of tissue sections with fluorescein-conjugated antibodies for localization of antigens, a great number of modifications were introduced to improve the validity of immunohistochemistry which has become a growingly popular tool.", {"entities": []}], ["The use of immunoenzymatic techniques eliminates the need for expensive fluorescence microscopy equipment, the lack of permanency of preparations and the lack of electron density required in ultrastructural localization of antigens.", {"entities": []}], ["Regardless of the technique, it is also important to choose a correct fixation which allows the proper preservation of antigens and morphology and the penetration of antibodies through the entire thickness of the preparation.", {"entities": []}], ["A variety of immunohistochemical techniques have been applied to study several components of the lung, such as collagen, surface active material, lung specific antigens, and enzymes and the detection of tumor markers, immunoglobulins and infectious agents in the respiratory system which is reviewed.", {"entities": []}], ["The large surface area and the multiplicity of cell types provided by the respiratory tract epithelium of humans for exposure to microbial as well as toxic substances in the environment make this organ system very vulnerable but a good early indicator of adverse health effects.", {"entities": []}], ["Immunohistochemistry provides valuable information complementary to the immunochemical and biochemical characterization of this barrier.", {"entities": []}], ["The study focused on assessment of the health status of workers during construction phase of highway rehabilitation projects at six selected sites of N5 around Lahore, including Kala Shah Kaku, Muridke, Kamuki, Bhaipheru, Pattoki, and Okara.", {"entities": []}], ["The study was based on multi-methods approach involving hazard identification through survey and checklist as well as a questionnaire for health status assessment and measurements of health parameters including peak expiratory flow rate (PEFR) and audiometric screening of 300 subjects.", {"entities": []}], ["The study revealed non-congenial working conditions at the sites.", {"entities": []}], ["Noise, vibrations, dust, asphalt fumes, poor work postures, and injuries were found to be major health hazards.", {"entities": []}], ["PEFR of most of the workers was found to be significantly lower than the reference value.", {"entities": []}], ["Average PEFR\u00b1SEM values were 187\u00b15.1 l /min, 178\u00b14.3 l /min, and 266\u00b15.3 l /min in ground preparation workers, asphalt workers, and heavy vehicle drivers, respectively.", {"entities": []}], ["The highest rate (29%) of hearing loss was recorded among heavy vehicle drivers.", {"entities": []}], ["Musculoskeletal problems were found to be more common among ground preparation workers.", {"entities": []}], ["Data revealed unsatisfactory health status of most of the workers.", {"entities": []}], ["Direct relationship between health outcomes and the type of construction activities were observed.", {"entities": []}], ["The current study focuses on the importance of including occupational health and safety plan in the execution phase of every developmental project that involves construction activities.", {"entities": []}], ["On 30 January 2012, the US FDA approved vismodegib (Erivedge Our objective was to identify evidence of hepatotoxicity with vismodegib in the FDA Adverse Event Reporting System (FAERS) in treated patients in two National Cancer Institute Comprehensive Cancer Centers.", {"entities": [[220, 226, "DISEASE"], [251, 257, "DISEASE"]]}], ["FAERS was searched for reports dated 1 January 2009 through 31 December 2015 using terms including hedgehog pathway and vismodegib and hepatic-related terms such as liver, jaundice, and hepatitis, among others.", {"entities": [[186, 195, "DISEASE"]]}], ["Disproportionality analyses with estimates of proportional reporting ratio and empirical Bayesian geometric mean were conducted.", {"entities": []}], ["A comprehensive literature review was conducted, and the clinical databases at the University of Texas MD Anderson Cancer Center and Robert H. Lurie Comprehensive Cancer Center of Northwestern University were searched.", {"entities": [[115, 121, "DISEASE"], [163, 169, "DISEASE"]]}], ["Two cases of severe liver dysfunction were published (Common Terminology Criteria for Adverse Events [CTCAE] class III), and 94 reports of adverse events (AEs) were detected in FAERS, 35 of which were serious AEs.", {"entities": []}], ["Safety notifications related to hepatotoxicity have not been issued by the manufacturer or the FDA, although vismodegib is listed in LiverTox and the European Medicines Agency website.", {"entities": []}], ["We identified a detectable safety signal for hepatotoxicity for vismodegib within 4\u00a0years of FDA approval.", {"entities": []}], ["Vismodegib should be used in patients with severe liver disease only after careful consideration, and concomitant hepatotoxic medications should be avoided.", {"entities": [[50, 63, "DISEASE"]]}], ["Rapid dissemination of such safety concerns is expected to result in fewer serious hepatotoxic AEs and more optimal outcomes for patients with cancer receiving vismodegib.", {"entities": [[143, 149, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s40268-016-0168-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Pulp necrosis is one of the main complications of dental trauma.", {"entities": []}], ["When it happens on an immature tooth, pulp necrosis implies a lack of root maturation and apical closure.", {"entities": []}], ["A therapy called apexification is required to induce the formation of a calcified apical barrier allowing a permanent and hermetic root filling.", {"entities": []}], ["The aim of this prospective randomized clinical trial is to compare Mineral Trioxide Aggregate(MTA)with Calcium Hydroxide(CH)as materials used to induce root-end closure in necrotic permanent immature incisors.", {"entities": []}], ["This study, promoted by AP-HP, was approved by the ethics committee(CPP Paris Ile de France IV).", {"entities": []}], ["34 children aged from 6 to 18 years and presenting a non-vital permanent incisor are selected.", {"entities": []}], ["Prior to treatment, an appropriate written consent has to be obtained from both parents and from children.", {"entities": []}], ["Patients are then randomly assigned to either the MTA(experimental)or CH(control)groups.", {"entities": []}], ["Recalls are performed after 3, 6 and 12 months to determine the presence or absence of a calcified apical barrier through the use of clinical and radiographic exams.", {"entities": []}], ["Additional criteria such as clinical symptoms, apical radiolucencies, periapical index(PAI)are also noted.", {"entities": []}], ["ClinicalTrials.gov no.", {"entities": []}], ["NCT00472173 (First inclusion: May 10, 2007; Last inclusion: April 23, 2009; study completed: April 15, 2010)", {"entities": []}], ["Paracetamol is the first choice for antipyretic or analgesic treatment throughout pregnancy.", {"entities": []}], ["Products with Paracetamol are readily available over the counter and therefore easily accessible for self-medication.", {"entities": []}], ["Epidemiological data on Paracetamol intake pattern during pregnancy and its potential immunological effects are sparse.", {"entities": []}], ["We aimed to analyze a possible association between Paracetamol medication and numbers of hematopoietic stem cells (HSC) in cord blood.", {"entities": []}], ["The objective was addressed in the PRINCE ( PR ENATAL DETERM IN ANTS OF C HILDREN'S H E ALTH) study, a population-based prospective pregnancy cohort study initiated in 2011 at the University Medical Center in Hamburg, Germany.", {"entities": []}], ["518 healthy pregnant women with singleton pregnancies were recruited during the first trimester.", {"entities": []}], ["Three examinations were scheduled at the end of the 1st (gestational week 12\u201314), the 2nd (gestational week 22\u201324) and the 3rd trimester (gestational week 34\u201336).", {"entities": []}], ["For 146 of these women, cord blood flow cytometry data were available.", {"entities": []}], ["Paracetamol intake was assessed for each trimester of pregnancy.", {"entities": []}], ["Among the 518 enrolled women, 40% took Paracetamol as main analgesic treatment during pregnancy.", {"entities": []}], ["The intake frequency and dosage of Paracetamol varied between the women and was overall low with a tendency towards higher frequencies and higher dosages in the third trimester.", {"entities": []}], ["Paracetamol intake, particularly during the third trimester, resulted in decreased relative numbers of HSCs in cord blood, independent of maternal age, first-trimester BMI, parity, gestational age and birth weight (\u2212\u00a00.286 (95% CI \u2212\u00a00.592, 0.021), p \u00a0=\u00a00.068).", {"entities": []}], ["Prenatal Paracetamol intake, especially during the third trimester, may be causally involved in decreasing HSCs in cord blood.", {"entities": []}], ["Image 1 \u2022 Paracetamol is the main analgesic agent used during pregnancy.", {"entities": []}], ["\u2022 Maternal Paracetamol intake was negatively associated with hematopoietic stem cell frequencies in cord blood.", {"entities": []}], ["\u2022 The third trimester seems to be most susceptible for Paracetamol induced reduction of the immune cell progenitors.", {"entities": []}], ["Paracetamol is the main analgesic agent used during pregnancy.", {"entities": []}], ["Maternal Paracetamol intake was negatively associated with hematopoietic stem cell frequencies in cord blood.", {"entities": []}], ["The third trimester seems to be most susceptible for Paracetamol induced reduction of the immune cell progenitors.", {"entities": []}], ["Our study focuses on the impact of Paracetamol intake during pregnancy on the offspring's immune development.", {"entities": []}], ["We were able to show that maternal Paracetamol intake, particularly in the third trimester of pregnancy, was negatively associated with hematopoietic stem cell frequencies in cord blood.", {"entities": []}], ["These results provide a potential missing link for an association between prenatal Paracetamol medication and childhood disease, particularly asthma, by adding a possible immunological pathway.", {"entities": [[142, 148, "DISEASE"]]}], ["While we fully acknowledge the medical need of analgesics in pregnancy to prevent or treat more harmful events, our data are valuable for clinical recommendations on self-medication with the OTC drug Paracetamol.", {"entities": [[191, 194, "GENE"]]}], ["Skin tags (ST) are common benign tumors of the skin but their etiopathogenesis is not well understood.", {"entities": []}], ["STs arise in sites subjected to trauma.", {"entities": [[0, 3, "GENE"]]}], ["It was proved that mast cells are recruited to sites of skin trauma and increase their tumor necrosis factor-\u03b1 (TNF-\u03b1) content.", {"entities": []}], ["STs are linked to obesity and frictional sites, but this has not been studied at the molecular level.", {"entities": [[18, 25, "DISEASE"], [0, 3, "GENE"]]}], ["We hypothesized that mast cells, TNF-\u03b1 and its family member, TNF-related apoptosis-inducing ligand (TRAIL) might play a role in the pathogenesis of STs as a response to trauma.", {"entities": [[149, 152, "GENE"]]}], ["A study was done on 15 patients with STs.", {"entities": [[37, 40, "GENE"]]}], ["Two STs and a snip of normal skin were obtained in each subject.", {"entities": [[4, 7, "GENE"]]}], ["We counted the mast cells after Toluidine blue staining.", {"entities": []}], ["Enzyme-linked immunosorbant assay was used to measure TNF-\u03b1 level while reverse transcriptase polymerase chain reaction was used to evaluate the level of TRAIL mRNA expression.", {"entities": []}], ["Mast cell count in all STs was significantly higher than that in control ( P =0.0355).", {"entities": [[23, 26, "GENE"]]}], ["There was a highly significant increase in the level of TNF-\u03b1 in all STs as compared to its level in controls ( P <0.0001).", {"entities": [[69, 72, "GENE"]]}], ["Expression of TRAIL mRNA was significantly higher in STs as compared to its expression in controls ( P <0.0001).", {"entities": [[53, 56, "GENE"]]}], ["Our study suggests that mast cells, TNF-\u03b1 and TRAIL may play a role in the pathogenesis of STs.", {"entities": [[91, 94, "GENE"]]}], ["Ghrelin is a peptide with attenuating effect on inflammatory pain.", {"entities": []}], ["Both anti- and pro-inflammatory mediators have a role in the nociception and development of pain and hyperalgesia.", {"entities": []}], ["IL-10 and TGF-\u03b2 are anti-inflammatory cytokines and inhibit the expression of pro-inflammatory cytokines related to peripheral and central inflammatory pain.", {"entities": []}], ["In this study, the effects of i.p.", {"entities": []}], ["injection of ghrelin on the early and the late phases of pain, as well as serum levels of IL-10 and TGF-\u03b2, as anti-inflammatory cytokines, were investigated in formalin-induced pain in male rats.", {"entities": []}], ["Adult male Wistar rats (n=48) were randomly divided into six groups: control, formalin+saline, ghrelin (40, 80, and 160 \u03bcg/kg), and morphine.", {"entities": []}], ["Ghrelin was administered i.p.", {"entities": []}], ["30 min before inducing pain by formalin.", {"entities": []}], ["Pain induced by intraplantar (i.pl.)", {"entities": []}], ["injection of 50 \u00b5l formalin 5%, and pain behavior was studied for 60 min.", {"entities": []}], ["Serum IL-10 and TGF-\u03b2 levels were assessed by ELISA method.", {"entities": []}], ["The findings of the present study showed that ghrelin with high doses (80 and 160 \u03bcg/kg) significantly reduced pain intensity in both the early and the late phases of pain.", {"entities": []}], ["The serum levels of cytokines, IL-10, and TGF-\u03b21 showed a significant elevation with ghrelin at the dose of 160 \u03bcg/kg.", {"entities": []}], ["Ghrelin is effective in reducing the intensity of both the early and the late phases of inflammatory pain.", {"entities": []}], ["It seems that ghrelin exerts its analgesic effects in part by increasing the serum levels of anti-inflammatory cytokines.", {"entities": []}], ["The biomechanics stress and chronic inflammation in obesity are causally linked to osteoarthritis.", {"entities": [[52, 59, "DISEASE"], [83, 97, "DISEASE"]]}], ["However, the metabolic factors mediating obesity-related osteoarthritis are still obscure.", {"entities": [[41, 48, "DISEASE"], [57, 71, "DISEASE"]]}], ["Here we scanned and identified at least two elevated metabolites (stearic acid and lactate) from the plasma of diet-induced obese mice.", {"entities": []}], ["We found that stearic acid potentiated LDH-a-dependent production of lactate, which further stabilized HIF1\u03b1 protein and increased VEGF and proinflammatory cytokine expression in primary mouse chondrocytes.", {"entities": []}], ["Treatment with LDH-a and HIF1\u03b1 inhibitors notably attenuated stearic acid-or high fat diet-stimulated proinflammatory cytokine production in vitro and in vivo .", {"entities": []}], ["Furthermore, positive correlation of plasma lactate, cartilage HIF1\u03b1 and cytokine levels with the body mass index was observed in subjects with osteoarthritis.", {"entities": [[144, 158, "DISEASE"]]}], ["In conclusion, saturated free fatty acid induced proinflammatory cytokine production partly through activation of a novel lactate-HIF1\u03b1 pathway in chondrocytes.", {"entities": []}], ["Our findings hold promise of developing novel clinical strategies for the management of obesity-related diseases such as osteoarthritis.", {"entities": [[88, 95, "DISEASE"], [121, 135, "DISEASE"]]}], ["Acute respiratory infections are a leading cause of infectious disease-related morbidity, hospitalisation and mortality among children worldwide, and particularly in developing countries.", {"entities": []}], ["In these low-income countries, most patients with acute respiratory infection (ARI), whether it is mild or severe, are still treated empirically.", {"entities": []}], ["The aim of the study was to evaluate the risk factors associated with the evolution and outcome of respiratory illnesses in patients aged under 5 years old.", {"entities": []}], ["We conducted a prospective study in a paediatric ward in Antananarivo from November 2010 to July 2012 including patients under 5 years old suffering from respiratory infections.", {"entities": []}], ["We collected demographic, socio-economic, clinical and epidemiological data, and samples for laboratory analysis.", {"entities": []}], ["Deaths, rapid progression to respiratory distress during hospitalisation, and hospitalisation for more than 10 days were considered as severe outcomes.", {"entities": []}], ["We used multivariate analysis to study the effects of co-infections.", {"entities": []}], ["From November 2010 to July 2012, a total of 290 patients were enrolled.", {"entities": []}], ["Co-infection was found in 192 patients (70%).", {"entities": []}], ["Co-infections were more frequent in children under 36 months, with a significant difference for the 19\u201324 month-old group (OR: 8.0).", {"entities": []}], ["Sixty-nine percent (230/290) of the patients recovered fully and without any severe outcome during hospitalisation; the outcome was scored as severe for 60 children and nine patients (3%) died.", {"entities": []}], ["Risk factors significantly associated with worsening evolution during hospitalisation (severe outcome) were admission at age under 6 months (OR\u200a=\u200a5.3), comorbidity (OR\u200a=\u200a4.6) and low household income (OR\u200a=\u200a4.1).", {"entities": []}], ["Co-mordidity, low-income and age under 6 months increase the risk of severe outcome for children infected by numerous respiratory pathogens.", {"entities": []}], ["These results highlight the need for implementation of targeted public health policy to reduce the contribution of respiratory diseases to childhood morbidity and mortality in low income countries.", {"entities": []}], ["Renal and lung epithelial cells are exposed to some significant concentrations of H 2 O 2 .", {"entities": []}], ["In urine it may reach 100\u2009 \u03bc M, while in the epithelial lining fluid in the lung it is estimated to be in micromolar to tens-micromolar range.", {"entities": []}], ["Hydrogen peroxide has a stimulatory action on the epithelial sodium channel (ENaC) single-channel activity.", {"entities": []}], ["It also increases stability of the channel at the membrane and slows down the transcription of the ENaC subunits.", {"entities": []}], ["The expression and the activity of the channel may be inhibited in some other, likely higher, oxidative states of the cell.", {"entities": []}], ["This review discusses the role and the origin of H 2 O 2 in the lung and kidney.", {"entities": []}], ["Concentration-dependent effects of hydrogen peroxide on ENaC and the mechanisms of its action have been summarized.", {"entities": []}], ["This review also describes outlooks for future investigations linking oxidative stress, epithelial sodium transport, and lung and kidney function.", {"entities": []}], ["As the number of older adults in the United States rises, maintaining functional independence among older Americans has emerged as a major clinical and public health priority.", {"entities": []}], ["Older people who lose mobility are less likely to remain in the community; demonstrate higher rates of morbidity, mortality, and hospitalizations; and experience a poorer quality of life.", {"entities": []}], ["Several studies have shown that regular physical activity improves functional limitations and intermediate functional outcomes, but definitive evidence showing that major mobility disability can be prevented is lacking.", {"entities": []}], ["A Phase 3 randomized controlled trial is needed to fill this evidence gap.", {"entities": []}], ["The Lifestyle Interventions and Independence for Elders (LIFE) Study is a Phase 3 multicenter randomized controlled trial designed to compare a supervised moderate-intensity physical activity program with a successful aging health education program in 1,600 sedentary older persons followed for an average of 2.7 years.", {"entities": []}], ["LIFE's primary outcome is major mobility disability, defined as the inability to walk 400 m. Secondary outcomes include cognitive function, serious fall injuries, persistent mobility disability, the combined outcome of major mobility disability or death, disability in activities of daily living, and cost-effectiveness.", {"entities": []}], ["Results of this study are expected to have important public health implications for the large and growing population of older sedentary men and women.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a chronic disease with a poor prognosis and is characterized by the accumulation of fibrotic tissue in lungs resulting from a dysfunction in the healing process.", {"entities": [[11, 29, "DISEASE"]]}], ["In humans, the pathological process is patchy and temporally heterogeneous and the exact mechanisms remain poorly understood.", {"entities": []}], ["Different animal models were thus developed.", {"entities": []}], ["Among these, intratracheal administration of bleomycin (BML) is one of the most frequently used methods to induce lung fibrosis in rodents.", {"entities": []}], ["In the present study, we first characterized histologically the time-course of lung alteration in rats submitted to BLM instillation.", {"entities": [[116, 119, "GENE"]]}], ["Heterogeneous damages were observed among lungs, consisting in an inflammatory phase at early time-points.", {"entities": []}], ["It was followed by a transition to a fibrotic state characterized by an increased myofibroblast number and collagen accumulation.", {"entities": []}], ["We then compared instillation and aerosolization routes of BLM administration.", {"entities": [[59, 62, "GENE"]]}], ["The fibrotic process was studied in each pulmonary lobe using a modified Ashcroft scale.", {"entities": []}], ["The two quantification methods were confronted and the interobserver variability evaluated.", {"entities": []}], ["Both methods induced fibrosis development as demonstrated by a similar progression of the highest modified Ashcroft score.", {"entities": []}], ["However, we highlighted that aerosolization allows a more homogeneous distribution of lesions among lungs, with a persistence of higher grade damages upon time.", {"entities": []}], ["E-mail communication has the potential to improve communication between patients and doctors.", {"entities": []}], ["The objective of the study is to describe the access of patients to physicians who conduct e-mail consults.", {"entities": []}], ["We analyzed data from the National Ambulatory Medical Care Survey (NAMCS), a nationally representative cross-sectional survey of office-based physician visits, in 2001, 2002, and 2003.", {"entities": []}], ["The main outcome measure was the percentage of visits to a provider who reported doing internet or e-mail consults.", {"entities": []}], ["There was fewer than 1 in 10 outpatient visits in 2001 (9.2%) to physicians who reported doing internet or e-mail consults, and this did not increase in 2002 (5.8%) or 2003 (5.5%).", {"entities": []}], ["Access to these physicians was greater among patients who were male, nonminority, lived in the Western United States, seen for pre-/postoperative care, seen by a primary care provider, and not seen by a nurse during their visit.", {"entities": []}], ["Access to physicians who conducted internet or e-mail consults was independent of other patient (e.g., chronic conditions), provider (e.g., office setting), and visit (e.g., medications prescribed) characteristics.", {"entities": []}], ["Access to physicians who do internet or e-mail consults is generally low and did not increase between 2001 and 2003, despite growth in internet access and in other internet-related activities.", {"entities": []}], ["We developed a simple but efficient method to synthesize protein-inorganic hybrid nanostructures with a flower-like shape (nanoflowers), which relies on sonication to facilitate the synthesis of the nanoflowers.", {"entities": []}], ["With this technique, we synthesized nanoflowers containing laccase as a model protein and copper phosphate within 5 minutes at room temperature.", {"entities": []}], ["The resulting laccase nanoflowers yielded greatly enhanced activity, stability, and reusability, and their usefulness was successfully demonstrated by applying them in the colorimetric detection of epinephrine.", {"entities": []}], ["The strategy developed could be used to rapidly synthesize nanoflowers for various applications in biosensor and enzyme catalysis and would expand the utilization of nanoflowers in diverse fields of biotechnology.", {"entities": []}], ["Neutrophil recruitment guided by chemotactic cues is a central event in host defense against infection and tissue injury.", {"entities": []}], ["While the mechanisms underlying neutrophil chemotaxis have been extensively studied, these are just recently being addressed by using high-content approaches or surface-bound chemotactic gradients (haptotaxis) in vitro .", {"entities": []}], ["Here, we report a haptotaxis assay, based on the classic under-agarose assay, which combines an optical patterning technique to generate surface-bound formyl peptide gradients as well as an automated imaging and analysis of a large number of migration trajectories.", {"entities": []}], ["We show that human neutrophils migrate on covalently-bound formyl-peptide gradients, which influence the speed and frequency of neutrophil penetration under the agarose.", {"entities": []}], ["Analysis revealed that neutrophils migrating on surface-bound patterns accumulate in the region of the highest peptide concentration, thereby mimicking in vivo events.", {"entities": []}], ["We propose the use of a chemotactic precision index, gyration tensors and neutrophil penetration rate for characterizing haptotaxis.", {"entities": []}], ["This high-content assay provides a simple approach that can be applied for studying molecular mechanisms underlying haptotaxis on user-defined gradient shape.", {"entities": []}], ["To observe the effect of alogliptin combined with metformin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy (500\u200amg, bid po, for at least 3 months), and evaluate its efficacy and safety.", {"entities": []}], ["After a 2-week screening period, adult patients (aged 36\u201372 years) entered a 4-week run-in/stabilization period.", {"entities": []}], ["Then, patients were randomly assigned to either the intervention group (n = 55) or the control group (n = 50) for 26 weeks.", {"entities": []}], ["The patients in the control group were given metformin (1000\u200amg, bid po) and the patients in the intervention group were given metformin (500\u200amg, bid po) combined with alogliptin (25\u200amg, qd po).", {"entities": []}], ["All the patients received counseling about diet and exercise from a nutritionist during run-in and treatment periods.", {"entities": []}], ["The primary endpoints were the between-group differences in the changes in pulmonary function parameters (vital capacity [VC]%, forced vital capacity [FVC]%, forced expiratory volume in 1 second (FEV1)%, peak expiratory force [PEF]%, maximal voluntary ventilation [MVV]%, total lung capacity [TLC%], forced expiratory volume in 1\u200asecond/forced vital capacity [FEV1/FVC%], diffusing capacity for carbon monoxide of lung [DLCO]%, and diffusing capacity for carbon monoxide of lung/unit volume [DLCO/VA%]) between pretherapy and posttreatment.", {"entities": []}], ["The secondary endpoints were changes from baseline to week 26 in glycosylated hemoglobinA1c (HbA1c), FPG, 2hPG, homeostasis model assessment insulin resistance (HOMA-IR), waist circumference (WC), and BMI.", {"entities": []}], ["The tertiary endpoints were the changes from baseline to week 26 in blood-fat (total cholesterol [TC], high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C], and triglycerides [TG]).", {"entities": [[213, 215, "GENE"]]}], ["The quartus endpoints were the changes from baseline to week 26 in systolic blood pressure (SBP) and diastolic blood pressure (DBP).", {"entities": [[127, 130, "GENE"]]}], ["The 5th endpoints were the changes from baseline to week 26 in oxidative/antioxidative parameters (reactive oxygen species [ROS], malondialdehyde [MDA], superioxide dismutase [SOD], and glutathione peroxidase [GSH-Px]).", {"entities": []}], ["In addition, safety endpoints were assessed (AEs, clinical laboratory tests, vital signs, and electrocardiographic readings).", {"entities": []}], ["Eighty-one patients completed our clinical trial: intervention group (n = 44) and control group (n = 37).", {"entities": []}], ["At week 26, pulmonary function parameters (VC%, FVC%, FEV1%, PEF%, MVV%, TLC%, FEV1/FVC%, DLCO%, and DLCO/VA%) had increased significantly from pretherapy values in both groups ( P \u200a<\u200a0.05), and the pulmonary function tests were significantly greater ( P \u200a<\u200a0.05) in intervention group than in controls posttherapy.", {"entities": []}], ["Pulmonary function (FVC%, FEV1%, PEF%, TLC%, FEV1/FVC%, DLCO%, and DLCO/VA%) was lower in the group with HbA1c levels \u22658.0 at 26 weeks, but VC%, FEV1%, MVV%, and TLC% were not significantly lower ( P \u200a>\u200a0.05).", {"entities": []}], ["Pulmonary function parameters were positively correlated with GSH-Px and SOD and negatively correlated with ROS and MDA.", {"entities": []}], ["Mean declines in HbA1c, FPG, 2hPG, HOMA-IR, and blood-fat (TC, HDL-C, LDL-C, and TG) were significantly greater ( P \u200a<\u200a0.05) in intervention group compared with the controls, but mean declines in BMI, WC, and BP (SBP, DBP) did not differ significantly between the 2 groups ( P \u200a>\u200a0.05).", {"entities": [[81, 83, "GENE"], [218, 221, "GENE"]]}], ["SOD and GSH-Px increased more ( P \u200a<\u200a0.05) in the intervention group, compared with the controls; ROS and MDA declined more ( P \u200a<\u200a0.05) in intervention group, as compared with the control group.", {"entities": []}], ["The most common AEs were gastrointestinal events, headaches, skin-related AEs (mostly pruritic events), and hypoglycemia.", {"entities": [[108, 120, "DISEASE"]]}], ["The incidences of AEs did not differ significantly ( P \u200a>\u200a0.05) between the 2 groups except for the headache and skin-related adverse events (the incidence of headache was higher in the intervention group than in controls; P \u200a<\u200a0.05).", {"entities": []}], ["No patient died during the study.", {"entities": []}], ["In patients with type 2 diabetes mellitus (T2DM) inadequately controlled by metformin monotherapy, the addition of alogliptin contributed to clinically significant increases in pulmonary function through regulating glycemia and improving the imbalance of the oxidative-related substances in the serum, without increasing the incidence of hypoglycemia, dyslipidemia, dysarteriotony, and any notable increase in body weight.", {"entities": [[338, 350, "DISEASE"], [24, 41, "DISEASE"], [17, 41, "DISEASE"]]}], ["An important feature that emerges from analyzing gene regulatory networks is the \"switch-like behavior\" or \"bistability\", a dynamic feature of a particular gene to preferentially toggle between two steady-states.", {"entities": []}], ["The state of gene switches plays pivotal roles in cell fate decision, but identifying switches has been difficult.", {"entities": []}], ["Therefore a challenge confronting the field is to be able to systematically identify gene switches.", {"entities": []}], ["We propose a top-down mining approach to exploring gene switches on a genome-scale level.", {"entities": []}], ["Theoretical analysis, proof-of-concept examples, and experimental studies demonstrate the ability of our mining approach to identify bistable genes by sampling across a variety of different conditions.", {"entities": []}], ["Applying the approach to human breast cancer data identified genes that show bimodality within the cancer samples, such as estrogen receptor (ER) and ERBB2, as well as genes that show bimodality between cancer and non-cancer samples, where tumor-associated calcium signal transducer 2 (TACSTD2) is uncovered.", {"entities": [[31, 44, "DISEASE"], [38, 44, "DISEASE"], [99, 105, "DISEASE"], [203, 209, "DISEASE"], [218, 224, "DISEASE"], [150, 155, "GENE"], [286, 293, "GENE"]]}], ["We further suggest a likely transcription factor that regulates TACSTD2.", {"entities": [[64, 71, "GENE"]]}], ["Our mining approach demonstrates that one can capitalize on genome-wide expression profiling to capture dynamic properties of a complex network.", {"entities": []}], ["To the best of our knowledge, this is the first attempt in applying mining approaches to explore gene switches on a genome-scale, and the identification of TACSTD2 demonstrates that single cell-level bistability can be predicted from microarray data.", {"entities": [[156, 163, "GENE"]]}], ["Experimental confirmation of the computational results suggest TACSTD2 could be a potential biomarker and attractive candidate for drug therapy against both ER+ and ER- subtypes of breast cancer, including the triple negative subtype.", {"entities": [[181, 194, "DISEASE"], [188, 194, "DISEASE"], [63, 70, "GENE"]]}], ["Typical measures of childhood socioeconomic status (SES), such as father's occupation, have limited the ability to elucidate mechanisms by which childhood SES affects adult health.", {"entities": []}], ["Mechanisms could include schooling experiences or work opportunities.", {"entities": []}], ["Having previously used qualitative methods for concept development, we developed new retrospective measures of multiple domains of childhood social and economic circumstances in ethnically diverse older adults.", {"entities": []}], ["We administered the new measures in a large sample and explored their association with adult SES.", {"entities": []}], ["We used a cross-sectional survey design with a community sample.", {"entities": []}], ["The San Francisco Bay Area in California.", {"entities": []}], ["400 community-dwelling adults from diverse racial/ethnic backgrounds (Whites, African Americans, Latinos and Asians/Pacific Islanders) aged 55 and older (mean=67\u2005years); 61% were women.", {"entities": []}], ["We measured attitudes towards schooling, extracurricular activities and adult encouragement and discouragement during the childhood/teen years.", {"entities": []}], ["Bivariate analysis tested racial/ethnic differences on the various measures.", {"entities": []}], ["Multivariate regression models estimated the extent to which retrospective circumstances were independently associated with adult educational attainment and adult health.", {"entities": []}], ["Most of the childhood circumstances measures differed across racial/ethnic groups.", {"entities": []}], ["In general, Whites reported more positive circumstances than non-Whites.", {"entities": []}], ["Family financial circumstances, respondent's perception of schooling as a means to get ahead, high school extracurricular activities, summer travel and summer reading were each statistically significantly associated with adult SES.", {"entities": []}], ["Family composition, age began work, high school extracurricular activities, attitudes towards schooling and adult discouragement were associated with adult health.", {"entities": []}], ["Eosinophils are effector cells that have an important role in the pathogenesis of allergic disease.", {"entities": []}], ["Defective removal of these cells likely leads to chronic inflammatory diseases such as asthma.", {"entities": [[87, 93, "DISEASE"]]}], ["Thus, there is great interest in understanding the mechanisms responsible for the elimination of eosinophils from inflammatory sites.", {"entities": []}], ["Previous studies have demonstrated a role for certain mediators and molecular pathways responsible for the survival and death of leukocytes at sites of inflammation.", {"entities": []}], ["Reactive oxygen species have been described as proinflammatory mediators but their role in the resolution phase of inflammation is poorly understood.", {"entities": []}], ["The aim of this study was to investigate the effect of reactive oxygen species in the resolution of allergic inflammatory responses.", {"entities": []}], ["An eosinophilic cell line (Eol-1) was treated with hydrogen peroxide and apoptosis was measured.", {"entities": []}], ["Allergic inflammation was induced in ovalbumin sensitized and challenged mouse models and reactive oxygen species were administered at the peak of inflammatory cell infiltrate.", {"entities": []}], ["Inflammatory cell numbers, cytokine and chemokine levels, mucus production, inflammatory cell apoptosis and peribronchiolar matrix deposition was quantified in the lungs.", {"entities": []}], ["Resistance and elastance were measured at baseline and after aerosolized methacholine.", {"entities": []}], ["Hydrogen peroxide accelerates resolution of airway inflammation by induction of caspase-dependent apoptosis of eosinophils and decrease remodeling, mucus deposition, inflammatory cytokine production and airway hyperreactivity.", {"entities": []}], ["Moreover, the inhibition of reactive oxygen species production by apocynin or in gp91 in vitro and enhances the resolution of inflammation and improves lung function in vivo by inducing caspase-dependent apoptosis of eosinophils.", {"entities": []}], ["This study was undertaken to estimate utility values for alternative treatment intervals for long acting antipsychotic intramuscular injections for the treatment of schizophrenia.", {"entities": [[165, 178, "DISEASE"]]}], ["Vignettes were developed using the published literature and an iterative consultation process with expert clinicians and patient representative groups.", {"entities": []}], ["Four vignettes were developed.", {"entities": []}], ["The first was a vignette of relapsed/untreated schizophrenia.", {"entities": [[47, 60, "DISEASE"]]}], ["The other three vignettes presented a standardised picture of well-managed schizophrenia with variations in the intervals between injections: once every 2-weeks, 4-weeks and 3-months.", {"entities": [[75, 88, "DISEASE"]]}], ["A standardised time trade off (TTO) approach was used to obtain utility values for the vignettes.", {"entities": []}], ["As a societal perspective was sought, a representative sample of individuals from across the community (Sydney, Australia) was recruited.", {"entities": []}], ["Ninety-eight people completed the TTO interview.", {"entities": []}], ["The vignettes were presented in random order to prevent possible ordering effects.", {"entities": []}], ["A clear pattern of increasing utility was observed with increasing time between injections.", {"entities": []}], ["Untreated schizophrenia was rated as very poor health-related quality of life with a mean (median) utility of 0.27 (0.20).", {"entities": [[10, 23, "DISEASE"]]}], ["The treated health states were rated at much higher utilities and were statistically significantly different ( p < 0.001) from each other: (1) 2-weekly: mean (median) utility = 0.61 (0.65); (2) 4-weekly: mean (median) utility = 0.65 (0.70); (3) 3-monthly: mean (median) utility = 0.70 (0.75).", {"entities": []}], ["This study has provided robust data indicating that approximately a 0.05 utility difference exists between treatment options, with the highest utility assigned to 3-monthly injections.", {"entities": []}], ["Recurrent cutaneous necrotizing eosinophilic vasculitis is a rare entity described by Chen et al .", {"entities": [[45, 55, "DISEASE"]]}], ["It has a benign course without any systemic involvement.", {"entities": []}], ["However, often long-term treatment with systemic steroids is required.", {"entities": []}], ["The exact etiopathogenesis remains unknown.", {"entities": []}], ["We report a female patient, who presented with recurrent pruritic purpuric papules and plaques affecting different body parts of long duration.", {"entities": []}], ["Disease was well controlled with low dose systemic steroids, but invariably recurred on its withdrawal.", {"entities": []}], ["Histology revealed the features of eosinophilic vasculitis.", {"entities": [[48, 58, "DISEASE"]]}], ["Subsequent detailed evaluation ruled out systemic involvement, underlying diseases, and any precipitating factors.", {"entities": []}], ["Hence, a diagnosis of recurrent cutaneous eosinophilic vasculitis was made.", {"entities": [[55, 65, "DISEASE"]]}], ["Patient showed excellent response to prednisolone, and on tapering the drug, it was found that she needed a maintenance dose of 5 mg/day.", {"entities": []}], ["We did not come across any previous reports of recurrent cutaneous eosinophilic vasculitis from India.", {"entities": [[80, 90, "DISEASE"]]}], ["It has been reported that IKAROS family of zinc finger 3 (IKZF3)-deficient mice spontaneously develop human systemic lupus erythematosus (SLE)-like phenotypes and produce anti-dsDNA Ab leading to immune complex-mediated glomerulonephritis.", {"entities": [[220, 238, "DISEASE"], [117, 136, "DISEASE"], [108, 136, "DISEASE"], [58, 63, "GENE"]]}], ["Polymorphism of the IKZF3 gene corresponds with the susceptibility to several immune-related diseases.", {"entities": [[20, 25, "GENE"]]}], ["Our intention was to establish an association between polymorphisms in the IKZF3 gene and SLE in the Chinese Han population.", {"entities": [[75, 80, "GENE"]]}], ["The study involved obtaining blood samples for DNA extraction and genotyping the 4 selected single-nucleotide polymorphisms (SNPs) in IKZF3, including rs12150079, rs9909593, rs907091, and rs2872507, by performing PCR restriction fragment length polymorphism analysis (PCR-RFLP).", {"entities": [[134, 139, "GENE"]]}], ["A group of 366 SLE patients were compared to 455 healthy controls.", {"entities": []}], ["A significant decrease in frequencies of the rs907091 CC genotype and C allele appeared in the SLE patients unlike that observed in the controls (p\u200a=\u200a0.001 and 0.015, respectively).", {"entities": []}], ["The frequencies of the rs12150079 genotype and allele were different between the SLE patients and the control individuals, although the significance was only marginal (p\u200a=\u200a0.046 and 0.049, respectively).", {"entities": []}], ["In addition, a significantly low frequency of the GGCG haplotype was observed in the SLE patients, suggesting that it may provide protection against SLE (p\u200a=\u200a0.011).", {"entities": []}], ["To the best of our knowledge, this is the first study to demonstrate an important association between polymorphisms in IKZF3 and SLE in the Chinese Han population.", {"entities": [[119, 124, "GENE"]]}], ["A strong association between rs907091 in the IKZF3 gene and SLE was identified.", {"entities": [[45, 50, "GENE"]]}], ["Ozone concentrations in ambient air are related to cardiopulmonary perturbations in the aging population.", {"entities": []}], ["Increased central sympathetic nerve activity induced by local airway inflammation may be one possible mechanism.", {"entities": []}], ["To elucidate this issue further, we performed a randomized, double-blind, cross-over study, including 14 healthy subjects (3 females, age 22\u201347 years), who underwent a 3 h exposure with intermittent exercise to either ozone (250 ppb) or clean air.", {"entities": []}], ["Induced sputum was collected 3 h after exposure.", {"entities": []}], ["Nineteen to 22 hours after exposure, we recorded ECG, finger blood pressure, brachial blood pressure, respiration, cardiac output, and muscle sympathetic nerve activity (MSNA) at rest, during deep breathing, maximum-inspiratory breath hold, and a Valsalva maneuver.", {"entities": []}], ["While the ozone exposure induced the expected airway inflammation, as indicated by a significant increase in sputum neutrophils, we did not detect a significant estimated treatment effect adjusted for period on cardiovascular measurements.", {"entities": []}], ["Resting heart rate (clean air: 59\u00b12, ozone 60\u00b12 bpm), blood pressure (clean air: 121\u00b13/71\u00b12 mmHg; ozone: 121\u00b12/71\u00b12 mmHg), cardiac output (clean air: 7.42\u00b10.29 mmHg; ozone: 7.98\u00b10.60 l/min), and plasma norepinephrine levels (clean air: 213\u00b121 pg/ml; ozone: 202\u00b116 pg/ml), were similar on both study days.", {"entities": []}], ["No difference of resting MSNA was observed between ozone and air exposure (air: 23\u00b12, ozone: 23\u00b12 bursts/min).", {"entities": []}], ["Maximum MSNA obtained at the end of apnea (air: 44\u00b14, ozone: 48\u00b14 bursts/min) and during the phase II of the Valsalva maneuver (air: 64\u00b15, ozone: 57\u00b16 bursts/min) was similar.", {"entities": []}], ["Our study suggests that acute ozone-induced airway inflammation does not increase resting sympathetic nerve traffic in healthy subjects, an observation that is relevant for environmental health.", {"entities": []}], ["However, we can not exclude that chronic airway inflammation may contribute to sympathetic activation.", {"entities": []}], ["Patients\u2019 smoking status is routinely collected by General Practitioners (GP) in UK primary health care.", {"entities": []}], ["There is an abundance of Read codes pertaining to smoking, including those relating to smoking cessation therapy, prescription, and administration codes, in addition to the more regularly employed smoking status codes.", {"entities": []}], ["Large databases of primary care data are increasingly used for epidemiological analysis; smoking status is an important covariate in many such analyses.", {"entities": []}], ["However, the variable definition is rarely documented in the literature.", {"entities": []}], ["The Secure Anonymised Information Linkage (SAIL) databank is a repository for a national collection of person-based anonymised health and socio-economic administrative data in Wales, UK.", {"entities": []}], ["An exploration of GP smoking status data from the SAIL databank was carried out to explore the range of codes available and how they could be used in the identification of different categories of smokers, ex-smokers and never smokers.", {"entities": []}], ["An algorithm was developed which addresses inconsistencies and changes in smoking status recording across the life course and compared with recorded smoking status as recorded in the Welsh Health Survey (WHS), 2013 and 2014 at individual level.", {"entities": []}], ["However, the WHS could not be regarded as a \u201cgold standard\u201d for validation.", {"entities": []}], ["There were 6836 individuals in the linked dataset.", {"entities": []}], ["Missing data were more common in GP records (6%) than in WHS (1.1%).", {"entities": []}], ["Our algorithm assigns ex-smoker status to 34% of never-smokers, and detects 30% more smokers than are declared in the WHS data.", {"entities": []}], ["When distinguishing between current smokers and non-smokers, the similarity between the WHS and GP data using the nearest date of comparison was \u03ba\u2009=\u20090.78.", {"entities": []}], ["When temporal conflicts had been accounted for, the similarity was \u03ba\u2009=\u20090.64, showing the importance of addressing conflicts.", {"entities": []}], ["We present an algorithm for the identification of a patient\u2019s smoking status using GP self-reported data.", {"entities": []}], ["We have included sufficient details to allow others to replicate this work, thus increasing the standards of documentation within this research area and assessment of smoking status in routine data.", {"entities": []}], ["The online version of this article (doi:10.1186/s12911-016-0400-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Allergic rhinitis (AR) has high prevalence and substantial socio-economic burden.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["The study included 35 Italian Centers recruiting an overall number of 3383 adult patients with rhinitis (48% males, 52% females, mean age 29.1, range 18\u201345 years).", {"entities": [[95, 103, "DISEASE"]]}], ["For each patient, the attending physician had to fill in a standardized questionnaire, covering, in particular, some issues such as the ARIA classification of allergic rhinitis (AR), the results of skin prick test (SPT), the kind of treatment, the response to treatment, and the satisfaction with treatment.", {"entities": [[159, 176, "DISEASE"], [168, 176, "DISEASE"]]}], ["Out of the 3383 patients with rhinitis, 2788 (82.4%) had AR: 311 (11.5%) had a mild intermittent, 229 (8.8%) a mild persistent, 636 (23.5%) a moderate-severe intermittent, and 1518 (56.1%) a moderate-severe persistent form.", {"entities": [[30, 38, "DISEASE"]]}], ["The most frequently used drugs were oral antihistamines (77.1%) and topical corticosteroids (60.8%).", {"entities": []}], ["The response to treatment was judged as excellent in 12.2%, good in 41.3%, fair in 31.2%, poor in 14.5%, and very bad in 0.8% of subjects.", {"entities": []}], ["The rate of treatment dissatisfaction was significantly higher in patients with moderate-to-severe AR than in patients with mild AR ( p <0.0001).", {"entities": []}], ["Indication to allergen immunotherapy (AIT) was significantly more frequent ( p <0.01) in patients with severe AR than with mild AR.", {"entities": []}], ["These findings confirm the appropriateness of ARIA guidelines in classifying the AR patients and the association of severe symptoms with unsuccessful drug treatment.", {"entities": []}], ["The optimal targeting of patients to be treated with AIT needs to be reassessed.", {"entities": []}], ["To explore and compare perinatal and maternal outcomes in women at \u2018higher risk\u2019 of complications planning home versus obstetric unit (OU) birth.", {"entities": []}], ["Prospective cohort study.", {"entities": []}], ["OUs and planned home births in England.", {"entities": []}], ["8180 \u2018higher risk\u2019 women in the Birthplace cohort.", {"entities": []}], ["We used Poisson regression to calculate relative risks adjusted for maternal characteristics.", {"entities": []}], ["Sensitivity analyses explored possible effects of differences in risk between groups and alternative outcome measures.", {"entities": []}], ["Composite perinatal outcome measure encompassing \u2018intrapartum related mortality and morbidity\u2019 (intrapartum stillbirth, early neonatal death, neonatal encephalopathy, meconium aspiration syndrome, brachial plexus injury, fractured humerus or clavicle) and neonatal admission within 48\u00a0hours for more than 48\u00a0hours.", {"entities": [[187, 195, "DISEASE"], [167, 195, "DISEASE"]]}], ["Two composite maternal outcome measures capturing intrapartum interventions/adverse maternal outcomes and straightforward birth.", {"entities": []}], ["The risk of \u2018intrapartum related mortality and morbidity\u2019 or neonatal admission for more than 48\u00a0hours was lower in planned home births than planned OU births [adjusted relative risks (RR) 0.50, 95% CI 0.31\u20130.81].", {"entities": []}], ["Adjustment for clinical risk factors did not materially affect this finding.", {"entities": []}], ["The direction of effect was reversed for the more restricted outcome measure \u2018intrapartum related mortality and morbidity\u2019 (RR adjusted for parity 1.92, 95% CI 0.97\u20133.80).", {"entities": []}], ["Maternal interventions were lower in planned home births.", {"entities": []}], ["The babies of \u2018higher risk\u2019 women who plan birth in an OU appear more likely to be admitted to neonatal care than those whose mothers plan birth at home, but it is unclear if this reflects a real difference in morbidity.", {"entities": []}], ["Rates of intrapartum related morbidity and mortality did not differ statistically significantly between settings at the 5% level but a larger study would be required to rule out a clinically important difference between the groups.", {"entities": []}], ["Asthma is a chronic inflammatory airway disease influenced by genetic and environmental factors that affects ~300 million people worldwide, leading to ~250,000 deaths annually.", {"entities": [[0, 6, "DISEASE"]]}], ["Glucocorticoids (GCs) are well-known therapeutics that are used extensively to suppress airway inflammation in asthmatics.", {"entities": []}], ["The airway epithelium plays an important role in the initiation and modulation of the inflammatory response.", {"entities": []}], ["While the role of GCs in disease management is well understood, few studies have examined the holistic effects on the airway epithelium.", {"entities": []}], ["Gene expression data were used to generate a co-transcriptional network, which was interrogated to identify modules of functionally related genes.", {"entities": []}], ["In parallel, expression data were mapped to the human protein-protein interaction (PPI) network in order to identify modules with differentially expressed genes.", {"entities": []}], ["A common pathways approach was applied to highlight genes and pathways functionally relevant and significantly altered following GC treatment.", {"entities": [[129, 131, "GENE"]]}], ["Co-transcriptional network analysis identified pathways involved in inflammatory processes in the epithelium of asthmatics, including the Toll-like receptor (TLR) and PPAR signaling pathways.", {"entities": []}], ["Analysis of the PPI network identified RXRA , PPARGC1A , STAT1 and IRF9 , among others genes, as differentially expressed.", {"entities": [[39, 43, "GENE"], [46, 54, "GENE"], [57, 62, "GENE"], [67, 71, "GENE"]]}], ["Common pathways analysis highlighted TLR and PPAR signaling pathways, providing a link between general inflammatory processes and the actions of GCs.", {"entities": []}], ["Promoter analysis identified genes regulated by the glucocorticoid receptor (GCR) and PPAR pathways as well as highlighted the interferon pathway as a target of GCs.", {"entities": []}], ["Network analyses identified known genes and pathways associated with inflammatory processes in the airway epithelium of asthmatics.", {"entities": []}], ["This workflow illustrated a hypothesis generating experimental design that integrated multiple analysis methods to produce a weight-of-evidence based approach upon which future focused studies can be designed.", {"entities": []}], ["In this case, results suggested a mechanism whereby GCs repress TLR-mediated interferon production via upregulation of the PPAR signaling pathway.", {"entities": []}], ["These results highlight the role of interferons in asthma and their potential as targets of future therapeutic efforts.", {"entities": [[51, 57, "DISEASE"]]}], ["Protracted bacterial bronchitis (PBB) is the common cause of chronic cough in children worldwide, but its etiology has not been fully recognized in China.", {"entities": [[21, 31, "DISEASE"]]}], ["We retrospectively investigated a total of 66 hospitalized infants under the age of three years with chronic wet cough enrolled in the Affiliated Children\u2019s Hospital of Soochow University from October 2010 to March 2014.", {"entities": []}], ["All patients underwent bronchoscopy and broncho-alveolar lavage (BAL) samples were processed for microbiological and cytological analysis.", {"entities": []}], ["Of 66 patients with wet cough, 50 (75.8%) were diagnosed with PBB.", {"entities": []}], ["In the PBB group, wet cough was accompanied by wheezing (90%).", {"entities": []}], ["Airway malacia were identified in 22 cases (44%).", {"entities": []}], ["The clinical manifestations of PBB with airway malacia did not differ from those without malacia.", {"entities": []}], ["Haemophilus influenzae (47.4%) and Streptococcus pneumoniae (36.8%) were the most commonly identified pathogens.", {"entities": []}], ["Furthermore, CD3", {"entities": []}], ["Seasonal influenza is a significant cause of morbidity and mortality of children in Korea.", {"entities": [[9, 18, "DISEASE"]]}], ["However, few data are available on parental perception and action toward childhood influenza.", {"entities": [[83, 92, "DISEASE"]]}], ["This study aimed to characterize parental perception and patterns of action in response to influenza and influenza-like illnesses (ILIs), including vaccination and healthcare use.", {"entities": [[91, 100, "DISEASE"], [105, 114, "DISEASE"]]}], ["This prospective study involved a random survey of parents whose children were aged 6\u201359 months.", {"entities": []}], ["The survey was conducted in October 2014.", {"entities": []}], ["The study included 638 parents of 824 children younger than 6 years.", {"entities": []}], ["Most parental information of influenza came from mass media (28.2%) and social media (15.5%).", {"entities": [[29, 38, "DISEASE"]]}], ["The factor that most often motivated parents to vaccinate their children against influenza was promotion of the government or mass media (36.6%).", {"entities": [[81, 90, "DISEASE"]]}], ["Negative predictors of immunization included safety concerns about influenza vaccination (28.1%) and mistrust in the vaccine's effectiveness (23.3%).", {"entities": [[67, 76, "DISEASE"]]}], ["Therefore, correct information about influenza and vaccination from mass media will be one of the cornerstones for implementing a successful childhood immunization program and reducing morbidity and mortality in Korea.", {"entities": [[37, 46, "DISEASE"]]}], ["Furthermore, to enroll younger children in vaccination programs, and to minimize coverage gaps, public concerns about vaccine safety should be resolved.", {"entities": []}], ["The demographic data in the present study will be used to provide a deeper insight into a parental perception and will help health care providers increase influenza immunization rate.", {"entities": [[155, 164, "DISEASE"]]}], ["The parts-per-billion-level nitric oxide (NO) gas sensing capability of a copper-ion-doped polyaniline/tungsten oxide nanocomposite (Cu 3 ) film coated on a Rayleigh surface acoustic wave device was investigated.", {"entities": []}], ["The sensor developed in this study was sensitive to NO gas at room temperature in dry nitrogen.", {"entities": []}], ["The surface morphology, dopant distribution, and electric properties were characterized using scanning electron microscopy, energy-dispersive X-ray spectroscopy mapping, and Hall effect measurements, respectively.", {"entities": []}], ["The Cu 3 film exhibited high NO gas sensitivity and selectivity as well as long-term stability.", {"entities": []}], ["At 1 ppb of NO, a signal with a frequency shift of 4.3 ppm and a signal-to-noise ratio of 17 was observed.", {"entities": []}], ["The sensor exhibited distinct selectivity toward NO gas with no substantial response to O 2 , NH 3 and CO 2 gases.", {"entities": []}], ["In the European Union and Canada, an Ann Arbor strain live attenuated influenza vaccine (LAIV) is approved for use in children aged 2\u201317\u00a0years, including those with mild to moderate asthma or prior wheezing.", {"entities": [[70, 79, "DISEASE"], [182, 188, "DISEASE"]]}], ["The safety and efficacy of LAIV versus trivalent inactivated influenza vaccine (TIV) in children with asthma aged 6\u201317\u00a0years have been demonstrated.", {"entities": [[61, 70, "DISEASE"], [102, 108, "DISEASE"]]}], ["However, few data are available for children younger than 6\u00a0years of age with asthma or prior wheezing.", {"entities": [[78, 84, "DISEASE"]]}], ["Safety and efficacy data were collected for children aged 2\u20135\u00a0years with asthma or prior wheezing from two randomized, multinational trials of LAIV and TIV ( N \u2009=\u20091,940).", {"entities": [[73, 79, "DISEASE"]]}], ["Wheezing, lower respiratory illness, and hospitalization were not significantly increased among children receiving LAIV compared with TIV.", {"entities": []}], ["Increased upper respiratory symptoms and irritability were observed among LAIV recipients ( p \u2009<\u20090.05).", {"entities": []}], ["Relative efficacies were consistent with the results observed in the overall study populations, which demonstrated fewer cases of culture-confirmed influenza illness in LAIV compared with TIV recipients.", {"entities": [[148, 157, "DISEASE"]]}], ["Study results support the safety and efficacy of LAIV among children aged 2\u201317\u00a0years with mild to moderate asthma or a history of wheezing.", {"entities": [[107, 113, "DISEASE"]]}], ["Data regarding LAIV use are limited among individuals with severe asthma or active wheezing within the 7\u00a0days before vaccination.", {"entities": [[66, 72, "DISEASE"]]}], ["Our study analyses the main determinants of refusal or acceptance of the 2009 A/H1N1 vaccine in patients with cystic fibrosis, a high-risk population for severe flu infection, usually very compliant for seasonal flu vaccine.", {"entities": [[110, 125, "DISEASE"]]}], ["We conducted a qualitative study based on semi-structured interviews in 3 cystic fibrosis referral centres in Paris, France.", {"entities": [[74, 89, "DISEASE"]]}], ["The study included 42 patients with cystic fibrosis: 24 who refused the vaccine and 18 who were vaccinated.", {"entities": [[36, 51, "DISEASE"]]}], ["The two groups differed quite substantially in their perceptions of vaccine- and disease-related risks.", {"entities": []}], ["Those who refused the vaccine were motivated mainly by the fears it aroused and did not explicitly consider the 2009 A/H1N1 flu a potentially severe disease.", {"entities": []}], ["People who were vaccinated explained their choice, first and foremost, as intended to prevent the flu's potential consequences on respiratory cystic fibrosis disease.", {"entities": [[142, 157, "DISEASE"]]}], ["Moreover, they considered vaccination to be an indirect collective prevention tool.", {"entities": []}], ["Patients who refused the vaccine mentioned multiple, contradictory information sources and did not appear to consider the recommendation of their local health care provider as predominant.", {"entities": []}], ["On the contrary, those who were vaccinated stated that they had based their decision solely on the clear and unequivocal advice of their health care provider.", {"entities": []}], ["These results of our survey led us to formulate three main recommendations for improving adhesion to new pandemic vaccines.", {"entities": []}], ["(1) it appears necessary to reinforce patient education about the disease and its specific risks, but also general population information about community immunity.", {"entities": []}], ["(2) it is essential to disseminate a clear and effective message about the safety of novel vaccines.", {"entities": []}], ["(3) this message should be conveyed by local health care providers, who should be involved in implementing immunization.", {"entities": []}], ["The primary objective of the study was to find out the frequency of tobacco smoking among health care providers in tertiary care hospitals of Karachi.", {"entities": []}], ["The secondary objective was to identify the common factors responsible for the continuation of smoking.", {"entities": []}], ["This cross sectional study was conducted in the wards and out-patient departments of three selected tertiary hospitals of Karachi.", {"entities": []}], ["A total of 180 health care providers were enrolled in the study using proportionate stratified sampling.", {"entities": []}], ["Postgraduate students, house officers and trainees were excluded from the study.", {"entities": []}], ["Data were collected from randomly selected health care providers using survey methodology.", {"entities": []}], ["SPSS v. 20.0 was used to enter and analyze the data.", {"entities": []}], ["Fifty two participants out of 180 were smokers for past one year (28.9%).", {"entities": []}], ["Among them, 21 (11.7%) smoked more than 5 cigarettes per day.", {"entities": []}], ["Twenty smokers (11.1%) were found to smoke due to peer influence.", {"entities": []}], ["It was found that those who were influenced by their peers were 8.33 times more prone to be addicted to smoking than those who were less influenced.", {"entities": []}], ["Similarly, the likelihood of addiction increased up to 76.9% with the lack of incentives.", {"entities": []}], ["Our results clearly indicate that a large number of health care providers smoke which should be a serious concern.", {"entities": []}], ["Hence our health agencies should take immediate action in order to curtail the heaving burden of smoking and its related health consequences.", {"entities": []}], ["Platelet-activating factor (PAF) is a potent phospholipid mediator with diverse biological activities in addition to its well-known ability to stimulate platelet aggregation.", {"entities": []}], ["Pharmacologic studies had suggested a role for PAF in pregnancy, neuronal cell migration, anaphylaxis, and endotoxic shock.", {"entities": []}], ["Here we show that disruption of the PAF receptor gene in mice caused a marked reduction in systemic anaphylactic symptoms.", {"entities": []}], ["Unexpectedly, however, the PAF receptor\u2013deficient mice developed normally, were fertile, and remained sensitive to bacterial endotoxin.", {"entities": []}], ["These mutant mice clearly show that PAF plays a dominant role in eliciting anaphylaxis, but that it is not essential for reproduction, brain development, or endotoxic shock.", {"entities": []}], ["The Cord Pilot Trial compared alternative policies for timing of cord clamping at very preterm birth at eight UK hospitals.", {"entities": []}], ["In addition to standard written consent, an oral assent pathway was developed for use when birth was imminent.", {"entities": []}], ["The aim of this study was to explore women\u2019s views and experiences of two alternative consent pathways to participate in the Cord Pilot Trial.", {"entities": []}], ["We conducted a qualitative study using semi-structured interviews.", {"entities": []}], ["A total of 179 participants in the Cord Pilot Trial were sent a postal invitation to take part in interviews.", {"entities": []}], ["Women who agreed were interviewed in person or by telephone to explore their experiences of two consent pathways for a preterm intrapartum trial.", {"entities": []}], ["Data were analysed using inductive systematic thematic analysis.", {"entities": []}], ["Twenty-three women who gave either written consent ( n \u2009=\u200918) or oral assent followed by written consent ( n \u2009=\u20095) to participate in the trial were interviewed.", {"entities": []}], ["Five themes were identified: (1) understanding of the implications of randomisation, (2) importance of staff offering participation, (3) information about the trial and time to consider participation, (4) trial secondary in women\u2019s minds and (5) reasons for agreeing to take part in the trial.", {"entities": []}], ["Experiences were similar for the two consent pathways.", {"entities": []}], ["Women recruited by the oral assent pathway reported being given less information about the trial but felt it was sufficient to make a decision regarding participation.", {"entities": []}], ["There were gaps in women\u2019s understanding of the trial and intervention, regardless of the consent pathway.", {"entities": []}], ["Overall, women were positive about their experiences of being invited to participate in the trial.", {"entities": []}], ["The oral assent pathway seems an acceptable option for women if the intervention is low-risk and time is limited.", {"entities": []}], ["ISRCTN Registry, ISRCTN21456601 .", {"entities": []}], ["Registered on 28 February 2013.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-2149-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Given the rising number of asthma cases and the increasing costs of health care, prevention may be the best cure.", {"entities": [[27, 33, "DISEASE"]]}], ["Decisions regarding the implementation of prevention programmes in general and choosing between unifaceted and multifaceted strategies in particular are urgently needed.", {"entities": []}], ["Existing trials on the primary prevention of asthma are, however, insufficient on their own to inform the decision of stakeholders regarding the cost-effectiveness of such prevention strategies.", {"entities": [[45, 51, "DISEASE"]]}], ["Decision analytic modelling synthesises available data for the cost-effectiveness evaluation of strategies in an explicit manner.", {"entities": []}], ["Published reports on model development should provide the detail and transparency required to increase the acceptability of cost-effectiveness modelling.", {"entities": []}], ["But, detail on the explicit steps and the involvement of experts in structuring a model is often unevenly reported.", {"entities": []}], ["In this paper, we describe a procedure to structure and validate a model for the primary prevention of asthma in children.", {"entities": [[103, 109, "DISEASE"]]}], ["An expert panel was convened for round-table discussions to frame the cost-effectiveness research question and to select and structure a model.", {"entities": []}], ["The model's structural validity, which indicates how well a model reflects the reality, was determined through descriptive and parallel validation.", {"entities": []}], ["Descriptive validation was performed with the experts.", {"entities": []}], ["Parallel validation qualitatively compared similarity between other published models with different decision problems.", {"entities": []}], ["The multidisciplinary input of experts helped to develop a decision-tree structure which compares the current situation with screening and prevention.", {"entities": []}], ["The prevention was further divided between multifaceted and unifaceted approaches to analyse the differences.", {"entities": []}], ["The clinical outcome was diagnosis of asthma.", {"entities": [[38, 44, "DISEASE"]]}], ["No similar model was found in the literature discussing the same decision problem.", {"entities": []}], ["Structural validity in terms of descriptive validity was achieved with the experts and was supported by parallel validation.", {"entities": []}], ["A decision-tree model developed with experts in round-table discussions benefits from a systematic and transparent approach and the multidisciplinary contributions of the experts.", {"entities": []}], ["Parallel validation provides a feasible alternative to validating novel models.", {"entities": []}], ["The process of structuring and validating a model presented in this paper could be a useful guide to increase transparency, credibility, and acceptability of (future, novel) models when experts are involved.", {"entities": []}], ["In 2011, the Taiwan Food and Drug Administration inadvertently discovered that, for decades, manufacturers had replaced expensive natural emulsifiers in food products with diethylhexyl phthalate (DEHP).", {"entities": []}], ["We wanted to compare urinary phthalate metabolite levels of children before and after the DEHP food contamination event and identify source(s) of phthalate exposure in addition to the illegal food additives.", {"entities": []}], ["In the present study, morning urine samples were collected from a cohort of 453 children in 2010 in Taipei.", {"entities": []}], ["After the DEHP food contamination event, there were 200 cohort children left at follow-up in 2013.", {"entities": []}], ["The geometric means (GMs) of urinary mono(2-ethyl-5-hydroxyhexyl) phthalate (5OH-MEHP) levels before and after the event were 9.39 and 13.34 \u00b5g/g of creatinine, respectively, with no significant difference ( p = 0.093).", {"entities": []}], ["After the DEHP food contamination event, we found that urinary phthalate metabolite levels were significantly higher in people who frequently consumed microwave-heated food and used fragrance-containing products ( p < 0.05).", {"entities": []}], ["In addition, children who did not frequently wash hands before eating had significantly higher urinary phthalate metabolite levels than those who did ( p < 0.05).", {"entities": []}], ["These results demonstrate that urinary phthalate metabolite levels did not decrease after the DEHP food contamination event, thus, other sources must contribute to phthalate exposure in daily life.", {"entities": []}], ["Public awareness of approaches to reducing phthalate exposure is necessary.", {"entities": []}], ["Chronic constipation is a common health problem that significantly affects the quality of life of patients and impacts in terms of costs; current treatments based on fiber and laxatives cause dissatisfaction to doctors and patients in more than half of the cases.", {"entities": [[8, 20, "DISEASE"]]}], ["New drugs are now available or in very advanced stages of research, with different and innovative mechanisms of action as prucalopride, lubiprostone, and linaclotide.", {"entities": []}], ["Prucalopride an enterokinetic, is a selective high-affinity 5-hydroxytryptamine (5-HT) 4 receptor agonist of serotonin that increases the peristaltic reflex and the colonic contractions; lubiprostone, a type 2 chlorine channel activator, or linaclotide, a guanylate cyclase-C agonist of enterocytes, both prosecretory agents, stimulate the secretion of fluid within the intestinal lumen.", {"entities": []}], ["In general, these promising drugs have proven efficacy and safety as a specific therapeutic option in patients with chronic constipation.", {"entities": [[124, 136, "DISEASE"]]}], ["Yet the solution might not be sufficient for everybody and still without the ideal drug that might be useful in all cases, the pharmacological revolution for colonic motility disorders has arrived.", {"entities": []}], ["Laparoscopic ventral hernia repair with carboxymethylcellulose-sodium hyaluronate coating appears to be safe, effective, and durable.", {"entities": []}], ["Repair of ventral hernias, including primary ventral hernias and incisional ventral hernias, is performed in the United States 90,000 times per year.", {"entities": []}], ["Open or traditional ventral hernia repairs involve the significant morbidity and expense of a laparotomy and a significant risk of recurrent herniation.", {"entities": []}], ["Laparoscopic ventral hernia repair (LVHR) may offer a less-invasive alternative with shorter length of hospital stay, fewer cardiopulmonary complications, and low recurrence rates.", {"entities": []}], ["225 patients underwent laparoscopic ventral hernia repairs in which carboxymethylcellulose-sodium hyaluronate coating (Sepramesh, Davol, Providence, RI) was used primarily.", {"entities": []}], ["All cases were included prospectively from the study period of 2002 through 2009.", {"entities": []}], ["Patient characteristics were recorded, and follow-up analysis was performed over a period of 42 mo following surgery.", {"entities": []}], ["Recurrence, reoperations, and all complications were recorded.", {"entities": []}], ["Mesh awareness and mesh-related pain were assessed using the hernia-specific Carolinas Comfort Scale (CCS) instrument, completed by 72 patients.", {"entities": [[102, 105, "GENE"]]}], ["Over 42 mo of follow-up, 2 ventral hernias have recurred, and no long-term bowel erosion or fistulization has occurred.", {"entities": []}], ["Little or no mesh-related symptoms were reported, and mean scores for mesh awareness and mesh pain were 3.6 and 3.2, respectively, on a scale from 0\u201340 (lower scores signify less pain or awareness).", {"entities": []}], ["Two serious early complications occurred related to intestinal ileus and metal tacks producing intestinal perforation, and this led to a change in the tacking devices used.", {"entities": [[95, 117, "DISEASE"], [63, 68, "DISEASE"]]}], ["LVHR with carboxymethylcellulose-sodium hyaluronate coating (Sepramesh) is safe and effective.", {"entities": []}], ["Complications are rare, the repair is durable, and long-term results are good with rare recurrences, low awareness of mesh, and little pain.", {"entities": []}], ["Technical lessons include use of at least one transfascial suture and the avoidance of metal tacks for fixation.", {"entities": []}], ["Most published environmental remediation interventions have been directed at single allergens and have employed demanding strategies; few have been performed in the homes of inner-city children disproportionately burdened by asthma.", {"entities": [[225, 231, "DISEASE"]]}], ["Our objective was a) to describe the allergen sensitivities, environmental tobacco smoke (ETS) exposure, and home environmental characteristics of a national sample of inner-city children with moderate to severe asthma and b) to develop and implement a multifaceted, home-based comprehensive intervention to reduce home allergens and ETS, tailored to the specific sensitization and exposure profiles of those children.", {"entities": [[212, 218, "DISEASE"]]}], ["Allergen skin testing and a home evaluation were performed to determine the presence of ETS and factors known to be associated with increased indoor allergen levels.", {"entities": []}], ["Based on published remediation techniques, a home environmental intervention, organized into modules, each addressing one of five specific allergen groups or ETS, was designed.", {"entities": []}], ["Of 994 allergic children from seven U.S. urban communities, 937 successfully completed baseline interviews and home allergen surveys and were enrolled.", {"entities": []}], ["More than 50% of children had positive skin tests to three or more allergen groups.", {"entities": []}], ["Cockroaches were reported in 58% of homes, wall-to-wall carpeting in the child's bedroom in 55%, a smoker in 48%, mice or rats in 40%, and furry pets in 28%.", {"entities": []}], ["More than 60% of enrolled families received four or more modules, and between 94% and 98% of all modules were completed.", {"entities": []}], ["We conclude that most inner-city children with moderate to severe asthma are sensitized to multiple indoor allergens and that environmental factors known to be associated with asthma severity are commonly present in their homes.", {"entities": [[66, 72, "DISEASE"], [176, 182, "DISEASE"]]}], ["The intervention developed for the Inner-City Asthma Study employs accepted methods to address an array of allergens and ETS exposure while ensuring that the intervention is tailored to the specific sensitization profiles and home characteristics of these children.", {"entities": [[46, 52, "DISEASE"]]}], ["Immunoglobulin A (IgA) deficiency is the most common primary immunodeficiency defined as decreased serum level of IgA in the presence of normal levels of other immunoglobulin isotypes.", {"entities": []}], ["Most individuals with IgA deficiency are asymptomatic and identified coincidentally.", {"entities": []}], ["However, some patients may present with recurrent infections of the respiratory and gastrointestinal tracts, allergic disorders, and autoimmune manifestations.", {"entities": []}], ["Although IgA is the most abundant antibody isotype produced in the body, its functions are not clearly understood.", {"entities": []}], ["Subclass IgA1 in monomeric form is mainly found in the blood circulation, whereas subclass IgA2 in dimeric form is the dominant immunoglobulin in mucosal secretions.", {"entities": []}], ["Secretory IgA appears to have prime importance in immune exclusion of pathogenic microorganisms and maintenance of intestinal homeostasis.", {"entities": []}], ["Despite this critical role, there may be some compensatory mechanisms that would prevent disease manifestations in some IgA-deficient individuals.", {"entities": []}], ["In IgA deficiency, a maturation defect in B cells to produce IgA is commonly observed.", {"entities": []}], ["Alterations in transmembrane activator and calcium modulator and cyclophilin ligand interactor gene appear to act as disease-modifying mutations in both IgA deficiency and common variable immunodeficiency, two diseases which probably lie in the same spectrum.", {"entities": [[172, 204, "DISEASE"]]}], ["Certain major histocompatibility complex haplotypes have been associated with susceptibility to IgA deficiency.", {"entities": []}], ["The genetic basis of IgA deficiency remains to be clarified.", {"entities": []}], ["Better understanding of the production and function of IgA is essential in elucidating the disease mechanism in IgA deficiency.", {"entities": []}], ["We used 16S rRNA gene sequencing to examine the posteffects of antibiotic treatment on the structure and metabolism of rumen microbiota.", {"entities": []}], ["Twelve goats were randomly assigned into two groups, with one group receiving intramuscular streptomycin injection at 40\u00a0mg/kg bodyweight daily for 10\u00a0days.", {"entities": []}], ["At 4\u00a0weeks after treatment with antibiotic, three goats were randomly selected from each group and switched to a 35% concentrate diet.", {"entities": []}], ["The remaining six goats continued with the 10% concentrate diet.", {"entities": []}], ["At 4\u00a0weeks after dietary shift, ruminal fluid and epithelium were collected to analyze the microbiota composition and short\u2010chain fatty acid ( SCFA ) concentrations of the rumen.", {"entities": []}], ["We found that antibiotic administration led to increases in the diversity and richness of recovered mucosal microbiota and to decreases in those of recovered fluid microbiota.", {"entities": []}], ["When dietary modulation was performed after antibiotic intake, both communities showed little difference in structure from premodulated states.", {"entities": []}], ["Additionally, antibiotic pretreatment reduced the basal lines of individual SCFA s but did not affect the increased percentages of SCFA s. Overall, our results indicate that antibiotic administration affects the structure of both rumen fluid and mucosal microbiota and reduces the functional redundancy of rumen microbiota.", {"entities": []}], ["Vitamin D is synthesised by ultraviolet (UV) irradiation of skin and is hypothesized to be a direct mediator of the immunosuppression that occurs following UV radiation (UVR) exposure.", {"entities": []}], ["Both UVR and vitamin D drive immune responses towards tolerance by ultimately increasing the suppressive activities of regulatory T cells.", {"entities": []}], ["To examine a role for UVR-induced vitamin D, vitamin D 3 -deficient mice were established by dietary vitamin D 3 restriction.", {"entities": []}], ["In comparison to vitamin D 3 -replete mice, vitamin D 3 -deficient mice had significantly reduced serum levels of 25-hydroxyvitamin D 3 (25(OH)D 3 , <20 nmol.L 3 (1,25(OH) 2 D 3 , <20 pmol.L 3 levels significantly increased in vitamin D 3 -deficient female but not male mice.", {"entities": []}], ["To determine if UVR-induced vitamin D was a mediator of UVR-induced systemic immunosuppression, responses were measured in mice that were able (female) or unable (male) to increase systemic levels of 25(OH)D 3 after UVR.", {"entities": []}], ["Erythemal UVR (\u22654 kJ/m in vivo priming capacity of bone marrow-derived dendritic cells to a similar degree in female and male vitamin D 3 -deficient mice.", {"entities": []}], ["Thus, in male mice, UVR-induced 25(OH)D 3 is not essential for mediating the immunosuppressive effects of erythemal UVR.", {"entities": []}], ["Prostanoids, consisting of prostaglandins (PGs) and thromboxanes (TXs), are oxygenated products of C 20 unsaturated fatty acids.", {"entities": []}], ["They include PGD 2 , PGE 2 , PGF 2 \u03b1 , PGI 2 , and TXA 2 .", {"entities": [[13, 16, "GENE"], [29, 32, "GENE"]]}], ["Given that aspirin-like nonsteroidal anti-inflammatory drugs exert their actions by suppressing prostanoid production, prostanoids have been implicated in processes inhibited by these drugs, including inflammation, fever, and pain.", {"entities": []}], ["Prostanoids also contribute to vascular homeostasis, reproduction, and regulation of kidney and gastrointestinal functions.", {"entities": []}], ["How prostanoids exert such a variety of actions had remained unclear, however.", {"entities": []}], ["Prostanoids are released outside of cells immediately after their synthesis and exert their actions by binding to receptors on target cells.", {"entities": []}], ["We have identified a family of eight types or subtypes of G protein\u2013coupled receptors that mediate prostanoid actions.", {"entities": []}], ["Another G protein\u2013coupled receptor was also identified as an additional receptor for PGD 2 .", {"entities": [[85, 88, "GENE"]]}], ["Genes for these receptors have been individually disrupted in mice, and analyses of these knockout mice have not only elucidated the molecular and cellular mechanisms of known prostanoid actions but also revealed previously unknown actions.", {"entities": []}], ["In this article, I review the physiological and pathophysiological roles of prostanoids and their receptors revealed by these studies.", {"entities": []}], ["Protein phosphatases 1 and 2A (PP1 and PP2A) are the most ubiquitous and abundant serine/threonine phosphatases in eukaryotic cells.", {"entities": []}], ["They play fundamental roles in the regulation of various cellular functions.", {"entities": []}], ["This review focuses on recent advances in the functional studies of these enzymes in the field of smooth muscle physiology.", {"entities": []}], ["Many naturally occurring protein phosphatase inhibitors with different relative PP1/PP2A affinities have been discovered and are widely used as powerful research tools.", {"entities": []}], ["Current topics in the chemical biology of PP1/PP2A inhibitors are introduced and discussed, highlighting the identification of the gene cluster responsible for the biosynthesis of calyculin A in a symbiont microorganism of a marine sponge.", {"entities": []}], ["Early mobilization can be performed in critically ill patients and improves outcomes.", {"entities": []}], ["A daily cycling exercise started from day 5 after ICU admission is feasible and can enhance functional capacity after hospital discharge.", {"entities": []}], ["In the present study we verified the physiological changes and safety of an earlier cycling intervention (< 72 hrs of mechanical ventilation) in critical ill patients.", {"entities": []}], ["Nineteen hemodynamically stable and deeply sedated patients within the first 72 hrs of mechanical ventilation were enrolled in a single 20 minute passive leg cycling exercise using an electric cycle ergometer.", {"entities": []}], ["A minute-by-minute evaluation of hemodynamic, respiratory and metabolic variables was undertaken before, during and after the exercise.", {"entities": []}], ["Analyzed variables included the following: cardiac output, systemic vascular resistance, central venous blood oxygen saturation, respiratory rate and tidal volume, oxygen consumption, carbon dioxide production and blood lactate levels.", {"entities": []}], ["We enrolled 19 patients (42% male, age 55\u00b117 years, SOFA = 6 \u00b1 3, SAPS3 score = 58 \u00b1 13, PaO 2 /FIO 2 = 223\u00b175).", {"entities": []}], ["The median time of mechanical ventilation was 1 day (02), and 68% (n=13) of our patients required norepinephrine (maximum concentration = 0.47 \u00b5g.kg In our study, this very early passive cycling exercise in sedated, critically ill, mechanically ventilated patients was considered safe and was not associated with significant alterations in hemodynamic, respiratory or metabolic variables even in those requiring vasoactive agents.", {"entities": []}], ["Environmental exposures and immune conditions during pregnancy could influence development of autism spectrum disorder (ASD) in offspring.", {"entities": [[94, 118, "DISEASE"]]}], ["However, few studies have examined immune-triggering exposures in relation to ASD.", {"entities": []}], ["We evaluated the association between parental workplace exposures to risk factors for asthma (\u201casthmagens\u201d) and ASD.", {"entities": [[86, 92, "DISEASE"]]}], ["We conducted a population-based case-control study in the Danish population using register linkage.", {"entities": []}], ["Our study population consisted of 11,869 ASD cases and 48,046 controls born from 1993 through 2007.", {"entities": []}], ["Cases were identified by ICD-10 codes in the Danish Psychiatric Central Register.", {"entities": []}], ["ASD cases and controls were linked to parental Danish International Standard Classification of Occupations (DISCO-88) job codes.", {"entities": []}], ["Parental occupational asthmagen exposure was estimated by linking DISCO-88 codes to an asthma-specific job-exposure matrix.", {"entities": [[87, 93, "DISEASE"]]}], ["Our maternal analyses included 6706 case mothers and 29,359 control mothers employed during the pregnancy period.", {"entities": []}], ["We found a weak inverse association between ASD and any maternal occupational asthmagen exposure, adjusting for sociodemographic covariates (adjusted OR: 0.92, 95% CI: 0.86\u20130.99).", {"entities": []}], ["In adjusted analyses, including 7647 cases and 31,947 controls with employed fathers, paternal occupational asthmagen exposure was not associated with ASD (adjusted OR: 0.98, 95% CI: 0.92\u20131.05).", {"entities": []}], ["We found a weak inverse association between maternal occupational asthmagen exposure and ASD, and a null association between paternal occupational exposure and ASD.", {"entities": []}], ["We suggest that unmeasured confounding negatively biased the estimate, but that this unmeasured confounding is likely not strong enough to bring the effect above the null.", {"entities": []}], ["Overall, our results were consistent with no positive association between parental asthmagen exposure and ASD in the children.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-017-0230-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Exhaled nitric oxide (NO) production is increased in asthma and reflects the degree of airway inflammation.", {"entities": [[53, 59, "DISEASE"]]}], ["The alveolar NO concentration (Calv) in interstitial pneumonia is reported to be increased.", {"entities": [[53, 62, "DISEASE"]]}], ["However, it remains unknown whether NO production is increased and nitrosative stress occurs in eosinophilic pneumonia (EP).", {"entities": [[109, 118, "DISEASE"], [96, 118, "DISEASE"]]}], ["We hypothesized that nitrosative stress markers including Calv, inducible type of NO synthase (iNOS), and 3-nitrotyrosine (3-NT), are upregulated in EP.", {"entities": []}], ["Exhaled NO including fractional exhaled NO (FE NO ) and Calv was measured in ten healthy subjects, 13 patients with idiopathic pulmonary fibrosis (IPF), and 13 patients with EP.", {"entities": [[127, 145, "DISEASE"], [116, 145, "DISEASE"]]}], ["iNOS expression and 3-NT formation were assessed by immunocytochemistory in BALf cells.", {"entities": []}], ["The exhaled NO, lung function, and systemic inflammatory markers of the EP patients were investigated after corticosteroid treatment for 4 weeks.", {"entities": []}], ["The Calv levels in the EP group (14.4 \u00b1 2.0 ppb) were significantly higher than those in the healthy subjects (5.1 \u00b1 0.6 ppb, p < 0.01) and the IPF groups (6.3 \u00b1 0.6 ppb, p < 0.01) as well as the FE NO and the corrected Calv levels (all p < 0.01).", {"entities": []}], ["More iNOS and 3-NT positive cells were observed in the EP group compared to the healthy subject and IPF patient.", {"entities": []}], ["The Calv levels had significant positive correlations with both iNOS (r = 0.858, p < 0.05) and 3-NT positive cells (r = 0.924, p < 0.01).", {"entities": []}], ["Corticosteroid treatment significantly reduced both the FE NO (p < 0.05) and the Calv levels (p < 0.01).", {"entities": []}], ["The magnitude of reduction in the Calv levels had a significant positive correlation with the peripheral blood eosinophil counts (r = 0.802, p < 0.05).", {"entities": []}], ["These results suggested that excessive nitrosative stress occurred in EP and that Calv could be a marker of the disease activity.", {"entities": []}], ["The rates of childhood allergic conditions are changing, prompting the need for continued surveillance.", {"entities": []}], ["Examination of healthcare provider-based diagnosis data is an important and lacking methodology needed to complement existing studies that rely on participant reporting.", {"entities": []}], ["Utilizing our care network of 1,050,061 urban and sub-urban children, we defined two retrospective cohorts: (1) a closed birth cohort of 29,662 children and (2) a cross-sectional cohort of 333,200 children.", {"entities": []}], ["These cohorts were utilized to determine the epidemiologic characteristics of the conditions studied.", {"entities": []}], ["Logistic regression was utilized to determine the extent to which food allergy was associated with respiratory allergy.", {"entities": [[66, 78, "DISEASE"]]}], ["In our birth cohort, the peak age at diagnosis of eczema, asthma, rhinitis, and food allergy was between 0 and 5\u00a0months (7.3\u00a0%), 12 and 17\u00a0months (8.7\u00a0%), 24 and 29\u00a0months (2.5\u00a0%), and 12 and 17\u00a0months (1.9\u00a0%), respectively.", {"entities": [[66, 74, "DISEASE"], [80, 92, "DISEASE"], [58, 64, "DISEASE"]]}], ["In our cross-sectional cohort, eczema and rhinitis prevalence rates were 6.7\u00a0% and 19.9\u00a0%, respectively.", {"entities": [[42, 50, "DISEASE"]]}], ["Asthma prevalence was 21.8\u00a0%, a rate higher than previously reported.", {"entities": [[0, 6, "DISEASE"]]}], ["Food allergy prevalence was 6.7\u00a0%, with the most common allergenic foods being peanut (2.6\u00a0%), milk (2.2\u00a0%), egg (1.8\u00a0%), shellfish (1.5\u00a0%), and soy (0.7\u00a0%).", {"entities": [[0, 12, "DISEASE"]]}], ["Food allergy was associated with development of asthma (OR 2.16, 95\u00a0% CI 1.94-2.40), and rhinitis (OR 2.72, 95\u00a0% CI 2.45-3.03).", {"entities": [[89, 97, "DISEASE"], [0, 12, "DISEASE"], [48, 54, "DISEASE"]]}], ["Compared with previous reports, we measure lower rates of eczema and higher rates of asthma.", {"entities": [[85, 91, "DISEASE"]]}], ["The distribution of the major allergenic foods diverged from prior figures, and food allergy was associated with the development of respiratory allergy.", {"entities": [[80, 92, "DISEASE"]]}], ["The utilization of provider-based diagnosis data contributes an important and lacking methodology that complements existing studies.", {"entities": []}], ["The online version of this article (doi:10.1186/s12887-016-0673-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["IL23/IL17 pathway plays an important role in the development of inflammatory bowel diseases (IBD).", {"entities": []}], ["In general, the genes encoding the cytokines are genetically polymorphic and polymorphisms in genes IL23R and IL17 have been proved to be associated with its susceptibility to inflammatory diseases as well as cancer including colorectal cancer.", {"entities": [[226, 243, "DISEASE"], [209, 215, "DISEASE"], [237, 243, "DISEASE"], [100, 105, "GENE"]]}], ["Moreover, it has been shown that these interleukins are involved in anti-tumor or pro-tumor effects of various cancers.", {"entities": []}], ["Previously, we showed that there is a significant association between IL17A, IL17F and IL23R polymorphisms as well as the occurrence of colorectal cancer and the clinical features of the disease.", {"entities": [[136, 153, "DISEASE"], [147, 153, "DISEASE"], [70, 75, "GENE"], [77, 82, "GENE"], [87, 92, "GENE"]]}], ["The purpose of the present work is to investigate an association between IL17A, IL17F and IL23R polymorphisms in 102 Tunisian patients with colorectal cancer treatment.", {"entities": [[140, 157, "DISEASE"], [151, 157, "DISEASE"], [73, 78, "GENE"], [80, 85, "GENE"], [90, 95, "GENE"]]}], ["The association was analyzed by statistical tools.", {"entities": []}], ["We found that patients with mutated genotypes of IL17A G197A SNP could be a risk factor for the inefficiency of chemotherapy and radiotherapy.", {"entities": [[49, 54, "GENE"]]}], ["Unlike IL17F variant, patients with wild type genotypes require surgery and adjuvant chemotherapy.", {"entities": [[7, 12, "GENE"]]}], ["On the one hand, we found no evidence that supports a significant association between IL23R polymorphism and the combined genotypes of these three genes and the colorectal cancer treatment.", {"entities": [[161, 178, "DISEASE"], [172, 178, "DISEASE"], [86, 91, "GENE"]]}], ["On the other hand, we showed that there is an important interaction between IL17A/IL17F polymorphisms and the stage of the disease as well as its treatment.", {"entities": []}], ["Finally, patients with IL17F wild type genotype highlighted that there is a valid longer OS without all treatments and with radiotherapy and a neoadjuvant chemotherapy.", {"entities": [[23, 28, "GENE"]]}], ["In contrast, we observed that there are no relationships between IL17A, IL23R and the survival of these patients neither with nor without the treatment.", {"entities": [[65, 70, "GENE"], [72, 77, "GENE"]]}], ["Our results suggest that polymorphisms in IL17A and IL17F genes may be a predictive source of colorectal cancer therapy type.", {"entities": [[94, 111, "DISEASE"], [105, 111, "DISEASE"], [42, 47, "GENE"], [52, 57, "GENE"]]}], ["Therefore, IL17F may serve as an independent prognostic factor for overall survival in patients with colorectal cancer.", {"entities": [[101, 118, "DISEASE"], [112, 118, "DISEASE"], [11, 16, "GENE"]]}], ["Scavenger receptor A (SRA) is expressed predominantly in phagocytic cells playing an essential role in the host immune defense against invading microorganisms.", {"entities": []}], ["Our previous study reported the presence of SRA in a soluble form in patients with infection of hepatitis B viruses (HBV).", {"entities": [[96, 105, "DISEASE"]]}], ["However, the association of soluble SRA with stages of HBV infection and the immune response induced by HBV is not fully determined.", {"entities": []}], ["In this study, we detected soluble SRA in serum from 29 chronic hepatitis B (CHB) patients, 28 chronic HBV carriers in the immune tolerant (IT) stage, 33 in the HBeAg-negative inactive carrier (IC) stage, and 22 healthy controls (HCs), respectively.", {"entities": [[64, 73, "DISEASE"]]}], ["We further analyzed the correlation of detected soluble SRA to inflammation and serum viral load.", {"entities": []}], ["In addition, we investigated the regulatory role of soluble SRA in T cell activation, especially in CD8 We demonstrated that Median levels of serum soluble SRA in CHB and IT patients were significantly higher than those of IC patients and HCs.", {"entities": []}], ["Additionally, the concentrations of soluble SRA were negatively correlated with alanine transaminase levels in CHB patients.", {"entities": []}], ["We also found that serum concentration of SRA was decreased during telbivudine treatment.", {"entities": []}], ["Expressed SRA extracellular domain suppressed HBV core peptide-stimulated interferon-\u03b3 and tumor necrosis factor-\u03b1 production in CD8 In summary, we determined the level of soluble SRA in different stages of CHB patients.", {"entities": []}], ["SRA might inhibit T cell proliferation and activation as a soluble form.", {"entities": []}], ["These results not only revealed a previously unknown feature of soluble SRA in CHB patients but also provided broad understanding of SRA in T cell activation.", {"entities": []}], ["The online version of this article (doi:10.1186/s12865-015-0088-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Blocking CCR8 inhibits entry of metastases from the collecting lymphatic vessel into the lymph node.", {"entities": [[9, 13, "GENE"]]}], ["Lymphatic vessels are thought to contribute to metastasis primarily by serving as a transportation system.", {"entities": []}], ["It is widely believed that tumor cells enter lymph nodes passively by the flow of lymph.", {"entities": []}], ["We demonstrate that lymph node lymphatic sinuses control tumor cell entry into the lymph node, which requires active tumor cell migration.", {"entities": []}], ["In human and mouse tissues, CCL1 protein is detected in lymph node lymphatic sinuses but not in the peripheral lymphatics.", {"entities": [[28, 32, "GENE"]]}], ["CCR8, the receptor for CCL1, is strongly expressed by human malignant melanoma.", {"entities": [[70, 78, "DISEASE"], [0, 4, "GENE"], [23, 27, "GENE"]]}], ["Tumor cell migration to lymphatic endothelial cells (LECs) in vitro is inhibited by blocking CCR8 or CCL1, and recombinant CCL1 promotes migration of CCR8", {"entities": [[93, 97, "GENE"], [150, 154, "GENE"], [101, 105, "GENE"], [123, 127, "GENE"], [101, 105, "GENE"], [123, 127, "GENE"], [93, 97, "GENE"], [150, 154, "GENE"]]}], ["Personal continuity is a core value for family practice, but policy and performance targets emphasise other aspects of care, particularly waiting times for consultation.", {"entities": []}], ["This study examined patient and general practitioner (GP) perceptions of the value of personal continuity and rapid access, and the relationship between them.", {"entities": []}], ["Qualitative analysis of semi-structured interviews with a purposive sample of 16 GPs and 32 patients in the Lothian region of Scotland, to identify whether, how, why and in which circumstances personal continuity and rapid access were valued.", {"entities": []}], ["From the patients' perspective, what mattered was 'access to appropriate care' depending on the problem to be dealt with.", {"entities": []}], ["For a few patients, rapid access was the only priority.", {"entities": []}], ["For most, rapid access was balanced against greater involvement in the consultation when seeing 'their' trusted doctor, which was particularly valued for chronic, complex and emotional problems.", {"entities": []}], ["GPs focused on the value of personal continuity in the consultation for improving the diagnosis and management of the same kinds of problem.", {"entities": []}], ["GPs did not perceive enabling access to be a core part of their work.", {"entities": []}], ["There was little evidence that GPs routinely discussed with patients when or how personal continuity and access should be balanced.", {"entities": []}], ["'Access to appropriate care' from the patients' perspective is not fully addressed by GPs' focus on personal continuity, nor by performance targets focused only on speed of access.", {"entities": []}], ["GPs need to make enabling access as much a part of their core values as personal continuity, and access targets need to be based on less simplistic measures that account for the appropriateness of care as well as speed of access.", {"entities": []}], ["Pseudomonas aeruginosa infections are associated with progressive life threatening decline of lung function in cystic fibrosis sufferers.", {"entities": [[111, 126, "DISEASE"]]}], ["Growth of Ps.", {"entities": []}], ["aeruginosa releases a \"grape-like\" odour that has been identified as the microbial volatile organic compound 2-aminoacetophenone (2-AA).", {"entities": []}], ["We investigated 2-AA for its specificity to Ps.", {"entities": []}], ["aeruginosa and its suitability as a potential breath biomarker of colonisation or infection by Solid Phase Micro Extraction and Gas Chromatography-Mass Spectrometry (GC/MS).", {"entities": []}], ["Cultures of 20 clinical strains of Ps.", {"entities": []}], ["aeruginosa but not other respiratory pathogens had high concentrations of 2-AA in the head space of in vitro cultures when analysed by GC/MS.", {"entities": []}], ["2-AA was stable for 6 hours in deactivated glass sampling bulbs but was not stable in Tedlar Ps.", {"entities": []}], ["aeruginosa 15/16 (93.7%) than both the healthy controls 5/17 (29%) (p < 0.0002) and CF patients not colonised with Ps.", {"entities": []}], ["aeruginosa 4/13(30.7%) (p < 0.001).", {"entities": []}], ["The sensitivity and specificity of the 2-AA breath test compared to isolation of Ps.", {"entities": []}], ["aeruginosa in sputum and/or BALF was 93.8% (95% CI, 67-99) and 69.2% (95% CI, 38-89) respectively.", {"entities": []}], ["The peak integration values for 2-AA analysis in the breath samples were significantly higher in Ps.", {"entities": []}], ["aeruginosa colonised subjects (median 242, range 0-1243) than the healthy controls (median 0, range 0-161; p < 0.001) and CF subjects not colonised with Ps.", {"entities": []}], ["aeruginosa (median 0, range 0-287; p < 0.003) Our results report 2-AA as a promising breath biomarker for the detection of Ps.", {"entities": []}], ["aeruginosa infections in the cystic fibrosis lung.", {"entities": [[29, 44, "DISEASE"]]}], ["Respiratory Syncytial Virus (RSV) is the leading cause of acute lower respiratory infections (ALRI) in children.", {"entities": []}], ["It is estimated to cause approximately 33.8 million new episodes of ALRI in children annually, 96% of these occurring in developing countries.", {"entities": []}], ["It is also estimated to result in about 53,000 to 199,000 deaths annually in young children.", {"entities": []}], ["Currently there are several vaccine and immunoprophylaxis candidates against RSV in the developmental phase targeting active and passive immunization.", {"entities": []}], ["We used a modified CHNRI methodology for setting priorities in health research investments.", {"entities": []}], ["This was done in two stages.", {"entities": []}], ["In Stage I, we systematically reviewed the literature related to emerging vaccines against RSV relevant to 12 criteria of interest.", {"entities": []}], ["In Stage II, we conducted an expert opinion exercise by inviting 20 experts (leading basic scientists, international public health researchers, international policy makers and representatives of pharmaceutical companies).", {"entities": []}], ["The policy makers and industry representatives accepted our invitation on the condition of anonymity, due to the sensitive nature of their involvement in such exercises.", {"entities": []}], ["They answered questions from the CHNRI framework and their \u201ccollective optimism\u201d towards each criterion was documented on a scale from 0 to 100%.", {"entities": []}], ["In the case of candidate vaccines for active immunization of infants against RSV, the experts expressed very low levels of optimism for low product cost, affordability and low cost of development; moderate levels of optimism regarding the criteria of answerability, likelihood of efficacy, deliverability, sustainability and acceptance to end users for the interventions; and high levels of optimism regarding impact on equity and acceptance to health workers.", {"entities": []}], ["While considering the candidate vaccines targeting pregnant women, the panel expressed low levels of optimism for low product cost, affordability, answerability and low development cost; moderate levels of optimism for likelihood of efficacy, deliverability, sustainability and impact on equity; high levels of optimism regarding acceptance to end users and health workers.", {"entities": []}], ["The group also evaluated immunoprophylaxis against RSV using monoclonal antibodies and expressed no optimism towards low product cost; very low levels of optimism regarding deliverability, affordability, sustainability, low implementation cost and impact on equity; moderate levels of optimism against the criteria of answerability, likelihood of efficacy, acceptance to end-users and health workers; and high levels of optimism regarding low development cost.", {"entities": []}], ["They felt that either of these vaccines would have a high impact on reducing burden of childhood ALRI due to RSV and reduce the overall childhood ALRI burden by a maximum of about 10%.", {"entities": []}], ["Although monoclonal antibodies have proven to be effective in providing protection to high-risk infants, their introduction in resource poor settings might be limited by high cost associated with them.", {"entities": []}], ["Candidate vaccines for active immunization of infants against RSV hold greatest promise.", {"entities": []}], ["Introduction of a low cost vaccine against RSV would reduce the inequitable distribution of burden due to childhood ALRI and will most likely have a high impact on morbidity and mortality due to severe ALRI.", {"entities": []}], ["Consumer directed health care proposes that patients will engage as informed consumers of health care services by sharing in more of their medical costs, often through deductibles.", {"entities": []}], ["We examined knowledge of deductible plan details among new enrollees, as well as anticipated care-seeking changes in response to the deductible.", {"entities": []}], ["In a large integrated delivery system with a range of deductible-based health plans which varied in services included or exempted from deductible, we conducted a mixed-method, cross-sectional telephone interview study.", {"entities": []}], ["Among 458 adults newly enrolled in a deductible plan (71% response rate), 51% knew they had a deductible, 26% knew the deductible amount, and 6% knew which medical services were included or exempted from their deductible.", {"entities": []}], ["After adjusting for respondent characteristics, those with more deductible-applicable services and those with lower self-reported health status were significantly more likely to know they had a deductible.", {"entities": []}], ["Among those who knew of their deductible, half anticipated that it would cause them to delay or avoid medical care, including avoiding doctor's office visits and medical tests, even services that they believed were medically necessary.", {"entities": []}], ["Many expressed concern about their costs, anticipating the inability to afford care and expressing the desire to change plans.", {"entities": []}], ["Early in their experience with a deductible, patients had limited awareness of the deductible and little knowledge of the details.", {"entities": []}], ["Many who knew of the deductible reported that it would cause them to delay or avoid seeking care and were concerned about their healthcare costs.", {"entities": []}], ["Human leucocyte antigen-G (HLA-G) plays a key role in maternal\u2013foetal tolerance and allotransplantation acceptance and is also implicated in tumour escape from the immune system.", {"entities": [[27, 32, "GENE"]]}], ["The modulation of HLA-G expression can prove to be very important to therapeutic goals in some pregnancy complications, transplantation, cancer and possibly autoimmune diseases.", {"entities": [[137, 143, "DISEASE"], [18, 23, "GENE"]]}], ["In spite of substantial similarities with classical HLA -class I genes, HLA-G is characterized by a restricted tissue-specific expression in non-pathological situations.", {"entities": [[52, 55, "GENE"], [72, 75, "GENE"], [72, 77, "GENE"]]}], ["HLA-G expression is mainly controlled at the transcriptional level by a unique gene promoter when compared with classical HLA -class I genes, and at the post-transcriptional level including alternative splicing, mRNA stability, translation and protein transport to the cell surface.", {"entities": [[0, 5, "GENE"], [0, 3, "GENE"], [122, 125, "GENE"]]}], ["We focus on the characteristics of the HLA-G gene promoter and the factors which are involved in HLA-G transcriptional modulation.", {"entities": [[39, 44, "GENE"], [97, 102, "GENE"], [39, 44, "GENE"], [97, 102, "GENE"]]}], ["They take part in epigenetic mechanisms that control key functions of the HLA-G gene in the regulation of immune tolerance.", {"entities": [[74, 79, "GENE"]]}], ["While there are state and national estimates of serious psychological distress (SPD), these are not useful for targeting local mental health interventions or for addressing the needs of sub-populations at increased risk for SPD.", {"entities": []}], ["This cross-sectional study uses data from the population-based 2010 Health of Houston Survey (n\u00a0=\u00a05,116) to examine (1) the prevalence of SPD and its determinants in Houston area and (2) predictors of the utilization of mental health services among people with SPD.", {"entities": []}], ["The prevalence of SPD among the Houston area adult population was 7\u00a0%, more than twice the national average.", {"entities": []}], ["Correlates of SPD included: being female, under 65, lacking emotional support, smoking, having poor health status and financial distress.", {"entities": []}], ["The odds of utilizing health services by those with SPD were affected by financial distress, insurance, employment and perceived need for services, among other factors.", {"entities": []}], ["Interventions should be tailored to mitigate risk factors for SPD and to improve access to mental health services in the SPD sub-population.", {"entities": []}], ["High numbers of eosinophils are observed in parasitic infections and allergic diseases, where they are proposed to be terminally differentiated effector cells that play beneficial role in host defence, or cause harmful inflammatory response.", {"entities": []}], ["Eosinophils have been associated with killing of schistosomulae in\u00a0vitro , but there is growing evidence that eosinophils can play additional immuno\u2010regulatory role.", {"entities": []}], ["Here, we report results of a study that examines peripheral blood mononuclear cell ( PBMC ) cytokine responses to Schistosoma mansoni adult worm antigen ( SWA ) when stimulated alone or enriched with autologous eosinophils.", {"entities": []}], ["Production of the Th\u20102 type cytokines interleukin ( IL )\u20104, IL \u20105 and IL \u201013 was lower (P\u00a0=\u00a00\u00b7017, 0\u00b7018 and <0\u00b7001, respectively) in PBMC + eosinophil cultures than in PBMC \u2010only cultures stimulated with SWA .", {"entities": []}], ["Substantial levels of IL \u201013, IL \u201010, interferon gamma and tumour necrosis factor alpha were recorded in cultures of eosinophils, but none of these cytokines showed significant association with the observed eosinophil\u2010induced drop in cytokine responses of PBMC .", {"entities": []}], ["Transwell experiments suggested that the observed effect is due to soluble mediators that downmodulate production of Th\u20102 type cytokines.", {"entities": []}], ["This study shows that eosinophils may down\u2010modulate schistosome\u2010specific Th\u20102 type cytokine responses in S.\u00a0mansoni \u2010infected individuals.", {"entities": []}], ["The mechanism of this immune modulation remains to be elucidated.", {"entities": []}], ["Many studies have suggested exposure to secondhand smoke (SHS) is a risk factor for various somatic diseases, but only few studies based on small sample size or specific groups have explored the association between passive smoking and mental distress.", {"entities": []}], ["We performed this study to examine the relationship between passive smoking and mental distress in adult never-smokers of north-east China.", {"entities": []}], ["Multistage, stratified random cluster sampling design was used in this cross-sectional study in 2012.", {"entities": []}], ["A total of 12\u2005978 never-smokers from Jilin, north-east China, were included.", {"entities": []}], ["Data on passive smoking and baseline characteristics were collected by face-to-face interviews.", {"entities": []}], ["The 12-item General Health Questionnaire (GHQ-12) was used to measure mental health status.", {"entities": []}], ["Rao-Scott \u03c7 The estimated prevalence of mental distress among never-smokers in Jilin province is 24.5%, and the estimated prevalence of passive smoking among the mental distressing group is 65.0%.", {"entities": []}], ["After adjusting for gender, age, region, body mass index (BMI), occupation, marriage, education, drinking status and family monthly income per capita, passive smoking conferred a risk for mental distress (adjusted OR=1.26, 95% CI 1.13 to 1.40).", {"entities": []}], ["A high proportion of adults, especially women, were passive smokers at home, but for men, passive smoking was more common at workplace.", {"entities": []}], ["The more frequently participants exposed to SHS, the higher GHQ-12 scores they got.", {"entities": []}], ["Passive smoking is an important risk factor for mental distress in never-smokers of Jilin province, which reminds Chinese government of increasing the awareness of public health and take measure to prevent SHS, especially with regard to SHS exposure at home and workplace.", {"entities": []}], ["Social networking sites (SNSs) have changed the way people communicate.", {"entities": []}], ["They may also change the way people seek health advice.", {"entities": []}], ["This study describes the provision of a medicines information service on Facebook to individual consumers.", {"entities": []}], ["It aimed to discuss the pros and cons, and inform health and pharmacy stakeholders and researchers about the opportunities and challenges of providing such a service.", {"entities": []}], ["We adopted an exploratory approach using a case study method.", {"entities": []}], ["NPS MedicineWise, an independent, not-for-profit Australian organization, runs a public question-and-answer service on Facebook, dubbed Pharmacist Hour.", {"entities": [[0, 3, "GENE"]]}], ["Consumers following the organization\u2019s Facebook page are invited to post medication-related questions often with a suggested health topic.", {"entities": []}], ["A wide range of questions and comments are posted related to medication usage.", {"entities": []}], ["The pharmacist answers the queries, providing evidence-based medicines information and using consumer-friendly language, during the specific 1-hour period.", {"entities": []}], ["The most popular questions in the past 12 months were related to adverse effects, treatment options for conditions, and drug interactions.", {"entities": []}], ["The service had a mean number of engagements (defined as a like or share of the Pharmacy Hour post) of 38 (SD 19) people and a mean 5 (SD 3) questions per session.", {"entities": []}], ["The Pharmacist Hour Facebook service addresses the medicines information needs of consumers and indirectly promotes other appropriate and relevant NPS MedicineWise products and services to further assist consumers.", {"entities": [[147, 150, "GENE"]]}], ["The service offers a new medium for a quality use of medicines organization committed to promoting awareness about the correct and safe use of medicines in Australia.", {"entities": []}], ["Diabetic nephropathy (DN) causes high mortality in patients with diabetes mellitus and imposes heavy burden on individuals and society.", {"entities": [[65, 82, "DISEASE"]]}], ["In previous studies, various researches have investigated the association of DN with CCR5 59029G/A polymorphism, but relevant findings were controversial.", {"entities": [[85, 89, "GENE"]]}], ["Therefore, we performed this meta-analysis to obtain a conclusion on this issue.", {"entities": []}], ["CCR5 59029G/A polymorphism showed significant risk-increasing effects on DN in all analyses under AA vs. GG, AA+GA vs. GG, AA vs. GG+GA, A vs. G and GA vs. GG model contrasts.", {"entities": [[0, 4, "GENE"]]}], ["Besides, a similar result was also obtained in Asian and type 2 diabetes mellitus groups under these five contrasts after subgroup analyses.", {"entities": [[64, 81, "DISEASE"], [57, 81, "DISEASE"]]}], ["The relevant publications were searched from the electronic databases and other sources.", {"entities": []}], ["The association intensity between CCR5 59029G/A polymorphism and DN susceptibility was measured using pooled odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs).", {"entities": [[34, 38, "GENE"]]}], ["Inter-study heterogeneity was inspected with Q test, and sensitivity analysis was conducted to verify the stability of the final outcomes by removing one study each time in turn.", {"entities": []}], ["Begg\u2019s funnel plot and Egger\u2019s test were utilized to examine publication bias among selected studies.", {"entities": []}], ["CCR5 59029G/A polymorphism is significantly related to enhanced susceptibility to DN, especially in Asian populations and people with type 2 diabetes mellitus.", {"entities": [[141, 158, "DISEASE"], [134, 158, "DISEASE"], [0, 4, "GENE"]]}], ["Infection-triggered disease onset, chronic immune activation and autonomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) point to an autoimmune disease directed against neurotransmitter receptors.", {"entities": []}], ["We had observed elevated autoantibodies against \u00df2 adrenergic receptors, and muscarinic 3 and 4 acetylcholine receptors in a subset of patients.", {"entities": []}], ["Immunoadsorption (IA) was shown to be effective in removing autoantibodies and improve outcome in various autoimmune diseases.", {"entities": []}], ["10 patients with post-infectious CFS/ME and elevated \u00df2 autoantibodies were treated with IA with an IgG-binding column for 5 days.", {"entities": []}], ["We assessed severity of symptoms as outcome parameter by disease specific scores.", {"entities": []}], ["Antibodies were determined by ELISA and B cell phenotype by flow cytometry.", {"entities": []}], ["IgG levels dropped to median 0.73 g/l (normal 7\u201316 g/l) after the 4 IA can remove autoantibodies against \u00df2 adrenergic receptor and lead to clinical improvement.", {"entities": []}], ["B cell phenotyping provides evidence for an effect of IA on memory B cell development.", {"entities": []}], ["Data from our pilot trial warrants further studies in CFS/ME.", {"entities": []}], ["Supplemental Digital Content is available in the text In carcinoma, such as of the lung, the histological subtype is important to select an appropriate therapeutic strategy for patients.", {"entities": [[57, 66, "DISEASE"]]}], ["However, carcinomas with poor differentiation cannot always be distinguished on the basis of morphology alone nor on clinical findings.", {"entities": []}], ["Hence, delineation of poorly differentiated adenocarcinoma and squamous cell carcinoma, the 2 most common epithelial-origin carcinomas, is pivotal for selection of optimum therapy.", {"entities": [[44, 58, "DISEASE"], [77, 86, "DISEASE"], [63, 86, "DISEASE"]]}], ["Herein, we explored the potential utility of trefoil factor 3 (TFF3) as a biomarker for primary lung adenocarcinoma and extrapulmonary adenocarcinomas derived from different organs.", {"entities": [[101, 115, "DISEASE"], [96, 115, "DISEASE"], [63, 67, "GENE"]]}], ["We observed that 90.9% of lung adenocarcinomas were TFF3-positive, whereas no expression of TFF3 was observed in squamous cell carcinomas.", {"entities": [[52, 56, "GENE"], [92, 96, "GENE"]]}], ["The subtype of lung carcinoma was confirmed by four established biomarkers, cytokeratin 7 and thyroid transcription factor 1 for adenocarcinoma and P63 and cytokeratin 5/6 for squamous cell carcinoma.", {"entities": [[129, 143, "DISEASE"], [20, 29, "DISEASE"], [190, 199, "DISEASE"], [176, 199, "DISEASE"], [15, 29, "DISEASE"]]}], ["Furthermore, expression of TFF3 mRNA was observed by quantitative PCR in all of 11 human lung adenocarcinoma cell lines and highly correlated with markers of the adenocarcinomatous lineage.", {"entities": [[94, 108, "DISEASE"], [89, 108, "DISEASE"], [27, 31, "GENE"]]}], ["In contrast, little or no expression of TFF3 was observed in 4 lung squamous cell carcinoma cell lines.", {"entities": [[82, 91, "DISEASE"], [68, 91, "DISEASE"], [63, 91, "DISEASE"], [40, 44, "GENE"]]}], ["By use of forced expression, or siRNA-mediated depletion of TFF3, we determined that TFF3 appeared to maintain rather than promote glandular differentiation of lung carcinoma cells.", {"entities": [[165, 174, "DISEASE"], [160, 174, "DISEASE"], [60, 64, "GENE"], [85, 89, "GENE"], [60, 64, "GENE"], [85, 89, "GENE"]]}], ["In addition, TFF3 expression was also determined in adenocarcinomas from colorectum, stomach, cervix, esophagus, and larynx.", {"entities": [[13, 17, "GENE"]]}], ["Among all these extrapulmonary carcinomas, 93.7% of adenocarcinomas exhibited TFF3 positivity, whereas only 2.9% of squamous cell carcinomas were TFF3-positive.", {"entities": [[78, 82, "GENE"], [146, 150, "GENE"]]}], ["Totally, 92.9% of both pulmonary and extrapulmonary adenocarcinomas exhibited TFF3 positivity, whereas only 1.5% of squamous cell carcinomas were TFF3-positive.", {"entities": [[78, 82, "GENE"], [146, 150, "GENE"]]}], ["In conclusion, TFF3 is preferentially expressed in adenocarcinoma and may function as an additional biomarker for distinguishing adenocarcinoma from squamous cell carcinoma.", {"entities": [[51, 65, "DISEASE"], [129, 143, "DISEASE"], [163, 172, "DISEASE"], [149, 172, "DISEASE"], [15, 19, "GENE"]]}], ["Impairment of (inspiratory and expiratory) respiratory muscles is a common clinical finding, not only in patients with neuromuscular disease but also in patients with primary disease of the lung parenchyma or airways.", {"entities": [[119, 140, "DISEASE"]]}], ["Although such impairment is common, its recognition is usually delayed because its signs and symptoms are nonspecific and late.", {"entities": []}], ["This delayed recognition, or even the lack thereof, occurs because the diagnostic tests used in the assessment of respiratory muscle strength are not widely known and available.", {"entities": []}], ["There are various methods of assessing respiratory muscle strength during the inspiratory and expiratory phases.", {"entities": []}], ["These methods are divided into two categories: volitional tests (which require patient understanding and cooperation); and non-volitional tests.", {"entities": []}], ["Volitional tests, such as those that measure maximal inspiratory and expiratory pressures, are the most commonly used because they are readily available.", {"entities": []}], ["Non-volitional tests depend on magnetic stimulation of the phrenic nerve accompanied by the measurement of inspiratory mouth pressure, inspiratory esophageal pressure, or inspiratory transdiaphragmatic pressure.", {"entities": []}], ["Another method that has come to be widely used is ultrasound imaging of the diaphragm.", {"entities": []}], ["We believe that pulmonologists involved in the care of patients with respiratory diseases should be familiar with the tests used in order to assess respiratory muscle function.Therefore, the aim of the present article is to describe the advantages, disadvantages, procedures, and clinical applicability of the main tests used in the assessment of respiratory muscle strength.", {"entities": []}], ["Inversion polymorphisms have important phenotypic and evolutionary consequences in humans.", {"entities": []}], ["Two different methodologies have been used to infer inversions from SNP dense data, enabling the use of large cohorts for their study.", {"entities": []}], ["One approach relies on the differences in linkage disequilibrium across breakpoints; the other one captures the internal haplotype groups that tag the inversion status of chromosomes.", {"entities": []}], ["In this article, we assessed the convergence of the two methods in the detection of 20 human inversions that have been reported in the literature.", {"entities": []}], ["The methods converged in four inversions including inv-8p23, for which we studied its association with low-BMI in American children.", {"entities": []}], ["Using a novel haplotype tagging method with control on inversion ancestry, we computed the frequency of inv-8p23 in two American cohorts and observed inversion haplotype admixture.", {"entities": []}], ["Accounting for haplotype ancestry, we found that the European inverted allele in children carries a recessive risk of underweight, validated in an independent Spanish cohort (combined: OR= 2.00, P = 0.001).", {"entities": []}], ["While the footprints of inversions on SNP data are complex, we show that systematic analyses, such as convergence of different methods and controlling for ancestry, can reveal the contribution of inversions to the ancestral composition of populations and to the heritability of human disease.", {"entities": []}], ["Health care utilization and costs among US veterans with chronic obstructive pulmonary disease (COPD) were compared with those in veterans without COPD.", {"entities": [[57, 94, "DISEASE"]]}], ["A cohort of veterans with COPD was matched for age, sex, race, and index fiscal year to a cohort of veterans without COPD (controls) using data from the Veterans Integrated Service Network (VISN) 16 from 10/1/1997 to 9/30/2004.", {"entities": []}], ["Annual total and respiratory-related health care service utilization, costs of care, comorbidities, and respiratory medication use at the time of diagnosis were assessed.", {"entities": []}], ["A total of 59,906 patients with COPD were identified for a 7-year period prevalence of 8.2%, or 82 per 1000 population.", {"entities": []}], ["Patients with COPD compared with controls had significantly higher all-cause and respiratory-related inpatient and outpatient health care utilization for every parameter examined including mean numbers of physician encounters, other outpatient encounters, emergency room visits, acute inpatient discharges, total bed days of care, and percentage of patients with any emergency room visits or any acute inpatient discharge.", {"entities": []}], ["Patients with COPD had statistically significantly higher mean outpatient, inpatient, pharmacy, and total costs than the control group.", {"entities": []}], ["The mean Charlson comorbidity index in patients with COPD was 1 point higher than in controls (2.85 versus 1.84, P < 0.001).", {"entities": []}], ["60% of COPD patients were prescribed medications recommended in treatment guidelines at diagnosis.", {"entities": []}], ["Veterans with COPD compared with those without COPD suffer a tremendous disease burden manifested by higher rates of all-cause and respiratory-related health care utilization and costs and a high prevalence of comorbidities.", {"entities": []}], ["Furthermore, COPD patients do not receive appropriate treatment for their disease on diagnosis.", {"entities": []}], ["Domestic waste generation has contributed significantly to hampering national waste management efforts.", {"entities": []}], ["It poses serious threat to national development and requires proper treatment and management within and outside households.", {"entities": []}], ["The problem of improper waste management has always been a challenge in Ghana, compelling several national surveys to report on the practice of waste management.", {"entities": []}], ["However, little is known about how much waste is generated and managed within households and there is a serious dearth of information for national policy and planning.", {"entities": []}], ["This paper seeks to document the handling and practice of waste management, including collection, storage, transportation and disposal along with the types and amount of waste generated by Households and their related health outcome.", {"entities": []}], ["The study was a descriptive cross-sectional study and used a multi-stage sampling technique to sample 700 households.", {"entities": []}], ["The study was planned and implemented from January to May 2015.", {"entities": []}], ["It involved the use of structured questionnaires in the data collection over the period.", {"entities": []}], ["Factors such as demographic characteristics, amount of waste generated, types of waste bins used within households, waste recycling, cost of disposing waste, and distance to dumpsite were all assessed.", {"entities": []}], ["The paper shows that each surveyed household generated 0.002\u00a0t of waste per day, of which 29% are both organic and inorganic.", {"entities": []}], ["Though more than half of the respondents (53.6%) had positive attitude towards waste management, only 29.1% practiced waste management.", {"entities": []}], ["The study reveals that there is no proper management of domestic waste except in few households that segregate waste.", {"entities": []}], ["The study identified several elements as determinants of waste management practice.", {"entities": []}], ["Female respondents were less likely to practice waste management (AOR 0.45; 95% Cl 0.29, 0.79), household size also determined respondents practice (AOR 0.26; Cl 0.09, 0.77).", {"entities": []}], ["Practice of recycling (AOR 0.03; Cl 0.02, 0.08), distance to dumpsite (AOR 0.45; Cl 0.20, 0.99), were all significant predictors of waste management practice.", {"entities": []}], ["Cholera which is a hygiene related disease was three times more likely to determine households\u2019 waste management practice (AOR 3.22; Cl 1.33, 7.84).", {"entities": []}], ["Considering the low waste management practice among households, there is the need for improved policy and enhanced education on proper waste management practice among households.", {"entities": []}], ["Objective \u00a0To ascertain long term cardiovascular outcomes in patients whose chest pain remained undiagnosed six months after first presentation.", {"entities": []}], ["Design \u00a0Cohort study.", {"entities": []}], ["Setting \u00a0UK electronic health record database (CALIBER) linking primary care, secondary care, coronary registry, and death registry information.", {"entities": []}], ["Participants \u00a0172\u2009180 adults aged \u226518 from 223 general practices presenting with a first episode of recorded chest pain, classified from medical records as diagnosed (non-coronary condition or angina) or undiagnosed (cause unattributed) at first consultation between 2002 and 2009 and with no previous record of cardiovascular disease.", {"entities": []}], ["Main outcome measures \u00a0Fatal or non-fatal cardiovascular events over 5.5 years\u2019 follow-up.", {"entities": []}], ["Adjustments were made for age, sex, deprivation, body mass index, smoking status, year of index presentation, and previous records of diabetes or hypertension or previous prescriptions for lipid lowering drugs.", {"entities": [[146, 158, "DISEASE"]]}], ["Results \u00a0At the index presentation, 72.4% of patients (124\u2009688) did not have a cause attributed for their chest pain; 118\u2009687 (95.2%) of these did not receive any type of cardiovascular diagnosis over the next six months.", {"entities": []}], ["Only a minority of patients in all three groups (non-coronary 2.0% (769 of 39\u2009232); unattributed 11.7% (14\u2009582 of 124\u2009688); angina 31.5% (2606 of 8260)) had a recorded cardiac diagnostic investigation in the first six months after presentation.", {"entities": []}], ["The long term incidence of cardiovascular events was higher in those whose chest pain remained unattributed after six months (5126 of 109\u2009628; 4.7%) compared with patients with an initial diagnosis of non-coronary pain (1073 of 36\u2009097; 3.0%) (adjusted hazard ratios for 0.5-1 year after presentation: 1.95, 95% confidence interval 1.66 to 2.31; for 1-3 years: 1.35, 1.23 to 1.48); for 3-5.5 years: 1.21, 1.08 to 1.37).", {"entities": []}], ["Owing to the larger number of patients in the unattributed group, there were more excess myocardial infarctions in the long term in this group (214 more than expected based on the rate in the non-coronary group) than in the angina group (132 more than expected).", {"entities": []}], ["Patients who had cardiac diagnostic investigations in the first six months had a higher long term risk of cardiovascular events, regardless of the initial chest pain label.", {"entities": []}], ["Incidence of unattributed chest pain and angina decreased between 2002 (124 per 10\u2009000 person years and 13 per 10\u2009000 person years, respectively) and 2009 (107 per 10\u2009000 person years and 5 per 10\u2009000 person years, respectively), but the incidence of chest pain attributed to a non-coronary cause remained stable (37-40 per 10\u2009000 person years).", {"entities": []}], ["Risk of cardiovascular events did not change over time.", {"entities": []}], ["Conclusions \u00a0Most patients with first onset chest pain do not have a diagnosis recorded at presentation or in the subsequent six months, including those who undergo cardiac investigations.", {"entities": []}], ["These patients have an increased risk of cardiovascular events for at least five years.", {"entities": []}], ["Efforts to better assess and reduce the cardiovascular risk of such patients are warranted.", {"entities": []}], ["Tanzania is doubly burdened with both non-communicable and infectious diseases, but information on how Tanzanians experience the co-existence of these conditions is limited.", {"entities": []}], ["Using Kleinman\u2019s eight prompting questions the study synthesizes explanatory models from patients to describe common illness experiences of diabetes in a rural setting where malaria is the predominant health threat.", {"entities": [[174, 181, "DISEASE"]]}], ["We conducted 17 focus group discussions with adult members of the general community, diabetes patients, neighbours and relatives of diabetes patients to gain insight into shared experiences.", {"entities": []}], ["To gain in-depth understanding of the individual illness experiences, we conducted 41 in-depth interviews with malaria or diabetes patients and family members of diabetes patients.", {"entities": [[111, 118, "DISEASE"]]}], ["The analysis followed grounded theory principles and the illness experiences were derived from the emerging themes.", {"entities": []}], ["The illness experiences showed that malaria and diabetes are both perceived to be severe and fatal conditions, but over the years people have learned to live with malaria and the condition is relatively manageable compared with diabetes.", {"entities": [[36, 43, "DISEASE"], [163, 170, "DISEASE"]]}], ["In contrast, diabetes was perceived as a relatively new disease, with serious life-long consequences.", {"entities": []}], ["Uncertainty, fear of those consequences, and the increased risk for severe malaria and other illnesses impacted diabetes patients and their families\u2019 illness experiences.", {"entities": [[75, 82, "DISEASE"]]}], ["Unpredictable ailments and loss of consciousness, memory, libido, and functional incapability were common problems reported by diabetes patients.", {"entities": []}], ["These problems had an effect on their psychological and emotional health and limited their social life.", {"entities": []}], ["Direct and indirect costs of illness pushed individuals and their families further into poverty and were more pronounced for diabetes patients.", {"entities": []}], ["The illness experiences revealed both malaria and diabetes as distressing conditions, however, diabetes showed a higher level of stress because of its chronicity.", {"entities": [[38, 45, "DISEASE"]]}], ["Strategies for supporting social, emotional, and psychological well-being that build on the patient accounts are likely to improve illness experiences and quality of life for the chronically ill patient.", {"entities": []}], ["It has been proposed that helminth infection may be particularly detrimental during pregnancy, through adverse effects on maternal anaemia and on birth outcomes, and that anthelminthic treatment during pregnancy will therefore be particularly beneficial.", {"entities": []}], ["However, the few treatment trials that have been conducted have given, but little support to this notion and further trials in settings of nutritional stress are needed.", {"entities": []}], ["It has also been proposed that prenatal exposure to helminth infection has an important effect on the development of the foetal immune response.", {"entities": []}], ["There is evidence that this may impact, long-term, upon responses to helminth and nonhelminth antigens, and to allergens.", {"entities": []}], ["Exposure to helminths in utero may also have nonspecific effects that may modify the offspring's susceptibility to diseases mediated by inflammation, including metabolic disorders.", {"entities": []}], ["The mechanisms of such effects are not known, but they deserve to be explored as current epidemiological findings suggest the possibility of primary prevention for inflammatory conditions such as allergy, through intervention during pregnancy.", {"entities": []}], ["The immune system is likely to be involved in some of the health effects caused by certain indoor air exposures, and immune biomarkers can help determine which exposures and health effects have important immune components.", {"entities": []}], ["However, the lack of standardized laboratory tests for most human immune markers and the many confounding variables that can influence them makes interpretation of results for exposure and disease end points uncertain.", {"entities": []}], ["This paper presents an overview of the immune system and the considerations involved in using tests for immune markers in clinical epidemiology studies, particularly those concerned with indoor air exposures.", {"entities": []}], ["Careful study design, well-characterized laboratory methods, and rigorous documentation of exposure status are required to determine the predictive value of such tests.", {"entities": []}], ["Clinical tests currently available for some immune markers could help identify and characterize both irritative and hypersensitivity reactions to indoor air pollutants.", {"entities": []}], ["Newer tests developed in research settings might provide more incisive indicators of immune status that could help identify exposure, susceptibility, or preclinical disease states, but their methodologies must be refined and tested in multicenter studies before they can be used reliably in public health applications.", {"entities": []}], ["It has recently been demonstrated that patients who develop chronic illness after prior exposure to water damaged buildings (WDB) and mold have the presence of mycotoxins, which can be detected in the urine.", {"entities": []}], ["We hypothesized that the mold may be harbored internally and continue to release and/or produce mycotoxins which contribute to ongoing chronic illness.", {"entities": []}], ["The sinuses are the most likely candidate as a site for the internal mold and mycotoxin production.", {"entities": []}], ["In this paper, we review the literature supporting this concept.", {"entities": []}], ["There is an increasing prevalence of asthma in the Caribbean and patients remain non-compliant to therapy despite the development of guidelines for management and prevention.", {"entities": [[37, 43, "DISEASE"]]}], ["Some patients may self-medicate with medicinal herbs for symptomatic relief, as there is a long tradition of use for a variety of ailments.", {"entities": []}], ["The study assessed the prevalence of use and the factors affecting the decision to use herbs in asthmatic patients attending a public specialty care clinic in Trinidad.", {"entities": []}], ["A descriptive, cross-sectional study was conducted at the Chest Clinic in Trinidad using a de novo , pilot-tested, researcher-administered questionnaire between June and July 2003.", {"entities": []}], ["Fifty-eight out of 191 patients (30.4%) reported using herbal remedies for symptomatic relief.", {"entities": []}], ["Gender, age, ethnicity, and asthma severity did not influence the decision to use herbs; however, 62.5% of patients with tertiary level schooling used herbs, p = 0.025.", {"entities": [[28, 34, "DISEASE"]]}], ["Thirty-four of these 58 patients (58.6%) obtained herbs from their backyards or the supermarket; only 14 patients (24.1%) obtained herbs from an herbalist, herbal shop or pharmacy.", {"entities": []}], ["Relatives and friends were the sole source of information for most patients (70.7%), and only 10.3% consulted an herbalist.", {"entities": []}], ["Ginger, garlic, aloes, shandileer, wild onion, pepper and black sage were the most commonly used herbs.", {"entities": []}], ["Among patients attending the Chest Clinic in Trinidad the use of herbal remedies in asthma is relatively common on the advice of relatives and friends.", {"entities": [[84, 90, "DISEASE"]]}], ["It is therefore becoming imperative for healthcare providers to become more knowledgeable on this modality and to keep abreast with the latest developments.", {"entities": []}], ["Astrocytes are highly involved in regulation and homeostasis of the extracellular environment in the healthy brain.", {"entities": []}], ["In pathological conditions, these cells play a major role in the inflammatory response seen in CNS tissues, which is called reactive astrogliosis and includes hypertrophy and proliferation of astrocytes.", {"entities": []}], ["Here, we performed 3D confocal microscopy to evaluate the morphological response of reactive astrocytes positive for glial fibrillary acidic protein (GFAP) in rats, to the presence of A\u03b2 1\u201340 in the rat brain before and after treatment with genistein.", {"entities": [[150, 154, "GENE"]]}], ["In 50 astrocytes per animal, we measured the volume and surface area for the nucleus, cell body, the entire cell, the tissue covered by single astrocytes and quantified the number and length of branches, the density of the astrocytes and the intensity of GFAP immunoreactivity.", {"entities": [[255, 259, "GENE"]]}], ["Injecting A\u03b2 1\u201340 into the brain of rats caused astrogliosis indicated by increased values for all measured parameters.", {"entities": []}], ["Mass spectrometric analysis of hippocampal tissue in A\u03b2 1\u201340 -injected brain showed decreased amounts of tubulins, enolases and myelin basic protein, and increased amounts of dihydropyrimidinase-related protein 2.", {"entities": []}], ["In A\u03b2 1\u201340 -injected rats pretreated with genistein, GFAP intensity was decreased to the sham-operated group level, and A\u03b2 1\u201340 -induced astrogliosis was significantly ameliorated.", {"entities": [[53, 57, "GENE"]]}], ["We report associations between social capital and health among 82,482 adults in a national cohort of Open University students residing throughout Thailand.", {"entities": []}], ["After adjusting for covariates, poor self-assessed health was positively associated with low social trust (OR = 1.88; 95% CI 1.76\u20132.01) and low social support (OR = 1.79; 95% CI 1.63\u20131.95).", {"entities": []}], ["In addition, poor psychological health was also associated with low social trust (OR = 2.52; 95% CI 2.41\u20132.64) and low social support (OR = 1.80; 95% CI 1.69\u20131.92).", {"entities": []}], ["Females, elderly, unpartnered, low income, and urban residents were associated with poor health.", {"entities": []}], ["Findings suggest ways to improve social capital and heath in Thailand and other middle-income countries.", {"entities": []}], ["Monitoring plays an important role in the current management of patients with acute respiratory failure but sometimes lacks definition regarding which 'signals' and 'derived variables' should be prioritized as well as specifics related to timing (continuous versus intermittent) and modality (static versus dynamic).", {"entities": [[84, 103, "DISEASE"]]}], ["Many new techniques of respiratory monitoring have been made available for clinical use recently, but their place is not always well defined.", {"entities": []}], ["Appropriate use of available monitoring techniques and correct interpretation of the data provided can help improve our understanding of the disease processes involved and the effects of clinical interventions.", {"entities": []}], ["In this consensus paper, we provide an overview of the important parameters that can and should be monitored in the critically ill patient with respiratory failure and discuss how the data provided can impact on clinical management.", {"entities": [[144, 163, "DISEASE"]]}], ["Low vitamin D is involved in allergic asthma and rhinitis.", {"entities": [[29, 44, "DISEASE"], [49, 57, "DISEASE"], [38, 44, "DISEASE"]]}], ["IL-31 and IL-33 correlate with Th2-associated cytokines in allergic disease.", {"entities": []}], ["We investigated whether low vitamin D is linked with circulating IL-31 and IL-33 in children with allergic disease of the airways.", {"entities": []}], ["25-Hydroxyvitamin D [25(OH) Vit D], IL-31, and IL-33 plasma levels were measured in 28 controls (HC), 11 allergic rhinitis (AR) patients, and 35 allergic asthma with rhinitis (AAR) patients.", {"entities": [[105, 122, "DISEASE"], [145, 160, "DISEASE"], [114, 122, "DISEASE"], [166, 174, "DISEASE"], [154, 160, "DISEASE"], [28, 31, "GENE"]]}], ["We found significant lower levels of 25(OH) Vit D in AR and in AAR than in HC.", {"entities": [[44, 47, "GENE"]]}], ["IL-31 and IL-33 plasma levels significantly increased in AAR than HC.", {"entities": []}], ["IL-31 and IL-33 positively correlated in AR and AAR.", {"entities": []}], ["25(OH) Vit D deficient AAR had higher levels of blood eosinophils, exacerbations, disease duration, and total IgE than patients with insufficient or sufficient 25(OH) Vit D. In AAR 25(OH) Vit D levels inversely correlated with total allergen sIgE score and total atopy index.", {"entities": [[7, 10, "GENE"], [167, 170, "GENE"], [188, 191, "GENE"], [7, 10, "GENE"], [167, 170, "GENE"], [188, 191, "GENE"], [7, 10, "GENE"], [167, 170, "GENE"], [188, 191, "GENE"]]}], ["IL-31 and IL-33 did not correlate with 25(OH) Vit D in AR and AAR.", {"entities": [[46, 49, "GENE"]]}], ["In conclusion, low levels of 25(OH) Vit D might represent a risk factor for the development of concomitant asthma and rhinitis in children with allergic disease of the airways independently of IL-31/IL-33 Th2 activity.", {"entities": [[118, 126, "DISEASE"], [107, 113, "DISEASE"], [36, 39, "GENE"]]}], ["Nocturnal cardiac arrhythmias (NCA) were analyzed in patients with sleep apnea/hypopnea syndrome (SAHS) and controls.", {"entities": [[88, 96, "DISEASE"]]}], ["Occurrence and severity of NCA were compared in 33 SAHS patients and 16 control subjects, matched for cardiovascular risk factors.", {"entities": []}], ["Continuous overnight polysomnography provided ECG, respiratory and sleep parameters for a comparative analysis.", {"entities": []}], ["Various types and severity of NCA were detected already in moderate SAHS (apnea/hypopnea index = 26 \u00b1 15.6/h), reflecting the respiratory and atherosclerotic changes.", {"entities": []}], ["Moderately severe arrhythmias, represented with benign and 2 complex types were caused by hypoxemia characterized by AHI, minimal SaO 2 , and lower values after desaturation.", {"entities": []}], ["Three-time higher prevalence of complex arrhythmias in SAHS patients was not significantly different by usual statistical comparison, likely due to a low number of controls and a joint occurrence of various types and complex severity of arrhythmias in some patients.", {"entities": []}], ["Therefore, a complex assessment of different types and varying severity of arrhythmias would require a scale specifically constructed for their evaluation.", {"entities": []}], ["Background: Reducing inappropriate antibiotic prescribing in primary care is a public health priority.", {"entities": []}], ["Objectives: We hypothesized that a subset of patients account for the majority of antibiotic prescriptions in primary care.", {"entities": []}], ["We investigated the relationship between the total amount of antibiotics prescribed, individual-level antibiotic use and comorbidity.", {"entities": []}], ["Methods: This was a cohort study using electronic health records from 1\u2009948\u2009390 adults registered with 385 primary care practices in the UK in 2011\u201313.", {"entities": []}], ["We estimated the average number of antibiotic prescriptions per patient and the association between prescribing and comorbidity.", {"entities": []}], ["We modelled the impact on total prescribing of reducing antibiotic use in those prescribed antibiotics most frequently.", {"entities": []}], ["Results: On average 30.1% (586\u2009194/1\u2009948\u2009390) of patients were prescribed at least one antibiotic per year.", {"entities": []}], ["Nine percent (174\u2009602/1\u2009948\u2009390) of patients were prescribed 53% (2\u2009091\u2009496/3\u2009922\u2009732) of the total amount of antibiotics, each of whom received at least five antibiotic prescriptions over 3\u2005years.", {"entities": []}], ["The presence of any comorbidity increased the prescribing rate by 44% [adjusted incidence rate ratio (IRR) 1.44, 95% CI 1.43\u20131.45]; rates of prescribing to women exceeded those in men by 62% (adjusted IRR 1.62, 95% CI 1.62\u20131.63).", {"entities": []}], ["Conclusions: Half of antibiotics prescribed to adults in primary care were for <10% of patients.", {"entities": []}], ["Efforts to tackle antimicrobial resistance should consider the impact of this on total prescribing.", {"entities": []}], ["To test the impact of a UK pay-for-performance indicator, the Quality and Outcomes Framework (QOF) dementia review, on three types of hospital admission for people with dementia: emergency admissions where dementia was the primary diagnosis; emergency admissions for ambulatory care sensitive conditions (ACSCs); and elective admissions for cataract, hip replacement, hernia, prostate disease, or hearing loss.", {"entities": [[341, 349, "DISEASE"], [99, 107, "DISEASE"], [169, 177, "DISEASE"], [206, 214, "DISEASE"], [376, 392, "DISEASE"]]}], ["Count data regression analyses of hospital admissions from 8,304 English general practices from 2006/7 to 2010/11.", {"entities": []}], ["We identified relevant admissions from national Hospital Episode Statistics and aggregated them to practice level.", {"entities": []}], ["We merged these with practice-level data on the QOF dementia review.", {"entities": [[52, 60, "DISEASE"]]}], ["In the base case, the exposure measure was the reported QOF register.", {"entities": []}], ["As dementia is commonly under-diagnosed, we tested a predicted practice register based on consensus estimates.", {"entities": [[3, 11, "DISEASE"]]}], ["We adjusted for practice characteristics including measures of deprivation and uptake of a social benefit to purchase care services (Attendance Allowance).", {"entities": []}], ["In the base case analysis, higher QOF achievement had no significant effect on any type of hospital admission.", {"entities": []}], ["However, when the predicted register was used to account for under-diagnosis, a one-percentage point improvement in QOF achievement was associated with a small reduction in emergency admissions for both dementia (-0.1%; P=0.011) and ACSCs (-0.1%; P=0.001).", {"entities": [[203, 211, "DISEASE"]]}], ["In areas of greater deprivation, uptake of Attendance Allowance was consistently associated with significantly lower emergency admissions.", {"entities": []}], ["In all analyses, practices with a higher proportion of nursing home patients had significantly lower admission rates for elective and emergency care.", {"entities": []}], ["In one of three analyses at practice level, the QOF review for dementia was associated with a small but significant reduction in unplanned hospital admissions.", {"entities": [[63, 71, "DISEASE"]]}], ["Given the rising prevalence of dementia, increasing pressures on acute hospital beds and poor outcomes associated with hospital stays for this patient group, this small change may be clinically and economically relevant.", {"entities": [[31, 39, "DISEASE"]]}], ["Six million children live in poverty in America's inner cities.", {"entities": []}], ["These children are at high risk of exposure to pesticides that are used extensively in urban schools, homes, and day-care centers for control of roaches, rats, and other vermin.", {"entities": []}], ["The organophosphate insecticide chlorpyrifos and certain pyrethroids are the registered pesticides most heavily applied in cities.", {"entities": []}], ["Illegal street pesticides are also in use, including tres pasitos (a carbamate), tiza china, and methyl parathion.", {"entities": []}], ["In New York State in 1997, the heaviest use of pesticides in all counties statewide was in the urban boroughs of Manhattan and Brooklyn.", {"entities": []}], ["Children are highly vulnerable to pesticides.", {"entities": []}], ["Because of their play close to the ground, their hand-to-mouth behavior, and their unique dietary patterns, children absorb more pesticides from their environment than adults.", {"entities": []}], ["The long persistence of semivolatile pesticides such as chlorpyrifos on rugs, furniture, stuffed toys, and other absorbent surfaces within closed apartments further enhances urban children's exposures.", {"entities": []}], ["Compounding these risks of heavy exposures are children's decreased ability to detoxify and excrete pesticides and the rapid growth, development, and differentiation of their vital organ systems.", {"entities": []}], ["These developmental immaturities create early windows of great vulnerability.", {"entities": []}], ["Recent experimental data suggest, for example, that chlorpyrifos may be a developmental neurotoxicant and that exposure in utero may cause biochemical and functional aberrations in fetal neurons as well as deficits in the number of neurons.", {"entities": []}], ["Certain pyrethroids exert hormonal activity that may alter early neurologic and reproductive development.", {"entities": []}], ["Assays currently used for assessment of the toxicity of pesticides are insensitive and cannot accurately predict effects to children exposed in utero or in early postnatal life.", {"entities": []}], ["Protection of American children, and particularly of inner-city children, against the developmental hazards of pesticides requires a comprehensive strategy that monitors patterns of pesticide use on a continuing basis, assesses children's actual exposures to pesticides, uses state-of-the-art developmental toxicity testing, and establishes societal targets for reduction of pesticide use.", {"entities": []}], ["Disparities in child health outcomes persist despite advances in medical technology and increased global wealth.", {"entities": []}], ["The social determinants of health approach is useful in explaining the disparities in health.", {"entities": []}], ["Our objective in this paper is four-fold: (1) to test whether the income relationship (and the related income gradient) is the same across different child health outcomes; (2) to test whether the association between income and child health outcomes persists after controlling for other traditional socioeconomic characteristics of children and their family (education and employment status); (3) to test the role of other potentially mediating variables, namely parental mental health, number of children, and family structure; and (4) to test the interaction between income and education.", {"entities": []}], ["This population-based cross-sectional study used data from the 2003 US National Survey of Children's Health involving 102,353 children aged 0 to 17 years.", {"entities": []}], ["Using multivariate logistic regression models, the association between household income, education, employment status, parental mental health, number of children, family structure and the following child health outcomes were examined: presence or absence of asthma, headaches/migraine, ear infections, respiratory allergy, food/digestive allergy, or skin allergy.", {"entities": [[276, 284, "DISEASE"], [258, 264, "DISEASE"]]}], ["While the associations of some determinants were found to be consistent across different health outcomes, the association of other determinants such as household income depended on the specific outcome.", {"entities": []}], ["Controlling for other factors, a gradient association persisted between household income and a child having asthma, migraine/severe headaches, or ear infections with children more likely to have the illness if their family is closer to the federal poverty level.", {"entities": [[116, 124, "DISEASE"], [108, 114, "DISEASE"]]}], ["Potentially mediating variables, namely parental mental health, number of children, and family structure had consistent associations across health outcomes.", {"entities": []}], ["There appears to be evidence of an income gradient for certain child health outcomes, even after controlling for other traditional measures of socioeconomic status.", {"entities": []}], ["Our study also found evidence of an association between certain child health outcomes and potential mediating factors.", {"entities": []}], ["Chemokine (C-C motif) receptor 8 (CCR8) could drive cancer progress through recruiting certain immune cells.", {"entities": [[52, 58, "DISEASE"], [34, 38, "GENE"]]}], ["Recent evidences revealed the chemotaxis of CCR8 P < 0.001).", {"entities": [[44, 48, "GENE"]]}], ["In multivariate analyses, CCR8 expression was identified as an independent prognostic factor ( P = 0.008) and entered into a newly-built nomogram together with T stage, Fuhrman grade, tumor size, necrosis and lymphovascular invasion.", {"entities": [[26, 30, "GENE"]]}], ["Calibration curves showed optimal agreement between predictions and observations, while its C-index was higher than that of Leibovich score for predicting recurrence-free survival (RFS) of localised RCC patients (0.854 vs 0.836, respectively; P = 0.044).", {"entities": []}], ["The practical prognostic nomogram model may help clinicians in decision making and design of clinical studies.", {"entities": []}], ["An enriched diet with antioxidants, such as vitamin E, vitamin C, \u03b2-carotene and phenolic compounds, has always been suggested to improve oxidative stress, preventing related diseases.", {"entities": []}], ["In this respect, marine natural product (MNP), such as COX inhibitors, marine steroids, molecules interfering with factors involved in the modulation of gene expression (such as NF-\u03baB), macrolides, many antioxidant agents, thermogenic substances and even substances that could help the immune system and that result in the protection of cartilage, have been recently gaining attention.", {"entities": []}], ["The marine world represents a reserve of bioactive ingredients, with considerable potential as functional food.", {"entities": []}], ["Substances, such as chitin, chitosan, n -3 oils, carotenoids, vitamins, minerals and bioactive peptides, can provide several health benefits, such as the reduction of cardiovascular diseases, anti-inflammatory and anticarcinogenic activities.", {"entities": []}], ["In addition, new marine bioactive substances with potential anti-inflammatory, antioxidant and thermogenic capacity may provide health benefits and performance improvement, especially in those who practice physical activity, because of their increased free radical and Reacting Oxygen Species (ROS) production during exercise, and, particularly, in athletes.", {"entities": []}], ["The aim of this review is to examine the potential pharmacological properties and application of many marine bioactive substances in sports.", {"entities": []}], ["Cigarette smoke has both pro-inflammatory and immunosuppressive effects.", {"entities": []}], ["Both active and passive cigarette smoke exposure are linked to an increased incidence and severity of respiratory virus infections, but underlying mechanisms are not well defined.", {"entities": []}], ["We hypothesized, based on prior gene expression profiling studies, that upregulation of pro-inflammatory mediators by short term smoke exposure would be protective against a subsequent influenza infection.", {"entities": [[185, 194, "DISEASE"]]}], ["BALB/c mice were subjected to whole body smoke exposure with 9 cigarettes/day for 4 days.", {"entities": []}], ["Mice were then infected with influenza A (H3N1, Mem71 strain), and analyzed 3 and 10 days later (d3, d10).", {"entities": [[29, 38, "DISEASE"]]}], ["These time points are the peak and resolution (respectively) of influenza infection.", {"entities": [[64, 73, "DISEASE"]]}], ["Inflammatory cell influx into the bronchoalveolar lavage (BALF), inflammatory mediators, proteases, histopathology, viral titres and T lymphocyte profiles were analyzed.", {"entities": []}], ["Compared to smoke or influenza alone, mice exposed to smoke and then influenza had more macrophages, neutrophils and total lymphocytes in BALF at d3, more macrophages in BALF at d10, lower net gelatinase activity and increased activity of tissue inhibitor of metalloprotease-1 in BALF at d3, altered profiles of key cytokines and CD4+ and CD8+ T lymphocytes, worse lung pathology and more virus-specific, activated CD8+ T lymphocytes in BALF.", {"entities": [[21, 30, "DISEASE"], [69, 78, "DISEASE"]]}], ["Mice smoke exposed before influenza infection had close to 10-fold higher lung virus titres at d3 than influenza alone mice, although all mice had cleared virus by d10, regardless of smoke exposure.", {"entities": [[26, 35, "DISEASE"], [103, 112, "DISEASE"]]}], ["Smoke exposure caused temporary weight loss and when smoking ceased after viral infection, smoke and influenza mice regained significantly less weight than smoke alone mice.", {"entities": [[101, 110, "DISEASE"]]}], ["Smoke induced inflammation does not protect against influenza infection.", {"entities": [[52, 61, "DISEASE"]]}], ["In most respects, smoke exposure worsened the host response to influenza.", {"entities": [[63, 72, "DISEASE"]]}], ["This animal model may be useful in studying how smoke worsens respiratory viral infections.", {"entities": []}], ["People in modern societies spend more than 90% of their time indoors.", {"entities": []}], ["Hence, indoor environmental quality (IEQ) has a significant impact on public health.", {"entities": []}], ["In this article we describe health risks associated with indoor environments, illuminate barriers to overcoming these risks, and provide policy recommendations to achieve healthier indoor environments.", {"entities": []}], ["The weight of evidence suggests that indoor environmental contaminants pose significant public health risks, particularly among children and the poor, and the societal costs of illnesses related to indoor environments are considerable.", {"entities": []}], ["Despite the evidence of harm to human health, poor indoor environments are generally difficult to regulate and not of sufficient concern to the general public.", {"entities": []}], ["We discuss several reasons for this lack of concern about IEQ, focusing specifically on home environments.", {"entities": []}], ["Economics plays a large role both in political inaction and individual-level indifference.", {"entities": []}], ["Because little effort has been made to quantify the value of the societal and individual costs of poor housing quality, as well as the benefits achievable by simple interventions, policymakers lack motivation to act on IEQ.", {"entities": []}], ["Similarly, individual homeowners lack the incentive to remediate homes, as other problems may be more pressing than home environmental quality.", {"entities": []}], ["Although the problem of IEQ involves multiple stakeholders and multiple levels of governance, it is possible to establish economic incentives that would set the wheels in motion for action at all levels to achieve healthy home environments.", {"entities": []}], ["Also important are education and information dissemination on the public health risks associated with indoor environments.", {"entities": []}], ["These recommendations are intended for all decision makers who have an influence in developing policy to improve indoor environmental quality.", {"entities": []}], ["Behavioral inhibition reflects a disposition to react warily to novel situations, and has been associated with atopic diseases such as asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["Retrospective work established the relationship between behavioral inhibition in rhesus monkeys ( Macaca mulatta ) and airway hyperresponsiveness, but not atopy, and the suggestion was made that behavioral inhibition might index components of asthma that are not immune-related.", {"entities": [[243, 249, "DISEASE"]]}], ["In the present study, we prospectively examined the relationship between behavioral inhibition and airway hyperresponsiveness, and whether hormonal and immune measures often associated with asthma were associated with behavioral inhibition and/or airway hyperresponsiveness.", {"entities": [[190, 196, "DISEASE"]]}], ["In a sample of 49 yearling rhesus monkeys (mean\u200a=\u200a1.25 years, n\u200a=\u200a24 behaviorally inhibited animals), we measured in vitro cytokine levels (IL-4, IL-10, IL-12, IFN-\u03b3) in response to stimulation, as well as peripheral blood cell percentages, cortisol levels, and percentage of regulatory T-cells (CD3+CD4+CD25+FOXP3+).", {"entities": []}], ["Airway reactivity was assessed using an inhaled methacholine challenge.", {"entities": []}], ["Bronchoalveolar lavage was performed and the proportion of immune cells was determined.", {"entities": []}], ["Behaviorally inhibited monkeys had airway hyperresponsiveness as indicated by the methacholine challenge (p\u200a=\u200a0.031), confirming our earlier retrospective result.", {"entities": []}], ["Airway hyperresponsiveness was also associated with lower lymphocyte percentages in lavage fluid and marginally lower plasma cortisol concentrations.", {"entities": []}], ["However, none of the tested measures was significantly related to both behavioral inhibition and airway hyperresponsiveness, and so could not mediate their relationship.", {"entities": []}], ["Airway hyperresponsiveness is common to atopic and non-atopic asthma and behavioral inhibition has been related to altered autonomic activity in other studies.", {"entities": [[62, 68, "DISEASE"]]}], ["Our results suggest that behavioral inhibition might index an autonomically mediated reactive airway phenotype, and that a variety of stimuli (including inflammation within lung tissue that is not specifically associated with behavioral inhibition) may trigger the airways response.", {"entities": []}], ["Data on the burden and risk groups for influenza-associated mortality from Africa are limited.", {"entities": [[39, 48, "DISEASE"]]}], ["We aimed to estimate the incidence and risk-factors for in-hospital influenza-associated severe acute respiratory illness (SARI) deaths.", {"entities": [[68, 77, "DISEASE"]]}], ["Hospitalised patients with SARI were enrolled prospectively in four provinces of South Africa from 2009\u20132013.", {"entities": []}], ["Using polymerase chain reaction, respiratory samples were tested for ten respiratory viruses and blood for pneumococcal DNA.", {"entities": []}], ["The incidence of influenza-associated SARI deaths was estimated at one urban hospital with a defined catchment population.", {"entities": [[17, 26, "DISEASE"]]}], ["We enrolled 1376 patients with influenza-associated SARI and 3% (41 of 1358 with available outcome data) died.", {"entities": [[31, 40, "DISEASE"]]}], ["In patients with available HIV-status, the case-fatality proportion (CFP) was higher in HIV-infected (5%, 22/419) than HIV-uninfected individuals (2%, 13/620; p = 0.006).", {"entities": [[69, 72, "GENE"]]}], ["CFPs varied by age group, and generally increased with increasing age amongst individuals >5 years (p<0.001).", {"entities": []}], ["On multivariable analysis, factors associated with death were age-group 45\u201364 years (odds ratio (OR) 4.0, 95% confidence interval (CI) 1.01\u201316.3) and \u226565 years (OR 6.5, 95%CI 1.2\u201334.3) compared to 1\u20134 year age-group who had the lowest CFP, HIV-infection (OR 2.9, 95%CI 1.1\u20137.8), underlying medical conditions other than HIV (OR 2.9, 95%CI 1.2\u20137.3) and pneumococcal co-infection (OR 4.1, 95%CI 1.5\u201311.2).", {"entities": [[235, 238, "GENE"]]}], ["The estimated incidence of influenza-associated SARI deaths per 100,000 population was highest in children <1 year (20.1, 95%CI 12.1\u201331.3) and adults aged 45\u201364 years (10.4, 95%CI 8.4\u201312.9).", {"entities": [[27, 36, "DISEASE"]]}], ["Adjusting for age, the rate of death was 20-fold (95%CI 15.0\u201327.8) higher in HIV-infected individuals than HIV-uninfected individuals.", {"entities": []}], ["Influenza causes substantial mortality in urban South Africa, particularly in infants aged <1 year and HIV-infected individuals.", {"entities": [[0, 9, "DISEASE"]]}], ["More widespread access to antiretroviral treatment and influenza vaccination may reduce this burden.", {"entities": [[55, 64, "DISEASE"]]}], ["The aim of this study was to investigate the plasma inflammatory cytokine levels and their correlations with pulmonary function in patients with asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).", {"entities": [[152, 189, "DISEASE"], [198, 206, "DISEASE"], [145, 151, "DISEASE"]]}], ["Between January 2013 and December 2014, a total of 96 patients with asthma, acute exacerbation of chronic obstructive pulmonary disease (AECOPD), or ACOS were enrolled, and 35 healthy people were included as a control group.", {"entities": [[98, 135, "DISEASE"], [68, 74, "DISEASE"]]}], ["Fasting plasma interleukin (IL)-4, IL-8, IL-10, and tumor necrosis factor alpha (TNF-\u03b1) levels were detected using enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["Correlations between the plasma inflammatory cytokine levels and forced expiratory volume in 1 second (FEV1), FEV1/predicted value ratio (FEV1%pred), and FEV1/forced vital capacity (FVC) were analyzed.", {"entities": []}], ["IL-4 and IL-8 levels showed statistically significant differences among the 3 groups of patients (both P <0.001); IL-4 level was significantly lower, while IL-8 level was significantly higher in the AECOPD group and ACOS group than those in the asthma group (all P <0.05).", {"entities": [[245, 251, "DISEASE"]]}], ["IL-10 level and TNF-\u03b1 level were significantly different among the 3 patient groups (both P <0.001).", {"entities": []}], ["IL-10 level was significantly different between each of the 2 groups (all P <0.001).", {"entities": []}], ["TNF-\u03b1 level in the asthma group was higher than in the AECOPD group and ACOS group (both P <0.001).", {"entities": [[19, 25, "DISEASE"]]}], ["IL-4 and IL-10 were positively and IL-8 and TNF-\u03b1 were negatively related with FEV1, FEV1%pred, and FEV1/FVC.", {"entities": []}], ["Plasma levels of inflammatory cytokines IL-4, IL-8, IL-10, and TNF-\u03b1 are related with severity of airway diseases and could be potential markers for the evaluation of asthma, COPD, and ACOS.", {"entities": [[167, 173, "DISEASE"]]}], ["Cells of the innate immune system including monocytes and macrophages are the first line of defence against infections and are critical regulators of the inflammatory response.", {"entities": []}], ["These cells express toll-like receptors (TLRs), innate immune receptors which govern tailored inflammatory gene expression patterns.", {"entities": []}], ["Monocytes, which produce pro-inflammatory mediators, are readily recruited to the central nervous system (CNS) in neurodegenerative diseases.", {"entities": []}], ["This study explored the expression of receptors (CD11b, TLR2 and TLR4) on circulating monocyte-derived macrophages (MDMs) and peripheral blood mononuclear cells (PBMCs) isolated from healthy elderly adults who we classified as either IQ memory-consistent (high-performing, HP) or IQ memory-discrepant (low-performing, LP).", {"entities": [[56, 60, "GENE"], [65, 69, "GENE"], [273, 275, "GENE"]]}], ["The expression of CD11b, TLR4 and TLR2 was increased in MDMs from the LP group when compared to HP cohort.", {"entities": [[25, 29, "GENE"], [34, 38, "GENE"], [96, 98, "GENE"]]}], ["MDMs from both groups responded robustly to treatment with the TLR4 activator, lipopolysaccharide (LPS), in terms of cytokine production.", {"entities": [[63, 67, "GENE"]]}], ["Significantly, MDMs from the LP group displayed hypersensitivity to LPS exposure.", {"entities": []}], ["Overall these findings define differential receptor expression and cytokine profiles that occur in MDMs derived from a cohort of IQ memory-discrepant individuals.", {"entities": []}], ["These changes are indicative of inflammation and may be involved in the prodromal processes leading to the development of neurodegenerative disease.", {"entities": [[122, 147, "DISEASE"]]}], ["Overproduction of vascular endothelial growth factor (VEGF) in atopic dermatitis (AD) lesions has previously been observed.", {"entities": [[63, 80, "DISEASE"], [70, 80, "DISEASE"]]}], ["It is also known that platelet is an important source of VEGF and platelet factor 4 (PF-4), a potential marker of AD severity.", {"entities": []}], ["To evaluate concentrations of VEGF and its soluble receptors (sVEGF-R1 and sVEGF-R2) in the plasma of AD patients and to examine its possible correlation with disease severity and plasma concentrations of PF-4, a platelet activation marker.", {"entities": []}], ["Plasma concentrations of VEGF and its receptors and levels of PF-4 were measured by an immunoenzymatic assay in 51 AD patients and in 35 healthy non-atopic controls.", {"entities": []}], ["The severity of the disease was evaluated using the eczema area and severity index.", {"entities": []}], ["AD patients showed significantly increased VEGF and PF-4 plasma concentrations as compared with the controls.", {"entities": []}], ["Plasma concentrations of sVEGF-R1 and sVEGF-R2 did not differ between the groups.", {"entities": []}], ["There were no remarkable correlations between plasma VEGF concentration and disease severity or between VEGF and PF-4 concentration.", {"entities": []}], ["This study shows that plasma concentration of VEGF may be increased in patients suffering from AD.", {"entities": []}], ["It seems that plasma VEGF concentration is not a useful marker of disease severity and, apart from platelets, other cells might also release the cytokine.", {"entities": []}], ["Surfactant protein A (SP-A) enhances phagocytosis of bacteria, including Klebsiella pneumoniae , by alveolar macrophages.", {"entities": []}], ["Ozone, a major air pollutant, can cause oxidation of surfactant and may influence lung immune function.", {"entities": []}], ["Immune function may also be affected by sex-specific mechanisms.", {"entities": []}], ["We hypothesized that ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure, and that sex differences in the effect of ozone do exist.", {"entities": []}], ["Male and female SP-A (-/-) mice on the C57BL/6J background were exposed to ozone or to filtered air (FA) used as a control and then infected intratracheally with K. pneumoniae bacteria.", {"entities": []}], ["Survival rate was monitored during a 14-day period.", {"entities": []}], ["In addition, protein oxidation levels and in vivo phagocytosis were checked 1 h after inoculation of PBS used as a sham control and after inoculation of K. pneumoniae bacteria in PBS, respectively.", {"entities": []}], ["We found: 1) ozone exposure followed by K. pneumoniae infection decreases survival and alveolar macrophage phagocytic function of SP-A (-/-) mice compared to filtered air exposure ( p < 0.05), and females are more affected than males; 2) SP-A (-/-) mice (exposed either to ozone or FA) are more susceptible to infection with K. pneumoniae than wild type (WT) mice regarding their survival rate and macrophage phagocytic function; the phagocytic function of FA SP-A(-/-) is similar to that of ozone exposed WT.", {"entities": []}], ["3) ozone exposure appears to increase infiltration of PMNs, total protein, and SP-A oxidation in WT mice; infiltration of PMNs and total protein oxidation appears to be more pronounced in female mice in response to ozone; 4) ozone exposure increases SP-A oxidation in WT females significantly more than in males.", {"entities": []}], ["Absence (i.e.", {"entities": []}], ["ablation of SP-A in SP-A (-/-) mice) or reduction of functional activity of SP-A (i.e.", {"entities": []}], ["oxidation of SP-A in WT mice) increases the susceptibility of mice to experimental pneumonia after ozone exposure, and in both cases females are more affected by ozone exposure than males.", {"entities": [[83, 92, "DISEASE"]]}], ["Motivation : It remains a challenge to detect associations between genotypes and phenotypes because of insufficient sample sizes and complex underlying mechanisms involved in associations.", {"entities": []}], ["Fortunately, it is becoming more feasible to obtain gene expression data in addition to genotypes and phenotypes, giving us new opportunities to detect true genotype\u2013phenotype associations while unveiling their association mechanisms.", {"entities": []}], ["Results : In this article, we propose a novel method, NETAM, that accurately detects associations between SNPs and phenotypes, as well as gene traits involved in such associations.", {"entities": []}], ["We take a network-driven approach: NETAM first constructs an association network, where nodes represent SNPs, gene traits or phenotypes, and edges represent the strength of association between two nodes.", {"entities": []}], ["NETAM assigns a score to each path from an SNP to a phenotype, and then identifies significant paths based on the scores.", {"entities": []}], ["In our simulation study, we show that NETAM finds significantly more phenotype-associated SNPs than traditional genotype\u2013phenotype association analysis under false positive control, taking advantage of gene expression data.", {"entities": []}], ["Furthermore, we applied NETAM on late-onset Alzheimer\u2019s disease data and identified 477 significant path associations, among which we analyzed paths related to beta-amyloid, estrogen, and nicotine pathways.", {"entities": []}], ["We also provide hypothetical biological pathways to explain our findings.", {"entities": []}], ["Availability and implementation : Software is available at http://www.sailing.cs.cmu.edu/ .", {"entities": []}], ["Contact : epxing@cs.cmu.edu", {"entities": []}], ["Migraine follows circadian rhythm in which headache is more painful at the awakening time.", {"entities": [[0, 8, "DISEASE"]]}], ["This needs administration of dosage form at night time to release drug after lag period when pain gets worse.", {"entities": []}], ["Sumatriptan succinate is a drug of choice for migraine.", {"entities": [[46, 54, "DISEASE"]]}], ["Sumatriptan succinate has bitter taste, low oral bioavailability, and shorter half-life.", {"entities": []}], ["Present work deals with application of design of experiment for polyox and xanthan gum in development of press coated floating pulsatile tablet.", {"entities": []}], ["Floating pulsatile concept was applied to increase gastric residence of the dosage form.", {"entities": []}], ["Burst release was achieved through immediate release tablet using crospovidone as superdisintegrant (10%).", {"entities": []}], ["Pulse lag time was achieved using swellable polymer polyox WSR 205 and xanthan gum.", {"entities": []}], ["3 in-vitro and in-vivo study.", {"entities": []}], ["From results, it can be concluded that optimized batch F8 containing polyox WSR205 (72.72%) and xanthan gum (27.27%) of total weight of polymer has shown floating lag time of 55 \u00b1 2\u2009sec, drug content of 100.35 \u00b1 0.4%, hardness of 6 \u00b1 0.1\u2009Kg/cm in-vivo X-ray study.", {"entities": [[55, 57, "GENE"]]}], ["Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid.", {"entities": []}], ["LOX enzymes are expressed in immune, epithelial, and tumor cells that display a variety of physiological functions, including inflammation, skin disorder, and tumorigenesis.", {"entities": []}], ["In the humans and mice, six LOX isoforms have been known.", {"entities": []}], ["15-LOX, a prototypical enzyme originally found in reticulocytes shares the similarity of amino acid sequence as well as the biochemical property to plant LOX enzymes.", {"entities": []}], ["15-LOX-2, which is expressed in epithelial cells and leukocytes, has different substrate specificity in the humans and mice, therefore, the role of them in mammals has not been established.", {"entities": []}], ["12-LOX is an isoform expressed in epithelial cells and myeloid cells including platelets.", {"entities": []}], ["Many mutations in this isoform are found in epithelial cancers, suggesting a potential link between 12-LOX and tumorigenesis.", {"entities": []}], ["12R-LOX can be found in the epithelial cells of the skin.", {"entities": []}], ["Defects in this gene result in ichthyosis, a cutaneous disorder characterized by pathophysiologically dried skin due to abnormal loss of water from its epithelial cell layer.", {"entities": []}], ["Similarly, eLOX-3, which is also expressed in the skin epithelial cells acting downstream 12R-LOX, is another causative factor for ichthyosis.", {"entities": []}], ["5-LOX is a distinct isoform playing an important role in asthma and inflammation.", {"entities": [[57, 63, "DISEASE"]]}], ["This isoform causes the constriction of bronchioles in response to cysteinyl leukotrienes such as LTC 4 , thus leading to asthma.", {"entities": [[122, 128, "DISEASE"]]}], ["It also induces neutrophilic inflammation by its recruitment in response to LTB 4 .", {"entities": [[76, 79, "GENE"]]}], ["Importantly, 5-LOX activity is strictly regulated by 5-LOX activating protein (FLAP) though the distribution of 5-LOX in the nucleus.", {"entities": []}], ["Currently, pharmacological drugs targeting FLAP are actively developing.", {"entities": []}], ["This review summarized these functions of LOX enzymes under pathophysiological conditions in mammals.", {"entities": []}], ["Azathioprine is efficacious in the treatment of severe childhood atopic dermatitis; however, robust data on adverse effects in this population are lacking.", {"entities": [[65, 82, "DISEASE"], [72, 82, "DISEASE"]]}], ["We sought to assess adverse effects of azathioprine treatment in a pediatric atopic dermatitis cohort, and make recommendations for monitoring based on these data.", {"entities": [[77, 94, "DISEASE"], [84, 94, "DISEASE"]]}], ["Blood test results for all 82 children prescribed oral azathioprine for atopic dermatitis in our department between 2010 and 2012 were collated prospectively, and clinical notes were reviewed retrospectively.", {"entities": [[72, 89, "DISEASE"], [79, 89, "DISEASE"]]}], ["Mean age at commencing azathioprine was 8.3 years (SEM 0.4).", {"entities": []}], ["Mean maximum doses were 2.4\u00a0mg/kg (SEM 0.1) and 1.5 mg/kg (SEM 0.1) for normal and reduced serum thiopurine-S-methyltransferase levels, respectively.", {"entities": []}], ["Adverse effects on blood indices occurred in 34 of 82 patients (41%), with pronounced effects in 18 of 82 (22%) after a median time of 0.4 years.", {"entities": []}], ["Two patients stopped therapy as a result of abnormal blood indices.", {"entities": []}], ["Clinical adverse effects occurred in 16 of 82 (20%), two resulting in cessation of therapy.", {"entities": []}], ["Incidence of adverse effects was unaffected by age, sex, thiopurine-S-methyltransferase level, and drug dose on multivariate regression.", {"entities": []}], ["Comparison with other studies is limited by varying definitions of adverse effects.", {"entities": []}], ["Oral azathioprine was associated with few pronounced adverse effects for the duration of\u00a0use\u00a0and dosage in this cohort.", {"entities": []}], ["Recommendations for monitoring are made.", {"entities": []}], ["Quantitative studies are becoming more recognized as important to understanding health care with all of its richness and complexities.", {"entities": []}], ["The purpose of this descriptive survey was to provide a quantitative evaluation of the qualitative studies published in 170 core clinical journals for 2000.", {"entities": []}], ["All identified studies that used qualitative methods were reviewed to ascertain which clinical journals publish qualitative studies and to extract research methods, content (persons and health care issues studied), and whether mixed methods (quantitative and qualitative methods) were used.", {"entities": []}], ["60 330 articles were reviewed.", {"entities": []}], ["355 reports of original qualitative studies and 12 systematic review articles were identified in 48 journals.", {"entities": []}], ["Most of the journals were in the discipline of nursing.", {"entities": []}], ["Only 4 of the most highly cited health care journals, based on ISI Science Citation Index (SCI) Impact Factors, published qualitative studies.", {"entities": []}], ["37 of the 355 original reports used both qualitative and quantitative (mixed) methods.", {"entities": []}], ["Patients and non-health care settings were the most common groups of people studied.", {"entities": []}], ["Diseases and conditions were cancer, mental health, pregnancy and childbirth, and cerebrovascular disease with many other diseases and conditions represented.", {"entities": [[82, 105, "DISEASE"], [29, 35, "DISEASE"]]}], ["Phenomenology and grounded theory were commonly used; substantial ethnography was also present.", {"entities": []}], ["No substantial differences were noted for content or methods when articles published in all disciplines were compared with articles published in nursing titles or when studies with mixed methods were compared with studies that included only qualitative methods.", {"entities": []}], ["The clinical literature includes many qualitative studies although they are often published in nursing journals or journals with low SCI Impact Factor journals.", {"entities": []}], ["Many qualitative studies incorporate both qualitative and quantitative methods.", {"entities": []}], ["MPO (myeloperoxidase) catalyses the oxidation of chloride, bromide and thiocyanate by hydrogen peroxide to HOCl (hypochlorous acid), HOBr (hypobromous acid) and HOSCN (hypothiocyanous acid) respectively.", {"entities": [[0, 3, "GENE"]]}], ["Specificity constants indicate that SCN K a species.", {"entities": []}], ["In the present study we show that HOSCN targets cysteine residues present in PTPs (protein tyrosine phosphatases) with this resulting in a loss of PTP activity for the isolated enzyme, in cell lysates and intact J774A.1 macrophage-like cells.", {"entities": []}], ["Inhibition also occurs with MPO-generated HOCl and HOBr, but is more marked with MPO-generated HOSCN, particularly at longer incubation times.", {"entities": []}], ["This inhibition is reversed by dithiothreitol, particularly at early time points, consistent with the reversible oxidation of the active site cysteine residue to give either a cysteine\u2013SCN adduct or a sulfenic acid.", {"entities": []}], ["Inhibition of PTP activity is associated with increased phosphorylation of p38a and ERK2 (extracellular-signal-regulated kinase 2) as detected by Western blot analysis and phosphoprotein arrays, and results in altered MAPK (mitogen-activated protein kinase) signalling.", {"entities": []}], ["These data indicate that the highly selective targeting of some protein thiols by HOSCN can result in perturbation of cellular phosphorylation and altered cell signalling.", {"entities": []}], ["These changes occur with (patho)physiological concentrations of SCN", {"entities": []}], ["Over the past three decades, a large number of genetic studies have been aimed at finding genetic variants associated with the risk of asthma, applying various genetic and genomic approaches including linkage analysis, candidate gene polymorphism studies, and genome-wide association studies (GWAS).", {"entities": [[135, 141, "DISEASE"]]}], ["However, contrary to general expectation, even single nucleotide polymorphisms (SNPs) discovered by GWAS failed to fully explain the heritability of asthma.", {"entities": [[149, 155, "DISEASE"]]}], ["Thus, application of rare allele polymorphisms in well defined phenotypes and clarification of environmental factors have been suggested to overcome the problem of 'missing' heritability.", {"entities": []}], ["Such factors include allergens, cigarette smoke, air pollutants, and infectious agents during pre- and post-natal periods.", {"entities": []}], ["The first and simplest interaction between a gene and the environment is a candidate interaction of both a well known gene and environmental factor in a direct physical or chemical interaction such as between CD14 and endotoxin or between HLA and allergens.", {"entities": [[209, 213, "GENE"], [239, 242, "GENE"]]}], ["Several GWAS have found environmental interactions with occupational asthma, aspirin exacerbated respiratory disease, tobacco smoke-related airway dysfunction, and farm-related atopic diseases.", {"entities": [[69, 75, "DISEASE"]]}], ["As one of the mechanisms behind gene-environment interaction is epigenetics, a few studies on DNA CpG methylation have been reported on subphenotypes of asthma, pitching the exciting idea that it may be possible to intervene at the junction between the genome and the environment.", {"entities": [[153, 159, "DISEASE"]]}], ["Epigenetic studies are starting to include data from clinical samples, which will make them another powerful tool for research on gene-environment interactions in asthma.", {"entities": [[163, 169, "DISEASE"]]}], ["A trans-ethnic meta-analysis of type 2 diabetes genome-wide association studies has identified seven novel susceptibility variants in or near TMEM154 , SSR1/RREB1 , FAF1 , POU5F1/TCF19 , LPP , ARL15 and ABCB9/MPHOSPH9 .", {"entities": [[142, 149, "GENE"], [165, 169, "GENE"], [187, 190, "GENE"], [193, 198, "GENE"]]}], ["The aim of our study was to investigate associations between these novel risk variants and type 2 diabetes and pre-diabetic traits in a Danish population-based study with measurements of plasma glucose and serum insulin after an oral glucose tolerance test in order to elaborate on the physiological impact of the variants.", {"entities": []}], ["Case-control analyses were performed in up to 5,777 patients with type 2 diabetes and 7,956 individuals with normal fasting glucose levels.", {"entities": []}], ["Quantitative trait analyses were performed in up to 5,744 Inter99 participants na\u00efve to glucose-lowering medication.", {"entities": []}], ["Significant associations between TMEM154 -rs6813195 and the beta cell measures insulinogenic index and disposition index and between FAF1 -rs17106184 and 2-hour serum insulin levels were selected for further investigation in additional Danish studies and results were combined in meta-analyses including up to 6,486 Danes.", {"entities": [[33, 40, "GENE"], [133, 137, "GENE"]]}], ["We confirmed associations with type 2 diabetes for five of the seven SNPs ( TMEM154 -rs6813195, FAF1 -rs17106184, POU5F1/TCF19 -rs3130501, ARL15 -rs702634 and ABCB9/MPHOSPH9 -rs4275659).", {"entities": [[76, 83, "GENE"], [96, 100, "GENE"], [139, 144, "GENE"]]}], ["The type 2 diabetes risk C-allele of TMEM154 -rs6813195 associated with decreased disposition index (n=5,181, \u03b2=-0.042, p =0.012) and insulinogenic index (n=5,181, \u03b2=-0.032, p =0.043) in Inter99 and these associations remained significant in meta-analyses including four additional Danish studies (disposition index n=6,486, \u03b2=-0.042, p =0.0044; and insulinogenic index n=6,486, \u03b2=-0.037, p =0.0094).", {"entities": [[37, 44, "GENE"]]}], ["The type 2 diabetes risk G-allele of FAF1 -rs17106184 associated with increased levels of 2-hour serum insulin (n=5,547, \u03b2=0.055, p =0.017) in Inter99 and also when combining effects with three additional Danish studies (n=6,260, \u03b2=0.062, p =0.0040).", {"entities": [[37, 41, "GENE"]]}], ["Studies of type 2 diabetes intermediary traits suggest the diabetogenic impact of the C-allele of TMEM154 -rs6813195 is mediated through reduced beta cell function.", {"entities": [[98, 105, "GENE"]]}], ["The impact of the diabetes risk G-allele of FAF1 -rs17106184 on increased 2-hour insulin levels is however unexplained.", {"entities": [[44, 48, "GENE"]]}], ["Few studies have evaluated the coexistence of bronchiectasis (BE) and chronic obstructive pulmonary disease (COPD) in series of patients diagnosed primarily with BE.", {"entities": [[70, 107, "DISEASE"], [46, 60, "DISEASE"]]}], ["The aim of this study was to analyse the characteristics of patients with BE associated with COPD included in the Spanish Bronchiectasis Historical Registry and compare them to the remaining patients with non-cystic fibrosis BE.", {"entities": [[122, 136, "DISEASE"], [209, 224, "DISEASE"]]}], ["We conducted a multicentre observational study of historical cohorts, analysing the characteristics of 1,790 patients who had been included in the registry between 2002 and 2011.", {"entities": []}], ["Of these, 158 (8.8%) were registered as BE related to COPD and were compared to the remaining patients with BE of other aetiologies.", {"entities": []}], ["Patients with COPD were mostly male, older, had a poorer respiratory function and more frequent exacerbations.", {"entities": []}], ["There were no differences in the proportion of patients with chronic bronchial colonisation or in the isolated microorganisms.", {"entities": []}], ["A significantly larger proportion of patients with COPD received treatment with bronchodilators, inhaled steroids and intravenous antibiotics, but there was no difference in the use of long term oral or inhaled antibiotherapy.", {"entities": []}], ["During a follow-up period of 3.36 years, the overall proportion of deaths was 13.8%.", {"entities": []}], ["When compared to the remaining aetiologies, patients with BE associated with COPD presented the highest mortality rate.", {"entities": []}], ["The multivariate analysis showed that the diagnosis of COPD in a patient with BE as a primary diagnosis increased the risk of death by 1.77.", {"entities": []}], ["Patients with BE related to COPD have the same microbiological characteristics as patients with BE due to other aetiologies.", {"entities": []}], ["They receive treatment with long term oral and inhaled antibiotics aimed at controlling chronic bronchial colonisation, even though the current COPD treatment guidelines do not envisage this type of therapy.", {"entities": []}], ["These patients\u2019 mortality is notably higher than that of remaining patients with non-cystic fibrosis BE.", {"entities": [[85, 100, "DISEASE"]]}], ["Helminth parasites control host-immune responses by secreting immunomodulatory glycoproteins.", {"entities": []}], ["Clinical trials and mouse model studies have demonstrated the potential of helminth-derived glycoproteins for the treatment of immune-related diseases, like allergies and autoimmune diseases.", {"entities": []}], ["Studies are however hampered by the limited availability of native parasite-derived proteins.", {"entities": []}], ["Moreover, recombinant protein production systems have thus far been unable to reconstitute helminth-like glycosylation essential for the functionality of some helminth glycoproteins.", {"entities": []}], ["Here we exploited the flexibility of the N-glycosylation machinery of plants to reconstruct the helminth glycoproteins omega-1 and kappa-5, two major constituents of immunomodulatory Schistosoma mansoni soluble egg antigens.", {"entities": []}], ["Fine-tuning transient co-expression of specific glycosyltransferases in Nicotiana benthamiana enabled the synthesis of Lewis X (LeX) and LDN/LDN-F glycan motifs as found on natural omega-1 and kappa-5, respectively.", {"entities": []}], ["In vitro and in vivo evaluation of the introduction of native LeX motifs on plant-produced omega-1 confirmed that LeX on omega-1 contributes to the glycoprotein\u2019s Th2-inducing properties.", {"entities": []}], ["These data indicate that mimicking the complex carbohydrate structures of helminths in plants is a promising strategy to allow targeted evaluation of therapeutic glycoproteins for the treatment of inflammatory disorders.", {"entities": []}], ["In addition, our results offer perspectives for the development of effective anti-helminthic vaccines by reconstructing native parasite glycoprotein antigens.", {"entities": []}], ["The use of mesh in the surgical repair of adult indirect inguinal hernias is widely recommended in Western countries, but no randomized controlled trials have so far been reported in Japan.", {"entities": []}], ["The purpose of the present randomized prospective trial was to compare a mesh method with non-mesh method for surgical repair of primary adult indirect inguinal hernias in which the diameter of the internal inguinal ring was up to 3.0\u00a0cm (I-1 or I-2 of Japanese Hernia Society Classification).", {"entities": []}], ["Patients with a primary unilateral inguinal hernia and I-1 or I-2 surgical findings were randomized to undergo either Marcy repair or Prolene Hernia System Ninety-one of 479 patients with an inguinal hernia during the study period did not meet the exclusion criteria, and 46 were allocated to Marcy repair and 45 were allocated to Prolene Hernia System This randomized prospective trial of I-1 and I-2 inguinal hernias suggests that Marcy repair is not inferior to PHS repair.", {"entities": []}], ["A large-scale randomized controlled trial appears warranted to confirm whether to use mesh for Japanese adult I-1 and I-2 hernias.", {"entities": []}], ["Coexistent lung cancer and pulmonary tuberculosis is an urgent problem of thoracic surgery presenting a challenging task for diagnosis and surgical treatment.", {"entities": [[11, 22, "DISEASE"], [37, 49, "DISEASE"], [27, 49, "DISEASE"], [16, 22, "DISEASE"]]}], ["From 1990 to 2005, 2218 patients with lung cancer underwent surgical treatment in Department of Thoracic Surgery and Oncology, Institute of Oncology, Vilnius University.", {"entities": [[38, 49, "DISEASE"], [43, 49, "DISEASE"]]}], ["In 46 (2.1%) patients coexistence of lung cancer and tuberculosis was found.", {"entities": [[37, 48, "DISEASE"], [53, 65, "DISEASE"], [42, 48, "DISEASE"]]}], ["Central lung cancer was diagnosed in 37 (80.4%) and peripheral \u2013 in 9 (19.6%) patients.", {"entities": [[8, 19, "DISEASE"], [13, 19, "DISEASE"]]}], ["Epidermoid cancer was diagnosed in 24 (52.2%) patients, adenocarcinoma \u2013 in 10 (21.7%) and adenoepidermoid carcinoma \u2013 in 12 (26.1%) patients.", {"entities": [[56, 70, "DISEASE"], [107, 116, "DISEASE"], [11, 17, "DISEASE"]]}], ["Stage I cancer was diagnosed in 12 (26.1%), stage II \u2013 in 11 (23.9%), and stage IIIA \u2013 in 23 (50%) patients.", {"entities": [[8, 14, "DISEASE"]]}], ["Pneumonectomy was performed in 18 (39.2%), lobectomy in 10 (21.7%), bilobectomy in 10 (21.7%), segmentectomy in 8 (17.4%) patients.", {"entities": []}], ["Postoperative surgical complications were observed in 9 (19.5%) patients, non-surgical complications occurred in 19 patients (41.3%).", {"entities": []}], ["Six patients (13.04%) died.", {"entities": []}], ["Combined treatment was applied to 23 (50%) patients.", {"entities": []}], ["Coexistence of tuberculosis and lung cancer in thoracic surgery is fairly rare.", {"entities": [[32, 43, "DISEASE"], [15, 27, "DISEASE"], [37, 43, "DISEASE"]]}], ["This combination was diagnosed only in 46 cases (2.1%) out of 2218 operated lung cancer patients.", {"entities": [[76, 87, "DISEASE"], [81, 87, "DISEASE"]]}], ["Epidermoid carcinoma and stage IIIA disease was diagnosed in 50% of patients.", {"entities": [[11, 20, "DISEASE"]]}], ["Postoperative surgical complications occurred in 9 patients (19.5%) with lung cancer and tuberculosis.", {"entities": [[73, 84, "DISEASE"], [89, 101, "DISEASE"], [78, 84, "DISEASE"]]}], ["Six patients (13%) died in postoperative period.", {"entities": []}], ["Surgery is the method of choice in treatment of combination of tuberculosis and lung cancer.", {"entities": [[80, 91, "DISEASE"], [63, 75, "DISEASE"], [85, 91, "DISEASE"]]}], ["Median survival of these patients was 28 \u00b1 2 months.", {"entities": []}], ["As a peroxisome proliferator-activated receptor alpha (PPAR\u03b1) agonist, fenofibrate favorably modulates dyslipidemia and inflammation markers, which are associated with cardiovascular risk.", {"entities": []}], ["To determine whether variation in the PPAR\u03b1 receptor gene was associated with lipid and inflammatory marker response, we conducted a three week trial of fenofibrate in 861 men and women.", {"entities": []}], ["Mixed linear models which controlled for age and sex, as well as family pedigree and study-center, were constructed using SNPs in the PPAR\u03b1 gene as predictors and changes in fasting triglycerides (TGs), cholesterol and inflammatory markers as outcomes.", {"entities": []}], ["Significant associations with low-density cholesterol (LDL-C) and interleukin-2 (IL-2; P <.001) responses to fenofibrate were found.", {"entities": []}], ["Although there were suggestive associations with tumour necrosis factor-alpha (TNF-\u03b1) and TG responses ( P <.05), these did not survive the correction for multiple testing.", {"entities": [[90, 92, "GENE"]]}], ["We conclude that variants in the PPAR\u03b1 gene may contribute to future pharmacogenomic paradigms seeking to predict fenofibrate responders from both an anti-dyslipidemic and anti-inflammatory perspective.", {"entities": []}], ["Exposure to airborne particulate matter (PM), a major component of air pollution, has been associated with increases in both exacerbations of and hospitalizations for asthma.", {"entities": [[167, 173, "DISEASE"]]}], ["We have previously shown that exposure to ambient PM collected in urban Baltimore (AUB) induces airway hyperresponsiveness (AHR), eosinophilic and neutrophilic inflammation, and the recruitment of T cells.", {"entities": [[124, 127, "GENE"]]}], ["However, the mechanism(s) by which it induces these features of asthma remains unknown.", {"entities": [[64, 70, "DISEASE"]]}], ["We investigated whether T lymphocytes play a role in AUB-induced AHR.", {"entities": [[65, 68, "GENE"]]}], ["We compared the effects of AUB exposure on the allergic phenotype in wild-type (WT) BALB/c mice and in mice deficient in recombinase-activating gene-1 ( Rag1 We found that exposure of WT mice to AUB induced AHR concomitant with increases in the numbers of bronchoalveolar lavage (BAL) fluid lymphocytes, eosinophils, neutrophils, and mucus-containing cells in the lungs of WT mice.", {"entities": [[153, 157, "GENE"], [207, 210, "GENE"]]}], ["Interestingly, we show for the first time that these effects were associated with significant elevations in interleukin (IL)-17A, IL-17F, and T-helper 2 cell (T H 2) (IL-13, IL-5) cytokine levels in lung cells, as well as reductions in the levels of the suppressive cytokine IL-10.", {"entities": []}], ["Interestingly, Rag1 Rag1 Taken together, our results suggest that AUB exposure increases the pathophysiological features of asthma via activation of lymphocyte-dependent pathways.", {"entities": [[124, 130, "DISEASE"], [15, 19, "GENE"], [20, 24, "GENE"], [15, 19, "GENE"], [20, 24, "GENE"]]}], ["These results provide a plausible biological mechanism for the strong association between PM exposure and the increased severity of asthma.", {"entities": [[132, 138, "DISEASE"]]}], ["From October 4 to November 2, 2001, the first 10 confirmed cases of inhalational anthrax caused by intentional release of Bacillus anthracis were identified in the United States.", {"entities": []}], ["Epidemiologic investigation indicated that the outbreak, in the District of Columbia, Florida, New Jersey, and New York, resulted from intentional delivery of B. anthracis spores through mailed letters or packages.", {"entities": []}], ["We describe the clinical presentation and course of these cases of bioterrorism-related inhalational anthrax.", {"entities": []}], ["The median age of patients was 56 years (range 43 to 73 years), 70% were male, and except for one, all were known or believed to have processed, handled, or received letters containing B. anthracis spores.", {"entities": []}], ["The median incubation period from the time of exposure to onset of symptoms, when known (n=6), was 4 days (range 4 to 6 days).", {"entities": []}], ["Symptoms at initial presentation included fever or chills (n=10), sweats (n=7), fatigue or malaise (n=10), minimal or nonproductive cough (n=9), dyspnea (n=8), and nausea or vomiting (n=9).", {"entities": []}], ["The median white blood cell count was 9.8 X 10(3)/mm(3) (range 7.5 to 13.3), often with increased neutrophils and band forms.", {"entities": []}], ["Nine patients had elevated serum transaminase levels, and six were hypoxic.", {"entities": []}], ["All 10 patients had abnormal chest X-rays; abnormalities included infiltrates (n=7), pleural effusion (n=8), and mediastinal widening (seven patients).", {"entities": []}], ["Computed tomography of the chest was performed on eight patients, and mediastinal lymphadenopathy was present in seven.", {"entities": []}], ["With multidrug antibiotic regimens and supportive care, survival of patients (60%) was markedly higher (<15%) than previously reported.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) present systemic inflammation.", {"entities": [[14, 51, "DISEASE"]]}], ["Strenuous resistive breathing induces systemic inflammation in healthy subjects.", {"entities": []}], ["We hypothesized that the increased respiratory load that characterizes COPD can contribute to systemic inflammation in these patients.", {"entities": []}], ["To test this hypothesis, we compared leukocyte numbers and levels of circulating cytokines (tumor necrosis factor alpha [TNF\u03b1], interleukin-1\u03b2 [IL-1\u03b2], IL-6, IL-8, and IL-10), before and 1 hour after maximal incremental inspiratory loading in 13 patients with stable COPD (forced expiratory volume in one second [FEV 1 ] 29 \u00b1 2.5% ref) and in 8 healthy sedentary subjects (FEV 1 98 \u00b1 5% ref).", {"entities": [[313, 316, "GENE"], [373, 376, "GENE"], [313, 316, "GENE"], [373, 376, "GENE"]]}], ["We found that: (1) at baseline, patients with COPD showed higher leukocyte counts and IL-8 levels than controls (p < 0.01); and, (2) one hour after maximal inspiratory loading these values were unchanged, except for IL-10, which increased in controls (p < 0.05) but not in patients with COPD.", {"entities": []}], ["This study confirms the presence of systemic inflammation in COPD, shows that maximal inspiratory loading does not increase the levels of pro-inflammatory cytokines (IL-1\u03b2, IL-8) in COPD patients or controls, but suggests that the former may be unable to mount an appropriate systemic anti-inflammatory response to exercise.", {"entities": []}], ["This article investigates the effects of hydraulic fracturing on infant health.", {"entities": []}], ["The development of hydraulic fracturing (\u201cfracking\u201d) is considered the biggest change to the global energy production system in the last half-century.", {"entities": []}], ["However, several communities have banned fracking because of unresolved concerns about the impact of this process on human health.", {"entities": []}], ["To evaluate the potential health impacts of fracking, we analyzed records of more than 1.1 million births in Pennsylvania from 2004 to 2013, comparing infants born to mothers living at different distances from active fracking sites and those born both before and after fracking was initiated at each site.", {"entities": []}], ["We adjusted for fixed maternal determinants of infant health by comparing siblings who were and were not exposed to fracking sites in utero.", {"entities": []}], ["We found evidence for negative health effects of in utero exposure to fracking sites within 3 km of a mother\u2019s residence, with the largest health impacts seen for in utero exposure within 1 km of fracking sites.", {"entities": []}], ["Negative health impacts include a greater incidence of low\u2013birth weight babies as well as significant declines in average birth weight and in several other measures of infant health.", {"entities": []}], ["There is little evidence for health effects at distances beyond 3 km, suggesting that health impacts of fracking are highly local.", {"entities": []}], ["Informal estimates suggest that about 29,000 of the nearly 4 million annual U.S. births occur within 1 km of an active fracking site and that these births therefore may be at higher risk of poor birth outcomes.", {"entities": []}], ["Self-reported medical history data are frequently used in epidemiological studies.", {"entities": []}], ["Self-reported diagnoses may differ from medical record diagnoses due to poor patient-clinician communication, self-diagnosis in the absence of a satisfactory explanation for symptoms, or the \"health literacy\" of the patient.", {"entities": []}], ["The US Department of Defense military health system offers a unique opportunity to evaluate electronic medical records with near complete ascertainment while on active duty.", {"entities": []}], ["This study compared 38 self-reported medical conditions to electronic medical record data in a large population-based US military cohort.", {"entities": []}], ["The objective of this study was to better understand challenges and strengths in self-reporting of medical conditions.", {"entities": []}], ["Using positive and negative agreement statistics for less-prevalent conditions, near-perfect negative agreement and moderate positive agreement were found for the 38 diagnoses.", {"entities": []}], ["This report highlights the challenges of using self-reported medical data and electronic medical records data, but illustrates that agreement between the two data sources increases with increased surveillance period of medical records.", {"entities": []}], ["Self-reported medical data may be sufficient for ruling out history of a particular condition whereas prevalence studies may be best served by using an objective measure of medical conditions found in electronic healthcare records.", {"entities": []}], ["Defining medical conditions from multiple sources in large, long-term prospective cohorts will reinforce the value of the study, particularly during the initial years when prevalence for many conditions may still be low.", {"entities": []}], ["The pathogenic mechanism of ASA-induced urticaria/angioedema (AIU) is still poorly understood, but it has been known that histamine releasing by cutaneous mast cell activation is considered to be an important role.", {"entities": [[40, 49, "DISEASE"], [50, 60, "DISEASE"]]}], ["Considering the importance of histamine in AIU, we speculated that a genetic abnormality of histamine-related genes such as a high-affinity IgE receptor, a metabolic enzyme of histamines and histamine receptors, may be involved in the development of AIU.", {"entities": []}], ["Enrolled in the study were 110 patients with AIU, 53 patients without ASA hypersensitivity who had various drug allergies presenting as exanthematous skin symptoms, and 99 normal healthy controls (NC).", {"entities": []}], ["Eleven single nucleotide polymorphisms (SNPs) of the \u03b2 chain of the high-affinity IgE receptor (FCER1B) and three histamine-related genes-histamine N-methyltransferase (HNMT), histamine H1 receptor (HRH1), histamine H2 receptor (HRH2)-were screened using the SNP-IT assay based on a single base extension method.", {"entities": [[169, 173, "GENE"], [199, 203, "GENE"], [229, 233, "GENE"]]}], ["No significant differences were observed in allele and genotype frequencies, and haplotype frequencies of all the SNPs of FCER1B, HNMT, HRH1, and HRH2 among the three groups ( p >0.05, respectively).", {"entities": [[130, 134, "GENE"], [136, 140, "GENE"], [146, 150, "GENE"]]}], ["These results suggest that the polymorphisms of FCER1B and the three histamine-related genes may not contribute to the development of AIU phenotype in the Korean population.", {"entities": []}], ["Asthma is associated with allergic sensitization in about half of all cases, and asthma phenotypes can vary by age and sex.", {"entities": [[0, 6, "DISEASE"], [81, 87, "DISEASE"]]}], ["DNA methylation in the promoter of the allergy regulatory gene interferon gamma (IFN\u03b3) has been linked to the maintenance of allergic immune function in human cell and mouse models.", {"entities": []}], ["We hypothesized that IFN\u03b3 promoter methylation at two well-studied, key cytosine phosphate guanine (CpG) sites (-186 and -54), may differ by age, sex, and airway versus systemic tissue in a cohort of 74 allergic asthmatics.", {"entities": []}], ["After sampling buccal cells, a surrogate for airway epithelial cells, and CD4+ lymphocytes, we found that CD4+ lymphocyte methylation was significantly higher in children compared to adults at both CpG sites ( P <0.01).", {"entities": []}], ["Buccal cell methylation was significantly higher in children at CpG -186 ( P \u2009=\u20090.03) but not CpG -54 ( P \u2009=\u20090.66).", {"entities": []}], ["Methylation was higher in males compared to females at both CpG sites in CD4+ lymphocytes (-186: P <0.01, -54: P \u2009=\u20090.02) but not buccal cells (-186: P \u2009=\u20090.14, -54: P \u2009=\u20090.60).", {"entities": []}], ["In addition, methylation was lower in CD4+ lymphocytes compared to buccal cells ( P <0.01) and neighboring CpG sites were strongly correlated in CD4+ lymphocytes (r\u2009=\u20090.84, P <0.01) and weakly correlated in buccal cells (r\u2009=\u20090.24, P \u2009=\u20090.04).", {"entities": []}], ["At CpG -186, there was significant correlation between CD4+ lymphocytes and buccal cells (r\u2009=\u20090.24, P \u2009=\u20090.04) but not at CpG -54 (r\u2009=\u2009-0.03, P \u2009=\u20090.78).", {"entities": []}], ["These findings highlight significant age, sex, and tissue-related differences in IFN\u03b3 promoter methylation that further our understanding of methylation in the allergic asthma pathway and in the application of biomarkers in clinical research.", {"entities": [[160, 175, "DISEASE"], [169, 175, "DISEASE"]]}], ["\u03c9-3 fatty acid desaturase is a key enzyme for the biosynthesis of \u03c9-3 polyunsaturated fatty acids via the oxidative desaturase/elongase pathways.", {"entities": []}], ["Here we report the identification of three \u03c9-3 desaturases from oomycetes, Pythium aphanidermatum , Phytophthora sojae , and Phytophthora ramorum .", {"entities": []}], ["These new \u03c9-3 desaturases share 55\u00a0% identity at the amino acid level with the known \u0394-17 desaturase of Saprolegnia diclina , and about 31\u00a0% identity with the bifunctional \u0394-12/\u0394-15 desaturase of Fusarium monoliforme .", {"entities": []}], ["The three enzymes were expressed in either wild-type or codon optimized form in an engineered arachidonic acid producing strain of Yarrowia lipolytica to study their activity and substrate specificity.", {"entities": []}], ["All three were able to convert the \u03c9-6 arachidonic acid to the \u03c9-3 eicosapentanoic acid, with a substrate conversion efficiency of 54\u201365\u00a0%.", {"entities": []}], ["These enzymes have a broad \u03c9-6 fatty acid substrate spectrum, including both C18 and C20 \u03c9-6 fatty acids although they prefer the C20 substrates, and have strong \u0394-17 desaturase activity but weaker \u0394-15 desaturase activity.", {"entities": []}], ["Thus, they belong to the \u0394-17 desaturase class.", {"entities": []}], ["Unlike the previously identified bifunctional \u0394-12/\u0394-15 desaturase from F. monoliforme , they lack \u0394-12 desaturase activity.", {"entities": []}], ["The newly identified \u0394-17 desaturases could use fatty acids in both acyl-CoA and phospholipid fraction as substrates.", {"entities": []}], ["The identification of these \u0394-17 desaturases provides a set of powerful new tools for genetic engineering of microbes and plants to produce \u03c9-3 fatty acids, such as eicosapentanoic acid and docosahexanoic acid, at high levels.", {"entities": []}], ["Hospital readmission for acute exacerbation of COPD (AECOPD) occurs in up to 30% of patients, leading to excess morbidity and poor survival.", {"entities": []}], ["Physiological risk factors predict readmission, but the impact of modifiable psychosocial risk factors remains uncertain.", {"entities": []}], ["We aimed to evaluate whether psychosocial risk factors independently predict readmission for AECOPD in patients referred to early discharge services (EDS).", {"entities": []}], ["This prospective cohort study included 79 patients with AECOPD cared for by nurse led EDS in the UK, and followed up for 12 months.", {"entities": []}], ["Data on lung function, medical comorbidities, previous hospital admissions, medications, and sociodemographics were collected at baseline; St George's Respiratory Questionnaire (SGRQ), Hospital Anxiety and Depression Scale (HADS), and social support were measured at baseline, 3 and 12-months.", {"entities": []}], ["Exploratory multivariate models were fitted to identify psychosocial factors associated with readmission adjusted for known confounders.", {"entities": []}], ["26 patients were readmitted within 90 days and 60 patients were readmitted at least once during follow-up.", {"entities": []}], ["Depression at baseline predicted readmission adjusted for sociodemographics and forced expiratory volume in 1 second (odds ratio 1.30, 95% CI 1.06 to 1.60, p = 0.013).", {"entities": []}], ["Perceived social support was not significantly associated with risk of readmission.", {"entities": []}], ["Home ownership was associated with the total number of readmissions ( B = 0.46, 95% CI -0.86 to -0.06, p = 0.024).", {"entities": []}], ["Compared with those not readmitted, readmitted patients had worse SGRQ and HADS scores at 12 months.", {"entities": []}], ["Depressive symptoms and socioeconomic status, but not perceived social support, predict risk of readmission and readmission frequency for AECOPD in patients cared for by nurse-led EDS.", {"entities": []}], ["Future work on reducing demand for unscheduled hospital admissions could include the design and evaluation of interventions aimed at optimising the psychosocial care of AECOPD patients managed at home.", {"entities": []}], ["Pharmacogenetics is an emerging field currently being implemented to improve safety when prescribing drugs.", {"entities": []}], ["While many women who take drugs during pregnancy would likely benefit from such personalized drug therapy, data is lacking on the awareness towards pharmacogenetics among women.", {"entities": []}], ["We aim to determine the level of knowledge and acceptance of formerly pregnant women in the Netherlands regarding pharmacogenetics and its implementation, and their interest in pharmacogenetic research.", {"entities": []}], ["A population-based survey using postal questionnaires was conducted among formerly pregnant women in the Northern parts of the Netherlands.", {"entities": []}], ["A total of 986 women were invited to participate.", {"entities": []}], ["Of the 219 women who returned completed questionnaires (22.2% response rate), only 22.8% had heard of pharmacogenetics, although the majority understood the concept (64.8%).", {"entities": []}], ["Women who had experience with drug side-effects were more likely to know about pharmacogenetics [OR\u2009=\u20092.06, 95% CI 1.16, 3.65].", {"entities": []}], ["Of the respondents, 53.9% were positive towards implementing pharmacogenetics in their future drug therapy, while 46.6% would be willing to participate in pharmacogenetic research.", {"entities": []}], ["Among those who were either not willing or undecided in this regard, their concerns were about the consequences of the pharmacogenetic test, including the privacy and anonymity of their genetic information.", {"entities": []}], ["The knowledge and attitude regarding the concept of pharmacogenetics among our population of interest is good.", {"entities": []}], ["Also, their interest in pharmacogenetic research provides opportunities for future research related to drug use during pregnancy and fetal outcome.", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-017-1290-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Introduction: The prevention and management of cow milk allergy (CMA) is still debated.", {"entities": []}], ["Since CMA is much less frequent in breastfed infants, breastfeeding should be stimulated.", {"entities": []}], ["Method: Literature was searched using databases to find original papers and reviews on this topic.", {"entities": []}], ["Results: Hydrolysates with a clinical proof of efficacy are recommended in the prevention and treatment of CMA.", {"entities": []}], ["However, not all meta-analyses conclude that hydrolysates do prevent CMA or other atopic manifestations such as atopic dermatitis.", {"entities": [[112, 129, "DISEASE"], [119, 129, "DISEASE"]]}], ["There are pros and cons to consider partially hydrolysed protein as an option for starter infant formula for each non-exclusively breastfed infant.", {"entities": []}], ["A challenge test is still recommended as the most specific and sensitive diagnostic test, although a positive challenge test does not proof that the immune system is involved.", {"entities": []}], ["The Cow Milk Symptom Score (CoMiSS\u2122) is an awareness tool that enables healthcare professionals to better recognize symptoms related to the ingestion of cow milk, but it still needs validation as diagnostic tool.", {"entities": []}], ["The current recommended elimination diet is a cow milk based extensive hydrolysate, although rice hydrolysates or soy infant formula can be considered in some cases.", {"entities": []}], ["About 10 to 15% of infants allergic to cow milk will also react to soy.", {"entities": []}], ["Mainly because of the higher cost, amino acid based formula is reserved for severe cases.", {"entities": []}], ["There is no place for infant formula with intact protein from other animals as cross-over allergenicity is high.", {"entities": []}], ["During recent years, attention focused also on the bifidogenic effect of prebiotics and more recently also on human milk oligosaccharides.", {"entities": []}], ["A bifidogenic gastrointestinal microbiome may decrease the risk to develop allergic disease.", {"entities": []}], ["The addition of probiotics and prebiotics to the elimination diet in treatment may enhance the development of tolerance development.", {"entities": []}], ["Conclusion: Breastfeeding is the best way to feed infants.", {"entities": []}], ["Cow milk based extensive hydrolysates remain the first option for the treatment of CMA for the majority of patients, while amino acid formulas are reserved for the most severe cases.", {"entities": []}], ["Rice hydrolysates and soy infant formula are second choice options.", {"entities": []}], ["Partial hydrolysates with clinical proof of efficacy are recommended in some guidelines in the prevention of CMA and allergic disease in at risk infants, and may be considered as an option as protein source in starter infant formula.", {"entities": []}], ["Background : Air pollution is a problem, especially in developing countries.", {"entities": []}], ["We examined the association between personal exposure to particulate matter with an aerodynamic diameter less than 2.5 \u00b5m (PM 2.5 ) on respiratory health in a group of adults with chronic obstructive pulmonary disease (COPD).", {"entities": [[180, 217, "DISEASE"]]}], ["Methods : All participants resided in Mexico City and during follow-up, personal exposure to PM 2.5 , respiratory symptoms, medications, and daily activity were registered daily.", {"entities": []}], ["Peak expiratory flow (PEF) was measured twice daily, from February through December, 2000, in 29 adults with moderate, severe, and very severe COPD.", {"entities": []}], ["PEF changes were estimated for each 10 \u00b5g/m 2.5 , adjustment for severity of COPD, minimum temperature, and day of the sampling.", {"entities": []}], ["Results : For a 10-\u00b5g/m 2.5 , there was a significant 33% increase in cough (95% CI, range, 5\u201269%), and 23% in phlegm (95% CI, range, 2\u201254%), a reduction of the PEF average in the morning of \u22121.4 L/min.", {"entities": []}], ["(95% CI , range, \u22122.8 to \u22120.04), and at night of \u22123.0 L/min (95% CI, range, \u22125.7 to \u22120.3), respectively.", {"entities": []}], ["Conclusions : Exposure to PM 2.5 was associated with reductions in PEF and increased respiratory symptoms in adults with COPD.", {"entities": []}], ["The PEF reduction was observed both at morning and at night.", {"entities": []}], ["Noncommunicable diseases are the leading cause of illness and death worldwide; behavioral risk factors (BRFs) contribute to these diseases.", {"entities": []}], ["We assessed the presence of multiple BRFs among European adults according to their physical and mental health status.", {"entities": []}], ["We used data from 26,026 adults aged 50 years or older from 11 countries that participated in the Survey of Health, Ageing and Retirement in Europe (2004\u20132005).", {"entities": []}], ["BRFs (overweight or obesity, smoking, physical inactivity, and risky alcohol consumption) were assessed according to physical health (ie, presence of chronic diseases, disease symptoms, or limitations in activities of daily living) and mental health (depression) through multiple regression estimations.", {"entities": [[20, 27, "DISEASE"]]}], ["Overweight or obesity in men and physical inactivity in women were the most prevalent BRFs.", {"entities": [[14, 21, "DISEASE"]]}], ["Compared with physically active adults, physically inactive adults had a higher mean number of chronic diseases (1.33 vs 1.26) and chronic disease symptoms (1.55 vs 1.47).", {"entities": []}], ["Risky alcohol consumption (\u22654 servings of an alcohol beverage \u22653 times a week) was associated with a higher mean depression score (2.84 vs 2.47).", {"entities": []}], ["Compared with adults with 0 or 1 BRF, adults with 2 or more BRFs had significantly higher odds of having 1 or more chronic diseases (men: 1.52; women: 1.73) and functional limitations (men: 1.65; women: 1.79) and higher prevalence of high blood pressure (37.8% vs 28.2).", {"entities": []}], ["Belgian adults with BRFs had the highest mean number of chronic diseases or functional limitations among those who were overweight or obese and the highest mean number of chronic diseases and disease symptoms among those who smoked and were physically inactive.", {"entities": []}], ["We found revealed significant positive associations between BRFs and poor health among middle-aged and older European adults.", {"entities": []}], ["Primary health care intervention programs should focus on developing ways to reduce BRF prevalence in this population.", {"entities": []}], ["One of the most remarkable properties of interleukin 8 (CXCL8/IL-8), a chemokine with known additional functions also in angiogenesis and tissue remodeling, is the variation of its expression levels.", {"entities": []}], ["In healthy tissues, IL-8 is barely detectable, but it is rapidly induced by several folds in response to proinflammatory cytokines, bacterial or viral products, and cellular stress.", {"entities": []}], ["Although mouse cells do not bear a clear homologous IL-8 gene, the murine transcriptional apparatus may well be capable of activating or repressing a heterologous IL-8 gene promoter driving a reporter gene.", {"entities": []}], ["In order to induce a transient transgenic expression, mice were systemically injected with a bovine IL-8 promoter\u2013luciferase construct.", {"entities": []}], ["Subsequently mice were monitored for luciferase expression in the lung by in vivo bioluminescent image analysis over an extended period of time (up to 60 days).", {"entities": []}], ["We demonstrate that the bovine IL-8 promoter\u2013luciferase construct is transiently and robustly activated 3\u20135 hours after LPS and TNF-\u03b1 instillation into the lung, peaking at 35 days after construct delivery.", {"entities": []}], ["Bovine IL-8 promoter\u2013luciferase activation correlates with white blood cell and neutrophil infiltration into the lung.", {"entities": []}], ["This study demonstrates that a small experimental rodent model can be utilized for non-invasively monitoring, through a reporter gene system, the activation of an IL-8 promoter region derived from a larger size animal (bovine).", {"entities": []}], ["This proof of principle study has the potential to be utilized also for studying primate IL-8 promoter regions.", {"entities": []}], ["Interferon lambdas (IFNLs) have important anti-viral/bacterial and immunomodulatory functions in the respiratory tract.", {"entities": []}], ["How do IFNLs impact COPD and its exacerbations?", {"entities": []}], ["Five hundred twenty eight patients were recruited in a prospective observational multicentre cohort (PROMISE) study.", {"entities": []}], ["The genetic polymorphisms (rs8099917 and rs12979860) within the IFNL3/4 gene region and circulating levels of IFNL3 in COPD patients were determined and associated with disease activity and outcome during a median follow-up of 24 months.", {"entities": []}], ["The GG genotype significantly influenced severe exacerbation rate (42 vs. 23%; p = 0.032) and time to severe exacerbation (HR = 2.260; p = 0.012).", {"entities": [[123, 125, "GENE"]]}], ["Compared to the TT or TG genotypes, the GG genotype was associated with severe dyspnoea (modified medical research council score \u2265 median 3; 22 vs 42%, p = 0.030).", {"entities": [[22, 24, "GENE"]]}], ["The CC genotype of the rs12979860 SNP was associated with a poorer prognosis (body mass index, airflow obstruction, dyspnea and exercise capacity index \u2265 median 4; 46 vs. 36% TC vs. 20.5% TT; p = 0.031).", {"entities": []}], ["Patients with stable COPD and at exacerbation had significantly lower circulating IFNL3 compared to healthy controls ( p < 0.001 and p < 0.001, respectively).", {"entities": []}], ["Circulating IFNL3 correlated to post-bronchodilator FEV 1 %predicted and the tissue maturation biomarker Pro-collagen 3.", {"entities": [[52, 55, "GENE"]]}], ["IFNL3/4 polymorphisms and circulating IFNL3 may be associated with disease activity and outcomes in COPD.", {"entities": []}], ["Clinical Trial registration http://www.isrctn.com/ identifier ISRCTN99586989 on 16 April 2008.", {"entities": []}], ["Despite preclinical evidence suggesting a synergistic interaction between ketamine and opioids promoting analgesia, several clinical trials have not identified dosing regimens capable of eliciting a benefit in the co-administration of ketamine with opioids.", {"entities": []}], ["Ten healthy volunteers participated in a double blinded, randomised, placebo controlled, crossover laboratory study in order to determine whether a low dose of ketamine potentiated the antinociceptive effect of fentanyl without causing an increase in sedative effects.", {"entities": []}], ["A battery of tests was used to assess both nociception and sedation including electrical current, pressure, thermal stimuli, psychometric tests, and both subjective and objective scores of sedation.", {"entities": []}], ["Target controlled infusions of the study drugs were used.", {"entities": []}], ["Ketamine and fentanyl were administered alone and in combination in a double-blinded randomised crossover design.", {"entities": []}], ["Saline was used as the control, and propofol was used to validate the tests of sedation.", {"entities": []}], ["Cardiovascular and respiratory parameters were also assessed.", {"entities": []}], ["The electrical current pain threshold dose response curve of fentanyl combined with ketamine was markedly steeper than the dose response curve of fentanyl alone.", {"entities": []}], ["While a ketamine serum concentration of 30 ng/ml did not result in a change in electrical pain threshold when administered alone, when it was added to fentanyl, the combination resulted in greater increase in pain threshold than that of fentanyl administered alone.", {"entities": []}], ["When nociception was assessed using heat and pressure stimuli, ketamine did not potentiate the anti-nociceptive effect of fentanyl.", {"entities": []}], ["There was no difference between the sedative effect of fentanyl and fentanyl in combination with ketamine as assessed by both subjective and objective measures of sedation.", {"entities": []}], ["Cardiovascular and respiratory parameters were unaffected by the study drugs at the doses given.", {"entities": []}], ["A serum concentration of ketamine that did not alter indices of sedation potentiated the antinociceptive effect of fentanyl.", {"entities": []}], ["This potentiation of antinociception occurred without an increase in sedation suggesting that low steady doses of ketamine (30\u2013120 ng/ml) might be combined with \u03bc opioid agonists to improve their analgesic effect in a clinical setting.", {"entities": []}], ["(296 words)", {"entities": []}], ["Management of severe asthma remains a challenge despite treatment with glucocorticosteroid therapy.", {"entities": [[21, 27, "DISEASE"]]}], ["The majority of studies investigating disease mechanisms in treatment-resistant severe asthma have previously focused on the large central airways, with very few utilizing transcriptomic approaches.", {"entities": [[87, 93, "DISEASE"]]}], ["The small peripheral airways, which comprise the majority of the airway surface area, remain an unexplored area in severe asthma and were targeted for global epithelial gene expression profiling in this study.", {"entities": [[122, 128, "DISEASE"]]}], ["Differences between central and peripheral airways were evaluated using transcriptomic analysis (Affymetrix HG U133 plus 2.0 GeneChips) of epithelial brushings obtained from severe asthma patients (N = 17) and healthy volunteers (N = 23).", {"entities": [[181, 187, "DISEASE"]]}], ["Results were validated in an independent cohort (N = 10) by real-time quantitative PCR.", {"entities": []}], ["The IL-13 disease signature that is associated with an asthmatic phenotype was upregulated in severe asthmatics compared to healthy controls but was predominantly evident within the peripheral airways, as were genes related to mast cell presence.", {"entities": []}], ["The gene expression response associated with glucocorticosteroid therapy (i.e.", {"entities": []}], ["FKBP5 ) was also upregulated in severe asthmatics compared to healthy controls but, in contrast, was more pronounced in central airways.", {"entities": [[0, 5, "GENE"]]}], ["Moreover, an altered epithelial repair response (e.g.", {"entities": []}], ["FGFBP1 ) was evident across both airway sites reflecting a significant aspect of disease in severe asthma unadressed by current therapies.", {"entities": [[99, 105, "DISEASE"], [0, 6, "GENE"]]}], ["A transcriptomic approach to understand epithelial activation in severe asthma has thus highlighted the need for better-targeted therapy to the peripheral airways in severe asthma, where the IL-13 disease signature persists despite treatment with currently available therapy.", {"entities": [[72, 78, "DISEASE"], [173, 179, "DISEASE"]]}], ["There is increasing agreement among medical educators regarding the importance of improving the integration between public health and clinical education, understanding and implementation of epidemiological methods, and the ability to critically appraise medical literature.", {"entities": []}], ["The Sackler School of Medicine at Tel-Aviv University revised its public health and preventive medicine curriculum, during 2013\u20132014, according to the competency-based medical education (CBME) approach in training medical students.", {"entities": []}], ["We describe the revised curriculum, which aimed to strengthen competencies in quantitative research methods, epidemiology, public health and preventive medicine, and health service organization and delivery.", {"entities": []}], ["We report the process undertaken to establish a relevant 6-year longitudinal curriculum and describe its contents, implementation, and continuous assessment and evaluation.", {"entities": []}], ["Central competencies included: epidemiology and statistics for appraisal of the literature and implementation of research; the application of health promotion principles and health education strategies in disease prevention; the use of an evidence-based approach in clinical and public health decision making; the examination and analysis of disease trends at the population level; and knowledge of the structure of health systems and the role of the physician in these systems.", {"entities": []}], ["Two new courses, in health promotion, and in public health, were added to the curriculum, and the courses in statistics and epidemiology were joined.", {"entities": []}], ["Annual evaluation of each course results in continuous revisions of the syllabi as needed, while we continue to monitor the whole curriculum.", {"entities": []}], ["The described revision in a 6\u00a0year-medical school training curriculum addresses the currently identified needs in public health.", {"entities": []}], ["Ongoing feedback from students, and re-evaluation of syllabus by courses teams are held annually.", {"entities": []}], ["Analysis of student\u2019s written feedbacks and courses evaluations of \u201cbefore and after\u201d the implementation of this intervention is taking place to examine the effect of the new curriculum on the perceived clinical and research capacities of our 6-year students.", {"entities": []}], ["Antibody-dependent enhancement (ADE) has been proposed as a mechanism to explain dengue hemorrhagic fever (DHF) in the course of a secondary dengue infection.", {"entities": [[81, 105, "DISEASE"]]}], ["Very recently, Dejnirattisai et al.", {"entities": []}], ["Circulating markers of inflammation in chronic obstructive pulmonary disease (COPD) may correlate to disease progression and extrapulmonary complications such as malnourishment.", {"entities": [[39, 76, "DISEASE"]]}], ["However, surprisingly little is known about gender-related differences for circulating inflammatory markers in COPD.", {"entities": []}], ["To characterize differences in circulating markers of inflammation in malnourished female and male patients with COPD.", {"entities": []}], ["Thirty female and 11 male patients with a clinical diagnosis of COPD and malnourishment were examined.", {"entities": []}], ["A group of control subjects without evidence of COPD was recruited for comparison of some variables.", {"entities": []}], ["Blood samples were drawn, and the following parameters were studied: leukocytes and differential counts, C-reactive protein (CRP), tumor necrosis factor-\u03b1, interleukin (IL)-6 and IL-8, myeloperoxidase (MPO), neutrophil elastase (NE), intracellular adhesion molecule-1, vascular endothelial adhesion molecule-1, and E-selectin.", {"entities": [[125, 128, "GENE"], [202, 205, "GENE"]]}], ["The mean neutrophil concentration was significantly ( P = 0.019) higher in female (4.5 \u00d7 10 P < 0.01, n = 85).", {"entities": []}], ["The mean CRP values were considerably higher in female (4.9 mg/mL) than in male patients with COPD (1.5 mg/mL), but the difference was not statistically significant ( P = 0.20).", {"entities": [[9, 12, "GENE"]]}], ["The mean concentrations of IL-6 and IL-8 tended to be higher in female than in male patients with COPD, but these differences did not reach statistical significance either ( P > 0.05).", {"entities": []}], ["Confounding factors (smoking, medication) could not explain the gender differences noted.", {"entities": []}], ["The concentrations of MPO and NE displayed a strong correlation (r = 0.89; P < 0.01, n = 41) but revealed no gender differences.", {"entities": [[22, 25, "GENE"]]}], ["The latter was true for concentrations of adhesion molecules as well.", {"entities": []}], ["Our study puts forward evidence of a gender-related difference in systemic inflammation in malnourished patients with COPD in terms of circulating neutrophils being more abundant in female patients.", {"entities": []}], ["Among these female patients, there was also a trend toward an increase in two neutrophil-mobilizing cytokines.", {"entities": []}], ["New and better-powered studies are warranted to confirm and characterize this potentially important phenomenon in greater detail.", {"entities": []}], ["Over\u2010the\u2010counter ( OTC ) labels help support safe medication use by consumers.", {"entities": [[19, 22, "GENE"]]}], ["In 2012, the A ustralian T herapeutic G oods A dministration ( TGA ) released a consultation paper proposing OTC label standardization to improve label quality via implementation of the M edicine I nformation B ox ( MIB ) label.", {"entities": [[109, 112, "GENE"]]}], ["However, consumer opinions of the MIB and standardization of OTC labelling remain unexplored.", {"entities": [[61, 64, "GENE"]]}], ["To explore consumer perspectives of OTC label standardization and the proposed MIB .", {"entities": [[36, 39, "GENE"]]}], ["Mock MIB labels were developed by the research team, guided by the TGA consultation paper, and used as interview stimulus material.", {"entities": []}], ["Semi\u2010structured interviews were conducted with 38 Australian and 39 UK adult participants.", {"entities": []}], ["Participant perspectives on OTC label standardization, opinions on the MIB and perceived improvements were explored.", {"entities": [[28, 31, "GENE"]]}], ["All interviews were audio\u2010recorded with permission, transcribed verbatim, and the content thematically analysed.", {"entities": []}], ["Participants expressed a range of opinions towards OTC label standardization, from welcoming standardization to concern that important details may be overlooked.", {"entities": [[51, 54, "GENE"]]}], ["The MIB was generally positively received due to its perceived good information design and ease of navigation.", {"entities": []}], ["Participants requested reordering of information\u2010specifically, for the active ingredient to be moved to a less prominent position.", {"entities": []}], ["Suggested improvements centred on content and design changes, for example colour, pictograms, bolding.", {"entities": []}], ["Participants felt positively towards OTC label standardization and saw the MIB as a feasible standardized format to implement for OTC labels.", {"entities": [[37, 40, "GENE"], [130, 133, "GENE"], [37, 40, "GENE"], [130, 133, "GENE"]]}], ["Although they appreciated its good information design, they felt further improvements to its content and design are required to enhance its quality and usability.", {"entities": []}], ["Panic disorder (PD) affects about four million Europeans, with women affected twice as likely as men, causing substantial suffering and high economic costs.", {"entities": []}], ["The etiopathogenesis of PD remains largely unknown, but both genetic and environmental factors contribute to risk.", {"entities": []}], ["An epigenome-wide association study (EWAS) was conducted to compare medication-free PD patients ( n \u2009=\u200989) with healthy controls ( n \u2009=\u200976) stratified by gender.", {"entities": []}], ["Replication was sought in an independent sample (131 cases, 169 controls) and functional analyses were conducted in a third sample ( N \u2009=\u200971).", {"entities": []}], ["DNA methylation was assessed in whole blood using the Infinium HumanMethylation450 BeadChip.", {"entities": []}], ["One genome-wide association surviving FDR of 5% (cg07308824, P \u2009=\u20091.094\u2009\u00d7\u200910-7, P-adj\u2009=\u20090.046) was identified in female PD patients ( N \u2009=\u200949) compared to controls ( N \u2009=\u200948).", {"entities": []}], ["The same locus, located in an enhancer region of the HECA gene, was also hypermethylated in female PD patients in the replication sample ( P \u2009=\u20090.035) and the significance of the association improved in the meta-analysis (P-adj\u2009=\u20090.004).", {"entities": [[53, 57, "GENE"]]}], ["Methylation at this CpG site was associated with HECA mRNA expression in another independent female sample ( N \u2009=\u200971) both at baseline ( P \u2009=\u20090.046) and after induction by dexamethasone ( P \u2009=\u20090.029).", {"entities": [[49, 53, "GENE"]]}], ["Of 15 candidates, 5 previously reported as associated with PD or anxiety traits also showed differences in DNA methylation after gene-wise correction and included SGK1 , FHIT , ADCYAP1 , HTR1A , HTR2A .", {"entities": [[163, 167, "GENE"], [170, 174, "GENE"], [177, 184, "GENE"], [187, 192, "GENE"], [195, 200, "GENE"]]}], ["Our study examines epigenome-wide differences in peripheral blood for PD patients.", {"entities": []}], ["Our results point to possible sex-specific methylation changes in the HECA gene for PD but overall highlight that this disorder is not associated with extensive changes in DNA methylation in peripheral blood.", {"entities": [[70, 74, "GENE"]]}], ["Seasonal influenza imposes a substantial personal morbidity and societal cost burden.", {"entities": [[9, 18, "DISEASE"]]}], ["Vaccination is the major strategy for influenza prevention; however, because antigenically drifted influenza A and B viruses circulate annually, influenza vaccines must be updated to provide protection against the predicted prevalent strains for the next influenza season.", {"entities": [[38, 47, "DISEASE"], [99, 108, "DISEASE"], [145, 154, "DISEASE"], [255, 264, "DISEASE"]]}], ["The aim of this study was to assess the efficacy, safety, reactogenicity, and immunogenicity of a trivalent inactivated split virion influenza vaccine (TIV) in healthy adults over two influenza seasons in the US.", {"entities": [[133, 142, "DISEASE"], [184, 193, "DISEASE"]]}], ["The primary endpoint of this double-blind, randomized study was the average efficacy of TIV versus placebo for the prevention of vaccine-matched, culture-confirmed influenza (VMCCI) across the 2005-2006 and 2006-2007 influenza seasons.", {"entities": [[164, 173, "DISEASE"], [217, 226, "DISEASE"]]}], ["Secondary endpoints included the prevention of laboratory-confirmed (defined by culture and/or serology) influenza, as well as safety, reactogenicity, immunogenicity, and consistency between three consecutive vaccine lots.", {"entities": [[105, 114, "DISEASE"]]}], ["Participants were assessed actively during both influenza seasons, and nasopharyngeal swabs were collected for viral culture from individuals with influenza-like illness.", {"entities": [[48, 57, "DISEASE"], [147, 156, "DISEASE"]]}], ["Blood specimens were obtained for serology one month after vaccination and at the end of each influenza season's surveillance period.", {"entities": [[94, 103, "DISEASE"]]}], ["Although the point estimate for efficacy in the prevention of all laboratory-confirmed influenza was 63.2% (97.5% confidence interval [CI] lower bound of 48.2%), the point estimate for the primary endpoint, efficacy of TIV against VMCCI across both influenza seasons, was 46.3% with a 97.5% CI lower bound of 9.8%.", {"entities": [[87, 96, "DISEASE"], [249, 258, "DISEASE"]]}], ["This did not satisfy the pre-specified success criterion of a one-sided 97.5% CI lower bound of >35% for vaccine efficacy.", {"entities": []}], ["The VMCCI attack rates were very low overall at 0.6% and 1.2% in the TIV and placebo groups, respectively.", {"entities": []}], ["Apart from a mismatch for influenza B virus lineage in 2005-2006, there was a good match between TIV and the circulating strains.", {"entities": [[26, 35, "DISEASE"]]}], ["TIV was highly immunogenic, and immune responses were consistent between three different TIV lots.", {"entities": []}], ["The most common reactogenicity events and spontaneous adverse events were associated with the injection site, and were mild in severity.", {"entities": []}], ["Despite a good immune response, and an average efficacy over two influenza seasons against laboratory-confirmed influenza of 63.2%, the pre-specified target (lower one-sided 97.5% confidence bound for efficacy > 35%) for the primary efficacy endpoint, the prevention of VMCCI, was not met.", {"entities": [[65, 74, "DISEASE"], [112, 121, "DISEASE"]]}], ["However, the results should be interpreted with caution in view of the very low attack rates we observed at the study sites in the 2005-2006 and 2006-2007, which corresponded to relatively mild influenza seasons in the US.", {"entities": [[194, 203, "DISEASE"]]}], ["Overall, the results showed that TIV has an acceptable safety profile and offered clinical benefit that exceeded risk.", {"entities": []}], ["NCT00216242", {"entities": []}], ["Fluticasone furoate (FF)/vilanterol (VI) is a once daily (OD) inhaled corticosteroid/long-acting \u03b2 2 -agonist combination asthma therapy approved in Japan and the EU.", {"entities": [[122, 128, "DISEASE"]]}], ["FF/VI efficacy and safety data from asthma studies including patients in East Asia were evaluated to assess ethnic sensitivity.", {"entities": [[36, 42, "DISEASE"]]}], ["Randomized, double-blind, multicenter Phase IIb/III trials were assessed.", {"entities": []}], ["Change from baseline relative to placebo or twice-daily fluticasone propionate 500\u00a0\u03bcg in trough FEV 1 was compared between patients from Japan ( N \u2009=\u2009148) and Not-Japan ( N \u2009=\u20093,066; three studies).", {"entities": [[96, 99, "GENE"]]}], ["Adverse events (AEs), laboratory results, and electrocardiograms were compared between patients from Japan\u2009+\u2009Korea ( N \u2009=\u2009188) and Not-Japan\u2009+\u2009Korea ( N \u2009=\u20093,840; five studies).", {"entities": []}], ["For trough FEV 1 , improvements from baseline (least-squares mean difference [95\u00a0% confidence interval]) were reported for FF/VI 100/25\u00a0\u03bcg OD versus placebo at Week 12 (Japan: 0.323\u00a0L [0.104\u20130.542]; Not-Japan: 0.168\u00a0L [0.095\u20130.241]).", {"entities": [[11, 14, "GENE"]]}], ["Improvements from baseline (least-squares mean change [standard error]) were reported with FF/VI 200/25\u00a0\u03bcg OD at Week 24 (Japan: 0.355\u00a0L [0.1152]; Not-Japan: 0.396\u00a0L [0.0313]).", {"entities": []}], ["A greater proportion of patients from Japan\u2009+\u2009Korea versus Not-Japan\u2009+\u2009Korea reported AEs in all treatment arms including placebo (FF/VI 100/25\u00a0\u03bcg: 79\u00a0% versus 57\u00a0%; FF/VI 200/25\u00a0\u03bcg: 64\u00a0% versus 45\u00a0%; placebo: 41\u00a0% versus 23\u00a0%).", {"entities": []}], ["There were no notable differences in treatment-related or class-related AEs.", {"entities": []}], ["No clinically significant changes in electrocardiogram assessments or statistically significant differences in 24\u00a0h urinary cortisol excretion were observed between the Japan\u2009+\u2009Korea and Not-Japan\u2009+\u2009Korea cohorts.", {"entities": []}], ["Good efficacy and an acceptable safety profile were observed for FF/VI 100/25\u00a0\u03bcg and 200/25\u00a0\u03bcg OD in East Asian asthma patients; these globally recommended doses are appropriate for asthma patients in Japan.", {"entities": [[112, 118, "DISEASE"], [182, 188, "DISEASE"]]}], ["Clinicaltrials.gov registration numbers: NCT01165138 , NCT01134042 , NCT01086384 , NCT00603278 , NCT00603382 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-015-0159-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is a treatment option for selected patients with peritoneal carcinomatosis.", {"entities": []}], ["There are limited data available on anaesthesia management and its impact on patients\u2019 outcome.", {"entities": []}], ["Our aim was to retrospectively analyze and evaluate perioperative management and the clinical course of patients undergoing CRS/HIPEC within a three-year period.", {"entities": []}], ["After ethic committee approval, patient charts were retrospectively reviewed for patient characteristics, interventions, perioperative management, postoperative course, and complications.", {"entities": []}], ["Analysis was intervention based.", {"entities": []}], ["Data are presented as median (range).", {"entities": []}], ["Between 2009 and 2011, 54 consecutive patients underwent 57 interventions; median anaesthesia time was 715 (range 370 to 1135) minutes.", {"entities": []}], ["HIPEC induced hyperthermia with an overall median peak temperature of 38.1 (35.7-40.2)\u00b0C with active cooling.", {"entities": []}], ["Bleeding, expressed as median blood loss was 0.8 (0 to 6) litre and large fluid shifts occurred, requiring a total fluid input of 8.4 (4.2 to 29.4) litres per patient.", {"entities": []}], ["Postoperative renal function was dependent on preoperative function and the type of fluids used.", {"entities": []}], ["Administration of hydroxyethyl starch colloid solution had a significant negative impact on renal function, especially in younger patients.", {"entities": []}], ["Major complications occurred after 12 procedures leading to death in 2 patients.", {"entities": []}], ["Procedure time and need for blood transfusion were associated with a significantly higher risk for major complications.", {"entities": []}], ["Cytoreductive surgery with HIPEC is a high-risk surgical procedure associated with major hemodynamic and metabolic changes.", {"entities": []}], ["As well as primary disease and complexity of surgery, we have shown that anaesthesia management, the type and amount of fluids used, and blood transfusions may also have a significant effect on patients\u2019 outcome.", {"entities": []}], ["As prolonged hyperoxia induces extensive lung tissue damage, we set out to investigate the involvement of endothelin-1 (ET-1) receptors in these adverse changes.", {"entities": []}], ["Experiments were performed on four groups of mice: control animals kept in room air and a group of mice exposed to hyperoxia for 60 h were not subjected to ET-1 receptor blockade, whereas the dual ETA/ETB-receptor blocker tezosantan (TEZ) was administered via an intraperitoneal pump (10 mg/kg/day for 6 days) to other groups of normal and hyperoxic mice.", {"entities": []}], ["The respiratory system impedance (Zrs) was measured by means of forced oscillations in the anesthetized, paralyzed and mechanically ventilated mice before and after the iv injection of ET-1 (2 \u03bcg).", {"entities": []}], ["Changes in the airway resistance (Raw) and in the tissue damping (G) and elastance (H) of a constant-phase tissue compartment were identified from Zrs by model fitting.", {"entities": []}], ["The plasma ET-1 level increased in the mice exposed to hyperoxia (3.3 \u00b1 1.6 pg/ml) relative to those exposed to room air (1.6 \u00b1 0.3 pg/ml, p < 0.05).", {"entities": []}], ["TEZ administration prevented the hyperoxia-induced increases in G (13.1 \u00b1 1.7 vs. 9.6 \u00b1 0.3 cmH 2 O/l, p < 0.05) and H (59 \u00b1 9 vs. 41 \u00b1 5 cmH 2 O/l, p < 0.05) and inhibited the lung responses to ET-1.", {"entities": []}], ["Hyperoxia decreased the reactivity of the airways to ET-1, whereas it elevated the reactivity of the tissues.", {"entities": []}], ["These findings substantiate the involvement of the ET-1 receptors in the physiopathogenesis of hyperoxia-induced lung damage.", {"entities": []}], ["Dual ET-1 receptor antagonism may well be of value in the prevention of hyperoxia-induced parenchymal damage.", {"entities": []}], ["This study explored demographic, clinical, and psychological moderators of the effect of a group-based physical exercise intervention on global quality of life (QoL) among cancer survivors who completed treatment.", {"entities": [[172, 178, "DISEASE"]]}], ["Cancer survivors were assigned to a 12-week physical exercise ( n \u2009=\u2009147) or a wait-list control group ( n \u2009=\u200962).", {"entities": [[0, 6, "DISEASE"]]}], ["The main outcome measure was global QoL, assessed with the EORTC QLQ-C30 at baseline and 12\u00a0weeks later.", {"entities": []}], ["Potential moderators were age, gender, education level, marital status, employment status, type of treatment, time since treatment, the presence of comorbidities, fatigue, general self-efficacy, depression, and anxiety.", {"entities": []}], ["Linear regression analyses were used to test effect modification of the intervention by each moderator variable using interaction tests ( p \u2009\u2264\u20090.10).", {"entities": []}], ["The physical exercise intervention effect on global QoL was larger for cancer survivors who received radiotherapy (\u03b2\u2009=\u200910.3, 95\u00a0% confidence interval (CI)\u2009=\u20094.4; 16.2) than for cancer survivors who did not receive radiotherapy (\u03b2\u2009=\u20091.8, 95\u00a0% CI\u2009=\u2009\u22125.9; 9.5, p interaction \u2009=\u20090.10), larger for cancer survivors who received a combination of chemoradiotherapy (\u03b2\u2009=\u200913.0, 95\u00a0% CI\u2009=\u20096.0; 20.1) than for those who did not receive this combination of treatments (\u03b2\u2009=\u20092.5, 95\u00a0% CI\u2009=\u2009\u22123.7; 8.7, p interaction \u2009=\u20090.02), and larger for cancer survivors with higher baseline levels of fatigue (\u03b2\u2009=\u200912.6, 95\u00a0% CI\u2009=\u20095.7; 19.6) than for those with lower levels (\u03b2\u2009=\u20092.4, 95\u00a0% CI\u2009=\u2009\u22123.9; 8.7, p interaction \u2009=\u20090.03).", {"entities": [[71, 77, "DISEASE"], [177, 183, "DISEASE"], [293, 299, "DISEASE"], [526, 532, "DISEASE"]]}], ["No other moderating effects were found.", {"entities": []}], ["This study suggests that cancer treatment modality and baseline fatigue levels moderate the effect of a physical exercise program on cancer survivors\u2019global QoL.", {"entities": [[25, 31, "DISEASE"], [133, 139, "DISEASE"]]}], ["Patient: Female, 69 Final Diagnosis: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia Symptoms: Occasional and mild shortness of breath \u2022 persistent nocturnal cough Medication: \u2014 Clinical Procedure: Surgical intervention: right middle lobectomy Specialty: Surgery Rare disease Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare pulmonary disorder that is characterized by diffuse hyperplasia of bronchiolar and bronchial pulmonary neuroendocrine cells.", {"entities": []}], ["In this condition, when no other pathological pulmonary condition is detected, DIPNECH is considered to be an idiopathic lung disease.", {"entities": [[121, 133, "DISEASE"]]}], ["DIPNECH is a rare condition that can be difficult to distinguish from other forms of reactive pulmonary neuroendocrine cell hyperplasia (NECH).", {"entities": []}], ["We present a case of DIPNECH and describe the approach to diagnosis of this rare condition.", {"entities": []}], ["A 69-year-old woman with a past medical history of successfully treated lobular carcinoma of the breast, presented to our department with a respiratory tract infection.", {"entities": [[80, 89, "DISEASE"]]}], ["High-resolution computed tomography (HRCT) of the chest showed a suspicious pulmonary nodule, measuring 13 mm, in the right middle pulmonary lobe.", {"entities": []}], ["Combined positron emission tomography (PET) and computed tomography (CT), showed a solid and metabolically active nodule.", {"entities": []}], ["A transbronchial biopsy and histopathology confirmed a diagnosis of DIPNECH.", {"entities": []}], ["It is possible that DIPNECH is an under-diagnosed pulmonary condition because it is rarely associated with symptoms.", {"entities": []}], ["At this time, there are no evidence-based management guidelines.", {"entities": []}], ["While the majority of cases have stable clinical course, some cases can progress to cause airway obstruction.", {"entities": []}], ["This case report highlights this rare, but potentially progressive condition, and the need for evidence-based management guidelines for DIPNECH.", {"entities": []}], ["The risk to die from an infectious disease in Germany has been continuously decreasing over the last century.", {"entities": []}], ["Since infections are, however, not only causes of death but risk factors for diseases like cardiovascular diseases, it is essential to monitor and analyze their prevalence and frequency, especially in consideration of the increased life expectancy.", {"entities": []}], ["To gain more knowledge about infectious diseases as risk factors and their implications on the condition and change of the immune status, the German National Cohort (GNC), a population-based prospective cohort study, will recruit 200,000 subjects between 2014 and 2017.", {"entities": []}], ["In Pretest\u00a01, a feasibility study for the GNC, we evaluated a self-administered and self-report questionnaire on infectious diseases and on the use of health care facilities (hereinafter called \u201cID Screen\u201d) for feasibility and validity.", {"entities": []}], ["From August\u2013November 2011, 435\u00a0participants between the ages of 20\u201369 completed the ID Screen.", {"entities": []}], ["All subjects had been recruited via a random sample from the local residents\u2019 registration offices by 4\u00a0of the 18\u00a0participating study centers.", {"entities": []}], ["The questionnaire encompasses 77 variables in six sections assessing items such as 12-month prevalence of infections, cumulative prevalence of infectious diseases, visit of health care facilities and vaccination.", {"entities": []}], ["The feasibility was amongst others evaluated by assessing the completeness and comprehensiveness of the questionnaire.", {"entities": []}], ["To assess the questionnaires ability to measure \u201cimmune status\u201d and \u201csusceptibility to infections\u201d, multivariate analysis was used.", {"entities": []}], ["The overall practicability was good and most items were well understood, demonstrated by <\u20092/33 missing questions per questionnaire and only three variables: vaccination for influenza and pneumococci and infection with chickenpox had a frequency >\u20095\u2009% of missing values.", {"entities": [[174, 183, "DISEASE"], [219, 229, "DISEASE"]]}], ["However, direct comparison of the items 12-month prevalence and lifetime prevalence of nephritis/pyelitis showed poor agreement and thereby poor understanding by 80\u2009%\u00a0of the participants, illustrating the necessity for a clear, lay person appropriate description of rare diseases to increase comprehensibility.", {"entities": [[97, 105, "DISEASE"], [87, 96, "DISEASE"]]}], ["The questionnaire will be used to support the assessment of immune dysfunction and frequency of infection.", {"entities": []}], ["An analysis of these constructs in an exploratory factor analysis revealed limited applicability due to low interitem correlation (Cronbach\u2019s \u03b1\u2009<\u20090.5).", {"entities": []}], ["This is corroborated by the extraction of more than one factor with a Kaiser\u2013Meyer\u2013Olkin measure of 0.6 instead of a unidimensional latent construct for \u201cimmune status\u201d.", {"entities": []}], ["All in all, the ID Screen is a good and reliable tool to measure infectious diseases as risk factors and outcome in general, but requires a better translation of infection specific terms into lay person terms.", {"entities": []}], ["For the assessment of the overall immune status, the tool has strong limitations.", {"entities": []}], ["Vaccinations status should also rather be assessed based on vaccination certificates than on participants\u2019 recall.", {"entities": []}], ["The online version of this article (doi: 10.1007/s00103-014-2052-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Changes in scores on health status questionnaires are difficult to interpret.", {"entities": []}], ["Several methods to determine minimally important changes (MICs) have been proposed which can broadly be divided in distribution-based and anchor-based methods.", {"entities": []}], ["Comparisons of these methods have led to insight into essential differences between these approaches.", {"entities": []}], ["Some authors have tried to come to a uniform measure for the MIC, such as 0.5 standard deviation and the value of one standard error of measurement (SEM).", {"entities": []}], ["Others have emphasized the diversity of MIC values, depending on the type of anchor, the definition of minimal importance on the anchor, and characteristics of the disease under study.", {"entities": []}], ["A closer look makes clear that some distribution-based methods have been merely focused on minimally detectable changes.", {"entities": []}], ["For assessing minimally important changes, anchor-based methods are preferred, as they include a definition of what is minimally important.", {"entities": []}], ["Acknowledging the distinction between minimally detectable and minimally important changes is useful, not only to avoid confusion among MIC methods, but also to gain information on two important benchmarks on the scale of a health status measurement instrument.", {"entities": []}], ["Appreciating the distinction, it becomes possible to judge whether the minimally detectable change of a measurement instrument is sufficiently small to detect minimally important changes.", {"entities": []}], ["Existing evidence on the effects of smoke-free policies on respiratory diseases is scarce and inconclusive.", {"entities": []}], ["Spain enacted two consecutive smoke-free regulations: a partial ban in 2006 and a comprehensive ban in 2011.", {"entities": []}], ["We estimated their impact on hospital admissions via emergency departments for chronic obstructive pulmonary disease (COPD) and asthma.", {"entities": [[79, 116, "DISEASE"], [128, 134, "DISEASE"]]}], ["Data for COPD (ICD-9 490\u2013492, 494\u2013496) came from 2003\u20132012 hospital admission records from the fourteen largest provinces of Spain and from five provinces for asthma (ICD-9 493).", {"entities": [[159, 165, "DISEASE"]]}], ["We estimated changes in hospital admission rates within provinces using Poisson additive models adjusted for long-term linear trends and seasonality, day of the week, temperature, influenza, acute respiratory infections, and pollen counts (asthma models).", {"entities": [[180, 189, "DISEASE"], [240, 246, "DISEASE"]]}], ["We estimated immediate and gradual effects through segmented-linear models.", {"entities": []}], ["The coefficients within each province were combined through random-effects multivariate meta-analytic models.", {"entities": []}], ["The partial ban was associated with a strong significant pooled immediate decline in COPD-related admission rates (14.7%, 95%CI: 5.0, 23.4), sustained over time with a one-year decrease of 13.6% (95%CI: 2.9, 23.1).", {"entities": []}], ["The association was consistent across age and sex groups but stronger in less economically developed Spanish provinces.", {"entities": []}], ["Asthma-related admission rates decreased by 7.4% (95%CI: 0.2, 14.2) immediately after the comprehensive ban was implemented, although the one-year decrease was sustained only among men (9.9%, 95%CI: 3.9, 15.6).", {"entities": [[0, 6, "DISEASE"]]}], ["The partial ban was associated with an immediate and sustained strong decline in COPD-related admissions, especially in less economically developed provinces.", {"entities": []}], ["The comprehensive ban was related to an immediate decrease in asthma, sustained for the medium-term only among men.", {"entities": [[62, 68, "DISEASE"]]}], ["Osteoporosis affects over 200 million people worldwide, and represents a significant cost burden.", {"entities": [[0, 12, "DISEASE"]]}], ["Although guidelines are available for best practice in osteoporosis, evidence indicates that patients are not receiving appropriate diagnostic testing or treatment according to guidelines.", {"entities": [[55, 67, "DISEASE"]]}], ["The use of clinical decision support systems (CDSSs) may be one solution because they can facilitate knowledge translation by providing high-quality evidence at the point of care.", {"entities": []}], ["Findings from a systematic review of osteoporosis interventions and consultation with clinical and human factors engineering experts were used to develop a conceptual model of an osteoporosis tool.", {"entities": [[37, 49, "DISEASE"], [179, 191, "DISEASE"]]}], ["We conducted a qualitative study of focus groups to better understand physicians' perceptions of CDSSs and to transform the conceptual osteoporosis tool into a functional prototype that can support clinical decision making in osteoporosis disease management at the point of care.", {"entities": [[135, 147, "DISEASE"], [226, 238, "DISEASE"]]}], ["The conceptual design of the osteoporosis tool was tested in 4 progressive focus groups with family physicians and general internists.", {"entities": [[29, 41, "DISEASE"]]}], ["An iterative strategy was used to qualitatively explore the experiences of physicians with CDSSs; and to find out what features, functions, and evidence should be included in a working prototype.", {"entities": []}], ["Focus groups were conducted using a semi-structured interview guide using an iterative process where results of the first focus group informed changes to the questions for subsequent focus groups and to the conceptual tool design.", {"entities": []}], ["Transcripts were transcribed verbatim and analyzed using grounded theory methodology.", {"entities": []}], ["Of the 3 broad categories of themes that were identified, major barriers related to the accuracy and feasibility of extracting bone mineral density test results and medications from the risk assessment questionnaire; using an electronic input device such as a Tablet PC in the waiting room; and the importance of including well-balanced information in the patient education component of the osteoporosis tool.", {"entities": [[391, 403, "DISEASE"], [267, 269, "GENE"]]}], ["Suggestions for modifying the tool included the addition of a percentile graph showing patients' 10-year risk for osteoporosis or fractures, and ensuring that the tool takes no more than 5 minutes to complete.", {"entities": [[114, 126, "DISEASE"]]}], ["Focus group data revealed the facilitators and barriers to using the osteoporosis tool at the point of care so that it can be optimized to aid physicians in their clinical decision making.", {"entities": [[69, 81, "DISEASE"]]}], ["With the increasingly polarized distribution of dental caries among children and adolescents, the usual DMFT measure has become a less meaningful population descriptor.", {"entities": [[48, 61, "DISEASE"]]}], ["To re-focus on identifying the high caries prevalence group the Significant Caries Index (SiC) was created.", {"entities": []}], ["The aims of this study were to analyze the prevalence and severity of dental caries in Nevada youth over a period of eight years and to compare its expression by means of DMFT and SiC; analyze the caries trends in the population and their underlying factors, and determine whether Nevada youth were at risk for significantly high levels of dental caries.", {"entities": [[70, 83, "DISEASE"], [340, 353, "DISEASE"]]}], ["Retrospective data was analyzed from a series of sequential, standardized oral health surveys across eight years (2001/2002-2008/2009) that included over 62,000 examinations of adolescents 13-19 years of age, attending public/private Nevada schools.", {"entities": []}], ["Mean Decayed-Missing-Filled Teeth index (DMFT) and Significant Caries Index (SiC) were subsequently computed for each academic year.", {"entities": []}], ["Descriptive statistics were reported for analysis of comparative DMFT and SiC scores in relation to age, gender, racial background, and residence in a fluoridated/non-fluoridated community.", {"entities": []}], ["Logistic regression analysis was used to analyze the differential impact of the variables on the probability of being in the high caries prevalence group.", {"entities": []}], ["Comparison of students' mean DMFT to National (NHANES) data confirmed that dental caries remains a common chronic disease among Nevada youth, presenting higher prevalence rates and greater mean scores than the national averages.", {"entities": [[75, 88, "DISEASE"]]}], ["Downward trends were found across all demographics compared between survey years 1 and 6 with the exception of survey year 3.", {"entities": []}], ["An upward trend began in survey year six.", {"entities": []}], ["Over time, the younger group displayed an increasing proportion of cariesfree individuals while a decreasing proportion was found among older examinees.", {"entities": []}], ["As expected, the mean SiC score was significantly higher than DMFT scores within each survey year across comparison groups (p < 0.001).", {"entities": []}], ["Using both caries indices together may help to highlight oral health inequalities more accurately among different population groups within the community in order to identify the need for special preventive oral health interventions in adolescent Nevadans.", {"entities": []}], ["At the community level, action should focus on retaining and expanding the community fluoridation program as an effective preventive measure.", {"entities": []}], ["At the individual level the study identifies the need for more targeted efforts to reach children early with a focus on females, Hispanics and Blacks, and uninsured children.", {"entities": []}], ["Sinonasal polyposis (SNP) is a chronic inflammatory pathology with an unclear aetiopathogenesis.", {"entities": []}], ["Human papillomavirus (HPV) infection is one candidate for the development of SNP for its epithelial cell trophism, hyperproliferative effect, and the induction of immune-modulatory molecules as HLA-G. We enrolled 10 patients with SNP without concomitant allergic diseases (SNP-WoAD), 10 patients with SNP and suffering from allergic diseases (SNP-WAD), and 10 control subjects who underwent rhinoplasty.", {"entities": []}], ["We analyzed the presence of high- and low-risk HPV DNA and the expression of membrane HLA-G (mHLA-G) and IL-10 receptor (IL-10R) and of soluble HLA-G (sHLA-G) and IL-10 by polyp epithelial cells.", {"entities": [[86, 91, "GENE"], [144, 149, "GENE"], [86, 91, "GENE"], [144, 149, "GENE"]]}], ["The results showed the presence of HPV-11 in 50% of SNP-WoAD patients (OR:5.5), all characterized by a relapsing disease.", {"entities": []}], ["HPV-11 infection was absent in nonrelapsing SNP-WoAD patients, in SNP-WAD patients and in controls, supporting the hypothesis that HPV-11 increases risk of relapsing disease.", {"entities": []}], ["HPV-11 positive SNP-WoAD patients presented with mHLA-G and IL-10R on epithelial cells from nasal polyps and showed secretion of sHLA-G and IL-10 in culture supernatants.", {"entities": []}], ["No HLA-G expression was observed in HPV negative polyps.", {"entities": [[3, 8, "GENE"]]}], ["These data highlight new aspects of polyposis aetiopathogenesis and suggest HPV-11 and HLA-G/IL-10 presence as prognostic markers in the follow-up of SNP-WoAD.", {"entities": []}], ["We investigated the effects of microRNA-587b (miR-487b) in a rat model of chronic heart failure (CHF).", {"entities": [[46, 54, "GENE"]]}], ["Wistar rats were assigned to 10 groups (n=8 per group).", {"entities": []}], ["Expression of interleukin-33 (IL-33), somatostatin 2 (ST2), IL-6, and TNF-\u03b1 was higher in the CHF group than the control group.", {"entities": []}], ["In the CHF, negative control (NC) for si-IL-33, NC for miR-487b mimic, NC for miR-487b inhibitor, and miR-487b inhibitor + si IL-33 groups, as compared to the blank and sham groups: steroid binding protein (SBP), D binding protein (DBP), left ventricular systolic pressure (LVSP), \u00b1 dp/dt max , and superoxide dismutase (SOD) were all lower; myocardial fibrosis, MDA, left ventricular end-diastolic pressure (LVEDP), myocardial apoptosis rate, IL-6, and TNF-\u03b1 were all higher; levels of IL-33 and ST2 mRNA and protein were higher; and levels of miR-487b were lower.", {"entities": [[55, 63, "GENE"], [78, 86, "GENE"], [102, 110, "GENE"], [545, 553, "GENE"], [55, 63, "GENE"], [78, 86, "GENE"], [102, 110, "GENE"], [545, 553, "GENE"], [55, 63, "GENE"], [78, 86, "GENE"], [102, 110, "GENE"], [545, 553, "GENE"], [232, 235, "GENE"], [289, 292, "GENE"], [55, 63, "GENE"], [78, 86, "GENE"], [102, 110, "GENE"], [545, 553, "GENE"]]}], ["Levels of IL-33 and ST2 mRNA and protein were lower, and SBP, DBP, LVSP, \u00b1 dp/dt max , and SOD were higher in the miR-487b mimic and si-IL-33 groups than the CHF group.", {"entities": [[62, 65, "GENE"], [81, 84, "GENE"], [114, 122, "GENE"]]}], ["Expression of miR-487b was increased in the miR-487b mimic group, and expression of IL-33 and ST2 were increased and expression of miR-487b was decreased in the miR-487b inhibitor group.", {"entities": [[14, 22, "GENE"], [44, 52, "GENE"], [131, 139, "GENE"], [161, 169, "GENE"], [14, 22, "GENE"], [44, 52, "GENE"], [131, 139, "GENE"], [161, 169, "GENE"], [14, 22, "GENE"], [44, 52, "GENE"], [131, 139, "GENE"], [161, 169, "GENE"], [14, 22, "GENE"], [44, 52, "GENE"], [131, 139, "GENE"], [161, 169, "GENE"]]}], ["MiR-487b reduces apoptosis, inflammatory responses, and fibrosis in CHF by suppressing IL-33 through inhibition the IL-33/ST2 signaling pathway.", {"entities": [[0, 8, "GENE"]]}], ["Arc welding produces the full spectrum of ultraviolet radiation and may be a contributory cause of skin cancer; however, there has been little research into this occupational hazard.", {"entities": [[99, 110, "DISEASE"], [104, 110, "DISEASE"]]}], ["The aim of this study is to explore if metal arc welding increases the risk of malignant melanoma and/or basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) on skin areas which may possibly be exposed (neck, head, and upper extremities).", {"entities": [[116, 125, "DISEASE"], [150, 159, "DISEASE"], [105, 125, "DISEASE"], [136, 159, "DISEASE"], [89, 97, "DISEASE"]]}], ["A Danish national company-based historic cohort of 4333 male metal arc welders was followed from 1987 through 2012 to identify the risk of skin cancer.", {"entities": [[139, 150, "DISEASE"], [144, 150, "DISEASE"]]}], ["An external reference group was established including all Danish skilled and unskilled male workers with similar age distribution.", {"entities": []}], ["Occupational histories were gathered by questionnaires in 1986 and information about skin cancer diagnoses [BCC, SCC, cutaneous malignant melanoma (CMM), and precancerous conditions, actinic keratosis (AK)] were gathered from the Danish Cancer Registry supplemented by the data from the Danish Pathology Register.", {"entities": [[183, 200, "DISEASE"], [85, 96, "DISEASE"], [191, 200, "DISEASE"], [138, 146, "DISEASE"], [90, 96, "DISEASE"], [237, 243, "DISEASE"]]}], ["Hazard ratios (HRs) were calculated in the follow-up period from 1987 until 2012 using Cox regression analysis and adjusted for baseline data regarding age and social group.", {"entities": []}], ["The adjusted HR and 95% confidence interval (CI) for skin cancer (all types) were 0.99 (CI 0.94\u20131.04) for welders.", {"entities": [[53, 64, "DISEASE"], [58, 64, "DISEASE"], [13, 15, "GENE"]]}], ["The adjusted HR for AK and BCC located only at neck was 2.49 (CI 1.03\u20135.99) for welders exposed >20\u00a0years ( n \u00a0=\u00a05) and 2.46 (CI 1.02\u20135.94), respectively, for welders exposed >30\u00a0years ( n \u00a0=\u00a05).", {"entities": [[13, 15, "GENE"]]}], ["No statistically significant difference was observed for SCC.", {"entities": []}], ["The risk of CMM at the neck was also significantly elevated after 30\u00a0years of welding, but this is based upon only one exposed case.", {"entities": []}], ["This study indicates that long-term exposure to metal arc welding may be related to increased risk of BCC and AK located exclusively at the neck.", {"entities": []}], ["The study provides no support for the hypothesis that welding exposure increases the risk for skin cancer at other locations.", {"entities": [[94, 105, "DISEASE"], [99, 105, "DISEASE"]]}], ["Previous studies have shown that ragweed pollen arrives in Poland from sources in the south, in Slovakia, the Czech Republic, Hungary and Austria.", {"entities": []}], ["It is likely that ragweed pollen also arrives from sources in the southeast (e.g.", {"entities": []}], ["This hypothesis was investigated using 13\u00a0years of pollen data and back-trajectory analysis.", {"entities": []}], ["Ambrosia pollen data were collected at three sites in Poland, Rzesz\u00f3w, Krak\u00f3w and Pozna\u0144.", {"entities": []}], ["The amount of ragweed pollen recorded at Rzesz\u00f3w was significantly higher than in Pozna\u0144 and Krak\u00f3w.", {"entities": []}], ["This can be related to either a higher abundance of local populations of Ambrosia in south-east Poland or the proximity of Rzesz\u00f3w to foreign sources of ragweed pollen.", {"entities": []}], ["The combined results of pollen measurements and air mass trajectory calculations identified plumes of Ambrosia pollen that were recorded at Rzesz\u00f3w, Krak\u00f3w and Pozna\u0144 on 4 and 5 September 1999 and 3 September 2002.", {"entities": []}], ["These plumes arrived at the pollen-monitoring sites from an easterly direction, indicating sources of Ambrosia pollen in eastern Poland or Ukraine.", {"entities": []}], ["This identifies Ukraine as a possible new source of ragweed pollen for Poland and therefore an important source area of Ambrosia pollen on the European Continent.", {"entities": []}], ["Chronic cough, defined it lasts more than 8 weeks.", {"entities": []}], ["The symptom is common, but highly troublesome, and it reduces quality of life.", {"entities": []}], ["Despite much effort to develop a protocol for diagnosis and treatment of chronic cough, it remains problematic to determine its cause.", {"entities": []}], ["As a result, treatment is often unsuccessful.", {"entities": []}], ["Thus, there is much interest regarding the use of symptomatic drugs to control chronic cough.", {"entities": []}], ["Maekmoondong-tang is widely used in East Asian countries to treat chronic dry cough.", {"entities": []}], ["Several experimental studies have reported that the herbal medicine has immunomodulatory and antitussive effects.", {"entities": []}], ["Clinical studies involving Maekmoondong-tang have also been carried out; however, these studies have involved treating various diseases as a whole rather than chronic cough itself.", {"entities": []}], ["Thus, we aim to evaluate the efficacy and safety of Maekmoondong-tang in chronic dry cough patients with a randomized controlled trial.", {"entities": []}], ["This study is designed as an exploratory, single-center, placebo-controlled, double-blind, randomized, parallel group clinical trial.", {"entities": []}], ["Patients with dry cough that has lasted more than 8 weeks will be recruited, after a 1-week run-in period, and randomly allocated to either the Maekmoondong-tang treatment group or the placebo group.", {"entities": []}], ["The patients will receive Maekmoondong-tang or placebo granules 3 times daily for 4 weeks, with a 2-week follow-up.", {"entities": []}], ["The primary outcome is a 10-point cough diary that will be recorded on a daily basis.", {"entities": []}], ["The secondary outcomes comprise a cough visual analog scale, the Leicester Cough Questionnaire (Korean version), the Pattern Identification for Chronic Cough Questionnaire, biomarkers, safety testing, etc.", {"entities": []}], ["Adverse events will also be reported.", {"entities": []}], ["This trial will assess the efficacy and safety of Maekmoondong-tang in chronic dry cough.", {"entities": []}], ["Korean Clinical Trial Registry ( http://cris.nih.go.kr ; registration number: KCT0001646).", {"entities": []}], ["Date of registration: October 5 2015", {"entities": []}], ["Protease-activated receptors (PAR) are seven transmembrane G-coupled receptors comprising four genes (PAR-1 ~ PAR-4).", {"entities": []}], ["Mast cell has been identified to be able to express PARs and release an array of cytokines upon activation.", {"entities": []}], ["Recently, it was reported that interleukin (IL)-12 could regulate the expression of PARs in mast cells, and tryptase could induce IL-4 and IL-6 release from mast cells.", {"entities": []}], ["In order to further investigate the issues, RNA interference (RNAi) technique was employed and small interfering RNAs (siRNA) of PARs were transfected in P815 cells.", {"entities": []}], ["The results showed that siRNAs for PAR-1, PAR-2 and PAR-4 significantly downregulated expression of PAR-1, PAR-2 and PAR-4 mRNAs and proteins in P815 cells at 24, 48 and 72 h following transfection.", {"entities": []}], ["siRNA PAR-1.2 and siRNA PAR-4.2 significantly reduced IL-12 induced upregulation of PAR-1 and PAR-4 expression, respectively when P815 cells were transfected with them for 48 h. siRNA PAR-2.3 blocked IL-12 induced downregulation of PAR-2 expression on both mRNA and protein levels.", {"entities": []}], ["It was also observed that siRNA PAR-2.3 and siRNA PAR-1.2 reduced trypsin induced IL-4 release by approximately 92.6% and 65.3%, and SLIGKV-NH 2 induced IL-4 release by 82.1% and 60.1%, respectively.", {"entities": []}], ["Similarly, siRNA PAR-2.3 eliminated tryptase-induced IL-4 release by 75.3%, and siRNA PAR-1.2 diminished SFLLR-NH 2 induced IL-4 release by 79.3%.", {"entities": []}], ["However, siRNA PAR-1.2, siRNA PAR-2.3 and siRNA PAR-4.3 at 10 nM did not show any effect on tryptase-induced IL-6 release from P815 cells.", {"entities": []}], ["In conclusion, siRNAs of PARs can modulate PAR expression and PAR related cytokine production in mast cells, confirming that PARs are likely to play a role in allergic reactions.", {"entities": []}], ["Persistent postoperative supraventricular tachyarrhythmias (SVTs) increase cardiac burden and aggravate cardiac hemodynamics.", {"entities": []}], ["Therefore, for patients in unstable conditions after surgery, prompt and sustained control of heart rate is essential.", {"entities": []}], ["The importance of \u03b2-adrenoceptor antagonists (\u03b2-blockers) in controlling such postoperative atrial fibrillation or atrial flutter has been established, and the usefulness of ultra-short-acting \u03b2 1 -blockers with high \u03b2 1 selectivity has been suggested based on their safety and efficacy under such circumstances.", {"entities": []}], ["Our objectives were to evaluate the effectiveness and safety of landiolol hydrochloride, an ultra-short-acting \u03b2 1 -selective blocker, in the treatment of postoperative SVT in patients with a high risk of myocardial ischemia, or in patients after highly invasive surgery, in a multicenter, randomized, double-blind, placebo-controlled, group-comparative study.", {"entities": [[216, 224, "DISEASE"]]}], ["A total of 165 patients were randomly allocated to three groups and received LM or MH doses of landiolol hydrochloride or placebo.", {"entities": []}], ["LM group: dose L (1-min loading dose at a rate of 0.03\u00a0mg/kg/min, followed by a 10-min infusion at 0.01\u00a0mg/kg/min) followed by dose M (1-min loading at a rate of 0.06\u00a0mg/kg/min, followed by a 10-min infusion at 0.02\u00a0mg/kg/min); MH group: dose M followed by dose H (1-min loading dose at a rate of 0.125\u00a0mg/kg/min, followed by a 10-min infusion at 0.04\u00a0mg/kg/min); placebo (PP) group: dose P (1-min loading dose at a rate of 0\u00a0mg/kg/min, followed by a 10-min infusion at 0\u00a0mg/kg/min) followed by another round of dose P. If the targeted heart-rate reduction was not obtained at the end of the first 10-min infusion, the higher dose was started.", {"entities": []}], ["The primary endpoint was the percentage of patients who met the heart-rate reduction criteria (\u226520\u00a0% reduction and <100\u00a0beats/min).", {"entities": []}], ["The safety endpoint was the incidence of adverse events in each of the three groups.", {"entities": []}], ["The percentages of patients who met the heart-rate reduction criteria (\u226520\u00a0% reduction and <100\u00a0beats/min) were 0.0, 60.4, and 42.0\u00a0% in the PP, LM, and MH groups, respectively.", {"entities": []}], ["There were significant differences in the LM and MH groups relative to the PP group, but there was no significant difference between the LM and MH groups.", {"entities": []}], ["No significant difference was observed in the incidence of adverse events among the three groups: 29.6\u00a0% in the PP group, 45.5\u00a0% in the LM group, and 43.1\u00a0% in the MH group.", {"entities": []}], ["Landiolol hydrochloride is effective and safe for patients with postoperative SVT.", {"entities": []}], ["Conduct of stable inhalational anesthetic induction in children with congenital heart disease (CHD) presents special challenges.", {"entities": [[80, 93, "DISEASE"]]}], ["It requires in-depth understanding of the effect of congenital shunt lesions on the uptake, delivery, and equilibration of anesthetic drugs.", {"entities": []}], ["Intracardiac shunts can alter the induction time and if delivery of anesthetic agent is not carefully titrated, can lead to overdosing and undesirable myocardial depression.", {"entities": []}], ["To study the effect of congenital shunt lesions on the speed of inhalational induction and also the impact of inhalational induction on hemodynamics in the presence of congenital shunt lesions.", {"entities": []}], ["Tertiary care hospital.", {"entities": []}], ["A prospective, single-center clinical study.", {"entities": []}], ["Ninety-three pediatric patients undergoing elective surgery were segregated into three equal groups, namely, Group 1: no CHD, Group 2: acyanotic CHD, and Group 3: cyanotic CHD.", {"entities": []}], ["General anesthesia was induced with 8% sevoflurane in 6 L/min air-oxygen.", {"entities": []}], ["The time to induction was noted at loss of eyelash reflex and decrease in bispectral index (BIS) value below 60.", {"entities": []}], ["End-tidal sevoflurane concentration, minimum alveolar concentration, and BIS were recorded at 15 s intervals for the 1 Patients in Group 3 had significantly prolonged induction time (99 \u00b1 12.3 s; P < 0.001), almost twice that of the patients in other two groups (51 \u00b1 11.3 s in Group 1 and 53 \u00b1 12.0 s in Group 2).", {"entities": []}], ["Hypotension occurred after induction in Group 1.", {"entities": []}], ["No other adverse hemodynamic perturbations were observed.", {"entities": []}], ["The time to inhalational induction of anesthesia is significantly prolonged in patients with right-to-left shunt, compared to patients without CHD or those with left-to-right shunt, in whom it is similar.", {"entities": []}], ["Sevoflurane is safe and maintains stable hemodynamics in the presence of CHD.", {"entities": []}], ["Background: Previous review studies have suggested that computer games can serve as an alternative or additional form of treatment in several areas (schizophrenia, asthma or motor rehabilitation).", {"entities": [[149, 162, "DISEASE"], [164, 170, "DISEASE"]]}], ["Although several naturalistic studies have been conducted showing the usefulness of serious video games in the treatment of some abnormal behaviours, there is a lack of serious games specially designed for treating mental disorders.", {"entities": []}], ["Aim: The purpose of our project was to develop and evaluate a serious video game designed to remediate attitudinal, behavioural and emotional processes of patients with impulse-related disorders.", {"entities": []}], ["Method and results: The video game was created and developed within the European research project PlayMancer.", {"entities": []}], ["It aims to prove potential capacity to change underlying attitudinal, behavioural and emotional processes of patients with impulse-related disorders.", {"entities": []}], ["New interaction modes were provided by newly developed components, such as emotion recognition from speech, face and physiological reactions, while specific impulsive reactions were elicited.", {"entities": []}], ["The video game uses biofeedback for helping patients to learn relaxation skills, acquire better self-control strategies and develop new emotional regulation strategies.", {"entities": []}], ["In this article, we present a description of the video game used, rationale, user requirements, usability and preliminary data, in several mental disorders.", {"entities": []}], ["Genetic studies of human local adaptation have been facilitated greatly by recent advances in high-throughput genotyping and sequencing technologies.", {"entities": []}], ["However, few studies have investigated local adaptation in Asian populations on a genome-wide scale and with a high geographic resolution.", {"entities": []}], ["In this study, taking advantage of the dense population coverage in Southeast Asia, which is the part of the world least studied in term of natural selection, we depicted genome-wide landscapes of local adaptations in 63 Asian populations representing the majority of linguistic and ethnic groups in Asia.", {"entities": []}], ["Using genome-wide data analysis, we discovered many genes showing signs of local adaptation or natural selection.", {"entities": []}], ["Notable examples, such as FOXQ1 , MAST2 , and CDH4 , were found to play a role in hair follicle development and human cancer, signal transduction, and tumor repression, respectively.", {"entities": [[118, 124, "DISEASE"], [26, 31, "GENE"], [34, 39, "GENE"], [46, 50, "GENE"]]}], ["These showed strong indications of natural selection in Philippine Negritos, a group of aboriginal hunter-gatherers living in the Philippines.", {"entities": []}], ["MTTP , which has associations with metabolic syndrome, body mass index, and insulin regulation, showed a strong signature of selection in Southeast Asians, including Indonesians.", {"entities": [[45, 53, "DISEASE"], [0, 4, "GENE"]]}], ["Functional annotation analysis revealed that genes and genetic variants underlying natural selections were generally enriched in the functional category of alternative splicing.", {"entities": []}], ["Specifically, many genes showing significant difference with respect to allele frequency between northern and southern Asian populations were found to be associated with human height and growth and various immune pathways.", {"entities": []}], ["In summary, this study contributes to the overall understanding of human local adaptation in Asia and has identified both known and novel signatures of natural selection in the human genome.", {"entities": []}], ["Smoke inhalation injury is a serious medical problem that increases morbidity and mortality after severe burns.", {"entities": []}], ["The National Repository of the American Burn Association houses data from 203,422 patients treated at 99 U.S. burn hospitals and centers between 2005 and 2014.", {"entities": []}], ["These data show that the presence of smoke inhalation injury increases mortality (by nearly 24-fold) in burn patients under 60 years and in those with a total burned surface area between 0.1 and 19.9%.", {"entities": []}], ["Non-steroidal anti-inflammatory drugs (NSAIDs) are the most consumed drugs worldwide because of their efficacy and utility in the treatment of pain and inflammatory diseases.", {"entities": []}], ["However, they are also responsible for an important number of adverse effects including hypersensitivity reactions.", {"entities": []}], ["The most important group of these reactions is triggered by non-immunological, pharmacological mechanisms catalogued under the denomination of cross-intolerance (CRI), with acute urticaria/angioedema induced by multiple NSAIDs (MNSAID-UA) the most frequently associated clinical entity.", {"entities": [[179, 188, "DISEASE"], [189, 199, "DISEASE"]]}], ["A recent genome-wide association study identified the gene encoding the centrosomal protein of 68 KDa ( CEP68 ) as the major locus associated with aspirin intolerance susceptibility in asthmatics.", {"entities": [[104, 109, "GENE"]]}], ["In this study, we aimed to assess the role of this locus in susceptibility to CRI to NSAIDs by examining 53 common gene variants in a total of 635 patients that were classified as MNSAID-UA (n\u200a=\u200a399), airway exacerbations (n\u200a=\u200a110) or blended pattern (n\u200a=\u200a126), and 425 controls.", {"entities": []}], ["We found in the MNSAID-UA group a number of variants (17) associated (lowest p -value\u200a=\u200a1.13\u00d710 CEP68 gene variants may play an important role in MNSAID-UA susceptibility and, despite the different regulatory mechanisms involved depending on the specific affected organ, in the development of hypersensitivity reactions to NSAIDs.", {"entities": [[96, 101, "GENE"]]}], ["The aim of this study was to design and assess the effects of hydroalcoholic extract of Matricaria chamomilla (MC) on preantral follicle culture of mouse ovaries in a three-dimensional culture system.", {"entities": []}], ["Isolated preantral follicles were randomly divided into three main groups: the control group containing 10% fetal bovine serum without MC extract (G1), the first experimental group supplemented with 25 \u03bcg/ml hydroalcoholic extract of chamomile (G2), and the second experimental group supplemented with 50 \u03bcg/ml hydroalcoholic extract of chamomile (G3).", {"entities": []}], ["After 12 days of culture, the survival rate ( P < 0.05), antrum formation ( P < 0.01), metaphase two oocytes ( P < 0.01), and the expression of PCNA ( P < 0.05) and FSHR ( P < 0.05) genes significantly decreased in G3 as compared with G1.", {"entities": [[144, 148, "GENE"], [165, 169, "GENE"]]}], ["On the other hand, at the last day of culture (day 12), the mean diameter of follicles cultured in the medium which was supplemented with 50 \u03bcg/ml hydroalcoholic extract of chamomile significantly decreased as compared with the G1 ( P < 0.05).", {"entities": []}], ["In addition, the levels of progesterone and dehydroepiandrosterone hormones significantly increased in the medium of G3 relative to G1 ( P < 0.01), while in the medium of G1, the level of 17\u03b2-estradiol was significantly higher than that of other groups ( P < 0.01).", {"entities": []}], ["Reactive oxygen species levels of metaphase II oocytes were significantly decreased in G2 as compared with G1 ( P < 0.01).", {"entities": []}], ["Adding chamomile extract to culture media appeared to decrease follicular function and development.", {"entities": []}], ["The forced oscillation technique provides information concerning respiratory impedance, which comprises resistance and reactance of the respiratory system.", {"entities": []}], ["However, its relationship with morphological changes of the lungs in chronic obstructive pulmonary disease (COPD) remains unclear.", {"entities": [[69, 106, "DISEASE"]]}], ["Respiratory impedance and spirometric data were evaluated in 98 patients with COPD and 49 reference subjects.", {"entities": []}], ["Wall thickness (WT) and airway intraluminal area (Ai) of third- to sixth-generation bronchi, and percentage low-attenuation area with less than \u2212950 HU (%LAA) of lungs were measured using three-dimensional computed tomography.", {"entities": []}], ["COPD patients had higher respiratory impedance, decreased Ai, and increased %LAA compared with reference subjects.", {"entities": []}], ["Indices of respiratory resistance and reactance and forced expiratory volume in 1\u2009second (FEV 1 ) were correlated with Ai, and the association between percent predicted FEV 1 and Ai was predominant in distal bronchi.", {"entities": [[90, 93, "GENE"], [169, 172, "GENE"], [90, 93, "GENE"], [169, 172, "GENE"]]}], ["The difference in respiratory resistance between 5\u2009Hz and 20\u2009Hz (R5\u2013R20) and FEV 1 /forced vital capacity ratio (FEV 1 /FVC) were correlated with WT.", {"entities": [[77, 80, "GENE"], [113, 116, "GENE"], [77, 80, "GENE"], [113, 116, "GENE"]]}], ["The %LAA was correlated with the FEV 1 /FVC ratio and respiratory reactance.", {"entities": [[33, 36, "GENE"]]}], ["Airway function measurements with the forced oscillation technique provide complementary information to spirometry in COPD.", {"entities": []}], ["Immune responses to Helicobacter pylori are orchestrated through complex balances of host-bacterial interactions, including inflammatory and regulatory immune responses across scales that can lead to the development of the gastric disease or the promotion of beneficial systemic effects.", {"entities": []}], ["While inflammation in response to the bacterium has been reasonably characterized, the regulatory pathways that contribute to preventing inflammatory events during H .", {"entities": []}], ["pylori infection are incompletely understood.", {"entities": []}], ["To aid in this effort, we have generated a computational model incorporating recent developments in the understanding of H .", {"entities": []}], ["pylori -host interactions.", {"entities": []}], ["Sensitivity analysis of this model reveals that a regulatory macrophage population is critical in maintaining high H .", {"entities": []}], ["pylori colonization without the generation of an inflammatory response.", {"entities": []}], ["To address how this myeloid cell subset arises, we developed a second model describing an intracellular signaling network for the differentiation of macrophages.", {"entities": []}], ["Modeling studies predicted that LANCL2 is a central regulator of inflammatory and effector pathways and its activation promotes regulatory responses characterized by IL-10 production while suppressing effector responses.", {"entities": [[32, 38, "GENE"]]}], ["The predicted impairment of regulatory macrophage differentiation by the loss of LANCL2 was simulated based on multiscale linkages between the tissue-level gastric mucosa and the intracellular models.", {"entities": [[81, 87, "GENE"]]}], ["The simulated deletion of LANCL2 resulted in a greater clearance of H .", {"entities": [[26, 32, "GENE"]]}], ["pylori , but also greater IFN\u03b3 responses and damage to the epithelium.", {"entities": []}], ["The model predictions were validated within a mouse model of H .", {"entities": []}], ["pylori colonization in wild-type (WT), LANCL2 whole body KO and myeloid-specific LANCL2-/- (LANCL2 H .", {"entities": [[39, 45, "GENE"], [81, 87, "GENE"], [92, 98, "GENE"], [39, 45, "GENE"], [81, 87, "GENE"], [92, 98, "GENE"]]}], ["pylori burden, CX3CR1+ IL-10-producing macrophages, and type 1 regulatory (Tr1) T cells.", {"entities": []}], ["This study shows the importance of LANCL2 in the induction of regulatory responses in macrophages and T cells during H .", {"entities": [[35, 41, "GENE"]]}], ["pylori infection.", {"entities": []}], ["Most studies on global health inequality consider unequal health care and socio-economic conditions but neglect inequality in the production of health knowledge relevant to addressing disease burden.", {"entities": []}], ["We demonstrate this inequality and identify likely causes.", {"entities": []}], ["Using disability-adjusted life years (DALYs) for 111 prominent medical conditions, assessed globally and nationally by the World Health Organization, we linked DALYs with MEDLINE articles for each condition to assess the influence of DALY-based global disease burden, compared to the global market for treatment, on the production of relevant MEDLINE articles, systematic reviews, clinical trials and research using animal models vs. humans.", {"entities": []}], ["We then explored how DALYs, wealth, and the production of research within countries correlate with this global pattern.", {"entities": []}], ["We show that global DALYs for each condition had a small, significant negative relationship with the production of each type of MEDLINE articles for that condition.", {"entities": []}], ["Local processes of health research appear to be behind this.", {"entities": []}], ["Clinical trials and animal studies but not systematic reviews produced within countries were strongly guided by local DALYs.", {"entities": []}], ["More and less developed countries had very different disease profiles and rich countries publish much more than poor countries.", {"entities": []}], ["Accordingly, conditions common to developed countries garnered more clinical research than those common to less developed countries.", {"entities": []}], ["Many of the health needs in less developed countries do not attract attention among developed country researchers who produce the vast majority of global health knowledge\u2014including clinical trials\u2014in response to their own local needs.", {"entities": []}], ["This raises concern about the amount of knowledge relevant to poor populations deficient in their own research infrastructure.", {"entities": []}], ["We recommend measures to address this critical dimension of global health inequality.", {"entities": []}], ["Over 25% of the world's population are infected with helminth parasites, the majority of which colonise the gastrointestinal tract.", {"entities": []}], ["However, no vaccine is yet available for human use, and mechanisms of protective immunity remain unclear.", {"entities": []}], ["In the mouse model of Heligmosomoides polygyrus infection, vaccination with excretory-secretory (HES) antigens from adult parasites elicits sterilising immunity.", {"entities": []}], ["Notably, three purified HES antigens (VAL-1, -2 and -3) are sufficient for effective vaccination.", {"entities": []}], ["Protection is fully dependent upon specific IgG1 antibodies, but passive transfer confers only partial immunity to infection, indicating that cellular components are also required.", {"entities": []}], ["Moreover, immune mice show greater cellular infiltration associated with trapping of larvae in the gut wall prior to their maturation.", {"entities": []}], ["Intra-vital imaging of infected intestinal tissue revealed a four-fold increase in extravasation by LysM Despite the high prevalence of gastrointestinal helminth parasites in human and animal populations throughout the world, no vaccines are yet available and we lack understanding of how anti-parasite protective immunity may operate effectively.", {"entities": []}], ["We have used a model system with a natural mouse nematode parasite, Heligmosomoides polygyrus , which establishes long-term chronic infection in laboratory mice through the secretion of immunosuppressive molecules.", {"entities": []}], ["Immunization of mice with as few as 3 secreted proteins, collected from parasites in vitro, confers complete immunity to challenge infection.", {"entities": []}], ["We show here that immunity requires specific IgG1 antibodies directed to the secreted products, acting together with innate myeloid cells that require activation through the canonical Type 2 cytokine receptor, IL-4R\u03b1, as well as through a pathway not previously known to be involved in effector mechanisms, IL-25.", {"entities": []}], ["These myeloid cells act to trap and envelop helminth larvae while in the submucosal tissues of the small intestine, massing in large numbers and preventing their maturation and exit into the gut lumen.", {"entities": []}], ["Thus the combined effects of specific antibodies from the adaptive immune system, and Type 2 cytokine activation of the innate immune system, co-operate to ensure elimination of the helminth parasite.", {"entities": []}], ["We examined the geographic distribution of the blood lead levels (BLLs) of 677,112 children born between 1994 and 1997 in New York State and screened before 2 years of age.", {"entities": []}], ["Five percent of the children screened had BLLs higher than the current Centers for Disease Control and Prevention action level of 10 \u03bcg/dL.", {"entities": []}], ["Rates were higher in upstate cities than in the New York City area.", {"entities": []}], ["We modeled the relationship between BLLs and housing and socioeconomic characteristics at the ZIP code level.", {"entities": []}], ["Older housing stock, a lower proportion of high school graduates, and a higher percentage of births to African-American mothers were the community characteristics most associated with elevated BLLs.", {"entities": []}], ["Although the prevalence of children with elevated BLLs declined 44% between those born in 1994 and those born in 1997, the rate of improvement may be slowing down.", {"entities": []}], ["Lead remains an environmental health problem in inner-city neighborhoods, particularly in upstate New York.", {"entities": []}], ["We identified areas having a high prevalence of children with elevated BLLs.", {"entities": []}], ["These communities can be targeted for educational and remediation programs.", {"entities": []}], ["The model locates areas with a higher or lower prevalence of elevated BLLs than expected.", {"entities": []}], ["These communities can be studied further at the individual level to better characterize the factors that contribute to these differences.", {"entities": []}], ["The German National Cohort (GNC) is a joint interdisciplinary endeavour of scientists from the Helmholtz and the Leibniz Association, universities, and other research institutes.", {"entities": []}], ["Its aim is to investigate the causes for the development of major chronic diseases, i.e.", {"entities": []}], ["cardiovascular diseases, cancer, diabetes, neurodegenerative/-psychiatric diseases, musculoskeletal diseases, respiratory and infectious diseases, and their pre-clinical stages or functional health impairments.", {"entities": [[25, 31, "DISEASE"]]}], ["Across Germany, a random sample of the general population will be drawn by 18 regional study centres, including a total of 100,000 women and 100,000 men aged 20\u201369\u00a0years.", {"entities": []}], ["The baseline assessments include an extensive interview and self-completion questionnaires, a wide range of medical examinations and the collection of various biomaterials.", {"entities": []}], ["In a random subgroup of 20\u00a0% of the participants (n\u00a0=\u00a040,000) an intensified examination (\u201cLevel 2\u201d) programme will be performed.", {"entities": []}], ["In addition, in five of the 18 study centres a total of 30,000 study participants will take part in a magnetic resonance imaging examination programme, and all of these participants will also be offered the intensified Level 2 examinations.", {"entities": []}], ["After 4\u20135\u00a0years, all participants will be invited for a re-assessment.", {"entities": []}], ["Information about chronic disease endpoints will be collected through a combination of active follow-up (including questionnaires every 2\u20133\u00a0years) and record linkages.", {"entities": []}], ["The GNC is planned for an overall duration of 25\u201330\u00a0years.", {"entities": []}], ["It will provide a major, central resource for population-based epidemiology in Germany, and will help to identify new and tailored strategies for early detection, prediction, and primary prevention of major diseases.", {"entities": []}], ["Interleukin (IL)-33 promotes T helper (Th)2 immunity and systemic inflammation.", {"entities": []}], ["The role of IL-33 in asthma has been widely investigated.", {"entities": [[21, 27, "DISEASE"]]}], ["IL-33 has also been suggested to play an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[79, 116, "DISEASE"]]}], ["This study investigated the clinical significance and usefulness of plasma IL-33 level in patients with COPD.", {"entities": []}], ["A total of 307 patients with stable COPD from 15 centers, who were in the Korean Obstructive Lung Disease cohort, were enrolled in this study.", {"entities": []}], ["Plasma IL-33 levels were measured by enzyme-linked immunosorbent assay.", {"entities": []}], ["We analyzed the association between IL-33 level and other clinical characteristics related to COPD.", {"entities": []}], ["We also examined the features of patients with COPD who exhibited high IL-33 levels.", {"entities": []}], ["IL-33 levels varied, but were very low in most patients.", {"entities": []}], ["Eosinophil count was significantly correlated with a plasma IL-33 level.", {"entities": []}], ["In addition, old age and current smoking were related to a low IL-33 level.", {"entities": []}], ["Significantly more patients with a higher IL-33 level had chronic bronchitis compared with those with a low IL-33 level.", {"entities": [[66, 76, "DISEASE"]]}], ["Plasma IL-33 level in patients with stable COPD was related to eosinophil count and chronic bronchitis phenotype.", {"entities": [[92, 102, "DISEASE"]]}], ["Further studies are needed to identify the precise mechanisms of IL-33/ST2 pathway in patients with COPD.", {"entities": []}], ["The health benefits of an active lifestyle have been extensively documented and generally accepted.", {"entities": []}], ["In the UK, declining physical activity levels are a major contributing factor to a number of public health concerns such as obesity and coronary heart disease.", {"entities": [[145, 158, "DISEASE"], [136, 158, "DISEASE"], [124, 131, "DISEASE"]]}], ["Clearly, there is an urgent need to support people in developing sustainable active lifestyles.", {"entities": []}], ["In 2003, a new lifestyle-based physical activity service called Active Lifestyles (AL) was set up in Kingston-upon-Hull to help local residents to become more active and develop healthier lifestyles.", {"entities": []}], ["The service targeted the most deprived communities in the city.", {"entities": []}], ["The aim of the study was to explore participants' perceptions of the operation and effectiveness of the AL service.", {"entities": []}], ["Five focus groups were conducted in community centres and offices in the health promotion service in Kingston-upon-Hull.", {"entities": []}], ["Sixteen white adult males ( n = 5) and females ( n = 11) participated in the study.", {"entities": []}], ["Ages ranged from 15\u201373 years (mean age = 53 years).", {"entities": []}], ["Data were analysed using a content analysis technique based on the 'framework' approach.", {"entities": []}], ["Three broad themes emerged from the focus groups; the referral process; operational aspects of the AL service; and perceived benefits of the service.", {"entities": []}], ["Overall, participants were extremely positive about the AL service.", {"entities": []}], ["Many reported increased activity levels, modified eating habits, and enhanced awareness and education regarding healthier living.", {"entities": []}], ["Most participants reported that local awareness of the AL service was low and greater promotion was required so more people could benefit.", {"entities": []}], ["The success of the service was highly dependent upon the qualities and approach of the AL advisor.", {"entities": []}], ["The service appears to have filled a gap in service provision since it offered support to the most sedentary, older, unfit and overweight individuals, many of whom live in the most deprived parts of Kingston-upon-Hull.", {"entities": []}], ["Traditional exercise referral schemes that focus solely on facility-based exercise should be broadened to encompass everyday lifestyle activity, where referral to a gym or exercise facility is just one of a number of physical activity options.", {"entities": []}], ["Most ventral hernia recurrences happen within 2 years of surgery.", {"entities": []}], ["There appears to be a continued although low subsequent yearly rate of recurrence for open repairs.", {"entities": []}], ["Ventral hernia repairs continue to have high recurrence rates.", {"entities": []}], ["The surgical literature is lacking data assessing the time trend to hernia recurrence after ventral hernia repairs and whether over time the recurrence rates change with laparoscopic technique compared to open repairs.", {"entities": []}], ["Our aim was to carry out a long-term comparative analysis of ventral hernia repairs performed at our hospital over the last 10-y period to assess if outcomes change during the follow-up period.", {"entities": []}], ["We conducted a retrospective observational study analyzing electronic medical records of all consecutive patients who had a ventral hernia repair from January 2001 to February 2010 at our hospital.", {"entities": []}], ["During the study period, 436 ventral hernia repairs were performed: laparoscopic repairs (n=156; 36%), laparoscopic converted to open (n=8; 2%), and open repairs (n=272; 62%).", {"entities": []}], ["We analyzed the time distribution to hernia recurrence after surgery and found that 85% of recurrences after laparoscopic repairs and 77% of recurrences after open repairs occurred within 2 y of surgery.", {"entities": []}], ["We did a Kaplan-Meier analysis for the subgroup of patients for whom we had a minimum 4-y follow-up and found that there continued to be a low subsequent yearly recurrence rate for open repairs after the initial 2-y follow-up.", {"entities": []}], ["Most hernia recurrences occur within 2 y after surgery for ventral hernias.", {"entities": []}], ["There appears to be a continued although low subsequent yearly rate of recurrence for open repairs.", {"entities": []}], ["Recent calls for reform in healthcare training emphasize using competency-based curricula and information technology-empowered learning.", {"entities": []}], ["Continuing Medical Education programs are essential in maintaining physician accreditation.", {"entities": []}], ["Haitian physicians have expressed a lack access to these activities.", {"entities": []}], ["The Haiti Medical Education Project works in alliance with Haitian medical leadership, faculty and students to support the Country\u2019s medical education system.", {"entities": []}], ["We present the creation, delivery and evaluation of a competency-based continuing medical education curriculum for physicians in rural Haiti.", {"entities": []}], ["Real time lectures from local and international institutions were teleconferenced to physicians in remote Haitian sites using VidyoConferencing\u2122 technology.", {"entities": []}], ["With American Academy of Family Physicians (AAFP) and College of Family Physicians Canada (CFPC) guidelines as references, a competency-derived syllabus was created for a Haitian continuing medical education program.", {"entities": []}], ["The resulting educational goals were reviewed by a committee of Haitian and North American physician/medical education practitioners to reflect local needs.", {"entities": []}], ["All authors reviewed lectures and then conferred to establish agreement on competencies presented for each lecture.", {"entities": []}], ["Sixty-seven lectures were delivered.", {"entities": []}], ["Human immunodeficiency virus/Acquired Immunodeficiency Syndrome, ophthalmologic, infectious diseases, renal and endocrine competencies were well-represented, with more than 50\u00a0% of the joint AAFP and CFPC recommended competencies outlined.", {"entities": []}], ["Areas under-represented included allergy and immunology, cardiology, surgery, pain management, gastroenterology, neurology, pulmonology, men\u2019s health and rheumatology; these topics accounted for less than 25\u00a0% of AAFP/CFPC recommended competencies.", {"entities": []}], ["Areas not covered included geriatrics, nutrition, occupational health and women\u2019s health.", {"entities": []}], ["Within practice-based lectures, only disaster medicine, health promotion and information management were included, but only partially covered.", {"entities": []}], ["We identified teaching goals covered and competencies that were missing from a CME program for rural Haitian physicians.", {"entities": []}], ["We aim to use this analysis to provide a competency-based CME lecture series that proportionally meets local needs while following recommendations of recognized national family medicine organizations.", {"entities": []}], ["Over the last few decades, the ever-increasing output of scientific publications has led to new challenges to keep up to date with the literature.", {"entities": []}], ["In the biomedical area, this growth has introduced new requirements for professionals, e.g., physicians, who have to locate the exact papers that they need for their clinical and research work amongst a huge number of publications.", {"entities": []}], ["Against this backdrop, novel information retrieval methods are even more necessary.", {"entities": []}], ["While web search engines are widespread in many areas, facilitating access to all kinds of information, additional tools are required to automatically link information retrieved from these engines to specific biomedical applications.", {"entities": []}], ["In the case of clinical environments, this also means considering aspects such as patient data security and confidentiality or structured contents, e.g., electronic health records (EHRs).", {"entities": []}], ["In this scenario, we have developed a new tool to facilitate query building to retrieve scientific literature related to EHRs.", {"entities": []}], ["We have developed CDAPubMed, an open-source web browser extension to integrate EHR features in biomedical literature retrieval approaches.", {"entities": []}], ["Clinical users can use CDAPubMed to: (i) load patient clinical documents, i.e., EHRs based on the Health Level 7-Clinical Document Architecture Standard (HL7-CDA), (ii) identify relevant terms for scientific literature search in these documents, i.e., Medical Subject Headings (MeSH), automatically driven by the CDAPubMed configuration, which advanced users can optimize to adapt to each specific situation, and (iii) generate and launch literature search queries to a major search engine, i.e., PubMed, to retrieve citations related to the EHR under examination.", {"entities": []}], ["CDAPubMed is a platform-independent tool designed to facilitate literature searching using keywords contained in specific EHRs.", {"entities": []}], ["CDAPubMed is visually integrated, as an extension of a widespread web browser, within the standard PubMed interface.", {"entities": []}], ["It has been tested on a public dataset of HL7-CDA documents, returning significantly fewer citations since queries are focused on characteristics identified within the EHR.", {"entities": []}], ["For instance, compared with more than 200,000 citations retrieved by breast neoplasm , fewer than ten citations were retrieved when ten patient features were added using CDAPubMed.", {"entities": []}], ["This is an open source tool that can be freely used for non-profit purposes and integrated with other existing systems.", {"entities": []}], ["Much of the biology surrounding macrophage functional specificity has arisen through examining inflammation-induced polarising signals, but this also occurs in homeostasis, requiring tissue-specific environmental triggers that influence macrophage phenotype and function.", {"entities": []}], ["The TAM receptor family of receptor tyrosine kinases (Tyro3, Axl and MerTK) mediates the non-inflammatory removal of apoptotic cells by phagocytes through the bridging phosphatidylserine-binding molecules Gas6 or Protein S. We show that one such TAM receptor (Axl) is exclusively expressed on mouse airway macrophages, but not interstitial macrophages and other lung leukocytes, under homeostatic conditions and is constitutively ligated to Gas6.", {"entities": [[54, 59, "GENE"], [61, 64, "GENE"], [260, 263, "GENE"], [69, 74, "GENE"], [205, 209, "GENE"], [441, 445, "GENE"], [61, 64, "GENE"], [260, 263, "GENE"], [205, 209, "GENE"], [441, 445, "GENE"]]}], ["Axl expression is potently induced by GM-CSF expressed in the healthy and inflamed airway, and by type I interferon or TLR3 stimulation on human and mouse macrophages, indicating potential involvement of Axl in apoptotic cell removal under inflammatory conditions.", {"entities": [[0, 3, "GENE"], [204, 207, "GENE"], [119, 123, "GENE"], [0, 3, "GENE"], [204, 207, "GENE"]]}], ["Indeed, an absence of Axl does not cause sterile inflammation in health, but leads to exaggerated lung inflammatory disease upon influenza infection.", {"entities": [[129, 138, "DISEASE"], [22, 25, "GENE"]]}], ["These data imply that Axl allows specific identification of airway macrophages, and that its expression is critical for macrophage functional compartmentalisation in the airspaces or lung interstitium.", {"entities": [[22, 25, "GENE"]]}], ["We propose that this may be a critical feature to prevent excessive inflammation due to secondary necrosis of apoptotic cells that have not been cleared by efferocytosis.", {"entities": []}], ["Studies derived from continuous national surveys have shown that the prevalence of diagnosed diabetes mellitus in the US is increasing.", {"entities": [[93, 110, "DISEASE"]]}], ["This study estimated the prevalence in 2004 of self-reported diagnosis of diabetes and other conditions in a community-based population, using data from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD).", {"entities": []}], ["The initial screening questionnaire was mailed in 2004 to a stratified random sample of 200,000 households in the US, to identify individuals, age \u2265 18 years of age, with diabetes or risk factors associated with diabetes.", {"entities": []}], ["Follow-up disease impact questionnaires were then mailed to a representative, stratified random sample of individuals (n = 22,001) in each subgroup of interest (those with diabetes or different numbers of risk factors for diabetes).", {"entities": []}], ["Estimated national prevalence of diabetes and other conditions was calculated, and compared to prevalence estimates from the National Health and Nutrition Examination Survey (NHANES) 1999\u20132002.", {"entities": []}], ["Response rates were 63.7% for the screening, and 71.8% for the follow-up baseline survey.", {"entities": []}], ["The SHIELD screening survey found overall prevalence of self-reported diagnosis of diabetes (either type 1 or type 2) was 8.2%, with increased prevalence with increasing age and decreasing income.", {"entities": []}], ["In logistic regression modeling, individuals were more likely to be diagnosed with type 2 diabetes if they had abdominal obesity (odds ratio [OR] = 3.50; p < 0.0001), BMI \u226528 kg/m The SHIELD design allowed for a very large, community-based sample with broad demographic representation of the population of interest.", {"entities": [[121, 128, "DISEASE"]]}], ["When comparing results from the SHIELD screening survey (self-report only) to those from NHANES 1999\u20132002 (self-report, clinical and laboratory evaluations), the prevalence of diabetes was similar.", {"entities": []}], ["SHIELD allows the identification of respondents with and without a current diagnosis of the illness of interest, and potential longitudinal evaluation of risk factors for future diagnosis of that illness.", {"entities": []}], ["The study was to explore whether auricular acupressure (AA) can relieve anxiety during the period from trans-vaginal oocyte retrieval to the embryo transfer in IVF treatment and whether AA can improve the outcomes of IVF.", {"entities": []}], ["305 infertile patients with tubal blockage who were referred for IVF were included.", {"entities": []}], ["The women were randomized into a control group with 102 cases, a Sham-AA group with 102 cases and an AA group with 101 cases.", {"entities": []}], ["The anxiety levels were rated with Spielberger's State Trait Anxiety Inventory and the Amsterdam Preoperative Anxiety and Information Scale.", {"entities": []}], ["Data of clinical pregnancy rate (CPR), implantation rate (IR) and live birth rate (LBR) were obtained.", {"entities": [[83, 86, "GENE"]]}], ["The levels of neuropeptide Y (NPY) and transforming growth factor alpha (TGF-alpha) in the follicular fluids were detected with ELISA.", {"entities": [[30, 33, "GENE"]]}], ["After treatment, in AA group, the levels of state anxiety, preoperative anxiety and need-for-information were significantly lower, whereas CPR, IR, LBR and NPY levels in the follicular fluids were markedly higher than Sham-AA group and control group.", {"entities": [[148, 151, "GENE"], [156, 159, "GENE"]]}], ["We concluded that AA could help to reduce anxiety levels associated with IVF and improves the outcomes of IVF partly through increasing the levels of NPY in the follicular fluids.", {"entities": [[150, 153, "GENE"]]}], ["Naturally occurring polymers, particularly of the polysaccharide type, have been used pharmaceutically for the delivery of a wide variety of therapeutic agents.", {"entities": []}], ["Chitosan, the second abundant naturally occurring polysaccharide next to cellulose, is a biocompatible and biodegradable mucoadhesive polymer that has been extensively used in the preparation of micro-as well as nanoparticles.", {"entities": []}], ["The prepared particles have been exploited as a potential carrier for different therapeutic agents such as peptides, proteins, vaccines, DNA, and drugs for parenteral and nonparenteral administration.", {"entities": []}], ["Therapeutic agent-loaded chitosan micro- or nanoparticles were found to be more stable, permeable, and bioactive.", {"entities": []}], ["In this review, we are highlighting the different methods of preparation and characterization of chitosan micro- and nanoparticles, while reviewing the pharmaceutical applications of these particles in drug delivery.", {"entities": []}], ["Moreover, the roles of chitosan derivatives and chitosan metal nanoparticles in drug delivery have been illustrated.", {"entities": []}], ["Bee venom acupuncture (BVA), a novel type of acupuncture therapy in which purified bee venom is injected into the specific acupuncture point on the diseased part of the body, is used primarily for relieving pain and other musculoskeletal symptoms.", {"entities": []}], ["In the present study, therapeutic potential of BVA to improve atopic dermatitis, a representative allergic dysfunction, was evaluated in the mouse model of trimellitic anhydride (TMA)-induced skin impairment.", {"entities": [[62, 79, "DISEASE"], [69, 79, "DISEASE"]]}], ["Mice were treated with 5\u00a0% TMA on the dorsal flank for sensitization and subsequently treated with 2\u00a0% TMA on the dorsum of both ears for an additional 12\u00a0days after a 3-day interval.", {"entities": []}], ["From the 7 BVA treatment markedly inhibited the expression levels of both T helper cell type 1 (Th1) and Th2 cytokines in ear skin and lymph nodes of TMA-treated mice.", {"entities": []}], ["Clinical features of AD-like symptoms such as ear skin symptom severity and thickness, inflammation, and lymph node weight were significantly alleviated by BV treatment.", {"entities": []}], ["BV treatment also inhibited the proliferation and infiltration of T cells, the production of Th1 and Th2 cytokines, and the synthesis of interleukin (IL)-4 and immunoglobulin E (IgE)\u2014typical allergic Th2 responses in blood.", {"entities": []}], ["The inhibitory effect of BVA was more pronounced at BL40 acupoint than non-acupuncture point located at the base of the tail.", {"entities": []}], ["These results indicate that BV injection at specific acupuncture points effectively alleviates AD-like skin lesions by inhibiting inflammatory and allergic responses in a TMA-induced contact hypersensitivity mouse model.", {"entities": []}], ["The online version of this article (doi:10.1186/s12906-016-1019-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In the N-end rule pathway of protein degradation, the destabilizing activity of N-terminal Asp, Glu or (oxidized) Cys residues requires their conjugation to Arg, which is recognized directly by pathway's ubiquitin ligases.", {"entities": []}], ["N-terminal arginylation is mediated by the Ate1 arginyltransferase, whose physiological substrates include the Rgs4, Rgs5 and Rgs16 regulators of G proteins.", {"entities": [[43, 47, "GENE"], [111, 115, "GENE"], [117, 121, "GENE"], [126, 131, "GENE"]]}], ["Here, we employed the Cre-lox technique to uncover new physiological functions of N-terminal arginylation in adult mice.", {"entities": []}], ["We show that postnatal deletion of mouse Ate1 (its unconditional deletion is embryonic lethal) causes a rapid decrease of body weight and results in early death of \u223c15% of Ate1-deficient mice.", {"entities": [[41, 45, "GENE"], [172, 176, "GENE"]]}], ["Despite being hyperphagic, the surviving Ate1-deficient mice contain little visceral fat.", {"entities": []}], ["They also exhibit an increased metabolic rate, ectopic induction of the Ucp1 uncoupling protein in white fat, and are resistant to diet-induced obesity.", {"entities": [[144, 151, "DISEASE"], [72, 76, "GENE"]]}], ["In addition, Ate1-deficient mice have enlarged brains, an enhanced startle response, are strikingly hyperkinetic, and are prone to seizures and kyphosis.", {"entities": []}], ["Ate1-deficient males are also infertile, owing to defects in Ate1 spermatocytes.", {"entities": [[0, 4, "GENE"], [61, 65, "GENE"]]}], ["The remarkably broad range of specific biological processes that are shown here to be perturbed by the loss of N-terminal arginylation will make possible the dissection of regulatory circuits that involve Ate1 and either its known substrates, such as Rgs4, Rgs5 and Rgs16, or those currently unknown.", {"entities": [[205, 209, "GENE"], [251, 255, "GENE"], [257, 261, "GENE"], [266, 271, "GENE"]]}], ["The role of traffic-related air pollution (TRAP) exposure in the development of allergic sensitization in children is unclear, and few birth cohort studies have incorporated spatiotemporal exposure assessment.", {"entities": []}], ["We aimed to examine the association between TRAP and atopy in 1-year-old children from an ongoing national birth cohort study in four Canadian cities.", {"entities": []}], ["We identified 2,477 children of approximately 1 year of age with assessment of atopy for inhalant ( Alternaria , Der p , Der f , cat, dog, cockroach) and food-related (milk, eggs, peanuts, soy) allergens.", {"entities": []}], ["Exposure to nitrogen dioxide (NO 2 ) was estimated from city-specific land use regression models accounting for residential mobility and temporal variability in ambient concentrations.", {"entities": []}], ["We used mixed models to examine associations between atopy and exposure during pregnancy and the first year of life, including adjustment for covariates (maternal atopy, socioeconomic status, pets, mold, nutrition).", {"entities": []}], ["We also conducted analyses stratified by time-location patterns, daycare attendance, and modeled home ventilation.", {"entities": []}], ["Following spatiotemporal adjustment, TRAP exposure after birth increased the risk for development of atopy to any allergens [adjusted odds ratio (aOR) per 10 \u03bcg/m 2 = 1.16; 95% CI: 1.00, 1.41], but not during pregnancy (aOR = 1.02; 95% CI: 0.86, 1.22).", {"entities": []}], ["This association was stronger among children not attending daycare (aOR = 1.61; 95% CI: 1.28, 2.01) compared with daycare attendees (aOR = 1.05; 95% CI: 0.81, 1.28).", {"entities": []}], ["Trends to increased risk were also found for food (aOR = 1.17; 95% CI: 0.95, 1.47) and inhalant allergens (aOR = 1.28; 95% CI: 0.93, 1.76).", {"entities": []}], ["Using refined exposure estimates that incorporated temporal variability and residential mobility, we found that traffic-related air pollution during the first year of life was associated with atopy.", {"entities": []}], ["Sbihi H, Allen RW, Becker A, Brook JR, Mandhane P, Scott JA, Sears MR, Subbarao P, Takaro TK, Turvey SE, Brauer M. 2015.", {"entities": []}], ["Perinatal exposure to traffic-related air pollution and atopy at 1 year of age in a multi-center Canadian birth cohort study.", {"entities": []}], ["Environ Health Perspect 123:902\u2013908;\u2002 http://dx.doi.org/10.1289/ehp.1408700", {"entities": []}], ["Oral health is essential to the general health and well-being of individuals and the population.", {"entities": []}], ["Yet significant oral health disparities persist in the U.S. population because of a web of influences that include complex cultural and social processes that affect both oral health and access to effective dental health care.", {"entities": []}], ["This paper introduces an organizing framework for addressing oral health disparities.", {"entities": []}], ["We present and discuss how the multiple influences on oral health and oral health disparities operate using this framework.", {"entities": []}], ["Interventions targeted at different causal pathways bring new directions and implications for research and policy in reducing oral health disparities.", {"entities": []}], ["Systemic treatment with statins mitigates allergic airway inflammation, T H 2 cytokine production, epithelial mucus production, and airway hyperreactivity (AHR) in murine models of asthma.", {"entities": [[181, 187, "DISEASE"], [156, 159, "GENE"]]}], ["We hypothesized that pravastatin delivered intratracheally would be quantifiable in lung tissues using mass spectrometry, achieve high drug concentrations in the lung with minimal systemic absorption, and mitigate airway inflammation and structural changes induced by ovalbumin.", {"entities": []}], ["Male BALB/c mice were sensitized to ovalbumin (OVA) over 4\u00a0weeks, then exposed to 1% OVA aerosol or filtered air (FA) over 2\u00a0weeks.", {"entities": []}], ["Mice received intratracheal instillations of pravastatin before and after each OVA exposure (30\u00a0mg/kg).", {"entities": []}], ["Ultra performance liquid chromatography \u2013 mass spectrometry was used to quantify plasma, lung, and bronchoalveolar lavage fluid (BALF) pravastatin concentration.", {"entities": []}], ["Pravastatin was quantifiable in mouse plasma, lung tissue, and BALF (BALF\u00a0>\u00a0lung\u00a0>\u00a0plasma for OVA and FA groups).", {"entities": []}], ["At these concentrations pravastatin inhibited airway goblet cell hyperplasia/metaplasia, and reduced BALF levels of cytokines TNF \u03b1 and KC, but did not reduce BALF total leukocyte or eosinophil cell counts.", {"entities": [[126, 129, "GENE"]]}], ["While pravastatin did not mitigate AHR, it did inhibit airway hypersensitivity (AHS).", {"entities": [[35, 38, "GENE"]]}], ["In this proof-of-principle study, using novel mass spectrometry methods we show that pravastatin is quantifiable in tissues, achieves high levels in mouse lungs with minimal systemic absorption, and mitigates some pathological features of allergic asthma.", {"entities": [[239, 254, "DISEASE"], [248, 254, "DISEASE"]]}], ["Inhaled pravastatin may be beneficial for the treatment of asthma by having direct airway effects independent of a potent anti-inflammatory effect.", {"entities": [[59, 65, "DISEASE"]]}], ["Statins with greater lipophilicity may achieve better anti-inflammatory effects warranting further research.", {"entities": []}], ["Diffuse panbronchiolitis (DPB) is a bronchiolitis affecting the whole lung fields which can be treated by macrolide.", {"entities": [[36, 49, "DISEASE"]]}], ["Especially East Asian patients are more susceptible to diffuse panbronchiolitis.", {"entities": []}], ["As asthma and DPB both can cause airway obstruction, differential diagnosis is important for the 2 diseases.", {"entities": [[3, 9, "DISEASE"]]}], ["Here we report 5 patients with DPB clinically presenting as severe asthma in Korea, who were well treated by macrolide.", {"entities": [[67, 73, "DISEASE"]]}], ["Among the 5 patients, 2 could stop their asthma inhalers and the other 3 could reduce asthma medications after diagnosis and treatment of DPB.", {"entities": [[41, 47, "DISEASE"], [86, 92, "DISEASE"]]}], ["In conclusion, considering DPB as differential diagnosis for asthmatics in Asian ethnic groups is important.", {"entities": []}], ["While tobacco smoking is the main risk factor for chronic obstructive pulmonary disease (COPD) only a fraction of smokers go on to develop the disease.", {"entities": [[50, 87, "DISEASE"]]}], ["We investigated the relationship between the insertion (I) \u2013 deletion (D) polymorphisms in the Angiotensin converting enzyme (ACE) gene and the risk of developing COPD in smokers by determining the distribution of the ACE genotypes (DD, ID and II) in 151 life-long male smokers.", {"entities": []}], ["74 of the smokers had developed COPD (62 \u00b1 2 years; FEV 1 44 \u00b1 6 % reference) whereas the rest retained normal lung function (56 \u00b1 2 yrs; FEV 1 95 \u00b1 3 % reference).", {"entities": [[52, 55, "GENE"], [138, 141, "GENE"], [52, 55, "GENE"], [138, 141, "GENE"]]}], ["In addition, we genotyped 159 males recruited randomly from the general population.", {"entities": []}], ["The prevalence of the DD genotype was highest ( p = 0.01) in the smokers that developed COPD and its presence was associated with a 2-fold increase in the risk for COPD (OR 2.2; IC95% 1.1 to 5.5).", {"entities": []}], ["Surprisingly, the 151 individuals in the smoking population did not demonstrate Hardy-Weinberg equilibrium unlike the 159 recruited from the general population.", {"entities": []}], ["Our results suggest that ACE polymorphisms are associated with both the smoking history of an individual and their risk of developing COPD.", {"entities": []}], ["Bacterial and viral infections are often clinically indistinguishable, leading to inappropriate patient management and antibiotic misuse.", {"entities": []}], ["Bacterial-induced host proteins such as procalcitonin, C-reactive protein (CRP), and Interleukin-6, are routinely used to support diagnosis of infection.", {"entities": [[75, 78, "GENE"]]}], ["However, their performance is negatively affected by inter-patient variability, including time from symptom onset, clinical syndrome, and pathogens.", {"entities": [[124, 132, "DISEASE"]]}], ["Our aim was to identify novel viral-induced host proteins that can complement bacterial-induced proteins to increase diagnostic accuracy.", {"entities": []}], ["Initially, we conducted a bioinformatic screen to identify putative circulating host immune response proteins.", {"entities": []}], ["The resulting 600 candidates were then quantitatively screened for diagnostic potential using blood samples from 1002 prospectively recruited patients with suspected acute infectious disease and controls with no apparent infection.", {"entities": []}], ["For each patient, three independent physicians assigned a diagnosis based on comprehensive clinical and laboratory investigation including PCR for 21 pathogens yielding 319 bacterial, 334 viral, 112 control and 98 indeterminate diagnoses; 139 patients were excluded based on predetermined criteria.", {"entities": []}], ["The best performing host-protein was TNF-related apoptosis-inducing ligand (TRAIL) (area under the curve [AUC] of 0.89; 95% confidence interval [CI], 0.86 to 0.91), which was consistently up-regulated in viral infected patients.", {"entities": []}], ["We further developed a multi-protein signature using logistic-regression on half of the patients and validated it on the remaining half.", {"entities": []}], ["The signature with the highest precision included both viral- and bacterial-induced proteins: TRAIL, Interferon gamma-induced protein-10, and CRP (AUC of 0.94; 95% CI, 0.92 to 0.96).", {"entities": [[142, 145, "GENE"]]}], ["The signature was superior to any of the individual proteins (P<0.001), as well as routinely used clinical parameters and their combinations (P<0.001).", {"entities": []}], ["It remained robust across different physiological systems, times from symptom onset, and pathogens (AUCs 0.87-1.0).", {"entities": []}], ["The accurate differential diagnosis provided by this novel combination of viral- and bacterial-induced proteins has the potential to improve management of patients with acute infections and reduce antibiotic misuse.", {"entities": []}], ["Despite the evidence that Lactoferrin (Lf) is involved in allergic asthma processes, it is unknown whether neutrophils can be one of the main cellular sources of this key inflammatory mediator directly in response of an IgE mediated stimulus.", {"entities": [[58, 73, "DISEASE"], [67, 73, "DISEASE"]]}], ["The present study was undertaken to analyze this question.", {"entities": []}], ["Neutrophils from healthy subjects (n = 34) and neutrophils from allergic asthmatic patients (n = 102) were challenged in vitro with specific allergens to which the patients were sensitized, PAF, or agonist mAbs against IgE-receptors, and the levels of Lf were measured in the culture supernatant.", {"entities": []}], ["The levels of serum IgE together with the severity of symptoms were also analyzed.", {"entities": []}], ["Lf was released into the culture supernatant of neutrophils from allergic asthmatic patients in response to allergens and PAF.", {"entities": []}], ["This response was highly allergen-specific, and did not happen in neutrophils from healthy donors.", {"entities": []}], ["Allergen effect was mimicked by Abs against Fc\u03b5RI and galectin-3 but not by Fc\u03b5RII.", {"entities": []}], ["The levels of released Lf correlated well with the levels of serum specific IgE and severity of asthma symptoms.", {"entities": [[96, 102, "DISEASE"]]}], ["These observations represent a novel view of neutrophils as an important source of Lf in allergic asthma.", {"entities": [[89, 104, "DISEASE"], [98, 104, "DISEASE"]]}], ["Importantly, the levels of released Lf by neutrophils could therefore be used to evaluate disease severity in allergic asthmatic patients.", {"entities": []}], ["In Burkina Faso, the tuberculosis (TB) treatment failure rate increased from 2.5% in 2000 to 8.3% in 2006.", {"entities": [[21, 33, "DISEASE"]]}], ["The risk factors for TB treatment failure in the country are not well known.", {"entities": []}], ["The study aims to determine the risk factors for treatment failure among pulmonary tuberculosis patients in four health region of Burkina Faso and to recommend appropriate interventions.", {"entities": [[83, 95, "DISEASE"], [73, 95, "DISEASE"]]}], ["A case control study was conducted among pulmonary TB patients who began TB treatment in 2009.", {"entities": []}], ["A case was any patient who remained smear-positive at fifth month of TB treatment and a control was a patient who tested smear-negative at fifth month of treatment.", {"entities": []}], ["A structured questionnaire was administered to one hundred cases and one hundred controls to collect information on exposure factors.", {"entities": []}], ["Odds ratio were calculated using bivariate and multivariate analysis to determine the association between exposures and outcome.", {"entities": []}], ["Multivariate analysis showed that independent risk factors for TB treatment failure were fail to take TB drugs for more than 14 consecutive days (OR = 18.53; 95% CI:4.56 - 75.22), sputum smear-positive at two months of treatment (OR = 11.52; 95%CI:5.18-25.60), existence of comorbidity (OR = 5.74; 95%CI:1.69-19.44), and use of traditional medicines or herbs (OR = 2.97; 95%CI:1.12-7.85).", {"entities": []}], ["Early identification of patients with the above risk factors for intense case management will improve TB treatment outcome.", {"entities": []}], ["Patient with smear positive at 2nd", {"entities": []}], ["Frequent attenders receive much attention in primary care research.", {"entities": []}], ["Defining frequent attendance is crucial for an adequate view on this group of demanding patients.", {"entities": []}], ["We aimed to develop a purely contact-based definition of \u201cfrequent attendance\u201d and to apply it to real patients.", {"entities": []}], ["From electronic records of 123 general practices in Germany, patients\u2019 inter-contact intervals (ICI) between two consecutive doctor-patient-contacts were calculated in this retrospective observational study.", {"entities": []}], ["ICI less than 7\u00a0days were labelled \u201cfrequent attendance\u201d, patients with 60% or more of such intervals \u201cfrequent attenders (new view)\u201d.", {"entities": []}], ["In contrast, patients having at least 24 contacts per calendar year were considered \u201cfrequent attenders (traditional view)\u201d.", {"entities": []}], ["Both groups were analysed in their diseases and demands, using multiple logistic regression.", {"entities": []}], ["A total of 177,057 patients with at least 3 ICI in 1996 until 2006 yielded 4,408,033 ICI.", {"entities": []}], ["One third were \u201cshort\u201d ICI (less than 7\u00a0days), resulting in 19,759 (11.2%) frequent attenders (new).", {"entities": []}], ["In contrast, 22,921 (12.9%) patients were frequent attenders (traditional).", {"entities": []}], ["Compared to non-frequent attenders, frequent attenders (new) were more likely to have pneumonia (OR 1.66), stroke (OR 1.49), dementia (OR 1.46), or severe substance abuse (OR 1.44), also to need home visits or emergency attention.", {"entities": [[155, 170, "DISEASE"], [125, 133, "DISEASE"], [86, 95, "DISEASE"]]}], ["Frequent attenders (traditional) were more likely to have dementia (OR 2.76) or stroke (OR 2.06), and by far to need home visits (OR 5.43; all p\u2009<\u20090.001).", {"entities": [[58, 66, "DISEASE"]]}], ["A new measure, the interval in days of two consecutive face-to-face contacts (ICI), widens our perspective on frequent attenders in general practice.", {"entities": []}], ["In many cases, their consultation behaviour and need for medical services seem to follow \u201cdisease logic\u201d.", {"entities": []}], ["Post-translational modification is considered an important biological mechanism with critical impact on the diversification of the proteome.", {"entities": []}], ["Although a long list of such modifications has been studied, succinylation of lysine residues has recently attracted the interest of the scientific community.", {"entities": []}], ["The experimental detection of succinylation sites is an expensive process, which consumes a lot of time and resources.", {"entities": []}], ["Therefore, computational predictors of this covalent modification have emerged as a last resort to tackling lysine succinylation.", {"entities": []}], ["In this paper, we propose a novel computational predictor called \u2018Success\u2019, which efficiently uses the structural and evolutionary information of amino acids for predicting succinylation sites.", {"entities": []}], ["To do this, each lysine was described as a vector that combined the above information of surrounding amino acids.", {"entities": []}], ["We then designed a support vector machine with a radial basis function kernel for discriminating between succinylated and non-succinylated residues.", {"entities": []}], ["We finally compared the Success predictor with three state-of-the-art predictors in the literature.", {"entities": []}], ["As a result, our proposed predictor showed a significant improvement over the compared predictors in statistical metrics, such as sensitivity (0.866), accuracy (0.838) and Matthews correlation coefficient (0.677) on a benchmark dataset.", {"entities": []}], ["The proposed predictor effectively uses the structural and evolutionary information of the amino acids surrounding a lysine.", {"entities": []}], ["The bigram feature extraction approach, while retaining the same number of features, facilitates a better description of lysines.", {"entities": []}], ["A support vector machine with a radial basis function kernel was used to discriminate between modified and unmodified lysines.", {"entities": []}], ["The aforementioned aspects make the Success predictor outperform three state-of-the-art predictors in succinylation detection.", {"entities": []}], ["The online version of this article (10.1186/s12864-017-4336-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A large number of G-protein-coupled receptors (GPCRs) show varying degrees of basal or constitutive activity.", {"entities": []}], ["This constitutive activity is usually minimal in natural receptors but is markedly observed in wild type and mutated (naturally or induced) receptors.", {"entities": []}], ["According to conventional two-state drug receptor interaction model, binding of a ligand may initiate activity (agonist with varying degrees of positive intrinsic activity) or prevent the effect of an agonist (antagonist with zero intrinsic activity).", {"entities": []}], ["Inverse agonists bind with the constitutively active receptors, stabilize them, and thus reduce the activity (negative intrinsic activity).", {"entities": []}], ["Receptors of many classes (\u03b1-and \u03b2-adrenergic, histaminergic, GABAergic, serotoninergic, opiate, and angiotensin receptors) have shown basal activity in suitable in vitro models.", {"entities": []}], ["Several drugs that have been conventionally classified as antagonists (\u03b2-blockers, antihistaminics) have shown inverse agonist effects on corresponding constitutively active receptors.", {"entities": []}], ["Nearly all H 1 and H 2 antihistaminics (antagonists) have been shown to be inverse agonists.", {"entities": []}], ["Among the \u03b2-blockers, carvedilol and bucindolol demonstrate low level of inverse agonism as compared to propranolol and nadolol.", {"entities": []}], ["Several antipsychotic drugs (D 2 receptors antagonist), antihypertensive (AT 1 receptor antagonists), antiserotoninergic drugs and opioid antagonists have significant inverse agonistic activity that contributes partly or wholly to their therapeutic value.", {"entities": []}], ["Inverse agonism may also help explain the underlying mechanism of beneficial effects of carvedilol in congestive failure, naloxone-induced withdrawal syndrome in opioid dependence, clozapine in psychosis, and candesartan in cardiac hypertrophy.", {"entities": [[150, 158, "DISEASE"]]}], ["Understanding inverse agonisms has paved a way for newer drug development.", {"entities": []}], ["It is now possible to develop agents, which have only desired therapeutic value and are devoid of unwanted adverse effect.", {"entities": []}], ["Pimavanserin (ACP-103), a highly selective 5-HT 2A inverse agonist, attenuates psychosis in patients with Parkinson's disease with psychosis and is devoid of extrapyramidal side effects.", {"entities": []}], ["This dissociation is also evident from the development of anxioselective benzodiazepines devoid of habit-forming potential.", {"entities": []}], ["Hemopressin is a peptide ligand that acts as an antagonist as well as inverse agonist.", {"entities": []}], ["This agent acts as an antinociceptive agent in different in vivo models of pain.", {"entities": []}], ["Treatment of obesity by drugs having inverse agonist activity at CB 1/2 receptors is also underway.", {"entities": [[13, 20, "DISEASE"]]}], ["An exciting development is evaluation of \u03b2-blockers in chronic bronchial asthma\u2014a condition akin to congestive heart failure where \u03b2-blockade has become the standard mode of therapy.", {"entities": [[100, 124, "DISEASE"], [73, 79, "DISEASE"]]}], ["Synthesis and evaluation of selective agents is underway.", {"entities": []}], ["Therefore, inverse agonism is an important aspect of drug\u2013receptor interaction and has immense untapped therapeutic potential.", {"entities": []}], ["Ortholog detection (OD) is a lynchpin of most statistical methods in comparative genomics.", {"entities": []}], ["This task involves accurately identifying genes across species that descend from a common ancestral sequence.", {"entities": []}], ["OD methods comprise a wide variety of approaches, each with their own benefits and costs under a variety of evolutionary and practical scenarios.", {"entities": []}], ["In this article, we examine the proteomes of ten mammals by using four methodologically distinct, rigorously filtered OD methods.", {"entities": []}], ["In head-to-head comparisons, we find that these algorithms significantly outperform one another for 38\u201345% of the genes analyzed.", {"entities": []}], ["We leverage this high complementarity through the development MOSAIC, or M ultiple O rthologous S equence A nalysis and I ntegration by C luster optimization, the first tool for integrating methodologically diverse OD methods.", {"entities": []}], ["Relative to the four methods examined, MOSAIC more than quintuples the number of alignments for which all species are present while simultaneously maintaining or improving functional-, phylogenetic-, and sequence identity-based measures of ortholog quality.", {"entities": []}], ["Further, this improvement in alignment quality yields more confidently aligned sites and higher levels of overall conservation, while simultaneously detecting of up to 180% more positively selected sites.", {"entities": []}], ["We close by highlighting a MOSAIC-specific positively selected sites near the active site of TPSAB1, an enzyme linked to asthma, heart disease, and irritable bowel disease.", {"entities": [[129, 142, "DISEASE"], [121, 127, "DISEASE"], [93, 99, "GENE"]]}], ["MOSAIC alignments, source code, and full documentation are available at http://pythonhosted.org/bio-MOSAIC .", {"entities": []}], ["Since the Doi Moi reform 1986 economic conditions in Vietnam have changed significantly and positive health and health care developments have been observed.", {"entities": []}], ["International experience shows that improved economic conditions in a country can reduce the risk of perinatal mortality, decrease the risk of low birth weight and increase the mean birth weight in newborns.", {"entities": []}], ["The Health and Demographic Surveillance Site (HDSS) FilaBavi in Bavi district outside Hanoi city has been operational since 1999.", {"entities": []}], ["An open cohort of more than 12,000 households (52,000 persons) has been followed primarily with respect to demography, economy and education.", {"entities": []}], ["The aim of this research is to study trends in birth weight as well as birth and delivery practices over the time period 1999\u20132010 in FilaBavi in relation to the social and economic development.", {"entities": []}], ["Information about birth weight, sex, place and method of delivery, mother\u2019s age and education as well as household economy of 10,114 children, born from 1999 to 2010, was obtained from the routine data collection in the HDSS.", {"entities": []}], ["Over the study period the mean birth weight remained at the same level, about 3,100 g, in spite of increased economic resources and technology development.", {"entities": []}], ["At the individual child level we found associations between birth weight and household economy as well as the education of the mother.", {"entities": []}], ["Hospital delivery increased from about 35% to 65% and the use of Caesarian section increased from 2.6% to 10.1%.", {"entities": []}], ["During the twelve years studied, household income as well as the use of modern technology increased rapidly.", {"entities": []}], ["In spite of that, the mean and variation of birth weight did not change systematically.", {"entities": []}], ["It is suggested that increasing gaps in economic conditions and misallocation of resources, possibly to overuse of technology, are partly responsible.", {"entities": []}], ["Heligmosomoides polygyrus (formerly known as Nematospiroides dubius, and also referred to by some as H. bakeri ) is a gastrointestinal helminth that employs multiple immunomodulatory mechanisms to establish chronic infection in mice and closely resembles prevalent human helminth infections.", {"entities": []}], ["H. polygyrus has been studied extensively in the field of helminth-derived immune regulation and has been found to potently suppress experimental models of allergy and autoimmunity (both with active infection and isolated secreted products).", {"entities": []}], ["The protocol described in this paper outlines management of the H. polygyrus life cycle for consistent production of L3 larvae, recovery of adult parasites, and collection of their excretory-secretory products (HES).", {"entities": []}], ["Recent studies describe new genome-wide mutagenesis strategies, coupled with phenotypic screening, and demonstrate the power of such approaches to provide new insights into the genetics of the immune response.", {"entities": []}], ["Recent studies describe new genome-wide mutagenesis strategies, coupled with phenotypic screening, and demonstrate the power of such approaches to provide new insights into the genetics of the immune response.", {"entities": []}], ["Increases in ceramide levels have been implicated in the pathogenesis of both acute or chronic lung injury models.", {"entities": []}], ["However, the role of individual ceramide species, or of the enzymes that are responsible for their synthesis, in lung health and disease has not been clarified.", {"entities": []}], ["We now show that C24- and C16-ceramides are the most abundant lung ceramide species, paralleled by high expression of their synthetic enzymes, ceramide synthase 2 (CerS2) and CerS5, respectively.", {"entities": []}], ["Furthermore, the ceramide species synthesis in the lung is homeostatically regulated, since mice lacking very long acyl chain C24-ceramides due to genetic deficiency of CerS2 displayed a ten-fold increase in C16-ceramides and C16-dihydroceramides along with elevation of acid sphingomyelinase and CerS5 activities.", {"entities": []}], ["Despite relatively preserved total lung ceramide levels, inhibition of de novo sphingolipid synthesis at the level of CerS2 was associated with significant airflow obstruction, airway inflammation, and increased lung volumes.", {"entities": []}], ["Our results suggest that ceramide species homeostasis is crucial for lung health and that CerS2 dysfunction may predispose to inflammatory airway and airspace diseases.", {"entities": []}], ["Food taboos are known from virtually all human societies and pregnant women have often been targeted.", {"entities": []}], ["We qualitatively assessed food taboos during pregnancy, its motivating factors, and enforcement mechanisms in the Upper Manya Krobo district of Ghana.", {"entities": []}], ["This was an exploratory cross sectional study using qualitative focus group discussions (FGDs).", {"entities": []}], ["Sixteen FGDs were conducted.", {"entities": []}], ["Participants were purposively selected using the maximum variation sampling technique.", {"entities": []}], ["Tape recorded FGDs were transcribed verbatim and analyzed using Malterudian systematic text condensation technique.", {"entities": []}], ["All the participants were aware of the existence of food prohibitions and beliefs targeting pregnant women in Upper Manya Krobo.", {"entities": []}], ["The study identified snails, rats, hot foods, and animal lungs as tabooed during pregnancy.", {"entities": []}], ["Adherence motivators included expectation of safe and timely delivery, avoidance of \u201cmonkey babies\u201d (deformed babies); respect for ancestors, parents, and community elders.", {"entities": []}], ["Enforcement mechanisms identified included constant reminders by parents, family members and significant others.", {"entities": []}], ["Stigmatization and community sanctions are deployed sparingly.", {"entities": []}], ["Food taboos and traditional beliefs targeting pregnant women exist in Upper Manya Krobo.", {"entities": []}], ["Pregnant women are forbidden from eating snails, rats, snakes, hot foods and animal lungs.", {"entities": []}], ["To a large extent, socio-cultural, and to a lesser, health concerns motivate the practice.", {"entities": []}], ["The nature and constituents of ballistic aerosol created by kinetic energy penetrator rods of tungsten heavy alloys (W-Fe-Ni and W-Fe-Co) perforating steel target plates was characterized by scanning and transmission electron microscopy.", {"entities": []}], ["These aerosol regimes, which can occur in closed, armored military vehicle penetration, are of concern for potential health effects, especially as a consequence of being inhaled.", {"entities": []}], ["In a controlled volume containing 10 equispaced steel target plates, particulates were systematically collected onto special filters.", {"entities": []}], ["Filter collections were examined by scanning and transmission electron microscopy (SEM and TEM) which included energy-dispersive (X-ray) spectrometry (EDS).", {"entities": []}], ["Dark-field TEM identified a significant nanoparticle concentration while EDS in the SEM identified the propensity of mass fraction particulates to consist of Fe and FeO, representing target erosion and formation of an accumulating debris field.", {"entities": []}], ["Direct exposure of human epithelial cells (A549), a model for lung tissue, to particulates (especially nanoparticulates) collected on individual filters demonstrated induction of rapid and global cell death to the extent that production of inflammatory cytokines was entirely inhibited.", {"entities": []}], ["These observations along with comparisons of a wide range of other nanoparticulate species exhibiting cell death in A549 culture may suggest severe human toxicity potential for inhaled ballistic aerosol, but the complexity of the aerosol (particulate) mix has not yet allowed any particular chemical composition to be identified.", {"entities": []}], ["The risk of herpes zoster (HZ) between patients with psoriasis receiving and not receiving systemic therapy has received increasing attention.", {"entities": [[53, 62, "DISEASE"], [12, 25, "DISEASE"]]}], ["This study investigated the association of psoriasis with the risk of HZ.", {"entities": [[43, 52, "DISEASE"]]}], ["We conducted a population-based retrospective cohort study by using the Taiwan National Health Insurance Research Database.", {"entities": []}], ["The psoriasis cohort consisted of 4077 patients with newly diagnosed psoriasis between 2000 and 2006.", {"entities": [[4, 13, "DISEASE"], [69, 78, "DISEASE"]]}], ["Each patient with psoriasis was frequency-matched with four people without psoriasis, by sex, age and index year.", {"entities": [[18, 27, "DISEASE"], [75, 84, "DISEASE"]]}], ["(nonpsoriasis cohort; 16308 subjects).", {"entities": []}], ["Patients who received systemic therapy were classified as having severe psoriasis, whereas those who did not receive systemic therapy were classified as having mild psoriasis.", {"entities": [[72, 81, "DISEASE"], [165, 174, "DISEASE"]]}], ["The Cox proportional hazards regression analysis was conducted to estimate the association between psoriasis and HZ risk.", {"entities": [[99, 108, "DISEASE"]]}], ["The overall incidence density rate of HZ in the psoriasis cohort than in the nonpsoriasis cohort (4.50 vs. 3.44 per 1,000 person-years), with a multivariable Cox proportional hazards model measured adjusted HR of 1.29 [95% confidence interval (CI) = 1.07\u20131.56].", {"entities": [[48, 57, "DISEASE"], [207, 209, "GENE"]]}], ["In additional, compared with the nonpsoriasis cohort, the risk of HZ was higher in the severe psoriasis cohort than in the nonpsoriasis cohort (adjusted hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.15\u20132.27).", {"entities": [[94, 103, "DISEASE"], [167, 169, "GENE"]]}], ["The comparison between psoriasis and nonpsoriasis cohorts revealed a greatest magnitude risk of HZ in women (adjusted HR, 1.36; 95% CI, 1.04\u20131.79), study participants in the age group of 20\u201339 years (adjusted HR, 1.77; 95% CI, 1.17\u20132.66), and study participants without any comorbidities (adjusted HR, 1.37; 95% CI, 1.02\u20131.84).", {"entities": [[23, 32, "DISEASE"], [118, 120, "GENE"], [209, 211, "GENE"], [298, 300, "GENE"], [118, 120, "GENE"], [209, 211, "GENE"], [298, 300, "GENE"], [118, 120, "GENE"], [209, 211, "GENE"], [298, 300, "GENE"]]}], ["Our results suggest that psoriasis is associated with an increased risk of HZ, which involves differences in sex and age.", {"entities": [[25, 34, "DISEASE"]]}], ["Although systemic therapy may have a major role in the risk of HZ, the intrinsic factors of psoriasis cannot be excluded.", {"entities": [[92, 101, "DISEASE"]]}], ["We used two-dimensional quantitative trait locus analysis to identify interacting genetic loci that contribute to the native airway constrictor hyperresponsiveness to methacholine that characterizes A/J mice, relative to C57BL/6J mice.", {"entities": []}], ["We quantified airway responsiveness to intravenous methacholine boluses in eighty-eight (C57BL/6J X A/J) F 2 and twenty-seven (A/J X C57BL/6J) F 2 mice as well as ten A/J mice and six C57BL/6J mice; all studies were performed in male mice.", {"entities": []}], ["Mice were genotyped at 384 SNP markers, and from these data two-QTL analyses disclosed one pair of interacting loci on chromosomes 11 and 18; the homozygous A/J genotype at each locus constituted the genetic interaction linked to the hyperresponsive A/J phenotype.", {"entities": []}], ["Bioinformatic network analysis of potential interactions among proteins encoded by genes in the linked regions disclosed two high priority subnetworks - Myl7 , Rock1 , Limk2 ; and Npc1 , Npc1l1 .", {"entities": [[153, 157, "GENE"], [160, 165, "GENE"], [168, 173, "GENE"], [180, 184, "GENE"], [187, 193, "GENE"]]}], ["Evidence in the literature supports the possibility that either or both networks could contribute to the regulation of airway constrictor responsiveness.", {"entities": []}], ["Together, these results should stimulate evaluation of the genetic contribution of these networks in the regulation of airway responsiveness in humans.", {"entities": []}], ["Recognition of maternal emotional distress during pregnancy and the identification of risk factors for this distress are of considerable clinical- and public health importance.", {"entities": []}], ["The mental health of the mother is important both for herself, and for the physical and psychological health of her children and the welfare of the family.", {"entities": []}], ["The first aim of the present study was to identify risk factors for maternal emotional distress during pregnancy with special focus on partner relationship satisfaction.", {"entities": []}], ["The second aim was to assess interaction effects between relationship satisfaction and the main predictors.", {"entities": []}], ["Pregnant women enrolled in the Norwegian Mother and Child Cohort Study (n = 51,558) completed a questionnaire with questions about maternal emotional distress, relationship satisfaction, and other risk factors.", {"entities": []}], ["Associations between 37 predictor variables and emotional distress were estimated by multiple linear regression analysis.", {"entities": []}], ["Relationship dissatisfaction was the strongest predictor of maternal emotional distress (\u03b2 = 0.25).", {"entities": []}], ["Other predictors were dissatisfaction at work (\u03b2 = 0.11), somatic disease (\u03b2 = 0.11), work related stress (\u03b2 = 0.10) and maternal alcohol problems in the preceding year (\u03b2 = 0.09).", {"entities": []}], ["Relationship satisfaction appeared to buffer the effects of frequent moving, somatic disease, maternal smoking, family income, irregular working hours, dissatisfaction at work, work stress, and mother's sick leave ( P < 0.05).", {"entities": []}], ["Dissatisfaction with the partner relationship is a significant predictor of maternal emotional distress in pregnancy.", {"entities": []}], ["A good partner relationship can have a protective effect against some stressors.", {"entities": []}], ["A number of studies suggest that the ubiquitin\u2013proteasome system (UPS) impairment may underlie neuronal death in Parkinson\u2019s disease.", {"entities": []}], ["Celastrol is a neuroprotective agent with anti-inflammatory and antioxidant properties.", {"entities": []}], ["The aim of this study was to determine whether celastrol may exert neuroprotective effects both in vitro and in vivo under conditions of the lactacystin-induced UPS inhibition.", {"entities": []}], ["In the in vitro study, mouse primary cortical neurons and neuroblastoma SH-SY5Y cells were incubated with lactacystin for 48\u00a0h (2.5 and 10\u00a0\u03bcg/ml, respectively).", {"entities": [[58, 71, "DISEASE"]]}], ["The animal study was performed on male Wistar rats injected unilaterally with lactacystin (5\u00a0\u03bcg/2\u00a0\u03bcl) into the substantia nigra (SN) pars compacta.", {"entities": []}], ["In the in vitro study, we did not found any protective effects of celastrol, given either in the pre- or co-treatment mode.", {"entities": []}], ["Moreover, in the higher concentrations, celastrol itself reduced cell viability, and enhanced the lactacystin-induced cell death in both types of cells.", {"entities": []}], ["In the in vivo study, none of the celastrol doses (0.3\u20133\u00a0mg/kg) attenuated the lactacystin-induced decrease in the level of dopamine (DA) and its metabolites or protected nigral dopaminergic neurons against the lactacystin-induced degeneration.", {"entities": []}], ["The highest celastrol dose potentiated the lactacystin-induced decrease in the level of DA and its metabolites in the lesioned striatum, and accelerated the lactacystin-induced increase in the oxidative and total metabolism of DA.", {"entities": []}], ["Moreover, when given alone, this dose of celastrol bilaterally decreased the number and/or density of dopaminergic neurons in the SN.", {"entities": []}], ["Our results demonstrate that celastrol does not induce neuroprotective effects under conditions of UPS inhibition.", {"entities": []}], ["Mapping has been used to convert scores from condition-specific measures into utility scores, and to produce estimates of cost-effectiveness.", {"entities": []}], ["We sought to compare the QALY gains, and incremental cost per QALY estimates, predicted on the basis of mapping to those based on actual EQ-5D scores.", {"entities": []}], ["In order to compare 4 different interventions 389 individuals were asked to complete both the EQ-5D and the Western Ontartio and McMaster Universities Osteoarthritis Index (WOMAC) at baseline, 6, 12, and 24 months post-intervention.", {"entities": []}], ["Using baseline data various mapping models were developed, where WOMAC scores were used to predict the EQ-5D scores.", {"entities": []}], ["The performance of these models was tested by predicting the EQ-5D post-intervention scores.", {"entities": []}], ["The preferred model (that with the lowest mean absolute error (MAE)) was used to predict the EQ-5D scores, at all time points, for individuals who had complete WOMAC and EQ-5D data.", {"entities": []}], ["The mean QALY gain associated with each intervention was calculated, using both actual and predicted EQ-5D scores.", {"entities": []}], ["These QALY gains, along with previously estimated changes in cost, were also used to estimate the actual and predicted incremental cost per QALY associated with each of the four interventions.", {"entities": []}], ["The EQ-5D and the WOMAC were completed at baseline by 348 individuals, and at all time points by 259 individuals.", {"entities": []}], ["The MAE in the preferred model was 0.129, and the mean QALY gains for each of the four interventions was predicted to be 0.006, 0.058, 0.058, and 0.136 respectively, compared to the actual mean QALY gains of 0.087, 0.081, 0.120, and 0.149.", {"entities": []}], ["The most effective intervention was estimated to be associated with an incremental cost per QALY of \u00a36,068, according to our preferred model, compared to \u00a313,154 when actual data was used.", {"entities": []}], ["We found that actual QALY gains, and incremental cost per QALY estimates, differed from those predicted on the basis of mapping.", {"entities": []}], ["This suggests that though mapping may be of value in predicting the cost-effectiveness of interventions which have not been evaluated using a utility measure, future studies should be encouraged to include a method of actual utility measurement.", {"entities": []}], ["Current Controlled Trials ISRCTN93206785", {"entities": []}], ["Little is known about preschool parents\u2019 cognitions, barriers, supports and modeling of key obesogenic behaviors, including breakfast, fruit and vegetable consumption, sugary beverage intake, feeding practices, portion sizes, active playtime, reduced screen-time, sleep and selection of child-care centers with characteristics that promote healthy behaviors.", {"entities": []}], ["Thus, the purpose of this study was to examine these factors via survey and focus groups among 139 parents of 2- to 5-year-old children.", {"entities": []}], ["Standard content analysis procedures were used to identify trends and themes in the focus group data, and Analysis of Variance was used to test for differences between groups in the survey data.", {"entities": []}], ["Results showed 80% of parents ate breakfast daily, consumed sugary beverages 2.7\u2009\u00b1\u20092.5SD days per week, and had at least two different vegetables and fruits an average of 5.2\u2009\u00b1\u20091.8SD and 4.6\u2009\u00b1\u20092.0SD days per week.", {"entities": []}], ["Older parents and those with greater education drank significantly fewer sugary drinks.", {"entities": []}], ["Parents played actively a mean 4.2\u2009\u00b1\u20092.2\u00a0hours/week with their preschoolers, who watched television a mean 2.4\u2009\u00b1\u20091.7\u00a0hours/day.", {"entities": []}], ["Many parents reported having a bedtime routine for their preschooler and choosing childcare centers that replaced screen-time with active play and nutrition education.", {"entities": []}], ["Common barriers to choosing healthful behaviors included lack of time; neighborhood safety; limited knowledge of portion size, cooking methods, and ways to prepare healthy foods or play active indoor games; the perceived cost of healthy options, and family members who were picky eaters.", {"entities": []}], ["Supports for performing healthful behaviors included planning ahead, introducing new foods and behaviors often and in tandem with existing preferred foods and behaviors, and learning strategies from other parents.", {"entities": []}], ["Future education programs with preschool parents should emphasize supports and encourage parents to share helpful strategies with each other.", {"entities": []}], ["To analyze the outcome of endoscopic sinus surgery (ESS) after preoperative systemic steroid (PSS) treatment for chronic rhinosinusitis (CRS) with nasal polyposis (NP) and to investigate and compare clinicopathological factors associated with the outcome.", {"entities": []}], ["We performed a retrospective chart review of 468 patients with CRS with NP who underwent primary ESS between January 2005 and October 2011.", {"entities": []}], ["124 patients who met the inclusion criteria were included.", {"entities": []}], ["Beginning from 2008, our clinic administered steroid preoperatively in patients of CRS with NP, thus there were 84 patients with preoperative systemic steroid (PSS group) and another 40 patients without such regimen (no PSS group).", {"entities": []}], ["To evaluate the outcome after ESS, poor outcome and complication were analyzed according to the following parameters: age, sex, follow-up duration, eosinophilic infiltration, atopy, asthma, Lund-Mackay score, and polyp grade.", {"entities": [[182, 188, "DISEASE"]]}], ["There was no significant difference in poor outcome rates between the PSS and no PSS group (35.0% vs. 47.6%, p =0.185).", {"entities": []}], ["There was no significant difference in complication rates between the PSS and no PSS group (10% vs. 6%, p =0.468).", {"entities": []}], ["As with the multivariate analysis of the clincopathological factors to the poor outcome rate, presence of asthma and eosinophilic infiltration were significantly related (odds ratio as 6.555 and 4.505, respectively), whereas PSS was confirmed as less likely related (odds ratio 0.611).", {"entities": [[106, 112, "DISEASE"]]}], ["Low dose PSS administration does not seem to have an effect on the outcome after ESS in patients who have CRS with NP.", {"entities": []}], ["Eosinophilic infiltration and presence of asthma are important predictors of surgical outcome.", {"entities": [[42, 48, "DISEASE"]]}], ["The mind-body nexus has been a topic of growing interest.", {"entities": []}], ["Further data are however required to understand the specific relationship between mood and anxiety disorders and individual physical health conditions, and to verify whether these psychiatric disorders are linked to overall medical burden.", {"entities": []}], ["This study examined data collected from 942 men, 20 to 97 years old, participating in the Geelong Osteoporosis Study.", {"entities": []}], ["A lifetime history of mood and anxiety disorders was identified using the Structured Clinical Interview for DSM-IV-TR Research Version, Non-patient edition (SCID-I/NP).", {"entities": []}], ["The presence of medical conditions (lifetime) was self-reported and confirmed by medical records, medication use or clinical data.", {"entities": []}], ["Anthropometric measurements and socioeconomic status (SES) were determined and information on medication use and lifestyle was obtained via questionnaire.", {"entities": []}], ["Logistic regression models were used to test the associations.", {"entities": []}], ["After adjustment for age, socioeconomic status, and health risk factors (body mass index, physical activity and smoking), mood disorders were associated with gastro oesophageal reflux disease (GORD), recurrent headaches, blackouts and/or epilepsy, liver disorders and pulmonary disease in older people, whilst anxiety disorders were significantly associated with thyroid, GORD and other gastrointestinal disorders, and psoriasis.", {"entities": [[419, 428, "DISEASE"]]}], ["Increased odds of high medical burden were associated with both mood and anxiety disorders.", {"entities": []}], ["Our study provides further population-based evidence supporting the link between mental and physical illness in men.", {"entities": []}], ["Understanding these associations is not only necessary for individual management, but also to inform the delivery of health promotion messages and health care.", {"entities": []}], ["Tropospheric ozone is the major oxidizing component in photochemical smog and is one of the most pervasive problems to human health of the criteria air pollutants for which the National Ambient Air Quality Standards have been designated by the Clean Air Act.", {"entities": []}], ["Although many adverse health effects of ozone exposure have been documented in both humans and laboratory animals, controversy surrounds the establishment and implementation of ozone standards set forth by the U.S. Environmental Protection Agency.", {"entities": []}], ["Because people are commonly exposed to more than one air pollutant at a time, studies that examine coexposures to airborne materials may be more relevant for assessing their risks to human health.", {"entities": []}], ["Airborne biogenic substances such as pollens, spores, and bacterial products are ubiquitous in the environment, and when inhaled can cause adverse respiratory symptoms.", {"entities": []}], ["One such biogenic agent, bacterial endotoxin, is a potent stimulus of airway inflammation and is a ubiquitous airborne contaminant commonly found in domestic, agricultural, and industrial settings.", {"entities": []}], ["Little is known about the interaction of exposures to biogenic substances and criteria air pollutants such as ozone.", {"entities": []}], ["In the last few years we have performed a series of studies in rodents that examined the biologic responses of the respiratory epithelium after airway exposures to both endotoxin and ozone.", {"entities": []}], ["When exposed to ozone (0.5 ppm 8 hr/day for 3 days), Fischer rats develop lesions in the nasal transitional epithelium, whereas intranasal instillation of endotoxin (20 microg) elicits epithelial lesions in the respiratory epithelium of the nose and conducting airways.", {"entities": []}], ["Our studies were designed to examine how exposure to one toxicant may affect the airway epithelial lesions induced by the other toxicant.", {"entities": []}], ["We investigated the potential role of acute inflammation in the enhancement of airway epithelial lesions after exposure of these two toxicants in neutrophil-sufficient and neutrophil-deficient rodents.", {"entities": []}], ["A summary of these results indicates that epithelial and inflammatory responses to coexposure of these two pollutants are greater than those elicited by either agent alone.", {"entities": []}], ["Interestingly, each toxicant enhances the epithelial alterations induced by the other.", {"entities": []}], ["Furthermore, the synergistic effects elicited by coexposure to ozone and endotoxin are mediated partly by neutrophils.", {"entities": []}], ["These studies provided some new insights into how inhaled co-pollutants interact to initiate and promote alterations of airway epithelium.", {"entities": []}], ["Further studies with these and other air pollutants will help define their true risk to human health.", {"entities": []}], ["Obesity is a chronic disease with a high prevalence in both developed and developing countries.", {"entities": [[0, 7, "DISEASE"]]}], ["Effective management of this worldwide epidemic will have a significant impact on the health care system globally.", {"entities": []}], ["Lifestyle interventions, such as restricting calorie consumption and increasing physical activity, remain a major component of weight-reduction programs.", {"entities": []}], ["The development of pharmacotherapy for the management of obesity is still at the infancy stage.", {"entities": [[57, 64, "DISEASE"]]}], ["Side effects have been the key issue for anti-obesity drugs previously withdrawn from the market.", {"entities": [[46, 53, "DISEASE"]]}], ["The focus of this review, lorcaserin, is a selective serotonin receptor agonist that is currently undergoing Phase III evaluations.", {"entities": []}], ["The efficacy of this drug in reducing body weight and improving metabolic parameters of obese patients has been demonstrated in two recent clinical trials.", {"entities": []}], ["The available evidence indicates that this drug does not show unwanted effects on heart valves or pulmonary artery pressure, and the treatment improves the risk factors for type 2 diabetes and cardiovascular diseases.", {"entities": []}], ["Despite these promising results, additional experimental and clinical studies are critical for the approval of lorcaserin as a new anti-obesity monodrug therapy by the US Food and Drug Administration.", {"entities": [[136, 143, "DISEASE"]]}], ["E3 ubiquitin ligase Cbl-b has emerged as a gatekeeper that controls the activation threshold of the T cell antigen receptor and maintains the balance between tolerance and autoimmunity.", {"entities": []}], ["Here, we report that the loss of Cbl-b facilitates T helper 2 (Th2) and Th9 cell differentiation in vitro.", {"entities": []}], ["In a mouse model of asthma, the absence of Cbl-b results in severe airway inflammation and stronger Th2 and Th9 responses.", {"entities": [[20, 26, "DISEASE"]]}], ["Mechanistically, Cbl-b selectively associates with Stat6 upon IL-4 ligation and targets Stat6 for ubiquitination and degradation.", {"entities": [[51, 56, "GENE"], [88, 93, "GENE"], [51, 56, "GENE"], [88, 93, "GENE"]]}], ["These processes are heightened in the presence of T cell receptor (TCR)/ CD28 costimulation.", {"entities": [[73, 77, "GENE"]]}], ["Furthermore, we identify K108 and K398 as Stat6 ubiquitination sites.", {"entities": [[42, 47, "GENE"]]}], ["Intriguingly, introducing Stat6 deficiency into Cblb", {"entities": [[26, 31, "GENE"], [48, 52, "GENE"]]}], ["Beta-blockers reduce mortality among patients with systolic heart failure (HF), yet primary care provider prescription rates remain low.", {"entities": [[51, 73, "DISEASE"]]}], ["To examine the association between primary care physician characteristics and both self-reported and actual prescription of beta-blockers among patients with systolic HF.", {"entities": []}], ["Cross-sectional survey with supplementary retrospective chart review.", {"entities": []}], ["Primary care providers at three New York City Veterans Affairs medical centers.", {"entities": []}], ["Main outcomes were: 1) self-reported prescribing of beta-blockers, and 2) actual prescribing of beta-blockers among HF patients.", {"entities": []}], ["Physician HF practice patterns and confidence levels, as well as socio-demographic and clinical characteristics, were also assessed.", {"entities": []}], ["Sixty-nine of 101 physicians (68%) completed the survey examining self-reported prescribing of beta-blockers.", {"entities": []}], ["Physicians who served as inpatient ward attendings self-reported significantly higher rates of beta-blocker prescribing among their HF patients when compared with physicians who did not attend (78% vs. 58%; p\u200a=\u200a0.002), as did physicians who were very confident in managing HF patients when compared with physicians who were not (82% vs. 68%; p\u200a=\u200a0.009).", {"entities": []}], ["Fifty-one of these 69 surveyed physicians (74%) were successfully matched to 287 HF patients for whom beta-blocker prescribing data was available.", {"entities": []}], ["Physicians with greater self-reported rates of prescribing beta-blockers were significantly more likely to actually prescribe beta-blockers (p\u200a=\u200a0.02); however, no other physician characteristics were significantly associated with actual prescribing of beta-blockers among HF patients.", {"entities": []}], ["Physician teaching responsibilities and confidence levels were associated with self-reported beta-blocker prescribing among their HF patients.", {"entities": []}], ["Educational efforts focused on improving confidence levels in HF care and increasing exposure to teaching may improve beta-blocker presciption in HF patients managed in primary care.", {"entities": []}], ["Chemotherapy of cholangiocarcinoma (CCA), a devastating cancer with increasing worldwide incidence and mortality rates, is largely ineffective.", {"entities": [[56, 62, "DISEASE"], [16, 34, "DISEASE"]]}], ["The discovery and development of effective chemotherapeutics is urgently needed.", {"entities": []}], ["The study aimed at evaluating anticancer activities, toxicity, and pharmacological activities of the curcumin compound (CUR), the crude ethanolic extracts of rhizomes of Zingiber officinale Roscoe (Ginger: ZO) and Atractylodes lancea thung.", {"entities": []}], ["DC (Khod-Kha-Mao: AL), fruits of Piper chaba Hunt.", {"entities": []}], ["(De-Plee: PC), and Pra-Sa-Prao-Yhai formulation (a mixture of parts of 18 Thai medicinal plants: PPF) were investigated in animal models.", {"entities": [[10, 12, "GENE"]]}], ["Anti-cholangiocarcinoma (anti-CCA) was assessed using CCA-xenograft nude mouse model.", {"entities": [[5, 23, "DISEASE"]]}], ["The antihypertensive, analgesic, anti-inflammatory, antipyretic, and anti-ulcer activities and effects on motor coordination were investigated using Rota-rod test, CODA tail-cuff system, writhing and hot plate tests, carrageenan-induced paw edema test, brewer's yeast test, and alcohol-induced gastric ulcer test, respectively.", {"entities": [[294, 307, "DISEASE"]]}], ["Acute and subacute toxicity tests were performed according to the OECD guideline for testing of chemicals with modification.", {"entities": []}], ["Promising anticancer activity against CCA in nude mouse xenograft model was shown for the ethanolic extract of AL at all oral dose levels (1000, 3000, and 5000 mg/kg body weight) as well as the extracts of ZO, PPF, and CUR compound at the highest dose level (5000, 4000, and 5000 mg/kg body weight, respectively).", {"entities": []}], ["PC produced no significant anti-CCA activity.", {"entities": [[0, 2, "GENE"]]}], ["Results from acute and subacute toxicity tests both in mice and rats indicate safety profiles of all the test materials in a broad range of dose levels.", {"entities": []}], ["No significant toxicity except stomach irritation and general CNS depressant signs were observed.", {"entities": []}], ["Investigation of pharmacological activities of the test materials revealed promising anti-inflammatory (ZO, PPF, and AL), analgesic (CUR and PPF), antipyretic (CUR and AL), antihypertensive (ZO and AL), and anti-ulcer (CUR, ZO, and AL) activities.", {"entities": []}], ["Plants used in Thai traditional medicine for the treatment of various ailments may provide reservoirs of promising candidate chemotherapeutics for the treatment of CCA.", {"entities": []}], ["The aim of the present review is to discuss the participation of mast cells in the pathogenesis of erosion and rupture of atherosclerotic plaques, the major causes behind acute coronary syndromes and myocardial infarction.", {"entities": [[200, 221, "DISEASE"]]}], ["We present ex vivo observations describing mast cells and their activation in human atherosclerotic plaques and discuss in vitro and in vivo data showing that mast cells are potential regulators of inflammation, immunity and adverse remodeling, including matrix remodeling and cell death.", {"entities": []}], ["Furthermore, we focus on studies that have been performed with human tissues and human mast cells, but when appropriate, we also discuss observations made in animal models.", {"entities": []}], ["Finally, we present potential pharmacological means to modulate mast cell responses in the arterial vessel walls.", {"entities": []}], ["Cell therapies for intervertebral disc (IVD) regeneration presently rely on transplantation of IVD cells or stem cells directly to the lesion site.", {"entities": [[40, 43, "GENE"], [95, 98, "GENE"], [40, 43, "GENE"], [95, 98, "GENE"]]}], ["Still, the harsh IVD environment, with low irrigation and high mechanical stress, challenges cell administration and survival.", {"entities": [[17, 20, "GENE"]]}], ["In this study, we addressed systemic transplantation of allogeneic bone marrow mesenchymal stem cells (MSCs) intravenously into a rat IVD lesion model, exploring tissue regeneration via cell signaling to the lesion site.", {"entities": [[134, 137, "GENE"]]}], ["MSC transplantation was performed 24 hours after injury, in parallel with dermal fibroblasts as a control; 2 weeks after transplantation, animals were killed.", {"entities": [[0, 3, "GENE"]]}], ["Disc height index and histological grading score indicated less degeneration for the MSC\u2010transplanted group, with no significant changes in extracellular matrix composition.", {"entities": []}], ["Remarkably, MSC transplantation resulted in local downregulation of the hypoxia responsive GLUT\u20101 and in significantly less herniation, with higher amounts of Pax5+ B lymphocytes and no alterations in CD68+ macrophages within the hernia.", {"entities": [[12, 15, "GENE"]]}], ["The systemic immune response was analyzed in the blood, draining lymph nodes, and spleen by flow cytometry and in the plasma by cytokine array.", {"entities": []}], ["Results suggest an immunoregulatory effect in the MSC\u2010transplanted animals compared with control groups, with an increase in MHC class II+ and CD4+ cells, and also upregulation of the cytokines IL\u20102, IL\u20104, IL\u20106, and IL\u201010, and downregulation of the cytokines IL\u201013 and TNF\u2010\u03b1.", {"entities": []}], ["Overall, our results indicate a beneficial effect of systemically transplanted MSCs on in situ IVD regeneration and highlight the complex interplay between stromal cells and cells of the immune system in achieving successful tissue regeneration.", {"entities": [[95, 98, "GENE"]]}], ["S tem C ells T ranslational M edicine 2017;6:1029\u20131039", {"entities": []}], ["Elucidating the biological and biochemical roles of proteins, and subsequently determining their interacting partners, can be difficult and time consuming using in vitro and/or in vivo methods, and consequently the majority of newly sequenced proteins will have unknown structures and functions.", {"entities": []}], ["However, in silico methods for predicting protein\u2013ligand binding sites and protein biochemical functions offer an alternative practical solution.", {"entities": []}], ["The characterisation of protein\u2013ligand binding sites is essential for investigating new functional roles, which can impact the major biological research spheres of health, food, and energy security.", {"entities": []}], ["In this review we discuss the role in silico methods play in 3D modelling of protein\u2013ligand binding sites, along with their role in predicting biochemical functionality.", {"entities": []}], ["In addition, we describe in detail some of the key alternative in silico prediction approaches that are available, as well as discussing the Critical Assessment of Techniques for Protein Structure Prediction (CASP) and the Continuous Automated Model EvaluatiOn (CAMEO) projects, and their impact on developments in the field.", {"entities": []}], ["Furthermore, we discuss the importance of protein function prediction methods for tackling 21st century problems.", {"entities": []}], ["The ethanol extract of KOTMIN13, composed of Inula japonica Flowers, Trichosanthes kirilowii Semen, Peucedanum praeruptorum Radix, and Allium macrostemon Bulbs, was investigated for its anti-asthmatic and anti-allergic activities.", {"entities": []}], ["The anti-asthmatic effects of KOTMIN13 were evaluated on ovalbumin (OVA)-induced murine asthma model.", {"entities": [[88, 94, "DISEASE"]]}], ["Anti-allergic properties of KOTMIN13 in bone-marrow derived mast cells (BMMC) and passive cutaneous anaphylaxis (PCA) in vivo were also examined.", {"entities": []}], ["In asthma model, KOTMIN13 effectively suppressed airway hyperresponsiveness induced by aerosolized methacholine when compared to the levels of OVA-induced mice.", {"entities": [[3, 9, "DISEASE"]]}], ["KOTMIN13 treatment reduced the total leukocytes, eosinophil percentage, and Th2 cytokines in the bronchoalveolar lavage fluids in OVA-induced mice.", {"entities": []}], ["The increased levels of eotaxin and Th2 cytokines in the lung as well as serum IgE were decreased by KOTMIN13.", {"entities": []}], ["The histological analysis shows that the increased inflammatory cell infiltration and mucus secretion were also reduced.", {"entities": []}], ["In addition, the degranulation and leukotriene C 4 production were inhibited in BMMC with IC 50 values of 3.9\u00a0\u03bcg/ml and 1.7\u00a0\u03bcg/ml, respectively.", {"entities": []}], ["Furthermore, KOTMIN13 treatment attenuated mast-mediated PCA reaction.", {"entities": []}], ["These results demonstrate that KOTMIN13 has anti-asthmatic and anti-allergic effects in vivo and in vitro models.", {"entities": []}], ["Access to health services is an important health determinant.", {"entities": []}], ["New research in health equity is required, especially amongst economic migrants from developing countries.", {"entities": []}], ["Studies conducted on the use of health services by migrant populations highlight existing gaps in understanding which factors affect access to these services from a qualitative perspective.", {"entities": []}], ["We aim to describe the views of the migrants regarding barriers and determinants of access to health services in the international literature (1997\u20132011).", {"entities": []}], ["A systematic review was conducted for Qualitative research papers (English/Spanish) published in 13 electronic databases.", {"entities": []}], ["A selection of articles that accomplished the inclusion criteria and a quality evaluation of the studies were carried out.", {"entities": []}], ["The findings of the selected studies were synthesised by means of metasynthesis using different analysis categories according to Andersen\u2019s conceptual framework of access and use of health services and by incorporating other emergent categories.", {"entities": []}], ["We located 3,025 titles, 36 studies achieved the inclusion criteria.", {"entities": []}], ["After quality evaluation, 28 articles were definitively synthesised.", {"entities": []}], ["12 studies (46.2%) were carried out in the U.S and 11 studies (42.3%) dealt with primary care services.", {"entities": []}], ["The participating population varied depending mainly on type of host country.", {"entities": []}], ["Barriers were described, such as the lack of communication between health services providers and migrants, due to idiomatic difficulties and cultural differences.", {"entities": []}], ["Other barriers were linked to the economic system, the health service characteristics and the legislation in each country.", {"entities": []}], ["This situation has consequences for the lack of health control by migrants and their social vulnerability.", {"entities": []}], ["Economic migrants faced individual and structural barriers to the health services in host countries, especially those with undocumented situation and those experimented idiomatic difficulties.", {"entities": []}], ["Strategies to improve the structures of health systems and social policies are needed.", {"entities": []}], ["Antibiotic treatment during pregnancy and birth is very common.", {"entities": []}], ["In this study, we describe the estimated prevalence of antibiotic administration during pregnancy and birth in the COPSAC 2010 pregnancy cohort, and analyze dependence on social and lifestyle-related factors.", {"entities": []}], ["706 pregnant women from the novel unselected Copenhagen Prospective Study on Asthma in Childhood (COPSAC 2010 ) pregnancy cohort participated in this analysis.", {"entities": [[77, 83, "DISEASE"]]}], ["Detailed information on oral antibiotic prescriptions during pregnancy filled at the pharmacy was obtained and verified longitudinally.", {"entities": []}], ["Information on intrapartum antibiotics, social, and lifestyle-factors was obtained by personal interviews.", {"entities": []}], ["The prevalence of antibiotic use was 37% during pregnancy and 33% intrapartum.", {"entities": []}], ["Lower maternal age at birth; adjusted odds ratio (aOR) 0.94, 95% CI, [0.90-0.98], p = 0.003 and maternal smoking; aOR 1.97, 95% CI, [1.07-3.63], p = 0.030 were associated with use of antibiotics for urinary tract infection during pregnancy.", {"entities": []}], ["Maternal educational level (low vs. high), aOR 2.32, 95% CI, [1.24-4.35], p = 0.011, maternal asthma; aOR 1.99, 95% CI, [1.33-2.98], p < 0.001 and previous childbirth; aOR 1.80, 95% CI, [1.21-2.66], p = 0.004 were associated with use of antibiotics for respiratory tract infection during pregnancy.", {"entities": [[94, 100, "DISEASE"]]}], ["Lower gestational age; aOR 0.72, 95% CI, [0.61-0.85], p < 0.001, maternal smoking; aOR 2.84, 95% CI, [1.33-6.06], p = 0.007, and nulliparity; aOR 1.79, 95% CI, [1.06-3.02], p = 0.030 were associated with administration of intrapartum antibiotics in women giving birth vaginally.", {"entities": []}], ["Antibiotic administration during pregnancy and birth may be influenced by social and lifestyle-factors.", {"entities": []}], ["Understanding such risk factors may guide preventive strategies in order to avoid unnecessary use of antibiotics.", {"entities": []}], ["To ascertain the effect of obesity-related inflammation on maternal and fetal iron status.", {"entities": [[27, 34, "DISEASE"]]}], ["We hypothesized that obese pregnant women would have increased inflammation, hepcidin levels, and that their infants would have impaired iron status compared to lean controls.", {"entities": []}], ["Fifteen obese (Ob) and fifteen lean (Lc) women were recruited in their second trimester of pregnancy.", {"entities": []}], ["Markers of iron status, inflammation and hepcidin were measured in maternal and cord blood.", {"entities": []}], ["Student\u2019s t test was used to compare obese and lean groups, and Pearson correlation coefficients were determined between maternal and cord blood values.", {"entities": []}], ["Maternal C-reactive protein (CRP) (p<0.01) and hepcidin (p<0.01) were higher, and cord blood iron (p<0.01) was lower in the obese group.", {"entities": [[29, 32, "GENE"]]}], ["Maternal BMI (p<0.01) and hepcidin (p<0.05) were negatively correlated with cord blood iron status.", {"entities": []}], ["Maternal obesity is associated with impaired maternal-fetal iron transfer, potentially through hepcidin upregulation.", {"entities": [[9, 16, "DISEASE"]]}], ["Esophageal squamous cell carcinoma (ESCC) is a deadly disease with high risk of tumor recurrence even among patients with an early pathologic stage of tumor.", {"entities": [[25, 34, "DISEASE"], [11, 34, "DISEASE"]]}], ["In the current study, we investigate the association between 20 SNPs of the ATG5 gene and prognosis of patients with early-stage ESCC.", {"entities": [[76, 80, "GENE"]]}], ["A total of 305 patients diagnosed with early-stage ESCC were enrolled in the study and randomly assigned to a training set (n=93) or replication set (n=212).", {"entities": []}], ["The genotypes of candidate SNPs (single nucleotide polymorphisms) within ATG5 were analyzed and correlated with the prognosis of ESCC patients.", {"entities": [[73, 77, "GENE"]]}], ["We repeatedly demonstrated that 3 SNPs in ATG5, rs1322178, rs3804329, and rs671116, were significantly correlated with the prognosis of patients with early-stage ESCC (HR[95 % CI]=2.01[1.19-3.40], p=0.009 for ATG5: rs1322178; HR[95 % CI]=1.88 [1.08-3.26], p=0.025 for ATG5:rs3804329; HR[95 % CI]=1.73[1.24-2.42], p=0.001 for ATG5:rs671116, in combined group).", {"entities": [[42, 46, "GENE"], [209, 213, "GENE"], [268, 272, "GENE"], [325, 329, "GENE"], [168, 170, "GENE"], [226, 228, "GENE"], [284, 286, "GENE"], [42, 46, "GENE"], [209, 213, "GENE"], [268, 272, "GENE"], [325, 329, "GENE"], [168, 170, "GENE"], [226, 228, "GENE"], [284, 286, "GENE"], [42, 46, "GENE"], [209, 213, "GENE"], [268, 272, "GENE"], [325, 329, "GENE"], [168, 170, "GENE"], [226, 228, "GENE"], [284, 286, "GENE"], [42, 46, "GENE"], [209, 213, "GENE"], [268, 272, "GENE"], [325, 329, "GENE"]]}], ["Both rs1322178 and rs3804329 can predict early distant metastasis of patients.", {"entities": []}], ["Furthermore, increased expression of ATG5 was observed in ESCC tumor tissue as compared to adjacent normal tissue.", {"entities": [[37, 41, "GENE"]]}], ["Moreover, higher levels of ATG5 expression in both normal and tumor tissues exhibited a trend to correlate with poor prognosis of patients.", {"entities": [[27, 31, "GENE"]]}], ["However, the expression of ATG5 did not correlate with these 3 relevant prognostic SNPs.", {"entities": [[27, 31, "GENE"]]}], ["We concluded that hereditary genetic polymorphisms and gene expression of ATG5 can serve as prognostic predictors of patients with early-stage ESCC.", {"entities": [[74, 78, "GENE"]]}], ["Leishmania are obligate intracellular parasites that cause a wide spectrum of diseases ranging from cutaneous, mucocutaneous and the visceral kind.", {"entities": []}], ["Persistence or resolution of leishmaniasis is governed by host immune response.", {"entities": [[29, 42, "DISEASE"]]}], ["Co-stimulation is an important secondary signal that governs the extent, strength and direction of the immune response that follows.", {"entities": []}], ["Co-stimulation by CD40, B7 and OX40 family has been shown to influence the outcome following Leishmania infection and manipulation of these pathways has shown promise for use in immune therapy of leishmaniasis.", {"entities": [[196, 209, "DISEASE"], [18, 22, "GENE"]]}], ["In this review, we discuss the roles of CD40, B7 and OX40 co-stimulatory pathways in regulating immunity to Leishmania and their implications in the treatment of this disease.", {"entities": [[40, 44, "GENE"]]}], ["Acne vulgaris affects about 85% of adolescents, often extending into adulthood.", {"entities": [[0, 4, "DISEASE"]]}], ["Psychosocial impact of acne on health-related quality of life (QoL) has been identified, but it remains under-evaluated, especially in Indian patients.", {"entities": [[23, 27, "DISEASE"]]}], ["This study was aimed to assess the impact of acne and its sequelae on the QoL.", {"entities": [[45, 49, "DISEASE"]]}], ["This was a hospital-based, prospective, cross-sectional study done between June and November 2014 on 114 consenting patients above 15 years of age with acne vulgaris.", {"entities": [[152, 156, "DISEASE"]]}], ["Acne vulgaris and its sequelae were graded, and QoL was assessed by using Dermatology Life Quality Index (DLQI) questionnaire.", {"entities": [[0, 4, "DISEASE"]]}], ["Most cases (64%) were between 15 and 20 years.", {"entities": []}], ["Females (57%) outnumbered males.", {"entities": []}], ["Facial lesions (61.4%) and grade II acne were most common.", {"entities": [[36, 40, "DISEASE"]]}], ["Mean DLQI score was 7.22.", {"entities": []}], ["DLQI scores were statistically influenced by the age of the patient, duration and grade of acne, acne scar, and postacne hyperpigmentation.", {"entities": [[91, 95, "DISEASE"], [97, 101, "DISEASE"]]}], ["This study showed significant impairment of QoL in acne patients.", {"entities": [[51, 55, "DISEASE"]]}], ["Assurance and counseling along with early treatment of acne vulgaris are important to reduce disease-related psychosocial sequelae and increase the efficacy of treatment.", {"entities": [[55, 59, "DISEASE"]]}], ["Electronic administrative data exist in several domains which, if linked, are potentially useful for research.", {"entities": []}], ["However, benefits from data linkage should be considered alongside risks such as the threat to privacy.", {"entities": []}], ["Avon Longitudinal Study of Parents and Children (ALSPAC) is a birth cohort study.", {"entities": []}], ["The Project to Enhance ALSPAC through Record Linkage (PEARL) was established to enrich the ALSPAC resource through linkage between ALSPAC participants and routine sources of health and social data.", {"entities": []}], ["Qualitative research was incorporated in the PEARL study to examine participants\u2019 views about data linkage and inform approaches to information sharing.", {"entities": []}], ["This paper focusses on issues of consent.", {"entities": []}], ["Digitally recorded interviews were conducted with 55 participants aged 17\u201319 years.", {"entities": []}], ["Terms and processes relating to consent, anonymization and data linkage were explained to interviewees.", {"entities": []}], ["Scenarios were used to prompt consideration of linking different sources of data, and whether consent should be requested.", {"entities": []}], ["Interview recordings were fully transcribed.", {"entities": []}], ["Thematic analysis was undertaken using the Framework approach.", {"entities": []}], ["Participant views on data linkage appeared to be most influenced by: considerations around the social sensitivity of the research question, and; the possibility of tangible health benefits in the public interest.", {"entities": []}], ["Some participants appeared unsure about the effectiveness of anonymization, or did not always view effective anonymization as making consent unnecessary.", {"entities": []}], ["This was related to notions of ownership of personal information and etiquette around asking permission for secondary use.", {"entities": []}], ["Despite different consent procedures being explained, participants tended to equate consent with \u2018opt-in\u2019 consent through which participants are \u2018asked\u2019 if their data can be used for a specific study.", {"entities": []}], ["Participants raising similar concerns came to differing conclusions about whether consent was needed.", {"entities": []}], ["Views changed when presented with different scenarios, and were sometimes inconsistent.", {"entities": []}], ["Findings from this study question the validity of \u2018informed consent\u2019 as a cornerstone of good governance, and the extent to which potential research participants understand different types of consent and what they are consenting, or not consenting, to.", {"entities": []}], ["Pragmatic, imaginative and flexible approaches are needed if research using data linkage is to successfully realise its potential for public good without undermining public trust in the research process.", {"entities": []}], ["Chitosan polyplexes containing plasmid DNA (pDNA) have significant potential for pulmonary gene delivery applications.", {"entities": []}], ["However, prior to using chitosan/pDNA polyplexes (CSpp) in clinical applications, their potential cytotoxicity needs to be investigated.", {"entities": []}], ["In this study, we formulated 200\u2013400 nm CSpp with amine to phosphate (N/P) ratios that ranged from 1 to 100.", {"entities": []}], ["We compared two types of plasmids within CSpp: pDNA that was free of CpG sequences (CpG(\u2212)) and pDNA that contained CpG sequences (CpG(+)).", {"entities": []}], ["Both forms of CSpp showed low cytotoxicity when cultured with A549 and HEK293 cell lines in vitro .", {"entities": []}], ["CSpp(CpG(\u2212)) generated higher luciferase expression both in vitro , for A549 cells, and in vivo , compared with CSpp(CpG(+)).", {"entities": []}], ["In addition, CSpp(CpG(\u2212)) elicited milder inflammatory responses in mice one day subsequent to nasal instillation, as determined by proinflammatory cytokine levels within the bronchoalveolar lavage fluid.", {"entities": []}], ["Our findings suggest that to achieve optimal gene expression with minimal cytotoxicity, inflammation, and oxidative stress, the N/P ratios and CpG sequences in the pDNA of CSpp need to be considered.", {"entities": []}], ["These findings will inform the preclinical safety assessments of CSpp in pulmonary gene delivery systems.", {"entities": []}], ["Acute respiratory infections are a leading cause of death worldwide.", {"entities": []}], ["Clinical data is conflicted regarding whether statins improve outcomes for pneumonia.", {"entities": [[75, 84, "DISEASE"]]}], ["Potential confounding factors including specific etiology of pneumonia as well as obesity could potentially mask protective benefit.", {"entities": [[61, 70, "DISEASE"], [82, 89, "DISEASE"]]}], ["Obesity is a risk factor for high cholesterol, the main target for statin therapy.", {"entities": [[0, 7, "DISEASE"]]}], ["We demonstrate that statin intervention conferred no protective benefit in the context of wild-type mice regardless of infectious agent.", {"entities": []}], ["Statin intervention conferred either a protective benefit, during influenza infection, or detrimental effect, in the case of pneumococcal infection, in obese animals.", {"entities": [[66, 75, "DISEASE"]]}], ["These data suggest etiology of pneumonia in the context of obesity could be dramatically altered by the protective effects of statin therapy during bacterial and viral pneumonia.", {"entities": [[31, 40, "DISEASE"], [168, 177, "DISEASE"], [59, 66, "DISEASE"], [162, 177, "DISEASE"]]}], ["Limited research has assessed associations between schizophrenia and genetic variants of the ankyrin repeat and kinase domain containing 1 ( ANKK1 ) and lymphotoxin-alpha ( LTA ) genes among individuals of Middle Eastern ancestry.", {"entities": [[51, 64, "DISEASE"], [141, 146, "GENE"], [173, 176, "GENE"]]}], ["Here we present the first association study investigating the ANKK1 rs1800497 (T>C) and LTA rs909253 (A>G) single-nucleotide polymorphisms in an Egyptian population.", {"entities": [[62, 67, "GENE"], [88, 91, "GENE"]]}], ["Among 120 patients with DSM-IV and PANSS (Positive and Negative Syndrome Scale) assessments of schizophrenia and 100 healthy controls, we determined the genotypes for the polymorphisms using endonuclease digestion of amplified genomic DNA.", {"entities": [[95, 108, "DISEASE"]]}], ["Results confirmed previous findings from different ethnic populations, in that the rs1800497 and rs909253 polymorphisms were both associated with risk of schizophrenia.", {"entities": [[154, 167, "DISEASE"]]}], ["Differences between the genotypes of cases and controls were strongly significant ( P = 0.0005 for rs1800497 and P = 0.001 for rs909253).", {"entities": []}], ["The relative risk to schizophrenia was 1.2 ( P = 0.01) for the C allele and 0.8 ( P = 0.04) for the G allele.", {"entities": [[21, 34, "DISEASE"]]}], ["The CC, GG, and combined CC/AA genotypes were all more frequent in cases than in controls.", {"entities": []}], ["These results support an association between ANKK1 and LTA genetic markers and vulnerability to schizophrenia and show the potential influence of just one copy of the mutant C or G allele in the Egyptian population.", {"entities": [[96, 109, "DISEASE"], [45, 50, "GENE"], [55, 58, "GENE"]]}], ["The diagnosis of IgE\u2010mediated food allergy based solely on the clinical history and the documentation of specific IgE to whole allergen extract or single allergens is often ambiguous, requiring oral food challenges (OFCs), with the attendant risk and inconvenience to the patient, to confirm the diagnosis of food allergy.", {"entities": [[30, 42, "DISEASE"], [309, 321, "DISEASE"]]}], ["This is a considerable proportion of patients assessed in allergy clinics.", {"entities": []}], ["The basophil activation test (BAT) has emerged as having superior specificity and comparable sensitivity to diagnose food allergy, when compared with skin prick test and specific IgE.", {"entities": [[117, 129, "DISEASE"]]}], ["BAT, therefore, may reduce the number of OFC required for accurate diagnosis, particularly positive OFC.", {"entities": []}], ["BAT can also be used to monitor resolution of food allergy and the clinical response to immunomodulatory treatments.", {"entities": [[46, 58, "DISEASE"]]}], ["Given the practicalities involved in the performance of BAT, we propose that it can be applied for selected cases where the history, skin prick test and/or specific IgE are not definitive for the diagnosis of food allergy.", {"entities": [[209, 221, "DISEASE"]]}], ["In the cases that the BAT is positive, food allergy is sufficiently confirmed without OFC; in the cases that BAT is negative or the patient has non\u2010responder basophils, OFC may still be indicated.", {"entities": [[39, 51, "DISEASE"]]}], ["However, broad clinical application of BAT demands further standardization of the laboratory procedure and of the flow cytometry data analyses, as well as clinical validation of BAT as a diagnostic test for multiple target allergens and confirmation of its feasibility and cost\u2010effectiveness in multiple settings.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is associated with smoking but other etiological factors contribute.", {"entities": []}], ["Chlamydia pneumoniae is an obligate intracellular bacterium causing both acute and chronic respiratory tract infections.", {"entities": []}], ["Studies have revealed an association between chronic C. pneumoniae infection and COPD, asthma and lung cancer but there have been difficulties detecting C. pneumoniae in the bronchial tree.", {"entities": [[98, 109, "DISEASE"], [87, 93, "DISEASE"], [103, 109, "DISEASE"]]}], ["Cytospin slides prepared from bronchoalveolar lavage (BAL) fluid from 14 patients with COPD, 10 healthy smokers (S) and 7 non smokers (NS) were analyzed with a fluorescein isothiocyanate labeled monoclonal antibody to C. pneumoniae .", {"entities": []}], ["Lung tissue from 24 patients with advanced emphysema who had undergone lung volume reduction surgery (LVRS) was examined with immunohistochemistry for C. pneumoniae .", {"entities": []}], ["Archived serum samples for detection of specific C. pneumoniae antibodies by microimmunofluorescence were available for 30 of the BAL subjects and 11 of LVRS patients.", {"entities": []}], ["C. pneumoniae elementary body like structures were found in 29% of cytospin specimens from COPD patients, 14% of NS and 10% of HS.", {"entities": []}], ["C. pneumoniae was detected in lung tissue in 8%.", {"entities": []}], ["COPD patients had higher titres of IgG and IgA than NS and S. There was no association between occurrence of C. pneumoniae in BAL fluid and antibody titres.", {"entities": []}], ["In conclusion, the assays used for detection of C. pneumoniae in lung tissue are feasible, and could be adapted in adequately powered studies to further confirm an association between C. pneumoniae infection and COPD.", {"entities": []}], ["The biomarker discovery field is replete with molecular signatures that have not translated into the clinic despite ostensibly promising performance in predicting disease phenotypes.", {"entities": []}], ["One widely cited reason is lack of classification consistency, largely due to failure to maintain performance from study to study.", {"entities": []}], ["This failure is widely attributed to variability in data collected for the same phenotype among disparate studies, due to technical factors unrelated to phenotypes (e.g., laboratory settings resulting in \u201cbatch-effects\u201d) and non-phenotype-associated biological variation in the underlying populations.", {"entities": []}], ["These sources of variability persist in new data collection technologies.", {"entities": []}], ["Here we quantify the impact of these combined \u201cstudy-effects\u201d on a disease signature\u2019s predictive performance by comparing two types of validation methods: ordinary randomized cross-validation (RCV), which extracts random subsets of samples for testing, and inter-study validation (ISV), which excludes an entire study for testing.", {"entities": []}], ["Whereas RCV hardwires an assumption of training and testing on identically distributed data, this key property is lost in ISV, yielding systematic decreases in performance estimates relative to RCV.", {"entities": []}], ["Measuring the RCV-ISV difference as a function of number of studies quantifies influence of study-effects on performance.", {"entities": []}], ["As a case study, we gathered publicly available gene expression data from 1,470 microarray samples of 6 lung phenotypes from 26 independent experimental studies and 769 RNA-seq samples of 2 lung phenotypes from 4 independent studies.", {"entities": []}], ["We find that the RCV-ISV performance discrepancy is greater in phenotypes with few studies, and that the ISV performance converges toward RCV performance as data from additional studies are incorporated into classification.", {"entities": []}], ["We show that by examining how fast ISV performance approaches RCV as the number of studies is increased, one can estimate when \u201csufficient\u201d diversity has been achieved for learning a molecular signature likely to translate without significant loss of accuracy to new clinical settings.", {"entities": []}], ["We present immunological data from two clinical trials where the effect of experimental human hookworm ( Necator americanus ) infection on the pathology of celiac disease was evaluated.", {"entities": [[156, 170, "DISEASE"]]}], ["We found that basal production of Interferon- (IFN-)\u03b3 and Interleukin- (IL-)17A from duodenal biopsy culture was suppressed in hookworm-infected participants compared to uninfected controls.", {"entities": []}], ["Increased levels of CD4+CD25+Foxp3+ cells in the circulation and mucosa are associated with active celiac disease.", {"entities": [[99, 113, "DISEASE"]]}], ["We show that this accumulation also occurs during a short-term (1 week) oral gluten challenge, and that hookworm infection suppressed the increase of circulating CD4+CD25+Foxp3+ cells during this challenge period.", {"entities": []}], ["When duodenal biopsies from hookworm-infected participants were restimulated with the immunodominant gliadin peptide QE65, robust production of IL-2, IFN-\u03b3 and IL-17A was detected, even prior to gluten challenge while participants were strictly adhering to a gluten-free diet.", {"entities": []}], ["Intriguingly, IL-5 was produced only after hookworm infection in response to QE65.", {"entities": []}], ["Thus we hypothesise that hookworm-induced TH2 and IL-10 cross-regulation of the TH1/TH17 inflammatory response may be responsible for the suppression of these responses during experimental hookworm infection.", {"entities": []}], ["Interprofessional education is a collaborative approach to develop healthcare students as future interprofessional team members and a recommendation suggested by the Institute of Medicine.", {"entities": []}], ["Complex medical issues can be best addressed by interprofessional teams.", {"entities": []}], ["Training future healthcare providers to work in such teams will help facilitate this model resulting in improved healthcare outcomes for patients.", {"entities": []}], ["In this paper, three universities, the Rosalind Franklin University of Medicine and Science, the University of Florida and the University of Washington describe their training curricula models of collaborative and interprofessional education.", {"entities": []}], ["The models represent a didactic program, a community-based experience and an interprofessional-simulation experience.", {"entities": []}], ["The didactic program emphasizes interprofessional team building skills, knowledge of professions, patient centered care, service learning, the impact of culture on healthcare delivery and an interprofessional clinical component.", {"entities": []}], ["The community-based experience demonstrates how interprofessional collaborations provide service to patients and how the environment and availability of resources impact one's health status.", {"entities": []}], ["The interprofessional-simulation experience describes clinical team skills training in both formative and summative simulations used to develop skills in communication and leadership.", {"entities": []}], ["One common theme leading to a successful experience among these three interprofessional models included helping students to understand their own professional identity while gaining an understanding of other professional's roles on the health care team.", {"entities": []}], ["Commitment from departments and colleges, diverse calendar agreements, curricular mapping, mentor and faculty training, a sense of community, adequate physical space, technology, and community relationships were all identified as critical resources for a successful program.", {"entities": []}], ["Summary recommendations for best practices included the need for administrative support, interprofessional programmatic infrastructure, committed faculty, and the recognition of student participation as key components to success for anyone developing an IPE centered program.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is frequent and often coexists with other diseases.", {"entities": []}], ["The aim of this study was to quantify the prevalence of COPD and related chronic comorbidity among patients aged over 40 years visiting family practices in an area of Madrid.", {"entities": []}], ["An observational, descriptive, cross-sectional study was conducted in a health area of the Madrid Autonomous Region ( Comunidad Aut\u00f3noma de Madrid ).", {"entities": []}], ["The practice population totalled 198,670 persons attended by 129 Family Physicians (FPs), and the study population was made up of persons over the age of 40 years drawn from this practice population.", {"entities": []}], ["Patients were deemed to have COPD if this diagnosis appeared on their clinical histories.", {"entities": []}], ["Prevalence of COPD; prevalence of a further 25 chronic diseases in patients with COPD; and standardised prevalence ratios, were calculated.", {"entities": []}], ["Prevalence of COPD in family medicine was 3.2% (95% CI 3.0\u20133.3) overall, 5.3% among men and 1.4% among women; 90% of patients presented with comorbidity, with a mean of 4\u2009\u00b1\u20092.04 chronic diseases per patient, with the most prevalent related diseases being arterial hypertension (52%), disorders of lipid metabolism (34%), obesity (25%), diabetes (20%) and arrhythmia (15%).", {"entities": [[264, 276, "DISEASE"], [321, 328, "DISEASE"]]}], ["After controlling for age and sex, the observed prevalence of the following ten chronic diseases was higher than expected: heart failure; chronic liver disease; asthma; generalised artherosclerosis; osteoporosis; ischaemic heart disease; thyroid disease; anxiety/depression; arrhythmia; and obesity.", {"entities": [[146, 159, "DISEASE"], [223, 236, "DISEASE"], [291, 298, "DISEASE"], [199, 211, "DISEASE"], [161, 167, "DISEASE"]]}], ["Patients with COPD, who are frequent in family practice, have a complex profile and pose a clinical and organisational challenge to FPs.", {"entities": []}], ["Health status, dyspnea and psychological status are important clinical outcomes in chronic obstructive pulmonary disease (COPD).", {"entities": [[83, 120, "DISEASE"]]}], ["However, forced expiratory volume in one second (FEV 1 ) measured by spirometry, the standard measurement of airflow limitation, has only a weak relationship with these outcomes in COPD.", {"entities": [[49, 52, "GENE"]]}], ["Recently, in addition to spirometry, impulse oscillometry (IOS) measuring lung resistance (R) and reactance (X) is increasingly being used to assess pulmonary functional impairment.", {"entities": []}], ["We aimed to identify relationships between IOS measurements and patient-reported outcomes in 65 outpatients with stable COPD.", {"entities": []}], ["We performed pulmonary function testing, IOS, high-resolution computed tomography (CT), and assessment of health status using the St. George's Respiratory Questionnaire (SGRQ), dyspnea using the Medical Research Council (MRC) scale and psychological status using the Hospital Anxiety and Depression Scale (HADS).", {"entities": []}], ["We then investigated the relationships between these parameters.", {"entities": []}], ["For the IOS measurements, we used lung resistance at 5 and 20 Hz (R5 and R20, respectively) and reactance at 5 Hz (X5).", {"entities": []}], ["Because R5 and R20 are regarded as reflecting total and proximal airway resistance, respectively, the fall in resistance from R5 to R20 (R5-R20) was used as a surrogate for the resistance of peripheral airways.", {"entities": []}], ["X5 was also considered to represent peripheral airway abnormalities.", {"entities": []}], ["R5-R20 and X5 were significantly correlated with the SGRQ and the MRC.", {"entities": []}], ["These correlation coefficients were greater than when using other objective measurements of pulmonary function, R20 on the IOS and CT instead of R5-R20 and X5.", {"entities": []}], ["Multiple regression analyses showed that R5-R20 or X5 most significantly accounted for the SGRQ and MRC scores.", {"entities": []}], ["IOS measurements, especially indices of peripheral airway function, are significantly correlated with health status and dyspnea in patients with COPD.", {"entities": []}], ["Therefore, in addition to its simplicity and non-invasiveness, IOS may be a useful clinical tool not only for detecting pulmonary functional impairment, but also to some extent at least estimating the patient's quality of daily life and well-being.", {"entities": []}], ["The Affordable Care Act resulted in unprecedented reductions in the uninsured population through subsidized private insurance and an expansion of Medicaid.", {"entities": []}], ["Early estimates from the beginning of 2014 showed that the Medicaid expansion decreased uninsured discharges and increased Medicaid discharges with no change in total discharges.", {"entities": []}], ["To provide new estimates of the effect of the ACA on discharges for specific conditions.", {"entities": []}], ["We compared outcomes between states that did and did not expand Medicaid using state-level all-capture discharge data from 2009\u20132014 for 42 states from the Healthcare Costs and Utilization Project\u2019s FastStats database; for a subset of states we used data through 2015.", {"entities": []}], ["We stratified the analysis by baseline uninsured rates and used difference-in-differences and synthetic control methods to select comparison states with similar baseline characteristics that did not expand Medicaid.", {"entities": []}], ["Our main outcomes were total and condition-specific hospital discharges per 1,000 population and the share of total discharges by payer.", {"entities": []}], ["Conditions reported separately in FastStats included maternal, surgical, mental health, injury, and diabetes.", {"entities": []}], ["The share of uninsured discharges fell in Medicaid expansion states with below (-4.39 percentage points (p.p.", {"entities": []}], ["), -6.04 \u2013-2.73) or above (-7.66 p.p., -9.07 \u2013-6.24) median baseline uninsured rates.", {"entities": []}], ["The share of Medicaid discharges increased in both small (6.42 p.p.", {"entities": []}], ["4.22\u20136.62) and large (10.5 p.p., 8.48\u201312.5) expansion states.", {"entities": []}], ["Total and most condition-specific discharges per 1,000 residents did not change in Medicaid expansion states with high or low baseline uninsured rates relative to non-expansion states (0.418, p = 0.225), with one exception: diabetes.", {"entities": []}], ["Discharges for that condition per 1,000 fell in states with high baseline uninsured rates relative to non-expansion states (-0.038 95% p = 0.027).", {"entities": []}], ["Early changes in payer mix identified in the first two quarters of 2014 continued through the Medicaid expansion\u2019s first year and are distributed across all condition types studied.", {"entities": []}], ["We found no change in total discharges between Medicaid expansion and non-expansion states, however residents of states that should have been most affected by the Medicaid expansion were less likely to be hospitalized for diabetes.", {"entities": []}], ["Probiotics such as L .", {"entities": []}], ["plantarum WCFS1 can modulate immune responses in healthy subjects but how this occurs is still largely unknown.", {"entities": []}], ["Immune-sampling in the Peyer Patches has been suggested to be one of the mechanisms.", {"entities": []}], ["Here we studied the systemic and intestinal immune effects in combination with a trafficking study through the intestine of a well-established immunomodulating probiotic, i.e.", {"entities": []}], ["plantarum WCFS1.", {"entities": []}], ["We demonstrate that not more than 2\u20133 bacteria were sampled and in many animals not any bacterium could be found in the PP.", {"entities": []}], ["Despite this, L .", {"entities": []}], ["plantarum was associated with a strong increase in infiltration of regulatory CD103 ex vivo restimulation.", {"entities": []}], ["plantarum enhanced Treg cells and attenuated the T helper 2 response in healthy mice.", {"entities": []}], ["We demonstrate that, in healthy mice, immune sampling is a rare phenomenon and not required for immunomodulation.", {"entities": []}], ["Also in absence of any sampling immune activation was found illustrating that host-microbe interaction on the Peyer Patches was enough to induce immunomodulation of DCs and T-cells.", {"entities": []}], ["Organ perfusion is regulated by vasoactivity and structural adaptation of small arteries and arterioles.", {"entities": []}], ["These resistance vessels are sensitive to pressure, flow and a range of vasoactive stimuli.", {"entities": []}], ["Several strongly interacting control loops exist.", {"entities": []}], ["As an example, the myogenic response to a change of pressure influences the endothelial shear stress, thereby altering the contribution of shear-dependent dilation to the vascular tone.", {"entities": []}], ["In addition, acute responses change the stimulus for structural adaptation and vice versa.", {"entities": []}], ["Such control loops are able to maintain resistance vessels in a functional and stable state, characterized by regulated wall stress, shear stress, matched active and passive biomechanics and presence of vascular reserve.", {"entities": []}], ["In this modeling study, four adaptation processes are identified that together with biomechanical properties effectuate such integrated regulation: control of tone, smooth muscle cell length adaptation, eutrophic matrix rearrangement and trophic responses.", {"entities": []}], ["Their combined action maintains arteries in their optimal state, ready to cope with new challenges, allowing continuous long-term vasoregulation.", {"entities": []}], ["The exclusion of any of these processes results in a poorly regulated state and in some cases instability of vascular structure.", {"entities": []}], ["Neonatal respiratory distress syndrome, as a consequence of preterm birth, is a major cause of early mortality and morbidity.", {"entities": [[30, 38, "DISEASE"]]}], ["The withdrawal of progesterone, either actual or functional, is thought to be an antecedent to the onset of labour.", {"entities": []}], ["There remains limited information on clinically relevant health outcomes as to whether vaginal progesterone may be of benefit for pregnant women with a history of a previous preterm birth, who are at high risk of a recurrence.", {"entities": []}], ["Our primary aim was to assess whether the use of vaginal progesterone pessaries in women with a history of previous spontaneous preterm birth reduced the risk and severity of respiratory distress syndrome in their infants, with secondary aims of examining the effects on other neonatal morbidities and maternal health and assessing the adverse effects of treatment.", {"entities": [[196, 204, "DISEASE"]]}], ["Women with a live singleton or twin pregnancy between 18 to <24 weeks\u2019 gestation and a history of prior preterm birth at less than 37 weeks\u2019 gestation in the preceding pregnancy, where labour occurred spontaneously or in association with cervical incompetence or following preterm prelabour rupture of the membranes, were eligible.", {"entities": [[238, 259, "DISEASE"]]}], ["Women were recruited from 39 Australian, New Zealand, and Canadian maternity hospitals and assigned by randomisation to vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone) ( n = 398) or placebo ( n = 389).", {"entities": []}], ["Participants and investigators were masked to the treatment allocation.", {"entities": []}], ["The primary outcome was respiratory distress syndrome and severity.", {"entities": [[45, 53, "DISEASE"]]}], ["Secondary outcomes were other respiratory morbidities; other adverse neonatal outcomes; adverse outcomes for the woman, especially related to preterm birth; and side effects of progesterone treatment.", {"entities": []}], ["Data were analysed for all the 787 women (100%) randomised and their 799 infants.", {"entities": []}], ["Most women used their allocated study treatment (740 women, 94.0%), with median use similar for both study groups (51.0 days, interquartile range [IQR] 28.0\u201369.0, in the progesterone group versus 52.0 days, IQR 27.0\u201376.0, in the placebo group).", {"entities": []}], ["The incidence of respiratory distress syndrome was similar in both study groups\u201410.5% (42/402) in the progesterone group and 10.6% (41/388) in the placebo group (adjusted relative risk [RR] 0.98, 95% confidence interval [CI] 0.64\u20131.49, p = 0.912)\u2014as was the severity of any neonatal respiratory disease (adjusted treatment effect 1.02, 95% CI 0.69\u20131.53, p = 0.905).", {"entities": [[38, 46, "DISEASE"]]}], ["No differences were seen between study groups for other respiratory morbidities and adverse infant outcomes, including serious infant composite outcome (155/406 [38.2%] in the progesterone group and 152/393 [38.7%] in the placebo group, adjusted RR 0.98, 95% CI 0.82\u20131.17, p = 0.798).", {"entities": []}], ["The proportion of infants born before 37 weeks\u2019 gestation was similar in both study groups (148/406 [36.5%] in the progesterone group and 146/393 [37.2%] in the placebo group, adjusted RR 0.97, 95% CI 0.81\u20131.17, p = 0.765).", {"entities": []}], ["A similar proportion of women in both study groups had maternal morbidities, especially those related to preterm birth, or experienced side effects of treatment.", {"entities": []}], ["In 9.9% (39/394) of the women in the progesterone group and 7.3% (28/382) of the women in the placebo group, treatment was stopped because of side effects (adjusted RR 1.35, 95% CI 0.85\u20132.15, p = 0.204).", {"entities": []}], ["The main limitation of the study was that almost 9% of the women did not start the medication or forgot to use it 3 or more times a week.", {"entities": []}], ["Our results do not support the use of vaginal progesterone pessaries in women with a history of a previous spontaneous preterm birth to reduce the risk of neonatal respiratory distress syndrome or other neonatal and maternal morbidities related to preterm birth.", {"entities": [[185, 193, "DISEASE"]]}], ["Individual participant data meta-analysis of the relevant trials may identify specific women for whom vaginal progesterone might be of benefit.", {"entities": []}], ["Current Clinical Trials ISRCTN20269066 .", {"entities": []}], ["In a randomized controlled trial, Caroline Crowther and colleagues examine the effect of vaginal progesterone pessaries for pregnant women to prevent neonatal respiratory distress syndrome.", {"entities": [[180, 188, "DISEASE"]]}], ["Prevention of preterm birth remains a global challenge.", {"entities": []}], ["Vaginal progesterone has been suggested to reduce the incidence of preterm birth in women at risk, but there has been limited assessment of the effects on relevant neonatal morbidity.", {"entities": []}], ["The aim of our trial was to assess whether vaginal progesterone pessaries in pregnant women with a history of previous spontaneous preterm birth reduced the risk and severity of respiratory distress syndrome, other neonatal morbidities, and maternal health outcomes and if there were any side effects of treatment.", {"entities": [[199, 207, "DISEASE"]]}], ["Seven hundred and eighty-seven women were randomly allocated to receive vaginal progesterone or placebo from between 20 to 24 weeks\u2019 to 34 weeks\u2019 gestation.", {"entities": []}], ["The rate of respiratory distress syndrome amongst infants in both treatment groups was similar, as were the outcomes for other respiratory measures and adverse outcomes.", {"entities": [[33, 41, "DISEASE"]]}], ["Maternal health outcomes and side effects of treatment were also similar between treatment groups.", {"entities": []}], ["Vaginal progesterone pessaries did not reduce the risk of respiratory distress syndrome compared to placebo vaginal pessaries.", {"entities": [[79, 87, "DISEASE"]]}], ["Vaginal progesterone pessaries cannot be recommended in women with a history of previous preterm birth to reduce infant or maternal morbidity associated with any recurrence.", {"entities": []}], ["These results provide robust evidence for health practitioners and consumers to make informed clinical decisions.", {"entities": []}], ["We compared the acute toxicity of nanosilica and polyacrylate/nanosilica instillation in Wistar rats ( n = 60).", {"entities": []}], ["Exposure to nanosilica and polyacrylate/nanosilica showed a 30% mortality rate.", {"entities": []}], ["When compared with saline-treated rats, animals in both exposure groups exhibited a significant reduction of PO 2 ( P < 0.05) at both 24 and 72\u2009hr.", {"entities": [[144, 146, "GENE"]]}], ["after exposure.", {"entities": []}], ["Both exposure groups exhibited a significant reduction of neutrophils in arterial blood compared to saline controls ( P < 0.05) 24\u2009hr.", {"entities": [[131, 133, "GENE"]]}], ["after exposure.", {"entities": []}], ["The levels of blood ALT and LDH in exposed groups were found to be significantly increased ( P < 0.05) 24\u2009hr.", {"entities": [[106, 108, "GENE"]]}], ["following exposure.", {"entities": []}], ["The exposed groups exhibited various degrees of pleural effusion and pericardial effusion.", {"entities": [[69, 89, "DISEASE"]]}], ["Our findings indicated respiratory exposure to polyacrylate/nanosilica and nanosilica is likely to cause multiple organ toxicity.", {"entities": []}], ["China and India are the world\u2019s two most populous countries.", {"entities": []}], ["Although their populations are growing in number and life expectancies are extending they have different trajectories of economic growth, epidemiological transition and social change.", {"entities": []}], ["Cross-country comparisons can allow national and global insights and provide evidence for policy and decision-making.", {"entities": []}], ["The aim of this study is to measure and compare disability in men and women, and in urban and rural dwellers in China and India, and assess the extent to which social and other factors contribute to the inequalities.", {"entities": []}], ["National samples of adults aged 50 to 79\u00a0years in China ( n \u00a0=\u00a011,694) and India ( n \u00a0=\u00a06187) from the World Health Organization (WHO) longitudinal Study on global AGEing and adult health (SAGE) Wave 1 were analysed.", {"entities": []}], ["Stratified multiple linear regressions were undertaken to assess disability differences by sex and residence, controlling for other biological and socioeconomic determinants of disability.", {"entities": []}], ["Oaxaca-Blinder decomposition partitioned the two-group inequalities into explained and unexplained components.", {"entities": []}], ["In both countries women and rural residents reported more disability.", {"entities": []}], ["In India, the gender inequality is attributed to the distribution of the determinants (employment, education and chronic conditions) but in China about half the inequality is attributed to the same.", {"entities": []}], ["In India, more than half of the urban rural inequality is attributed to the distribution of the determinants (education, household wealth) compared with under 20% in China.", {"entities": []}], ["Education and employment were important drivers of these measured inequalities.", {"entities": []}], ["Overall inequalities in disability among older adults in China and India were shaped by gender and residence, suggesting the need for policies that target women and rural residents.", {"entities": []}], ["There is a need for further research, using both qualitative and quantitative methods, to question and challenge entrenched practices and institutions and grasp the implications of global economic and social changes that are impacting on population health and ageing in China and India.", {"entities": []}], ["The online version of this article (doi:10.1186/s12877-017-0589-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The expression of CD45RA is generally associated with naive T cells.", {"entities": []}], ["However, a subset of effector memory T cells re-expresses CD45RA (termed TEMRA) after antigenic stimulation with unknown molecular characteristics and functions.", {"entities": []}], ["CD4 TEMRA cells have been implicated in protective immunity against pathogens such as dengue virus (DENV).", {"entities": [[0, 3, "GENE"]]}], ["Here we show that not only the frequency but also the phenotype of CD4 TEMRA cells are heterogeneous between individuals.", {"entities": [[67, 70, "GENE"]]}], ["These cells can be subdivided into two major subsets based on the expression of the adhesion G protein-coupled receptor GPR56, and GPR56 Memory T cells are essential for combating recurring infection by promoting prompt and effective immune responses.", {"entities": [[120, 125, "GENE"], [131, 136, "GENE"], [120, 125, "GENE"], [131, 136, "GENE"]]}], ["Here the authors show, via system biology approaches, that human CD4 memory T cells contains a CD45RA-rexpressing pool that can be further subsetted by the expression of GPR56 for distinct functionalities.", {"entities": [[65, 68, "GENE"], [170, 175, "GENE"]]}], ["Breath volatile organic compounds (VOCs) have been reported as biomarkers of lung cancer, but it is not known if biomarkers identified in one group can identify disease in a separate independent cohort.", {"entities": [[77, 88, "DISEASE"], [82, 88, "DISEASE"]]}], ["Also, it is not known if combining breath biomarkers with chest CT has the potential to improve the sensitivity and specificity of lung cancer screening.", {"entities": [[131, 142, "DISEASE"], [136, 142, "DISEASE"]]}], ["Model-building phase (unblinded) : Breath VOCs were analyzed with gas chromatography mass spectrometry in 82 asymptomatic smokers having screening chest CT, 84 symptomatic high-risk subjects with a tissue diagnosis, 100 without a tissue diagnosis, and 35 healthy subjects.", {"entities": []}], ["Multiple Monte Carlo simulations identified breath VOC mass ions with greater than random diagnostic accuracy for lung cancer, and these were combined in a multivariate predictive algorithm.", {"entities": [[114, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["Model-testing phase (blinded validation) : We analyzed breath VOCs in an independent cohort of similar subjects (n = 70, 51, 75 and 19 respectively).", {"entities": []}], ["The algorithm predicted discriminant function (DF) values in blinded replicate breath VOC samples analyzed independently at two laboratories (A and B).", {"entities": []}], ["Outcome modeling : We modeled the expected effects of combining breath biomarkers with chest CT on the sensitivity and specificity of lung cancer screening.", {"entities": [[134, 145, "DISEASE"], [139, 145, "DISEASE"]]}], ["Unblinded model-building phase .", {"entities": []}], ["The algorithm identified lung cancer with sensitivity 74.0%, specificity 70.7% and C-statistic 0.78.", {"entities": [[25, 36, "DISEASE"], [30, 36, "DISEASE"]]}], ["Blinded model-testing phase : The algorithm identified lung cancer at Laboratory A with sensitivity 68.0%, specificity 68.4%, C-statistic 0.71; and at Laboratory B with sensitivity 70.1%, specificity 68.0%, C-statistic 0.70, with linear correlation between replicates (r = 0.88).", {"entities": [[55, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["In a projected outcome model, breath biomarkers increased the sensitivity, specificity, and positive and negative predictive values of chest CT for lung cancer when the tests were combined in series or parallel.", {"entities": [[148, 159, "DISEASE"], [153, 159, "DISEASE"]]}], ["Breath VOC mass ion biomarkers identified lung cancer in a separate independent cohort, in a blinded replicated study.", {"entities": [[42, 53, "DISEASE"], [47, 53, "DISEASE"]]}], ["Combining breath biomarkers with chest CT could potentially improve the sensitivity and specificity of lung cancer screening.", {"entities": [[103, 114, "DISEASE"], [108, 114, "DISEASE"]]}], ["ClinicalTrials.gov NCT00639067", {"entities": []}], ["Humans are frequently exposed to various airborne allergens.", {"entities": []}], ["In addition to producing antibodies, B cells participate in immune responses via various mechanisms.", {"entities": []}], ["The roles of B cells in allergic airway inflammation and asthma have been controversial.", {"entities": [[57, 63, "DISEASE"]]}], ["We examined the functional importance of B cells in a mouse model of asthma, in which mice were exposed repeatedly to common airborne allergens.", {"entities": [[69, 75, "DISEASE"]]}], ["Na\u00efve wild-type BALB/c mice or B cell-deficient JH Alternaria , Aspergillus , and house dust mite, every other day for two weeks.", {"entities": []}], ["Ovalbumin was included in the cocktail to monitor the T cell immune response.", {"entities": []}], ["Airway inflammation, lung pathology, and airway reactivity were analyzed.", {"entities": []}], ["The airway exposure of na\u00efve wild type mice to airborne allergens induced robust eosinophilic airway inflammation, increased the levels of Th2 cytokines and chemokines in the lung, and increased the reactivity to inhaled methacholine.", {"entities": []}], ["These pathological changes and immune responses were attenuated in B cell-deficient JH in vitro .", {"entities": []}], ["Our results suggest that B cells are required for the optimal development of Th2-type immune responses and airway inflammation when exposed to common airborne allergens.", {"entities": []}], ["The therapeutic targeting of B cells may be beneficial to treat asthma in certain patients.", {"entities": [[64, 70, "DISEASE"]]}], ["It is well established that psychological distress (depression and anxiety) is related to an increased risk of mortality.", {"entities": []}], ["The personality trait of neuroticism, reflecting a relatively stable tendency towards negative emotions, has also been associated with elevated rates of death in some studies.", {"entities": []}], ["Accordingly, we tested the possibility that it is the neuroticism trait itself, rather than the distress state, that is generating an increased risk of mortality.", {"entities": []}], ["We used data from the UK Biobank study, a UK-wide prospective cohort study (2006\u20132010) in which distress was ascertained using the Patient Health Questionnaire and neuroticism using the Eysenck Personality Questionnaire-Revised Short Form.", {"entities": []}], ["A mean of 6.2\u2005years of follow-up of 308\u2005721 study members gave rise to 4334 deaths.", {"entities": []}], ["Higher neuroticism was weakly associated with total mortality (age-adjusted and sex-adjusted HR per SD increase; 95% CI 1.05; 1.02 to 1.09), and moderately strongly correlated with distress symptoms (r=0.55, p<0.0001).", {"entities": [[93, 95, "GENE"]]}], ["Distress symptoms were positively related to risk of total mortality (age-adjusted and sex-adjusted HR per SD increase in distress; 95% CI 1.23; 1.20 to 1.26).", {"entities": [[100, 102, "GENE"]]}], ["This gradient was, in fact, slightly strengthened after adding neuroticism to the multivariable model (1.30; 1.26 to 1.34) but markedly attenuated after taking into account other covariates which included health behaviours and somatic disease (1.16; 1.12 to 1.20).", {"entities": []}], ["Similar results were apparent when cardiovascular disease, cancer and external cause of death were the end points of interest.", {"entities": [[59, 65, "DISEASE"]]}], ["While there was good a priori reasons to anticipate the neuroticism would at least partially explain the relation between distress symptoms and cause-specific mortality, we found no such evidence in the present study.", {"entities": []}], ["Micronodular lesions are common findings in lung imaging.", {"entities": []}], ["As an important differential diagnosis, we describe a case of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; it is notable that the diagnosis of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia is often delayed.", {"entities": []}], ["This case provides supporting evidence to establish lung biopsy by cryotechnique as the option of first choice when considering a diagnostic strategy for micronodular lung lesions.", {"entities": []}], ["We report a case of a 65-year-old white woman who presented with obstructive symptoms of chronic coughing and dyspnea confirmed by conventional lung function tests.", {"entities": []}], ["A computed tomography scan presented disseminated micronodules in all the lobes of her lungs.", {"entities": []}], ["With the help of bronchoscopic cryobiopsy it was possible to obtain a high yield sample of lung parenchyma.", {"entities": []}], ["On histologic examination, the micronodules correlated with a diffuse neuroendocrine cell hyperplasia.", {"entities": []}], ["In the context of clinical symptoms, radiological aspects, and histomorphological aspects we made the diagnosis of a diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.", {"entities": []}], ["Obstructive symptoms were treated with inhaled steroids and beta-2-mimetics continuously.", {"entities": []}], ["A comparison between current computed tomography scans of our patient and scans of 2014 revealed no significant changes.", {"entities": []}], ["Last ambulatory checks occurred in January and May of 2016.", {"entities": []}], ["The course of disease and the extent of limitation of lung function have remained stable.", {"entities": []}], ["The diagnosis of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia is best made in a multidisciplinary review including clinical presentation, lung imaging, and histomorphological aspects.", {"entities": []}], ["This report and current literature indicate that transbronchial lung cryobiopsy can be used as a safe and practicable tool to obtain high quality biopsies of lung parenchyma in order to diagnose micronodular lesions of the lung.", {"entities": []}], ["Invariant Natural Killer T (iNKT) cells are a subset of T cells recognizing glycolipid antigens presented by CD1d.", {"entities": [[109, 113, "GENE"]]}], ["Human iNKT cells express a conserved T cell receptor (TCR)-\u03b1 chain (V\u03b124-J\u03b118) paired with a specific beta chain, V\u03b211.", {"entities": []}], ["The cells are both innate-like, with rapid cytokine release, and adaptive-like, including thymic positive selection.", {"entities": []}], ["Over activation of iNKT cells can mediate tissue injury and inflammation in multiple organ systems and play a role in mediating the pathology associated with clinically important inflammatory diseases.", {"entities": []}], ["At the same time, iNKT cell activation can play a role in protecting against infectious disease and cancer or modulate certain autoimmune diseases through its impact on both the innate and adaptive immune system.", {"entities": [[100, 106, "DISEASE"]]}], ["This suggests that approaches to cause iNKT cell reduction and/or depletion could treat inflammatory diseases while approaches to promote activation may have therapeutic potential in certain infections, cancer or autoimmune disease.", {"entities": [[203, 209, "DISEASE"]]}], ["This report summarizes the characterization of a humanized monoclonal depleting antibody (NKTT120) in the cynomolgus macaque.", {"entities": []}], ["NKTT120 is being developed to treat iNKT mediated inflammation that is associated with chronic inflammatory conditions like sickle cell disease and asthma.", {"entities": [[148, 154, "DISEASE"]]}], ["NKTT120 binds to human iTCRs and to FC\u03b3RI and FC\u03b3RIII and has been shown to kill target cells in an ADCC assay at low concentrations consistent with the FC\u03b3R binding.", {"entities": []}], ["iNKT cells were depleted within 24 hours in cynomolgus macaques, but T cell, B cell, and NK cell frequencies were unchanged.", {"entities": []}], ["iNKT cell recovery was dose and time dependent.", {"entities": []}], ["T cell dependent antigen responses were not impaired by NKTT120 mediated iNKT depletion as measured by response to KLH challenge.", {"entities": []}], ["NKTT120 administration did not induce an inflammatory cytokine release at doses up to 10 mg/kg.", {"entities": []}], ["These data support the use of NKTT120 as an intervention in inflammatory diseases where iNKT reduction or depletion could be beneficial.", {"entities": []}], ["Peroxisome proliferator-activated receptor-gamma (PPAR\u03b3) is a ligand-activated transcription factor that exerts multiple biological effects.", {"entities": []}], ["Growing evidence suggests that PPAR\u03b3 plays an important role in inflammation; however, the effects of this transcription factor on the inflammation caused by smoking are unclear.", {"entities": []}], ["We measured the expression of inflammatory cytokines (leukotriene B4, LTB4 and interleukin 8, IL-8), PPAR\u03b3 and toll-like receptors (TLR2 and TLR4) in alveolar macrophages (AMs) harvested from rats exposed to cigarette smoke (CS) for 3 months in vivo .", {"entities": [[132, 136, "GENE"], [141, 145, "GENE"], [225, 227, "GENE"]]}], ["Some of the rats were pre-treated with rosiglitazone (PPAR\u03b3 agonist, 3 mg/kg/day, ip), rosiglitazone (3 mg/kg/day, ip)\u2009+\u2009BADGE (bisphenol A diglycidyl ether, a PPAR\u03b3 antagonist, 30 mg/kg/day, ig), or BADGE alone (30 mg/kg/day, ig).", {"entities": []}], ["We also measured the expression of PPAR\u03b3, TLR2, TLR4 and nuclear factor-kappaB (NF-\u03baB) in AMs gained from normal rats, which exposed to 5% CSE (cigarette smoke extract) for 12hrs, respectively pretreated with PBS, rosiglitazone (30 uM), rosiglitazone (30 uM)\u2009+\u2009BADGE (100 uM), 15d-PGJ2 (PPAR\u03b3 agonist, 5 uM), 15d-PGJ2 (5 uM)\u2009+\u2009BADGE (100 uM), or BADGE (100 uM) alone for 30 min in vitro .", {"entities": [[42, 46, "GENE"], [48, 52, "GENE"]]}], ["In vivo, rosiglitazone counteracted CS-induced LTB4 and IL-8 release and PPAR\u03b3 downregulation, markedly lowering the expression of TLR4 and TLR2.", {"entities": [[131, 135, "GENE"], [140, 144, "GENE"]]}], ["In vitro, both rosiglitazone and 15d-PGJ2 inhibited CS-induced inflammation through the TLR4 signaling pathway.", {"entities": [[88, 92, "GENE"]]}], ["These results suggest that PPAR\u03b3 agonists regulate inflammation in alveolar macrophages and may play a role in inflammatory diseases such as COPD.", {"entities": []}], ["The rising prevalence of obesity and metabolic syndrome (MetS) has received increased attention since both place individuals at risk for Type II diabetes and cardiovascular disease.", {"entities": [[25, 32, "DISEASE"], [47, 55, "DISEASE"]]}], ["Insulin resistance (IR) has been implicated in the pathogenesis of obesity and MetS in both children and adults and is a known independent cardiovascular risk factor.", {"entities": [[67, 74, "DISEASE"]]}], ["However measures of IR are not routinely performed in children while MetS or severe obesity when present, are considered as clinical markers for IR.", {"entities": [[84, 91, "DISEASE"]]}], ["The study was undertaken to assess the utility of ATPIII defined metabolic syndrome (MetS) and severe obesity as predictors of insulin resistance (IR) in a group of 576 overweight children and adolescents attending a pediatric obesity clinic in Brooklyn.", {"entities": [[102, 109, "DISEASE"], [227, 234, "DISEASE"], [75, 83, "DISEASE"]]}], ["Inclusion criteria were children ages 3\u201319, and body mass index > 95th percentile for age.", {"entities": []}], ["MetS was defined using ATP III criteria, modified for age.", {"entities": []}], ["IR was defined as upper tertile of homeostasis model assessment (HOMA) within 3 age groups (3\u20138, n = 122; 9\u201311, n = 164; 12\u201319, n = 290).", {"entities": []}], ["Sensitivity, specificity, positive predictive values and odds ratios (OR) with 95% confidence intervals (CI) were calculated within age groups for predicting IR using MetS and severe obesity respectively.", {"entities": [[183, 190, "DISEASE"]]}], ["MetS was present in 45%, 48% and 42% of the respective age groups and significantly predicted IR only in the oldest group (OR = 2.0, 95% CI 1.2, 3.4; p = .006).", {"entities": []}], ["Sensitivities were <55%; specificities <63% and positive predictive values \u2264 42% in all groups.", {"entities": []}], ["Severe obesity was significantly associated with IR in both the 9\u201311 (p = .002) and 12\u201318 (p = .01) groups but positive predictive values were nonetheless \u2264 51% for all groups.", {"entities": [[7, 14, "DISEASE"]]}], ["The expression of IR in overweight children and adolescents is heterogeneous and MetS or severe obesity may not be sufficiently sensitive and specific indicators of insulin resistance.", {"entities": [[96, 103, "DISEASE"]]}], ["In addition to screening for MetS in overweight children markers for IR should be routinely performed.", {"entities": []}], ["Further research is needed to establish threshold values of insulin measures in overweight children who may be at greater associated risk of adverse outcomes whether or not MetS is present.", {"entities": []}], ["Objective : To assess the impact of different smoking behaviors of caregivers on environmental tobacco smoke (ETS) exposure in children aged 5\u20136 years in Changsha, China.", {"entities": []}], ["Methods : We conducted a cross-sectional, random digit-dial telephone survey of caregivers ( n = 543) between August and October 2013.", {"entities": []}], ["Caregivers\u2019 smoking behaviors were collected by a questionnaire.", {"entities": []}], ["Exposure assessment was based upon determination of urinary cotinine levels in children employing gas chromatography\u2013triple quadrupole mass spectrometry (GC-MS/MS).", {"entities": []}], ["Results : In children not living with a smoker, children living with one smoker, and children living with more than one smoker at home, median urinary cotinine concentrations (ng/mL) were 0.72, 2.97, and 4.46, respectively.", {"entities": []}], ["For children living with one smoker, median urinary cotinine levels of children exposed to ETS were associated with caregiver smoking behaviors, i.e.", {"entities": []}], [", if a caregiver consumed more cigarettes (>20 compared with \u226410; 7.73 versus 2.29 ng/mL, respectively).", {"entities": []}], ["Conclusions : The magnitude of ETS exposure in children is correlated with the smoking behaviors of the caregiver.", {"entities": []}], ["Counseling for smoking cessation and educational interventions are needed urgently for smoking caregivers to increase their awareness about ETS exposure and to encourage smoking cessation at home or to take precautions to protect children\u2019s health.", {"entities": []}], ["Mometasone furoate (MF) is a highly potent glucocorticoid used topically to treat inflammation in the lung, nose and on the skin.", {"entities": []}], ["However, so far no information has been published on the human glucocorticoid receptor activity of the metabolites or degradation products of MF.", {"entities": []}], ["We have now determined the relative receptor binding affinities of the known metabolite 6\u03b2-OH MF and the degradation product 9,11-epoxy MF to understand their possible contribution to undesirable systemic side effects.", {"entities": []}], ["In competition experiments with human lung glucocorticoid receptors we have determined the relative receptor affinities (RRA) of these substances with reference to dexamethasone (RRA = 100).", {"entities": []}], ["We have discovered that 6\u03b2-OH MF and 9,11-epoxy MF display RRAs of 206 \u00b1 15 and 220 \u00b1 22, respectively.", {"entities": [[59, 63, "GENE"]]}], ["This level of activity is similar to that of the clinically used inhaled corticosteroid flunisolide (RRA 180 \u00b1 11).", {"entities": []}], ["Furthermore we observed that 9,11-epoxy MF is a chemically reactive metabolite.", {"entities": []}], ["In recovery experiments with human plasma and lung tissue we found a time dependent decrease in extractability of the compound.", {"entities": []}], ["Hence, we provide data that might contribute to the understanding of the pharmacokinetics as well as the clinical effects of MF.", {"entities": []}], ["Respiratory syncytial virus (RSV) preferentially infects airway epithelial cells,which might be responsible for susceptibility to asthma; however, the underlying mechanism is not clear.", {"entities": [[130, 136, "DISEASE"]]}], ["This study determined the activation of lymphocytes and drift of helper T (Th) subsets induced by RSV-infected human bronchial epithelial cells (HBECs) in vitro .", {"entities": []}], ["HBECs had prolonged infection with RSV, and lymphocytes isolated from human peripheral blood were co-cultured with RSV-infected HBECs.", {"entities": []}], ["Four groups were established, as follows: lymphocytes (group L); lymphocytes infected with RSV (group RL); co-culture of lymphocytes with non-infected HBECs (group HL); and co-culture of lymphocytes with infected HBECs (group HRL).", {"entities": []}], ["After co-culture with HBECs for 24 hours, lymphocytes were collected and the following were determined in the 4 groups: cell cycle status; apoptosis rate; and concentrations of IL-4, IFN-\u03b3, and IL-17 in the supernatants.", {"entities": []}], ["Cell cycle analysis for lymphocytes showed a significant increase in S phase cells, a decrease in G1 phase cells, and a higher apoptosis rate in group HRL compared with the other three groups.", {"entities": []}], ["In group HRL, the levels of IL-4, IFN-\u03b3, and IL-17 in supernatants were also higher than the other three groups.", {"entities": []}], ["For further study, lymphocytes were individually treated with supernatants from non-infected and RSV-infected HBECs for 24 h. We showed that supernatants from RSV-infected HBECs induced the differentiation of Th2 and Th17 subsets, and suppressed the differentiation of Treg subsets.", {"entities": []}], ["Our results showed that HBECs with prolonged RSV infection can induce lymphocyte proliferation and apoptosis, and enhance the release of cytokines by lymphocytes.", {"entities": []}], ["Moreover, subset drift might be caused by RSV-infected HBECs.", {"entities": []}], ["An ozone exposure assessment study was conducted in a Southern California community.", {"entities": []}], ["The Harvard ozone passive sampler was used to monitor cohorts of 22 and 18 subjects for 8 weeks during the spring and fall of 1994, respectively.", {"entities": []}], ["Ozone exposure variables included 12-hr personal O3 measurements, stationary outdoor O3 measurements from a continuous UV photometer and from 12-hr Harvard active monitors, and time-activity information.", {"entities": []}], ["Results showed that personal O3 exposure levels averaged one-fourth of outdoor stationary O3 levels, attributable to high percentages of time spent indoors.", {"entities": []}], ["Personal O3 levels were not predicted well by outdoor measurements.", {"entities": []}], ["A random-effect general linear model analysis indicated that variance in personal exposure measurements was largely accounted for by random error (59-82%), followed by inter-subject (9-18%) and between-day (9-23%) random effects.", {"entities": []}], ["The microenvironmental model performs differently by season, with the regression model for spring cohorts exhibiting two times the R2 of the fall cohorts (R2 = 0.21 vs. 0.09).", {"entities": []}], ["When distance from the stationary monitoring site, elevation, and traffic are taken into account in the microenvironmental models, the adjusted R2 increased almost twofold for the fall personal exposure data.", {"entities": []}], ["The low predictive power is due primarily to the apparent spatial variation of outdoor O3 and errors in O3 measurements and in time-activity records (particularly in recording the use of air conditioning).", {"entities": []}], ["This study highlights the magnitude of O3 exposure misclassification in epidemiological settings and proposes an approach to reduce exposure uncertainties in assessing air pollution health effects.", {"entities": []}], ["It has been shown that dendritic cells (DCs) and fractalkine play a role in accelerating progression of the inflamed atherosclerotic lesions and plaque rupture.", {"entities": []}], ["We evaluated the numbers and functional changes of DCs and its subsets in human type 2 diabetes with or without unstable angina pectoris (UAP).", {"entities": []}], ["The study population consisted of 39 diabetic patients (DM:18 without CAD; DM + UAP: 21 with UAP), 18 non-diabetic UAP patients (UAP), and 15 healthy control (Normal).", {"entities": []}], ["Peripheral blood DCs and its subsets were measured by three color flow cytometry.", {"entities": []}], ["Serum levels of fractalkine, IL-12, and IFN-\u03b1 were also measured.", {"entities": []}], ["The functional status of the monocyte-derived DCs was analyzed by flow cytometry and allogeneic mixed T lymphocytes reaction.", {"entities": []}], ["The percent and absolute numbers of DCs and mDC within the total leukocyte population was similar for Normal and DM, while significantly lower in DM + UAP.", {"entities": []}], ["pDC numbers were not significantly altered.", {"entities": [[0, 3, "GENE"]]}], ["Serum fractalkine in DM + UAP was highest among the four groups ( p = 0.04 vs. UAP, p = 0.0003 vs. DM, p < 0.0001 vs. Normal).", {"entities": []}], ["Circulating mDC inversely correlated with serum fractalkine (r = -0.268, p = 0.01) level.", {"entities": []}], ["Compared with DM and UAP, the costimulatory molecules CD86 and proliferation of T cells stimulated by DCs were significantly increased in DM + UAP group.", {"entities": [[54, 58, "GENE"]]}], ["Our study suggested that increases in the fractalkine level and the number and functional changes of blood DCs might contribute to diabetic coronary atherosclerosis and plaque destabilization.", {"entities": [[149, 164, "DISEASE"]]}], ["End stage dementia is a particularly difficult aspect of care for patients with Alzheimer's disease and related dementias.", {"entities": [[10, 18, "DISEASE"]]}], ["In care institutions, caregivers and family are concerned by treatment decision-making for an acute life threatening complication occurring in Alzheimer patients at the end of life.", {"entities": []}], ["How should the best treatment pathway be decided: to treat or not to treat?", {"entities": []}], ["Which arguments are used for decision-making?", {"entities": []}], ["These are mainly ethical questions which are currently difficult to express and investigate.", {"entities": []}], ["Cross sectional multicentre study of clinical cases involving 67 health centres (university hospitals, general hospitals, local hospitals and homes for the elderly) in the east of France.", {"entities": []}], ["The method was based on the \"card sorting\" technique, with a set of 36 cards, each labelled with a different item relating to arguments for treatment decision-making.", {"entities": []}], ["For each clinical case, medical staff and carers expressed in a meeting the pieces of information which they believed had been taken into account in the decision.", {"entities": []}], ["Each participant received a card game, selected fewer than ten and ranked them according to the importance they attached to each one.", {"entities": []}], ["All selected cards were then put on the table anonymously for participants, respecting the order of importance of the cards in each pile.", {"entities": []}], ["Lastly, all games were photographed together in order to analyse occurrence and order frequencies.", {"entities": []}], ["The cards were then classified on the table by frequency to open the discussion.", {"entities": []}], ["Discussion time, which was conducted by the head carer of the department, concerned the clinical situation of the patient based on the shared responses.", {"entities": []}], ["During team meetings, the \"card sorting\" method was quickly adopted by professionals as a tool to assist with discussion beyond the context of the study.", {"entities": []}], ["The participants were not compelled to mention their feelings in relation to a case, and it is significant that the anonymity which we tried to maintain so that each person felt \"listened to\" without value judgement was very often discarded by the individuals themselves.", {"entities": []}], ["The financial costs associated with asthma care continue to increase while care remains suboptimal.", {"entities": [[36, 42, "DISEASE"]]}], ["Promoting optimal self-management, including the use of asthma action plans, along with regular health professional review has been shown to be an effective strategy and is recommended in asthma guidelines internationally.", {"entities": [[56, 62, "DISEASE"], [188, 194, "DISEASE"]]}], ["Despite evidence of benefit, guided self-management remains underused, however the potential for online resources to promote self-management behaviors is gaining increasing recognition.", {"entities": []}], ["The aim of this paper is to describe the protocol for a pilot evaluation of a website \u2018Living well with asthma\u2019 which has been developed with the aim of promoting self-management behaviors shown to improve outcomes.", {"entities": [[104, 110, "DISEASE"]]}], ["The study is a parallel randomized controlled trial, where adults with asthma are randomly assigned to either access to the website for 12\u00a0weeks, or usual asthma care for 12\u00a0weeks (followed by access to the website if desired).", {"entities": [[71, 77, "DISEASE"], [155, 161, "DISEASE"]]}], ["Individuals are included if they are over 16-years-old, have a diagnosis of asthma with an Asthma Control Questionnaire (ACQ) score of greater than, or equal to 1, and have access to the internet.", {"entities": [[76, 82, "DISEASE"], [91, 97, "DISEASE"]]}], ["Primary outcomes for this evaluation include recruitment and retention rates, changes at 12\u00a0weeks from baseline for both ACQ and Asthma Quality of Life Questionnaire (AQLQ) scores, and quantitative data describing website usage (number of times logged on, length of time logged on, number of times individual pages looked at, and for how long).", {"entities": [[129, 135, "DISEASE"]]}], ["Secondary outcomes include clinical outcomes (medication use, health services use, lung function) and patient reported outcomes (including adherence, patient activation measures, and health status).", {"entities": []}], ["Piloting of complex interventions is considered best practice and will maximise the potential of any future large-scale randomized controlled trial to successfully recruit and be able to report on necessary outcomes.", {"entities": []}], ["Here we will provide results across a range of outcomes which will provide estimates of efficacy to inform the design of a future full-scale randomized controlled trial of the \u2018Living well with asthma\u2019 website.", {"entities": [[194, 200, "DISEASE"]]}], ["This trial is registered with Current Controlled Trials ISRCTN78556552 on 18/06/13.", {"entities": []}], ["Aspiration can cause a variety of pulmonary syndromes, some of which are not well recognized.", {"entities": []}], ["The objective of this study was to assess the demographic, clinical, radiological, and histopathological correlates of diffuse aspiration bronchiolitis (DAB), a bronchiolocentric disorder caused by recurrent aspiration.", {"entities": [[138, 151, "DISEASE"]]}], ["This was a retrospective study of 20 consecutive patients with DAB seen at the Mayo Clinic in Rochester, Minnesota, between January 1, 1998 and June 30, 2014.", {"entities": []}], ["The median age of the patients was 56.5 years (range, 22-76 years), and the male/female ratio was 2.3:1.0.", {"entities": []}], ["In 18 patients, the diagnosis of DAB was based on the results of a lung biopsy; in the 2 remaining patients, it was based on clinical and radiological features, together with documented aspiration observed in a videofluoroscopic swallow study.", {"entities": []}], ["In 19 patients (95%), we identified predisposing factors for aspiration, including gastroesophageal reflux disease (GERD), drug abuse, and dysphagia.", {"entities": [[83, 114, "DISEASE"]]}], ["Common presenting features included cough, sputum production, dyspnea, and fever.", {"entities": []}], ["Twelve patients (60%) had a history of recurrent pneumonia.", {"entities": [[49, 58, "DISEASE"]]}], ["In all of the patients, chest CT revealed bilateral pulmonary infiltrates consisting of micronodules and tree-in-bud opacities.", {"entities": []}], ["In the majority of patients, interventions aimed at preventing recurrent aspiration (e.g., anti-GERD therapies) led to improvement in the symptoms of DAB.", {"entities": []}], ["Young to middle-aged subjects with recognizable predisposing factors for aspiration and who report a history of recurrent pneumonia are at increased risk for DAB.", {"entities": [[122, 131, "DISEASE"]]}], ["Although DAB is not well recognized, certain chest CT features are characteristic of the disorder.", {"entities": []}], ["The lung cancer incidence in the Xuanwei and neighboring region, Yunnan, China, is among the highest in China and is attributed to severe air pollution with high benzo(a)pyrene levels.", {"entities": [[4, 15, "DISEASE"], [9, 15, "DISEASE"]]}], ["We systematically and comparatively analyzed DNA methylation alterations at genome and gene levels in Xuanwei lung cancer tissues and cell lines, as well as benzo(a)pyrene-treated cells and mouse samples.", {"entities": [[110, 121, "DISEASE"], [115, 121, "DISEASE"]]}], ["We obtained a comprehensive dataset of genome-wide cytosine-phosphate-guanine island methylation in air pollution-related lung cancer samples.", {"entities": [[122, 133, "DISEASE"], [127, 133, "DISEASE"]]}], ["Benzo(a)pyrene exposure induced multiple alterations in DNA methylation and in mRNA expressions of DNA methyltransferases and ten-11 translocation proteins; these alterations partially occurred in Xuanwei lung cancer.", {"entities": [[205, 216, "DISEASE"], [210, 216, "DISEASE"]]}], ["Furthermore, benzo(a)pyrene-induced DKK2 and EN1 promoter hypermethylation and LPAR2 promoter hypomethylation led to down-regulation and up-regulation of the genes, respectively; the down-regulation of DKK2 and EN1 promoted the cellular proliferation.", {"entities": [[36, 40, "GENE"], [202, 206, "GENE"], [45, 48, "GENE"], [211, 214, "GENE"], [79, 84, "GENE"], [36, 40, "GENE"], [202, 206, "GENE"], [45, 48, "GENE"], [211, 214, "GENE"]]}], ["Thus, DNA methylation alterations induced by benzo(a)pyrene contribute partially to abnormal DNA methylation in air pollution-related lung cancer, and these DNA methylation alterations may affect the development and progression of lung cancer.", {"entities": [[134, 145, "DISEASE"], [231, 242, "DISEASE"], [139, 145, "DISEASE"], [236, 242, "DISEASE"]]}], ["Additionally, vitamin C and B6 can reduce benzo(a)pyrene-induced DNA methylation alterations and may be used as chemopreventive agents for air pollution-related lung cancer.", {"entities": [[161, 172, "DISEASE"], [166, 172, "DISEASE"]]}], ["This study aims to investigate the additive effect of the Hedera helix (HH) and Rhizoma coptidis (RC) extracts mixture on antitussive and expectorant activities in animals.", {"entities": []}], ["The expectorant assay was performed with phenol red secretion in mice trachea.", {"entities": []}], ["Mice or guinea pigs were randomly divided into groups of 8 each, including negative and positive control groups.", {"entities": []}], ["After gastric administration of the test extracts in mice, 2.5% phenol red solution (0.2 mL) was intraperitoneally injected.", {"entities": []}], ["Trachea was dissected and optical density of tracheal secretion was measured.", {"entities": []}], ["After gastric administration of the test extracts in guinea pigs, the antitussive activities were assessed using a citric acid-induced cough measurement.", {"entities": []}], ["The extracts of HH and RC significantly increased tracheal secretion and inhibited cough.", {"entities": []}], ["The mixture of HH and RC extracts in a 1:1 concentration at a dose of 200 mg/kg showed a more potent effect on phenol red secretion (25.25\u00b13.14) and cough inhibition (61.25\u00b15.36) than the individual use of each extracts [phenol red secretion; HH 13.39\u00b14.22 ( p =0.000), RC 20.78\u00b12.50 ( p =0.010), cough inhibition; HH 9.89\u00b14.14 ( p =0.010), RC 30.25\u00b17.69 ( p =0.000)].", {"entities": []}], ["A 3:1 ratio mixture of HH to RC demonstrated an optimal expectorant effect ( p <0.001), and this mixture showed expectorant and antitussive effects in a dose-dependent manner.", {"entities": []}], ["This study provides evidence for antitussive and expectorant effect of a 3:1 mixture of HH and RC, which may be a useful therapeutic option for respiratory diseases.", {"entities": []}], ["Deleterious mutations of SLC26A4 cause Pendred syndrome (PS), an autosomal recessive disorder comprising goitre and deafness with enlarged vestibular aqueducts (EVA), and nonsyndromic hearing loss (NSHL).", {"entities": [[47, 55, "DISEASE"], [25, 32, "GENE"]]}], ["However, the SLC26A4 hyperactivity was recently associated with the emergence of autoimmune thyroid diseases (AITD) and asthma among human and mouse model.", {"entities": [[120, 126, "DISEASE"], [13, 20, "GENE"]]}], ["Here, by direct sequencing, we investigate the sequences of the 20 coding exons (2 to 21) of SLC26A4 and their flanking intron-exon junctions among patients affected with Graves' disease (GD) hyperthyroidism.", {"entities": [[192, 207, "DISEASE"], [93, 100, "GENE"]]}], ["Ten mono-allelic variants were identified, seven of which are intronic and previously unreported.", {"entities": []}], ["Two, c.898A>C (p.I300L) and c.1061T>C (p.F354S), of the three exonic variants are non synonymous.", {"entities": []}], ["The p.F354S variant is already described to be involved in PS or NSHL inheritances.", {"entities": []}], ["The exploration by PCR-RFLP of p.I300L and p.F354S variants among 132 GD patients, 105 Hashimoto thyroiditis (HT), 206 Healthy subjects and 102 families with NSHL have shown the presence of both variants.", {"entities": [[97, 108, "DISEASE"]]}], ["The p.F354S variation was identified both among patients (1~HT and 3 GD) and healthy subjects ( n =5).", {"entities": []}], ["Whereas, the p.I300L variant was identified only in GD patients ( n =3).", {"entities": []}], ["Our studies provide evidence of the importance of systematic analysis of SLC26A4 gene sequences on models other than deafness.", {"entities": [[73, 80, "GENE"]]}], ["This approach allows the identification of new variants and the review of the pathogenic effects of certain mono-allelic variants reported responsible for PS and NSHL development.", {"entities": []}], ["LDs (lipid droplets) are metabolically highly active intracellular organelles.", {"entities": []}], ["The lipid and protein profiles of LDs are cell-type-specific, and they undergo dynamic variation upon changes in the physiological state of a cell.", {"entities": []}], ["It is well known that the main function of the LDs in adipocytes is to ensure energy supply and to maintain lipid homoeostasis in the body.", {"entities": []}], ["In contrast, LDs in inflammatory cells have been implicated in eicosanoid biosynthesis, particularly under inflammatory conditions, thereby enabling them to regulate immune responses.", {"entities": []}], ["Human mast cells are potent effector cells of the innate immune system, and the triacylglycerol (triglyceride) stores of their cytoplasmic LDs have been shown to contain large amounts of arachidonic acid, the main precursor of pro-inflammatory eicosanoids.", {"entities": []}], ["In the present review, we discuss the current knowledge about the formation and function of LDs in inflammatory cells with specific emphasis on arachidonic acid and eicosanoid metabolism.", {"entities": []}], ["On the basis of findings reported previously and our new observations, we propose a model in which lipolysis of LD-triacylglycerols provides arachidonic acid for lipid mediator generation in human mast cells.", {"entities": []}], ["Bronchiolitis is the most common cause of lower respiratory tract illness in infancy, and hospital admission rates appear to be increasing in Canada and the United States.", {"entities": [[0, 13, "DISEASE"]]}], ["Inhaled beta agonists offer only modest short-term improvement.", {"entities": []}], ["Trials of racemic epinephrine have shown conflicting results.", {"entities": []}], ["We sought to determine if administration of racemic epinephrine during hospital stay for bronchiolitis improved respiratory distress, was safe, and shortened length of stay.", {"entities": [[89, 102, "DISEASE"]]}], ["The study was a randomized, double-blind controlled trial of aerosolized racemic epinephrine compared to salbutamol every one to 4 hours in previously well children aged 6 weeks to \u2264 2 years of age hospitalized with bronchiolitis.", {"entities": [[216, 229, "DISEASE"]]}], ["The primary outcome was symptom improvement as measured by the Respiratory Distress Assessment Instrument (RDAI); secondary outcomes were length of stay in hospital, adverse events, and report of symptoms by structured parental telephone interview one week after discharge.", {"entities": []}], ["62 children with a mean age of 6.4 months were enrolled; 80% of children had Respiratory Syncytial Virus (RSV).", {"entities": []}], ["Racemic epinephrine resulted in significant improvement in wheezing and the total RDAI score on day 2 and over the entire stay (p < 0.05).", {"entities": []}], ["The mean LOS in the epinephrine arm was 2.6 days (95% CI 2, 3.2) v. 3.4 days in those in the salbutamol group (95% CI 2.6, 4.2) (p > 0.05).", {"entities": []}], ["Adverse events were not significantly different in the two arms.", {"entities": []}], ["At one week post-discharge, over half of parents reported that their child still had a respiratory symptom and 40% had less than normal feeding.", {"entities": []}], ["Racemic epinephrine relieves respiratory distress in hospitalized infants with bronchiolitis and is safe but does not abbreviate hospital stay.", {"entities": [[79, 92, "DISEASE"]]}], ["Morbidity associated with bronchiolitis as identified by parents persists for at least one week after hospital discharge in most infants.", {"entities": [[26, 39, "DISEASE"]]}], ["Mortality of severe acute respiratory distress syndrome in adults is still unacceptably high.", {"entities": [[47, 55, "DISEASE"]]}], ["Extracorporeal membrane oxygenation (ECMO) could represent an important treatment option, if complications were reduced by new technical developments.", {"entities": []}], ["Efficiency, side effects and outcome of treatment with a new miniaturized device for veno-venous extracorporeal gas transfer were analysed in 60 consecutive patients with life-threatening respiratory failure.", {"entities": [[188, 207, "DISEASE"]]}], ["A rapid increase of partial pressure of arterial oxygen/fraction of inspired oxygen (PaO 2 /FiO 2 ) from 64 (48 to 86) mmHg to 120 (84 to 171) mmHg and a decrease of PaCO 2 from 63 (50 to 80) mmHg to 33 (29 to 39) mmHg were observed after start of the extracorporeal support ( P < 0.001).", {"entities": []}], ["Gas exchange capacity of the device averaged 155 (116 to 182) mL/min for oxygen and 210 (164 to 251) mL/min for carbon dioxide.", {"entities": []}], ["Ventilatory parameters were reduced to a highly protective mode, allowing a fast reduction of tidal volume from 495 (401 to 570) mL to 336 (292 to 404) mL ( P < 0.001) and of peak inspiratory pressure from 36 (32 to 40) cmH 2 O to 31 (28 to 35) cmH 2 O ( P < 0.001).", {"entities": []}], ["Transfusion requirements averaged 0.8 (0.4 to 1.8) units of red blood cells per day.", {"entities": []}], ["Sixty-two percent of patients were weaned from the extracorporeal system, and 45% survived to discharge.", {"entities": []}], ["Veno-venous extracorporeal membrane oxygenation with a new miniaturized device supports gas transfer effectively, allows for highly protective ventilation and is very reliable.", {"entities": []}], ["Modern ECMO technology extends treatment opportunities in severe lung failure.", {"entities": []}], ["Bronchiolitis is a risk factor for the development of childhood asthma.", {"entities": [[64, 70, "DISEASE"], [0, 13, "DISEASE"]]}], ["Eosinophilic inflammation in airways plays an important role in the pathophysiology of both bronchiolitis and asthma.", {"entities": [[110, 116, "DISEASE"], [92, 105, "DISEASE"]]}], ["To investigate this inflammation, we measured the eosinophil cationic protein (ECP), regulated on activation normal T-cell expressed and secreted (RANTES) and eotaxin levels in nasopharyngeal secretions (NPS).", {"entities": [[204, 207, "GENE"]]}], ["Twenty-eight patients with RSV bronchiolitis (RSV group), 11 patients with non-RSV bronchiolitis (non-RSV group) and 7 controls were enrolled in this study.", {"entities": [[31, 44, "DISEASE"], [83, 96, "DISEASE"]]}], ["ECP, RANTES, and eotaxin levels were measured by enzyme immunoassays.", {"entities": []}], ["The ECP level in the NPS of the RSV group was significantly higher than that in the NPS of the non-RSV group and controls.", {"entities": [[21, 24, "GENE"], [84, 87, "GENE"], [21, 24, "GENE"], [84, 87, "GENE"]]}], ["RANTES and eotaxin levels in infants with bronchiolitis were significantly higher than those in the controls, but there was no significant difference between the RSV and non-RSV groups.", {"entities": [[42, 55, "DISEASE"]]}], ["In conclusion, with regard to eosinophilic airway inflammation, as compared with non-RSV bronchiolitis, RSV bronchiolitis may be more similar to childhood asthma.", {"entities": [[155, 161, "DISEASE"], [89, 102, "DISEASE"], [108, 121, "DISEASE"]]}], ["The articles in this monograph focus on the mechanisms whereby ambient particulate matter (PM) and co-pollutants deposited in the respiratory tract cause cardiovascular and systemic effects, especially in persons with preexisting conditions such as allergic hyperresponsiveness and pulmonary, cardiac, and vascular diseases.", {"entities": []}], ["During the past few years, it has become clear that inhaled pollutants cause adverse effects outside the respiratory tract and that these effects may in some cases be more important than respiratory effects.", {"entities": []}], ["Investigators pursuing traditional approaches to understanding mechanisms of air pollution effects need to be brought together with those outside that community who have expertise in pathogenetic mechanisms by which deposited air pollutants might affect nonrespiratory organs.", {"entities": []}], ["To this end, a workshop was held and papers were developed from a broad range of scientists having specialized expertise in allergic and cardiovascular physiology.", {"entities": []}], ["The overall goal of this monograph is to benchmark current thinking and enhance progress toward identifying and understanding the mechanisms by which nonrespiratory health effects occur and, by extension, to facilitate the appropriate management of relationships between air quality and health.", {"entities": []}], ["This monograph contains a compilation of multidisciplinary research that forms a framework for generating and testing plausible new research hypotheses.", {"entities": []}], ["Not only will this information stimulate the thinking of researchers, but it will also provide an improved foundation for funding agencies and advisory groups to frame research strategies, programs, and priorities.", {"entities": []}], ["This population-based cohort study investigated the risk of developing peripheral arterial occlusive disease (PAOD) in patients with Bell\u2019s palsy.", {"entities": [[82, 108, "DISEASE"]]}], ["We used longitudinal claims data of health insurance of Taiwan to identify 5,152 patients with Bell\u2019s palsy newly diagnosed in 2000\u20132010 and a control cohort of 20,608 patients without Bell\u2019s palsy matched by propensity score.", {"entities": []}], ["Incidence and hazard ratio (HR) of PAOD were assessed by the end of 2013.", {"entities": [[28, 30, "GENE"]]}], ["The incidence of PAOD was approximately 1.5 times greater in the Bell\u2019s palsy group than in the non-Bell\u2019s palsy controls (7.75 vs. 4.99 per 1000 person-years).", {"entities": []}], ["The Cox proportional hazards regression analysis measured adjusted HR was 1.54 (95% confidence interval (CI) = 1.35\u20131.76) for the Bell\u2019s palsy group compared to the non-Bell\u2019s palsy group, after adjusting for sex, age, occupation, income and comorbidities.", {"entities": [[67, 69, "GENE"]]}], ["Men were at higher risk of PAOD than women in the Bell\u2019s palsy group, but not in the controls.", {"entities": []}], ["The incidence of PAOD increased with age in both groups, but the Bell\u2019s palsy group to control group HR of PAOD decreased as age increased.", {"entities": [[101, 103, "GENE"]]}], ["The systemic steroid treatment reduced 13% of PAOD hazard for Bell\u2019s palsy patients, compared to those without the treatment, but not significant.", {"entities": []}], ["Bell\u2019s palsy appears to be associated with an increased risk of developing PAOD.", {"entities": []}], ["Further pathophysiologic, histopathology and immunologic research is required to explore the underlying biologic mechanism.", {"entities": []}], ["In January 1985 a smog period occurred for 5 days in parts of West Germany, including the Rhur District.", {"entities": []}], ["Mortality (24,000 death certificates), morbidity in hospitals (13,000 hospital admissions, 5400 outpatients, 1500 ambulance transports) and consultations in doctors' offices (1,250,000 contacts) were studied for a 6-week period including the smog episode and a time interval before and thereafter.", {"entities": []}], ["The study region was the State of North Rhine-Westfalia (16 million inhabitants), but the analysis is restricted to the comparison of the polluted area and a control area (6 million inhabitants each).", {"entities": []}], ["During the smog period, mortality and morbidity in hospitals increased in the polluted area, but there was no substantial increase in the control area.", {"entities": []}], ["The increases were for the total number of deaths 8 vs. 2% (polluted area vs. control area), for hospital admissions 15 vs. 3%, for outpatients 12 vs. 5% and for deliveries by ambulance to hospitals 28% in the polluted area (not investigated in the control area).", {"entities": []}], ["The effects were more pronounced for cardiovascular diseases than for respiratory diseases.", {"entities": []}], ["The consultations in doctors' offices show a slight decrease (-2 vs. -4%).", {"entities": []}], ["Regression analysis shows a moderate influence of temperature, but a strong influence of ambient air pollution.", {"entities": []}], ["The maxima of the ambient concentrations are more important on the same day, whereas the influence of the daily averages is more pronounced after a delay of 2 days.", {"entities": []}], ["The results are discussed considering other possible confounders such as indoor pollution and psychogenic influences of the alarm situation.", {"entities": []}], ["In total, the study suggests moderate health effects due to increased air pollution during the smog episode.", {"entities": []}], ["show that the chemokine receptor CCR4 is involved in thymocyte medullary entry, interactions with dendritic cells, and negative selection.", {"entities": [[33, 37, "GENE"]]}], ["In the absence of CCR4, central tolerance is not established, promoting autoimmunity.", {"entities": [[18, 22, "GENE"]]}], ["Autoimmunity results from a breakdown in central or peripheral tolerance.", {"entities": []}], ["To establish central tolerance, developing T cells must enter the thymic medulla, where they scan antigen-presenting cells (APCs) displaying a diverse array of autoantigens.", {"entities": [[124, 128, "GENE"]]}], ["If a thymocyte is activated by a self-antigen, the cell undergoes either deletion or diversion into the regulatory T cell (T reg) lineage, thus maintaining self-tolerance.", {"entities": []}], ["Mechanisms promoting thymocyte medullary entry and interactions with APCs are incompletely understood.", {"entities": [[69, 73, "GENE"]]}], ["CCR4 is poised to contribute to central tolerance due to its expression by post-positive selection thymocytes, and expression of its ligands by medullary thymic dendritic cells (DCs).", {"entities": [[0, 4, "GENE"]]}], ["Here, we use two-photon time-lapse microscopy to demonstrate that CCR4 promotes medullary entry of the earliest post-positive selection thymocytes, as well as efficient interactions between medullary thymocytes and DCs.", {"entities": [[66, 70, "GENE"]]}], ["In keeping with the contribution of thymic DCs to central tolerance, CCR4 is involved in regulating negative selection of polyclonal and T cell receptor (TCR) transgenic thymocytes.", {"entities": [[69, 73, "GENE"]]}], ["In the absence of CCR4, autoreactive T cells accumulate in secondary lymphoid organs and autoimmunity ensues.", {"entities": [[18, 22, "GENE"]]}], ["These studies reveal a previously unappreciated role for CCR4 in the establishment of central tolerance.", {"entities": [[57, 61, "GENE"]]}], ["Childhood obesity is a growing health concern known to adversely affect quality of life in children and adolescents.", {"entities": [[10, 17, "DISEASE"]]}], ["The Patient Reported Outcomes Measurement Information System (PROMIS) pediatric measures were developed to capture child self-reports across a variety of health conditions experienced by children and adolescents.", {"entities": []}], ["The purpose of this study is to begin the process of validation of the PROMIS pediatric measures in children and adolescents affected by obesity.", {"entities": [[137, 144, "DISEASE"]]}], ["The pediatric PROMIS instruments were administered to 138 children and adolescents in a cross-sectional study of patient reported outcomes in children aged 8\u201317 years with age-adjusted body mass index (BMI) greater than the 85th percentile in a design to establish known-group validity.", {"entities": []}], ["The children completed the depressive symptoms, anxiety, anger, peer relationships, pain interference, fatigue, upper extremity, and mobility PROMIS domains utilizing a computer interface.", {"entities": []}], ["PROMIS domains and individual items were administered in random order and included a total of 95 items.", {"entities": []}], ["Patient responses were compared between patients with BMI 85 to\u2009<\u200999th percentile versus\u2009\u2265\u200999th percentile.", {"entities": []}], ["136 participants were recruited and had all necessary clinical data for analysis.", {"entities": []}], ["Of the 136 participants, 5% ended the survey early resulting in missing domain scores at the end of survey administration.", {"entities": []}], ["In multivariate analysis, patients with BMI\u2009\u2265\u200999th percentile had worse scores for depressive symptoms, anger, fatigue, and mobility ( p \u2009<\u20090.05).", {"entities": []}], ["Parent-reported exercise was associated with better scores for depressive symptoms, anxiety, and fatigue ( p \u2009<\u20090.05).", {"entities": []}], ["Children and adolescents ranging from overweight to severely obese can complete multiple PROMIS pediatric measures using a computer interface in the outpatient setting.", {"entities": []}], ["In the 5% with missing domain scores, the missing scores were consistently found in the domains administered last, suggesting the length of the assessment is important.", {"entities": []}], ["The differences in domain scores found in this study are consistent with previous reports investigating the quality of life in children and adolescents with obesity.", {"entities": [[157, 164, "DISEASE"]]}], ["We show that the PROMIS instrument represents a feasible and potentially valuable instrument for the future study of the effect of pediatric obesity on quality of life.", {"entities": [[141, 148, "DISEASE"]]}], ["Serum interleukin (IL)-17 concentrations have been reported to be increased in systemic lupus erythematosus (SLE), but associations with clinical characteristics are not well understood.", {"entities": [[88, 107, "DISEASE"], [79, 107, "DISEASE"]]}], ["We characterized clinical associations of serum IL-17 in SLE.", {"entities": []}], ["We quantified IL-17 in serum samples from 98 SLE patients studied cross-sectionally, and in 246 samples from 75 of these patients followed longitudinally over two years.", {"entities": []}], ["Disease activity was recorded using the SLE Disease Activity Index (SLEDAI)-2k.", {"entities": []}], ["Serum IL-6, migration inhibitory factor (MIF), and B cell activating factor of the tumour necrosis factor family (BAFF) were also measured in these samples.", {"entities": [[41, 44, "GENE"]]}], ["Serum IL-17 levels were significantly higher in SLE patients compared to healthy donors ( P <0.0001).", {"entities": []}], ["No correlation was observed between serum IL-17 and SLEDAI-2k, at baseline or during longitudinal follow-up.", {"entities": []}], ["However, we observed that SLEDAI-2k was positively correlated with IL-17/IL-6 ratio.", {"entities": []}], ["Serum IL-17 was significantly increased in SLE patients with central nervous system (CNS) disease ( P = 0.0298).", {"entities": []}], ["A strong correlation was observed between serum IL-17 and IL-6 (r = 0.62, P <0.0001), and this relationship was observed regardless of disease activity and persisted when integrating cytokine levels over the period observed (r = 0.66, P <0.0001).", {"entities": []}], ["A strong correlation of serum IL-17 was also observed with serum BAFF (r = 0.64, P <0.0001), and MIF (r = 0.36, P = 0.0016).", {"entities": [[97, 100, "GENE"]]}], ["Serum IL-17 concentration correlates poorly with SLE disease activity but is significantly elevated in patients with CNS disease.", {"entities": []}], ["IL-17/IL-6 ratio may be more useful than IL-17 or IL-6 alone to characterize Th17-driven disease, such as SLE.", {"entities": []}], ["The association of other cytokines with serum IL-17 suggests that IL-17 may drive activation of diverse immune pathways in SLE.", {"entities": []}], ["To determine the association between inflammatory bowel disease (IBD) and rural/urban household at the time of diagnosis, or within the first 5 years (y) of life.", {"entities": [[37, 63, "DISEASE"]]}], ["Population-based cohorts of residents of four Canadian provinces were created using health administrative data.", {"entities": []}], ["Rural/urban status was derived from postal codes based on population density and distance to metropolitan areas.", {"entities": []}], ["Validated algorithms identified all incident IBD cases from administrative data (Alberta: 1999\u20132008, Manitoba and Ontario: 1999\u20132010, and Nova Scotia: 2000\u20132008).", {"entities": []}], ["We determined sex-standardized incidence (per 100,000 patient-years) and incident rate ratios (IRR) using Poisson regression.", {"entities": []}], ["A birth cohort was created of children in whom full administrative data were available from birth (Alberta 1996\u20132010, Manitoba 1988\u20132010, and Ontario 1991\u20132010).", {"entities": []}], ["IRR was calculated for residents who lived continuously in rural/urban households during each of the first 5 years of life.", {"entities": []}], ["There were 6,662 rural residents and 38,905 urban residents with IBD.", {"entities": []}], ["Incidence of IBD per 100,000 was 33.16 (95% CI 27.24\u201339.08) in urban residents, and 30.72 (95% CI 23.81\u201337.64) in rural residents (IRR 0.90, 95% CI 0.81\u20130.99).", {"entities": []}], ["The protective association was strongest in children <10 years (IRR 0.58, 95% CI 0.43\u20130.73) and 10\u201317.9 years (IRR 0.72, 95% CI 0.64\u20130.81).", {"entities": []}], ["In the birth cohort, comprising 331 rural and 2,302 urban residents, rurality in the first 1\u20135 years of life was associated with lower risk of IBD (IRR 0.75\u20130.78).", {"entities": []}], ["People living in rural households had lower risk of developing IBD.", {"entities": []}], ["This association is strongest in young children and adolescents, and in children exposed to the rural environment early in life.", {"entities": []}], ["To assess the risk of psychiatric disorders and suicide attempts in children with type 1 diabetes and their healthy siblings.", {"entities": []}], ["We performed a population-based case-cohort study of individuals born in Sweden between 1973 and 2009.", {"entities": []}], ["Children with type 1 diabetes ( n = 17,122) and their healthy siblings ( n = 18,847) were identified and followed until their 18th birthday.", {"entities": []}], ["Their risk of psychiatric disorders was compared with that of matched control subjects.", {"entities": []}], ["The risk of psychiatric morbidity in children with type 1 diabetes compared with the general population was tripled within 6 months after the onset of diabetes (hazard ratio [HR] 3.0 [95% CI 2.7\u20133.4]) and doubled within the total observation period (HR 2.1 [95% CI 2.0\u20132.2]).", {"entities": [[175, 177, "GENE"], [250, 252, "GENE"], [175, 177, "GENE"], [250, 252, "GENE"]]}], ["An increased risk was noted in suicide attempts (HR 1.7 [95% CI 1.4\u20132.0]) and in most categories of psychiatric disorders.", {"entities": [[49, 51, "GENE"]]}], ["The risk of psychiatric disorders in probands declined from HR 2.7 (95% CI 2.2\u20133.3) for those in the cohort born 1973\u20131986 to 1.9 (95% CI 1.8\u20132.0) in those born 1997\u20132009.", {"entities": [[60, 62, "GENE"]]}], ["The risk for any psychiatric disorders among siblings of patients with type 1 diabetes was estimated to be HR 1.1 (95% CI 1.0\u20131.1), and there was no increased risk in any of the specific category of disorders.", {"entities": [[107, 109, "GENE"]]}], ["Children with type 1 diabetes are at high risk of psychiatric disorders, which seems to be a consequence of the disease rather than due to a common familial etiology.", {"entities": []}], ["The results support recommendations on comprehensive mental health surveillance in children with type 1 diabetes, especially in recently diagnosed children.", {"entities": []}], ["Genetically tractable model organisms from phages to mice have taught us invaluable lessons about fundamental biological processes and disease-causing mutations.", {"entities": []}], ["Owing to technological and computational advances, human biology and the causes of human diseases have become accessible as never before.", {"entities": []}], ["Progress in identifying genetic determinants for human diseases has been most remarkable for Mendelian traits.", {"entities": []}], ["In contrast, identifying genetic determinants for complex diseases such as diabetes, cancer, and cardiovascular and neurological diseases has remained challenging, despite the fact that these diseases cluster in families.", {"entities": [[85, 91, "DISEASE"]]}], ["Hundreds of variants associated with complex diseases have been found in genome-wide association studies (GWAS), yet most of these variants explain only a modest amount of the observed heritability, a phenomenon known as \u201cmissing heritability.\u201d The missing heritability has been attributed to many factors, mainly inadequacies in genotyping and phenotyping.", {"entities": []}], ["We argue that lessons learned about complex traits in model organisms offer an alternative explanation for missing heritability in humans.", {"entities": []}], ["In diverse model organisms, phenotypic robustness differs among individuals, and those with decreased robustness show increased penetrance of mutations and express previously cryptic genetic variation.", {"entities": []}], ["We propose that phenotypic robustness also differs among humans and that individuals with lower robustness will be more responsive to genetic and environmental perturbations and hence susceptible to disease.", {"entities": []}], ["Phenotypic robustness is a quantitative trait that can be accurately measured in model organisms, but not as yet in humans.", {"entities": []}], ["We propose feasible approaches to measure robustness in large human populations, proof-of-principle experiments for robustness markers in model organisms, and a new GWAS design that takes differences in robustness into account.", {"entities": []}], ["An extensive number of pathologies are associated with mitochondrial dysfunction (MDF) and oxidative stress (OS).", {"entities": []}], ["Thus, mitochondrial cofactors termed \u201cmitochondrial nutrients\u201d (MN), such as \u03b1-lipoic acid (ALA), Coenzyme Q10 (CoQ10), and l -carnitine (CARN) (or its derivatives) have been tested in a number of clinical trials, and this review is focused on the use of MN-based clinical trials.", {"entities": []}], ["The papers reporting on MN-based clinical trials were retrieved in MedLine up to July 2014, and evaluated for the following endpoints: (a) treated diseases; (b) dosages, number of enrolled patients and duration of treatment; (c) trial success for each MN or MN combinations as reported by authors.", {"entities": []}], ["The reports satisfying the above endpoints included total numbers of trials and frequencies of randomized, controlled studies, i.e.", {"entities": []}], [", 81 trials testing ALA, 107 reports testing CoQ10, and 74 reports testing CARN, while only 7 reports were retrieved testing double MN associations, while no report was found testing a triple MN combination.", {"entities": []}], ["A total of 28 reports tested MN associations with \u201cclassical\u201d antioxidants, such as antioxidant nutrients or drugs.", {"entities": []}], ["Combinations of MN showed better outcomes than individual MN, suggesting forthcoming clinical studies.", {"entities": []}], ["The criteria in study design and monitoring MN-based clinical trials are discussed.", {"entities": []}], ["Atopic dermatitis (AD) is a chronic, relapsing and pruritic inflammatory skin disease whose management remains unclear to most non-dermatologists.", {"entities": [[73, 85, "DISEASE"], [7, 17, "DISEASE"]]}], ["This study aimed to assess the knowledge, attitudes and practices (KAP) of the medical staff regarding AD in Yaound\u00e9, Cameroon.", {"entities": []}], ["This was a cross-sectional study conducted from January to April 2014 in 20 health facilities located in Yaound\u00e9, the capital city of Cameroon.", {"entities": []}], ["All medical staff who provided their consent were included in the study.", {"entities": []}], ["A score was established for each of the KAP categories, and subsequently grouped into 4 classes considering a score <50, 50-<65, 65-<85 or \u226585%, respectively.", {"entities": []}], ["We enrolled 100 medical personnel, 62% of whom were females.", {"entities": []}], ["Overall, the level of knowledge on AD was moderate (65%).", {"entities": []}], ["Allergy was the main cause of AD, stated by 64% of participants.", {"entities": []}], ["Only 43% personnel cited the genetic cause.", {"entities": []}], ["Asthma was mentioned by 78% as an associated pathology.", {"entities": []}], ["Regarding attitudes, the majority (84%) thought that AD is equally common among Black and Caucasian populations; 42% of participants believed that evolution is favorable when appropriate medical treatment is prescribed.", {"entities": []}], ["These attitudes were considered wrong (64%).", {"entities": []}], ["Similarly, the general level of practice was inadequate: 50%.", {"entities": []}], ["Levels of knowledge, attitudes and practices of the medical staff regarding AD were poor, implying that management of this condition is non optimal in our setting.", {"entities": []}], ["The online version of this article (doi:10.1186/s12895-017-0053-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Care for patients with chronic diseases is challenging and requires multifaceted interventions to appropriately coordinate the entire treatment process.", {"entities": []}], ["The effect of such interventions on clinical outcomes has been assessed, but evidence of the effect on organization of care is scarce.", {"entities": []}], ["The aim is to assess the effect of structured diabetes care on organization of care from the perspective of patients and healthcare professionals in routine practice, and to ascertain whether this effect persists In a quasi-experimental study the effect of structured care (SC) was compared with care-as-usual (CAU).", {"entities": []}], ["Questionnaires were sent to healthcare professionals (SC n = 31; CAU n = 11) and to patients (SC n = 301; CAU n = 102).", {"entities": []}], ["A follow-up questionnaire was sent after formal support of the intervention ended (2007).", {"entities": []}], ["SC does have an effect on the organization of care.", {"entities": []}], ["More cooperation between healthcare professionals, less referrals to secondary care and more education were reported in the SC group as compared to the CAU group.", {"entities": []}], ["These changes were found both at the healthcare professional and at the patient level.", {"entities": []}], ["Organizational changes remained after formal support for the intervention support had ended.", {"entities": []}], ["According to patients and healthcare professionals, structured care does have a positive effect on the organization of care.", {"entities": []}], ["The use of these two sources of information is important, not only to assess the value of changes in care for the patient and the healthcare provider but also to ascertain the validity of the results found.", {"entities": []}], ["Electronic cigarette (E-cigarettes) emissions present a potentially new hazard to neonates through inhalation, dermal and oral contact.", {"entities": []}], ["Exposure to nicotine containing E-cigarettes may cause significant systemic absorption in neonates due to the potential for multi-route exposure.", {"entities": []}], ["Systemic absorption of nicotine and constituents of E-cigarette emissions may adversely impact weight and lung development in the neonate.", {"entities": []}], ["To address these questions we exposed neonatal mice to E-cigarette emissions and measured systemic cotinine levels and alveolar lung growth.", {"entities": []}], ["Neonatal mice were exposed to E-cigarettes for the first 10 days of life.", {"entities": []}], ["E-cigarette cartridges contained either 1.8% nicotine in propylene glycol (PG) or PG vehicle alone.", {"entities": []}], ["Daily weights, plasma and urine cotinine levels and lung growth using the alveolar mean linear intercept (MLI) method were measured at 10 days of life and compared to room air controls.", {"entities": []}], ["Mice exposed to 1.8% nicotine/PG had a 13.3% decrease in total body weight compared to room air controls.", {"entities": []}], ["Plasma cotinine levels were found to be elevated in neonatal mice exposed to 1.8% nicotine/PG E-cigarettes (mean 62.34\u00b1 3.3 ng/ml).", {"entities": []}], ["After adjusting for sex and weight, the nicotine exposed mice were found to have modestly impaired lung growth by MLI compared to room air control mice ( p <.054 trial 1; p <.006 trial 2).", {"entities": []}], ["These studies indicate that exposure to E-cigarette emissions during the neonatal period can adversely impact weight gain.", {"entities": []}], ["In addition exposure to nicotine containing E-cigarettes can cause detectable levels of systemic cotinine, diminished alveolar cell proliferation and a modest impairment in postnatal lung growth.", {"entities": []}], ["Allergic airways inflammation in asthma is characterized by an airway epithelial gene signature composed of POSTN , CLCA 1 , and SERPINB 2 .", {"entities": [[33, 39, "DISEASE"], [108, 113, "GENE"]]}], ["This Th2 gene signature is proposed as a tool to classify patients with asthma into Th2\u2010high and Th2\u2010low phenotypes.", {"entities": [[72, 78, "DISEASE"]]}], ["However, many asthmatics smoke and the effects of cigarette smoke exposure on the epithelial Th2 gene signature are largely unknown.", {"entities": []}], ["Therefore, we investigated the combined effect of IL \u201013 and whole cigarette smoke ( CS ) on the Th2 gene signature and the mucin\u2010related genes MUC 5 AC and SPDEF in air\u2013liquid interface differentiated human bronchial ( ALI \u2010 PBEC ) and tracheal epithelial cells ( ALI \u2010 PTEC ).", {"entities": [[85, 87, "GENE"], [157, 162, "GENE"]]}], ["Cultures were exposed to IL \u201013 for 14\u00a0days followed by 5\u00a0days of IL \u201013 with CS exposure.", {"entities": [[78, 80, "GENE"]]}], ["Alternatively, cultures were exposed once daily to CS for 14\u00a0days, followed by 5\u00a0days CS with IL \u201013.", {"entities": [[51, 53, "GENE"], [86, 88, "GENE"], [51, 53, "GENE"], [86, 88, "GENE"]]}], ["POSTN , SERPINB 2 , and CLCA 1 expression were measured 24\u00a0h after the last exposure to CS and IL \u201013.", {"entities": [[0, 5, "GENE"], [88, 90, "GENE"]]}], ["In both models POSTN , SERPINB 2 , and CLCA 1 expression were increased by IL \u201013.", {"entities": [[15, 20, "GENE"]]}], ["CS markedly affected the IL \u201013\u2010induced Th2 gene signature as indicated by a reduced POSTN , CLCA 1 , and MUC 5 AC expression in both models.", {"entities": [[0, 2, "GENE"], [85, 90, "GENE"]]}], ["In contrast, IL \u201013\u2010induced SERPINB 2 expression remained unaffected by CS , whereas SPDEF expression was additively increased.", {"entities": [[72, 74, "GENE"], [85, 90, "GENE"]]}], ["Importantly, cessation of CS exposure failed to restore IL \u201013\u2010induced POSTN and CLCA 1 expression.", {"entities": [[26, 28, "GENE"], [71, 76, "GENE"]]}], ["We show for the first time that CS differentially affects the IL \u201013\u2010induced gene signature for Th2\u2010high asthma.", {"entities": [[105, 111, "DISEASE"], [32, 34, "GENE"]]}], ["These findings provide novel insights into the interaction between Th2 inflammation and cigarette smoke that is important for asthma pathogenesis and biomarker\u2010guided therapy in asthma.", {"entities": [[126, 132, "DISEASE"], [178, 184, "DISEASE"]]}], ["Asthma is a heterogeneous disease with many phenotypes, and age at disease onset is an important factor in separating the phenotypes.", {"entities": [[0, 6, "DISEASE"]]}], ["Genetic factors, atopy, and early respiratory tract infections are well-recognized factors predisposing to childhood-onset asthma.", {"entities": [[123, 129, "DISEASE"]]}], ["Adult-onset asthma is more often associated with obesity, smoking, depression, or other life-style or environmental factors, even though genetic factors and respiratory tract infections may also play a role in adult-onset disease.", {"entities": [[49, 56, "DISEASE"], [12, 18, "DISEASE"]]}], ["Adult-onset asthma is characterized by absence of atopy and is often severe requiring treatment with high dose of inhaled and/or oral steroids.", {"entities": [[12, 18, "DISEASE"]]}], ["Variety of risk factors and nonatopic nature of adult-onset disease suggest that variety of mechanisms is involved in the disease pathogenesis and that these mechanisms differ from the pathobiology of childhood-onset asthma with prevailing Th2 airway inflammation.", {"entities": [[217, 223, "DISEASE"]]}], ["Recognition of the mechanisms and mediators that drive the adult-onset disease helps to develop novel strategies for the treatment.", {"entities": []}], ["The aim of this review was to summarize the current knowledge on the pathogenesis of adult-onset asthma and to concentrate on the mechanisms and mediators involved in establishing adult-onset asthma in response to specific risk factors.", {"entities": [[97, 103, "DISEASE"], [192, 198, "DISEASE"]]}], ["We also discuss the involvement of these mechanisms in the currently recognized phenotypes of adult-onset asthma.", {"entities": [[106, 112, "DISEASE"]]}], ["Both black (B) and green (G) cardamom are used as flavours during food preparation.", {"entities": []}], ["This study investigated the responses to B and G in a diet-induced rat model of human metabolic syndrome.", {"entities": [[96, 104, "DISEASE"]]}], ["Male Wistar rats were fed either a corn starch-rich diet (C) or a high-carbohydrate, high-fat diet with increased simple sugars along with saturated and trans fats (H) for 16 weeks.", {"entities": []}], ["H rats showed signs of metabolic syndrome leading to visceral obesity with hypertension, glucose intolerance, cardiovascular remodelling and nonalcoholic fatty liver disease.", {"entities": [[75, 87, "DISEASE"], [154, 173, "DISEASE"], [160, 173, "DISEASE"], [89, 108, "DISEASE"], [62, 69, "DISEASE"], [33, 41, "DISEASE"]]}], ["Food was supplemented with 3% dried B or G for the final eight weeks only.", {"entities": []}], ["The major volatile components were the closely related terpenes, 1,8-cineole in B and \u03b1-terpinyl acetate in G. HB (high-carbohydrate, high-fat + black cardamom) rats showed marked reversal of diet-induced changes, with decreased visceral adiposity, total body fat mass, systolic blood pressure and plasma triglycerides, and structure and function of the heart and liver.", {"entities": []}], ["In contrast, HG (high-carbohydrate, high-fat + green cardamom) rats increased visceral adiposity and total body fat mass, and increased heart and liver damage, without consistent improvement in the signs of metabolic syndrome.", {"entities": [[217, 225, "DISEASE"]]}], ["These results suggest that black cardamom is more effective in reversing the signs of metabolic syndrome than green cardamom.", {"entities": [[96, 104, "DISEASE"]]}], ["Two once-daily inhaled bronchodilators, indacaterol and tiotropium, are widely used as first-line therapy in stable COPD patients.", {"entities": []}], ["This study was performed to compare the clinical efficacy and safety between indacaterol and tiotropium in patients with moderate-to-severe COPD.", {"entities": []}], ["MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched to identify all published randomized controlled trials (RCTs).", {"entities": []}], ["The primary outcome was trough forced expiratory volume in 1 second (FEV 1 ) at week 12.", {"entities": [[69, 72, "GENE"]]}], ["Four RCTs were eligible for inclusion (three RCTs with moderate-to-severe COPD patients and one RCT with only severe COPD patients).", {"entities": []}], ["Trough FEV 1 at weeks 12 and 26 were not significantly different between indacaterol and tiotropium by the standardized mean difference with 0.014 (95% CI, -0.036, 0.063, I = 23.5%) and with 0.037 (95% CI, -0.059 to 0.133, I = 0%) along with differences in means of 0.003L and 0.014L, respectively.", {"entities": [[7, 10, "GENE"]]}], ["Indacaterol and tiotropium also showed similar St. George`s Respiratory Questionnaire (SGRQ) total scores and percentages of patients with SGRQ improvement (\u2265 4 units) at week 26.", {"entities": []}], ["The incidences of nasopharyngitis, serious cardiovascular events, and serious adverse events were not different between indacaterol and tiotropium, while those of cough (OR = 1.68, P < 0.001, and RR = 1.63) and COPD worsening (OR = 1.18, P = 0.003, and RR = 1.12) were higher for indacaterol than tiotropium.", {"entities": [[18, 33, "DISEASE"]]}], ["However, when one study with only severe COPD patients was removed from the meta-analysis, the difference in the incidence of COPD worsening between indacaterol and tiotropium became non-significant (OR = 1.13, P = 0.204, and RR = 1.09).", {"entities": []}], ["The clinical efficacy and serious adverse events between indacaterol and tiotropium were equivocal in patients with moderate-to-severe COPD.", {"entities": []}], ["Cough is a common complaint associated with indacaterol, and COPD worsening needs to be carefully monitored in severe COPD patients when treated with indacaterol.", {"entities": []}], ["In Brazil, health is fundamental human right guaranteed by the Constitution of 1988, which created the Brazilian Universal Health System (Sistema \u00danico de Sa\u00fade - SUS).", {"entities": []}], ["The SUS provides medications for outpatient care via policy of pharmaceutical assistance (PA) programmes.", {"entities": []}], ["Despite the advances in PA policies which include the improvement in access to medications, there has been a significant increase in lawsuits related to health products and services.", {"entities": []}], ["This study aimed to characterize the medication processes filed between 2010 and 2014 against the Secretary of State for Health of S\u00e3o Paulo (State Health Department of S\u00e3o Paulo - SES/SP), in Brazil, following PA policies.", {"entities": []}], ["This descriptive study used secondary data on medication lawsuits filed against the SES/SP between 2010 and 2014.", {"entities": []}], ["The data source was the S-Codes computerized system.", {"entities": []}], ["In the period evaluated, the number of lawsuits filed concerning health-related products increased approximately 63%; requests for medications were predominant.", {"entities": []}], ["Approximately 30% of the medications involved in court proceedings were supplied via PA programmes.", {"entities": []}], ["With regard to medications supplied via specialized component, 81.3% were prescribed in disagreement with the protocols published by the Ministry of Health.", {"entities": []}], ["Insulin glargine was the most requested medication (6.3%), followed by insulin aspart (3.3%).", {"entities": []}], ["Because there is no scientific evidence that either of these medicines is superior for the treatment of diabetes, neither of them has been incorporated into the SUS by the National Commission for Technology Incorporation.", {"entities": []}], ["The judicial data showed that most of the lawsuits involved normal proceedings (i.e., individual demands), were filed by private lawyers, and named the State of S\u00e3o Paulo as the sole defendant, demonstrating the individual nature of these claims.", {"entities": []}], ["The data indicate inequality in the distribution between the number of cases and lawyers and the number of lawsuits and prescribers, evidencing the concentration of lawyers and physicians in filing lawsuits.", {"entities": []}], ["The judicialization of health in the State of S\u00e3o Paulo with the characteristics presented herein is a threat to the SUS.", {"entities": []}], ["There are ongoing debates on issues relating to returning individual research results (IRRs) and incidental findings (IFs) generated by genetic research in population-based biobanks.", {"entities": []}], ["To understand how to appropriately return genetic results from biobank studies, we surveyed preferences for returning IRRs and IFs among participants of the Tohoku Medical Megabank Project (TMM).", {"entities": []}], ["We mailed a questionnaire to individuals enrolled in the TMM cohort study (Group 1; n =1031) and a group of Tohoku region residents (Group 2; n =2314).", {"entities": []}], ["The respondents were required to be over 20 years of age.", {"entities": []}], ["Nearly 90% of Group 1 participants and over 80% of Group 2 participants expressed a preference for receiving their genetic test results.", {"entities": []}], ["Furthermore, over 60% of both groups preferred to receive their genetic results \u2018from a genetic specialist.\u2019 A logistic regression analysis revealed that engaging in \u2018health-conscious behaviors\u2019 (such as regular physical activity, having a healthy diet, intentionally reducing alcohol intake and/or smoking and so on) was significant, positively associated with preferring to receive their genetic test results (odds ratio=2.397 (Group 1) and 1.897 (Group 2)).", {"entities": []}], ["Our findings provided useful information and predictors regarding the return of IRRs and IFs in a population-based biobank.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by non-reversible airflow limitation.", {"entities": []}], ["A common symptom of COPD is dyspnea or shortness of breath.", {"entities": []}], ["Dyspnea may vary daily, with a large impact on patients\u2019 lives.", {"entities": []}], ["Previous clinical trials used patient-reported outcome (PRO) measures that quantified dyspnea at discrete intervals and hence did not reflect this variability.", {"entities": []}], ["Recently the Shortness of Breath with Daily Activities (SOBDA) questionnaire was developed as a PRO measure of dyspnea utilizing a daily diary.", {"entities": []}], ["This confirmatory post hoc meta-analysis of SOBDA data from a large clinical study program further supports the questionnaire and clarifies the minimum threshold of SOBDA response.", {"entities": []}], ["Data from four clinical trials (DB2113361, NCT01313637; DB2113373, NCT01313650; DB2113360, NCT01316900; DB2113374, NCT01316913) were analyzed.", {"entities": []}], ["These 24-week trials were randomized, blinded studies investigating the efficacy and safety of several COPD treatments.", {"entities": []}], ["These post hoc analyses focused on the SOBDA questionnaire properties.", {"entities": []}], ["This electronic-diary consists of 13 items completed daily, in which patients rate their breathlessness level during common daily activities.", {"entities": []}], ["Resultant SOBDA scores were compared with related, commonly used assessments: modified Medical Research Council Research Dyspnea Scale (mMRC), Baseline Dyspnea Index (BDI), Transition Dyspnea Index (TDI), St George\u2019s Respiratory Questionnaire (SGRQ), COPD Assessment Test (CAT), and trough forced expiratory volume in 1\u00a0s (FEV 1 ).", {"entities": [[323, 326, "GENE"]]}], ["The consistency, reliability, validity (convergent, known groups), and responsiveness of the SOBDA questionnaire was assessed.", {"entities": []}], ["In total, 4967 patients with COPD provided data for these analyses.", {"entities": []}], ["The SOBDA questionnaire had high internal consistency (Cronbach\u2019s alpha\u2009=\u20090.936), high test-retest reliability (Pearson\u2019s correlation coefficient\u2009=\u20090.86) and convergent validity with related measures (SGRQ total score, Pearson\u2019s correlation coefficient\u2009=\u20090.59; CAT, Spearman rank-order correlation coefficient\u2009=\u20090.50).", {"entities": []}], ["SOBDA scores were statistically significantly lower in responders (as defined by TDI, SGRQ, CAT, and trough FEV 1 levels) versus non-responders ( p \u2009<\u20090.001 for all assessments and all time points).", {"entities": [[108, 111, "GENE"]]}], ["Using an anchor-based method, the threshold of a minimum response was calculated as a SOBDA score change of \u22120.2 (SOBDA score range\u2009=\u20091\u20134).", {"entities": []}], ["The reliability, validity, and responsiveness of the SOBDA questionnaire as a PRO measure to quantify dyspnea was supported in a large clinical trial population of patients with moderate\u2013very severe COPD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12955-015-0369-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Neutrophil to lymphocyte ratio (NLR) in peripheral blood is a useful systemic inflammatory response biomarker.", {"entities": []}], ["However, NLR has not been studied in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[51, 88, "DISEASE"]]}], ["This study was aimed to evaluate the usefulness of NLR in patients with COPD.", {"entities": []}], ["NLR was prospectively measured and compared in patients with COPD exacerbation (n = 59), patients with stable COPD (n = 61), and healthy controls (n = 28).", {"entities": []}], ["NLR in patients with COPD exacerbation was repeatedly measured in the convalescent period.", {"entities": []}], ["The correlation between NLR and clinical parameters was evaluated, and the predictors for respiratory hospitalization were analyzed by multivariate logistic regression.", {"entities": []}], ["NLR values were significantly higher in patients with COPD exacerbation compared with stable COPD patients and controls (12.4 \u00b1 10.6, 2.4 \u00b1 0.7, 1.4 \u00b1 0.5, respectively; p < 0.001).", {"entities": []}], ["NLR was significantly decreased during the convalescent period in patients with COPD exacerbation (4.5 \u00b1 4.6 vs. 11.5 \u00b1 8.8, p < 0.001).", {"entities": []}], ["NLR exhibited a significant correlation with the body mass index, degree of airway obstruction, dyspnea, and exercise capacity (BODE) index, the 6-minute walk test, and the modified Medical Research Council scale.", {"entities": []}], ["NLR \u2265 2.8 was an independent predictor with a borderline significance for respiratory hospitalization (odds ratio, 2.083; p = 0.079).", {"entities": []}], ["Body mass index and forced expiratory volume in 1 second were independent predictors for respiratory hospitalization.", {"entities": []}], ["NLR is a straightforward and effective biomarker of COPD exacerbation that may serve as a predictor for respiratory hospitalization in patients with COPD.", {"entities": []}], ["Improving patients' health-related quality of life (HRQoL) is recognized as a fundamental part of asthma management.", {"entities": [[98, 104, "DISEASE"]]}], ["The aims of this study were to evaluate the long-term efficacy (including symptom-free days and exacerbations) and impact on HRQoL of a stable-dose regimen of salmeterol/fluticasone propionate (SAL/FP) and an adjustable maintenance dosing (AMD) regimen of formoterol/budesonide (FOR/BUD) where treatment is adjusted based on symptoms [SAM40056].", {"entities": []}], ["A total of 688 outpatients with asthma receiving regular low-dose inhaled corticosteroids (ICS) plus a long-acting \u03b2 2 -agonist, or medium dose ICS alone participated in this randomized, double-blind, double-dummy, parallel-group, 1-year trial, which was conducted in 91 centers in 15 countries.", {"entities": [[32, 38, "DISEASE"]]}], ["Patients were randomized to receive 1 inhalation of SAL/FP 50/250 \u03bcg BID or 2 inhalations of FOR/BUD 6/200 \u03bcg BID during Weeks 1\u20134.", {"entities": []}], ["For Weeks 5\u201352, patients meeting strict continuation criteria for stable asthma at Week 4 received AMD with FOR/BUD or stable-dose SAL/FP.", {"entities": [[73, 79, "DISEASE"]]}], ["The percentage of symptom-free days was significantly greater (58.8% vs 52.1%; p = 0.034) and the annual exacerbation rate was significantly lower (47%; p = 0.008) with stable-dose SAL/FP compared with FOR/BUD AMD.", {"entities": []}], ["A total of 568 patients completed the Asthma Quality of Life Questionnaire (AQLQ) at least once during the study.", {"entities": [[38, 44, "DISEASE"]]}], ["The mean change from baseline in AQLQ overall score was numerically greater with SAL/FP than FOR/BUD at week 28 and week 52, but did not reach statistical significance (p = 0.121 at Week 52).", {"entities": []}], ["However, in a post hoc logistic regression analyses for any AQLQ improvement, significant benefits with SAL/FP were seen at both time points (p = 0.038 and p = 0.009, respectively).", {"entities": []}], ["The minimally important difference of \u2265 0.5-point improvement in AQLQ overall score was achieved by a significantly greater number of patients receiving SAL/FP at Week 28 (68% vs 60%; p = 0.049); a trend for this difference remained at Week 52 (71% vs 65%) (p = 0.205).", {"entities": []}], ["In this population of patients with persistent asthma, stable-dose SAL/FP resulted in significantly greater increases in symptom-free days, a reduction in exacerbation rates, and provided greater HRQoL benefits compared with FOR/BUD AMD.", {"entities": [[47, 53, "DISEASE"]]}], ["Clinical Trials registration number NCT00479739", {"entities": []}], ["This study aimed to examine the association between performance of self\u2010care activities and patient or disease factors as well as patient activation levels in patients with diabetes and chronic kidney disease ( CKD ) in Australia.", {"entities": [[194, 208, "DISEASE"]]}], ["A cross\u2010sectional study was conducted among adults with diabetes and CKD ( eGFR <60 mL /min/1.73m PAM ) and the Summary of Diabetes Self\u2010Care Activities ( SDSCA ) scale.", {"entities": [[75, 79, "GENE"]]}], ["Regression analyses were performed to determine the relationship between activation and performance of self\u2010care activities.", {"entities": []}], ["A total of 317 patients (70% men) with a mean age of 66.9 ( SD =11.0) years participated.", {"entities": []}], ["The mean ( SD ) PAM and composite SDSCA scores were 57.6 (15.5) % (range 0\u2010100) and 37.3 (11.2) (range 0\u201070), respectively.", {"entities": []}], ["Younger age, being male, advanced stages of CKD and shorter duration of diabetes were associated with lower scores in one or more self\u2010care components.", {"entities": []}], ["Patient activation was positively associated with the composite SDSCA score, and in particular the domains of general diet and blood sugar checking ( P <.05), but not specific diet, exercising and foot checking.", {"entities": []}], ["In people with diabetes and CKD , a high level of patient activation was positively associated with a higher overall level of self\u2010care.", {"entities": []}], ["Our results identify subgroups of people who may benefit from tailored interventions to further improve their health outcomes.", {"entities": []}], ["Further prospective studies are warranted to confirm present findings.", {"entities": []}], ["To investigate the incidence of achalasia in Algeria and to determine its clinical and para-clinical profile.", {"entities": [[32, 41, "DISEASE"]]}], ["To evaluate the impact of continuing medical education (CME) on the incidence of this disease.", {"entities": []}], ["From 1990 to 2014, 1256 patients with achalasia were enrolled in this prospective study.", {"entities": [[38, 47, "DISEASE"]]}], ["A campaign of CME on diagnosis involving different regions of the country was conducted between 1999 and 2003.", {"entities": []}], ["Annual incidence and prevalence were calculated by relating the number of diagnosed cases to 10 The mean annual incidence raised from 0.04 (95%CI: 0.028-0.052) during the 1990s to 0.27/10 The mean incidence of achalasia in Algeria is at least 0.27/10", {"entities": [[210, 219, "DISEASE"]]}], ["To investigate whether genetic polymorphisms of glutathione S-transferases ( GSTM1 , GSTT1 , and GSTO2 ) in relation to the work place contribute to the development of cataract.", {"entities": [[168, 176, "DISEASE"], [77, 82, "GENE"], [85, 90, "GENE"], [97, 102, "GENE"]]}], ["The present case-control study consisted of 186 patients (108 females, 78 males) with cataract and 195 gender-matched healthy controls (111 females, 84 males) were randomly selected from unrelated volunteers in the same clinic.", {"entities": [[86, 94, "DISEASE"]]}], ["The GSTM1 , GSTT1 , and GSTO2 genotypes were determined using polymerase chain reaction (PCR) based methods.", {"entities": [[4, 9, "GENE"], [12, 17, "GENE"], [24, 29, "GENE"]]}], ["The null genotype of GSTM1 increased the risk of cataract (OR=1.51, 95%CI: 1.01\u20132.26, p=0.045).", {"entities": [[49, 57, "DISEASE"], [21, 26, "GENE"]]}], ["The prevalence of GSTT1 and GSTO2 genotypes was similar between cases and controls.", {"entities": [[18, 23, "GENE"], [28, 33, "GENE"]]}], ["There was significant difference between cases and controls for work place (\u03c7 GSTM1 , GSTO2 ) and work place that were significant by p<0.3 in the univariate analysis were included in the analysis for investigating the additive effects of the genotypes and work place on risk of cataract.", {"entities": [[279, 287, "DISEASE"], [78, 83, "GENE"], [86, 91, "GENE"]]}], ["Statistical analysis showed that the risk of cataract increased as a function of number of putative high risk factors (\u03c7 This finding suggests that the polymorphisms of GSTM1 and GSTO2 and also work place may act additively for developing cataract.", {"entities": [[45, 53, "DISEASE"], [239, 247, "DISEASE"], [169, 174, "GENE"], [179, 184, "GENE"]]}], ["Study question How safe is live attenuated influenza vaccine (LAIV), which contains egg protein, in young people with egg allergy?", {"entities": [[43, 52, "DISEASE"], [118, 129, "DISEASE"]]}], ["Methods In this open label, phase IV intervention study, 779 young people (2-18 years) with egg allergy were recruited from 30 UK allergy centres and immunised with LAIV.", {"entities": [[92, 103, "DISEASE"]]}], ["The cohort included 270 (34.7%) young people with previous anaphylaxis to egg, of whom 157 (20.1%) had experienced respiratory and/or cardiovascular symptoms.", {"entities": []}], ["445 (57.1%) had doctor diagnosed asthma or recurrent wheeze.", {"entities": [[33, 39, "DISEASE"]]}], ["Participants were observed for at least 30 minutes after vaccination and followed-up by telephone 72 hours later.", {"entities": []}], ["Participants with a history of recurrent wheeze or asthma underwent further follow-up four weeks later.", {"entities": [[51, 57, "DISEASE"]]}], ["The main outcome measure was incidence of an adverse event within two hours of vaccination in young people with egg allergy.", {"entities": [[112, 123, "DISEASE"]]}], ["Study answer and limitations No systemic allergic reactions occurred (upper 95% confidence interval for population 0.47% and in participants with anaphylaxis to egg 1.36%).", {"entities": []}], ["Nine participants (1.2%, 95% CI 0.5% to 2.2%) experienced mild symptoms, potentially consistent with a local, IgE mediated allergic reaction.", {"entities": []}], ["Delayed events potentially related to the vaccine were reported in 221 participants.", {"entities": []}], ["62 participants (8.1%, 95% CI for population 6.3% to 10.3%) experienced lower respiratory tract symptoms within 72 hours, including 29 with parent reported wheeze.", {"entities": []}], ["No participants were admitted to hospital.", {"entities": []}], ["No increase in lower respiratory tract symptoms occurred in the four weeks after vaccination (assessed with asthma control test).", {"entities": [[108, 114, "DISEASE"]]}], ["The study cohort may represent young people with more severe allergy requiring specialist input, since they were recruited from secondary and tertiary allergy centres.", {"entities": []}], ["What this study adds LAIV is associated with a low risk of systemic allergic reactions in young people with egg allergy.", {"entities": [[108, 119, "DISEASE"]]}], ["The vaccine seems to be well tolerated in those with well controlled asthma or recurrent wheeze.", {"entities": [[69, 75, "DISEASE"]]}], ["Funding, competing interests, data sharing This report is independent research commissioned and funded by a Department of Health policy research programme grant to the National Vaccine Evaluation Consortium.", {"entities": []}], ["Additional funding was provided by the NIHR Clinical Research Networks, Health Protection Scotland (Edinburgh site), and Health & Social Care Services in Northern Ireland (Belfast site).", {"entities": []}], ["PJT and MEL had support from the Department of Health for the submitted work; PJT has received research grants from the Medical Research Council and NIHR.", {"entities": []}], ["No additional data available.", {"entities": []}], ["Study registration ClinicalTrials.gov (NCT02111512) and the EU Clinical Trials Register EudraCT (2014-001537-92).", {"entities": []}], ["Respiratory disorders are associated with occupational and environmental exposures.", {"entities": []}], ["The latency period between exposure and disease onset remains uncertain.", {"entities": []}], ["The World Trade Center (WTC) disaster presents a unique opportunity to describe the latency period for obstructive airway disease (OAD) diagnoses.", {"entities": []}], ["This prospective cohort study of New York City firefighters compared the timing and incidence of physician-diagnosed OAD relative to WTC exposure.", {"entities": []}], ["Exposure was categorized by WTC arrival time as high (on the morning of September 11, 2001), moderate (after noon on September 11, 2001, or on September 12, 2001), or low (during September 13\u201324, 2001).", {"entities": []}], ["We modeled relative rates and 95% confidence intervals of OAD incidence by exposure over the first 5 years after September 11, 2001, estimating the times of change in the relative rate with change point models.", {"entities": []}], ["We observed a change point at 15 months after September 11, 2001.", {"entities": []}], ["Before 15 months, the relative rate for the high- versus low-exposure group was 3.96 (95% confidence interval: 2.51, 6.26) and thereafter, it was 1.76 (95% confidence interval: 1.26, 2.46).", {"entities": []}], ["Incident OAD was associated with WTC exposure for at least 5 years after September 11, 2001.", {"entities": []}], ["There were higher rates of new-onset OAD among the high-exposure group during the first 15 months and, to a lesser extent, throughout follow-up.", {"entities": []}], ["This difference in relative rate by exposure occurred despite full and free access to health care for all WTC-exposed firefighters, demonstrating the persistence of WTC-associated OAD risk.", {"entities": []}], ["Chronic disease among school-aged children is a public health concern, particularly for asthma and food allergy.", {"entities": [[99, 111, "DISEASE"], [88, 94, "DISEASE"]]}], ["In Chicago Public Schools (CPS), rates of asthma and food allergy among students are underreported.", {"entities": [[53, 65, "DISEASE"], [42, 48, "DISEASE"]]}], ["The aim of this study was to determine the barriers to chronic disease reporting as experienced by CPS parents and school nurses.", {"entities": []}], ["A mixed-methods approach included focus groups and key informant interviews with parents and school nurses, and a cross-sectional survey was completed by parents.", {"entities": []}], ["Qualitative data analysis was performed and survey data were analyzed to determine the significant demographic and knowledge variables associated with successfully completing the reporting process.", {"entities": []}], ["The three main barriers identified were 1) a lack of parental process knowledge; 2) limited communication from schools; and 3) insufficient availability of school nurses.", {"entities": []}], ["Parents were significantly more likely to successfully complete the reporting process if they knew about special accommodations for chronic diseases, understood the need for physician verification, and/or knew the school nurse.", {"entities": []}], ["These findings suggest that increasing parental knowledge of the reporting process will allow schools to better identify and manage their students\u2019 chronic conditions.", {"entities": []}], ["A parent-focused intervention informed by these results has been completed.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2458-14-1250) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Over the past decades, water pollution by trace organic compounds (ng/L) has become one of the key environmental issues in developed countries.", {"entities": []}], ["This is the case of the emerging contaminants called endocrine disrupting compounds (EDCs).", {"entities": []}], ["EDCs are a new class of environmental pollutants able to mimic or antagonize the effects of endogenous hormones, and are recently drawing scientific and public attention.", {"entities": []}], ["Their widespread presence in the environment solicits the need of their removal from the contaminated sites.", {"entities": []}], ["One promising approach to face this challenge consists in the use of enzymatic systems able to react with these molecules.", {"entities": []}], ["Among the possible enzymes, oxidative enzymes are attracting increasing attention because of their versatility, the possibility to produce them on large scale, and to modify their properties.", {"entities": []}], ["In this study five different EDCs were treated with four different fungal laccases, also in the presence of both synthetic and natural mediators.", {"entities": []}], ["Mediators significantly increased the efficiency of the enzymatic treatment, promoting the degradation of substrates recalcitrant to laccase oxidation.", {"entities": []}], ["The laccase showing the best performances was chosen to further investigate its oxidative capabilities against micropollutant mixtures.", {"entities": []}], ["Improvement of enzyme performances in nonylphenol degradation rate was achieved through immobilization on glass beads.", {"entities": []}], ["Intrauterine exposure to antidepressants may lead to neonatal symptoms from the central nervous system, respiratory system and gastrointestinal system.", {"entities": []}], ["Finnegan score (Neonatal Abstinence Score, NAS) has routinely been used to assess infants exposed to antidepressants in utero.", {"entities": []}], ["The purpose was to study neonatal maladaptation syndrome in infants exposed to selective serotonin reuptake inhibitors (SSRI) or serotonin-norepinephrine reuptake inhibitors (SNRI) in utero.", {"entities": [[48, 56, "DISEASE"]]}], ["Retrospective cohort study of women using antidepressants during pregnancy and their infants.", {"entities": []}], ["Patients were identified from the electronic health record system at Karolinska University Hospital Huddinge containing pre-, peri- and postnatal information.", {"entities": []}], ["Information was collected on maternal and infant health, social factors and pregnancy.", {"entities": []}], ["NAS sheets were scrutinized.", {"entities": []}], ["220 women with reported 3 Severe abstinence in infants prenatally exposed to antidepressants was found to be rare (3%) in this study population, a slightly lower prevalence than reported in previous studies.", {"entities": []}], ["Neonatal hypoglycemia in infants prenatally exposed to antidepressant may however be more common than previously described.", {"entities": [[9, 21, "DISEASE"]]}], ["The sst1 , \u201c supersusceptibility to tuberculosis ,\u201d locus has previously been shown to be a genetic determinant of host resistance to infection with the intracellular pathogen, Mycobacterium tuberculosis .", {"entities": [[36, 48, "DISEASE"], [191, 203, "DISEASE"]]}], ["Chlamydia pneumoniae is an obligate intracellular bacterium associated with community acquired pneumonia, and chronic infection with C. pneumoniae has been linked to asthma and atherosclerosis.", {"entities": [[177, 192, "DISEASE"], [95, 104, "DISEASE"], [166, 172, "DISEASE"]]}], ["C. pneumoniae is a highly adapted pathogen that can productively infect macrophages and inhibit host cell apoptosis.", {"entities": []}], ["Here we examined the role of sst1 in regulating the host response to infection with C. pneumoniae .", {"entities": []}], ["Although mice carrying the sst1 susceptible ( sst1 ) locus were not impaired in their ability to clear the acute infection, they were dramatically less tolerant of the induced immune response, displaying higher clinical scores, more severe lung inflammation, exaggerated macrophage and neutrophil influx, and the development of fibrosis compared to wild type mice.", {"entities": []}], ["This correlated with increased activated caspase-3 in the lungs of infected sst1 mice.", {"entities": []}], ["Infection of sst1 macrophages with C. pneumoniae resulted in a shift in the secreted cytokine profile towards enhanced production of interferon-\u03b2 and interleukin-10, and induced apoptotic cell death, which was dependent on secretion of interferon-\u03b2.", {"entities": []}], ["Intriguingly macrophages from the sst1 mice failed to support normal chlamydial growth, resulting in arrested development and failure of the organism to complete its infectious cycle.", {"entities": []}], ["We conclude that the sst1 locus regulates a shared macrophage-mediated innate defense mechanism against diverse intracellular bacterial pathogens.", {"entities": []}], ["Its susceptibility allele leads to upregulation of type I interferon pathway, which, in the context of C. pneumoniae , results in decreased tolerance, but not resistance, to the infection.", {"entities": []}], ["Further dissection of the relationship between type I interferons and host tolerance during infection with intracellular pathogens may provide identification of biomarkers and novel therapeutic targets.", {"entities": []}], ["Chlamydia pneumoniae is a highly adapted intracellular pathogen and a common cause of atypical, community acquired pneumonia.", {"entities": [[115, 124, "DISEASE"]]}], ["It has also been suggested as a trigger or promoter of asthma and atherosclerosis.", {"entities": [[66, 81, "DISEASE"], [55, 61, "DISEASE"]]}], ["In this study, we examined the role of a genetic locus on mouse chromosome 1 that has been associated with susceptibility to another intracellular pathogen, Mycobacterium tuberculosis , in the pathogenesis of respiratory infections secondary to Chlamydia pneumoniae .", {"entities": [[171, 183, "DISEASE"]]}], ["We have determined that a variant at this locus, known as sst1 and associated with destructive pulmonary tuberculosis, makes mice dramatically more sensitive in vivo to the inflammatory changes following respiratory infection with C. pneumoniae .", {"entities": [[105, 117, "DISEASE"], [95, 117, "DISEASE"]]}], ["This appears to arise from activation of type I interferons and apoptotic cell death, two signaling pathways that are normally silent during productive C. pneumoniae infection.", {"entities": []}], ["Despite a noted inability of sst1 susceptible macrophages to support chlamydial development, exuberant lung tissue damage resulted in overall more severe disease in vivo .", {"entities": []}], ["We conclude the sst1 -mediated control of lung tissue damage is an important determinant of the genetic susceptibility of a given host to a number of diverse intracellular bacterial pathogens, which may provide predictors of outcomes to infectious diseases as well as possible target for novel therapeutics.", {"entities": []}], ["Molecular mediators influencing the transition from acute to persistent musculoskeletal pain following common stress exposures such as motor vehicle collision (MVC) remain poorly understood.", {"entities": []}], ["In this exploratory, proof of concept study, we compared circulating microRNA (miRNA) expression profiles in the early aftermath of MVC among individuals who did and did not subsequently develop persistent pain.", {"entities": []}], ["Blood RNA samples were obtained from African American individuals (n\u00a0=\u00a053) who presented to the emergency department after MVC and were discharged to home after evaluation.", {"entities": []}], ["The presence or absence of severe pain in the axial region, the most common and morbid region in which post-MVC pain occurs, was assessed 6\u00a0weeks following MVC via standardized questionnaire.", {"entities": []}], ["miRNA expression was determined using miRNA-sequencing; nonparametric analyses were used to compare miRNA expression levels among individuals with and without persistent pain.", {"entities": []}], ["Thirty-two mature miRNA were differentially expressed (p\u00a0<\u00a00.05) in those with and without severe axial pain at 6\u00a0weeks.", {"entities": []}], ["miR-135a-5p, a regulator of the serotonin receptor that is known to be stress-responsive, differed most significantly between groups (p\u00a0=\u00a03\u00a0\u00d7\u00a010 These results show that circulating miRNA predict persistent severe axial pain after MVC and suggest that they may be involved in the pathogenesis of post-traumatic musculoskeletal pain.", {"entities": []}], ["However, further studies are needed to determine if these miRNA play a direct causal role.", {"entities": []}], ["The online version of this article (doi:10.1186/s12990-015-0069-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Air pollution epidemiology since the 1950s has been able to demonstrate that increases in daily mortality in London, England, were associated with elevated concentrations of index air pollutants, i.e., British Smoke (BS) and sulfur dioxide (SO2).", {"entities": []}], ["In this work, we reanalyze that portion of the 1958-1972 winter mortality-pollution record for which daily direct acid aerosol measurements were made at a central site in London (St. Bartholomew's Medical College).", {"entities": []}], ["The purposes of these exploratory analyses are to examine the dataset for indications of a relationship between acid aerosol pollution and human mortality and to compare any noted associations with those for other pollution variables.", {"entities": []}], ["It is found that the log of acid aerosol concentrations is more strongly associated with raw total mortality in bivariate analyses than is BS or SO2, despite the fact that acid data are available from only one central site (versus seven disperse sites for BS and SO2).", {"entities": []}], ["The logarithmic nature of the exposure side of the H2SO4-mortality relationship implies a saturation model of pollution effects, possibly due to multiday pollution harvesting influences on a susceptible subpopulation.", {"entities": []}], ["Moreover, mortality-pollution cross-correlation analyses indicate that mortality effects usually follow pollution in time, supporting a causal relationship between the two.", {"entities": []}], ["The apparent advantage of H2SO4 over BS in predicting total raw mortality is consistent with the hypothesis that it is the portion of particulate mass of greater health significance and may also allow the development of London mortality results which are more easily transferable to other environments than is the case for existing BS results.", {"entities": []}], ["Allergen immunotherapy is the only treatment option for allergic rhinitis with disease-altering potential.", {"entities": [[56, 73, "DISEASE"], [65, 73, "DISEASE"]]}], ["It was the objective of this study to assess the effectiveness and tolerability of a 5-grass pollen tablet in a large population of non-selected grass pollen allergic patients, i.e.", {"entities": []}], ["patients with different clinical profiles in daily clinical practice.", {"entities": []}], ["In a 2-year, prospective, open-label, multicenter, non-controlled, observational study patients were included from 327 centers across Germany.", {"entities": []}], ["Rhinoconjunctivitis symptoms, symptomatic medication intake and adverse events were recorded.", {"entities": []}], ["A total of 1482 patients aged 4\u201375\u00a0years were included.", {"entities": []}], ["During the 2-year period of 5-grass pollen tablet therapy, mean rhinoconjunctivitis score decreased significantly in the overall study population by 65.5% ( P \u00a0<\u00a00.001).", {"entities": []}], ["The percentage of patients taking symptomatic medication decreased from 83.8% to 42.7%.", {"entities": []}], ["Mean 2-year improvements in rhinoconjunctivitis scores and decreases in the percentage of patients taking symptomatic medication were broadly similar in adults, adolescents and children, in patients with polyallergy versus monoallergy, and in patients with/without asthma.", {"entities": [[265, 271, "DISEASE"]]}], ["Among polyallergic patients, concomitant application of another specific immunotherapy did not impair treatment outcomes.", {"entities": []}], ["Adverse drug reactions, predominantly affecting the local application area, occurred in 15.4% of the overall patient population ( n \u00a0=\u00a0229).", {"entities": []}], ["No cases of anaphylaxis or epinephrine use were documented.", {"entities": []}], ["This study indicates that sublingual immunotherapy with the 5-grass pollen tablet is well tolerated and provides sustained effectiveness over 2\u00a0years in patients with different clinical profiles, producing a significant decrease in allergic symptoms and a reduction in the use of symptomatic medication.", {"entities": []}], ["Stallergenes GmbH.", {"entities": []}], ["To characterize the coupling effect between patient flow to access the emergency department (ED) and that to access the inpatient unit (IU), we develop a model with two connected queues: one upstream queue for the patient flow to access the ED and one downstream queue for the patient flow to access the IU.", {"entities": []}], ["Building on this patient flow model, we employ queueing theory to estimate the average waiting time across patients.", {"entities": []}], ["Using priority specific wait time targets, we further estimate the necessary number of ED and IU resources.", {"entities": []}], ["Finally, we investigate how an alternative way of accessing ED (Fast Track) impacts the average waiting time of patients as well as the necessary number of ED/IU resources.", {"entities": []}], ["This model as well as the analysis on patient flow can help the designer or manager of a hospital make decisions on the allocation of ED/IU resources in a hospital.", {"entities": []}], ["Inflammatory bowel disease (IBD) is an immune-mediated inflammatory condition causing inflammation of gastrointestinal and systemic cells, with an increasing prevalence worldwide.", {"entities": []}], ["Many factors are known to trigger and maintain inflammation in IBD including the innate and adaptive immune systems, genetics, the gastrointestinal microbiome and several environmental factors.", {"entities": []}], ["Our knowledge of the involvement of the immune system in the pathophysiology of IBD has advanced rapidly over the last two decades, leading to the development of several immune-targeted treatments with a biological source, known as biologic agents.", {"entities": []}], ["The initial focus of these agents was directed against the pro-inflammatory cytokine tumor necrosis factor-\u03b1 (TNF-\u03b1) leading to dramatic changes in the disease course for a proportion of patients with IBD.", {"entities": []}], ["However, more recently, it has been shown that a significant proportion of patients do not respond to anti-TNF-\u03b1 directed therapies, leading a shift to other inflammatory pathways and targets, including those of both the innate and adaptive immune systems, and targets linking both systems including anti-leukocyte trafficking agents-integrins and adhesion molecules.", {"entities": []}], ["This review briefly describes the molecular basis of immune based gastrointestinal inflammation in IBD, and then describes how several current and future biologic agents work to manipulate these pathways, and their clinical success to date.", {"entities": []}], ["The airway mucosal epithelium is permanently exposed to airborne particles.", {"entities": []}], ["A network of immune cells patrols at this interface to the environment.", {"entities": []}], ["The interplay of immune cells is orchestrated by different mediators.", {"entities": []}], ["In the current study we investigated the impact of neuronal signals on key functions of dendritic cells (DC).", {"entities": []}], ["Using two-photon microscopic time-lapse analysis of living lung sections from CD11c-EYFP transgenic mice we studied the influence of neuropeptides on airway DC motility.", {"entities": []}], ["Additionally, using a confocal microscopic approach, the phagocytotic capacity of CD11c 8\u201337 .", {"entities": []}], ["Additionally, the phagocytotic capacity of bone marrow-derived and whole lung CD11c in vivo situation by analyzing DC motility in two different OVA asthma models.", {"entities": [[148, 154, "DISEASE"]]}], ["Both in the acute and prolonged OVA asthma model altered neuropeptide amounts and DC motility in the airways could be measured.", {"entities": [[36, 42, "DISEASE"]]}], ["In summary, our data suggest that neuropeptides modulate key features motility and phagocytosis of mouse airway DC.", {"entities": []}], ["Therefore altered neuropeptide levels in airways during allergic inflammation have impact on regulation of airway immune mechanisms and therefore might contribute to the pathophysiology of asthma.", {"entities": [[189, 195, "DISEASE"]]}], ["Please cite this paper as: Tran et\u00a0al.", {"entities": []}], ["(2012) Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients.", {"entities": [[28, 37, "DISEASE"], [60, 66, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(601), e105\u2013e113.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 The impact of pandemic H1N1 influenza (pH1N1) virus in pediatric cancer is uncertain.", {"entities": [[40, 49, "DISEASE"], [77, 83, "DISEASE"]]}], ["The objectives of this study were to characterize the clinical course of pH1N1 and identify factors associated with severe outcomes.", {"entities": []}], ["Methods\u2002 We conducted a Canadian multicenter retrospective review of children with cancer and stem cell transplant (SCT) recipients who were diagnosed with laboratory\u2010confirmed pH1N1 infection between May 1, 2009 and January 31, 2010.", {"entities": [[83, 89, "DISEASE"]]}], ["Results\u2002 We identified 100 (19 in wave 1 and 81 in wave 2) cases of pH1N1 infection.", {"entities": []}], ["Median age was 8\u00b77\u2003years.", {"entities": []}], ["71% had a hematologic malignancy, and 20% received SCT.", {"entities": []}], ["Median duration of fever and illness was 2 and 12\u00b75\u2003days, respectively.", {"entities": []}], ["51 (51\u00b75%) were hospitalized for a median of 5\u2003days, with no deaths and only 1 requiring admission to the intensive care unit.", {"entities": []}], ["Radiologically confirmed pneumonia was diagnosed in 10 (10%).", {"entities": [[25, 34, "DISEASE"]]}], ["Interruption of chemotherapy or conditioning occurred in 43 patients.", {"entities": []}], ["In multivariable analyses, age <5\u2003years (relative to \u226510\u2003years) and neutropenia were associated with hospitalization while neutropenia was associated with pneumonia.", {"entities": [[155, 164, "DISEASE"], [68, 79, "DISEASE"], [123, 134, "DISEASE"]]}], ["Despite oseltamivir use in 89%, viral shedding was prolonged (median, 46\u2003days) and often persisted after symptom resolution.", {"entities": []}], ["However, an extended treatment course (>5\u2003days) correlated with shortened duration of viral shedding ( P\u2003 = \u2003 0\u00b7041).", {"entities": []}], ["Conclusions\u2002 pH1N1 infection in pediatric cancer and SCT patients infrequently caused complications but commonly interrupted cancer treatment.", {"entities": [[42, 48, "DISEASE"], [125, 131, "DISEASE"]]}], ["Persistent shedding of virus after illness resolution was common.", {"entities": []}], ["Further research is needed to verify this finding as it could have implications for treatment guidelines and infection control practices.", {"entities": []}], ["To evaluate the 12-month costs and quality-adjusted life years (QALYs) gained to the Italian National Health Service of facilitated access to a website for hazardous drinkers compared with a standard face-to-face brief intervention (BI).", {"entities": []}], ["Randomised 1:1 non-inferiority trial.", {"entities": []}], ["Practices of 58 general practitioners (GPs) in Italy.", {"entities": []}], ["Of 9080 patients (>18\u2009years old) approached to take part in the trial, 4529 (49\u00b79%) logged on to the website and 3841 (84.8%) undertook online screening for hazardous drinking.", {"entities": []}], ["822 (21.4%) screened positive and 763 (19.9%) were recruited to the trial.", {"entities": []}], ["Patients were randomised to receive either a face-to-face BI or access via a brochure from their GP to an alcohol reduction website (facilitated access).", {"entities": []}], ["The primary outcome is the cost per QALY gained of facilitated access compared with face-to-face.", {"entities": []}], ["A secondary analysis includes total costs and benefits per 100 patients, including number of hazardous drinkers prevented at 12 months.", {"entities": []}], ["The average time required for the face-to-face BI was 8\u2009min (95% CI 7.5\u2009min to 8.6\u2009min).", {"entities": []}], ["Given the maximum time taken for facilitated access of 5\u2009min, face-to-face is an additional 3\u2009min: equivalent to having time for another GP appointment for every three patients referred to the website.", {"entities": []}], ["Complete case analysis adjusting for baseline the difference in QALYs for facilitated access is 0.002 QALYs per patient (95%\u2009CI \u22120.007 to 0.011).", {"entities": []}], ["Facilitated access to a website to reduce hazardous drinking costs less than a face-to-face BI given by a GP with no worse outcomes.", {"entities": []}], ["The lower cost of facilitated access, particularly in regards to investment of time, may facilitate the increase in provision of BIs for hazardous drinking.", {"entities": []}], ["NCT 01638338 ;Post-results.", {"entities": []}], ["This study developed an electronic-nose sensor node based on a polymer-coated surface acoustic wave (SAW) sensor array.", {"entities": []}], ["The sensor node comprised an SAW sensor array, a frequency readout circuit, and an Octopus II wireless module.", {"entities": []}], ["The sensor array was fabricated on a large K", {"entities": []}], ["The study aims to investigate the effect of repeated infusions of recombinant erythropoietin (EPO) on plasma brain derived neurotrophic factor (BDNF) levels in patients with affective disorders.", {"entities": [[94, 97, "GENE"], [144, 148, "GENE"]]}], ["In total, 83 patients were recruited: 40 currently depressed patients with treatment-resistant depression (TRD) (Hamilton Depression Rating Scale-17 items (HDRS-17) score >17) (study 1) and 43 patients with bipolar disorder (BD) in partial remission (HDRS-17 and Young Mania Rating Scale (YMRS) \u2264 14) (study 2).", {"entities": [[207, 223, "DISEASE"]]}], ["In both studies, patients were randomised to receive eight weekly EPO (Eprex; 40,000 IU) or saline (0.9% NaCl) infusions in a double-blind, placebo-controlled, parallel\u2014group design.", {"entities": [[66, 69, "GENE"]]}], ["Plasma BDNF levels were measured at baseline and at weeks 5, 9 and at follow up, week 14.", {"entities": [[7, 11, "GENE"]]}], ["In contrast with our hypothesis, EPO down regulated plasma BDNF levels in patients with TRD (mean reduction at week 9 (95% CI): EPO 10.94 ng/l (4.51-21.41 ng/l); mean increase at week 9: Saline 0.52 ng/l, p=0.04 (-5.88-4.48 ng/l) p=0.04, partial \u014b ClinicalTrials.gov: NCT00916552 .", {"entities": [[33, 36, "GENE"], [128, 131, "GENE"], [59, 63, "GENE"], [33, 36, "GENE"], [128, 131, "GENE"]]}], ["Piper longum ( P .", {"entities": []}], ["longum , also called as long pepper) is one of the common culinary herbs that has been extensively used as a crucial constituent in various indigenous medicines, specifically in traditional Indian medicinal system known as Ayurveda.", {"entities": []}], ["For exploring the comprehensive effect of its constituents in humans at proteomic and metabolic levels, we have reviewed all of its known phytochemicals and enquired about their regulatory potential against various protein targets by developing high-confidence tripartite networks consisting of phytochemical\u2014protein target\u2014disease association.", {"entities": []}], ["We have also (i) studied immunomodulatory potency of this herb; (ii) developed subnetwork of human PPI regulated by its phytochemicals and could successfully associate its specific modules playing important role in diseases, and (iii) reported several novel drug targets.", {"entities": []}], ["P10636 (microtubule-associated protein tau, that is involved in diseases like dementia etc.)", {"entities": [[78, 86, "DISEASE"]]}], ["was found to be the commonly screened target by about seventy percent of these phytochemicals.", {"entities": []}], ["We report 20 drug-like phytochemicals in this herb, out of which 7 are found to be the potential regulators of 5 FDA approved drug targets.", {"entities": []}], ["Multi-targeting capacity of 3 phytochemicals involved in neuroactive ligand receptor interaction pathway was further explored via molecular docking experiments.", {"entities": []}], ["To investigate the molecular mechanism of P .", {"entities": []}], ["longum \u2019s action against neurological disorders, we have developed a computational framework that can be easily extended to explore its healing potential against other diseases and can also be applied to scrutinize other indigenous herbs for drug-design studies.", {"entities": []}], ["The pathogenesis of Kawasaki disease (KD) is commonly ascribed to an exaggerated immunologic response to an unidentified environmental or infectious trigger in susceptible children.", {"entities": []}], ["A comprehensive framework linking epidemiological data and global distribution of KD has not yet been proposed.", {"entities": []}], ["Patients with KD (n = 81) were enrolled within 6 weeks of diagnosis along with control subjects (n = 87).", {"entities": []}], ["All completed an extensive epidemiological questionnaire.", {"entities": []}], ["Geographic localization software characterized the subjects\u2019 neighborhood.", {"entities": []}], ["KD incidence was compared to atmospheric biological particles counts and winds patterns.", {"entities": []}], ["These data were used to create a comprehensive risk framework for KD, which we tested against published data on the global distribution.", {"entities": []}], ["Compared to controls, patients with KD were more likely to be of Asian ancestry and were more likely to live in an environment with low exposure to environmental allergens.", {"entities": []}], ["Higher atmospheric counts of biological particles other than fungus/spores were associated with a temporal reduction in incidence of KD.", {"entities": []}], ["Finally, westerly winds were associated with increased fungal particles in the atmosphere and increased incidence of KD over the Greater Toronto Area.", {"entities": []}], ["Our proposed framework was able to explain approximately 80% of the variation in the global distribution of KD.", {"entities": []}], ["The main limitations of the study are that the majority of data used in this study are limited to the Canadian context and our proposed disease framework is theoretical and circumstantial rather than the result of a single simulation.", {"entities": []}], ["Our proposed etiologic framework incorporates the 1) proportion of population that are genetically susceptible; 2) modulation of risk, determined by habitual exposure to environmental allergens, seasonal variations of atmospheric biological particles and contact with infectious diseases; and 3) exposure to the putative trigger.", {"entities": []}], ["Future modelling of individual risk and global distribution will be strengthened by taking into consideration all of these non-traditional elements.", {"entities": []}], ["Recent studies have demonstrated an association between short-term elevations in air pollution and an increased risk of exacerbating gastrointestinal disease.", {"entities": []}], ["The objective of the study was to evaluate if day-to-day increases in air pollution concentrations were positively associated with upper gastrointestinal bleeding (UGIB) secondary to peptic ulcer disease (PUD).", {"entities": [[183, 195, "DISEASE"]]}], ["A time-stratified case-crossover study design was used.", {"entities": []}], ["Adults presenting to hospitals with their first UGIB secondary to PUD from 2004\u20132010 were identified using administrative databases from Calgary ( n\u2009= \u20091374; discovery cohort) and Edmonton ( n\u2009= \u20091159; replication cohort).", {"entities": []}], ["Daily concentrations of ozone, nitrogen dioxide, sulfur dioxide, carbon monoxide, and particulate matter (PM 10 and PM 2.5 ) were estimated in these two cities.", {"entities": []}], ["Conditional logistic regression models were employed, adjusting for temperature and humidity.", {"entities": []}], ["Odds ratios (OR) with 95 % confidence intervals (CI) were expressed relative to an interquartile range increase in the concentration of each pollutant.", {"entities": []}], ["No statistically significant associations were observed for any of the individual pollutants based on same-day, or 1-day lag effects within the Calgary discovery cohort.", {"entities": []}], ["When the air pollution exposures were assessed as 3-, 5-, and 7-day averages, some pollutants were inversely associated with UGIB in the discovery cohort; for example, 5-day averages of nitrogen dioxide (OR\u2009=\u20090.68; 95 % CI: 0.53\u20130.88), and particulate matter <2.5 \u03bcm (OR\u2009=\u20090.75; 95 % CI: 0.61\u20130.90).", {"entities": []}], ["However, these findings could not be reproduced in the replication cohort.", {"entities": []}], ["Our findings suggest that short-term elevations in the level of ambient air pollutants does not increase the incidence of UGIB secondary to PUD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12876-015-0363-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Hospitalizations and deaths attributed to asthma are increasing, and the disease has disproportionate impacts on children and minority populations, particularly African-Americans.", {"entities": [[42, 48, "DISEASE"]]}], ["Because asthma hospitalizations and deaths are viewed by many experts as preventable events, and because asthma's toll is so significant in economic terms, increased efforts to reverse these trends, particularly among the most affected groups, are warranted.", {"entities": [[8, 14, "DISEASE"], [105, 111, "DISEASE"]]}], ["Reducing exposures to airborne pollutants known to trigger asthma in both indoor and outdoor environments is one important preventive strategy.", {"entities": [[59, 65, "DISEASE"]]}], ["The public-private partnership effort to implement the Open Airways for Schools asthma management curriculum in urban elementary schools, with its emphasis on pollution prevention, is an example of a community-based effort that may help decrease the toll asthma takes on society.", {"entities": [[80, 86, "DISEASE"], [255, 261, "DISEASE"]]}], ["To clarify the relationship between asthma\u2013chronic obstructive pulmonary disease overlap syndrome (ACOS) and depression.", {"entities": [[43, 80, "DISEASE"], [89, 97, "DISEASE"], [36, 42, "DISEASE"]]}], ["We identified 10,911 patients who received an ACOS diagnosis and concurrent treatment between January 2000 and December 2009.", {"entities": []}], ["Subjects without ACOS were included in the non-ACOS cohort ( n = 10,911).", {"entities": []}], ["Cox proportional hazard regression analysis was performed to compare the risk of depression between the ACOS and non-ACOS cohorts.", {"entities": []}], ["The risk of depression was higher in the ACOS cohort than in the non-ACOS cohort (adjusted hazard ratios (aHRs) = 1.67, 95% confidence interval [CI] = 1.48\u20131.88).", {"entities": []}], ["In the ACOS cohort, the aHRs for depression were [2.44 (95% CI = 1.45\u20134.11); 2.36 (95% CI = 1.58\u20133.52)] in patients [aged 20\u201339 years; without comorbidity].", {"entities": []}], ["In the ACOS cohort, the aHRs for depression were 1.70 (95% CI = 1.51\u20131.93) and 1.84 (95% CI = 1.55\u20132.19) in patients without inhaled corticosteroids (ICSs) and oral steroids (OSs) use, respectively.", {"entities": []}], ["Moreover, the aHRs for the risk of depression were 1.16 (95% CI = 0.95\u20131.41) and 1.12 (95% CI = 0.96\u20131.29) in patients with ICSs and OSs use, respectively.", {"entities": []}], ["The risk of depression is higher in ACOS patients, even in those without comorbidities or in young adults.", {"entities": []}], ["The events of the depression were not significant difference in patients receiving the ICSs/OSs between the ACOS and the non-ACOS cohorts.", {"entities": []}], ["Despite a regional decline in influenza A(H1N1)pdm09 virus infections during 2013\u201314, cases at a Florida hospital were more severe than those during 2009\u201310.", {"entities": [[30, 39, "DISEASE"]]}], ["Examined strains had a hemagglutinin polymorphism associated with enhanced binding to lower respiratory tract receptors.", {"entities": []}], ["Genetic changes in this virus must be monitored to predict the effect of future pandemic viruses.", {"entities": []}], ["Background .", {"entities": []}], ["In the fall of 2014, a North American outbreak of enterovirus D68 resulted in a significant number of pediatric hospital admissions for respiratory illness throughout North America.", {"entities": []}], ["This study characterized the clinical presentation and risk factors for a severe clinical course in children admitted to British Columbia Children's Hospital during the 2014 outbreak.", {"entities": []}], ["Retrospective chart review of patients with confirmed EV-D68 infection admitted to BCCH with respiratory symptoms in the fall of 2014.", {"entities": []}], ["Past medical history, clinical presentation, management, and course in hospital was collected and analyzed using descriptive statistics.", {"entities": []}], ["Comparison was made between those that did and did not require ICU admission to identify risk factors.", {"entities": []}], ["Thirty-four patients were included (median age 7.5 years).", {"entities": []}], ["Fifty-three percent of children had a prior history of wheeze, 32% had other preexisting medical comorbidities, and 15% were previously healthy.", {"entities": []}], ["Ten children (29%) were admitted to the pediatric intensive care unit.", {"entities": []}], ["The presence of complex medical conditions (excluding wheezing) ( P = 0.03) and copathogens was associated with PICU admission ( P = 0.02).", {"entities": []}], ["Conclusions .", {"entities": []}], ["EV-D68 infection resulted in severe, prolonged presentations of asthma-like illness in the hospitalized pediatric population.", {"entities": [[64, 70, "DISEASE"]]}], ["Patients with a prior history of wheeze and preexisting medical comorbidities appear to be most severely affected, but the virus can also cause wheezing in previously well children.", {"entities": []}], ["A disintegrin and metalloprotease 10 (ADAM10) is a ubiquitously expressed transmembrane metalloprotease that cleaves the extracellular regions from its transmembrane substrates.", {"entities": [[38, 44, "GENE"]]}], ["ADAM10 is essential for embryonic development and is implicated in cancer, Alzheimer, and inflammatory diseases.", {"entities": [[67, 73, "DISEASE"], [0, 6, "GENE"]]}], ["The tetraspanins are a superfamily of 33 four-transmembrane proteins in mammals, of which the TspanC8 subgroup (Tspan5, 10, 14, 15, 17, and 33) promote ADAM10 intracellular trafficking and enzymatic maturation.", {"entities": [[112, 118, "GENE"], [152, 158, "GENE"]]}], ["However, the interaction between TspanC8s and ADAM10 has only been demonstrated in overexpression systems and the interaction mechanism remains undefined.", {"entities": [[46, 52, "GENE"]]}], ["To address these issues, an antibody was developed to Tspan14, which was used to show co-immunoprecipitation of Tspan14 with ADAM10 in primary human cells.", {"entities": [[54, 61, "GENE"], [112, 119, "GENE"], [54, 61, "GENE"], [112, 119, "GENE"], [125, 131, "GENE"]]}], ["Chimeric Tspan14 constructs demonstrated that the large extracellular loop of Tspan14 mediated its co-immunoprecipitation with ADAM10, and promoted ADAM10 maturation and trafficking to the cell surface.", {"entities": [[9, 16, "GENE"], [78, 85, "GENE"], [9, 16, "GENE"], [78, 85, "GENE"], [127, 133, "GENE"], [148, 154, "GENE"], [127, 133, "GENE"], [148, 154, "GENE"]]}], ["Chimeric ADAM10 constructs showed that membrane-proximal stalk, cysteine-rich, and disintegrin domains of ADAM10 mediated its co-immunoprecipitation with Tspan14 and other TspanC8s.", {"entities": [[9, 15, "GENE"], [106, 112, "GENE"], [9, 15, "GENE"], [106, 112, "GENE"], [154, 161, "GENE"]]}], ["This TspanC8-interacting region was required for ADAM10 exit from the endoplasmic reticulum.", {"entities": [[49, 55, "GENE"]]}], ["Truncated ADAM10 constructs revealed differential TspanC8 binding requirements for the stalk, cysteine-rich, and disintegrin domains.", {"entities": [[10, 16, "GENE"]]}], ["Moreover, Tspan15was the only TspanC8 to promote cleavage of the ADAM10 substrate N-cadherin, whereas Tspan14 was unique in reducing cleavage of the platelet collagen receptor GPVI.", {"entities": [[65, 71, "GENE"], [102, 109, "GENE"]]}], ["These findings suggest that ADAM10 may adopt distinct conformations in complex with different TspanC8s, which could impact on substrate selectivity.", {"entities": [[28, 34, "GENE"]]}], ["Furthermore, this study identifies regions of TspanC8s and ADAM10 for potential interaction-disrupting therapeutic targeting.", {"entities": [[59, 65, "GENE"]]}], ["The posttranslational modification of proteins by the ubiquitination pathway is an important regulatory mechanism in eukaryotes.", {"entities": []}], ["To date, however, studies on the evolutionary history of the proteins involved in this pathway have been restricted to E1 and E2 enzymes, whereas E3 studies have been focused mainly in metazoans and plants.", {"entities": []}], ["To have a wider perspective, here we perform a genomic survey of the HECT family of E3 ubiquitin-protein ligases, an important part of this posttranslational pathway, in genomes from representatives of all major eukaryotic lineages.", {"entities": []}], ["We classify eukaryotic HECTs and reconstruct, by phylogenetic analysis, the putative repertoire of these proteins in the last eukaryotic common ancestor (LECA).", {"entities": []}], ["Furthermore, we analyze the diversity and complexity of protein domain architectures of HECTs along the different extant eukaryotic lineages.", {"entities": []}], ["Our data show that LECA had six different HECTs and that protein expansion and N-terminal domain diversification shaped HECT evolution.", {"entities": []}], ["Our data reveal that the genomes of animals and unicellular holozoans considerably increased the molecular and functional diversity of their HECT system compared with other eukaryotes.", {"entities": []}], ["Other eukaryotes, such as the Apusozoa Thecanomas trahens or the Heterokonta Phytophthora infestans , independently expanded their HECT repertoire.", {"entities": []}], ["In contrast, plant, excavate, rhodophyte, chlorophyte, and fungal genomes have a more limited enzymatic repertoire.", {"entities": []}], ["Our genomic survey and phylogenetic analysis clarifies the origin and evolution of different HECT families among eukaryotes and provides a useful phylogenetic framework for future evolutionary studies of this regulatory pathway.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible and usually progressive.", {"entities": []}], ["Current guidelines, among which the Dutch, have so far based their management strategy mainly on lung function impairment as measured by FEV 1 , while it is well known that FEV 1 has a poor correlation with almost all features of COPD that matter to patients.", {"entities": [[137, 140, "GENE"], [173, 176, "GENE"], [137, 140, "GENE"], [173, 176, "GENE"]]}], ["Based on this discrepancy the GOLD 2011 update included symptoms and impact in their treatment algorithm proposal.", {"entities": []}], ["Health status measures capture both symptoms and impact and could therefore be used as a standardized way to capture the information a doctor could otherwise only collect by careful history taking and recording.", {"entities": []}], ["We hypothesize that a treatment algorithm that is based on a simple validated 10 item health status questionnaire, the Clinical COPD Questionnaire (CCQ), improves health status (as measured by SGRQ) and classical COPD outcomes like exacerbation frequency, patient satisfaction and health care utilization compared to usual care based on guidelines.", {"entities": []}], ["This hypothesis will be tested in a randomized controlled trial (RCT) following 330 patients for two years.", {"entities": []}], ["During this period general practitioners will receive treatment advices every four months that are based on the patient\u2019s health status (in half of the patients, intervention group) or on lung function (the remaining half of the patients, usual care group).", {"entities": []}], ["During the design process, the selection of outcomes and the development of the treatment algorithm were challenging.", {"entities": []}], ["This is discussed in detail in the manuscript to facilitate researchers in designing future studies in this changing field of implementation research.", {"entities": []}], ["Netherlands Trial Register, NTR2643", {"entities": []}], ["The Farnesoid X receptor (FXR) regulates bile salt, glucose and cholesterol homeostasis by binding to DNA response elements, thereby activating gene expression (direct transactivation).", {"entities": []}], ["FXR also inhibits the immune response via tethering to NF-\u03baB (tethering transrepression).", {"entities": []}], ["FXR activation therefore has therapeutic potential for liver and intestinal inflammatory diseases.", {"entities": []}], ["We aim to identify and develop gene-selective FXR modulators, which repress inflammation, but do not interfere with its metabolic capacity.", {"entities": []}], ["In a high-throughput reporter-based screen, mometasone furoate (MF) was identified as a compound that reduced NF-\u03baB reporter activity in an FXR-dependent manner.", {"entities": []}], ["MF reduced mRNA expression of pro-inflammatory cytokines, and induction of direct FXR target genes in HepG2-GFP-FXR cells and intestinal organoids was minor.", {"entities": []}], ["Computational studies disclosed three putative binding modes of the compound within the ligand binding domain of the receptor.", {"entities": []}], ["Interestingly, mutation of W469A residue within the FXR ligand binding domain abrogated the decrease in NF-\u03baB activity.", {"entities": []}], ["Finally, we show that MF-bound FXR inhibits NF-\u03baB subunit p65 recruitment to the DNA of pro-inflammatory genes CXCL2 and IL8 .", {"entities": [[111, 116, "GENE"], [121, 124, "GENE"]]}], ["Although MF is not suitable as selective anti-inflammatory FXR ligand due to nanomolar affinity for the glucocorticoid receptor, we show that separation between metabolic and anti-inflammatory functions of FXR can be achieved.", {"entities": []}], ["ANCA vasculitis encompasses several autoimmune conditions characterised by destruction of small vessels, inflammation of the respiratory tract and glomerulonephritis.", {"entities": [[147, 165, "DISEASE"], [5, 15, "DISEASE"]]}], ["Most patients harbour autoantibodies to myeloperoxidase (MPO) or proteinase 3 (PR3).", {"entities": [[57, 60, "GENE"]]}], ["Clinical and experimental data suggest that pathogenesis is driven by ANCA-mediated activation of neutrophils and monocytes.", {"entities": []}], ["We investigated a potential role for distinct monocyte subsets.", {"entities": []}], ["We found that the relative proportion of intermediate monocytes is increased in patients versus control individuals, and both MPO and PR3 are preferentially expressed on these cells.", {"entities": [[126, 129, "GENE"]]}], ["We demonstrate that MPO and PR3 are expressed independently of each other on monocytes and that PR3 is not associated with CD177.", {"entities": [[20, 23, "GENE"], [123, 128, "GENE"]]}], ["MPO expression correlates with that of Fc receptor CD16 on intermediate monocytes.", {"entities": [[0, 3, "GENE"]]}], ["Monocyte subsets respond differently to antibodies directed against MPO and PR3, with anti-MPO but not anti-PR3 leading to increased IL-1\u03b2, IL-6 and IL-8 production.", {"entities": [[68, 71, "GENE"], [91, 94, "GENE"]]}], ["In concordance with the observed higher surface expression of MPO on intermediate monocytes, this subset produces the highest quantity of IL-1\u03b2 in response to anti-MPO stimulation.", {"entities": [[62, 65, "GENE"], [164, 167, "GENE"]]}], ["These data suggest that monocytes, specifically, the intermediate subset, may play a role in ANCA vasculitis, and also indicate that substantial differences exist between the effect of anti-MPO and anti-PR3 antibodies on these cells.", {"entities": [[98, 108, "DISEASE"]]}], ["As care for preterm and low birth weight (LBW) infants improves in resource-limited settings, more infants are surviving the neonatal period.", {"entities": []}], ["Preterm and (LBW) infants are at high-risk of nutritional and medical comorbidities, yet little is known about their developmental outcomes in low-income countries.", {"entities": []}], ["This study evaluated the health, nutritional, and developmental status of preterm/LBW children at ages 1\u20133\u00a0years in Rwanda.", {"entities": []}], ["Cross-sectional study of preterm/LBW infants discharged between October 2011 and October 2013 from a hospital neonatal unit in rural Rwanda.", {"entities": []}], ["Gestational age and birth weight were gathered from hospital records to classify small for gestational age (SGA)\u00a0at birth and prematurity.", {"entities": []}], ["Children were located in the community for household assessments in November\u2013December 2014.", {"entities": []}], ["Caregivers reported demographics, health status, and child development using locally-adapted Ages and Stages Questionnaires (ASQ-3).", {"entities": []}], ["Anthropometrics were measured.", {"entities": []}], ["Bivariate associations with continuous ASQ-3 scores were conducted using Wilcoxon Rank Sum and Kruskal Wallis tests.", {"entities": []}], ["Of 158 eligible preterm/LBW children discharged from the neonatal unit, 86 (54.4%) were alive and located for follow-up.", {"entities": []}], ["Median birth weight was 1650\u00a0grams, median gestational age was 33\u00a0weeks, and 50.5% were SGA at birth.", {"entities": []}], ["At the time of household interviews, median age was 22.5\u00a0months, 46.5% of children had feeding difficulties and 39.5% reported signs of anemia.", {"entities": [[136, 142, "DISEASE"]]}], ["78.3% of children were stunted and 8.8% wasted.", {"entities": []}], ["67.4% had abnormal developmental screening.", {"entities": []}], ["Feeding difficulties ( p \u2009=\u20090.008), anemia symptoms ( p \u2009=\u20090.040), microcephaly ( p \u2009=\u20090.004), stunting ( p \u2009=\u20090.034), SGA ( p \u2009=\u20090.023), very LBW ( p \u2009=\u20090.043), lower caregiver education ( p \u2009=\u20090.001), and more children in the household ( p \u2009=\u20090.016) were associated with lower ASQ-3 scores.", {"entities": [[67, 79, "DISEASE"], [36, 42, "DISEASE"]]}], ["High levels of health, growth, and developmental abnormalities were seen in preterm/LBW children at age 1\u20133\u00a0years.", {"entities": []}], ["As we achieve necessary gains in newborn survival in resource-limited settings, follow-up and early intervention services are critical for ensuring high-risk children reach their developmental potential.", {"entities": []}], ["The online version of this article doi: (10.1186/s12887-017-0946-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Surgical and medical treatments of nasal obstruction are a common parts of otolaryngologist practice.", {"entities": []}], ["The definitive treatment of deviated nasal septum is septoplasty.", {"entities": []}], ["In this study was to evaluate the values of subjective parameters, and active anterior rhinomanometry parameters prior and three months after the septoplasty.", {"entities": []}], ["We analyzed the subjective parameters (\u201cNOSE\u201d scale), the active anterior rhinomanometry parameters according to International Committee on Standardization of Rhinomanometry, on 40 patients.", {"entities": []}], ["Thirty healthy adult volunteers participated belonged to the control group.", {"entities": []}], ["None of the patients or healthy volunteers had previous history of nasal surgery or active rhinological disease.", {"entities": []}], ["The post-operative improvement in symptoms of nasal obstruction obtained in 92,5% patients and improvement parameters of the active anterior rhinomanometry in 42,5% patients.", {"entities": []}], ["The correlation between the findings with rhinomanometry and subjective sensation of nasal patency remains uncertain.", {"entities": []}], ["There still seems to be only a limited argument for the use of rhinomanometry for quantifying surgical results.", {"entities": []}], ["Three months postoperative findings are very early results to interpret the permanent effects.", {"entities": []}], ["Hantavirus infections may cause severe and sometime life-threatening lung failure.", {"entities": []}], ["The pathogenesis is not fully known and there is an urgent need for effective treatment.", {"entities": []}], ["We aimed to investigate the association between pulmonary viral load and immune responses, and their relation to disease severity.", {"entities": []}], ["Bronchoscopy with sampling of bronchoalveolar lavage (BAL) fluid was performed in 17 patients with acute Puumala hantavirus infection and 16 healthy volunteers acting as controls.", {"entities": []}], ["Lymphocyte subsets, granzyme concentrations, and viral load were determined by flow cytometry, enzyme-linked immunosorbent assay (ELISA), and quantitative reverse transcription polymerase chain reaction (RT-PCR), respectively.", {"entities": []}], ["Analyses of BAL fluid revealed significantly higher numbers of activated CD8", {"entities": []}], ["Preterm birth is associated with altered angiogenesis and with increased risk of cardiovascular dysfunction and hypertension at adulthood.", {"entities": [[112, 124, "DISEASE"]]}], ["We previously demonstrated that in preterm newborns circulating cord blood endothelial progenitor cells (ECFC), responsible for angio/vasculogenesis, are reduced in number and display altered angiogenic properties.", {"entities": []}], ["Altered angiogenic function was associated with a decreased expression of pro-angiogenic genes, among which the AMOT gene which is a strong positive regulator of angiogenesis.", {"entities": [[112, 116, "GENE"]]}], ["Such dysregulation may be related to epigenetic factors.", {"entities": []}], ["In this study we analyse the methylation profiling of the AMOT gene during development, through a comparative analysis of the cord blood ECFC of preterm newborns and their term counterpart.", {"entities": [[58, 62, "GENE"]]}], ["We used both cloning-sequencing and pyrosequencing experiments to perform a comparative analysis of the DNA methylation profile of the promoter CpG island of AMOT gene in the cord blood ECFC of 16 preterm newborns (28\u201335 weeks gestational age-GA) and 15 term newborns (>37 weeks GA).", {"entities": [[158, 162, "GENE"]]}], ["Twenty nine clones (obtained from 2 term newborns) and forty clones (obtained from 3 preterm newborns) were sequenced.", {"entities": []}], ["The AMOT gene methylation rate was significantly higher in preterm compared to term newborns (4.5% versus 2.5% respectively: \u03c72 = 3.84; P = 1.8 10 These findings highlight importance of pro-angiogenic AMOT gene methylation in ECFC, suggesting that epigenetic mechanisms may control the regulation of angiogenesis during development.", {"entities": [[4, 8, "GENE"], [201, 205, "GENE"], [4, 8, "GENE"], [201, 205, "GENE"]]}], ["Therefore they pave the way to specific short term and long term complications of preterm birth by altered angiogenesis.", {"entities": []}], ["Hunter syndrome (mucopolysaccharidosis type II (MPS II)) is a rare metabolic disease that can severely compromise health, well-being and life expectancy.", {"entities": [[17, 38, "DISEASE"], [7, 15, "DISEASE"]]}], ["Little evidence has been published on the impact of MPS II on health-related quality of life (HRQL).", {"entities": []}], ["The objective of this study was to describe this impact using the Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS) questionnaire and a range of standard validated questionnaires previously used in paediatric populations.", {"entities": [[73, 81, "DISEASE"]]}], ["Clinical and demographic characteristics collected in a clinical trial and responses to four HRQL questionnaires completed both by patients and parents prior to enzyme replacement treatment were used.", {"entities": []}], ["The association between questionnaire scores and clinical function parameters were tested using Spearman rank-order correlations.", {"entities": []}], ["Results were compared to scores in other paediatric populations with chronic conditions obtained through a targeted literature search of published studies.", {"entities": []}], ["Overall, 96 male patients with MPS II and their parents were enrolled in the trial.", {"entities": []}], ["All parents completed the questionnaires and 53 patients above 12\u00a0years old also completed the self-reported versions.", {"entities": []}], ["Parents\u2019 and patients\u2019 responses were analysed separately and results were very similar.", {"entities": []}], ["Dysfunction according to the HS-FOCUS and the CHAQ was most pronounced in the physical function domains.", {"entities": []}], ["Very low scores were reported in the Self Esteem and Family Cohesion domains in the CHQ and HUI3 disutility values indicated a moderate impact.", {"entities": []}], ["Scores reported by patients and their parents were consistently lower than scores in the other paediatric populations identified (except the parent-reported Behaviour score); and considerably lower than normative values.", {"entities": []}], ["This study describes the impact on HRQL in patients with MPS II and provides a broader context by comparing it with that of other chronic paediatric diseases.", {"entities": []}], ["Physical function and the ability to perform day-to-day activities were the most affected areas and a considerable impact on the psychological aspects of patients\u2019 HRQL was also found, with a higher level of impairment across most dimensions (particularly Pain and Self Esteem) than that of other paediatric populations.", {"entities": []}], ["Such humanistic data provide increasingly important support for establishing priorities for health care spending, and as a component of health economic analysis.", {"entities": []}], ["To investigate the effect of regular paracetamol on bronchial hyper-responsiveness (BHR) and asthma control in adult asthma.", {"entities": [[93, 99, "DISEASE"], [117, 123, "DISEASE"]]}], ["Single research-based outpatient clinic.", {"entities": []}], ["94 adults with mild-to-moderate asthma received randomised treatment; 85 completed the study.", {"entities": [[32, 38, "DISEASE"]]}], ["Key inclusion criteria were age 18\u201365\u2005years, forced expiratory volume in 1\u2005s (FEV 1 ) >70% predicted, provocation concentration of methacholine causing a 20% reduction in FEV 1 (PC 20 ) between 0.125 and 16\u2005mg/mL.", {"entities": [[78, 81, "GENE"], [171, 174, "GENE"], [78, 81, "GENE"], [171, 174, "GENE"], [178, 180, "GENE"]]}], ["Key exclusion criteria included an asthma exacerbation within the previous 2\u2005months, current regular use of paracetamol, use of high-dose aspirin or non-steroidal anti-inflammatory drugs, current or past cigarette smoking >10 pack-years.", {"entities": [[35, 41, "DISEASE"]]}], ["In a 12-week randomised, double-blind, placebo-controlled, parallel-group study, participants received 12\u2005weeks of 1\u2005g paracetamol twice daily or placebo twice daily.", {"entities": []}], ["The primary outcome variable was BHR, measured as the PC 20 at week 12.", {"entities": [[54, 56, "GENE"]]}], ["Secondary outcome variables included FEV 1 , fractional exhaled nitric oxide (FeNO) and asthma control questionnaire (ACQ) score.", {"entities": [[88, 94, "DISEASE"], [37, 40, "GENE"]]}], ["At 12\u2005weeks, the mean (SD) logarithm base two PC 20 was 1.07 (2.36) in the control group (N=54) and 0.62 (2.09) in the paracetamol group (N=31).", {"entities": [[46, 48, "GENE"]]}], ["After controlling for baseline PC 20 , the mean difference (paracetamol minus placebo) was \u22120.48 doubling dose worsening in BHR in the paracetamol group (95% CI \u22121.28 to 0.32), p=0.24.", {"entities": [[31, 33, "GENE"]]}], ["There were no statistically significant differences (paracetamol minus placebo) in log FeNO (0.09 (95% CI \u22120.097 to 0.27)), FEV 1 (\u22120.07\u2005L (95% CI \u22120.15 to 0.01)) or ACQ score (\u22120.04 (95% CI \u22120.27 to 0.18)).", {"entities": [[124, 127, "GENE"]]}], ["There was no significant effect of paracetamol on BHR and asthma control in adults with mild-to-moderate asthma.", {"entities": [[58, 64, "DISEASE"], [105, 111, "DISEASE"]]}], ["However, the study findings are limited by low power and the upper confidence limits did not rule out clinically relevant adverse effects.", {"entities": []}], ["Australia New Zealand Clinical Trials Registry Number: NZCTR12609000551291.", {"entities": []}], ["Analysis of exhaled breath condensate (EBC) is a non-invasive method for studying the acidity (pH) of airway secretions in patients with inflammatory lung diseases.", {"entities": []}], ["To assess the reproducibility of EBC pH for two commercially available devices (portable RTube and non-portable ECoScreen) in healthy controls, patients with asthma or COPD, and subjects suffering from an acute cold with lower-airway symptoms.", {"entities": [[158, 164, "DISEASE"]]}], ["In addition, we assessed the repeatability in healthy controls.", {"entities": []}], ["EBC was collected from 40 subjects (n = 10 in each of the above groups) using RTube and ECoScreen.", {"entities": []}], ["EBC was collected from controls on two separate occasions within 5 days.", {"entities": []}], ["pH in EBC was assessed after degasification with argon for 20 min.", {"entities": []}], ["In controls, pH-measurements in EBC collected by RTube or ECoScreen showed no significant difference between devices (p = 0.754) or between days (repeatability coefficient RTube: 0.47; ECoScreen: 0.42) of collection.", {"entities": []}], ["A comparison between EBC pH collected by the two devices in asthma, COPD and cold patients also showed good reproducibility.", {"entities": [[60, 66, "DISEASE"]]}], ["No differences in pH values were observed between controls (mean pH 8.27; RTube) and patients with COPD (pH 7.97) or asthma (pH 8.20), but lower values were found using both devices in patients with a cold (pH 7.56; RTube, p < 0.01; ECoScreen, p < 0.05).", {"entities": [[117, 123, "DISEASE"]]}], ["We conclude that pH measurements in EBC collected by RTube and ECoScreen are repeatable and reproducible in healthy controls, and are reproducible and comparable in healthy controls, COPD and asthma patients, and subjects with a common cold.", {"entities": [[229, 240, "DISEASE"], [192, 198, "DISEASE"]]}], ["\u2018Clinically important deterioration\u2019 (CID) is a composite endpoint measuring worsening of the key clinical features of chronic obstructive pulmonary disease (COPD), namely lung function, patient-reported outcomes, and exacerbations.", {"entities": [[119, 156, "DISEASE"]]}], ["ACLIFORM and AUGMENT were two 24-week, randomized, double-blind, phase III studies assessing twice-daily (BID) aclidinium bromide (AB) 400\u00a0\u03bcg/formoterol fumarate (FF) 12\u00a0\u03bcg.", {"entities": []}], ["This pooled post-hoc analysis assessed the effects of AB/FF 400/12\u00a0\u03bcg on both first and sustained CID events versus placebo and monotherapies in patients with moderate to severe COPD.", {"entities": []}], ["A first CID event was defined as the occurrence of a moderate/severe exacerbation or the worsening from baseline in \u22651 of the following: trough forced expiratory volume in 1\u00a0second (FEV 1 ; \u2265100\u00a0mL), Transition Dyspnea Index (TDI) focal score (\u22651 unit), or St George\u2019s Respiratory Questionnaire (SGRQ) total score (\u22654 units).", {"entities": [[182, 185, "GENE"]]}], ["A \u2018sustained\u2019 CID was defined as a worsening maintained at all subsequent visits from appearance to week 24 or a moderate/severe exacerbation at any time.", {"entities": []}], ["CID events were assessed at three visits (weeks 4, 12, and 24); trough FEV 1 was also measured at weeks 1 and 18.", {"entities": [[71, 74, "GENE"]]}], ["AB/FF 400/12\u00a0\u03bcg reduced the risk of a first CID event by 45% versus placebo (hazard ratio [HR] 0.55, p \u2009<\u20090.001), 18% versus FF 12\u00a0\u03bcg (HR 0.82, p \u2009<\u20090.01), and 15% versus AB 400\u00a0\u03bcg (HR 0.85, p \u2009<\u20090.05).", {"entities": [[91, 93, "GENE"], [135, 137, "GENE"], [182, 184, "GENE"], [91, 93, "GENE"], [135, 137, "GENE"], [182, 184, "GENE"], [91, 93, "GENE"], [135, 137, "GENE"], [182, 184, "GENE"]]}], ["Similarly, AB/FF 400/12\u00a0\u03bcg reduced the risk of a sustained CID event by 48% versus placebo (HR 0.52, p \u2009<\u20090.001) and 22% versus FF 12\u00a0\u03bcg (HR 0.78, p \u2009<\u20090.01).", {"entities": [[92, 94, "GENE"], [138, 140, "GENE"], [92, 94, "GENE"], [138, 140, "GENE"]]}], ["AB/FF 400/12\u00a0\u03bcg reduced the risk of a first or sustained CID event for all four components versus placebo (trough FEV 1 and TDI, first and sustained CID, all p \u2009<\u20090.001; SGRQ first CID p \u2009<\u20090.001; SGRQ sustained CID, p \u2009<\u20090.01; exacerbations first and sustained CID, both p \u2009<\u20090.05) and TDI and SGRQ versus FF 12\u00a0\u03bcg (TDI, first and sustained CID both p \u2009<\u20090.05; SGRQ first CID p \u2009<\u20090.01), and SGRQ versus AB 400\u00a0\u03bcg (first CID, p \u2009<\u20090.05).", {"entities": [[114, 117, "GENE"]]}], ["AB/FF 400/12\u00a0\u03bcg BID may provide greater airway stability and fewer exacerbations or deteriorations in lung function, health status, or dyspnea compared with placebo or monotherapies.", {"entities": []}], ["Clinicaltrials.gov NCT01462942 (ACLIFORM); registered 26 October 2011.", {"entities": []}], ["Clinicaltrials.gov NCT01437397 (AUGMENT); registered 19 September 2011.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0583-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Globally, more than 20% of women of reproductive age are currently estimated to be obese.", {"entities": []}], ["Children born to obese mothers are at higher risk of developing obesity, coronary heart disease, diabetes, stroke, and asthma in adulthood.", {"entities": [[82, 95, "DISEASE"], [73, 95, "DISEASE"], [64, 71, "DISEASE"], [119, 125, "DISEASE"]]}], ["Increasing clinical and experimental evidence suggests that maternal obesity also affects the health and function of the offspring brain across the lifespan.", {"entities": [[69, 76, "DISEASE"]]}], ["This review summarizes the current findings from human and animal studies that detail the impact of maternal obesity on aspects of learning, memory, motivation, affective disorders, attention-deficit hyperactivity disorder, autism spectrum disorders, and neurodegeneration in the offspring.", {"entities": [[109, 116, "DISEASE"]]}], ["Epigenetic mechanisms that may contribute to this mother\u2013child interaction are also discussed.", {"entities": []}], ["Staphylococcus aureus ( S. aureus ) is a Gram positive bacterium that is carried by about one third of the general population and is responsible for common and serious diseases.", {"entities": []}], ["These diseases include food poisoning and toxic shock syndrome, which are caused by exotoxins produced by S. aureus .", {"entities": [[54, 62, "DISEASE"], [42, 62, "DISEASE"]]}], ["Of the more than 20 Staphylococcal enterotoxins, SEA and SEB are the best characterized and are also regarded as superantigens because of their ability to bind to class II MHC molecules on antigen presenting cells and stimulate large populations of T cells that share variable regions on the \u03b2 chain of the T cell receptor.", {"entities": []}], ["The result of this massive T cell activation is a cytokine bolus leading to an acute toxic shock.", {"entities": []}], ["These proteins are highly resistant to denaturation, which allows them to remain intact in contaminated food and trigger disease outbreaks.", {"entities": []}], ["A recognized problem is the emergence of multi-drug resistant strains of S. aureus and these are a concern in the clinical setting as they are a common cause of antibiotic-associated diarrhea in hospitalized patients.", {"entities": [[183, 191, "DISEASE"]]}], ["In this review, we provide an overview of the current understanding of these proteins.", {"entities": []}], ["The S-stereoisomer found in racemic albuterol may have associated proinflammatory properties.", {"entities": []}], ["We tested the hypothesis that airway inflammation as assessed by exhaled nitric oxide is no different in patients with COPD when using racemic albuterol relative to levalbuterol or placebo.", {"entities": []}], ["Twelve mild to moderate COPD patients were assigned to five days each of nebulized racemic albuterol, levalbuterol, and saline placebo.", {"entities": []}], ["Before and after each course of treatment, airway inflammation was assessed via exhaled nitric oxide breath testing.", {"entities": []}], ["Secondary functional outcomes that were measured included spirometry, a functional assessment utilizing a six-minute walk, and symptoms score using the University of California, San Diego Shortness of Breath Questionnaire.", {"entities": []}], ["There was no statistically significant difference in pre and post FeNO levels within and between treatment groups (p = 0.121).", {"entities": []}], ["There were also no significant differences within or between treatment groups for the secondary outcome measurements of FEV 1 (p = 0.913), functional assessment utilizing a six-minute walk (p = 0.838) and the symptom scores using Shortness of Breath Questionnaire (p = 0.500).", {"entities": [[120, 123, "GENE"]]}], ["We found no difference in mild to moderate COPD patients treated with racemic albuterol, levalbuterol or placebo for measurement of exhaled nitric oxide or the secondary outcomes that were measured.", {"entities": []}], ["Asthma is one of the major chronic health problems in children in the Netherlands.", {"entities": [[0, 6, "DISEASE"]]}], ["The Pelican is a paediatric asthma-related quality of life instrument for children with asthma from 6\u201311\u2009years old, which is suitable for clinical practice in primary and specialized care.", {"entities": [[28, 34, "DISEASE"], [88, 94, "DISEASE"]]}], ["Based on this instrument, we developed a self-management treatment to improve asthma-related quality of life.", {"entities": [[78, 84, "DISEASE"]]}], ["The Pelican intervention will be investigated in different health care settings.", {"entities": []}], ["Results of intervention studies are often extrapolated to other health care settings than originally investigated.", {"entities": []}], ["Because of differences in organization, disease severity, patient characteristics and care provision between health care settings, extrapolating research results could lead to unnecessary health costs without the desired health care achievements.", {"entities": []}], ["Therefore, interventions have to be investigated in different health care settings when possible.", {"entities": []}], ["This study is an example of an intervention study in different health care settings.", {"entities": []}], ["In this article, we will present the study protocol of the Pelican study in primary and specialized care.", {"entities": []}], ["This study consists of two randomized controlled trials to assess the effectiveness of the Pelican intervention in primary and specialized care.", {"entities": []}], ["The trial in primary care is a multilevel design with 170 children with asthma in 16 general practices.", {"entities": [[72, 78, "DISEASE"]]}], ["All children in one general practices are allocated to the same treatment group.", {"entities": []}], ["The trial in specialized care is a multicentre trial with 100 children with asthma.", {"entities": [[76, 82, "DISEASE"]]}], ["Children in one outpatient clinic are randomly allocated to the intervention or usual care group.", {"entities": []}], ["In both trials, children will visit the care provider four times during a follow-up of nine months.", {"entities": []}], ["This study is registered and ethically approved.", {"entities": []}], ["This article describes the study protocol of the Pelican study in different health care settings.", {"entities": []}], ["If the Pelican intervention proves to be effective and efficient, implementation in primary and specialized care for paediatric asthma in the Netherlands will be recommended.", {"entities": [[128, 134, "DISEASE"]]}], ["This study is registered by clinicaltrial.gov (NCT01109745)", {"entities": []}], ["The adverse effects of traffic-related air pollution on children\u2019s respiratory health have been widely reported, but few studies have evaluated the impact of traffic-control policies designed to reduce urban air pollution.", {"entities": []}], ["We assessed associations between traffic-related air pollutants and respiratory/allergic symptoms amongst 8\u20139 year-old schoolchildren living within the London Low Emission Zone (LEZ).", {"entities": []}], ["Information on respiratory/allergic symptoms was obtained using a parent-completed questionnaire and linked to modelled annual air pollutant concentrations based on the residential address of each child, using a multivariable mixed effects logistic regression analysis.", {"entities": []}], ["Exposure to traffic-related air pollutants was associated with current rhinitis: NOx (OR 1.01, 95% CI 1.00\u20131.02), NO 2 (1.03, 1.00\u20131.06), PM 10 (1.16, 1.04\u20131.28) and PM 2.5 (1.38, 1.08\u20131.78), all per \u03bcg/m", {"entities": [[71, 79, "DISEASE"]]}], ["Both air pollution exposure and the presence of mental illness are associated with an increased risk of physical illness.", {"entities": []}], ["To determine whether or not children with less favourable mental health are more susceptible to pulmonary and cardiovascular effects of ambient air pollution, compared to those who are mentally healthy.", {"entities": []}], ["We carried out a cross-sectional study of 1,883 children between the ages of 6 and 17 years of age who participated in the Canadian Health Measures population survey between 2007 and 2009.", {"entities": []}], ["Subjects were assigned the air pollution values obtained from the National Air Pollution monitor closest to their neighborhood.", {"entities": []}], ["Lung function, heart rate and blood pressure were stratified by indicators of mental health.", {"entities": []}], ["The latter were ascertained by questions about feelings of happiness, a diagnosed mood disorder, and the emotional symptom subscale of the Strengths and Difficulties Questionnaire.", {"entities": [[82, 95, "DISEASE"]]}], ["Among those who reported a mood disorder, an interquartile increase in ozone was associated with increases in systolic and diastolic pressures of 3.8 mmHg (95% CI 1.6, 5.9) and 3.0mmHg (95%CI 0.9, 5.2) respectively, and a decreases in FVC of 7.6% (95% CI 2.9, 12.3).", {"entities": [[27, 40, "DISEASE"]]}], ["No significant changes in these variables were observed in those who did not report a mood disorder.", {"entities": [[86, 99, "DISEASE"]]}], ["Among those with unfavourable emotional symptoms, ozone was associated with a 6.4% (95% CI 1.7, 11.3) increase in heart rate, a 4.1% (95%CI 1.2, 7.1) increase in systolic blood pressure, and a 6.0% (95% CI 1.4, 10.6) decrease in FEV l .", {"entities": [[229, 232, "GENE"]]}], ["No significant effect was seen in these variables among those with no emotional symptoms.", {"entities": []}], ["In the Canadian population, children who report mood disorders or unfavourable emotional symptoms appear to be more vulnerable to the adverse physiologic effects of air pollution.", {"entities": []}], ["Surgical site infections (SSIs) are wound infections that occur after an operative procedure.", {"entities": []}], ["A preventable complication, they are costly and associated with poorer patient outcomes, increased mortality, morbidity and reoperation rates.", {"entities": []}], ["Surgical wound irrigation is an intraoperative technique, which may reduce the rate of SSIs through removal of dead or damaged tissue, metabolic waste, and wound exudate.", {"entities": []}], ["Irrigation can be undertaken prior to wound closure or postoperatively.", {"entities": []}], ["Intracavity lavage is a similar technique used in operations that expose a bodily cavity; such as procedures on the abdominal cavity and during joint replacement surgery.", {"entities": []}], ["To assess the effects of wound irrigation and intracavity lavage on the prevention of surgical site infection (SSI).", {"entities": []}], ["In February 2017 we searched the Cochrane Wounds Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL); Ovid MEDLINE; Ovid Embase and EBSCO CINAHL Plus.", {"entities": []}], ["We also searched three clinical trials registries and references of included studies and relevant systematic reviews.", {"entities": []}], ["There were no restrictions on language, date of publication or study setting.", {"entities": []}], ["We included all randomised controlled trials (RCTs) of participants undergoing surgical procedures in which the use of a particular type of intraoperative washout (irrigation or lavage) was the only systematic difference between groups, and in which wounds underwent primary closure.", {"entities": []}], ["The primary outcomes were SSI and wound dehiscence.", {"entities": []}], ["Secondary outcomes were mortality, use of systemic antibiotics, antibiotic resistance, adverse events, re-intervention, length of hospital stay, and readmissions.", {"entities": []}], ["Two review authors independently assessed studies for inclusion at each stage.", {"entities": []}], ["Two review authors also undertook data extraction, assessment of risk of bias and GRADE assessment.", {"entities": []}], ["We calculated risk ratios or differences in means with 95% confidence intervals where possible.", {"entities": []}], ["We included 59 RCTs with 14,738 participants.", {"entities": []}], ["Studies assessed comparisons between irrigation and no irrigation, between antibacterial and non-antibacterial irrigation, between different antibiotics, different antiseptics or different non-antibacterial agents, or between different methods of irrigation delivery.", {"entities": []}], ["No studies compared antiseptic with antibiotic irrigation.", {"entities": []}], ["Surgical site infection Irrigation compared with no irrigation (20 studies; 7192 participants): there is no clear difference in risk of SSI between irrigation and no irrigation (RR 0.87, 95% CI 0.68 to 1.11; I Antibacterial irrigation compared with non-antibacterial irrigation (36 studies, 6163 participants): there may be a lower incidence of SSI in participants treated with antibacterial irrigation compared with non-antibacterial irrigation (RR 0.57, 95% CI 0.44 to 0.75; I Comparison of irrigation of two agents of the same class (10 studies; 2118 participants): there may be a higher incidence of SSI in participants treated with povidone iodine compared with superoxidised water (Dermacyn) (RR 2.80, 95% CI 1.05 to 7.47; low-certainty evidence from one study, 190 participants).", {"entities": []}], ["This would represent an absolute difference of 95 more SSIs per 1000 people treated with povidone iodine than with superoxidised water (95% CI 3 more to 341 more).", {"entities": []}], ["All other comparisons found low- or very low-certainty evidence of no clear difference between groups.", {"entities": []}], ["Comparison of two irrigation techniques: two studies compared standard (non-pulsed) methods with pulsatile methods.", {"entities": []}], ["There may, on average, be fewer SSIs in participants treated with pulsatile methods compared with standard methods (RR 0.34, 95% CI 0.19 to 0.62; I Wound dehiscence Few studies reported wound dehiscence.", {"entities": []}], ["No comparison had evidence for a difference between intervention groups.", {"entities": []}], ["This included comparisons between irrigation and no irrigation (one study, low-certainty evidence); antibacterial and non-antibacterial irrigation (three studies, very low-certainty evidence) and pulsatile and standard irrigation (one study, low-certainty evidence).", {"entities": []}], ["Secondary outcomes Few studies reported outcomes such as use of systemic antibiotics and antibiotic resistance and they were poorly and incompletely reported.", {"entities": []}], ["There was limited reporting of mortality; this may have been partially due to failure to specify zero events in participants at low risk of death.", {"entities": []}], ["Adverse event reporting was variable and often limited to individual event types.", {"entities": []}], ["The evidence for the impact of interventions on length of hospital stay was low or moderate certainty; where differences were seen they were too small to be clinically important.", {"entities": []}], ["The evidence base for intracavity lavage and wound irrigation is generally of low certainty.", {"entities": []}], ["Therefore where we identified a possible difference in the incidence of SSI (in comparisons of antibacterial and non-antibacterial interventions, and pulsatile versus standard methods) these should be considered in the context of uncertainty, particularly given the possibility of publication bias for the comparison of antibacterial and non-antibacterial interventions.", {"entities": []}], ["Clinicians should also consider whether the evidence is relevant to the surgical populations under consideration, the varying reporting of other prophylactic antibiotics, and concerns about antibiotic resistance.", {"entities": []}], ["We did not identify any trials that compared an antibiotic with an antiseptic.", {"entities": []}], ["This gap in the direct evidence base may merit further investigation, potentially using network meta-analysis; to inform the direction of new primary research.", {"entities": []}], ["Any new trial should be adequately powered to detect a difference in SSIs in eligible participants, should use robust research methodology to reduce the risks of bias and internationally recognised criteria for diagnosis of SSI, and should have adequate duration and follow-up.", {"entities": []}], ["What is the aim of this review?", {"entities": []}], ["The aim of this review was to find out whether intracavity lavage and wound irrigation (washing out a wound during surgery) can help to prevent surgical site infection (SSI).", {"entities": []}], ["Researchers from Cochrane collected and analysed all relevant studies (randomised controlled trials) to answer this question and found 59 relevant studies.", {"entities": []}], ["Key messages The certainty of all the evidence we gathered on the effect of washing out wounds on SSIs was low or very low.", {"entities": []}], ["This was due to problems with how results were reported, some small sample sizes and concern that not all relevant evidence was published.", {"entities": []}], ["This means that the true effects of treatments may be substantially different from our results.", {"entities": []}], ["Washing out surgical wounds may make no clear difference to SSI rates compared with not washing out.", {"entities": []}], ["Using antibacterial solutions to wash out wounds may reduce infection rates compared with non-antibacterial products.", {"entities": []}], ["Pumping the washing solution into the wound may reduce infections compared with other methods of washing out.", {"entities": []}], ["Side effects were not well reported.", {"entities": []}], ["What was studied in the review?", {"entities": []}], ["Infections can often develop in wounds following surgery.", {"entities": []}], ["This can prevent the wound from healing and can lead to infection spreading through the body.", {"entities": []}], ["People with SSIs spend longer in hospital and are more likely to need a repeat operation.", {"entities": []}], ["Techniques used to reduce the risk of infection include intracavity lavage or wound irrigation (washing out the wound during surgery using water or medicated solutions).", {"entities": []}], ["We wanted to find out if this reduced SSI rates, and improved wound healing.", {"entities": []}], ["We also wanted to find out about serious consequences such as severe infections that cannot be treated with antibiotics, abscesses, and lengthy hospital stays.", {"entities": []}], ["What are the main results of the review?", {"entities": []}], ["We found 59 studies involving 14,738 participants (both adults and children).", {"entities": []}], ["Some studies enrolled only women because of the type of surgery (e.g.", {"entities": []}], ["caesarean sections).", {"entities": []}], ["The studies compared washing out wounds with no treatment, antibacterial and non-antibacterial washing solutions, and different methods of washing.", {"entities": []}], ["Follow-up times ranged from a few days to several months but most were between two and eight weeks.", {"entities": []}], ["Most studies did not state how they were funded, but when funding was reported it was mostly non-commercial.", {"entities": []}], ["Twenty studies involving 7192 participants compared washing out with no washing.", {"entities": []}], ["The results showed no clear difference in SSI rates (low-certainty evidence).", {"entities": []}], ["Antibacterial washing solutions may reduce infection rates compared with non-antibacterial solutions (low-certainty evidence from 36 trials involving 6163 participants).", {"entities": []}], ["Two studies involving 484 participants compared standard washing methods (pouring using a jug or a syringe) with pumping or pulsing the washing solution.", {"entities": []}], ["There may be fewer SSIs when the solution is pumped into the wound (low-certainty evidence).", {"entities": []}], ["There may be fewer SSIs when a solution of povidone iodine is used compared with an alternative antiseptic (superoxidised water, Dermacyn) (low-certainty evidence from 1 trial with 190 participants).", {"entities": []}], ["The results for all other comparisons showed no clear differences or were very uncertain.", {"entities": []}], ["Wound reopening (dehiscence), infections, which are hard to treat with antibiotics, and deaths were not widely reported.", {"entities": []}], ["Washing out wounds may not affect the length of time people stay in hospital (low- or moderate-certainty evidence).", {"entities": []}], ["How up to date is this review?", {"entities": []}], ["We searched for studies that had been published up to February 2017.", {"entities": []}], ["Traditionally, CD4 IL-17 has now been described.", {"entities": [[15, 18, "GENE"]]}], ["The data suggest that IL-23 plays an important role in the differentiation of autoreactive pathogenic T cells.", {"entities": []}], ["Whether these IL-23\u2013induced Th IL-17 cells are a unique subset or are related to other Th subsets is discussed.", {"entities": []}], ["To assess clinical feasibility of low-attenuation cluster analysis in evaluation of chronic obstructive pulmonary disease (COPD).", {"entities": [[84, 121, "DISEASE"]]}], ["Subjects were 199 current and former cigarette smokers that underwent CT for quantification of COPD and had physiological measurements.", {"entities": []}], ["Quantitative CT (QCT) measurements included low-attenuation area percent (LAA%) (voxels \u2264 \u2212950 Hounsfield unit [HU]), and two-dimensional (2D) and three-dimensional D values of cluster analysis at three different thresholds of CT value (\u2212856, \u2212910, and \u2212950 HU).", {"entities": []}], ["Correlation coefficients between QCT measurements and physiological indices were calculated.", {"entities": []}], ["Multivariable analyses for percentage of predicted forced expiratory volume at one second (%FEV1) was performed including sex, age, body mass index, LAA%, and D value had the highest correlation coefficient with %FEV1 as independent variables.", {"entities": []}], ["These analyses were conducted in subjects including those with mild COPD (global initiative of chronic obstructive lung disease stage = 0\u2013II).", {"entities": [[103, 127, "DISEASE"], [115, 127, "DISEASE"]]}], ["LAA% had a higher correlation coefficient (-0.549, p < 0.001) with %FEV1 than D values in subjects while 2D D \u2212910HU (\u22120.350, p < 0.001) revealed slightly higher correlation coefficient than LAA% (\u22120.343, p < 0.001) in subjects with mild COPD.", {"entities": []}], ["Multivariable analyses revealed that LAA% and 2D D value \u2212910HU were significant independent predictors of %FEV1 in subjects and that only 2D D value \u2212910HU revealed a marginal p value (0.05) among independent variables in subjects with mild COPD.", {"entities": []}], ["Low-attenuation cluster analysis provides incremental information regarding physiologic severity of COPD, independent of LAA%, especially with mild COPD.", {"entities": []}], ["The aim of this study was to explore the prevalence, pattern, and social determinants of chronic conditions multimorbidity among chronic disease primary care patients in four Greater Mekong countries (Cambodia, Myanmar, Thailand, and Vietnam).", {"entities": []}], ["In a cross-sectional survey, chronic disease patients accessing primary care were recruited if they had been diagnosed with any of 21 chronic conditions in the past 12 months, and were interviewed with a structured questionnaire on anxiety, depression, alcohol use, tobacco use, dietary behaviour, physical activity, and quality of life.", {"entities": []}], ["The sample included 6236 public primary care patients (32.8% men and 67.2% women), with a mean age of 53.0 years (SD = 16.8).", {"entities": []}], ["From 21 chronic conditions, the three most common were hypertension (37.4%), depression (34.4%), and digestive diseases (32.0%).", {"entities": [[55, 67, "DISEASE"]]}], ["In all, 27.4% had one chronic condition, 28.6% had two, 22.4% had three, and 21.6% had four or more chronic conditions.", {"entities": []}], ["The percentage with the highest comorbidity was depression (47.3%), hypertension (43.4%), and digestive diseases (34.1%).", {"entities": [[68, 80, "DISEASE"]]}], ["The highest mean multimorbidity reported was for mental illness (4.44), kidney disease (4.11), and Parkinson\u2019s disease (4.10), and the lowest multimorbidity for epilepsy (2.43) and cancer (2.80).", {"entities": [[72, 86, "DISEASE"], [181, 187, "DISEASE"]]}], ["Compared to those who had only one chronic condition, being male, older age, lower education, and lower quality of life were associated with having two and three or more chronic conditions.", {"entities": []}], ["Multimorbidity is a prevalent problem among chronic condition primary care patients\u2014a finding with implications for health care delivery, management, and research.", {"entities": []}], ["Multimorbidity places a substantial burden on patients and the healthcare system, but few contemporary epidemiological data are available.", {"entities": []}], ["To describe the epidemiology of multimorbidity in adults in England, and quantify associations between multimorbidity and health service utilisation.", {"entities": []}], ["Retrospective cohort study, undertaken in England.", {"entities": []}], ["The study used a random sample of 403 985 adult patients (aged \u226518 years), who were registered with a general practice on 1 January 2012 and included in the Clinical Practice Research Datalink.", {"entities": []}], ["Multimorbidity was defined as having two or more of 36 long-term conditions recorded in patients\u2019 medical records, and associations between multimorbidity and health service utilisation (GP consultations, prescriptions, and hospitalisations) over 4 years were quantified.", {"entities": []}], ["In total, 27.2% of the patients involved in the study had multimorbidity.", {"entities": []}], ["The most prevalent conditions were hypertension (18.2%), depression or anxiety (10.3%), and chronic pain (10.1%).", {"entities": [[35, 47, "DISEASE"]]}], ["The prevalence of multimorbidity was higher in females than males (30.0% versus 24.4% respectively) and among those with lower socioeconomic status (30.0% in the quintile with the greatest levels of deprivation versus 25.8% in that with the lowest).", {"entities": []}], ["Physical\u2013mental comorbidity constituted a much greater proportion of overall morbidity in both younger patients (18\u201344 years) and those patients with a lower socioeconomic status.", {"entities": []}], ["Multimorbidity was strongly associated with health service utilisation.", {"entities": []}], ["Patients with multimorbidity accounted for 52.9% of GP consultations, 78.7% of prescriptions, and 56.1% of hospital admissions.", {"entities": []}], ["Multimorbidity is common, socially patterned, and associated with increased health service utilisation.", {"entities": []}], ["These findings support the need to improve the quality and efficiency of health services providing care to patients with multimorbidity at both practice and national level.", {"entities": []}], ["Eosinophils are present throughout the airway wall of asthmatics.", {"entities": []}], ["The nature of the interaction between human airway smooth muscle cells (ASMC) and eosinophils was investigated in this study.", {"entities": []}], ["We demonstrated, using light microscopy, that freshly isolated eosinophils from healthy donors rapidly attach to ASMC in vitro.", {"entities": []}], ["Numbers of attached eosinophils were highest at 2 h, falling to 50% of maximum by 20 h. Eosinophil attachment at 2 h was reduced to 72% of control by anti-VCAM-1, and to 74% at 20 h by anti-ICAM-1.", {"entities": []}], ["Pre-treatment of ASMC for 24h with TNF-alpha, 10 nM, significantly increased eosinophil adhesion to 149 and 157% of control after 2 and 20 h. These results provide evidence that eosinophil interactions with ASMC involve VCAM-1 and ICAM-1 and are modulated by TNF-alpha.", {"entities": []}], ["Many disease phenotypes are outcomes of the complicated interplay between multiple genes, and multiple phenotypes are affected by a single or multiple genotypes.", {"entities": []}], ["Therefore, joint analysis of multiple phenotypes and multiple markers has been considered as an efficient strategy for genome-wide association analysis, and in this work we propose an omnibus family-based association test for the joint analysis of multiple genotypes and multiple phenotypes.", {"entities": []}], ["The proposed test can be applied for both quantitative and dichotomous phenotypes, and it is robust under the presence of population substructure, as long as large-scale genomic data is available.", {"entities": []}], ["Using simulated data, we showed that our method is statistically more efficient than the existing methods, and the practical relevance is illustrated by application of the approach to obesity-related phenotypes.", {"entities": [[184, 191, "DISEASE"]]}], ["The proposed method may be more statistically efficient than the existing methods.", {"entities": []}], ["The application was developed in C++ and is available at the following URL: http://healthstat.snu.ac.kr/software/mfqls/ .", {"entities": []}], ["The objective was to determine the effectiveness of Doppler velocimetry results in the management of high-risk pregnancy.", {"entities": []}], ["This cohort study was conducted from January 2005 to December 2006 in Obstetrics and Gynecology Department of Alnoor Specialist Hospital, Makkah, Saudi Arabia.", {"entities": []}], ["A total of 200 high-risk pregnant women with gestational age >28 weeks were selected for the study and divided into group A (100) subjected to Doppler velocimetry and group B (100) without Doppler velocimetry.", {"entities": []}], ["Standard management protocols were followed in all cases.", {"entities": []}], ["The primary outcome measures were mode of delivery and gestational age at the time of delivery.", {"entities": []}], ["The secondary outcome measures were prenatal and neonatal complications.", {"entities": []}], ["Data were analyzed using SPSS version 16 (SPSS Inc., Chicago, IL, USA).", {"entities": []}], ["Preterm deliveries, preterm as well as full-term neonatal admissions were more frequent in group A than those in group B, i.e., (39% vs. 26%), (56% vs. 88%) (OR 0.2, 95% CI 0.04-0.7), and (30% vs. 57%) (OR 0.3, 95% CI 0.2-0.7), respectively.", {"entities": []}], ["Similarly preterm and full-term neonatal deaths were rare in group A than those in group B, i.e., (9% vs. 78%) (OR 0.1, 95% CI 0.02-0.7), and (6% vs. 29%) (OR 0.2, 95% CI 0.03-1.8), respectively.", {"entities": []}], ["Emergency caesarean section rate was rare in the subjects with normal Doppler than those with abnormal Doppler (48% vs. 100%) (OR 0.1, 95% CI 0.03-0.4) as well as in group B (48% vs. 82%) (OR 0.2, 95% CI 0.1-0.4).", {"entities": []}], ["Doppler studies in high-risk pregnancies are more beneficial in the management of perinatal as well as neonatal management.", {"entities": []}], ["Background.", {"entities": []}], ["Allergic diseases impair health-related quality of life (HR-QoL).", {"entities": []}], ["However, the relationship between airway inflammation and HR-QoL in patients with asthma and rhinitis has not been fully investigated.", {"entities": [[93, 101, "DISEASE"], [82, 88, "DISEASE"]]}], ["We explored whether the inflammation of upper and lower airways is associated with HR-QoL.", {"entities": []}], ["Twenty-two mild allergic asthmatics with concomitant rhinitis (10 males, 38 \u00b1 17 years) were recruited.", {"entities": [[53, 61, "DISEASE"]]}], ["The Rhinasthma was used to identify HR-QoL, and the Asthma Control Test (ACT) was used to assess asthma control.", {"entities": [[52, 58, "DISEASE"], [97, 103, "DISEASE"]]}], ["Subjects underwent lung function and exhaled nitric oxide (eNO) test, collection of exhaled breath condensate (EBC), and nasal wash.", {"entities": []}], ["The Rhinasthma Global Summary score (GS) was 25 \u00b1 11.", {"entities": []}], ["No relationships were found between GS and markers of nasal allergic inflammation (% eosinophils: r = 0.34, P = 0.24; ECP: r = 0.06, P = 0.87) or bronchial inflammation (pH of the EBC: r = 0.12, P = 0.44; bronchial NO: r = 0.27, P = 0.22; alveolar NO: r = 0.38, P = 0.10).", {"entities": []}], ["The mean ACT score was 18.", {"entities": []}], ["When subjects were divided into controlled (ACT \u2265 20) and uncontrolled (ACT < 20), the alveolar NO significantly correlated with GS in uncontrolled asthmatics ( r = 0.60, P = 0.04).", {"entities": []}], ["Conclusions.", {"entities": []}], ["Upper and lower airways inflammation appears unrelated to HR-QoL associated with respiratory symptoms.", {"entities": []}], ["These preliminary findings suggest that, in uncontrolled asthma, peripheral airway inflammation could be responsible for impaired HR-QoL.", {"entities": [[57, 63, "DISEASE"]]}], ["One of the most formidable questions facing the environmental health research community today is how to translate basic fundamental research into a product (e.g., disease outcome) that meets the needs of its stakeholders--the medical community, regulatory agencies, and ultimately, the citizens of our nation.", {"entities": []}], ["Historically, a successful research program could be defined as one that received continuous funding, produced high-quality publications, and was respected by scientists in related fields.", {"entities": []}], ["However, it is now apparent that this is not sufficient for attaining improved public health--the ultimate goal of these research efforts.", {"entities": []}], ["Research results must be transferred in a more active way to the communities and professionals who have need of this information.", {"entities": []}], ["The link must be recognized, and the roles of the stakeholders in the entire research process must be acknowledged to ensure full impact of the research endeavors.", {"entities": []}], ["Using the Internet to seek health information is becoming more common.", {"entities": []}], ["Its consequences on health care utilisation are hardly known in the general population, in particular among children whose parents seek health information on the Internet.", {"entities": []}], ["Our objective was to investigate the relationship between parental use of the Internet to seek health information and primary care utilisation for their child.", {"entities": []}], ["This cross-sectional survey has been carried out in a population of parents of pre-school children in France.", {"entities": []}], ["The main outcome measure was the self-reported number of primary care consultations for the child, according to parental use of the Internet to seek health information, adjusted for the characteristics of the parents and their child respectively, and parental use of other health information sources.", {"entities": []}], ["A total of 1 068 out of 2 197 questionnaires were returned (response rate of 49%).", {"entities": []}], ["No association was found between parental use of the Internet to seek health information and the number of consultations within the last 12 months for their child.", {"entities": []}], ["Variables related to the number of primary care consultations were characteristics of the child (age, medical conditions, homeopathic treatment), parental characteristics (occupation, income, stress level) and consultation of other health information sources (advice from pharmacist, relatives).", {"entities": []}], ["We did not find any relationship between parental use of the Internet to seek health information and primary care utilisation for children.", {"entities": []}], ["The Internet seems to be used as a supplement to health services rather than as a replacement.", {"entities": []}], ["Current management in primary care of depression, with or without comorbid physical illness, has been found to be suboptimal.", {"entities": []}], ["We therefore conducted a systematic review to identify clinician perceived barriers to and facilitators for good depression care.", {"entities": []}], ["We conducted a systematic literature search to identify qualitative and quantitative studies published in the UK since 2000 of GPs' and practice nurses' attitudes to the management of depression.", {"entities": []}], ["We used principles from meta-ethnography to identify common and refuted themes across studies.", {"entities": []}], ["We identified 7 qualitative and 10 quantitative studies; none concerned depression and co-morbid physical illness of any kind.", {"entities": []}], ["The studies of managing patients with a primary diagnosis of depression indicated that GPs and PNs are unsure of the exact nature of the relationship between mood and social problems and of their role in managing it.", {"entities": []}], ["Among some clinicians, ambivalent attitudes to working with depressed people, a lack of confidence, the use of a limited number of management options and a belief that a diagnosis of depression is stigmatising complicate the management of depression.", {"entities": []}], ["Detection and management of depression is considered complex.", {"entities": []}], ["In particular, primary care clinicians need guidance to address the social needs of depressed patients.", {"entities": []}], ["It is not known whether the same issues are important when managing depressed people with co-morbid physical illness.", {"entities": []}], ["Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory disorder of the gastrointestinal tract, and an impaired immune response plays a critical role in IBD.", {"entities": []}], ["The current drugs and therapies for IBD treatment are of limited use, therefore, there is a need to find novel drugs or therapies for this disease.", {"entities": []}], ["We investigated the effect of cambogin in a mouse model of dextran sulphate sodium (DSS)\u2010induced colitis and whether cambogin attenuates inflammation via a Treg\u2010cell\u2010mediated effect on the immune response.", {"entities": []}], ["Chronic colitis was established in mice using 2% DSS, and cambogin (10\u00a0mg\u00b7kg elisa and quantitative real\u2010time PCR.", {"entities": []}], ["To evaluate the mechanism of cambogin, human CD4 Cambogin attenuated diarrhoea, colon shortening and colon histological injury and IL\u20106, IFN\u2010\u03b3 and TNF\u2010\u03b1 production in DSS\u2010treated mice.", {"entities": [[45, 48, "GENE"]]}], ["Cambogin also up\u2010regulated Treg cell numbers in both the spleen and mesenteric lymph nodes.", {"entities": []}], ["Furthermore, cambogin (10\u00a0\u03bcM) prevented Foxp3 loss in human primary Treg cells in vitro , and promoted USP7\u2010mediated Foxp3 deubiquitination and increased Foxp3 protein expression in LPS\u2010treated cells.", {"entities": [[40, 45, "GENE"], [117, 122, "GENE"], [154, 159, "GENE"], [40, 45, "GENE"], [117, 122, "GENE"], [154, 159, "GENE"], [40, 45, "GENE"], [117, 122, "GENE"], [154, 159, "GENE"]]}], ["The effect of cambogin on DSS\u2010induced colitis is expedited by a Treg\u2010cell\u2010mediated modification of the immune response, suggesting that cambogin could be applied as a novel agent for treating colitis and other Treg cell\u2010related diseases.", {"entities": []}], ["This study examined the association between the type, and cumulative number of lifetime potentially traumatic events (PTEs), and chronic physical conditions, in a South African sample.", {"entities": []}], ["PTE exposures have been associated with an increased risk for a wide range of chronic physical conditions, but it is unclear whether psychiatric disorders mediate this association.", {"entities": []}], ["Given the established differences in trauma occurrence, and the epidemiology of posttraumatic stress disorder (PTSD) in South Africa relative to other countries, examining associations between PTEs and chronic physical conditions, particularly while accounting for psychiatric comorbidity is important.", {"entities": []}], ["Data were drawn from the South African Stress and Health Study, a cross-sectional population-representative study of psychological and physical health of South African adults.", {"entities": []}], ["Twenty-seven PTEs, based on the World Health Organization Composite International Diagnostic Interview Version 3.0, DSM-IV PTSD module were grouped into seven PTE types (war events, physical violence, sexual violence, accidents, unexpected death of a loved one, network events, and witnessing PTEs).", {"entities": []}], ["Five clusters of physical conditions (cardiovascular, arthritis, respiratory, chronic pain, and other health conditions) were examined.", {"entities": [[54, 63, "DISEASE"]]}], ["Logistic regressions assessed the odds of reporting a physical condition in relation to type and cumulative number of PTEs.", {"entities": []}], ["Cochran-Armitage test for trend was used to examine dose-response effect of cumulative PTEs on physical conditions.", {"entities": []}], ["After adjusting for sociodemographic variables and psychiatric disorders, respondents with any PTE had increased odds of all assessed physical conditions, ranging between 1.48 (95\u00a0% CI: 1.06\u20132.07) for arthritis and 2.07 (95\u00a0% CI: 1.57\u20132.73) for respiratory conditions, compared to those without PTE exposure.", {"entities": [[201, 210, "DISEASE"]]}], ["Sexual violence, physical violence, unexpected death of a loved one, and network PTEs significantly increased the odds of all or nearly all the physical conditions assessed.", {"entities": []}], ["There was a dose-response relationship between number of PTEs and increased odds of all physical conditions.", {"entities": []}], ["Results from this study, the first in an African general population, are consistent with other population-based studies; PTEs confer a broad-spectrum risk for chronic physical conditions, independent of psychiatric disorders.", {"entities": []}], ["These risks increase with each cumulative PTE exposure.", {"entities": []}], ["Clinically, comprehensive evaluations for risk of mental and physical health morbidities should be considered among PTE survivors.", {"entities": []}], ["Indigenous biocultural knowledge is a vital part of Nepalese environmental management strategies; however, much of it may soon be lost given Nepal\u2019s rapidly changing socio-ecological climate.", {"entities": []}], ["This is particularly true for knowledge surrounding parasitic and mycoheterotrophic plant species, which are well represented throughout the Central-Eastern Himalayas but lack a collated record.", {"entities": []}], ["Our study addresses this disparity by analyzing parasitic and mycoheterotrophic plant species diversity in Nepal as well as the ethnobotanical knowledge that surrounds them.", {"entities": []}], ["Botanical texts, online databases, and herbarium records were reviewed to create an authoritative compendium of parasitic and mycoheterotrophic plant species native or naturalized to the Nepal Central-Eastern Himalaya.", {"entities": []}], ["Semi-structured interviews were then conducted with 141 informants to better understand the biocultural context of these species, emphasizing ethnobotanical uses, in 12 districts of Central-Eastern Nepal.", {"entities": []}], ["Nepal is a hotspot of botanical diversity, housing 15 families and 29 genera of plants that exhibit parasitic or mycoheterotrophic habit.", {"entities": []}], ["Over 150 of the known 4500 parasitic plant species (~3\u00a0%) and 28 of the 160 mycoheterotrophic species (~18\u00a0%) are native or naturalized to Nepal; 13 of our surveyed parasitic species are endemic.", {"entities": []}], ["Of all species documented, approximately 17\u00a0% of parasitic and 7\u00a0% of mycoheterotrophic plants have ethnobotanical uses as medicine (41\u00a0%), fodder (23\u00a0%), food (17\u00a0%), ritual objects (11\u00a0%), or material (8\u00a0%).", {"entities": []}], ["Parasitic and mycoheterotrophic plant species exhibit high diversity in the Nepal Central-Eastern Himalaya and are the fodder for biocultural relationships that may help inform future environmental management projects in the region.", {"entities": []}], ["The online version of this article (doi:10.1186/s13002-016-0086-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Environmental factors such as diet, intake of vitamin D supplements and exposure to sunlight are known to influence serum vitamin D concentrations.", {"entities": []}], ["Genetic epidemiology of vitamin D is in its infancy and a better understanding on how genetic variation influences vitamin D concentration is needed.", {"entities": []}], ["We aimed to analyse previously reported vitamin D-related polymorphisms in relation to serum 25(OH)D concentrations in 201 healthy Danish families with dependent children in late summer in Denmark.", {"entities": []}], ["Serum 25(OH)D concentrations and a total of 25 SNPs in GC , VDR , CYP2R1 , CYP24A1 , CYP27B1 , C10or88 and DHCR7/NADSYN1 genes were analysed in 758 participants.", {"entities": [[55, 57, "GENE"], [60, 63, "GENE"], [66, 72, "GENE"], [75, 82, "GENE"], [85, 92, "GENE"]]}], ["Genotype distributions were in Hardy\u2013Weinberg equilibrium for the adult population for all the studied polymorphisms.", {"entities": []}], ["Four SNPs in CYP2R1 (rs1562902, rs7116978, rs10741657 and rs10766197) and six SNPs in GC (rs4588, rs842999, rs2282679, rs12512631, rs16846876 and rs17467825) were statistically significantly associated with serum 25(OH)D concentrations in children, adults and all combined.", {"entities": [[13, 19, "GENE"], [86, 88, "GENE"]]}], ["Several of the SNPs were in strong linkage disequilibrium, and the associations were driven by CYP2R1 -rs10741657 and rs10766197, and by GC -rs4588 and rs842999.", {"entities": [[95, 101, "GENE"], [137, 139, "GENE"]]}], ["Genetic risk score analysis showed that carriers with no risk alleles of CYP2R1 -rs10741657 and rs10766197, and/or GC rs4588 and rs842999 had significantly higher serum 25(OH)D concentrations compared to carriers of all risk alleles.", {"entities": [[73, 79, "GENE"], [115, 117, "GENE"]]}], ["To conclude, our results provide supporting evidence that common polymorphisms in GC and CYP2R1 are associated with serum 25(OH)D concentrations in the Caucasian population and that certain haplotypes may predispose to lower 25(OH)D concentrations in late summer in Denmark.", {"entities": [[82, 84, "GENE"], [89, 95, "GENE"]]}], ["The variation in the rate of intraoperative respiratory events (IRE) over time under anesthesia and the influence of anesthesia-related factors have not yet been described.", {"entities": []}], ["The objectives of this study were to describe the risk over time and the risk factors for IRE in children at a tertiary care hospital in southern Thailand.", {"entities": []}], ["The surveillance anesthetic database and chart review of IRE of 14,153 children who received surgery at Songklanagarind Hospital during January 2005 to December 2011 were used to obtain demographic, surgical and anesthesia-related data.", {"entities": []}], ["Incidence density of IRE per person-time was determined by a Poisson modelling.", {"entities": []}], ["Risk of IRE over time was displayed using Kaplan Meier survival and Nelson-Aalen curves.", {"entities": []}], ["Multivariate Cox regression was employed to identify independent predictors for IRE.", {"entities": []}], ["Adjusted hazard ratios (HR) and their 95% confidence intervals (CI) were obtained from the final Cox model.", {"entities": [[24, 26, "GENE"]]}], ["Overall, IRE occurred in 315 out of 14,153 children.", {"entities": []}], ["The number (%) of desaturation, wheezing or bronchospasm, laryngospasm, reintubation and upper airway obstruction were 235 (54%), 101 (23%), 75 (17%), 21 (5%) and 4 (1%) out of 315 IRE, respectively.", {"entities": []}], ["The incidence density per 100,000 person-minutes of IRE at the induction period (61.3) was higher than that in the maintenance (13.7) and emergence periods (16.5) (p\u2009<\u20090.001).", {"entities": []}], ["The risk of desaturation, wheezing and laryngospasm was highest during the first 15, 20 and 30\u00a0minutes of anesthesia, respectively.", {"entities": []}], ["After adjusting for age, history of respiratory disease and American Society of Anesthesiologist (ASA) classification, anesthesia-related risk factors for laryngospasm were assisted ventilation via facemask (HR: 18.1, 95% CI: 6.4-51.4) or laryngeal mask airway (HR: 12.5, 95% CI: 4.6-33.9) compared to controlled ventilation via endotracheal tube (p\u2009<\u20090.001), and desflurane (HR: 11.0, 95% CI: 5.1-23.9) compared to sevoflurane anesthesia (p\u2009<\u20090.001).", {"entities": [[208, 210, "GENE"], [262, 264, "GENE"], [376, 378, "GENE"], [208, 210, "GENE"], [262, 264, "GENE"], [376, 378, "GENE"], [208, 210, "GENE"], [262, 264, "GENE"], [376, 378, "GENE"]]}], ["IRE risk was highest in the induction and early maintenance period.", {"entities": []}], ["Assisted ventilation via facemask or LMA and desflurane anesthesia were anesthesia-related risk factors for laryngospasm.", {"entities": []}], ["Therefore, anesthesiologists should pay more attention during the induction and early maintenance period especially when certain airway devices incorporated with assisted ventilation or desflurane are used.", {"entities": []}], ["Background: Blacks have higher hypertension rates than whites, but the reasons for these disparities are unknown.", {"entities": [[31, 43, "DISEASE"]]}], ["Differential vulnerability, through which stress alters vulnerability to the effects of environmental hazards, is an emergent notion in environmental health that may contribute to these disparities.", {"entities": []}], ["Objectives: We examined whether blacks and whites exhibit different associations between blood lead (BPb) and blood pressure (BP) and whether depressive symptoms may play a role.", {"entities": []}], ["Methods: Using the National Health and Nutrition Examination Survey 2005\u20132008, we regressed BP on the three-way interaction among race/ethnicity, BPb, and depressive symptoms in blacks and whites \u2265 20 years of age.", {"entities": []}], ["Results: Blacks but not whites showed a positive association between BPb and systolic blood pressure (SBP).", {"entities": []}], ["The disparity in this association between blacks and whites appeared to be specific to the high depressive symptoms group.", {"entities": []}], ["In the low depressive symptoms group, there was no significant black\u2013white disparity (\u03b2 interaction = 0.9 mmHg; 95% CI: \u20130.9, 2.7).", {"entities": []}], ["However, of those with high depressive symptoms, blacks and whites had 5.6 mmHg (95% CI: 2.0, 9.2) and 1.2 mmHg (95% CI: \u20130.5, 2.9) increases in SBP, respectively, in association with each doubling of BPb (\u03b2 interaction = 4.4 mmHg; 95% CI: 0.5, 8.3).", {"entities": []}], ["The pattern of results was similar for diastolic blood pressure.", {"entities": []}], ["Conclusions: Our results suggest that depressive symptoms may contribute to the black\u2013white disparity in the association between BPb and BP.", {"entities": []}], ["Depressive symptoms may result, in part, from psychosocial stress.", {"entities": []}], ["Our results support the notion that stress increases vulnerability to the health effects of environmental hazards and suggest that stress-related vulnerability may be an important determinant of racial/ethnic health disparities.", {"entities": []}], ["Fibromyalgia syndrome (FMS), a common, chronic, widespread musculoskeletal pain disorder found in 2% of the general population and with a preponderance of 85% in females, has both genetic and environmental contributions.", {"entities": [[75, 88, "DISEASE"], [13, 21, "DISEASE"]]}], ["Patients and their parents have high plasma levels of the chemokines MCP-1 and eotaxin, providing evidence for both a genetic and an immunological/inflammatory origin for the syndrome (Zhang et al., 2008, Exp.", {"entities": [[175, 183, "DISEASE"]]}], ["233: 1171\u20131180).", {"entities": []}], ["In a search for a candidate gene affecting inflammatory pathways, among five screened in our patient samples (100 probands with FMS and their parents), we found 10 rare and one common alleles for MEFV , a gene in which various compound heterozygous mutations lead to Familial Mediterranean Fever (FMF).", {"entities": [[196, 200, "GENE"]]}], ["A total of 2.63 megabases of genomic sequence of the MEFV gene were scanned by direct sequencing.", {"entities": [[53, 57, "GENE"]]}], ["The collection of rare missense mutations (all heterozygotes and tested in the aggregate) had a significant elevated frequency of transmission to affecteds ( p \u200a=\u200a0.0085, one-sided, exact binomial test).", {"entities": []}], ["Our data provide evidence that rare missense variants of the MEFV gene are, collectively, associated with risk of FMS and are present in a subset of 15% of FMS patients.", {"entities": [[61, 65, "GENE"]]}], ["This subset had, on average, high levels of plasma IL-1\u03b2 (p\u200a=\u200a0.019) compared to FMS patients without rare variants, unaffected family members with or without rare variants, and unrelated controls of unknown genotype.", {"entities": []}], ["IL-1\u03b2 is a cytokine associated with the function of the MEFV gene and thought to be responsible for its symptoms of fever and muscle aches.", {"entities": [[56, 60, "GENE"]]}], ["Since misregulation of IL-1\u03b2 expression has been predicted for patients with mutations in the MEFV gene, we conclude that patients heterozygous for rare missense variants of this gene may be predisposed to FMS, possibly triggered by environmental factors.", {"entities": [[94, 98, "GENE"]]}], ["Scale invariance is a feature of complex biological systems, and abnormality of multi-scale behaviour may serve as an indicator of pathology.", {"entities": []}], ["The hypothalamic suprachiasmatic nucleus (SCN) is a major node in central neural networks responsible for regulating multi-scale behaviour in measures of human locomotor activity.", {"entities": []}], ["SCN also is implicated in the pathophysiology of bipolar disorder (BD) or manic-depressive illness, a severe, episodic disorder of mood, cognition and behaviour.", {"entities": [[49, 65, "DISEASE"]]}], ["Here, we investigated scaling behaviour in actigraphically recorded human motility data for potential indicators of BD, particularly its manic phase.", {"entities": []}], ["A proposed index of scaling behaviour ( Vulnerability Index [VI]) derived from such data distinguished between: [i] healthy subjects at high versus low risk of mood disorders; [ii] currently clinically stable BD patients versus matched controls; and [iii] among clinical states in BD patients.", {"entities": []}], ["Increasing the number of women birthing with skilled birth attendants (SBAs) as one of the strategies to reduce maternal mortality and morbidity must be partnered with a minimum standard of care.", {"entities": []}], ["This manuscript describes the quality of intrapartum care provided by SBAs in Mae La camp, a low resource, protracted refugee context on the Thai-Myanmar border.", {"entities": []}], ["In the obstetric department of Shoklo Malaria Research Unit (SMRU) the standardized WHO Safe Motherhood Needs Assessment tool was adapted to the setting and used: to assess the facility; interview SBAs; collect data from maternal records during a one year period (August 2007 \u2013 2008); and observe practice during labour and childbirth.", {"entities": []}], ["The facility assessment recorded no \u2018out of stock\u2019 or \u2018out of date\u2019 drugs and supplies, equipment was in operating order and necessary infrastructure e.g.", {"entities": []}], ["a stand-by emergency car, was present.", {"entities": []}], ["Syphilis testing was not available.", {"entities": []}], ["SBA interviews established that danger signs and symptoms were recognized except for sepsis and endometritis.", {"entities": [[96, 108, "DISEASE"]]}], ["All SBAs acknowledged receiving theoretical and \u2018hands-on\u2019 training and regularly attended deliveries.", {"entities": []}], ["Scores for the essential elements of antenatal care from maternal records were high (>90%) e.g.", {"entities": []}], ["providing supplements, recording risk factors as well as regular and correct partogram use.", {"entities": []}], ["Observed good clinical practice included: presence of a support person; active management of third stage; post-partum monitoring; and immediate and correct neonatal care.", {"entities": []}], ["Observed incorrect practice included: improper controlled cord traction; inadequate hand washing; an episiotomy rate in nulliparous women 49% (34/70) and low rates 30% (6/20) of newborn monitoring in the first hours following birth.", {"entities": []}], ["Overall observed complications during labour and birth were low with post-partum haemorrhage being the most common in which case the SBAs followed the protocol but were slow to recognize severity and take action.", {"entities": []}], ["In the clinic of SMRU in Mae La refugee camp, SBAs were able to comply with evidence-based guidelines but support to improve quality of care in specific areas is required.", {"entities": []}], ["The structure of the WHO Safe Motherhood Needs Assessment allowed significant insights into the quality of intrapartum care particularly through direct observation, identifying a clear pathway for quality improvement.", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-015-0444-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The purpose of this study was to investigate the change in plasma protein expression in first episode schizophrenia after an 8-week treatment with risperidone, and to explore potential biomarkers for metabolic side effects associated with risperidone treatment.", {"entities": [[102, 115, "DISEASE"]]}], ["Eighty first-episode schizophrenia patientswere enrolled in the study.", {"entities": [[21, 34, "DISEASE"]]}], ["Fifteen of the 80 patients were randomly selected to undergo proteomic analysis.", {"entities": []}], ["Plasma proteins were obtained before and after the 8-week risperidone treatment, and measured using two-dimensional gel electrophoresis (2-DE), Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry(MALDI-TOF/TOF) and peptide mass fingerprinting.Proteins with the highest fold changes after risperidone treatment were then measured for all 80 patients using enzyme linked immunosorbent assay (ELISA).", {"entities": []}], ["The relationship between changes in plasma protein levels and changes in metabolic parameters after risperidone treatment was examined.", {"entities": []}], ["In 15 randomly selected patients, approximately 1,500 protein spots were detected in each gel by 2-DE.", {"entities": []}], ["Of those proteins, 22 spots showed significant difference in abundance after risperidone treatment (p's<0.05).", {"entities": []}], ["After MALDI-TOF peptide mass fingerprinting, apolipoprotein A-I (APOA-I) and Guanine Nucleotide Binding Protein, Alpha Stimulating (GNAS), were found to have the highest fold changes.The content of APOA-I was significantly increased, and the content of GNAS was significantly decreased after risperidone treatment (p's<0.05).", {"entities": [[132, 136, "GENE"], [253, 257, "GENE"], [132, 136, "GENE"], [253, 257, "GENE"]]}], ["The analysis in the entire study sample showed similar findings in changes of APOA-I and GNAS after risperidone treatment.", {"entities": [[89, 93, "GENE"]]}], ["Further analysis showed significant relationships between changesin APOA-1 and changes in triglyceride, total cholesterol, and body mass index after controlling for age, gender and family history of diabetes.", {"entities": []}], ["Similar analysis showed a trend positive relationship between changes in GNAS and changes in BMI.", {"entities": [[73, 77, "GENE"]]}], ["Using proteomic analysis, the study suggested that APOA-I might be a novel biomarkers related to metabolic side effects in first episode schizophrenia treated with risperidone.", {"entities": [[137, 150, "DISEASE"]]}], ["To compare the absolute serum von Willebrand factor (vWF) levels and relative serum vWF activity in patients with clinically stable COPD, smokers without airway obstruction, and healthy never-smokers.", {"entities": [[53, 56, "GENE"], [84, 87, "GENE"], [53, 56, "GENE"], [84, 87, "GENE"]]}], ["The study included 57 subjects, in three groups: COPD (n = 36); smoker (n = 12); and control (n = 9).", {"entities": []}], ["During the selection phase, all participants underwent chest X-rays, spirometry, and blood testing.", {"entities": []}], ["Absolute serum vWF levels and relative serum vWF activity were obtained by turbidimetry and ELISA, respectively.", {"entities": [[15, 18, "GENE"], [45, 48, "GENE"], [15, 18, "GENE"], [45, 48, "GENE"]]}], ["The modified Medical Research Council scale (cut-off score = 2) was used in order to classify COPD patients as symptomatic or mildly symptomatic/asymptomatic.", {"entities": []}], ["Absolute vWF levels were significantly lower in the control group than in the smoker and COPD groups: 989 \u00b1 436 pg/mL vs. 2,220 \u00b1 746 pg/mL (p < 0.001) and 1,865 \u00b1 592 pg/mL (p < 0.01).", {"entities": [[9, 12, "GENE"]]}], ["Relative serum vWF activity was significantly higher in the COPD group than in the smoker group (136.7 \u00b1 46.0% vs. 92.8 \u00b1 34.0%; p < 0.05), as well as being significantly higher in the symptomatic COPD subgroup than in the mildly symptomatic/asymptomatic COPD subgroup (154 \u00b1 48% vs. 119 \u00b1 8%; p < 0.05).", {"entities": [[15, 18, "GENE"]]}], ["In all three groups, there was a negative correlation between FEV 1 (% of predicted) and relative serum vWF activity (r Our results suggest that increases in vWF levels and activity contribute to the persistence of systemic inflammation, as well as increasing cardiovascular risk, in COPD patients.", {"entities": [[62, 65, "GENE"], [104, 107, "GENE"], [158, 161, "GENE"], [104, 107, "GENE"], [158, 161, "GENE"]]}], ["Comparar os n\u00edveis s\u00e9ricos absolutos e a atividade s\u00e9rica em percentual do fator de von Willebrand (FvW) em pacientes com DPOC clinicamente est\u00e1veis, tabagistas sem obstru\u00e7\u00e3o das vias a\u00e9reas e em indiv\u00edduos saud\u00e1veis que nunca fumaram.", {"entities": []}], ["Foram inclu\u00eddos no estudo 57 indiv\u00edduos, em tr\u00eas grupos: DPOC (n = 36), tabagista (n = 12) e controle (n = 9).", {"entities": []}], ["Todos os participantes realizaram radiografia do t\u00f3rax, espirometria e exame de sangue durante a fase de sele\u00e7\u00e3o.", {"entities": []}], ["Os n\u00edveis s\u00e9ricos absolutos e a atividade s\u00e9rica em percentual do FvW foram obtidos por turbidimetria e ELISA, respectivamente.", {"entities": [[84, 87, "GENE"]]}], ["A escala Medical Research Council modificada foi utilizada para classificar pacientes como sintom\u00e1ticos ou assintom\u00e1ticos/pouco sintom\u00e1ticos no grupo DPOC (ponto de corte = 2).", {"entities": []}], ["Os n\u00edveis absolutos do FvW no grupo controle foram significativamente menores que os nos grupos tabagista e DPOC: 989 \u00b1 436 pg/mL vs. 2.220 \u00b1 746 pg/mL (p < 0,001) e 1.865 \u00b1 592 pg/mL (p < 0,01).", {"entities": []}], ["Os valores em percentual de atividade do FvW no grupo DPOC foram significativamente maiores que no grupo tabagista (136,7 \u00b1 46,0% vs. 92,8 \u00b1 34,0%; p < 0,05), assim como foram significativamente maiores no subgrupo DPOC sintom\u00e1tico que no subgrupo DPOC assintom\u00e1tico/pouco sintom\u00e1tico (154 \u00b1 48% vs. 119 \u00b1 8%; p < 0,05).", {"entities": []}], ["Houve uma correla\u00e7\u00e3o negativa entre o VEF 1 (% do previsto) e os n\u00edveis em percentual de atividade do FvW nos tr\u00eas grupos (r Nossos resultados sugerem que aumentos nos n\u00edveis de FvW e de sua atividade contribuem para a manuten\u00e7\u00e3o da inflama\u00e7\u00e3o sist\u00eamica e o aumento do risco cardiovascular em pacientes com DPOC.", {"entities": []}], ["Uremic pruritus is a common complication in patients undergoing dialysis.", {"entities": []}], ["The pathophysiological mechanisms of pruritus in patients with end-stage renal disease remain unknown.", {"entities": []}], ["Neuropeptides, including substance P, are postulated to play an important role in the pathogenesis of pruritus.", {"entities": []}], ["The aim of this study was to evaluate the role of substance P in uremic pruritus in patients on hemodialysis and peritoneal dialysis.", {"entities": []}], ["We included 197 patients with end-stage renal disease: 54 on continuous ambulatory peritoneal dialysis and 143 on hemodialysis.", {"entities": []}], ["Substance P, calcium, phosphorus, iron, ferritin, CRP, albumin, hemoglobin, Ca \u00d7 P product, and iPTH level were determined in all participants.", {"entities": [[50, 53, "GENE"]]}], ["The correlation between these parameters and self-reported itching was evaluated in patients on hemodialysis in comparison with peritoneal dialysis patients.", {"entities": []}], ["The incidence of itching was similar in hemodialysis and peritoneal dialysis patients.", {"entities": []}], ["No differences in substance P level between the 2 groups were found.", {"entities": []}], ["There was no correlation between substance P level and the incidence or intensity of pruritus in dialyzed patients.", {"entities": []}], ["This study demonstrates that substance P does not play any important role in pruritus in hemodialysed and peritoneal dialyzed patients.", {"entities": []}], ["However, further studies are necessary to assess the exact role of neuropeptides in uremic pruritus.", {"entities": []}], ["Phospholipases A 2 (PLA 2 ) hydrolyzes phospholipids, initiating the production of inflammatory lipid mediators.", {"entities": []}], ["We have previously shown that in rats, sPLA 2 and cPLA 2 play opposing roles in the pathophysiology of ovalbumin (OVA)-induced experimental allergic bronchitis (OVA-EAB), an asthma model: Upon disease induction sPLA 2 expression and production of the broncho-constricting CysLTs are elevated, whereas cPLA 2 expression and the broncho-dilating PGE 2 production are suppressed.", {"entities": [[174, 180, "DISEASE"], [149, 159, "DISEASE"]]}], ["These were reversed upon disease amelioration by treatment with an sPLA 2 inhibitor.", {"entities": []}], ["However, studies in mice reported the involvement of both sPLA 2 and cPLA 2 in EAB induction.", {"entities": []}], ["To examine the relevance of mouse and rat models to understanding asthma pathophysiology.", {"entities": [[66, 72, "DISEASE"]]}], ["OVA-EAB was induced in mice using the same methodology applied in rats.", {"entities": []}], ["Disease and biochemical markers in mice were compared with those in rats.", {"entities": []}], ["As in rats, EAB in mice was associated with increased mRNA of sPLA 2 , specifically sPLA 2 gX, in the lungs, and production of the broncho-constricting eicosanoids CysLTs, PGD 2 and TBX 2 in bronchoalveolar lavage (BAL).", {"entities": [[172, 175, "GENE"]]}], ["In contrast, EAB in mice was associated also with elevated cPLA 2 mRNA and PGE 2 production.", {"entities": []}], ["Yet, treatment with an sPLA 2 inhibitor ameliorated the EAB concomitantly with reverting the expression of both cPLA 2 and sPLA 2 , and eicosanoid production.", {"entities": []}], ["In both mice and rats sPLA 2 is pivotal in OVA-induced EAB.", {"entities": []}], ["Yet, amelioration of asthma markers in mouse models, and human tissues, was observed also upon cPLA 2 inhibition.", {"entities": [[21, 27, "DISEASE"]]}], ["It is plausible that airway conditions, involving multiple cell types and organs, require the combined action of more than one, essential, PLA 2 s.", {"entities": []}], ["Vasculitis, characterized by inflammation of vessel walls, is comprised of heterogeneous clinicopathological entities, and thus poses a diagnostic challenge.", {"entities": [[0, 10, "DISEASE"]]}], ["The most widely used approach for classifying vasculitides is based on the International Chapel Hill Consensus Conference (CHCC) nomenclature system.", {"entities": []}], ["Based on the recently revised CHCC 2012, we propose computed tomography (CT) features of vasculitides and a differential diagnosis based on location and morphological characteristics.", {"entities": []}], ["Finally, vasculitis mimics should be differentiated, because erroneous application of immunosuppressive drugs on vasculitis mimics may be ineffective, even deteriorating.", {"entities": [[9, 19, "DISEASE"], [113, 123, "DISEASE"]]}], ["This article presents the utility of CT in the diagnosis and differential diagnosis of vasculitides.", {"entities": []}], ["In-vitro studies suggest that vitamin D reduces inflammation by inhibiting nuclear factor kappa-B (NF\u03baB) activity.", {"entities": []}], ["Yet, no trials have examined the effects of vitamin D supplementation on NF\u03baB activity in-vivo in humans.", {"entities": []}], ["We conducted a double-blind randomized trial (RCT) examining effects of vitamin D supplementation on inflammatory markers and NF\u03baB activity in peripheral blood mononuclear cells (PBMCs).", {"entities": []}], ["Sixty-five overweight/obese, vitamin D-deficient (25-hydroxyvitamin D [25(OH)D]\u2009\u2264\u200950 nmol/L) adults were randomized to a single 100,000 IU bolus followed by 4,000 IU daily cholecalciferol or matching placebo for 16 weeks.", {"entities": []}], ["We measured BMI, %\u00a0body fat, serum 25(OH)D, high-sensitivity C-reactive protein (hsCRP), tumour necrosis factor (TNF), monocyte chemoattractant protein-1 (MCP-1), interferon-gamma (IFN-\u03b3), several interleukins, and NF\u03baB activity in PBMCs.", {"entities": [[113, 116, "GENE"]]}], ["Fifty-four participants completed the study.", {"entities": []}], ["Serum 25(OH)D concentrations increased with vitamin D supplementation compared to placebo (p\u2009<\u20090.001).", {"entities": []}], ["Vitamin D and placebo groups did not differ in any inflammatory markers or NF\u03baB activity (all p\u2009>\u20090.05).", {"entities": []}], ["Results remained non-significant after adjustment for age, sex, and % body fat, and after further adjustment for sun exposure, physical activity, and dietary vitamin D intake.", {"entities": []}], ["Although in-vitro studies report anti-inflammatory effects of vitamin D, our RCT data show no effect of vitamin D supplementation on inflammatory markers or NF\u03baB activity in-vivo in humans.", {"entities": []}], ["The peripheral circadian clock is entrained by factors in the external environment such as scheduled feeding, exercise, and mental and physical stresses.", {"entities": []}], ["In addition, recent studies in mice demonstrated that some food components have the potential to control the peripheral circadian clock during scheduled feeding, although information about these components remains limited.", {"entities": []}], ["l- Ornithine is a type of non-protein amino acid that is present in foods and has been reported to have various physiological functions.", {"entities": []}], ["In human trials, for example, l- ornithine intake improved a subjective index of sleep quality.", {"entities": []}], ["Here we demonstrate, using an in vivo monitoring system, that repeated oral administration of l- ornithine at an early inactive period in mice induced a phase advance in the rhythm of PER2 expression.", {"entities": [[184, 188, "GENE"]]}], ["By contrast, l- ornithine administration to mouse embryonic fibroblasts did not affect the expression of PER2, indicating that l- ornithine indirectly alters the phase of PER2.", {"entities": [[105, 109, "GENE"], [171, 175, "GENE"], [105, 109, "GENE"], [171, 175, "GENE"]]}], ["l- Ornithine also increased plasma levels of insulin, glucose and glucagon-like peptide-1 alongside m Per2 expression, suggesting that it exerts its effects probably via insulin secretion.", {"entities": [[102, 106, "GENE"]]}], ["Collectively, these findings demonstrate that l-ornithine affects peripheral clock gene expression and may expand the possibilities of L-ornithine as a health food.", {"entities": []}], ["The objective of this study was to explore the burden of SLE and its effect on patients\u2019 lives.", {"entities": []}], ["The Lupus European Online (LEO) survey included patient-designed questions on demographics, SLE diagnosis, and the impact of SLE on careers.", {"entities": []}], ["Three SLE-specific patient-reported outcome (PRO) questionnaires were also completed: the Lupus Quality of Life (LupusQoL), the Fatigue Severity Scale (FSS), and the Work Productivity and Activity Impairment (WPAI)-Lupus v2.0.", {"entities": []}], ["The survey was available online in five languages from May through August 2010.", {"entities": []}], ["All self-identified SLE participants were eligible to respond.", {"entities": []}], ["Survey results were analysed using descriptive statistics.", {"entities": []}], ["Multivariate linear regression explored factors contributing to impaired productivity.", {"entities": []}], ["Of the 2070 European SLE patients completing the survey, 93.1% were women, 86.7% were aged <50 years and 71.8% had a college or university education.", {"entities": []}], ["More than two-thirds of respondents (69.5%) reported that SLE affected their careers; 27.7% changed careers within a year of diagnosis.", {"entities": []}], ["All LupusQoL domains (score range 0\u2013100) were impaired, with fatigue (median domain score 43.8) being the most affected and intimate relationships (median domain score 75.0) the least.", {"entities": []}], ["Most patients (82.5%) reported fatigue (FSS score \u22654).", {"entities": []}], ["Productivity was impaired across all WPAI domains, both at work and in general activities.", {"entities": []}], ["Fatigue, an inability to plan and reduced physical health were significantly associated with impaired productivity.", {"entities": []}], ["Patients whose careers were affected by SLE had worse health-related quality of life, more fatigue and worse productivity than patients whose careers were not affected.", {"entities": []}], ["Conclusion.", {"entities": []}], ["LEO survey respondents reported that SLE negatively affects their daily lives, productivity and career choices.", {"entities": []}], ["Viruses are intracellular parasites that ensure their existence by converting host cells into viral particle producing entities or into hiding places rendering the virus invisible to the host immune system.", {"entities": []}], ["Some viruses may also survive by transforming the infected cell into an immortal tumour cell.", {"entities": []}], ["MicroRNAs are small non-coding transcripts that function as posttranscriptional regulators of gene expression.", {"entities": []}], ["Viruses encode miRNAs that regulate expression of both cellular and viral genes, and contribute to the pathogenic properties of viruses.", {"entities": []}], ["Hence, neutralizing the action of viral miRNAs expression by complementary single-stranded oligonucleotides or so-called anti-miRNAs may represent a strategy to combat viral infections and viral-induced pathogenesis.", {"entities": []}], ["This review describes the miRNAs encoded by human viruses, and discusses the possible therapeutic applications of anti-miRNAs against viral diseases.", {"entities": []}], ["A number of scientific organisations have developed guidelines for the primary prevention of allergic disease through nutritional interventions.", {"entities": []}], ["However, even if the best evidence-based guidelines are available, these guidelines do not necessarily lead to adherence and improved health outcomes.", {"entities": []}], ["To determine how closely the practice of physicians in select Middle Eastern and North African countries compares with the current recommendations on the primary prevention of allergy a survey study was performed using a structured questionnaire and convenience sampling.", {"entities": []}], ["A total of 1481 physicians responded, of which 66.1% were pediatricians.", {"entities": []}], ["A total of 76.6% of responding physicians routinely identify infants who are at risk for developing allergy.", {"entities": []}], ["In infants at risk for developing allergy, 89.1% recommend exclusive breastfeeding for at least 4\u00a0months.", {"entities": []}], ["In contrast to current recommendations, 51.6% routinely recommend avoidance of any allergenic food in the lactating mother.", {"entities": []}], ["In infants at risk of developing allergy who are completely formula fed, standard infant formula was recommended by 22.5% of responders.", {"entities": []}], ["Of the responding physicians, 50.6% would recommend delaying the introduction of complementary food in infants at risk of allergy compared to those not at risk, whereas 62.5% would recommend postponing the introduction of potentially allergenic foods.", {"entities": []}], ["Only 6.6% stated they follow all current recommendations on food allergy prevention.", {"entities": [[60, 72, "DISEASE"]]}], ["The results of this survey suggest that a substantial part of responding physicians from select Middle Eastern and North African (MENA) countries do not follow current recommendations on primary prevention of allergic disease through nutritional interventions.", {"entities": []}], ["The online version of this article (doi:10.1186/s12887-017-0871-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To assess the association between secondhand smoke exposure and blood lead and cadmium concentration in women in South Korea.", {"entities": []}], ["Population-based cross-sectional study.", {"entities": []}], ["South Korea (Korea National Health and Nutrition Examination Survey V).", {"entities": []}], ["1490 non-smoking women who took part in the fifth Korea National Health and Nutrition Examination Survey (2010\u20132012), in which blood levels of lead and cadmium were measured.", {"entities": []}], ["The primary outcome was blood levels of lead and cadmium in accordance with the duration of secondhand smoke exposure.", {"entities": []}], ["The adjusted mean level of blood cadmium in women who were never exposed to secondhand smoke was 1.21 (0.02) \u00b5g/L.", {"entities": []}], ["Among women who were exposed less than 1\u2005h/day, the mean cadmium level was 1.13 (0.03) \u00b5g/L, and for those exposed for more than 1\u2005h, the mean level was 1.46 (0.06) \u00b5g/L.", {"entities": []}], ["In particular, there was a significant association between duration of secondhand smoke exposure at the workplace and blood cadmium concentration.", {"entities": []}], ["The adjusted mean level of blood cadmium concentration in the never exposed women's group was less than that in the 1\u2005h and more exposed group, and the 1\u2005h and more at workplace exposed group: 1.20, 1.24 and 1.50\u2005\u00b5g/L, respectively.", {"entities": []}], ["We could not find any association between lead concentration in the blood and secondhand smoke exposure status.", {"entities": []}], ["This study showed that exposure to secondhand smoke and blood cadmium levels are associated.", {"entities": []}], ["Especially, there was a significant association at the workplace.", {"entities": []}], ["Therefore, social and political efforts for reducing the exposure to secondhand smoke at the workplace are needed in order to promote a healthier working environment for women.", {"entities": []}], ["Dampness and mould exposure have been repeatedly associated with respiratory health.", {"entities": []}], ["However, less is known about the specific agents provoking or arresting health effects in adult populations.", {"entities": []}], ["We aimed to assess predictors of microbial agents in mattress dust throughout Europe and to investigate associations between microbial exposures, home characteristics and respiratory health.", {"entities": []}], ["Seven different fungal and bacterial parameters were assessed in mattress dust from 956 adult ECRHS II participants in addition to interview based home characteristics.", {"entities": []}], ["Associations between microbial parameters and the asthma score and lung function were examined using mixed negative binomial regression and linear mixed models, respectively.", {"entities": [[50, 56, "DISEASE"]]}], ["Indoor dampness and pet keeping were significant predictors for higher microbial agent concentrations in mattress dust.", {"entities": []}], ["Current mould and condensation in the bedroom were significantly associated with lung function decline and current mould at home was positively associated with the asthma score.", {"entities": [[164, 170, "DISEASE"]]}], ["Higher concentrations of muramic acid were associated with higher mean ratios of the asthma score (aMR 1.37, 95%CI 1.17-1.61).", {"entities": [[85, 91, "DISEASE"]]}], ["There was no evidence for any association between fungal and bacterial components and lung function.", {"entities": []}], ["Indoor dampness was associated with microbial levels in mattress dust which in turn was positively associated with asthma symptoms.", {"entities": [[115, 121, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12890-015-0042-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Symptom monitoring is a cornerstone of asthma self-management.", {"entities": [[39, 45, "DISEASE"]]}], ["Conventional methods of symptom monitoring have fallen short in producing objective data and eliciting patients\u2019 consistent adherence, particularly in teen patients.", {"entities": []}], ["We have recently developed an Automated Device for Asthma Monitoring (ADAM) using a consumer mobile device as a platform to facilitate continuous and objective symptom monitoring in adolescents in vivo.", {"entities": [[51, 57, "DISEASE"]]}], ["The objectives of the study were to evaluate the validity of the device using spirometer data, fractional exhaled nitric oxide (FeNO), existing measures of asthma symptoms/control and health care utilization data, and to examine the sensitivity and specificity of the device in discriminating asthma cases from nonasthma cases.", {"entities": [[156, 162, "DISEASE"], [293, 299, "DISEASE"]]}], ["A total of 84 teens (42 teens with a current asthma diagnosis; 42 without asthma) aged between 13 and 17 years participated in the study.", {"entities": [[45, 51, "DISEASE"], [74, 80, "DISEASE"]]}], ["All participants used ADAM for 7 consecutive days during which participants with asthma completed an asthma diary two times a day.", {"entities": [[81, 87, "DISEASE"], [101, 107, "DISEASE"]]}], ["ADAM recorded the frequency of coughing for 24 hours throughout the 7-day trial.", {"entities": []}], ["Pearson correlation and multiple regression were used to examine the relationships between ADAM data and asthma control, quality of life, and health care utilization at the time of the 7-day trial and 3 months later.", {"entities": [[105, 111, "DISEASE"]]}], ["A receiver operating characteristic (ROC) curve analysis was conducted to examine sensitivity and specificity based on the area under the curve (AUC) as an indicator of the device\u2019s capacity to discriminate between asthma versus nonasthma cases.", {"entities": [[215, 221, "DISEASE"]]}], ["ADAM data (cough counts) were negatively associated with forced expiratory volume in first second of expiration (FEV 1 ) ( r =\u2013.26, P =.05), forced vital capacity (FVC) ( r =\u2013.31, P =.02), and overall asthma control ( r =\u2013.41, P =.009) and positively associated with daily activity limitation ( r =.46, P =.01), nighttime ( r =.40, P =.02) and daytime symptoms ( r =.38, P =.02), and health care utilization ( r =.61, P <.001).", {"entities": [[201, 207, "DISEASE"], [113, 116, "GENE"]]}], ["Device data were also a significant predictor of asthma control (\u03b2=\u2013.48, P =.003), quality of life (\u03b2=\u2013.55, P =.001), and health care utilization (\u03b2=.74, P =.004) after 3 months.", {"entities": [[49, 55, "DISEASE"]]}], ["The ROC curve analysis for the presence of asthma diagnosis had an AUC of 0.71 (95% CI 0.58-0.84), which was significantly different from chance (\u03c7 1 =9.7, P =.002), indicating the device\u2019s discriminating capacity.", {"entities": [[43, 49, "DISEASE"]]}], ["The optimal cutoff value of the device was 0.56 with a sensitivity of 51.3% and a specificity of 72.7%.", {"entities": []}], ["This study demonstrates validity of ADAM as a symptom-monitoring device in teens with asthma.", {"entities": [[86, 92, "DISEASE"]]}], ["ADAM data reflect the current status of asthma control and predict asthma morbidity and quality of life for the near future.", {"entities": [[40, 46, "DISEASE"], [67, 73, "DISEASE"]]}], ["A monitoring device such as ADAM can increase patients\u2019 awareness of the patterns of cough for early detection of worsening asthma and has the potential for preventing serious and costly future consequences of asthma.", {"entities": [[124, 130, "DISEASE"], [210, 216, "DISEASE"]]}], ["Non-Hispanic (nH) Black and Hispanic women are disproportionately affected by early onset disease, later stage, and with more aggressive, higher grade and ER/PR negative breast cancers.", {"entities": []}], ["The purpose of this analysis was to examine whether genetic ancestry could account for these variation in breast cancer characteristics, once data were stratified by self-reported race/ethnicity and adjusted for potential confounding by social and behavioral factors.", {"entities": [[106, 119, "DISEASE"], [113, 119, "DISEASE"]]}], ["We used a panel of 100 ancestry informative markers (AIMs) to estimate individual genetic ancestry in 656 women from the \u201cBreast Cancer Care in Chicago\u201d study, a multi-ethnic cohort of breast cancer patients to examine the association between individual genetic ancestry and breast cancer characteristics.", {"entities": [[122, 135, "DISEASE"], [185, 198, "DISEASE"], [275, 288, "DISEASE"], [129, 135, "DISEASE"], [192, 198, "DISEASE"], [282, 288, "DISEASE"]]}], ["In addition we examined the association of individual AIMs and breast cancer to identify genes/regions that may potentially play a role in breast cancer disease disparities.", {"entities": [[63, 76, "DISEASE"], [139, 152, "DISEASE"], [70, 76, "DISEASE"], [146, 152, "DISEASE"]]}], ["As expected, nH Black and Hispanic patients were more likely than nH White patients to be diagnosed at later stages, with higher grade, and with ER/PR negative tumors.", {"entities": []}], ["Higher European genetic ancestry was protective against later stage at diagnosis (OR 0.7 95%CI: 0.54\u20130.92) among Hispanic patients, and higher grade (OR 0.73, 95%CI: 0.56\u20130.95) among nH Black patients.", {"entities": []}], ["After adjustment for multiple social and behavioral risk factors, the association with later stage remained, while the association with grade was not significant.", {"entities": []}], ["We also found that the AIM SNP rs10954631 on chromosome 7 was associated with later stage (p\u200a=\u200a0.02) and higher grade (p\u200a=\u200a0.012) in nH Whites and later stage (p\u200a=\u200a0.03) in nH Blacks.", {"entities": []}], ["Non-European genetic ancestry was associated with later stage at diagnosis in ethnic minorities.", {"entities": []}], ["The relation between genetic ancestry and stage at diagnosis may be due to genetic factors and/or unmeasured environmental factors that are overrepresented within certain racial/ethnic groups.", {"entities": []}], ["Olodaterol is a novel long-acting \u03b2 2 -agonist with proven \u226524-hour duration of action in preclinical and clinical studies.", {"entities": []}], ["This randomized, double-blind, placebo-controlled, parallel-group study evaluated the dose response of once-daily (QD) olodaterol based on bronchodilator efficacy, safety, and pharmacokinetics over 4 weeks in Japanese patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[232, 269, "DISEASE"]]}], ["All eligible patients were randomized to receive 2 \u00b5g, 5 \u00b5g, or 10 \u00b5g of olodaterol or placebo for 4 weeks via the Respimat 1 ) after 4 weeks of olodaterol treatment.", {"entities": []}], ["Secondary end points included trough FEV 1 after 1 week and 2 weeks of treatment, FEV 1 area under the curve from 0 hour to 3 hours (AUC 0\u20133 ), peak FEV 1 from 0 hour to 3 hours (peak FEV 1 ), and corresponding forced vital capacity (FVC) responses.", {"entities": [[37, 40, "GENE"], [82, 85, "GENE"], [149, 152, "GENE"], [184, 187, "GENE"], [37, 40, "GENE"], [82, 85, "GENE"], [149, 152, "GENE"], [184, 187, "GENE"], [37, 40, "GENE"], [82, 85, "GENE"], [149, 152, "GENE"], [184, 187, "GENE"], [37, 40, "GENE"], [82, 85, "GENE"], [149, 152, "GENE"], [184, 187, "GENE"]]}], ["Rescue medication use, COPD symptoms, physician global evaluation, pharmacokinetics, and safety were also assessed.", {"entities": []}], ["A total of 328 patients with COPD were randomized to receive treatment.", {"entities": []}], ["All olodaterol doses assessed in the study showed statistically significant increases in trough FEV 1 compared to placebo at Day 29 ( P <0.0001).", {"entities": [[96, 99, "GENE"]]}], ["Mean increases in peak FEV 1 and FEV 1 AUC 0\u20133 compared to placebo were also significant ( P <0.0001).", {"entities": [[23, 26, "GENE"], [33, 36, "GENE"], [23, 26, "GENE"], [33, 36, "GENE"]]}], ["A clear dose\u2013response relationship was observed across all treatment groups.", {"entities": []}], ["FVC responses (trough and FVC AUC 0\u20133 ) supported FEV 1 outcomes.", {"entities": [[50, 53, "GENE"]]}], ["All doses of olodaterol were well tolerated, and no safety concerns were identified.", {"entities": []}], ["QD olodaterol demonstrated 24-hour bronchodilator efficacy and was well tolerated in Japanese patients with COPD.", {"entities": []}], ["ClinicalTrials.gov : NCT00824382.", {"entities": []}], ["Dehydration is common among elderly people.", {"entities": []}], ["The aim of this study was to perform validation analysis of a geriatric dehydration-screening tool (DST) in the assessment of hydration status in elderly people.", {"entities": [[100, 103, "GENE"]]}], ["This tool was based on the DST proposed by Vivanti et al.", {"entities": [[27, 30, "GENE"]]}], [", which is composed by 11 items (four physical signs of dehydration and seven questions about thirst sensation, pain and mobility), with four questions extra about drinking habits.", {"entities": []}], ["The resulting questionnaire was evaluated in a convenience sample comprising institutionalized ( n = 29) and community-dwelling ( n = 74) elderly people.", {"entities": []}], ["Urinary parameters were assessed (24-h urine osmolality and volume) and free water reserve (FWR) was calculated.", {"entities": []}], ["Exploratory factor analysis was used to evaluate the scale\u2019s dimensionality and Cronbach\u2019s alpha was used to measure the reliability of each subscale.", {"entities": []}], ["Construct\u2019s validity was tested using linear regression to estimate the association between scores in each dimension and urinary parameters.", {"entities": []}], ["Two factors emerged from factor analysis, which were named \u201cHydration Score\u201d and \u201cPain Score\u201d, and both subscales showed acceptable reliabilities.", {"entities": []}], ["The \u201cHydration Score\u201d was negatively associated with 24-h urine osmolality in community-dwelling; and the \u201cPain Score\u201d was negatively associated with 24-h urine osmolality, and positively associated with 24-h urine volume and FWR in institutionalized elderly people.", {"entities": []}], ["The respiratory tract is endowed with an interlocking array of nonspecific and specific defense mechanisms which protect it from the effects of inhaled microbes and toxicants, and reduce the risk of absorption of materials into the bloodstream, with subsequent systemic translocation.", {"entities": []}], ["Ambient acids may compromise these defenses, perhaps providing a link between exposure and development of chronic and acute pulmonary disease.", {"entities": []}], ["This paper reviews the effects of inhaled acids upon the nonspecific clearance system of the lungs.", {"entities": []}], ["Crude extract from the pericarp of the mangosteen (mangosteen extract [ME]) has exhibited several medicinal properties in both animal models and human cell lines.", {"entities": []}], ["Interestingly, the cytotoxic activities were always observed in nonpolar fraction of the extract whereas the potent antioxidant was often found in polar fraction.", {"entities": []}], ["Although it has been demonstrated that the polar fraction of ME exhibited the antioxidant activity, the safety of the polar fraction of ME has never been thoroughly investigated in humans.", {"entities": []}], ["In this study, we investigated the safety of oral administration of the polar fraction of ME in 11 healthy Thai volunteers.", {"entities": []}], ["During a 24-week period of the study, only minor and tolerable side effects were reported; no serious side effects were documented.", {"entities": []}], ["Blood chemistry studies also showed no liver damage or kidney dysfunction in all subjects.", {"entities": []}], ["We also demonstrated antioxidant property of the polar fraction of ME both in vitro and in vivo .", {"entities": []}], ["Interestingly, oral administration of the polar fraction of ME enhanced the antioxidant capability of red blood cells and decreased oxidative damage to proteins within red blood cells and whole blood.", {"entities": []}], ["We have designed and developed a data integration and visualization platform that provides evidence about the association of known and potential drug targets with diseases.", {"entities": []}], ["The platform is designed to support identification and prioritization of biological targets for follow-up.", {"entities": []}], ["Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources.", {"entities": []}], ["The platform provides either a target-centric workflow to identify diseases that may be associated with a specific target, or a disease-centric workflow to identify targets that may be associated with a specific disease.", {"entities": []}], ["Users can easily transition between these target- and disease-centric workflows.", {"entities": []}], ["The Open Targets Validation Platform is accessible at https://www.targetvalidation.org .", {"entities": []}], ["Objective To investigate whether an early rehabilitation intervention initiated during acute admission for exacerbations of chronic respiratory disease reduces the risk of readmission over 12 months and ameliorates the negative effects of the episode on physical performance and health status.", {"entities": []}], ["Design Prospective, randomised controlled trial.", {"entities": []}], ["Setting An acute cardiorespiratory unit in a teaching hospital and an acute medical unit in an affiliated teaching district general hospital, United Kingdom.", {"entities": []}], ["Participants 389 patients aged between 45 and 93 who within 48 hours of admission to hospital with an exacerbation of chronic respiratory disease were randomised to an early rehabilitation intervention (n=196) or to usual care (n=193).", {"entities": []}], ["Main outcome measures The primary outcome was readmission rate at 12 months.", {"entities": []}], ["Secondary outcomes included number of hospital days, mortality, physical performance, and health status.", {"entities": []}], ["The primary analysis was by intention to treat, with prespecified per protocol analysis as a secondary outcome.", {"entities": []}], ["Interventions Participants in the early rehabilitation group received a six week intervention, started within 48 hours of admission.", {"entities": []}], ["The intervention comprised prescribed, progressive aerobic, resistance, and neuromuscular electrical stimulation training.", {"entities": []}], ["Patients also received a self management and education package.", {"entities": []}], ["Results Of the 389 participants, 320 (82%) had a primary diagnosis of chronic obstructive pulmonary disease.", {"entities": [[70, 107, "DISEASE"]]}], ["233 (60%) were readmitted at least once in the following year (62% in the intervention group and 58% in the control group).", {"entities": []}], ["No significant difference between groups was found (hazard ratio 1.1, 95% confidence interval 0.86 to 1.43, P=0.4).", {"entities": []}], ["An increase in mortality was seen in the intervention group at one year (odds ratio 1.74, 95% confidence interval 1.05 to 2.88, P=0.03).", {"entities": []}], ["Significant recovery in physical performance and health status was seen after discharge in both groups, with no significant difference between groups at one year.", {"entities": []}], ["Conclusion Early rehabilitation during hospital admission for chronic respiratory disease did not reduce the risk of subsequent readmission or enhance recovery of physical function following the event over 12 months.", {"entities": []}], ["Mortality at 12 months was higher in the intervention group.", {"entities": []}], ["The results suggest that beyond current standard physiotherapy practice, progressive exercise rehabilitation should not be started during the early stages of the acute illness.", {"entities": []}], ["Trial registration Current Controlled Trials ISRCTN05557928.", {"entities": []}], ["Some studies have recently focused on the association between glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms and hypertension; however, results have been inconsistent.", {"entities": [[163, 175, "DISEASE"], [92, 97, "GENE"], [133, 138, "GENE"]]}], ["In order to drive a more precise estimation, the present systematic review and meta-analysis is performed to investigate the relationship between the GSTM1 and GSTT1 null polymorphisms and hypertension.", {"entities": [[189, 201, "DISEASE"], [150, 155, "GENE"], [160, 165, "GENE"]]}], ["Eligible articles were identified by a search of several bibliographic databases for the period up to August 17, 2013.", {"entities": []}], ["Odds ratios were pooled using either fixed-effects or random-effects models.", {"entities": []}], ["Regarding the GSTM1 null/present genotype, 14 case\u2014control studies were eligible (2773 hypertension cases and 3189 controls).", {"entities": [[87, 99, "DISEASE"], [14, 19, "GENE"]]}], ["The meta-analysis revealed that it might present a small increased risk for hypertension, although the effect was not statistically significant (odd ratio (OR) = 1.16, 95% confidence interval (CI): 0.96, 1.40; P = 0.002, I2 = 59.8%).", {"entities": [[76, 88, "DISEASE"]]}], ["Further subgroup analysis by ethnicity and control source suggested that the association was still not significant.", {"entities": []}], ["Thirteen case\u2014control studies were eligible for GSTT1 (2497 hypertension cases and 3078 controls).", {"entities": [[60, 72, "DISEASE"], [48, 53, "GENE"]]}], ["No statistically significant association was observed between the GSTT1 null genotype and hypertension risk (OR = 1.14, 95% CI: 0.85, 1.53; P = 0.000, I2 = 80.3%).", {"entities": [[90, 102, "DISEASE"], [66, 71, "GENE"]]}], ["Furthermore, stratification by ethnicity and control source indicated no association between the GSTT1 null genotype and hypertension risk.", {"entities": [[121, 133, "DISEASE"], [97, 102, "GENE"]]}], ["We further confirmed the association by sensitivity analysis.", {"entities": []}], ["No publication bias was detected.", {"entities": []}], ["This meta-analysis suggests that the GSTM1 and GSTT1 null polymorphisms are not associated with the risk of hypertension.", {"entities": [[108, 120, "DISEASE"], [37, 42, "GENE"], [47, 52, "GENE"]]}], ["Future large well-designed epidemiological studies with individual information, lifestyle factors, and environmental factors are warranted to validate the present findings.", {"entities": []}], ["Despite the growing use of complementary and alternative medicine (CAM) by consumers in the U.S., little is known about the practice of CAM providers.", {"entities": []}], ["The objective of this study was to describe and compare the practice patterns of naturopathic physicians in Washington State and Connecticut.", {"entities": []}], ["Telephone interviews were conducted with state-wide random samples of licensed naturopathic physicians and data were collected on consecutive patient visits in 1998 and 1999.", {"entities": []}], ["The main outcome measures were: Sociodemographic, training and practice characteristics of naturopathic physicians; and demographics, reasons for visit, types of treatments, payment source and visit duration for patients.", {"entities": []}], ["One hundred and seventy practitioners were interviewed and 99 recorded data on a total of 1817 patient visits.", {"entities": []}], ["Naturopathic physicians in Washington and Connecticut had similar demographic and practice characteristics.", {"entities": []}], ["Both the practitioners and their patients were primarily White and female.", {"entities": []}], ["Almost 75% of all naturopathic visits were for chronic complaints, most frequently fatigue, headache, and back symptoms.", {"entities": []}], ["Complete blood counts, serum chemistries, lipids panels and stool analyses were ordered for 4% to 10% of visits.", {"entities": []}], ["All other diagnostic tests were ordered less frequently.", {"entities": []}], ["The most commonly prescribed naturopathic therapeutics were: botanical medicines (51% of visits in Connecticut, 43% in Washington), vitamins (41% and 43%), minerals (35% and 39%), homeopathy (29% and 19%) and allergy treatments (11% and 13%).", {"entities": []}], ["The mean visit length was about 40 minutes.", {"entities": []}], ["Approximately half the visits were paid directly by the patient.", {"entities": []}], ["This study provides information that will help other health care providers, patients and policy makers better understand the nature of naturopathic care.", {"entities": []}], ["Non-communicable diseases (NCDs) have large economic impact at multiple levels.", {"entities": []}], ["To systematically review the literature investigating the economic impact of NCDs [including coronary heart disease (CHD), stroke, type 2 diabetes mellitus (DM), cancer (lung, colon, cervical and breast), chronic obstructive pulmonary disease (COPD) and chronic kidney disease (CKD)] on macro-economic productivity.", {"entities": [[262, 276, "DISEASE"], [102, 115, "DISEASE"], [93, 115, "DISEASE"], [205, 242, "DISEASE"], [162, 168, "DISEASE"], [138, 155, "DISEASE"], [131, 155, "DISEASE"]]}], ["Systematic search, up to November 6th 2014, of medical databases (Medline, Embase and Google Scholar) without language restrictions.", {"entities": []}], ["To identify additional publications, we searched the reference lists of retrieved studies and contacted authors in the field.", {"entities": []}], ["Randomized controlled trials, cohort, case\u2013control, cross-sectional, ecological studies and modelling studies carried out in adults (>18\u00a0years old) were included.", {"entities": []}], ["Two independent reviewers performed all abstract and full text selection.", {"entities": []}], ["Disagreements were resolved through consensus or consulting a third reviewer.", {"entities": []}], ["Two independent reviewers extracted data using a predesigned data collection form.", {"entities": []}], ["Main outcome measure was the impact of the selected NCDs on productivity, measured in DALYs, productivity costs, and labor market participation, including unemployment, return to work and sick leave.", {"entities": []}], ["From 4542 references, 126 studies met the inclusion criteria, many of which focused on the impact of more than one NCD on productivity.", {"entities": []}], ["Breast cancer was the most common (n\u00a0=\u00a045), followed by stroke (n\u00a0=\u00a031), COPD (n\u00a0=\u00a024), colon cancer (n\u00a0=\u00a024), DM (n\u00a0=\u00a022), lung cancer (n\u00a0=\u00a016), CVD (n\u00a0=\u00a015), cervical cancer (n\u00a0=\u00a07) and CKD (n\u00a0=\u00a02).", {"entities": [[124, 135, "DISEASE"], [88, 100, "DISEASE"], [7, 13, "DISEASE"], [94, 100, "DISEASE"], [129, 135, "DISEASE"], [169, 175, "DISEASE"], [160, 175, "DISEASE"]]}], ["Four studies were from the WHO African Region, 52 from the European Region, 53 from the Region of the Americas and 16 from the Western Pacific Region, one from the Eastern Mediterranean Region and none from South East Asia.", {"entities": []}], ["We found large regional differences in DALYs attributable to NCDs but especially for cervical and lung cancer.", {"entities": [[98, 109, "DISEASE"], [103, 109, "DISEASE"]]}], ["Productivity losses in the USA ranged from 88 million US dollars (USD) for COPD to 20.9 billion USD for colon cancer.", {"entities": [[104, 116, "DISEASE"], [110, 116, "DISEASE"]]}], ["CHD costs the Australian economy 13.2 billion USD per year.", {"entities": []}], ["People with DM, COPD and survivors of breast and especially lung cancer are at a higher risk of reduced labor market participation.", {"entities": [[60, 71, "DISEASE"], [65, 71, "DISEASE"]]}], ["Overall NCDs generate a large impact on macro-economic productivity in most WHO regions irrespective of continent and income.", {"entities": []}], ["The absolute global impact in terms of dollars and DALYs remains an elusive challenge due to the wide heterogeneity in the included studies as well as limited information from low- and middle-income countries.", {"entities": []}], ["The online version of this article (doi:10.1007/s10654-015-0026-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Combined inhaled long-acting beta-agonists and corticosteroids (LABA+ICS) are costly.", {"entities": []}], ["They are recommended in severe or very severe chronic obstructive pulmonary disease (COPD).", {"entities": [[46, 83, "DISEASE"]]}], ["They should not be prescribed in mild or moderate disease.", {"entities": []}], ["In COPD ICS are associated with side-effects including risk of pneumonia.", {"entities": [[63, 72, "DISEASE"]]}], ["We quantified appropriateness of prescribing and examined the risks and costs associated with overuse.", {"entities": []}], ["Data were extracted from the electronic and paper records of 41 London general practices (population 310,775) including spirometry, medications and exacerbations.", {"entities": []}], ["We classified severity, assessed appropriateness of prescribing using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for 2009, and performed a sensitivity analysis using the broader recommendations of the 2011 revision.", {"entities": []}], ["3537 patients had a diagnosis of COPD.", {"entities": []}], ["Spirometry was recorded for 2458(69%).", {"entities": []}], ["709(29%) did not meet GOLD criteria.", {"entities": []}], ["1749(49%) with confirmed COPD were analysed: 8.6% under-treated, 38% over-treated.", {"entities": []}], ["Over-prescription of ICS in GOLD stage I or II (n=403, 38%) and in GOLD III or IV without exacerbations (n=231, 33.6%) was common.", {"entities": []}], ["An estimated 12 cases (95%CI 7-19) annually of serious pneumonia were likely among 897 inappropriately treated.", {"entities": [[55, 64, "DISEASE"]]}], ["535 cases of overtreatment involved LABA+ICS with a mean per patient cost of \u00a3553.56/year (\u20ac650.03).", {"entities": []}], ["Using the broader indications for ICS in the 2011 revised GOLD guideline 25% were still classified as over-treated.", {"entities": []}], ["The estimated risk of 15 cases of pneumonia (95%CI 8-22) in 1074 patients currently receiving ICS would rise by 20% to 18 (95%CI 9.8-26.7) in 1305 patients prescribed ICS if all with GOLD grade 3 and 4 received LABA+ICS.", {"entities": [[34, 43, "DISEASE"]]}], ["Over-prescription of ICS in confirmed COPD was widespread with considerable potential for harm.", {"entities": []}], ["In COPD where treatment is often escalated in the hope of easing the burden of disease clinicians should consider both the risks and benefits of treatment and the costs where the benefits are unproven.", {"entities": []}], ["The authors consider the advantages and limitations of self-management tools used for treating chronic illness.", {"entities": []}], ["Chitosan, a polymer derived from chitin, has been used for nasal drug delivery because of its biocompatibility, biodegradability and bioadhesiveness.", {"entities": []}], ["Theophylline is a drug that reduces the inflammatory effects of allergic asthma but is difficult to administer at an appropriate dosage without causing adverse side effects.", {"entities": [[64, 79, "DISEASE"], [73, 79, "DISEASE"]]}], ["It was hypothesized that adsorption of theophylline to chitosan nanoparticles modified by the addition of thiol groups would improve theophylline absorption by the bronchial epithelium and enhance its anti-inflammatory effects.", {"entities": []}], ["We sought to develop an improved drug-delivery matrix for theophylline based on thiolated chitosan, and to investigate whether thiolated chitosan nanoparticles (TCNs) can enhance theophylline's capacity to alleviate allergic asthma.", {"entities": [[216, 231, "DISEASE"], [225, 231, "DISEASE"]]}], ["A mouse model of allergic asthma was used to test the effects of theophylline in vivo .", {"entities": [[17, 32, "DISEASE"], [26, 32, "DISEASE"]]}], ["BALB/c mice were sensitized to ovalbumin (OVA) and OVA-challenged to produce an inflammatory allergic condition.", {"entities": []}], ["They were then treated intranasally with theophylline alone, chitosan nanoparticles alone or theophylline adsorbed to TCNs.", {"entities": []}], ["The effects of theophylline on cellular infiltration in bronchoalveolar lavage (BAL) fluid, histopathology of lung sections, and apoptosis of lung cells were investigated to determine the effectiveness of TCNs as a drug-delivery vehicle for theophylline.", {"entities": []}], ["Theophylline alone exerts a moderate anti-inflammatory effect, as evidenced by the decrease in eosinophils in BAL fluid, the reduction of bronchial damage, inhibition of mucus hypersecretion and increased apoptosis of lung cells.", {"entities": []}], ["The effects of theophylline were significantly enhanced when the drug was delivered by TCNs.", {"entities": []}], ["Intranasal delivery of theophylline complexed with TCNs augmented the anti-inflammatory effects of the drug compared to theophylline administered alone in a mouse model of allergic asthma.", {"entities": [[172, 187, "DISEASE"], [181, 187, "DISEASE"]]}], ["The beneficial effects of theophylline in treating asthma may be enhanced through the use of this novel drug delivery system.", {"entities": [[51, 57, "DISEASE"]]}], ["There is evidence that newly qualified doctors do not feel prepared to start work.", {"entities": []}], ["This study examined views of first year Foundation doctors (F1s) regarding how prepared they felt by their undergraduate medical education for skills required during the first Foundation training year in relation to their type of training.", {"entities": []}], ["One-hundred and eighty two F1s completed a questionnaire during their first rotation of Foundation training.", {"entities": []}], ["Analysis was conducted by type of medical school training: Problem-Based Learning (PBL), Traditional or Reformed.", {"entities": []}], ["F1s from medical schools with a PBL curriculum felt better prepared for tasks associated with communication and team working, and paperwork than graduates from the other medical school types; but the majority of F1s from all three groups felt well prepared for most areas of practice.", {"entities": []}], ["Less than half of graduates in all three groups felt well prepared to deal with a patient with neurological/visual problems; write referral letters; understand drug interactions; manage pain; and cope with uncertainty.", {"entities": []}], ["F1s also indicated that lack of induction or support on starting work was affecting their ability to work in some areas.", {"entities": []}], ["Whilst F1s from medical schools with a PBL curriculum did feel better prepared in multiple areas compared to graduates from the other medical school types, specific areas of unpreparedness related to undergraduate and postgraduate medical training were identified across all F1s.", {"entities": []}], ["These areas need attention to ensure F1s are optimally prepared for starting work.", {"entities": []}], ["The online version of this article (doi:10.1186/s12909-017-0859-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The peripheral airway innervation of the lower respiratory tract of mammals is not completely functionally characterized.", {"entities": []}], ["Recently, we have shown in rats that precision-cut lung slices (PCLS) respond to electric field stimulation (EFS) and provide a useful model to study neural airway responses in distal airways.", {"entities": [[109, 112, "GENE"]]}], ["Since airway responses are known to exhibit considerable species differences, here we examined the neural responses of PCLS prepared from mice, rats, guinea pigs, sheep, marmosets and humans.", {"entities": []}], ["Peripheral neurons were activated either by EFS or by capsaicin.", {"entities": [[44, 47, "GENE"]]}], ["Bronchoconstriction in response to identical EFS conditions varied between species in magnitude.", {"entities": [[45, 48, "GENE"]]}], ["Frequency response curves did reveal further species-dependent differences of nerve activation in PCLS.", {"entities": []}], ["Atropine antagonized the EFS-induced bronchoconstriction in human, guinea pig, sheep, rat and marmoset PCLS, showing cholinergic responses.", {"entities": []}], ["Capsaicin (10 \u00b5M) caused bronchoconstriction in human (4 from 7) and guinea pig lungs only, indicating excitatory non-adrenergic non-cholinergic responses (eNANC).", {"entities": []}], ["However, this effect was notably smaller in human responder (30\u00b17.1%) than in guinea pig (79\u00b15.1%) PCLS.", {"entities": []}], ["The transient receptor potential (TRP) channel blockers SKF96365 and ruthenium red antagonized airway contractions after exposure to EFS or capsaicin in guinea pigs.", {"entities": [[133, 136, "GENE"]]}], ["In conclusion, the different species show distinct patterns of nerve-mediated bronchoconstriction.", {"entities": []}], ["In the most common experimental animals, i.e.", {"entities": []}], ["in mice and rats, these responses differ considerably from those in humans.", {"entities": []}], ["On the other hand, guinea pig and marmoset monkey mimic human responses well and may thus serve as clinically relevant models to study neural airway responses.", {"entities": []}], ["A new generation of user-centric information systems is emerging in health care as patient health record (PHR) systems.", {"entities": []}], ["These systems create a platform supporting the new vision of health services that empowers patients and enables patient-provider communication, with the goal of improving health outcomes and reducing costs.", {"entities": []}], ["This evolution has generated new sets of data and capabilities, providing opportunities and challenges at the user, system, and industry levels.", {"entities": []}], ["The objective of our study was to assess PHR data types and functionalities through a review of the literature to inform the health care informatics community, and to provide recommendations for PHR design, research, and practice.", {"entities": []}], ["We conducted a review of the literature to assess PHR data types and functionalities.", {"entities": []}], ["We searched PubMed, Embase, and MEDLINE databases from 1966 to 2015 for studies of PHRs, resulting in 1822 articles, from which we selected a total of 106 articles for a detailed review of PHR data content.", {"entities": []}], ["We present several key findings related to the scope and functionalities in PHR systems.", {"entities": []}], ["We also present a functional taxonomy and chronological analysis of PHR data types and functionalities, to improve understanding and provide insights for future directions.", {"entities": []}], ["Functional taxonomy analysis of the extracted data revealed the presence of new PHR data sources such as tracking devices and data types such as time-series data.", {"entities": []}], ["Chronological data analysis showed an evolution of PHR system functionalities over time, from simple data access to data modification and, more recently, automated assessment, prediction, and recommendation.", {"entities": []}], ["Efforts are needed to improve (1) PHR data quality through patient-centered user interface design and standardized patient-generated data guidelines, (2) data integrity through consolidation of various types and sources, (3) PHR functionality through application of new data analytics methods, and (4) metrics to evaluate clinical outcomes associated with automated PHR system use, and costs associated with PHR data storage and analytics.", {"entities": []}], ["Hematopoietic stem and progenitor cells arise from the vascular endothelium of the dorsal aorta and subsequently switch niche to the fetal liver through unknown mechanisms.", {"entities": []}], ["Here we report that vascular endothelium-specific deletion of mouse Drosha ( Drosha Drosha let-7 family of microRNAs is a primary cause of this defect, as it leads to activation of leukotriene B4 signaling and induction of the \u03b14\u03b21 integrin cell adhesion complex in hematopoietic stem and progenitor cells.", {"entities": []}], ["Inhibition of leukotriene B4 or integrin rescues maturation and migration of Drosha Hematopoietic stem and progenitor cells are generated first from the vascular endothelium of the dorsal aorta and then the fetal liver but what regulates this switch is unknown.", {"entities": []}], ["Here, the authors show that changing miRNA biogenesis and leukotriene B4 signaling in mice modulates this switch in the niche.", {"entities": []}], ["Levels of Interleukin-6 (IL-6) and C-creative protein (CRP) indicating systemic inflammation are known to be elevated in chronic diseases including chronic obstructive pulmonary disease (COPD) and depression.", {"entities": [[148, 185, "DISEASE"], [55, 58, "GENE"]]}], ["Comorbid depression is common in patients with COPD, but no studies have investigated whether proinflammatory cytokines mediate the association between pulmonary function and depressive symptoms in healthy individuals with no known history of obstructive pulmonary diseases.", {"entities": []}], ["In a population-based sample (n\u2009=\u20092077) of individuals aged 55 and above with no known history of obstructive pulmonary disease in the Singapore Longitudinal Ageing Study (SLAS), we analyzed the relationships between IL-6 and CRP, depressive symptoms (GDS-15 \u22655) and obstructive pulmonary function (FEV1% predicted and FEV1/FVC% predicted).", {"entities": [[226, 229, "GENE"]]}], ["High serum levels of IL-6 and CRP were associated with greater prevalence of depressive symptoms (p\u2009<\u20090.05).", {"entities": [[30, 33, "GENE"]]}], ["High IL-6, high CRP and depressive symptoms were independently associated with decreased FEV1% predicted and FEV1/FVC% predicted after adjusting for smoking status, BMI and number of chronic inflammatory diseases.", {"entities": [[16, 19, "GENE"]]}], ["Increasing grades of combination of inflammatory markers and/or depressive symptoms was associated with progressive increases in pulmonary obstruction.", {"entities": []}], ["In hierarchical models, the significant association of depressive symptoms with pulmonary obstruction was reduced by the presence of IL-6 and CRP.", {"entities": [[142, 145, "GENE"]]}], ["This study found for the first time an association of depressive symptoms and pulmonary function in older adults which appeared to be partly mediated by proinflammatory cytokines.", {"entities": []}], ["Further studies should be conducted to investigate proinflammatory immune markers and depressive symptoms as potential phenotypic indicators for chronic obstructive airway disorders in older adults.", {"entities": []}], ["Group 2 Innate lymphoid cells (ILC2s) are innate cells that produce the TH2 cytokines IL-5 and IL-13.", {"entities": []}], ["The importance of these cells has recently been demonstrated in experimental models of parasitic diseases but there is a paucity of data on ILC2s in the context of human parasitic infections and in particular of the blood dwelling parasite Schistosoma haematobium .", {"entities": []}], ["In this case-control study human peripheral blood ILC2s were analysed in relation to infection with the helminth parasite Schistosoma haematobium .", {"entities": []}], ["Peripheral blood mononuclear cells of 36 S .", {"entities": []}], ["haematobium infected and 36 age and sex matched uninfected children were analysed for frequencies of ILC2s identified as Lin-CD45+CD127+CD294+CD161+.", {"entities": []}], ["ILC2s were significantly lower particularly in infected children aged 6\u20139 years compared to healthy participants.", {"entities": []}], ["Curative anti-helminthic treatment resulted in an increase in levels of the activating factor TSLP and restoration of ILC2 levels.", {"entities": [[94, 98, "GENE"]]}], ["This study demonstrates that ILC2s are diminished in young helminth infected children and restored by removal of the parasites by treatment, indicating a previously undescribed association between a human parasitic infection and ILC2s and suggesting a role of ILC2s before the establishment of protective acquired immunity in human schistosomiasis.", {"entities": [[332, 347, "DISEASE"]]}], ["Understanding how immune responses are generated is critical for vaccine development.", {"entities": []}], ["There are comparatively few studies on the interface between the innate and adaptive immune system in generating protective immune responses.", {"entities": []}], ["Infections with helminth parasites, a cause of neglected tropical diseases, have a huge collective impact on public health in affected developing countries.", {"entities": []}], ["Helminths are associated with a complex type 2 immune response mediated by cytokines characteristically produced by adaptive T helper 2 cells (T H 2).", {"entities": []}], ["However in recent years a newly described type of innate immune cells has been shown to produce T H 2 cytokines.", {"entities": []}], ["This cell type was subsequently called \u2018Group 2 innate lymphoid cells\u2019 (ILC2s).", {"entities": []}], ["The importance of these cells has been demonstrated in experimental models of helminth infection as well as in allergic diseases.", {"entities": []}], ["The present study describes changes in human ILC2s during the human helminth infection schistosomiasisas (bilharzia).", {"entities": []}], ["Our study shows that the proportions of ILC2s, were lower in young, but not older infected children when compared to uninfected participants, suggesting a role for ILC2s before the establishment of helminth protective acquired immunity.", {"entities": []}], ["Furthermore ILC2s were restored after curative treatment of the helminth infection.", {"entities": []}], ["Human mechanistic studies will determine if the association between ILC2s and schistosome infection is causal or a marker of resistance to infection.", {"entities": []}], ["Oral immunotherapy (OIT) has been considered a promising approach for food allergies (FAs).", {"entities": [[86, 89, "GENE"]]}], ["However, the current OIT strategy is limited in terms of the long-term efficacy and safety.", {"entities": []}], ["We have previously demonstrated that kakkonto, a traditional Japanese herbal medicine, suppresses the occurrence of allergic symptoms in a murine model of ovalbumin (OVA)-induced FA, which is attributed to the induction of the Foxp3", {"entities": [[227, 232, "GENE"]]}], ["Childhood asthma and obesity prevalence have increased in recent years suggesting a potential association.", {"entities": [[21, 28, "DISEASE"], [10, 16, "DISEASE"]]}], ["However, the direction of any association is poorly understood and the potential causal-relationship is unknown.", {"entities": []}], ["We examined the association between overweight/obesity, defined by body mass index (BMI) <18\u00a0years of age, and subsequent physician-diagnosed incident asthma at least one year after BMI assessment.", {"entities": [[47, 54, "DISEASE"], [151, 157, "DISEASE"]]}], ["We sought to explore potential effect modification by sex.", {"entities": []}], ["PubMed and Embase were searched using keywords and restricted to subjects aged 0\u201318\u00a0years.", {"entities": []}], ["There were no date or language restrictions.", {"entities": []}], ["From each study we extracted: authors, publication date, location, overweight/obesity definitions, asthma definitions, number of participants, recruitment duration, description of cohort, follow-up time, adjusted effect estimates (with 95% CI) and estimates of subgroup analysis.", {"entities": [[78, 85, "DISEASE"], [99, 105, "DISEASE"]]}], ["Six prospective cohort studies which focused on children <18\u00a0years of age met criteria for inclusion.", {"entities": []}], ["The combined risk ratio (RR) of overweight was associated with asthma (RR\u2009=\u20091.35; 95% CI\u2009=\u20091.15, 1.58).", {"entities": [[63, 69, "DISEASE"]]}], ["In boys, the combined RR of overweight on asthma was significant (RR\u2009=\u20091.41; 95% CI\u2009=\u20091.05, 1.88).", {"entities": [[42, 48, "DISEASE"]]}], ["For girls, when BMI was defined by Z-score, the combined RR of overweight on asthma was also significant (RR\u2009=\u20091.19; 95% CI\u2009=\u20091.06, 1.34).", {"entities": [[77, 83, "DISEASE"]]}], ["The combined risk ratio (RR) of obesity was associated with asthma in both boys and girls (RR\u2009=\u20091.50; 95% CI\u2009=\u20091.22, 1.83), in boys only (RR\u2009=\u20091.40; 95% CI\u2009=\u20091.01, 1.93) and in girls only (RR\u2009=\u20091.53; 95% CI\u2009=\u20091.09, 2.14).", {"entities": [[32, 39, "DISEASE"], [60, 66, "DISEASE"]]}], ["Overweight and, especially, obese children are at increased risk of subsequent physician diagnosed asthma in comparison to normal weight children.", {"entities": [[99, 105, "DISEASE"]]}], ["Except for sex, no studies reported any other potential effect modifiers.", {"entities": []}], ["The observed sex effects were inconsistent.", {"entities": []}], ["Medicinal plants remain an integral part of the lives of people in rural areas.", {"entities": []}], ["The aim of this study was to document information about the medicinal plants used by Shangaan people in villages under Jongilanga tribal council, Bushbuckridge municipality, Mpumalanga Province, South Africa.", {"entities": []}], ["An ethnobotanical survey of medicinal plants was conducted using a semi-structured questionnaire with 15 traditional healers as informants; one of them also served as a field guide during data collection.", {"entities": []}], ["Results were analysed by using various quantitative indices of information consensus factor (ICF), use report (UR), frequency citation (FC) and relative frequency citation (RFC).", {"entities": []}], ["The study reported 86 medicinal plants used in villages for the treatment of various ailments, the majority (25 species) of which were used for urino-genital disorders.", {"entities": []}], ["The Fabaceae family was the most represented family (17 species) of all the medicinal plants recorded in this study.", {"entities": []}], ["The roots were the most frequently used plant part, accounting for 56% of the plants reported, and decoctions were often used in the preparation of herbal remedies.", {"entities": []}], ["Respiratory diseases had the highest ICF value recorded among the 8 categories of ailments.", {"entities": []}], ["The highest use report was reported for Combretum collinum (4), while the FC and RFC values (15) were highest in 12 plant species.", {"entities": []}], ["The study revealed that medicinal plants are still widely used in rural areas and this documentation can serve as an ethno pharmacological basis for selecting plants with potential pharmaceutical properties.", {"entities": []}], ["The article discusses the clinical management of patients affected by food protein-induced enterocolitis syndrome (FPIES), focusing on established therapeutic choices and future options.", {"entities": [[105, 113, "DISEASE"]]}], ["After FPIES has been diagnosed and avoidance of the culprit food prescribed, the most important management needs are as follows.", {"entities": []}], ["First, recurrence of acute FPIES episodes due to accidental ingestion of culprit food.", {"entities": []}], ["It may be useful to give patients\u2019 families an action plan.", {"entities": []}], ["The principal suggested treatments are intravenous fluids and steroids, whereas the use of epinephrine and ondansetron requires further study.", {"entities": []}], ["In mild-to-moderate cases, oral rehydration should be sufficient.", {"entities": []}], ["Second, dietary introduction of at-risk foods.", {"entities": []}], ["In children with FPIES, in addition to that/those identified as culprit(s), some foods may not be tolerated (typically cow's milk, legumes, cereals, poultry).", {"entities": []}], ["It has been suggested to avoid introducing these foods during the baby's first year.", {"entities": []}], ["Otherwise, they may be given for the first time in hospital, performing an oral food challenge.", {"entities": []}], ["Third, acquisition of tolerance.", {"entities": []}], ["Children affected by cow's milk-FPIES have a good chance of acquiring tolerance by the time they reach age 18\u201324\u200amonths.", {"entities": []}], ["For other culprit foods, insufficient data are available to indicate the appropriate time, so that it is suggested that an oral food challenge be performed about 1 \u200ayear after the last acute episode.", {"entities": []}], ["Future clinical management of FPIES must take into account, among other factors, improved understanding of pathogenesis, possible detection of different phenotypes, and the introduction of more effective therapies for acute episodes.", {"entities": []}], ["These factors will undoubtedly influence management decisions, which will become more diversified and effective.", {"entities": []}], ["Among elderly patients with chronic obstructive pulmonary disease (COPD), there are some patients who cannot inhale tiotropium via Respimat 1 ) in patients with COPD.", {"entities": [[28, 65, "DISEASE"]]}], ["A randomized, crossover, single-center study was conducted in 18 patients with stable COPD.", {"entities": []}], ["Tiotropium (5 \u03bcg) via Respimat 1 was measured at every visit using a spirometer.", {"entities": []}], ["A questionnaire regarding inhalation therapy was administered to patients at the final visit.", {"entities": []}], ["The administration of tiotropium via Respimat 1 from baseline during each treatment period, with mean differences of 115.0\u00b1169.6 mL and 92.8\u00b1128.1 mL, respectively.", {"entities": []}], ["There was no significant difference in the change in the trough FEV 1 between the 2 procedures (p=0.66).", {"entities": [[64, 67, "GENE"]]}], ["A total of 86% of patients reported that inhalation using a spacer was not difficult, and more than half also rated both the usage and maintenance of the AeroChamber Tiotropium inhalation therapy administered via Respimat", {"entities": []}], ["To assess the direct and indirect costs of diagnosing and treating community-acquired pneumonia (CAP), correlating those costs with CAP severity at diagnosis and identifying the major cost drivers.", {"entities": [[86, 95, "DISEASE"]]}], ["This was a prospective cost analysis study using bottom-up costing.", {"entities": []}], ["Clinical severity and mortality risk were assessed with the pneumonia severity index (PSI) and the mental Confusion-Urea-Respiratory rate-Blood pressure-age \u2265 65 years (CURB-65) scale, respectively.", {"entities": [[60, 69, "DISEASE"]]}], ["The sample comprised 95 inpatients hospitalized for newly diagnosed CAP.", {"entities": []}], ["The analysis was run from a societal perspective with a time horizon of one year.", {"entities": []}], ["Expressed as mean \u00b1 standard deviation, in Euros, the direct and indirect medical costs per CAP patient were 696 \u00b1 531 and 410 \u00b1 283, respectively, the total per-patient cost therefore being 1,106 \u00b1 657.", {"entities": []}], ["The combined budget impact of our patient cohort, in Euros, was 105,087 (66,109 and 38,979 in direct and indirect costs, respectively).", {"entities": []}], ["The major cost drivers, in descending order, were the opportunity cost (lost productivity); diagnosis and treatment of comorbidities; and administration of medications, oxygen, and blood derivatives.", {"entities": []}], ["The CURB-65 and PSI scores both correlated with the indirect costs of CAP treatment.", {"entities": []}], ["The PSI score correlated positively with the overall frequency of use of health care services.", {"entities": []}], ["Neither score showed any clear relationship with the direct costs of CAP treatment.", {"entities": []}], ["Clinical severity at admission appears to be unrelated to the costs of CAP treatment.", {"entities": []}], ["This is mostly attributable to unwarranted hospital admission (or unnecessarily long hospital stays) in cases of mild pneumonia, as well as to over-prescription of antibiotics.", {"entities": [[118, 127, "DISEASE"]]}], ["Authorities should strive to improve adherence to guidelines and promote cost-effective prescribing practices among physicians in southeastern Europe.", {"entities": []}], ["Symptoms consistent with inhalation toxicity have long been associated with Florida red tides, and various causal agents have been proposed.", {"entities": []}], ["Research since 1981 has centered on a group of naturally occurring trans -fused cyclic polyether compounds called brevetoxins that are produced by a marine dinoflagellate known as Karenia brevis .", {"entities": []}], ["Numerous individual brevetoxins have been identified from cultures as well as from natural bloom events.", {"entities": []}], ["A spectrum of brevetoxin derivatives produced by chemical modification of the natural toxins has been prepared to examine the effects of functional group modification on physiologic activity.", {"entities": []}], ["Certain structural features of natural and synthetic derivatives of brevetoxin appear to ascribe specific physiologic consequences to each toxin.", {"entities": []}], ["Differential physiologic effects have been documented with many of the natural toxins and derivatives, reinforcing the hypothesis that metabolism or modification of toxin structures modulates both the specific toxicity (lethality on a per milligram basis) and potentially the molecular mechanism(s) of action.", {"entities": []}], ["A series of naturally occurring fused-ring polyether compounds with fewer rings than brevetoxin, known as brevenals, exhibit antagonistic properties and counteract the effects of the brevetoxins in neuronal and pulmonary model systems.", {"entities": []}], ["Taken together, the inhalation toxicity of Florida red tides would appear to depend on the amount of each toxin present, as well as on the spectrum of molecular activities elicited by each toxin.", {"entities": []}], ["Toxicity in a bloom is diminished by the amount brevenal present.", {"entities": []}], ["Chronic pelvic pain (CPP) has a prevalence similar to asthma and chronic back pain, but little is known about how general practitioners (GPs) and practice nurses manage women with this problem.", {"entities": [[54, 60, "DISEASE"]]}], ["A clearer understanding of current management is necessary to develop appropriate strategies, in keeping with current health care policy, for the supported self-management of patients with long term conditions.", {"entities": []}], ["The aim of this study was to explore GPs' and practice nurses' understanding and perspectives on the management of chronic pelvic pain.", {"entities": []}], ["Data were collected using semi-structured interviews with a purposive sample of 21 GPs and 20 practice nurses, in three primary care trusts in the North West of England.", {"entities": []}], ["Data were analysed using the principles of Framework analysis.", {"entities": []}], ["Analysis suggests that women who present with CPP pose a challenge to GPs and practice nurses.", {"entities": []}], ["CPP is not necessarily recognized as a diagnostic label and making the diagnosis was achieved only by exclusion.", {"entities": []}], ["This contrasts with the relative acceptability of labels such as irritable bowel syndrome (IBS).", {"entities": [[65, 89, "DISEASE"], [81, 89, "DISEASE"]]}], ["GPs expressed elements of therapeutic nihilism about the condition.", {"entities": []}], ["Despite practice nurses taking on increasing responsibilities for the management of patients with long term conditions, respondents did not feel that CPP was an area that they were comfortable in managing.", {"entities": []}], ["The study demonstrates an educational/training need for both GPs and practice nurses.", {"entities": []}], ["GPs described a number of skills and clinical competencies which could be harnessed to develop a more targeted management strategy.", {"entities": []}], ["There is potential to develop facilitated self- management for use in this patient group, given that this approach has been successful in patients with similar conditions such as IBS.", {"entities": []}], ["Tumor necrosis factor-\u03b1 (TNF-\u03b1) is one of the most typical pro-inflammatory cytokines with both beneficial and destructive properties for the central nervous system.", {"entities": []}], ["Increasing evidences have demonstrated the important role of TNF-\u03b1 in the development of ischemic stroke, but studies examining the possible association with stroke or direct functional effects of polymorphisms in TNF-\u03b1 have been contradictory.", {"entities": []}], ["In this study, a 2-kb length of the proximal promoter of the TNF-\u03b1 was screened and four polymorphisms were investigated in the case\u2013control study.", {"entities": []}], ["Our data confirmed the association between -308G/A variant with stroke in 1,388 stroke patients and 1,027 controls and replicated in an independent population of 961 stroke patients and 821 controls (odds ratio (OR)\u2009=\u20091.34, 95% confidence interval (CI) =1.02 to 1.77 and OR\u2009=\u20091.56, 95% CI\u2009=\u20091.09 to 2.23, respectively).", {"entities": []}], ["To reconcile the association between polymorphisms and stroke and to give a comprehensive picture of the genetic architecture of this important gene, we performed a meta-analysis of 15 published studies in an Asian population.", {"entities": []}], ["Our results demonstrated an association between rs1800629 and ischemic stroke (OR\u2009=\u20091.43, 95% CI\u2009=\u20091.21 to 1.69).", {"entities": []}], ["Another meta-analysis results of 14 studies demonstrated that ischemic stroke patients have higher serum TNF-\u03b1 level than the control subjects (standardized mean difference (SMD) = 2.33, 95% CI = 1.85 to 2.81).", {"entities": []}], ["In vitro evaluation of potential interaction between variants of the TNF-\u03b1 gene (\u2212308G/A, -857C/T, and -1031T/C) demonstrated that these three polymorphisms could interact together to determine the overall activity of the TNF-\u03b1 gene.", {"entities": []}], ["These findings strongly implicate the involvement of TNF-\u03b1 in the pathogenesis of stroke.", {"entities": []}], ["Smoking-related emphysema is a chronic inflammatory disease driven by T helper 17 (T H 17) cells through molecular mechanisms that remain obscure.", {"entities": []}], ["Here we have explored the role of microRNA-22 (miR-22) in emphysema.", {"entities": [[47, 53, "GENE"]]}], ["MiR-22 was upregulated in lung myeloid dendritic cells (mDCs) of smokers with emphysema and antigen-presenting cells (APCs) of mice exposed to smoke or nanoparticulate carbon black (nCB) through a mechanism involving NF-\u03baB.", {"entities": [[0, 6, "GENE"], [118, 122, "GENE"]]}], ["MiR-22-deficient mice, but not wild-type, showed attenuated T H 17 responses and failed to develop emphysema after exposure to either smoke or nCB.", {"entities": []}], ["We further show that miR-22 controls APC activation and T H 17 responses through activation of AP-1 transcription factor complexes and histone deacetylase (HDAC) 4.", {"entities": [[21, 27, "GENE"], [37, 40, "GENE"]]}], ["Thus, miR-22 is a critical regulator of both emphysema and T H 17 responses.", {"entities": [[6, 12, "GENE"]]}], ["Serious infection is a concern for patients with psoriasis receiving biologic therapies.", {"entities": [[49, 58, "DISEASE"]]}], ["We assessed the risk of serious infections for biologics used to treat psoriasis by comparison with a cohort receiving non-biologic systemic therapies in a propensity score-weighted Cox proportional hazards model using data from the British Association of Dermatologists Biologic Interventions Register.", {"entities": [[71, 80, "DISEASE"]]}], ["Overall, 1,352; 3,271; and 994 participants were included in the etanercept, adalimumab, ustekinumab cohorts, respectively, and 3,421 participants were in the non-biologic cohort.", {"entities": []}], ["A total of 283 patients had a serious infection; the incidence rates with 95% confidence intervals (CI) per 1,000 person-years were as follows: non-biologic, 14.2 (11.5\u201317.4); etanercept, 15.3 (11.6\u201320.1); adalimumab, 13.9 (11.4\u201316.6); and ustekinumab, 15.1 (10.8\u201321.1).", {"entities": []}], ["No significant increases in the risk of serious infection were observed for etanercept (hazard ratio [HR]\u00a0= 1.10, 95% CI\u00a0= 0.75\u20131.60), adalimumab (HR\u00a0= 0.93, 95% CI\u00a0= 0.69\u20131.26), or ustekinumab (HR\u00a0= 0.92, 95% CI\u00a0= 0.60\u20131.41) compared with non-biologic systemic therapies or methotrexate-only (etanercept: HR\u00a0= 1.47, 95% CI\u00a0= 0.95\u20132.28; adalimumab: HR\u00a0= 1.26, 95% CI\u00a0= 0.86\u20131.84; ustekinumab: HR\u00a0= 1.22, 95% CI\u00a0= 0.75\u20131.99).", {"entities": [[102, 104, "GENE"], [147, 149, "GENE"], [195, 197, "GENE"], [306, 308, "GENE"], [349, 351, "GENE"], [393, 395, "GENE"], [102, 104, "GENE"], [147, 149, "GENE"], [195, 197, "GENE"], [306, 308, "GENE"], [349, 351, "GENE"], [393, 395, "GENE"], [102, 104, "GENE"], [147, 149, "GENE"], [195, 197, "GENE"], [306, 308, "GENE"], [349, 351, "GENE"], [393, 395, "GENE"], [102, 104, "GENE"], [147, 149, "GENE"], [195, 197, "GENE"], [306, 308, "GENE"], [349, 351, "GENE"], [393, 395, "GENE"], [102, 104, "GENE"], [147, 149, "GENE"], [195, 197, "GENE"], [306, 308, "GENE"], [349, 351, "GENE"], [393, 395, "GENE"], [102, 104, "GENE"], [147, 149, "GENE"], [195, 197, "GENE"], [306, 308, "GENE"], [349, 351, "GENE"], [393, 395, "GENE"]]}], ["The risk of serious infection should not be a key discriminator for patients and clinicians when choosing between non-biologic systemic therapies, etanercept, adalimumab, and ustekinumab for the treatment of psoriasis.", {"entities": [[208, 217, "DISEASE"]]}], ["Objectives: In the public mind, later life is being transformed by the emerging possibility of a flourishing third age with sustained quality of life.", {"entities": []}], ["We draw trajectories of life quality measured using CASP-19 over eight years.", {"entities": []}], ["We refine these trajectories by jointly modelling attrition, since older people tend to leave longitudinal studies (attrite) not at random.", {"entities": []}], ["Methods: Growth curve models are applied to the English Longitudinal Study of Ageing waves 1 to 5.", {"entities": []}], ["Then joint model is estimated where attrition is considered.", {"entities": []}], ["Extensive predictors are entered including demographic attributes, social and economic status, health conditions, and behaviours.", {"entities": []}], ["Results: Strong non-linear age trajectory of life quality is revealed by the growth curve models where the peak is achieved in the late 60s.", {"entities": []}], ["Then the joint model uncovers the peak somewhat later in time, and also reveals secular improvement in life quality experienced by recent cohorts.", {"entities": []}], ["Sharp estimates for many predictors of higher levels of life quality are also found.", {"entities": []}], ["Conclusion: For the first time, the trajectories of life quality in the third age are drawn and improvement across cohorts is demonstrated.", {"entities": []}], ["The contributions are estimated for predictors amenable to intervention such as social capital.", {"entities": []}], ["This can help in policy discussion on improving the lives of older people in the third age.", {"entities": []}], ["Contemporary information on mechanical ventilation (MV) use in emerging countries is limited.", {"entities": []}], ["Moreover, most epidemiological studies on ventilatory support were carried out before significant developments, such as lung protective ventilation or broader application of non-invasive ventilation (NIV).", {"entities": []}], ["We aimed to evaluate the clinical characteristics, outcomes and risk factors for hospital mortality and failure of NIV in patients requiring ventilatory support in Brazilian intensive care units (ICU).", {"entities": []}], ["In a multicenter, prospective, cohort study, a total of 773 adult patients admitted to 45 ICUs over a two-month period requiring invasive ventilation or NIV for more than 24 hours were evaluated.", {"entities": []}], ["Causes of ventilatory support, prior chronic health status and physiological data were assessed.", {"entities": []}], ["Multivariate analysis was used to identifiy variables associated with hospital mortality and NIV failure.", {"entities": []}], ["Invasive MV and NIV were used as initial ventilatory support in 622 (80%) and 151 (20%) patients.", {"entities": []}], ["Failure with subsequent intubation occurred in 54% of NIV patients.", {"entities": []}], ["The main reasons for ventilatory support were pneumonia (27%), neurologic disorders (19%) and non-pulmonary sepsis (12%).", {"entities": [[46, 55, "DISEASE"]]}], ["ICU and hospital mortality rates were 34% and 42%.", {"entities": []}], ["Using the Berlin definition, acute respiratory distress syndrome (ARDS) was diagnosed in 31% of the patients with a hospital mortality of 52%.", {"entities": [[56, 64, "DISEASE"]]}], ["In the multivariate analysis, age (odds ratio (OR), 1.03; 95% confidence interval (CI), 1.01 to 1.03), comorbidities (OR, 2.30; 95% CI, 1.28 to 3.17), associated organ failures (OR, 1.12; 95% CI, 1.05 to 1.20), moderate (OR, 1.92; 95% CI, 1.10 to 3.35) to severe ARDS (OR, 2.12; 95% CI, 1.01 to 4.41), cumulative fluid balance over the first 72 h of ICU (OR, 2.44; 95% CI, 1.39 to 4.28), higher lactate (OR, 1.78; 95% CI, 1.27 to 2.50), invasive MV (OR, 2.67; 95% CI, 1.32 to 5.39) and NIV failure (OR, 3.95; 95% CI, 1.74 to 8.99) were independently associated with hospital mortality.", {"entities": []}], ["The predictors of NIV failure were the severity of associated organ dysfunctions (OR, 1.20; 95% CI, 1.05 to 1.34), ARDS (OR, 2.31; 95% CI, 1.10 to 4.82) and positive fluid balance (OR, 2.09; 95% CI, 1.02 to 4.30).", {"entities": []}], ["Current mortality of ventilated patients in Brazil is elevated.", {"entities": []}], ["Implementation of judicious fluid therapy and a watchful use and monitoring of NIV patients are potential targets to improve outcomes in this setting.", {"entities": []}], ["ClinicalTrials.gov NCT01268410 .", {"entities": []}], ["Few studies have investigated the presence of shift work disorder (SWD) in the general community.", {"entities": []}], ["We addressed many of the limitations in this literature and present new findings.", {"entities": []}], ["SWD has been treated as an \u2018all or none\u2019 construct but we propose the need to consider the \u2018severity\u2019 of the disorder.", {"entities": []}], ["Using random digit dialling, we randomly recruited 1163 participants.", {"entities": []}], ["Participants completed an extensive battery of scales and questions concerning work, health and individual differences.", {"entities": []}], ["Three questions based on the criteria from the International Classification for Sleep Disorders were used to categorise participants with SWD (n\u200a=\u200a176).", {"entities": []}], ["In addition, we asked participants whether SWD interfered with aspects of their life and high ratings were used to define severe shift work disorder (SSWD).", {"entities": []}], ["The prevalence of SWD was 32.1% among night workers and 10.1% in day workers (p<.001).", {"entities": []}], ["SSWD was present in 9.1% of night workers and 1.3% of day workers (p<.001).", {"entities": []}], ["Adjusted logistic regression analyses found significant associations between SWD and night work (OR \u200a=\u200a3.35, CI 2.19-5.12), weekly work hours (OR \u200a=\u200a1.02, CI 1.00\u20131.04), short sleep (\u22646 h; OR \u200a=\u200a2.93, CI 1.94\u20134.41), languidity (OR \u200a=\u200a1.11, CI 1.06\u20131.16) and resilience (OR \u200a=\u200a0.56, CI 0.43\u20130.81).", {"entities": []}], ["Night work, short sleep, languidity, and hypertension were significantly associated with SSWD.", {"entities": [[41, 53, "DISEASE"]]}], ["Overall, participants with SSWD slept 0.80 h less than other participants (p<.001).", {"entities": []}], ["Night work, short sleep and languidity were associated with both SWD and SSWD.", {"entities": []}], ["Day workers with SWD symptoms reported significantly shorter sleep duration, higher levels of languidity and worked longer working hours compared to day workers without SWD.", {"entities": []}], ["The impact of intestinal helminth infection on the clinical presentation and immune response during active tuberculosis (TB) infection is not well characterized.", {"entities": [[107, 119, "DISEASE"]]}], ["Our aim was to investigate whether asymptomatic intestinal helminth infection alters the clinical signs and symptoms as well as the cell mediated immune responses in patients with active TB.", {"entities": []}], ["Consecutive, newly diagnosed TB patients and healthy community controls (CCs) were recruited in North-west Ethiopia.", {"entities": [[73, 76, "GENE"]]}], ["TB-score, body mass index and stool samples were analyzed.", {"entities": []}], ["Cells from HIV-negative TB patients (HIV-/TB) and from CCs were analyzed for regulatory T-cells (Tregs) and cytokine responses using flow cytometry and ELISPOT, respectively.", {"entities": [[55, 58, "GENE"]]}], ["A significantly higher ratio of helminth co-infection was observed in TB patients without HIV (Helm+/HIV-/TB) compared to HIV negative CCs, (40% (121/306) versus 28% (85/306), p = 0.003).", {"entities": [[135, 138, "GENE"]]}], ["Helm+/HIV-/TB patients showed significantly increased IL-5 secreting cells compared to Helm-/HIV-/TB (37 SFU (IQR:13\u2013103) versus 2 SFU (1\u201350); p = 0.02, n = 30).", {"entities": []}], ["Likewise, levels of absolute Tregs (9.4 (3.2\u201316.7) cells/\u03bcl versus 2.4 (1.1\u20134.0) cells/\u03bcl; p = 0.041) and IL-10 secreting cells (65 SFU (7\u2013196) versus 1 SFU (0\u201331); p = 0.014) were significantly higher in Helm+/HIV-/TB patients compared to Helm-/HIV-/TB patients.", {"entities": []}], ["In a multivariate analysis, a lower rate of sputum smear positivity for acid fast bacilli, lower body temperature, and eosinophilia were independently associated with helminth infection in TB patients.", {"entities": [[119, 131, "DISEASE"]]}], ["Asymptomatic helminth infection is associated with increased regulatory T-cell and Th2-type responses and a lower rate of sputum smear positivity.", {"entities": []}], ["Further studies are warranted to investigate the clinical and immunological impact of helminth infection in TB patients.", {"entities": []}], ["The effects of helminth infection on chronic infectious diseases such as tuberculosis (TB) merit further characterization.", {"entities": [[73, 85, "DISEASE"]]}], ["There is limited data regarding the impact of helminth co-infection on clinical and immunological outcomes of TB from clinical field studies in high endemic areas.", {"entities": []}], ["We tried to address some of these issues in a randomized clinical trial in order to investigate the impact of albendazole treatment on helminth co-infected TB patients.", {"entities": []}], ["In the present study we focused on the clinical and immunological effects of helminth infection on TB.", {"entities": []}], ["We found that concomitant asymptomatic helminth infection profoundly affects the immune phenotype of TB patients with a strong leaning towards Th2 types of immune response such as increased regulatory T cells as well as IL-5 and IL-10 secreting cells.", {"entities": []}], ["Furthermore, helminth co-infection was associated with a significantly lower ratio of sputum smear positivity which correlated to the egg load in helminth positive TB patients.", {"entities": []}], ["Whether the effect of helminth infection may have an impact on the diagnosis and treatment of active TB remains to be further investigated.", {"entities": []}], ["This review covers recent developments in the area of particle engineering via spray drying.", {"entities": []}], ["The last decade has seen a shift from empirical formulation efforts to an engineering approach based on a better understanding of particle formation in the spray drying process.", {"entities": []}], ["Microparticles with nanoscale substructures can now be designed and their functionality has contributed significantly to stability and efficacy of the particulate dosage form.", {"entities": []}], ["The review provides concepts and a theoretical framework for particle design calculations.", {"entities": []}], ["It reviews experimental research into parameters that influence particle formation.", {"entities": []}], ["A classification based on dimensionless numbers is presented that can be used to estimate how excipient properties in combination with process parameters influence the morphology of the engineered particles.", {"entities": []}], ["A wide range of pharmaceutical application examples\u2014low density particles, composite particles, microencapsulation, and glass stabilization\u2014is discussed, with specific emphasis on the underlying particle formation mechanisms and design concepts.", {"entities": []}], ["Biological sex plays a prominent role in the prevalence and severity of a number of important stress-related gastrointestinal and immune-related diseases including IBS and allergy/anaphylaxis.", {"entities": []}], ["Despite the establishment of sex differences in these diseases, the underlying mechanisms contributing to sex differences remain poorly understood.", {"entities": []}], ["The objective of this study was to define the role of biological sex on mast cells (MCs), an innate immune cell central to the pathophysiology of many GI and allergic disorders.", {"entities": []}], ["Twelve-week-old C57BL/6 male and female mice were exposed to immunological stress (2\u00a0h of IgE-mediated passive systemic anaphylaxis (PSA)) or psychological stress (1\u00a0h of restraint stress (RS)) and\u00a0temperature, clinical scores, serum histamine, and intestinal permeability (for RS) were measured.", {"entities": []}], ["Primary bone marrow-derived MCs (BMMCs) were harvested from male and female mice and analyzed for MC degranulation, signaling pathways, mediator content, and RNA transcriptome analysis.", {"entities": []}], ["Sexually dimorphic responses were observed in both models of PSA and RS and in primary MCs.", {"entities": []}], ["Compared with male mice, female mice exhibited increased clinical scores, hypothermia, and serum histamine levels in response to PSA and had greater intestinal permeability and serum histamine responses to RS.", {"entities": []}], ["Primary BMMCs from female mice exhibited increased release of \u03b2-hexosaminidase, histamine, tryptase, and TNF-\u03b1 upon stimulation with IgE/DNP and A23187.", {"entities": []}], ["Increased mediator release in female BMMCs was not associated with increased upstream phospho-tyrosine signaling pathways or downstream Ca These results provide a new understanding of sexual dimorphic responses in MCs and have direct implications for stress-related diseases associated with a female predominance and MC hyperactivity including irritable bowel syndrome, allergy, and anaphylaxis.", {"entities": [[344, 368, "DISEASE"], [360, 368, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s13293-016-0113-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To evaluate the association between environmental tobacco smoke (ETS) exposure and depression among Korean women.", {"entities": []}], ["Between 2008 and 2011, we examined 731 men and 1249 women (aged 39\u201385\u2005years) for the Korean Genome and Epidemiology Study (KoGES)-Kangwha.", {"entities": []}], ["Among 1208 never-smoking women, we excluded two women taking antidepressants and five women who did not complete the Beck Depression Inventory (BDI).", {"entities": []}], ["Therefore, we performed a cross-sectional analysis on 1201 women.", {"entities": []}], ["ETS exposure was assessed using a self-reported questionnaire, and was classified into three groups: no exposure, occasional exposure and regular exposure.", {"entities": []}], ["Depression was assessed using the BDI score, which ranged from 0 to 63, and the presence of depression was defined as a BDI score \u226510.", {"entities": []}], ["Women exposed to ETS were more likely to have depression than those without ETS exposure (p=0.019).", {"entities": []}], ["When BDI was analysed as a continuous variable, women exposed to ETS had significantly higher BDI scores after full adjustment (overall exposure: \u03b2=1.36, p=0.013; occasional exposure: \u03b2=1.15, p=0.063; regular exposure: \u03b2=1.90, p=0.039).", {"entities": []}], ["ETS exposure was significantly associated with depression in a dose\u2013response manner even after adjusting for age, body mass index, menopause, socioeconomic status, lifestyle and prevalent chronic diseases.", {"entities": []}], ["The adjusted OR for depression (95% CI) was 1.72 (1.25 to 2.37) for overall ETS exposure, 1.56 (1.09 to 2.24) for occasional exposure and 2.19 (1.30 to 3.69) for regular exposure, when compared to no exposure.", {"entities": []}], ["Exposure to ETS was associated with depression among middle aged and elderly Korean women.", {"entities": []}], ["Flow cytometry is a method widely used to quantify suspended solids such as cells or bacteria in a size range from 0.5 to several tens of micrometers in diameter.", {"entities": []}], ["In addition to a characterization of forward and sideward scatter properties, it enables the use of fluorescent labeled markers like antibodies to detect respective structures.", {"entities": []}], ["Using indirect antibody staining, flow cytometry is employed here to quantify birch pollen allergen (precisely Bet v 1)-loaded particles of 0.5 to 10 \u00b5m in diameter in inhalable particulate matter (PM10, particle size \u226410 \u00b5m in diameter).", {"entities": []}], ["PM10 particles may act as carriers of adsorbed allergens possibly transporting them to the lower respiratory tract, where they could trigger allergic reactions.", {"entities": []}], ["So far the allergen content of PM10 has been studied by means of enzyme linked immunosorbent assays (ELISAs) and scanning electron microscopy.", {"entities": []}], ["ELISA measures the dissolved and not the particle-bound allergen.", {"entities": []}], ["Compared to scanning electron microscopy, which can visualize allergen-loaded particles, flow cytometry may additionally quantify them.", {"entities": []}], ["As allergen content of ambient air can deviate from birch pollen count, allergic symptoms might perhaps correlate better with allergen exposure than with pollen count.", {"entities": []}], ["In conjunction with clinical data, the presented method offers the opportunity to test in future experiments whether allergic reactions to birch pollen antigens are associated with the Bet v 1 allergen content of PM10 particles >0.5 \u00b5m.", {"entities": []}], ["Total cholesterol (TC) concentration is the most commonly used measure of statin efficacy in the UK.", {"entities": []}], ["This study aimed to evaluate the effectiveness of statins in lowering TC, cardiovascular events (CV) and mortality five common chronic diseases (chronic obstructive pulmonary disease (COPD), osteoarthritis (OA), rheumatoid arthritis (RA), chronic kidney disease (CKD), and diabetes mellitus (DM)) and to compare effectiveness with the rest of the population not recorded as having these diseases.", {"entities": [[247, 261, "DISEASE"], [212, 232, "DISEASE"], [145, 182, "DISEASE"], [223, 232, "DISEASE"], [191, 205, "DISEASE"], [273, 290, "DISEASE"]]}], ["A population-based cohort study was conducted in Tayside population who had at least two TC measurements between 1993 and 2007.", {"entities": []}], ["There were 12,140 patients with chronic diseases and 9,481 patients in the rest of the population not recorded as having these chronic diseases.", {"entities": []}], ["The main outcomes were TC change from baseline, CV events and all-cause mortality.", {"entities": []}], ["Statin-associated TC reductions varied from 15% to 28% with baseline value of between 5.1 and 5.9\u2009mmol/L in the primary prevention (PP) and from 7% to 23% with baseline value of 4.5 to 5.2\u2009mmol/L in the secondary prevention (SP) among chronic diseases patients.", {"entities": []}], ["In the rest of the population, TC reductions with statins were 31% in PP and 28% in SP with baselines of 6.3\u2009mmol/L and 5.3\u2009mmol/L, respectively (test of heterogeneity with chronic disease groups: p\u2009<\u20090.001).", {"entities": []}], ["A notional reduction of 0.5\u2009mmol/L in TC predicted variable reductions in incident CV events of 30% in RA, 19% in CKD, and 20% in DM, and recurrent CV events by 62% in COPD, 16% in CKD, and 19% in DM.", {"entities": []}], ["The corresponding figures for the rest of population were 12% for incident CV events and 17% for the recurrent CV events, respectively.", {"entities": []}], ["Risk reductions for all-cause mortality varied from 20% to 36% in PP and from 18% to 40% in SP, except in OA or RA patients in the chronic diseases and 11% in PP and 16% in the rest of population (test of heterogeneity: p\u2009>\u20090.05).", {"entities": []}], ["The effectiveness of statins in common chronic diseases varied.", {"entities": []}], ["With the exception of diabetes, statins tends to be less effective in patients with the chronic diseases compared with the rest of the study population.", {"entities": []}], ["Changes in TC with statins appear not to correlate well with the changes in cardiovascular events and all-cause mortality.", {"entities": []}], ["DNA diagnostics are useful but are hampered by difficult ethical issues.", {"entities": []}], ["Moreover, it cannot provide enough information on the environmental factors that are important for pathogenesis of certain diseases.", {"entities": []}], ["However, this is not a problem for RNA diagnostics, which evaluate the expression of the gene in question.", {"entities": []}], ["We here report a novel RNA diagnostics tool that can be employed with peripheral blood mononuclear cells (PBMCs).", {"entities": []}], ["To establish this tool, we identified 290 genes that are highly expressed in normal PBMCs but not in TIG-1, a normal human fibroblast cell.", {"entities": []}], ["These genes were entitled PREP after predominantly expressed in PBMC and included 50 uncharacterized genes.", {"entities": []}], ["We then conducted PREP gene-focused microarray analysis on PBMCs from seven cases of Churg\u2013Strauss syndrome (CSS), which is a small-vessel necrotizing vasculitis.", {"entities": [[99, 107, "DISEASE"], [151, 161, "DISEASE"]]}], ["We found that PREP135 (coactosin-like protein), PREP77 (prosaposin), PREP191 (cathepsin D), PREP234 ( c -fgr), and PREP136 (lysozyme) were very highly up-regulated in all seven CSS patients.", {"entities": []}], ["Another 28 genes were also up-regulated, albeit more moderately, and three were down-regulated in all CSS patients.", {"entities": []}], ["The nature of these up- and down-regulated genes suggest that the immune systems of the patients are activated in response to invading microorganisms.", {"entities": []}], ["These observations indicate that focused microarray analysis of PBMCs may be a practical, useful, and low-cost bedside diagnostics tool.", {"entities": []}], ["History of acute symptoms (cough, wheezing, shortness of breath, fever, stuffy nose, and skin itching/rash) following exposure to grain dust was obtained from 661 male and 535 female current and former farmers.", {"entities": []}], ["These symptoms were relatively common: 60% of male and 25% of female farmers reported at least one such symptom on exposure to grain dust.", {"entities": []}], ["Association of cough, wheezing, shortness of breath, and stuffy nose with skin reactivity and capacity to form IgE is consistent with an allergic nature of these symptoms.", {"entities": []}], ["Barley and oats dust were perceived as dust most often producing symptoms.", {"entities": []}], ["On the other hand, grain fever showed a different pattern, i.e., it was not associated with either skin reactivity or total IgE.", {"entities": []}], ["Smoking might modify the susceptibility to react to grain dust with symptoms.", {"entities": []}], ["Only those who reported wheezing on exposure to grain dust may have an increased risk to develop chronic airflow obstruction.", {"entities": []}], ["Adenosine, a purine nucleoside has been described as a \u2018retaliatory metabolite\u2019 by virtue of its ability to function in an autocrine manner and to modify the activity of a range of cell types, following its extracellular accumulation during cell stress or injury.", {"entities": []}], ["These effects are largely protective and are triggered by binding of adenosine to any of the four adenosine receptor subtypes namely A1, A2a, A2b, A3, which have been cloned in humans, and are expressed in most of the organs.", {"entities": []}], ["Each is encoded by a separate gene and has different functions, although overlapping.", {"entities": []}], ["For instance, both A1 and A2a receptors play a role in regulating myocardial oxygen consumption and coronary blood flow.", {"entities": []}], ["It is a proven fact that adenosine plays pivotal role in different physiological functions, such as induction of sleep, neuroprotection and protection against oxidative stress.", {"entities": []}], ["Until now adenosine was used for certain conditions like paroxysmal supraventricular tachycardia (PSVT) and Wolff Parkinson White (WPW) syndrome.", {"entities": [[136, 144, "DISEASE"]]}], ["Now there is a growing evidence that adenosine receptors could be promising therapeutic targets in a wide range of conditions including cardiac, pulmonary, immunological and inflammatory disorders.", {"entities": []}], ["After more than three decades of research in medicinal chemistry, a number of selective agonists and antagonists of adenosine receptors have been discovered and some have been clinically evaluated, although none has yet received regulatory approval.", {"entities": []}], ["So this review focuses mainly on the newer potential role of adenosine and its receptors in different clinical conditions.", {"entities": []}], ["Human milk (HM) is the optimal source of nutrition, protection and developmental programming for infants.", {"entities": []}], ["It is species-specific and consists of various bioactive components, including microRNAs, small non-coding RNAs regulating gene expression at the post-transcriptional level.", {"entities": []}], ["microRNAs are both intra- and extra-cellular and are present in body fluids of humans and animals.", {"entities": []}], ["Of these body fluids, HM appears to be one of the richest sources of microRNA, which are highly conserved in its different fractions, with milk cells containing more microRNAs than milk lipids, followed by skim milk.", {"entities": []}], ["Potential effects of exogenous food-derived microRNAs on gene expression have been demonstrated, together with the stability of milk-derived microRNAs in the gastrointestinal tract.", {"entities": []}], ["Taken together, these strongly support the notion that milk microRNAs enter the systemic circulation of the HM fed infant and exert tissue-specific immunoprotective and developmental functions.", {"entities": []}], ["This has initiated intensive research on the origin, fate and functional significance of milk microRNAs.", {"entities": []}], ["Importantly, recent studies have provided evidence of endogenous synthesis of HM microRNA within the human lactating mammary epithelium.", {"entities": []}], ["These findings will now form the basis for investigations of the role of microRNA in the epigenetic control of normal and aberrant mammary development, and particularly lactation performance.", {"entities": []}], ["Self-management is becoming increasingly important in COPD health care although it remains difficult to embed self-management into routine clinical care.", {"entities": []}], ["The implementation of self-management is understood as a complex interaction at the level of patient, health care provider (HCP), and health system.", {"entities": []}], ["Nonetheless there is still a poor understanding of the barriers and effective facilitators.", {"entities": []}], ["Comprehension of these determinants can have significant implications in optimizing self-management implementation and give further directions for the development of self-management interventions.", {"entities": []}], ["Data were collected among COPD patients (N=46) and their HCPs (N=11) in three general practices and their collaborating affiliated hospitals.", {"entities": []}], ["Mixed methods exploration of the data was conducted and collected by interviews, video-recorded consultations (N=50), and questionnaires on consultation skills.", {"entities": []}], ["Influencing determinants were monitored by 1) interaction and communication between the patient and HCP, 2) visible and invisible competencies of both the patient and the HCP, and 3) degree of embedding self-management into the health care system.", {"entities": []}], ["Video observations showed little emphasis on effective behavioral change and follow-up of given lifestyle advice during consultation.", {"entities": []}], ["A strong presence of COPD assessment and monitoring negatively affects the patient-centered communication.", {"entities": []}], ["Both patients and HCPs experience difficulties in defining personalized goals.", {"entities": []}], ["The satisfaction of both patients and HCPs concerning patient centeredness during consultation was measured by the patient feedback questionnaire on consultation skills.", {"entities": []}], ["The patients scored high (84.3% maximum score) and differed from the HCPs (26.5% maximum score).", {"entities": []}], ["Although the patient-centered approach accentuating self-management is one of the dominant paradigms in modern medicine, our observations show several influencing determinants causing difficulties in daily practice implementation.", {"entities": []}], ["This research is a first step unravelling the determinants of self-management leading to a better understanding.", {"entities": []}], ["Interleukin 4 (IL-4) is a key regulator of the immune system and an important factor in the development of allergic hypersensitivity.", {"entities": []}], ["Together with interleukin 13 (IL-13), IL-4 plays an important role in exacerbating allergic and asthmatic symptoms.", {"entities": []}], ["For signal transduction, both cytokines can utilise the same receptor, consisting of the IL-4R\u03b1 and the IL-13R\u03b11 chain, offering an explanation for their overlapping biological functions.", {"entities": []}], ["Since both cytokine ligands share only moderate similarity on the amino acid sequence level, molecular recognition of the ligands by both receptor subunits is of great interest.", {"entities": []}], ["IL-4 and IL-13 are interesting targets for allergy and asthma therapies.", {"entities": [[55, 61, "DISEASE"]]}], ["Knowledge of the binding mechanism will be important for the generation of either IL-4 or IL-13 specific drugs.", {"entities": []}], ["We present a structure/function analysis of the IL-4 ligand-receptor interaction.", {"entities": []}], ["Structural determination of a number of IL-4 variants together with in vitro binding studies show that IL-4 and its high-affinity receptor subunit IL-4R\u03b1 interact via a modular protein-protein interface consisting of three independently-acting interaction clusters.", {"entities": []}], ["For high-affinity binding of wild-type IL-4 to its receptor IL-4R\u03b1, only two of these clusters ( i.e .", {"entities": []}], ["cluster 1 centered around Glu9 and cluster 2 around Arg88) contribute significantly to the free binding energy.", {"entities": []}], ["Mutating residues Thr13 or Phe82 located in cluster 3 to aspartate results in super-agonistic IL-4 variants.", {"entities": []}], ["All three clusters are fully engaged in these variants, generating a three-fold higher binding affinity for IL-4R\u03b1.", {"entities": []}], ["Mutagenesis studies reveal that IL-13 utilizes the same main binding determinants, i.e .", {"entities": []}], ["Glu11 (cluster 1) and Arg64 (cluster 2), suggesting that IL-13 also uses this modular protein interface architecture.", {"entities": []}], ["The modular architecture of the IL-4-IL-4R\u03b1 interface suggests a possible mechanism by which proteins might be able to generate binding affinity and specificity independently.", {"entities": []}], ["So far, affinity and specificity are often considered to co-vary, i.e .", {"entities": []}], ["high specificity requires high affinity and vice versa.", {"entities": []}], ["Although the binding affinities of IL-4 and IL-13 to IL-4R\u03b1 differ by a factor of more than 1000, the specificity remains high because the receptor subunit IL-4R\u03b1 binds exclusively to IL-4 and IL-13.", {"entities": []}], ["An interface formed by several interaction clusters/binding hot-spots allows for a broad range of affinities by selecting how many of these interaction clusters will contribute to the overall binding free energy.", {"entities": []}], ["Understanding how proteins generate affinity and specificity is essential as more and more growth factor receptor families show promiscuous binding to their respective ligands.", {"entities": []}], ["This limited specificity is, however, not accompanied by low binding affinities.", {"entities": []}], ["Tumor necrosis factor-alpha inhibitors treatment is accosiated with several side effects.", {"entities": []}], ["The most common are injection side reactions, headache, nausea and infections.", {"entities": []}], ["The more rare are development of systemic autoimmune diseases.", {"entities": []}], ["We describe two patients, who developed ANCA associated vasculitis during Tumor necrosis factor alpha inhibitors treatment.", {"entities": [[56, 66, "DISEASE"]]}], ["The diagnosis was confirmed by appropriate tissue picture, CT scan and laboratory findings.", {"entities": []}], ["Our case series are unique, because vasculitis appeared after many years of the treatment and during complete patient\u2019s remission of there main illness.", {"entities": [[36, 46, "DISEASE"]]}], ["Apical potassium channels regulate ion transport in airway epithelial cells and influence air surface liquid (ASL) hydration and mucociliary clearance (MCC).", {"entities": [[110, 113, "GENE"], [152, 155, "GENE"]]}], ["We sought to identify whether genetic variation within genes encoding airway potassium channels is associated with chronic rhinosinusitis (CRS).", {"entities": []}], ["Single nucleotide polymorphism (SNP) genotypes for selected potassium channels were derived from data generated on the Illumnia HumanHap550 BeadChip or Illumina Human610-Quad BeadChip for 828 unrelated individuals diagnosed with CRS and 5,083 unrelated healthy controls from the Children's Hospital of Philadelphia (CHOP).", {"entities": []}], ["Statistical analysis was performed with set-based tests using PLINK, and corrected for multiple testing.", {"entities": []}], ["Set-based case control analysis revealed the gene KCNMA1 was associated with CRS in our Caucasian subset of the cohort (598 CRS cases and 3,489 controls; p\u200a=\u200a0.022, based on 10,000 permutations).", {"entities": [[50, 56, "GENE"]]}], ["In addition there was borderline evidence that the gene KCNQ5 (p\u200a=\u200a0.0704) was associated with the trait in our African American subset of the cohort (230 CRS cases and 1,594 controls).", {"entities": [[56, 61, "GENE"]]}], ["In addition to the top significant SNPs rs2917454 and rs6907229, imputation analysis uncovered additional genetic variants in KCNMA1 and in KCNQ5 that were associated with CRS.", {"entities": [[126, 132, "GENE"], [140, 145, "GENE"]]}], ["We have implicated two airway epithelial potassium channels as novel susceptibility loci in contributing to the pathogenesis of CRS.", {"entities": []}], ["The relative contributions of genetics and environment to asthma in Hispanics or to asthma in children younger than 3 years are not well understood.", {"entities": [[58, 64, "DISEASE"], [84, 90, "DISEASE"]]}], ["To examine the relative contributions of genetics and environment to early-childhood asthma by performing a longitudinal twin study of asthma in Puerto Rican children \u22643 years old.", {"entities": [[85, 91, "DISEASE"], [135, 141, "DISEASE"]]}], ["678 twin infants from the Puerto Rico Neo-Natal Twin Registry were assessed for asthma at age 1 year, with follow-up data obtained for 624 twins at age 3 years.", {"entities": [[80, 86, "DISEASE"]]}], ["Zygosity was determined by DNA microsatellite profiling.", {"entities": []}], ["Structural equation modeling was performed for three phenotypes at ages 1 and 3 years: physician-diagnosed asthma, asthma medication use in the past year, and \u22651 hospitalization for asthma in the past year.", {"entities": [[107, 113, "DISEASE"], [115, 121, "DISEASE"], [182, 188, "DISEASE"]]}], ["Models were additionally adjusted for early-life environmental tobacco smoke exposure, sex, and age.", {"entities": []}], ["The prevalences of physician-diagnosed asthma, asthma medication use, and hospitalization for asthma were 11.6%, 10.8%, 4.9% at age 1 year, and 34.1%, 40.1%, and 8.5% at 3 years, respectively.", {"entities": [[39, 45, "DISEASE"], [47, 53, "DISEASE"], [94, 100, "DISEASE"]]}], ["Shared environmental effects contributed to the majority of variance in susceptibility to physician-diagnosed asthma and asthma medication use in the first year of life (84%\u201386%), while genetic effects drove variance in all phenotypes (45%\u201365%) at age 3 years.", {"entities": [[110, 116, "DISEASE"], [121, 127, "DISEASE"]]}], ["Early-life environmental tobacco smoke, sex, and age contributed to variance in susceptibility.", {"entities": []}], ["Our longitudinal study in Puerto Rican twins demonstrates a changing contribution of shared environmental effects to liability for physician-diagnosed asthma and asthma medication use between ages 1 and 3 years.", {"entities": [[151, 157, "DISEASE"], [162, 168, "DISEASE"]]}], ["Early-life environmental tobacco smoke reduction could markedly reduce asthma morbidity in young Puerto Rican children.", {"entities": [[71, 77, "DISEASE"]]}], ["Respiratory syncytial virus (RSV) infection causes bronchiolitis in infants and children, which can be fatal, especially in immunocompromised patients.", {"entities": [[51, 64, "DISEASE"]]}], ["The BALB/c mouse, currently used as a model for studying RSV immunopathology, is semi-permissive to the virus.", {"entities": []}], ["A mouse model that more closely mimics human RSV infection is needed.", {"entities": []}], ["Since immunocompromised conditions increase risk of RSV infection, the possibility of enhancing RSV infection in the BALB/c mouse by pretreatment with cyclophosphamide was examined in this study.", {"entities": []}], ["BALB/c mice were treated with cyclophosphamide (CYP) and five days later, they were infected with RSV intranasally.", {"entities": []}], ["Pulmonary RSV titers, inflammation and airway hyperresponsiveness were measured five days after infection.", {"entities": []}], ["CYP-treated mice show higher RSV titers in their lungs of than the untreated mice.", {"entities": []}], ["Also, a decreased percentage of macrophages and an increased number of lymphocytes and neutrophils were present in the BAL of CYP-treated mice compared to controls.", {"entities": []}], ["The CYP-treated group also exhibited augmented bronchoalveolar and interstitial pulmonary inflammation.", {"entities": []}], ["The increased RSV infection in CYP-treated mice was accompanied by elevated expression of IL-10, IL-12 and IFN-\u03b3 mRNAs and proteins compared to controls.", {"entities": []}], ["Examination of CYP-treated mice before RSV infection showed that CYP treatment significantly decreased both IFN-\u03b3 and IL-12 expression.", {"entities": []}], ["These results demonstrate that CYP-treated BALB/c mice provide a better model for studying RSV immunopathology and that decreased production of IL-12 and IFN-\u03b3 are important determinants of susceptibility to RSV infection.", {"entities": []}], ["We investigated the association between rice burning and daily asthma hospitalizations in Butte County, California, from 1983 to 1992.", {"entities": [[63, 69, "DISEASE"]]}], ["Eighty-two percent of planted rice was burned, with a mean of 555 acres burned on days when burning was permitted.", {"entities": []}], ["For 60% of the days during this period, no rice burning occurred.", {"entities": []}], ["Peak burning occurred in fall and spring but was not correlated with criteria pollutants.", {"entities": []}], ["Asthma admissions averaged 0.65/day and peaked in March.", {"entities": [[0, 6, "DISEASE"]]}], ["In the basic Poisson model with daily asthma hospitalizations as the outcome of interest, burn acreage showed a small but statistically significant elevation of risk for hospitalization per acre of rice burned [relative risk (RR) = 1.0001; 95% confidence interval (CI), 1.", {"entities": [[38, 44, "DISEASE"]]}], ["00004-1.0002], after adjusting for maximum daily temperature, seasonal factors, and yearly population.", {"entities": []}], ["In this model, burn acreage showed a dose-response effect as acreage burned increased.", {"entities": []}], ["Days with the greatest acreage burned (>499 acres) had the largest risk of hospitalization (RR = 1.23; CI, 1.09-1.39), and days with moderate burning (between 100 and 499 acres) had a slightly lower risk of admission (RR = 1.2; CI, 1.05-1.37).", {"entities": []}], ["Elevations of air pollutants were not associated with days of increased rice burning; however, rice burn acreage was shown to have a small but statistically significant effect on asthma morbidity in Butte County.", {"entities": [[179, 185, "DISEASE"]]}], ["This evidence suggests that further limitations on the daily amount of rice straw permitted to be burned should be considered to reduce pulmonary morbidity related to asthma.", {"entities": [[167, 173, "DISEASE"]]}], ["Supplemental Digital Content is available in the text.", {"entities": []}], ["The Respiratory Syncytial Virus (RSV) Respiratory Events Among Preterm Infants Outcomes and Risk Tracking (REPORT) study evaluated RSV disease burden in US preterm infants 32\u201335 weeks gestational age (wGA) not receiving RSV prophylaxis.", {"entities": []}], ["Preterm infants <6 months of age as of November 1st were followed prospectively at 188 clinics from September to May 2009\u20132010 or 2010\u20132011.", {"entities": []}], ["Nasal and pharyngeal swabs were collected for medically attended acute respiratory illnesses (MAARI) and tested for RSV by qRT-polymerase chain reaction.", {"entities": []}], ["Risk factors were assessed using multivariate Cox proportional hazard model adjusted for seasonality.", {"entities": []}], ["Of 1642 evaluable infants, 287 experienced RSV MAARI.", {"entities": []}], ["Rates of RSV-related MAARI, outpatient lower respiratory tract illness, emergency department visits and hospitalization (RSVH) during November to March were 25.4, 13.7, 5.9 and 4.9 per 100 infant-seasons, respectively.", {"entities": []}], ["Preschool-aged, nonmultiple-birth siblings and daycare attendance were consistently associated with increased risk of RSV.", {"entities": []}], ["RSVH rates were highest in infants 32\u201334 and 35 wGA who were <6 months of age during November to March with daycare attendance or nonmultiple-birth, preschool-aged siblings (8.9 and 9.3 per 100 infant-seasons, respectively, versus 3.5 for all other infants, P <0.001).", {"entities": []}], ["Chronologic age <3 months was associated with a higher RSVH rate for infants 35 wGA but not for infants 32\u201334 wGA.", {"entities": []}], ["In US preterm infants who were 32\u201335 wGA, <6 months on November 1st and not receiving RSV prophylaxis, the burden of RSV MAARI was 25 per 100 infant-seasons.", {"entities": []}], ["The highest RSVH rates occurred among those with daycare attendance or nonmultiple-birth, preschool-aged siblings while they were <6 months of age during the RSV season.", {"entities": []}], ["CCL11 is an important inflammatory cytokine associated with inflammation-related diseases such as atherosclerosis and stroke.", {"entities": [[98, 113, "DISEASE"], [0, 5, "GENE"]]}], ["The aim of this study was to investigate the relationship between CCL11 gene polymorphism with subtypes of ischemic stroke in Xinjiang Han populations.", {"entities": [[66, 71, "GENE"]]}], ["The improved multiple ligase detection reaction (iMLDR) method was used to analyze the genotypes of 6 tag SNPs in the CCL11 gene (rs1129844, rs17809012, rs1860183, rs1860184, rs4795898, and rs4795895) in a case-control study of 406 lacunar stroke patients, 214 large-artery atherosclerotic (LAA) stroke patients, and 425 controls.", {"entities": [[118, 123, "GENE"]]}], ["We found the GG genotype of rs4795895 was significantly associated with increased risk of lacunar stroke (adjusted OR=1.676, 95%CI=1.117\u20132.515), and the GA genotype of rs17809012 was associated with a significant increase in risk of LAA stroke (adjusted OR=1.337, 95%CI=1.127\u20131.585).", {"entities": []}], ["Hypertension stratification analyses showed that the GA genotype of rs17809012 was significantly associated with LAA stroke in the hypertensive group (adjusted OR=1.274, 95%CI=1.015\u20131.601).", {"entities": []}], ["In the non-hypertensive group, the GA genotype of rs17809012 was significantly associated with LAA stroke (adjusted OR=1.361, 95%CI=1.041\u20131.780).", {"entities": []}], ["The GG genotype of rs4795895 (adjusted OR=1.147, 95%CI=1.115\u20134.134) and the TT genotype of rs1860184 were significantly associated with lacunar stroke (adjusted OR=2.440, 95%CI=1.550\u20133.840).", {"entities": []}], ["This study demonstrates that the CCL11 gene could play an important role in the pathogenesis of lacunar stroke and LAA stroke in the Han population of China.", {"entities": [[33, 38, "GENE"]]}], ["Regular exercise is associated with substantial health benefits; however, little is known about the health impact of extreme levels of exercise.", {"entities": []}], ["This study examined the prevalence of chronic diseases, health-care utilization, and risk factors for exercise-related injuries among ultramarathon runners.", {"entities": []}], ["Retrospective, self-reported enrollment data from an ongoing longitudinal observational study of 1,212 active ultramarathon runners were analyzed.", {"entities": []}], ["The most prevalent chronic medical conditions were allergies/hay fever (25.1%) and exercise-induced asthma (13.0%), but there was a low prevalence of serious medical issues including cancers (4.5%), coronary artery disease (0.7%), seizure disorders (0.7%), diabetes (0.7%), and human immunodeficiency virus (HIV) infection (0.2%).", {"entities": [[100, 106, "DISEASE"]]}], ["In the year preceding enrollment, most (64.6%) reported an exercise-related injury that resulted in lost training days (median of 14 days), but little nonattendance of work or school due to illness, injury, or exercise-related medical conditions (medians of 0 days for each).", {"entities": []}], ["The knee was the most common area of exercise-related injury.", {"entities": []}], ["Prior year incidence of stress fractures was 5.5% with most (44.5%) involving the foot.", {"entities": []}], ["Ultramarathon runners who sustained exercise-related injuries were younger (p<0.001) and less experienced (p<0.01) than those without injury.", {"entities": []}], ["Stress fractures were more common (p<0.01) among women than men.", {"entities": []}], ["We conclude that, compared with the general population, ultramarathon runners appear healthier and report fewer missed work or school days due to illness or injury.", {"entities": []}], ["Ultramarathon runners have a higher prevalence of asthma and allergies than the general population, and the prevalence of serious medical issues was nontrivial and should be recognized by those providing medical care to these individuals.", {"entities": [[50, 56, "DISEASE"]]}], ["Ultramarathon runners, compared with shorter distance runners, have a similar annual incidence of exercise-related injuries but higher proportion of stress fractures involving the foot, and it is the younger and less experienced ultramarathoners who appear most at risk for injury.", {"entities": []}], ["Rural residents are increasingly identified as being at greater risk for health disparities.", {"entities": []}], ["These inequities may be related to health behaviors such as adequate fruits and vegetable consumption.", {"entities": []}], ["There is little national-level population-based research about the prevalence of fruit and vegetable consumption by US rural population adults.", {"entities": []}], ["The objective of this study was to examine the prevalence differences between US rural and non-rural adults in consuming at least five daily servings of combined fruits and vegetables.", {"entities": []}], ["Cross-sectional analysis of weighted 2009 Behavioral Risk Factor Surveillance Survey (BRFSS) data using bivariate and multivariate techniques.", {"entities": []}], ["52,259,789 US adults were identified as consuming at least five daily servings of fruits and vegetables of which 8,983,840 were identified as living in rural locales.", {"entities": []}], ["Bivariate analysis revealed that in comparison to non-rural US adults, rural adults were less likely to consume five or more daily servings of fruits and vegetables (OR\u2009=\u20091.161, 95% CI 1.160-1.162).", {"entities": []}], ["Logistic regression analysis revealed that US rural adults consuming at least five daily servings of fruits and vegetables were more likely to be female, non-Caucasian, married or living with a partner, living in a household without children, living in a household whose annual income was\u2009 > \u2009$35,000, and getting at least moderate physical activity.", {"entities": []}], ["They were also more likely to have a BMI of <30, have a personal physician, have had a routine medical exam in the past 12 months, self-defined their health as good to excellent and to have deferred medical care because of cost.", {"entities": []}], ["When comparing the prevalence differences between rural and non-rural US adults within a state, 37 States had a lower prevalence of rural adults consuming at least five daily servings of fruits and vegetables and 11 States a higher prevalence of the same.", {"entities": []}], ["This enhanced understanding of fruit and vegetable consumption should prove useful to those seeking to lessen the disparity or inequity between rural and non-rural adults.", {"entities": []}], ["Additionally, those responsible for health-related planning could benefit from the knowledge of how their state ranks in comparison to others vis-\u00e0-vis the consumption of fruits and vegetables by rural adults---a population increasingly being identified as one at risk for health disparities.", {"entities": []}], ["Crohn\u2019s disease (CD) is a chronic inflammatory bowel disease and a genetic variant in the OCTN2 , g.-207G\u2009>\u2009C is significantly associated with CD susceptibility.", {"entities": [[34, 60, "DISEASE"]]}], ["This study was aimed to identify novel OCTN2 functional promoter variants and their roles in transcriptional regulation using various in vitro assays.", {"entities": []}], ["In addition, we investigated the association between OCTN2 genotypes and CD through genetic analysis using DNA samples from 193 patients with CD and 281 healthy controls.", {"entities": []}], ["Among the three major promoter haplotypes of OCTN2 identified, one haplotype, H3, showed a significant decrease in promoter activity: two polymorphisms in H3 were associated with a significant reduction in promoter activity.", {"entities": []}], ["In particular, we found that the reduced transcriptional activity of those two polymorphisms results from a reduction in the binding affinity of the activators, NF-E2 and YY1, to the OCTN2 promoter.", {"entities": [[171, 174, "GENE"]]}], ["The functional haplotype of the OCTN2 promoter was associated with clinical course of CD such as the disease behavior and need for surgery.", {"entities": []}], ["However, genetic variants or haplotypes of OCTN2 did not affect the susceptibility to CD.", {"entities": []}], ["Our results suggest that a common promoter haplotype of OCTN2 regulates the transcriptional rate of OCTN2 and influences the clinical course of CD.", {"entities": []}], ["To fulfill its function, the immune system must detect and interpret a wide variety of signals and adjust the magnitude, duration, and specific traits of each response during the complex host-parasite relationships in parasitic infections.", {"entities": []}], ["Inflammation must be tightly regulated since uncontrolled inflammation may be as destructive as the triggering stimulus and leads to immune-mediated tissue injury.", {"entities": []}], ["During recent years, increasing evidence points to regulatory T cells (Tregs) as key anti-inflammatory cells, critically involved in limiting the inflammatory response.", {"entities": []}], ["Herein, we review the published information on the induction of Tregs and summarize the most recent findings on Treg generation in parasitic diseases.", {"entities": []}], ["Drop the mop and play with Fido is Patrick Holt's recommendation for raising an allergy-free child.", {"entities": []}], ["Although a tangled web of factors underlies allergies and asthma, Holt believes that preventing lifelong affliction could be simple.", {"entities": [[58, 64, "DISEASE"]]}], ["Deregulated CD8+ T cell cytotoxicity plays a central role in enhancing disease severity in several conditions.", {"entities": []}], ["However, we have little understanding of the mechanisms by which immunopathology develops as a consequence of cytotoxicity.", {"entities": []}], ["Using murine models of inflammation induced by the protozoan parasite leishmania, and data obtained from patients with cutaneous leishmaniasis, we uncovered a previously unrecognized role for NLRP3 inflammasome activation and IL-1\u03b2 release as a detrimental consequence of CD8+ T cell-mediated cytotoxicity, ultimately resulting in chronic inflammation.", {"entities": [[129, 142, "DISEASE"], [119, 142, "DISEASE"], [192, 197, "GENE"]]}], ["Critically, pharmacological blockade of NLRP3 or IL-1\u03b2 significantly ameliorated the CD8+ T cell-driven immunopathology in leishmania-infected mice.", {"entities": [[40, 45, "GENE"]]}], ["Confirming the relevance of these findings to human leishmaniasis, blockade of the NLRP3 inflammasome in skin biopsies from leishmania-infected patients prevented IL-1\u03b2 release.", {"entities": [[52, 65, "DISEASE"], [83, 88, "GENE"]]}], ["Thus, these studies link CD8+ T cell cytotoxicity with inflammasome activation and reveal novel avenues of treatment for cutaneous leishmaniasis, as well as other of diseases where CD8+ T cell-mediated cytotoxicity induces pathology.", {"entities": [[131, 144, "DISEASE"], [121, 144, "DISEASE"]]}], ["Leishmaniasis is a neglected tropical disease endemic in 98 countries and approximately 1 million new cases occur each year.", {"entities": [[0, 13, "DISEASE"]]}], ["Disease caused by Leishmania braziliensis , the main causative agent of leishmaniasis in South America, leads to skin ulcers that are difficult to heal with drugs that target the parasites.", {"entities": [[72, 85, "DISEASE"]]}], ["This is because disease severity seen in patients infected with L .", {"entities": []}], ["braziliensis is largely due to the immune response that develops, rather than the number of parasites in the skin.", {"entities": []}], ["CD8+ T cells induce cell death in the lesions of L .", {"entities": []}], ["braziliensis- infected mice, as well as in the lesions from L .", {"entities": []}], ["braziliensis- infected patients, which promotes disease.", {"entities": []}], ["However, the mechanism mediating CD8+ T cell dependent pathology is unknown.", {"entities": []}], ["Here, using studies in mice and experiments with L .", {"entities": []}], ["braziliensis patients\u2019 samples we show that increased disease severity is due to inflammasome activation, and furthermore that therapies that block either inflammasome activation or IL-1\u03b2 ameliorate disease in mouse models of severe leishmaniasis.", {"entities": [[233, 246, "DISEASE"]]}], ["Based on these studies we propose a novel strategy of therapy for L .", {"entities": []}], ["braziliensis infection and other diseases in which cytotoxicity plays a central role in promoting disease severity.", {"entities": []}], ["To optimise the health of pregnant women and their children by evidence-based primary and secondary prevention, more scientific knowledge is needed.", {"entities": []}], ["To overcome the methodological limitations of many studies on pregnancy and child health, which often use a retrospective design, we established the PRIDE (PRegnancy and Infant DEvelopment) Study.", {"entities": []}], ["The PRIDE Study is a large prospective cohort study that aims at including 150 000\u2013200 000 women in early pregnancy to study a broad range of research questions pertaining to pregnancy complications, maternal and child health, and adverse developmental effects in offspring.", {"entities": []}], ["Women are invited to participate by their prenatal care provider before or at their first prenatal care visit and are asked to fill out web-based questionnaires in gestational weeks 8\u201310, 17, and 34, as well as biannually throughout childhood.", {"entities": []}], ["In addition, a food frequency questionnaire and a paternal questionnaire are administered and medical records are consulted.", {"entities": []}], ["Multiple validation studies will be conducted and paper-and-pencil questionnaires are available for women who cannot or do not want to participate through the Internet.", {"entities": []}], ["For subgroups of participants, blood and saliva samples for genetic and biochemical analyses are being collected.", {"entities": []}], ["The pilot phase, which started in July 2011, showed a response rate of 47%.", {"entities": []}], ["Recruitment will eventually cover all of the Netherlands.", {"entities": []}], ["We expect that this study, which will be the largest birth cohort in the world so far, will provide new insights in the aetiology of disorders and diseases that originate in pregnancy.", {"entities": []}], ["The PRIDE Study is open for collaboration.", {"entities": []}], ["Inflammation when unchecked is associated with many prevalent disorders such as the classic inflammatory diseases arthritis and periodontal disease, as well as the more recent additions that include diabetes and cardiovascular maladies.", {"entities": [[114, 123, "DISEASE"], [128, 147, "DISEASE"]]}], ["Hence mechanisms to curtail the inflammatory response and promote catabasis are of immense interest.", {"entities": []}], ["In recent years, evidence has prompted a paradigm shift whereby the resolution of acute inflammation is a biochemically active process regulated in part by endogenous PUFA (polyunsaturated fatty acid)-derived autacoids.", {"entities": []}], ["Among these are a novel genus of SPMs (specialized proresolving mediators) that comprise novel families of mediators including lipoxins, resolvins, protectins and maresins.", {"entities": []}], ["SPMs have distinct structures and act via specific G-protein seven transmembrane receptors that signal intracellular events on selective cellular targets activating proresolving programmes while countering pro-inflammatory signals.", {"entities": []}], ["An appreciation of these endogenous pathways and mediators that control timely resolution opened a new terrain for therapeutic approaches targeted at stimulating resolution of local inflammation.", {"entities": []}], ["In the present review, we provide an overview of the biosynthesis and actions of resolvin E1, underscoring its protective role in vascular systems and regulating platelet responses.", {"entities": []}], ["We also give an overview of newly described resolution circuitry whereby resolvins govern miRNAs (microRNAs), and transcription factors that counter-regulate pro-inflammatory chemokines, cytokines and lipid mediators.", {"entities": []}], ["This study compares different risk factors in patients visiting a hospital during five rainfall-associated bronchospasm epidemics in Ahvaz and those visiting on other occasions.", {"entities": []}], ["This case-control study was conducted on 5307 patients with bronchospasm admitted to the Emergency Department of Imam Khomeini Hospital in Ahvaz (Iran) from late October to December (as the epidemic) and 916 patients admitted from late January to March (as the nonepidemic) in 2011 to 2015.", {"entities": []}], ["A total of the 41.7% of the cases and 48.8% of the controls had episodes of bronchospasm, suggesting a significant difference between the two groups ( P < 0.001).", {"entities": []}], ["The mean concentrations of PM 10 , NO, NO 2 , and NO x pollutants (except O 3 ) were significantly higher in the nonepidemic periods ( P < 0.05).", {"entities": []}], ["The adjusted analysis showed a direct significant relationship between emergency respiratory admissions and each unit of increase in NO and SO 2 concentration during the epidemic periods and NO 2 concentration during the nonepidemic periods.", {"entities": []}], ["During the epidemic periods, a direct and significant relationship was also observed between respiratory admissions and each unit of increase in relative humidity and evaporation.", {"entities": []}], ["The results suggest that certain pollutants and weather variables are associated with the risk of emergency respiratory admissions during epidemic periods.", {"entities": []}], ["The wide spectrum of vitamin D activity has focused attention on its potential role in the elevated burden of disease in a northern Canadian First Nations (Den\u00e9) cohort.", {"entities": []}], ["Vitamin D insufficiency, and gene polymorphisms in the vitamin D receptor (VDR) and vitamin D binding protein (VDBP) have been implicated in susceptibility to infectious and chronic diseases.", {"entities": [[75, 78, "GENE"]]}], ["The objectives of this study were to determine the contribution of vitamin D from food, and measure the serum concentrations of 25-hydroxyvitamin D 3 (25-OHD 3 ) and VDBP in Den\u00e9 participants.", {"entities": []}], ["Single nucleotide polymorphisms (SNPs) associated with the dysregulation of the innate immune response were typed and counted.", {"entities": []}], ["Potential correlations between the SNPs and serum concentrations of 25-OHD 3 and VDBP were evaluated.", {"entities": []}], ["Venous blood was collected in summer and winter over a one-year period and analyzed for 25-OHD 3 and VDBP concentrations (N\u200a=\u200a46).", {"entities": []}], ["A questionnaire was administered to determine the amount of dietary vitamin D consumed.", {"entities": []}], ["Sixty-one percent and 30% of the participants had 25-OHD 3 serum concentrations <75 nmol/L in the winter and summer respectively.", {"entities": []}], ["Mean vitamin D binding protein concentrations were within the normal range in the winter but below normal in the summer.", {"entities": []}], ["VDBP and VDR gene polymorphisms affect the bioavailability and regulation of 25-OHD 3 .", {"entities": [[9, 12, "GENE"]]}], ["The Den\u00e9 had a high frequency of the VDBP D432E-G allele (71%) and the Gc1 genotype (90%), associated with high concentrations of VDBP and a high binding affinity to 25-OHD 3 .", {"entities": []}], ["The Den\u00e9 had a high frequency of VDR Fok1-f allele (82%), which has been associated with a down-regulated Th1 immune response.", {"entities": [[33, 36, "GENE"]]}], ["VDBP and VDR polymorphisms, and low winter 25-OHD 3 serum concentrations may be risk factors for infectious diseases and chronic conditions related to the dysregulation of the vitamin D pathway.", {"entities": [[9, 12, "GENE"]]}], ["The aim of the study is to characterize the phenotypes of CD4 P <0.01).", {"entities": [[58, 61, "GENE"]]}], ["The percentage of T regulatory cells (CD4 P <0.01) in the immunized group compared to the infected control at weeks 8 and 16 PI.", {"entities": [[38, 41, "GENE"]]}], ["The FOXP-3 expression in hepatic granulomas increased from 10 at week 8 to 30 fold at week 16 PI in the infected control group.", {"entities": []}], ["However, its expression in the immunized group showed an increase from 30 at week 8 to 70 fold at week 16 PI.", {"entities": []}], ["The splenic cytokine levels of pro-inflammatory cytokines, IFN-\u03b3, IL-4, and TNF-\u03b1, showed significant decreases ( P <0.05) compared to the infected control group.", {"entities": []}], ["In conclusion, the magnitude and phenotype of the egg-induced effects on T helper responses were found to be controlled by a parallel response within the T regulatory population which provides protection in worm parasite-induced immunopathology.", {"entities": []}], ["Mangosteen ( Garcinia mangostana L.) is a tropical tree native to Southeast Asia that produces a fruit whose pericarp contains a family of tricyclic isoprenylated polyphenols referred to as xanthones.", {"entities": []}], ["Numerous in vitro studies have shown that these xanthones possess anti-oxidant, anti-proliferative, pro-apoptotic, anti-inflammatory and anti-carcinogenic activities.", {"entities": []}], ["Aggressive marketing of such health promoting benefits has resulted in mangosteen\u2019s classification as a \u201csuperfruit\u201d.", {"entities": []}], ["This has led to sales of mangosteen containing beverages in USA alone exceeding $200 million in 2008 despite very limited animal and human studies.", {"entities": []}], ["This review will (a) critically address recent reports of in vivo studies on the bioavailability and metabolism of mangosteen xanthones, (b) update the in vitro and in vivo data on anti-cancer and anti-inflammatory activities of mangosteen xanthones, and (c) suggest needed areas of inquiry regarding the absorption, metabolism and efficacy of mangosteen xanthones.", {"entities": [[186, 192, "DISEASE"]]}], ["Gastro-esophageal reflux has been suggested to be associated with several pulmonary complications such as asthma, and post-transplant bronchiolitis obliterans (BO).", {"entities": [[134, 158, "DISEASE"], [106, 112, "DISEASE"], [134, 147, "DISEASE"]]}], ["Pepsin or bile salts in the sputum is shown to be an optimal molecular marker of gastric contents macro/micro aspiration.", {"entities": []}], ["In this study, we investigated sputum pepsin as a marker of micro-aspiration in sulfur mustard (SM) exposed cases compared to healthy controls.", {"entities": []}], ["In a case controlled study, 26 cases with BO and 12 matched healthy controls were recruited and all cases were symptomatic and their exposure to SM was previously documented during Iran-Iraq conflict.", {"entities": []}], ["Pepsin levels in sputum and total bile acids were measured using enzymatic assay.", {"entities": []}], ["The severity of respiratory disorder was categorized based upon the spirometric values.", {"entities": []}], ["The average concentration of pepsin in sputum was higher in the case group (0.29 \u00b1 0.23) compared with healthy subjects (0.13 \u00b1 0.07; P \u00b1 0.003).", {"entities": []}], ["Moreover, the average concentration of bile acids in the sputum cases was not significantly different in comparison to the controls ( P = 0.5).", {"entities": []}], ["Higher pepsin concentrations in sputum of SM exposed patients compared with healthy control subjects indicate the occurrence of significantly more gastric micro-aspiration in SM exposed patients.", {"entities": []}], ["Asthma and chronic obstructive pulmonary disease (COPD) are obstructive airway disorders which differ in their underlying causes and phenotypes but overlap in patterns of pharmacological treatments.", {"entities": [[11, 48, "DISEASE"], [0, 6, "DISEASE"]]}], ["In both asthma and COPD, oxidative stress contributes to airway inflammation by inducing inflammatory gene expression.", {"entities": [[8, 14, "DISEASE"]]}], ["The redox-sensitive transcription factor, nuclear factor (NF)-kappaB (NF-\u03baB), is an important participant in a broad spectrum of inflammatory networks that regulate cytokine activity in airway pathology.", {"entities": []}], ["The anti-inflammatory actions of glucocorticoids (GCs), a mainstay treatment for asthma, involve inhibition of NF-\u03baB induced gene transcription.", {"entities": [[81, 87, "DISEASE"]]}], ["Ligand bound GC receptors (GRs) bind NF-\u03baB to suppress the transcription of NF-\u03baB responsive genes ( i.e.", {"entities": [[13, 15, "GENE"]]}], [", transrepression).", {"entities": []}], ["However, in severe asthma and COPD, the transrepression of NF-\u03baB by GCs is negated as a consequence of post-translational changes to GR and histones involved in chromatin remodeling.", {"entities": [[19, 25, "DISEASE"]]}], ["Therapeutics which target NF-\u03baB activation, including inhibitors of I\u03baB kinases (IKKs) are potential treatments for asthma and COPD.", {"entities": [[116, 122, "DISEASE"]]}], ["Furthermore, reversing GR/histone acetylation shows promise as a strategy to treat steroid refractory airway disease by augmenting NF-\u03baB transrepression.", {"entities": []}], ["This review examines NF-\u03baB signaling in airway inflammation and its potential as target for treatment of asthma and COPD.", {"entities": [[105, 111, "DISEASE"]]}], ["The NF- \u03ba B is a transcription factor which plays a key role in regulating biological processes.", {"entities": []}], ["In response to signals, NF- \u03ba B activation occurs via phosphorylation of its inhibitor, which dissociates from the NF- \u03ba B dimer allowing the translocation to the nucleus, inducing gene expression.", {"entities": []}], ["NF- \u03ba B activation has direct screening applications for drug discovery for several therapeutic indications.", {"entities": []}], ["Thus, pathway-specific reporter cell systems appear as useful tools to screen and unravel the mode of action of probiotics and natural and synthetic compounds.", {"entities": []}], ["Here, we describe the generation, characterization, and validation of human epithelial reporter cell lines for functional studies of NF- \u03ba B activation by different pro- and anti-inflammatory agents.", {"entities": []}], ["Caco-2 and HT-29 cells were transfected with a pNF- \u03ba B-hrGFP plasmid which contains the GFP gene under the control of NF- \u03ba B binding elements.", {"entities": []}], ["Three proinflammatory cytokines (TNF- \u03b1 , IL-1 \u03b2 , and LPS) were able to activate the reporter systems in a dose-response manner, which corresponds to the activation of the NF- \u03ba B signaling pathway.", {"entities": []}], ["Finally, the reporter cell lines were validated using lactic acid bacteria and a natural compound.", {"entities": []}], ["We have established robust Caco-2-NF- \u03ba B-hrGFP and HT-29-NF- \u03ba B-hrGFP reporter cell lines which represent a valuable tool for primary screening and identification of bacterial strains and compounds with a potential therapeutic interest.", {"entities": []}], ["To compare quantitative fractional ventilation measurements from multiple breath washout imaging (MBW\u2010I) using hyperpolarized Seven healthy subjects were scanned using High\u2010quality MBW images were obtained with bSSFP sequences using a reduced dose (100 mL) of inhaled hyperpolarized P < 0.001) with mean Pearson's correlation coefficients of r = 0.61 and r = 0.52 for Improved sensitivity in MBW\u2010I can be achieved with polarization\u2010efficient bSSFP sequences.", {"entities": []}], ["Same scan\u2010session 3D MBW\u2010I with", {"entities": []}], ["Mouse Gasdermin A3 ( Gsdma3 ) is the causative gene for dominant skin mutations exhibiting alopecia.", {"entities": [[91, 99, "DISEASE"]]}], ["Mouse has two other Gsdma3 -related genes, Gsdma and Gsdma2 , whereas human and rat have only one related gene.", {"entities": [[43, 48, "GENE"]]}], ["To date, no skin mutation has been reported for human GSDMA and rat Gsdma as well as mouse Gsdma and Gsdma2 .", {"entities": [[54, 59, "GENE"], [68, 73, "GENE"], [91, 96, "GENE"], [54, 59, "GENE"], [68, 73, "GENE"], [91, 96, "GENE"], [54, 59, "GENE"], [68, 73, "GENE"], [91, 96, "GENE"]]}], ["Therefore, it is possible that only Gsdma3 has gain-of-function type mutations to cause dominant skin phenotype.", {"entities": []}], ["To elucidate functional divergence among the Gsdm a-related genes in mice, and to infer the function of the human and rat orthologs, we examined in vivo function of mouse Gsdma by generating Gsdma knockout mice and transgenic mice that overexpress wild-type Gsdma or Gsdma harboring a point mutation (Alanine339Threonine).", {"entities": [[171, 176, "GENE"], [191, 196, "GENE"], [258, 263, "GENE"], [267, 272, "GENE"], [171, 176, "GENE"], [191, 196, "GENE"], [258, 263, "GENE"], [267, 272, "GENE"], [171, 176, "GENE"], [191, 196, "GENE"], [258, 263, "GENE"], [267, 272, "GENE"], [171, 176, "GENE"], [191, 196, "GENE"], [258, 263, "GENE"], [267, 272, "GENE"]]}], ["The Gsdma knockout mice shows no visible phenotype, indicating that Gsdma is not essential for differentiation of epidermal cells and maintenance of the hair cycle, and that Gsdma is expressed specifically both in the inner root sheath of hair follicles and in suprabasal cell layers, whereas Gsdma3 is expressed only in suprabasal layers.", {"entities": [[4, 9, "GENE"], [68, 73, "GENE"], [174, 179, "GENE"], [4, 9, "GENE"], [68, 73, "GENE"], [174, 179, "GENE"], [4, 9, "GENE"], [68, 73, "GENE"], [174, 179, "GENE"]]}], ["By contrast, both types of the transgenic mice exhibited epidermal hyperplasia resembling the Gsdma3 mutations, although the phenotype depended on the genetic background.", {"entities": []}], ["These results indicate that the mouse Gsdma and Gsdma3 genes share common function to regulate epithelial maintenance and/or homeostasis, and suggest that the function of human GSDMA and rat Gsdma , which are orthologs of mouse Gsdma , is conserved as well.", {"entities": [[38, 43, "GENE"], [177, 182, "GENE"], [191, 196, "GENE"], [228, 233, "GENE"], [38, 43, "GENE"], [177, 182, "GENE"], [191, 196, "GENE"], [228, 233, "GENE"], [38, 43, "GENE"], [177, 182, "GENE"], [191, 196, "GENE"], [228, 233, "GENE"], [38, 43, "GENE"], [177, 182, "GENE"], [191, 196, "GENE"], [228, 233, "GENE"]]}], ["There is a growing emphasis on the importance of research having demonstrable public benefit.", {"entities": []}], ["Measurements of the impacts of research are therefore needed.", {"entities": []}], ["We applied a modified impact assessment process that builds on best practice to 5\u00a0years (2003\u20132007) of intervention research funded by Australia\u2019s National Health and Medical Research Council to determine if these studies had post-research real-world policy and practice impacts.", {"entities": []}], ["We used a mixed method sequential methodology whereby chief investigators of eligible intervention studies who completed two surveys and an interview were included in our final sample (n\u2009=\u200950), on which we conducted post-research impact assessments.", {"entities": []}], ["Data from the surveys and interviews were triangulated with additional information obtained from documentary analysis to develop comprehensive case studies.", {"entities": []}], ["These case studies were then summarized and the reported impacts were scored by an expert panel using criteria for four impact dimensions: corroboration; attribution, reach, and importance.", {"entities": []}], ["Nineteen (38%) of the cases in our final sample were found to have had policy and practice impacts, with an even distribution of high, medium, and low impact scores.", {"entities": []}], ["While the tool facilitated a rigorous and explicit criterion-based assessment of post-research impacts, it was not always possible to obtain evidence using documentary analysis to corroborate the impacts reported in chief investigator interviews.", {"entities": []}], ["While policy and practice is ideally informed by reviews of evidence, some intervention research can and does have real world impacts that can be attributed to single studies.", {"entities": []}], ["We recommend impact assessments apply explicit criteria to consider the corroboration, attribution, reach, and importance of reported impacts on policy and practice.", {"entities": []}], ["Impact assessments should also allow sufficient time between impact data collection and completion of the original research and include mechanisms to obtain end-user input to corroborate claims and reduce biases that result from seeking information from researchers only.", {"entities": []}], ["After exposure to mitogenic lectins in vitro, human mononuclear cells (95% lymphocytes) that had been prelabeled with [14C]arachidonic acid rapidly released a portion of their radioactivity in the medium.", {"entities": []}], ["Most of the released radioactivity was demonstrated to be free arachidonic acid.", {"entities": []}], ["Although other sources are not excluded, the most important source of cell-bound radioactivity in the release reaction appeared to be phosphatidylinositol, suggesting that at least part of the response is occurring through an increase in phospholipase A2 activity.", {"entities": []}], ["By gas liquid chromatography, other fatty acids were also shown to be released, but there was considerable selectivity in the response for arachidonic acid.", {"entities": []}], ["The response was dependent on the availability of free Ca++ in the medium and was enhanced by serum proteins and unlabeled arachidonic acid.", {"entities": []}], ["Most of the response appeared to be from the the lymphocytes themselves rather than from contaminating cells.", {"entities": []}], ["The rapid generation of free arachidonic acid in response to mitogenic lectins suggests a possible role for arachidonic acid metabolites in the activation process.", {"entities": []}], ["The pro-inflammatory cytokine thymic stromal lymphopoietin (TSLP) is pivotal to the pathophysiology of widespread allergic diseases mediated by type 2 helper T cell (Th2) responses, including asthma and atopic dermatitis.", {"entities": [[203, 220, "DISEASE"], [192, 198, "DISEASE"], [210, 220, "DISEASE"], [60, 64, "GENE"]]}], ["The emergence of human TSLP as a clinical target against asthma calls for maximally harnessing its therapeutic potential via structural and mechanistic considerations.", {"entities": [[57, 63, "DISEASE"], [23, 27, "GENE"]]}], ["Here we employ an integrative experimental approach focusing on productive and antagonized TSLP complexes and free cytokine.", {"entities": [[91, 95, "GENE"]]}], ["We reveal how cognate receptor TSLPR allosterically activates TSLP to potentiate the recruitment of the shared interleukin 7 receptor \u03b1-chain (IL-7R\u03b1) by leveraging the flexibility, conformational heterogeneity and electrostatics of the cytokine.", {"entities": [[62, 66, "GENE"]]}], ["We further show that the monoclonal antibody Tezepelumab partly exploits these principles to neutralize TSLP activity.", {"entities": [[104, 108, "GENE"]]}], ["Finally, we introduce a fusion protein comprising a tandem of the TSLPR and IL-7R\u03b1 extracellular domains, which harnesses the mechanistic intricacies of the TSLP-driven receptor complex to manifest high antagonistic potency.", {"entities": []}], ["The pro-inflammatory cytokine thymic stromal lymphopoietin (TSLP) is a promising therapeutic target.", {"entities": [[60, 64, "GENE"]]}], ["Here the authors characterize the assembly mechanism of the receptor complex driven by human TSLP, and its antagonism by the monoclonal antibody Tezepelumab and a fusion protein comprising the TSLP receptors.", {"entities": [[93, 97, "GENE"], [193, 197, "GENE"], [93, 97, "GENE"], [193, 197, "GENE"]]}], ["Microorganisms inhabiting human body form a complex ecosystem.", {"entities": []}], ["The mutual influence of the microbiome and the immune system of the host constitute the basis for numerous diseases, e.g.", {"entities": []}], ["pseudomembranous colitis, inflammatory bowel disease, type 1 diabetes, atopic diseases, obesity, reactive arthritis.", {"entities": [[26, 52, "DISEASE"], [97, 115, "DISEASE"], [88, 95, "DISEASE"], [106, 115, "DISEASE"]]}], ["New molecular diagnostic methods and multi-center studies may help in understanding of the role of microbiota in health and disease.", {"entities": []}], ["Rheumatoid arthritis has a multi-faceted etiology, and its causes are not entirely understood.", {"entities": [[0, 20, "DISEASE"], [11, 20, "DISEASE"]]}], ["There are indications for the influence of microbiomes of oral cavity, intestines, lungs and urinary tract on the development of rheumatoid arthritis.", {"entities": [[129, 149, "DISEASE"], [140, 149, "DISEASE"]]}], ["Interactions between microorganisms and human immune system play role in the pathogenesis of the disease.", {"entities": []}], ["Here, we review recent literature indicating a role of innate lymphoid cells in human inflammatory bowel disease with a focus on the plastic population of ILC3.", {"entities": [[86, 112, "DISEASE"]]}], ["Many studies suggest an involvement of ILC3 in human intestinal inflammation.", {"entities": []}], ["ILC3 present the most abundant ILC subtype in the human intestine at steady state.", {"entities": []}], ["In IBD, this composition is skewed towards ILCs showing an ILC1 phenotype and cytokine profile.", {"entities": []}], ["This change is likely due to the microenvironment causing skewing of the functionally plastic ILC subsets.", {"entities": []}], ["Interactions between ILCs and other cells are important to keep homeostasis and intestinal barrier integrity.", {"entities": []}], ["The knowledge about the involvement of ILCs in IBD is rapidly increasing, and with the help of mouse models, new pathways and functions of ILCs are continuously unraveled.", {"entities": []}], ["In the majority of human studies, a potential role for ILCs in Crohn\u2019s disease is found.", {"entities": []}], ["However, less data is available for a possible role in ulcerative colitis.", {"entities": [[55, 73, "DISEASE"]]}], ["Results from mice are obtained from diverse model systems, and more research in this field is needed to clarify and integrate the current knowledge in order to improve treatment strategies for IBD patients.", {"entities": []}], ["The role of endogenous nitric oxide (NO) on vascular and respiratory smooth muscle basal tone was evaluated in six anaesthetized, paralysed, mechanically ventilated pigs.", {"entities": []}], ["The involvement of endogenous NO in PAF-induced shock and airway hyperresponsiveness was also studied.", {"entities": []}], ["PAF (50 ng/kg, i.v.)", {"entities": []}], ["was administered before and after pretreatment with N", {"entities": []}], ["The widespread overuse of antibiotics promotes the development of antibiotic resistance in bacteria, which can cause severe illness and constitutes a major public health concern.", {"entities": []}], ["Haemophilus species are a common cause of community- and nosocomial-acquired pneumonia.", {"entities": [[77, 86, "DISEASE"]]}], ["The antibiotic resistance of these Gram-negative bacteria can be prevented through the reduction of unnecessary antibiotic prescriptions, the correct use of antibiotics, and good hygiene and infection control.", {"entities": []}], ["This article examines, retrospectively, antibiotic resistance in patients with community- and nosocomial-acquired pneumonia caused by Haemophilus species .", {"entities": [[114, 123, "DISEASE"]]}], ["The demographic, clinical, and laboratory data of all patients with community- and nosocomial-acquired pneumonia caused by Haemophilus species were collected from the hospital charts at the HELIOS Clinic, Witten/Herdecke University, Wuppertal, Germany, within a study period from 2004 to 2014.", {"entities": [[103, 112, "DISEASE"]]}], ["Antimicrobial susceptibility testing was performed for the different antibiotics that have been consistently used in the treatment of patients with pneumonia caused by Haemophilus species.", {"entities": [[148, 157, "DISEASE"]]}], ["During the study period of January 1, 2004, to August 12, 2014, 82 patients were identified with community- and nosocomial-acquired pneumonia affected by Haemophilus species.", {"entities": [[132, 141, "DISEASE"]]}], ["These patients had a mean age of 63.8\u2009\u00b1\u200915.5 (60 [73.2\u00a0%, 95\u00a0% CI 63.6\u00a0%\u201382.8\u00a0%] males and 22 [26.8\u00a0%, 95\u00a0% CI 17.2\u00a0%\u201336.4\u00a0%] females).", {"entities": []}], ["Haemophilus species had a high resistance rate to erythromycin (38.3\u00a0%), ampicillin (24.4\u00a0%), piperacillin (20.8\u00a0%), cefuroxime (8.5\u00a0%), ampicillin-sulbactam (7.3\u00a0%), piperacillin-sulbactam (4.3\u00a0%), piperacillin-tazobactam (2.5\u00a0%), cefotaxime (2.5\u00a0%), and levofloxacin (1.6\u00a0%).", {"entities": []}], ["In contrast, they were not resistant to ciprofloxacin in patients with pneumonia ( P \u2009=\u20090.016).", {"entities": [[71, 80, "DISEASE"]]}], ["Haemophilus species were resistant to many of the typically used antibiotics.", {"entities": []}], ["Resistance toward ciprofloxacin was not detected in patients with pneumonia caused by Haemophilus species.", {"entities": [[66, 75, "DISEASE"]]}], ["Background .", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is gaining an importance over the world, and its effect on quality of life is better grasped.", {"entities": []}], ["Our objective was to use the Clinical COPD Questionnaire (CCQ) to describe the respiratory quality of life in the Lebanese population, stressing on differences between smokers and nonsmokers.", {"entities": []}], ["Using data from a cross-sectional national study, we checked the construct validity and reliability of the CCQ.", {"entities": []}], ["Factors and items correlation with postbronchodilator FEV1/FVC were reported, in addition to factors and scale association with COPD and its severity.", {"entities": []}], ["We then conducted a multiple regression to find predictors of quality of life.", {"entities": []}], ["The CCQ demonstrated excellent psychometric properties, with adequacy to the sample and high consistency.", {"entities": []}], ["Smokers had a decreased respiratory quality of life versus nonsmokers, independently of their respiratory disease status and severity.", {"entities": []}], ["This finding was confirmed in COPD individuals, where several environmental factors, lower education, and cumulative smoking of cigarette and of waterpipe were found to be independent predictors of a lower quality of life, after adjusting for COPD severity.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Smoking decreases the respiratory quality of life of Lebanese adults; this issue has to be further emphasized during smoking cessation and patients' education.", {"entities": []}], ["Arterial stiffness is an early marker of atherosclerosis.", {"entities": [[41, 56, "DISEASE"]]}], ["The carotid arteries are easily accessible by ultrasound and are commonly used for the evaluation of atherosclerosis development.", {"entities": [[101, 116, "DISEASE"]]}], ["However, this stiffness assessment is based on the elastic properties of the artery, which may be influenced by the adjacent internal jugular vein (IJV).", {"entities": []}], ["The aim of the present study is to evaluate the influence of internal jugular vein morphology on the stiffness of the common carotid artery.", {"entities": []}], ["Bilateral carotid ultrasound was performed in 248 individuals.", {"entities": []}], ["When no carotid plaque was detected (90.9\u00a0% cases), the distensibility coefficient and \u03b2 - stiffness index were calculated.", {"entities": []}], ["The global and segmental circumferential strain parameters of the carotid wall were evaluated with 2D-Speckle Tracking.", {"entities": []}], ["The cross-sectional area of the IJV and degree of its adherence to the carotid wall (angle of adherence) were measured.", {"entities": []}], ["The morphology of the IJV did not influence the standard stiffness parameters nor the global circumferential strain.", {"entities": []}], ["However, segmental analysis found the sector adjacent to the IJV to have significantly higher strain parameters than its opposite counterpart.", {"entities": []}], ["In addition, the strain correlated significantly and positively with IJV cross-sectional area and angle of adherence.", {"entities": []}], ["The movement of the carotid artery wall caused by the passage of the pulse wave is not homogeneous.", {"entities": []}], ["The greatest strain is observed in a segment adjacent to the IJV, and the degree of wall deformation is associated with the size of the vein and the degree of its adherence.", {"entities": []}], ["Sex hormones may contribute to the symptomatology of female-predominant temporomandibular disorders (TMDs) inflammatory pain.", {"entities": []}], ["Pregnant women show less symptoms of TMDs than that of non-pregnant women.", {"entities": []}], ["Whether progesterone (P4), one of the dominant sex hormones that regulates multiple biological functions, is involved in symptoms of TMDs remains to be explored.", {"entities": []}], ["Freund\u2019s complete adjuvant were used to induce joint inflammation.", {"entities": []}], ["We evaluated the behavior-related and histologic effects of P4 and the expression of tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2, and IL-6 in the synovial membrane.", {"entities": [[108, 111, "GENE"]]}], ["Primary TMJ synoviocytes were treated with TNF-\u03b1 or IL-1\u03b2 with the combination of P4.", {"entities": []}], ["Progesterone receptor antagonist RU-486 were further applied.", {"entities": []}], ["We found that P4 replacement attenuated TMJ inflammation and the nociceptive responses in a dose-dependent manner in the ovariectomized rats.", {"entities": []}], ["Correspondingly, P4 diminished the DNA-binding activity of NF-\u03baB and the transcription of its target genes in a dose-dependent manner in the synovial membrane of TMJ.", {"entities": []}], ["Furthermore, P4 treatment showed decreased mRNA expression of proinflammatory cytokines, and partially reversed TNF-\u03b1 and IL-1\u03b2 induced transcription of proinflammatory cytokines in the primary synoviocytes.", {"entities": []}], ["Moreover, progesterone receptor antagonist RU-486 partially reversed the effects of P4 on NF-\u03baB pathway.", {"entities": []}], ["In conclusion, progesterone ameliorated TMJ inflammation through inhibition of NF-\u03baB pathway.", {"entities": []}], ["Nanoparticle (NP) drug delivery systems (5\u2212250 nm) have the potential to improve current disease therapies because of their ability to overcome multiple biological barriers and releasing a therapeutic load in the optimal dosage range.", {"entities": []}], ["Rapid clearance of circulating nanoparticles during systemic delivery is a critical issue for these systems and has made it necessary to understand the factors affecting particle biodistribution and blood circulation half-life.", {"entities": []}], ["In this review, we discuss the factors which can influence nanoparticle blood residence time and organ specific accumulation.", {"entities": []}], ["These factors include interactions with biological barriers and tunable nanoparticle parameters, such as composition, size, core properties, surface modifications (pegylation and surface charge), and finally, targeting ligand functionalization.", {"entities": []}], ["All these factors have been shown to substantially affect the biodistribution and blood circulation half-life of circulating nanoparticles by reducing the level of nonspecific uptake, delaying opsonization, and increasing the extent of tissue specific accumulation.", {"entities": []}], ["Prenatal alcohol exposure (PAE) has been shown to impair learning, memory and executive functioning in children.", {"entities": []}], ["Perseveration, or the failure to respond adaptively to changing contingencies, is a hallmark on neurobehavioral assessment tasks for human fetal alcohol spectrum disorder (FASD).", {"entities": [[139, 170, "DISEASE"]]}], ["Adaptive responding is predominantly a product of the medial prefrontal cortex (mPFC) and is regulated by corticosteroids.", {"entities": []}], ["In our mouse model of PAE we recently reported deficits in hippocampal formation-dependent learning and memory and a dysregulation of hippocampal formation glucocorticoid receptor (GR) subcellular distribution.", {"entities": []}], ["Here, we examined the effect of PAE on frontal cortical-dependent behavior, as well as mPFC GR subcellular distribution and the levels of regulators of intracellular GR transport.", {"entities": []}], ["PAE mice displayed significantly reduced response flexibility in a Y-maze reversal learning task.", {"entities": []}], ["While the levels of total nuclear GR were reduced in PAE mPFC, levels of GR phosphorylated at serines 203, 211 and 226 were not significantly changed.", {"entities": []}], ["Cytosolic, but not nuclear, MR levels were elevated in the PAE mPFC.", {"entities": []}], ["The levels of critical GR trafficking proteins, FKBP51, Hsp90, cyclophilin 40, dynamitin and dynein intermediate chain, were altered in PAE mice, in favor of the exclusion of GR from the nucleus, indicating dysregulation of GR trafficking.", {"entities": []}], ["Our findings suggest that there may be a link between a deficit in GR nuclear localization and frontal cortical learning deficits in prenatal alcohol-exposed mice.", {"entities": []}], ["Chinese herbal medicine formula Yu ping feng san (YPFS) is commonly used for allergic rhinitis (AR).", {"entities": [[77, 94, "DISEASE"], [86, 94, "DISEASE"]]}], ["Previous review had summarized the effectiveness and safety of YPFS, however without any subgroup analysis performed to provide detailed evidence for guiding clinical practice.", {"entities": []}], ["YPFS was recommended for the management of AR by Chinese medicine clinical practice guideline, but the treatment duration of YPFS was also not specified.", {"entities": []}], ["The aim of this study is to evaluate the effectiveness and safety of YPFS in treating adult AR with the most recent evidence, and attempt to specify the duration of utilisation through subgroup meta-analyses.", {"entities": []}], ["Seven databases were searched from their inceptions to September 2017.", {"entities": []}], ["Randomized controlled trials (RCTs) evaluating YPFS for adult AR were included.", {"entities": []}], ["Methodological quality of studies was assessed using the Cochrane risk of bias tool.", {"entities": []}], ["Meta-analysis and subgroup meta-analyses were conducted for evaluating the effectiveness of YPFS.", {"entities": []}], ["The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used for rating the quality of evidence.", {"entities": []}], ["Twenty-two RCTs involving 23 comparisons were included in this review.", {"entities": []}], ["YPFS was compared to placebo, pharmacotherapy, and used as an add-on treatment compared to pharmacotherapy.", {"entities": []}], ["Meta-analyses were feasible for the outcomes of four individual nasal symptom scores and \u201ceffective rate\u201d.", {"entities": []}], ["Four individual nasal symptom scores decreased after YPFS\u2019 combination treatment: itchy nose (MD-0.46, 95% CI[\u22120.50, \u22120.42]), sneezing (MD-0.41, 95% CI[\u22120.47, \u22120.35]), blocked nose (MD-0.46, 95% CI[\u22120.54, \u22120.39]) and runny nose (MD-0.42, 95% CI[\u22120.58, \u22120.26]).", {"entities": []}], ["Based on \u201ceffective rate\u201d, meta-analysis showed that YPFS did not achieve better effect than pharmacotherapy (RR1.07, 95%CI [0.94, 1.22), but its combination with pharmacotherapy seemed more effective than pharmacotherapy alone (RR1.27, 95%CI [1.19, 1.34]) (low quality).", {"entities": []}], ["Subgroup analysis suggested that YPFS was not superior to the second-generation antihistamine (RR1.04, 95%CI [0.90, 1.19]) (low quality).", {"entities": []}], ["Further, YPFS\u2019 combination treatment seemed more beneficial when it was used for more than three weeks (RR1.15, 95%CI [1.01, 1.32]).", {"entities": []}], ["In addition, YPFS was well-tolerated for treating adult AR.", {"entities": []}], ["Chinese herbal medicine formula YPFS seems beneficial for adult AR.", {"entities": []}], ["This potential benefit need to be further evaluated by more rigorous RCTs.", {"entities": []}], ["The online version of this article (10.1186/s12906-017-1988-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The diagnosis of COPD is dependent upon clinical judgment and confirmation of the presence of airflow obstruction using spirometry.", {"entities": []}], ["Spirometry is now routinely available; however, spirometry incorrectly performed or interpreted can lead to misdiagnosis.", {"entities": []}], ["We aimed to determine whether spirometry undertaken in primary care for patients suspected to have COPD was of sufficient quality and whether their spirometry was correctly interpreted.", {"entities": []}], ["Two chest physicians re-read all spirometric readings for both quality of the procedure and interpretation, received as a part of COPD validation studies using data from the Clinical Practice Research Datalink (CPRD).", {"entities": []}], ["We then used logistic regression to investigate predictors of correct interpretation.", {"entities": []}], ["Spirometry traces were obtained for 306 patients, of which 221 (72.2%) were conducted in primary care.", {"entities": []}], ["Of those conducted in primary care, 98.6% (n=218) of spirometry traces were of adequate quality.", {"entities": []}], ["Of those traces that were of adequate quality and conducted in primary care, and in whom a general practitioner (GP) diagnosis of COPD had been made, 72.5% (n=218) were consistent with obstruction.", {"entities": []}], ["Historical records for asthma diagnosis significantly decreased odds of correct interpretation.", {"entities": [[23, 29, "DISEASE"]]}], ["The quality of the spirometry procedure undertaken in primary care is high.", {"entities": []}], ["However, this was not reflected in the quality of interpretation, suggesting an unmet training in primary care.", {"entities": []}], ["The quality of the spirometry procedure as demonstrated by spirometric tracings provides a re-assurance for the use of spirometric values available in the electronic health care record databases for research purposes.", {"entities": []}], ["Interleukin 1 and its receptors are associated with allergic diseases such as asthma.", {"entities": [[78, 84, "DISEASE"]]}], ["In the present study, we measured DNA methylation at the IL1R1 and IL1R2 gene loci and assessed for associations with asthma-related phenotypes and gene expressions.", {"entities": [[118, 124, "DISEASE"], [57, 62, "GENE"], [67, 72, "GENE"]]}], ["We found that asthmatic and atopic individuals have higher IL1R2 promoter DNA methylation than control subjects.", {"entities": [[59, 64, "GENE"]]}], ["Additionally, we observed a negative correlation between DNA methylation at the IL1R2 promoter and IL1R2 mRNA expression.", {"entities": [[80, 85, "GENE"], [99, 104, "GENE"], [80, 85, "GENE"], [99, 104, "GENE"]]}], ["These results suggest for the first time that IL1R2 promoter DNA methylation is associated with its gene repression in allergic diseases such as asthma.", {"entities": [[145, 151, "DISEASE"], [46, 51, "GENE"]]}], ["The online version of this article (doi:10.1186/s13148-015-0114-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to evaluate the effect of blood-letting with wet cupping therapy (WCT) in migraine treatment and to determine whether there was any difference according to the phase of the moon when the treatment was applied.", {"entities": [[100, 108, "DISEASE"]]}], ["This self-controlled study was conducted in Karabuk between 2014 and 2016.", {"entities": []}], ["Patients who were diagnosed with migraine were enrolled in the study.", {"entities": [[33, 41, "DISEASE"]]}], ["Migraine disability assessment questionnaire (MIDAS), demographic characteristics, migraine attack frequency and duration, and family history was used to assess the severity of headache.", {"entities": [[0, 8, "DISEASE"], [83, 91, "DISEASE"]]}], ["WCT was applied in 3 sessions and the questionnaire was administered before and 3 months after the final WCT session.", {"entities": []}], ["Wilcoxon signed-rank test was used in pre-and posttreatment measurements, and the Chi-square test was used to check independence in two-way categorical tables.", {"entities": []}], ["A total of 85 patients were included.", {"entities": []}], ["The reduction in MIDAS scores and number of migraine attacks was significantly greater in the WCT applications made in the first half of the month compared to those in the second half of the month.", {"entities": [[44, 52, "DISEASE"]]}], ["Although the reduction in visual analog scale (VAS) scores was greater in the second half of the month, it was also significant in the applications made in the first half of the month.", {"entities": []}], ["WCT was found to be an effective treatment of migraine.", {"entities": [[46, 54, "DISEASE"]]}], ["The effect on MIDAS, VAS, and the number of attacks was significantly better when the application was made in the second half of the month compared to those made in the first half.", {"entities": []}], ["Background .", {"entities": []}], ["Asthma and allergic rhinitis are highly prevalent conditions that cause major illness worldwide.", {"entities": [[11, 28, "DISEASE"], [20, 28, "DISEASE"], [0, 6, "DISEASE"]]}], ["This study aimed to assess the association between allergic rhinitis and asthma control in Peruvian school children.", {"entities": [[51, 68, "DISEASE"], [60, 68, "DISEASE"], [73, 79, "DISEASE"]]}], ["A cross-sectional study was conducted among 256 children with asthma recruited in 5 schools from Lima and Callao cities.", {"entities": [[62, 68, "DISEASE"]]}], ["The outcome was asthma control assessed by the asthma control test.", {"entities": [[16, 22, "DISEASE"], [47, 53, "DISEASE"]]}], ["A score test for trend of odds was used to evaluate the association between allergic rhinitis severity and the prevalence of inadequate asthma control.", {"entities": [[76, 93, "DISEASE"], [85, 93, "DISEASE"], [136, 142, "DISEASE"]]}], ["A generalized linear regression model was used to estimate the adjusted prevalence ratios of inadequate asthma control.", {"entities": [[104, 110, "DISEASE"]]}], ["Allergic rhinitis was present in 66.4% of the population with asthma.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"], [62, 68, "DISEASE"]]}], ["The trend analysis showed a positive association between allergic rhinitis and the probability of inadequate asthma control ( P < 0.001).", {"entities": [[57, 74, "DISEASE"], [66, 74, "DISEASE"], [109, 115, "DISEASE"]]}], ["It was associated with an increased prevalence of inadequate asthma control, with adjusted prevalence ratios of 1.53 (95% confidence interval: 1.19\u22121.98).", {"entities": [[61, 67, "DISEASE"]]}], ["Conclusion .", {"entities": []}], ["This study indicates that allergic rhinitis is associated with an inadequate level of asthma control, giving support to the recommendation of evaluating rhinitis to improve asthma control in children.", {"entities": [[26, 43, "DISEASE"], [35, 43, "DISEASE"], [153, 161, "DISEASE"], [86, 92, "DISEASE"], [173, 179, "DISEASE"]]}], ["A comprehensive survey of late effects (physical, social and reproductive) following treatment at a single institution for early stage Hodgkin's disease (HD) was performed.", {"entities": []}], ["A total of 611 patients with stage I and II HD treated between 1973 and 1984 were reviewed; 460 were alive and were mailed a self-reported questionnaire.", {"entities": []}], ["A total of 363 (79%) replies were received.", {"entities": []}], ["Twenty patients died of second malignancy, 14 of heart disease and nine from respiratory disease.", {"entities": [[49, 62, "DISEASE"]]}], ["There were 37 cases of second malignancy [relative risk (RR) 2.2, absolute excess risk (AR) 35.8].", {"entities": []}], ["The 15-year incidence of heart disease was 11% and there were nine myocardial infarction deaths (RR 1.55, AR 5.4).", {"entities": [[25, 38, "DISEASE"], [67, 88, "DISEASE"]]}], ["Twenty-eight (8%) respondents stated that their career had been greatly interfered with, 53 (14.5%) perceived financial loss.", {"entities": []}], ["Sexual activity was disrupted in 25.8%.", {"entities": []}], ["In total, 56 men had fathered 112 pregnancies.", {"entities": []}], ["Of 171 women, 40.3% became pregnant, resulting in 92 live births.", {"entities": []}], ["A total of 43 men and 16 women had sought medical advice with regard to infertility.", {"entities": [[72, 83, "DISEASE"]]}], ["Silk sericin is a natural polymer produced by silkworm, Bombyx mori , which surrounds and keeps together two fibroin filaments in silk thread used in the cocoon.", {"entities": []}], ["The recovery and reuse of sericin usually discarded by the textile industry not only minimizes environmental issues but also has a high scientific and commercial value.", {"entities": []}], ["The physicochemical properties of the molecule are responsible for numerous applications in biomedicine and are influenced by the extraction method and silkworm lineage, which can lead to variations in molecular weight and amino acid concentration of sericin.", {"entities": []}], ["The presence of highly hydrophobic amino acids and its antioxidant potential make it possible for sericin to be applied in the food and cosmetic industry.", {"entities": []}], ["The moisturizing power allows indications as a therapeutic agent for wound healing, stimulating cell proliferation, protection against ultraviolet radiation, and formulating creams and shampoos.", {"entities": []}], ["The antioxidant activity associated with low digestibility of sericin that expands the application in the medical field, such as antitumour, antimicrobial and anti-inflammatory agent, anticoagulant, acts in colon health, improving constipation and protects the body from obesity through improved plasma lipid profile.", {"entities": [[231, 243, "DISEASE"], [271, 278, "DISEASE"]]}], ["In addition, the properties of sericin allow its application as a culture medium and cryopreservation, in tissue engineering and for drug delivery, demonstrating its effective use, as an important biomaterial.", {"entities": []}], ["Previous reports have shown that the gastrointestinal (GI) bacterial microbiota can have profound effects on the lungs, which has been described as the \u201cgut-lung axis\u201d.", {"entities": []}], ["However, whether a \u201clung-gut\u201d axis exists wherein acute lung inflammation perturbs the gut and blood microbiota is unknown.", {"entities": []}], ["Adult C57/Bl6 mice were exposed to one dose of LPS or PBS instillation (n\u200a=\u200a3 for each group) directly into lungs.", {"entities": []}], ["Bacterial microbiota of the bronchoalveolar lavage fluid, blood, and cecum were determined using 454 pyrotag sequencing and quantitative polymerase chain reaction (qPCR) at 4 through 168 hours post-instillation.", {"entities": []}], ["We then investigated the effects of oral neomycin and streptomycin (n\u200a=\u200a8) on the microbiota at 4 and 24 hours post LPS instillation versus control treatment (n\u200a=\u200a5 at baseline and 4 hours, n\u200a=\u200a7 at 24 hours).", {"entities": []}], ["At 24 hours post LPS instillation, the total bacterial count was significantly increased in the cecum (P<0.05); whereas the total bacterial count in blood was increased at 4, 48, and 72 hours (P<0.05).", {"entities": []}], ["Antibiotic treatment reduced the total bacteria in blood but not in the cecum.", {"entities": []}], ["The increase in total bacteria in the blood correlated with Phyllobacteriaceae OTU 40 and was significantly reduced in the blood for both antibiotic groups (P<0.05).", {"entities": []}], ["LPS instillation in lungs leads to acute changes in the bacterial microbiota in the blood and cecum, which can be modulated with antibiotics.", {"entities": []}], ["The \u03b2 2-adrenergic receptor ( \u03b2 2AR) is a seven-transmembrane (7TM) G-protein coupled receptor that is expressed on cells of the pulmonary, cardiac, skeletal muscle, and immune systems.", {"entities": []}], ["Previous work has shown that stimulation of this receptor on immune cells has profound effects on the regulatory activity of both adaptive and innate immune cells.", {"entities": []}], ["This review examines the functional dichotomy associated with stimulation of \u03b2 2AR and microglial cells.", {"entities": []}], ["As well, recent studies targeting these receptors with long-acting agonists are considered with respect to their therapeutic potential in management of Parkinson \u03bc s disease.", {"entities": []}], ["Background: In the United States, most of the treated sewage sludge (biosolids) is applied to farmland as a soil amendment.", {"entities": []}], ["Critics suggest that rules regulating sewage sludge treatment and land application may be insufficient to protect public health and the environment.", {"entities": []}], ["Neighbors of land application sites report illness following land application events.", {"entities": []}], ["Objectives: We used qualitative research methods to evaluate health and quality of life near land application sites.", {"entities": []}], ["Methods: We conducted in-depth interviews with neighbors of land application sites and used qualitative analytic software and team-based methods to analyze interview transcripts and identify themes.", {"entities": []}], ["Results: Thirty-four people in North Carolina, South Carolina, and Virginia responded to interviews.", {"entities": []}], ["Key themes were health impacts, environmental impacts, and environmental justice.", {"entities": []}], ["Over half of the respondents attributed physical symptoms to application events.", {"entities": []}], ["Most noted offensive sludge odors that interfere with daily activities and opportunities to socialize with family and friends.", {"entities": []}], ["Several questioned the fairness of disposing of urban waste in rural neighborhoods.", {"entities": []}], ["Although a few respondents were satisfied with the responsiveness of public officials regarding sludge, many reported a lack of public notification about land application in their neighborhoods, as well as difficulty reporting concerns to public officials and influencing decisions about how the practice is conducted where they live.", {"entities": []}], ["Conclusions: Community members are key witnesses of land application events and their potential impacts on health, quality of life, and the environment.", {"entities": []}], ["Meaningful involvement of community members in decision making about land application of sewage sludge will strengthen environmental health protections.", {"entities": []}], ["Residential property is reported as the most valuable asset people will own and therefore provides the potential to be used as a socio-economic status (SES) measure.", {"entities": []}], ["Location is generally recognised as the most important determinant of residential property value.", {"entities": []}], ["Extending the well-established relationship between poor health and socio-economic disadvantage and the role of residential property in the overall wealth of individuals, this study tested the predictive value of the Relative Location Factor (RLF), a SES measure designed to reflect the relationship between location and residential property value, and six cardiometabolic disease risk factors, central obesity, hypertriglyceridemia, reduced high density lipoprotein (HDL), hypertension, impaired fasting glucose, and high low density lipoprotein (LDL).", {"entities": [[474, 486, "DISEASE"], [403, 410, "DISEASE"]]}], ["These risk factors were also summed and expressed as a cumulative cardiometabolic risk (CMR) score.", {"entities": []}], ["RLF was calculated using a global hedonic regression model from residential property sales transaction data based upon several residential property characteristics, but deliberately blind to location, to predict the selling price of the property.", {"entities": []}], ["The predicted selling price was divided by the actual selling price and the results interpolated across the study area and classified as tertiles.", {"entities": []}], ["The measures used to calculate CMR were collected via clinic visits from a population-based cohort study.", {"entities": []}], ["Models with individual risk factors and the cumulative cardiometabolic risk (CMR) score as dependent variables were respectively tested using log binomial and Poisson generalised linear models.", {"entities": []}], ["A statistically significant relationship was found between RLF, the cumulative CMR score and all but one of the risk factors.", {"entities": []}], ["In all cases, participants in the most advantaged and intermediate group had a lower risk for cardio-metabolic diseases.", {"entities": []}], ["For the CMR score the RR for the most advantaged was 19% lower (RR\u2009=\u20090.81; CI 0.76-0.86; p <0.0001) and the middle group was 9% lower (RR\u2009=\u20090.91; CI 0.86-0.95; p <0.0001) than the least advantaged group.", {"entities": []}], ["This paper advances the understanding of the nexus between place, health and SES by providing an objective spatially informed SES measure for testing health outcomes and reported a robust association between RLF and several health measures.", {"entities": []}], ["Housing is a significant determinant of health, particularly in developing countries such as Tonga.", {"entities": []}], ["Currently, very little is known about the quality of the housing in Tonga, as is the case with many developing countries, nor about the interaction between children and the home environment.", {"entities": []}], ["This study aimed to identify the nature and extent of health risk factors and behaviours in Tongan houses from a child\u2019s perspective.", {"entities": []}], ["An innovative methodology was used, Kids\u2019Cam Tonga.", {"entities": []}], ["Seventy-two Class 6 children (10 to 13-year-olds) were randomly selected from 12 randomly selected schools in Tongatapu, the main island.", {"entities": []}], ["Each participating child wore a wearable camera on lanyards around their neck.", {"entities": []}], ["The device automatically took wide-angled, 136\u00b0 images of the child\u2019s perspective every seven seconds.", {"entities": []}], ["The children were instructed to wear the camera all day from Friday morning to Sunday evening, inclusive.", {"entities": []}], ["The analysis showed that the majority of Tongan children in the study live in houses that have structural deficiencies and hazards, including water damage (42%), mould (36%), and electrical (89%) and burn risk factors (28%).", {"entities": []}], ["The findings suggest that improvements to the housing stock may reduce the associated health burden and increase buildings\u2019 resilience to natural hazards.", {"entities": []}], ["A collaborative approach between communities, community leaders, government and non-governmental organisations (NGOs) is urgently needed.", {"entities": []}], ["This research methodology may be of value to other developing countries.", {"entities": []}], ["The purpose of this study is to investigate the reliability and validity of new clinical performance examination (CPX) for assessing clinical reasoning skills and evaluating clinical reasoning ability of the students.", {"entities": []}], ["Third-year medical school students (n=313) in Busan-Gyeongnam consortium in 2014 were included in the study.", {"entities": []}], ["One of 12 stations was developed to assess clinical reasoning abilities.", {"entities": []}], ["The scenario and checklists of the station were revised by six experts.", {"entities": []}], ["Chief complaint of the case was rhinorrhea, accompanied by fever, headache, and vomiting.", {"entities": []}], ["Checklists focused on identifying of the main problem and systematic approach to the problem.", {"entities": []}], ["Students interviewed the patient and recorded subjective and objective findings, assessments, plans (SOAP) note for 15 minutes.", {"entities": []}], ["Two professors assessed students simultaneously.", {"entities": []}], ["We performed statistical analysis on their scores and survey.", {"entities": []}], ["The Cronbach \u03b1 of subject station was 0.878 and Cohen \u03ba coefficient between graders was 0.785.", {"entities": []}], ["Students agreed on CPX as an adequate tool to evaluate students\u2019 performance, but some graders argued that the CPX failed to secure its validity due to their lack of understanding the case.", {"entities": []}], ["One hundred eight students (34.5%) identified essential problem early and only 58 (18.5%) performed systematic history taking and physical examination.", {"entities": []}], ["One hundred seventy-three of them (55.3%) communicated correct diagnosis with the patient.", {"entities": []}], ["Most of them had trouble in writing SOAP notes.", {"entities": []}], ["To gain reliability and validity, interrater agreement should be secured.", {"entities": []}], ["Students' clinical reasoning skills were not enough.", {"entities": []}], ["Students need to be trained on problem identification, reasoning skills and accurate record-keeping.", {"entities": []}], ["We examined how emergency department (ED) visits for potentially preventable, mental health, and other diagnoses were related to same-day access and provider continuity in primary care using administrative data from 71,296 patients in 22 VHA clinics over a three-year period.", {"entities": []}], ["ED visits were categorized as non-emergent; primary care treatable; preventable; not preventable; or mental health-related.", {"entities": []}], ["We conducted multi-level regression models adjusted for patient and clinic factors.", {"entities": []}], ["More same-day access significantly predicted fewer non-emergent and primary care treatable ED visits while continuity was not significantly related to any type of ED visit.", {"entities": []}], ["Neither measure was related to ED visits for mental health problems.", {"entities": []}], ["Biomedical knowledge claims are often expressed as hypotheses, speculations, or opinions, rather than explicit facts (propositions).", {"entities": []}], ["Much biomedical text mining has focused on extracting propositions from biomedical literature.", {"entities": []}], ["One such system is SemRep, which extracts propositional content in the form of subject-predicate-object triples called predications.", {"entities": []}], ["In this study, we investigated the feasibility of assessing the factuality level of SemRep predications to provide more nuanced distinctions between predications for downstream applications.", {"entities": []}], ["We annotated semantic predications extracted from 500 PubMed abstracts with seven factuality values ( fact , probable , possible , doubtful , counterfact , uncommitted , and conditional ).", {"entities": []}], ["We extended a rule-based, compositional approach that uses lexical and syntactic information to predict factuality levels.", {"entities": []}], ["We compared this approach to a supervised machine learning method that uses a rich feature set based on the annotated corpus.", {"entities": []}], ["Our results indicate that the compositional approach is more effective than the machine learning method in recognizing the factuality values of predications.", {"entities": []}], ["The annotated corpus as well as the source code and binaries for factuality assignment are publicly available.", {"entities": []}], ["We will also incorporate the results of the better performing compositional approach into SemMedDB, a PubMed-scale repository of semantic predications extracted using SemRep.", {"entities": []}], ["Sputum is a key diagnostic sample for those with chronic chest conditions including chronic and allergic aspergillus-related disease, but often not obtained in clinic.", {"entities": []}], ["The objective of this study was to evaluate physiotherapeutic interventions to obtain sputum from those not able to spontaneously produce and the subsequent microbiological result.", {"entities": []}], ["Sputum samples were collected by physiotherapists from patients attending routine outpatient clinics managing their aspergillus-related diseases who were unable to spontaneously produce.", {"entities": []}], ["Active Cycle of Breathing Techniques (ACBT) technique was applied first, for 10\u00a0min, followed by hypertonic saline induction using a Pari LC plus or Pari Sprint nebuliser, if necessary and deemed safe to do so.", {"entities": []}], ["Samples processed in the laboratory using standard microbiological techniques for bacterial and fungal culture with the addition of Aspergillus real-time PCR.", {"entities": []}], ["Samples were procured from 353 of 364 (97\u00a0%) patients, 231 (65\u00a0%) by ACBT and 119 (34\u00a0%) with administration of hypertonic saline.", {"entities": []}], ["Three of 125 (2.4\u00a0%) patients had significant bronchospasm during sputum induction.", {"entities": []}], ["Sixteen patients\u2019 sputum tested positive for Aspergillus culture, contrasting with 82 whose Aspergillus PCR was positive, 59 with a strong signal.", {"entities": []}], ["PCR improved detection of Aspergillus by 350\u00a0%.", {"entities": []}], ["Sputum from 124 (34\u00a0%) patients cultured other potentially pathogenic organisms which justified specific therapy.", {"entities": []}], ["Physiotherapeutic interventions safely and effectively procured sputum from patients unable to spontaneously produce.", {"entities": []}], ["The method for sputum induction was well-tolerated and time-efficient, with important microbiological results.", {"entities": []}], ["Risk factors for persistence of food-related symptoms (FRS) and food allergy (FA) from early life to adolescence are incompletely understood.", {"entities": [[64, 76, "DISEASE"]]}], ["The aim of this study was to identify risk factors for FRS and FA in adolescence amongst children with FRS or FA in the first four years of life (early life).", {"entities": []}], ["In children enrolled in a Swedish birth cohort and followed to 16 years (n = 2572), we defined children with early life FRS in the absence of FA, and FA.", {"entities": []}], ["Corresponding phenotypes were defined at 16 years.", {"entities": []}], ["Associations between potential risk factors at 4 years and FRS and FA at 16 years were investigated using logistic regression.", {"entities": []}], ["Early life FRS and FA prevalences were 12.2% and 6.8%, respectively.", {"entities": []}], ["Amongst children with early life FRS, 35.7% had FRS or FA at 16 years, whereas 74.3% of the children with early life FA had FA at 16 years.", {"entities": []}], ["For each of the early life phenotypes, parental allergy, early life allergic multimorbidity, early life reactions to peanuts/tree nuts and IgE reactivity at 4 years were statistically significantly associated with FRS or FA at 16 years.", {"entities": []}], ["In contrast, male sex was associated with an increased risk of FA at 16 years among children with early life FA only.", {"entities": []}], ["In early life, food-related symptoms are twice as common as food allergy.", {"entities": [[60, 72, "DISEASE"]]}], ["Unlike food allergy, food-related symptoms often remit by adolescence.", {"entities": [[7, 19, "DISEASE"]]}], ["Yet, these phenotypes have many common risk factors for persistence to adolescence.", {"entities": []}], ["To analyze the state of psychosocial and mental health of professionals affected by asbestos.", {"entities": []}], ["A cross-sectional study was conducted with 110 professionals working in the Ferrolterra region of Spain, who were affected by asbestos poisoning.", {"entities": []}], ["This group was compared with a group of 70 shipyard workers with no manifestation of work-related diseases.", {"entities": []}], ["All the participants were male with a mean age of 67 years.", {"entities": []}], ["This study was conducted in 2013, between January and June, and used the SCL-90 questionnaire by Derogatis as its primary measure for research.", {"entities": []}], ["This questionnaire consists of 9 variables that measure psychosomatic symptoms.", {"entities": []}], ["In addition, an overall index of psychosomatic gravity was calculated.", {"entities": []}], ["The participants were also asked two questions concerning their overall perception of feeling good.", {"entities": []}], ["Data were analyzed by ANOVA and logistic regression.", {"entities": []}], ["Participants affected by asbestos poisoning showed high occurrence rates of psychological health variables such as somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and global severity index.", {"entities": []}], ["Social interaction as a differentiating factor between workers affected by work-related chronic syndromes as compared to healthy participants will possibly aid in the development of intervention programs by improving the social network of affected individuals.", {"entities": []}], ["Analizar el estado de salud psicosocial y mental de profesionales afectados por el amianto.", {"entities": [[76, 79, "GENE"]]}], ["Estudio transversal con 110 profesionales en la comarca de Ferrolterra, Espa\u00f1a, afectadas por intoxicaci\u00f3n por amianto; y un grupo de comparaci\u00f3n de 70 trabajadores de astilleros, que no presentaban manifestaci\u00f3n de enfermedades profesionales.", {"entities": [[90, 93, "GENE"], [107, 110, "GENE"], [90, 93, "GENE"], [107, 110, "GENE"]]}], ["Todos fueron del sexo masculino con edad promedio de 67 a\u00f1os.", {"entities": []}], ["El estudio se llev\u00f3 a cabo entre Enero y Junio de 2013.", {"entities": []}], ["Para la realizaci\u00f3n de la investigaci\u00f3n se emple\u00f3 como instrumento el cuestionario SCL-90 de Derogatis.", {"entities": []}], ["Este cuestionario est\u00e1 formado por nueve variables que miden la sintomatolog\u00eda psicosom\u00e1tica, y tambi\u00e9n, se calcul\u00f3 un \u00edndice global de gravedad psicosom\u00e1tica.", {"entities": [[31, 34, "GENE"]]}], ["Se les pregunt\u00f3 a los sujetos sobre su percepci\u00f3n global de sentirse bien.", {"entities": []}], ["Se analizaron los datos mediante la t\u00e9cnica del Anova, y se realiz\u00f3 una regresi\u00f3n log\u00edstica.", {"entities": []}], ["Los sujetos afectados por la intoxicaci\u00f3n por amianto presentaron altos \u00edndices de alteraci\u00f3n de su salud psicol\u00f3gica en variables como somatizaci\u00f3n, obsesi\u00f3n-compulsi\u00f3n, sensibilidad interpersonal, depresi\u00f3n, ansiedad, hostilidad, ansiedad f\u00f3bica, ideaci\u00f3n paranoide, psicoticismo e indicador global de gravedad.", {"entities": [[22, 25, "GENE"], [42, 45, "GENE"], [22, 25, "GENE"], [42, 45, "GENE"]]}], ["La interacci\u00f3n social como factor diferenciador entre trabajadores afectados por s\u00edndromes cr\u00f3nicos, debidos al trabajo, frente a los no afectados, permitir\u00e1 desarrollar programas de intervenci\u00f3n basados en el fomento de la red social de los afectados.", {"entities": [[77, 80, "GENE"]]}], ["Heart failure (HF) has a high incidence and prevalence in the USA and worldwide.", {"entities": []}], ["It is a very common cause of significant morbidity and mortality with serious cost implications on the US health sector.", {"entities": []}], ["The primary focus of this review is to synthesize an effective comprehensive care plan for patients in acute decompensated heart failure (ADHF) based on the most current evidence available.", {"entities": []}], ["It begins with a brief overview of the pathophysiology, clinical presentation and evaluation of patients in ADHF.", {"entities": []}], ["It then reviews management goals and treatment guidelines, with emphasis on challenges presented by diuretic resistance and worsening renal function (WRF).", {"entities": []}], ["It provides information on recognition of advanced HF even during acute presentation, estimation of prognosis and proactive identification of patients that will benefit from mechanical cardiac devices, transplantation and palliative care/hospice.", {"entities": []}], ["In addition, it presents strategies to address the problem of readmissions, which is an ominous prognostic factor with enormous economic burden.", {"entities": []}], ["Currently, 1% of the United States population holds a diagnosis for celiac disease (CD), however, a more recently recognized and possibly related condition, \u201cnon-celiac gluten sensitivity\u201d (NCGS) has been suggested to affect up to 6% of the United States public.", {"entities": [[68, 82, "DISEASE"]]}], ["While reliable clinical tests for CD exist, diagnosing individuals affected by NCGS is still complicated by the lack of reliable biomarkers and reliance upon a broad set of intestinal and extra intestinal symptoms possibly provoked by gluten.", {"entities": []}], ["NCGS has been proposed to exhibit an innate immune response activated by gluten and several other wheat proteins.", {"entities": []}], ["At present, an enormous food industry has developed to supply gluten-free products (GFP) with GFP sales in 2014 approaching $1 billion, with estimations projecting sales to reach $2 billion in the year 2020.", {"entities": []}], ["The enormous demand for GFP also reflects a popular misconception among consumers that gluten avoidance is part of a healthy lifestyle choice.", {"entities": []}], ["Features of NCGS and other gluten related disorders ( e.g ., irritable bowel syndrome) call for a review of current distinctive diagnostic criteria that distinguish each, and identification of biomarkers selective or specific for NCGS.", {"entities": [[61, 85, "DISEASE"], [77, 85, "DISEASE"]]}], ["The aim of this paper is to review our current understanding of NCGS, highlighting the remaining challenges and questions which may improve its diagnosis and treatment.", {"entities": []}], ["Pulmonary surfactant is a unique mixture of lipids and surfactant-specific proteins that covers the entire alveolar surface of the lungs.", {"entities": []}], ["Surfactant is not restricted to the alveolar compartment; it also reaches terminal conducting airways and is present in upper airway secretions.", {"entities": []}], ["While the role of surfactant in the alveolar compartment has been intensively elucidated both in health and disease states, the possible role of surfactant in the airways requires further research.", {"entities": []}], ["This review summarizes the current knowledge on surfactant functions regarding the airway compartment and highlights the impact of various surfactant components on allergic inflammation in asthma.", {"entities": [[189, 195, "DISEASE"]]}], ["Mouse kallikrein 1b26 (klk1b26) protein is more abundant in male submandibular glands (SMGs) than in female ones.", {"entities": []}], ["This sexual dimorphism has been thought to be due to increased mRNA synthesis stimulated by androgen.", {"entities": []}], ["However, the klk1b26 protein level in female SMG is far less than that expected from the mRNA level, suggesting an additional mechanism for down-regulation of klk1b26 expression in female SMGs.", {"entities": []}], ["We examined the effects of small non-coding RNAs in mouse SMGs on in vitro translation of klk1b26 using a reticulocyte lysate system and reverse transcription (RT)-PCR for klk1b26 mRNA.", {"entities": []}], ["Statistical analyses were performed with a computer package (Microsoft Excel).", {"entities": []}], ["The microRNA (miRNA) preparation from female SMGs, but not male SMGs, interfered with the in vitro translation of the klk1b26 protein and inhibited the RT-PCR for klk1b26 mRNA with forward primers targeting its 5'-terminal region (between the 15th and 40th nucleotide from the 5'-terminal).", {"entities": []}], ["The miRNA preparation from castrated mouse SMGs showed the inhibitory effect on the klk1b26 translation, but that from a 5\u03b1-dihydrotestosterone-treated female mouse SMGs did not.", {"entities": []}], ["Synthetic miRNAs (miR-325 and miR-1497a), which have partial complementarity with klk1b26 mRNA at its 5'-terminal region (15th to 40th nucleotide position from the 5'-terminal), also interfered with the in vitro klk1b26 translation.", {"entities": [[18, 25, "GENE"]]}], ["When the female miRNA preparation was incubated with a 30-nucleotide-long single-strand oligoDNA (named [15th-44th]ssDNA, whose sequence corresponded to the 15th to 44th position from the 5'-terminal of klk1b26 mRNA) prior to the addition into the in vitro translation system, the inhibitory effect of the miRNA preparation on klk1b26 translation disappeared, while [15th-44th]ssDNA itself had no effect on the translation.", {"entities": []}], ["Preincubation of the miRNA preparation with another single-strand DNA ([169th-198th]ssDNA, whose sequence corresponded with 169th to 198th position of klk1b26 mRNA) did not show the inhibitory effect.", {"entities": []}], ["The small non-coding RNA, most probably miRNA, specifically expressed in female mouse SMGs interfered with klk1b26 protein synthesis in the in vitro translation system.", {"entities": []}], ["Therefore sexual dimorphism observed in klk1b26 expression in mouse SMGs is due at least in part to the female-specific small non-coding RNA in SMGs.", {"entities": []}], ["KLF4 is a transcription factor that is highly expressed in the gastrointestinal tract.", {"entities": [[0, 4, "GENE"]]}], ["Previously we have demonstrated that KLF4 represses HDC promoter activity in a gastric cell line through both an upstream Sp1 binding GC box and downstream gastrin responsive elements.", {"entities": [[37, 41, "GENE"], [52, 55, "GENE"], [122, 125, "GENE"], [134, 136, "GENE"]]}], ["However, the mechanism by which KLF4 inhibits HDC promoter is not well defined.", {"entities": [[32, 36, "GENE"], [46, 49, "GENE"]]}], ["In the current study, by using yeast two-hybrid screening, Tip60 was identified as a KLF4 interacting protein.", {"entities": [[85, 89, "GENE"]]}], ["Further coimmunoprecipitation and functional reporter assays support the interaction between these two proteins.", {"entities": []}], ["In addition, Tip60 and HDAC7, previously shown to interact with each other and repress transcription, inhibited HDC promoter activity in a dose-dependent fashion.", {"entities": [[23, 28, "GENE"], [112, 115, "GENE"]]}], ["Consistently, knock down of Tip60 or HDAC7 gene expression by specific shRNA increased endogenous HDC mRNA level.", {"entities": [[37, 42, "GENE"], [98, 101, "GENE"]]}], ["Co-immunoprecipitation assays showed that HDAC7 was pulled down by KLF4 and Tip60, suggesting that these three proteins form a repressive complex.", {"entities": [[42, 47, "GENE"], [67, 71, "GENE"]]}], ["Further chromatin immuno-precipitation indicated that all three proteins associated with HDC promoter.", {"entities": [[89, 92, "GENE"]]}], ["Two-hour gastrin treatment, known to activate HDC gene expression, significantly decreased the association of KLF4, Tip60 and HDAC7 with HDC promoter, suggesting that gastrin activates HDC gene expression at least partly by decreasing the formation of KLF4/Tip60/HDAC7 repressive complexes at the HDC promoter.", {"entities": [[46, 49, "GENE"], [137, 140, "GENE"], [185, 188, "GENE"], [297, 300, "GENE"], [110, 114, "GENE"], [252, 256, "GENE"], [126, 131, "GENE"], [263, 268, "GENE"], [46, 49, "GENE"], [137, 140, "GENE"], [185, 188, "GENE"], [297, 300, "GENE"], [46, 49, "GENE"], [137, 140, "GENE"], [185, 188, "GENE"], [297, 300, "GENE"], [46, 49, "GENE"], [137, 140, "GENE"], [185, 188, "GENE"], [297, 300, "GENE"]]}], ["Melanoma cells release different types of extracellular vesicles (EVs) into the extracellular milieu that are involved with communication and signaling in the tumor microenvironment.", {"entities": [[0, 8, "DISEASE"]]}], ["Subsets of EVs include exosomes, microvesicles, and apoptotic bodies that carry protein and genetic (RNA) cargos.", {"entities": []}], ["To define the contribution of the RNA cargo of melanoma cell derived EVs we performed small RNA sequencing to identify different small RNAs in the EV subsets.", {"entities": [[47, 55, "DISEASE"]]}], ["Using validated centrifugation protocols, we separated these EV subsets released by the melanoma cell line MML-1, and performed RNA sequencing with the Ion Torrent platform.", {"entities": [[88, 96, "DISEASE"]]}], ["Various, but different, non-coding RNAs were detected in the EV subsets, including microRNA, mitochondrial associated tRNA, small nucleolar RNA, small nuclear RNA, Ro associated Y-RNA, vault RNA and Y-RNA.", {"entities": []}], ["We identified in total 1041 miRNAs in cells and EV subsets.", {"entities": []}], ["Hierarchical clustering showed enrichment of specific miRNAs in exosomes, including hsa-miR-214-3p, hsa-miR-199a-3p and hsa-miR-155-5p, all being associated with melanoma progression.", {"entities": [[162, 170, "DISEASE"]]}], ["Comparison of exosomal miRNAs with miRNAs in clinical melanoma samples indicate that multiple miRNAs in exosomes also are expressed specifically in melanoma tissues, but not in benign naevi.", {"entities": [[54, 62, "DISEASE"], [148, 156, "DISEASE"]]}], ["This study shows for the first time the presence of distinct small RNAs in subsets of EVs released by melanoma cells, with significant similarities to clinical melanoma tissue, and provides unique insights into the contribution of EV associated extracellular RNA in cancer.", {"entities": [[102, 110, "DISEASE"], [160, 168, "DISEASE"], [266, 272, "DISEASE"]]}], ["SF-36 has been both translated into different languages and adapted to different cultures to obtain comparable data on health status internationally.", {"entities": []}], ["However there have been only a limited number of studies focused on the discriminative ability of SF-36 regarding social and disease status in developing countries.", {"entities": []}], ["The aim of this study was to obtain population norms of the short form 36 (SF-36) health survey and the association of SF-36 domains with demographic and socioeconomic variables in an urban population in Turkey.", {"entities": []}], ["A cross-sectional study.", {"entities": []}], ["Face to face interviews were carried out with a sample of households.", {"entities": []}], ["The sample was systematically selected from two urban Health Districts in Izmir, Turkey.", {"entities": []}], ["The study group consisted of 1,279 people selected from a study population of 46,290 people aged 18 and over.", {"entities": []}], ["Internal consistencies of the scales were high, with the exception of mental health and vitality.", {"entities": []}], ["Physical health scales were associated with both age and gender.", {"entities": []}], ["On the other hand, mental health scales were less strongly associated with age and gender.", {"entities": []}], ["Women reported poorer health compared to men in general.", {"entities": []}], ["Social risk factors (employment status, lower education and economic strain) were associated with worse health profiles.", {"entities": []}], ["The SF-36 was found to be capable of discriminating disease status.", {"entities": []}], ["Our findings, cautiously generalisable to urban population, suggest that the SF-36 can be a valuable tool for studies on health outcomes in Turkish population.", {"entities": []}], ["SF-36 may also be a promising measure for research on health inequalities in Turkey and other developing countries.", {"entities": []}], ["Preterm prelabour rupture of the fetal membranes (PPROM) precedes 30% of preterm births and is a risk factor for early onset neonatal sepsis.", {"entities": []}], ["As PPROM is strongly associated with ascending vaginal infection, prophylactic antibiotics are widely used.", {"entities": []}], ["The evolution of vaginal microbiota compositions associated with PPROM and the impact of antibiotics on bacterial compositions are unknown.", {"entities": []}], ["We prospectively assessed vaginal microbiota prior to and following PPROM using MiSeq-based sequencing of 16S rRNA gene amplicons and examined the impact of erythromycin prophylaxis on bacterial load and community structures.", {"entities": []}], ["In contrast to pregnancies delivering at term, vaginal dysbiosis characterised by Lactobacillus spp.", {"entities": []}], ["depletion was present prior to the rupture of fetal membranes in approximately a third of cases (0% vs. 27%, P \u2009=\u20090.026) and persisted following membrane rupture (31%, P \u2009=\u20090.005).", {"entities": []}], ["Vaginal dysbiosis was exacerbated by erythromycin treatment (47%, P \u2009=\u20090.00009) particularly in women initially colonised by Lactobacillus spp.", {"entities": []}], ["Lactobacillus depletion and increased relative abundance of Sneathia spp.", {"entities": []}], ["were associated with subsequent funisitis and early onset neonatal sepsis.", {"entities": [[32, 41, "DISEASE"]]}], ["Our data show that vaginal microbiota composition is a risk factor for subsequent PPROM and is associated with adverse short-term maternal and neonatal outcomes.", {"entities": []}], ["This highlights vaginal microbiota as a potentially modifiable antenatal risk factor for PPROM and suggests that routine use of erythromycin for PPROM be re-examined.", {"entities": []}], ["The online version of this article 10.1186/s12916-017-0999-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Previously unreported CD8 \u03b3 .", {"entities": []}], ["Cytotoxic activity was evaluated in a chromium releasing test.", {"entities": []}], ["Induced sputum CD8 \u03b3 in severe asthmatics than mild asthma and age-matched healthy controls.", {"entities": [[52, 58, "DISEASE"]]}], ["The predominance of CD8", {"entities": []}], ["Characterizing intra-urban variation in air quality is important for epidemiological investigation of health outcomes and disparities.", {"entities": []}], ["To date, however, few studies have been designed to capture spatial variation during select hours of the day, or to examine the roles of meteorology and complex terrain in shaping intra-urban exposure gradients.", {"entities": []}], ["We designed a spatial saturation monitoring study to target local air pollution sources, and to understand the role of topography and temperature inversions on fine-scale pollution variation by systematically allocating sampling locations across gradients in key local emissions sources (vehicle traffic, industrial facilities) and topography (elevation) in the Pittsburgh area.", {"entities": []}], ["Street-level integrated samples of fine particulate matter (PM 2.5 ), black carbon (BC), nitrogen dioxide (NO 2 ), sulfur dioxide (SO 2 ), and ozone (O 3 ) were collected during morning rush and probable inversion hours (6-11\u00a0AM), during summer and winter.", {"entities": []}], ["We hypothesized that pollution concentrations would be: 1) higher under inversion conditions, 2) exacerbated in lower-elevation areas, and 3) vary by season.", {"entities": []}], ["During July - August 2011 and January - March 2012, we observed wide spatial and seasonal variability in pollution concentrations, exceeding the range measured at regulatory monitors.", {"entities": []}], ["We identified elevated concentrations of multiple pollutants at lower-elevation sites, and a positive association between inversion frequency and NO 2 concentration.", {"entities": []}], ["We examined temporal adjustment methods for deriving seasonal concentration estimates, and found that the appropriate reference temporal trend differs between pollutants.", {"entities": []}], ["Our time-stratified spatial saturation approach found some evidence for modification of inversion-concentration relationships by topography, and provided useful insights for refining and interpreting GIS-based pollution source indicators for Land Use Regression modeling.", {"entities": []}], ["An important feature of atopic asthma is the T cell\u2013driven late phase reaction involving transient bronchoconstriction followed by development of airways hyperresponsiveness (AHR).", {"entities": [[31, 37, "DISEASE"], [175, 178, "GENE"]]}], ["Using a unique rat asthma model we recently showed that the onset and duration of the aeroallergen-induced airway mucosal T cell activation response in sensitized rats is determined by the kinetics of functional maturation of resident airway mucosal dendritic cells (AMDCs) mediated by cognate interactions with CD4", {"entities": [[19, 25, "DISEASE"], [312, 315, "GENE"]]}], ["Reliable, real-time heart and respiratory rates are key vital signs used in evaluating the physiological status in many clinical and non-clinical settings.", {"entities": []}], ["Measuring these vital signs generally requires superficial attachment of physically or logistically obtrusive sensors to subjects that may result in skin irritation or adversely influence subject performance.", {"entities": []}], ["Given the broad acceptance of ingestible electronics, we developed an approach that enables vital sign monitoring internally from the gastrointestinal tract.", {"entities": []}], ["Here we report initial proof-of-concept large animal (porcine) experiments and a robust processing algorithm that demonstrates the feasibility of this approach.", {"entities": []}], ["Implementing vital sign monitoring as a stand-alone technology or in conjunction with other ingestible devices has the capacity to significantly aid telemedicine, optimize performance monitoring of athletes, military service members, and first-responders, as well as provide a facile method for rapid clinical evaluation and triage.", {"entities": []}], ["Multiple mechanisms such as genetic and epigenetic variations within a key gene may play a role in malarial susceptibility and response to anti-malarial drugs in the population.", {"entities": []}], ["ABCB1 is one of the well-studied membrane transporter genes that code for the P-glycoprotein (an efflux protein) and whose effect on malaria disease predisposition and susceptibility to drugs remains to be understood.", {"entities": [[133, 140, "DISEASE"], [0, 5, "GENE"]]}], ["We studied the association of single nucleotide variations in human ABCB1 that influences its function in subjects with uncomplicated and complicated malaria caused by Plasmodium falciparum (Pf) .", {"entities": [[150, 157, "DISEASE"], [68, 73, "GENE"]]}], ["Global DNA methylation and ABCB1 DNA promoter methylation levels were performed along with transcriptional response and protein expression in subjects with malaria and healthy controls.", {"entities": [[156, 163, "DISEASE"], [27, 32, "GENE"]]}], ["The rs2032582 locus was significantly associated with complicated and combined malaria groups when compared to controls ( p < 0.05).", {"entities": [[79, 86, "DISEASE"]]}], ["Significant DNA methylation difference was noticed between case and control ( p < 0.05).", {"entities": []}], ["In addition, global DNA methylation levels of the host DNA were inversely proportional to parasitemia in individuals with Pf infection.", {"entities": []}], ["Our study also revealed the correlation between ABCB1 DNA promoter methylation with rs1128503 and rs2032582 polymorphisms in malaria and was related to increased expression of ABCB1 protein levels in complicated malaria group ( p < 0.05) when compared to uncomplicated malaria and control groups.", {"entities": [[125, 132, "DISEASE"], [212, 219, "DISEASE"], [269, 276, "DISEASE"], [48, 53, "GENE"], [176, 181, "GENE"], [48, 53, "GENE"], [176, 181, "GENE"]]}], ["The study provides evidence for multiple mechanisms that may regulate the role of host ABCB1 function to mediate aetiology of malaria susceptibility, prognosis and drug response.", {"entities": [[126, 133, "DISEASE"], [87, 92, "GENE"]]}], ["These may have clinical implications and therapeutic application for various malarial conditions.", {"entities": []}], ["Epidemiological and experimental studies suggest that exposure to ultrafine particles (UFP) might aggravate the allergic inflammation of the lung in asthmatics.", {"entities": []}], ["We exposed 12 allergic asthmatics in two subgroups in a double-blinded randomized cross-over design, first to freshly generated ultrafine carbon particles (64\u00a0\u03bcg/m For the entire study group, inhalation of UFP by itself had no significant effect on the allergen induced inflammatory response measured with total cell count as compared to exposure with filtered air (p\u2009=\u20090.188).", {"entities": []}], ["However, the subgroup of subjects, which inhaled UFP during the first exposure, exhibited a significant increase in total BAL cells (p\u2009=\u20090.021), eosinophils (p\u2009=\u20090.031) and monocytes (p\u2009=\u20090.013) after filtered air exposure and subsequent allergen challenge 28\u00a0days later.", {"entities": []}], ["Additionally, the potential of BAL cells to generate oxidant radicals was significantly elevated at that time point.", {"entities": []}], ["The subgroup that was exposed first to filtered air and 28\u00a0days later to UFP did not reveal differences between sessions.", {"entities": []}], ["Our data demonstrate that pre-allergen exposure to UFP had no acute effect on the allergic inflammation.", {"entities": []}], ["However, the subgroup analysis lead to the speculation that inhaled UFP particles might have a long-term effect on the inflammatory course in asthmatic patients.", {"entities": []}], ["This should be reconfirmed in further studies with an appropriate study design and sufficient number of subjects.", {"entities": []}], ["The optimal use of various therapeutic combinations for moderate/severe chronic obstructive pulmonary disease (COPD) is unclear.", {"entities": [[72, 109, "DISEASE"]]}], ["The GLISTEN trial compared the efficacy of two long-acting anti-muscarinic antagonists (LAMA), when combined with an inhaled corticosteroid (ICS) and a long-acting \u03b22 agonist (LABA).", {"entities": []}], ["This randomised, blinded, placebo-controlled trial in moderate/severe COPD patients compared once-daily glycopyrronium (GLY) 50\u2005\u00b5g, once-daily tiotropium (TIO) 18\u2005\u00b5g or placebo (PLA), when combined with salmeterol/fluticasone propionate (SAL/FP) 50/500\u2005\u00b5g twice daily.", {"entities": []}], ["The primary objective was to determine the non-inferiority of GLY+SAL/FP versus TIO+SAL/FP on trough FEV 1 after 12\u2005weeks.", {"entities": [[101, 104, "GENE"]]}], ["An important secondary objective was whether addition of GLY to SAL/FP was better than SAL/FP alone.", {"entities": []}], ["773 patients (mean FEV 1 57.2% predicted) were randomised; 84.9% completed the trial.", {"entities": [[19, 22, "GENE"]]}], ["At week 12, GLY+SAL/FP demonstrated non-inferiority to TIO+SAL/FP for trough FEV 1 : least square mean treatment difference (LSMdiff) \u22127\u2005mL (SE 17.4) with a lower limit for non-inferiority of \u221260\u2005mL.", {"entities": [[77, 80, "GENE"]]}], ["There was significant increase in week 12 trough FEV 1 with GLY+SAL/FP versus PLA+SAL/FP (LSMdiff 101\u2005mL, p<0.001).", {"entities": [[49, 52, "GENE"]]}], ["At 12\u2005weeks, GLY+SAL/FP produced significant improvement in St George's Respiratory Questionnaire total score versus PLA+SAL/FP (LSMdiff \u22122.154, p=0.02).", {"entities": []}], ["GLY+SAL/FP demonstrated significant rescue medication reduction versus PLA+SAL/FP (LSMdiff \u22120.72 puffs/day, p<0.001).", {"entities": []}], ["Serious adverse events were similar for GLY+SAL/FP, TIO+SAL/FP and PLA+SAL/FP with an incidence of 5.8%, 8.5% and 5.8%, respectively.", {"entities": []}], ["GLY+SAL/FP showed comparable improvements in lung function, health status and rescue medication to TIO+SAL/FP.", {"entities": []}], ["Importantly, addition of GLY to SAL/FP demonstrated significant improvements in lung function, health status and rescue medication compared to SAL/FP.", {"entities": []}], ["NCT01513460.", {"entities": []}], ["Biomass smoke is the leading cause of COPD in developing countries such as Turkey.", {"entities": []}], ["In rural areas of Turkey, females are more exposed to biomass smoke because of traditional lifestyles.", {"entities": []}], ["The aim of this study was to determine the adverse effects of biomass smoke on pulmonary functions and define the relationship between duration in years and an index (cumulative exposure index) with altered pulmonary function test results.", {"entities": []}], ["A total of 115 females who lived in the village of Ka\u011fizman (a borough of Kars located in the eastern part of Turkey) and were exposed to biomass smoke were included in the study.", {"entities": [[74, 78, "GENE"]]}], ["The control group was generated with 73 individuals living in the same area who were never exposed to biomass smoke.", {"entities": []}], ["Twenty-seven (23.8%) females in the study group and four (5.5%) in the control group had small airway disease ( P =0.038).", {"entities": []}], ["Twenty-two (19.1%) females in the study group and ten (13.7%) in the control group had obstruction ( P =0.223).", {"entities": []}], ["Twenty (17.3%) females in the study group who were exposed to biomass smoke had restriction compared with ten (13%) in the control group ( P =0.189).", {"entities": []}], ["The duration needed for the existence of small airway disease was 16 years, for obstructive airway disease was 17 years, and for restrictive airway disease was 17 years.", {"entities": []}], ["The intensity of biomass smoke was defined in terms of cumulative exposure index; it was calculated by multiplying hours per day, weeks per month, and total years of smoke exposure and dividing the result by three.", {"entities": []}], ["Exposure to biomass smoke is a serious public health problem, especially in rural areas of developing countries, because of its negative effects on pulmonary functions.", {"entities": []}], ["As the duration and the intensity of exposure increase, the probability of having altered pulmonary function test results is higher.", {"entities": []}], ["The dust mite Blomia tropicalis is an important source of aeroallergens in tropical areas.", {"entities": []}], ["Although a mouse model for B. tropicalis extract ( Bt E)-induced asthma has been described, no study comparing different mouse strains in this asthma model has been reported.", {"entities": [[65, 71, "DISEASE"], [143, 149, "DISEASE"]]}], ["The relevance and reproducibility of experimental animal models of allergy depends on the genetic background of the animal, the molecular composition of the allergen and the experimental protocol.", {"entities": []}], ["This work had two objectives.", {"entities": []}], ["The first was to study the anti- B. tropicalis allergic responses in different mouse strains using a short-term model of respiratory allergy to Bt E. This study included the comparison of the allergic responses elicited by Bt E with those elicited by ovalbumin in mice of the strain that responded better to Bt E sensitization.", {"entities": []}], ["The second objective was to investigate whether the best responder mouse strain could be used in an experimental model of allergy employing relatively low Bt E doses.", {"entities": []}], ["Groups of mice of four different syngeneic strains were sensitized subcutaneously with 100 \u03bcg of Bt E on days 0 and 7 and challenged four times intranasally, at days 8, 10, 12, and 14, with 10 \u03bcg of Bt E. A/J mice, that were the best responders to Bt E sensitization, were used to compare the B. tropicalis -specific asthma experimental model with the conventional experimental model of ovalbumin (OVA)-specific asthma.", {"entities": [[317, 323, "DISEASE"], [412, 418, "DISEASE"]]}], ["A/J mice were also sensitized with a lower dose of Bt E. Mice of all strains had lung inflammatory-cell infiltration and increased levels of anti- Bt E IgE antibodies, but these responses were significantly more intense in A/J mice than in CBA/J, BALB/c or C57BL/6J mice.", {"entities": []}], ["Immunization of A/J mice with Bt E induced a more intense airway eosinophil influx, higher levels of total IgE, similar airway hyperreactivity to methacholine but less intense mucous production, and lower levels of specific IgE, IgG1 and IgG2 antibodies than sensitization with OVA.", {"entities": []}], ["Finally, immunization with a relatively low Bt E dose (10 \u03bcg per subcutaneous injection per mouse) was able to sensitize A/J mice, which were the best responders to high-dose Bt E immunization, for the development of allergy-associated immune and lung inflammatory responses.", {"entities": []}], ["The described short-term model of Bt E-induced allergic lung disease is reproducible in different syngeneic mouse strains, and mice of the A/J strain was the most responsive to it.", {"entities": [[56, 68, "DISEASE"]]}], ["In addition, it was shown that OVA and Bt E induce quantitatively different immune responses in A/J mice and that the experimental model can be set up with low amounts of Bt E.", {"entities": []}], ["Aging is associated with a dysregulation of the immune system, leading to a general pro-inflammatory state of the organism, a process that has been named inflamm-aging.", {"entities": []}], ["Oxidative stress has an important role in aging and in the regulation of immune responses, probably playing a role in the development of age-related diseases.", {"entities": []}], ["The respiratory system function physiologically declines with the advancement of age.", {"entities": []}], ["In elderly asthmatic patients, this may contribute to disease expression.", {"entities": []}], ["In this review, we will focus on age-related changes affecting the immune system and in respiratory structure and function that could contribute to asthma occurrence, and/or clinical presentation in the elderly.", {"entities": [[148, 154, "DISEASE"]]}], ["Also, naturally occurring equine asthma will be discussed as a possible model for studying the importance of oxidative stress and immun-aging/inflamm-aging in humans.", {"entities": [[33, 39, "DISEASE"]]}], ["The aim of the study was to estimate the prevalence of depression in the population diagnosed with diabetes type 2 and to test the hypothesis that the presence of depression in such cases was associated with a) worse glycaemic control, and b) higher healthcare costs.", {"entities": []}], ["We conducted a cross-sectional analysis, from 1st September 2010 to 31st August 2011, among patients with type 2 diabetes aged 35\u00a0years and over in the Basque Country.", {"entities": []}], ["It was identified how many of them had also depression.", {"entities": []}], ["The database included administrative individual level information on age, sex, healthcare costs, other comorbidities, and values of glycaemic control (HbA 1c ).", {"entities": []}], ["Deprivation index variable was used as socioeconomic measure and, to observe the coexistent pathologies, all the patients diagnoses were categorized by Adjusted Clinical Groups.", {"entities": []}], ["We used a measure of association, a logistic and a linear regression for analysis.", {"entities": []}], ["12.392 (9.8%) of type 2 diabetes patients were diagnosed with depression, being the prevalence 5.2% for males and 15.1% for females.", {"entities": []}], ["This comorbidity was higher among the most deprived population.", {"entities": []}], ["There was no association between the presence of depression and glycaemic control.", {"entities": []}], ["We estimated that the comorbidity average cost per patient/year was 516\u20ac higher than in patients with just type 2 diabetes (P\u2009<\u20090.001) adjusted by the other covariates.", {"entities": []}], ["We did not find any relationship between depression and glycaemic control in patients with type 2 diabetes.", {"entities": []}], ["However, the comorbidity was associated with significantly high healthcare costs compared to that of type 2 diabetes occurring alone, after adjusting by other illness.", {"entities": []}], ["Thus, there is a need of more precise recognition, screening and monitoring of depression among diabetic population.", {"entities": []}], ["Evidence-based treatment for depression should be included in type 2 diabetes clinical guidelines.", {"entities": []}], ["Physicians are increasingly being asked to diagnose and treat people made ill by exposure to water-damaged environments, mold, and mycotoxins.", {"entities": []}], ["In addition to avoidance of further exposure to these environments and to items contaminated by these environments, a number of approaches have been used to help persons affected by exposure to restore their health.", {"entities": []}], ["Illness results from a combination of factors present in water-damaged indoor environments including, mold spores and hyphal fragments, mycotoxins, bacteria, bacterial endotoxins, and cell wall components as well as other factors.", {"entities": []}], ["Mechanisms of illness include inflammation, oxidative stress, toxicity, infection, allergy, and irritant effects of exposure.", {"entities": []}], ["This paper reviews the scientific literature as it relates to commonly used treatments such as glutathione, antioxidants, antifungals, and sequestering agents such as Cholestyramine, charcoal, clay and chlorella, antioxidants, probiotics, and induced sweating.", {"entities": []}], ["We report exploratory gene-expression profiling data from a single-arm Phase-II-study in patients with non-squamous (ns)NSCLC treated with pemetrexed and cisplatin.", {"entities": []}], ["Previously disclosed results indicated a significant association of low thymidylate-synthase (TS)-expression with longer progression-free and overall survival (PFS/OS).", {"entities": []}], ["Treatment-na\u00efve nsNSCLC patients (IIIB/IV) received 4 cycles of pemetrexed/cisplatin; non-progressing patients continued on pemetrexed-maintenance.", {"entities": []}], ["Diagnostic tissue-samples were used to assess TS-expression by immunohistochemistry (IHC) and mRNA-expression array-profiling (1,030 lung cancer-specific genes).", {"entities": [[133, 144, "DISEASE"], [138, 144, "DISEASE"]]}], ["Cox proportional-hazard models were applied to explore the association between each gene and PFS/OS.", {"entities": []}], ["Genes significantly correlated with PFS/OS were further correlated with TS-protein expression (Spearman-rank).", {"entities": []}], ["Unsupervised clustering was applied to all evaluable samples (n\u200a=\u200a51) for all 1,030 genes and an overlapping 870-gene subset associated with adenocarcinoma (ADC, n\u200a=\u200a47).", {"entities": [[141, 155, "DISEASE"], [157, 160, "GENE"]]}], ["51/70 tissue-samples (72.9%) were evaluable; 9 of 1,030 genes were significantly associated with PFS/OS (unadjusted p<0.01, genes: Chromosome 16 open reading frame 89, napsin A, surfactant protein B, aquaporin 4, TRAF2- and Nck-interacting kinase, Lysophosphatidylcholine acyltransferase 1, Interleukin 1 receptor type II, NK2 homeobox 1, ABO glycosyl-transferase); expression for all except IL1R2 correlated negatively with nuclear TS-expression (statistically significant for 5/8 genes, unadjusted p<0.01).", {"entities": [[339, 342, "GENE"], [392, 397, "GENE"]]}], ["Cluster-analysis based on 1,030 genes revealed no clear trend regarding PFS/OS; the ADC-based cluster analysis identified 3 groups (n\u200a=\u200a21/11/15) with median (95%CI) PFS of 8.1(6.9,NE)/2.4(1.2,NE)/4.4(1.2,NE) months and OS of 20.3(17.5,NE)/4.3(1.4,NE)/8.3(3.9,NE) months, respectively.", {"entities": []}], ["These exploratory gene-expression profiling results describe genes potentially linked to low TS-expression.", {"entities": []}], ["Nine genes were significantly associated with PFS/OS but could not be differentiated as prognostic or predictive as this was a single-arm study.", {"entities": []}], ["Although these hypotheses-generating results are interesting, they provide no evidence to change the current histology-based treatment approach with pemetrexed.", {"entities": []}], ["One hundred and forty-eight patients with Hodgkin's disease (HD) were stratified into 4 groups according to atopic status.", {"entities": []}], ["Group 1 had a personal history of atopy and Group 2 a family history of atopy.", {"entities": []}], ["In Groups 3 and 4 there was no history of atopy but high serum IgE levels (Group 3) and normal IgE levels (Group 4).", {"entities": []}], ["Comparison of the survival of these groups by the logrank method showed a significant trend (P = less than 0.0001) where survival was ranked Group 1 greater than 2 greater than 3 greater than 4.", {"entities": []}], ["Known prognostic factors in HD--age, sex, stage, symptoms and histology--had to be taken into account, since their distribution differed between the atopic groups.", {"entities": []}], ["In Group I there was more stage IA and IIA disease and less \"B\" symptoms, in Group 3 more nodular sclerosis histology and more \"B\" symptoms and in Group 4 more lymphocyte-depleted histology and a higher mean age than expected from their distribution in the combined groups.", {"entities": []}], ["Adjustment to allow for the variation in each of the other prognostic factors and for a combination of age, symptoms and histology still showed a significant trend of survival on the basis of atopic status.", {"entities": []}], ["The increased survival of atopic patients suggests that atopic mechanisms or the genetic basis to atopy has a protective effect in HD either directly or by interaction with treatment.", {"entities": []}], ["In two trials, the influences of hepatic and renal impairment on the pharmacokinetics of olodaterol, a novel long-acting inhaled \u03b2 2 -agonist for treatment of COPD, were investigated.", {"entities": []}], ["The first trial included eight subjects with mild hepatic function impairment (Child\u2013Pugh A), eight subjects with moderate impairment (Child\u2013Pugh B), and 16 matched healthy subjects with normal hepatic function.", {"entities": []}], ["The second trial included eight subjects with severe renal impairment (creatinine clearance <30 mL\u00b7min Olodaterol was well tolerated in all subjects.", {"entities": []}], ["The geometric mean ratios and 90% confidence intervals of dose-normalized area under the plasma concentration-time curve from time zero to 4 hours (AUC 0\u20134 ) for subjects with mild and moderate hepatic impairment compared to healthy subjects were 97% (75%\u2013125%) and 105% (79%\u2013140%), respectively.", {"entities": []}], ["Corresponding values for dose-normalized maximum concentration ( C max ) were 112% (84%\u2013151%) (mild impairment) and 99% (73%\u2013135%) (moderate impairment).", {"entities": [[67, 70, "GENE"]]}], ["The geometric mean ratio (90% confidence interval) of AUC 0\u20134 for subjects with severe renal impairment compared to healthy subjects was 135% (94%\u2013195%), and for C max was 137% (84%\u2013222%).", {"entities": [[164, 167, "GENE"]]}], ["There was no significant relationship between creatinine clearance and AUC 0\u20134 or C max .", {"entities": [[84, 87, "GENE"]]}], ["Renal clearance of olodaterol was reduced to 20% of normal in severe renal impairment.", {"entities": []}], ["Mild to moderate hepatic function impairment or severe renal function impairment did not result in a clinically relevant increase of olodaterol systemic exposure after a single inhaled dose.", {"entities": []}], ["While the importance of the Th2 cytokine IL-13 as a central mediator of airway hyperreactivity (AHR) has been described in allergic protein-induced asthma, this has never been investigated in chemical-induced asthma.", {"entities": [[148, 154, "DISEASE"], [209, 215, "DISEASE"], [96, 99, "GENE"]]}], ["We examined the importance of IL-13 in a mouse model of chemical-induced AHR, using toluene-2,4-diisocyanate (TDI).", {"entities": [[73, 76, "GENE"]]}], ["In a first set-up, wild type (WT) and IL-13 knockout (KO) C57Bl/6 mice were dermally treated on days 1 and 8 with 1% TDI or vehicle (acetone/olive oil) on both ears.", {"entities": []}], ["On day 15, mice received an intranasal instillation with 0.1% TDI or vehicle.", {"entities": []}], ["In a second set-up, WT mice sensitized with 1% TDI or vehicle, received i.v.", {"entities": []}], ["either anti-IL-13 or control antibody prior to the intranasal challenge.", {"entities": []}], ["TDI-sensitized and TDI-challenged WT mice showed AHR to methacholine, in contrast to TDI-sensitized and TDI-challenged IL-13 KO mice, which also showed lower levels of total serum IgE.", {"entities": [[49, 52, "GENE"]]}], ["TDI-sensitized and TDI-challenged IL-13 KO mice had lower numbers of T-cells in the auricular lymph nodes.", {"entities": []}], ["TDI-treated WT mice, receiving anti-IL-13, showed no AHR, in contrast to those receiving control antibody, despite increased levels of IgE.", {"entities": [[53, 56, "GENE"]]}], ["Anti-IL-13 treatment in TDI-treated WT mice resulted in lower levels of serum IL-13, but did not induce changes in T- and B-cell numbers, and in the cytokine production profile.", {"entities": []}], ["We conclude that IL-13 plays a critical role in the effector phase of chemical-induced, immune-mediated AHR.", {"entities": [[104, 107, "GENE"]]}], ["This implicates that anti-IL-13 treatment could have a beneficial effect in patients with this asthma phenotype.", {"entities": [[95, 101, "DISEASE"]]}], ["IgG antibodies produced by rabbits immunized against S .", {"entities": []}], ["mansoni antigens cross-reacted with aqueous soluble constituents of a variety of allergens.", {"entities": []}], ["The antibody cross-reactivity was largely sensitive to degradation by treatment of the target antigens with sodium meta-periodate, suggesting the cross-reactivity was due to carbohydrate determinants that were common to both the schistosome and the allergens (CCDs).", {"entities": []}], ["The reaction between the rabbit antibodies and a 43 kDa molecule in a rubber latex extract was analysed further: tandem mass spectrometry identified the latex molecule as allergen Hev b 7.", {"entities": []}], ["Rabbit anti-schistosome IgG antibodies purified by acid-elution from solid-phase latex Hev b 7 reacted with the S .", {"entities": []}], ["mansoni egg antigens IPSE/alpha-1 and kappa-5 and cercarial antigens SPO-1 and a fatty acid-binding protein.", {"entities": []}], ["Moreover, purified anti- S .", {"entities": []}], ["mansoni egg, latex cross-reactive antibodies reacted with antigenic constituents of some fruits, a result of potential relevance to the latex-fruit syndrome of allergic reactions.", {"entities": [[148, 156, "DISEASE"]]}], ["We propose that IgG anti-schistosome antibodies that cross-react with allergens may be able to block IgE-induced allergic reactions and thus provide a possible explanation for the hygiene hypothesis.", {"entities": []}], ["Pathogenesis of complex diseases involves the integration of genetic and environmental factors over time, making it particularly difficult to tease apart relationships between phenotype, genotype, and environmental factors using traditional experimental approaches.", {"entities": []}], ["Using gene-centered databases, we have developed a network of complex diseases and environmental factors through the identification of key molecular pathways associated with both genetic and environmental contributions.", {"entities": []}], ["Comparison with known chemical disease relationships and analysis of transcriptional regulation from gene expression datasets for several environmental factors and phenotypes clustered in a metabolic syndrome and neuropsychiatric subnetwork supports our network hypotheses.", {"entities": [[200, 208, "DISEASE"]]}], ["This analysis identifies natural and synthetic retinoids, antipsychotic medications, Omega 3 fatty acids, and pyrethroid pesticides as potential environmental modulators of metabolic syndrome phenotypes through PPAR and adipocytokine signaling and organophosphate pesticides as potential environmental modulators of neuropsychiatric phenotypes.", {"entities": [[183, 191, "DISEASE"]]}], ["Identification of key regulatory pathways that integrate genetic and environmental modulators define disease associated targets that will allow for efficient screening of large numbers of environmental factors, screening that could set priorities for further research and guide public health decisions.", {"entities": []}], ["A recent epidemiological study showed that eating \u2018fast food\u2019 items such as potato chips increased likelihood of obesity, whereas eating yogurt prevented age-associated weight gain in humans.", {"entities": [[113, 120, "DISEASE"]]}], ["It was demonstrated previously in animal models of obesity that the immune system plays a critical role in this process.", {"entities": [[51, 58, "DISEASE"]]}], ["Here we examined human subjects and mouse models consuming Westernized \u2018fast food\u2019 diet, and found CD4 Lactobacillus reuteri ATCC 6475 in drinking water.", {"entities": [[99, 102, "GENE"]]}], ["Surprisingly, we discovered that oral L. reuteri therapy alone was sufficient to change the pro-inflammatory immune cell profile and prevent abdominal fat pathology and age-associated weight gain in mice regardless of their baseline diet.", {"entities": []}], ["These beneficial microbe effects were transferable into na\u00efve recipient animals by purified CD4 ad libitum caloric intake.", {"entities": [[92, 95, "GENE"]]}], ["Our finding that microbial targeting restored CD4", {"entities": [[46, 49, "GENE"]]}], ["Diet and chronic inflammation of the colon have been suggested to be risk factors in the development of colorectal cancer (CRC).", {"entities": [[104, 121, "DISEASE"], [115, 121, "DISEASE"]]}], ["The possible link between inflammatory potential of diet, measured through the Dietary Inflammatory Index (DII I p < 0.001].", {"entities": []}], ["When analyzed as a continuous variable, results showed an increased risk of CRC of 7% for a 1-point increase in the DII score.", {"entities": []}], ["Results remained unchanged when analyses were restricted to the four prospective studies.", {"entities": []}], ["Results of our meta-analysis support the importance of adopting a healthier anti-inflammatory diet in preventing CRC.", {"entities": []}], ["These results further substantiate the utility of DII as tool to characterize the inflammatory potential of diet and to predict CRC.", {"entities": []}], ["Interleukin- (IL-) 18 and tryptase were previously reported to relate to asthma, but the correlation between these two potent proinflammatory molecules in asthma and their roles in mast cell accumulation remain uninvestigated.", {"entities": [[73, 79, "DISEASE"], [155, 161, "DISEASE"]]}], ["Using flow cytometric analysis technique and ovalbumin- (OVA-) sensitized mouse model, it was found that IL-18 and tryptase levels in the plasma of moderate and severe asthma were elevated, and they correlated well with each other.", {"entities": [[168, 174, "DISEASE"]]}], ["Tryptase and agonist peptides of protease activated receptor- (PAR-) 2 induced substantial quantity of IL-18 release.", {"entities": []}], ["IL-18 and tryptase provoked mast cell accumulation in peritoneum of OVA-sensitized mice.", {"entities": []}], ["OVA-sensitization increased number of IL-18 receptor (R)", {"entities": []}], ["Hyperglycemia is among the potent factors that may induce or facilitate apoptosis.", {"entities": []}], ["TNF-Related Apoptosis-Inducing Factor (TRAIL) is known for its apoptotic and immunomodulatory effects that have recently been correlated with diabetes.", {"entities": []}], ["We examined serum-soluble TRAIL (sTRAIL) and high-sensitivity CRP (hs-CRP) levels and their association with various distinct parameters in type 2 diabetic nephropathy patients with diabetic foot disease.", {"entities": [[62, 65, "GENE"], [70, 73, "GENE"]]}], ["Twenty-two diabetic nephropathy patients with foot ulcers were enrolled in our study.", {"entities": []}], ["Patients had been diagnosed with diabetes at age 24\u00b110.58 years.", {"entities": []}], ["Circulating sTRAIL and Hs-CRP levels were compared with control values, and possible correlations were investigated with parameters such as age, Wagner\u2019s Grade (WG), BMI, HbA1c, and creatinine.", {"entities": []}], ["Serum sTRAIL levels were significantly reduced in the patient group, compared to healthy subjects.", {"entities": []}], ["High HsCRP levels correlated with age, and WGS correlated with BMI and creatinine levels.", {"entities": []}], ["Significantly suppressed sTRAIL levels in diabetic nephropathy patients with foot ulcers compared to healthy controls suggest a protective role for TRAIL in the disease setting.", {"entities": []}], ["Asthma and chronic obstructive pulmonary disease (COPD) are heterogeneous diseases.", {"entities": [[11, 48, "DISEASE"], [0, 6, "DISEASE"]]}], ["We sought to determine, in terms of their sputum cellular and mediator profiles, the extent to which they represent distinct or overlapping conditions supporting either the \u201cBritish\u201d or \u201cDutch\u201d hypotheses of airway disease pathogenesis.", {"entities": []}], ["We compared the clinical and physiological characteristics and sputum mediators between 86 subjects with severe asthma and 75 with moderate-to-severe COPD.", {"entities": [[112, 118, "DISEASE"]]}], ["Biological subgroups were determined using factor and cluster analyses on 18 sputum cytokines.", {"entities": []}], ["The subgroups were validated on independent severe asthma (n\u00a0= 166) and COPD (n\u00a0= 58) cohorts.", {"entities": [[51, 57, "DISEASE"]]}], ["Two techniques were used to assign the validation subjects to subgroups: linear discriminant analysis, or the best identified discriminator (single cytokine) in combination with subject disease status (asthma or COPD).", {"entities": [[202, 208, "DISEASE"]]}], ["Discriminant analysis distinguished severe asthma from COPD completely using a combination of clinical and biological variables.", {"entities": [[43, 49, "DISEASE"]]}], ["Factor and cluster analyses of the sputum cytokine profiles revealed 3 biological clusters: cluster 1: asthma predominant, eosinophilic, high T H 2 cytokines; cluster 2: asthma and COPD overlap, neutrophilic; cluster 3: COPD predominant, mixed eosinophilic and neutrophilic.", {"entities": [[103, 109, "DISEASE"], [170, 176, "DISEASE"]]}], ["Validation subjects were classified into 3 subgroups using discriminant analysis, or disease status with a binary assessment of sputum IL-1\u03b2 expression.", {"entities": []}], ["Sputum cellular and cytokine profiles of the validation subgroups were similar to the subgroups from the test study.", {"entities": []}], ["Sputum cytokine profiling can determine distinct and overlapping groups of subjects with asthma and COPD, supporting both the British and Dutch hypotheses.", {"entities": [[89, 95, "DISEASE"]]}], ["These findings may contribute to improved patient classification to enable stratified medicine.", {"entities": []}], ["The aim of this study was to determine the association of hormone levels with the occurrence of musculoskeletal pain.", {"entities": []}], ["Men ages 40 to 79\u00a0years were recruited from population registers in 8 European centres.", {"entities": []}], ["Subjects were asked to complete a postal questionnaire, which enquired about lifestyle and the occurrence of musculoskeletal pain over the past month.", {"entities": []}], ["Total testosterone (T), oestradiol (E2), luteinising hormone (LH), and follicle-stimulating hormone (FSH) were assayed from a fasting blood sample.", {"entities": []}], ["The association between pain status and hormone levels was assessed using multinomial logistic regression with results expressed as relative risk ratios (RRR) and 95% confidence intervals (CI).", {"entities": []}], ["A total of 3206 men had complete data on pain status.", {"entities": []}], ["Of these, 8.7% reported chronic widespread pain (CWP), whereas 50% had some pain although not CWP and were classified as having some pain.", {"entities": []}], ["T and E2 were not associated with musculoskeletal pain, whereas significant differences in LH and FSH levels were found between pain groups.", {"entities": []}], ["After adjustment for age and other possible confounders, the association between pain status and both LH and FSH persisted.", {"entities": []}], ["Compared with those in the lowest tertile of LH, those in the highest tertile were more likely to report some pain (vs no pain, RRR\u00a0=\u00a01.28; 95% CI 1.09 to 1.50) and also CWP (vs no pain, RRR\u00a0=\u00a01.51; 95% CI 1.10 to 2.07).", {"entities": []}], ["Similar results were found for FSH.", {"entities": []}], ["Gonadotrophins, but not sex steroid hormone levels, are associated with musculoskeletal pain in men.", {"entities": []}], ["Higher levels of gonadotrophins but not androgens were significantly associated with musculoskeletal pain in men.", {"entities": []}], ["Alterations in hypothalamic\u2013pituitary\u2013testicular feedback mechanisms may play a role in the onset of chronic widespread pain.", {"entities": []}], ["Intravenous iron supplementation is widespread in the hemodialysis population, but there is uncertainty about the safest dosing strategy.", {"entities": []}], ["We compared the safety of different intravenous iron dosing practices on the risk of adverse cardiovascular outcomes in a large population of hemodialysis patients.", {"entities": []}], ["A retrospective cohort was created from the clinical database of a large dialysis provider (years 2004-2008) merged with administrative data from the United States Renal Data System.", {"entities": []}], ["Dosing comparisons were (1) bolus (consecutive doses \u2265 100 mg exceeding 600 mg during one month) versus maintenance (all other iron doses during the month); and (2) high (> 200 mg over 1 month) versus low dose (\u2264 200 mg over 1 month).", {"entities": []}], ["We established a 6-month baseline period (to identify potential confounders and effect modifiers), a one-month iron exposure period, and a three-month follow-up period.", {"entities": []}], ["Outcomes were myocardial infarction, stroke, and death from cardiovascular disease.", {"entities": [[14, 35, "DISEASE"]]}], ["117,050 patients contributed 776,203 unique iron exposure/follow-up periods.", {"entities": []}], ["After adjustment, we found no significant associations of bolus dose versus maintenance, hazards ratio for composite outcome, 1.03 (95% C.I.", {"entities": []}], ["0.99, 1.07), or high dose versus low dose intravenous iron, hazards ratio for composite outcome, 0.99 (95% C.I.", {"entities": []}], ["0.96, 1.03).", {"entities": []}], ["There were no consistent associations of either high or bolus dose versus low or maintenance respectively among pre-specified subgroups.", {"entities": []}], ["Strategies favoring large doses of intravenous iron were not associated with increased short-term cardiovascular morbidity and mortality.", {"entities": []}], ["Investigation of the long-term safety of the various intravenous iron supplementation strategies may still be warranted.", {"entities": []}], ["Theophylline has been used widely as a bronchodilator for the treatment of bronchial asthma and has been suggested to modulate immune response.", {"entities": [[85, 91, "DISEASE"]]}], ["While the importance of macrophages in asthma has been reappraised and emphasized, their significance has not been well investigated.", {"entities": [[39, 45, "DISEASE"]]}], ["We conducted a genome-wide profiling of the gene expressions of macrophages in response to theophylline.", {"entities": []}], ["Microarray technology was used to profile the gene expression patterns of macrophages modulated by theophylline.", {"entities": []}], ["Northern blot and real-time quantitative RT-PCR were also used to validate the microarray data, while Western blot and ELISA were used to measure the levels of IL-13 and LTC4.", {"entities": []}], ["We identified dozens of genes in macrophages that were dose-dependently down- or up-regulated by theophylline.", {"entities": []}], ["These included genes related to inflammation, cytokines, signaling transduction, cell adhesion and motility, cell cycle regulators, and metabolism.", {"entities": []}], ["We observed that IL-13, a central mediator of airway inflammation, was dramatically suppressed by theophylline.", {"entities": []}], ["Real-time quantitative RT-PCR and ELISA analyses also confirmed these results, without respect to PMA-treated THP-1 cells or isolated human alveolar macrophages.", {"entities": []}], ["Theophylline, rolipram, etazolate, db-cAMP and forskolin suppressed both IL-13 mRNA expression (~25%, 2.73%, 8.12%, 5.28%, and 18.41%, respectively) and protein secretion (<10% production) in macrophages.", {"entities": []}], ["These agents also effectively suppressed LTC4 expression.", {"entities": []}], ["Our results suggest that the suppression of IL-13 by theophylline may be through cAMP mediation and may decrease LTC4 production.", {"entities": []}], ["This study supports the role of theophylline as a signal regulator of inflammation, and that down regulation of IL-13 by theophylline may have beneficial effects in inflammatory airway diseases.", {"entities": []}], ["Interleukin (IL)-32, mainly produced by T-lymphocytes, natural killer cells, epithelial cells, and blood monocytes, is dominantly known as a pro-inflammatory cytokine.", {"entities": []}], ["However, the role of IL-32 on inflammatory disease has been doubtful according to diverse conflicting results.", {"entities": []}], ["This study was designed to examine the role of IL-32\u03b2 on the development of collagen antibody (CAIA) and lipopolysaccharide (LPS)-induced inflammatory arthritis.", {"entities": [[151, 160, "DISEASE"]]}], ["Our data showed that the paw swelling volume and clinical score were significantly reduced in the CAIA and LPS-treated IL-32\u03b2 transgenic mice compared with non-transgenic mice.", {"entities": []}], ["The populations of cytotoxic T, NK and dendritic cells was inhibited and NF-\u03baB and STAT3 activities were significantly lowered in the CAIA and LPS-treated IL-32\u03b2 transgenic mice.", {"entities": [[83, 88, "GENE"]]}], ["The expression of pro-inflammatory proteins was prevented in the paw tissues of CAIA and LPS-treated IL-32\u03b2 transgenic mice.", {"entities": []}], ["In addition, IL-32\u03b2 altered several cytokine levels in the blood, spleen and paw joint.", {"entities": []}], ["Our data indicates that IL-32\u03b2 comprehensively inhibits the inflammation responses in the CAIA and LPS-induced inflammatory arthritis model.", {"entities": [[124, 133, "DISEASE"]]}], ["Obesity has become a major health issue not only in the West but also in Asia.", {"entities": [[0, 7, "DISEASE"]]}], ["Morbid obesity can lead to much comorbidity and can markedly interfere with quality of life.", {"entities": [[7, 14, "DISEASE"], [0, 14, "DISEASE"]]}], ["The aim of this study was to compare the health-related quality of life (HRQL) between patients with morbid obesity coming for bariatric surgery and the healthy population in Taiwan.", {"entities": [[108, 115, "DISEASE"], [101, 115, "DISEASE"]]}], ["Patients were between age 18 and 65\u00a0years.", {"entities": []}], ["Patients had a BMI between 32 and 40\u00a0kg/m A total of 114 consecutive patients with obesity coming for bariatric surgery at our hospital were enrolled in 2007.", {"entities": [[83, 90, "DISEASE"]]}], ["Obese subjects had poorer WHOQOL-BREF scores than those of the healthy referents in physical, psychological, and social domains but not in environmental domain ( P \u2009<\u20090.05).", {"entities": []}], ["Patients with BMI levels above 32\u00a0kg/m The higher the BMI level the poorer the HRQL.", {"entities": []}], ["Our findings seem to support the recommendations of Asia-Pacific consensus based on HRQL considerations.", {"entities": []}], ["This article briefly summarizes the epidemiology of the health effects of fine particulate air pollution, provides an early, somewhat speculative, discussion of the contribution of epidemiology to evaluating biologic mechanisms, and evaluates who's at risk or is susceptible to adverse health effects.", {"entities": []}], ["Based on preliminary epidemiologic evidence, it is speculated that a systemic response to fine particle-induced pulmonary inflammation, including cytokine release and altered cardiac autonomic function, may be part of the pathophysiologic mechanisms or pathways linking particulate pollution with cardiopulmonary disease.", {"entities": []}], ["The elderly, infants, and persons with chronic cardiopulmonary disease, influenza, or asthma are most susceptible to mortality and serious morbidity effects from short-term acutely elevated exposures.", {"entities": [[72, 81, "DISEASE"], [86, 92, "DISEASE"]]}], ["Others are susceptible to less serious health effects such as transient increases in respiratory symptoms, decreased lung function, or other physiologic changes.", {"entities": []}], ["Chronic exposure studies suggest relatively broad susceptibility to cumulative effects of long-term repeated exposure to fine particulate pollution, resulting in substantive estimates of population average loss of life expectancy in highly polluted environments.", {"entities": []}], ["Additional knowledge is needed about the specific pollutants or mix of pollutants responsible for the adverse health effects and the biologic mechanisms involved.", {"entities": []}], ["Smoking is the major etiologic factor in COPD, yet the exact underlying pathogenetic mechanisms have not been elucidated.", {"entities": []}], ["Since a few years, there is mounting evidence that a specific immune response, partly present as an autoimmune response, contributes to the pathogenesis of COPD.", {"entities": []}], ["Increased levels of anti-Hep-2 epithelial cell and anti-elastin autoantibodies as well as antibodies against airway epithelial and endothelial cells have been observed in COPD patients.", {"entities": []}], ["Whether the presence of these autoantibodies contributes to the pathogenesis of COPD is unclear.", {"entities": []}], ["To test whether induction of autoantibodies against lung matrix proteins can augment the smoke-induced inflammatory response, we immunized mice with a mixture of the lung extracellular matrix (ECM) proteins elastin, collagen, and decorin and exposed them to cigarette smoke for 3 or 6 months.", {"entities": []}], ["To evaluate whether the immunization was successful, the presence of specific antibodies was assessed in serum, and presence of specific antibody producing cells in spleen and lung homogenates.", {"entities": []}], ["In addition, the presence of inflammatory cells and cytokines was assessed in lung tissue and emphysema development was evaluated by measuring the mean linear intercept.", {"entities": []}], ["We demonstrated that both ECM immunization and smoke exposure induced a humoral immune response against ECM proteins and that ECM immunization itself resulted in increased macrophage numbers in the lung.", {"entities": []}], ["The specific immune response against ECM proteins did not augment the smoke-induced inflammatory response in our model.", {"entities": []}], ["By demonstrating that smoke exposure itself can result in a specific immune response and that presence of this specific immune response is accompanied by an influx of macrophages, we provide support for the involvement of a specific immune response in the smoke-induced inflammatory response as can be seen in patients with COPD.", {"entities": []}], ["Childhood obesity is a substantial public health problem.", {"entities": [[10, 17, "DISEASE"]]}], ["The extent to which health state preferences (utilities) are related to a child's weight status has not been reported.", {"entities": []}], ["The aims of this study were (1) to use a generic health state classification system to measure health related quality of life and calculate health utilities in a convenience sample of children and adolescents and (2) to determine the extent to which these measures are associated with weight status and body mass index (BMI).", {"entities": []}], ["We enrolled 76 children 5-18 years of age from a primary care clinic and an obesity clinic in Boston MA.", {"entities": [[76, 83, "DISEASE"]]}], ["We administered the Health Utilities Index (HUI) and used the HUI Mark 3 single- and multi-attribute utility functions to calculate health utilities.", {"entities": []}], ["We determined BMI percentile and weight status based on CDC references.", {"entities": []}], ["We examined single-attribute and overall utilities in relation to weight status and BMI.", {"entities": []}], ["Mean (range) age was 10.8 (5-18) years.", {"entities": []}], ["Mean (SD) BMI percentile was 76 (26); 55% of children were overweight or obese.", {"entities": []}], ["The mean (SD) overall utility was 0.79 (0.17) in the entire sample.", {"entities": []}], ["For healthy-weight children, the mean overall utility was higher than for overweight or obese children (0.81 vs. 0.78), but the difference was not statistically significant (difference 0.04, 95% CI -0.04, 0.11).", {"entities": []}], ["Our results provide a quantitative estimate of the health utility associated with overweight and obesity in children, and will be helpful to researchers performing cost effectiveness analyses of interventions to prevent and/or treat childhood obesity.", {"entities": [[97, 104, "DISEASE"], [243, 250, "DISEASE"]]}], ["Early detection of symptoms arising from exposure to pathogens, harmful substances, or environmental changes is required for timely intervention.", {"entities": []}], ["The administration of Web-based questionnaires is a potential method for collecting information from a sample population.", {"entities": []}], ["The objective of our study was to develop a Web-based daily questionnaire for health (WDQH) for symptomatic surveillance.", {"entities": []}], ["We adopted two different survey methods to develop the WDQH: an Internet panel survey, which included participants already registered with an Internet survey company, and the Tokyo Consumers\u2019 Co-operative Union (TCCU) Internet survey, in cooperation with the Japanese Consumers\u2019 Co-operative Union, which recruited participants by website advertising.", {"entities": []}], ["The Internet panel survey participants were given a fee every day for providing answers, and the survey was repeated twice with modified surveys and collection methods: Internet Panel Survey I was conducted every day, and Internet Panel Survey II was conducted every 3 days to reduce costs.", {"entities": []}], ["We examined whether the survey remained valid by reporting health conditions on day 1 over a 3-day period, and whether the response rate would vary among groups with different incentives.", {"entities": []}], ["In the TCCU survey, participants were given a fee only for initially registering, and health information was provided in return for survey completion.", {"entities": []}], ["The WDQH included the demographic details of participants and prompted them to answer questions about the presence of various symptoms by email.", {"entities": []}], ["Health information collected by the WDQH was then used for the syndromic surveillance of infection.", {"entities": []}], ["Response rates averaged 47.3% for Internet Panel Survey I, 42.7% for Internet Panel Survey II, and 40.1% for the TCCU survey.", {"entities": []}], ["During a seasonal influenza epidemic, the WDQH detected a rapid increase in the number of participants with fever through the early aberration reporting system.", {"entities": [[18, 27, "DISEASE"]]}], ["We developed a health observation method based on self-reporting by participants via the Internet.", {"entities": []}], ["We validated the usefulness of the WDQH by its practical use in syndromic surveillance.", {"entities": []}], ["Hypertensive emergency has a high mortality risk and the treatment goal is to quickly lower blood pressure with intravenous (IV) medications.", {"entities": []}], ["Characteristics that are associated with non-response to IV antihypertensives have not been identified.", {"entities": []}], ["The objective is to identify patient characteristics associated with resistance to IV antihypertensives.", {"entities": []}], ["This was a subanalysis of patients enrolled in the previously described comparative effectiveness trial of IV nicardipine vs. labetalol use in the emergency department (CLUE) study, a randomized trial of nicardipine vs. labetalol.", {"entities": []}], ["Non-responders were defined as those patients who did not achieve target systolic blood pressure (SBP), as set by the treating physician, within thirty minutes of IV antihypertensive medication, +/\u2212 20mmHg.", {"entities": []}], ["Stepwise logistic regression was used to identify covariates associated with the measurement outcomes.", {"entities": []}], ["CLUE enrolled 226 patients, 52.7% female, 76.4% black, mean age of 52.6\u00b114.6 years, of whom 110 were treated with nicardipine and 116 with labetalol.", {"entities": []}], ["The median (IQR) initial systolic blood pressure was 211mmHg (198, 226), 210 (200, 230), and 211mmHg (198, 226), for the total, non-responder, and responder cohorts, respectively (p-value=0.65, 95% CI [\u22125.8\u201311.3]).", {"entities": []}], ["Twenty-nine were non-responders, 9 in the nicardipine and 20 in the labetalol group.", {"entities": []}], ["In univariate analysis, several symptoms suggestive of end organ damage were associated with non-response.", {"entities": []}], ["After multiple variable logistic regression (AUC = 0.72), treatment with labetalol (OR 2.7, 95% CI [1.1\u20136.7]), history of stroke (OR 5.4, 95% CI [1.6\u201318.5]), and being male (OR 3.3, 95% CI [1.4\u20138.1]) were associated with failure to achieve target blood pressure.", {"entities": []}], ["Male gender and history of previous stroke are associated with difficult to control blood pressure.", {"entities": []}], ["A high-quality programmed cell-death ligand 1 (PD-L1) diagnostic assay may help predict which patients are more likely to respond to anti-programmed cell death-1 (PD-1)/PD-L1 antibody-based cancer therapy.", {"entities": [[190, 196, "DISEASE"]]}], ["Here we describe a PD-L1 immunohistochemical (IHC) staining protocol developed by Ventana Medical Systems Inc. and key analytical parameters of its use in formalin-fixed, paraffin-embedded (FFPE) samples of non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC).", {"entities": [[222, 233, "DISEASE"], [274, 283, "DISEASE"], [260, 283, "DISEASE"], [227, 233, "DISEASE"]]}], ["An anti-human PD-L1 rabbit monoclonal antibody (SP263) was optimized for use with the VENTANA OptiView DAB IHC Detection Kit on the automated VENTANA BenchMark ULTRA platform.", {"entities": []}], ["The VENTANA PD-L1 (SP263) Assay was validated for use with FFPE NSCLC and HNSCC tissue samples in a series of studies addressing sensitivity, specificity, robustness, and precision.", {"entities": []}], ["Samples from a subset of 181 patients from a Phase 1/2 study of durvalumab (NCT01693562) were analyzed to determine the optimal PD-L1 staining cut-off for enriching the probability of responses to treatment.", {"entities": []}], ["The scoring algorithm was defined using statistical analysis of clinical response data from this clinical trial and PD-L1 staining parameters in HNSCC and NSCLC tissue.", {"entities": []}], ["Inter-reader agreement was established by three pathologists who evaluated 81 NSCLC and 100 HNSCC samples across the range of PD-L1 expression levels.", {"entities": []}], ["The VENTANA PD-L1 (SP263) Assay met all pre-defined acceptance criteria.", {"entities": []}], ["For both cancer types, a cut-off of 25\u00a0% of tumor cells with PD-L1 membrane staining of any intensity best discriminated responders from nonresponders.", {"entities": [[9, 15, "DISEASE"]]}], ["Samples with staining above this value were deemed to have high PD-L1 expression, and those with staining below it were deemed to have low or no PD-L1 expression.", {"entities": []}], ["Inter-reader agreement on PD-L1 status was 97 and 92\u00a0% for NSCLC and HNSCC, respectively.", {"entities": []}], ["These results highlight the robustness and reproducibility of the VENTANA PD-L1 (SP263) Assay and support its suitability for use in the evaluation of NSCLC and HNSCC FFPE tumor samples using the devised \u226525\u00a0% tumor cell staining cut-off in a clinical setting.", {"entities": []}], ["The clinical utility of the PD-L1 diagnostic assay as a predictive biomarker will be further validated in ongoing durvalumab studies.", {"entities": []}], ["ClinicalTrials.gov: NCT01693562", {"entities": []}], ["Medically unexplained physical symptoms (MUPS) are common in general practice (GP), and are even more problematic as they become persistent.", {"entities": []}], ["The present study examines the relationship between persistent MUPS in general practice on the one hand and quality of life, social conditions, and coping on the other hand.", {"entities": []}], ["Additionally, it is examined how patients with persistent MUPS evaluate the quality of GP-care.", {"entities": []}], ["Data were used from a representative survey of morbidity in Dutch general practice, in which data from the electronic medical records were extracted.", {"entities": []}], ["A random sample of patients participated in an extensive health interview and completed self-reported measures on social isolation, coping and the quality of GP-care.", {"entities": []}], ["Patients with persistent MUPS (N = 192) were compared with general practice patients not meeting the criteria for persistent MUPS (N = 7.314), and with a group of patients that visited the GP in comparable rates for medical diagnoses (N = 2.265).", {"entities": []}], ["Multiple logistic regression analyses were used to control for relevant socio-demographic variables and chronic diseases.", {"entities": []}], ["After adjustment for demographics and chronic diseases, patients with persistent MUPS reported more psychological distress, more functional impairment, more social isolation, and they evaluated the quality of GP-care less positive than the other two patient groups.", {"entities": []}], ["Although the majority of MUPS patients were positive about the quality of GP-care, they more often felt that they were not taken seriously or not involved in treatment decisions, and more often reported that the GP did not take sufficient time.", {"entities": []}], ["The three groups did not differ with respect to the statement that the GP unnecessarily explains physical problems as psychological ones.", {"entities": []}], ["Strengthening MUPS patients' social network and encouraging social activities may be a meaningful intervention in which the GP may play a stimulating role.", {"entities": []}], ["To further improve MUPS patients' satisfaction with GP-care, GPs may pay extra attention to taking sufficient time when treating MUPS patients, taking the problems seriously, and involving them in treatment decisions.", {"entities": []}], ["Understanding the three-dimensional (3-D) micro-architecture of lung tissue can provide insights into the pathology of lung disease.", {"entities": [[119, 131, "DISEASE"]]}], ["Micro computed tomography (\u00b5CT) has previously been used to elucidate lung 3D histology and morphometry in fixed samples that have been stained with contrast agents or air inflated and dried.", {"entities": []}], ["However, non-destructive microstructural 3D imaging of formalin-fixed paraffin embedded (FFPE) tissues would facilitate retrospective analysis of extensive tissue archives of lung FFPE lung samples with linked clinical data.", {"entities": []}], ["FFPE human lung tissue samples (n = 4) were scanned using a Nikon metrology \u00b5CT scanner.", {"entities": []}], ["Semi-automatic techniques were used to segment the 3D structure of airways and blood vessels.", {"entities": []}], ["Airspace size (mean linear intercept, Lm) was measured on \u00b5CT images and on matched histological sections from the same FFPE samples imaged by light microscopy to validate \u00b5CT imaging.", {"entities": []}], ["The \u00b5CT imaging protocol provided contrast between tissue and paraffin in FFPE samples (15mm x 7mm).", {"entities": []}], ["Resolution (voxel size 6.7 \u00b5m) in the reconstructed images was sufficient for semi-automatic image segmentation of airways and blood vessels as well as quantitative airspace analysis.", {"entities": []}], ["The scans were also used to scout for regions of interest, enabling time-efficient preparation of conventional histological sections.", {"entities": []}], ["The Lm measurements from \u00b5CT images were not significantly different to those from matched histological sections.", {"entities": []}], ["We demonstrated how non-destructive imaging of routinely prepared FFPE samples by laboratory \u00b5CT can be used to visualize and assess the 3D morphology of the lung including by morphometric analysis.", {"entities": []}], ["Macrophages have been implicated in the pathogenesis of COPD.", {"entities": []}], ["M1 and M2 macrophages constitute subpopulations displaying pro- and anti-inflammatory properties.", {"entities": []}], ["We hypothesized that smoking cessation affects macrophage heterogeneity in the lung of patients with COPD.", {"entities": []}], ["Our aim was to study macrophage heterogeneity using the M2-marker CD163 and selected pro- and anti-inflammatory mediators in bronchoalveolar lavage (BAL) fluid and induced sputum from current smokers and ex-smokers with COPD.", {"entities": [[66, 71, "GENE"]]}], ["114 COPD patients (72 current smokers; 42 ex-smokers, median smoking cessation 3.5 years) were studied cross-sectionally and underwent sputum induction (M/F 99/15, age 62 \u00b1 8 [mean \u00b1 SD] years, 42 (31-55) [median (range)] packyears, post-bronchodilator FEV 1 63 \u00b1 9% predicted, no steroids past 6 months).", {"entities": [[253, 256, "GENE"]]}], ["BAL was collected from 71 patients.", {"entities": []}], ["CD163 Ex-smokers with COPD had a higher percentage, but lower number of CD163 Our data suggest that smoking cessation partially changes the macrophage polarization in vivo in the periphery of the lung towards an anti-inflammatory phenotype, which is not accompanied by a decrease in inflammatory parameters.", {"entities": [[0, 5, "GENE"], [72, 77, "GENE"], [0, 5, "GENE"], [72, 77, "GENE"]]}], ["The slope of phase III of the capnogram (S III ) relates to progressive emptying of the alveoli, a ventilation/perfusion mismatch, and ventilation inhomogeneity.", {"entities": []}], ["S III depends not only on the airway geometry, but also on the dynamic respiratory compliance (Crs); this latter effect has not been evaluated.", {"entities": []}], ["Accordingly, we established the value of S III for monitoring airway resistance during mechanical ventilation.", {"entities": []}], ["Sidestream capnography was performed during mechanical ventilation in patients undergoing elective cardiac surgery ( n = 144).", {"entities": []}], ["The airway resistance (Raw), total respiratory resistance and Crs displayed by the ventilator, the partial pressure of arterial oxygen (PaO 2 ) and S III were measured in time domain (S T-III ) and in a smaller cohort ( n = 68) by volumetry (S V-III ) with and without normalization to the average CO 2 phase III concentration.", {"entities": []}], ["Measurements were performed at positive end-expiratory pressure (PEEP) levels of 3, 6 and 9 cmH 2 O in patients with healthy lungs (Group HL), and in patients with respiratory symptoms involving low (Group LC), medium (Group MC) or high Crs (Group HC).", {"entities": []}], ["S T-III and S V-III exhibited similar PEEP dependencies and distribution between the protocol groups formed on the basis of Crs.", {"entities": []}], ["A wide interindividual scatter was observed in the overall Raw-S T-III relationship, which was primarily affected by Crs.", {"entities": []}], ["Decreases in Raw with increasing PEEP were reflected in sharp falls in S III in Group HC, and in moderate decreases in S III in Group MC, whereas S T-III was insensitive to changes in airway caliber in Groups LC and HL.", {"entities": []}], ["S III assessed in the time domain and by volumetry provide meaningful information about alterations in airway caliber, but only within an individual patient.", {"entities": []}], ["Although S T-III may be of value for bedside monitoring of the airway properties, its sensitivity depends on Crs.", {"entities": []}], ["Thus, assessment of the capnogram shape should always be coupled with Crs when the airway resistance or oxygenation are evaluated.", {"entities": []}], ["A single treatment with a CpG-containing immunostimulatory DNA sequence (ISS) given before allergen challenge can inhibit T helper type 2 cell (Th2)\u2013mediated airway responses in animal models of allergic asthma; however, the mechanism of this inhibition remains largely undefined.", {"entities": [[195, 210, "DISEASE"], [204, 210, "DISEASE"]]}], ["Here, we demonstrate that airway delivery of ISS before allergen challenge in Th2-primed mice acts in two distinct ways to prevent the allergic responses to this challenge.", {"entities": []}], ["The first is to prevent induction of cytokines from allergen-specific Th2 cells, as demonstrated by the nearly complete inhibition of Th2 cytokine production, Th2-dependent functional responses, and gene induction patterns.", {"entities": []}], ["ISS inhibits the Th2 response by rendering lung antigen-presenting cells (APCs) unable to effectively present antigen to Th2 cells, but not to Th1 cells.", {"entities": [[74, 78, "GENE"]]}], ["This loss of APC function correlates with a reduced expression of costimulatory molecules, including programmed cell death ligand (PD-L)1, PD-L2, CD40, CD80, CD86, and inducible T cell costimulator, and of major histocompatibility complex class II on CD11c", {"entities": [[13, 16, "GENE"], [146, 150, "GENE"], [152, 156, "GENE"], [158, 162, "GENE"]]}], ["Although mast cell functions classically relate to allergic responses", {"entities": []}], ["The differential diagnosis of chronic progressive multifocal asymmetric neuropathies is challenging.", {"entities": []}], ["Vasculitic neuropathies, multifocal forms of chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathies, and asymmetric lower motor neuron disorders are important considerations.", {"entities": [[66, 94, "DISEASE"], [80, 94, "DISEASE"]]}], ["We report a patient with an unusually long 12-year course of nonsystemic vasculitic neuropathy prior to the development of systemic manifestations.", {"entities": [[84, 94, "DISEASE"]]}], ["We discuss some of the difficulties involved in the diagnosis of chronic progressive multifocal asymmetric neuropathies.", {"entities": []}], ["Intratracheal delivery of stem cells into injured or diseased lungs can provide a variety of therapeutic and immunomodulatory effects for the treatment of acute lung injury and chronic lung disease.", {"entities": [[185, 197, "DISEASE"]]}], ["While the efficacy of this approach depends on delivering the proper cell dosage into the target region of the airway, tracking and analysis of the cells have been challenging, largely due to the limited understanding of cell transport and lack of suitable cell monitoring techniques.", {"entities": []}], ["We report on the transport and deposition of intratracheally delivered stem cells as well as strategies to modulate the number of cells (e.g., dose), topographic distribution, and region-specific delivery in small (rodent) and large (porcine and human) lungs.", {"entities": []}], ["We also developed minimally invasive imaging techniques for real-time monitoring of intratracheally delivered cells.", {"entities": []}], ["We propose that this approach can facilitate the implementation of patient-specific cells and lead to enhanced clinical outcomes in the treatment of lung disease with cell-based therapies.", {"entities": [[149, 161, "DISEASE"]]}], ["We describe the impact of community health workers (CHWs) providing community-based support services to enrollees who are high consumers of health resources in a Medicaid managed care system.", {"entities": []}], ["We conducted a retrospective study on a sample of 448 enrollees who were assigned to field-based CHWs in 11 of New Mexico\u2019s 33 counties.", {"entities": []}], ["The CHWs provided patients education, advocacy and social support for a period up to 6\u00a0months.", {"entities": []}], ["Data was collected on services provided, and community resources accessed.", {"entities": []}], ["Utilization and payments in the emergency department, inpatient service, non-narcotic and narcotic prescriptions as well as outpatient primary care and specialty care were collected on each patient for a 6\u00a0month period before, for 6\u00a0months during and for 6\u00a0months after the intervention.", {"entities": []}], ["For comparison, data was collected on another group of 448 enrollees who were also high consumers of health resources but who did not receive CHW intervention.", {"entities": []}], ["For all measures, there was a significant reduction in both numbers of claims and payments after the community health worker intervention.", {"entities": []}], ["Costs also declined in the non-CHW group on all measures, but to a more modest degree, with a greater reduction than in the CHW group in use of ambulatory services.", {"entities": []}], ["The incorporation of field-based, community health workers as part of Medicaid managed care to provide supportive services to high resource-consuming enrollees can improve access to preventive and social services and may reduce resource utilization and cost.", {"entities": []}], ["There is a lack of health economics evidence on the use of fecal microbiota transplantation (FMT) for inflammatory bowel disease (IBD).", {"entities": [[102, 128, "DISEASE"]]}], ["This study aims to evaluate the cost-effectiveness before (with conventional therapy) and after introducing FMT for treating IBD.", {"entities": []}], ["104 patients with IBD received FMT were recruited.", {"entities": []}], ["Health status was evaluated by European dimension health table (ED-5Q).", {"entities": []}], ["Incremental cost-effectiveness ratio (ICER) and net monetary benefit (NB) were calculated by different age groups, genders, smoking status, and disease subtypes.", {"entities": []}], ["The willingness-to-pay threshold was set to the value equal to three times China\u2019s per capita GDP (141240 CNY/QALY, 2014).", {"entities": []}], ["From the health-care perspective, FMT strategy was 73% likely to be cost-effective compared with the conventional therapy before FMT with an ICER of -185712 CNY/QALY and a positive NB of CNY 45150.", {"entities": []}], ["From the societal perspective, FMT strategy was 75% likely to be cost-effective with an ICER of -207417 CNY/QALY and a positive NB of CNY 48395.", {"entities": []}], ["Moreover, younger patients (\u2264 24), females, non-smokers and Crohn\u2019s disease (CD) achieved more benefits.", {"entities": []}], ["This study for the first time demonstrated that FMT showed its cost-effectiveness, especially on improving the life quality and decreasing the medical and societal cost, for the moderate to severe IBD in a Chinese cohort.", {"entities": []}], ["The attributable fraction (AF) of influenza virus detection to illness has not been described for patients in different age groups or with different HIV infection statuses.", {"entities": [[34, 43, "DISEASE"]]}], ["We compared the age group\u2013specific prevalence of influenza virus infection among patients with influenza-like illness (ILI) or severe acute or chronic respiratory illness (SARI and SCRI, respectively) with that among controls, stratified by HIV serostatus.", {"entities": [[49, 58, "DISEASE"], [95, 104, "DISEASE"]]}], ["The overall AF for influenza virus detection to illness was 92.6% for ILI, 87.4% for SARI, and 86.2% for SCRI.", {"entities": [[19, 28, "DISEASE"]]}], ["Among HIV-uninfected patients, the AF for all syndromes was highest among persons <1 and > 65 years of age and lowest among persons 25\u201344 years of age; this trend was not observed among HIV-infected patients.", {"entities": []}], ["Overall, influenza viruses when detected in patients with ILI, SARI, or SCRI are likely attributable to illness.", {"entities": [[9, 18, "DISEASE"]]}], ["This finding is particularly likely among children and the elderly irrespective of HIV serostatus and among HIV-infected persons irrespective of age.", {"entities": []}], ["We aimed to determine the association between physician adherence to prescribing guideline-recommended medications during hospitalisation and 6-month major adverse outcomes of patients with acute coronary syndrome in Vietnam.", {"entities": [[205, 213, "DISEASE"]]}], ["Prospective cohort study.", {"entities": []}], ["The study was carried out in two public hospitals in Vietnam between January and October 2015.", {"entities": []}], ["Patients were followed for 6\u2009months after discharge.", {"entities": []}], ["Patients who survived during hospitalisation with a discharge diagnosis of acute coronary syndrome and who were eligible for receiving at least one of the four guideline-recommended medications.", {"entities": [[90, 98, "DISEASE"]]}], ["Guideline adherence was defined as prescribing all guideline-recommended medications at both hospital admission and discharge for eligible patients.", {"entities": []}], ["Medications were antiplatelet agents, beta-blockers, ACE inhibitors or angiotensin II receptor blockers and statins.", {"entities": []}], ["Six-month major adverse outcomes were defined as all-cause mortality or hospital readmission due to cardiovascular causes occurring during 6\u2009months after discharge.", {"entities": []}], ["Cox regression models were used to estimate the association between guideline adherence and 6-month major adverse outcomes.", {"entities": []}], ["Overall, 512 patients were included.", {"entities": []}], ["Of those, there were 242 patients (47.3%) in the guideline adherence group and 270 patients (52.3%) in the non-adherence group.", {"entities": []}], ["The rate of 6-month major adverse outcomes was 30.5%.", {"entities": []}], ["A 29% reduction in major adverse outcomes at 6\u2009months after discharge was found for patients of the guideline adherence group compared with the non-adherence group (adjusted HR, 0.71; 95% CI, 0.51 to 0.98; p=0.039).", {"entities": [[174, 176, "GENE"]]}], ["Covariates significantly associated with the major adverse outcomes were percutaneous coronary intervention, prior heart failure and renal insufficiency.", {"entities": []}], ["In-hospital guideline adherence was associated with a significant decrease in major adverse outcomes up to 6\u2009months after discharge.", {"entities": []}], ["It supports the need for improving adherence to guidelines in hospital practice in low-income and middle-income countries like Vietnam.", {"entities": []}], ["Neonatal respiratory distress syndrome is a restrictive lung disease characterized by surfactant deficiency.", {"entities": [[30, 38, "DISEASE"], [56, 68, "DISEASE"]]}], ["Decreased vascular endothelial growth factor (VEGF), which demonstrates important roles in angiogenesis and vasculogenesis, has been implicated in the pathogenesis of restrictive lung diseases.", {"entities": []}], ["Current animal models investigating VEGF in the etiology and outcomes of RDS require premature delivery, hypoxia, anatomically or temporally limited inhibition, or other supplemental interventions.", {"entities": []}], ["Consequently, little is known about the isolated effects of chronic VEGF inhibition, started at birth, on subsequent developing lung structure and function.", {"entities": []}], ["To determine whether inducible, mesenchyme-specific VEGF inhibition in the neonatal mouse lung results in long-term modulation of AECII and whole lung function.", {"entities": []}], ["Triple transgenic mice expressing the soluble VEGF receptor sFlt-1 specifically in the mesenchyme (Dermo-1/rtTA/sFlt-1) were generated and compared to littermate controls at 3 months to determine the impact of neonatal downregulation of mesenchymal VEGF expression on lung structure, cell composition and function.", {"entities": []}], ["Reduced tissue VEGF bioavailability has previously been demonstrated with this model.", {"entities": []}], ["Triple transgenic mice demonstrated restrictive lung pathology.", {"entities": []}], ["No differences in gross vascular development or protein levels of vascular endothelial markers was noted, but there was a significant decrease in perivascular smooth muscle and type I collagen.", {"entities": []}], ["Mutants had decreased expression levels of surfactant protein C and hypoxia inducible factor 1-alpha without a difference in number of type II pneumocytes.", {"entities": []}], ["These data show that mesenchyme-specific inhibition of VEGF in neonatal mice results in late restrictive disease, making this transgenic mouse a novel model for future investigations on the consequences of neonatal RDS and potential interventions.", {"entities": []}], ["One of the limitations for ranking foods and meals for healthiness on the basis of the glycaemic index (GI) is that the GI is subject to manipulation by addition of fat.", {"entities": []}], ["Postprandial lipemia, defined as a rise in circulating triglyceride containing lipoproteins following consumption of a meal, has been recognised as a risk factor for the development of cardiovascular disease and other chronic diseases.", {"entities": []}], ["Many non-modifiable factors (pathological conditions, genetic background, age, sex and menopausal status) and life-style factors (physical activity, smoking, alcohol and medication use, dietary choices) may modulate postprandial lipemia.", {"entities": []}], ["The structure and the composition of a food or a meal consumed also plays an important role in the rate of postprandial appearance and clearance of triglycerides in the blood.", {"entities": []}], ["However, a major difficulty in grading foods, meals and diets according to their potential to elevate postprandial triglyceride levels has been the lack of a standardised marker that takes into consideration both the general characteristics of the food and the food\u2019s fat composition and quantity.", {"entities": []}], ["The release rate of lipids from the food matrix during digestion also has an important role in determining the postprandial lipemic effects of a food product.", {"entities": []}], ["This article reviews the factors that have been shown to influence postprandial lipemia with a view to develop a novel index for ranking foods according to their healthiness.", {"entities": []}], ["This index should take into consideration not only the glycaemic but also lipemic responses.", {"entities": []}], ["Regulatory T cells (Treg) play a critical role to control immune responses and to prevent autoimmunity, thus selective increase of Treg cells in vivo has broad therapeutic implications for autoimmune and inflammatory diseases.", {"entities": []}], ["Licorice is a well-known herbal medicine used worldwide for over thousands of years, and accumulating evidence has shown its immunomodulatory potential.", {"entities": []}], ["However, it is not clear whether licorice could regulate the induction and function of Treg cells.", {"entities": []}], ["Here we found licorice extract could promote Treg cell induction, and then we used a rational approach to isolate its functional fractions and constituents.", {"entities": []}], ["The results showed that two constituents, isoliquiritigenin and naringenin, promoted Treg cell induction both in vitro and in vivo .", {"entities": []}], ["The effective fractions and two constituents of licorice also enhanced immune suppression of Treg cells, and they further reduced severity of DSS-induced colitis in mice.", {"entities": []}], ["This study suggested that promotion of regulatory T cell induction could be an underlying mechanism of the historically and widely used herbal medicine licorice, providing its two effective molecules against autoimmune and inflammatory diseases.", {"entities": []}], ["Apart from its classical function in bone and calcium metabolism, vitamin D is also involved in immune regulation and has been linked to various cancers, immune disorders and allergic diseases.", {"entities": []}], ["Within the innate and adaptive immune systems, the vitamin D receptor and enzymes in monocytes, dendritic cells, epithelial cells, T lymphocytes and B lymphocytes mediate the immune modulatory actions of vitamin D. Vitamin D insufficiency/deficiency early in life has been identified as one of the risk factors for food allergy.", {"entities": [[315, 327, "DISEASE"]]}], ["Several studies have observed an association between increasing latitude and food allergy prevalence, plausibly linked to lower ultraviolet radiation (UVR) exposure and vitamin D synthesis in the skin.", {"entities": [[77, 89, "DISEASE"]]}], ["Along with mounting epidemiological evidence of a link between vitamin D status and food allergy, mice and human studies have shed light on the modulatory properties of vitamin D on the innate and adaptive immune systems.", {"entities": [[84, 96, "DISEASE"]]}], ["This review will summarize the literature on the metabolism and immune modulatory properties of vitamin D, with particular reference to food allergy.", {"entities": [[136, 148, "DISEASE"]]}], ["Mitochondria are the main source of reactive oxygen species (ROS).", {"entities": []}], ["Human mitochondrial haplogroups are linked to differences in ROS production and oxidative-stress induced inflammation that may influence disease pathogenesis, including coronary artery disease (CAD).", {"entities": []}], ["We previously showed that traffic-related air pollutants were associated with biomarkers of systemic inflammation in a cohort panel of subjects with CAD in the Los Angeles air basin.", {"entities": []}], ["We tested whether air pollutant exposure-associated inflammation was stronger in mitochondrial haplogroup H than U (high versus low ROS production) in this panel (38 subjects and 417 observations).", {"entities": []}], ["Inflammation biomarkers were measured weekly in each subject (\u226412 weeks), including interleukin-6 (IL-6), tumor necrosis factor-\u03b1 (TNF-\u03b1), C-reactive protein, interleukin-6 soluble receptor and tumor necrosis factor-soluble receptor II.", {"entities": []}], ["We determined haplogroup by restriction fragment length polymorphism analysis.", {"entities": []}], ["Air pollutants included nitrogen oxides (NO x ), carbon monoxide (CO), organic carbon, elemental and black carbon (EC, BC); and particulate matter mass, three size fractions (<0.25 \u00b5m, 0.25\u20132.5 \u00b5m, and 2.5\u201310 \u00b5m in aerodynamic diameter).", {"entities": []}], ["Particulate matter extracts were analyzed for organic compounds, including polycyclic aromatic hydrocarbons (PAH), and in vitro oxidative potential of aqueous extracts.", {"entities": []}], ["Associations between exposures and biomarkers, stratified by haplogroup, were analyzed by mixed-effects models.", {"entities": []}], ["IL-6 and TNF-\u03b1 were associated with traffic-related air pollutants (BC, CO, NO x and PAH), and with mass and oxidative potential of quasi-ultrafine particles <0.25 \u00b5m.", {"entities": []}], ["These associations were stronger for haplogroup H than haplogroup U.", {"entities": []}], ["Results suggest that mitochondrial haplogroup U is a novel protective factor for air pollution-related systemic inflammation in this small group of subjects.", {"entities": []}], ["Inflammation and oxidative stress play critical roles in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[71, 108, "DISEASE"]]}], ["Mitochondrial oxidative stress might be involved in driving the oxidative stress\u2013induced pathology.", {"entities": []}], ["We sought to determine the effects of oxidative stress on mitochondrial function in the pathophysiology of airway inflammation in ozone-exposed mice and human airway smooth muscle (ASM) cells.", {"entities": []}], ["Mice were exposed to ozone, and lung inflammation, airway hyperresponsiveness (AHR), and mitochondrial function were determined.", {"entities": [[79, 82, "GENE"]]}], ["Human ASM cells were isolated from bronchial biopsy specimens from healthy subjects, smokers, and patients with COPD.", {"entities": []}], ["Inflammation and mitochondrial function in mice and human ASM cells were measured with and without the presence of the mitochondria-targeted antioxidant MitoQ.", {"entities": []}], ["Mice exposed to ozone, a source of oxidative stress, had lung inflammation and AHR associated with mitochondrial dysfunction and reflected by decreased mitochondrial membrane potential (\u0394\u03a8m), increased mitochondrial oxidative stress, and reduced mitochondrial complex I, III, and V expression.", {"entities": [[79, 82, "GENE"]]}], ["Reversal of mitochondrial dysfunction by the mitochondria-targeted antioxidant MitoQ reduced inflammation and AHR.", {"entities": [[110, 113, "GENE"]]}], ["ASM cells from patients with COPD have reduced \u0394\u03a8m, adenosine triphosphate content, complex expression, basal and maximum respiration levels, and respiratory reserve capacity compared with those from healthy control subjects, whereas mitochondrial reactive oxygen species (ROS) levels were increased.", {"entities": []}], ["Healthy smokers were intermediate between healthy nonsmokers and patients with COPD.", {"entities": []}], ["Hydrogen peroxide induced mitochondrial dysfunction in ASM cells from healthy subjects.", {"entities": []}], ["MitoQ and Tiron inhibited TGF-\u03b2\u2013induced ASM cell proliferation and CXCL8 release.", {"entities": []}], ["Mitochondrial dysfunction in patients with COPD is associated with excessive mitochondrial ROS levels, which contribute to enhanced inflammation and cell hyperproliferation.", {"entities": []}], ["Targeting mitochondrial ROS represents a promising therapeutic approach in patients with COPD.", {"entities": []}], ["Lung transplant patients are a vulnerable group of immunosuppressed patients that are prone to frequent respiratory infections.", {"entities": []}], ["We studied 60 episodes of respiratory symptoms in 71 lung transplant patients.", {"entities": []}], ["Almost half of these episodes were of unknown infectious etiology despite extensive routine diagnostic testing.", {"entities": []}], ["We re-analyzed respiratory samples of all episodes with undetermined etiology in order to detect potential viral pathogens missed/not accounted for in routine diagnostics.", {"entities": []}], ["Respiratory samples were enriched for viruses by filtration and nuclease digestion, whole nucleic acids extracted and randomly amplified before high throughput metagenomic virus sequencing.", {"entities": []}], ["Viruses were identified by a bioinformatic pipeline and confirmed and quantified using specific real-time PCR.", {"entities": []}], ["In completion of routine diagnostics, we identified and confirmed a viral etiology of infection by our metagenomic approach in four patients (three Rhinovirus A, one Rhinovirus B infection) despite initial negative results in specific multiplex PCR.", {"entities": []}], ["Notably, the majority of samples were also positive for Torque teno virus (TTV) and Human Herpesvirus 7 (HHV-7).", {"entities": []}], ["While TTV viral loads increased with immunosuppression in both throat swabs and blood samples, HHV-7 remained at low levels throughout the observation period and was restricted to the respiratory tract.", {"entities": []}], ["This study highlights the potential of metagenomic sequencing for virus diagnostics in cases with previously unknown etiology of infection and in complex diagnostic situations such as in immunocompromised hosts.", {"entities": []}], ["This study evaluates the thermographic changes associated with moxa burner moxibustion at the SP6 acupuncture point to establish an appropriate, safe distance of efficacy for moxibustion.", {"entities": [[94, 97, "GENE"]]}], ["Baseline temperature changes using a moxa burner were obtained for a paper substrate at various distances and times, and the tested with volunteers in a pilot study.", {"entities": []}], ["A single-group trial was then conducted with 36 healthy women to monitor temperature changes on the body surface at the acupuncture point (SP6).", {"entities": [[139, 142, "GENE"]]}], ["Based on the temperature changes seen for the paper substrate and in the pilot study, a distance of 3\u2005cm was chosen as the intervention distance.", {"entities": []}], ["Moxibustion significantly increased the SP6 point skin surface temperature, with a peak increase of 11\u00b0C at 4\u2005min (p\u2009<0.001).", {"entities": [[40, 43, "GENE"]]}], ["This study also found that during moxibustion the temperature of the moxa burner's rubber layer and moxa cautery were 56.9\u00b10.9\u00b0C and 65.8\u00b11.2\u00b0C, as compared to baseline values of 35.1\u00b0C and 43.8\u00b0C (p<0.001).", {"entities": []}], ["We determined 3\u2005cm was a safe distance between the moxa burner and acupuncture point.", {"entities": []}], ["Moxibustion can increase the skin surface temperature at the SP6 point.", {"entities": [[61, 64, "GENE"]]}], ["This data will aid traditional Chinese medicine (TCM) practitioners in gauging safer treatment distances when using moxibustion treatments.", {"entities": []}], ["Many adults 65 years or older have high health care needs and costs.", {"entities": []}], ["Here, we describe their care coordination challenges.", {"entities": []}], ["Individuals with an AARP Medicare Supplement Insurance plan insured by UnitedHealthcare Insurance Company (for New York residents, UnitedHealthcare Insurance Company of New York).", {"entities": []}], ["The three groups included the highest needs, highest costs (the \u201chighest group\u201d), the high needs, high costs (the \u201chigh group\u201d), and the \u201call other group.\u201d Eligibility was determined by applying an internally developed algorithm based upon a number of criteria, including hierarchical condition category score, the Optum ImpactPro prospective risk score, as well as diagnoses of coronary artery disease, congestive heart failure, or diabetes.", {"entities": [[404, 428, "DISEASE"]]}], ["The highest group comprised 2%, although consumed 12% of health care expenditures.", {"entities": []}], ["The high group comprised 20% and consumed 46% of expenditures, whereas the all other group comprised 78% and consumed 42% of expenditures.", {"entities": []}], ["On average, the highest group had $102,798 in yearly health care expenditures, compared with $34,610 and $7,634 for the high and all other groups, respectively.", {"entities": []}], ["Fifty-seven percent of the highest group saw 16 or more different providers annually, compared with 21% and 2% of the high and all other groups, respectively.", {"entities": []}], ["Finally, 28% of the highest group had prescriptions from at least seven different providers, compared with 20% and 5% of the high and all other groups, respectively.", {"entities": []}], ["Individuals with high health care needs and costs have visits to numerous health care providers and receive multiple prescriptions for pharmacotherapy.", {"entities": []}], ["As a result, these individuals can become overwhelmed trying to manage and coordinate their health care needs.", {"entities": []}], ["Care coordination programs may help these individuals coordinate their care.", {"entities": []}], ["Many clinical and animal studies have shown that certain dietary components exert anti-inflammatory properties that aid in the amelioration of chronic inflammatory diseases.", {"entities": []}], ["Among the various proposed channels through which dietary components affect immune responses, regulatory T-cells (Tregs) are emerging as key targets for the dietary prevention of chronic inflammatory diseases.", {"entities": []}], ["In this review, immunoregulation by Tregs is briefly described, followed by a summary of recent advances and possible applications of techniques for the study of Tregs.", {"entities": []}], ["In addition, this review provides an overview of the current knowledge on Treg regulation by certain dietary components, including vitamins, omega-3 polyunsaturated fatty acids, and polyphenols.", {"entities": []}], ["The caveats of previous studies are also discussed in order to highlight the distinctions between dietary studies and immunological approaches.", {"entities": []}], ["Consequently, this review may help to clarify the means by which nutritional components influence Tregs.", {"entities": []}], ["Patients with type 2 diabetes are likely to have comorbid conditions which represent a high burden for patients and a challenge for primary care physicians.", {"entities": []}], ["The aim of this cross-sectional survey was to assess the impact of additional comorbidities on quality of life within a large sample of patients with type 2 diabetes in primary care.", {"entities": []}], ["A cross-sectional survey within a large sample (3.546) of patients with type 2 diabetes in primary care was conducted.", {"entities": []}], ["Quality of life (QoL) was assessed by means of the Medical Outcome Study Short Form (SF-36), self reported presence of comorbid conditions was assessed and groups with single comorbidities were selected.", {"entities": []}], ["QoL subscales of these groups were compared to diabetes patients with no comorbidities.", {"entities": []}], ["Group comparisons were made by ANCOVA adjusting for sociodemographic covariates and the presence of depressive disorder.", {"entities": []}], ["Of 3546 questionnaires, 1532 were returned, thereof 1399 could be analysed.", {"entities": []}], ["The mean number of comorbid conditions was 2.1.", {"entities": []}], ["235 patients declared to have only hypertension as comorbid condition, 97 patients declared to have osteoarthritis only.", {"entities": [[35, 47, "DISEASE"], [100, 114, "DISEASE"]]}], ["Patients suffering from diabetes and hypertension reached similar scores like diabetic patients with no comorbidities.", {"entities": [[37, 49, "DISEASE"]]}], ["Patients with diabetes and osteoarthritis reached remarkable lower scores in all subscales.", {"entities": [[27, 41, "DISEASE"]]}], ["Compared to patients with diabetes alone these differences were statistically significant in the subscales representing pain and physical impairment.", {"entities": []}], ["The impact of osteoarthritis as an often disabling and painful condition on QoL in patients with type 2 diabetes is higher than the impact of hypertension as common but often asymptomatic comorbidity.", {"entities": [[142, 154, "DISEASE"], [14, 28, "DISEASE"]]}], ["Individual care of patients with chronic conditions should aim at both improving QoL and controlling risk factors for severe complications.", {"entities": []}], ["Avicins, a family of apoptotic triterpene electrophiles, are known to regulate cellular metabolism and energy homeostasis, by targeting the mitochondria.", {"entities": []}], ["Having evolved from \u201cancient hopanoids,\u201d avicins bear a structural resemblance with glucocorticoids (GCs), which are the endogenous regulators of metabolism and energy balance.", {"entities": []}], ["These structural and functional similarities prompted us to compare the mode of action of avicin D with dexamethasone (Dex), a prototypical GC.", {"entities": [[140, 142, "GENE"]]}], ["Using cold competition assay, we show that Avicin D competes with Dex for binding to the GC receptor (GR), leading to its nuclear translocation.", {"entities": [[89, 91, "GENE"]]}], ["In contrast to Dex, avicin-induced nuclear translocation of GR does not result in transcriptional activation of GC-dependent genes.", {"entities": []}], ["Instead we observe a decrease in the expression of GC-dependent metabolic proteins such as PEPCK and FASN.", {"entities": [[101, 105, "GENE"]]}], ["However, like Dex, avicin D treatment does induce a transrepressive effect on the pro-inflammatory transcription factor NF-\u03baB.", {"entities": []}], ["While avicin's ability to inhibit NF-\u03baB and its downstream targets appear to be GR-dependent, its pro-apoptotic effects were independent of GR expression.", {"entities": []}], ["Using various deletion mutants of GR, we demonstrate the requirement of both the DNA and ligand binding domains of GR in mediating avicin D's transrepressive effects.", {"entities": []}], ["Modeling of avicin-GR interaction revealed that avicin molecule binds only to the antagonist confirmation of GR.", {"entities": []}], ["These findings suggest that avicin D has properties of being a selective GR modulator that separates transactivation from transrepression.", {"entities": []}], ["Since the gene-activating properties of GR are mainly linked to its metabolic effects, and the negative interference with the activity of transcription factors to its anti-inflammatory and immune suppressive effects, the identification of such a dissociated GR ligand could have great potential for therapeutic use.", {"entities": []}], ["Acute and recurrent acute urticaria are often associated with multiple factors including infections and recent data suggest a role for herpesviruses.", {"entities": [[26, 35, "DISEASE"]]}], ["To test the null hypothesis, that is, there is no association of herpesvirus infections with urticaria.", {"entities": [[93, 102, "DISEASE"]]}], ["Thirty-seven patients between one month and 15 years of age were age matched to 37 controls who were healthy or had mild acute respiratory infections but without urticaria.", {"entities": [[162, 171, "DISEASE"]]}], ["Patients and controls were followed for 1 to 6 years.", {"entities": []}], ["Diagnostic studies included DNA detection by real-time PCR for herpes simplex virus (HSV) types 1 and 2, Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human herpesvirus-6 (HHV-6).", {"entities": [[63, 77, "DISEASE"]]}], ["Tests for other infections included adenovirus, parvovirus B 19, respiratory syncytial virus, influenza A, Group A streptococci, rotavirus, and parasites.", {"entities": [[94, 103, "DISEASE"]]}], ["Specific infections were diagnosed in 26 of 37 cases and among 9 of 37 control children (P=0.0002).", {"entities": []}], ["Single or concomitant herpesvirus infections occurred in 24 cases and in 4 controls (65% vs 11 %, p=0.0003).", {"entities": []}], ["Cases had 10 HHV-6 infections, 8 CMV infections, 5 EBV infections, and 4 HSV-1 infections.", {"entities": []}], ["Herpesvirus infections are associated with acute or recurrent acute urticaria.", {"entities": [[68, 77, "DISEASE"]]}], ["The objective of this study is to investigate symptoms, clinical factors and socio-demographic factors associated with colorectal cancer (CRC) diagnosis and time to diagnosis.", {"entities": [[119, 136, "DISEASE"], [130, 136, "DISEASE"]]}], ["Prospective cohort study of participants referred for suspicion of CRC in two English regions.", {"entities": []}], ["Data were collected using a patient questionnaire, primary care and hospital records.", {"entities": []}], ["Descriptive and regression analyses examined associations between symptoms and patient factors with total diagnostic interval (TDI), patient interval (PI), health system interval (HSI) and stage.", {"entities": []}], ["A total of 2677 (22%) participants responded; after exclusions, 2507 remained.", {"entities": []}], ["Participants were diagnosed with CRC (6.1%, 56% late stage), other cancers (2.0%) or no cancer (91.9%).", {"entities": [[88, 94, "DISEASE"]]}], ["Half the cohort had a solitary first symptom (1332, 53.1%); multiple first symptoms were common.", {"entities": []}], ["In this referred population, rectal bleeding was the only initial symptom more frequent among cancer than non-cancer cases (34.2% vs 23.9%, P =0.004).", {"entities": [[94, 100, "DISEASE"], [110, 116, "DISEASE"]]}], ["There was no evidence of differences in TDI, PI or HSI for those with cancer vs non-cancer diagnoses (median TDI CRC 124 vs non-cancer 138 days, P =0.142).", {"entities": [[70, 76, "DISEASE"], [84, 90, "DISEASE"], [128, 134, "DISEASE"]]}], ["First symptoms associated with shorter TDIs were rectal bleeding, change in bowel habit, \u2018feeling different' and fatigue/tiredness.", {"entities": []}], ["Anxiety, depression and gastro-intestinal co-morbidities were associated with longer HSIs and TDIs.", {"entities": []}], ["Symptom duration-dependent effects were found for rectal bleeding and change in bowel habit.", {"entities": []}], ["Doctors and patients respond less promptly to some symptoms of CRC than others.", {"entities": []}], ["Healthcare professionals should be vigilant to the possibility of CRC in patients with relevant symptoms and mental health or gastro-intestinal comorbidities.", {"entities": []}], ["This study aimed to analyze trends in the 10 leading causes of death in Korea from 1983 to 2012.", {"entities": []}], ["Death rates were derived from the Korean Statistics Information Service database and age-adjusted to the 2010 population.", {"entities": []}], ["Joinpoint regression analysis was used to identify the points when statistically significant changes occurred in the trends.", {"entities": []}], ["Between 1983 and 2012, the age-standardized death rate (ASR) from all causes decreased by 61.6% for men and 51.2% for women.", {"entities": []}], ["ASRs from malignant neoplasms, diabetes mellitus, and transport accidents increased initially before decreasing.", {"entities": [[31, 48, "DISEASE"]]}], ["ASRs from hypertensive diseases, heart diseases, cerebrovascular diseases and diseases of the liver showed favorable trends (ASR % change: -94.4%, -53.8%, -76.0%, and -78.9% for men, and -77.1%, -36.5%, -67.8%, and -79.9% for women, respectively).", {"entities": []}], ["ASRs from pneumonia decreased until the mid-1990s and thereafter increased.", {"entities": [[10, 19, "DISEASE"]]}], ["ASRs from intentional self-harm increased persistently since around 1990 (ASR % change: 122.0% for men and 217.4% for women).", {"entities": []}], ["In conclusion, death rates from all causes in Korea decreased significantly in the last three decades except in the late 1990s.", {"entities": []}], ["Despite the great strides made in the overall mortality, temporal trends varied widely by cause.", {"entities": []}], ["Mortality trends for malignant neoplasms, diabetes mellitus, pneumonia and intentional self-harm were unfavorable.", {"entities": [[61, 70, "DISEASE"], [42, 59, "DISEASE"]]}], ["Following the discovery of endotoxins by Richard Pfeiffer, such bacterial product was associated to many severe disorders produced by an overwhelming inflammatory response and often resulting in endotoxic shock and multiple organ failure.", {"entities": []}], ["However, recent clinical and basic sciences investigations claimed some beneficial roles of typical as well as atypical endotoxins.", {"entities": []}], ["The aim of this paper is to focus on recent data supporting a beneficial activity of both typical and atypical endotoxins.", {"entities": []}], ["Such novel perspective looks promising for development of new drugs for prevention and therapy of several human diseases.", {"entities": []}], ["To estimate the disability-adjusted life years (DALY) in a nationwide representative sample of postmenopausal women with osteoporosis.", {"entities": [[121, 133, "DISEASE"]]}], ["The effects of drug-based therapy and risk factors for osteoporotic bone fractures on DALY losses were also explored.", {"entities": []}], ["DALY were estimated based on participant\u2019s clinical characteristics and Health-Related Quality-of-Life (HRQoL) data obtained from a cross-sectional, epidemiological one-visit study (the GINERISK study).", {"entities": []}], ["The study enrolled postmenopausal women (at least 12-months after their last menstrual period) with osteoporosis, above 18-years old, who attended Spanish outpatient Gynaecology clinics.", {"entities": [[100, 112, "DISEASE"]]}], ["HRQoL was assessed using the generic SF-12v2 questionnaire, which was used to derive disutility values.", {"entities": []}], ["Mortality rates were extracted from the Spanish national statistics database.", {"entities": []}], ["Factors explored to be associated with DALY losses were examined using ANOVA, ANCOVA and MANCOVA models.", {"entities": []}], ["DALY could be computed in 2,782 (67%) out of 4,157 postmenopausal women, with a mean (95% CI) age of 61.0 (60.7-61.2) years.", {"entities": []}], ["Overall individual undiscounted DALY per woman were 6.1 (5.9-6.2), resulting to be significantly higher in women with severe osteoporosis with prior bone fracture; 7.8 (7.2-8.4) compared to osteoporotic women [5.8 (5.6-6.0)] or postmenopausal women with a BMD\u2009>\u2009\u22122.5\u00a0T-score that received a drug-based therapy [6.2 (5.8-6.5)]; F\u2009=\u200927.0 ( P \u2009<\u20090.01).", {"entities": [[125, 137, "DISEASE"]]}], ["Models explaining the variation in the levels of health based on the use of a selective estrogen receptor modulator (SERM) or possession of risk factors for osteoporotic BF were found ( P \u2009<\u20090.05).", {"entities": []}], ["DALY losses were considerable amongst postmenopausal women with osteoporosis.", {"entities": [[64, 76, "DISEASE"]]}], ["Not having a prior bone fracture, being older, using a SERM and having less osteoporotic risk factors were all linked to less DALY losses.", {"entities": []}], ["Hyperoxia exposure leads to the development of lung injury and bronchial hyperreactivity (BHR) via involvement of nitric oxide (NO) pathway.", {"entities": []}], ["We aimed at characterizing whether the stimulation of the NO pathway by sildenafil or vasoactive intestinal peptide (VIP) is able to prevent the hyperoxia-induced development of BHR.", {"entities": [[117, 120, "GENE"]]}], ["The respective roles of the preserved lung volume and alveolar architecture, the anti-inflammatory and anti-apoptotic potentials of these treatments in the diminished lung responsiveness were also characterized.", {"entities": []}], ["Immature (28-day-old) rats were exposed for 72\u00a0hours to room air (Group C), hyperoxia (>95%, Group HC), or hyperoxia with the concomitant administration of vasoactive intestinal peptide (VIP, Group HV) or sildenafil (Group HS).", {"entities": [[187, 190, "GENE"]]}], ["Following exposure, the end-expiratory lung volume (EELV) was assessed plethysmographically.", {"entities": []}], ["Airway and respiratory tissue mechanics were measured under baseline conditions and following incremental doses of methacholine to assess BHR.", {"entities": []}], ["Inflammation was assessed by analyzing the bronchoalveolar lavage fluid (BALF), while biochemical and histological analyses were used to characterize the apoptotic and structural changes in the lungs.", {"entities": []}], ["The BHR, the increased EELV, the aberrant alveolarization, and the infiltration of inflammatory cells into the BALF that developed in Group HC were all suppressed significantly by VIP or sildenafil treatment.", {"entities": [[180, 183, "GENE"]]}], ["The number of apoptotic cells increased significantly in Group HC, with no evidence of statistically significant effects on this adverse change in Groups HS and HV.", {"entities": []}], ["These findings suggest that stimulating the NO pathway by sildenafil and VIP exert their beneficial effect against hyperoxia-induced BHR via preserving normal EELV, inhibiting airway inflammation and preserving the physiological lung structure, whereas the antiapoptotic potential of these treatments were not apparent in this process.", {"entities": [[73, 76, "GENE"]]}], ["Drugs can influence the whole biological system by targeting interaction reactions.", {"entities": []}], ["The existence of interactions between drugs and network reactions suggests a potential way to discover targets.", {"entities": []}], ["The in silico prediction of potential interactions between drugs and target proteins is of core importance for the identification of new drugs or novel targets for existing drugs.", {"entities": []}], ["However, only a tiny portion of drug-targets in current datasets are validated interactions.", {"entities": []}], ["This motivates the need for developing computational methods that predict true interaction pairs with high accuracy.", {"entities": []}], ["Currently, network pharmacology has used in identifying potential drug targets to predicting the spread of drug activity and greatly contributed toward the analysis of biological systems on a much larger scale than ever before.", {"entities": []}], ["In this article, we present a computational method to predict targets for rhein by exploring drug-reaction interactions.", {"entities": []}], ["We have implemented a computational platform that integrates pathway, protein-protein interaction, differentially expressed genome and literature mining data to result in comprehensive networks for drug-target interaction.", {"entities": []}], ["We used Cytoscape software for prediction rhein-target interactions, to facilitate the drug discovery pipeline.", {"entities": []}], ["Results showed that 3 differentially expressed genes confirmed by Cytoscape as the central nodes of the complicated interaction network (99 nodes, 153 edges).", {"entities": []}], ["Of note, we further observed that the identified targets were found to encompass a variety of biological processes related to immunity, cellular apoptosis, transport, signal transduction, cell growth and proliferation and metabolism.", {"entities": []}], ["Our findings demonstrate that network pharmacology can not only speed the wide identification of drug targets but also find new applications for the existing drugs.", {"entities": []}], ["It also implies the significant contribution of network pharmacology to predict drug targets.", {"entities": []}], ["The field of risk assessment has focused on protecting the health of individual people or populations of wildlife from single risks, mostly from chemical exposure.", {"entities": []}], ["The U.S. Environmental Protection Agency recently began to address multiple risks to communities in the \u201cFramework for Cumulative Risk Assessment\u201d [EPA/630/P02/001F.", {"entities": []}], ["Washington DC:Risk Assessment Forum, Simultaneously, several reports concluded that some individuals and groups are more vulnerable to environmental risks than the general population.", {"entities": []}], ["However, vulnerability has received little specific attention in the risk assessment literature.", {"entities": []}], ["Our objective is to examine the issue of vulnerability in cumulative risk assessment and present a conceptual framework rather than a comprehensive review of the literature.", {"entities": []}], ["In this article we consider similarities between ecologic and human communities and the factors that make communities vulnerable to environmental risks.", {"entities": []}], ["The literature provides substantial evidence on single environmental factors and simple conditions that increase vulnerability or reduce resilience for humans and ecologic systems.", {"entities": []}], ["This observation is especially true for individual people and populations of wildlife.", {"entities": []}], ["Little research directly addresses the topic of vulnerability in cumulative risk situations, especially at the community level.", {"entities": []}], ["The community level of organization has not been adequately considered as an end point in either human or ecologic risk assessment.", {"entities": []}], ["Furthermore, current information on human risk does not completely explain the level of response in cumulative risk conditions.", {"entities": []}], ["Ecologic risk situations are similarly more complex and unpredictable for cases of cumulative risk.", {"entities": []}], ["Psychosocial conditions and responses are the principal missing element for humans.", {"entities": []}], ["We propose a model for including psychologic and social factors as an integral component of cumulative risk assessment.", {"entities": []}], ["Bacterial biofilm-associated chronic sinusitis in cystic fibrosis (CF) patients caused by Pseudomonas aeruginosa infections and the lack of available treatments for such infections constitute a critical aspect of CF disease management.", {"entities": [[37, 46, "DISEASE"], [50, 65, "DISEASE"]]}], ["Currently, inhalation therapies to combat P. aeruginosa infections in CF patients are focused mainly on the delivery of antimicrobials to the lower respiratory tract, disregarding the sinuses.", {"entities": []}], ["However, the sinuses constitute a reservoir for P. aeruginosa growth, leading to re-infection of the lungs, even after clearing an initial lung infection.", {"entities": []}], ["Eradication of P. aeruginosa from the respiratory tract after a first infection has been shown to delay chronic pulmonary infection with the bacteria for up to two years.", {"entities": []}], ["The challenges with providing a suitable treatment for bacterial sinusitis include: (i) identifying a suitable antimicrobial compound; (ii) selecting a suitable device to deliver the drug to the sinuses and nasal cavities; and (iii) applying a formulation design, which will mediate delivery of a high dose of the antimicrobial directly to the site of infection.", {"entities": [[65, 74, "DISEASE"]]}], ["This review highlights currently available inhalable antimicrobial formulations for treatment and management of biofilm infections caused by P. aeruginosa and discusses critical issues related to novel antimicrobial drug formulation design approaches.", {"entities": []}], ["The aim of the study was to describe patterns of neuromuscular weakness using a combination of electromyography and histology, and to evaluate functional outcome in patients following complicated cardiovascular surgery.", {"entities": []}], ["Fifteen adults requiring long-term mechanical ventilation (>15 days) following cardiovascular surgery associated with postoperative complications were prospectively included.", {"entities": []}], ["Electrophysiological and histological analyses (muscle and nerve) were performed when failure to wean from mechanical ventilation associated with peripheral neuromuscular weakness was noticed.", {"entities": []}], ["Functional disability was evaluated 12 months after surgery.", {"entities": []}], ["Six patients had a predominantly axonal neuropathy, six presented with myopathy, and three patients had a combination of axonal neuropathy and myopathy.", {"entities": [[71, 79, "DISEASE"], [143, 151, "DISEASE"], [40, 50, "DISEASE"], [128, 138, "DISEASE"], [33, 50, "DISEASE"], [121, 138, "DISEASE"]]}], ["All of them presented with acute tetraparesis and failure to wean from mechanical ventilation.", {"entities": []}], ["All of the study patients who received corticosteroids exhibited a myopathic pattern (with or without axonopathic changes) but never an axonopathic pattern only.", {"entities": []}], ["Only two of the eight survivors at 12 months were not ambulatory.", {"entities": []}], ["These two patients had no detectable compound muscle action potential on electrophysiological examination.", {"entities": []}], ["The combination of electromyographic evaluation and neuromuscular histological abnormalities could help to identify the type and severity of neuromuscular weakness, in turn helping to evaluate the patient's potential functional prognosis.", {"entities": []}], ["The associations between particulate matter from Asian dust storms (ADS) and health disorders differ among studies, and the underlying mechanisms remain unclear.", {"entities": []}], ["In this study, ADS and non-ADS particles were tested for their potential to induce pro-inflammatory cytokines associated with adverse respiratory effects.", {"entities": []}], ["Particulate matter was collected in Japan during four periods in 2013 (2 \u00d7 ADS periods; 2 \u00d7 non-ADS).", {"entities": []}], ["THP1 cells were exposed to this particulate matter, and the levels of various interleukins (ILs), and tumor necrosis factor (TNF)-\u03b1 were measured.", {"entities": [[125, 128, "GENE"]]}], ["Levels of IL-2 increased significantly following exposure to all particulate matter samples (compared to levels in a solvent control).", {"entities": []}], ["Increased levels of IL-10 and TNF-\u03b1 were also observed following exposure to particles collected during three (one ADS and two non-ADS) and two (one ADS and one non-ADS) collection periods, respectively.", {"entities": []}], ["Thus, the effects of particulate matter on cytokine responses differed according to collection period, and the effects of ADS particles differed for each ADS event.", {"entities": []}], ["Additionally, the levels of pro-inflammatory cytokines induced by ADS particles were not always higher than those induced by non-ADS particles.", {"entities": []}], ["Multipotent stromal cells (MSCs) are currently in clinical trials for a number of inflammatory diseases.", {"entities": []}], ["Recent studies have demonstrated the ability of MSCs to attenuate inflammation in rodent models of acute lung injury (ALI) suggesting that MSCs may also be beneficial in treating ALI.", {"entities": []}], ["To better understand how human MSCs (hMSCs) may act in ALI, the lungs of immunocompetent mice were exposed to lipopolysaccharide (LPS) and four hours later bone marrow derived hMSCs were delivered by oropharyngeal aspiration (OA).", {"entities": []}], ["The effect of hMSCs on lung injury was assessed by measuring the lung wet/dry weight ratio and total protein in bronchoalveolar lavage (BAL) fluid 24 or 48 h after LPS.", {"entities": []}], ["BAL fluid was also analyzed for the presence of inflammatory cells and cytokine expression by multiplex immunoassay.", {"entities": []}], ["Microarray analysis of total RNA isolated from treated and untreated lungs was performed to elucidate the mechanism(s) involved in hMSC modulation of lung inflammation.", {"entities": []}], ["Administration of hMSCs significantly reduced the expression of pro-inflammatory cytokines, neutrophil counts and total protein in bronchoalveolar lavage.", {"entities": []}], ["There was a concomitant reduction in pulmonary edema.", {"entities": [[37, 52, "DISEASE"]]}], ["The anti-inflammatory effects of hMSCs were not dependent on localization to the lung, as intraperitoneal administration of hMSCs also attenuated LPS-induced inflammation in the lung.", {"entities": []}], ["Microarray analysis revealed significant induction of tumor necrosis factor ( TNF )-\u03b1-induced protein 6 ( TNFAIP6/ TSG-6) expression by hMSCs 12 h after OA delivery to LPS-exposed lungs.", {"entities": [[78, 81, "GENE"]]}], ["Knockdown of TSG-6 expression in hMSCs by RNA interference abrogated most of their anti-inflammatory effects.", {"entities": []}], ["In addition, intra-pulmonary delivery of recombinant human TSG-6 reduced LPS-induced inflammation in the lung.", {"entities": []}], ["These results show that hMSCs recapitulate the observed beneficial effects of rodent MSCs in animal models of ALI and suggest that the anti-inflammatory properties of hMSCs in the lung are explained, at least in part, by activation of hMSCs to secrete TSG-6.", {"entities": []}], ["A common feature of the inflammatory response in patients who have actually contracted influenza is the generation of a number of volatile products of the alveolar and airway epithelium.", {"entities": [[87, 96, "DISEASE"]]}], ["These products include a number of volatile organic compounds (VOCs) and nitric oxide (NO).", {"entities": []}], ["These may be used as biomarkers to detect the disease.", {"entities": []}], ["A portable 3-sensor array microsystem-based tool that can potentially detect flu infection biomarkers is described here.", {"entities": []}], ["Whether used in connection with in-vitro cell culture studies or as a single exhale breathalyzer, this device may be used to provide a rapid and non-invasive screening method for flu and other virus-based epidemics.", {"entities": []}], ["We investigated whether metalloproteinase-9 (MMP-9) values in induced sputum (IS) and pulmonary function tests can serve as a marker of damage and intensity of exposure to hazardous dust.", {"entities": []}], ["Thirty-nine factory employees (28 workers exposed to metal particles and 11 supposedly nonexposed office workers) underwent IS induction.", {"entities": []}], ["Samples were processed by conventional methods within 2 hours.", {"entities": []}], ["The proportion of particles with diameters of 0\u20132 \u03bc in IS samples was significantly higher in nonexposed than exposed workers and in smoker compared to nonsmoker workers.", {"entities": []}], ["MMP-9 and TIMP-1 levels were similar for both groups.", {"entities": []}], ["A linear regression model for MMP-9 based on exposure, smoking habits, and proportion of particles < 5 \u03bc revealed a positive correlation between each of the explanatory variables and MMP-9 values.", {"entities": []}], ["MMP-9 may serve as a marker for pulmonary injury.", {"entities": []}], ["This work describes a methodology for modeling the impact of traffic-generated air pollutants in an urban area.", {"entities": []}], ["This methodology presented here utilizes road network geometry, traffic volume, temporal allocation factors, fleet mixes, and emission factors to provide critical modeling inputs.", {"entities": []}], ["These inputs, assembled from a variety of sources, are combined with meteorological inputs to generate link-based emissions for use in dispersion modeling to estimate pollutant concentration levels due to traffic.", {"entities": []}], ["A case study implementing this methodology for a large health study is presented, including a sensitivity analysis of the modeling results reinforcing the importance of model inputs and identify those having greater relative impact, such as fleet mix.", {"entities": []}], ["In addition, an example use of local measurements of fleet activity to supplement model inputs is described, and its impacts to the model outputs are discussed.", {"entities": []}], ["We conclude that with detailed model inputs supported by local traffic measurements and meteorology, it is possible to capture the spatial and temporal patterns needed to accurately estimate exposure from traffic-related pollutants.", {"entities": []}], ["Southeast Asia is a region with great potential for the emergence of a pandemic influenza virus.", {"entities": [[80, 89, "DISEASE"]]}], ["Global efforts to improve influenza surveillance in this region have documented the burden and seasonality of influenza viruses and have informed influenza prevention strategies, but little information exists about influenza vaccination guidelines and vaccine sales.", {"entities": [[26, 35, "DISEASE"], [110, 119, "DISEASE"], [146, 155, "DISEASE"], [215, 224, "DISEASE"]]}], ["To ascertain the existence of influenza vaccine guidelines and define the scope of vaccine sales, we sent a standard three-page questionnaire to the ten member nations of the Association of Southeast Asian Nations.", {"entities": [[30, 39, "DISEASE"]]}], ["We also surveyed three multinational manufacturers who supply influenza vaccines in the region.", {"entities": [[62, 71, "DISEASE"]]}], ["Vaccine sales in the private sector were <1000 per 100,000 population in the 10 countries.", {"entities": []}], ["Five countries reported purchasing vaccine for use in the public sector.", {"entities": []}], ["In 2011, Thailand had the highest combined reported rate of vaccine sales (10,333 per 100,000).", {"entities": []}], ["In the 10 countries combined, the rate of private sector sales during 2010\u20132011 (after the A(H1N1)2009pdm pandemic) exceeded 2008 pre-pandemic levels.", {"entities": []}], ["Five countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vaccination but only two were consistent with global guidelines.", {"entities": [[89, 98, "DISEASE"]]}], ["Four recommended vaccination for health care workers, four for elderly persons, three for young children, three for persons with underlying disease, and two for pregnant women.", {"entities": []}], ["The rate of vaccine sales in Southeast Asia remains low, but there was a positive impact in sales after the A(H1N1)2009pdm pandemic.", {"entities": []}], ["Low adherence to global vaccine guidelines suggests that more work is needed in the policy arena.", {"entities": []}], ["Obesity is an escalating issue, with an accompanying increase in referrals of patients with obesity-related respiratory failure.", {"entities": [[108, 127, "DISEASE"], [0, 7, "DISEASE"], [92, 99, "DISEASE"]]}], ["Currently, these patients are electively admitted to hospital for initiation of non-invasive ventilation (NIV), but it is unknown whether outpatient initiation is as effective as inpatient set-up.", {"entities": []}], ["We hypothesise that outpatient set-up using an autotitrating NIV device will be more cost-effective than a nurse-led inpatient titration and set-up.", {"entities": []}], ["We will undertake a multinational, multicentre randomised controlled trial.", {"entities": []}], ["Participants will be randomised to receive the usual inpatient set-up, which will include nurse-led initiation of NIV or outpatient set-up with an automated NIV device.", {"entities": []}], ["They will be stratified according to the trial site, gender and previous use of NIV or continuous positive airway pressure.", {"entities": []}], ["Assuming a 10% dropout rate, a total sample of 82 patients will be required.", {"entities": []}], ["Cost-effectiveness will be evaluated using standard treatment costs and health service utilisation as well as health-related quality of life measures (severe respiratory insufficiency (SRI) and EuroQol-5 dimensions (EQ-5D)).", {"entities": []}], ["A change in the SRI questionnaire will be based on the analysis of covariance adjusting for the baseline measurements between the two arms of patients.", {"entities": []}], ["This study has been approved by the Westminster National Research Ethics Committee (11/LO/0414) and is the trial registered on the UKCRN portfolio.", {"entities": []}], ["The trial is planned to start in January 2015 with publication of the trial results in 2017.", {"entities": []}], ["ISRCTN 51420481.", {"entities": []}], ["Background: Mucin polymer formation is a complex intracellular process.", {"entities": []}], ["Results: MUC5B N-terminal D3-domains form reversible pH-sensitive calcium mediated cross-links between linear MUC5B polymer chains.", {"entities": [[9, 14, "GENE"], [110, 115, "GENE"], [9, 14, "GENE"], [110, 115, "GENE"]]}], ["Conclusion: Intracellular assembly of MUC5B generates disulfide-bonded polymers which form calcium mediated condensed networks in secretory granules.", {"entities": [[38, 43, "GENE"]]}], ["Significance: This identifies a new model for mucin assembly that may be common to other polymeric mucins.", {"entities": []}], ["Mucins are essential components in mucus gels that form protective barriers at all epithelial surfaces, but much remains unknown about their assembly, intragranular organization, and post-secretion unfurling to form mucus.", {"entities": []}], ["MUC5B is a major polymeric mucin expressed by respiratory epithelia, and we investigated the molecular mechanisms involved during its assembly.", {"entities": [[0, 5, "GENE"]]}], ["Studies of intact polymeric MUC5B revealed a single high affinity calcium-binding site, distinct from multiple low affinity sites on each MUC5B monomer.", {"entities": [[28, 33, "GENE"], [138, 143, "GENE"], [28, 33, "GENE"], [138, 143, "GENE"]]}], ["Self-diffusion studies with intact MUC5B showed that calcium binding at the protein site catalyzed reversible cross-links between MUC5B chains to form networks.", {"entities": [[35, 40, "GENE"], [130, 135, "GENE"], [35, 40, "GENE"], [130, 135, "GENE"]]}], ["The site of cross-linking was identified in the MUC5B D3-domain as it was specifically blocked by D3 peptide antibodies.", {"entities": [[48, 53, "GENE"]]}], ["Biophysical analysis and single particle EM of recombinant MUC5B N terminus (D1D2D\u2032D3; NT5B) and subdomains (D1, D1-D2, D2-D\u2032-D3, and D3) generated structural models of monomers and disulfide-linked dimers and suggested that MUC5B multimerizes by disulfide linkage between D3-domains to form linear polymer chains.", {"entities": [[59, 64, "GENE"], [225, 230, "GENE"], [59, 64, "GENE"], [225, 230, "GENE"]]}], ["Moreover, these analyses revealed reversible homotypic interactions of NT5B at low pH and in high calcium, between disulfide-linked NT5B dimers, but not monomers.", {"entities": []}], ["These results enable a model of MUC5B to be derived, which predicts mechanisms of mucin intracellular assembly and storage, which may be common to the other major gel-forming polymeric mucins.", {"entities": [[32, 37, "GENE"]]}], ["Dengue fever, also known as breakbone fever, is a mosquito-borne infectious tropical disease caused by the dengue virus.", {"entities": []}], ["Symptoms include fever, headache, muscle and joint pains, and a characteristic skin rash that is similar to measles.", {"entities": [[108, 115, "DISEASE"]]}], ["In a small proportion of cases, the disease develops into life-threatening dengue hemorrhagic fever, which results in bleeding, thrombocytopenia, and leakage of blood plasma, or into dengue shock syndrome, in which dangerously low blood pressure occurs.", {"entities": [[128, 144, "DISEASE"], [196, 204, "DISEASE"], [183, 204, "DISEASE"], [75, 99, "DISEASE"]]}], ["Treatment of acute dengue fever is supportive, with either oral or intravenous rehydration for mild or moderate disease and use of intravenous fluids and blood transfusion for more severe cases.", {"entities": []}], ["Along with attempts to eliminate the mosquito vector, work is ongoing to develop a vaccine and medications targeted directly at the virus.", {"entities": []}], ["Earlier menarche and irregular periods, among other markers of sex-hormone levels, have been associated with a higher risk of asthma and allergic diseases.", {"entities": [[126, 132, "DISEASE"]]}], ["This has suggested an etiologic role of sex hormones in the development of these conditions.", {"entities": []}], ["The authors investigated the association of age at menarche, irregular periods, duration of menstruation, and acne with reported medical history of asthma and/or atopy (hay fever and/or eczema/urticaria) in a historical cohort of students born before the rise in asthma prevalence in the United Kingdom and attending university in 1948\u20131968.", {"entities": [[193, 202, "DISEASE"], [110, 114, "DISEASE"], [148, 154, "DISEASE"], [263, 269, "DISEASE"]]}], ["Finding consistent associations in a cohort that has experienced different life-course exposures and has different confounding structure can help to identify causal associations.", {"entities": []}], ["In the Glasgow Alumni Cohort, irregular periods were associated with atopic asthma (multinomial odds ratio (MOR) = 2.79, 95% confidence interval (CI): 1.33, 5.83) and atopy alone (MOR = 1.40, 95% CI: 1.06, 1.84) but not with nonatopic asthma (MOR = 1.02, 95% CI: 0.45, 2.30), compared with students reporting no asthma and no atopy.", {"entities": [[76, 82, "DISEASE"], [235, 241, "DISEASE"], [312, 318, "DISEASE"]]}], ["The authors found no association with acne, a marker of high testosterone levels, that they hypothesized could point to polycystic ovary syndrome underpinning these associations.", {"entities": [[38, 42, "DISEASE"], [120, 145, "DISEASE"], [137, 145, "DISEASE"]]}], ["In summary, the authors found evidence for a potentially etiologic role of irregular menstruations with some specific asthma phenotypes, namely, atopic asthma and atopy, but not with nonatopic asthma.", {"entities": [[118, 124, "DISEASE"], [152, 158, "DISEASE"], [193, 199, "DISEASE"]]}], ["The Centers for Disease Control and Prevention (CDC) has published significant data and trends related to the rising epidemic of usage of alternate forms of tobacco among the nation\u2019s youth.", {"entities": []}], ["For the first time ever, the use of the electronic cigarette (e-cigarrette) has surpassed traditional cigarette usage in adolescents.", {"entities": []}], ["E-cigarettes are battery-operated products designed to deliver aerosolized nicotine and other flavors to the consumer.", {"entities": []}], ["Most look like conventional cigarettes but some resemble everyday items such as pens, USB drives, and memory sticks.", {"entities": []}], ["Parkinson's disease is a chronic, debilitating neurodegenerative movement disorder characterized by progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta region in human midbrain.", {"entities": []}], ["To date, oxidative stress is the well accepted concept in the etiology and progression of Parkinson's disease.", {"entities": []}], ["Hence, the therapeutic agent is targeted against suppressing and alleviating the oxidative stress-induced cellular damage.", {"entities": []}], ["Within the past decades, an explosion of research discoveries has reported on the protective mechanisms of flavonoids, which are plant-based polyphenols, in the treatment of neurodegenerative disease using both in vitro and in vivo models.", {"entities": [[174, 199, "DISEASE"]]}], ["In this paper, we have reviewed the literature on the neuroprotective mechanisms of flavonoids in protecting the dopaminergic neurons hence reducing the symptoms of this movement disorder.", {"entities": []}], ["The mechanism reviewed includes effect of flavonoids in activation of endogenous antioxidant enzymes, suppressing the lipid peroxidation, inhibition of inflammatory mediators, flavonoids as a mitochondrial target therapy, and modulation of gene expression in neuronal cells.", {"entities": []}], ["During chronic inflammation, immune cells, notably Th17 cells, infiltrate the inflammatory site and interact with local mesenchymal cells.", {"entities": []}], ["Applied to rheumatoid arthritis (RA), the aim is to study the interactions between synoviocytes and peripheral blood mononuclear cells (PBMC) with a focus on the Th17 pathway and to identify a mechanism which leads to high IL-17 secretion with an interest on podoplanin.", {"entities": [[11, 31, "DISEASE"], [22, 31, "DISEASE"]]}], ["PBMC from healthy donors and RA patients were co-cultured with RA synoviocytes during 48\u00a0h, in the presence or not of phytohemagglutinin.", {"entities": []}], ["An antibody against podoplanin was used in co-culture.", {"entities": []}], ["Cytokine production (IL-6, IL-1\u03b2 and IL-17) was measured by ELISA and cell staining (CD3, CD4, IL-17 and podoplanin) by flow cytometry.", {"entities": [[90, 93, "GENE"]]}], ["In control conditions, IL-6 and IL-1\u03b2 production was increased in PBMC-synoviocyte co-culture compared to PBMC alone ( p \u2009=\u20090.02).", {"entities": []}], ["No additional effect was observed with PBMC activation.", {"entities": []}], ["Flow cytometry analysis showed no difference in the percentage of Th17 cells in activated PBMC alone or with synoviocytes ( p \u2009=\u20090.4), indicating that Th17 differentiation requires only T cell activation.", {"entities": []}], ["Conversely, IL-17 production was highly increased in co-cultures with activated PBMC vs. activated PBMC alone ( p \u2009=\u20090.002).", {"entities": []}], ["Transwell experiments confirm that cell-cell contact was critical for IL-17 secretion.", {"entities": []}], ["The incubation of either PBMC or synoviocytes with an anti-podoplanin antibody decreased IL-17 secretion by 60\u00a0% ( p \u2009=\u20090.008).", {"entities": []}], ["Interactions between resting PBMC and synoviocytes are sufficient to induce IL-6 and IL-1\u03b2 production.", {"entities": []}], ["Both PBMC activation and cell interactions are needed to induce a high IL-17 secretion.", {"entities": []}], ["Podoplanin contributes at the level of both lymphocytes and synoviocytes.", {"entities": []}], ["In this study we evaluated the association between temperature variation and mortality and compared it with the contribution due to mean daily temperature in 6 cities with different climates.", {"entities": []}], ["Quasi-Poisson time series regression models were applied to estimate the associations (relative risk and 95% confidence interval) of mean daily temperature (99th and 1st percentiles, with temperature of minimum mortality as the reference category), interday temperature variation (difference between the mean temperatures of 2 neighboring days) and intraday temperature variation (diurnal temperature range (DTR)) (referred to as median variation) with mortality in 6 cities: London, United Kingdom; Madrid, Spain; Stockholm, Sweden; New York, New York; Miami, Florida; and Houston, Texas (date range, 1985\u20132010).", {"entities": []}], ["All cities showed a substantial increase in mortality risk associated with mean daily temperature, with relative risks reaching 1.428 (95% confidence interval (CI): 1.329, 1.533) for heat in Madrid and 1.467 (95% CI: 1.385, 1.555) for cold in London.", {"entities": []}], ["Inconsistent results for inter-/intraday change were obtained, except for some evidence of protective associations on hot and cold days (relative risk (RR) = 0.977 (95% CI: 0.955, 0.999) and RR = 0.981 (95% CI: 0.971, 0.991), respectively) in Madrid and on cold days in Stockholm (RR = 0.989, 95% CI: 0.980, 0.998).", {"entities": []}], ["Our results indicate that the association between mortality and temperature variation is generally minimal compared with mean daily temperatures, although further research on intraday changes is needed.", {"entities": []}], ["Normal thyroid metabolism is essential for human development, including the formation and functioning of the central and peripheral nervous system.", {"entities": []}], ["Disorders of thyroid metabolism are increasingly recognized within the spectrum of paediatric neurological disorders.", {"entities": []}], ["Both hypothyroid and hyperthyroid disease states (resulting from genetic and acquired aetiologies) can lead to characteristic neurological syndromes, with cognitive delay, extrapyramidal movement disorders, neuropsychiatric symptoms, and neuromuscular manifestations.", {"entities": []}], ["In this review, the neurological manifestations of genetic disorders of thyroid metabolism are outlined, with particular focus on Allan-Herndon-Dudley syndrome and benign hereditary chorea.", {"entities": [[151, 159, "DISEASE"]]}], ["We report in detail the clinical features, major neurological and neuropsychiatric manifestations, molecular genetic findings, disease mechanisms, and therapeutic strategies for these emerging genetic \u2018brain-thyroid\u2019 disorders.", {"entities": []}], ["The kynurenine pathway (KP) is the main route of tryptophan degradation whose final product is NAD", {"entities": []}], ["This study was designated to evaluate the influence of behavioral depression on the airway leukocyte recruitment in allergic animals.", {"entities": []}], ["To achieve this, total and differential cell counts in bronchoalveolar (BAL) fluid of ovalbumin (OVA)-sensitized and depressed rats was evaluated.", {"entities": []}], ["Inescapable electric footshock, applied on day 0, 7 and 13 after OVA sensitization, was used as a model to induce depression.", {"entities": []}], ["In both nondepressed and depressed groups, the number of total and differential cells (eosinophils and mononuclear cells) in BAL fluid was significantly larger in sensitized compared with non-sensitized animals.", {"entities": []}], ["However, no statistical differences were found between these groups with respect to the number of total and differential leukocytes, irrespective of the day inescapable shock was applied.", {"entities": []}], ["Thus, behavioral depression does not influence the pattern of cell infiltration into the airways of allergen-induced airway inflammation.", {"entities": []}], ["This paper reports the irritant effects associated with formaldehyde exposures in mobile homes.", {"entities": []}], ["Week-long, integrated formaldehyde concentrations were measured using passive monitors in summer and winter while the mobile home residents continued their normal activities.", {"entities": []}], ["Information on acute health problems, chronic respiratory/allergic illnesses, smoking behavior, demographic variables, and time spent at home was obtained on over 1000 individuals during the sampling period.", {"entities": []}], ["Measured formaldehyde concentrations varied from under the limit of detection (0.01 ppm) to 0.46 ppm.", {"entities": []}], ["Formaldehyde exposure was estimated for each individual by multiplying the concentration measured in his or her home by the time he or she spent at home.", {"entities": []}], ["Irritant effects were found to be associated with formaldehyde exposure after controlling for age, sex, smoking status, and chronic illnesses using a logistic procedure.", {"entities": []}], ["Some of the interaction terms found to be significant indicated that there were synergistic effects between formaldehyde exposure and chronic health problems.", {"entities": []}], ["Permanent hair dye contains aromatic amines which are carcinogenic, and can cause allergic skin reactions.", {"entities": []}], ["In the long term personal use of hair dye might therefore influence both morbidity and mortality.", {"entities": []}], ["We tested the hypothesis that personal use of hair dye in women is associated with increased morbidity and mortality in the general population.", {"entities": []}], ["We included 7,684 women from the Copenhagen City Heart Study with information on the use of personal hair dye.", {"entities": []}], ["We assessed the risk of cancer, skin diseases, other morbidities, and mortality during a median follow-up of 27 years (range 0\u201337).", {"entities": [[24, 30, "DISEASE"]]}], ["The multivariable adjusted hazard ratio for malignant melanoma in women with versus without personal use of hair dye was 2.07 (95% confidence interval 1.25\u20133.42).", {"entities": [[54, 62, "DISEASE"]]}], ["There was no increased risk of other cancer types.", {"entities": [[37, 43, "DISEASE"]]}], ["For other skin diseases and other major causes of morbidity we found no differences between the two groups, except for a minor excess of digestive diseases and increased risk of Parkinson\u2019s disease among women using hair dye.", {"entities": []}], ["Finally, we found no difference in all-cause mortality comparing women using personal hair dye or not.", {"entities": []}], ["After correction for multiple comparisons, none of the results remained significant.", {"entities": []}], ["However, in sensitivity analysis the excess risk of malignant melanoma remained increased with a hazard ratio of 2.58 (95%CI 1.33\u20135.03) among users of personal hair dye.", {"entities": [[62, 70, "DISEASE"]]}], ["Personal use of hair dye does not have major influences on morbidity and mortality.", {"entities": []}], ["Our finding of a 2-fold risk of malignant melanoma in women using hair dye is hypothesis generating.", {"entities": [[42, 50, "DISEASE"]]}], ["The ICOS-B7h costimulatory receptor-ligand pair is required for germinal center formation, the production of isotype-switched antibodies, and antibody affinity maturation in response to T cell-dependent antigens.", {"entities": []}], ["However, the potentially distinct roles of regulated B7h expression on B cells and dendritic cells in T cell-dependent antibody responses have not been defined.", {"entities": []}], ["We generated transgenic mice with lineage-restricted B7h expression to assess the cell-type specific roles of B7h expression on B cells and dendritic cells in regulating T cell-dependent antibody responses.", {"entities": []}], ["Our results show that endogenous B7h expression is reduced on B cells after activation in vitro and is also reduced in vivo on antibody-secreting plasma B cells in comparison to both na\u00efve and germinal center B cells from which they are derived.", {"entities": []}], ["Increasing the level of B7h expression on activated and plasma B cells in B-B7hTg mice led to an increase in the number of antibody-secreting plasma cells generated after immunization and a corresponding increase in the concentration of antigen-specific high affinity serum IgG antibodies of all isotypes, without affecting the number of responding germinal center B cells.", {"entities": []}], ["In contrast, ICOS costimulation mediated by dendritic cells in DC-B7hTg mice contributed to germinal center formation and selectively increased IgG2a production without affecting the overall magnitude of antibody responses.", {"entities": [[13, 17, "GENE"]]}], ["Using transgenic mice with lineage-restricted B7h expression, we have revealed distinct roles of ICOS costimulation mediated by dendritic cells and B cells in the regulation of T cell-dependent antibody responses.", {"entities": [[97, 101, "GENE"]]}], ["Oxidative stress in the lung is important in the pathogenesis of COPD.", {"entities": []}], ["Published data indicate that glucocorticoids inhibit blood cells in their capacity to produce reactive oxygen species (ROS).", {"entities": []}], ["We investigated the effect of Fluticasone propionate (FP) on the ROS production capabilities of pulmonary cells.", {"entities": []}], ["Bronchoalveolar lavage (BAL) was performed in smoking COPD patients, before and after a six month, placebo-controlled treatment with FP.", {"entities": []}], ["BAL cells were stimulated with phorbol myristrate acetate (PMA) alone, and together with superoxide dismutase (SOD).", {"entities": []}], ["From kinetic plots of ferricytochrome-c conversion we calculated the maximal rate of superoxide production: V(max).", {"entities": [[110, 113, "GENE"]]}], ["We also examined BAL cell subsets and performed correlation analyses on ROS production and relevant clinical determinants.", {"entities": []}], ["Paired results were obtained from 6 FP- and 9 placebo-treated patients.", {"entities": []}], ["No significant change of V(max) was found in both patient groups.", {"entities": [[27, 30, "GENE"]]}], ["Also BAL cellularity was unchanged.", {"entities": []}], ["Correlation analyses showed a significant (inverse) association of V(max) with the number of cigarettes smoked per day.", {"entities": [[69, 72, "GENE"]]}], ["We concluded that a potent inhaled glucocorticoid had no effect on the ROS production capability of BAL cells from smoking COPD patients.", {"entities": []}], ["Apparently, heavy smoking impaired the ability of alveolar macrophages to produce ROS, which was not further decreased by FP.", {"entities": []}], ["Most individuals throughout the Americas are admixed descendants of Native American, European, and African ancestors.", {"entities": []}], ["Complex historical factors have resulted in varying proportions of ancestral contributions between individuals within and among ethnic groups.", {"entities": []}], ["We developed a panel of 446 ancestry informative markers (AIMs) optimized to estimate ancestral proportions in individuals and populations throughout Latin America.", {"entities": []}], ["We used genome-wide data from 953 individuals from diverse African, European, and Native American populations to select AIMs optimized for each of the three main continental populations that form the basis of modern Latin American populations.", {"entities": []}], ["We selected markers on the basis of locus-specific branch length to be informative, well distributed throughout the genome, capable of being genotyped on widely available commercial platforms, and applicable throughout the Americas by minimizing within-continent heterogeneity.", {"entities": []}], ["We then validated the panel in samples from four admixed populations by comparing ancestry estimates based on the AIMs panel to estimates based on genome-wide association study (GWAS) data.", {"entities": []}], ["The panel provided balanced discriminatory power among the three ancestral populations and accurate estimates of individual ancestry proportions (R Individuals from Latin America are descendants of multiple ancestral populations, primarily Native American, European, and African ancestors.", {"entities": []}], ["The relative proportions of these ancestries can be estimated using genetic markers, known as ancestry informative markers (AIMs), whose allele frequency varies between the ancestral groups.", {"entities": []}], ["Once determined, these ancestral proportions can be correlated with normal phenotypes, can be associated with disease, can be used to control for confounding due to population stratification, or can inform on the history of admixture in a population.", {"entities": []}], ["In this study, we identified a panel of AIMs relevant to Latin American populations, validated the panel by comparing estimates of ancestry using the panel to ancestry determined from genome-wide data, and tested the panel in a diverse set of populations from the Americas.", {"entities": []}], ["The panel of AIMs produces ancestry estimates that are highly accurate and appropriately controlled for population stratification, and it was used to genotype 18 populations from throughout Latin America.", {"entities": []}], ["We have made the panel of AIMs available to any researcher interested in estimating ancestral proportions for populations from the Americas.", {"entities": []}], ["Oxidative stress has been implicated in the pathophysiology of multiple human diseases, in addition to the aging process.", {"entities": []}], ["Although various stimuli exist, acute exercise is known to induce a transient increase in reactive oxygen and nitrogen species (RONS), evident by several reports of increased oxidative damage following acute bouts of aerobic and anaerobic exercise.", {"entities": []}], ["Although the results are somewhat mixed and appear disease dependent, individuals with chronic disease experience an exacerbation in oxidative stress following acute exercise when compared to healthy individuals.", {"entities": []}], ["However, this increased oxidant stress may serve as a necessary \u201csignal\u201d for the upregulation in antioxidant defenses, thereby providing protection against subsequent exposure to prooxidant environments within susceptible individuals.", {"entities": []}], ["Here we present studies related to both acute exercise-induced oxidative stress in those with disease, in addition to studies focused on adaptations resulting from increased RONS exposure associated with chronic exercise training in persons with disease.", {"entities": []}], ["Despite well-documented evidence that physical activity is beneficial to children, average fitness levels of US children have declined.", {"entities": []}], ["Lack of physical activity has been associated with childhood obesity.", {"entities": [[61, 68, "DISEASE"]]}], ["We evaluated the effects of a physical activity program in the elementary school classroom on health outcomes.", {"entities": []}], ["Three schools in the Independence School District in Independence, Missouri, were assigned to receive the ABC (Activity Bursts in the Classroom) for Fitness program, and 2 comparable schools served as controls.", {"entities": []}], ["The program, led by classroom teachers, provides multiple, brief, structured physical activity breaks throughout the day.", {"entities": []}], ["Baseline data for the study were collected in September 2007, and follow-up data were collected in April 2008.", {"entities": []}], ["Physical fitness measures of upper-body strength, abdominal strength, and trunk extensor improved ( P <.001).", {"entities": []}], ["Medication use for asthma ( P = .03), attention-deficit hyperactivity disorder ( P = .07), or either medication combined ( P = .005) decreased.", {"entities": [[19, 25, "DISEASE"]]}], ["The effects of the program on daily physical activity, fitness, and measures of health are beneficial.", {"entities": []}], ["Dengue virus (DENV), a mosquito-borne flavivirus, is a public health problem in many tropical countries.", {"entities": []}], ["Recent clinical data have shown an association between levels of different chemokines in plasma and severity of dengue.", {"entities": []}], ["We evaluated the role of CC chemokine receptors CCR1, CCR2 and CCR4 in an experimental model of DENV-2 infection in mice.", {"entities": [[48, 52, "GENE"], [54, 58, "GENE"], [63, 67, "GENE"]]}], ["Infection of mice induced evident clinical disease and tissue damage, including thrombocytopenia, hemoconcentration, lymphopenia, increased levels of transaminases and pro-inflammatory cytokines, and lethality in WT mice.", {"entities": [[80, 96, "DISEASE"], [117, 128, "DISEASE"]]}], ["Importantly, infected WT mice presented increased levels of chemokines CCL2/JE, CCL3/MIP-1\u03b1 and CCL5/RANTES in spleen and liver.", {"entities": []}], ["Atopic dermatitis (eczema) in childhood is socially patterned, with higher incidence in more advantaged populations.", {"entities": [[0, 17, "DISEASE"], [7, 17, "DISEASE"]]}], ["However, it is unclear what factors explain the social differences.", {"entities": []}], ["To identify early\u2010life risk factors for eczema, and to explore how early\u2010life risk factors explain any differences in eczema.", {"entities": []}], ["We estimated odds ratios ( OR s) for ever having had eczema by age 5 years in 14 499 children from the U.K. Millennium Cohort Study ( MCS ), with a focus on maternal, antenatal and early\u2010life risk factors and socioeconomic circumstances ( SEC s).", {"entities": []}], ["Risk factors were explored to assess whether they attenuated associations between SEC s and eczema.", {"entities": []}], ["Overall 35\u00b71% of children had ever had eczema by age 5 years.", {"entities": []}], ["Children of mothers with degree\u2010level qualifications vs. no educational qualifications were more likely to have eczema ( OR 1\u00b752, 95% confidence interval 1\u00b731\u20131\u00b776), and there was a gradient across the socioeconomic spectrum.", {"entities": []}], ["Maternal atopy, breastfeeding (1\u20136 weeks and \u2265 6 months), introduction of solids under 4 months or cow's milk under 9 months, antibiotic exposure in the first year of life and grime exposure were associated with an increased odds of having eczema.", {"entities": []}], ["Female sex, Pakistani and Bangladeshi ethnicity, smoking during pregnancy, exposure to environmental tobacco smoke and having more siblings were associated with reduced odds for eczema.", {"entities": []}], ["Controlling for maternal, antenatal and early\u2010life characteristics (particularly maternal smoking during pregnancy, breastfeeding and number of siblings) reduced the OR for eczema to 1\u00b726 (95% confidence interval 1\u00b703\u20131\u00b750) in the group with the highest educational qualifications compared with the least.", {"entities": []}], ["In a representative U.K. child cohort, eczema was more common in more advantaged children.", {"entities": []}], ["This was explained partially by early\u2010life factors including not smoking during pregnancy, breastfeeding and having fewer siblings.", {"entities": []}], ["What's already known about this topic?", {"entities": []}], ["Previous studies have suggested that atopic dermatitis (eczema) in childhood is socially patterned, with higher incidence in more advantaged populations.", {"entities": [[37, 54, "DISEASE"], [44, 54, "DISEASE"]]}], ["It is unclear what explains these differences.", {"entities": []}], ["Previous studies have suggested that atopic dermatitis (eczema) in childhood is socially patterned, with higher incidence in more advantaged populations.", {"entities": [[37, 54, "DISEASE"], [44, 54, "DISEASE"]]}], ["It is unclear what explains these differences.", {"entities": []}], ["What does this study add?", {"entities": []}], ["This large longitudinal study confirmed a significant excess of atopic dermatitis in more advantaged children born in 2000.", {"entities": [[64, 81, "DISEASE"], [71, 81, "DISEASE"]]}], ["This could be explained partially by maternal and early\u2010life factors including less maternal smoking in pregnancy, prolonged breastfeeding and fewer siblings.", {"entities": []}], ["This large longitudinal study confirmed a significant excess of atopic dermatitis in more advantaged children born in 2000.", {"entities": [[64, 81, "DISEASE"], [71, 81, "DISEASE"]]}], ["This could be explained partially by maternal and early\u2010life factors including less maternal smoking in pregnancy, prolonged breastfeeding and fewer siblings.", {"entities": []}], ["Plain language summary available online", {"entities": []}], ["A number of studies have reported that the interleukin 13 (IL-13) gene is associated with asthma susceptibility.", {"entities": [[90, 96, "DISEASE"]]}], ["However, the reported relationships between the +2044G/A and +1923C/T polymorphisms and asthma susceptibility are inconsistent, especially in Asian adults and children with atopic status.", {"entities": [[88, 94, "DISEASE"]]}], ["Meta-analysis was used to analyze combined data.", {"entities": []}], ["The +2044G/A and +1923C/T polymorphisms were investigated using data from 18 and 11 studies, respectively.", {"entities": []}], ["The results suggested that there was an association between asthma and the IL-13 +2044G/A polymorphisms: odds ratio (OR) 1.34, 95% confidence interval (CI) 1.03\u20131.75 for AA versus GG\u200a+\u200aGA and +1923C/T; OR 1.50, 95% CI 1.26\u20131.78 for TT versus CC; and OR 1.15, 95% CI 1.10\u20131.21 for TC versus CC.", {"entities": [[60, 66, "DISEASE"]]}], ["The subgroup meta-analysis demonstrated that IL-13 +2044G/A polymorphisms are associated with asthma: OR 1.47, 95% CI 1.06\u20132.04 for AA versus GG\u200a+\u200aGA and +1923C/T; OR 1.70, 95% CI 1.26\u20132.30 for TT versus CC; and OR 1.27, 95% CI 1.03\u20131.56 for TC versus CC.", {"entities": [[94, 100, "DISEASE"]]}], ["In particular, IL-13 +2044G/A polymorphisms are specifically associated with Asian ethnicity in both adults and children with atopic status.", {"entities": []}], ["However, the 1923C/T polymorphisms were not significantly associated with age group or atopic status within the Asian subgroups.", {"entities": []}], ["Further investigation using larger samples and meta-analysis is required.", {"entities": []}], ["No publication bias was detected.", {"entities": []}], ["This meta-analysis indicates that the IL13 +2044G/A and +1923C/T polymorphisms are risk factors for asthma, especially among Asians.", {"entities": [[100, 106, "DISEASE"], [38, 42, "GENE"]]}], ["We examined the understanding of the harms of secondhand smoke (SHS) exposure among low-income, hospitalized adults with cardiovascular disease.", {"entities": []}], ["Participants were 15 nonsmokers reporting daily SHS exposure and 15 light or nondaily cigarette smokers.", {"entities": []}], ["We coded responses from audiotaped semistructured interviews for themes.", {"entities": []}], ["No participant spontaneously identified heart risks related to SHS exposure.", {"entities": []}], ["Strategies to avoid SHS included verbal requests to not smoke and physically avoiding smoke; both smokers and nonsmokers prioritized politeness over urgency.", {"entities": []}], ["Most participants thought a blood test quantifying SHS exposure would be clinically useful.", {"entities": []}], ["Health education, assertiveness communication training, and protective policies (eg, smoke-free multiunit housing) also were supported.", {"entities": []}], ["Combining in vitro mouth\u2013throat deposition measurements, cascade impactor data and computational fluid dynamics (CFD) simulations, four different inhalers were compared which are indicated for chronic obstructive pulmonary disease (COPD) treatment.", {"entities": [[193, 230, "DISEASE"], [113, 116, "GENE"]]}], ["The Respimat inhaler, the Breezhaler, the Genuair, and the Ellipta were coupled to the idealized Alberta throat model.", {"entities": []}], ["The modeled dose to the lung (mDTL) was collected downstream of the Alberta throat model using either a filter or a next generation impactor (NGI).", {"entities": []}], ["Idealized breathing patterns from COPD patient groups \u2013 moderate and very severe COPD \u2013 were applied.", {"entities": []}], ["Theoretical lung deposition patterns were assessed by an individual path model.", {"entities": []}], ["For the Respimat the mDTL was found to be 59% (SD 5%) for the moderate COPD breathing pattern and 67% (SD 5%) for very severe COPD breathing pattern.", {"entities": []}], ["The percentages refer to nominal dose (ND) in vitro.", {"entities": []}], ["This is in the range of 44%\u201363% in vivo in COPD patients who display large individual variability.", {"entities": []}], ["Breezhaler showed a mDTL of 43% (SD 2%) for moderate disease simulation and 51% (SD 2%) for very severe simulation.", {"entities": []}], ["The corresponding results for Genuair are mDTL of 32% (SD 2%) for moderate and 42% (SD 1%) for very severe disease.", {"entities": []}], ["Ellipta vilanterol particles showed a mDTL of 49% (SD 3%) for moderate and 55% (SD 2%) for very severe disease simulation, and Ellipta fluticasone particles showed a mDTL of 33% (SD 3%) and 41% (SD 2%), respectively for the two breathing patterns.", {"entities": []}], ["Based on the throat output and average flows of the different inhalers, CFD simulations were performed.", {"entities": [[72, 75, "GENE"]]}], ["Laminar and turbulent steady flow calculations indicated that deposition occurs mainly in the small airways.", {"entities": []}], ["In summary, Respimat showed the lowest amount of particles depositing in the mouth\u2013throat model and the highest amount reaching all regions of the simulation lung model.", {"entities": []}], ["Int22h1/int22h2 -mediated Xq28 duplication syndrome is caused by ~0.5\u00a0Mb chromosomal duplications mediated by nonallelic homologous recombination between intron 22 homologous region 1 ( int22h1 ) and 2 ( int22h2 ), which, in addition to int22h3 , are also responsible for inversions disrupting the F8 gene in hemophilia A.", {"entities": [[43, 51, "DISEASE"], [70, 72, "GENE"], [298, 300, "GENE"]]}], ["This syndrome has recently been described in 9 males with cognitive impairment, behavioral problems, and distinctive facial features; and 6 females with milder phenotypes.", {"entities": [[5, 13, "DISEASE"]]}], ["The reciprocal deletion was previously reported in a mother and daughter.", {"entities": []}], ["It was suggested that this deletion may not have phenotypic effects in females because of skewed chromosome X inactivation, but may be embryonic lethal in males.", {"entities": []}], ["Array comparative genomic hybridization analyses were performed using oligonucleotide-based chromosomal microarray.", {"entities": []}], ["Chromosome X inactivation studies were performed at the AR (androgen receptor) and FMR1 (fragile X mental retardation 1) loci.", {"entities": [[83, 87, "GENE"]]}], ["We present here 5 males and 6 females with int22h1/int22h2 -mediated Xq28 duplication syndrome.", {"entities": [[86, 94, "DISEASE"]]}], ["The males manifested cognitive impairment, behavioral problems, and distinctive facial features.", {"entities": []}], ["Two of the six females manifested mild cognitive impairment.", {"entities": []}], ["This duplication was maternally inherited, and skewed chromosome X inactivation was observed in the majority of females carrying the duplication.", {"entities": []}], ["We also report the reciprocal deletion in a mother and daughter with overweight, but normal cognition.", {"entities": []}], ["In addition, we present the first case of a prenatally diagnosed de novo int22h1/int22h2 -mediated deletion in a healthy female infant.", {"entities": []}], ["We reviewed individuals previously reported with similar or overlapping rearrangements and evaluated the potential roles of genes in the rearrangement region.", {"entities": []}], ["The similarity of clinical features among individuals with the int22h1/int22h2 -mediated Xq28 duplication supports the notion that this duplication causes a recognizable syndrome that affects males with females exhibiting milder phenotypes.", {"entities": [[170, 178, "DISEASE"]]}], ["It is suggested that the observed cognitive impairment in this syndrome results from increased dosage of RAB39B gene located within the duplicated region.", {"entities": [[63, 71, "DISEASE"], [105, 111, "GENE"]]}], ["Increased dosage of CLIC2 may also contribute to the phenotype.", {"entities": [[20, 25, "GENE"]]}], ["The reciprocal deletion results in skewed chromosome X inactivation and no clinical phenotype in females.", {"entities": []}], ["Review of overlapping deletions suggests that hemizygous loss of VBP1 may be the cause for the proposed male lethality associated with this deletion.", {"entities": [[65, 69, "GENE"]]}], ["A controlled inflammatory response is required for protection against infection, but persistent inflammation causes tissue damage.", {"entities": []}], ["Dendritic cells (DCs) have a unique capacity to promote both inflammatory and anti-inflammatory processes.", {"entities": []}], ["One key mechanism involved in DC-mediated immunosuppression is the expression of tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase (IDO).", {"entities": []}], ["IDO has been implicated in diverse processes in health and disease but its role in endotoxin tolerance in human DCs is still controversial.", {"entities": []}], ["Here we investigated the role of IDO in shaping DCs phenotype and function under endotoxin tolerance conditions.", {"entities": []}], ["Our data show that TLR4 ligation in LPS-primed DCs, induced higher levels of both IDO isoforms together with the transcription factor aryl-hydrocarbon receptor (AhR), compared to unprimed controls.", {"entities": [[19, 23, "GENE"], [161, 164, "GENE"]]}], ["Additionally, LPS conditioning induced an anti-inflammatory phenotype in DCs - with an increase in IL-10 and higher expression of programmed death ligand (PD-L)1 and PD-L2 - which were partially dependent on IDO.", {"entities": []}], ["Furthermore, we demonstrated that the AhR-IDO pathway was responsible for the preferential activation of non-canonical NF-\u03baB pathway in LPS-conditioned DCs.", {"entities": []}], ["These data provide new insight into the mechanisms of the TLR4-induced tolerogenic phenotype in human DCs, which can help the better understanding of processes involved in induction and resolution of chronic inflammation and tolerance.", {"entities": []}], ["The aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs .", {"entities": []}], ["a dosing regimen adjusted by body weight.", {"entities": []}], ["Individual concentration\u2013time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab.", {"entities": []}], ["Patients received two or three intravenous doses (2.5, 5 or 10\u00a0mg) every 8\u00a0weeks.", {"entities": []}], ["Blood samples for assessment of tanezumab PK were collected at baseline, 1\u00a0h post\u2010dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies.", {"entities": []}], ["Blood samples were collected at week 32 in two studies.", {"entities": []}], ["Plasma samples were analyzed using a sensitive, specific, validated enzyme\u2010linked immunosorbent assay.", {"entities": []}], ["A two compartment model with parallel linear and non\u2010linear elimination processes adequately described the data.", {"entities": []}], ["Population estimates for clearance (CL), central volume ( V 1 ), peripheral volume ( V 2 ), inter\u2010compartmental clearance, maximum elimination capacity (VM) and concentration at half\u2010maximum elimination capacity were 0.135\u00a0l\u00a0day V 1 , V 2 and VM.", {"entities": []}], ["A mixture model accounted for the distribution of residual error.", {"entities": []}], ["While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V 1 and V 2 significantly reduced IIV.", {"entities": []}], ["The small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk\u00a0:\u00a0benefit.", {"entities": []}], ["Physical activity (PA) is associated with lower risk for non-communicable diseases and mortality.", {"entities": []}], ["We aimed to investigate the prospective association between PA and all-cause and cause-specific mortality, and the impact of other potentially contributing factors.", {"entities": []}], ["Data from the community-based Hordaland Health Study (HUSK, 1997\u201399) were linked to the Norwegian Cause of Death Registry.", {"entities": []}], ["The study included 20,506 individuals born 1950\u20131957 and 2,225 born in 1925\u20131927 (baseline age 40\u201349 and 70\u201374).", {"entities": []}], ["Based on self-report, individuals were grouped as habitually performing low intensity, short duration, low intensity, longer duration or high intensity PA.", {"entities": []}], ["The hazard ratios (HR) for all-cause and cause-specific mortality during follow-up were calculated.", {"entities": [[19, 21, "GENE"]]}], ["Measures of socioeconomic status, physical health, mental health, smoking and alcohol consumption were added separately and cumulatively to the model.", {"entities": []}], ["PA was associated with lower all-cause mortality in both older (HR 0.75 (95% CI 0.67\u20130.84)) and younger individuals (HR 0.82 (95% CI 0.72\u20130.92)) (crude models, HR: risk associated with moving from low intensity, short duration to low intensity, longer duration PA, and from low intensity, longer duration to high intensity).", {"entities": [[64, 66, "GENE"], [117, 119, "GENE"], [160, 162, "GENE"], [64, 66, "GENE"], [117, 119, "GENE"], [160, 162, "GENE"], [64, 66, "GENE"], [117, 119, "GENE"], [160, 162, "GENE"]]}], ["Smoking, education, somatic diagnoses and mental health accounted for some of the association between physical activity and mortality, but a separate protective effect of PA remained in fully adjusted models for cardiovascular (HR 0.78 (95% CI 0.66\u20130.92)) and respiratory (HR 0.45 (95% CI 0.32\u20130.63) mortality (both age-groups together), as well as all-cause mortality in the older age group (HR 0.74, 95%CI 0.66\u20130.83).", {"entities": [[228, 230, "GENE"], [273, 275, "GENE"], [393, 395, "GENE"], [228, 230, "GENE"], [273, 275, "GENE"], [393, 395, "GENE"], [228, 230, "GENE"], [273, 275, "GENE"], [393, 395, "GENE"]]}], ["Low intensity, longer duration and high intensity physical activity was associated with reduced all-cause, respiratory and cardiovascular mortality, indicating that physical activity is beneficial also among older individuals, and that a moderate increase in PA can be beneficial.", {"entities": []}], ["The price per milligram for most statin medications decreases at higher strengths, which provides an economic incentive to split tablets.", {"entities": []}], ["We sought to determine the frequency with which statin tablets are split, and to evaluate factors associated with this practice.", {"entities": []}], ["We obtained prescription claims data for statins from the BC Ministry of Health for the period Jan. 1, 1996, to Dec. 31, 2006.", {"entities": []}], ["We estimated the number of tablets per day, based on the ratio of the number of tablets to days-supply in each prescription, to estimate the frequency with which splitting occurred with each statin.", {"entities": []}], ["We used multivariable logistic regression to assess patient and physician characteristics and the level of public drug plan coverage associated with tablet splitting.", {"entities": []}], ["To estimate related cost savings, we used information on drug costs and quantities of dispensed statins reported by pharmacies.", {"entities": []}], ["During the 11-year study period, we estimated that tablet splitting occurred in 2.6% of 7.2 million statin prescriptions.", {"entities": []}], ["There was an increasing trend in the practice over time, to 4.5% of prescriptions in 2006.", {"entities": []}], ["Lovastatin was the only scored tablet and was the most likely to be split, followed by rosuvastatin and atorvastatin.", {"entities": []}], ["Fifty percent of the prescriptions in which tablet splitting occurred were prescribed by only 7.9% of the routine statin prescribers (i.e., >\u00a010 statin prescriptions over the study period).", {"entities": []}], ["Specialists were less likely than general practitioners to prescribe statins that were subsequently split (odds ratio [OR] 0.43, 95% confidence interval [CI] 0.40\u20130.46).", {"entities": []}], ["Statin prescriptions that were fully covered by the public drug plan were half as likely as those with no such coverage to involve tablet splitting (OR 0.48, 95% CI 0.44\u20130.92).", {"entities": []}], ["Having no public drug coverage, having a low annual household income and being female were patient factors found to be positively associated with tablet splitting.", {"entities": []}], ["In 2006, the cost savings associated with tablet splitting was $2.3 million.", {"entities": []}], ["The frequency of tablet splitting in statin prescriptions in British Columbia was low but increased over time.", {"entities": []}], ["It varied between patients, physicians and different levels of insurance coverage.", {"entities": []}], ["In the final study year, 94.5% of the statin prescriptions were dispensed at strengths for which a tablet of twice the strength was available and could have been split, which suggests a potentially enormous cost savings.", {"entities": []}], ["To study prevalence and determinants of pulmonary hypertension (PH) in a group of Cameroonian patients without chronic lung disease.", {"entities": [[50, 62, "DISEASE"], [40, 62, "DISEASE"], [119, 131, "DISEASE"]]}], ["We conducted a cross-sectional study conducted between April and December 2011 in a private cardiology clinic in Bafoussam, Cameroon.", {"entities": []}], ["We included consenting participants aged\u00a0\u2265\u00a018, who underwent a Doppler echocardiography.", {"entities": []}], ["Patients with chronic lung disease were excluded.", {"entities": [[22, 34, "DISEASE"]]}], ["A total of 178 participants were enrolled, of whom 44.4% were males with a mean age of 63.1\u00a0\u00b1\u00a017.3\u00a0years.", {"entities": []}], ["The prevalence of PH was 25.3%.", {"entities": []}], ["Among patients with PH 44.4% had severe disease, (11.2% of study population).", {"entities": []}], ["Age\u00a0\u2265\u00a055\u00a0years, systolic blood pressure\u00a0\u2265\u00a0140\u00a0mmHg, low left ventricular ejection fraction (<\u00a055%), left atrial enlargement, left ventricular hypertrophy and presence of left heart disease (left ventricular hypertrophy with systolic dysfunction and left atrial enlargement) were predictors of echocardiography PH.", {"entities": [[175, 188, "DISEASE"]]}], ["Obesity was negatively associated with pulmonary hypertension.", {"entities": [[49, 61, "DISEASE"], [39, 61, "DISEASE"]]}], ["Pulmonary hypertension is found in a quarter of the participants.", {"entities": [[10, 22, "DISEASE"], [0, 22, "DISEASE"]]}], ["Age, systolic hypertension, and any left heart disease were strongly associated to pulmonary hypertension.", {"entities": [[14, 26, "DISEASE"], [93, 105, "DISEASE"], [41, 54, "DISEASE"], [83, 105, "DISEASE"]]}], ["The online version of this article (10.1186/s13104-017-2903-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study aimed to measure the percent agreement between Exhaled Breath Carbon Monoxide (eBCO) measure using a piCO n = 439) had a mean age of 12.5 years (SD = 0.50) and 174 (39.9%) reported being an ever smoker of whom 59 (33.9%) reported being a recent (30-day) smoker.", {"entities": []}], ["The optimal eBCO cut-off point for recent smoking was 4.5 ppm with a sensitivity of 84.7% and specificity of 65.5%.", {"entities": []}], ["Overall, eBCO can accurately identify recent smokers and distinguish them from non-smokers.", {"entities": []}], ["The eBCO use enables healthcare professionals and researchers to assess efficacy of smoking cessation and prevention programs without necessarily relying on self-report.", {"entities": []}], ["Further research is indicated to validate our findings and should be expanded to include females, detailed characteristics of cigarette and waterpipe smoking.", {"entities": []}], ["Suicide is a serious public health concern worldwide, and the fourth leading cause of death in Korea.", {"entities": []}], ["Few studies have focused on risk factors for suicide attempt among people with suicidal ideation.", {"entities": []}], ["The aim of the present study was to investigate the risk factors and develop prediction models for suicide attempt among people with suicidal ideation in the Korean population.", {"entities": []}], ["This study included 1567 men and 3726 women aged 20\u00a0years and older who had suicidal ideation from the Korea National Health and Nutrition Examination Survey from 2007 to 2012.", {"entities": []}], ["Among them, 106 men and 188 women attempted suicide.", {"entities": []}], ["Multivariate logistic regression analysis with backward stepwise elimination was performed to find risk factors for suicide attempt.", {"entities": []}], ["Sub-group analysis, dividing participants into under 50 and at least 50\u00a0years old was also performed.", {"entities": []}], ["Among people with suicidal ideation, age, education, cancer, and depressive disorder were selected as risk factors for suicide attempt in men.", {"entities": [[53, 59, "DISEASE"]]}], ["Age, education, national basic livelihood security, daily activity limitation, depressive disorder, stress, smoking, and regular exercise were selected in women.", {"entities": []}], ["Area under curves of our prediction models in men and women were 0.728 and 0.716, respectively.", {"entities": []}], ["It is important to pay attention to populations with suicidal ideation and the risk factors mentioned above.", {"entities": []}], ["Prediction models using the determined risk factors could be useful to detect high-risk groups early for suicide attempt among people with suicidal ideation.", {"entities": []}], ["It is necessary to develop specific action plans for these high-risk groups to prevent suicide.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-017-4491-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Since its first splash 30 years ago, the use of the zebrafish model has been extended from a tool for genetic dissection of early vertebrate development to the functional interrogation of organogenesis and disease processes such as infection and cancer.", {"entities": [[246, 252, "DISEASE"]]}], ["In particular, there is recent and growing attention in the scientific community directed at the immune systems of zebrafish.", {"entities": []}], ["This development is based on the ability to image cell movements and organogenesis in an entire vertebrate organism, complemented by increasing recognition that zebrafish and vertebrate immunity have many aspects in common.", {"entities": []}], ["Here, we review zebrafish immunity with a particular focus on recent studies that exploit the unique genetic and in vivo imaging advantages available for this organism.", {"entities": []}], ["These unique advantages are driving forward our study of vertebrate immunity in general, with important consequences for the understanding of mammalian immune function and its role in disease pathogenesis.", {"entities": []}], ["Recent studies have found associations between particulate air pollution and total and adult mortality.", {"entities": []}], ["The relationship between particulate air pollution and mortality among infants has not been examined in the United States.", {"entities": []}], ["This study evaluates the relationship between postneonatal infant mortality and particulate matter in the United States.", {"entities": []}], ["Our study involved analysis of cohorts consisting of approximately 4 million infants born between 1989 and 1991 in states that report relevant covariates; this included 86 metropolitan statistical areas (MSAs) in the United States.", {"entities": []}], ["Data from the National Center for Health Statistics-linked birth/infant death records were combined at the MSA level with measurements of particulate matter 10 microns or less (PM10) from the EPA's Aerometric Database.", {"entities": []}], ["Infants were categorized as having high, medium, or low exposures based on tertiles of PM10.", {"entities": []}], ["Total and cause-specific postneonatal mortality rates were examined using logistic regression to control for demographic and environmental factors.", {"entities": []}], ["Overall postneonatal mortality rates were 3.1 among infants with low PM10 exposures, 3.5 among infants with medium PM10 exposures, and 3.7 among highly exposed infants.", {"entities": []}], ["After adjustment for other covariates, the odds ratio (OR) and 95% confidence intervals (CI) for total postneonatal mortality for the high exposure versus the low exposure group was 1.10 (1.04, 1.16).", {"entities": []}], ["In normal birth weight infants, high PM10 exposure was associated with respiratory causes [OR = 1.40, (1.05, 1.85)] and sudden infant death syndrome [OR = 1.26, (1.14, 1.39)].", {"entities": [[140, 148, "DISEASE"], [120, 148, "DISEASE"]]}], ["For low birth weight babies, high PM10 exposure was associated, but not significantly, with mortality from respiratory causes [OR = 1.18, (0.86, 1.61)].", {"entities": []}], ["This study suggests that particulate matter is associated with risk of postneonatal mortality.", {"entities": []}], ["Continued attention should be paid to air quality to ensure optimal health of infants in the United States.", {"entities": []}], ["Asthma affects 300 million people worldwide.", {"entities": [[0, 6, "DISEASE"]]}], ["In asthma, the major cause of morbidity and mortality is acute airway narrowing, due to airway smooth muscle (ASM) hypercontraction, associated with airway remodelling.", {"entities": [[3, 9, "DISEASE"]]}], ["However, little is known about the transcriptional differences between healthy and asthmatic ASM cells.", {"entities": []}], ["To investigate the transcriptional differences between asthmatic and healthy airway smooth muscle cells (ASMC) in culture and investigate the identified targets using in vitro and ex vivo techniques.", {"entities": []}], ["Human asthmatic and healthy ASMC grown in culture were run on Affymetrix_Hugene_1.0_ST microarrays.", {"entities": []}], ["Identified candidates were confirmed by PCR, and immunohistochemistry.", {"entities": []}], ["Functional analysis was conducted using in vitro ASMC proliferation, attachment and contraction assays and ex vivo contraction of mouse airways.", {"entities": []}], ["We suggest a novel role for latrophilin (LPHN) receptors, finding increased expression on ASMC from asthmatics, compared with non-asthmatics in vivo and in vitro, suggesting a role in mediating airway function.", {"entities": []}], ["A single nucleotide polymorphism in LPHN1 was associated with asthma and with increased LPHN1 expression in lung tissue.", {"entities": [[62, 68, "DISEASE"], [36, 41, "GENE"], [88, 93, "GENE"], [36, 41, "GENE"], [88, 93, "GENE"]]}], ["When activated, LPHNs regulated ASMC adhesion and proliferation in vitro, and promoted contraction of mouse airways and ASMC.", {"entities": []}], ["Given the need for novel inhibitors of airway remodelling and bronchodilators in asthma, the LPHN family may represent promising novel targets for future dual therapeutic intervention.", {"entities": [[81, 87, "DISEASE"]]}], ["Adipose tissue produces adiponectin, an anti-inflammatory protein.", {"entities": []}], ["Adiponectin deficiency in mice is associated with abnormal post-natal alveolar development.", {"entities": []}], ["We hypothesized that lower serum adiponectin concentrations are associated with lower lung function in humans, independent of obesity.", {"entities": [[126, 133, "DISEASE"]]}], ["We explored mediation of this association by insulin resistance and systemic inflammation.", {"entities": []}], ["Spirometry testing was conducted at years 10 and 20 follow-up evaluation visits in 2,056 eligible young adult participants in the Coronary Artery Risk Development in Young Adults (CARDIA) study.", {"entities": []}], ["Body mass index, serum adiponectin, serum C-reactive protein (a marker of systemic inflammation), and insulin resistance were assessed at year 15.", {"entities": []}], ["After controlling for body mass index, years 10 and 20 forced vital capacity (FVC) were 81 ml and 82 ml lower respectively (p = 0.004 and 0.01 respectively) in the lowest vs .", {"entities": []}], ["highest adiponectin quartiles.", {"entities": []}], ["Similarly, years 10 and 20 forced expiratory volume in one second (FEV 1 ) were 50 ml and 38 ml lower (p = 0.01 and 0.09, respectively) in the lowest vs .", {"entities": [[67, 70, "GENE"]]}], ["highest adiponectin quartiles.", {"entities": []}], ["These associations were no longer significant after adjustment for insulin resistance and C-reactive protein.", {"entities": []}], ["Serum adiponectin was not associated with FEV 1 /FVC or peak FEV 1 .", {"entities": [[42, 45, "GENE"], [61, 64, "GENE"], [42, 45, "GENE"], [61, 64, "GENE"]]}], ["Independent of obesity, lower serum adiponectin concentrations are associated with lower lung function.", {"entities": [[15, 22, "DISEASE"]]}], ["The attenuation of this association after adjustment for insulin resistance and systemic inflammation suggests that these covariates are on a causal pathway linking adiponectin and lung function.", {"entities": []}], ["Denatonium, a widely used bitter agonist, activates bitter taste receptors on many cell types and plays important roles in chemical release, ciliary beating and smooth muscle relaxation through intracellular Ca Bright-field microscopy, cell counting kit-8 (CCK-8) assay and flow cytometry analysis were used to examine cellular morphology, proliferation and cell cycle, respectively.", {"entities": []}], ["Transmission electron microscopy (TEM) was used to examine mitochondrial integrity.", {"entities": []}], ["JC-1 dye and western blotting techniques were used to measure mitochondrial membrane potential and protein expression, respectively.", {"entities": []}], ["For airway epithelial cells, we observed that denatonium significantly effects cellular morphology, decreases cell proliferation and reduces the number of cells in S phase in a dose-dependent manner.", {"entities": []}], ["TEM analysis demonstrated that denatonium causes large amplitude swelling of mitochondria, which was confirmed by the loss of mitochondrial membrane potential, the down-regulation of Bcl-2 protein and the subsequent enhancement of the mitochondrial release of cytochrome c and Smac/DIABLO after denatonium treatment.", {"entities": []}], ["In this study, we demonstrated for the first time that denatonium damages mitochondria and thus induces apoptosis in airway epithelial cells.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0183-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Procalcitonin (PCT), a precursor protein of the hormone calcitonin, is a sensitive inflammatory marker in human medicine, which is primarily used for diagnosis of bacterial sepsis, but is also useful in diagnosis of exacerbation of asthma and COPD.", {"entities": [[232, 238, "DISEASE"]]}], ["In this study, PCT was evaluated as a potential biomarker for different chronic pneumopathies in the horse using an equine specific ELISA in comparison to established clinical markers and different interleukins.", {"entities": []}], ["Sixty-four horses were classified as free of respiratory disease, recurrent airway obstruction (RAO), inflammatory airway disease (IAD) or chronic interstitial pneumopathy (CIP) using a scoring system.", {"entities": []}], ["PCT concentrations were measured in plasma ( n \u2009=\u200917) and in the cell-free supernatant of bronchoalveolar lavage ( n \u2009=\u200964).", {"entities": []}], ["PCT concentrations were correlated to interleukins IL-1\u00df and IL-6 in BALF, clinical findings and BALF cytology.", {"entities": []}], ["The median PCT concentrations in plasma were increased in respiratory disease (174.46\u00a0ng/ml, n \u2009=\u20097) compared to controls (13.94\u00a0ng/ml, n \u2009=\u200910, P \u2009=\u20090.05) and correlated to PCT in BALF supernatant (rs\u2009=\u20090.48).", {"entities": []}], ["Compared to controls (5.49\u00a0ng/ml, n \u2009=\u200915), median PCT concentrations in BALF supernatant correlated to the overall clinical score (rs\u2009=\u20090.32, P \u2009=\u20090.007) and were significantly increased in RAO (13.40\u00a0ng/ml, n \u2009=\u200921) and IAD (16.89\u00a0ng/ml, n \u2009=\u200916), while no differences were found for CIP (12.02\u00a0ng/ml, n \u2009=\u200912).", {"entities": []}], ["No significant increases were found for IL-1 and IL-6 between controls and respiratory disease in general as well as different disease groups.", {"entities": []}], ["Although some correlations were found between PCT in plasma, BALF supernatant and clinical scores, PCT in BALF does not seem to be a superior marker compared to established clinical markers.", {"entities": []}], ["PCT in plasma seems to be more promising and a greater number of samples should be evaluated in further studies.", {"entities": []}], ["A phenocopy is defined as an environmentally induced phenotype of one individual which is identical to the genotype-determined phenotype of another individual.", {"entities": []}], ["The phenocopy phenomenon has been translated to the drug discovery process as phenotypes produced by the treatment of biological systems with new chemical entities (NCE) may resemble environmentally induced phenotypic modifications.", {"entities": []}], ["Various new chemical entities exerting inhibition of the kinase activity of Transforming Growth Factor \u03b2 Receptor I (TGF-\u03b2R1) were qualified by high-throughput RNA expression profiling.", {"entities": []}], ["This chemical genomics approach resulted in a precise time-dependent insight to the TGF-\u03b2 biology and allowed furthermore a comprehensive analysis of each NCE's off-target effects.", {"entities": []}], ["The evaluation of off-target effects by the phenocopy approach allows a more accurate and integrated view on optimized compounds, supplementing classical biological evaluation parameters such as potency and selectivity.", {"entities": []}], ["It has therefore the potential to become a novel method for ranking compounds during various drug discovery phases.", {"entities": []}], ["A number of studies have shown that both temperature and air pollution are associated with health outcomes.", {"entities": []}], ["In assessing air pollution effects, temperature is usually considered a confounder.", {"entities": []}], ["However, only a few recent studies considered air pollution as confounders while assessing temperature effects.", {"entities": []}], ["Few studies are available on whether or not air pollution modifies the temperature\u2013disease relationship.", {"entities": []}], ["In this study, we used three parallel Poisson generalized additive models to examine whether particulate matter < 10 \u03bcm in aerodynamic diameter (PM 10 ) modified the effects of minimum temperature on cardiorespiratory morbidity and mortality in Brisbane, Australia.", {"entities": []}], ["Results show that PM 10 statistically significantly modified the effects of temperature on respiratory and cardiovascular hospital admissions, all nonexternal-cause mortality, and cardiovascular mortality at different lags.", {"entities": []}], ["The enhanced adverse temperature effects were found at higher levels of PM 10 , but no clear evidence emerged for interactive effects on respiratory and cardiovascular emergency visits.", {"entities": []}], ["Three parallel models produced similar results, which strengthened the validity of findings.", {"entities": []}], ["We conclude that it is important to evaluate the modification role of air pollution in the assessment of temperature-related health impacts.", {"entities": []}], ["Activity-based funding (ABF) of hospitals is a policy intervention intended to re-shape incentives across health systems through the use of diagnosis-related groups.", {"entities": []}], ["Many countries are adopting or actively promoting ABF.", {"entities": []}], ["We assessed the effect of ABF on key measures potentially affecting patients and health care systems: mortality (acute and post-acute care); readmission rates; discharge rate to post-acute care following hospitalization; severity of illness; volume of care.", {"entities": []}], ["We undertook a systematic review and meta-analysis of the worldwide evidence produced since 1980.", {"entities": []}], ["We included all studies reporting original quantitative data comparing the impact of ABF versus alternative funding systems in acute care settings, regardless of language.", {"entities": []}], ["We searched 9 electronic databases (OVID MEDLINE, EMBASE, OVID Healthstar, CINAHL, Cochrane CENTRAL, Health Technology Assessment, NHS Economic Evaluation Database, Cochrane Database of Systematic Reviews, and Business Source), hand-searched reference lists, and consulted with experts.", {"entities": [[131, 134, "GENE"]]}], ["Paired reviewers independently screened for eligibility, abstracted data, and assessed study credibility according to a pre-defined scoring system, resolving conflicts by discussion or adjudication.", {"entities": []}], ["Of 16,565 unique citations, 50 US studies and 15 studies from 9 other countries proved eligible (i.e.", {"entities": []}], ["Australia, Austria, England, Germany, Israel, Italy, Scotland, Sweden, Switzerland).", {"entities": []}], ["We found consistent and robust differences between ABF and no-ABF in discharge to post-acute care, showing a 24% increase with ABF (pooled relative risk \u200a=\u200a1.24, 95% CI 1.18\u20131.31).", {"entities": []}], ["Results also suggested a possible increase in readmission with ABF, and an apparent increase in severity of illness, perhaps reflecting differences in diagnostic coding.", {"entities": []}], ["Although we found no consistent, systematic differences in mortality rates and volume of care, results varied widely across studies, some suggesting appreciable benefits from ABF, and others suggesting deleterious consequences.", {"entities": []}], ["Transitioning to ABF is associated with important policy- and clinically-relevant changes.", {"entities": []}], ["Evidence suggests substantial increases in admissions to post-acute care following hospitalization, with implications for system capacity and equitable access to care.", {"entities": []}], ["High variability in results of other outcomes leaves the impact in particular settings uncertain, and may not allow a jurisdiction to predict if ABF would be harmless.", {"entities": []}], ["Decision-makers considering ABF should plan for likely increases in post-acute care admissions, and be aware of the large uncertainty around impacts on other critical outcomes.", {"entities": []}], ["The human respiratory tract is heavily exposed to microorganisms.", {"entities": []}], ["Viral respiratory tract pathogens, like RSV, influenza and rhinoviruses cause major morbidity and mortality from respiratory tract disease.", {"entities": [[45, 54, "DISEASE"]]}], ["Furthermore, as viruses have limited means of transmission, viruses that cause pathogenicity in other tissues may be transmitted through the respiratory tract.", {"entities": []}], ["It is therefore important to chart the human virome in this compartment.", {"entities": []}], ["We have studied nasopharyngeal aspirate samples submitted to the Karolinska University Laboratory, Stockholm, Sweden from March 2004 to May 2005 for diagnosis of respiratory tract infections.", {"entities": []}], ["We have used a metagenomic sequencing strategy to characterize viruses, as this provides the most unbiased view of the samples.", {"entities": []}], ["Virus enrichment followed by 454 sequencing resulted in totally 703,790 reads and 110,931 of these were found to be of viral origin by using an automated classification pipeline.", {"entities": []}], ["The snapshot of the respiratory tract virome of these 210 patients revealed 39 species and many more strains of viruses.", {"entities": []}], ["Most of the viral sequences were classified into one of three major families; Paramyxoviridae , Picornaviridae or Orthomyxoviridae .", {"entities": []}], ["The study also identified one novel type of Rhinovirus C, and identified a number of previously undescribed viral genetic fragments of unknown origin.", {"entities": []}], ["Air pollution is involved in many pathologies.", {"entities": []}], ["These pollutants act through several mechanisms that can affect numerous physiological functions, including reproduction: as endocrine disruptors or reactive oxygen species inducers, and through the formation of DNA adducts and/or epigenetic modifications.", {"entities": []}], ["We conducted a systematic review of the published literature on the impact of air pollution on reproductive function.", {"entities": []}], ["Eligible studies were selected from an electronic literature search from the PUBMED database from January 2000 to February 2016 and associated references in published studies.", {"entities": []}], ["Search terms included (1) ovary or follicle or oocyte or testis or testicular or sperm or spermatozoa or fertility or infertility and (2) air quality or O 3 or NO 2 or PM2.5 or diesel or SO 2 or traffic or PM10 or air pollution or air pollutants.", {"entities": [[118, 129, "DISEASE"]]}], ["The literature search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.", {"entities": []}], ["We have included the human and animal studies corresponding to the search terms and published in English.", {"entities": []}], ["We have excluded articles whose results did not concern fertility or gamete function and those focused on cancer or allergy.", {"entities": [[106, 112, "DISEASE"]]}], ["We have also excluded genetic, auto-immune or iatrogenic causes of reduced reproduction function from our analysis.", {"entities": []}], ["Finally, we have excluded animal data that does not concern mammals and studies based on results from in vitro culture.", {"entities": []}], ["Data have been grouped according to the studied pollutants in order to synthetize their impact on fertility and the molecular pathways involved.", {"entities": []}], ["Both animal and human epidemiological studies support the idea that air pollutants cause defects during gametogenesis leading to a drop in reproductive capacities in exposed populations.", {"entities": []}], ["Air quality has an impact on overall health as well as on the reproductive function, so increased awareness of environmental protection issues is needed among the general public and the authorities.", {"entities": []}], ["Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD).", {"entities": [[61, 98, "DISEASE"]]}], ["Long-acting muscarinic antagonists (LAMAs) and long-acting \u03b2 2 -agonists (LABAs) are the main classes of long-acting bronchodilators.", {"entities": []}], ["To date, tiotropium is the only once-daily LAMA available for the treatment of COPD.", {"entities": []}], ["Glycopyrronium is a novel LAMA, currently in development for COPD.", {"entities": []}], ["Phase II studies have shown that glycopyrronium 50 \u03bcg once daily provides clinically significant 24-hour bronchodilation with a rapid onset of action, which is faster than that of tiotropium, and a favorable safety and tolerability profile.", {"entities": []}], ["The Phase III GLycopyrronium bromide in COPD airWays (GLOW) program has now confirmed the long-term efficacy and tolerability of glycopyrronium 50 \u03bcg once daily.", {"entities": []}], ["The three studies included in this program have further shown that the effect of glycopyrronium versus placebo is similar to that of tiotropium in reducing dyspnea and the risk of exacerbations, as well as improving lung function, exercise tolerance, and health status in patients with COPD.", {"entities": []}], ["The safety profile of glycopyrronium is also similar to that of tiotropium in terms of overall incidence of adverse events and muscarinic side effects.", {"entities": []}], ["Glycopyrronium could be an alternative choice to tiotropium, and like tiotropium, has the potential to be used as a monotherapy or combination therapy.", {"entities": []}], ["Phase II studies have shown that a fixed-dose combination of glycopyrronium and the 24-hour LABA indacaterol, produces rapid and sustained bronchodilation compared with indacaterol monotherapy in patients with COPD.", {"entities": []}], ["Phase III studies are currently ongoing to assess the long-term efficacy and safety of this combination.", {"entities": []}], ["Upper and lower airways diseases share in part their pathogenic mechanisms and frequently occur simultaneously as \u201cUnited Airway Disease.\u201d Local treatment with nebulizers delivers anti-symptomatic drugs in either the upper or the lower airways, according to the particle size generated by the nebulizer.", {"entities": []}], ["To our knowledge, no nebulizer combines both application ways.", {"entities": []}], ["The aim of this study is to test the efficacy and usability of a new nebulizer (OMRON A3 complete), generating aerosols with particles diameters of 2-4.5\u00a0\u03bcm, 4.5-7.5\u00a0\u03bcm or >7.5\u00a0\u03bcm, according to the user\u2019s choice.", {"entities": []}], ["Seventy-seven patients between 5 and 17\u00a0years of age with a diagnosis of rhinitis or asthma were examined.", {"entities": [[73, 81, "DISEASE"], [85, 91, "DISEASE"]]}], ["Oxymetazoline or Salbutamol were prescribed according to best clinical practice guidelines.", {"entities": []}], ["Both drugs were administered through the OMRON A3 Complete nebulizer, with a particle dimension of >7.5\u00a0\u03bcm to treat nasal obstruction and 2-4.5\u00a0\u03bcm for bronchial obstruction.", {"entities": []}], ["The efficacy of treatment was assessed by total nasal inspiratory airflow and FEV-1, Tiffeneau index (FEV1/FVC) and MMEF 25/75 respectively, 10\u00a0min before and after treatment.", {"entities": []}], ["Symptom improvement and usability were measured by patients\u2019 and doctors\u2019 questionnaires.", {"entities": []}], ["Overall, 77 patients seeking care for acute respiratory symptoms were assigned to the upper ( n \u00a0=\u00a039) or lower ( n \u00a0=\u00a038) airways disease group.", {"entities": []}], ["For symptoms of the upper airways, 92% (95% CI, 77-97%) of the patients reported subjective improvement, while 87% (95% CI, 73-94%) did so for the lower airways.", {"entities": []}], ["The average total nasal inspiratory airflow improved significantly ( p \u00a0=\u00a00.030) among the patients with upper airways symptoms, from 275\u00a0ml/s (95% CI, 207-342\u00a0ml/s) to 359\u00a0ml/s (95% CI, 300-419\u00a0ml/s) after Oxymetazoline administration.", {"entities": []}], ["All selected lung function parameters (FEV1, Tiffeneau Index and MMEF25-75) significantly improved among the patients with lower airways symptoms after inhalation of Salbutamol ( p \u00a0<\u00a00.001).", {"entities": []}], ["The nebulizer was assessed as \u201ceasy to use\u201d by over 95% of participants in both groups.", {"entities": []}], ["The OMRON A3 efficiently delivers anti-symptomatic drugs in both upper and lower airways in a user-friendly way.", {"entities": []}], ["This device may be useful to facilitate adherence to a complete treatment of respiratory symptoms in patients with symptoms of the so-called United Airway Disease.", {"entities": []}], ["Health-related quality of life (HRQOL) has been recognized as an important health outcome measurement for pediatric patients.", {"entities": []}], ["One of the most promising instruments in measuring pediatric HRQOL emerged in recent years is the Pediatric Quality of Life Inventory (PedsQL\u2122).", {"entities": []}], ["The PedsQL\u2122 3.0 Asthma Module, one of the PedsQL\u2122disease-specific scales, was designed to measure HRQOL dimensions specifically tailored for pediatric asthma.", {"entities": [[16, 22, "DISEASE"], [151, 157, "DISEASE"]]}], ["The present study is aimed to evaluate the psychometric properties of the Chinese version of the PedsQL\u2122 3.0 Asthma Module.", {"entities": [[109, 115, "DISEASE"]]}], ["The PedsQL\u2122 3.0 Asthma Module was translated into Chinese following the PedsQL\u2122 Measurement Model Translation Methodology.", {"entities": [[16, 22, "DISEASE"]]}], ["The Chinese version scale was administered to 204 children with asthma and 337 parents of children with asthma from four Triple A hospitals.", {"entities": [[64, 70, "DISEASE"], [104, 110, "DISEASE"]]}], ["The psychometric properties were then evaluated.", {"entities": []}], ["The percentage of missing value for each item of the scale ranged from 0.00% to 8.31%.", {"entities": []}], ["All child self-report subscales and parent proxy-report subscales approached or exceeded the minimum reliability standard of 0.70 for alpha coefficient, except 3 subscales of Young Child (aged 5-7) self-report (alphas ranging from 0.59 to 0.68).", {"entities": []}], ["Test-retest reliability was satisfactory with intraclass correlation coefficients (ICCs) which exceeded the recommended standard of 0.80 in all subscales.", {"entities": []}], ["Correlation coefficients between items and their hypothesized subscales were higher than those with other subscales.", {"entities": []}], ["The PedsQL\u2122 3.0 Asthma Module distinguished between outpatients and inpatients.", {"entities": [[16, 22, "DISEASE"]]}], ["Patients with mild asthma reported higher scores than those with moderate/severe asthma in majority of subscales.", {"entities": [[19, 25, "DISEASE"], [81, 87, "DISEASE"]]}], ["The intercorrelations among the PedsQL\u2122 3.0 Asthma Module subscales and the PedsQL\u2122 4.0 Generic Core Scales were in medium to large effect size.", {"entities": [[44, 50, "DISEASE"]]}], ["The child self-report scores were consistent with the parent proxy-report scores.", {"entities": []}], ["The Chinese version of the PedsQL\u2122 3.0 Asthma Module has acceptable psychometric properties, except the internal consistency reliability for Young Child (aged 5-7) self-report.", {"entities": [[39, 45, "DISEASE"]]}], ["Further studies should be focused on testing responsiveness of the Chinese version scale in longitudinal studies, evaluating the reliability and validity of the scale for the patients with severe asthma or teens independently, and assessing HRQOL of children with asthma in other areas.", {"entities": [[196, 202, "DISEASE"], [264, 270, "DISEASE"]]}], ["Exposure to formaldehyde may lead to exacerbation of asthma.", {"entities": [[53, 59, "DISEASE"]]}], ["Our aim in this study was to investigate whether exposure to a low level (500 \u03bcg/m Twelve subjects with intermittent asthma and allergy to pollen were exposed, at rest, in a double-blind crossover study to either formaldehyde or purified air for 60 min.", {"entities": [[117, 123, "DISEASE"]]}], ["The order of exposure to formaldehyde and air-only was randomized, and exposures were separated by 2 weeks.", {"entities": []}], ["We also performed an allergen inhalation challenge after each exposure.", {"entities": []}], ["Airway responsiveness to methacholine and lower airway inflammation (induced sputum) were assessed 8 hr after allergen challenge.", {"entities": [[101, 103, "GENE"]]}], ["The median dose of allergen producing a 15% decrease in forced expiratory volume in 1 sec (PD 15 FEV 1 ) was 0.80 IR (index of reactivity) after formaldehyde exposure compared with 0.25 IR after air-only exposure ( p = 0.06).", {"entities": [[97, 100, "GENE"]]}], ["Formaldehyde exposure did not affect allergen-induced increase in responsiveness to methacholine ( p = 0.42).", {"entities": []}], ["We found no formaldehyde-associated effect on the airway inflammatory response, in particular the eosinophilic inflammatory response, induced by the allergen challenge 8 hr before.", {"entities": [[170, 172, "GENE"]]}], ["In this study, exposure to 500 \u03bcg/m", {"entities": []}], ["Pediatric asthma is a growing public health issue, disproportionately affecting low-income people and people of color.", {"entities": [[10, 16, "DISEASE"]]}], ["Exposure to indoor asthma triggers plays an important role in the development and exacerbation of asthma.", {"entities": [[19, 25, "DISEASE"], [98, 104, "DISEASE"]]}], ["We describe the implementation of the Seattle-King County Healthy Homes Project, a randomized, controlled trial of an outreach/education intervention to improve asthma-related health status by reducing exposure to allergens and irritants in the home.", {"entities": [[161, 167, "DISEASE"]]}], ["We randomly assigned 274 low-income children with asthma ages 4-12 to either a high- or a low-intensity group.", {"entities": [[50, 56, "DISEASE"]]}], ["In the high-intensity group, community health workers called Community Home Environmental Specialists (CHES) conducted initial home environmental assessments, provided individualized action plans, and made additional visits over a 12-month period to provide education and social support, encouragement of participant actions, provision of materials to reduce exposures (including bedding encasements), assistance with roach and rodent eradication, and advocacy for improved housing conditions.", {"entities": []}], ["Members of the low-intensity group received the initial assessment, home action plan, limited education during the assessment visit, and bedding encasements.", {"entities": []}], ["We describe the recruitment and training of CHES and challenges they faced and explain the assessment and exposure reduction protocols addressing dust mites, mold, tobacco smoke, pets, cockroaches, rodents, dust, moisture, and toxic or hazardous chemicals.", {"entities": []}], ["We also discuss the gap between the practices recommended in the literature and what is feasible in the home.", {"entities": []}], ["We accomplished home interventions and participants found the project very useful.", {"entities": []}], ["The project was limited in resolving structural housing quality issues that contributed to exposure to indoor triggers.", {"entities": []}], ["Preventive health check-ups in Austria are offered free of charge to all insured adults (98% of the population) and focus on early detection of chronic diseases, primary prevention, and health counseling.", {"entities": []}], ["The study aims to explore predictors of compliance with the recommended interval of preventive health check-up performance.", {"entities": []}], ["Source of data was the Austrian Health Interview Survey 2006/07 (15,474 subjects).", {"entities": []}], ["Participation in a preventive health examination during the last three years was used as dependent variable.", {"entities": []}], ["Socio-demographic and health-related characteristics were used as independent variables in a multivariate logistic regression analysis.", {"entities": []}], ["Results show that 41.6% of men and 41.8% of women had attended a preventive health check-up within the last three years.", {"entities": []}], ["In multivariate analysis, subjects \u226540\u00a0years, with higher education, higher income or born in Austria were significantly more likely to attend a preventive health check-up.", {"entities": []}], ["Furthermore, a chronic disease was associated with a higher attendance rate (OR: 1.21; CI: 1.07-1.36 in men; OR: 1.19; CI: 1.06-1.33 in women).", {"entities": []}], ["Attendance rates for health check-ups in the general Austrian population are comparatively high but not equally distributed among subgroups.", {"entities": []}], ["Health check-ups must increase among people at a young age, with a lower socio-economic status, migration background and in good health.", {"entities": []}], ["To examine the relationship between lifecourse factors from preschoolers\u2019 microecosystem and their parent-reported (mother-reported) health (PRH), following them prospectively from preconception to age 5\u2005years.", {"entities": []}], ["To investigate if preschoolers\u2019 body mass index (BMI) and waist circumference were associated with preschoolers\u2019 PRH when controlled for lifecourse predictors.", {"entities": []}], ["Lifeways cross-generation cohort study.", {"entities": []}], ["Of 1082 families, 62% mothers responded on a health and lifestyle questionnaire at follow-up.", {"entities": []}], ["Food frequency, BMI and waist circumference were measured.", {"entities": []}], ["There were 547 family data sets available for analysis of children's PRH.", {"entities": []}], ["Mother-reported children's PRH at age 5.", {"entities": []}], ["Associations with child's individual and familial exposures from preconception to age 5\u2005years examined using logistic regression.", {"entities": []}], ["In univariate analysis, relatively positive rating of children's PRH were associated with children's lower intake of fats (OR (95% CI) 2.2 (1.1 to 4.3)), higher intake of fruits/vegetables (OR (95% CI) 2.2 (1.1 to 4.3)); as well as familial socioeconomic characteristics {higher household income (OR (95% CI) 3.0 (1.6 to 5.9)), non-entitlement to means-tested healthcare (OR (95% CI) 2.1 (1.0 to 4.3)), mothers\u2019 higher education (OR (95% CI) 1.9 (1.0 to 3.6))}, psychosocial characteristics {father's participation in study (OR (95% CI) 2.1 (1.0 to 4.3)), mothers\u2019 perceiving better support from partner (OR (95% CI) 2.3 (1.2 to 4.3)), children (OR (95% CI) 1.9 (1.0 to 3.7)) or relatives (OR (95% CI) 2.2 (1.1 to 4.1))}, parents\u2019 lifestyle {mothers\u2019 lower intake of energy (OR (95% CI) 2.2 (1.1 to 4.3)), fathers\u2019 non-smoking status (OR (95% CI) 2.2 (1.1 to 4.4))} and parents\u2019 health {mothers\u2019 self-rated health relatively positive (OR (95% CI) 5.1 (2.6 to 9.9)), fathers\u2019 self-rated health relatively positive (OR (95% CI) 3.0 (1.5 to 6.0))}.", {"entities": []}], ["In multivariable analysis (\u03c7 Preschoolers\u2019 health is adversely associated with obesity and this is independent of lifecourse and social and environmental inequalities.", {"entities": [[79, 86, "DISEASE"]]}], ["The findings suggest that reducing childhood obesity and improving maternal health may be useful ways to improve child's global health.", {"entities": [[45, 52, "DISEASE"]]}], ["Clara cell protein (CC16) is an anti-inflammatory protein, which is expressed in the airway epithelium.", {"entities": []}], ["It is involved in the development of airway inflammatory diseases, including chronic obstructive pulmonary disease and asthma.", {"entities": [[77, 114, "DISEASE"], [119, 125, "DISEASE"]]}], ["However, the exact molecular mechanism underlying its anti-inflammatory action remains to be fully elucidated.", {"entities": []}], ["The aim of the present study was to define the protein profiles of the anti-inflammatory effect of CC16 in lipopolysaccharide (LPS)-treated rat tracheal epithelial (RTE) cells using shotgun proteomics.", {"entities": []}], ["Protein extracts were obtained from control RTE cells, RTE cells treated with LPS and RTE cells treated with LPS and recombinant CC16 (rCC16).", {"entities": []}], ["Subsequent label-free quantification and bioinformatics analyses identified 12 proteins that were differentially expressed in the three treatment groups as a cluster of five distinct groups according to their molecular functions.", {"entities": []}], ["Five of the twelve proteins were revealed to be associated with the cytoskeleton: Matrix metalloproteinase-9, myosin heavy chain 10, actin-related protein-3 homolog, elongation factor 1-\u03b1-1 (EF-1-\u03b1-1), and acidic ribosomal phosphoprotein P0.", {"entities": []}], ["Five of the twelve proteins were associated with cellular proliferation: DNA-dependent protein kinase catalytic subunit, EF-1-\u03b1-1, tyrosine 3-monooxygenase, caspase recruitment domain (CARD) protein 12 and adenosylhomocysteinase (SAHH) 3.", {"entities": []}], ["Three proteins were associated with gene regulation: EF-1-\u03b1-1, SAHH 3 and acidic ribosomal phosphoprotein P0.", {"entities": []}], ["Three proteins were associated with inflammation: Tyrosine 3-monooxygenase, CARD protein 12 and statin-related protein.", {"entities": []}], ["ATPase (H+-transporting, V1 subunit A, isoform 1) was revealed to be associated with energy metabolism, and uridine diphosphate glycosyltransferase 1 family polypeptide A8 with drug metabolism and detoxification.", {"entities": []}], ["The identified proteins were further validated using reverse transcription-quantitative polymerase chain reaction.", {"entities": []}], ["These protein profiles, and their interacting protein network, may facilitate the elucidation of the molecular mechanisms underlying the anti-inflammatory effects of CC16.", {"entities": []}], ["Supplemental Digital Content is available in the text We performed a multicenter prospective observational cohort study (Epid\u00e9miologie et Pronostic de l\u2019Insuffisance Cardiaque Aigu\u00eb en Lorraine, Epidemiology and Prognosis of Acute Heart Failure in Lorraine [EPICAL2]) to evaluate the effectiveness on mortality of a community-based multidisciplinary disease management programme (DMP) for heart failure (HF) patients.", {"entities": []}], ["Between October 2011 and October 2012, 1816 patients, who were hospitalized for acute HF or who developed acute HF during a hospitalization, were included from 21 hospitals in a northeast region of France.", {"entities": []}], ["At hospital admission, their mean age was 77.3 (standard deviation [SD] 11.6) years and mean left ventricular ejection fraction was 45.0 (SD 16.0)%.", {"entities": []}], ["A subset of patients were enrolled in a multidimensional DMP for HF (n\u200a=\u200a312, 17.2%), based on structured patient education, home monitoring visits by HF-trained nurses, and automatic alerts triggered by significant clinical and biological changes to the patient.", {"entities": []}], ["The DMP involved general practitioners, nurses, and cardiologists collaborating via an individual web-based medical electronic record.", {"entities": []}], ["The outcome was all-cause mortality from the 3rd to the 12th month after discharge.", {"entities": []}], ["During the follow-up, a total of 377 (20.8%) patients died: 321 (21.3%) in the control group and 56 (17.9%) in the DMP group.", {"entities": []}], ["In a propensity score analysis, DMP was associated with lower 1-year all-cause mortality (hazard ratio 0.65, 95% CI 0.46\u20130.92).", {"entities": []}], ["Instrumental variable analysis gave similar results (hazard ratio 0.56, 0.27\u20131.16).", {"entities": []}], ["In a real world setting, a multidimensional DMP for HF with structured patient education, home nurse monitoring, and appropriate physician alerts may improve survival when implemented after discharge from hospitalization due to worsening HF.", {"entities": []}], ["Neutrophils play a critical role in the host defense against bacterial and fungal infections, but their inappropriate activation also contributes to tissue damage during autoimmune and inflammatory diseases.", {"entities": []}], ["Neutrophils express a large number of cell surface receptors for the recognition of pathogen invasion and the inflammatory environment.", {"entities": []}], ["Those include G-protein-coupled chemokine and chemoattractant receptors, Fc-receptors, adhesion receptors such as selectins/selectin ligands and integrins, various cytokine receptors, as well as innate immune receptors such as Toll-like receptors and C-type lectins.", {"entities": []}], ["The various cell surface receptors trigger very diverse signal transduction pathways including activation of heterotrimeric and monomeric G-proteins, receptor-induced and store-operated Ca \u2022 Neutrophils are crucial players in innate and adaptive immunity.", {"entities": []}], ["\u2022 Neutrophils also participate in autoimmune and inflammatory diseases.", {"entities": []}], ["\u2022 Various neutrophil receptors recognize pathogens and the inflammatory environment.", {"entities": []}], ["\u2022 The various cell surface receptors trigger diverse intracellular signaling.", {"entities": []}], ["\u2022 Neutrophil receptors and signaling are potential targets in inflammatory diseases.", {"entities": []}], ["Neutrophils are crucial players in innate and adaptive immunity.", {"entities": []}], ["Neutrophils also participate in autoimmune and inflammatory diseases.", {"entities": []}], ["Various neutrophil receptors recognize pathogens and the inflammatory environment.", {"entities": []}], ["The various cell surface receptors trigger diverse intracellular signaling.", {"entities": []}], ["Neutrophil receptors and signaling are potential targets in inflammatory diseases.", {"entities": []}], ["Adverse psychosocial exposures in early life, namely experiences such as child maltreatment, caregiver stress or depression, and domestic or community violence, have been associated in epidemiological studies with increased lifetime risk of adverse outcomes, including diabetes, heart disease, cancers, and psychiatric illnesses.", {"entities": [[279, 292, "DISEASE"]]}], ["Additional work has shed light on the potential molecular mechanisms by which early adversity becomes \u201cbiologically embedded\u201d in altered physiology across body systems.", {"entities": []}], ["This review surveys evidence on such mechanisms and calls on researchers, clinicians, policymakers, and other practitioners to act upon evidence.", {"entities": []}], ["Childhood psychosocial adversity has wide-ranging effects on neural, endocrine, immune, and metabolic physiology.", {"entities": []}], ["Molecular mechanisms broadly implicate disruption of central neural networks, neuroendocrine stress dysregulation, and chronic inflammation, among other changes.", {"entities": []}], ["Physiological disruption predisposes individuals to common diseases across the life course.", {"entities": []}], ["Reviewed evidence has important implications for clinical practice, biomedical research, and work across other sectors relevant to public health and child wellbeing.", {"entities": []}], ["Warranted changes include increased clinical screening for exposures among children and adults, scale-up of effective interventions, policy advocacy, and ongoing research to develop new evidence-based response strategies.", {"entities": []}], ["The human gut has been continuously exposed to a broad spectrum of intestinal organisms, including viruses, bacteria, fungi, and parasites (protozoa and worms), over millions of years of coevolution, and plays a central role in human health.", {"entities": []}], ["The modern lifestyles of Western countries, such as the adoption of highly hygienic habits, the extensive use of antimicrobial drugs, and increasing globalisation, have dramatically altered the composition of the gut milieu, especially in terms of its eukaryotic \u201ccitizens.\u201d In the past few decades, numerous studies have highlighted the composition and role of human intestinal bacteria in physiological and pathological conditions, while few investigations exist on gut parasites and particularly on their coexistence and interaction with the intestinal microbiota.", {"entities": []}], ["Studies of the gut \u201cparasitome\u201d through \u201comic\u201d technologies, such as (meta)genomics, transcriptomics, proteomics, and metabolomics, are herein reviewed to better understand their role in the relationships between intestinal parasites, host, and resident prokaryotes, whether pathogens or commensals.", {"entities": []}], ["Systems biology\u2013based profiles of the gut \u201cparasitome\u201d under physiological and severe disease conditions can indeed contribute to the control of infectious diseases and offer a new perspective of omics-assisted tropical medicine.", {"entities": []}], ["Human enterovirus D68 (EV-D68) was first reported in the United States in 1962; thereafter, a few cases were reported from 1970 to 2005, but 2 outbreaks occurred in the Philippines (2008) and the United States (2014).", {"entities": []}], ["However, little is known regarding the molecular evolution of this globally reemerging virus due to a lack of whole-genome sequences and analyses.", {"entities": []}], ["Here, all publically available sequences including 147 full and 1248 partial genomes from GenBank were collected and compared at the clade and subclade level; 11 whole genomes isolated in Taiwan (TW) in 2014 were also added to the database.", {"entities": []}], ["Phylogenetic trees were constructed to identify a new subclade, B3, and represent clade circulations among strains.", {"entities": []}], ["Nucleotide sequence identities of the VP1 gene were 94% to 95% based on a comparison of subclade B3 to B1 and B2 and 87% to 91% when comparing A, C, and D. The patterns of clade circulation need to be clarified to improve global monitoring of EV-D68, even though this virus showed lower diversity among clades compared with the common enterovirus EV-71.", {"entities": []}], ["Notably, severe cases isolated from Taiwan and China in 2014 were found in subclade B3.", {"entities": []}], ["One severe case from Taiwan occurred in a female patient with underlying angioimmunoblastic T-cell lymphoma, from whom a bronchoalveolar lavage specimen was obtained.", {"entities": [[99, 107, "DISEASE"]]}], ["Although host factors play a key role in disease severity, we cannot exclude the possibility that EV-D68 may trigger clinical symptoms or death.", {"entities": []}], ["To further investigate the genetic diversity of EV-D68, we reported 34 amino acid (aa) polymorphisms identified by comparing subclade B3 to B1 and B2.", {"entities": []}], ["Clade D strains had a 1-aa deletion and a 2-aa insertion in the VP1 gene, and 1 of our TW/2014 strains had a shorter deletion in the 5\u2032 untranslated region than a previously reported deletion.", {"entities": []}], ["In summary, a new subclade, genetic indels, and polymorphisms in global strains were discovered elucidating evolutionary and epidemiological trends of EV-D68, and 11 genomes were added to the database.", {"entities": []}], ["Virus variants may contribute to disease severity and clinical manifestations, and further studies are needed to investigate the associations between genetic diversity and clinical outcomes.", {"entities": []}], ["We investigated the effects of antioxidant activity of safranal, a constituent of Crocus sativus L., against lung oxidative damage in diabetic rats.", {"entities": []}], ["The rats were divided into the following groups of 8 animals each: control, diabetic, and three diabetic + safranal-treated (0.25, 0.50, and 0.75\u2009mg/kg/day) groups.", {"entities": []}], ["Streptozotocin (STZ) was injected intraperitoneally (i.p.)", {"entities": []}], ["at a single dose of 60\u2009mg/kg for diabetes induction.", {"entities": []}], ["Safranal was administered (i.p.)", {"entities": []}], ["from 3 days after STZ administration to the end of the study.", {"entities": []}], ["At the end of the 4-week period, malondialdehyde (MDA), nitric oxide (NO) and reduced glutathione (GSH) contents, activity of superoxide dismutase (SOD), and catalase (CAT) were measured in the bronchoalveolar lavage fluid (BALF) and lung tissue.", {"entities": []}], ["Safranal in the diabetic groups inhibited the level of MDA and NO in BALF supernatant and lung homogenate.", {"entities": []}], ["The median effective dose (ED 50 ) values were 0.42, 0.58, and 0.48, 0.71\u2009mg/kg, respectively.", {"entities": []}], ["Safranal in the diabetic groups increased the level of GSH and the activity of CAT and SOD in BALF supernatant and lung homogenate.", {"entities": []}], ["The ED 50 values were 0.25, 0.33, 0.26 in BALF and 0.33, 0.35, 0.46\u2009mg/kg in lung, respectively.", {"entities": []}], ["Thus, safranal may be effective to prevent lung distress by amelioration oxidative damage in STZ diabetic rats.", {"entities": []}], ["Only approximately half of patients with hypertension have their blood pressure controlled, due in large part to the tendency of primary care providers (PCPs) not to intensify treatment when blood pressure values are elevated.", {"entities": [[41, 53, "DISEASE"]]}], ["This study tested the effect of an intervention designed to help patients ask questions at the point of care to encourage PCPs to appropriately intensify blood pressure treatment.", {"entities": []}], ["PCPs and their patients with hypertension (N=500) were recruited by letter and randomized into 2 study groups: (1) intervention condition in which patients used a fully automated website each month to receive tailored messages suggesting questions to ask their PCP to improve blood pressure control, and (2) control condition in which a similar tool suggested questions to ask about preventive services (eg, cancer screening).", {"entities": [[29, 41, "DISEASE"], [408, 414, "DISEASE"]]}], ["The Web-based tool was designed to be used during each of the 12 study months and before scheduled visits with PCPs.", {"entities": []}], ["The primary outcome was the percentage of patients in both conditions with controlled blood pressure.", {"entities": []}], ["Of 500 enrolled patients (intervention condition: n=282; control condition: n=218), 418 (83.6%) completed the 12-month follow-up visit.", {"entities": []}], ["At baseline, 289 (61.5%) of participants had controlled blood pressure.", {"entities": []}], ["Most (411/500, 82.2%) participants used the intervention during at least 6 of 12 months and 222 (62.5%) reported asking questions directly from the Web-based tool.", {"entities": []}], ["There were no group differences in asking about medication intensification and there were no differences in blood pressure control after 12 months between the intervention condition (201/282, 71.3%) and control condition (143/218, 65.6%; P =.27) groups.", {"entities": []}], ["More intervention condition participants discussed having a creatinine test (92, 52.6% vs 49, 35.5%; P =.02) and urine protein test (81, 44.8% vs 21, 14.6%; P <.001), but no group differences were observed in the rate of testing.", {"entities": []}], ["The control condition participants reported more frequent discussions about tetanus and pneumonia vaccines and reported more tetanus (30, 13.8% vs 15, 5.3%; P =.02) and pneumonia (25, 11.5% vs 16, 5.7%; P =.02) vaccinations after 12 months.", {"entities": [[76, 83, "DISEASE"], [125, 132, "DISEASE"], [88, 97, "DISEASE"], [169, 178, "DISEASE"]]}], ["The use of an interactive website designed to overcome clinical inertia for hypertension care did not lead to improvements in blood pressure control.", {"entities": [[76, 88, "DISEASE"]]}], ["Participant adherence to the intervention was high.", {"entities": []}], ["The control intervention led to positive changes in the use of preventive services (eg, tetanus immunization) and the intervention condition led to more discussions of hypertension-relevant tests (eg, serum creatinine and urine protein).", {"entities": [[168, 180, "DISEASE"], [88, 95, "DISEASE"]]}], ["By providing patients with individually tailored questions to ask during PCP visits, this study demonstrated that participants were likely to discuss the questions with PCPs.", {"entities": []}], ["These discussions did not, however, lead to improvements in blood pressure control.", {"entities": []}], ["ClinicalTrials.gov NCT00377208; http://clinicaltrials.gov/ct2/show/NCT00377208 (Archived by WebCite at http://www.webcitation.org/6IqWiPLon).", {"entities": []}], ["Diwaniyyah is a traditional gathering place for men in the Arab world.", {"entities": []}], ["Most Kuwaiti men spend most of their time in the diwaniyyah , which is an important part of their social activity.", {"entities": []}], ["The current study aims to examine the relationship between the diwaniyyah as a social community and the attendees\u2019 health conditions to determine how the diwaniyyah affects Kuwaiti men\u2019s lifestyle.", {"entities": []}], ["A questionnaire was distributed among 500 men 16 years old and above.", {"entities": []}], ["It comprised five parts of data: sociodemographic information, frequency of attending diwaniyyah , types of diwaniyyah s, and health lifestyle of members attending the diwaniyyah .", {"entities": []}], ["A t -test, one-way analysis of variance (ANOVA) and linear regression were used to test the study\u2019s questions.", {"entities": []}], ["A significant difference in negative effect of diwaniyyah s on attendees\u2019 physical health was detected according to the participants\u2019 ethnic roots, affection for and length of time they spent in the diwaniyyah , time of day or evening that they visited, and dealing with chronic disease ( p < .05).", {"entities": []}], ["Also the results reveal significant differences in the positive effect of diwaniyyah s on the attendees\u2019 lifestyle behavior according to their age, occupational status, religious affiliation, government, prayer time, and type of diwaniyyah ( p < .05).", {"entities": []}], ["Inhaled glucocorticosteroids (ICS) are the mainstay of treatment in asthma.", {"entities": [[68, 74, "DISEASE"]]}], ["Fluticasone furoate (FF) is a novel, once-daily ICS asthma therapy.", {"entities": [[52, 58, "DISEASE"]]}], ["This study investigated the efficacy and safety of FF\u00a050\u00a0mcg in patients with mild-to-moderate persistent asthma.", {"entities": [[106, 112, "DISEASE"]]}], ["A 24-week, multicenter, randomized, placebo-controlled and active-controlled, double-blind, double-dummy, parallel-group phase III study.", {"entities": []}], ["Three hundred and fifty-one patients (aged \u226512\u00a0years; uncontrolled by non-ICS therapy) were randomized to treatment (1\u00a0:\u00a01\u00a0:\u00a01) with once-daily FF\u00a050\u00a0mcg dosed in the evening, twice-daily fluticasone propionate (FP) 100\u00a0mcg or placebo.", {"entities": []}], ["The primary endpoint was change from baseline in evening trough forced expiratory volume in 1\u00a0s (FEV 1 ) at Week\u00a024.", {"entities": [[97, 100, "GENE"]]}], ["Secondary endpoints were change from baseline in the percentage of rescue-free 24-h periods (powered endpoint), change from baseline in evening and morning peak expiratory flow, change from baseline in the percentage of symptom-free 24-h periods and number of withdrawals due to lack of efficacy.", {"entities": []}], ["Evening trough FEV 1 at Week 24 was not statistically significantly increased with FF 50\u00a0mcg once-daily (37\u00a0ml [95% CI: \u221255, 128]; P\u00a0 = \u00a0 0.430), but was with FP 100\u00a0mcg twice daily (102\u00a0ml [10, 194]; P\u00a0 = \u00a0 0.030), vs placebo.", {"entities": [[15, 18, "GENE"]]}], ["No consistent trends were observed across other endpoints, including the powered secondary endpoint.", {"entities": []}], ["No safety concerns were raised for either active treatment.", {"entities": []}], ["FP 100\u00a0mcg twice daily improved evening trough FEV 1 in patients with mild-to-moderate persistent asthma, but FF 50\u00a0mcg once daily did not demonstrate a significant effect.", {"entities": [[98, 104, "DISEASE"], [47, 50, "GENE"]]}], ["Secondary endpoints showed variable results.", {"entities": []}], ["No safety concerns were identified for FF or FP.", {"entities": []}], ["Pregnancies induced by in vitro fertilisation (IVF) often result in twin gestations, which are associated with both maternal and perinatal complications.", {"entities": []}], ["An effective way to reduce the number of IVF twin pregnancies is to decrease the number of embryos transferred from two to one.", {"entities": []}], ["The interpretation of current studies is limited because they used live birth as outcome measure and because they applied limited time horizons.", {"entities": []}], ["So far, research on long-term outcomes of IVF twins and singletons is scarce and inconclusive.", {"entities": []}], ["The objective of this study is to investigate the short (1-year) and long-term (5 and 18-year) costs and health outcomes of IVF singleton and twin children and to consider these in estimating the cost-effectiveness of single embryo transfer compared with double embryo transfer, from a societal and a healthcare perspective.", {"entities": []}], ["A multi-centre cohort study will be performed, in which IVF singletons and IVF twin children born between 2003 and 2005 of whom parents received IVF treatment in one of the five participating Dutch IVF centres, will be compared.", {"entities": []}], ["Data collection will focus on children at risk of health problems and children in whom health problems actually occurred.", {"entities": []}], ["First year of life data will be collected in approximately 1,278 children (619 singletons and 659 twin children).", {"entities": []}], ["Data up to the fifth year of life will be collected in approximately 488 children (200 singletons and 288 twin children).", {"entities": []}], ["Outcome measures are health status, health-related quality of life and costs.", {"entities": []}], ["Data will be obtained from hospital information systems, a parent questionnaire and existing registries.", {"entities": []}], ["Furthermore, a prognostic model will be developed that reflects the short and long-term costs and health outcomes of IVF singleton and twin children.", {"entities": []}], ["This model will be linked to a Markov model of the short-term cost-effectiveness of single embryo transfer strategies versus double embryo transfer strategies to enable the calculation of the long-term cost-effectiveness.", {"entities": []}], ["This is, to our knowledge, the first study that investigates the long-term costs and health outcomes of IVF singleton and twin children and the long-term cost-effectiveness of single embryo transfer strategies versus double embryo transfer strategies.", {"entities": []}], ["mTORC2 has been shown to be involved in cytoskeletal regulation, but the mechanisms by which this takes place are poorly understood.", {"entities": []}], ["This study shows that PKC\u03b2II is specifically required for mTORC2-dependent activation of adenylyl cyclase 9 and back retraction during neutrophil chemotaxis to chemoattractants.", {"entities": []}], ["Chemotaxis is a process by which cells polarize and move up a chemical gradient through the spatiotemporal regulation of actin assembly and actomyosin contractility, which ultimately control front protrusions and back retractions.", {"entities": []}], ["We previously demonstrated that in neutrophils, mammalian target of rapamycin complex 2 (mTORC2) is required for chemoattractant-mediated activation of adenylyl cyclase 9 (AC9), which converts ATP into cAMP and regulates back contraction through MyoII phosphorylation.", {"entities": []}], ["Here we study the mechanism by which mTORC2 regulates neutrophil chemotaxis and AC9 activity.", {"entities": []}], ["We show that inhibition of protein kinase C\u03b2II (PKC\u03b2II) by CPG53353 or short hairpin RNA knockdown severely inhibits chemoattractant-induced cAMP synthesis and chemotaxis in neutrophils.", {"entities": []}], ["Remarkably, PKC\u03b2II-inhibited cells exhibit specific and severe tail retraction defects.", {"entities": []}], ["In response to chemoattractant stimulation, phosphorylated PKC\u03b2II, but not PKC\u03b1, is transiently translocated to the plasma membrane, where it phosphorylates and activates AC9.", {"entities": []}], ["mTORC2-mediated PKC\u03b2II phosphorylation on its turn motif, but not its hydrophobic motif, is required for membrane translocation of PKC\u03b2II.", {"entities": []}], ["Inhibition of mTORC2 activity by Rictor knockdown not only dramatically decreases PKC\u03b2II activity, but it also strongly inhibits membrane translocation of PKC\u03b2II.", {"entities": [[33, 39, "GENE"]]}], ["Together our findings show that PKC\u03b2II is specifically required for mTORC2-dependent AC9 activation and back retraction during neutrophil chemotaxis.", {"entities": []}], ["In 1994 we repeated a study first performed in 1989 to assess the change in general practitioners' use of and attitudes to peak flow measurement.", {"entities": []}], ["Of 232 general practitioners surveyed, 199 (86%) and 192 (83%) responded in 1989 and 1994 respectively.", {"entities": []}], ["The percentage who reported having patients using domiciliary peak flow monitoring rose form 58.3 (95% confidence limits 51.4 to 65.2)% to 97.9 (95.9 to 99.9)%.", {"entities": []}], ["The percentage who reported 'usually' using peak flow measurements for the diagnosis and management of asthma rose from 81.9 (76.5 to 87.3)% to 93.2 (89.6 to 96.8)% and from 83.3 (78.1 to 88.5)% to 95.8 (92.9 to 98.7)% respectively.", {"entities": [[103, 109, "DISEASE"]]}], ["An unchanged proportion took peak flow meters on house calls.", {"entities": []}], ["General practitioners have become more aware of the potential of peak flow measurements but are still unlikely to have a meter available to assess patients seen at home.", {"entities": []}], ["They are therefore likely to be ill-equipped to manage acute exacerbations of asthma in this setting.", {"entities": [[78, 84, "DISEASE"]]}], ["The local treatment of lung disorders such as asthma and chronic obstructive pulmonary disease via pulmonary drug delivery offers many advantages over oral or intravenous routes of administration.", {"entities": [[57, 94, "DISEASE"], [46, 52, "DISEASE"]]}], ["This is because direct deposition of a drug at the diseased site increases local drug concentrations, which improves the pulmonary receptor occupancy and reduces the overall dose required, therefore reducing the side effects that result from high drug doses.", {"entities": []}], ["From a clinical point of view, although jet nebulizers have been used for aerosol delivery of water-soluble compounds and micronized suspensions, their use with hydrophobic drugs has been inadequate.", {"entities": []}], ["Aim: To evaluate the feasibility of sterically stabilized phospholipid nanomicelles (SSMs) loaded with beclomethasone dipropionate (BDP) as a carrier for pulmonary delivery.", {"entities": []}], ["1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 5000) polymeric micelles containing BDP (BDP-SSMs) were prepared by the coprecipitation and reconstitution method, and the physicochemical and in vitro characteristics of BDP-SSMs were investigated.", {"entities": []}], ["BDP-SSMs were successfully prepared with a content uniformity and reproducibility suitable for pulmonary administration.", {"entities": []}], ["The maximum solubility of BDP in SSMs was approximately 1300 times its actual solubility.", {"entities": []}], ["The particle size and zeta potential of BDP-SSMs were 19.89 \u00b1 0.67 nm and \u221228.03 \u00b1 2.05 mV, respectively.", {"entities": []}], ["The SSMs system slowed down the release of BDP and all of the aerodynamic values of the aerosolized rehydrated BDP-SSMs were not only acceptable but indicated a significant level of deposition in the lungs.", {"entities": []}], ["The SSM system might be an effective way of improving the therapeutic index of nebulized, poorly soluble corticosteroids.", {"entities": []}], ["The effects of neutral endopeptidase (NEP) in acute inflammation in the lung were studied using a newly developed murine model of smoke and burn (SB) injury.", {"entities": []}], ["C57BL/6 mice were pretreated with an i.v.", {"entities": []}], ["dose of a specific NEP antagonist CGS-24592 (10 mg/Kg) 1 h prior to SB injury (n = 5\u20138/group).", {"entities": []}], ["Mice were anesthetized with i.p.", {"entities": []}], ["ketamine/xylazine, intubated, and exposed to cooled cotton smoke (2 \u00d7 30 s).", {"entities": []}], ["After s.c. injection of 1 ml 0.9% saline, each received a 40% total body surface area (TBSA) flame burn.", {"entities": []}], ["Buprenorphene (2 mg/kg) was given i.p.", {"entities": []}], ["and resuscitated by saline.", {"entities": []}], ["Evans Blue dye (EB) was injected i.v.", {"entities": []}], ["15 min before sacrifice.", {"entities": []}], ["Lung wet/dry weight ratio was measured.", {"entities": []}], ["After vascular perfusion, lungs were analyzed for their levels of EB dye and myeloperoxidase (MPO).", {"entities": [[94, 97, "GENE"]]}], ["In mice pretreated with CGS-24592 followed by SB injury the EB levels were significantly higher (61%, p = 0.043) than those with SB injury alone.", {"entities": []}], ["There was a significant increase (144%, p = 0.035) in EB dye in animals with SB injury alone as compared to shams.", {"entities": []}], ["In mice pretreated with CGS-24592 prior to SB injury wet/dry weight ratios were significantly (27%, p = 0.042) higher compared to animals with SB injury alone.", {"entities": []}], ["CGS-24592 pretreatment also caused a significant increase in MPO (29%, p = 0.026) as compared to mice with SB injury alone.", {"entities": [[61, 64, "GENE"]]}], ["In conclusion the current study indicates that specific NEP inhibitor CGS 24592 exacerbates the SB-induced lung injury and inflammation in mice.", {"entities": []}], ["The Japanese Study on Stratification, Health, Income, and Neighborhood (J-SHINE) aims to clarify the complex associations between social factors and health from an interdisciplinary perspective and to provide a database for use in various health policy evaluations.", {"entities": []}], ["J-SHINE is an ongoing longitudinal panel study of households of adults aged 25\u201350 years.", {"entities": []}], ["The wave 1 survey was carried out in 2010 among adults randomly selected from the resident registry of four urban and suburban municipalities in the greater Tokyo metropolitan area, Japan.", {"entities": []}], ["In 2011, surveys for the participants\u2019 spouse/partner and child were additionally conducted.", {"entities": []}], ["The wave 2 survey was conducted in 2012 for the wave 1 participants and will be followed by the wave 2 survey for spouse/partner and child in 2013.", {"entities": []}], ["Wave 1 sample sizes were 4357 for wave 1 participants (valid response rate: 31.3%; cooperation rate: 51.8%), 1873 for spouse/partner (response rate: 61.9%), and 1520 for child (response rate: 67.7%).", {"entities": []}], ["Wave 2 captured 69.0% of wave 1 participants.", {"entities": []}], ["Information gathered covered socio-demographics, household economy, self-reported health conditions and healthcare utilization, stress and psychological values, and developmental history.", {"entities": []}], ["A subpopulation underwent physiological ( n = 2468) and biomarker ( n = 1205) measurements.", {"entities": []}], ["Longitudinal survey data, including repeated measures of social factors evaluated based on theories and techniques of various disciplines, like J-SHINE, should contribute toward opening a web of causality for society and health, which may have important policy implications for recent global health promotion strategies such as the World Health Organization\u2019s Social Determinants of Health approach and the second round of Japan\u2019s Healthy Japan 21.", {"entities": []}], ["Disability weights (DWs) are important for estimating burden of disease in terms of disability-adjusted life years.", {"entities": []}], ["The previous practice of eliciting DWs by expert opinion has been challenged.", {"entities": []}], ["More recent approaches employed quality of life (QoL) questionnaires to establish patient-based DWs, but results are ambiguous.", {"entities": []}], ["In early 2010, we administered a questionnaire pertaining to physical fitness to 200 schoolchildren in C\u00f4te d'Ivoire.", {"entities": []}], ["Helminth and Plasmodium spp.", {"entities": []}], ["infections were determined and schoolchildren's physical fitness objectively measured in a maximal multistage 20 m shuttle run test.", {"entities": []}], ["Associations between objectively measured and self-reported physical fitness and between self-reported physical fitness and infection status were determined.", {"entities": []}], ["Spearman rank correlation coefficient, uni- and multivariable linear regression models adjusting for children's age and sex, ambient air temperature and humidity, Fisher's test, \u03c7\u00b2 and t-test statistics were used for statistical analysis.", {"entities": []}], ["The prevalence of Schistosoma haematobium, Plasmodium spp., Schistosoma mansoni , hookworm and Ascaris lumbricoides in 167 children with complete parasitological results was 84.4%, 74.9%, 54.5%, 14.4% and 1.2%, respectively.", {"entities": []}], ["High infection intensities and multiple species parasite infections were common.", {"entities": []}], ["In the 137 children with complete data also from the shuttle run test, we found statistically significant correlations between objectively measured and self-reported physical fitness.", {"entities": []}], ["However, no statistically significant correlation between the children's parasitic infection status and self-reported physical fitness was identified.", {"entities": []}], ["An attrition analysis revealed considerably lower self-reported physical fitness scores of parasitized children who were excluded from shuttle run testing due to medical concerns in comparison to parasitized children who were able to successfully complete the shuttle run test.", {"entities": []}], ["Our QoL questionnaire proofed valid to assess children's physical fitness in the current study area.", {"entities": []}], ["Reasons why no differences in self-reported physical fitness in children with different parasitic infections were found are manifold, but do not preclude the use of QoL questionnaires in the elicitation of DWs.", {"entities": []}], ["Indeed, the questionnaire was particularly useful in assessing physical fitness of those children, who were - supposedly due to parasitic infections - unable to complete the shuttle run test.", {"entities": []}], ["Hence, we encourage others to use QoL questionnaires to determine not only physical fitness, but also more subtle morbidities.", {"entities": []}], ["Cardiovascular diseases are the leading cause of death in the world and are responsible for a high number of disability-adjusted life years.", {"entities": []}], ["Elevated blood pressure is an independent, linear and continuous risk factor for cardiovascular disease and has also been reported in the young population.", {"entities": []}], ["Brazil is a country of continental dimensions, and is very heterogeneous with respect to socioeconomic and cultural aspects.", {"entities": []}], ["Brazilian studies on the subject of hypertension in adolescence are not nationally representative, and this provides a rationale for the conduction of a meta-analysis to assess the magnitude of the problem in the country.", {"entities": [[36, 48, "DISEASE"]]}], ["Hypertension studies in adolescents published from 1990 to September 2010 were searched in six electronic databases.", {"entities": [[0, 12, "DISEASE"]]}], ["Forest plots of the prevalence of hypertension were built for the overall population and by gender.", {"entities": [[34, 46, "DISEASE"]]}], ["Heterogeneity was assessed using I Of 3,631 articles initially identified, 17 were considered eligible for systematic review.", {"entities": []}], ["The pooled prevalence of hypertension, estimated through random effects models, was 8.12% (95% CI 6.24 - 10.52) for the total population.", {"entities": [[25, 37, "DISEASE"]]}], ["Overall, prevalence was higher in males, 8.75% (95% CI 5.81 - 12.96) than females, 6.31%, (95% CI 4.41 - 8.96).", {"entities": []}], ["Several variables were investigated in the heterogeneity analysis: region of the study, sample size, age and method of blood pressure measurement.", {"entities": []}], ["The only variables that partially and inconsistently explained the observed heterogeneity (I There was a large variation in hypertension prevalence and in the methods used for its evaluation throughout studies with Brazilian adolescents, indicating the need for standardized procedures and validated methods for hypertension measurement.", {"entities": [[124, 136, "DISEASE"], [312, 324, "DISEASE"]]}], ["Despite the large observed heterogeneity, and the small number of studies in some regions of Brazil, the pooled prevalence found in both males and females shows that systemic arterial hypertension should be monitored in the population aged 10\u201320 years and that specific measures are required to prevent and control the disease, as well as its risk factors.", {"entities": [[184, 196, "DISEASE"]]}], ["Studies that compare regional heterogeneities may contribute to the knowledge of factors associated with increased blood pressure among adolescents.", {"entities": []}], ["Hepatocellular carcinoma (HCC) frequently develops in a pro-inflammatory and pro-fibrogenic environment with hepatic stellate cells (HSCs) remodeling the extracellular matrix composition.", {"entities": [[15, 24, "DISEASE"]]}], ["Molecules secreted by liver tumors contributing to HSC activation and peritumoral stromal transformation remain to be fully identified.", {"entities": []}], ["Here we show that conditioned medium from HCC cell lines, Hep3B and HepG2, induced primary mouse HSCs transdifferentiation, characterized by profibrotic properties and collagen modification, with similar results seen in the human HSC cell line LX2.", {"entities": []}], ["Moreover, tumor growth was enhanced by coinjection of HepG2/LX2 cells in a xenograft murine model, supporting a HCC-HSC crosstalk in liver tumor progression.", {"entities": []}], ["Protein microarray secretome analyses revealed angiogenin as the most robust and selective protein released by HCC compared to LX2 secreted molecules.", {"entities": []}], ["In fact, recombinant angiogenin induced in vitro HSC activation requiring its nuclear translocation and rRNA transcriptional stimulation.", {"entities": []}], ["Moreover, angiogenin antagonism by blocking antibodies or angiogenin inhibitor neomycin decreased in vitro HSC activation by conditioned media or recombinant angiogenin.", {"entities": []}], ["Finally, neomycin administration reduced tumor growth of HepG2-LX2 cells coinjected in mice.", {"entities": []}], ["In conclusion, angiogenin secretion by HCCs favors tumor development by inducing HSC activation and ECM remodeling.", {"entities": [[39, 43, "GENE"]]}], ["These findings indicate that targeting angiogenin signaling may be of potential relevance in HCC management.", {"entities": []}], ["Mycoplasma pneumoniae causes a range of airway and extrapulmonary pathologies in humans.", {"entities": []}], ["Clinically, M. pneumoniae is associated with acute exacerbations of human asthma and a worsening of experimentally induced asthma in mice.", {"entities": [[74, 80, "DISEASE"], [123, 129, "DISEASE"]]}], ["Recently, we demonstrated that Community Acquired Respiratory Distress Syndrome (CARDS) toxin, an ADP-ribosylating and vacuolating toxin synthesized by M. pneumoniae , is sufficient to induce an asthma-like disease in BALB/cJ mice.", {"entities": [[195, 201, "DISEASE"]]}], ["To test the potential of CARDS toxin to exacerbate preexisting asthma, we examined inflammatory responses to recombinant CARDS toxin in an ovalbumin (OVA) murine model of asthma.", {"entities": [[63, 69, "DISEASE"], [171, 177, "DISEASE"]]}], ["Differences in pulmonary inflammatory responses between treatment groups were analyzed by histology, cell differentials and changes in cytokine and chemokine concentrations.", {"entities": []}], ["Additionally, assessments of airway hyperreactivity were evaluated through direct pulmonary function measurements.", {"entities": []}], ["Analysis of histology revealed exaggerated cellular inflammation with a strong eosinophilic component in the CARDS toxin-treated group.", {"entities": []}], ["Heightened T-helper type-2 inflammatory responses were evidenced by increased expression of IL-4, IL-13, CCL17 and CCL22 corresponding with increased airway hyperreactivity in the CARDS toxin-treated mice.", {"entities": [[105, 110, "GENE"], [115, 120, "GENE"]]}], ["These data demonstrate that CARDS toxin can be a causal factor in the worsening of experimental allergic asthma, highlighting the potential importance of CARDS toxin in the etiology and exacerbation of human asthma.", {"entities": [[96, 111, "DISEASE"], [105, 111, "DISEASE"], [208, 214, "DISEASE"]]}], ["With the ever increasing cost and time required for drug development, new strategies for drug development are highly demanded, whereas repurposing old drugs has attracted much attention in drug discovery.", {"entities": []}], ["In this paper, we introduce a new network pharmacology approach, namely PINA, to predict potential novel indications of old drugs based on the molecular networks affected by drugs and associated with diseases.", {"entities": []}], ["Benchmark results on FDA approved drugs have shown the superiority of PINA over traditional computational approaches in identifying new indications of old drugs.", {"entities": []}], ["We further extend PINA to predict the novel indications of Traditional Chinese Medicines (TCMs) with Liuwei Dihuang Wan (LDW) as a case study.", {"entities": []}], ["The predicted indications, including immune system disorders and tumor, are validated by expert knowledge and evidences from literature, demonstrating the effectiveness of our proposed computational approach.", {"entities": []}], ["Acute kidney injury (AKI) is being increasingly recognised in ageing populations.", {"entities": []}], ["There are a paucity of data about AKI risk factors among older individuals with diabetes and infections, who are at particularly high risk of AKI.", {"entities": []}], ["The objective of this study was to evaluate the risk factors for developing acute kidney injury (AKI) amongst older patients with diabetes and community-acquired pneumonia (CAP) in England, and whether the impact of underlying kidney function varied with age.", {"entities": [[162, 171, "DISEASE"]]}], ["This was a population-based retrospective cohort study over 7 years (01/04/2004\u201331/3/2011) using electronic health records from the Clinical Practice Research Datalink linked to Hospital Episode Statistics.", {"entities": []}], ["The study population comprised individuals with diabetes aged \u226565\u00a0years with CAP.", {"entities": []}], ["Associations between demographic, lifestyle factors, co-morbidities and medications and development of AKI within 28\u00a0days of CAP were explored in a logistic regression model.", {"entities": []}], ["Among 3471 patients with CAP and complete covariate data, 298 patients developed subsequent AKI.", {"entities": []}], ["In multivariable analyses, factors found to be independently associated with AKI included: male sex (adjusted odds ratio, aOR: 1.56 95% confidence interval (CI): 1.20\u20132.04), hypertension (aOR1.36 95% CI 1.01\u20131.85), being prescribed either angiotensin-converting-enzyme inhibitors or angiotensin-II-receptor-blockers (aOR: 1.59 95% CI: 1.19\u20132.13), or insulin (aOR: 2.27 95% CI: 1.27\u20134.05), presence of proteinuria (aOR 1.27 95% CI 0.98\u20131.63), and low estimated glomerular filtration rate (eGFR).", {"entities": [[174, 186, "DISEASE"], [401, 412, "DISEASE"], [488, 492, "GENE"]]}], ["The odds of AKI were more graded amongst older participants aged \u226580\u00a0years compared to those of younger age: for eGFR of \u226429\u00a0mL/min/1.73m p -value for interaction\u00a0=\u00a00.007).", {"entities": [[113, 117, "GENE"]]}], ["The identified risk factors should help primary care and hospital providers identify high risk patients in need of urgent management including more intensive monitoring, and prevention of AKI following pneumonia.", {"entities": [[202, 211, "DISEASE"]]}], ["Infection with respiratory viruses, including rhinoviruses, influenza virus, and respiratory syncytial virus, exacerbates asthma, which is associated with processes such as airway inflammation, airway hyperresponsiveness, and mucus hypersecretion.", {"entities": [[60, 69, "DISEASE"], [122, 128, "DISEASE"]]}], ["In patients with viral infections and with infection-induced asthma exacerbation, inflammatory mediators and substances, including interleukins (ILs), leukotrienes and histamine, have been identified in the airway secretions, serum, plasma, and urine.", {"entities": [[61, 67, "DISEASE"]]}], ["Viral infections induce an accumulation of inflammatory cells in the airway mucosa and submucosa, including neutrophils, lymphocytes and eosinophils.", {"entities": []}], ["Viral infections also enhance the production of inflammatory mediators and substances in airway epithelial cells, mast cells, and other inflammatory cells, such as IL-1, IL-6, IL-8, GM-CSF, RANTES, histamine, and intercellular adhesion molecule-1.", {"entities": []}], ["Viral infections affect the barrier function of the airway epithelial cells and vascular endothelial cells.", {"entities": []}], ["Recent reports have demonstrated augmented viral production mediated by an impaired interferon response in the airway epithelial cells of asthma patients.", {"entities": [[138, 144, "DISEASE"]]}], ["Several drugs used for the treatment of bronchial asthma reduce viral and pro-inflammatory cytokine release from airway epithelial cells infected with viruses.", {"entities": [[50, 56, "DISEASE"]]}], ["Here, I review the literature on the pathogenesis of the viral infection-induced exacerbation of asthma and on the modulation of viral infection-induced airway inflammation.", {"entities": [[97, 103, "DISEASE"]]}], ["Numerous genome-wide association studies (GWAS) have been performed to identify susceptibility genes to various human complex diseases.", {"entities": []}], ["However, in many cases, neither a functional variant nor a disease susceptibility gene have been clarified.", {"entities": []}], ["Here, we show an efficient approach for identification of a functional variant in a primary biliary cholangitis (PBC)-susceptible region, chromosome 17q12-21 ( ORMDL3 - GSDMB - ZPBP2 - IKZF3 ).", {"entities": [[100, 111, "DISEASE"], [160, 166, "GENE"], [169, 174, "GENE"], [177, 182, "GENE"], [185, 190, "GENE"]]}], ["High-density association mapping was carried out based on SNP imputation analysis by using the whole-genome sequence data from a reference panel of 1,070 Japanese individuals (1KJPN), together with genotype data from our previous GWAS (PBC patients: n\u2009=\u20091,389; healthy controls: n\u2009=\u20091,508).", {"entities": []}], ["Among 23 single nucleotide polymorphisms (SNPs) with P \u2009<\u20091.0\u2009\u00d7\u200910 in vitro .", {"entities": []}], ["Moreover, expression-quantitative trait locus (e-QTL) analyses showed that the PBC susceptibility allele of rs12946510 was significantly associated with lower endogenous expression of ORMDL3 and GSDMB in whole blood and spleen.", {"entities": [[184, 190, "GENE"], [195, 200, "GENE"]]}], ["This study not only identified the functional variant in chr.17q12-21 and its molecular mechanism through which it conferred susceptibility to PBC, but it also illustrated an efficient systematic approach for post-GWAS analysis that is applicable to other complex diseases.", {"entities": []}], ["Synthetic extreme environments like carwash effluent tanks and drains are potential sources of biotechnologically important microorganisms and molecules which have, however, remained unexplored.", {"entities": []}], ["Using culture\u2010 and molecular\u2010based methods, a total of 17 bacterial isolates belonging to the genera Shewanella , Proteus , Paenibacillus, Enterobacter and Citrobacter , Aeromonas , Pseudomonas and Pantoea were identified.", {"entities": []}], ["Hydrocarbon utilization and enzyme production screening assays showed that Aeromonas sp.", {"entities": []}], ["CAC 11, Paenibacillus sp.", {"entities": []}], ["CAC 12 and Paenibacillus sp.", {"entities": []}], ["CAC 13 and Citrobacter sp.", {"entities": []}], ["PCW 7 were able to degrade benzanthracene, naphthalene and diesel oil, Paenibacillus sp.", {"entities": []}], ["CAC 12 and Paenibacillus sp.", {"entities": []}], ["CAC 13 could produce cellulase enzyme, while Proteus sp.", {"entities": []}], ["BPS 2, Pseudomonas sp.", {"entities": []}], ["SAS 8 and Proteus sp.", {"entities": []}], ["CAL 3 could produce lipase.", {"entities": []}], ["GC \u2010 MS analysis of bacterial secondary metabolites resulted in identification of 107 different compounds produced by Proteus sp.", {"entities": [[0, 2, "GENE"]]}], ["BPS 2, Paenibacillus sp.", {"entities": []}], ["CAC 12, Pseudomonas sp.", {"entities": []}], ["SAS 8, Proteus sp.", {"entities": []}], ["CAL 3 and Paenibacillus sp.", {"entities": []}], ["Most of the compounds identified by both GC \u2010 MS and LC \u2010 MS have previously been determined to have antibacterial, antifungal and/or anticancer properties.", {"entities": [[41, 43, "GENE"]]}], ["Further, microbial metabolites which have previously been known to be produced only by plants or microorganisms found in natural extreme environments were also identified in this study.", {"entities": []}], ["This research has revealed the immense bioresource potential of microorganisms inhabiting synthetic extreme environments.", {"entities": []}], ["Complementary traditional Chinese medicine (TCM) has been used to treat patients with cerebral palsy (CP).", {"entities": [[86, 100, "DISEASE"], [102, 104, "GENE"]]}], ["However, large-scale surveys examining its use in the treatment of CP and associated disorders are lacking.", {"entities": [[67, 69, "GENE"]]}], ["We enrolled 11,218 patients\u2009\u2264\u200918\u00a0years of age with CP in the Taiwanese National Health Insurance Research Database from 1995 to 2011.", {"entities": [[51, 53, "GENE"]]}], ["Patients were categorized as TCM users ( n \u2009=\u20096,997; 62.37%) and non-TCM users ( n \u2009=\u20094,221; 37.63%) based on the inclusion of TCM in their treatment plan.", {"entities": []}], ["Children with higher proportions of complementary TCM use were male, younger, and lived in urbanized areas.", {"entities": []}], ["Most TCM users ( n \u2009=\u20095332, 76.2%) visited TCM outpatient departments more than 20 times per year.", {"entities": []}], ["In both groups, the three most common reasons for clinical visits were problems of the nervous system, respiratory system, and digestive system.", {"entities": []}], ["Acupuncture was commonly used in problems of injury, musculoskeletal system and connective tissue, and nervous system.", {"entities": []}], ["Chinese herbal medicine was used to improve the primary symptoms of CP in patients, as well as its associated disorders.", {"entities": [[68, 70, "GENE"]]}], ["The incidence rate ratios in allergic rhinitis, dyspepsia, menstrual disorders, and musculoskeletal system and connective tissue diseases among TCM users were significantly higher than non-TCM users.", {"entities": [[29, 46, "DISEASE"], [48, 57, "DISEASE"], [38, 46, "DISEASE"]]}], ["Although patients receiving complementary TCM therapies had higher medical expenditure for utilizing outpatient clinical consultations, their medical costs for visiting ER and hospitalization were significantly lower than that of non-TCM user within one year of the diagnosis of CP.", {"entities": [[279, 281, "GENE"]]}], ["This study was a large-scale survey to characterize patterns of complementary TCM use among children with CP.", {"entities": [[106, 108, "GENE"]]}], ["The complementary use of TCM in children with CP was considerably high.", {"entities": [[46, 48, "GENE"]]}], ["Future clinical trials and basic researches can be developed based on the findings of this study.", {"entities": []}], ["The global increase in the prevalence and incidence of obesity has called serious attention to this issue as a major public health concern.", {"entities": [[55, 62, "DISEASE"]]}], ["Obesity is associated with many chronic diseases, including cardiovascular disease and diabetes, and recently the role of overweight and obesity in lung disease has received new interest.", {"entities": [[0, 7, "DISEASE"], [137, 144, "DISEASE"], [148, 160, "DISEASE"]]}], ["Independently of obesity, diet also plays a role as a risk factor for many chronic diseases, and evidence is accumulating to support a role for diet in the prevention and management of several lung diseases.", {"entities": [[17, 24, "DISEASE"]]}], ["Chronic obstructive lung disease is the third-leading cause of death globally, and both obesity and diet appear to play roles in its pathophysiology.", {"entities": [[8, 32, "DISEASE"], [88, 95, "DISEASE"], [20, 32, "DISEASE"]]}], ["Obesity has been associated with decreased lung-function measures in population-based studies, with increased prevalence of several lung diseases and with compromised pulmonary function.", {"entities": [[0, 7, "DISEASE"]]}], ["In contrast, obesity has a protective effect against mortality in severe chronic obstructive pulmonary disease (COPD).", {"entities": [[73, 110, "DISEASE"], [13, 20, "DISEASE"]]}], ["Nutrient intake and dietary patterns have also been associated with lung-function measures and the development and progression of COPD.", {"entities": []}], ["Taken together, this suggests that a focus on obesity and diet should be part of public health campaigns to reduce the burden of lung disease, and could have important implications for clinicians in the management of their patients.", {"entities": [[46, 53, "DISEASE"], [129, 141, "DISEASE"]]}], ["Future research should also focus on elucidating these relationships in diverse populations and age-groups, and on understanding the complex interaction between behavior, environment, and genetics in the development and progression of COPD.", {"entities": []}], ["The goal of this article is to review current evidence regarding the role that obesity and diet play in the development of COPD, and in COPD-related outcomes.", {"entities": [[79, 86, "DISEASE"]]}], ["\u25ba First-episode psychosis is characterised by a pro-inflammatory state supported partly by activation of leukocytes.", {"entities": []}], ["Stress contributes to this pro-inflammatory state.", {"entities": []}], ["An inflammatory syndrome has been previously reported in chronic schizophrenia.", {"entities": [[65, 78, "DISEASE"], [16, 24, "DISEASE"]]}], ["The aims of this study were to investigate: (1) serum levels and leukocyte gene expression of cytokines in patients with first-episode psychosis and controls; and (2) possible causes of abnormal cytokine levels in first-episode psychosis, testing their association with psychosocial stressors, current nicotine and cannabis use, and duration of antipsychotic treatment.", {"entities": []}], ["We recruited 24 first-episode psychosis patients and 24 healthy controls matched for age, gender, ethnicity and body mass index.", {"entities": []}], ["Serum interleukin(IL)-1\u03b1, IL-1\u03b2, IL-2, IL-4, IL-6, IL-8, IL-10, Tumour Necrosis Factor- \u03b1 (TNF-\u03b1), Interferon- \u03b3 (IFN-\u03b3), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and monocyte chemotactic protein-1 (MCP-1) were analysed in all subjects.", {"entities": [[190, 193, "GENE"]]}], ["Leukocyte gene expression analyses were conducted only for those cytokines that were different between-groups in the serum analyses.", {"entities": []}], ["Patients had significantly higher serum levels of IL-1\u03b1 (effect size d \u00a0=\u00a00.6, p \u00a0=\u00a00.03), IL-1\u03b2 ( d \u00a0=\u00a00.4, p \u00a0=\u00a00.01), IL-8 ( d \u00a0=\u00a00.6, p \u00a0=\u00a00.01) and TNF-\u03b1 ( d \u00a0=\u00a00.7, p \u00a0=\u00a00.05) and a trend for higher IL-6 serum levels ( d \u00a0=\u00a00.3, p \u00a0=\u00a00.09) when compared with controls.", {"entities": []}], ["Leukocyte m-RNA levels of IL-1\u03b1 ( d \u00a0=\u00a00.6, p \u00a0=\u00a00.04), IL-6 ( d \u00a0=\u00a00.7, p \u00a0=\u00a00.01) and TNF-\u03b1 ( d \u00a0=\u00a01.6, p \u00a0<\u00a00.001), but not IL-1\u03b2 and IL-8, were also significantly higher in patients.", {"entities": []}], ["A history of childhood trauma was associated with higher TNF-\u03b1 serum levels ( p \u00a0=\u00a00.01), while more recent stressful life-events were associated with higher TNF-\u03b1 mRNA levels in leukocytes ( p \u00a0=\u00a00.002).", {"entities": []}], ["In conclusion, first-episode psychosis is characterised by a pro-inflammatory state supported, at least in part, by activation of leukocytes.", {"entities": []}], ["Past and recent stressors contribute to this pro-inflammatory state.", {"entities": []}], ["Crohn\u2019s disease (CD) and ulcerative colitis (UC) are immunologically-mediated, debilitating conditions resulting from destructive inflammation of the gastrointestinal tract.", {"entities": [[25, 43, "DISEASE"]]}], ["The pathogenesis of IBD is incompletely understood, but is considered to be the result of an abnormal immune response with a wide range of cell types and proteins involved.", {"entities": []}], ["Natural Killer Group 2D (NKG2D) is an activating receptor constitutively expressed on human Natural Killer (NK), \u03b3\u03b4 T, mucosal-associated invariant T (MAIT), CD56", {"entities": []}], ["Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) with increasing incidence mainly in high-income countries.", {"entities": [[50, 71, "DISEASE"]]}], ["One explanation of this phenomenon may be a higher prevalence of allergic and autoimmune diseases in industrialized countries as a consequence of otherwise beneficial advances in sanitation (hygiene hypothesis).", {"entities": []}], ["We investigated environmental factors in early childhood associated with MS. A case-control study was performed of 245 MS patients and 296 population-based controls in Berlin.", {"entities": []}], ["The study participants completed a standardized questionnaire on environmental factors in childhood and youth, including aspects of personal and community hygiene.", {"entities": []}], ["Multivariable logistic regression analysis was performed to investigate factors in childhood and youth associated with the occurrence of MS.", {"entities": []}], ["Mean age was 46 years (range, 20-80) in the MS group and 42 years (range 18-80) in the control group, of which 73.9% in the MS and 61.5% in the control group were female.", {"entities": []}], ["The multivariable analysis showed that having at least two older siblings (OR 0.54; p = 0.05, for individuals with two older siblings compared to individuals without older siblings), attending a day-care center (OR 0.5; p = 0.004) and growing up in an urban center with more than 100, 000 inhabitants (OR 0.43; p = 0.009) were factors independently associated with a lower chance for MS.", {"entities": []}], ["The hygiene hypothesis may play a role in the occurrence of MS and could explain disease distribution and increasing incidence.", {"entities": []}], ["Natural IgM antibodies in diverse species recognize conserved carbohydrates in fungal cell walls and influence early host defense against Pneumocystis in mice.", {"entities": []}], ["Host defense against opportunistic fungi requires coordination between innate and adaptive immunity for resolution of infection.", {"entities": []}], ["Antibodies generated in mice vaccinated with the fungus Pneumocystis prevent growth of Pneumocystis organisms within the lungs, but the mechanisms whereby antibodies enhance antifungal host defense are poorly defined.", {"entities": []}], ["Nearly all species of fungi contain the conserved carbohydrates \u03b2-glucan and chitin within their cell walls, which may be targets of innate and adaptive immunity.", {"entities": []}], ["In this study, we show that natural IgM antibodies targeting these fungal cell wall carbohydrates are conserved across many species, including fish and mammals.", {"entities": []}], ["Natural antibodies bind fungal organisms and enhance host defense against Pneumocystis in early stages of infection.", {"entities": []}], ["IgM antibodies influence recognition of fungal antigen by dendritic cells, increasing their migration to draining pulmonary lymph nodes.", {"entities": []}], ["IgM antibodies are required for adaptive T helper type 2 (Th2) and Th17 cell differentiation and guide B cell isotype class-switch recombination during host defense against Pneumocystis .", {"entities": []}], ["These experiments suggest a novel role for the IgM isotype in shaping the earliest steps in recognition and clearance of this fungus.", {"entities": []}], ["We outline a mechanism whereby serum IgM, containing ancient specificities against conserved fungal antigens, bridges innate and adaptive immunity against fungal organisms.", {"entities": []}], ["Based on the phenotypic and functional characteristics unconventional T-lymphocytes such as invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells link the innate and adaptive immune responses.", {"entities": []}], ["Up to now data are scarce about their involvement in pulmonary disorders including chronic obstructive pulmonary disease (COPD).", {"entities": [[83, 120, "DISEASE"]]}], ["This study explores simultaneously the frequencies of iNKT and MAIT cells in the peripheral blood and sputum of stable and exacerbating COPD patients.", {"entities": []}], ["By means of multicolor flow cytometry frequencies of total iNKT and MAIT cells and their subsets were enumerated in peripheral blood and sputum samples of healthy controls, and COPD patients.", {"entities": []}], ["In addition, gene expression of TCR for iNKT, MAIT cells, and CD1d, MR1 were assessed by qPCR in the study cohorts.", {"entities": [[62, 66, "GENE"]]}], ["Percentages of total iNKT and MAIT cells were dramatically dropped in blood, and reduced numbers of iNKT cells were observed in the sputum of COPD patients.", {"entities": []}], ["Furthermore decreased DN and increased CD4+ iNKT subsets, while increased DN and decreased CD8+ MAIT subpopulations were measured in the blood of COPD patients.", {"entities": []}], ["Reduced invariant TCR mRNA levels in COPD patients had confirmed these previous findings.", {"entities": []}], ["The mRNA expression of CD1d and MR1 were increased in stable and exacerbating COPD patients; however both molecules were decreased upon antibiotic and systemic steroid treatments.", {"entities": [[23, 27, "GENE"]]}], ["Our results support the notion that both invariant T-cell populations are affected in COPD.", {"entities": []}], ["Further detailed analysis of invariant T cells could shed more light into the complex interactions of these lymphocyte groups in COPD pathogenesis.", {"entities": []}], ["The online version of this article (10.1186/s12931-017-0671-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to evaluate whether Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification could predict mortality risk factors and whether baseline treatment intensity would relate to mortality within each group, using data from TIOSPIR A total of 17,135 patients from TIOSPIR Of the 16,326 patients classified, 1,248 died on treatment.", {"entities": []}], ["Group B patients received proportionally more CV treatment at baseline.", {"entities": []}], ["CV mortality risk, but not all-cause mortality risk, was significantly higher in Group B than Group C patients (CV mortality \u2013 hazard ratio [HR] =1.74, P =0.004; all-cause mortality \u2013 HR =1.18, P =0.11).", {"entities": [[141, 143, "GENE"], [184, 186, "GENE"], [141, 143, "GENE"], [184, 186, "GENE"]]}], ["Group D patients had a higher incidence of all-cause mortality than Group B patients (10.9% vs 6.6%).", {"entities": []}], ["Similar trends were observed regardless of respiratory or CV medication at baseline.", {"entities": []}], ["In contrast, respiratory deaths increased consistently from Groups A\u2013D (0.3%, 0.8%, 1.6%, and 4.2% of patients, respectively).", {"entities": []}], ["The data obtained from the TIOSPIR", {"entities": []}], ["In intensive pig husbandry systems, antibiotics are frequently administrated during early life stages to prevent respiratory and gastro-intestinal tract infections, often in combination with stressful handlings.", {"entities": []}], ["The immediate effects of these treatments on microbial colonization and immune development have been described recently.", {"entities": []}], ["Here we studied whether the early life administration of antibiotics has long-lasting effects on the pig\u2019s intestinal microbial community and on gut functionality.", {"entities": []}], ["To investigate the long-lasting effect of early-life treatment, piglets were divided into three different groups receiving the following treatments: 1) no antibiotics and no stress, 2) antibiotics and no stress, and 3) antibiotics and stress.", {"entities": []}], ["All treatments were applied at day four after birth.", {"entities": []}], ["Sampling of jejunal content for community scale microbiota analysis, and jejunal and ileal tissue for genome-wide transcription profiling, was performed at day 55 (~8 weeks) and day 176 (~25 weeks) after birth.", {"entities": []}], ["Antibiotic treatment in combination with or without exposure to stress was found to have long-lasting effects on host intestinal gene expression involved in a multitude of processes, including immune related processes.", {"entities": []}], ["The results obtained in this study indicate that early life (day 4 after birth) perturbations have long-lasting effects on the gut system, both in gene expression (day 55) as well as on microbiota composition (day 176).", {"entities": []}], ["At day 55 high variance was observed in the microbiota data, but no significant differences between treatment groups, which is most probably due to the newly acquired microbiota during and right after weaning (day 28).", {"entities": []}], ["Based on the observed difference in gene expression at day 55, it is hypothesized that due to the difference in immune programming during early life, the systems respond differently to the post-weaning newly acquired microbiota.", {"entities": []}], ["As a consequence, the gut systems of the treatment groups develop into different homeostasis.", {"entities": []}], ["Heat-related illness (HRI) is an important cause of non-fatal illness and death in farmworkers.", {"entities": []}], ["We sought to identify potential barriers to HRI prevention and treatment in Latino farmworkers.", {"entities": []}], ["We conducted three semi-structured focus group discussions with 35 Latino farmworkers in the Central Washington, USA area using participatory rural appraisal techniques.", {"entities": []}], ["Interviews were audio taped and transcribed in Spanish.", {"entities": []}], ["Three researchers reviewed and coded transcripts and field notes, and investigator triangulation was used to identify relevant themes and quotes.", {"entities": []}], ["Although the majority of participants in our study reported never receiving formal HRI training, most participants were aware that extreme heat can cause illness and were able to accurately describe HRI symptoms, risk factors, and certain prevention strategies.", {"entities": []}], ["Four main observations regarding farmworkers\u2019 HRI-relevant beliefs and attitudes were identified: 1) farmworkers subscribe to varying degrees to the belief that cooling treatments should be avoided after heat exposure, with some believing that such treatments should be avoided after heat exposure, and others encouraging the use of such treatments; 2) the desire to lose weight may be reflected in behaviors that promote increased sweating; 3) highly caffeinated energy drinks are preferred to increase work efficiency and maintain alertness; and 4) the location of drinking water at work (e.g.", {"entities": []}], ["next to restrooms) and whether water is clean, but not necessarily chemically-treated, are important considerations in deciding whether to drink the water provided at worksites.", {"entities": []}], ["We identified potential barriers to HRI prevention and treatment related to hydration, certain HRI treatments, clothing use, and the desire to lose weight among Latino farmworkers.", {"entities": []}], ["Strategies to address potential barriers to HRI prevention and treatment in this population may include engineering, administrative, and health education and health promotion strategies at individual, workplace, community, and societal levels.", {"entities": []}], ["Although farmworkers in our study were able to describe HRI risk factors, reported practices were not necessarily consistent with reported knowledge.", {"entities": []}], ["Further study of potential knowledge-behavior gaps may uncover opportunities for additional HRI prevention strategies.", {"entities": []}], ["Farmworkers and employers should be included in the development and evaluation of interventions to prevent HRI.", {"entities": []}], ["Lymphangiogenesis is the process by which new lymphatic vessels grow in response to pathologic stimuli such as wound healing, inflammation, and tumor metastasis.", {"entities": []}], ["It is well-recognized that growth factors and cytokines regulate lymphangiogenesis by promoting or inhibiting lymphatic endothelial cell (LEC) proliferation, migration and differentiation.", {"entities": []}], ["Our group has shown that the expression of T-helper 2 (Th2) cytokines is markedly increased in lymphedema, and that these cytokines inhibit lymphatic function by increasing fibrosis and promoting changes in the extracellular matrix.", {"entities": [[95, 105, "DISEASE"]]}], ["However, while the evidence supporting a role for T cells and Th2 cytokines as negative regulators of lymphatic function is clear, the direct effects of Th2 cytokines on isolated LECs remains poorly understood.", {"entities": []}], ["Using in vitro and in vivo studies, we show that physiologic doses of interleukin-4 (IL-4) and interleukin-13 (IL-13) have profound anti-lymphangiogenic effects and potently impair LEC survival, proliferation, migration, and tubule formation.", {"entities": []}], ["Inhibition of these cytokines with targeted monoclonal antibodies in the cornea suture model specifically increases inflammatory lymphangiogenesis without concomitant changes in angiogenesis.", {"entities": []}], ["These findings suggest that manipulation of anti-lymphangiogenic pathways may represent a novel and potent means of improving lymphangiogenesis.", {"entities": []}], ["Principles and methods for the allocation of healthcare resources among healthcare providers have long been health policy research issues in many countries.", {"entities": []}], ["Healthcare reforms including the development of a new case-mix system, Diagnosis Procedure Combination (DPC), and the introduction of a DPC-based payment system are currently underway in Japan, and a methodology for adequately assessing the functions of healthcare providers is needed to determine healthcare resource allocations.", {"entities": []}], ["By two-dimensional mapping of the rarity and complexity of diagnoses for patients receiving treatment, we were able to quantitatively demonstrate differences in the functions of different healthcare service provider groups.", {"entities": []}], ["On average, inpatients had diseases that were 3.6-times rarer than those seen in outpatients, while major teaching hospitals treated inpatients with diseases 3.0-times rarer on average than those seen at small hospitals.", {"entities": []}], ["We created and evaluated a new indicator for DPC, the diagnosis-dominant case-mix system developed in Japan, whereby the system was used to assess the functions of healthcare service providers.", {"entities": []}], ["The results suggest that it is possible to apply the case-mix system to the integrated evaluation of outpatient and inpatient healthcare services and to the appropriate allocation of healthcare resources among health service providers.", {"entities": []}], ["The Sabin Vaccine Institute Product Development Partnership is developing a Pan-anthelmintic vaccine that simultaneously targets the major soil-transmitted nematode infections, in other words, ascariasis, trichuriasis and hookworm infection.", {"entities": [[205, 217, "DISEASE"], [193, 203, "DISEASE"]]}], ["The approach builds off the current bivalent Human Hookworm Vaccine now in clinical development and would ultimately add both a larval Ascaris lumbricoides antigen and an adult-stage Trichuris trichiura antigen from the parasite stichosome.", {"entities": []}], ["Each selected antigen would partially reproduce the protective immunity afforded by UV-attenuated Ascaris eggs and Trichuris stichosome extracts, respectively.", {"entities": []}], ["Final antigen selection will apply a ranking system that includes the evaluation of expression yields and solubility, feasibility of process development and the absence of circulating antigen-specific IgE among populations living in helminth-endemic regions.", {"entities": []}], ["Here we describe a five year roadmap for the antigen discovery, feasibility and antigen selection, which will ultimately lead to the scale-up expression, process development, manufacture, good laboratory practices toxicology and preclinical evaluation, ultimately leading to Phase 1 clinical testing.", {"entities": []}], ["This study evaluated the effects of aclidinium bromide, a long-acting muscarinic antagonist indicated for maintenance treatment of chronic obstructive pulmonary disease (COPD), on exercise endurance, dyspnea, lung hyperinflation, and physical activity.", {"entities": [[131, 168, "DISEASE"]]}], ["In this randomized, double-blind, crossover study, patients with stable COPD and moderate-to-severe airflow limitation received aclidinium 400\u00a0\u03bcg twice daily or placebo via Genuair In total, 112\u00a0patients were randomized and treated (mean age 60.3\u00a0years; mean post-bronchodilator forced expiratory volume in 1\u00a0s 1.7\u00a0L [56.7% predicted]; mean endurance time 485.7\u00a0s).", {"entities": []}], ["After 3\u00a0weeks, endurance time was significantly increased with aclidinium versus placebo (treatment difference 58.5\u00a0s; p\u2009<\u20090.05).", {"entities": []}], ["At Week\u00a03, aclidinium significantly reduced dyspnea intensity at isotime during exercise (treatment difference -0.63; p\u2009<\u20090.05) and improved trough inspiratory capacity (treatment difference 78\u00a0mL; p\u2009<\u20090.05) versus placebo.", {"entities": []}], ["Significant improvements in spirometric, plethysmographic, and some physical activity parameters were observed with aclidinium versus placebo.", {"entities": []}], ["These results suggest that aclidinium significantly improves exercise endurance, exertional dyspnea, hyperinflation, and physical activity in patients with COPD.", {"entities": []}], ["ClinicalTrials.gov identifier: NCT01471171 ; URL: http://www.clinicaltrials.gov .", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2466-14-209) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Lethal acrodermatitis (LAD) is a genodermatosis with monogenic autosomal recessive inheritance in Bull Terriers and Miniature Bull Terriers.", {"entities": [[7, 21, "DISEASE"]]}], ["The LAD phenotype is characterized by poor growth, immune deficiency, and skin lesions, especially at the paws.", {"entities": []}], ["Utilizing a combination of genome wide association study and haplotype analysis, we mapped the LAD locus to a critical interval of ~1.11 Mb on chromosome 14.", {"entities": [[137, 139, "GENE"]]}], ["Whole genome sequencing of an LAD affected dog revealed a splice region variant in the MKLN1 gene that was not present in 191 control genomes (chr14:5,731,405T>G or MKLN1 :c.400+3A>C).", {"entities": [[87, 92, "GENE"], [165, 170, "GENE"], [87, 92, "GENE"], [165, 170, "GENE"]]}], ["This variant showed perfect association in a larger combined Bull Terrier/Miniature Bull Terrier cohort of 46 cases and 294 controls.", {"entities": []}], ["The variant was absent from 462 genetically diverse control dogs of 62 other dog breeds.", {"entities": []}], ["RT-PCR analysis of skin RNA from an affected and a control dog demonstrated skipping of exon 4 in the MKLN1 transcripts of the LAD affected dog, which leads to a shift in the MKLN1 reading frame.", {"entities": [[102, 107, "GENE"], [175, 180, "GENE"], [102, 107, "GENE"], [175, 180, "GENE"]]}], ["MKLN1 encodes the widely expressed intracellular protein muskelin 1, for which diverse functions in cell adhesion, morphology, spreading, and intracellular transport processes are discussed.", {"entities": [[0, 5, "GENE"]]}], ["While the pathogenesis of LAD remains unclear, our data facilitate genetic testing of Bull Terriers and Miniature Bull Terriers to prevent the unintentional production of LAD affected dogs.", {"entities": []}], ["This study may provide a starting point to further clarify the elusive physiological role of muskelin 1 in vivo .", {"entities": []}], ["Lethal acrodermatitis (LAD) is an autosomal recessive hereditary disease in dogs.", {"entities": [[7, 21, "DISEASE"]]}], ["It is characterized by poor growth, immune deficiency and characteristic skin lesions of the paws and of the face.", {"entities": []}], ["We mapped the LAD locus to a ~1.11 Mb segment on canine chromosome 14.", {"entities": [[35, 37, "GENE"]]}], ["Whole genome sequence data of an LAD affected dog and 191 controls revealed a candidate causative variant in the MKLN1 gene, encoding muskelin 1.", {"entities": [[113, 118, "GENE"]]}], ["The identified variant, a single nucleotide substitution, MKLN1 :c.400+3A>C, altered the 5\u2019-splice site at the beginning of intron 4.", {"entities": [[58, 63, "GENE"]]}], ["We experimentally confirmed that this variant leads to complete skipping of exon 4 in the MKLN1 mRNA in skin.", {"entities": [[90, 95, "GENE"]]}], ["Various cellular functions have been postulated for muskelin 1 including roles in intracellular transport processes, cell morphology, cell spreading, and cell adhesion.", {"entities": []}], ["Our data from dogs reveal a novel in vivo role for muskelin 1 that is related to the immune system and skin.", {"entities": []}], ["MKLN1 thus represents a novel candidate gene for human patients with unsolved acrodermatitis and/or immune deficiency phenotypes.", {"entities": [[78, 92, "DISEASE"], [0, 5, "GENE"]]}], ["LAD affected dogs may serve as models to gain more insights into the function of muskelin 1.", {"entities": []}], ["Unhealthy alcohol use is a major contributor to the global burden of disease and injury.", {"entities": []}], ["The US Preventive Services Task Force has recommended alcohol screening and intervention in general medical settings since 2004.", {"entities": []}], ["Yet less than one in six US adults report health care professionals discussing alcohol with them.", {"entities": []}], ["Little is known about methods for increasing implementation; different staffing models may be related to implementation effectiveness.", {"entities": []}], ["This implementation trial compared delivery of alcohol screening, brief intervention and referral to specialty treatment (SBIRT) by physicians versus non-physician providers receiving training, technical assistance, and feedback reports.", {"entities": []}], ["The study was a cluster randomized implementation trial (ADVISe [Alcohol Drinking as a Vital Sign]).", {"entities": []}], ["Within a private, integrated health care system, 54 adult primary care clinics were stratified by medical center and randomly assigned in blocked groups of three to SBIRT by physicians (PCP arm) versus non-physician providers and medical assistants (NPP and MA arm), versus usual care (Control arm).", {"entities": []}], ["NIH-recommended screening questions were added to the electronic health record (EHR) to facilitate SBIRT.", {"entities": []}], ["We examined screening and brief intervention and referral rates by arm.", {"entities": []}], ["We also examined patient-, physician-, and system-level factors affecting screening rates and, among those who screened positive, rates of brief intervention and referral to treatment.", {"entities": []}], ["Screening rates were highest in the NPP and MA arm (51\u00a0%); followed by the PCP arm (9\u00a0%) and the Control arm (3.5\u00a0%).", {"entities": []}], ["Screening increased over the 12\u00a0months after training in the NPP and MA arm but remained stable in the PCP arm.", {"entities": []}], ["The PCP arm had higher brief intervention and referral rates (44\u00a0%) among patients screening positive than either the NPP and MA arm (3.4\u00a0%) or the Control arm (2.7\u00a0%).", {"entities": []}], ["Higher ratio of MAs to physicians was related to higher screening rates in the NPP and MA arm and longer appointment times to screening and intervention rates in the PCP arm.", {"entities": []}], ["Findings suggest that time frames longer than 12 months may be required for full SBIRT implementation.", {"entities": []}], ["Screening by MAs with intervention and referral by physicians as needed can be a feasible model for increasing the implementation of this critical and under-utilized preventive health service within currently predominant primary care models.", {"entities": []}], ["Trial registration: Clinical Trials NCT01135654", {"entities": []}], ["In many chronic inflammatory disorders, glucocorticoid (GC) insensitivity is a challenging clinical problem associated with life-threatening disease progression.", {"entities": [[56, 58, "GENE"]]}], ["The molecular basis of GC insensitivity, however, is unknown.", {"entities": [[23, 25, "GENE"]]}], ["Alternative splicing of the GC receptor (R) pre\u2013messenger RNA generates a second GCR, termed GCR-\u03b2, which does not bind GCs but antagonizes the transactivating activity of the classic GCR, termed GCR-\u03b1.", {"entities": [[28, 30, "GENE"]]}], ["In the current study, we demonstrate that GC-insensitive asthma is associated with a significantly higher number of GCR-\u03b2\u2013immunoreactive cells in peripheral blood than GC-sensitive asthmatics or normal controls.", {"entities": [[57, 63, "DISEASE"]]}], ["Furthermore, we show that patients with GC-insensitive asthma have cytokine-induced abnormalities in the DNA binding capability of the GCR.", {"entities": [[55, 61, "DISEASE"]]}], ["These abnormalities can be reproduced by transfection of cell lines with the GCR-\u03b2 gene resulting in significant reduction of their GCR-\u03b1 DNA binding capacity.", {"entities": []}], ["We conclude that increased expression of GCR-\u03b2 is cytokine inducible and may account for GC insensitivity in this common inflammatory condition.", {"entities": [[89, 91, "GENE"]]}], ["Diabetes can increase the risk of cancers at several sites, but the association between diabetes and lung cancer remains unclear.", {"entities": [[101, 112, "DISEASE"], [106, 112, "DISEASE"]]}], ["We aimed to provide the quantitative estimates for the association between diabetes or antidiabetic treatment and lung cancer risk in the present meta\u2010analysis.", {"entities": [[114, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["Cohort studies were identified by searching the PubMed database (January 1960 through October 2012) and manually assessing the cited references in the retrieved articles.", {"entities": []}], ["Study\u2010specific relative risks ( RR s) and 95% confidence intervals ( CI s) were estimated using a random\u2010effects model.", {"entities": []}], ["Study quality was assessed using the Newcastle\u2013Ottawa scale.", {"entities": []}], ["A total of 19 cohort studies were included in the present meta\u2010analysis.", {"entities": []}], ["Of these, 14 studies focused on the association between diabetes and lung cancer incidence, and seven studies focused on the association between antidiabetic treatment and lung cancer incidence.", {"entities": [[69, 80, "DISEASE"], [172, 183, "DISEASE"], [74, 80, "DISEASE"], [177, 183, "DISEASE"]]}], ["Compared with non\u2010diabetic individuals, diabetic patients do not have an increased risk of lung cancer ( RR \u00a0=\u00a01.04, 95% CI 0.87\u20131.24).", {"entities": [[91, 102, "DISEASE"], [96, 102, "DISEASE"]]}], ["The association between diabetes and lung cancer remained not statistically significant in subgroup analysis stratified by study characteristics, study quality, diabetes ascertainment or important confounders.", {"entities": [[37, 48, "DISEASE"], [42, 48, "DISEASE"]]}], ["A null association between insulin or biguanides therapy and lung cancer risk was found.", {"entities": [[61, 72, "DISEASE"], [66, 72, "DISEASE"]]}], ["However, the diabetic patients receiving thiazolidinedione ( TZD ) treatment had a 20% reduced risk of lung cancer than those without TZD treatment.", {"entities": [[103, 114, "DISEASE"], [108, 114, "DISEASE"]]}], ["No association between diabetes and lung cancer risk was found.", {"entities": [[36, 47, "DISEASE"], [41, 47, "DISEASE"]]}], ["However, TZD treatment might reduce lung cancer risk in diabetic patients.", {"entities": [[36, 47, "DISEASE"], [41, 47, "DISEASE"]]}], ["Inflammation is a complex, multi-scale biologic response to stress that is also required for repair and regeneration after injury.", {"entities": []}], ["Despite the repository of detailed data about the cellular and molecular processes involved in inflammation, including some understanding of its pathophysiology, little progress has been made in treating the severe inflammatory syndrome of sepsis.", {"entities": [[228, 236, "DISEASE"]]}], ["To address the gap between basic science knowledge and therapy for sepsis, a community of biologists and physicians is using systems biology approaches in hopes of yielding basic insights into the biology of inflammation.", {"entities": []}], ["\u201cSystems biology\u201d is a discipline that combines experimental discovery with mathematical modeling to aid in the understanding of the dynamic global organization and function of a biologic system (cell to organ to organism).", {"entities": []}], ["We propose the term translational systems biology for the application of similar tools and engineering principles to biologic systems with the primary goal of optimizing clinical practice.", {"entities": []}], ["We describe the efforts to use translational systems biology to develop an integrated framework to gain insight into the problem of acute inflammation.", {"entities": []}], ["Progress in understanding inflammation using translational systems biology tools highlights the promise of this multidisciplinary field.", {"entities": []}], ["Future advances in understanding complex medical problems are highly dependent on methodological advances and integration of the computational systems biology community with biologists and clinicians.", {"entities": []}], ["Recent studies have indicated that arginase, which converts l -arginine into l -ornithine and urea, may play an important role in the pathogenesis of various pulmonary disorders.", {"entities": []}], ["In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may contribute to obstruction and hyperresponsiveness of the airways by inducing a reduction in the production of bronchodilatory nitric oxide (NO) that results from its competition with constitutive (cNOS) and inducible (iNOS) NO synthases for their common substrate.", {"entities": [[11, 48, "DISEASE"], [60, 75, "DISEASE"], [3, 9, "DISEASE"]]}], ["In addition, reduced l -arginine availability to iNOS induced by arginase may result in the synthesis of both NO and the superoxide anion by this enzyme, thereby enhancing the production of peroxynitrite, which has procontractile and pro-inflammatory actions.", {"entities": []}], ["Increased synthesis of l -ornithine by arginase may also contribute to airway remodelling in these diseases.", {"entities": []}], ["l -Ornithine is a precursor of polyamines and l -proline, and these metabolic products may promote cell proliferation and collagen production, respectively.", {"entities": []}], ["Increased arginase activity may also be involved in other fibrotic disorders of the lung, including idiopathic pulmonary fibrosis.", {"entities": [[111, 129, "DISEASE"], [100, 129, "DISEASE"]]}], ["Finally, through its action of inducing reduced levels of vasodilating NO, increased arginase activity has been associated with primary and secondary forms of pulmonary hypertension.", {"entities": [[169, 181, "DISEASE"], [159, 181, "DISEASE"]]}], ["Drugs targeting the arginase pathway could have therapeutic potential in these diseases.", {"entities": []}], ["Childhood obesity is an important cause of cardiovascular risk with chronic inflammation.", {"entities": [[10, 17, "DISEASE"]]}], ["Oxidative stress may contribute to the pathogenesis of obesity-related cardiovascular pathologies.", {"entities": [[55, 62, "DISEASE"]]}], ["We aimed to evaluate thiol/disulphide homeostasis as a novel and sensitive marker of oxidative stress and to evaluate its relationship with some inflammatory and cardiovascular markers in obese children.", {"entities": []}], ["In this case-controlled study, 65 children with exogenous obesity and 64 healthy children, as a control group, were included.", {"entities": [[58, 65, "DISEASE"]]}], ["In both groups, thiol/disulphide homeostasis parameters and inflammatory (white blood cells, platelets, mean corpuscular volume, neutrophil/lymphocyte ratio, and high-sensitivity C-reactive protein) and cardiovascular (epicardial adipose tissue thickness and left ventricular mass index) markers were studied.", {"entities": []}], ["Correlation analyses of thiol/disulphide homeostasis parameters with body mass index standard deviation scores (BMI SDS) and inflammatory and cardiovascular markers were performed.", {"entities": [[116, 119, "GENE"]]}], ["Receiver-operating characteristic analysis was performed to determine the sensitivity, specificity, and optimal cut-off values of thiol/disulphide homeostasis parameters.", {"entities": []}], ["Native thiol, total thiol, and native thiol/total thiol ratios (antioxidant parameters) were lower (p<0.05) and disulphide/native thiol and disulphide/total thiol ratios (oxidant parameters) were higher in the obese group than in the control group (p<0.01).", {"entities": []}], ["A positive correlation of oxidant parameters with BMI SDS and inflammatory markers was found.", {"entities": [[54, 57, "GENE"]]}], ["However, a negative correlation of antioxidant parameters with BMI SDS and inflammatory markers was found.", {"entities": [[67, 70, "GENE"]]}], ["The specificities of disulphide/native thiol and disulphide/total thiol ratios were higher in the obese group.", {"entities": []}], ["The impairment in thiol/disulphide homeostasis, which is indicative of oxidative stress, is associated with inflammation in obesity.", {"entities": [[124, 131, "DISEASE"]]}], ["In addition, cardiovascular involvement may also contribute to this impairment.", {"entities": []}], ["Acquired sensory hearing loss (SHL) is suggested to be associated with depression.", {"entities": []}], ["However, some studies have reported conflicting results.", {"entities": []}], ["Our study investigated the relationship between the prevalence of SHL and the incidence of depression over 12 years of follow-up by using data from the Taiwan National Health Insurance Research Database (NHIRD).", {"entities": []}], ["We sought to determine the association between SHL and subsequent development of depression and discuss the pathophysiological mechanism underlying the association.", {"entities": []}], ["Patients with SHL were identified from the NHIRD (SHL cohort).", {"entities": []}], ["A non-SHL cohort, comprising patients without SHL frequency-matched with the SHL patients according to age group, sex, and the year of diagnosis of SHL at the ratio of 1:4, was constructed, and the incidence of depression was evaluated in both cohorts.", {"entities": []}], ["A multivariable model was adjusted for age, sex, and comorbidity.", {"entities": []}], ["The SHL cohort and non-SHL cohort comprised 5043 patients with SHL and 20,172 patients without SHL, respectively.", {"entities": []}], ["The incidences density rates were 9.50 and 4.78 per 1000 person-years in the SHL cohort and non-SHL cohort, respectively.", {"entities": []}], ["After adjustment for age, sex, and comorbidities, the risk of depression was higher in the SHL cohort than in the non-SHL cohort (hazard ratio\u200a=\u200a1.73, 95% confidence interval\u200a=\u200a1.49\u20132.00).", {"entities": []}], ["Acquired SHL may increase the risk of subsequent depression.", {"entities": []}], ["The results demonstrated that SHL was an independent risk factor regardless of sex, age, and comorbidities.", {"entities": []}], ["Moreover, a strong association between hearing loss and subsequent depression among Taiwanese adults of all ages, particularly those aged \u226449 and >65 years and without using steroids for the treatment of SHL was observed.", {"entities": []}], ["Prospective clinical and biomedical studies on the relationship between hearing loss and depression are warranted for determining the etiopathology.", {"entities": []}], ["Oral lichen planus (OLP) is a T cell-mediated inflammatory autoimmune disease.", {"entities": [[5, 18, "DISEASE"]]}], ["Autophagy has emerged as a fundamental trafficking event in mediating T cell response, which plays crucial roles in innate and adaptive immunity.", {"entities": []}], ["The present study mainly investigated the mRNA expression of autophagy-associated genes in peripheral blood T cells of OLP patients and evaluated correlations between their expression and the clinical features of OLP.", {"entities": []}], ["Five differentially expressed autophagy-associated genes were identified by autophagy array.", {"entities": []}], ["Quantitative real-time RT-PCR results confirmed that IGF1 expression in the peripheral blood T cells of OLP patients was significantly higher than that in controls, especially in female and middle-aged (30\u201350 years old) OLP patients.", {"entities": [[53, 57, "GENE"]]}], ["In addition, ATG9B mRNA levels were significantly lower in nonerosive OLP patients.", {"entities": [[13, 18, "GENE"]]}], ["However, no significant differences were found in the expression of HGS , ESR1 , and SNCA between OLP patients and controls.", {"entities": [[68, 71, "GENE"], [74, 78, "GENE"], [85, 89, "GENE"]]}], ["Taken together, dysregulation of T cell autophagy may be involved in immune response of OLP and may be correlated with clinical patterns.", {"entities": []}], ["The objective of this study was to identify physical and mental outcomes of osteoporosis that affect quality of life in women.", {"entities": [[76, 88, "DISEASE"]]}], ["Data were from the Alameda County Study, a longitudinal study of health and mortality that since 1965 has followed a cohort of 6,928 American persons aged 16 to 94 years at baseline.", {"entities": []}], ["Subjects for this analysis were women who survived until at least 1994 (N = 1,171).", {"entities": []}], ["The variables analyzed as possible outcomes of osteoporosis included measures of physical health, quality of life, and mental health.", {"entities": [[47, 59, "DISEASE"]]}], ["Sequential logistic regression models were run, and associations were presented as odds ratios.", {"entities": []}], ["After controlling for age, ethnicity, education, financial strain, and physical activity, subjects with osteoporosis in 1994 were more likely to report the following outcomes in 1999: frailty, difficulty with balance, weakness, problems with activities of daily living, fair/poor perceived health, never going out for entertainment, and not enjoying free time much.", {"entities": [[104, 116, "DISEASE"]]}], ["When controlling for chronic medical conditions, the odds ratios were reduced, but remained significant for difficulty with balance and weakness (odds ratio = 2.48) and problems with activities of daily living (odds ratio = 2.80).", {"entities": []}], ["From this study, it appears that people with osteoporosis are at higher risk of developing problems with physical frailty and difficulties with activities of daily living, and may be at risk for reduced quality of life in terms of going out for entertainment and enjoying free time.", {"entities": [[45, 57, "DISEASE"]]}], ["Therefore, care should be taken to maintain the quality of life for people with osteoporosis by helping them to keep as physically functional as possible.", {"entities": [[80, 92, "DISEASE"]]}], ["Asthma is a major cause of disability, health resource utilization and poor quality of life world-wide.", {"entities": [[0, 6, "DISEASE"]]}], ["We set out to generate estimates of the global burden of asthma in adults, which may inform the development of strategies to address this common disease.", {"entities": [[57, 63, "DISEASE"]]}], ["The World Health Survey (WHS) was developed and implemented by the World Health Organization in 2002-2003.", {"entities": []}], ["A total of 178,215 individuals from 70 countries aged 18 to 45 years responded to questions related to asthma and related symptoms.", {"entities": [[103, 109, "DISEASE"]]}], ["The prevalence of asthma was based on responses to questions relating to self-reported doctor diagnosed asthma, clinical/treated asthma, and wheezing in the last 12 months.", {"entities": [[18, 24, "DISEASE"], [104, 110, "DISEASE"], [129, 135, "DISEASE"]]}], ["The global prevalence rates of doctor diagnosed asthma, clinical/treated asthma and wheezing in adults were 4.3%, 4.5%, and 8.6% respectively, and varied by as much as 21-fold amongst the 70 countries.", {"entities": [[48, 54, "DISEASE"], [73, 79, "DISEASE"]]}], ["Australia reported the highest rate of doctor diagnosed, clinical/treated asthma, and wheezing (21.0%, 21.5%, and 27.4%).", {"entities": [[74, 80, "DISEASE"]]}], ["Amongst those with clinical/treated asthma, almost 24% were current smokers, half reported wheezing, and 20% had never been treated for asthma.", {"entities": [[36, 42, "DISEASE"], [136, 142, "DISEASE"]]}], ["This study provides a global estimate of the burden of asthma in adults, and suggests that asthma continues to be a major public health concern worldwide.", {"entities": [[55, 61, "DISEASE"], [91, 97, "DISEASE"]]}], ["The high prevalence of smoking remains a major barrier to combating the global burden of asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["While the highest prevalence rates were observed in resource-rich countries, resource-poor nations were also significantly affected, posing a barrier to development as it stretches further the demands of non-communicable diseases.", {"entities": []}], ["Most pediatric adenovirus respiratory infections are mild and indistinguishable from other viral causes.", {"entities": []}], ["However, in a few children, the disease can be severe and result in substantial morbidity.", {"entities": []}], ["We describe the epidemiologic, clinical, radiologic features and outcome of adenovirus lower respiratory tract infections (LRTI) in Aboriginal and Non-Aboriginal children in Manitoba, Canada during the years 1991 and 2005.", {"entities": []}], ["This was a retrospective study of 193 children who presented to the department of pediatrics at Winnipeg Children's Hospital, Manitoba, Canada with LRTI and had a positive respiratory culture for adenovirus.", {"entities": []}], ["Patients' demographics, clinical and radiologic features and outcomes were collected.", {"entities": []}], ["Adenovirus serotype distributions and temporal associations were described.", {"entities": []}], ["Approximate incidence comparisons (detection rates) of adenovirus LRTI among Aboriginal and Non-Aboriginal children were estimated with 95% confidence intervals.", {"entities": []}], ["Adenovirus infections occurred throughout the year with clusters in the fall and winter.", {"entities": []}], ["Serotypes 1 to 3 were the predominant isolates (two thirds of the cases).", {"entities": []}], ["The infection was more frequent among Canadian Aboriginals, as illustrated in 2004, where its incidence in children 0-4 years old was 5.6 fold higher in Aboriginals (13.51 vs. 2.39 per 10,000, p < 0.000).", {"entities": []}], ["There were no significant differences in length of hospitalization and use of ventilator assistance between the two groups ( p > 0.185 and p > 0.624, respectively) nor across serotypes ( p > 0.10 and p > 0.05, respectively).", {"entities": []}], ["The disease primarily affected infants (median age, 9.5 months).", {"entities": []}], ["Most children presented with bronchiolitis or pneumonia, with multi-lobar consolidations on the chest x-ray.", {"entities": [[46, 55, "DISEASE"], [29, 42, "DISEASE"]]}], ["Chronic (residual) changes were documented in 16 patients, with eight patients showing bronchiectasis on the chest computerized tomography scan.", {"entities": [[87, 101, "DISEASE"]]}], ["Adenovirus infection is associated with significant respiratory morbidities, especially in young infants.", {"entities": []}], ["The infection appears to be more frequent in Aboriginal children.", {"entities": []}], ["These results justify a careful follow-up for children with adenovirus LRTI.", {"entities": []}], ["Aluminum salts gels (alum) are TLR-independent adjuvants and have been used to boost antibody responses in alum-based vaccines such as diphtheria, pertussis, and tetanus toxoid (DPT) triple vaccine.", {"entities": [[135, 145, "DISEASE"], [162, 169, "DISEASE"], [147, 156, "DISEASE"], [178, 181, "GENE"]]}], ["However, the pro-Th2 activity of alum-based vaccine formulations has not been fully appreciated.", {"entities": []}], ["Here we found that alum-based tetanus toxoid (TT) vaccine was biased toward a Th-2 profile as shown by TT-induced airway eosinophilic inflammation, type 2 cytokine production, and high levels of IgE anaphylactic antibodies.", {"entities": [[30, 37, "DISEASE"]]}], ["The adsorption into alum of prototypic TLR4 agonists such as lipopolysaccharides (LPS) derived from Escherichia coli consistently dampened TT-induced Th2 activities without inducing IFN \u03b3 or Th1-like responses in the lung.", {"entities": [[39, 43, "GENE"]]}], ["Conversely, adsorption of monophosphoryl lipid A (MPLA) extracted from Salmonella minnesota , which is a TIR-domain-containing adapter-inducing interferon- \u03b2 - (TRIF-) biased TLR4 agonist, was less effective in decreasing Th-2 responses.", {"entities": [[175, 179, "GENE"]]}], ["Importantly, in a situation with antigenic competition (OVA plus TT), TT-specific IgG1 or IgG2a was decreased compared with TT sensitization.", {"entities": []}], ["Notably, LPS increased the production of IgG1 and IgG2a TT-specific antibodies.", {"entities": []}], ["In conclusion, the addition of LPS induces a more robust IgG1 and IgG2a TT-specific antibody production and concomitantly decreases Th2-cellular and humoral responses, indicating a potential use of alum/TLR-based vaccines.", {"entities": []}], ["Activation-induced cytidine deaminase (AID) is an enzyme required for antibody diversification, and it causes DNA mutations and strand breaks.", {"entities": []}], ["Constitutive AID expression in mice invariably caused lung lesions morphologically similar to human atypical adenomatous hyperplasia (AAH), which can be a precursor of bronchioloalveolar carcinoma.", {"entities": [[187, 196, "DISEASE"]]}], ["Similar to AAH, mouse AAH-like lesion (MALL) exhibited signs of alveolar differentiation, judging from the expression of alveolar type II (AT2) cell marker surfactant protein C (SP-C).", {"entities": []}], ["However, electron microscopy indicated that MALL, which possessed certain features of a mucous cell, is distinct from an AAH or AT2 cell.", {"entities": []}], ["Although MALL developed in all individuals within 30 weeks after birth, lung tumors occurred in only 10%; this suggests that the vast majority of MALLs fail to grow into visible tumors.", {"entities": []}], ["MALL expressed several recently described markers of lung alveolar regeneration such as p63, keratin 5, keratin 14, leucine-rich repeat containing G protein-coupled receptor 5 (Lgr5), and Lgr6.", {"entities": [[177, 181, "GENE"], [188, 192, "GENE"]]}], ["Increased cell death was observed in the lungs of AID transgenic mice compared with wild-type mice.", {"entities": []}], ["Based on these observations, we speculate that MALL is a regenerating tissue compensating for cellular loss caused by AID cytotoxicity.", {"entities": []}], ["AID expression in such regenerating tissue should predispose cells to malignant transformation via its mutagenic activity.", {"entities": []}], ["P2Y receptors are expressed in virtually all epithelia and are responsible for the control of fluid and electrolyte transport.", {"entities": []}], ["In asthmatic inflammation, the bronchial epithelia are damaged by eosinophil-derived, highly toxic cationic proteins, such as major basic protein (MBP).", {"entities": [[147, 150, "GENE"]]}], ["Consequently, extracellular nucleotides are released into the extracellular space from airway epithelial cells, and act in an autocrine or paracrine fashion to regulate immune functions.", {"entities": []}], ["Our data show damage to the human bronchial epithelial cell line, 16HBE14o-, by poly-L-arginine-induced UDP release into the extracellular medium.", {"entities": []}], ["Activation of P2Y 6 receptor by its natural ligand, UDP, or its specific agonist, MRS 2693, led to the production of two proinflammatory cytokines, interleukin (IL)-6 and IL-8.", {"entities": []}], ["This may have resulted from increased IL-6 and IL-8 mRNA expression, and activation of p38 and ERK1/2 MAPK, and NF- \u03ba B pathways.", {"entities": []}], ["Our previous study demonstrated that UDP stimulated transepithelial Cl 6 receptor-mediated production of IL-6 and IL-8 was found to be dependent on Ca 6 receptors, which will lead to further release of inflammatory cytokines.", {"entities": []}], ["The secretion of cytokines and the formation of such \u201ccytokine networks\u201d play an important role in sustaining the airway inflammatory disease.", {"entities": []}], ["Bias is an inclination to present or hold a partial perspective at the expense of possibly equal or more valid alternatives.", {"entities": []}], ["In this paper, we present a series of conditional arguments to prove that intervention bias exists in the practice of medicine.", {"entities": []}], ["We then explore its potential causes, consequences, and criticisms.", {"entities": []}], ["We use the term to describe the bias on the part of physicians and the medical community to intervene, whether it is with drugs, diagnostic tests, non-invasive procedures, or surgeries, when not intervening would be a reasonable alternative.", {"entities": []}], ["The recognition of intervention bias in medicine is critically important given today\u2019s emphasis on providing high-value care and reducing unnecessary and potentially harmful interventions.", {"entities": []}], ["Nuclear factor kappa B ( NF\u2010kB )\u2010mediated inflammatory gene expression and vascular endothelial cell proliferation/remodelling are implicated in the pathophysiology of the fatal disease, pulmonary arterial hypertension ( PAH ).", {"entities": [[206, 218, "DISEASE"]]}], ["Bromodomain and extra\u2010terminal ( BET ) proteins are essential for the expression of a subset of NF\u2010kB \u2010induced inflammatory genes.", {"entities": []}], ["BET mimics including JQ1 + prevent binding of BETs to acetylated histones and down\u2010regulate the expression of selected genes.", {"entities": []}], ["The effects of JQ1 + on the proliferation of primary human pulmonary microvascular endothelial cells ( HPMECs ) from healthy subjects were measured by bromodeoxyuridine ( BrdU ) incorporation.", {"entities": []}], ["Cell cycle progression was assessed by flow cytometry; mRNA and protein levels of cyclin\u2010dependent kinases ( CDKs ), inhibitors and cytokines were determined by reverse transcription\u2010quantitative PCR ( RT\u2010qPCR ), Western blotting or ELISA .", {"entities": []}], ["Histone acetyltransferase ( HAT ) and deacetylase ( HDAC ) activities were determined in nuclear extracts from whole lung of PAH and control patients.", {"entities": []}], ["JQ1 + significantly inhibited IL 6 and IL 8 ( IL 6 and CXCL8 ) mRNA and protein in HPMECs compared with its inactive enantiomer JQ1 \u2212.", {"entities": []}], ["JQ1 + decreased NF\u2010kB p65 recruitment to native IL6 and IL8 promoters.", {"entities": [[48, 51, "GENE"], [56, 59, "GENE"]]}], ["JQ1 + showed a concentration\u2010dependent decrease in HPMEC proliferation compared with JQ1 \u2212\u2010treated cells.", {"entities": []}], ["JQ1 + induced G1 cell cycle arrest by increasing the expression of the CDK inhibitors (CDKN) 1A (p21 CDKN2D ( p19 ) and decreasing that of CDK2 , CDK4 and CDK6 .", {"entities": [[101, 107, "GENE"], [139, 143, "GENE"], [146, 150, "GENE"], [155, 159, "GENE"]]}], ["JQ1 + also inhibited serum\u2010stimulated migration of HPMECs .", {"entities": []}], ["Finally, HAT activity was significantly increased in the lung of PAH patients.", {"entities": []}], ["Inhibition of BETs in primary HPMECs decreases inflammation and remodelling.", {"entities": []}], ["BET proteins could be a target for future therapies for PAH .", {"entities": []}], ["Endothelial cell inflammation and proliferation are important in the pathogenesis of pulmonary arterial hypertension ( PAH ).", {"entities": [[104, 116, "DISEASE"]]}], ["Bromodomain and extra\u2010terminal ( BET ) mimics reduced inflammation and cell proliferation in primary human pulmonary vascular endothelial cells.", {"entities": []}], ["The enhanced histone acetyltransferase ( HAT ) activity in PAH suggests that BET mimics may be effective in PAH although experiments in disease cells/tissues are required.", {"entities": []}], ["Breast feeding improves the health of mothers and infants; the UK has low rates, with marked socioeconomic inequalities.", {"entities": []}], ["While trials of peer support services have been effective in some settings, UK trials have not improved breast feeding rates.", {"entities": []}], ["Qualitative research suggests that many women are alienated by the focus on breast feeding.", {"entities": []}], ["We propose a change from breast feeding-focused interactions to respecting a woman\u2019s feeding choices, inclusion of behaviour change theory and an increased intensity of contacts in the 2\u2009weeks after birth when many women cease to breast feed.", {"entities": []}], ["This will take place alongside an assets-based approach that focuses on the positive capability of individuals, their social networks and communities.", {"entities": []}], ["We propose a feasibility study for a multicentre randomised controlled trial of the Assets feeding help Before and After birth (ABA) infant feeding service versus usual care.", {"entities": []}], ["A two-arm, non-blinded randomised feasibility study will be conducted in two UK localities.", {"entities": []}], ["Women expecting their first baby will be eligible, regardless of feeding intention.", {"entities": []}], ["The ABA infant feeding intervention will apply a proactive, assets-based, woman-centred, non-judgemental approach, delivered antenatally and postnatally tailored through face-to-face contacts, telephone and SMS texts.", {"entities": [[207, 210, "GENE"]]}], ["Outcomes will test the feasibility of delivering the intervention with recommended intensity and duration to disadvantaged women; acceptability to women, feeding helpers and professionals; and feasibility of a future randomised controlled trial (RCT), detailing recruitment rates, willingness to be randomised, follow-up rates at 3 days, 8 weeks and 6 months, and level of outcome completion.", {"entities": []}], ["Outcomes of the proposed full trial will also be collected.", {"entities": []}], ["Mixed methods will include qualitative interviews with women/partners, feeding helpers and health service staff; feeding helper logs; and review of audio-recorded helper\u2013women interactions to assess intervention fidelity.", {"entities": []}], ["Study results will inform the design of a larger multicentre RCT.", {"entities": []}], ["The National Research Ethics Service Committee approved the study protocol.", {"entities": []}], ["ISRCTN14760978 ; Pre-results.", {"entities": []}], ["Cigarette smoke (CS) has been reported to induce autophagy in airway epithelial cells.", {"entities": [[17, 19, "GENE"]]}], ["The subsequent autophagic cell death has been proposed to play an important pathogenic role in chronic obstructive pulmonary disease (COPD); however, the underlying molecular mechanism is not entirely clear.", {"entities": [[95, 132, "DISEASE"]]}], ["Using CS extract (CSE) as a surrogate for CS, we found that it markedly increased the expressions of both LC3B-I and LC3B-II as well as autophagosomes in airway epithelial cells.", {"entities": [[6, 8, "GENE"], [42, 44, "GENE"], [6, 8, "GENE"], [42, 44, "GENE"]]}], ["This is in contrast to the common autophagy inducer (i.e., starvation) that increases LC3B-II but reduces LC3B-I.", {"entities": []}], ["Further studies indicate that CSE regulated LC3B at transcriptional and post-translational levels.", {"entities": []}], ["In addition, CSE, but not starvation, activated Nrf2-mediated adaptive response.", {"entities": []}], ["Increase of cellular Nrf2 by either Nrf2 overexpression or the knockdown of Keap1 (an Nrf2 inhibitor) significantly repressed CSE-induced LC3B-I and II as well as autophagosomes.", {"entities": [[76, 81, "GENE"]]}], ["Supplement of NAC (a GSH precursor) or GSH recapitulated the effect of Nrf2, suggesting the increase of cellular GSH level is responsible for Nrf2 effect on LC3B and autophagosome.", {"entities": []}], ["Interestingly, neither Nrf2 activation nor GSH supplement could restore the repressed activities of mTOR or its downstream effctor-S6K.", {"entities": [[100, 104, "GENE"]]}], ["Thus, the Nrf2-dependent autophagy-suppression was not due to the re-activation of mTOR-the master repressor of autophagy.", {"entities": []}], ["To search for the downstream effector of Nrf2 on LC3B and autophagosome, we tested Nrf2-dependent genes (i.e., NQO1 and P62) that are also increased by CSE treatment.", {"entities": [[111, 115, "GENE"]]}], ["We found that P62, but not NQO1, could mimic the effect of Nrf2 activation by repressing LC3B expression.", {"entities": [[27, 31, "GENE"]]}], ["Thus, Nrf2->P62 appears to play an important role in the regulation of CSE-induced LC3B and autophagosome.", {"entities": []}], ["Several studies have reported bidirectional inverse associations between cancer and Alzheimer's disease ( AD ) .", {"entities": [[73, 79, "DISEASE"]]}], ["This study evaluates these relationships in a Medicare population.", {"entities": []}], ["Using Surveillance, Epidemiology, and End Results ( SEER ) linked to Medicare data, 1992\u20132005, we evaluated cancer risks following AD in a case\u2013control study of 836,947 cancer cases and 142,869 controls as well as AD risk after cancer in 742,809 cancer patients and a non\u2010cancer group of 420,518.", {"entities": [[108, 114, "DISEASE"], [169, 175, "DISEASE"], [228, 234, "DISEASE"], [246, 252, "DISEASE"], [272, 278, "DISEASE"]]}], ["We applied unconditional logistic regression to estimate odds ratios ( OR s) and Cox proportional hazards models to estimate hazards ratios ( HR s).", {"entities": [[142, 144, "GENE"]]}], ["We also evaluated cancer in relation to automobile injuries as a negative control to explore potential study biases.", {"entities": [[18, 24, "DISEASE"]]}], ["In the case\u2013control analysis, cancer cases were less likely to have a prior diagnosis of AD than controls ( OR \u00a0=\u00a00.86; 95% CI \u00a0=\u00a00.81\u20130.92).", {"entities": [[30, 36, "DISEASE"]]}], ["Cancer cases were also less likely than controls to have prior injuries from automobile accidents to the same degree ( OR \u00a0=\u00a00.83; 95% CI \u00a0=\u00a00.78\u20130.88).", {"entities": [[0, 6, "DISEASE"]]}], ["In the prospective cohort, there was a lower risk observed in cancer survivors, HR \u00a0=\u00a00.87 (95% CI \u00a0=\u00a00.84\u20130.90).", {"entities": [[62, 68, "DISEASE"], [80, 82, "GENE"]]}], ["In contrast, there was no association between cancer diagnosis and subsequent automobile accident injuries ( HR \u00a0=\u00a01.03; 95% CI \u00a0=\u00a00.98\u20131.07).", {"entities": [[46, 52, "DISEASE"], [109, 111, "GENE"]]}], ["That cancer risks were similarly reduced after both AD and automobile injuries suggest biases against detecting cancer in persons with unrelated medical conditions.", {"entities": [[5, 11, "DISEASE"], [112, 118, "DISEASE"]]}], ["The modestly lower AD risk in cancer survivors may reflect underdiagnosis of AD in those with a serious illness.", {"entities": [[30, 36, "DISEASE"]]}], ["This study does not support a relationship between cancer and AD .", {"entities": [[51, 57, "DISEASE"]]}], ["Uncontrolled asthma negatively impacts patients, families, and the community.", {"entities": [[13, 19, "DISEASE"]]}], ["The level of symptom control among asthmatics in Ethiopia has not been well studied.", {"entities": []}], ["We investigated the level of asthma control and risk factors for poor asthma control in clinic patients seen in the largest public hospital in Ethiopia.", {"entities": [[29, 35, "DISEASE"], [70, 76, "DISEASE"]]}], ["In this cross-sectional study, we studied all 182 consecutive subjects with a physician diagnosis of asthma who were seen in chest clinic at Tikur Anbessa Specialized Hospital between July and December 2015.", {"entities": [[101, 107, "DISEASE"]]}], ["Of the 182 subjects, 68.1% were female.", {"entities": []}], ["The mean age was 52\u00a0\u00b1\u00a012\u00a0years and the median duration of asthma was 20\u00a0\u00b1\u00a012.7\u00a0years.", {"entities": [[58, 64, "DISEASE"]]}], ["One hundred and seventeen subjects (64.3%) had nighttime awakening due to asthma.", {"entities": [[74, 80, "DISEASE"]]}], ["Fifty-eight (31%) were not using controller medications and 62 (34.6%) had improper inhaler technique.", {"entities": []}], ["Only 44 (24.2%) subjects had well-controlled asthma.", {"entities": [[45, 51, "DISEASE"]]}], ["On multivariate analysis, variables associated with uncontrolled asthma included: use of biomass fuel for cooking, longer duration of asthma (>\u00a030\u00a0year), incorrect inhalation technique, and asthma exacerbation in the last 12\u00a0months.", {"entities": [[65, 71, "DISEASE"], [134, 140, "DISEASE"], [190, 196, "DISEASE"]]}], ["Most asthmatics attending in the largest public hospital in Ethiopia, had uncontrolled asthma.", {"entities": [[87, 93, "DISEASE"]]}], ["Several risk factors for poor asthma control were identified.", {"entities": [[30, 36, "DISEASE"]]}], ["Improved asthma control is possible through directed interventions.", {"entities": [[9, 15, "DISEASE"]]}], ["Innate lymphoid cells (ILCs) have emerged recently as an important component of the immune system and the cell type that regulates mucosal immune responses and tissue homeostasis.", {"entities": []}], ["Group 2 ILCs (ILC2s), a subset of ILCs, reside in various tissues and are characterized by their capacity to produce type 2 cytokines and tissue growth factors.", {"entities": []}], ["These ILC2s play an important role in allergic immune responses by linking signals in the atmospheric environment to the immune system.", {"entities": []}], ["Fungi are one of the major allergens associated with human asthma, and animal and in vitro models using the fungal allergens have provided significant information toward our understanding of the mechanisms of allergic disease.", {"entities": [[59, 65, "DISEASE"]]}], ["In mouse models of fungus-induced allergic airway inflammation, IL-33, IL-25, and TSLP are released by airway epithelial cells.", {"entities": [[82, 86, "GENE"]]}], ["Lung ILC2s that respond to these cytokines quickly produce a large quantity of type 2 cytokines, resulting in airway eosinophilia, mucus production, and airway hyperreactivity even in the absence of adaptive immune cells.", {"entities": [[117, 129, "DISEASE"]]}], ["Evidence also suggests that ILC2s interact with conventional immune cells, such as CD4", {"entities": [[83, 86, "GENE"]]}], ["Analysis of differentially expressed in circulating leukocytes from people who chronically experienced high versus low levels of subjective social isolation (loneliness) revealed over-expression of some anti-inflammatory genes and under-expression of some pro-inflammatory genes.", {"entities": []}], ["Social environmental influences on human health are well established in the epidemiology literature, but their functional genomic mechanisms are unclear.", {"entities": []}], ["The present study analyzed genome-wide transcriptional activity in people who chronically experienced high versus low levels of subjective social isolation (loneliness) to assess alterations in the activity of transcription control pathways that might contribute to increased adverse health outcomes in social isolates.", {"entities": []}], ["DNA microarray analysis identified 209 genes that were differentially expressed in circulating leukocytes from 14 high- versus low-lonely individuals, including up-regulation of genes involved in immune activation, transcription control, and cell proliferation, and down-regulation of genes supporting mature B lymphocyte function and type I interferon response.", {"entities": []}], ["Promoter-based bioinformatic analyses showed under-expression of genes bearing anti-inflammatory glucocorticoid response elements (GREs; p = 0.032) and over-expression of genes bearing response elements for pro-inflammatory NF-\u03baB/Rel transcription factors ( p = 0.011).", {"entities": []}], ["This reciprocal shift in pro- and anti-inflammatory signaling was not attributable to differences in circulating cortisol levels, or to other demographic, psychological, or medical characteristics.", {"entities": []}], ["Additional transcription control pathways showing differential activity in bioinformatic analyses included the CREB/ATF, JAK/STAT, IRF1, C/EBP, Oct, and GATA pathways.", {"entities": [[131, 135, "GENE"]]}], ["These data provide the first indication that human genome-wide transcriptional activity is altered in association with a social epidemiological risk factor.", {"entities": []}], ["Impaired transcription of glucocorticoid response genes and increased activity of pro-inflammatory transcription control pathways provide a functional genomic explanation for elevated risk of inflammatory disease in individuals who experience chronically high levels of subjective social isolation.", {"entities": []}], ["The aim of this study was to identify predictors of non-attendance and to investigate the influence of illness perceptions on attendance at diabetic outpatient clinics.", {"entities": []}], ["This is a descriptive study of 442 participants who were enrolled in a Diabetic Outpatient Clinic at Lerdsin Hospital, Thailand.", {"entities": []}], ["Illness perceptions were derived from a Thai version of the IPQ-R questionnaire consisting of the same 3 sections as the original Illness perception- Revised with the distinction that it had 68 items.", {"entities": []}], ["Test for validity was performed and the Cronbach\u2019s alpha reliability coefficient value was 0.87.", {"entities": []}], ["Data were analysed by using independent t-tests.", {"entities": []}], ["Binary logistic regression was used in order to assess the impact of illness perception scores on attendance among diabetic patients at the Outpatient Clinic.", {"entities": []}], ["The results of the study were as follows: Demographic data showed that all respondents were of Thai ethnic origin and two-thirds of the respondents were women.", {"entities": []}], ["The average age was 60 years.", {"entities": []}], ["The majority of the participants had completed primary school (7\u201312 years old), was married and were Buddhist.", {"entities": []}], ["The IPQ-R revealed the following findings: The illness perceptions at baseline and 6 months later showed that it illness perception had no effect on the participants\u2019 illness perception and attendance rate at the diabetic outpatient clinic.", {"entities": []}], ["Participants who hold negative illness perceptions were more likely to attend diabetes clinics than those participants who had positive illness perceptions.", {"entities": []}], ["A conceivable explanation for the non-significant findings in the study is the finding that during 6 month period there were some factors that have contributed to the failure of the participants to attend to their appointments.", {"entities": []}], ["This is beyond the scope of the socio-demographic and illness perception factors.", {"entities": []}], ["Thus, a plausible explanation for the non-significant findings in the study is that during 6 month period there were some factors that may have contributed to the appointment keeping among these patients beyond the scope of socio-demographic and illness perception factors.", {"entities": []}], ["Epithelial\u2013mesenchymal transition (EMT) is implicated in bronchial remodeling and loss of lung function in chronic inflammatory airway diseases.", {"entities": []}], ["Previous studies showed the involvement of the high mobility group box 1 (HMGB1) protein in the pathology of chronic pulmonary inflammatory diseases.", {"entities": [[74, 79, "GENE"]]}], ["However, the role of HMGB1 in EMT of human airway epithelial cells is still unclear.", {"entities": [[21, 26, "GENE"]]}], ["In this study, we used RNA sequencing to show that HMGB1 treatment regulated EMT-related gene expression in human primary-airway epithelial cells.", {"entities": [[51, 56, "GENE"]]}], ["The top five upregulated genes were SNAI2 , FGFBP1 , VIM , SPARC ( osteonectin), and SERPINE1 , while the downregulated genes included OCLN , TJP1 ( ZO-1 ), FZD7 , CDH1 (E-cadherin), and LAMA5 .", {"entities": [[36, 41, "GENE"], [44, 50, "GENE"], [59, 64, "GENE"], [85, 93, "GENE"], [135, 139, "GENE"], [142, 146, "GENE"], [157, 161, "GENE"], [164, 168, "GENE"], [187, 192, "GENE"]]}], ["We found that HMGB1 induced downregulation of E-cadherin and ZO-1, and upregulation of vimentin mRNA transcription and protein translation in a dose-dependent manner.", {"entities": [[14, 19, "GENE"]]}], ["Additionally, we observed that HMGB1 induced AKT phosphorylation, resulting in GSK3\u03b2 inactivation, cytoplasmic accumulation, and nuclear translocation of \u03b2-catenin to induce EMT in human airway epithelial cells.", {"entities": [[31, 36, "GENE"]]}], ["Treatment with PI3K inhibitor (LY294006) and \u03b2-catenin shRNA reversed HMGB1-induced EMT.", {"entities": []}], ["Moreover, HMGB1 induced expression of receptor for advanced glycation products (RAGE), but not that of Toll-like receptor (TLR) 2 or TLR4, and RAGE shRNA inhibited HMGB1-induced EMT in human airway epithelial cells.", {"entities": [[10, 15, "GENE"], [164, 169, "GENE"], [133, 137, "GENE"]]}], ["In conclusion, we found that HMGB1 induced EMT through RAGE and the PI3K/AKT/GSK3\u03b2/\u03b2-catenin signaling pathway.", {"entities": [[29, 34, "GENE"]]}], ["We studied the transcriptome landscape of skin cutaneous melanoma (SKCM) using 103 primary tumor samples from TCGA, and measured the expression levels of both protein coding genes and non-coding RNAs (ncRNAs).", {"entities": [[57, 65, "DISEASE"]]}], ["In particular, we emphasized pseudogenes potentially relevant to this cancer.", {"entities": [[70, 76, "DISEASE"]]}], ["While cataloguing the profiles based on the known biotypes, all the employed RNA-Seq methods generated just a small consensus of significant biotypes.", {"entities": []}], ["We thus designed an approach to reconcile the profiles from all methods following a simple strategy: we selected genes that were confirmed as differentially expressed by the ensemble predictions obtained in a regression model.", {"entities": []}], ["The main advantages of this approach are: 1) Selection of a high-confidence gene set identifying relevant pathways; 2) Use of a regression model whose covariates embed all method-driven outcomes to predict an averaged profile; 3) Method-specific assessment of prediction power and significance.", {"entities": []}], ["Furthermore, the approach can be generalized to any biological system for which noisy RNA-Seq profiles are computed.", {"entities": []}], ["As our analyses concerned bio-annotations of both high-quality protein coding genes and ncRNAs, we considered the associations between pseudogenes and parental genes (targets).", {"entities": []}], ["Among the candidate targets that were validated, we identified PINK1, which is studied in patients with Parkinson and cancer (especially melanoma).", {"entities": [[137, 145, "DISEASE"], [118, 124, "DISEASE"], [63, 68, "GENE"]]}], ["There is little current information about the unmet mental health care need (UMHCN) and reasons for it among those exposed to the World Trade Center (WTC) terrorist attacks.", {"entities": []}], ["The purpose of this study was to assess the level of UMHCN among symptomatic individuals enrolled in the WTC Health Registry (WTCHR) in 2011\u20132012, and to analyze the relationship between UMHCN due to attitudinal, cost, and access factors and mental health symptom severity, mental health care utilization, health insurance availability, and social support.", {"entities": []}], ["The WTCHR is a prospective cohort study of individuals with reported exposure to the 2001 WTC attacks.", {"entities": []}], ["This study used data from 9,803 adults who completed the 2003\u20132004 (Wave 1) and 2011\u20132012 (Wave 3) surveys and had posttraumatic stress disorder (PTSD) or depression in 2011\u20132012.", {"entities": []}], ["We estimated logistic regression models relating perceived attitudinal, cost and access barriers to symptom severity, health care utilization, a lack of health insurance, and social support after adjusting for sociodemographic characteristics.", {"entities": []}], ["Slightly more than one-third (34.2%) of study participants reported an UMHCN.", {"entities": []}], ["Symptom severity was a strong predictor of UMHCN due to attitudinal and perceived cost and access reasons.", {"entities": []}], ["Attitudinal UMHCN was common among those not using mental health services, particularly those with relatively severe mental health symptoms.", {"entities": []}], ["Cost-related UMHCN was significantly associated with a lack of health insurance but not service usage.", {"entities": []}], ["Access-related barriers were significantly more common among those who did not use any mental health services.", {"entities": []}], ["A higher level of social support served as an important buffer against cost and access UMHCN.", {"entities": []}], ["A significant proportion of individuals exposed to the WTC attacks with depression or PTSD 10\u00a0years later reported an UMHCN, and individuals with more severe and disabling conditions, those who lacked health insurance, and those with low levels of social support were particularly vulnerable.", {"entities": []}], ["HAPE susceptible (HAPE-S, had HAPE episode in past) subjects may have subclinical cardio-pulmonary dysfunction.", {"entities": []}], ["We compared the results of pulmonary function tests in 25 healthy HAPE-S non-mountaineers and 19 matched HAPE resistant (HAPE-R, no HAPE episode in past).", {"entities": []}], ["Acute normobaric hypoxia (FIo 2 0.12) was administered at sea level to confirm hypoxia intolerance in HAPE-S.", {"entities": []}], ["Unlike HAPE-R, HAPE-S subjects had elevated baseline and post-hypoxia systolic pulmonary arterial pressures (20.9\u2009\u00b1\u20093 vs 27.3\u2009\u00b1\u20095 mm Hg during normoxia and 26.2\u2009\u00b1\u20096 vs 45.44\u2009\u00b1\u200910 mm Hg during hypoxia, HAPE-R vs HAPE-S).", {"entities": []}], ["Forced vital capacity (FVC) and single breath alveolar volume (SBVA) were significantly lower in HAPE-S compared to HAPE-R (FVC: 4.33\u2009\u00b1\u20090.5 vs 4.6\u2009\u00b1\u20090.4; SBVA: 5.17\u2009\u00b1\u20091 vs 5.6\u2009\u00b1\u20091 Lt; HAPE-S vs HAPE-R).", {"entities": [[180, 182, "GENE"]]}], ["Two subgroups with abnormal pulmonary function could be identified within HAPE-S; HAPE-S1 (n\u2009=\u20094) showed DLCO>140% of predicted, suggestive of asthma and HAPE-S2 (n\u2009=\u200912) showed restrictive pattern.", {"entities": [[143, 149, "DISEASE"]]}], ["Each of these patterns have previously been linked to early small airway disease and may additionally represent a lower cross-sectional area of the pulmonary vascular bed, related to lower lung volumes.", {"entities": []}], ["HAPE susceptibility in healthy non-mountaineers may be related to sub-clinical pulmonary pathology that limits compensatory rise in ventilation and pulmonary circulation during hypoxic stress.", {"entities": []}], ["Staphylococcus aureus has been an important human pathogen throughout history and is currently a leading cause of bacterial infections worldwide.", {"entities": []}], ["S. aureus has the unique ability to cause a continuum of diseases, ranging from minor skin infections to fatal necrotizing pneumonia.", {"entities": [[123, 132, "DISEASE"]]}], ["Moreover, the emergence of highly virulent, drug-resistant strains such as methicillin-resistant S. aureus in both healthcare and community settings is a major therapeutic concern.", {"entities": []}], ["Neutrophils are the most prominent cellular component of the innate immune system and provide an essential primary defense against bacterial pathogens such as S. aureus .", {"entities": []}], ["Neutrophils are rapidly recruited to sites of infection where they bind and ingest invading S. aureus , and this process triggers potent oxidative and non-oxidative antimicrobial killing mechanisms that serve to limit pathogen survival and dissemination.", {"entities": []}], ["S. aureus has evolved numerous mechanisms to evade host defense strategies employed by neutrophils, including the ability to modulate normal neutrophil turnover, a process critical to the resolution of acute inflammation.", {"entities": []}], ["Here we provide an overview of the role of neutrophils in host defense against bacterial pathogens and discuss strategies employed by S. aureus to circumvent neutrophil function.", {"entities": []}], ["This study, supported by the Rwandan Ministry of Health and the World Health Organization, was conducted in 2005 to determine the prevalence of epilepsy and its sociocultural perception in Rwanda, as well as epilepsy-related knowledge and practices of health-care professionals (HCPs).", {"entities": []}], ["A cross-sectional, nationally representative survey was conducted throughout Rwanda by trained investigators.", {"entities": []}], ["Participants were recruited by random cluster sampling based on the organization of administrative units in the country.", {"entities": []}], ["Overall, 1137 individuals (62% from rural areas) were interviewed.", {"entities": []}], ["The prevalence of epilepsy was estimated to be 49 per 1000 people or 41 per 1000 for active epilepsy.", {"entities": []}], ["Onset of epilepsy before the age of 2\u00a0years was reported in 32% of the cases.", {"entities": []}], ["Family history of epilepsy, head trauma, and premature delivery were reported in 53%, 50%, and 68% of the cases, respectively.", {"entities": []}], ["Most (68%) patients did not receive any medical treatment for epilepsy; 21.5% had received some form of traditional treatment.", {"entities": []}], ["According to responses from the general population, people with epilepsy should not be entitled to schooling (according to 66%), to work (according to 72%), to the use of public places (according to 69%), or to marriage (according to 66%).", {"entities": []}], ["Furthermore, 50% believed that epilepsy was untreatable, and 40% thought that it was transmissible.", {"entities": []}], ["Of the 29 HCPs interviewed, the majority knew the definition of epilepsy and status epilepticus, as well as basic treatment options and side effects.", {"entities": []}], ["However, 90% believed that treatment was only necessary in the first week after a seizure.", {"entities": []}], ["Living with epilepsy was associated heavily with stigma, and a significant treatment gap (68%) was identified.", {"entities": []}], ["Following this study, numerous actions have been taken by the Rwandan government, the Rwandan League Against Epilepsy, and several nongovernmental organizations to increase awareness about epilepsy and to close the treatment gap.", {"entities": []}], ["An overview of these activities is provided.", {"entities": []}], ["\u2022 This Rwandan study was conducted to determine epilepsy prevalence and its perception.", {"entities": []}], ["\u2022 The prevalence of epilepsy in Rwanda was estimated to be 49 per 1000 people.", {"entities": []}], ["\u2022 Living with epilepsy was associated heavily with stigma.", {"entities": []}], ["\u2022 A significant treatment gap was identified.", {"entities": []}], ["\u2022 Actions have been taken to increase epilepsy awareness and to close the treatment gap.", {"entities": []}], ["This Rwandan study was conducted to determine epilepsy prevalence and its perception.", {"entities": []}], ["The prevalence of epilepsy in Rwanda was estimated to be 49 per 1000 people.", {"entities": []}], ["Living with epilepsy was associated heavily with stigma.", {"entities": []}], ["A significant treatment gap was identified.", {"entities": []}], ["Actions have been taken to increase epilepsy awareness and to close the treatment gap.", {"entities": []}], ["While morbidity outcomes for major disease categories during extreme heat have received increasing research attention, there has been very limited investigation at the level of specific disease subcategories.", {"entities": []}], ["We analyzed daily hospital admissions for cardiovascular (CVD), respiratory (RD), genitourinary (GU) and mental diseases (MD), diabetes (DIA), dehydration (DEH) and \u2018the effects of heat and light\u2019 (HEAT) in Sydney between 1991 and 2009.", {"entities": [[77, 79, "GENE"]]}], ["We further investigated the sensitivity to heat of subcategories within the major disease groups.", {"entities": []}], ["We defined hot days as those with temperatures in the 95 High ambient temperatures were associated with increased hospital admissions for several disease categories, with some within-category variation.", {"entities": []}], ["Future analyses should focus on subgroups within broad disease categories to pinpoint medical conditions most affected by ambient heat.", {"entities": []}], ["Prospective, multicenter, randomized, double-masked trials have shown latanoprost instilled once daily to be at least as effective as and generally superior to timolol administered twice daily and to be as effective as other frequently prescribed prostaglandin analogues.", {"entities": []}], ["This study prospectively assessed the efficacy of latanoprost monotherapy in a large cohort of treatment-naive patients with a broad range of baseline intraocular pressure (IOP) levels treated in actual clinical practice settings.", {"entities": []}], ["This prospective, open-label, multicenter, uncontrolled, phase IV study included treatment-naive ocular hypertension or open-angle glaucoma subjects initiating latanoprost once daily (evening).", {"entities": [[104, 116, "DISEASE"], [97, 116, "DISEASE"], [131, 139, "DISEASE"], [120, 139, "DISEASE"]]}], ["IOP levels were measured at baseline and after 1 and 3 months.", {"entities": []}], ["The primary efficacy outcome was mean change in IOP from baseline to month 3.", {"entities": []}], ["Analyses were stratified by baseline IOP: \u2265 20 and <24 mmHg vs \u2265 24 mmHg.", {"entities": []}], ["Efficacy analyses (intent to treat) included 572 subjects: 20 to <24 mmHg group, N = 252; \u2265 24 mmHg group, N = 320.", {"entities": []}], ["Mean baseline IOP levels were 22.2 \u00b1 0.9 mmHg and 26.7 \u00b1 2.8 mmHg, respectively.", {"entities": []}], ["At month 3, significant IOP reductions were seen in both groups (p < 0.0001, within-group differences); reductions were smaller in the 20 to <24 mmHg group (-6.3 \u00b1 2.4 vs -9.2 \u00b1 3.7 mmHg, respectively; -28.0 \u00b1 10.6% vs -34.1 \u00b1 11.9%, respectively).", {"entities": []}], ["An IOP reduction of \u2265 30% from baseline to month 3 was noted in 48.4% and 65.6% of subjects, respectively (p < 0.0001).", {"entities": []}], ["At month 3, targets IOPs of \u2264 18 mmHg were achieved by \u2265 70% of subjects in both groups.", {"entities": []}], ["Latanoprost was well tolerated with an adverse event profile similar to that reported in the literature.", {"entities": []}], ["This \"real world\" study found once-daily latanoprost to be effective and safe in treatment-naive ocular hypertension or open-angle glaucoma patients.", {"entities": [[104, 116, "DISEASE"], [97, 116, "DISEASE"], [131, 139, "DISEASE"], [120, 139, "DISEASE"]]}], ["Patients with baseline IOP levels of 20 to <24 mmHg as well as \u2265 24 mmHg benefitted from initial latanoprost therapy.", {"entities": []}], ["Trial Registration Number: NCT00647101", {"entities": []}], ["The role of the immune response in autoimmune hepatitis has not been studied before and after prednisone and azathioprine treatment.", {"entities": [[35, 55, "DISEASE"], [46, 55, "DISEASE"]]}], ["Distributions of blood lymphocytes (CD4+, CD8+, CD19+, CD23+, CD16/56+), levels of serum immunoglobulins (IgM, IgG, IgE, IgA) and cytokines (IFN-\u03b3, IL-4, IL-12, TNF\u03b1 ) were studied in a child (f/14 y/o) with autoimmune hepatitis before and after prednisone (20 mg/d) and azathioprine (50 mg/d) treatment (nephelometry, UniCAP Total IgE Fluoroenzymeimmunoassay, flow cytometry, cytokine ELISA).", {"entities": [[208, 228, "DISEASE"], [219, 228, "DISEASE"]]}], ["Patient was studied for 0-2.5 yrs; treatment was initiated 12 weeks post diagnosis.", {"entities": []}], ["Numbers of CD4+ T cells increased (50%), while CD19+ and CD23+ cells decreased (>50%) post treatment; other lymphocyte subsets were unaffected by treatment.", {"entities": []}], ["Serum IgG and IgE levels decreased (>50%) after treatment; serum IgM and IgA were within normal range and were not affected by treatment High levels of IFN-\u03b3 (5-23 pg/ml) were initially detected in serum, which decreased after treatment (<0.1 pg/ml).", {"entities": []}], ["Furthermore, low levels of IL-4 (0.2 pg/mL) were detected before treatment, which were not detected after treatment (<0.1 pg/ml).", {"entities": []}], ["In contrast, before treatment, IL-12 and TNF\u03b1 were not detected in serum; however after treatment the levels of IL-12 and TNF\u03b1 dramatically increased.", {"entities": []}], ["Prednisone and azathioprine treatment decreased total serum IgG, IgE, IFN-\u03b3 and IL-4 levels, and blood CD19+ and CD23+ cells; however serum IL-12, TNF\u03b1 and blood CD4+ T cells increased with treatment.", {"entities": []}], ["Understanding immunomodulation in autoimmune hepatitis will provide better insight and mechanisms of this disease and may tailor more effective therapeutic intervention.", {"entities": [[34, 54, "DISEASE"], [45, 54, "DISEASE"]]}], ["Despite extensive studies on exposure and disease misclassification, few studies have investigated misclassification of confounders.", {"entities": []}], ["This study aimed to identify differentially misclassified confounders in a comparative evaluation of hospital care quality and to quantify their impact on hospital-specific risk-adjusted estimates, focusing on the appropriateness of caesarean sections (CS).", {"entities": [[253, 255, "GENE"]]}], ["We gathered data from the Hospital Information System in Italy for women admitted in 2005\u20132010.", {"entities": []}], ["We estimated adjusted proportions of CS with logistic regression models.", {"entities": [[37, 39, "GENE"]]}], ["Among several confounders, we focused on high fetal head at term (HFH), which is seldom objectively documentable in medical records.", {"entities": []}], ["A total of 540 maternity units were compared.", {"entities": []}], ["The median HFH prevalence was 0.9%, ranging from 0 to 70%.", {"entities": []}], ["In some units, HFH was coded so frequently that it was unlikely to reflect a natural heterogeneity.", {"entities": []}], ["This \u201cover-coding\u201d was conditional on the outcome because it occurred more frequently for women that underwent CS.", {"entities": [[111, 113, "GENE"]]}], ["This suggested an opportunistic coding to justify the choice of a CS.", {"entities": [[66, 68, "GENE"]]}], ["HFH misclassification was not randomly distributed over Italy; it had an excess in the Campania region where, in some units, the proportion of HFHs gradually increased from 2005 to 2010 (e.g., from 0 to 26%), but the national average remained constant (2.5%).", {"entities": []}], ["The inclusion of the misclassified diagnosis in the models favored those hospitals that codified in a less-than-fair manner.", {"entities": []}], ["Our findings emphasized the importance of rigorously inspecting for differential misclassification of confounders.", {"entities": []}], ["Their validity may be subject to substantial heterogeneity over hospitals, over time and geographical areas.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2458-14-1049) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In New Zealand, as in many other countries, housing in the private-rental sector is in worse condition than in the owner-occupier housing sector.", {"entities": []}], ["New Zealand residential buildings have no inspection regime after original construction signoff.", {"entities": []}], ["Laws and regulations mandating standards for existing residential housing are outdated and spread over a range of instruments.", {"entities": []}], ["Policies to improve standards in existing housing have been notoriously difficult to implement.", {"entities": []}], ["In this methods paper, we describe the development and implementation of a rental Warrant of Fitness (WoF) intended to address these problems.", {"entities": []}], ["Dwellings must pass each of 29 criteria for habitability, insulation, heating, ventilation, safety, amenities, and basic structural soundness to reach the WoF minimum standard.", {"entities": []}], ["The WoF\u2019s development was based on two decades of research on the impact of housing quality on health and wellbeing, and strongly influenced by the UK Housing Health and Safety Rating System and US federal government housing standards.", {"entities": []}], ["Criteria were field-tested across a range of dwelling types and sizes, cities, and climate zones.", {"entities": []}], ["The implementation stage of our WoF research consists of a non-random controlled quasi-experimental study in which we work with two city-level local government councils to implement the rental WoF, recruiting adjoining council areas as controls, and measuring changes in health, economic, and social outcomes.", {"entities": []}], ["Adiposity greatly increases the risk of atherothrombotic events, a pathological condition where a chronic state of oxidative stress is reported to play a major role.", {"entities": []}], ["This study aimed to investigate the involvement of (NO)-soluble guanylyl cyclase (sGC) signaling pathway in the platelet dysfunction from high fat-fed (HFF) rats.", {"entities": []}], ["Male Wistar rats were fed for 10 weeks with standard chow (SCD) or high-fat diet (HFD).", {"entities": [[59, 62, "GENE"]]}], ["ADP (10 \u03bcM)- and thrombin (100 mU/ml)-induced washed platelet aggregation were evaluated.", {"entities": []}], ["Measurement of intracellular levels of ROS levels was carried out using flow cytometry.", {"entities": []}], ["Cyclic GMP levels were evaluated using ELISA kits.", {"entities": []}], ["High-fat fed rats exhibited significant increases in body weight, epididymal fat, fasting glucose levels and glucose intolerance compared with SCD group.", {"entities": [[109, 128, "DISEASE"], [143, 146, "GENE"]]}], ["Platelet aggregation induced by ADP ( n = 8) and thrombin from HFD rats ( n = 8) were significantly greater ( P < 0.05) compared with SCD group.", {"entities": [[134, 137, "GENE"]]}], ["Platelet activation with ADP increased by 54% the intraplatelet ROS production in HFD group, as measured by flow cytometry ( n = 6).", {"entities": []}], ["N-acetylcysteine (NAC; 1 mM) and PEG-catalase (1000 U/ml) fully prevented the increased ROS production and platelet hyperaggregability in HFD group.", {"entities": []}], ["The NO donors sodium nitroprusside (SNP; 10 \u03bcM) and SNAP (10 \u03bcM), as well as the NO-independent soluble guanylyl cyclase stimulator BAY 41-2272 (10 \u03bcM) inhibited the platelet aggregation in HFD group with lower efficacy ( P < 0.05) compared with SCD group.", {"entities": [[246, 249, "GENE"]]}], ["The cGMP levels in response to these agents were also markedly lower in HFD group ( P < 0.05).", {"entities": []}], ["The prostacyclin analogue iloprost (1 \u03bcM) reduced platelet aggregation in HFD and SCD rats in a similar fashion ( n = 4).", {"entities": [[82, 85, "GENE"]]}], ["Metabolic abnormalities as consequence of HFD cause platelet hyperaggregability involving enhanced intraplatelet ROS production and decreased NO bioavailability that appear to be accompanied by potential defects in the prosthetic haem group of soluble guanylyl cyclase.", {"entities": []}], ["To investigate the pathogenic mechanism of late asthmatic response in comparison to early asthmatic response, changes of serum neutrophil chemotactic activity (NCA) using the Boyden chamber method and histamine level using the automated fluorometric analyzer were observed in 13 aspirin (ASA)-sensitive asthma subjects (group I: 7 early responders and group II: 6 dual responders) during lysine aspirin bronchoprovocation test (L-ASA BPT).", {"entities": [[303, 309, "DISEASE"]]}], ["Sera were collected before, and 30 min and 240 min after L-ASA BPT.", {"entities": []}], ["Serum NCA increased significantly after 30 min (p=0.02) and decreased significantly at 240 min (p=0.02) in group I, while serum NCA of group II increased significantly at 30 min (p=0.04), tending to increase further up to 240 min with no statistical significance.", {"entities": []}], ["NCA at 240 min in group II subjects was significantly higher than baseline NCA (p=0.02).", {"entities": []}], ["The serum NCAs collected before and 240 min were significantly higher in group II than in group I (p<0.05, respectively).", {"entities": []}], ["There were no significant changes in serum histamine levels during L-ASA BPT in both groups.", {"entities": []}], ["NCA derived from mast cell may contribute to the development of early asthmatic response induced by L-ASA inhalation.", {"entities": []}], ["There may be a possible involvement of NCA derived from mononuclear cells during late asthmatic response.", {"entities": []}], ["Objectives : To evaluate the performance of the Visual Analogue Scale (VAS), in measuring overall health-related Quality of Life (HRQoL) in children with oral clefts relative to the Pediatric Quality of Life Inventory 4.0 (PedsQL Methods : The study included a population-based sample of 307 children aged 5 to 10 years who were born in Iowa, New York, and Arkansas with non-syndromic oral clefts.", {"entities": []}], ["Data on HRQoL were obtained using a VAS and PedsQL Results : The VAS and PedsQL r = 0.67).", {"entities": []}], ["There were no prominent differences between the correlations of VAS and PedsQL Conclusions : Our study finds the VAS to perform relatively well in measuring overall HRQoL among children with oral clefts.", {"entities": []}], ["The VAS may be useful as a screening tool to identify children with oral clefts at risk of low HRQoL for referral into more comprehensive evaluations and for measuring average HRQoL across a sample of children.", {"entities": []}], ["Takotsubo cardiomyopathy (TCM), also known as \u201cbroken heart syndrome\u201d, is a type of heart failure characterized by transient ventricular dysfunction in the absence of obstructive coronary lesions.", {"entities": [[10, 24, "DISEASE"], [60, 68, "DISEASE"]]}], ["Although associated with increased levels of catecholamines, pathophysiological mechanisms are unknown.", {"entities": []}], ["Relapses and family heritability indicate a genetic predisposition.", {"entities": []}], ["Several small studies have investigated associations between three different loci; the \u03b21-adrenic receptor (ADRB1), G-protein-coupled receptor kinase 5 (GRK5), Bcl-associated athanogene 3 (BAG3) and TCM but no consensus has been reached.", {"entities": [[108, 113, "GENE"], [153, 157, "GENE"], [189, 193, "GENE"]]}], ["Participants were recruited using the Swedish Coronary Angiography and Angioplasty Register (SCAAR).", {"entities": []}], ["TCM patients without coronary artery disease (CAD)( n \u2009=\u2009258) were identified and age- and sex-matched subjects with ( n \u2009=\u2009164) and without ( n \u2009=\u2009243) CAD were selected as controls.", {"entities": []}], ["DNA was isolated from saliva and genotyped for candidate single nucleotide polymorphisms in the ADRB1, GRK5 and BAG3 genes.", {"entities": [[96, 101, "GENE"], [103, 107, "GENE"], [112, 116, "GENE"]]}], ["Allele frequencies and Odds Ratios (OR) with 95% Confidence Intervals (CI) for the investigated polymorphisms were compared, respectively calculated for TCM patients and controls.", {"entities": []}], ["There were no differences in allele frequencies between TCM patients and controls.", {"entities": []}], ["OR (CI) for TCM patients having at least one minor allele using controls as reference were 1.07 (0.75\u20131.55) for ADRB1, 0.45 (0.11\u20131.85) for GRK5 and 1.27 (0.74\u20132.19) for BAG3.", {"entities": [[112, 117, "GENE"], [140, 144, "GENE"], [170, 174, "GENE"]]}], ["By genotyping a large takotsubo cohort, we demonstrate a lack of association between candidate SNPs in the ADRB1, GRK5 and BAG3 genes, earlier suggested to contribute to TCM.", {"entities": [[107, 112, "GENE"], [114, 118, "GENE"], [123, 127, "GENE"]]}], ["Our result indicates a need to expand the search for new genetic candidates contributing to TCM.", {"entities": []}], ["The online version of this article (10.1186/s12881-018-0544-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Vitamin D receptor (VDR) polymorphisms are associated with an increased asthma incidence in human populations; however, observations in Vdr knockout mice are unclear.", {"entities": [[72, 78, "DISEASE"], [20, 23, "GENE"], [136, 139, "GENE"], [20, 23, "GENE"], [136, 139, "GENE"]]}], ["The aim of our study was to determine the influence of the genetic variation in Vdr among inbred strains on lung resistance (i.e., dynamic and airway resistance).", {"entities": [[80, 83, "GENE"]]}], ["In an intercross between the strains C57BL/6J (B6) and KK/HlJ (KK), we identified that a significant QTL for dynamic resistance on Chr X was interacting with a QTL on Chr 15.", {"entities": []}], ["The Chr 15 QTL peak was located in close proximity to the Vdr locus.", {"entities": [[58, 61, "GENE"]]}], ["We further examined if phenotypes of several inbred strains with varying Vdr genotypes differed.", {"entities": [[73, 76, "GENE"]]}], ["Strains with a B6-like genotype on the Vdr locus had significantly lower airway resistance than strains with a KK-like genotype.", {"entities": [[39, 42, "GENE"]]}], ["Vdr knockout mice were examined for dynamic resistance and showed significantly higher resistance than mice with one (i.e., heterozygous) or both copies (i.e., wild-type) of the Vdr .", {"entities": [[0, 3, "GENE"], [178, 181, "GENE"], [0, 3, "GENE"], [178, 181, "GENE"]]}], ["In comparison to B6, the strain A/J is more resistant but carries the same genotype at the Vdr locus.", {"entities": [[91, 94, "GENE"]]}], ["Dietary vitamin D manipulation in the strain A/J did not rescue the high airway resistance phenotype.", {"entities": []}], ["Finally, we observed that serum vitamin D does not correlate significantly with lung resistance parameters in a survey of 18 strains.", {"entities": []}], ["Conclusively, Vdr contributes to the phenotypic variation of lung resistance in inbred mice but other molecules in the Vdr pathway and extended network [i.e., Chr X gene(s)] may contribute as well.", {"entities": [[14, 17, "GENE"], [119, 122, "GENE"], [14, 17, "GENE"], [119, 122, "GENE"]]}], ["The online version of this article (doi:10.1007/s00438-011-0642-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In this article we describe the development of an information system for environmental childhood cancer surveillance.", {"entities": [[97, 103, "DISEASE"]]}], ["The Wisconsin Cancer Registry annually receives more than 25,000 incident case reports.", {"entities": [[14, 20, "DISEASE"]]}], ["Approximately 269 cases per year involve children.", {"entities": []}], ["Over time, there has been considerable community interest in understanding the role the environment plays as a cause of these cancer cases.", {"entities": [[126, 132, "DISEASE"]]}], ["Wisconsin\u2019s Public Health Information Network (WI-PHIN) is a robust web portal integrating both Health Alert Network and National Electronic Disease Surveillance System components.", {"entities": []}], ["WI-PHIN is the information technology platform for all public health surveillance programs.", {"entities": []}], ["Functions include the secure, automated exchange of cancer case data between public health\u2013based and hospital-based cancer registrars; web-based supplemental data entry for environmental exposure confirmation and hypothesis testing; automated data analysis, visualization, and exposure\u2013outcome record linkage; directories of public health and clinical personnel for role-based access control of sensitive surveillance information; public health information dissemination and alerting; and information technology security and critical infrastructure protection.", {"entities": [[52, 58, "DISEASE"], [116, 122, "DISEASE"]]}], ["For hypothesis generation, cancer case data are sent electronically to WI-PHIN and populate the integrated data repository.", {"entities": [[27, 33, "DISEASE"]]}], ["Environmental data are linked and the exposure\u2013disease relationships are explored using statistical tools for ecologic exposure risk assessment.", {"entities": []}], ["For hypothesis testing, case\u2013control interviews collect exposure histories, including parental employment and residential histories.", {"entities": []}], ["This information technology approach can thus serve as the basis for building a comprehensive system to assess environmental cancer etiology.", {"entities": [[125, 131, "DISEASE"]]}], ["In order to adequately assess the effectiveness of vaccination in helping to control vaccine-preventable infectious disease, it is important to identify the adherence and uptake of risk-based recommendations.", {"entities": []}], ["The current project includes data from five consecutive datasets of the National Health and Wellness Survey (NHWS): 2007 through 2011.", {"entities": []}], ["The NHWS is an annual, Internet-based health questionnaire, administered to a nationwide sample of adults (aged 18 or older) which included items on vaccination history as well as high-risk group status.", {"entities": []}], ["Vaccination rates and characteristics of vaccinees were reported descriptively.", {"entities": []}], ["Logistic regressions were conducted to predict vaccination behavior from sociodemographics and risk-related variables.", {"entities": []}], ["The influenza vaccination rate for all adults 18 years and older has increased significantly from 28.0% to 36.2% from 2007 to 2011 (ps<.05).", {"entities": [[4, 13, "DISEASE"]]}], ["Compared with those not at high risk (25.1%), all high-risk groups were vaccinated at a higher rate, from 36.8% (pregnant women) to 69.7% (those with renal/kidney disease); however, considerable variability among high-risk groups was observed.", {"entities": [[156, 170, "DISEASE"]]}], ["Vaccination rates among high-risk groups for other vaccines varied considerably though all were below 50%, with the exception of immunocompromised respondents (57.5% for the hepatitis B vaccine and 52.5% for the pneumococcal vaccine) and the elderly (50.4% for the pneumococcal).", {"entities": [[174, 183, "DISEASE"]]}], ["Multiple risk factors were associated with increased rate of vaccination for most vaccines.", {"entities": []}], ["Significant racial/ethnic differences with influenza, hepatitis, and herpes zoster vaccination rates were also observed (ps<.05).", {"entities": [[43, 52, "DISEASE"], [54, 63, "DISEASE"], [69, 82, "DISEASE"]]}], ["Rates of influenza vaccination have increased over time.", {"entities": [[9, 18, "DISEASE"]]}], ["Rates varied by high-risk status, demographics, and vaccine.", {"entities": []}], ["There was a pattern of modest vaccination rate increases for individuals with multiple risk factors.", {"entities": []}], ["However, there were relatively low rates of vaccination for most risk-based recommendations and all fell below national goals.", {"entities": []}], ["Rotavirus is a common cause of diarrhea worldwide, and vaccination prevents rotaviral gastroenteritis.", {"entities": [[31, 39, "DISEASE"], [86, 101, "DISEASE"]]}], ["Since the rotavirus vaccine was introduced in Korea in 2007, the prevalence of rotaviral gastroenteritis has decreased.", {"entities": [[89, 104, "DISEASE"]]}], ["However, little is known on the economic burden of rotavirus infection and its variations in Korea.", {"entities": []}], ["Here, we estimated the economic costs of rotavirus infection from 2009 to 2012 using nationwide data from the National Health Insurance Service (NHIS) claims.", {"entities": []}], ["Socioeconomic costs were subdivided into direct and indirect and measured with a prevalence-based approach.", {"entities": []}], ["Costs were converted from Won to United States dollars (US$).", {"entities": []}], ["The number of children <5 years old infected with rotavirus decreased from 21,437 to 10,295 during the study period, representing a decrease in prevalence from 947 to 443 per 100,000.", {"entities": []}], ["The sum of direct and indirect costs also decreased, from $17.3 million to $9.6 million, and the days of admission decreased from 76,000 to 38,000.", {"entities": []}], ["However, per capita expenditures slightly increased, from $809 to $934.", {"entities": []}], ["Thus, the economic burden of rotavirus infection decreased after implementation of rotavirus vaccination.", {"entities": []}], ["Including the vaccine as part of the national essential vaccination program could reduce the prevalence of and economic loss from rotavirus infection in Korea.", {"entities": []}], ["Outcome reporting bias (ORB) occurs when variables are selected for publication based on their results.", {"entities": []}], ["This can impact upon the results of a meta-analysis, biasing the pooled treatment effect estimate.", {"entities": []}], ["The aim of this paper is to show how to assess a systematic review and corresponding trial reports for ORB using an example review of intravenous and nebulised magnesium in the treatment of asthma.", {"entities": [[190, 196, "DISEASE"]]}], ["The review was assessed for ORB by 1) checking the reasons, when available, for excluding studies to ensure that no studies were excluded because they did not report the outcomes of interest in the review; 2) assessing the eligible studies as to whether the review outcomes of interest were reported.", {"entities": []}], ["Each study was classified using a system developed in the ORBIT (Outcome Reporting Bias In Trials) project to indicate whether ORB was suspected and a reason for the suspicion.", {"entities": []}], ["Authors of trials that did not report the outcomes of interest were contacted for information.", {"entities": []}], ["A sensitivity analysis was performed to assess the robustness of the conclusions of the review to this potential source of bias.", {"entities": []}], ["Twenty-four studies were included in the review; two studies had been excluded for not reporting either of the two outcomes of interest.", {"entities": []}], ["Six included studies did not report hospital admission and two did not report pulmonary function.", {"entities": []}], ["There was high suspicion of outcome reporting bias in four studies.", {"entities": []}], ["Results from the sensitivity analysis indicate that review conclusions were not overturned.", {"entities": []}], ["This paper demonstrates, with the example of the magnesium review, how to assess a review for outcome reporting bias.", {"entities": []}], ["A review should not exclude studies if they have not reported the outcomes of interest and should consider the potential for outcome reporting bias in all included studies.", {"entities": []}], ["Eosinophils function contributes to human allergic and autoimmune diseases, many of which currently lack curative treatment.", {"entities": []}], ["Development of more effective treatments for eosinophil-related diseases requires expanded understanding of eosinophil signaling and biology.", {"entities": []}], ["Cell signaling requires integration of extracellular signals with intracellular responses, and is organized in part by cholesterol rich membrane microdomains (CRMMs), commonly referred to as lipid rafts.", {"entities": []}], ["Formation of these organizational membrane domains is in turn dependent upon the amount of available cholesterol, which can fluctuate widely with a variety of disease states.", {"entities": []}], ["We tested the hypothesis that manipulating membrane cholesterol content in primary human peripheral blood eosinophils (PBEos) would selectively alter signaling pathways that depend upon membrane-anchored signaling proteins localized within CRMMs ( e.g.", {"entities": []}], [", mitogen activated protein kinase [MAPK] pathway), while not affecting pathways that signal through soluble proteins, like the Janus Kinase/Signal Transducer and Activator of Transcription [JAK/STAT] pathway.", {"entities": []}], ["Cholesterol levels were increased or decreased utilizing cholesterol-chelating methyl-\u03b2-cyclodextrin (M\u03b2CD), which can either extract membrane cholesterol or add exogenous membrane cholesterol depending on whether M\u03b2CD is preloaded with cholesterol.", {"entities": []}], ["Human PBEos were pretreated with M\u03b2CD (cholesterol removal) or M\u03b2CD+Cholesterol (M\u03b2CD+Chol; cholesterol delivery); subsequent IL-5-stimulated signaling and physiological endpoints were assessed.", {"entities": []}], ["M\u03b2CD reduced membrane cholesterol in PBEos, and attenuated an IL-5-stimulated p38 and extracellular-regulated kinase 1/2 phosphorylation (p-p38, p-ERK1/2), and an IL-5-dependent increase in interleukin-1\u03b2 (IL-1\u03b2) mRNA levels.", {"entities": []}], ["In contrast, M\u03b2CD+Chol treatment elevated PBEos membrane cholesterol levels and basal p-p38, but did not alter IL-5-stimulated phosphorylation of ERK1/2, STAT5, or STAT3.", {"entities": [[164, 169, "GENE"]]}], ["Furthermore, M\u03b2CD+Chol pretreatment attenuated an IL-5-induced increase in cell survival at 48 hours, measured as total cellular metabolism.", {"entities": []}], ["The reduction in cell survival following cholesterol addition despite unaltered STAT phosphorylation contradicts the current dogma in which JAK/STAT activation is sufficient to promote eosinophil survival, and suggests an additional, unidentified mechanism critically regulates IL-5-mediated human PBEos survival.", {"entities": []}], ["Five years ago, we reported the identification and characterization of several regulatory T-cell epitopes (now called Tregitopes) that were discovered in the heavy and light chains of IgG (De Groot et al.", {"entities": []}], ["Blood, 2008).", {"entities": []}], ["When added ex vivo to human PBMCs, these Tregitopes activated regulatory T cells (Tregs), increased expression of the transcription factor FoxP3, and induced IL-10 expression in CD4", {"entities": [[139, 144, "GENE"], [178, 181, "GENE"]]}], ["The aim of this study was to compare the incidence of systemic adverse events in patients treated with intravitreal injections of bevacizumab or ranibizumab, and to evaluate whether compared to ranibizumab administration, bevacizumab constitutes a higher risk for systemic adverse events.", {"entities": []}], ["A retrospective review was conducted for 916 consecutive patients treated with at least 1 intravitreal injection of bevacizumab or ranibizumab.", {"entities": []}], ["Cox regression was performed to assess whether a variable had predictive value for occurrence of new systemic adverse events and to account for different follow-up times.", {"entities": []}], ["A total of 702 patients were analyzed; 503 patients received bevacizumab alone, and 199 patients received ranibizumab alone.", {"entities": []}], ["Systemic adverse events occurred in 10 of 702 patients (1.4%): 7 in the bevacizumab group (7/503; 1.4%) and 3 in the ranibizumab group (3/199; 1.5%).", {"entities": []}], ["This difference was not statistically significant (Fisher's exact test, P = 0.573).", {"entities": []}], ["Cox proportional hazards analysis of 4 models did not reveal a covariate that significantly changed the hazard for systemic adverse events.", {"entities": []}], ["In conclusion, compared to ranibizumab, bevacizumab may not increase the risk of systemic adverse events in patients receiving intravitreal injections.", {"entities": []}], ["We attempted to assess coronary artery flow using adenosine-stress and dual-energy mode with dual-source CT (DE-CT).", {"entities": []}], ["Data of 18 patients with suspected coronary arteries disease who had undergone cardiac DE-CT were retrospectively analyzed.", {"entities": []}], ["The patients were divided into two groups: 10 patients who performed adenosine stress CT, and 8 patients who performed rest CT as controls.", {"entities": []}], ["We reconstructed an iodine map and composite images at 120\u00a0kV (120\u00a0kV images) using raw data with scan parameters of 100 and 140\u00a0kV.", {"entities": []}], ["We measured mean attenuation in the coronary artery proximal to the distal portion on both the iodine map and 120\u00a0kV images.", {"entities": []}], ["Coronary enhancement ratio (CER) was calculated by dividing mean attenuation in the coronary artery by attenuation in the aortic root, and was used as an estimate of coronary enhancement.", {"entities": []}], ["Coronary stenosis was identified as a reduction in diameter of >50% on CT angiogram, and myocardial ischemia was diagnosed by adenosine-stress myocardial perfusion scintigraphy.", {"entities": [[100, 108, "DISEASE"]]}], ["The iodine map showed that CER was significantly lower for ischemic territories (0.76\u00a0\u00b1\u00a00.06) or stenosed coronary arteries (0.77\u00a0\u00b1\u00a00.06) than for non-ischemic territories (0.95\u00a0\u00b1\u00a00.21, P \u00a0=\u00a00.02) or non-stenosed coronary arteries (1.07\u00a0\u00b1\u00a00.33, P \u00a0<\u00a00.001).", {"entities": []}], ["The 120\u00a0kV images showed no difference in CER between these two groups.", {"entities": []}], ["Use of CER on the iodine map separated ischemic territories from non-ischemic territories with a sensitivity of 86% and a specificity of 75%.", {"entities": []}], ["Our quantification is the first non-invasive analytical technique for assessment of coronary artery flow using cardiac CT. CER on the iodine map is a candidate method for demonstration of alteration in coronary artery flow under adenosine stress, which is related to the physiological significance of coronary artery disease.", {"entities": []}], ["Gastro-oesophageal reflux disease (GORD) symptoms are common in asthma and have been extensively studied, but less so in the Asian continent.", {"entities": [[64, 70, "DISEASE"]]}], ["Reflux-associated respiratory symptoms (RARS) have, in contrast, been little-studied globally.", {"entities": [[40, 44, "GENE"]]}], ["We report the prevalence of GORD symptoms and RARS in adult asthmatics, and their association with asthma severity and medication use.", {"entities": [[99, 105, "DISEASE"], [46, 50, "GENE"]]}], ["A cross-sectional analytical study.", {"entities": []}], ["A validated interviewer-administered GORD scale was used to assess frequency and severity of seven GORD symptoms.", {"entities": []}], ["Subjects were consecutive asthmatics attending medical clinics.", {"entities": []}], ["Controls were matched subjects without respiratory symptoms.", {"entities": []}], ["The mean (SD) composite GORD symptom score of asthmatics was significantly higher than controls (21.8 (17.2) versus 12.0 (7.6); P < 0.001) as was frequency of each symptom and RARS.", {"entities": [[176, 180, "GENE"]]}], ["Prevalence of GORD symptoms in asthmatics was 59.4% (95% CI, 59.1%-59.6%) versus 28.5% in controls (95% CI, 29.0% - 29.4%).", {"entities": []}], ["36% of asthmatics experienced respiratory symptoms in association with both typical and atypical GORD symptoms, compared to 10% of controls ( P < 0.001).", {"entities": []}], ["An asthmatic had a 3.5 times higher risk of experiencing a GORD symptom after adjusting for confounders (OR 3.5; 95% CI 2.5-5.3).", {"entities": []}], ["Severity of asthma had a strong dose-response relationship with GORD symptoms.", {"entities": [[12, 18, "DISEASE"]]}], ["Asthma medication use did not significantly influence the presence of GORD symptoms.", {"entities": [[0, 6, "DISEASE"]]}], ["GORD symptoms and RARS were more prevalent in a cohort of Sri Lankan adult asthmatics compared to non-asthmatics.", {"entities": [[18, 22, "GENE"]]}], ["Increased prevalence of RARS is associated with both typical and atypical symptoms of GORD.", {"entities": [[24, 28, "GENE"]]}], ["Asthma disease and its severity, but not asthma medication, appear to influence presence of GORD symptoms.", {"entities": [[0, 6, "DISEASE"], [41, 47, "DISEASE"]]}], ["CpG oligodeoxynucleotides (ODN) show promise as immunoprotective agents and vaccine adjuvants.", {"entities": []}], ["CpG ODN type D were shown to improve clinical outcome in rhesus macaques challenged with Leishmania major .", {"entities": []}], ["These ODN have a self-complementary core sequence and a 3\u2032 end poly(G) track that favors G-tetrad formation leading to multimerization.", {"entities": []}], ["Although multimerization appears necessary for localization to early endosomes and signaling via Toll-like receptor 9 (TLR-9), it can result in product polymorphisms, aggregation and precipitation, thereby hampering their clinical applications.", {"entities": []}], ["This study shows that functionalizing the poly(G) track of D ODN with thermolytic 2-( N -formyl- N -methyl)aminoethyl ( fma ) phosphate/thiophosphate protecting groups (pro-D ODN) reduces G-tetrad formation in solution, while allowing tetrad formation inside the cell where the potassium concentration is higher.", {"entities": []}], ["Temperature-dependent cleavage of the fma groups over time further promoted formation of stable G-tetrads.", {"entities": []}], ["Peripheral blood cells internalized pro-D ODN efficiently, inducing high levels of IFN\u03b1, IL-6, IFN\u03b3 and IP-10 and triggering dendritic cell maturation.", {"entities": []}], ["Administration of pro-D35 to macaques challenged with L.major significantly increased the number of antigen-specific IFN\u03b3-secreting PBMC and reduced the severity of the skin lesions demonstrating immunoprotective activity of pro-D ODN in vivo .", {"entities": []}], ["This technology fosters the development of more efficient immunotherapeutic oligonucleotide formulations for the treatment of allergies, cancer and infectious diseases.", {"entities": [[137, 143, "DISEASE"]]}], ["The Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome (PFAPA) is the most common periodic fever syndrome in childhood.", {"entities": [[75, 83, "DISEASE"], [126, 134, "DISEASE"], [29, 39, "DISEASE"]]}], ["Clinically, PFAPA may resemble autoinflammatory diseases, but the etiology is not fully understood.", {"entities": []}], ["We measured inflammatory proteins in plasma and hematologic parameters in children with PFAPA during and between febrile episodes, and in a control group with suspected bacterial pneumonia.", {"entities": [[179, 188, "DISEASE"], [169, 188, "DISEASE"]]}], ["In children with PFAPA, a first blood sample was taken within 24\u00a0hours of a febrile episode and a second sample between episodes.", {"entities": []}], ["In children with pneumonia, the first sample was taken shortly after admission and a second sample after full recovery.", {"entities": [[17, 26, "DISEASE"]]}], ["A total of 22 children with PFAPA and 14 children with pneumonia were included.", {"entities": [[55, 64, "DISEASE"]]}], ["In children with PFAPA, levels of interleukin (IL) 6, CXCL10 and CCL4 were significantly increased during febrile episodes.", {"entities": [[54, 60, "GENE"], [65, 69, "GENE"]]}], ["The levels of IL-6 and CXCL10 were higher in children with PFAPA during febrile episodes than in children with pneumonia.", {"entities": [[111, 120, "DISEASE"], [23, 29, "GENE"]]}], ["The levels of CXCL10 remained higher in children with PFAPA between febrile episodes compared to children with pneumonia after recovery.", {"entities": [[111, 120, "DISEASE"], [14, 20, "GENE"]]}], ["Children with PFAPA had a relative eosinopenia and lymphocytopenia with reduced numbers of both CD4+ and CD8+ T cells during febrile episodes.", {"entities": []}], ["This pattern was not observed in the children with pneumonia.", {"entities": [[51, 60, "DISEASE"]]}], ["The results indicate an innate immune response as the initial step in PFAPA, and a subsequent adaptive response with activation and redistribution of T cells.", {"entities": []}], ["Moreover, an activation of the innate immune system involving CXCL10 may persist between febrile episodes.", {"entities": [[62, 68, "GENE"]]}], ["CXCL10 may be a possibly clinical marker in children with PFAPA.", {"entities": [[0, 6, "GENE"]]}], ["The usefulness of syndromic surveillance for early outbreak detection depends in part on effective statistical aberration detection.", {"entities": []}], ["However, few published studies have compared different detection algorithms on identical data.", {"entities": []}], ["In the largest simulation study conducted to date, we compared the performance of six aberration detection algorithms on simulated outbreaks superimposed on authentic syndromic surveillance data.", {"entities": []}], ["We compared three control-chart-based statistics, two exponential weighted moving averages, and a generalized linear model.", {"entities": []}], ["We simulated 310 unique outbreak signals, and added these to actual daily counts of four syndromes monitored by Public Health \u2013 Seattle and King County's syndromic surveillance system.", {"entities": []}], ["We compared the sensitivity of the six algorithms at detecting these simulated outbreaks at a fixed alert rate of 0.01.", {"entities": []}], ["Stratified by baseline or by outbreak distribution, duration, or size, the generalized linear model was more sensitive than the other algorithms and detected 54% (95% CI = 52%\u201356%) of the simulated epidemics when run at an alert rate of 0.01.", {"entities": []}], ["However, all of the algorithms had poor sensitivity, particularly for outbreaks that did not begin with a surge of cases.", {"entities": []}], ["When tested on county-level data aggregated across age groups, these algorithms often did not perform well in detecting signals other than large, rapid increases in case counts relative to baseline levels.", {"entities": []}], ["Eribulin is a non-taxane, microtubule dynamics inhibitor that increases survival of patients with metastatic breast cancer.", {"entities": [[109, 122, "DISEASE"], [116, 122, "DISEASE"]]}], ["Although eribulin is well tolerated in patients with heavily pretreated disease, eribulin-induced liver dysfunction (EILD) can occur, resulting in treatment modification and subsequent poor disease control.", {"entities": []}], ["We aimed to clarify the effect of EILD on patient survival.", {"entities": []}], ["The medical records of 157 metastatic breast cancer patients treated with eribulin between July 2011 and November 2013 at Cancer Institute Hospital were retrospectively analyzed.", {"entities": [[38, 51, "DISEASE"], [45, 51, "DISEASE"], [122, 128, "DISEASE"]]}], ["EILD was defined as 1) an increase in alanine aminotransferase or aspartate aminotransferase levels >3 times the upper limit of normal, and/or 2) initiation of a liver-supporting oral drug therapy such as ursodeoxycholic acid or glycyron.", {"entities": []}], ["Fatty liver was defined as a decrease in the liver-to-spleen attenuation ratio to <0.9 on a computed tomography scan.", {"entities": []}], ["EILD occurred in 42 patients, including one patient for whom eribulin treatment was discontinued due to severe EILD.", {"entities": []}], ["The patients who developed EILD had significantly higher body mass indices (BMIs) than those who did not develop EILD (24.5 vs. 21.5, respectively; P \u2009<\u20090.0001), with no difference in the dose intensity of eribulin between the two groups ( P \u2009=\u20090.76).", {"entities": []}], ["Interestingly, the patients with EILD exhibited significantly longer progression-free survival (PFS) and overall survival (OS) than those without EILD ( P \u2009=\u20090.010 and P \u2009=\u20090.032, respectively).", {"entities": []}], ["Similarly, among 80 patients without liver metastasis, 19 with EILD exhibited significantly longer PFS and OS than the others ( P \u2009=\u20090.0012 and P \u2009=\u20090.044, respectively), and EILD was an independent prognostic factor of PFS ( P \u2009=\u20090.0079) in multivariate analysis.", {"entities": []}], ["During eribulin treatment, 18 patients developed fatty liver, 11 of whom developed EILD, with a median BMI of 26.7.", {"entities": []}], ["Although EILD and fatty liver occurred at a relatively high frequency in our study, most of the patients did not experience severe adverse effects.", {"entities": []}], ["Surprisingly, the development of EILD was positively associated with patient survival, especially in patients without liver metastases.", {"entities": []}], ["EILD may be a clinically useful predictive biomarker of survival, but further studies are needed to confirm these findings in another cohort of patients.", {"entities": []}], ["Prostate cancer (PCa) is the second most common malignancy amongst men worldwide.", {"entities": [[9, 15, "DISEASE"], [0, 15, "DISEASE"]]}], ["Under PCa maintenance therapy drugs acting as antagonists/partial agonists of hormone receptors against the prostate tissue are used in clinical practices.", {"entities": []}], ["Prominent drugs being Cyproterone acetate, Flutamide, Bicalutamide, they not only cause acute and long-term toxicity, but also develops drug resistance among patients.", {"entities": []}], ["Our focus has been on phytochemicals which do not exhibit any cytotoxicity and have significant androgen receptor (AR) inhibition activity.", {"entities": []}], ["As Protein- Ligand interactions play a key role in structure based drug design, so by using molecular docking, we screened 803 phytochemicals and investigated their binding affinity against AR.", {"entities": []}], ["The three dimensional (3D) structure of AR was retrieved from Protein Data Bank, and docked with 3D Pubchem structures of 803 phytochemicals using Argus Lab.", {"entities": []}], ["Molecular docking and drug likeness studies were made using ADMET properties while Lipinski\u2019s rule of five was performed for the phytochemicals to evaluate their anti-prostate cancer activity.", {"entities": [[176, 182, "DISEASE"], [167, 182, "DISEASE"]]}], ["The results showed that Isobavachin exhibited best binding affinity of \u221213.73\u2009kcal/mol with AR followed by Glabranin, Anthocyanin and Eriosemation.", {"entities": []}], ["Our studies therefore reveal that these four phytochemicals could be promising candidates for further evaluation for PCa prevention or management.", {"entities": []}], ["Obese patients are more likely to encounter with difficult airway management, and supraglottic airway device has been adopted to facilitate tracheal intubation.", {"entities": []}], ["The optimum anesthetic concentration for obese patients to insert a supraglottic airway device with spontaneous respiration has not been investigated.", {"entities": []}], ["This study was designed to determine the end-tidal concentration of sevoflurane that would provide acceptable condition for supraglottic airway device insertion with propofol at induction in obese patients without using neuromuscular blockade.", {"entities": []}], ["Thirty elective obese patients [body mass index (BMI) 30\u201350\u200akg/m The minimum alveolar concentration of sevoflurane for successful insertion of supraglottic airway device calculated using up-and-down method were 2.25 (0.53) % for obese patients.", {"entities": []}], ["The values of the effective concentration of sevoflurane for successful supraglottic airway device insertion in 50% (EC 50 ) and 95% (EC 95 ) of the obese patients obtained by probit regression analysis were 2.09% (95% confidence interval 1.48\u20132.68) and 3.31% (95% confidence interval 2.70\u20138.12), respectively.", {"entities": []}], ["We conclude that sevoflurane at a minimum alveolar concentration of 2.25% can provide optimal conditions for insertion of supraglottic airway device with spontaneous respiration in obese patients with 1\u200amg/kg propofol at induction.", {"entities": []}], ["The lymphatic vasculature plays a critical role in a number of disease conditions of increasing prevalence, such as autoimmune disorders, obesity, blood vascular diseases, and cancer metastases.", {"entities": [[138, 145, "DISEASE"], [176, 182, "DISEASE"]]}], ["Yet, unlike the blood vasculature, the tools available to interrogate the molecular basis of lymphatic dysfunction/disease have been lacking.", {"entities": []}], ["More recently, investigators have reported that dysregulation of the PI3K pathway is involved in syndromic human diseases that involve abnormal lymphatic vasculatures, but there have been few compelling results that show the direct association of this molecular pathway with lymphatic dysfunction in humans.", {"entities": []}], ["Using near-infrared fluorescence lymphatic imaging (NIRFLI) to phenotype and next generation sequencing (NGS) for unbiased genetic discovery in a family with non-syndromic lymphatic disease, we discovered a rare, novel mutation in INPPL1 that encodes the protein SHIP2, which is a negative regulator of the PI3K pathway, to be associated with lymphatic dysfunction in the family.", {"entities": [[231, 237, "GENE"]]}], ["In vitro interrogation shows that SHIP2 is directly associated with impairment of normal lymphatic endothelial cell (LEC) behavior and that SHIP2 associates with receptors that are associated in lymphedema, implicating its direct involvement in the lymphatic vasculature.", {"entities": [[195, 205, "DISEASE"]]}], ["The sphingosine-1-phosphate (S1P) system regulates both thymic and lymph nodes T cell egress which is essential for producing and maintaining the recycling T cell repertoire.", {"entities": []}], ["Infection with the protozoan parasite Trypanosoma cruzi induces a hormonal systemic deregulation that has impact in the thymic S1P homeostasis that ultimately promotes the premature exit of immature CD4", {"entities": [[199, 202, "GENE"]]}], ["Because individual practitioner's commitment to routine screening for IPV is the greatest predictor that women will be screened and referred for services, it is vital that screeners are dedicated, knowledgeable, and confident in their ability to recognize and assist victims of violence.", {"entities": []}], ["Self-efficacy has been consistently linked in the literature with successful outcomes.", {"entities": []}], ["Intimate partner violence (IPV) constitutes a major public health problem.", {"entities": []}], ["In the absence of Federal or State regulation, individual hospitals and systems are left to develop their own policies and procedures.", {"entities": []}], ["This paper describes the policies and procedures developed by an American domestic violence counseling and resource center.", {"entities": []}], ["Design: Post test surveys were used.", {"entities": []}], ["Settings: Hospitals, medical offices, and medical schools surrounding an urban area in Pennsylvania participated.", {"entities": []}], ["Participants: 320 nurses and medical students participated in training provided by a domestic violence center.", {"entities": []}], ["Post test surveys measured self-efficacy, the perceived usefulness of screening the accessibility of victim services, understanding of obstacles faced by victims, and knowledge-level regarding local IPV services.", {"entities": []}], ["Participants also self-reported their gender, age, race, and position with the hospital system.", {"entities": []}], ["Nurses and medical interns exhibit a wide range of self-efficacy regarding their ability to screen victims of intimate partner violence.", {"entities": []}], ["Intimate partner violence (IPV) training yielded participants who were better informed about IPV services and the obstacles faced by victims.", {"entities": []}], ["In the absence of uniform screening guidelines, hospitals, systems, and individual practitioners must be vigilant in screening procedures.", {"entities": []}], ["Partnerships with women's centers may provide valuable resources and training that may ultimately improve patient care.", {"entities": []}], ["Galectin-3 (Gal-3), a \u03b2-galactoside-binding lectin, serves as a pattern-recognition receptor (PRR) of dendritic cells (DCs) in regulating proinflammatory cytokine production.", {"entities": []}], ["Galectin-3 (Gal-3) siRNA downregulates expression of IL-6, IL-1\u03b2 and IL-23 p19, while upregulates IL-10 and IL-12 p35 in TLR/NLR stimulated human MoDCs.", {"entities": []}], ["Furthermore, Gal-3 siRNA-treated MoDCs enhanced IFN-\u03b3 production in SEB-stimulated CD45RO CD4 T-cells, but attenuated IL-17A and IL-5 production by CD4 T-cells.", {"entities": [[90, 93, "GENE"], [148, 151, "GENE"], [90, 93, "GENE"], [148, 151, "GENE"]]}], ["Addition of neutralizing antibodies against Gal-3, or recombinant Gal-3 did not differentially modulate IL-23 p19 versus IL-12 p35.", {"entities": []}], ["The data indicate that intracellular Gal-3 acts as cytokine hub of human DCs in responding to innate immunity signals.", {"entities": []}], ["Gal-3 downregulation reprograms proinflammatory cytokine production by MoDCs that inhibit Th2/Th17 development.", {"entities": []}], ["The use of dietary quality scores/indices to describe diet quality in children has increased in the past decade.", {"entities": []}], ["However, to date, few studies have focused on the use of these scores on disease outcomes such as childhood obesity and most are developed from detailed dietary assessments.", {"entities": [[108, 115, "DISEASE"]]}], ["Therefore, the aims of this study were: firstly to construct a diet quality score (DQS) from a brief dietary assessment tool; secondly to examine the association between diet quality and childhood overweight or obesity; thirdly we also aim to examine the associations between individual DQS components and childhood overweight or obesity.", {"entities": [[211, 218, "DISEASE"], [330, 337, "DISEASE"]]}], ["A secondary analysis of cross sectional data of a sample of 8,568 9-year-old children and their families as part of the Growing Up in Ireland (GUI) study.", {"entities": []}], ["Subjects were drawn from a probability proportionate to size sampling of primary schools throughout Ireland over the school year 2007\u20132008.", {"entities": []}], ["Height and weight were measured by trained researchers using standardised methods and BMI was classified using the International Obesity Taskforce cut-points.", {"entities": [[129, 136, "DISEASE"]]}], ["The DQS (un-weighted) was developed using a 20-item, parent reported, food frequency questionnaire of foods consumed over the past 24\u00a0h. Adjusted odds ratios for overweight and obesity were examined by DQS quintile, using the first quintile (highest diet quality) as the reference category.", {"entities": [[177, 184, "DISEASE"]]}], ["The prevalence of normal weight, overweight and obese was 75, 19 and 6\u00a0% respectively.", {"entities": []}], ["DQS ranged from -5 to 25, higher scores indicated higher diet quality in the continuous score.", {"entities": []}], ["In analyses adjusted for gender, parent\u2019s education, physical activity and T.V.", {"entities": []}], ["viewing, child obesity but not overweight was significantly associated with poor diet quality: OR of 1.56 (95\u00a0% CI 1.02 2.38) in the 5th compared to the 1st DQS quintile.", {"entities": [[15, 22, "DISEASE"]]}], ["Findings from individual food items were inconsistent.", {"entities": []}], ["The findings suggest that diet quality may be an important factor in childhood obesity.", {"entities": [[79, 86, "DISEASE"]]}], ["A simple DQS developed from a short dietary assessment tool is significantly associated with childhood obesity.", {"entities": [[103, 110, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12889-015-1907-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["According to World Health Organisation figures, 30% of all cancer deaths, 20% of all coronary heart diseases and strokes and 80% of all chronic obstructive pulmonary disease are caused by cigarette smoking.", {"entities": [[136, 173, "DISEASE"], [59, 65, "DISEASE"]]}], ["Environmental Tobacco Smoke (ETS) exposure has also been shown to be associated with disease and premature death in non-smokers.", {"entities": []}], ["In response to this environmental health issue, several countries have brought about a smoking ban policy in public places and in the workplace.", {"entities": []}], ["Countries such as the U.S., France, Italy, Ireland, Malta, the Netherlands, Sweden, Scotland, Spain, and England have all introduced policies aimed at reducing the population exposure to ETS.", {"entities": []}], ["Several investigations have monitored the effectiveness of these smoking ban policies in terms of ETS concentrations, human health and smoking prevalence, while others have also investigated a number of alternatives to smoking ban policy measures.", {"entities": []}], ["This paper reviews the state of the art in research, carried out in the field of ETS, smoking bans and Tobacco Control to date and highlights the need for future research in the area.", {"entities": []}], ["Presently, nanotechnology is a multi-trillion dollar business sector that covers a wide range of industries, such as medicine, electronics and chemistry.", {"entities": []}], ["In the current era, the commercial transition of nanotechnology from research level to industrial level is stimulating the world\u2019s total economic growth.", {"entities": []}], ["However, commercialization of nanoparticles might offer possible risks once they are liberated in the environment.", {"entities": []}], ["In recent years, the use of zebrafish ( Danio rerio ) as an established animal model system for nanoparticle toxicity assay is growing exponentially.", {"entities": []}], ["In the current in-depth review, we discuss the recent research approaches employing adult zebrafish and their embryos for nanoparticle toxicity assessment.", {"entities": []}], ["Different types of parameters are being discussed here which are used to evaluate nanoparticle toxicity such as hatching achievement rate, developmental malformation of organs, damage in gill and skin, abnormal behavior (movement impairment), immunotoxicity, genotoxicity or gene expression, neurotoxicity, endocrine system disruption, reproduction toxicity and finally mortality.", {"entities": []}], ["Furthermore, we have also highlighted the toxic effect of different nanoparticles such as silver nanoparticle, gold nanoparticle, and metal oxide nanoparticles (TiO 2 , Al2O 3 , CuO, NiO and ZnO).", {"entities": []}], ["At the end, future directions of zebrafish model and relevant assays to study nanoparticle toxicity have also been argued.", {"entities": []}], ["Direct comparisons of tolerability and safety of concentrated intravenous immunoglobulin ( IVIG ) versus less concentrated products are scarce.", {"entities": []}], ["In this postauthorization, prospective, observational, multicenter study, a systematic comparison of 10% and 5% concentrations of Flebogamma\u00ae DIF IVIG was performed in both adult and pediatric patients treated with the studied IVIG products according to the approved indications under routine conditions.", {"entities": [[142, 145, "GENE"]]}], ["Dose of product administered, adverse events ( AE s), physical assessments, laboratory tests, and concomitant therapy were analyzed.", {"entities": []}], ["Patient recruitment in the 10% and 5% product groups was, respectively, 34 (32 analyzed, 13 of them children, receiving 130 IVIG infusions) and 35 (34 analyzed, receiving 135 IVIG infusions).", {"entities": []}], ["Twenty\u2010four infusions (18.5%; 95% CI : 11.8, 25.1) with the 10% product and 3 (2.2%; 95% CI : \u22120.3, 4.7) with the 5% product were associated with potentially treatment\u2010related AE s ( P \u00a0<\u00a00.0001).", {"entities": []}], ["Nine patients (28.1%) infused with the 10% product and 3 (8.8%) infused with the 5% product presented, respectively, 33 and 8 treatment\u2010related AE s (of which 7 and 6, respectively, were serious AE s, experienced by only three hypersensitive patients).", {"entities": []}], ["The profile of AE s occurring with the infusion of 10% and 5% products were comparable.", {"entities": []}], ["The most frequent treatment\u2010related AE s were headache ( n \u00a0=\u00a017, 3 patients; 15 episodes, 1 patient) and pyrexia ( n \u00a0=\u00a06, 4 patients).", {"entities": []}], ["In conclusion, no unpredictable risk was detected for both Flebogamma DIF 10% and 5% concentrations, which were therefore deemed as safe and well\u2010tolerated IVIG in the studied population.", {"entities": [[70, 73, "GENE"]]}], ["The frequency of infusions associated with treatment\u2010related AE s was lower with the 5% concentration.", {"entities": []}], ["In 2011, two roads in a residential area in Seoul were found to be contaminated with the radionuclide cesium-137 ( The standardized cancer incidence ratios in the affected and neighboring regions were calculated based on the central cancer registry.", {"entities": [[132, 138, "DISEASE"], [233, 239, "DISEASE"]]}], ["Households in the region were sampled using the random stratified sampling technique, and questionnaires were administered to family members, via home visit and via students in elementary to high schools.", {"entities": []}], ["Information on duration of residency and frequency of use of the roads was applied to calculate cumulative radiation exposure dose from the roads, alongside with the reported No significant association was found between self-informed diseases, including cancers, and estimated radiation exposure dose.", {"entities": []}], ["According to an increase of radiation level, a significant increase in anxiety in all and a decline in the psychosocial wellbeing of the adults was noted.", {"entities": []}], ["The risk perception level was higher in the elderly, females, the less educated, and the highest exposed individuals.", {"entities": []}], ["This study provides a basis for risk communication with residents and community environmental health policy.", {"entities": []}], ["Lower respiratory tract infection (LRTI) is a major cause of morbidity and mortality in children.", {"entities": []}], ["Human rhinovirus (HRV) is confirmed to be associated with pediatric lower respiratory tract infection.", {"entities": []}], ["Seasonal and meteorological factors may play a key role in the epidemiology of HRV.", {"entities": []}], ["The purposes of this study were to investigate the frequency, seasonal distribution, and clinical characteristics of hospitalized children with LRTI caused by HRVs.", {"entities": []}], ["In addition, associations between incidence of HRVs and meteorological factors in a subtropical region of China were discussed.", {"entities": []}], ["Hospitalized children <14\u00a0years old admitted to the Respiratory Department of the Children\u2019s Hospital, which is affiliated to Soochow University, between January 1, 2013 and December 31, 2015, were enrolled in this study.", {"entities": []}], ["Multi-pathogens were detected in nasopharyngeal aspirate samples.", {"entities": []}], ["Meanwhile, meteorological factors were recorded.", {"entities": []}], ["The average incidence of HRVs infection was 11.4% (707/6194) and 240 cases of which were co-infection cases with other pathogens.", {"entities": []}], ["Children with co-infection presented more frequent fever and tachypnea compared to children infected with HRVs only (both P \u2009<\u20090.05).", {"entities": []}], ["Among 707 HRV positive children, the mean age was 23.2\u00a0months (range 1 to 140\u00a0months).", {"entities": []}], ["Among all respiratory infections, the highest incidence of HRVs cases occurred in children age 13\u201336 months old (15.1%, 203/1341).", {"entities": []}], ["Of all 228 HRV cases in 2014, 85 cases (37.3%) were HRV-C positive.", {"entities": []}], ["HRVs and HRV-C infection occurred throughout the year during the study period, although a higher incidence was observed in summer and autumn seasons.", {"entities": []}], ["HRVs or HRV-C incidence in hospitalized children with LRTI was associated with the monthly mean temperature (both P \u2009<\u20090.05).", {"entities": []}], ["HRV was one of the most common viral pathogen detected in hospitalized children with LRTI at the Children\u2019s Hospital of Suzhou, China, and had its own seasonal distribution including HRV-C, which was partly caused by temperature.", {"entities": []}], ["Due to the pleiotropic effects of nitric oxide (NO) within the lungs, it is likely that NO is a significant factor in the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[138, 175, "DISEASE"]]}], ["The aim of this study was to test for association between single nucleotide polymorphisms (SNPs) in three NO synthase (NOS) genes and lung function, as well as to examine gene expression and protein levels in relation to the genetic variation.", {"entities": []}], ["One SNP in each NOS gene (neuronal NOS ( NOS1 ), inducible NOS ( NOS2 ), and endothelial NOS ( NOS3 )) was genotyped in the Lung Health Study (LHS) and correlated with lung function.", {"entities": [[41, 45, "GENE"], [65, 69, "GENE"], [95, 99, "GENE"]]}], ["One SNP (rs1800779) was also analyzed for association with COPD and lung function in four COPD case\u2013control populations.", {"entities": []}], ["Lung tissue expression of NOS3 mRNA and protein was tested in individuals of known genotype for rs1800779.", {"entities": [[26, 30, "GENE"]]}], ["Immunohistochemistry of lung tissue was used to localize NOS3 expression.", {"entities": [[57, 61, "GENE"]]}], ["For the NOS3 rs1800779 SNP, the baseline forced expiratory volume in one second in the LHS was significantly higher in the combined AG\u2009+\u2009GG genotypic groups compared with the AA genotypic group.", {"entities": [[8, 12, "GENE"]]}], ["Gene expression and protein levels in lung tissue were significantly lower in subjects with the AG\u2009+\u2009GG genotypes than in AA subjects.", {"entities": []}], ["NOS3 protein was expressed in the airway epithelium and subjects with the AA genotype demonstrated higher NOS3 expression compared with AG and GG individuals.", {"entities": [[0, 4, "GENE"], [106, 110, "GENE"], [0, 4, "GENE"], [106, 110, "GENE"]]}], ["However, we were not able to replicate the associations with COPD or lung function in the other COPD study groups.", {"entities": []}], ["Variants in the NOS genes were not associated with lung function or COPD status.", {"entities": []}], ["However, the G allele of rs1800779 resulted in a decrease of NOS3 gene expression and protein levels and this has implications for the numerous disease states that have been associated with this polymorphism.", {"entities": [[61, 65, "GENE"]]}], ["Aging is associated with an increase in a chronic, low-grade inflammation.", {"entities": []}], ["This phenomenon, termed \u201cinflammaging\u201d is also a risk factor for both morbidity and mortality in the elderly.", {"entities": []}], ["Frequent co-occurrence of chronic diseases, known as multi-morbidity, may be explained by interconnected pathophysiology of these conditions, most of which depend on its inflammatory component.", {"entities": []}], ["Here we present an analysis of the U.S. National Health and Nutrition Examination Survey data collected between 1999 and 2008, for the presence, and the number, of chronic diseases along with HDL-cholesterol, C-reactive protein, white blood cell count, lymphocyte percent, monocyte percent, segmented neutrophils percent, eosinophils percent, basophils percent, and glycohemoglobin levels.", {"entities": []}], ["Importantly, even after adjustment for age and BMI, many inflammatory markers continued to be associated to multi-morbidity.", {"entities": []}], ["C-reactive protein (CRP) levels and Glasgow Prognostic Score (GPS) were most dramatically increased in parallel with an accumulation of chronic diseases, and may be utilized as multi-morbidity predictors.", {"entities": [[20, 23, "GENE"]]}], ["These observations point at background inflammation as direct, age-independent contributor to an accumulation of the disease burden.", {"entities": []}], ["Our findings also suggest a possibility that systemic inflammation associated with chronic diseases may explain accelerated aging phenomenon previously observed among the patients with heavy disease burden.", {"entities": []}], ["Systems medicine has become a key word in biomedical research.", {"entities": []}], ["Although it is often referred to as P4-(predictive, preventive, personalized and participatory)-medicine, it still lacks a clear definition and is open to interpretation.", {"entities": []}], ["This conceptual lack of clarity complicates the scientific and public discourse on chances, risks and limits of Systems Medicine and may lead to unfounded hopes.", {"entities": []}], ["Against this background, our goal was to develop a sufficiently precise and widely acceptable definition of Systems Medicine.", {"entities": []}], ["In a first step, PubMed was searched using the keyword \u201csystems medicine\u201d.", {"entities": []}], ["A data extraction tabloid was developed putting forward a means/ends-division.", {"entities": []}], ["Full-texts of articles containing Systems Medicine in title or abstract were screened for definitions.", {"entities": []}], ["Definitions were extracted; their semantic elements were assigned as either means or ends.", {"entities": []}], ["To reduce complexity of the resulting list, summary categories were developed inductively.", {"entities": []}], ["In a second step, we applied six criteria for adequate definitions (necessity, non-circularity, non-redundancy, consistency, non-vagueness, and coherence) to these categories to derive a so-called pr\u00e9cising definition of Systems Medicine.", {"entities": []}], ["We identified 185 articles containing the term Systems Medicine in title or abstract.", {"entities": []}], ["67 contained at least one definition of Systems Medicine.", {"entities": []}], ["In 98 definitions, we found 114 means and 132 ends.", {"entities": []}], ["From these we derived the pr\u00e9cising definition: Systems Medicine is an approach seeking to improve medical research (i.e.", {"entities": []}], ["the understanding of complex processes occurring in diseases, pathologies and health states as well as innovative approaches to drug discovery) and health care (i.e.", {"entities": []}], ["prevention, prediction, diagnosis and treatment) through stratification by means of Systems Biology (i.e.", {"entities": []}], ["data integration, modeling, experimentation and bioinformatics).", {"entities": []}], ["Our study also revealed the visionary character of Systems Medicine.", {"entities": []}], ["Our insights, on the one hand, allow for a realistic identification of actual ethical as well as legal issues arising in the context of Systems Medicine and, in consequence, for a realistic debate of questions concerning its matter and (future) handling.", {"entities": []}], ["On the other hand, they help avoiding unfounded hopes and unrealistic expectations.", {"entities": []}], ["This especially holds for goals like improving patient participation which are intensely debated in the context of Systems Medicine, however not implied in the concept.", {"entities": []}], ["The online version of this article (10.1186/s12913-017-2688-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Healthy carriers of severe Hemoglobinopathies are usually asymptomatic and only efficiently detected through screening campaigns.", {"entities": []}], ["Based upon epidemiological data, screenings have been offered for decades to populations of endemic Southern Europe for primary prevention of Thalassemia Major, while for many populations of the highly endemic African and Asian countries prevention for Sickle Cell Disease and Thalassemia Major is mainly unavailable.", {"entities": []}], ["The massive migrations of the last decades have brought many healthy carriers of these diseases to live and reproduce in non-endemic immigration areas changing the epidemiological pattern of the local recessive diseases and bringing an urgent need for treatment and primary prevention in welfare countries.", {"entities": []}], ["Nonetheless, no screening for an informed reproductive choice is actively offered by the healthcare systems of most of these welfare countries.", {"entities": []}], ["As a consequence more children affected with severe Hemoglobinopathies are born today in the immigration countries of Northern Europe than in the endemic Southern European area.", {"entities": []}], ["Following the Mediterranean example, some countries like the UK and The Netherlands have been offering early pregnancy carrier screening at different levels and/or in specific areas but more accessible measures need to be taken at the national level in all immigration countries.", {"entities": []}], ["Identification of carriers using simple and inexpensive methods should be included in the Rhesus and infectious diseases screening which is offered early in pregnancy in most developed countries.", {"entities": []}], ["This would allow identification of couples at risk in time for an informed choice and for prenatal diagnosis if required before the first affected child is born.", {"entities": []}], ["The Family Smoking Prevention and Tobacco Control Act of 2009 gave the Food and Drug Administration (FDA) regulatory authority over cigarettes and smokeless tobacco products and authorised it to assert jurisdiction over other tobacco products.", {"entities": []}], ["As with other Federal agencies, FDA is required to assess the costs and benefits of its significant regulatory actions.", {"entities": []}], ["To date, FDA has issued economic impact analyses of one proposed and one final rule requiring graphic warning labels (GWLs) on cigarette packaging and, most recently, of a proposed rule that would assert FDA\u2019s authority over tobacco products other than cigarettes and smokeless tobacco.", {"entities": []}], ["Given the controversy over the FDA's approach to assessing net economic benefits in its proposed and final rules on GWLs and the importance of having economic impact analyses prepared in accordance with sound economic analysis, a group of prominent economists met in early 2014 to review that approach and, where indicated, to offer suggestions for an improved analysis.", {"entities": []}], ["We concluded that the analysis of the impact of GWLs on smoking substantially underestimated the benefits and overestimated the costs, leading the FDA to substantially underestimate the net benefits of the GWLs.", {"entities": []}], ["We hope that the FDA will find our evaluation useful in subsequent analyses, not only of GWLs but also of other regulations regarding tobacco products.", {"entities": []}], ["Most of what we discuss applies to all instances of evaluating the costs and benefits of tobacco product regulation and, we believe, should be considered in FDA's future analyses of proposed rules.", {"entities": []}], ["The neuropeptide Pituitary adenylate cyclase-activating polypeptide (PACAP) plays pivotal roles in immunity and inflammation.", {"entities": [[69, 74, "GENE"]]}], ["So far, potential immune-modulatory properties of PACAP have not been investigated in experimental ileitis.", {"entities": [[50, 55, "GENE"]]}], ["Mice were perorally infected with Toxoplasma (T.) gondii to induce acute ileitis (day 0) and treated daily with synthetic PACAP38 from day 1 to 6 post infection (p.i.", {"entities": []}], ["; prophylaxis) or from day 4 to 6 p.i.", {"entities": []}], ["Whereas placebo-treated control mice suffered from acute ileitis at day 7 p.i.", {"entities": []}], ["and succumbed to infection, intestinal immunopathology was ameliorated following PACAP prophylaxis.", {"entities": [[81, 86, "GENE"]]}], ["PACAP-treated mice exhibited increased abundance of small intestinal FOXP3+ cells, but lower numbers of ileal T lymphocytes, neutrophils, monocytes and macrophages, which was accompanied by less ileal expression of pro-inflammatory cytokines such as IL-23p19, IL-22, IFN-\u03b3, and MCP-1.", {"entities": []}], ["Furthermore, PACAP-treated mice displayed higher anti-inflammatory IL-4 concentrations in mesenteric lymph nodes and liver and higher systemic anti-inflammatory IL-10 levels in spleen and serum as compared to control animals at day 7 p.i.", {"entities": []}], ["Remarkably, PACAP-mediated anti-inflammatory effects could also be observed in extra-intestinal compartments as indicated by reduced pro-inflammatory mediator levels in spleen (TNF-\u03b1, nitric oxide) and liver (TNF-\u03b1, IFN-\u03b3, MCP-1, IL-6) and less severe histopathological sequelae in lungs and kidneys following prophylactic PACAP treatment.", {"entities": [[12, 17, "GENE"], [323, 328, "GENE"]]}], ["Strikingly, PACAP prolonged survival of T. gondii infected mice in a time-of-treatment dependent manner.", {"entities": [[12, 17, "GENE"]]}], ["Synthetic PACAP ameliorates acute small intestinal inflammation and extra-intestinal sequelae by down-regulating Th1-type immunopathology, reducing oxidative stress and up-regulating anti-inflammatory cytokine responses.", {"entities": [[10, 15, "GENE"]]}], ["These findings provide novel potential treatment options of inflammatory bowel diseases.", {"entities": []}], ["People of South Asian backgrounds living in the UK have a five-fold increased risk of diabetes and a two-fold increased risk of heart disease when compared to the general population.", {"entities": [[128, 141, "DISEASE"]]}], ["Physical activity can reduce the risk of premature death from a range of conditions.", {"entities": []}], ["The aim of the study was to explore the motivating and facilitating factors likely to increase physical activity for South Asian adults and their families, in order to develop successful interventions and services.", {"entities": []}], ["This was a qualitative study using focus groups and in-depth interviews.", {"entities": []}], ["Participants were 59 purposively selected Bangladeshi-, Indian- and Pakistani-origin men and women with an additional 10 key informants.", {"entities": []}], ["The setting was three urban areas of Scotland: Aberdeen, Glasgow and Edinburgh.", {"entities": []}], ["We undertook a theoretically informed thematic analysis of data.", {"entities": []}], ["Study participants described engaging in a range of physical activities, particularly football and the gym for men, and walking and swimming for women.", {"entities": []}], ["The main motivators for taking part in physical activity were external motivators \u2013 i.e.", {"entities": []}], ["undertaking physical activity as a means to an end, which included the opportunities that physical activity provided for social activity and enjoyment.", {"entities": []}], ["The goals of weight reduction and improving mental and physical health and were also mentioned.", {"entities": []}], ["Role models were seen as important to inspire and motivate people to undertake activities that they may otherwise lack confidence in.", {"entities": []}], ["Few people undertook physical activity for its own sake (intrinsic motivation).", {"entities": []}], ["Attempts at promoting physical activity in people of South Asian origin need to take account of the social context of people's lives and the external motivators that encourage them to engage in physical activity.", {"entities": []}], ["Undertaking group based physical activity is important and can be facilitated through religious, community, friendship or family networks.", {"entities": []}], ["Role models may also prove particularly helpful.", {"entities": []}], ["The objective of this study is to investigate whether the characteristics of the structure of primary health units and the work process of primary care teams are associated with the number of hospitalizations for primary care sensitive conditions.", {"entities": []}], ["In this ecological study, we have analyzed data of Brazilian municipalities related to sociodemographic characteristics, coverage of care programs, structure of primary health units, and work process of primary care teams.", {"entities": []}], ["We have obtained the data from the first cycle of the Brazilian Program for Improving Access and Quality of the Primary Care, of the Department of Information Technology of the Brazilian Unified Health System, the Brazilian Institute of Geography and Statistics, and the United Nations Development Programme.", {"entities": []}], ["The associations have been estimated using negative binomial regression coefficients (\u03b2) and respective 95% confidence intervals, with a hierarchical approach in three levels (alpha = 5%).", {"entities": []}], ["In the adjusted analysis for the outcome in 2013, in the distal level, the coverage of the Bolsa Fam\u00edlia Program (\u03b2 = -0.001) and private insurance (\u03b2 = -0.01) had a negative association, and the human development index (\u03b2 = 1.13), the proportion of older adults (\u03b2 = 0.05) and children under the age of five (\u03b2 = 0.05), and the coverage of the Community Health Agent Strategy (\u03b2 = 0.002) showed positive association with hospitalizations for primary care sensitive conditions.", {"entities": []}], ["In the intermediate level, minimum hours (\u03b2 = -0.14) and availability of vaccines (\u03b2 = -0.16) showed a negative association, and availability of medications showed a positive association (\u03b2 = 0.16).", {"entities": []}], ["In the proximal level, only the variable of matrix support (\u03b2 = 0.10) showed a positive association.", {"entities": []}], ["The variables in the adjusted analysis of the number of hospitalizations for primary care sensitive conditions in 2014 presented the same association as in 2013.", {"entities": []}], ["The characteristics of the structure of primary health units and the work process of the primary care teams impact the number of hospitalizations for primary care sensitive conditions in Brazilian municipalities.", {"entities": []}], ["In large cohort studies comorbidities are usually self-reported by the patients.", {"entities": []}], ["This way to collect health information only represents conditions known, memorized and openly reported by the patients.", {"entities": []}], ["Several studies addressed the relationship between self-reported comorbidities and medical records or pharmacy data, but none of them provided a structured, documented method of evaluation.", {"entities": []}], ["We thus developed a detailed procedure to compare self-reported comorbidities with information on comorbidities derived from medication inspection.", {"entities": []}], ["This was applied to the data of the German COPD cohort COSYCONET.", {"entities": []}], ["Approach I was based solely on ICD10-Codes for the diseases and the indications of medications.", {"entities": []}], ["To overcome the limitations due to potential non-specificity of medications, Approach II was developed using more detailed information, such as ATC-Codes specific for one disease.", {"entities": []}], ["The relationship between reported comorbidities and medication was expressed by a four-level concordance score.", {"entities": []}], ["Approaches I and II demonstrated that the patterns of concordance scores markedly differed between comorbidities in the COSYCONET data.", {"entities": []}], ["On average, Approach I resulted in more than 50% concordance of all reported diseases to at least one medication.", {"entities": []}], ["The more specific Approach II showed larger differences in the matching with medications, due to large differences in the disease-specificity of drugs.", {"entities": []}], ["The highest concordance was achieved for diabetes and three combined cardiovascular disorders, while it was substantial for dyslipidemia and hyperuricemia, and low for asthma.", {"entities": [[141, 154, "DISEASE"], [168, 174, "DISEASE"]]}], ["Both approaches represent feasible strategies to confirm self-reported diagnoses via medication.", {"entities": []}], ["Approach I covers a broad spectrum of diseases and medications but is limited regarding disease-specificity.", {"entities": []}], ["Approach II uses the information from medications specific for a single disease and therefore can reach higher concordance scores.", {"entities": []}], ["The strategies described in a detailed and reproducible manner are generally applicable in large studies and might be useful to extract as much information as possible from the available data.", {"entities": []}], ["The objective of this study was to evaluate the prevalence of asthma, allergic rhinitis, and atopic dermatitis, as well as the risk factors of wheezing among young adults in the Korean military.", {"entities": [[70, 87, "DISEASE"], [93, 110, "DISEASE"], [79, 87, "DISEASE"], [62, 68, "DISEASE"], [100, 110, "DISEASE"]]}], ["Young military conscripts in five areas completed a modified International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire.", {"entities": [[84, 90, "DISEASE"]]}], ["For subjects with current wheeze in one sample area, baseline spirometry and bronchodilator response were measured.", {"entities": []}], ["For subjects without a significant response to bronchodilator (improvement in FEV1 of more than 200 mL and 12%), methacholine challenge tests (MCT) were also performed.", {"entities": []}], ["Of 3,359 subjects that completed the questionnaire, 354 (10.5%) had current wheeze, 471 (14.0%) had current allergic rhinitis, and 326 (9.7%) had current eczema.", {"entities": [[108, 125, "DISEASE"], [117, 125, "DISEASE"]]}], ["Current wheeze was associated with family history of allergic disease, overweight, current smoking, allergic rhinitis, and atopic dermatitis.", {"entities": [[100, 117, "DISEASE"], [123, 140, "DISEASE"], [109, 117, "DISEASE"], [130, 140, "DISEASE"]]}], ["Of 36 subjects with current wheeze who underwent PFT with or without MCT in the Anyang area, 24 (66.7%) were confirmed to have current asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["In conclusion, the prevalence of allergic disease in young adults of Korean military is not low, and the risk factors of wheezing include family history of allergic disease, overweight, current smoking, allergic rhinitis, and atopic dermatitis.", {"entities": [[203, 220, "DISEASE"], [226, 243, "DISEASE"], [212, 220, "DISEASE"], [233, 243, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) and farming are two conditions that have been associated with an increased risk of anxiety and depression.", {"entities": []}], ["Dairy farming is an independent risk factor for COPD.", {"entities": []}], ["To test the hypotheses that the prevalence of anxiety and/or depression is higher in dairy farmers with COPD than in farmers without COPD, and higher in dairy farmers with COPD than in non-farmers with COPD.", {"entities": []}], ["Anxiety and depression were evaluated using the Hospital Anxiety and Depression Scale in 100 dairy farmers with COPD (DF-COPD), 98 dairy farmers without COPD (DF-controls), 85 non-farming patients with COPD (NF-COPD) and 89 non-farming subjects without COPD (NF-controls), all identified by screening in the Franche-Comt\u00e9 region of France.", {"entities": []}], ["Anxiety and depression were considered present when the Hospital Anxiety and Depression Scale score was \u22658.", {"entities": []}], ["COPD was defined by a post-bronchodilator forced expiratory volume in 1 second/forced vital capacity ratio <0.7.", {"entities": []}], ["The crude prevalence of anxiety did not differ between the four groups, ranging from 36% in NF-controls to 47% in NF-COPD ( p =0.15 between groups).", {"entities": []}], ["Similarly, the prevalence of depression did not differ significantly between the four groups ( p =0.16 between groups).", {"entities": []}], ["In dairy farmers (n=198), the only factors associated with anxiety were quality of life and current smoking.", {"entities": []}], ["Depression in dairy farmers was associated with airflow limitation (lower forced expiratory volume in 1 second and COPD grade 2 or more) as well as with some COPD-related features (dyspnea severity, current smoking, and poorer quality of life).", {"entities": []}], ["In non-farmers, both anxiety and depression were associated with airflow limitation and COPD-related features.", {"entities": []}], ["In our population, the prevalence of anxiety and/or depression was similar in dairy farmers with and without COPD and in non-farmers with COPD.", {"entities": []}], ["Nevertheless, the degree of airway obstruction and some COPD-related features were associated with depression among dairy farmers, whereas these factors were not associated with anxiety.", {"entities": []}], ["Hand dermatitis is a common, chronic relapsing skin disease, resulting from a variety of causes including endogenous predisposition and environmental exposures to irritants and allergens.", {"entities": [[47, 59, "DISEASE"], [5, 15, "DISEASE"]]}], ["Physical activities have been reported to be beneficial for patients with hand dermatitis.", {"entities": [[79, 89, "DISEASE"]]}], ["We aim to evaluate the association between self-reported physical activities and hand dermatitis using the 2003-2004 National Health and Nutrition Examination Survey (NHANES) database.", {"entities": [[86, 96, "DISEASE"]]}], ["Information regarding 2,688 participants aged 20 to 59 years from the 2003-2004 NHANES cycle were retrieved and analyzed.", {"entities": []}], ["Diagnosis of hand dermatitis was based on standardized photographs of the hands read by two dermatologists.", {"entities": [[18, 28, "DISEASE"]]}], ["Physical activity during leisure time for the prior 30 days was assessed using standardized questionnaire.", {"entities": []}], ["Based on the suggested MET scores provided for each response in the questionnaire section of the NHANES methodology, the MET scores for average level of physical activities, walking/bicycling, and performing tasks around home/yard for the past 30 days was calculated.", {"entities": []}], ["There were 42 (1.56%) diagnosed cases of active hand dermatitis among the 2,688 participants.", {"entities": [[53, 63, "DISEASE"]]}], ["Those who reported recent vigorous or moderate physical activities were less likely to have a diagnosis of active hand dermatitis (OR: 0.436, 95% CI: 0.200 to 0.947, P = 0.036 and OR: 0.489, 95% CI: 0.261 to 0.916, P = 0.025, respectively).", {"entities": [[119, 129, "DISEASE"]]}], ["This negative association remained statistically significant even after adjusting for age, gender, ethnic groups and atopic diathesis.", {"entities": []}], ["Moderate and vigorous levels of physical activities appeared to be beneficial for hand dermatitis.", {"entities": [[87, 97, "DISEASE"]]}], ["Therefore, it is important to advise patients with active hand dermatitis to remain physically active.", {"entities": [[63, 73, "DISEASE"]]}], ["However, clinicians should also be cognizant of the fact that the heat and sweat generated from physical activities might also exacerbate the condition.", {"entities": []}], ["Immunological parameters are hard to measure.", {"entities": []}], ["A well-known problem is the occurrence of values below the detection limit, the non-detects.", {"entities": []}], ["Non-detects are a nuisance, because classical statistical analyses, like ANOVA and regression, cannot be applied.", {"entities": []}], ["The more advanced statistical techniques currently available for the analysis of datasets with non-detects can only be used if a small percentage of the data are non-detects.", {"entities": []}], ["Quantile regression, a generalization of percentiles to regression models, models the median or higher percentiles and tolerates very high numbers of non-detects.", {"entities": []}], ["We present a non-technical introduction and illustrate it with an implementation to real data from a clinical trial.", {"entities": []}], ["We show that by using quantile regression, groups can be compared and that meaningful linear trends can be computed, even if more than half of the data consists of non-detects.", {"entities": []}], ["Quantile regression is a valuable addition to the statistical methods that can be used for the analysis of immunological datasets with non-detects.", {"entities": []}], ["Murine \u03b3 -herpesvirus 68 (MHV-68) infection of Mus musculus -derived strains of mice is an established model of \u03b3 -herpesvirus infection.", {"entities": []}], ["We have previously developed an alternative system using a natural host, the wood mouse ( Apodemus sylvaticus ), and shown that the MHV-68 M3 chemokine-binding protein contributes significantly to MHV-68 pathogenesis.", {"entities": []}], ["Here we demonstrate in A. sylvaticus using high-density micro-arrays that M3 influences the expression of genes involved in the host response including Scgb1a1 and Bpifa1 that encode potential innate defense proteins secreted into the respiratory tract.", {"entities": [[152, 159, "GENE"]]}], ["Further analysis of MHV-68-infected animals showed that the levels of both protein and RNA for SCGB1A1 and BPIFA1 were decreased at day 7 post infection (p.i.)", {"entities": [[95, 102, "GENE"]]}], ["but increased at day 14 p.i.", {"entities": []}], ["as compared with M3-deficient and mock-infected animals.", {"entities": []}], ["The modulation of expression was most pronounced in bronchioles but was also present in the bronchi and trachea.", {"entities": []}], ["Double staining using RNA in situ hybridization and immunohistology demonstrated that much of the BPIFA1 expression occurs in club cells along with SCGB1A1 and that BPIFA1 is stored within granules in these cells.", {"entities": [[148, 155, "GENE"]]}], ["The increase in SCGB1A1 and BPIFA1 expression at day 14 p.i.", {"entities": [[16, 23, "GENE"]]}], ["was associated with the differentiation of club cells into mucus-secreting cells.", {"entities": []}], ["Our data highlight the role of club cells and the potential of SCGB1A1 and BPIFA1 as innate defense mediators during respiratory virus infection.", {"entities": [[63, 70, "GENE"]]}], ["Methotrexate, a folate antagonist, is a mainstay treatment for childhood acute lymphoblastic leukemia.", {"entities": [[93, 101, "DISEASE"], [79, 101, "DISEASE"]]}], ["It is also widely used in a low dose formulation to treat patients with rheumatoid arthritis.", {"entities": [[72, 92, "DISEASE"], [83, 92, "DISEASE"]]}], ["In rats, methotrexate is known to induce micronuclei formation, leading to genetic damage, while vitamin A is known to protect against such methotrexate-induced genetic damage.", {"entities": []}], ["Leucovorin (folinic acid) is generally administered with methotrexate to decrease methotrexate-induced toxicity.", {"entities": []}], ["We aimed to determine whether vitamin A and leucovorin differed in their capacity to prevent formation of methotrexate-induced micronuclei in rat bone marrow erythrocytes.", {"entities": []}], ["The present study also aimed to evaluate the effect of combined treatment with vitamin A and leucovorin on the formation of methotrexate-induced micronuclei.", {"entities": []}], ["Male and female Wistar rats (n=8) were injected with 20 mg/kg methotrexate (single i.p.", {"entities": []}], ["The control group received an equal volume of distilled water.", {"entities": []}], ["The third and fourth groups of rats received vitamin A (5000 IU daily dose for 4 successive days) and leucovorin (0.5 mg/kg i.p.", {"entities": []}], ["dose for 4 successive days), respectively.", {"entities": []}], ["The fifth and sixth groups of rats received a combination of vitamin A and a single dose of methotrexate and a combination of leucovorin and methotrexate, respectively.", {"entities": []}], ["The last group of rats received a combination of leucovorin, vitamin A and single dose of methotrexate.", {"entities": []}], ["Samples were collected at 24 hours after the last dose of the treatment into 5% bovine albumin.", {"entities": []}], ["Smears were obtained and stained with May-Grunwald and Giemsa.", {"entities": []}], ["One thousand polychromatic erythrocytes were counted per animal for the presence of micronuclei and the percentage of polychromatic erythrocyte was determined.", {"entities": []}], ["Comparison of methotrexate-treated rats with the control group showed a significant increase in the percentage of cells with micronuclei and a significant decrease polychromatic erythrocyte percentage.", {"entities": []}], ["Combined methotrexate and vitamin A therapy and combined methotrexate and leucovorin therapy led to significant decreases in the micronuclei percentage and an increase in polychromatic erythrocyte percentage when compared to rats treated with methotrexate alone.", {"entities": []}], ["Leucovorin was found to be more effective than vitamin A against the formation of methotrexate-induced micronuclei.", {"entities": []}], ["Both vitamin A and leucovorin provided significant protection against genetic damage induced by methotrexate.", {"entities": []}], ["Atopic dermatitis (AD) is the most common dermatological disease of childhood.", {"entities": [[7, 17, "DISEASE"]]}], ["Many children with AD have asthma and AD shares regions of genetic linkage with psoriasis, another chronic inflammatory skin disease.", {"entities": [[80, 89, "DISEASE"], [27, 33, "DISEASE"], [120, 132, "DISEASE"]]}], ["We present here a genome-wide association study (GWAS) of childhood-onset AD in 1563 European cases with known asthma status and 4054 European controls.", {"entities": [[111, 117, "DISEASE"]]}], ["Using Illumina genotyping followed by imputation, we generated 268 034 consensus genotypes and in excess of 2 million single nucleotide polymorphisms (SNPs) for analysis.", {"entities": []}], ["Association signals were assessed for replication in a second panel of 2286 European cases and 3160 European controls.", {"entities": []}], ["Four loci achieved genome-wide significance for AD and replicated consistently across all cohorts.", {"entities": []}], ["These included the epidermal differentiation complex ( EDC ) on chromosome 1, the genomic region proximal to LRRC32 on chromosome 11, the RAD50/IL13 locus on chromosome 5 and the major histocompatibility complex (MHC) on chromosome 6; reflecting action of classical HLA alleles.", {"entities": [[109, 115, "GENE"], [266, 269, "GENE"]]}], ["We observed variation in the contribution towards co-morbid asthma for these regions of association.", {"entities": [[60, 66, "DISEASE"]]}], ["We further explored the genetic relationship between AD, asthma and psoriasis by examining previously identified susceptibility SNPs for these diseases.", {"entities": [[68, 77, "DISEASE"], [57, 63, "DISEASE"]]}], ["We found considerable overlap between AD and psoriasis together with variable coincidence between allergic rhinitis (AR) and asthma.", {"entities": [[98, 115, "DISEASE"], [45, 54, "DISEASE"], [107, 115, "DISEASE"], [125, 131, "DISEASE"]]}], ["Our results indicate that the pathogenesis of AD incorporates immune and epidermal barrier defects with combinations of specific and overlapping effects at individual loci.", {"entities": []}], ["The integrin alpha v beta 6 is only expressed in epithelial cells.", {"entities": []}], ["In healthy adult epithelia, this receptor is barely detectable, but expression is rapidly induced following epithelial injury.", {"entities": []}], ["Mice homozygous for a null mutation in the gene encoding the beta 6 subunit had juvenile baldness associated with infiltration of macrophages into the skin, and accumulated activated lymphocytes around conducting airways in the lungs.", {"entities": []}], ["Beta 6-/- mice also demonstrated airway hyperresponsiveness to acetylcholine, a hallmark feature of asthma.", {"entities": [[100, 106, "DISEASE"]]}], ["These results suggest that the epithelial integrin alpha v beta 6 participates in the modulation of epithelial inflammation.", {"entities": []}], ["Genetic or acquired alterations in this integrin could thus contribute to the development of inflammatory diseases of epithelial organs, such as the lungs and skin.", {"entities": []}], ["The objective of this review was to evaluate the use of all direct and indirect methods used to estimate health utilities in both children and adolescents.", {"entities": []}], ["Utilities measured pre- and post-intervention are combined with the time over which health states are experienced to calculate quality-adjusted life years (QALYs).", {"entities": []}], ["Cost-utility analyses (CUAs) estimate the cost-effectiveness of health technologies based on their costs and benefits using QALYs as a measure of benefit.", {"entities": []}], ["The accurate measurement of QALYs is dependent on using appropriate methods to elicit health utilities.", {"entities": []}], ["We sought studies that measured health utilities directly from patients or their proxies.", {"entities": []}], ["We did not exclude those studies that also included adults in the analysis, but excluded those studies focused only on adults.", {"entities": []}], ["We evaluated 90 studies from a total of 1,780 selected from the databases.", {"entities": []}], ["47 (52%) studies were CUAs incorporated into randomised clinical trials; 23 (26%) were health-state utility assessments; 8 (9%) validated methods and 12 (13%) compared existing or new methods.", {"entities": []}], ["22 unique direct or indirect calculation methods were used a total of 137 times.", {"entities": []}], ["Direct calculation through standard gamble, time trade-off and visual analogue scale was used 32 times.", {"entities": []}], ["The EuroQol EQ-5D was the most frequently-used single method, selected for 41 studies.", {"entities": []}], ["15 of the methods used were generic methods and the remaining 7 were disease-specific.", {"entities": []}], ["48 of the 90 studies (53%) used some form of proxy, with 26 (29%) using proxies exclusively to estimate health utilities.", {"entities": []}], ["Several child- and adolescent-specific methods are still being developed and validated, leaving many studies using methods that have not been designed or validated for use in children or adolescents.", {"entities": []}], ["Several studies failed to justify using proxy respondents rather than administering the methods directly to the patients.", {"entities": []}], ["Only two studies examined missing responses to the methods administered with respect to the patients\u2019 ages.", {"entities": []}], ["Public health research is an important component of United Kingdom (UK) health research and strategic analysis of its breadth and balance is key to ensure value.", {"entities": []}], ["The National Institute for Health Research (NIHR) is one of the main funders of health research in the UK and includes many research programmes and schools.", {"entities": []}], ["This study reports on public health research funded by the NIHR between April 2006 and March 2013.", {"entities": []}], ["The NIHR research programmes and schools were asked for information about all research funded during the study period.", {"entities": []}], ["Firstly, projects were classified as a public health research project according to inclusion and exclusion criteria.", {"entities": []}], ["The public health research projects were further categorised according to the Public Health Outcomes Framework and the National Institute for Health and Care Excellence taxonomy.", {"entities": []}], ["Approximately 3000 research projects were funded by the NIHR, of which about 900 were relevant to public health.", {"entities": []}], ["This represents approximately one-third of the research portfolio.", {"entities": []}], ["All NIHR research funding programmes and schools funded research related to public health.", {"entities": []}], ["The most prevalent domain of the Public Health Outcomes Framework was \u2018healthcare public health and preventing premature mortality\u2019 and there were a large number of health planning and self-management projects.", {"entities": []}], ["One-quarter of projects were concerned with mental health and behavioural conditions.", {"entities": []}], ["The NIHR is a significant funder of research relevant to public health.", {"entities": []}], ["This analysis offers a snapshot of the breadth and balance of NIHR research, which forms a basis for discussion.", {"entities": []}], ["This is important for the NIHR and other research funders as it shows areas that are better represented and opportunities to fill important gaps.", {"entities": []}], ["Appropriate research priority setting is an integral part of a needs-led research agenda and adds value to research.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-016-3521-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study aims to explore the relationship between serum vitamin A and 25-hydroxyvitamin D3 (25OHD3) levels with pulmonary function and quality of life (QOL) in children with stable asthma.", {"entities": [[183, 189, "DISEASE"]]}], ["A total of 117 cases of children with stable asthma were assigned into the case group and 129 healthy children underwent physical examination during the same period into the control group.", {"entities": [[45, 51, "DISEASE"]]}], ["Electrochemiluminescence was employed to determine serum vitamin A and 25OHD3 levels.", {"entities": []}], ["The children with stable asthma were further divided into the mild, moderate, and severe groups according to their degree of asthma.", {"entities": [[25, 31, "DISEASE"], [125, 131, "DISEASE"]]}], ["A pulmonary function meter was used to assess the pulmonary function indexes: percentage of forced expiratory volume in 1 sec/predictive value (FEV 1 %pred), forced vital capacity (FVC), forced expiratory volume in 1 sec/forced vital capacity (FEV 1 /FVC), peak expiratory flow (PEF), and maximal voluntary ventilation (MVV).", {"entities": [[144, 147, "GENE"], [244, 247, "GENE"], [144, 147, "GENE"], [244, 247, "GENE"]]}], ["The children's quality (QOL) of life with asthma was evaluated by their activities of daily living (ADLs) and Medical Research Council (MRC) scores.", {"entities": [[42, 48, "DISEASE"]]}], ["Pearson correlation analysis was applied to analyze the correlations of serum vitamin A and 25OHD3 levels with FEV 1 %pred, FVC, FEV 1 /FVC, PEF, MVV, ADL, and MRC.", {"entities": [[111, 114, "GENE"], [129, 132, "GENE"], [111, 114, "GENE"], [129, 132, "GENE"]]}], ["Serum vitamin A and 25OHD3 levels were lower in children with stable asthma than those who were in the control group ( P \u200a<\u200a.05).", {"entities": [[69, 75, "DISEASE"]]}], ["The severe group showed the lowest FEV 1 %pred, FVC, FEV 1 /FVC, PEF, MVV, and ADL scores, and the highest MRC score compared to the mild and moderate groups (all P \u200a<\u200a.05).", {"entities": [[35, 38, "GENE"], [53, 56, "GENE"], [35, 38, "GENE"], [53, 56, "GENE"]]}], ["Serum vitamin A and 25OHD3 levels were positively correlated with pulmonary function and ADL score in children with stable asthma, while serum vitamin A and 25OHD3 levels were negatively correlated with MRC score (all P \u200a<\u200a.05).", {"entities": [[123, 129, "DISEASE"]]}], ["In the case group, serum vitamin A and 25OHD3 levels were positively correlated with serum calcium and phosphorus levels (all P \u200a<\u200a.05).", {"entities": []}], ["These findings indicate that increased serum vitamin A and 25OHD3 levels reflect good pulmonary function and good QOL in children with stable asthma.", {"entities": [[142, 148, "DISEASE"]]}], ["Systemic sclerosis (SSc) is an autoimmune disease where controversy on Th1/Th2 balance dominates.", {"entities": []}], ["We investigated whether the recently discovered Th17 pattern was present in SSc.", {"entities": []}], ["Patients were subdivided as having limited cutaneous SSc (lcSSc, n\u200a=\u200a12) or diffuse cutaneous SSc (dcSSc, n\u200a=\u200a24).", {"entities": []}], ["A further arbitrary subdivision was made between early dcSSc (n\u200a=\u200a11) and late dcSSc (n\u200a=\u200a13) based upon the duration of disease.", {"entities": []}], ["As a comparator group 14 healthy controls were studied.", {"entities": []}], ["CD3+ cells were isolated using FACS and subsequently studied for the expression of CD4, CD8, CD25, CD45Ro, CD45Ra, IL-23, GITR, CD69 and intracellular expression of IL-17, TGF\u03b2 and IFN\u03b3 using flow cytometry.", {"entities": [[83, 86, "GENE"], [128, 132, "GENE"]]}], ["Levels of IL-17, IL-6, IL-1\u03b1 and IL-23 were measured using Bioplex assays.", {"entities": []}], ["SSc patients had more and more activated CD4+ cells.", {"entities": []}], ["In addition, CD4, CD45Ro and CD45Ra cells from all SSc patients highly expressed the IL23R, which was associated with a higher IL-17 expression as well.", {"entities": [[13, 16, "GENE"], [85, 90, "GENE"]]}], ["In contrast, IFN\u03b3 and TGF\u03b2 were selectively up regulated in SSc subsets.", {"entities": []}], ["In line with these observation, circulating levels of IL-17 inducing cytokines IL-6, IL-23 and IL-1\u03b1 were increased in all or subsets of SSc patients.", {"entities": []}], ["The combination of IL-17, IFN\u03b3 and TGF\u03b2 levels in CD45Ro and CD45Ra cells from SSc patients is useful to distinguish between lSSc, ldSSc or edSSc.", {"entities": []}], ["Blocking Th17 inducing cytokines such as IL-6 and IL-23 may provide a useful tool to intervene in the progression of SSc.", {"entities": []}], ["The inflammatory response in cutaneous leishmaniasis (CL), although responsible for controlling the infection, is associated with the pathogenesis of disease.", {"entities": [[39, 52, "DISEASE"], [29, 52, "DISEASE"]]}], ["Conversely, the immune response induced by S. mansoni antigens is able to prevent immune-mediated diseases.", {"entities": []}], ["The aim of this study was to evaluate the potential of the S. mansoni Sm29 antigen to change the profile of monocyte-derived dendritic cells (MoDCs) from subjects with cutaneous leishmaniasis (CL) in vitro .", {"entities": [[178, 191, "DISEASE"], [168, 191, "DISEASE"]]}], ["Monocytes derived from the peripheral blood mononuclear cells of twelve patients were cultured with GM-CSF and IL-4 for differentiation into dendritic cells and then stimulated with soluble Leishmania antigen (SLA) in the presence or absence of Sm29 antigen.", {"entities": []}], ["The expression of surface molecules associated with maturation and activation (HLA-DR, CD40, CD83, CD80, and CD86), inflammation (IL-12, TNF), and downregulation (IL-10, IL-10R) was evaluated using flow cytometry.", {"entities": [[87, 91, "GENE"], [93, 97, "GENE"], [99, 103, "GENE"], [109, 113, "GENE"], [137, 140, "GENE"]]}], ["We observed that the frequencies of HLA-DR, CD83, CD80, and CD86 as well as of IL-10 and IL-10R on MoDCs were higher in cultures stimulated with Sm29, compared to the unstimulated cell cultures.", {"entities": [[44, 48, "GENE"], [50, 54, "GENE"], [60, 64, "GENE"]]}], ["Our results indicate that the Sm29 antigen is able to activate regulatory MoDCs in patients with cutaneous leishmaniasis.", {"entities": [[107, 120, "DISEASE"], [97, 120, "DISEASE"]]}], ["It might be useful to control the inflammatory process associated with this disease.", {"entities": []}], ["Depression may increase the likelihood of adopting behaviors risky to health.", {"entities": []}], ["Population studies investigating the association between depressive symptoms and behavior-related risk factors are lacking in Italy.", {"entities": []}], ["The aim of this study was to estimate the prevalence of various self-reported behavior-related risk factors and to study their associations with current depressive symptoms in the Italian adult general population.", {"entities": []}], ["Data collected in 2013 from people aged 18 to 69 years participating in the Italian behavioral risk factor surveillance system were used for the analysis.", {"entities": []}], ["Indicators of no leisure-time physical activity, obesity, cigarette smoking, and excessive alcohol consumption were investigated.", {"entities": [[49, 56, "DISEASE"]]}], ["Depressive symptoms were explored through the Patient Health Questionnaire-2.", {"entities": []}], ["In the survey sample of 39,463 participants, 34.4% of adults engaged in no leisure-time physical activity, 26.2% were cigarette smokers, 11.5% were excessive alcohol consumers, and 10.3% were obese.", {"entities": []}], ["The prevalence of depressive symptoms was 6.2%.", {"entities": []}], ["People with depressive symptoms were more likely to be physically inactive (adjusted prevalence ratio [APR], 1.13), cigarette smokers (APR, 1.34), obese (APR, 1.27) and excessive alcohol consumers (APR, 1.43) than those without depressive symptoms.", {"entities": []}], ["The contribution of this study to the existing evidence lies not just in confirming the association between depression and behavior-related risk factors in the Italian context but also in suggesting that programs for simultaneously improving people\u2019s mental and physical health should be developed and implemented.", {"entities": []}], ["To understand the causal basis of TNF associations with disease, it is necessary to understand the haplotypic structure of this locus.", {"entities": [[34, 37, "GENE"]]}], ["The TNF locus in Gambian and Malawi human samples is haplotypically diverse and has a rich history of intragenic recombination.", {"entities": [[4, 7, "GENE"]]}], ["As a consequence, a large proportion of TNF single nucleotide polymorphisms (SNPs) must be typed to detect a disease-modifying SNP at this locus.", {"entities": [[40, 43, "GENE"]]}], ["The most informative subset of SNPs to genotype differs between the two populations.", {"entities": []}], ["To understand the causal basis of TNF associations with disease, it is necessary to understand the haplotypic structure of this locus.", {"entities": [[34, 37, "GENE"]]}], ["We genotyped 12 single-nucleotide polymorphisms (SNPs) distributed over 4.3 kilobases in 296 healthy, unrelated Gambian and Malawian adults.", {"entities": []}], ["We generated 592 high-quality haplotypes by integrating family- and population-based reconstruction methods.", {"entities": []}], ["We found 32 different haplotypes, of which 13 were shared between the two populations.", {"entities": []}], ["Both populations were haplotypically diverse (gene diversity = 0.80, Gambia; 0.85, Malawi) and significantly differentiated ( p < 10 TNF are poor markers of each other.", {"entities": [[133, 136, "GENE"]]}], ["The EMM showed that 8 of 12 SNPs (Gambia) and 7 of 12 SNPs (Malawi) are required to describe 95% of the haplotypic diversity.", {"entities": []}], ["The TNF locus in the Gambian and Malawi sample is haplotypically diverse and has a rich history of intragenic recombination.", {"entities": [[4, 7, "GENE"]]}], ["As a consequence, a large proportion of TNF SNPs must be typed to detect a disease-modifying SNP at this locus.", {"entities": [[40, 43, "GENE"]]}], ["The most informative subset of SNPs to genotype differs between the two populations.", {"entities": []}], ["Monoclonal antibodies have deserved a remarkable interest for more than 40 years as a vital tool for the treatment of various diseases.", {"entities": []}], ["Still, there is a raising interest to develop advanced monoclonal antibody delivery systems able to tailor pharmacokinetics.", {"entities": []}], ["Bevacizumab is a humanized immunoglobulin IgG1 used in antiangiogenic therapies due to its capacity to inhibit the interaction between vascular endothelial growth factor and its receptor.", {"entities": []}], ["However, bevacizumab-based antiangiogenic therapy is not always effective due to poor treatment compliance associated to multiples administrations and drug resistance.", {"entities": []}], ["In this work, we show a promising strategy of encapsulating bevacizumab to protect and deliver it, in a controlled manner, increasing the time between administrations and formulation shelf-life.", {"entities": []}], ["Nanoencapsulation of bevacizumab represents a significant advance for selective antiangiogenic therapies since extracellular, cell surface and intracellular targets can be reached.", {"entities": []}], ["The present study shows that bevacizumab-loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles does not impair its native-like structure after encapsulation and fully retain the bioactivity, making this nanosystem a new paradigm for the improvement of angiogenic therapy.", {"entities": []}], ["Tuberculosis (TB) is global health concern and a leading infectious cause of mortality.", {"entities": [[0, 12, "DISEASE"]]}], ["Reversing TB incidence and disease-related mortality is a major global health priority.", {"entities": []}], ["Infectious disease mortality is directly linked to failure to adhere to treatments.", {"entities": []}], ["Using technology to send reminders by short message services have been shown to improve treatment adherence.", {"entities": []}], ["However, few studies have examined tuberculosis patient perceptions and attitudes towards using SMS technology to increase treatment adherence.", {"entities": [[35, 47, "DISEASE"], [96, 99, "GENE"]]}], ["In this study, we sought to investigate perceptions related to feasibility and acceptability of using text messaging to improve treatment adherence among adults who were receiving treatment for TB in Callao, Peru.", {"entities": []}], ["We conducted focus group qualitative interviews with current TB positive and non-contagious participants to understand the attitudes, perceptions, and feasibility of using short message service (SMS) reminders to improve TB treatment adherence.", {"entities": [[195, 198, "GENE"]]}], ["Subjects receiving care through the National TB Program were recruited through public health centers in Ventanilla, Callao, Peru.", {"entities": []}], ["In four focus groups, we interviewed 16 patients.", {"entities": []}], ["All interviews were recorded and transcribed verbatim.", {"entities": []}], ["Thematic network analysis and codebook techniques were used to analyze data.", {"entities": []}], ["Three major themes emerged from the data: limits on health literacy and information posed challenges to successful TB treatment adherence, treatment motivation at times facilitated adherence to TB treatment, and acceptability of SMS including positive perceptions of SMS to improve TB treatment adherence.", {"entities": [[229, 232, "GENE"], [267, 270, "GENE"], [229, 232, "GENE"], [267, 270, "GENE"]]}], ["The majority of patients shared considerations about how to effectively and confidentially administer an SMS intervention with TB positive participants.", {"entities": [[105, 108, "GENE"]]}], ["The overall perceptions of the use of SMS were positive and indicated that SMS technology may be an efficient way to transmit motivational texts on treatment, health education information, and simple reminders to increase treatment adherence for low-income TB patients living in Peru.", {"entities": [[38, 41, "GENE"], [75, 78, "GENE"], [38, 41, "GENE"], [75, 78, "GENE"]]}], ["Properties of thyme extracts from three different species ( Thymus vulgaris , Thymus zygis, and Thymus hyemalis ) were examined.", {"entities": []}], ["Two oil fractions from each species were obtained by CO 2 supercritical fluid extraction.", {"entities": []}], ["Main compounds presented in the supercritical extracts of the three thyme varieties were 1,8 cineole, thymol, camphor, borneol, and carvacrol.", {"entities": []}], ["As a cellular model of inflammation/atherogenesis, we use human macrophages derived from THP-1 monocytes and activated by oxidized LDLs.", {"entities": []}], ["These cells were incubated with the thyme fraction oils, and the productions and gene expressions of the inflammatory mediators TNF- \u03b1 , IL-1B, IL-6, and IL-10 were determined.", {"entities": []}], ["Thyme extracts significantly reduced production and gene expression of the proinflammatory mediators TNF- \u03b1 , IL-1B, and IL-6 and highly increased these parameters on the anti-inflammatory IL-10 cytokine.", {"entities": []}], ["Changes on production and gene expressions were dose dependent and according to the thyme content of each species.", {"entities": []}], ["Taken together, these results may suggest that thyme extracts could have anti-inflammatory effects.", {"entities": []}], ["The carbohydrate \u2018fuel\u2019 metabolism in a pregnant woman may have a long-term impact on the development of her offspring (\u2018fuel-mediated teratogenesis\u2019 hypothesis) including in utero exposure to maternal hyperglycaemia leading to fetal hyperinsulinaemia, and the consequent increase in fetal fat cells.", {"entities": []}], ["Therefore, a feed-forward loop can exist of rising adiposity and hyperinsulinaemia throughout childhood, perhaps leading to obesity and diabetes in later life.", {"entities": [[124, 131, "DISEASE"]]}], ["There is a need for prospective examination of body fat distribution in children born to mothers with different glycaemic levels to understand the plausible association between glucose metabolism and future risk of diabetes in offspring.", {"entities": []}], ["The hypothesis is that maternal glucose levels in pregnant women are related to skinfold thickness in their infants.", {"entities": []}], ["Hyperglycaemia in pregnancy and adiposity in infants is a multicentre cohort study to evaluate the effects of glucose levels in pregnancy on the risk of adverse infant outcomes, especially in predicting the risk of chronic diseases in infants.", {"entities": []}], ["The study aims to recruit 1045 participants over a period of 1\u2005year, who will be followed up irrespective of their glycaemia status for a period of 15\u2005months, beginning in the 24th week of gestation.", {"entities": []}], ["The glucose levels in pregnant women would be obtained through oral glucose tolerance testing.", {"entities": []}], ["The primary outcome of our study was skinfold thickness in infants at the age of 6\u2005weeks, 3rd and 9th month (as a proxy for fat distribution/adiposity).", {"entities": []}], ["The institutional review board at The Indian Institute of Public Health (IIPH)-Hyderabad, Public Health Foundation of India has approved the protocol.", {"entities": []}], ["All participants are required to provide written informed consent.", {"entities": []}], ["HMGB1 is an alarmin that can stimulate the innate immune system alone or in a complex with other inflammatory mediators.", {"entities": [[0, 5, "GENE"]]}], ["Given the recent interest in HMGB1 with respect to the pathogenesis of eosinophil-associated disorders, including asthmatic inflammation and chronic rhinosinusitis, we have explored the role of this mediator and in promoting eosinophil activation.", {"entities": [[29, 34, "GENE"]]}], ["HMGB1 receptors RAGE and TLR4 but not TLR2 were detected on freshly isolated human eosinophils from healthy donors.", {"entities": [[0, 5, "GENE"], [25, 29, "GENE"], [38, 42, "GENE"]]}], ["Physiologic and relevant pathophysiologic levels of biologically-active HMGB1 had no effect on survival of human eosinophils alone or in combination with pro-survival cytokines IL-5, IL-3, or GM-CSF, and increasing concentrations of HMGB1 had no impact on surface expression of RAGE, TLR2 or TLR4.", {"entities": [[72, 77, "GENE"], [233, 238, "GENE"], [72, 77, "GENE"], [233, 238, "GENE"], [284, 288, "GENE"], [292, 296, "GENE"]]}], ["Similarly, HMGB1 did not elicit chemotaxis of human eosinophils alone and had no effect in combination with the eosinophil chemotactic agent, eotaxin-2 (CCL24).", {"entities": [[11, 16, "GENE"], [153, 158, "GENE"]]}], ["However, surface expression of TLR2 and TLR4 increased in response to cell stress, notably on eosinophils that remain viable after 48 hours without IL-5.", {"entities": [[31, 35, "GENE"], [40, 44, "GENE"]]}], ["As such, HMGB1 signaling on eosinophils may be substantially more detailed, and may involve complex immunostimulatory pathways other than or in addition to those evaluated here.", {"entities": [[9, 14, "GENE"]]}], ["Chronic diseases account for nearly 60% of deaths around the world.", {"entities": []}], ["The extent of this silent epidemic has not met determined responses in governments, policies or professionals in order to transform old Health Care Systems, configured for acute diseases.", {"entities": []}], ["There is a large list of research about alternative models for people with chronic conditions, many of them with an advanced practice nurse as a key provider, as case management.", {"entities": []}], ["But some methodological concerns raise, above all, the design of the intervention (intensity, frequency, components, etc).", {"entities": []}], ["Objectives : General: To develop the first and second phases (theorization and modeling) for designing a multifaceted case-management intervention in people with chronic conditions (COPD and heart failure) and their caregivers.", {"entities": []}], ["Specific aims: 1) To identify key events in people living with chronic disease and their relation with the Health Care System, from their point of view.", {"entities": []}], ["2) To know the coping mechanisms developed by patients and their caregivers along the story with the disease.", {"entities": []}], ["3) To know the information processing and its utilization in their interactions with health care providers.", {"entities": []}], ["4) To detect potential unmet needs and the ways deployed by patients and their caregivers to resolve them.", {"entities": []}], ["5) To obtain a description from patients and caregivers, about their itineraries along the Health Care System, in terms of continuity, accessibility and comprehensiveness of care.", {"entities": []}], ["6) To build up a list of promising case-management interventions in patients with Heart Failure and COPD with this information in order to frame it into theoretical models for its reproducibility and conceptualization.", {"entities": []}], ["7) To undergo this list to expert judgment to assess its feasibility and pertinence in the Andalusian Health Care.", {"entities": []}], ["Design : Qualitative research with two phases: For the first five objectives, a qualitative technique with biographic stories will be developed and, for the remaining objectives, an expert consensus through Delphi technique, on the possible interventions yielded from the first phase.", {"entities": []}], ["The study will be developed in the provinces of Almer\u00eda, M\u00e1laga and Granada in the Southern Spain, from patients included in the Andalusian Health Care Service database with the diagnosis of COPD or Heart Failure, with the collaboration of case manager nurses and general practitioners for the assessment of their suitability to inclusion criteria.", {"entities": []}], ["Patients and caregivers will be interviewed in their homes or their Health Centers, with their family or their case manager nurse as mediator.", {"entities": []}], ["First of a series of studies intended to design a case-management service for people with heart failure and COPD, in the Andalusian Health Care System, where case management has been implemented since 2002.", {"entities": []}], ["Accordingly with the steps of a theoretical model for complex interventions, in this study, theorization and intervention modeling phases will be developed.", {"entities": []}], ["The citrus red mite is a worldwide citrus pest and a common sensitizing allergen of asthma and rhinitis.", {"entities": [[95, 103, "DISEASE"], [84, 90, "DISEASE"]]}], ["It has developed strong resistance to many registered acaricides, However, the molecular mechanisms of resistance remain unknown.", {"entities": []}], ["we therefore used next generation sequencing technology to investigate the global transcriptomes between resistant strains and susceptible strains.", {"entities": []}], ["We obtained 34,159, 30,466 and 32,217 unigenes by assembling the SS reads, RS reads and SS&RS reads respectively.", {"entities": []}], ["There are total 17,581 annotated unigenes from SS&RS reads by BLAST searching databases of nr, the Clusters of Orthologous Groups (COGs) and Kyoto Encyclopedia of Genes and Genomes (KEGG) with an E-value \u2264 1e-5, in which 7,075 unigenes were annotated in the COG database, 12, 712 unigenes were found in the KEGG database and 3,812 unigenes were assigned to Gene ontology (GO).", {"entities": []}], ["Moreover, 2,701 unigenes were judged to be the differentially expressed genes (DEGs) based on the uniquely mapped reads.", {"entities": []}], ["There are 219 pathways in all annotated unigenes and 198 pathways in DEGs that mapped to the KEGG database.", {"entities": []}], ["We identified 211 metabolism genes and target genes related to general insecticide resistance such as P450 and Cytochrome b, and further compared their differences between RS and SS.", {"entities": []}], ["Meanwhile, we identified 105 and 194 genes related to growth and reproduction, respectively, based on the mode of action of Hexythiazox.", {"entities": []}], ["After further analyses, we found variation in sequences but not in gene expression related to mite growth and reproduction between different strains.", {"entities": []}], ["To our knowledge, this is the first comparative transcriptome study to discover candidate genes involved in phytophagous mite resistance.", {"entities": []}], ["This study identified differential unigenes related to general pesticide resistance and organism growth and reproduction in P .", {"entities": []}], ["The assembled, annotated transcriptomes provide a valuable genomic resource for further understanding the molecular basis of resistance mechanisms.", {"entities": []}], ["Exacerbations, a leading cause of hospitalization in patients with chronic obstructive pulmonary disease (COPD), affect the quality of life and prognosis.", {"entities": [[67, 104, "DISEASE"]]}], ["Treatment recommendations as provided in the evidence-based guidelines are not consistently followed, partly due to absence of simplified task-oriented approach to care.", {"entities": []}], ["In this study, we describe the development and implementation of a clinical pathway (CP) and evaluate its effectiveness in the management of COPD exacerbation.", {"entities": [[85, 87, "GENE"]]}], ["We developed a CP and evaluated its effectiveness in a non-randomized prospective study with historical controls on patients admitted for exacerbation of COPD to Universiti Kebangsaan Malaysia Medical Centre (UKMMC).", {"entities": [[15, 17, "GENE"]]}], ["Consecutive patients who were admitted between June 2009 and December 2010 were prospectively recruited into the CP group.", {"entities": [[113, 115, "GENE"]]}], ["Non-CP historical controls were obtained from case records of patients admitted between January 2008 and January 2009.", {"entities": []}], ["Clinical outcomes were evaluated by comparing the length of stay (LOS), complication rates, readmissions, and mortality rates.", {"entities": []}], ["Ninety-five patients were recruited in the CP group and 98 patients were included in the non-CP historical group.", {"entities": [[43, 45, "GENE"], [93, 95, "GENE"]]}], ["Both groups were comparable with no significant differences in age, sex and severity of COPD ( p \u2009=\u20090.641).", {"entities": []}], ["For clinical outcome measures, patients in the CP group had shorter length of stay than the non-CP group (median (IQR): 5 (4\u20137) days versus 7 (7\u20139) days, p \u2009<\u20090.001) and 24.1% less complications (14.7% versus 38.8%, p \u2009<\u20090.001).", {"entities": [[47, 49, "GENE"], [96, 98, "GENE"]]}], ["We did not find any significant differences in readmission and mortality rates.", {"entities": []}], ["The implementation of CP \u2013reduced the length of stay and complication rates of patients hospitalized for acute exacerbation of COPD.", {"entities": [[22, 24, "GENE"]]}], ["Immunoglobulin super family member 1 (IGSF1) deficiency syndrome is characterized by central hypothyroidism, delayed surge in testosterone during puberty, macro-orchidism, and in some cases, hypoprolactinemia and/or transient growth hormone (GH) deficiency.", {"entities": [[93, 107, "DISEASE"], [56, 64, "DISEASE"], [38, 43, "GENE"]]}], ["Our patient was a 19-year-old male adolescent who had been treated since the age of 9 years with GH and thyroxine for an idiopathic combined GH, thyroid-stimulating hormone (TSH), and prolactin (PRL) deficiency.", {"entities": [[195, 198, "GENE"]]}], ["His GH deficiency proved to be transient, but deficiencies of TSH and PRL persisted, and he had developed macro-orchidism since the end of puberty.", {"entities": [[70, 73, "GENE"]]}], ["Brain magnetic resonance imaging and PROP1 and POU1F1 sequencing were normal.", {"entities": [[37, 42, "GENE"], [47, 53, "GENE"]]}], ["A disharmonious puberty (delayed genital and pubic hair development, bone maturation, and pubertal growth spurt, despite normal testicular growth) was observed as well as a delayed adrenarche, as reflected by very low dehydroepiandrosterone sulfate and delayed pubarche.", {"entities": []}], ["Direct sequencing of the IGSF1 gene revealed a novel hemizygous mutation, c.3127T>C, p.Cys1043Arg.", {"entities": [[25, 30, "GENE"]]}], ["Pathogenicity of the mutation was demonstrated in vitro.", {"entities": []}], ["Male children with an idiopathic combined GH, PRL, and TSH deficiency, showing persistent central hypothyroidism but transient GH deficiency upon retesting at adult height, should be screened for mutations in the IGSF1 gene, especially when macro-orchidism and/or hypoprolactinemia are present.", {"entities": [[98, 112, "DISEASE"], [46, 49, "GENE"], [213, 218, "GENE"]]}], ["We suspect that delayed adrenarche, as a consequence of PRL deficiency, might be part of the clinical phenotype of patients with IGSF1 deficiency.", {"entities": [[56, 59, "GENE"], [129, 134, "GENE"]]}], ["Fusarium species are among airborne fungi and recognized as causative agents of human atopic disorders.", {"entities": []}], ["However, Fusarium allergens have not been well characterized and the lack of information limits clinical diagnosis and treatment of fungal allergy.", {"entities": []}], ["The purpose of this study is to identify and characterize important allergens of F. proliferatum .", {"entities": []}], ["IgE-reacting F. proliferatum components were identified by immunoblot using serum samples from patients of respiratory atopic diseases.", {"entities": []}], ["Characterization of allergens and determination of IgE cross-reactivity were performed by cDNA cloning, then homologous expression and immunoblot inhibition studies.", {"entities": []}], ["We identified nine different F. proliferatum components that can be recognized by IgE antibodies in 17 (28%) of the 60 atopic sera tested.", {"entities": []}], ["Components with molecular masses of about 43, 37.5 and 36.5 kDa with IgE-binding frequencies of about 88, 47 and 53%, respectively, were considered as important allergens of F. proliferatum .", {"entities": []}], ["The 37.5 kDa IgE-binding component was putatively considered as a transaldolase protein of F. proliferatum .", {"entities": []}], ["The full-length cDNA of F. proliferatum transaldolase was subsequently cloned.", {"entities": []}], ["It encodes an open reading frame of 312 amino acids and has sequence identifies of 73 and 61%, respectively, with Cladosporium and human transaldolases.", {"entities": []}], ["The purified recombinant F. proliferatum transaldolase can inhibit the IgE-binding against the 37.5 kDa component of F. proliferatum and the transaldolase allergen from Cladosporium cladosporioides .", {"entities": []}], ["More importantly, the recombinant F. proliferatum transaldolase can inhibit IgE-binding against human transaldolase in a concentration-dependent manner.", {"entities": []}], ["Thus, a novel and important F. proliferatum transaldolase allergen was identified.", {"entities": []}], ["In addition to IgE cross-reactivity between the Fusarium and the Cladosporium transaldolase allergens, IgE cross-reactivity between the Fusarium and the human transaldolases also exists and might contribute to atopic manifestations in the absence of exogenous allergen exposure.", {"entities": []}], ["Introduction : Many studies have reported the association between air pollution and human health based on regulatory air pollution monitoring data.", {"entities": []}], ["However, because regulatory monitoring networks were not designed for epidemiological studies, the collected data may not provide sufficient spatial contrasts for assessing such associations.", {"entities": []}], ["Our goal was to develop a monitoring design supplementary to the regulatory monitoring network in Seoul, Korea.", {"entities": []}], ["This design focused on the selection of 20 new monitoring sites to represent the variability in PM 2.5 across people\u2019s residences for cohort studies.", {"entities": []}], ["Methods : We obtained hourly measurements of PM 2.5 at 37 regulatory monitoring sites in 2010 in Seoul, and computed the annual average at each site.", {"entities": []}], ["We also computed 313 geographic variables representing various pollution sources at the regulatory monitoring sites, 31,097 children\u2019s homes from the Atopy Free School survey, and 412 community service centers in Seoul.", {"entities": []}], ["These three types of locations represented current, subject, and candidate locations.", {"entities": []}], ["Using the regulatory monitoring data, we performed forward variable selection and chose five variables most related to PM 2.5 .", {"entities": []}], ["Then, k-means clustering was applied to categorize all locations into several groups representing a diversity in the spatial variability of the five selected variables.", {"entities": []}], ["Finally, we computed the proportion of current to subject location in each cluster, and randomly selected new monitoring sites from candidate sites in the cluster with the minimum proportion until 20 sites were selected.", {"entities": []}], ["Results : The five selected geographic variables were related to traffic or urbanicity with a cross-validated R Discussion : The proposed monitoring design will help future studies determine the locations of new monitoring sites representing spatial variability across residences for epidemiological analyses.", {"entities": []}], ["The aim of this study was to investigate left ventricular (LV) and right ventricular (RV) structure, function, and mechanics in patients with subclinical hypothyroidism (SHT), and to evaluate the effect of a 1-year levothyroxine treatment.", {"entities": [[154, 168, "DISEASE"]]}], ["We compared 45 untreated women with subclinical hypothyroidism and 35 healthy control women matched by age.", {"entities": [[48, 62, "DISEASE"]]}], ["All the subjects underwent laboratory analyses, which included a thyroid hormone levels (free T3, free T4, and TSH) test, and a complete 2-dimensional echocardiographic study.", {"entities": []}], ["All the SHT patients received levothyroxine therapy and were followed for a year after euthyroid state was achieved.", {"entities": []}], ["The LV mass index in the SHT participants before and after replacement therapy was significantly higher than in controls.", {"entities": []}], ["In the SHT patients before the treatment, LV diastolic function and global function estimated by the Tei index were significantly impaired, whereas the LV systolic function was decreased.", {"entities": []}], ["The results show that LV mechanics was significantly impaired in the SHT patients at baseline.", {"entities": []}], ["Additionally, the SHT participants before levothyroxine substitution had increased RV wall thickness and significantly impaired RV diastolic and global function in comparison with the controls or the SHT subjects after the treatment.", {"entities": []}], ["Furthermore, RV mechanics was also significantly deteriorated in the SHT patients before the treatment.", {"entities": []}], ["Subclinical hypothyroidism significantly affected LV and RV structure, systolic, diastolic and global function, and LV and RV mechanics.", {"entities": [[12, 26, "DISEASE"]]}], ["Levothyroxine replacement therapy significantly improved cardiac structure, function, and mechanics in the SHT patients.", {"entities": []}], ["Nanomedicine studies have showed a great potential for drug delivery into the lung.", {"entities": []}], ["In this manuscript nanostructured lipid carriers (NLC) containing Fluticasone propionate (FP) were prepared and their biocompatibility and effects in a human bronchial epithelial cell line (16-HBE) stimulated with cigarette smoke extracts (CSE) were tested.", {"entities": []}], ["Biocompatibility studies showed that the NLC did not induce cell necrosis or apoptosis.", {"entities": []}], ["Moreover, it was confirmed that CSE increased intracellular ROS production and TLR4 expression in bronchial epithelial cells and that FP-loaded NLC were more effective than free drug in modulating these processes.", {"entities": [[79, 83, "GENE"]]}], ["Finally, the nanoparticles increased GSH levels improving cell protection against oxidative stress.", {"entities": []}], ["The present study shows that NLC may be considered a promising strategy to improve corticosteroid mediated effects in cellular models associated to corticosteroid resistance.", {"entities": []}], ["The NLC containing FP can be considered good systems for dosage forms useful for increasing the effectiveness of fluticasone decreasing its side effects.", {"entities": []}], ["At present, it is highly controversial whether pure mast cells can serve as antigen presenting cells, and it is not known whether the capacity of antigen presenting function is temporally restricted to a particular subset of differentiated mast cells.", {"entities": []}], ["Evidence is presented for a novel surface Fc\u03b5RI Bone marrow-derived mast cells (BMMC) cultured in the presence of IL-3 for three weeks are pure mast cells based on surface expression of lineage-specific marker, c-kit and Fc\u03b5RI.", {"entities": []}], ["Herein we present the first demonstration that approximately 98.7% c-kit + and Fc\u03b5RI expressing BMMC, further depleted of any contaminated professional antigen-presenting cells, are still fully capable of presenting antigens, i.e., OVA protein, OVA peptide, and IgE-TNP-OVA, to OVA peptide-specific T-cell hybridomas.", {"entities": []}], ["Notably, IgE-dependent antigen presentation is more efficient compared to that resulting from direct antigen uptake.", {"entities": []}], ["Importantly, we present the novel finding that only surface Fc\u03b5RI This is the first observation to attribute a spatiotemporally restricted antigen-presenting function to a subset of three-week old pure BMMC expressing both high levels of surface Fc\u03b5RI and surface MHC II.", {"entities": []}], ["We propose that mast cells play an important role in immune deviating and/or sustaining the activation of infiltrating CD4 T-cells, and modulating T-cell mediated allergic inflammation via its flexibility to present antigens and antigen-IgE complexes.", {"entities": [[119, 122, "GENE"]]}], ["Propensity score methods are increasingly being used to estimate causal treatment effects in observational studies.", {"entities": []}], ["In medical and epidemiological studies, outcomes are frequently time-to-event in nature.", {"entities": []}], ["Propensity-score methods are often applied incorrectly when estimating the effect of treatment on time-to-event outcomes.", {"entities": []}], ["This article describes how two different propensity score methods (matching and inverse probability of treatment weighting) can be used to estimate the measures of effect that are frequently reported in randomized controlled trials: (i) marginal survival curves, which describe survival in the population if all subjects were treated or if all subjects were untreated; and (ii) marginal hazard ratios.", {"entities": []}], ["The use of these propensity score methods allows one to replicate the measures of effect that are commonly reported in randomized controlled trials with time-to-event outcomes: both absolute and relative reductions in the probability of an event occurring can be determined.", {"entities": []}], ["We also provide guidance on variable selection for the propensity score model, highlight methods for assessing the balance of baseline covariates between treated and untreated subjects, and describe the implementation of a sensitivity analysis to assess the effect of unmeasured confounding variables on the estimated treatment effect when outcomes are time-to-event in nature.", {"entities": []}], ["The methods in the paper are illustrated by estimating the effect of discharge statin prescribing on the risk of death in a sample of patients hospitalized with acute myocardial infarction.", {"entities": [[167, 188, "DISEASE"], [161, 188, "DISEASE"]]}], ["In this tutorial article, we describe and illustrate all the steps necessary to conduct a comprehensive analysis of the effect of treatment on time-to-event outcomes.", {"entities": []}], ["\u00a9 2013 The authors.", {"entities": []}], ["Statistics in Medicine published by John Wiley & Sons, Ltd.", {"entities": []}], ["Neonates, infants, and children differ from adults in many aspects, not just in age, weight, and body composition.", {"entities": []}], ["Growth, maturation and environmental factors affect drug kinetics, response and dosing in pediatric patients.", {"entities": []}], ["Almost 80\u00a0% of drugs have not been studied in children, and dosing of these drugs is derived from adult doses by adjusting for body weight/size.", {"entities": []}], ["As developmental and maturational changes are complex processes, such simplified methods may result in subtherapeutic effects or adverse events.", {"entities": []}], ["Kidney function is impaired during the first 2\u00a0years of life as a result of normal growth and development.", {"entities": []}], ["Reduced kidney function during childhood has an impact not only on renal clearance but also on absorption, distribution, metabolism and nonrenal clearance of drugs.", {"entities": []}], ["\u2018Omics\u2019-based technologies, such as proteomics and metabolomics, can be leveraged to uncover novel markers for kidney function during normal development, acute kidney injury, and chronic diseases.", {"entities": []}], ["Pharmacometric modeling and simulation can be applied to simplify the design of pediatric investigations, characterize the effects of kidney function on drug exposure and response, and fine-tune dosing in pediatric patients, especially in those with impaired kidney function.", {"entities": []}], ["One case study of amikacin dosing in neonates with reduced kidney function is presented.", {"entities": []}], ["Collaborative efforts between clinicians and scientists in academia, industry, and regulatory agencies are required to evaluate new renal biomarkers, collect and share prospective pharmacokinetic, genetic and clinical data, build integrated pharmacometric models for key drugs, optimize and standardize dosing strategies, develop bedside decision tools, and enhance labels of drugs utilized in neonates, infants, and children.", {"entities": []}], ["The School Health Initiative: Environment, Learning, and Disease (SHIELD) study used a probability sample of children (second through fifth grades) from two low-income and racially mixed neighborhoods of Minneapolis, Minnesota, to assess childhood environmental health.", {"entities": []}], ["Children were eligible to participate in SHIELD regardless of whether they or their families spoke a foreign language, their household had a telephone, or they were enrolled in a special education program.", {"entities": []}], ["The overall enrollment rate in year 1 was 57%, with a substantial disparity between children from English-speaking (42%) versus non-English-speaking (71%) families.", {"entities": []}], ["At the end of year 1, 85% were retained in the study.", {"entities": []}], ["A relatively high percentage of children provided the two requested blood (82%) and urine (86%) samples in year 1, and 90% provided a valid spirometry sample.", {"entities": []}], ["Eighty-two percent provided both requested volatile organic chemical badge samples, and both time-activity logs were obtained from 66%.", {"entities": []}], ["However, only 32% provided both peak flow measurements.", {"entities": []}], ["All percentages increased for those participating in the second year of the study.", {"entities": []}], ["Results indicate that a school-based research design makes it feasible and practical to conduct probability-based assessments of children's environmental health in economically disadvantaged and ethnically diverse neighborhoods.", {"entities": []}], ["There is an ongoing need, however, to improve understanding of the cultural, economic, psychologic, and social determinants of study participation among this population.", {"entities": []}], ["Preterm birth (PTB) is the leading cause of neonatal mortality, and surviving infants are at increased risk for lifelong disabilities.", {"entities": []}], ["Intrauterine inflammation is an etiological factor that drives PTB, and oxidative stress is associated with PTB.", {"entities": []}], ["Nuclear erythroid 2-related factor 2 ( Nrf2 ) is a redox-sensitive transcription factor that is the key regulator of the response to oxidative and inflammatory stress.", {"entities": []}], ["Here, we used the established mouse model of intrauterine inflammation-induced PTB to determine whether Nrf2 is a modifier of susceptibility to PTB and prematurity-related morbidity and mortality in the offspring.", {"entities": []}], ["We determined that Nr2-deficient (Nrf2", {"entities": []}], ["Toxocariasis is a preventable parasitic disease that is caused by the dog and cat roundworms Toxocara cani and T. cati , respectively.", {"entities": [[0, 12, "DISEASE"]]}], ["Humans become infected when they accidently ingest infectious Toxocara eggs commonly found in contaminated soil; children are most often affected.", {"entities": []}], ["Clinical manifestations of Toxocara infection in humans include ocular toxocariasis and visceral toxocariasis.", {"entities": [[71, 83, "DISEASE"], [97, 109, "DISEASE"]]}], ["Although infection with Toxocara can cause devastating disease, the burden of toxocariasis in the United States population remains unknown.", {"entities": [[78, 90, "DISEASE"]]}], ["In addition, risk factors for acquiring infection need to be better defined, and research needs to be conducted to better understand the pathophysiology and clinical course of toxocariasis.", {"entities": [[176, 188, "DISEASE"]]}], ["Development of diagnostic tests would enable clinicians to detect active infection, and determination of optimal drug regiments would ensure patients were appropriately treated.", {"entities": []}], ["Addressing these public health gaps is necessary to understand and address the impact of toxocariasis in the United States.", {"entities": [[89, 101, "DISEASE"]]}], ["Terpene trilactones from Ginkgo biloba have been investigated extensively for their antioxidant and anti-ischaemic activities on the brain and the heart, but the mechanisms of these effects remain unclear.", {"entities": []}], ["For the present study, a terpenoid constituent from G. biloba , bilobalide, was screened for protective effects on the ischaemic heart and the involvement of the PAFR [PAF (platelet-activating factor) receptor] and the enzyme that degrades PAF, PAF-AH (PAF acetylhydrolase) during hypoxia.", {"entities": []}], ["The PAF pathway is supposed to play a role in hypoxia and its regulation may prevent or alleviate MI (myocardial infarction).", {"entities": [[102, 123, "DISEASE"]]}], ["Cardiomyocytes from neonatal rat hearts were cultured and treated with different concentrations of bilobalide (500\u20130.5\u00a0ng/ml).", {"entities": []}], ["After being subjected to a hypoxic environment, the cells' viability was evaluated and proteins as well as RNA were extracted for analysis by Western blotting and RT\u2013PCR (reverse transcription PCR) respectively.", {"entities": []}], ["With the MI model we tested for bilobalide's cardioprotective effects and the involvement of PAFR and PAF-AH.", {"entities": []}], ["Bilobalide (5\u00a0ng/ml) significantly decreased the mortality of cells in a concentration-dependent way.", {"entities": []}], ["mRNA expression of PAFR was up-regulated in hypoxic cells but in the groups treated with bilobalide, its expression was down-regulated to the level of the normal control.", {"entities": []}], ["In hypoxic tissue, PAFR protein expression was also up-regulated, but was reduced in the bilobalide (10\u00a0mg/kg of body weight) treated group.", {"entities": []}], ["Our results indicate that PAF and its receptor may be involved in the cellular response of cardiomyocytes to hypoxia and that bilobalide may interact with this receptor to exert its cardioprotective effects.", {"entities": []}], ["Secretoglobin family 3A member 2 (SCGB3A2) plays an important role in secreting lung surfactant protein, which is a downstream target of thyroid transcription factor.", {"entities": [[34, 41, "GENE"]]}], ["We investigated whether single-nucleotide polymorphisms (SNPs) of SCGB3A2 gene contribute to susceptibility to asthma.", {"entities": [[111, 117, "DISEASE"], [66, 73, "GENE"]]}], ["To explore this possible association, 2 promoter SNPs (rs6882292, 659 G/A and rs1368408, \u2212112 G/A) and missense SNP (rs151333009, stop codon) were tested in SCGB3A2 gene in 101 asthma patients and 377 healthy control subjects.", {"entities": [[177, 183, "DISEASE"], [157, 164, "GENE"]]}], ["SNPStats was used to obtain odds ratio (OR), 95% confidence intervals (CI), and P value adjusted for age and sex as covariables.", {"entities": []}], ["Logistic regression method in each model (dominant, recessive, and log-additive) was applied to analyze genetic data.", {"entities": []}], ["rs151333009 SNP showed a monomorphic genotype.", {"entities": []}], ["Two promoter SNPs (rs6882292, \u2212659 G/A and rs1368408, \u2212112 G/A) showed significant association with asthma (rs6882292, OR=2.66, 95% CI=1.42\u20135.01, p=0.0033 in dominant model, OR=2.45, 95% CI=1.33\u20134.54, p=0.0055 in log-additive model; rs1368408, OR=1.59, 95% CI=1.02\u20132.49, p=0.041 in dominant model, OR=3.02, 95% CI=1.15\u20137.90, p=0.03 in recessive model, OR=1.63, 95% CI=1.63, 95% CI=1.12\u20132.37, p=0.012 in log-additive model).", {"entities": [[100, 106, "DISEASE"]]}], ["These results suggest that the promoter SNPs (rs6882292 and rs1368408) of SCGB3A2 gene may contribute to susceptibility to asthma in a Korean population.", {"entities": [[123, 129, "DISEASE"], [74, 81, "GENE"]]}], ["Botulinum neurotoxin type A (BoNT/A) is the most potent protein toxin and causes fatal flaccid muscle paralysis by blocking neurotransmission.", {"entities": []}], ["Application of BoNT/A has been extended to the fields of therapeutics and biodefense.", {"entities": []}], ["Nevertheless, the global response of host immune cells to authentic BoNT/A has not been reported.", {"entities": []}], ["Employing microarray analysis, we performed global transcriptional profiling of RAW264.7 cells, a murine alveolar macrophage cell line.", {"entities": []}], ["We identified 70 genes that were modulated following 1 nM BoNT/A treatment.", {"entities": []}], ["The altered genes were mainly involved in signal transduction, immunity and defense, protein metabolism and modification, neuronal activities, intracellular protein trafficking, and muscle contraction.", {"entities": []}], ["Microarray data were validated with real-time RT-PCR for seven selected genes including tlr2 , tnf , inos , ccl4 , slpi , stx11 , and irg1 .", {"entities": [[88, 92, "GENE"], [95, 98, "GENE"], [108, 112, "GENE"], [115, 119, "GENE"], [122, 127, "GENE"], [134, 138, "GENE"]]}], ["Proinflammatory mediators such as nitric oxide (NO) and tumor necrosis factor alpha (TNF\u03b1) were induced in a dose-dependent manner in BoNT/A-stimulated RAW264.7 cells.", {"entities": []}], ["Increased expression of these factors was inhibited by monoclonal anti-Toll-like receptor 2 (TLR2) and inhibitors specific to intracellular proteins such as c-Jun N-terminal kinase (JNK), extracellular signal\u2013regulated kinase (ERK), and p38 mitogen\u2013activated protein kinase (MAPK).", {"entities": [[93, 97, "GENE"]]}], ["BoNT/A also suppressed lipopolysaccharide-induced NO and TNF\u03b1 production from RAW264.7 macrophages at the transcription level by blocking activation of JNK, ERK, and p38 MAPK.", {"entities": []}], ["As confirmed by TLR2-/- knock out experiments, these results suggest that BoNT/A induces global gene expression changes in host immune cells and that host responses to BoNT/A proceed through a TLR2-dependent pathway, which is modulated by JNK, ERK, and p38 MAPK.", {"entities": []}], ["Elaboration of tumor necrosis factor (TNF) is a very early event in development of ischemia/reperfusion injury pathophysiology.", {"entities": [[83, 91, "DISEASE"], [38, 41, "GENE"]]}], ["Therefore, TNF may be a prominent mediator of endothelial cell and vascular wall dysfunction in sickle cell anemia, a hypothesis we addressed using NY1DD, S+S", {"entities": [[96, 114, "DISEASE"], [108, 114, "DISEASE"], [11, 14, "GENE"]]}], ["Dental patients with special needs are people with different systemic diseases, multiple disorders or severe physical and/or mental disabilities.", {"entities": []}], ["A Medline search was made, yielding a total of 29 articles that served as the basis for this study, which offers a brief description of the dental intervention protocols in medically compromised patients.", {"entities": []}], ["Dental treatment in patients with special needs, whether presenting medical problems or disabilities, is sometimes complex.", {"entities": []}], ["For this reason the hospital should be regarded as the ideal setting for the care of these individuals.", {"entities": []}], ["Before starting any dental intervention, a correct patient evaluation is needed, based on a correct anamnesis, medical records and interconsultation reports, and with due assessment of the medical risks involved.", {"entities": []}], ["The hospital setting offers the advantage of access to electronic medical records and to data referred to any complementary tests that may have been made, and we moreover have the possibility of performing treatments under general anesthesia.", {"entities": []}], ["In this context, ambulatory major surgery is the best approach when considering general anesthesia in patients of this kind.", {"entities": []}], ["Key words: Hospital dentistry, special patients, medically compromised patients.", {"entities": []}], ["Medication errors are common, life threatening, costly but preventable.", {"entities": []}], ["Information technology and automated systems are highly efficient for preventing medication errors and therefore widely employed in hospital settings.", {"entities": []}], ["The aim of this study was to construct a probabilistic model that can reduce medication errors by identifying uncommon or rare associations between medications and diseases.", {"entities": []}], ["Association rules of mining techniques are utilized for 103.5 million prescriptions from Taiwan\u2019s National Health Insurance database.", {"entities": []}], ["The dataset included 204.5 million diagnoses with ICD9-CM codes and 347.7 million medications by using ATC codes.", {"entities": []}], ["Disease-Medication (DM) and Medication-Medication (MM) associations were computed by their co-occurrence and associations\u2019 strength were measured by the interestingness or lift values which were being referred as Q values.", {"entities": []}], ["The DMQs and MMQs were used to develop the AOP model to predict the appropriateness of a given prescription.", {"entities": []}], ["Validation of this model was done by comparing the results of evaluation performed by the AOP model and verified by human experts.", {"entities": []}], ["The results showed 96% accuracy for appropriate and 45% accuracy for inappropriate prescriptions, with a sensitivity and specificity of 75.9% and 89.5%, respectively.", {"entities": []}], ["We successfully developed the AOP model as an efficient tool for automatic identification of uncommon or rare associations between disease-medication and medication-medication in prescriptions.", {"entities": []}], ["The AOP model helps to reduce medication errors by alerting physicians, improving the patients\u2019 safety and the overall quality of care.", {"entities": []}], ["The present study examined the incidence of chronic stress in business executives (109 subjects: 75 male and 34 female) and its relationship with cortisol levels, cognitive performance, and autonomic nervous system (ANS) reactivity after an acute mental stressor.", {"entities": []}], ["Blood samples were collected from the subjects to measure cortisol concentration.", {"entities": []}], ["After the sample collection, the subjects completed the Lipp Inventory of Stress Symptoms for Adults and the Stroop Color-Word Test to evaluate stress and cognitive performance levels, respectively.", {"entities": []}], ["Saliva samples were collected prior to, immediately after, and five minutes after the test.", {"entities": []}], ["The results revealed that 90.1% of the stressed subjects experienced stress phases that are considered chronic stress.", {"entities": []}], ["At rest, the subjects with chronic stress showed higher cortisol levels, and no gender differences were observed.", {"entities": []}], ["No differences were found between the stressed and non-stressed subjects regarding salivary amylase activity prior to test.", {"entities": []}], ["Chronic stress also impaired performance on the Stroop test, which revealed higher rates of error and longer reaction times in the incongruent stimulus task independently of gender.", {"entities": []}], ["For the congruent stimulus task of the Stroop test, the stressed males presented a higher rate of errors than the non-stressed males and a longer reaction time than the stressed females.", {"entities": []}], ["After the acute mental stressor, the non-stressed male group showed an increase in salivary alpha-amylase activity, which returned to the initial values five minutes after the test; this ANS reactivity was not observed in the chronically stressed male subjects.", {"entities": []}], ["The ANS responses of the non-stressed vs stressed female groups were not different prior to or after the Stroop test.", {"entities": []}], ["This study is the first to demonstrate a blunted reactivity of the ANS when male subjects with chronic psychological stress were subjected to an acute mental stressor, and this change could contribute to impairments in cognitive performance.", {"entities": []}], ["Inadequate health literacy has been associated with poor management of long-term health conditions and has been identified as a key social determinant of health outcomes.", {"entities": []}], ["However, little is understood about how health literacy might develop over time or the processes by which people may become more health literate.", {"entities": []}], ["Our objectives were to describe how patients with a long-term condition practice health literacy in the management of their health and communication with health professionals, how they become more health literate over time and their experience of using health services.", {"entities": []}], ["We also sought to identify and describe the motivations, facilitators and barriers in the practice of health literacy in healthcare consultations.", {"entities": []}], ["We designed a longitudinal qualitative study using serial interviews with 18 participants to explore their experiences of learning to manage their condition and their experiences of health literacy when participating in healthcare processes.", {"entities": []}], ["Participants were recruited from patient education programmes and were interviewed three times over a period of 9 months.", {"entities": []}], ["A framework approach was used to analyse data.", {"entities": []}], ["A model is presented that illustrates the development of health literacy along a trajectory that includes the development of knowledge, health literacy skills and practices, health literacy actions, abilities in seeking options and informed and shared decision making opportunities.", {"entities": []}], ["Motivations and barriers to developing and practising health literacy skills partly reflected participants' characteristics but were also influenced by health professionals.", {"entities": []}], ["Some participants developed their health literacy to a point where they became more involved in healthcare processes (including informed and shared decision-making).", {"entities": []}], ["Patients with a long-term condition can develop health literacy skills over time and put their skills into practice in becoming more active in healthcare consultations.", {"entities": []}], ["Our findings have implications for developing health literacy interventions aimed at patient involvement in healthcare processes and improved self-management of long-term conditions.", {"entities": []}], ["To review and summarize existing literature on the indirect burden of chronic obstructive pulmonary disease (COPD) in the US.", {"entities": [[70, 107, "DISEASE"]]}], ["Medline, Scopus, and OvidSP databases were searched using defined search terms to identify relevant studies.", {"entities": []}], ["Eligible studies were published in English between January 2000 and April 2012 and calculated the indirect burden of COPD in a US population in terms of prevalence, incidence or costs of productivity loss, disability, morbidity, or mortality.", {"entities": []}], ["Of 53 studies identified, eleven met eligibility criteria, with data years spanning 1987\u20132009.", {"entities": []}], ["Estimates of workforce participation range from 56% to 69% among individuals with COPD and from 65% to 77% among individuals without COPD.", {"entities": []}], ["Approximately 13%\u201318% of those with COPD are limited in the amount or type of work they can do and one-third or more experience general activity limitation.", {"entities": []}], ["Estimates of restricted activity days range from 27\u201363 days per year.", {"entities": []}], ["Estimates of mean annual sick leave and/or disability days among employed individuals with COPD range from 1.3\u201319.4 days.", {"entities": []}], ["Estimates of bed confinement range from 13\u201332 days per year.", {"entities": []}], ["Estimated mean annual indirect costs were $893\u2013$2,234/person (US dollars) with COPD ($1,521\u2013$3,348 in 2010 [US dollars]) and varied with the population studied, specific cost outcomes, and economic inputs.", {"entities": []}], ["In studies that assessed total (direct and indirect) costs, indirect costs accounted for 27%\u201361% of total costs, depending on the population studied.", {"entities": []}], ["COPD is associated with substantial indirect costs.", {"entities": []}], ["The disease places a burden on employers in terms of lost productivity and associated costs and on individuals in terms of lost income related to absenteeism, activity limitation, and disability.", {"entities": []}], ["Consideration of indirect as well as direct costs is necessary to gain a more complete view of the societal burden of COPD.", {"entities": []}], ["Genome-scale \u201c-omics\u201d measurements are challenging to benchmark due to the enormous variety of unique biological molecules involved.", {"entities": []}], ["Mixtures of previously-characterized samples can be used to benchmark repeatability and reproducibility using component proportions as truth for the measurement.", {"entities": []}], ["We describe and evaluate experiments characterizing the performance of RNA-sequencing (RNA-Seq) measurements, and discuss cases where mixtures can serve as effective process controls.", {"entities": []}], ["We apply a linear model to total RNA mixture samples in RNA-seq experiments.", {"entities": []}], ["This model provides a context for performance benchmarking.", {"entities": []}], ["The parameters of the model fit to experimental results can be evaluated to assess bias and variability of the measurement of a mixture.", {"entities": []}], ["A linear model describes the behavior of mixture expression measures and provides a context for performance benchmarking.", {"entities": []}], ["Residuals from fitting the model to experimental data can be used as a metric for evaluating the effect that an individual step in an experimental process has on the linear response function and precision of the underlying measurement while identifying signals affected by interference from other sources.", {"entities": []}], ["Effective benchmarking requires well-defined mixtures, which for RNA-Seq requires knowledge of the post-enrichment \u2018target RNA\u2019 content of the individual total RNA components.", {"entities": []}], ["We demonstrate and evaluate an experimental method suitable for use in genome-scale process control and lay out a method utilizing spike-in controls to determine enriched RNA content of total RNA in samples.", {"entities": []}], ["Genome-scale process controls can be derived from mixtures.", {"entities": []}], ["These controls relate prior knowledge of individual components to a complex mixture, allowing assessment of measurement performance.", {"entities": []}], ["The target RNA fraction accounts for differential selection of RNA out of variable total RNA samples.", {"entities": []}], ["Spike-in controls can be utilized to measure this relationship between target RNA content and input total RNA.", {"entities": []}], ["Our mixture analysis method also enables estimation of the proportions of an unknown mixture, even when component-specific markers are not previously known, whenever pure components are measured alongside the mixture.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-015-1912-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although immuno-inflammatory response contributes to pathogenesis of AF, molecular and cellular mechanism in this process remains poorly understood.", {"entities": []}], ["Recently, increasing evidence suggests that Programmed death-1 (PD-1)/PD-1 ligand (PD-L) pathway may be a potential pathway participating in AF pathogenesis.", {"entities": []}], ["In this study, we detected the PD-1 and PD-L1, 2 expression on peripheral blood function cells by flow cytometry in 91 atrial fibrillation (AF) patients and 35 healthy volunteers.", {"entities": []}], ["The expression of PD-1 on CD", {"entities": []}], ["Interleukin 5 (IL-5), the major factor involved in eosinophil differentiation, is produced by T cells or mast cells.", {"entities": []}], ["In the present study, we found that eosinophils infiltrating the mucosa of four patients with active coeliac disease also express the IL-5 mRNA.", {"entities": []}], ["No positive signal was obtained in normal duodenum tissues and in the cell infiltrate from patients submitted to gluten restriction.", {"entities": []}], ["The identification of labeled mucosal cells as eosinophils relied on their typical morphology.", {"entities": []}], ["Moreover, highly purified blood eosinophils from three out of four patients with eosinophilia were also strongly labeled with the IL-5 antisense but not with the corresponding sense probe.", {"entities": [[81, 93, "DISEASE"]]}], ["Together, these results suggest that eosinophils have the capacity to synthesize IL-5, which could contribute to paracrine interactions with T and B cells and, in autocrine fashion, locally participate, through binding to the IL-5 receptor, to eosinophil differentiation and activation.", {"entities": []}], ["These data might have implications not only in the pathology of coeliac disease but also in other diseases associated with eosinophil infiltration.", {"entities": []}], ["BACKGROUND: One of the most promising markers of allergic inflammation is eotaxin, which has a selective influence on the migration of eosinophils.", {"entities": []}], ["Its serum content significantly correlates with the intensity of allergic symptoms, so it might be interesting to know whether vaccination has any influence on serum expression of this chemokine.", {"entities": []}], ["AIMS: Comparison of the humoral response to influenza vaccine and post-vaccination changes in the serum eotaxin level in patients with allergic bronchial asthma and healthy controls.", {"entities": [[44, 53, "DISEASE"], [154, 160, "DISEASE"]]}], ["METHODS: Forty-two asthmatics and 45 healthy individuals were vaccinated with a single dose of influenza subunit vaccine (Influvac).", {"entities": [[95, 104, "DISEASE"]]}], ["The serum eotaxin level and the antibody response to haemagglutinin (HI) and neuraminidase (NI) glycoproteins were measured before and after vaccination.", {"entities": []}], ["RESULTS: A significant increase of geometric mean titres of HI and NI was observed in both groups.", {"entities": []}], ["There were no significant differences between the groups in meanfold increase of HI and NI titres, response rate and protective level of HI.", {"entities": []}], ["After vaccination, a significant decrease of the mean serum eotaxin value was observed in patients with asthma (149.4 +/- 71.0 versus 125.1 +/- 67.0, p= 0.0017), while no similar effect was present in healthy individuals (153.4 +/- 56.9 versus 159.3 +/- 54.4, p= 0.5).", {"entities": [[104, 110, "DISEASE"]]}], ["CONCLUSIONS: The results indicate that in patients with allergic bronchial asthma influenza vaccinations assure efficient protective antibody level and modulate the serum level of eotaxin.", {"entities": [[82, 91, "DISEASE"], [75, 81, "DISEASE"]]}], ["Respiratory syncytial virus (RSV) infection is a common cause of pediatric hospitalization.", {"entities": []}], ["microRNA, key regulators of the immune system, have not previously been investigated in respiratory specimens during viral infection.", {"entities": []}], ["We investigated microRNA expression in the nasal mucosa of 42 RSV-positive infants, also comparing microRNA expression between disease severity subgroups.", {"entities": []}], ["Nasal mucosa cytology specimens were collected from RSV-positive infants and healthy controls.", {"entities": []}], ["32 microRNA were selected by microarray for qPCR verification in 19 control, 16 mild, 7 moderate and 19 severe disease samples.", {"entities": []}], ["Compared to healthy controls, RSV-positive infants downregulated miR-34b, miR-34c, miR-125b, miR-29c, mir125a, miR-429 and miR-27b and upregulated miR-155, miR-31, miR-203a, miR-16 and let-7d.", {"entities": [[65, 72, "GENE"], [83, 91, "GENE"], [93, 100, "GENE"], [111, 118, "GENE"], [123, 130, "GENE"], [147, 154, "GENE"], [156, 162, "GENE"], [185, 191, "GENE"]]}], ["On disease subgroups analysis, miR-125a and miR-429 were downregulated in mild disease (p\u2009=\u20090.03 and 0.02, respectively), but not in severe disease (p\u2009=\u20090.3 and 0.3).", {"entities": [[44, 51, "GENE"]]}], ["microRNA expression in nasal epithelium cytology brushings of RSV-positive infants shows a distinct profile of immune-associated miRNA.", {"entities": []}], ["miR-125a has important functions within NF-\u03baB signaling and macrophage function.", {"entities": []}], ["The lack of downregulation of miR-125a and miR-429 in severe disease may help explain differences in disease manifestations on infection with RSV.", {"entities": [[43, 50, "GENE"]]}], ["Adhatoda vasica (L.) (Acanthaceae) is used in the indigenous system of medicine in India.", {"entities": []}], ["The alkaloid Vasicine was isolated from ethanolic extract of the leaves of A. vasica using column chromatography.", {"entities": []}], ["Vasicine acetate was obtained by acetylation of Vasicine.", {"entities": []}], ["Vasicine acetate exhibited good zone of inhibition against bacteria: 10\u2009mm against E. aerogenes , 10\u2009mm against S. epidermidis , and 10\u2009mm against P. aeruginosa .", {"entities": []}], ["Vasicine acetate showed minimum inhibitory concentration values against bacteria: M. luteus (125\u2009 \u03bc g/mL), E. aerogenes (125\u2009 \u03bc g/mL), S. epidermidis (125\u2009 \u03bc g/mL), and P. aeruginosa (125\u2009 \u03bc g/mL).", {"entities": []}], ["The radical scavenging activity of Vasicine acetate was the maximum at 1000\u2009 \u03bc g/mL (66.15%).", {"entities": []}], ["The compound showed prominent cytotoxic activity in vitro against A549 lung adenocarcinoma cancer cell line.", {"entities": [[76, 90, "DISEASE"], [71, 90, "DISEASE"], [91, 97, "DISEASE"]]}], ["Quantification of Vasicine and Vasicine acetate by HPLC-DAD analysis showed their contents to be 0.2293% and 0.0156%, respectively, on dry weight basis of the leaves.", {"entities": []}], ["Vasicine acetate could be probed further in drug discovery programme.", {"entities": []}], ["Pain is one of the most common and distressing symptoms reported by adolescents with cancer.", {"entities": [[85, 91, "DISEASE"]]}], ["Despite advancements in pain assessment and management research, pain due to cancer and/or its treatments continues to be poorly managed.", {"entities": [[77, 83, "DISEASE"]]}], ["Our research group has developed a native iPhone application (app) called Pain Squad to tackle the problem of poorly managed pain in the adolescent with cancer group.", {"entities": [[153, 159, "DISEASE"], [62, 65, "GENE"]]}], ["The app functions as an electronic pain diary and is unique in its ability to collect data on pain intensity, duration, location, and the impact pain has on an adolescent\u2019s life (ie, relationships, school work, sleep, mood).", {"entities": [[4, 7, "GENE"]]}], ["It also evaluates medications and other physical and psychological pain management strategies used.", {"entities": []}], ["Users are prompted twice daily at configurable times to complete 20 questions characterizing their pain and the app transmits results to a database for aggregate reporting through a Web interface.", {"entities": [[112, 115, "GENE"]]}], ["Each diary entry represents a pain case filed by an adolescent with cancer and a reward system (ie, moving up through law-enforcement team ranks, built-in videotaped acknowledgements from fictitious officers) encourages consistent use of the diary.", {"entities": [[68, 74, "DISEASE"]]}], ["Our objective was to design, develop, and test the usability, feasibility, compliance, and satisfaction of a game-based smartphone pain assessment tool for adolescents with cancer.", {"entities": [[173, 179, "DISEASE"]]}], ["We used both low- and high-fidelity qualitative usability testing with qualitative semi-structured, audio-taped interviews and iterative cycles to design and refine the iPhone based Pain Squad app.", {"entities": [[193, 196, "GENE"]]}], ["Qualitative thematic analysis of interviews using constant comparative methodology captured emergent themes related to app usability.", {"entities": [[119, 122, "GENE"]]}], ["Content validity was assessed using question importance-rating surveys completed by participants.", {"entities": []}], ["Compliance and satisfaction data were collected following a 2-week feasibility trial where users were alarmed to record their pain twice daily on the app.", {"entities": [[150, 153, "GENE"]]}], ["Thematic analysis of usability interviews showed the app to be appealing overall to adolescents.", {"entities": [[53, 56, "GENE"]]}], ["Analyses of both low- and high-fidelity testing resulted in minor revisions to the app to refine the theme and improve its usability.", {"entities": [[83, 86, "GENE"]]}], ["Adolescents resoundingly endorsed the game-based nature of the app and its virtual reward system.", {"entities": [[63, 66, "GENE"]]}], ["The importance of app pain diary questions was established by content validity analysis.", {"entities": [[18, 21, "GENE"]]}], ["Compliance with the app, assessed during feasibility testing, was high (mean 81%, SD 22%) and adolescents from this phase of the study found the app likeable, easy to use, and not bothersome to complete.", {"entities": [[20, 23, "GENE"], [145, 148, "GENE"], [20, 23, "GENE"], [145, 148, "GENE"]]}], ["A multifaceted usability approach demonstrated how the Pain Squad app could be made more appealing to children and adolescents with cancer.", {"entities": [[132, 138, "DISEASE"], [66, 69, "GENE"]]}], ["The game-based nature and built-in reward system of the app was appealing to adolescents and may have resulted in the high compliance rates and satisfaction ratings observed during clinical feasibility testing.", {"entities": [[56, 59, "GENE"]]}], ["Esophageal adenocarcinoma (EA) is characterized by a strong male predominance.", {"entities": [[11, 25, "DISEASE"]]}], ["Sex steroid hormones have been hypothesized to underlie this sex disparity, but no population-based study to date has examined this potential association.", {"entities": []}], ["Using mass spectrometry and ELISA, we quantitated sex steroid hormones and sex hormone binding globulin, respectively, in plasma from males\u2013 172 EA cases and 185 controls\u2013within the Factors Influencing the Barrett/Adenocarcinoma Relationship (FINBAR) Study, a case-control investigation conducted in Northern Ireland and Ireland.", {"entities": [[214, 228, "DISEASE"]]}], ["Multivariable adjusted logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between circulating hormones and EA.", {"entities": []}], ["Higher androgen:estrogen ratio metrics were associated with increased odds of EA (e.g., testosterone:estradiol ratio OR Q4 v. Q1 = 2.58, 95%CI = 1.23\u20135.43; P trend = 0.009).", {"entities": []}], ["All estrogens and androgens were associated with significant decreased odds of EA.", {"entities": []}], ["When restricted to individuals with minimal to no decrease in body mass index, the size of association for the androgen:estrogen ratio was not greatly altered.", {"entities": []}], ["This first study of sex steroid hormones and EA provides tentative evidence that androgen:estrogen balance may be a factor related to EA.", {"entities": []}], ["Replication of these findings in prospective studies is needed to enhance confidence in the causality of this effect.", {"entities": []}], ["Multimorbidity is highly prevalent in the elderly and relates to many adverse outcomes, such as higher mortality, increased disability and functional decline.", {"entities": []}], ["Many studies tried to reduce the heterogeneity of multimorbidity by identifying multimorbidity clusters or disease combinations, however, the internal structure of multimorbidity clusters and the linking between disease combinations and clusters are still unknown.", {"entities": []}], ["The aim of this study was to depict which diseases were associated with each other on person-level within the clusters and which ones were responsible for overlapping multimorbidity clusters.", {"entities": []}], ["The study analyses insurance claims data of the Gm\u00fcnder ErsatzKasse from 2006 with 43,632 female and 54,987 male patients who were 65\u00a0years and older.", {"entities": []}], ["The analyses are based on multimorbidity clusters from a previous study and combinations of three diseases (\"triads\") identified by observed/expected ratios\u2009\u2265\u20092 and prevalence rates\u2009\u2265\u20091%.", {"entities": []}], ["In order to visualise a \"disease network\", an edgelist was extracted from these triads, which was analysed by network analysis and graphically linked to multimorbidity clusters.", {"entities": []}], ["We found 57 relevant triads consisting of 31 chronic conditions with 200 disease associations (\"edges\") in females and 51 triads of 29 diseases with 174 edges in males.", {"entities": []}], ["In the disease network, the cluster of cardiovascular and metabolic disorders comprised 12 of these conditions in females and 14 in males.", {"entities": []}], ["The cluster of anxiety, depression, somatoform disorders, and pain consisted of 15 conditions in females and 12 in males.", {"entities": []}], ["We were able to show which diseases were associated with each other in our data set, to which clusters the diseases were assigned, and which diseases were responsible for overlapping clusters.", {"entities": []}], ["The disease with the highest number of associations, and the most important mediator between diseases, was chronic low back pain.", {"entities": []}], ["In females, depression was also associated with many other diseases.", {"entities": []}], ["We found a multitude of associations between disorders of the metabolic syndrome of which hypertension was the most central disease.", {"entities": [[90, 102, "DISEASE"], [72, 80, "DISEASE"]]}], ["The most prominent bridges were between the metabolic syndrome and musculoskeletal disorders.", {"entities": [[54, 62, "DISEASE"]]}], ["Guideline developers might find our approach useful as a basis for discussing which comorbidity should be addressed.", {"entities": []}], ["Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipolar affective disorder are frequently treated with antipsychotics.", {"entities": [[73, 86, "DISEASE"]]}], ["National guidance advises the use of shared decision-making (SDM) in antipsychotic prescribing.", {"entities": []}], ["There is currently little data on the opinions of health professionals on the role of SDM.", {"entities": []}], ["Objective To explore the views and experiences of UK mental health pharmacists regarding the use of SDM in antipsychotic prescribing in people diagnosed with SMI.", {"entities": []}], ["Setting The study was conducted by interviewing secondary care mental health pharmacists in the UK to obtain qualitative data.", {"entities": []}], ["Methods Semi-structured interviews were recorded.", {"entities": []}], ["An inductive thematic analysis was conducted using the method of constant comparison.", {"entities": []}], ["Main outcome measure Themes evolving from mental health pharmacists on SDM in relation to antipsychotic prescribing in people with SMI.", {"entities": []}], ["Results Thirteen mental health pharmacists were interviewed.", {"entities": []}], ["SDM was perceived to be linked to positive clinical outcomes including adherence, service user satisfaction and improved therapeutic relations.", {"entities": []}], ["Despite more prescribers and service users supporting SDM, it was not seen as being practised as widely as it could be; this was attributed to a number of barriers, most predominantly issues surrounding service user\u2019s lacking capacity to engage in SDM and time pressures on clinical staff.", {"entities": []}], ["The need for greater effort to work around the issues, engage service users and adopt a more inter-professional approach was conveyed.", {"entities": []}], ["Conclusion The mental health pharmacists support SDM for antipsychotic prescribing, believing that it improves outcomes.", {"entities": []}], ["However, barriers are seen to limit implementation.", {"entities": []}], ["More research is needed into overcoming the barriers and measuring the benefits of SDM, along with exploring a more inter-professional approach to SDM.", {"entities": []}], ["The online version of this article (doi:10.1007/s11096-016-0352-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Efforts to assess health risks associated with exposures to multiple urban air toxics have been hampered by the lack of exposure data for people living in urban areas.", {"entities": []}], ["The TEACH (Toxic Exposure Assessment, a Columbia/Harvard) study was designed to characterize levels of and factors influencing personal exposures to urban air toxics among high school students living in inner-city neighborhoods of New York City and Los Angeles, California.", {"entities": []}], ["This present article reports methods and data for the New York City phase of TEACH, focusing on the relationships between personal, indoor, and outdoor concentrations in winter and summer among a group of 46 high school students from the A. Philip Randolph Academy, a public high school located in the West Central Harlem section of New York City.", {"entities": []}], ["Air pollutants monitored included a suite of 17 volatile organic compounds (VOCs) and aldehydes, particulate matter with a mass median aerodynamic diameter <or= 2.5 microm (PM2.5), black carbon, and a suite of 28 particle-associated trace elements.", {"entities": []}], ["Sequential 48-hr ambient samples also were collected over 8 weeks in each season at an urban fixed site and an upwind, nonurban fixed site.", {"entities": []}], ["Personal, indoor, and outdoor concentrations of particle elements were generally similar, suggesting that ambient sources may have driven indoor and personal exposures for most elements.", {"entities": []}], ["More varied relationships among personal, home indoor, and home outdoor concentrations were observed for VOCs and aldehydes.", {"entities": []}], ["For formaldehyde and acetaldehyde, and several VOCs, indoor concentrations far exceeded outdoor levels and appeared to dominate personal exposures.", {"entities": []}], ["Strong seasonal differences in indoor to outdoor concentration ratios were observed for these compounds, reflecting the influence of home air exchange rates.", {"entities": []}], ["For other VOCs, especially those related to motor vehicle exhaust, more consistent indoor, outdoor, and personal concentrations were observed, suggesting that ambient concentrations may have been the driving force for personal exposures to some VOCs.", {"entities": []}], ["These results demonstrate exposures to a wide range of air toxic pollutants among young people attending school in inner-city New York.", {"entities": []}], ["In Ethiopia, pesticides are widely used for a variety of purposes.", {"entities": []}], ["The occurrence of contamination and poisoning for farmers is highly reported due to unsafe handling practices and their usage.", {"entities": []}], ["We assessed knowledge, attitudes and experiences of previous pesticide exposure, and related health problems among farmers who use irrigation in Jimma Zone, Southwest Ethiopia.", {"entities": []}], ["A community based cross-sectional study was conducted among farmers living in the zone.", {"entities": []}], ["Respondents were 796 irrigation farmers from 20 kebeles (lowest administration unit) in Jimma Zone.", {"entities": []}], ["Data were collected using a pretested and structured questionnaire via face-to-face interviews.", {"entities": []}], ["Both descriptive and inferential statistics analysis were performed.", {"entities": []}], ["A binary logistic regression was used to identify factors associated with attitudes of farmers towards the safe use of pesticides at P value of \u2264 0.05 in the final model.", {"entities": []}], ["Among the participants, 54.4% (95%CI, 50.7\u201358%) knew at least one pesticide control method and 53.7% had positive attitudes towards safe use of pesticide.", {"entities": []}], ["The mean score of attitudes was found to be 3.9(\u00b10.4).", {"entities": []}], ["Knowledge including each of the following: the names of the pesticides (AOR, 0.41; 95%CI, 0.25\u20130.67), methods of pest control and the use of gloves during pesticide exposure (AOR, 1.52; 95%CI, 1.07\u20132.16) was found to be independent predictor of the farmers\u2019 attitudes about safe use of pesticides.", {"entities": []}], ["Past exposure of pesticide was reported by 89.6% of farmers.", {"entities": []}], ["Participants reported ingestion (88.9%) and inhalation (90.4%) as possible mechanisms of pesticide exposure.", {"entities": []}], ["Nearly 42% of farmers had never used any personal protective equipment (PPE) to protect themselves against pesticide exposure.", {"entities": []}], ["Farmers reported several health complications, which were perceived as complications of pesticide exposure, including: headache, nausea and vomiting, skin rash and irritation and abdominal pain.", {"entities": []}], ["The study exposed the existence of high probability of pesticide exposure, the low safe use of pesticide and the low use of PPE.", {"entities": []}], ["However, but farmers had positive attitudes towards safe use of pesticides.", {"entities": []}], ["These findings appeal for the development of effective public health strategies to improve farmers\u2019 awareness and safe use of PPE.", {"entities": []}], ["In addition, there is a need to inform farmers about integrated pest management to prevent severe health complications, which may occur as a result of unsafe and inappropriate use of pesticides.", {"entities": []}], ["This paper investigated the spatial and temporal variations in the amounts of PM accumulated on leaves of Ligustrum lucidum , a common evergreen tree species in North China.", {"entities": []}], ["The effects of rainfall and wind on the amounts of PM deposited on foliage were also determined.", {"entities": []}], ["The amounts of PM (g\u00b7m L. lucidum differed significantly among the sites (from 0.96 to 5.56) and over time (from 2.51 to 4.48).", {"entities": []}], ["The largest amounts of PM on foliage of L. lucidum were observed on plants growing at the most polluted site.", {"entities": []}], ["During the year, the highest and lowest accumulation of PM occurred in November and August, respectively.", {"entities": []}], ["A considerable proportion of the accumulated PM on leaves was removed by rainfall events (28\u201348% of PM) and strong winds (27\u201336% of PM), and more precipitation or higher maximum wind speed could remove more PM from leaves.", {"entities": []}], ["Rainfall removed mainly large and coarse particles, while fine particles adhered more strongly to the foliage.", {"entities": []}], ["These results suggested that the effects of local weather conditions (e.g., rainfall, strong wind), different seasons, and pollution levels should be considered in evaluating total PM accumulation on leaves.", {"entities": []}], ["Objectives.", {"entities": []}], ["To explore early experiences of sickle cell disorder (SCD) in families with a young affected child, and the way these experiences influence relations within families.", {"entities": [[54, 57, "GENE"]]}], ["To consider ways in which stigma could be counteracted in health and research programmes in sub Saharan Africa.", {"entities": []}], ["A qualitative study was conducted in a rural area of coastal Kenya including in-depth interviews with 13 families affected by SCD and 12 staff of a local biomedical research progamme.", {"entities": [[126, 129, "GENE"]]}], ["Purposive selection aimed to maximize diversity in socioeconomic and educational status, religion, severity of illness burden and religion amongst families and draw on relevant experience for staffs.", {"entities": []}], ["Interviews were recorded, transcribed and analysed using the constant comparative method for family interviews and a thematic framework approach for staff data.", {"entities": []}], ["Low initial recognition of SCD and its cause were associated with lay practices of surveillance within affected families, contributing to stigmatisation that occurred independently of genetic knowledge.", {"entities": [[27, 30, "GENE"]]}], ["Blame was often placed on mothers, including a risk of blame for misaligned paternity.", {"entities": []}], ["Mothers are often particularly affected by SCD through the loss of independent livelihoods and their limited options in coping with this chronic condition.", {"entities": [[43, 46, "GENE"]]}], ["Conclusions.", {"entities": []}], ["Mothers of children with SCD were particularly vulnerable to stigmatisation within families, with underlying structural influences that suggest these findings may apply to other similar settings in Africa, and have relevance for other genetic conditions.", {"entities": [[25, 28, "GENE"]]}], ["The potential, nature and form of stigmatisation point to the role of effective communication and SCD management in addressing for blame and discriminative effects of having a child with SCD.", {"entities": [[98, 101, "GENE"], [187, 190, "GENE"], [98, 101, "GENE"], [187, 190, "GENE"]]}], ["The findings highlight the importance of broader social programmes targeting underlying gender and economic inequalities.", {"entities": []}], ["Some bacterial and viral infections may reduce the risk of atopy, and this is based on the concept of their ability to divert the immune system towards the Th1 responses.", {"entities": []}], ["Most of the hepatitis B virus (HBV) infections occur in the developing countries and this is where atopic disorders are least prevalent.", {"entities": [[12, 21, "DISEASE"]]}], ["Th1 responses are important for the viral clearance of HBV and also for antibody production.", {"entities": []}], ["The aim of the study is to investigate whether the presence of antibodies to the hepatitis B surface antigen (anti-HBs) is inversely associated with atopy in adults.", {"entities": [[81, 90, "DISEASE"]]}], ["A random sample of 358 subjects, who were without hepatitis B surface antigen, was recruited; they were aged from 18 to 79 years (105 young adults aged \u226440 years and 253 older adults aged > 40 years).", {"entities": [[50, 59, "DISEASE"]]}], ["Determinations of the anti-HBs and skin prick tests using aeroallergens were performed.", {"entities": []}], ["Those subjects with one or more positive skin reactions (a mean wheal diameter \u22653 mm) were considered atopic.", {"entities": []}], ["The prevalence rate of atopy ( p =0.035) or the sensitization to Dermatophagoides farinae ( p =0.01) was significantly lower in the subjects with anti-HBs than in those subjects without anti-HBs for the young adults, but not for the older adults.", {"entities": []}], ["The logistic regression analysis that was done on the young adults showed that the presence of anti-HBs was associated with a significantly lower risk of atopy (the odds ratio adjusted for confounding variables = 0.40 [95% CI 0.16-0.98], p =0.046) or with the sensitization to D. farinae (0.20 [0.06-0.65], p = 0.008).", {"entities": []}], ["The presence of anti-HBs produced by a natural HBV infection or vaccination might be inversely associated with atopy in young adults.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a serious health problem that has significant effects on the life status of elderly persons.", {"entities": []}], ["Use of the empowerment approach is necessary for health promotion in older people with COPD, but little attention has so far been paid to all the dimensions of empowerment in the management of COPD, which would provide useful knowledge regarding elders with COPD.", {"entities": []}], ["This article reports on a study exploring people\u2019s experiences of the empowerment of older people with COPD.", {"entities": []}], ["This study adopted an exploratory qualitative design and was carried out using grounded theory methodology.", {"entities": []}], ["Grounded theory was considered appropriate for this study because of its focus on how people respond to and act on the problems that they encounter.", {"entities": []}], ["We collected data by conducting in-depth semi-structured interviews and taking field notes.", {"entities": []}], ["Twenty-four participants were selected through purposive sampling.", {"entities": []}], ["The results showed that in encountering the complexity of disease and in response to difficulties induced by COPD, three strategies were applied.", {"entities": []}], ["Elderly persons with COPD, their family caregivers, and professional team members engaged in \u201cmanaging life with COPD,\u201d \u201cstriving to keep abreast of life,\u201d \u201cpreparing for battle with disease,\u201d and \u201chelping to stabilize the elder\u2019s life.\u201d The outcome of these strategies was \u201cco-existence with disease.\u201d The potential of \u201cmanaging life with COPD\u201d was influenced by the following factors: \u201cco-existence with ageing,\u201d \u201cpersonal potential,\u201d \u201ca challenged health system,\u201d and \u201cweak social support.\u201d \u201cManaging life with COPD\u201d enables the elder to feel in control and live optimally.", {"entities": []}], ["This is a fragile balance, however, and the unpredictability of COPD can tip the elder into \u201cself-efficacy.\u201d Understanding the experiences of the empowerment process of older people with COPD can help health professionals provide more focused elderly care.", {"entities": []}], ["Sedentariness is an important risk factor for poor health.", {"entities": []}], ["The main objective of this work was to examine the prospective association between television viewing time and indicators of physical function, mobility, agility, and frailty.", {"entities": []}], ["Data came from two independent cohorts of community-dwelling older adults: the Seniors-ENRICA ( n \u2009=\u20092392, 3.5\u00a0year follow-up), and the ELSA ( n \u2009=\u20093989, 3.9\u00a0year follow-up).", {"entities": []}], ["At baseline, television viewing and other sedentary behaviors were ascertained using interviewer-administered questionnaires.", {"entities": []}], ["In the Seniors-ENRICA cohort overall physical function at baseline and follow-up was assessed using the physical component summary (PCS) of the SF-12 Health Survey.", {"entities": []}], ["Measures for incident mobility and agility limitations in both cohorts were based on standardized questions, and incident frailty was measured with the Fried criteria.", {"entities": []}], ["Analyses were adjusted for the main confounders, including physical activity at baseline.", {"entities": []}], ["Results across cohorts were pooled using a random effects model.", {"entities": []}], ["Lower (worse) scores in the PCS were observed among those in the highest (vs. the lowest) tertile of television viewing time (b-coefficient:-1.66; 95% confidence interval:-2.81,-0.52; p-trend\u2009=\u20090.01).", {"entities": []}], ["Moreover, the pooled odds ratios (95% CIs) for mobility limitations for the second and third (vs. the lowest) tertile of television viewing were 1.00 (0.84, 1.20) and 1.17 (1.00, 1.38); p-trend\u2009=\u20090.12, respectively.", {"entities": []}], ["The corresponding results for agility limitations were 1.18 (0.97, 1.44) and 1.25 (1.03, 1.51); p-trend\u2009=\u20090.02.", {"entities": []}], ["Results for incident frailty were 1.10 (0.80, 1.51) and 1.47 (1.09, 1.97); p-trend\u2009=\u20090.03.", {"entities": []}], ["No association between other types of sedentary behavior (time seated at the computer, while commuting, lying in the sun, listening to music/reading, internet use) and risk of functional limitations was found.", {"entities": []}], ["Among older adults, longer television viewing time is prospectively associated with limitations in physical function independently of physical activity.", {"entities": []}], ["The online version of this article (doi:10.1186/s12966-017-0511-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Histamine is used in bronchial and dermal provocation, but it is rarely considered an environmental risk factor in allergic disease.", {"entities": []}], ["Because bed bugs defecate large amounts of histamine as a component of their aggregation pheromone, we sought to determine if histamine accumulates in household dust in bed bug infested homes, and the effects of bed bug eradication with spatial heat on histamine levels in dust.", {"entities": []}], ["We collected dust in homes and analyzed for histamine before, and up to three months after bed bug eradication.", {"entities": []}], ["Histamine levels in bed bug infested homes were remarkably high (mean = 54.6\u00b118.9 \u03bcg/100 mg of sieved household dust) and significantly higher than in control homes not infested with bed bugs (mean < 2.5\u00b11.9 \u03bcg/100 mg of sieved household dust).", {"entities": []}], ["Heat treatments that eradicated the bed bug infestations failed to reduce histamine levels, even three months after treatment.", {"entities": []}], ["We report a clear association between histamine levels in household dust and bed bug infestations.", {"entities": []}], ["The high concentrations, persistence, and proximity to humans during sleep suggest that bed bug-produced histamine may represent an emergent contaminant and pose a serious health risk in the indoor environment.", {"entities": []}], ["Recent studies that assessed the relevance of the blood eosinophil count as a biomarker in patients with COPD may have overestimated it because they included patients with asthma\u2013COPD overlap syndrome (ACOS).", {"entities": [[192, 200, "DISEASE"], [172, 178, "DISEASE"]]}], ["We investigated the clinical implications of the blood eosinophil count in patients with non-ACOS COPD.", {"entities": []}], ["From a Korean COPD Subtype Study (KOCOSS) cohort, we selected patients with non-ACOS COPD after excluding ACOS patients according to Spanish criteria.", {"entities": []}], ["Clinical characteristics and the incidence of moderate-to-severe exacerbation were compared among the four groups stratified according to the quartiles of blood eosinophil percent and count.", {"entities": []}], ["Of the KOCOSS cohort of 1,132 patients with COPD, 467 non-ACOS COPD patients (41.2%) with data of blood eosinophil count remained after excluding those with ACOS based on the Spanish definition.", {"entities": []}], ["There was no difference in clinical characteristics among groups classified according to the quartiles of eosinophil percent and count.", {"entities": []}], ["On multivariate logistic regression, eosinophil quartiles in percent and absolute count were not associated with the incidence of moderate-to-severe acute exacerbations of COPD (AECOPD).", {"entities": []}], ["The eosinophil count did not affect the risk of AECOPD or forced expiratory volume in 1 second (FEV 1 ) changes according to exposure to inhaled corticosteroid (ICS).", {"entities": [[96, 99, "GENE"]]}], ["However, by increasing the cutoff value for the eosinophil count from 200/\u03bcL to 600/\u03bcL, the odds ratio for risk of exacerbation increased serially from 0.82 to 2.96 on trend analysis.", {"entities": []}], ["In patients with non-ACOS COPD, the blood eosinophil count and percent were not associated with FEV 1 changes, quality of life (QoL), AECOPD frequency, or response to ICS.", {"entities": [[96, 99, "GENE"]]}], ["The clinical implication of the blood eosinophil count should not be overestimated in patients with non-ACOS COPD.", {"entities": []}], ["Mucoepidermoid carcinoma (MEC) of the lung is a rare malignant neoplasm.", {"entities": [[15, 24, "DISEASE"]]}], ["We aimed to investigate clinicopathological features, therapies, and prognoses of eight MEC cases.", {"entities": []}], ["Eight patients underwent surgical treatment for pulmonary MEC between 2005 and 2012 at the Thoracic Surgical Department of West China Hospital, Sichuan, China.", {"entities": []}], ["The clinical data, radiological manifestation, treatment strategy, pathological findings, and prognoses of all patients were analyzed retrospectively.", {"entities": []}], ["Among the eight cases (four males and four females), the age of patients ranged from 35 to 71\u00a0years (mean age 50.67\u00a0years).", {"entities": []}], ["Two tumors were located in the upper lobes and three masses were located in the lower lobes.", {"entities": []}], ["The other three lumps were located in the left main bronchus, middle segmental bronchus of the right lobe, and trachea, respectively.", {"entities": []}], ["The characteristics of the tumors were consistent with low grade MEC (n\u2009=\u20096) and high grade MEC (n\u2009=\u20092).", {"entities": []}], ["All of the patients were sent for oncological evaluations, and three patients with N1 or N2 disease received chemotherapy.", {"entities": []}], ["One of the patients died from brain metastasis at 15\u00a0months.", {"entities": []}], ["Seven of the eight patients were alive at the time of evaluation.", {"entities": []}], ["The median survival time was 40 (range 8 to 88) months.", {"entities": []}], ["Mucoepidermoid tumors have to be treated by radical surgery with lymph node sampling and dissection.", {"entities": []}], ["Patients with low grade tumors can be expected to be cured following complete resection.", {"entities": []}], ["Careful histological typing plays a key role in prediction of late results, and further studies are needed.", {"entities": []}], ["The data regarding risk factors for death during tuberculosis (TB) treatment are inconsistent, and few studies examined this issue in Korea.", {"entities": [[49, 61, "DISEASE"]]}], ["The purpose of this study was to evaluate baseline prognostic factors for death during treatment of adult patients with pulmonary TB in Korea.", {"entities": []}], ["A multicenter retrospective cohort study of 2,481 patients who received TB treatment at eight hospitals from January 2009 to December 2010 was performed.", {"entities": []}], ["Successful treatment included cure (1,129, 45.5%) and treatment completion (1,204, 48.5%) in 2,333 patients (94.0%).", {"entities": []}], ["Unsuccessful treatment included death (85, 3.4%) and treatment failure (63, 2.5%) occurred in 148 patients (6.0%).", {"entities": []}], ["In multivariate analysis, male sex, anemia, dyspnea, chronic heart disease, malignancy, and intensive care unit (ICU) admission were significant risk factors for death during TB treatment.", {"entities": [[61, 74, "DISEASE"], [36, 42, "DISEASE"]]}], ["Therefore, male sex, anemia, dyspnea, chronic heart disease, malignancy, and ICU admission could be baseline prognostic factors for death during treatment of adult patients with pulmonary TB in Korea.", {"entities": [[46, 59, "DISEASE"], [21, 27, "DISEASE"]]}], ["The neuronal serpin neuroserpin undergoes polymerisation as a consequence of point mutations that alter its conformational stability, leading to a neurodegenerative dementia called familial encephalopathy with neuroserpin inclusion bodies ( FENIB ).", {"entities": [[165, 173, "DISEASE"]]}], ["Neuroserpin is a glycoprotein with predicted glycosylation sites at asparagines 157, 321 and 401.", {"entities": []}], ["We used site\u2010directed mutagenesis, transient transfection, western blot, metabolic labelling and ELISA to probe the relationship between glycosylation, folding, polymerisation and degradation of neuroserpin in validated cell models of health and disease.", {"entities": []}], ["Our data show that glycosylation at N157 and N321 plays an important role in maintaining the monomeric state of neuroserpin, and we propose this is the result of steric hindrance or effects on local conformational dynamics that can contribute to polymerisation.", {"entities": []}], ["Asparagine residue 401 is not glycosylated in wild type neuroserpin and in several polymerogenic variants that cause FENIB , but partial glycosylation was observed in the G392E mutant of neuroserpin that causes severe, early\u2010onset dementia.", {"entities": [[231, 239, "DISEASE"]]}], ["Our findings indicate that N401 glycosylation reports lability of the C\u2010terminal end of neuroserpin in its native state.", {"entities": []}], ["This C\u2010terminal lability is not required for neuroserpin polymerisation in the endoplasmic reticulum, but the additional glycan facilitates degradation of the mutant protein during proteasomal impairment.", {"entities": []}], ["In summary, our results indicate how normal and variant\u2010specific N\u2010linked glycosylation events relate to intracellular folding, misfolding, degradation and polymerisation of neuroserpin.", {"entities": []}], ["Untreated mental health problems may result in poor outcomes for youth with systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD).", {"entities": [[115, 146, "DISEASE"], [85, 104, "DISEASE"], [121, 146, "DISEASE"], [76, 104, "DISEASE"]]}], ["We investigated perceptions, barriers and facilitators for mental healthcare of these youth.", {"entities": []}], ["We conducted 32 semi-structured interviews with 16 outpatient youth with SLE/MCTD, ages 11\u201322 years, and their parents.", {"entities": []}], ["We used purposive sampling to deliberately obtain the experiences of youth screened during a previous study for depression and anxiety with the Patient Health Questionnaire 9 and the Screen for Childhood Anxiety and Related Disorders, respectively.", {"entities": []}], ["We recruited 6 youth with previous positive screens and 10 with negative screens.", {"entities": []}], ["We assessed interim mental health history, and qualitatively examined perceptions, barriers and facilitators for mental healthcare.", {"entities": []}], ["Youth with a mental health history increased from 6 (38\u00a0%) at initial screening to 9 (56\u00a0%) at interview (mean follow-up\u2009=\u20092.1\u00a0years).", {"entities": []}], ["Youth receiving mental health treatment increased from 33 to 67\u00a0%.", {"entities": []}], ["Youth and parents identified rheumatologists as primary physicians and found mental health screening in rheumatology acceptable.", {"entities": []}], ["Barriers to mental healthcare included: stigma; fear; uncertainty about getting help; parental emotional burden; minimization by doctors; and limited mental healthcare access.", {"entities": []}], ["Facilitators included: strong clinician relationships; clinician initiative, sincerity and normalization in discussing mental health; and increased patient/family awareness of mental health issues in SLE/MCTD.", {"entities": []}], ["Youth with SLE/MCTD and their parents perceive pediatric rheumatologists as a preferred source for mental health screening, guidance and referral.", {"entities": []}], ["Interventions addressing barriers and enhancing facilitators may improve mental healthcare for youth with SLE/MCTD.", {"entities": []}], ["Respiratory syncytial virus (RSV) is an important pathogen in lower respiratory tract infections (LRTI) in infants, but there are limited data concerning patients with underlying conditions and children older than 2 years of age.", {"entities": []}], ["We have designed a prospective observational multicenter national study performed in 26 Spanish hospitals (December 2011\u2013March 2012).", {"entities": []}], ["Investigational cases were defined as children with underlying chronic diseases and were compared with a group of previously healthy children (proportion 1:2).", {"entities": []}], ["Clinical data were compared between the groups.", {"entities": []}], ["A total of 1763 children hospitalized due to RSV infection during the inclusion period were analyzed.", {"entities": []}], ["Of them, 225 cases and 460 healthy children were enrolled in the study.", {"entities": []}], ["Underlying diseases observed were respiratory (64%), cardiovascular (25%), and neurologic (12%), as well as chromosomal abnormalities (7\u00b75%), immunodeficiencies (6\u00b77%), and inborn errors of metabolism (3\u00b75%).", {"entities": []}], ["Cases were statistically older than previously healthy children (average age: 16\u00b73 versus 5\u00b75 months).", {"entities": []}], ["Cases experienced hypoxemia more frequently ( P < 0\u00b7001), but patients with respiratory diseases required oxygen therapy more often (OR: 2\u00b799; 95% CI: 1\u00b703\u20138\u00b765).", {"entities": []}], ["Mechanical ventilation was used more in patients with cardiac diseases (OR: 3\u00b70; 95% CI: 1\u00b707\u20138\u00b744) and in those with inborn errors of metabolism (OR: 12\u00b727; 95% CI: 2\u00b711\u201371\u00b747).", {"entities": []}], ["This subgroup showed a higher risk of admission to the PICU (OR: 6\u00b77, 95% CI: 1\u00b718\u201338\u00b704).", {"entities": []}], ["Diagnosis of pneumonia was more frequently found in cases (18\u00b72% versus 9\u00b73%; P < 0\u00b701).", {"entities": [[13, 22, "DISEASE"]]}], ["A significant percentage of children with RSV infection have underlying diseases and the illness severity is higher than in healthy children.", {"entities": []}], ["People with asthma suffer from impaired health-related quality of life (HRQL), but the determinants of HRQL among asthmatics are not completely understood.", {"entities": [[12, 18, "DISEASE"]]}], ["The aim of this investigation was to study determinants of low HRQL in asthmatics and to study whether the determinants of HRQL differ between sexes and age groups.", {"entities": []}], ["A cohort of three age groups in Sweden was investigated in 1990 using a questionnaire with focus on respiratory symptoms.", {"entities": []}], ["To study quality of life, the generic instrument Gothenburg Quality of Life was used.", {"entities": []}], ["The participants were also investigated with interviews, spirometry, and allergy testing.", {"entities": []}], ["Asthma was diagnosed in 616 subjects.", {"entities": [[0, 6, "DISEASE"]]}], ["Fifty-eight per cent ( n = 359) of the subjects were women; and 24% were smokers, 22% ex-smokers, and 54% were non-smokers.", {"entities": []}], ["Women were more likely than men to report poor health-related quality of life.", {"entities": []}], ["Respiratory symptoms severity was another independent determinant of a lower quality of life as well as airway responsiveness to irritants.", {"entities": []}], ["Current and former smokers also reported lower quality of life.", {"entities": []}], ["Finally, absenteeism from school and work was associated with lower quality of life.", {"entities": []}], ["Factors such as sex, smoking habits, airway responsiveness to irritants, respiratory symptom severity, allergy, and absenteeism from school and work were associated with low HRQL in asthmatics.", {"entities": []}], ["Cathelicidin is an important antimicrobial peptide in the urinary tract.", {"entities": []}], ["Cathelicidin expression is strongly stimulated by 1,25-dihydroxy vitamin D in epithelial cells, macrophages/monocytes, and neutrophils.", {"entities": []}], ["Vitamin D and cathelicidin status in children with urinary tract infection (UTI) caused by Escherichia coli is unknown.", {"entities": []}], ["To establish the relationship between serum vitamin D and urine cathelicidin levels in children with a UTI caused by Escherichia coli.", {"entities": []}], ["Serum 25-hydroxy vitamin D and urine cathelicidin levels were measured in 36 patients with UTI (mean age 6.8\u00b13.6 years, range: 0.25-12.6 years) and 38 controls (mean age 6.3\u00b12.8 years, range: 0.42-13 years).", {"entities": []}], ["There were no significant differences in urine cathelicidin levels between the study and control groups (p>0.05).", {"entities": []}], ["Eight (22.2%) patients in the study group and 21 (58.3%) children in the control group were found to have sufficient vitamin D (\u226520 ng/mL).", {"entities": []}], ["Patients with sufficient vitamin D had higher urine cathelicidin levels than the controls with sufficient vitamin D (respectively 262.5\u00b141.1 vs. 168\u00b131.6 ng/mL, p=0.001).", {"entities": []}], ["There were no significant differences between the patients and controls with insufficient vitamin D (p>0.05).", {"entities": []}], ["The children with vitamin D insufficiency may not be able to increase their urine cathelicidin level during UTI caused by Escherichia coli.", {"entities": []}], ["There is a need of prospective studies in order to prove a beneficial effect of vitamin D supplementation for the restoration of cathelicidin stimulation and consequently for prevention of UTI recurrence.", {"entities": []}], ["Respiratory tract colonization with these bacteria may be common in this population.", {"entities": []}], ["An increasing body of evidence indicates that nondiphtheria corynebacteria may be responsible for respiratory tract infections.", {"entities": []}], ["We report an outbreak of Corynebacterium pseudodiphtheriticum infection in children with cystic fibrosis (CF).", {"entities": [[89, 104, "DISEASE"]]}], ["To identify 18 C. pseudodiphtheriticum strains isolated from 13 French children with CF, we used molecular methods (partial rpoB gene sequencing) and matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry.", {"entities": []}], ["Clinical symptoms were exhibited by 10 children (76.9%), including cough, rhinitis, and lung exacerbations.", {"entities": [[74, 82, "DISEASE"]]}], ["The results of MALDI-TOF identification matched perfectly with those obtained from molecular identification.", {"entities": []}], ["Retrospective analysis of sputum specimens by using specific real-time PCR showed that \u224820% of children with CF were colonized with these bacteria, whereas children who did not have CF had negative test results.", {"entities": []}], ["Our study reemphasizes the conclusion that correctly identifying bacteria at the species level facilitates detection of an outbreak of new or emerging infections in humans.", {"entities": []}], ["The complement system is an important part of our immune system, and complement defects lead generally to increased susceptibility to infections and autoimmune diseases.", {"entities": []}], ["We have studied the role of complement activity in relation with chronic rhinosinusitis (CRS), and more specifically studied whether complement defects collectively predispose individuals for CRS or affect CRS severity.", {"entities": []}], ["The participants comprised 87 CRS patients randomly selected from the general population, and a control group of 150 healthy blood donors.", {"entities": []}], ["The CRS patients were diagnosed according to the European Position Paper on Rhinosinusitis and nasal Polyps criteria, and severity was evaluated by the Sino-nasal Outcome Test-22.", {"entities": []}], ["Serum samples were analysed by ELISA for activity of the respective pathways of complement, and subsequently for serum levels of relevant components.", {"entities": []}], ["We found that the frequency of complement defects was significantly higher among CRS patients than among healthy control subjects.", {"entities": []}], ["A majority of Mannan-binding lectin deficient CRS patients was observed.", {"entities": []}], ["The presence of complement defects had no influence on the severity of subjective symptoms.", {"entities": []}], ["Our studies show that defects in the complement system collectively may play an immunological role related to the development of CRS.", {"entities": []}], ["However, an association between severity of symptoms and presence of complement defects could not be demonstrated.", {"entities": []}], ["The air quality in urban areas is a major concern in modern cities due to significant impacts of air pollution on public health, global environment, and worldwide economy.", {"entities": []}], ["Recent studies reveal the importance of micro-level pollution information, including human personal exposure and acute exposure to air pollutants.", {"entities": []}], ["A real-time system with high spatio-temporal resolution is essential because of the limited data availability and non-scalability of conventional air pollution monitoring systems.", {"entities": []}], ["Currently, researchers focus on the concept of The Next Generation Air Pollution Monitoring System (TNGAPMS) and have achieved significant breakthroughs by utilizing the advance sensing technologies, MicroElectroMechanical Systems (MEMS) and Wireless Sensor Network (WSN).", {"entities": []}], ["However, there exist potential problems of these newly proposed systems, namely the lack of 3D data acquisition ability and the flexibility of the sensor network.", {"entities": []}], ["In this paper, we classify the existing works into three categories as Static Sensor Network (SSN), Community Sensor Network (CSN) and Vehicle Sensor Network (VSN) based on the carriers of the sensors.", {"entities": []}], ["Comprehensive reviews and comparisons among these three types of sensor networks were also performed.", {"entities": []}], ["Last but not least, we discuss the limitations of the existing works and conclude the objectives that we want to achieve in future systems.", {"entities": []}], ["Individual and community health are adversely impacted by disparities in health outcomes among disadvantaged and vulnerable populations.", {"entities": []}], ["Understanding the underlying causes for variations in health outcomes is an essential step towards developing effective interventions to ameliorate inequalities and subsequently improve overall community health.", {"entities": []}], ["Working at the neighborhood scale, this study examines multiple social determinates that can cause health disparities including low neighborhood wealth, weak social networks, inadequate public infrastructure, the presence of hazardous materials in or near a neighborhood, and the lack of access to primary care services.", {"entities": []}], ["The goal of this research is to develop innovative and replicable strategies to improve community health in disadvantaged communities such as newly arrived Hispanic immigrants.", {"entities": []}], ["This project is taking place within a primary care practice-based research network (PBRN) using key principles of community-based participatory research (CBPR).", {"entities": []}], ["Associations between social determinants and rates of hospitalizations, emergency department (ED) use, and ED use for primary care treatable or preventable conditions are being examined.", {"entities": []}], ["Geospatial models are in development using both hospital and community level data to identify local areas where interventions to improve disparities would have the greatest impact.", {"entities": []}], ["The developed associations between social determinants and health outcomes as well as the geospatial models will be validated using community surveys and qualitative methods.", {"entities": []}], ["A rapidly growing and underserved Hispanic immigrant population will be the target of an intervention informed by the research process to impact utilization of primary care services and designed, deployed, and evaluated using the geospatial tools and qualitative research findings.", {"entities": []}], ["The purpose of this intervention will be to reduce health disparities by improving access to, and utilization of, primary care and preventative services.", {"entities": []}], ["The results of this study will demonstrate the importance of several novel approaches to ameliorating health disparities, including the use of CBPR, the effectiveness of community-based interventions to influence health outcomes by leveraging social networks, and the importance of primary care access in ameliorating health disparities.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease mediated by an array of inflammatory cells and mediators, but above all, CD8+ T-lymphocytes, macrophages and neutrophils are important players in disease pathogenesis.", {"entities": []}], ["Roflumilast, a first-in-class, potent and selective phosphodiesterase 4 (PDE4) inhibitor, reduces the rate of exacerbations in patients with a high risk of future exacerbations and has been shown to reduce inflammatory cells and mediators in induced sputum, a surrogate of airway inflammation.", {"entities": []}], ["However, these anti-inflammatory effects are yet to be confirmed in another robust study directly assessing inflammatory markers in bronchial sub-mucosa.", {"entities": []}], ["An international, 16-week, randomized, double-blind, placebo-controlled, parallel-group study investigating the effects of roflumilast 500\u00a0\u03bcg once-daily versus placebo on inflammatory parameters in bronchial biopsy tissue specimens, sputum and blood serum.", {"entities": []}], ["One hundred and fifty patients with COPD and chronic bronchitis for at least 12 months will be recruited into the study and randomized in a 1:1 ratio to receive either roflumilast or placebo.", {"entities": [[53, 63, "DISEASE"]]}], ["The primary endpoint will be the number of CD8+ cells (cell counts per mm It is hypothesized that treatment with roflumilast reduces the characteristic inflammation found in the airways of patients with moderate-to-severe COPD, compared with placebo.", {"entities": []}], ["The design of the present study has built on the work of previous bronchial biopsy studies available in the literature.", {"entities": []}], ["It is hoped that it will reveal the cellular mechanisms underlying the anti-inflammatory effects of roflumilast and identify potentially important biomarkers and other surrogate endpoints in patients with COPD.", {"entities": []}], ["The design and rationale for this trial are described herein.", {"entities": []}], ["Clinical trial identifier: NCT01509677 (clinicaltrials.gov)", {"entities": []}], ["IL-4 plays critical roles in allergic disorders, including food hypersensitivity.", {"entities": []}], ["The direct effects of the cytokine on the survival and function of mast cells, the key effectors of food anaphylaxis, have not been established.", {"entities": []}], ["In this study we demonstrate that IL-4 induces a marked intestinal mastocytosis in mice.", {"entities": [[67, 79, "DISEASE"]]}], ["This phenotype is reproduced in animals expressing Il4r\u03b1F709 , an activating variant of the IL-4 receptor \u03b1 (IL-4R\u03b1)-chain.", {"entities": []}], ["Il4r\u03b1F709 mice exhibit enhanced anaphylactic reactions but unaltered physiologic responses to vasoactive mediators.", {"entities": []}], ["IL-4 induces Bcl-2 and Bcl-X L , and enhances survival and stimulates proliferation in cultured bone marrow mast cells (BMMC).", {"entities": []}], ["These effects are STAT6-dependent and are amplified in Il4r\u03b1F709 BMMC.", {"entities": []}], ["In competitive bone marrow chimeras, Il4r\u03b1F709 mast cells display a substantial competitive advantage over wild-type mast cells which, in turn, prevail over IL-4R\u03b1", {"entities": []}], ["The Massachusetts Department of Public Health, in collaboration with the U.S. Centers for Disease Control and Prevention Environmental Public Health Tracking Program, initiated a 3-year statewide project for the routine surveillance of asthma in children using school health records as the primary data source.", {"entities": [[236, 242, "DISEASE"]]}], ["School district nurse leaders received electronic data reporting forms requesting the number of children with asthma by grade and gender for schools serving grades kindergarten (K) through 8.", {"entities": [[110, 116, "DISEASE"]]}], ["Verification efforts from an earlier community-level study comparing a select number of school health records with primary care provider records demonstrated a high level of agreement (i.e., > 95%).", {"entities": []}], ["First-year surveillance targeted approximately one-half ( n = 958 schools) of all Massachusetts\u2019s K\u20138 schools.", {"entities": []}], ["About 78% of targeted school districts participated, and 70% of the targeted schools submitted complete asthma data.", {"entities": [[104, 110, "DISEASE"]]}], ["School nurse\u2013reported asthma prevalence was as high as 30.8% for schools, with a mean of 9.2%.", {"entities": [[22, 28, "DISEASE"]]}], ["School-based asthma surveillance has been demonstrated to be a reliable and cost-effective method of tracking disease through use of an existing and enhanced reporting structure.", {"entities": [[13, 19, "DISEASE"]]}], ["\"Arthritis\" is a common musculoskeletal condition but the knowledge of what type of arthritis people have, may be limited but may have changed over time in response to campaigns, increased awareness and improved health literacy.", {"entities": [[1, 10, "DISEASE"], [84, 93, "DISEASE"]]}], ["This paper describes people who did not know what type of arthritis they had, by a range of relevant demographic and socioeconomic variables, and assesses changes over time in the proportion of people who report having arthritis but do not know what type, using representative population surveillance data.", {"entities": [[58, 67, "DISEASE"], [219, 228, "DISEASE"]]}], ["Data were collected using the South Australian Monitoring and Surveillance System (SAMSS), a risk factor surveillance system where each month, a representative random sample of South Australians is selected from the Electronic White Pages, with interviews conducted using computer assisted telephone interviewing (CATI).", {"entities": []}], ["Data were used for the period January 2006 to December 2008 (n = 16465) for respondents aged 18 years and over.", {"entities": []}], ["Overall, the proportion of respondents who did not know what type of arthritis they had, among people aged 18 years and over, for 2006 to 2008 was 6.5% (95% CI 6.1-6.9).", {"entities": [[69, 78, "DISEASE"]]}], ["When considering only those respondents reporting that they had been told by a doctor that they had arthritis, 30.1% did not know what type of arthritis they had.", {"entities": [[100, 109, "DISEASE"], [143, 152, "DISEASE"]]}], ["Multivariate analysis indicated that males, those with have a trade, certificate or diploma or secondary level of education, who spoke a language other than English at home, were widowed and earned $20,001 to $60,000, more than $80,000 or did not state their income were more likely to maintain that they did not know what type of arthritis they had.", {"entities": [[331, 340, "DISEASE"]]}], ["Population ageing and an increase in arthritis prevalence in the future will further increase the burden of arthritis.", {"entities": [[37, 46, "DISEASE"], [108, 117, "DISEASE"]]}], ["These increases in prevalence are not inevitable, especially if investments are made in public health prevention programs, particularly those addressing cultural and linguistic diversity and differences in socio-economic status and health literacy.", {"entities": []}], ["In high\u2010income countries, allergy\u2010related diseases ( ARD s) follow a typical sequence, the \u2018Atopic March\u2019.", {"entities": []}], ["Little is known about the life\u2010course of ARD s in the markedly different, low\u2010income, tropical environment.", {"entities": []}], ["We describe ARD s in a tropical, African birth cohort.", {"entities": []}], ["Ugandan children were followed from birth to 9\u00a0years.", {"entities": []}], ["ISAAC questionnaires were completed at intervals; doctor\u2010diagnosed ARD s were recorded throughout follow\u2010up.", {"entities": []}], ["Skin prick tests ( SPT s) were performed at 3 and 9\u00a0years.", {"entities": []}], ["Atopy was defined as \u22651 positive SPT .", {"entities": []}], ["Of the 2345 live\u2010born children, 1214 (52%) were seen at 9\u00a0years.", {"entities": []}], ["Wheeze and eczema were common in infancy, but by 9\u00a0years, only 4% reported recent wheeze, 5% eczema and 5% rhinitis.", {"entities": [[107, 115, "DISEASE"]]}], ["Between 3 and 9\u00a0years, atopy prevalence increased from 19% to 25%.", {"entities": []}], ["Atopy at 3 or 9\u00a0years was associated with reported ARD events at 9\u00a0years, for example OR \u00a0=\u00a05.2 (95% CI 2.9\u201310.7) for atopy and recent wheeze at 9\u00a0years.", {"entities": []}], ["Reported or doctor\u2010diagnosed ARD events in early childhood were associated with the same events in later childhood, for example OR \u00a0=\u00a04.4 (2.3\u20138.4) for the association between reported wheeze before 3\u00a0years with reported recent wheeze at 9\u00a0years, but progression from early eczema to later rhinitis or asthma was not observed.", {"entities": [[290, 298, "DISEASE"], [302, 308, "DISEASE"]]}], ["Allergen sensitization started early in childhood and increased with age.", {"entities": []}], ["Eczema and wheeze were common in infancy and declined with age.", {"entities": []}], ["Atopy was strongly associated with ARD among the few affected children.", {"entities": []}], ["The typical Atopic March did not occur.", {"entities": []}], ["Environmental exposures during childhood may dissociate atopy and ARD .", {"entities": []}], ["During inflammation, leukocyte-derived eosinophil peroxidase catalyses the formation of hypobromous acid, which can brominate tyrosine residues in proteins to form bromotyrosine.", {"entities": []}], ["Since eosinophils are involved in the pathogenesis of allergic reactions, such as asthma, urinary bromotyrosine level has been used for the assessment of children with asthma.", {"entities": [[82, 88, "DISEASE"], [168, 174, "DISEASE"]]}], ["However, little is known about the metabolism and disposition of bromotyrosine in vivo .", {"entities": []}], ["The aim of this study was to identify the major urinary metabolites formed during bromotyrosine metabolism and to develop mass spectrometric methods for their quantitation.", {"entities": []}], ["Deuterium-labeled bromotyrosine was synthesized by deuterium exchange.", {"entities": []}], ["[D 3 ]bromotyrosine (500\u00a0nmole) was injected intraperitoneally into Sprague-Dawley rats and urine was collected for 24\u00a0h in a metabolic cage.", {"entities": []}], ["3 ]bromotyrosine and 0.12\u00b10.02% of infused [D 3 ]bromotyrosine was excreted in the urine unchanged.", {"entities": []}], ["However, ~1.3% (6.66\u00b11.33\u00a0nmole) of infused [D 3 ]bromotyrosine was excreted in the urine as the de-brominated metabolite, [D 3 ]4-hydroxyphenylacetic acid, which is also a urinary metabolite of tyrosine in mammals.", {"entities": []}], ["We also tested whether or not iodotyrosine dehalogenase can catalyse de-bromination of bromotyrosine and showed that iodotyrosine dehalogenase is able to de-brominate free bromotyrosine in vitro .", {"entities": []}], ["We identified bromo-HPA as the main brominated urinary metabolite of bromotyrosine in rats.", {"entities": []}], ["However, de-halogenation of bromotyrosine is the major metabolic pathway to eliminate free brominated tyrosine in vivo .", {"entities": []}], ["fx1 \u2022 De-bromination of bromotyrosine occurs during metabolism of free bromotyrosine.", {"entities": []}], ["\u2022 4-Hydroxyphenylacetic acid is the major urinary metabolite of bromotyrosine in rats.", {"entities": []}], ["\u2022 3-Bromo-4-hydroxyphenylacetic acid was identified as a brominated metabolite of bromotyrosine.", {"entities": []}], ["\u2022 Iodotyrosine dehalogenase is able to de-brominate free bromotyrosine in vitro .", {"entities": []}], ["De-bromination of bromotyrosine occurs during metabolism of free bromotyrosine.", {"entities": []}], ["4-Hydroxyphenylacetic acid is the major urinary metabolite of bromotyrosine in rats.", {"entities": []}], ["3-Bromo-4-hydroxyphenylacetic acid was identified as a brominated metabolite of bromotyrosine.", {"entities": []}], ["Iodotyrosine dehalogenase is able to de-brominate free bromotyrosine in vitro .", {"entities": []}], ["Chitinase inhibitors have chemotherapeutic potential as fungicides, pesticides, and antiasthmatics.", {"entities": []}], ["Argifin, a natural product cyclopentapeptide, competitively inhibits family 18 chitinases in the nanomolar to micromolar range and shows extensive substrate mimicry.", {"entities": []}], ["In an attempt to map the active fragments of this large natural product, the cyclopentapeptide was progressively dissected down to four linear peptides and dimethylguanylurea, synthesized using a combination of solution and solid phase peptide synthesis.", {"entities": []}], ["The peptide fragments inhibit chitinase B1 from Aspergillus fumigatus ( Af ChiB1), the human chitotriosidase, and chitinase activity in lung homogenates from a murine model of chronic asthma, with potencies ranging from high nanomolar to high micromolar inhibition.", {"entities": [[184, 190, "DISEASE"]]}], ["X-ray crystallographic analysis of the chitinase-inhibitor\u00a0complexes revealed that the conformations of the linear peptides were remarkably similar to that of the natural product.", {"entities": []}], ["Strikingly, the dimethylguanylurea fragment, representing only a quarter of the natural product mass, was found to harbor all significant interactions with the protein and binds with unusually high efficiency.", {"entities": []}], ["The data provide useful information that could lead to the generation of drug-like, natural product-based chitinase inhibitors.", {"entities": []}], ["Linaclotide is a minimally absorbed guanylate cyclase-C agonist.", {"entities": []}], ["The objective of this trial was to determine the efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C).", {"entities": [[101, 125, "DISEASE"], [131, 143, "DISEASE"], [117, 125, "DISEASE"]]}], ["This phase 3, double-blind, parallel-group, placebo-controlled trial randomized IBS-C patients to placebo or 290\u2009\u03bcg oral linaclotide once daily in a 12-week treatment period, followed by a 4-week randomized withdrawal (RW) period.", {"entities": []}], ["There were four primary end points, the Food and Drug Administration's (FDA's) primary end point for IBS-C (responder: improvement of \u226530% in average daily worst abdominal pain score and increase by \u22651 complete spontaneous bowel movement (CSBM) from baseline (same week) for at least 50% of weeks assessed) and three other primary end points, based on improvements in abdominal pain and CSBMs for 9/12 weeks.", {"entities": []}], ["Adverse events (AEs) were monitored.", {"entities": []}], ["The trial evaluated 800 patients (mean age=43.5 years, female=90.5%, white=76.9%).", {"entities": []}], ["The FDA end point was met by 136/405 linaclotide-treated patients (33.6%), compared with 83/395 placebo-treated patients (21.0%) ( P <0.0001) (number needed to treat: 8.0, 95% confidence interval: 5.4, 15.5).", {"entities": []}], ["A greater percentage of linaclotide patients, compared with placebo patients, reported for at least 6/12 treatment period weeks, a reduction of \u226530% in abdominal pain (50.1 vs. 37.5%, P =0.0003) and an increase of \u22651 CSBM from baseline (48.6 vs. 29.6%, P <0.0001).", {"entities": []}], ["A greater percentage of linaclotide patients vs. placebo patients were also responders for the other three primary end points ( P <0.05).", {"entities": []}], ["Significantly greater improvements were seen in linaclotide vs. placebo patients for all secondary end points ( P <0.001).", {"entities": []}], ["During the RW period, patients remaining on linaclotide showed sustained improvement; patients re-randomized from linaclotide to placebo showed return of symptoms, but without worsening of symptoms relative to baseline.", {"entities": []}], ["Diarrhea, the most common AE, resulted in discontinuation of 5.7% of linaclotide and 0.3% of placebo patients.", {"entities": []}], ["Linaclotide significantly improved abdominal pain and bowel symptoms associated with IBS-C for at least 12 weeks; there was no worsening of symptoms compared with baseline following cessation of linaclotide during the RW period.", {"entities": []}], ["Given the health impacts of smoking during pregnancy and the opportunity for primary healthcare teams to encourage pregnant smokers to quit, our primary aim was to assess the completeness of gestational smoking status recording in primary care data and investigate whether completeness varied with women's characteristics.", {"entities": []}], ["As a secondary aim we assessed whether completeness of recording varied before and after the introduction of the Quality and Outcomes Framework (QOF).", {"entities": []}], ["In The Health Improvement Network (THIN) database we calculated the proportion of pregnancies ending in live births or stillbirths where there was a recording of maternal smoking status for each year from 2000 to 2009.", {"entities": []}], ["Logistic regression was used to assess variation in the completeness of maternal smoking recording by maternal characteristics, before and after the introduction of QOF.", {"entities": []}], ["Women had a record of smoking status during the gestational period in 28% of the 277,552 pregnancies identified.", {"entities": []}], ["In 2000, smoking status was recorded in 9% of pregnancies, rising to 43% in 2009.", {"entities": []}], ["Pregnant women from the most deprived group were 17% more likely to have their smoking status recorded than pregnant women from the least deprived group before QOF implementation (OR 1.17, 95% CI 1.10\u20131.25) and 42% more likely afterwards (OR 1.42, 95% CI 1.37\u20131.47).", {"entities": []}], ["A diagnosis of asthma was related to recording of smoking status during pregnancy in both the pre-QOF (OR 1.63, 95% CI 1.53\u20131.74) and post-QOF periods (OR 2.08, 95% CI 2.02\u20132.15).", {"entities": [[15, 21, "DISEASE"]]}], ["There was no association between having a diagnosis of diabetes and recording of smoking status during pregnancy pre-QOF however, post-QOF diagnosis of diabetes was associated with a 12% increase in recording of smoking status (OR 1.12, 95% CI 1.05\u20131.19).", {"entities": []}], ["Recording of smoking status during pregnancy in primary care data is incomplete though has improved over time, especially after the implementation of the QOF, and varies by maternal characteristics and QOF-incentivised morbidities.", {"entities": []}], ["Surface ozone pollution has been a persistent environmental problem in the US and Europe as well as the developing countries.", {"entities": []}], ["A key prerequisite to find effective alternatives to meeting an ozone air quality standard is to understand the importance of local anthropogenic emissions, the significance of biogenic emissions, and the contribution of long-range transport.", {"entities": []}], ["In this study, an air quality modeling system that includes chemistry and transport, CMAQ, an emission processing model, SMOKE, and a mesoscale numerical meteorological model, WRF, has been applied to investigate an ozone event occurring during the period of the 1996 Paso del Norte Ozone Campaign.", {"entities": []}], ["The results show that the modeling system exhibits the capability to simulate this high ozone occurrence by providing a comparable temporal variation of surface ozone concentration at one station and to capture the spatial evolution of the event.", {"entities": []}], ["Several sensitivity tests were also conducted to identify the contributions to high surface ozone concentration from eight VOC subspecies, biogenic VOCs, anthropogenic VOCs and long-range transportation of ozone and its precursors.", {"entities": []}], ["It is found that the reductions of ETH, ISOP, PAR, OLE and FORM help to mitigate the surface ozone concentration, and like anthropogenic VOCs, biogenic VOC plays a nonnegligible role in ozone formation.", {"entities": []}], ["But for this case, long-range transport of ozone and its precursors appears to produce an insignificant contribution.", {"entities": []}], ["Functional deficiency of mannan-binding lectin (MBL) has been associated with adverse pregnancy outcome.", {"entities": []}], ["Adverse events during pregnancy have also been described in women with autoimmune thyroid diseases (AITD), and thyroid hormones have been shown to influence serum levels of MBL.", {"entities": []}], ["Therefore, the aim of this study was to analyse the impact of MBL-deficiency on the outcome of pregnancy in relation to the presence of AITD.", {"entities": []}], ["Almost one year after delivery, we assessed serum MBL levels and MBL2- genotypes in 212 women positively screened for AITD in pregnancy.", {"entities": []}], ["In 103 of these women, we could also measure MBL levels in frozen serum samples from the 9-12 MBL2 -genotyping was performed using multiplex PCR.", {"entities": [[94, 98, "GENE"]]}], ["Women with thyroid dysfunction and/or thyroid peroxidase antibodies (TPOAb) had lower MBL levels during pregnancy than controls, (3275 vs. 5000 ng/ml, p<0.05).", {"entities": []}], ["The lowest levels were found in women with elevated thyroid-stimulating hormone (TSH) levels in the absence of TPOAb (2207 ng/ml; p<0.01 as compared to controls).", {"entities": []}], ["MBL2 genotype distribution did not differ between subgroups.", {"entities": [[0, 4, "GENE"]]}], ["At a median follow-up period of 17 months (range: 3\u201378 months) after delivery, median MBL level had decreased further to 1923 ng/ml (p<0.0001) without significant changes in TSH.", {"entities": []}], ["In an explorative survey, functional MBL-deficiency was neither linked to a history of spontaneous abortion, nor other obstetric complications, severe infections throughout life/pregnancy or antibiotics use in pregnancy.", {"entities": []}], ["In conclusion, hypothyroidism during pregnancy is associated with decreased MBL levels, and the levels decreased further after delivery.", {"entities": [[15, 29, "DISEASE"]]}], ["To describe chronic conditions and injuries as a proportion of total emergency presentations to a large public hospital in regional Queensland, and to investigate differences in presentation rates associated with Indigenous status.", {"entities": []}], ["Cross\u2010sectional analysis using Emergency Department Information System data between 1 July 2012 and 30 June 2014.", {"entities": []}], ["Regional Queensland, Australia.", {"entities": []}], ["A total of 95 238 emergency presentations were generated by 50 083 local residents living in the 10 statistical local areas ( SLA s) immediately around the hospital.", {"entities": []}], ["Emergency presentations for chronic conditions and injuries identified from discharge ICD \u201010\u2010 AM principal diagnosis.", {"entities": []}], ["Age\u2010standardised presentation rates were calculated using the Australian 2001 reference population.", {"entities": []}], ["Approximately half of all presentations were for chronic conditions (20.2%) and injuries (28.8%).", {"entities": []}], ["Two\u2010thirds of all chronic condition presentations were for mental and behavioural disorders (34.6%) and circulatory diseases (33.2%).", {"entities": []}], ["Head injuries accounted for the highest proportion of injuries (18.9%).", {"entities": []}], ["Age\u2010standardised rates for major diagnostic groups were consistently higher for Indigenous residents, whose presentations were lower in mean age (95% CI ) by 7.7 (7.3\u20138.1) years, 23% less likely to be potentially avoidable GP \u2010type presentations [ RR (95% CI ) = 0.77 (0.75\u20130.80)], 30% more likely to arrive by ambulance [1.31 (1.28\u20131.33)] and 11% more likely to require hospital admission [1.11 (1.08\u20131.13)].", {"entities": []}], ["Opportunities exist to enhance current coordinated hospital avoidance and primary health services in regional Queensland targeting common mental and circulatory disorders, especially for Indigenous Australians.", {"entities": []}], ["User involvement has become a growing importance in healthcare.", {"entities": []}], ["The United Nations state that adolescents have a right to be heard, and user involvement in healthcare is a legal right in many countries.", {"entities": []}], ["Some research provides an insight into the field of user involvement in somatic and mental healthcare for adults, but little is known about user involvement in adolescents\u2019 mental healthcare, and no overview of the existing research evidence exists.", {"entities": []}], ["The aim of this systematic review is to provide an overview of existing research reporting on experiences with and the effectiveness and safety issues associated with user involvement for adolescents\u2019 mental healthcare at the individual and organisational level.", {"entities": []}], ["A systematic literature search and assessment of published research in the field of user involvement in adolescents\u2019 mental healthcare will be carried out.", {"entities": []}], ["Established guidelines will be used for data extraction (Cochrane Collaboration guidelines, Strengthening the Reporting of Observational studies in Epidemiology and Critical Appraisal Skills Programme (CASP)), critical appraisal (Cochrane Collaboration guidelines and Pragmatic-Explanatory Continuum Indicator Summary) and reporting of results (Preferred Reporting Items for Systematic reviews and Meta-Analyses, Consolidated Standards of Reporting Trials and CASP).", {"entities": []}], ["Confidence in the research evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation approach.", {"entities": []}], ["Adolescents are included as coresearchers for the planning and carrying out of this systematic review.", {"entities": []}], ["This systematic review will provide an overview of the existing research literature and thereby fill a knowledge gap.", {"entities": []}], ["It may provide various stakeholders, including decision-makers, professionals, individuals and their families, with an overview of existing knowledge in an underexplored field of research.", {"entities": []}], ["Ethics approval is not required for this systematic review as we are not collecting primary data.", {"entities": []}], ["The results will be published in a peer-reviewed journal and at conference presentations and will be shared with stakeholder groups.", {"entities": []}], ["Maternal microchimerism, which occurs naturally during gestation in hemochorial placental mammals upon transplacental migration of maternal cells into the fetus, is suggested to significantly influence the fetal immune system.", {"entities": []}], ["In our previous publication, we explored the sensitivity of quantitative polymerase chain reaction and flow cytometry to detect cellular microchimerism.", {"entities": []}], ["With that purpose, we created mixed cells suspensions in vitro containing reciprocal frequencies of wild type cells and cells positive for enhanced green fluorescent protein or CD45.1", {"entities": []}], ["Pediatric asthma affects 7.1 million American children incurring an annual total direct healthcare cost around 9.3 billion dollars.", {"entities": [[10, 16, "DISEASE"]]}], ["Asthma control in children is suboptimal, leading to frequent asthma exacerbations, excess costs, and decreased quality of life.", {"entities": [[0, 6, "DISEASE"], [62, 68, "DISEASE"]]}], ["Successful prediction of risk for asthma control deterioration at the individual patient level would enhance self-management and enable early interventions to reduce asthma exacerbations.", {"entities": [[34, 40, "DISEASE"], [166, 172, "DISEASE"]]}], ["We developed and tested the first set of models for predicting a child\u2019s asthma control deterioration one week prior to occurrence.", {"entities": [[73, 79, "DISEASE"]]}], ["We previously reported validation of the Asthma Symptom Tracker, a weekly asthma self-monitoring tool.", {"entities": [[41, 47, "DISEASE"], [74, 80, "DISEASE"]]}], ["Over a period of two years, we used this tool to collect a total of 2912 weekly assessments of asthma control on 210 children.", {"entities": [[95, 101, "DISEASE"]]}], ["We combined the asthma control data set with patient attributes and environmental variables to develop machine learning models to predict a child\u2019s asthma control deterioration one week ahead.", {"entities": [[16, 22, "DISEASE"], [148, 154, "DISEASE"]]}], ["Our best model achieved an accuracy of 71.8\u00a0%, a sensitivity of 73.8\u00a0%, a specificity of 71.4\u00a0%, and an area under the receiver operating characteristic curve of 0.757.", {"entities": []}], ["We also identified potential improvements to our models to stimulate future research on this topic.", {"entities": []}], ["Our best model successfully predicted a child\u2019s asthma control level one week ahead.", {"entities": [[48, 54, "DISEASE"]]}], ["With adequate accuracy, the model could be integrated into electronic asthma self-monitoring systems to provide real-time decision support and personalized early warnings of potential asthma control deteriorations.", {"entities": [[70, 76, "DISEASE"], [184, 190, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a major global health problem and is predicted to become the third most common cause of death by 2020.", {"entities": []}], ["Apart from the important preventive steps of smoking cessation, there are no other specific treatments for COPD that are as effective in reversing the condition, and therefore there is a need to understand the pathophysiological mechanisms that could lead to new therapeutic strategies.", {"entities": []}], ["The development of experimental models will help to dissect these mechanisms at the cellular and molecular level.", {"entities": []}], ["COPD is a disease characterized by progressive airflow obstruction of the peripheral airways, associated with lung inflammation, emphysema and mucus hypersecretion.", {"entities": []}], ["Different approaches to mimic COPD have been developed but are limited in comparison to models of allergic asthma.", {"entities": [[98, 113, "DISEASE"], [107, 113, "DISEASE"]]}], ["COPD models usually do not mimic the major features of human COPD and are commonly based on the induction of COPD-like lesions in the lungs and airways using noxious inhalants such as tobacco smoke, nitrogen dioxide, or sulfur dioxide.", {"entities": []}], ["Depending on the duration and intensity of exposure, these noxious stimuli induce signs of chronic inflammation and airway remodelling.", {"entities": []}], ["Emphysema can be achieved by combining such exposure with instillation of tissue-degrading enzymes.", {"entities": []}], ["Other approaches are based on genetically-targeted mice which develop COPD-like lesions with emphysema, and such mice provide deep insights into pathophysiological mechanisms.", {"entities": []}], ["Future approaches should aim to mimic irreversible airflow obstruction, associated with cough and sputum production, with the possibility of inducing exacerbations.", {"entities": []}], ["Reliable semiquantitative assessment of histological placental acute inflammation is problematic, even among experts.", {"entities": []}], ["Tissue samples in histology slides often show variability in the extent and location of neutrophil infiltrates.", {"entities": []}], ["We sought to determine whether the variability in pathologists' scoring of neutrophil infiltrates in the placenta could be reduced by the use of \u2018regions of interest\u2019 (ROIs) that break the sample into smaller components.", {"entities": []}], ["ROIs were identified within stained H&E slides from a cohort of 56 women.", {"entities": []}], ["ROIs were scored using a semiquantitative scale (0\u20134) for the average number of neutrophils by at least two independent raters.", {"entities": []}], ["Preterm singleton births at Yale New Haven Hospital.", {"entities": []}], ["This study used stained H&E placental slides from a cohort of 56 women with singleton pregnancies who had a clinically indicated amniocentesis within 24\u2005hours of delivery.", {"entities": []}], ["Interrater agreement was assessed with the intraclass correlation coefficient (ICC) and log-linear regression.", {"entities": []}], ["Predictive validity was assessed using amniotic fluid protein profile scores (neutrophil defensin-2, neutrophil defensin-1, calgranulin C and calgranulin A).", {"entities": []}], ["Excellent agreement by the ICC was found for the average neutrophil scores within a region of interest.", {"entities": []}], ["Log-linear analyses suggest that even where there is disagreement, responses are positively associated along the diagonal.", {"entities": []}], ["There was also strong evidence of predictive validity comparing pathologists' scores with amniotic fluid protein profile scores.", {"entities": []}], ["Agreement among observers of semiquantitative neutrophil scoring through the use of digitised ROIs was demonstrated to be feasible with high reliability and validity.", {"entities": []}], ["It is generally assumed that the detection of disease susceptibility genes via fine-mapping association study is facilitated by consideration of marker haplotypes.", {"entities": []}], ["In this study, we compared the performance of genotype-based and haplotype-based association studies using the Collaborative Study of Genetics of Alcoholism dataset, on several chromosomal regions showing evidence for linkage with ALDX1.", {"entities": []}], ["After correction for multiple testing, the most significant results were observed with the genotype-based analyses on two regions of chromosomes 2 and 7.", {"entities": []}], ["Interestingly, the analyses results from this dataset showed that there was no advantage of the haplotype-based analyses over genotype-based (single-locus) analyses.", {"entities": []}], ["However, caution should be taken when generalizing these results to other chromosomal regions or to other populations.", {"entities": []}], ["Inhaled therapy is key to the management of chronic obstructive pulmonary disease (COPD).", {"entities": [[44, 81, "DISEASE"]]}], ["New drugs and inhalers have recently been launched or will soon become available, and the expiry of patent protection covering several currently used inhaled bronchodilators and corticosteroids will be accompanied by the development of bioequivalent, generic inhaled drugs.", {"entities": []}], ["Consequently, a broader availability of branded and generic compounds will increase prescription opportunities.", {"entities": []}], ["Given the time course of COPD, patients are likely to switch drugs and inhalers in daily practice.", {"entities": []}], ["Switching from one device to another, if not accompanied by appropriate training for the patient, can be associated with poor clinical outcomes and increased use of health care resources.", {"entities": []}], ["In fact, while it seems reasonable to prescribe generic inhaled drugs to reduce costs, inadequate use of inhaler devices, which is often associated with a poor patient\u2013physician or patient\u2013pharmacist relationship, is one of the most common reasons for failure to achieve COPD treatment outcomes.", {"entities": []}], ["Further research is needed to quantify, as in asthma, the impact of inappropriate switching of inhalers in patients with COPD and show the outcomes related to the effect of using the same device for delivering inhaled medications.", {"entities": [[46, 52, "DISEASE"]]}], ["Colorectal cancer (CRC) is one of the most common causes of cancer-related death worldwide due to the distant metastases.", {"entities": [[11, 17, "DISEASE"], [60, 66, "DISEASE"]]}], ["Compelling evidence has reported that epithelial-mesenchymal transition (EMT) is involved in promoting cancer invasion and metastasis.", {"entities": [[103, 109, "DISEASE"]]}], ["However, the precise molecular events that initiate this complex EMT process remain poorly understood.", {"entities": []}], ["Here, we showed that the pleiotropic cytokine interleukin-13 (IL-13) could induce an aggressive phenotype displaying EMT by enhancing the expression of EMT-promoting factor ZEB1.", {"entities": [[173, 177, "GENE"]]}], ["Importantly, STAT6 signaling inhibitor and STAT6 knockdown significantly reversed IL-13-induced EMT and ZEB1 induction in CRC cells, whereas ectopic STAT6 expression in STAT6 ZEB1 .", {"entities": [[13, 18, "GENE"], [43, 48, "GENE"], [149, 154, "GENE"], [169, 174, "GENE"], [13, 18, "GENE"], [43, 48, "GENE"], [149, 154, "GENE"], [169, 174, "GENE"], [104, 108, "GENE"], [175, 179, "GENE"], [13, 18, "GENE"], [43, 48, "GENE"], [149, 154, "GENE"], [169, 174, "GENE"], [13, 18, "GENE"], [43, 48, "GENE"], [149, 154, "GENE"], [169, 174, "GENE"], [104, 108, "GENE"], [175, 179, "GENE"]]}], ["Otherwise, we found IL-13 also up-regulated the stem cell markers (nanog, CD44, CD133 and CD166) and promoted cell migration and invasion through STAT6 pathway.", {"entities": [[67, 72, "GENE"], [74, 78, "GENE"], [146, 151, "GENE"]]}], ["We also found that siRNA-mediated knockdown of IL-13R\u03b11 could reverse IL-13-induced ZEB1 and EMT changes by preventing STAT6 signaling.", {"entities": [[84, 88, "GENE"], [119, 124, "GENE"]]}], ["Finally, we demonstrated positive correlation between IL-13R\u03b11 and ZEB1 at mRNA levels in human CRC samples.", {"entities": [[67, 71, "GENE"]]}], ["Taken together, our findings first demonstrated that IL-13/IL-13R\u03b11/STAT6/ZEB1 pathway plays a critical role in promoting EMT and aggressiveness of CRC.", {"entities": []}], ["Bronchoscopy is a vital diagnostic and therapeutic procedure in pulmonological practice.", {"entities": []}], ["The aim of this study was to determine the perception, use and challenges encountered by Nigerian medical doctors involved in this procedure.", {"entities": []}], ["A cross-sectional study was conducted among 250 medical doctors recruited from three major tertiary institutions in Nigeria between September 2013 and June 2014.", {"entities": []}], ["A semi-structured questionnaire was self-administered to adult physicians, paediatricians, and surgeons as well as their trainees to obtain their perception, use and associated challenges in the use of bronchoscopy in clinical practice.", {"entities": []}], ["The majority (91.6%) of the respondents perceived bronchoscopy as a beneficial procedure to respiratory medicine.", {"entities": []}], ["However, 59.2% of them were not aware of the low mortality rate associated with this procedure.", {"entities": []}], ["The commonest indications for bronchoscopic use were foreign body aspiration (88.8%) and management of lung tumors (75.6%).", {"entities": []}], ["Only 21 (8.4%) of the respondents had received formal training in bronchoscopy.", {"entities": []}], ["Very few procedures (1\u20135 cases per month) were performed.", {"entities": []}], ["The respondents identified the lack of formal training in the art of bronchoscopy as the foremost challenge facing its practice in Nigeria.", {"entities": []}], ["In addition, availability of bronchoscopes, level of awareness, knowledge of the procedure among medical doctors and the cost of the procedure were the challenges faced by the medical doctors.", {"entities": []}], ["There is an urgent need to equip training centers with modern bronchoscopic facilities.", {"entities": []}], ["In addition,well-structured bronchoscopic training programme is imperative to enhance the trainees' proficiency for the furtherance of bronchoscopic practice.", {"entities": []}], ["Currently there is no disease-specific outcome measure to assess the health-related quality of life (HRQOL) of pediatric patients with Eosinophilic Esophagitis (EoE).", {"entities": []}], ["Therefore, the objective of this qualitative study was to further develop and finalize the items and support the content validity for the new Pediatric Quality of Life Inventory\u2122 (PedsQL\u2122) Eosinophilic Esophagitis Module.", {"entities": []}], ["Multiphase qualitative methodology was utilized in the development of the PedsQL\u2122 EoE Module conceptual model.", {"entities": []}], ["Focus interview transcripts of pediatric patients with EoE and their parents and expert review were previously used to develop the initial items and domains for the PedsQL\u2122 EoE Module.", {"entities": []}], ["In the current investigation, utilizing the respondent debriefing methodology, cognitive interviewing was conducted individually with pediatric patients with EoE and their parents on each newly developed item.", {"entities": []}], ["Information from a total of 86 participants was obtained in combination from the previous investigation and the current study.", {"entities": []}], ["From the previous 42 focus interviews, items were developed around the domain themes of symptoms, difficulties with eating food, treatment adherence, worry about symptoms and illness, feelings of being different than family and peers, and problems discussing EoE with others.", {"entities": []}], ["In the current study\u2019s cognitive interviewing phase, a separate cohort of 44 participants systematically reviewed and provided feedback on each item.", {"entities": []}], ["Items were added, modified or deleted based on this feedback.", {"entities": []}], ["Items were finalized after this feedback from patients and parents.", {"entities": []}], ["Using well-established qualitative methods, the content validity of the new PedsQL\u2122 Eosinophilic Esophagitis Module items was supported in the current investigation.", {"entities": []}], ["In the next iterative instrument development phase, the PedsQL\u2122 Eosinophilic Esophagitis Module is now undergoing multisite national field testing.", {"entities": []}], ["This article surveys the ethnobotany of Ziziphus spina-christi (L.) Desf.", {"entities": []}], ["in the Middle East from various aspects: historical, religious, philological, literary, linguistic, as well as pharmacological, among Muslims, Jews, and Christians.", {"entities": []}], ["It is suggested that this is the only tree species considered \"holy\" by Muslims (all the individuals of the species are sanctified by religion) in addition to its status as \"sacred tree \" (particular trees which are venerated due to historical or magical events related to them, regardless of their botanical identity) in the Middle East.", {"entities": []}], ["It has also a special status as \"blessed tree\" among the Druze.", {"entities": []}], ["The aim of this study is to determine to what extent barriers perceived by general practitioners (GPs) for prescribing angiotensin-converting enzyme inhibitors (ACE-I) in chronic heart failure (CHF) patients are related to underuse and underdosing of these drugs in actual practice.", {"entities": []}], ["Barriers were assessed with a semi-structured questionnaire.", {"entities": []}], ["Prescribing data were extracted from GPs' computerised medical records for a random sample of their CHF patients.", {"entities": []}], ["Relations between barriers and prescribing behaviour were assessed by means of Spearman rank correlation and multivariate regression modelling.", {"entities": []}], ["GPs prescribed ACE-I to 45% of their patients and had previously initiated such treatment in an additional 3.5%, in an average standardised dose of 13.5 mg.", {"entities": []}], ["They perceived a median of four barriers in prescribing ACE-I or optimising ACE-I dose.", {"entities": []}], ["Many GPs found it difficult to change treatment initiated by a cardiologist.", {"entities": []}], ["Furthermore, initiating ACE-I in patients already using a diuretic or stable on their current medication was perceived as barrier.", {"entities": []}], ["Titrating the ACE-I dose was seen as difficult by more than half of the GPs.", {"entities": []}], ["No significant relationships could be found between the barriers perceived and actual ACE-I prescribing.", {"entities": []}], ["Regarding ACE-I dosing, the few GPs who did not agree that the ACE-I should be as high as possible prescribed higher ACE-I doses.", {"entities": []}], ["Variation between GPs in prescribing ACE-I for CHF cannot be explained by differences in the barriers they perceive.", {"entities": []}], ["Tailor-made interventions targeting only those doctors that perceive a specific barrier will therefore not be an efficient approach to improve quality of care.", {"entities": []}], ["Sepsis is an inflammatory syndrome caused by infection, and both its incidence and mortality are high.", {"entities": [[26, 34, "DISEASE"]]}], ["Because interferon-gamma (IFN-\u03b3) plays an important role in inflammation, this work assessed IFN-\u03b3 single nucleotide polymorphism (SNPs) that may be associated with sepsis.", {"entities": []}], ["A total of 196 patients with pneumonia-induced sepsis and 213 age- and sex-matched healthy volunteers participated in our study from July 2012 to July 2013 in Guangzhou, China.", {"entities": [[29, 38, "DISEASE"]]}], ["Patient clinical information was collected.", {"entities": []}], ["Clinical pathology was assessed in subgroups defined based on clinical criteria, APACHE II (acute physiology and chronic health evaluation) and SOFA (sepsis-related organ failure assessment) scores and discharge rate.", {"entities": []}], ["Four functional SNPs, \u22121616T/C (rs2069705), \u2212764G/C (rs2069707), +874A/T (rs2430561) and +3234C/T (rs2069718), were genotyped by Snapshot in both sepsis patients and healthy controls.", {"entities": []}], ["Pearson\u2019s chi-square test or Fisher\u2019s exact test were used to analyze the distribution of the SNPs, and the probability values (P values), odds ratios (OR) and 95% confidence intervals (CIs) were calculated.", {"entities": []}], ["No mutations in the IFN-\u03b3 \u2212764G/C SNP were detected among the participants in our study.", {"entities": []}], ["The +874A/T and +3234C/T SNPs were in strong linkage disequilibrium (LD) (r Our results suggest that functional IFN-\u03b3 SNPs and their haplotypes are associated with pneumonia-induced sepsis.", {"entities": [[164, 173, "DISEASE"]]}], ["Inequalities in demographic, socio-economic and health status for China labor force place them at greater health risks, and marginalized them in the utilization of healthcare services.", {"entities": []}], ["This paper identifies the inequalities which limit the utilization of health services among China labor force, and provides a reference point for health policy.", {"entities": []}], ["Data were collected from 23,505 participants aged 15 to 65, from the 2014 China Labor Force Dynamic Survey (a nationwide cross-sectional survey covering 29 provinces with a multi-stage cluster, and stratified, probability sampling strategy) conducted by Sun Yat-sen University.", {"entities": []}], ["Logistic regression models were used to study the effects of demographic (age, gender, marital status, type of hukou and migration status), socio-economic (education, social class and insurance) and health status (self-perceived general health and several chronic illnesses) variables on the utilization of health services (two-week visiting and hospitalization during the past 12\u00a0months).", {"entities": []}], ["Goodness of fit was assessed using Hosmer-Lemeshow test.", {"entities": []}], ["Discrimination ability was assessed based on the area under the receiver operating curve (AUC).", {"entities": []}], ["Migrants with more than 1 (OR 2.80, 95% CI 1.01\u2009~\u20097.82) or none chronic illnesses (OR 1.26, 95% CI 1.01\u2009~\u20097.82) are more likely to be two week visiting to the clinic than non-migrants; migrants with none chronic illnesses (OR 0.61, 95% CI 0.45\u2009~\u20090.82) are less likely to be in hospitalization during the past 12\u00a0months than non-migrants.", {"entities": []}], ["Female, elder, hukou of non-agriculture, higher education level, higher social class, purchasing more insurance and poorer self-perceived health were predictors for more utilization of health service.", {"entities": []}], ["More insurance benefited more two-week visiting (OR 1.12, 95% CI 1.06\u2009~\u20091.17) and hospitalization during the past 12\u00a0months (OR 1.12, 95% CI 1.07\u2009~\u20091.18) for individuals with none chronic illness but not \u22651 chronic illnesses.", {"entities": []}], ["All models achieved good calibration (Hosmer-Lemeshow test\u2019s P range of 0.258-0.987) and discrimination (AUC range of 0.626-0.725).", {"entities": []}], ["This study has shown that there are inequalities of demographic, socio-economic and health status in the utilization of health services for China labor force.", {"entities": []}], ["Prudent health policy with equitable utilization of health services eliminating mentioned inequalities should be a priority in shaping China\u2019s healthcare system reform.", {"entities": []}], ["Although oxidative stress is thought to play a pivotal role in the pathogenesis of inflammatory airway diseases, its assessment in clinical practice remains elusive.", {"entities": []}], ["In recent years, it has been conceptualized that oxidative stress markers in sputum should be employed to monitor oxidative processes in patients with asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis (CF).", {"entities": [[159, 196, "DISEASE"], [208, 223, "DISEASE"], [151, 157, "DISEASE"]]}], ["In this review, the use of sputum-based oxidative markers was explored and potential clinical applications were considered.", {"entities": []}], ["Among lipid peroxidation-derived products, 8-isoprostane and malondialdehyde have been the most frequently investigated, while nitrosothiols and nitrotyrosine may serve as markers of nitrosative stress.", {"entities": []}], ["Several studies have showed higher levels of these products in patients with asthma, COPD, or CF compared to healthy subjects.", {"entities": [[77, 83, "DISEASE"]]}], ["Marker concentrations could be further increased during exacerbations and decreased along with recovery of these diseases.", {"entities": []}], ["Measurement of oxidized guanine species and antioxidant enzymes in the sputum could be other approaches for assessing oxidative stress in pulmonary patients.", {"entities": []}], ["Collectively, even though there are promising findings in this field, further clinical studies using more established detection techniques are needed to clearly show the benefit of these measurements in the follow-up of patients with inflammatory airway diseases.", {"entities": []}], ["Ovarian cancer G protein-coupled receptor 1 (OGR1) is a proton-sensing molecule that can detect decreases in extracellular pH that occur during inflammation.", {"entities": [[8, 14, "DISEASE"]]}], ["Although OGR1 has been shown to have pro-inflammatory functions in various diseases, its role in autoimmunity has not been examined.", {"entities": []}], ["We therefore sought to determine whether OGR1 has a role in the development of T cell autoimmunity by contrasting the development of experimental autoimmune encephalomyelitis between wild type and OGR1-knockout mice.", {"entities": [[157, 174, "DISEASE"]]}], ["OGR1-knockout mice showed a drastically attenuated clinical course of disease that was associated with a profound reduction in the expansion of myelin oligodendrocyte glycoprotein 35-55-reactive T helper 1 (Th1) and Th17 cells in the periphery and a reduced accumulation of Th1 and Th17 effectors in the central nervous system.", {"entities": []}], ["We determined that these impaired T cell responses in OGR1-knockout mice associated with a reduced frequency and number of dendritic cells in draining lymph nodes during EAE and a higher production of nitric oxide by macrophages.", {"entities": []}], ["Our studies suggest that OGR1 plays a key role in regulating T cell responses during autoimmunity.", {"entities": []}], ["Subcutaneous specific immunotherapy (SCIT) has been\u00a0shown to modify the Dermatophagoides pteronissinus (DP) allergic response, characterized by generation of Treg cells.", {"entities": []}], ["However, studies have reported no changes in the proportion of Treg cells after immunotherapy, indicating that the effects may be due to modifications in their regulatory activities.", {"entities": []}], ["We aimed to determine whether Tregs generated by DP-SCIT can switch the allergic response to tolerant and study the involvement of suppressive cytokines on it.", {"entities": []}], ["Twenty-four DP-allergic rhinitis patients were recruited, 16 treated with DP-SCIT and 8 untreated.", {"entities": [[15, 32, "DISEASE"], [24, 32, "DISEASE"]]}], ["Treg and T effector cells were isolated before and after DP-SCIT, and cocultured in different combinations with \u03b1-IL-10, \u03b1-TGF-\u03b2 blocking antibodies and nDer p 1.", {"entities": []}], ["Treg cells after DP-SCIT increased Th1 and decreased Th2 and Th9 proliferation.", {"entities": []}], ["Similarly, they increased IL-10 and decreased IL-4 and IL-9-producing cells.", {"entities": []}], ["\u03b1-IL-10 affected the activity of Treg cells obtained after DP-SCIT only.", {"entities": []}], ["Finally, DP-specific IgG4 levels, Treg percentage and IL-10 production were correlated after DP-SCIT.", {"entities": []}], ["These results demonstrate that DP-SCIT induces Treg cells with different suppressive activities.", {"entities": []}], ["These changes could be mediated by IL-10 production and appear to play an important role in the induction of the tolerance response leading to a clinical improvement of symptoms.", {"entities": []}], ["Many epidemiological studies have suggested that the recent increase in prevalence and severity of allergic diseases such as asthma is inversely correlated with Mycobacterium bovis bacillus Calmette Guerin (BCG) vaccination.", {"entities": [[125, 131, "DISEASE"]]}], ["However, the underlying mechanisms by which mycobacterial components suppress allergic diseases are not yet fully understood.", {"entities": []}], ["Here we showed the inhibitory mechanisms for development of allergic airway inflammation by using highly purified recombinant Ag85B (rAg85B), which is one of the major protein antigens secreted from M. tuberculosis .", {"entities": [[202, 214, "DISEASE"]]}], ["Ag85B is thought to be a single immunogenic protein that can elicit a strong Th1-type immune response in hosts infected with mycobacteria, including individuals vaccinated with BCG.", {"entities": []}], ["Administration of rAg85B showed a strong inhibitory effect on the development of allergic airway inflammation with induction of Th1-response and IL-17and IL-22 production.", {"entities": []}], ["Both cytokines induced by rAg85B were involved in the induction of Th17-related cytokine-production innate immune cells in the lung.", {"entities": []}], ["Administration of neutralizing antibodies to IL-17 or IL-22 in rAg85B-treated mice revealed that IL-17 induced the infiltration of neutrophils in BAL fluid and that allergen-induced bronchial eosinophilia was inhibited by IL-22.", {"entities": [[192, 204, "DISEASE"]]}], ["Furthermore, enhancement of the expression of genes associated with tissue homeostasis and wound healing was observed in bronchial tissues after rAg85B administration in a Th17-related cytokine dependent manner.", {"entities": []}], ["The results of this study provide evidence for the potential usefulness of rAg85B as a novel approach for anti-allergic effect and tissue repair other than the role as a conventional TB vaccine.", {"entities": []}], ["Licorice ( Glycyrrhiza ) species have been widely used as a traditional medicine and a natural sweetener in foods.", {"entities": []}], ["The 18\u03b2-glycyrrhetinic acid (18\u03b2-GA) is a bioactive compound in licorice that exhibits potential anti-cancer, anti-inflammatory, and anti-microbial activities.", {"entities": [[102, 108, "DISEASE"]]}], ["Many synthesized derivatives of 18\u03b2-GA have been reported to be cytotoxic and suggested for the treatment of malignant diseases.", {"entities": []}], ["In this study, we explored the possible pharmacological roles of an 18\u03b2-GA derivative in skin biology using primary human dermal fibroblasts and HaCaT keratinocytes as cell models.", {"entities": []}], ["We found that this 18\u03b2-GA derivative did not cause cell death, but significantly enhanced the proliferation of dermal fibroblasts and HaCaT keratinocytes.", {"entities": []}], ["A scratch wound healing assay revealed that the 18\u03b2-GA derivative promoted the migration of fibroblasts.", {"entities": []}], ["Due to the important role of aquaporin-3 in cell migration and proliferation, we also investigated the expression of aquaporin-3 and found this compound up-regulated the expression of aquaporin-3 in dermal fibroblasts and HaCaT keratinocytes.", {"entities": []}], ["In dermal fibroblasts, the 18\u03b2-GA derivative induced the phosphorylation of Akt, ERK, and p38.", {"entities": []}], ["The inhibitor of Akt predominantly suppressed the 18\u03b2-GA derivative-induced expression of aquaporin-3.", {"entities": []}], ["Collectively, this compound had a positive effect on the proliferation, migration, and aquaporin-3 expression of skin cells, implying its potential role in the treatment of skin diseases characterized by impaired wound healing or dermal defects.", {"entities": []}], ["Severe acute respiratory syndrome (SARS) is frequently complicated with acute respiratory failure.", {"entities": [[78, 97, "DISEASE"], [25, 33, "DISEASE"], [35, 39, "GENE"]]}], ["In this article, we aim to focus on the management of the subgroup of SARS patients who are critically ill.", {"entities": [[70, 74, "GENE"]]}], ["Most SARS patients would require high flow oxygen supplementation, 20\u201330% required intensive care unit (ICU) or high dependency care, and 13\u201326% developed acute respiratory distress syndrome (ARDS).", {"entities": [[182, 190, "DISEASE"], [5, 9, "GENE"]]}], ["In some of these patients, the clinical course can progress relentlessly to septic shock and/or multiple organ dysfunction syndrome (MODS).", {"entities": [[123, 131, "DISEASE"]]}], ["The management of critically ill SARS patients requires timely institution of pharmacotherapy where applicable and supportive treatment (oxygen therapy, noninvasive and invasive ventilation).", {"entities": [[33, 37, "GENE"]]}], ["Superimposed bacterial and other opportunistic infections are common, especially in those treated with mechanical ventilation.", {"entities": []}], ["Subcutaneous emphysema, pneumothoraces and pneumomediastinum may arise spontaneously or as a result of positive ventilatory assistance.", {"entities": []}], ["Older age is a consistently a poor prognostic factor.", {"entities": []}], ["Appropriate use of personal protection equipment and adherence to infection control measures is mandatory for effective infection control.", {"entities": []}], ["Much of the knowledge about the clinical aspects of SARS is based on retrospective observational data and randomized-controlled trials are required for confirmation.", {"entities": [[52, 56, "GENE"]]}], ["Physicians and scientists all over the world should collaborate to study this condition which may potentially threaten human existence.", {"entities": []}], ["Increased antiretroviral therapy uptake in sub-Saharan Africa has resulted in improved survival of the infected.", {"entities": []}], ["Opportunistic infections are declining as leading causes of morbidity and mortality.", {"entities": []}], ["Though comprehensive data are lacking, concern has been raised about the rapid emergence of non-communicable diseases (NCDs) in the African HIV care setting.", {"entities": []}], ["We therefore set out to characterise the NCD/HIV burden among adults living and ageing with HIV infection in Zimbabwe.", {"entities": []}], ["We conducted a cross-sectional study among patients receiving care in a public sector facility.", {"entities": []}], ["We reviewed patient records and determined the prevalence of comorbid and multi-morbid NCDs.", {"entities": []}], ["Associations with patient characteristics were evaluated using univariate and multi-variate logistic regression modelling.", {"entities": []}], ["Significance testing was done using 2-sided p values and 95\u00a0% confidence intervals calculated.", {"entities": []}], ["We recruited 1033 participants.", {"entities": []}], ["31\u00a0% were men.", {"entities": []}], ["Significant gender differences included: older median age, more advanced disease at baseline, and greater use of stavudine and protease inhibitor containing regimens in men compared to women.", {"entities": []}], ["The prevalence of comorbidity and multi-morbidity were, respectively, 15.3\u00a0% (95\u00a0% CI 13.3\u201317.7\u00a0%) and 4.5\u00a0% (95\u00a0% CI 3.4\u20136.0\u00a0%).", {"entities": []}], ["Women had higher rates than men of both co-morbidity and multi-morbid ity: 21.8 vs. 14.9\u00a0%; p\u00a0=\u00a00.010 and 5.3 vs. 2.9\u00a0%; p\u00a0=\u00a00.025 respectively.", {"entities": []}], ["The commonly observed individual NCDs were hypertension [10.2\u00a0%; (95\u00a0% CI 8.4\u201312.2\u00a0%)], asthma [4.3\u00a0% (95\u00a0% CI 3.1\u20135.8\u00a0%)], type 2 diabetes mellitus [2.1\u00a0% (95\u00a0% CI 1.3\u20133.2\u00a0%)], cancer [1.8\u00a0% (95\u00a0% CI 1.1\u20132.8\u00a0%)], and congestive cardiac failure [1.5\u00a0% (95\u00a0% CI 0.9\u20132.5\u00a0%)].", {"entities": [[43, 55, "DISEASE"], [88, 94, "DISEASE"], [178, 184, "DISEASE"], [131, 148, "DISEASE"], [124, 148, "DISEASE"]]}], ["After adjusting for confounding, only age categories 45\u2013\u226455\u00a0years (AOR 2.25; 95\u00a0% CI 1.37\u20133.69) and >55\u00a0years (AOR 5.42; 95\u00a0% CI 3.17\u20139.26), and female gender (AOR 2.12; 95\u00a0% CI 1.45\u20133.11) remained significantly and strongly associated with comorbidity risk.", {"entities": []}], ["We found a substantial burden of comorbid non-communicable diseases among HIV infected patients in a high HIV and low-income setting.", {"entities": []}], ["Integrating non-communicable diseases care, including active screening, with HIV care is recommended.", {"entities": []}], ["Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are caused by a variety of different etiologic agents.", {"entities": [[23, 60, "DISEASE"]]}], ["Our aim was to phenotype COPD exacerbations using imaging (chest X-ray [CXR] and computed tomography [CT]) and to determine the possible role of the blood tests (C-reactive protein [CRP], the N-terminal prohormone brain natriuretic peptide [NT-proBNP]) as diagnostic biomarkers.", {"entities": [[182, 185, "GENE"]]}], ["Subjects who were hospitalized with a primary diagnosis of AECOPD and who had had CXRs, CT scans, and blood collection for CRP and NT-proBNP were assessed in this study.", {"entities": [[123, 126, "GENE"]]}], ["Radiologist blinded to the clinical and laboratory characteristics of the subjects interpreted their CXRs and CT images.", {"entities": []}], ["ANOVA and Spearman\u2019s correlation were performed to test for associations between these imaging parameters and the blood-based biomarkers NT-proBNP and CRP; logistic regression models were used to assess the performance of these biomarkers in predicting the radiological parameters.", {"entities": [[151, 154, "GENE"]]}], ["A total of 309 subjects were examined for this study.", {"entities": []}], ["Subjects had a mean age of 65.6\u00b111.1 years, 66.7% of them were males, and 62.4% were current smokers, with a mean FEV 1 54.4%\u00b121.5% of predicted.", {"entities": [[114, 117, "GENE"]]}], ["Blood NT-proBNP concentrations were associated with cardiac enlargement (area under the curve [AUC] =0.72, P <0.001), pulmonary edema (AUC =0.63, P =0.009), and pleural effusion on CXR (AUC =0.64, P =0.01); whereas on CT images, NT-proBNP concentrations were associated with pleural effusion (AUC =0.71, P =0.002).", {"entities": [[118, 133, "DISEASE"]]}], ["Serum CRP concentrations, on the other hand, were associated with consolidation on CT images (AUC =0.75, P <0.001), ground glass opacities (AUC =0.64, P =0.028), and pleural effusion (AUC =0.72, P <0.001) on CT images.", {"entities": [[6, 9, "GENE"]]}], ["A serum CRP sensitivity-oriented cutoff point of 11.5 mg/L was selected for the presence of consolidation on CT images in subjects admitted as cases of AECOPD, which has a sensitivity of 91% and a specificity of 53% ( P <0.001).", {"entities": [[8, 11, "GENE"]]}], ["Elevated CRP may indicate the presence of pneumonia, while elevated NT-proBNP may indicate cardiac dysfunction.", {"entities": [[42, 51, "DISEASE"], [9, 12, "GENE"]]}], ["These readily available blood-based biomarkers may provide more accurate phenotyping of AECOPD and enable the discovery of more precise therapies.", {"entities": []}], ["Butyrophilins are proteins secreted during lactation and thought to influence immune function.", {"entities": []}], ["Sarter et al.", {"entities": []}], ["generated butyrophilin-2a2\u2013deficient mice to show enhanced effector T cell responses, antitumor responses, and exacerbated EAE due to the impaired APC modulation of T cell immunity.", {"entities": [[147, 150, "GENE"]]}], ["Evidence has recently emerged that butyrophilins, which are members of the extended B7 family of co-stimulatory molecules, have diverse functions in the immune system.", {"entities": []}], ["We found that the human and mouse genes encoding butyrophilin-2A2 (BTN2A2) are regulated by the class II trans-activator and regulatory factor X, two transcription factors dedicated to major histocompatibility complex class II expression, suggesting a role in T cell immunity.", {"entities": []}], ["To address this, we generated Btn2a2 -deficient mice.", {"entities": []}], ["Btn2a2 mice exhibited enhanced effector CD4 Btn2a2 deficiency in antigen-presenting cells rather than T cells or nonhematopoietic cells.", {"entities": [[40, 43, "GENE"]]}], ["These results provide the first genetic evidence that BTN2A2 is a co-inhibitory molecule that modulates T cell\u2013mediated immunity.", {"entities": []}], ["Lungs are exposed to the outside environment and therefore to toxic and infectious agents or allergens.", {"entities": []}], ["This may lead to permanent activation of innate immune response elements.", {"entities": []}], ["A D isintegrin A nd M etalloproteinases (ADAMs) and ADAMs with T hrombo s pondin motifs (ADAMTS) are proteinases closely related to Matrix Metalloproteinases ( MMP s).", {"entities": []}], ["These multifaceted molecules bear metalloproteinase and disintegrin domains endowing them with features of both proteinases and adhesion molecules.", {"entities": []}], ["Proteinases of the ADAM family are associated to various physiological and pathological processes and display a wide spectrum of biological effects encompassing cell fusion, cell adhesion, \"shedding process\", cleavage of various substrates from the extracellular matrix, growth factors or cytokines...", {"entities": []}], ["This review will focus on the putative roles of ADAM/ADAMTS proteinases in airway diseases such as asthma and COPD.", {"entities": [[99, 105, "DISEASE"]]}], ["Non-attendance for hospital outpatient appointments is a significant problem in many countries.", {"entities": []}], ["It causes suboptimal use of clinical and administrative staff and financial losses, as well as longer waiting times.", {"entities": []}], ["The use of Short Message Service (SMS) appointment reminders potentially offers a cost-effective and time-efficient strategy to decrease non-attendance and so improve the efficiency of outpatient healthcare delivery.", {"entities": [[34, 37, "GENE"]]}], ["An SMS text message was sent to patients with scheduled appointments between April and September 2006 in a hospital ophthalmology department in London, reminding them of their appointments.", {"entities": [[3, 6, "GENE"]]}], ["This group acted as the intervention group.", {"entities": []}], ["Controls were patients with scheduled ophthalmology appointments who did not receive an SMS or any alternative reminder.", {"entities": [[88, 91, "GENE"]]}], ["During the period of the study, 11.2% (50/447) of patients who received an SMS appointment reminder were non-attenders, compared to 18.1% (1720/9512) who did not receive an SMS reminder.", {"entities": [[75, 78, "GENE"], [173, 176, "GENE"], [75, 78, "GENE"], [173, 176, "GENE"]]}], ["Non-attendance rates were 38% lower in patients who received an SMS reminder than in patients who did not receive a reminder (RR of non-attendance = 0.62; 95% CI = 0.48 \u2013 0.80).", {"entities": [[64, 67, "GENE"]]}], ["The use of SMS reminders for ophthalmology outpatient appointments was associated with a reduction of 38% in the likelihood of patients not attending their appointments, compared to no appointment reminder.", {"entities": [[11, 14, "GENE"]]}], ["The use of SMS reminders may also be more cost-effective than traditional appointment reminders and require less labour.", {"entities": [[11, 14, "GENE"]]}], ["These findings should be confirmed with a more rigorous study design before a wider roll-out.", {"entities": []}], ["Using a monoclonal antibody with greater affinity for IgE than omalizumab, we examined whether more complete suppression of IgE provided greater pharmacodynamic effects, including suppression of skin prick responses to allergen.", {"entities": []}], ["To explore the pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity humanized monoclonal IgG1\u03ba anti-IgE.", {"entities": []}], ["Preclinical assessments and two randomized, placebo-controlled, double-blind clinical trials were conducted in atopic subjects.", {"entities": []}], ["The first trial administered single doses of QGE031 (0.1\u201310\u00a0mg/kg) or placebo intravenously, while the second trial administered two to four doses of QGE031 (0.2\u2013 4\u00a0mg/kg) or placebo subcutaneously at 2-week intervals.", {"entities": []}], ["Both trials included an open-label omalizumab arm.", {"entities": []}], ["Sixty of 73 (82%) and 96 of 110 (87%) subjects completed the intravenous and subcutaneous studies, respectively.", {"entities": []}], ["Exposure to QGE031 and its half-life depended on the QGE031 dose and serum IgE level.", {"entities": []}], ["QGE031 had a biexponential pharmacokinetic profile after intravenous administration and a terminal half-life of approximately 20\u00a0days.", {"entities": []}], ["QGE031 demonstrated dose- and time-dependent suppression of free IgE, basophil Fc\u03b5RI and basophil surface IgE superior in extent (free IgE and surface IgE) and duration to omalizumab.", {"entities": []}], ["At Day 85, 6\u00a0weeks after the last dose, skin prick wheal responses to allergen were suppressed by >\u00a095% and 41% in subjects treated subcutaneously with QGE031 (2\u00a0mg/kg) or omalizumab, respectively ( P\u00a0 < \u00a0 0.001).", {"entities": []}], ["Urticaria was observed in QGE031- and placebo-treated subjects and was accompanied by systemic symptoms in one subject treated with 10\u00a0mg/kg intravenous QGE031.", {"entities": []}], ["There were no serious adverse events.", {"entities": []}], ["These first clinical data for QGE031, a high-affinity IgG1\u03ba anti-IgE, demonstrate that increased suppression of free IgE compared with omalizumab translated to superior pharmacodynamic effects in atopic subjects, including those with high IgE levels.", {"entities": []}], ["QGE031 may therefore benefit patients unable to receive, or suboptimally treated with, omalizumab.", {"entities": []}], ["To report pediatric cases of paradoxical respiratory adverse drug reactions (ADRs) after exposure to oral mucolytic drugs (carbocysteine, acetylcysteine) that led to the withdrawal of licenses for these drugs for infants in France and then Italy.", {"entities": []}], ["The study followed the recommendations of the European guidelines of pharmacovigilance for medicines used in the paediatric population.", {"entities": []}], ["Cases voluntarily reported by physicians from 1989 to 2008 were identified in the national French pharmacovigilance public database and in drug company databases.", {"entities": []}], ["The definition of paradoxical respiratory ADRs was based on the literature.", {"entities": []}], ["Exposure to mucolytic drugs was arbitrarily defined as having received mucolytic drugs for at least 2 days (>200 mg) and at least until the day before the first signs of the suspected ADR.", {"entities": []}], ["The non-exclusive paradoxical respiratory ADRs reported in 59 paediatric patients (median age 5 months, range 3 weeks to 34 months, 98% younger than 2 years old) were increased bronchorrhea or mucus vomiting (n\u200a=\u200a27), worsening of respiratory distress during respiratory tract infection (n\u200a=\u200a35), dyspnoea (n\u200a=\u200a18), cough aggravation or prolongation (n\u200a=\u200a11), and bronchospasm (n\u200a=\u200a1).", {"entities": []}], ["Fifty-one (86%) children required hospitalization or extended hospitalization because of the ADR; one patient died of pulmonary oedema after mucus vomiting.", {"entities": []}], ["Parents, physicians, pharmacists, and drug regulatory agencies should know that the benefit risk ratio of mucolytic drugs is at least null and most probably negative in infants according to available evidence.", {"entities": []}], ["Herpes zoster is a viral disease caused by the reactivation of varicella\u2013zoster virus (VZV) which remained latent in the cranial nerve or dorsal root ganglia.", {"entities": [[0, 13, "DISEASE"]]}], ["Cell-mediated immunity is known to decline with age as part of immunosenescence and can lead to the reactivation of VZV.", {"entities": []}], ["Whereas herpes zoster is usually mild in healthy young persons, older patients are at increased risk for complications.", {"entities": [[8, 21, "DISEASE"]]}], ["In the present study we investigated the serum cytokine profile (IL-17, IL-23, IL-21, IL-4, IL-12), representing cellular and humoral immunity and assessed the level of VZV IgG antibodies in patients with herpes zoster.", {"entities": [[205, 218, "DISEASE"]]}], ["We investigated the serum concentrations of IL-17, IL-23, IL-21, IL-4, IL-12 and the level of VZV IgG antibodies in 23 patients with herpes zoster who did not develop superinfection.", {"entities": [[133, 146, "DISEASE"]]}], ["The control group was represented by 21 individuals in similar age with no inflammatory and infectious diseases.", {"entities": []}], ["Cytokine and antibodies levels were measured by ELISA method.", {"entities": []}], ["Statistical analysis was performed using the ROC curve (receiver operating characteristic), t-test, Welch\u2019s t -test, and nonparametric tests with STATISTICA 10 software.", {"entities": []}], ["In patients with herpes zoster, the serum level of IL-17, IL-23, IL-21, IL-4 and IL-12 as well as VZV IgG antibodies titer were statistically significantly increased compared to control group.", {"entities": [[17, 30, "DISEASE"]]}], ["Our results confirm the broad activation of the immune system involving humoral and cell-mediated immunity.", {"entities": []}], ["To show how segmentation can enhance risk stratification tools for integrated care, by providing insight into different care usage patterns within the high-risk population.", {"entities": []}], ["A retrospective cohort study.", {"entities": []}], ["A risk score was calculated for each person using a logistic regression, which was then used to select the top 5% high-risk individuals.", {"entities": []}], ["This population was segmented based on the usage of different care settings using a k-means cluster analysis.", {"entities": []}], ["Data from 2008 to 2011 were used to create the risk score and segments, while 2012 data were used to understand the predictive abilities of the models.", {"entities": []}], ["Data were collected from administrative data sets covering primary and secondary care for a random sample of 300\u2005000 English patients.", {"entities": []}], ["The high-risk population was segmented based on their usage of 4 different care settings: emergency acute care, elective acute care, outpatient care and GP care.", {"entities": []}], ["While the risk strata predicted care usage at a high level, within the high-risk population, usage varied significantly.", {"entities": []}], ["4 different groups of high-risk patients could be identified.", {"entities": []}], ["These 4 segments had distinct usage patterns across care settings, reflecting different levels and types of care needs.", {"entities": []}], ["The 2008\u20132011 usage patterns of the 4 segments were consistent with the 2012 patterns.", {"entities": []}], ["Cluster analyses revealed that the high-risk population is not homogeneous, as there exist 4 groups of patients with different needs across the care continuum.", {"entities": []}], ["Since the patterns were predictive of future care use, they can be used to develop integrated care programmes tailored to these different groups.", {"entities": []}], ["Usage-based segmentation augments risk stratification by identifying patient groups with different care needs, around which integrated care programmes can be designed.", {"entities": []}], ["Programmed death cell 1 (PD-1) is an inhibitor of T cell activation and is also functionally linked to glycolysis.", {"entities": []}], ["We hypothesized that PD-1 expression is defective in activated T cells from children with type 1 diabetes (T1D), resulting in abnormal T cell glucose metabolism.", {"entities": []}], ["In this pilot study, we enrolled children with new onset T1D within 2 weeks of diagnosis (T1D), unaffected siblings of T1D (SIBS), unaffected, unrelated children (CTRL), children with new onset, and untreated Crohn disease (CD).", {"entities": [[163, 167, "GENE"]]}], ["We repeated the assays 4\u20136 months post-diagnosis in T1D (T1D follow up).", {"entities": []}], ["We analyzed anti-CD3/-CD28-stimulated peripheral blood mononuclear cells (PBMC) subsets for PD-1 expression by flow cytometry at baseline and after 24 h in culture.", {"entities": []}], ["We measured cytokines in the culture medium by multiplex ELISA and glycolytic capacity with a flux analyzer.", {"entities": []}], ["We enrolled 37 children.", {"entities": []}], ["T cells derived from subjects with T1D had decreased PD-1 expression compared to the other study groups.", {"entities": []}], ["However, in T1D follow-up T cells expressed PD-1 similarly to controls, but had no differences in PBMC cytokine production.", {"entities": []}], ["Nonetheless, T1D follow up PBMCs had enhanced glycolytic capacity compared to T1D.", {"entities": []}], ["Activated T cells from T1D fail to upregulate PD-1 upon T-cell receptor stimulation, which may contribute to the pathogenesis of T1D.", {"entities": []}], ["T1D follow up PBMC expression of PD-1 normalizes, together with a significant increase in glycolysis compared to T1D.", {"entities": []}], ["Thus, insulin therapy in T1D children is associated with normal PD1 expression and heightened glycolytic capacity in PBMC.", {"entities": []}], ["With increasing Internet coverage, the use of a web-based survey for epidemiological study is a possibility.", {"entities": []}], ["We performed an investigation in Japan in winter 2008 using the web-based daily questionnaire for health (WDQH).", {"entities": []}], ["The WDQH is a web-based questionnaire survey formulated to obtain information about the daily physical condition of the general public on a real-time basis, in order to study correlations between changes in physical health and changes in environmental factors.", {"entities": []}], ["Respondents were asked whether they felt ill and had specific symptoms including fever.", {"entities": []}], ["We analysed the environmental factors along with the health conditions obtained from the WDQH.", {"entities": []}], ["Four factors were found to influence health: minimum temperature, hours of sunlight, median humidity and weekday or holiday.", {"entities": []}], ["The WDQH allowed a daily health survey in the general population in real time via the Internet.", {"entities": []}], ["Western publicly funded health care systems increasingly rely on interdisciplinary teams to support primary care delivery and management of chronic conditions.", {"entities": []}], ["This knowledge synthesis focuses on what is known in the academic and grey literature about optimal structural characteristics of teams.", {"entities": []}], ["Its goal is to assess which factors contribute to the effective functioning of interdisciplinary primary care teams and improved health system outcomes, with specific focus on (i) team structure contribution to team process, (ii) team process contribution to primary care goals, and (iii) team structure contribution to primary care goals.", {"entities": []}], ["The systematic search of academic literature focuses on four chronic conditions and co-morbidities.", {"entities": []}], ["Within this scope, qualitative and quantitative studies that assess the effects of team characteristics (funding, governance, organization) on care process and patient outcomes will be searched.", {"entities": []}], ["Electronic databases (Ovid MEDLINE, Embase, CINAHL, PAIS, Web of Science) will be searched systematically.", {"entities": []}], ["Online web-based searches will be supported by the Grey Matters Tool.", {"entities": []}], ["Studies will be included, if they report on interdisciplinary primary care in publicly funded Western health systems, and address the relationships between team structure, process, and/or patient outcomes.", {"entities": []}], ["Studies will be selected in a three-stage screening process (title/abstract/full text) by two independent reviewers in each stage.", {"entities": []}], ["Study quality will be assessed using the Mixed Methods Assessment Tool.", {"entities": []}], ["An a priori framework will be applied to data extraction, and a narrative framework approach is used for the synthesis.", {"entities": []}], ["Using an integrated knowledge translation approach, an electronic decision support tool will be developed for decision makers.", {"entities": []}], ["It will be searchable along two axes of inquiry: (i) what primary care goals are supported by specific team characteristics and (ii) how should teams be structured to support specific primary care goals?", {"entities": []}], ["The results of this evidence review will contribute directly to the design of interdisciplinary primary care teams.", {"entities": []}], ["The optimized design will support the goals of primary care, contributing to the improved health of populations.", {"entities": []}], ["PROSPERO CRD42016041884 The online version of this article (doi:10.1186/s13643-016-0339-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Extracellular high-mobility group box-1 (HMGB1) acts as a signalling molecule during inflammation, cell differentiation and angiogenesis.", {"entities": [[41, 46, "GENE"]]}], ["Increased abundance of HMGB1 is associated with several pathological disorders such as cancer, asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[106, 143, "DISEASE"], [95, 101, "DISEASE"], [87, 93, "DISEASE"], [23, 28, "GENE"]]}], ["In this study, we investigated the relevance of HMGB1 in the pathological remodelling present in patients with idiopathic pulmonary arterial hypertension (IPAH) and pulmonary hypertension (PH) associated with COPD.", {"entities": [[141, 153, "DISEASE"], [175, 187, "DISEASE"], [165, 187, "DISEASE"], [48, 53, "GENE"]]}], ["Remodelled vessels present in COPD with PH and IPAH lung samples were often surrounded by HMGB1-positive cells.", {"entities": []}], ["Increased HMGB1 serum levels were detected in both patient populations compared to control samples.", {"entities": [[10, 15, "GENE"]]}], ["The effects of physiological HMGB1 concentrations were then examined on cellular responses in vitro .", {"entities": [[29, 34, "GENE"]]}], ["HMGB1 enhanced proliferation of pulmonary arterial smooth muscle cells (PASMC) and primary human arterial endothelial cells (PAEC).", {"entities": [[0, 5, "GENE"]]}], ["HMGB1 stimulated p38, extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) phosphorylation.", {"entities": [[0, 5, "GENE"]]}], ["Furthermore, activation of the downstream AP-1 complex proteins c-Fos and c-Jun was observed.", {"entities": []}], ["Silencing of c-Jun ablated the HMGB1-induced proliferation in PASMC.", {"entities": []}], ["Thus, an inflammatory component such as HMGB1 can contribute to PASMC and PAEC proliferation and therefore potentially to vascular remodelling and PH pathogenesis.", {"entities": [[40, 45, "GENE"]]}], ["In the current study, we examined cross-sectional associations among social-demographics, lifestyle behaviors, and relative telomere length (RTL) in peripheral blood leukocytes, as well as longitudinal relationships among major chronic diseases, weight gain, and RTL, among 12,792 Mexican Americans aged 20 to 85 years in the Mano-A-Mano, the Mexican American Cohort.", {"entities": []}], ["As expected, RTL was inversely correlated with age ( \u03c1 =-0.15, \u03c1 <0.001).", {"entities": []}], ["In the multivariate analysis, we found that RTL was positively correlated with levels of education ( \u03c1 =0.021), self-insurance ( \u03c1 =0.041), body mass index (BMI) ( \u03c1 <0.001), and sleeping time per day ( \u03c1 for trend<0.001), and RTL was inversely correlated with sitting time per day ( \u03c1 for trend =0.001).", {"entities": []}], ["In longitudinal analysis, we found that longer RTL was modestly but positively associated with increased risks of overall cancer (adjusted hazard ratio (adj.HR)=1.05, 95% conference interval (95%CI)=1.02-1.09).", {"entities": [[122, 128, "DISEASE"]]}], ["In quartile analysis, 4", {"entities": []}], ["Studies suggest that expectations powerfully shape clinical outcomes.", {"entities": []}], ["For subjective outcomes in adequately blinded trials, health improvements are substantial and largely explained by non-specific factors.", {"entities": []}], ["The objective of this study was to investigate if unblinding in randomized controlled trials (RCTs) is associated with enhanced placebo effects for intervention groups and nocebo effects for placebo groups.", {"entities": []}], ["For these effects, a secondary objective was to explore potential moderating factors.", {"entities": []}], ["We included RCTs that investigated the efficacy of phosphodiesterase-5 (PDE-5) inhibitors for male erectile dysfunction by comparing one PDE-5 inhibitor to placebo.", {"entities": []}], ["In addition, to be included studies must have reported scores for change from baseline, or baseline and final International Index of Erectile Functioning-Erectile Functioning domain score (IIEF-EF), and be published in either English, French, Dutch, or German.", {"entities": []}], ["We searched for both published and unpublished relevant trials using PUBMED, EMBASE, the Cochrane Central Register of Controlled Trials, a clinical trials register (clinicaltrials.gov) and the Food and Drug Administration clinical reviews through March 2012.", {"entities": []}], ["We evaluated the blinding status of trials with the Cochrane Risk of Bias Tool, using the domains of allocation sequence concealment, blinding of participants, healthcare providers and outcome assessors.", {"entities": []}], ["Across these four domains, studies that scored low risk of bias were judged to be adequately blinded and studies that scored unclear or high risk of bias were judged to be inadequately blinded.", {"entities": []}], ["We included 110 studies (205 journal publications and 2 unpublished sources) that involved 23,877 participants; 93 (85%), 51 (46%), 93 (85%) and 93 (85%) studies were assessed with an unclear risk of bias for allocation concealment, blinding of participant, blinding of caregiver and blinding of outcome assessor, respectively.", {"entities": []}], ["None of the studies reported testing of blinding.", {"entities": []}], ["None of the 205 journal publications provided sufficient details to assess allocation concealment, blinding of participants, caregivers and outcome assessors.", {"entities": []}], ["After contacting authors for additional information, we judged five studies to be adequately (n\u2009=\u20091,202) and 16 to be inadequately (n\u2009=\u20093,006) blinded.", {"entities": []}], ["The IIEF-EF score for placebo groups in adequately blinded trials versus inadequately blinded trials was 1.92 points (95% CI, 0.64 to 3.20) versus 1.56 (95% CI, 0.93 to 2.20), respectively.", {"entities": []}], ["The IIEF-EF score for intervention groups in adequately blinded trials versus inadequately blinded trials was 9.40 (95% CI, 6.96 to 11.83) versus 8.33 (95% CI, 7.29 to 9.37), respectively.", {"entities": []}], ["In a secondary analysis, prior experience with the drug affected the scores; in placebo groups with participants na\u00efve to the intervention the score was 2.89 (95% CI, 2.33 to 3.45) versus -0.11 (95% CI, -2.06 to 1.84) with participants having prior experience.", {"entities": []}], ["In the intervention groups, these scores were 7.99 (95% CI, 6.85 to 9.14) versus 8.33 (95% CI, 7.51 to 9.16), respectively.", {"entities": []}], ["Unblinding lowered placebo scores (creating a nocebo effect) by 19% (0.33 points; 95% CI, -0.96 to 1.62).", {"entities": []}], ["Unblinding lowered intervention scores by 11% (1.0; 95% CI, -1.35 to 3.47).", {"entities": []}], ["The results provided no conclusive evidence for nocebo or enhanced placebo effects.", {"entities": []}], ["Patients taking a PDE-5 inhibitor for the first time experience a larger placebo effect that accounts for 35% of the total effect.", {"entities": []}], ["Given the overall poor reporting of blinding in clinical trial reports and the small number of trials that could be rated as adequately or inadequately blinded, we could not draw any robust conclusions about the existence or absence of nocebo and enhanced placebo effects.", {"entities": []}], ["A large placebo effect was found for patients taking PDE-5 inhibitors for the first time.", {"entities": []}], ["It was not clear if previous exposure to the drug impacted trial blinding.", {"entities": []}], ["We found clear evidence that studies assessing a subjective continuous outcome fail to report on measures taken to secure double blinding.", {"entities": []}], ["Although we observed a trend for the presence of a nocebo effect, there was insufficient evidence to quantify its impact on expectations.", {"entities": []}], ["RCTs with patients with no prior experience with PDE-5 inhibitors reported larger placebo effects and possibly these studies were better blinded.", {"entities": []}], ["Future research should further investigate the factors that contribute to blinding and their impact on health outcomes in randomized trials of subjectively assessed conditions.", {"entities": []}], ["This research is part of a PhD project and has no external funding.", {"entities": []}], ["The authors have no competing interests to declare.", {"entities": []}], ["The aim of this study is to evaluate the ability and practice of spirometry, training of technicians, and spirometry features in primary care centers in Spain, evaluating those located in a rural environment against those in urban areas.", {"entities": []}], ["An observational cross-sectional study was conducted in 2012 by a telephone survey in 970 primary health care centers in Spain.", {"entities": []}], ["The centers were divided into rural or urban depending on the catchment population.", {"entities": []}], ["The survey contacted technicians in charge of spirometry and consisted of 36 questions related to the test that included the following topics: center resources, training doctors and technicians, using the spirometer, bronchodilator test, and the availability of spirometry and maintenance.", {"entities": []}], ["Although the sample size was achieved in both settings, rural centers (RCs) gave a lower response rate than urban centers (UCs).", {"entities": []}], ["The number of centers without spirometry in rural areas doubled those in the urban areas.", {"entities": []}], ["Most centers had between one and two spirometers.", {"entities": []}], ["However, the number of spirometry tests per week was significantly lower in RCs than in UCs (4 [4.1%] vs 6.9 [5.7%], P <0.01).", {"entities": []}], ["The availability of a specific schedule for conducting spirometries was higher in RCs than in UCs (209 [73.0%] vs 207 [64.2%], P =0.003).", {"entities": []}], ["RCs were more satisfied with the spirometries (7.8 vs 7.6, P =0.019) and received more training course for interpreting spirometry (41.0% vs 33.2%, P =0.004).", {"entities": []}], ["The performance of the bronchodilator test showed a homogeneous measure in different ways.", {"entities": []}], ["The spirometer type and the reference values were unknown to the majority of respondents.", {"entities": []}], ["This study shows the differences between primary care RCs and UCs in Spain in terms of performing spirometry.", {"entities": []}], ["The findings in the present study can be used to improve the performance of spirometry in these areas.", {"entities": []}], ["Chorioamnionitis is associated with preterm delivery and involution of the fetal thymus.", {"entities": [[0, 16, "DISEASE"]]}], ["Women at risk of preterm delivery receive antenatal corticosteroids which accelerate fetal lung maturation and improve neonatal outcome.", {"entities": []}], ["However, the effects of antenatal corticosteroids on the fetal thymus in the settings of chorioamnionitis are largely unknown.", {"entities": [[89, 105, "DISEASE"]]}], ["We hypothesized that intra-amniotic exposure to lipopolysaccharide (LPS) causes involution of the fetal thymus resulting in persistent effects on thymic structure and cell populations.", {"entities": []}], ["We also hypothesized that antenatal corticosteroids may modulate the effects of LPS on thymic development.", {"entities": []}], ["Time-mated ewes with singleton fetuses received an intra-amniotic injection of LPS 7 or 14 days before preterm delivery at 120 days gestational age (term\u200a=\u200a150 days).", {"entities": []}], ["LPS and corticosteroid treatment groups received intra-amniotic LPS either preceding or following maternal intra-muscular betamethasone.", {"entities": []}], ["Gestation matched controls received intra-amniotic and maternal intra-muscular saline.", {"entities": []}], ["The fetal intra-thoracic thymus was evaluated.", {"entities": []}], ["Intra-amniotic LPS decreased the cortico-medullary (C/M) ratio of the thymus and increased Toll-like receptor (TLR) 4 mRNA and CD3 expression indicating involution and activation of the fetal thymus.", {"entities": []}], ["Increased TLR4 and CD3 expression persisted for 14 days but Foxp3 expression decreased suggesting a change in regulatory T-cells.", {"entities": [[10, 14, "GENE"], [60, 65, "GENE"]]}], ["Sonic hedgehog and bone morphogenetic protein 4 mRNA, which are negative regulators of T-cell development, decreased in response to intra-amniotic LPS.", {"entities": []}], ["Betamethasone treatment before LPS exposure attenuated some of the LPS-induced thymic responses but increased cleaved caspase-3 expression and decreased the C/M ratio.", {"entities": []}], ["Betamethasone treatment after LPS exposure did not prevent the LPS-induced thymic changes.", {"entities": []}], ["Intra-amniotic exposure to LPS activated the fetal thymus which was accompanied by structural changes.", {"entities": []}], ["Treatment with antenatal corticosteroids before LPS partially attenuated the LPS-induced effects but increased apoptosis in the fetal thymus.", {"entities": []}], ["Corticosteroid administration after the inflammatory stimulus did not inhibit the LPS effects on the fetal thymus.", {"entities": []}], ["To study the 1-year outcome and to analyse predictors of outcome of a cohort of adolescent girls with anorexia nervosa (AN) or restrictive eating disorders not otherwise specified (EDNOSr) treated as out-patients in a family-based programme at a specialized eating disorder service.", {"entities": [[258, 273, "DISEASE"]]}], ["To calculate the incidence of anorexia nervosa among treatment-seeking girls younger than 18 in Uppsala County from 2004 to 2006.", {"entities": []}], ["A total of 168 female patients were offered treatment, and 141 were followed-up 1 year after starting treatment, 29 with AN and 112 with EDNOSr.", {"entities": []}], ["Of the 29 girls who initially had AN, 6 (20%) had a good outcome and were free of any form of eating disorder at follow-up; only 1 (3%) had AN.", {"entities": [[94, 109, "DISEASE"]]}], ["Of the patients with EDNOSr, 54 (48%) had a good outcome and were free of eating disorders.", {"entities": []}], ["Three (3%) had a poor outcome and had developed AN.", {"entities": []}], ["The incidence of AN was 18/100,000 person-years in girls younger than 12 and 63/100,000 in girls younger than 18.", {"entities": []}], ["Restrictive eating disorders, including AN, in children and adolescents can be successfully treated in a family-based specialized out-patient service without in-patient care.", {"entities": []}], ["Aerial emissions from a swine house at North Carolina State University\u2019s field laboratory were diluted to a level that could occur at varying distances downwind from a confined animal feeding operation (CAFO) both within and beyond the property line, and these emissions were delivered to an environmental exposure chamber.", {"entities": []}], ["The study design consisted of two 1-hr sessions, one in which 48 healthy human adult volunteers were exposed to diluted swine air and another in which they were exposed to clean air (control).", {"entities": []}], ["Objective measures of blood pressure, temperature, heart rate, respiratory rate, lung function, nasal inflammation, secretory immunity, mood, attention, and memory were correlated with objective measures of air quality.", {"entities": []}], ["Ratings of perceived (self-reported) health symptoms were also obtained.", {"entities": []}], ["The mean levels of airborne constituents in the swine air condition were hydrogen sulfide (24 ppb), ammonia (817 ppb), total suspended particulates (0.0241 mg/m p = 0.001) times more likely to report headaches, 6.1 ( p = 0.004) times more likely to report eye irritation, and 7.8 ( p = 0.014) times more likely to report nausea in the swine air (experimental) condition than in the control condition.", {"entities": []}], ["These results indicate that short-term exposure in an environmental chamber to malodorous emissions from a swine house at levels expected downwind can induce clinically important symptoms in healthy human volunteers.", {"entities": []}], ["To assess asthma among Brazilian pediatric population applying the International Study of Asthma and Allergies in Childhood (ISAAC), an internationally standardized and validated protocol.", {"entities": [[10, 16, "DISEASE"], [90, 96, "DISEASE"]]}], ["ISAAC was conceived to maximize the value of epidemiologic studies on asthma and allergic diseases, establishing a standardized method (self-applicable written questionnaire and/or video questionnaire) capable to facilitate the international collaboration.", {"entities": [[70, 76, "DISEASE"]]}], ["Designed to be carried out in three successive and dependent phases, the ISAAC gathered a casuistic hitherto unimaginable in the world and in Brazil.", {"entities": []}], ["This review included data gathered from ISAAC official Brazilian centers and others who used this method.", {"entities": []}], ["At the end of the first phase, it has been documented that the prevalence of asthma among Brazilian schoolchildren was the eighth among all centers participating all over the world.", {"entities": [[77, 83, "DISEASE"]]}], ["Few centers participated in the second phase and investigated possible etiological factors, especially those suggested by the first phase, and brought forth many conjectures.", {"entities": []}], ["The third phase, repeated seven years later, assessed the evolutionary trend of asthma and allergic diseases prevalence in centers that participated simultaneously in phases I and III and in other centers not involved in phase I.", {"entities": [[80, 86, "DISEASE"]]}], ["In Brazil, the ISAAC study showed that asthma is a disease of high prevalence and impact in children and adolescents and should be seen as a Public Health problem.", {"entities": [[39, 45, "DISEASE"]]}], ["Important regional variations, not well understood yet, and several risk factors were found, which makes us wonder: is there only one or many asthmas in Brazil?", {"entities": []}], ["Avaliar a asma na popula\u00e7\u00e3o pedi\u00e1trica brasileira pelo protocolo do International Study of Asthma and Allergies in Childhood (ISAAC), internacionalmente padronizado e validado.", {"entities": [[91, 97, "DISEASE"], [50, 54, "GENE"]]}], ["O ISAAC, idealizado para maximizar o valor de estudos epidemiol\u00f3gicos em asma e doen\u00e7as al\u00e9rgicas, estabeleceu um m\u00e9todo padronizado (question\u00e1rio escrito autoaplic\u00e1vel e/ou v\u00eddeo-question\u00e1rio) capaz de facilitar a colabora\u00e7\u00e3o internacional.", {"entities": []}], ["Concebido para ser realizado em tr\u00eas fases sucessivas e dependentes, o ISAAC reuniu uma casu\u00edstica at\u00e9 ent\u00e3o inimagin\u00e1vel no mundo e no Brasil.", {"entities": []}], ["Nesta revis\u00e3o, reuniram-se os dados de centros brasileiros oficiais do ISAAC e de outros que empregaram o seu m\u00e9todo.", {"entities": []}], ["Finalizada a primeira fase, a preval\u00eancia de asma entre escolares brasileiros foi documentada como a oitava em magnitude entre todos os centros participantes do estudo.", {"entities": []}], ["Os poucos centros envolvidos na segunda fase investigaram poss\u00edveis fatores etiol\u00f3gicos, especialmente aqueles sugeridos pelos resultados da primeira fase, e geraram muitas especula\u00e7\u00f5es.", {"entities": []}], ["A terceira fase, repetida ap\u00f3s sete anos, avaliou a tend\u00eancia evolutiva da preval\u00eancia de asma e das doen\u00e7as al\u00e9rgicas nos centros participantes simultaneamente das fases I e III e determinou a preval\u00eancia em outros n\u00e3o envolvidos na fase I.", {"entities": []}], ["No Brasil, o ISAAC demonstrou, de forma definitiva, que a asma \u00e9 uma doen\u00e7a de alta preval\u00eancia e impacto em crian\u00e7as e adolescentes, devendo ser encarada como problema de Sa\u00fade P\u00fablica.", {"entities": []}], ["Encontraram-se importantes varia\u00e7\u00f5es regionais, ainda n\u00e3o bem esclarecidas, assim como diversos fatores de risco, o que traz a quest\u00e3o: h\u00e1 no Brasil uma ou muitas asmas?", {"entities": []}], ["The aims of the present study were to examine relations between parents' self-reported smoking behavior and infants' daily exposure to environmental tobacco smoke, as assessed by urinary cotinine-to-creatinine ratio (CCR), and to describe the CCR over seven days among infants at home.", {"entities": []}], ["A convenience sample of 27 households was drawn.", {"entities": []}], ["Each household had to have at least one daily tobacco smoker and one child up to three years of age.", {"entities": []}], ["Over a seven-day period, urine samples were obtained from the child daily.", {"entities": []}], ["To examine relations between parents' self-reported smoking and infants' daily CCR, generalized estimating equation (GEE) analysis was used.", {"entities": []}], ["The data revealed that infants from households with indoor smoking had higher CCRs than infants in households with outdoor smoking.", {"entities": []}], ["CCRs were higher in girls than in boys.", {"entities": []}], ["Older infants had lower CCRs than younger infants.", {"entities": []}], ["Smoking outside the home versus inside the home, infant's gender, and infants' age accounted for 68% of the variance in CCR in a GEE data analysis model.", {"entities": []}], ["No increase or decrease of CCR over time was found.", {"entities": []}], ["The findings suggest that parents' self-reported smoking indoors at home versus outdoors is predictive of CCR among infants three and younger.", {"entities": []}], ["Higher CCR concentrations in girls' urine need further examination.", {"entities": []}], ["Furthermore, significant fluctuations in daily CCR were not apparent in infants over a seven-day time period.", {"entities": []}], ["Two different forms of clinical paratuberculosis in sheep are recognised, related to the level of bacterial colonization.", {"entities": []}], ["Paucibacillary lesions are largely composed of lymphocytes with few bacteria, and multibacillary pathology is characterized by heavily-infected macrophages.", {"entities": []}], ["Analysis of cytokine transcripts has shown that inflammatory Th1/Th17 T cells are associated with development of paucibacillary pathology and Th2 cytokines are correlated with multibacillary disease.", {"entities": []}], ["The master regulator T cell transcription factors TBX21 , GATA3 , RORC2 and RORA are critical for the development of these T cell subsets.", {"entities": [[50, 55, "GENE"], [58, 63, "GENE"], [76, 80, "GENE"]]}], ["Sequence variations of the transcription factors have also been implicated in the distinct disease forms of human mycobacterial and gastrointestinal inflammatory diseases.", {"entities": []}], ["Relative RT-qPCR was used to compare expression levels of each transcript variant of the master regulators in the ileo-caecal lymph nodes of uninfected controls and sheep with defined paucibacillary and multibacillary pathology.", {"entities": []}], ["Low levels of GATA3 in multibacillary sheep failed to confirm that multibacillary paratuberculosis is caused simply by a Th2 immune response.", {"entities": [[14, 19, "GENE"]]}], ["However, high levels of TBX21 , RORC2 and RORC2v1 highlights the role of Th1 and Th17 activation in paucibacillary disease.", {"entities": [[24, 29, "GENE"]]}], ["Increased RORAv1 levels in paucibacillary tissue suggests a role for ROR\u03b1 in Th17 development in sheep; while elevated levels of RORAv4 hints that this variant might inhibit ROR\u03b1 function and depress Th17 development in multibacillary sheep.", {"entities": []}], ["The online version of this article (doi:10.1186/s13567-016-0368-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Patients with pulmonary hypertension (PH) are considered to be at risk for complications associated with flexible bronchoscopy (FB), but data concerning the degree of PH are often lacking.", {"entities": [[24, 36, "DISEASE"], [14, 36, "DISEASE"]]}], ["We investigated whether COPD patients with PH who undergo bronchoscopy are at greater risk for complications.", {"entities": []}], ["This prospective study included 207 consecutive COPD patients undergoing FB.", {"entities": []}], ["All underwent an echo-Doppler to evaluate pulmonary artery pressure on the day of the bronchoscopy procedure.", {"entities": []}], ["Pulmonologists were blinded to the echocardiogram results.", {"entities": []}], ["A total of 167 patients (80.7%) had normal pulmonary pressure.", {"entities": []}], ["The remaining 40 patients (19.3%) had PH: 27 (13.0%) mild, eight (3.9%) moderate, and five (2.4%) severe.", {"entities": []}], ["Noninvasive hemodynamic parameters between groups before and after FB were similar.", {"entities": []}], ["Two patients with normal pulmonary pressure developed supraventricular tachycardia.", {"entities": []}], ["None developed hemodynamically significant dysrhythmia.", {"entities": []}], ["Bleeding episodes between groups in bronchoalveolar lavage (BAL) and transbronchial biopsy (TBB) did not differ.", {"entities": []}], ["PH patients who underwent BAL and TBB had decreased O 2 saturation during the procedure compared with the non-PH group (23.5% vs 6.9%, P =0.033).", {"entities": []}], ["No deaths were attributable to FB.", {"entities": []}], ["PH is common among COPD patients undergoing FB.", {"entities": []}], ["PH patients undergoing BAL and TBB are at higher risk of decreased O 2 saturation than those without PH.", {"entities": []}], ["Further studies should assess the risk among COPD patients with moderate-to-severe PH.", {"entities": []}], ["Allergic inflammation and severe allergic reactions (anaphylaxis) are important in allergen induced diseases.", {"entities": []}], ["Bacterial products such as lipopolysaccharide (LPS) are ubiquitous and can facilitate allergen induced Th2 immune responses.", {"entities": []}], ["Phosphatase SHP-1 is critical in regulating immunological homeostasis and in allergen induced Th2 immune responses in the lung.", {"entities": []}], ["However, the mechanisms underlying the initiation of allergic inflammation and allergen induced anaphylaxis are still not completely elucidated and it is unclear whether SHP-1 plays any role in LPS-induced airway inflammation and in allergen-induced anaphylaxis.", {"entities": []}], ["In this study we tested the hypothesis that phosphatase SHP-1 plays an important role in allergic inflammation and anaphylaxis and determined whether its effects are through regulation of mast cell functions.", {"entities": []}], ["SHP-1 deficient ( mev /+ and mev/mev ) and mast cell deficient ( Kit ) mice were examined in their responses to LPS airway stimulation and to ovalbumin (OVA) allergen induced systemic anaphylaxis.", {"entities": []}], ["Compared to wild type mice, mev /+ mice had significantly enhanced LPS induced airway inflammation and OVA induced anaphylactic responses, including hypothermia and clinical symptoms.", {"entities": []}], ["These changes were mast cell dependent as Kit mice had reduced responses whereas adoptive transfer of mast cells restored the responses.", {"entities": []}], ["However, T and B cells were not involved and macrophages did not play a significant role in LPS induced airway inflammation.", {"entities": []}], ["Interestingly, basophil differentiation from SHP-1 deficient bone marrow cells was significantly reduced.", {"entities": []}], ["These findings provided evidence that through regulation of mast cell functions SHP-1 plays a critical role as a negative regulator in allergic inflammation and in allergen induced anaphylaxis.", {"entities": []}], ["In addition, SHP-1 seems to be required for normal basophil development.", {"entities": []}], ["Smoking is the leading modifiable risk factor for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD), and lung cancer.", {"entities": [[130, 141, "DISEASE"], [50, 87, "DISEASE"], [135, 141, "DISEASE"]]}], ["Smoking cessation is the only proven way of modifying the natural course of COPD.", {"entities": []}], ["It is also the most effective way of reducing the risk for myocardial infarction and lung cancer.", {"entities": [[85, 96, "DISEASE"], [59, 80, "DISEASE"], [90, 96, "DISEASE"]]}], ["However, the full benefits of tobacco treatment may not be realized until many years of abstinence.", {"entities": []}], ["All patients with COPD, regardless of severity, appear to benefit from tobacco treatment.", {"entities": []}], ["Similarly, patients with recent CVD events also benefit from tobacco treatment.", {"entities": []}], ["The risk of total mortality and rate of recurrence of lung cancer is substantially lower in smokers who manage to quit smoking following the diagnosis of early stage lung cancer or small cell lung cancer.", {"entities": [[54, 65, "DISEASE"], [166, 177, "DISEASE"], [192, 203, "DISEASE"], [59, 65, "DISEASE"], [171, 177, "DISEASE"], [197, 203, "DISEASE"]]}], ["Together, these data suggest that tobacco treatment is effective both as a primary and a secondary intervention in reducing total morbidity and mortality related to COPD, CVD, and lung cancer.", {"entities": [[180, 191, "DISEASE"], [185, 191, "DISEASE"]]}], ["In this paper, we summarize the evidence for tobacco treatment and the methods by which smoking cessation can be promoted in smokers with lung disease.", {"entities": [[138, 150, "DISEASE"]]}], ["There is a pressing need to develop novel antibacterial agents given the widespread antibiotic resistance among pathogenic bacteria and the low specificity of the drugs available.", {"entities": []}], ["Endolysins are antibacterial proteins that are produced by bacteriophage\u2010infected cells to digest the bacterial cell wall for phage progeny release at the end of the lytic cycle.", {"entities": []}], ["These highly efficient enzymes show a considerable degree of specificity for the target bacterium of the phage.", {"entities": []}], ["Furthermore, the emergence of resistance against endolysins appears to be rare as the enzymes have evolved to target molecules in the cell wall that are essential for bacterial viability.", {"entities": []}], ["Taken together, these factors make recombinant endolysins promising novel antibacterial agents.", {"entities": []}], ["The chloroplast of the green unicellular alga Chlamydomonas reinhardtii represents an attractive platform for production of therapeutic proteins in general, not least due to the availability of established techniques for foreign gene expression, a lack of endotoxins or potentially infectious agents in the algal host, and low cost of cultivation.", {"entities": []}], ["The chloroplast is particularly well suited to the production of endolysins as it mimics the native bacterial expression environment of these proteins while being devoid of their cell wall target.", {"entities": []}], ["In this study, the endolysins Cpl\u20101 and Pal, specific to the major human pathogen Streptococcus pneumoniae, were produced in the C.\u00a0reinhardtii chloroplast.", {"entities": []}], ["The antibacterial activity of cell lysates and the isolated endolysins was demonstrated against different serotypes of S.\u00a0pneumoniae , including clinical isolates and total recombinant protein yield was quantified at ~1.3\u00a0mg/g algal dry weight.", {"entities": []}], ["Catalase, an endogenous antioxidant enzyme, is responsible for regulating reactive species levels.", {"entities": []}], ["Several epidemiologic studies have suggested that single nucleotide polymorphism in catalase gene may be associated with many diseases.", {"entities": []}], ["The genotype of CAT (-21 A/T) point mutation in promoter region of catalase gene was determined by polymerase chain based restriction fragment length polymorphism analysis in the DNA of 100 healthy volunteers.", {"entities": []}], ["The frequency of CAT (-21 A/T) gene polymorphism AA, AT, and TT genotypes was found to be 7, 23, and 70 percent, respectively.", {"entities": []}], ["The mutant \u201cT\u201d allele frequency was found to be 0.82 among the south Indian (Tamil) population.", {"entities": []}], ["Chi square analysis showed that the study population lies within the Hardy-Weinberg equilibrium.", {"entities": []}], ["The wild type genotype (AA) was found to be very low (7%) and the mutant genotype (AT/TT) was found to be more prevalent (93%) among the south Indian population.", {"entities": []}], ["This suggests that the high prevalence of mutant genotype may increase the susceptibility to oxidative stress associated diseases.", {"entities": []}], ["Type 2 diabetes mellitus is most prevalent in deprived communities and patients with low health literacy have worse glycaemic control and higher rates of diabetic complications.", {"entities": [[7, 24, "DISEASE"]]}], ["However, recruitment from this patient population into intervention trials is highly challenging.", {"entities": []}], ["We conducted a study to explore the feasibility of recruitment and to assess the effect of a lay health trainer intervention, in patients with low health literacy and poorly controlled diabetes from a socioeconomically disadvantaged population, compared with usual care.", {"entities": []}], ["A pilot RCT comparing the LHT intervention with usual care.", {"entities": []}], ["Patients with HbA1c > 7.5 (58\u2009mmol/mol) were recruited.", {"entities": []}], ["Baseline and 7-month outcome data were entered directly onto a laptop to reduce patient burden.", {"entities": []}], ["76 patients were recruited; 60.5% had low health literacy and 75% were from the most deprived areas of England.", {"entities": []}], ["Participants in the LHT arm had significantly improved mental health ( p = 0.049) and illness perception ( p = 0.040).", {"entities": []}], ["The intervention was associated with lower resource use, better patient self-care management, and better QALY profile at 7-month follow-up.", {"entities": []}], ["Conclusion .", {"entities": []}], ["This study describes successful recruitment strategies for hard-to-reach populations.", {"entities": []}], ["Further research is warranted for this cost-effective, relatively low-cost intervention for a population currently suffering a disproportionate burden of diabetes, to demonstrate its sustained impact on treatment effects, health, and health inequalities.", {"entities": []}], ["Exposure to polyunsaturated fatty acids (PUFA) influences immune function and may affect the risk of allergy development.", {"entities": []}], ["Long chain PUFAs are produced from dietary precursors catalyzed by desaturases and elongases encoded by FADS and ELOVL genes.", {"entities": []}], ["In 211 subjects, we investigated whether polymorphisms in the FADS gene cluster and the ELOVL2 gene were associated with allergy or PUFA composition in serum phospholipids in a Swedish birth-cohort sampled at birth and at 13 years of age; allergy was diagnosed at 13 years of age.", {"entities": [[88, 94, "GENE"]]}], ["Minor allele carriers of rs102275 and rs174448 ( FADS gene cluster) had decreased proportions of 20:4 n -6 in cord and adolescent serum and increased proportions of 20:3 n -6 in cord serum as well as a nominally reduced risk of developing atopic eczema, but not respiratory allergy, at 13 years of age.", {"entities": []}], ["Minor allele carriers of rs17606561 in the ELOVL2 gene had nominally decreased proportions of 20:4 n -6 in cord serum but ELOVL polymorphisms (rs2236212 and rs17606561) were not associated with allergy development.", {"entities": [[43, 49, "GENE"]]}], ["Thus, reduced capacity to desaturase n -6 PUFAs due to FADS polymorphisms was nominally associated with reduced risk for eczema development, which could indicate a pathogenic role for long-chain PUFAs in allergy development.", {"entities": []}], ["Poorly controlled asthma can lead to maternal and fetal complications.", {"entities": [[18, 24, "DISEASE"]]}], ["Despite the known risks of poorly controlled asthma during pregnancy and the need for stepping up therapy when appropriate, there are concerns that management is suboptimal in primary care.", {"entities": [[45, 51, "DISEASE"]]}], ["Our objective was to investigate the management of asthma during pregnancy by general practitioners providing shared maternity care.", {"entities": [[51, 57, "DISEASE"]]}], ["A pre-piloted, anonymous mail survey was sent to all general practitioners (n = 842) involved in shared maternity care at six maternity hospitals in Victoria, Australia.", {"entities": []}], ["Respondents were asked about their perceived safety of individual asthma medications during pregnancy.", {"entities": [[66, 72, "DISEASE"]]}], ["Approach to asthma management during pregnancy was further explored using scenarios of pregnant women with stable and deteriorating asthma and poor medication adherence.", {"entities": [[12, 18, "DISEASE"], [132, 138, "DISEASE"]]}], ["Inhaled corticosteroids (ICS) were perceived to be the safest and were the preferred preventive medication in first trimester (74.1%), whilst leukotriene receptor antagonists were the least preferred (2.9%).", {"entities": []}], ["A quarter (25.8%) of respondents would stop or decrease patients' ICS doses during pregnancy, even when their asthma was well controlled by current therapy.", {"entities": [[110, 116, "DISEASE"]]}], ["In addition, 12.1% of respondents were not sure how to manage deteriorating asthma during pregnancy and opted to refer to another health professional.", {"entities": [[76, 82, "DISEASE"]]}], ["Almost half the respondents (48.9%) reported encountering medication nonadherence during pregnancy.", {"entities": []}], ["A lack of confidence and/or knowledge among general practitioners in managing deteriorating asthma in pregnancy was observed despite a good understanding of the safety of asthma medications during pregnancy, compliance with evidence-based guidelines in the selection of preventive medications, and self reported good asthma knowledge.", {"entities": [[92, 98, "DISEASE"], [171, 177, "DISEASE"], [317, 323, "DISEASE"]]}], ["Preterm birth is a risk factor for decreased exercise capacity and impaired cognitive functions in later life.", {"entities": []}], ["The objective of this study was to disentangle the associations between preterm birth, physical fitness and cognitive performance in young adulthood.", {"entities": []}], ["This population-based cohort study included 218,802 young men born in Sweden 1973\u20131983.", {"entities": []}], ["Data on birth characteristics was obtained from the Medical Birth Register and linked to exercise capacity assessed by ergometer cycling and cognitive tests performed at conscription for military service in 1993\u20132001.", {"entities": []}], ["Cognitive performance was assessed using stanine (STAndard NINE) scores.", {"entities": []}], ["The results were adjusted for socioeconomic factors.", {"entities": []}], ["Exercise capacity was positively associated with cognitive performance across all gestational ages.", {"entities": []}], ["The sub-group of men who were born extremely preterm (gestational age <28 weeks) and had low exercise capacity exhibited the lowest odds ratio (OR = 0.26, 95%CI:0.09\u20130.82) of having a cognitive function above the mean stanine score (2.9) for men born at term with normal birth weight.", {"entities": []}], ["Men born extremely preterm with a high exercise capacity had similar or even higher ORs for cognitive function (OR = 0.59; 95% CI:0.35\u20130.99) than men born at term with low W max (OR = 0.57; 95% CI:0.55\u20130.59).", {"entities": [[174, 177, "GENE"]]}], ["Physical fitness is associated with higher cognitive function at all gestational ages, also in young men born extremely preterm.", {"entities": []}], ["Targeting early physical exercise may be a possible intervention to enhance cognitive performance and educational achievements in populations at risk, such as childhood and adult survivors of preterm birth.", {"entities": []}], ["Various applications, such as pollution monitoring, toxic-gas detection, non invasive medical diagnostics and industrial process control, require sensitive and selective detection of gas traces with concentrations in the parts in 10", {"entities": []}], ["Acute exacerbations of pulmonary fibrosis are characterized by rapid decrements in lung function.", {"entities": [[23, 41, "DISEASE"]]}], ["Environmental factors that may contribute to acute exacerbations remain poorly understood.", {"entities": []}], ["We have previously demonstrated that exposure to inhaled lipopolysaccharide (LPS) induces expression of genes associated with fibrosis.", {"entities": []}], ["To address whether exposure to LPS could exacerbate fibrosis, we exposed male C57BL/6 mice to crystalline silica, or vehicle, followed 28 days later by LPS or saline inhalation.", {"entities": []}], ["We observed that mice receiving both silica and LPS had significantly more total inflammatory cells, more whole lung lavage MCP-1, MIP-2, KC and IL-1\u03b2, more evidence of oxidative stress and more total lung hydroxyproline than mice receiving either LPS alone, or silica alone.", {"entities": []}], ["Blocking oxidative stress with N-acetylcysteine attenuated whole lung inflammation but had no effect on total lung hydroxyproline.", {"entities": []}], ["These observations suggest that exposure to innate immune stimuli, such as LPS in the environment, may exacerbate stable pulmonary fibrosis via mechanisms that are independent of inflammation and oxidative stress.", {"entities": [[121, 139, "DISEASE"]]}], ["Celiac disease is characterized by a chronic inflammatory reaction in the intestine and is triggered by gluten, a constituent derived from grains which is present in the common daily diet in the Western world.", {"entities": [[0, 14, "DISEASE"]]}], ["Despite decades of research, the mechanisms behind celiac disease etiology are still not fully understood, although it is clear that both genetic and environmental factors are involved.", {"entities": [[51, 65, "DISEASE"]]}], ["To improve the understanding of the disease, the genetic component has been extensively studied by genome-wide association studies.", {"entities": []}], ["These have uncovered a wealth of information that still needs further investigation to clarify its importance.", {"entities": []}], ["In this review, we summarize and discuss the results of the genetic studies in celiac disease, focusing on the \u201cnon-HLA\u201d genes.", {"entities": [[79, 93, "DISEASE"]]}], ["We also present novel approaches to identifying the causal variants in complex susceptibility loci and disease mechanisms.", {"entities": []}], ["To examine the hypothesis that respondents with any of three specific sleep patterns would have a higher likelihood of suicidality than those without reports of these patterns in Korean adolescents.", {"entities": []}], ["Data from the 2011\u20132013 Korea Youth Risk Behavior Web-based Survey were used.", {"entities": []}], ["191\u2005642 subjects were included.", {"entities": []}], ["The survey's target population was students in grades 7 through 12 in South Korea.", {"entities": []}], ["Sleep time.", {"entities": []}], ["Suicidal thoughts, plans and attempts.", {"entities": []}], ["The odds of suicidal thoughts in subjects with very short or long time in bed were 1.487-fold higher (95% CI 1.219 to 1.815) or 0.611-fold lower (95% CI 0.460 to 0.811), respectively, than for subjects with 7\u2005h/day in bed; the odds were similar for suicidal plans.", {"entities": []}], ["The odds of suicidal thoughts in subjects with early or late awakening times were 1.231-fold higher (95% CI 1.050 to 1.442) or 1.528-fold lower (95% CI 1.000 to 2.334), respectively, than for subjects with 7\u2005h/day in bed; these odds were lower for suicidal plans and attempts.", {"entities": []}], ["The odds of suicidal thoughts in subjects with early bedtime were 1.748-fold higher (95% CI 1.302 to 2.346), the odds of suicidal plans in people with an early bedtime were 2.494-fold higher (95% CI 1.671 to 3.722) and the odds of suicide attempts in subjects with late bedtime were 1.313-fold higher (95% CI 1.005 to 1.716) than for subjects with a bedtime of 23:00.", {"entities": []}], ["The sleep-related time is associated with suicide-related behaviours in Korean adolescents.", {"entities": []}], ["Multilateral approaches are needed to identify the greatest risk factors for suicidal behaviours.", {"entities": []}], ["Allergic rhinitis (AR) is the most common allergic disease but little is known about the difference of local immune responses in children and adults with AR.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["To compare local immune responses between children and adults with AR and nonallergic rhinitis (NAR), and to investigate whether the association of local and systemic immune responses is different between the two age groups.", {"entities": [[86, 94, "DISEASE"]]}], ["Fifty-one patients with chronic rhinitis were enrolled and grouped into children (N = 27, mean age 7.2 years) and adults (N = 24, mean age 29.9 years).", {"entities": [[32, 40, "DISEASE"], [24, 40, "DISEASE"]]}], ["Diagnosis of AR was based on symptoms, skin prick tests and serum specific IgEs.", {"entities": []}], ["Nasal lavage (NAL) fluids were collected from all subjects and used to measure the levels of total IgE, specific IgEs to house dust mites (Dp and Df), and cytokines (TNF-\u03b1, IL-4, IL-10, IL-17A and IFN-\u03b3).", {"entities": []}], ["Flow cytometry was used to measure inflammatory cell types in NAL fluids.", {"entities": []}], ["AR had significantly increased local levels of total IgE and specific IgEs to Dp and Df compared with NAR in both age groups ( P < 0.05).", {"entities": []}], ["Nasal eosinophils % ( P = 0.01) was significantly increased only in children with AR.", {"entities": []}], ["Local-systemic correlations of total IgE ( r = 0.662, P = 0.000) and eosinophil % ( r = 0.461, P = 0.015) between the peripheral blood and NAL fluids were found only in children.", {"entities": []}], ["Moreover, children had correlations between total IgE and eosinophil % in the peripheral blood ( r = 0.629, P = 0.001) and in NAL fluids ( r = 0.373, P = 0.061).", {"entities": []}], ["Elevated local IgE is a common feature of AR in children and adults.", {"entities": []}], ["Local measures in NAR showed na\u00efve state of immune response which disagree with the hypothesis of local allergic rhinitis.", {"entities": [[104, 121, "DISEASE"], [113, 121, "DISEASE"]]}], ["Children showed intense local inflammation and close local-systemic interactions compared to adults supporting pediatric AR as a distinct feature.", {"entities": []}], ["Angiogenesis is an essential process during tissue regeneration; however, the amount of angiogenesis directly correlates with the level of wound scarring.", {"entities": []}], ["Angiogenesis is lower in scar-free foetal wounds while angiogenesis is raised and abnormal in pathophysiological scarring such as hypertrophic scars and keloids.", {"entities": []}], ["Delineating the mechanisms that modulate angiogenesis and could reduce scarring would be clinically useful.", {"entities": []}], ["Beta-adrenoceptors (\u03b2-AR) are G protein-coupled receptors (GPCRs) expressed on all skin cell-types.", {"entities": []}], ["They play a role in wound repair but their specific role in angiogenesis is unknown.", {"entities": []}], ["In this study, a range of in vitro assays (single cell migration, scratch wound healing, ELISAs for angiogenic growth factors and tubule formation) were performed with human dermal microvascular endothelial cells (HDMEC) to investigate and dissect mechanisms underpinning \u03b2-AR-mediated modulation of angiogenesis in chick chorioallantoic membranes (CAM) and murine excisional skin wounds.", {"entities": []}], ["\u03b2-AR activation reduced HDMEC migration via cyclic adenosine monophosphate (cAMP)-dependent and protein kinase A (PKA)-independent mechanisms as demonstrated through use of an EPAC agonist that auto-inhibited the cAMP-mediated \u03b2-AR transduced reduction in HDMEC motility; a PKA inhibitor was, conversely, ineffective.", {"entities": []}], ["ELISA studies demonstrated that \u03b2-AR activation reduced pro-angiogenic growth factor secretion from HDMECs (fibroblast growth factor 2) and keratinocytes (vascular endothelial growth factor A) revealing possible \u03b2-AR-mediated autocrine and paracrine anti-angiogenic mechanisms.", {"entities": []}], ["In more complex environments, \u03b2-AR activation delayed HDMEC tubule formation and decreased angiogenesis both in the CAM assay and in murine excisional skin wounds in vivo.", {"entities": []}], ["\u03b2-AR activation reduced HDMEC function in vitro and angiogenesis in vivo; therefore, \u03b2-AR agonists could be promising anti-angiogenic modulators in skin.", {"entities": []}], ["230: 356\u2013365, 2015.", {"entities": []}], ["\u00a9 2014 The Authors.", {"entities": []}], ["Journal of Cellular Physiology Published by Wiley Periodicals, Inc.", {"entities": []}], ["Pathophysiology of type 1 autoimmune pancreatitis (AIP) is still unclear.", {"entities": [[37, 49, "DISEASE"], [51, 54, "GENE"]]}], ["We previously reported that M2 macrophages might play an important role in type 1 AIP.", {"entities": [[82, 85, "GENE"]]}], ["Recently, it has been reported that basophils regulate differentiation to M2 macrophages.", {"entities": []}], ["In this study, we investigated basophils from the pancreatic tissue and peripheral blood of individuals with type 1 AIP.", {"entities": [[116, 119, "GENE"]]}], ["By using immunohistochemistry, we investigated basophils in pancreatic tissue from 13 patients with type 1 AIP and examined expression of toll-like receptors (TLRs) by these cells.", {"entities": [[107, 110, "GENE"]]}], ["Additionally, we obtained peripheral blood samples from 27 healthy subjects, 40 patients with type 1 AIP, 8 patients with alcoholic chronic pancreatitis, 10 patients with bronchial asthma, and 10 patients with atopic dermatitis, and analyzed activation of basophils by stimulating them with ligands of TLR1\u20139.", {"entities": [[210, 227, "DISEASE"], [140, 152, "DISEASE"], [181, 187, "DISEASE"], [217, 227, "DISEASE"], [101, 104, "GENE"]]}], ["We also compared TLR expression in basophils from the tissue and blood samples.", {"entities": []}], ["Basophils were detected in pancreatic tissues from 10 of 13 patients with type 1 AIP.", {"entities": [[81, 84, "GENE"]]}], ["Flow cytometric analysis revealed that the ratios of basophils activated by TLR4 stimulation in type 1 AIP (9.875\u00a0\u00b1\u00a01.148%) and atopic dermatitis (11.768\u00a0\u00b1\u00a01.899%) were significantly higher than those in healthy subjects (5.051\u00a0\u00b1\u00a00.730%; P \u00a0<\u00a00.05).", {"entities": [[128, 145, "DISEASE"], [135, 145, "DISEASE"], [76, 80, "GENE"], [103, 106, "GENE"]]}], ["Levels of basophils activated by TLR2 stimulation were higher in seven type 1 AIP cases.", {"entities": [[33, 37, "GENE"], [78, 81, "GENE"]]}], ["Furthermore, stimulation of TLR2 and/or TLR4, which were expressed by basophils in pancreas, activated basophils in peripheral blood.", {"entities": [[28, 32, "GENE"], [40, 44, "GENE"]]}], ["Basophils activated via TLR signaling may play an important role in the pathophysiology of type 1 AIP.", {"entities": [[98, 101, "GENE"]]}], ["Asthma's sustenance as a global pandemic, across centuries, can be attributed to the lack of an understanding of its workings and the inability of the existing treatment modalities to provide a long lasting cure without major adverse effects.", {"entities": [[0, 6, "DISEASE"]]}], ["The discovery of statins boosted by a better comprehension of the pathophysiology of asthma in the past few decades has opened up a potentially alternative line of treatment that promises to be a big boon for the asthmatics globally.", {"entities": [[85, 91, "DISEASE"]]}], ["However, the initial excellent results from the preclinical and animal studies have not borne the results in clinical trials that the scientific world was hoping for.", {"entities": []}], ["In light of this, this review analyzes the ways by which statins could benefit in asthma via their pleiotropic anti-inflammatory properties and explain some of the queries raised in the previous studies and provide recommendations for future studies in this field.", {"entities": [[82, 88, "DISEASE"]]}], ["To study the incidence of de novo multimorbidity across all ages in a geographically defined population with an emphasis on sex and ethnic differences.", {"entities": []}], ["Historical cohort study.", {"entities": []}], ["All persons residing in Olmsted County, Minnesota, USA on 1 January 2000 who had granted permission for their records to be used for research (n=123\u2005716).", {"entities": []}], ["We used the Rochester Epidemiology Project medical records-linkage system to identify all of the county residents.", {"entities": []}], ["We identified and removed from the cohort all persons who had developed multimorbidity before 1 January 2000 (baseline date), and we followed the cohort over 14\u2005years (1 January 2000 through 31 December 2013).", {"entities": []}], ["Incident multimorbidity was defined as the development of the second of 2 conditions (dyads) from among the 20 chronic conditions selected by the US Department of Health and Human Services.", {"entities": []}], ["We also studied the incidence of the third of 3 conditions (triads) from among the 20 chronic conditions.", {"entities": []}], ["The incidence of multimorbidity increased steeply with older age; however, the number of people with incident multimorbidity was substantially greater in people younger than 65\u2005years compared to people age 65\u2005years or older (28\u2005378 vs 6214).", {"entities": []}], ["The overall risk was similar in men and women; however, the combinations of conditions (dyads and triads) differed extensively by age and by sex.", {"entities": []}], ["Compared to Whites, the incidence of multimorbidity was higher in Blacks and lower in Asians.", {"entities": []}], ["The risk of developing de novo multimorbidity increases steeply with older age, varies by ethnicity and is similar in men and women overall.", {"entities": []}], ["However, as expected, the combinations of conditions vary extensively by age and sex.", {"entities": []}], ["These data represent an important first step toward identifying the causes and the consequences of multimorbidity.", {"entities": []}], ["The evidence base of clinical interventions in paediatric hospitals of developing countries has not been formally assessed.", {"entities": []}], ["We performed this study to determine the proportion of evidence-based therapeutic interventions in a paediatric referral hospital of a developing country The medical records of 167 patients admitted in one-month period were revised.", {"entities": []}], ["Primary diagnosis and primary therapeutic interventions were determined for each patient.", {"entities": []}], ["A systematic search was performed to assess the level of evidence for each intervention.", {"entities": []}], ["Therapeutic interventions were classified using the Ellis score and the Oxford Centre for Evidence Based Medicine Levels of Evidence Any dehydration due to diarrhoea (59 cases) and pneumonia (42 cases) were the most frequent diagnoses.", {"entities": [[181, 190, "DISEASE"]]}], ["Based on Ellis score, level I evidence supported the primary therapeutic intervention in 21%, level II in 73% and level III in 6% cases.", {"entities": []}], ["Using the Oxford classification 16%, 8%, 1% and 75% therapeutic interventions corresponded to grades A, B, C, and D recommendations, respectively.", {"entities": []}], ["Overall, according to Ellis score, 94% interventions were evidence based.", {"entities": []}], ["However, out of the total, 75% interventions were based on expert opinion or basic sciences.", {"entities": []}], ["Most children with mild to moderate dehydration (52 cases) were inappropriately treated with slow intravenous fluids, and most children with non-complicated community acquired pneumonia (42 cases) received intravenous antibiotics Most interventions were inappropriate, despite the availability of effective therapy for several of them.", {"entities": [[176, 185, "DISEASE"]]}], ["Diarrhoeal dehydration and community acquired pneumonia were the most common diagnoses and were inappropriately managed.", {"entities": [[46, 55, "DISEASE"]]}], ["Existing effective interventions for dehydration and pneumonia need to be put into practice at referral hospitals of developing countries.", {"entities": [[53, 62, "DISEASE"]]}], ["For the remaining problems, there is the need to conduct appropriate clinical studies.", {"entities": []}], ["Caution must be taken when assigning the level of evidence supporting therapeutic interventions, as commonly used classifications may be misleading", {"entities": []}], ["Air pollution is exacerbated near heavy traffic roads in cities.", {"entities": []}], ["Air pollution concentration and composition vary by region and depend on urban-rural gradients.", {"entities": []}], ["The aim of this study was to evaluate the distribution of air pollution in areas of varying population densities and to compare plant biomonitoring with an established biomarker of human exposure to traffic-related air pollution in children.", {"entities": []}], ["The areas of study were selected near a major street in 3 different regions.", {"entities": []}], ["Areas A, B and C represent high, intermediate and low population densities, respectively.", {"entities": []}], ["Micronucleus assay, an established biomarker of human exposure, was performed in children from these areas.", {"entities": []}], ["For a plant biomonitoring assay, the pollen abortion assay was performed on Bauhinia variegata in these areas.", {"entities": []}], ["NO 2 and O 3 concentrations were determined by passive sampling.", {"entities": []}], ["We report here that the pollen abortion frequency in Bauhinia variegata is correlated with NO 2 concentration ( P = 0.004) and is strongly associated with vehicular flow and population density in the studied areas.", {"entities": []}], ["Micronuclei frequency in buccal cells of children was higher in the regions with more degree of urbanization ( P < 0.001) following the same pattern of O 3 concentrations ( P = 0.030).", {"entities": []}], ["In conclusion, our results demonstrate that high concentrations of air pollutants in Porto Alegre are related to both human and plant genotoxicity.", {"entities": []}], ["Areas with different concentration of pollutants demonstrated to have an urbanization gradient dependent pattern which also reflected on genotoxic damage among these areas.", {"entities": []}], ["According to the Centers for Disease Control and Prevention, approximately 5-20\u00a0% of people are affected by influenza annually, and influenza causes more than 200,000 hospitalizations each year.", {"entities": [[108, 117, "DISEASE"], [132, 141, "DISEASE"]]}], ["The purpose of this study is to estimate the prevalence of influenza vaccination among high risk adults in Kansas.", {"entities": [[59, 68, "DISEASE"]]}], ["The 2013 Kansas BRFSS data (n\u2009=\u200920,712) were analyzed to assess the prevalence of receiving influenza vaccination among Kansas adults, overall and for selected demographic characteristics within the past 12\u00a0months.", {"entities": [[92, 101, "DISEASE"]]}], ["Crude and adjusted prevalence rate ratios were computed using univariate logistic regression models with influenza vaccination as the dependent variable and health conditions or high risk groups as the main independent variables; these models were then adjusted for potential confounding.", {"entities": [[105, 114, "DISEASE"]]}], ["Overall, influenza vaccination rate was lower than the Healthy People 2020 target (42.2\u00a0% vs. 80\u00a0%).", {"entities": [[9, 18, "DISEASE"]]}], ["The prevalence of receiving influenza vaccination was higher among adults 65\u00a0years and older compared to adults 64\u00a0years and younger after adjusting for gender, annual household income, education, marital status, insurance status, and race/ethnicity.", {"entities": [[28, 37, "DISEASE"]]}], ["Similarly, the prevalence of receiving influenza vaccination was higher among adults who have current asthma, or have ever been diagnosed with diabetes, high blood pressure, cancer (excluding skin), and COPD compared to those who did not have these health conditions, as well as pregnant women compared to women who were not pregnant.", {"entities": [[39, 48, "DISEASE"], [102, 108, "DISEASE"], [174, 180, "DISEASE"]]}], ["Although high risk groups have higher rates of influenza vaccination compared to low risk groups, more concerted efforts are needed to improve seasonal influenza vaccination in Kansas.", {"entities": [[47, 56, "DISEASE"], [152, 161, "DISEASE"]]}], ["The long-lasting interest in bioactive molecules (namely toxins) produced by (microalga) dinoflagellates has risen in recent years.", {"entities": []}], ["Exhibiting wide diversity and complexity, said compounds are well-recognized for their biological features, with great potential for use as pharmaceutical therapies and biological research probes.", {"entities": []}], ["Unfortunately, provision of those compounds is still far from sufficient, especially in view of an increasing demand for preclinical testing.", {"entities": []}], ["Despite the difficulties to establish dinoflagellate cultures and obtain reasonable productivities of such compounds, intensive research has permitted a number of advances in the field.", {"entities": []}], ["This paper accordingly reviews the characteristics of some of the most important biotoxins (and other bioactive substances) produced by dinoflagellates.", {"entities": []}], ["It also presents and discusses (to some length) the main advances pertaining to dinoflagellate production, from bench to large scale\u2014with an emphasis on material published since the latest review available on the subject.", {"entities": []}], ["Such advances encompass improvements in nutrient formulation and light supply as major operational conditions; they have permitted adaptation of classical designs, and aided the development of novel configurations for dinoflagellate growth\u2014even though shearing-related issues remain a major challenge.", {"entities": []}], ["Discoveries from the human genome, HapMap, and 1000 genome projects have collectively contributed toward the creation of a catalog of human genetic variations that has improved our understanding of human diversity.", {"entities": []}], ["Despite the collegial nature of many of these genome study consortiums, which has led to the cataloging of genetic variations of different ethnic groups from around the world, genome data on the Arab population remains overwhelmingly underrepresented.", {"entities": []}], ["The National Arab Genome project in the United Arab Emirates (UAE) aims to address this deficiency by using Next Generation Sequencing (NGS) technology to provide data to improve our understanding of the Arab genome and catalog variants that are unique to the Arab population of the UAE.", {"entities": []}], ["The project was conceived to shed light on the similarities and differences between the Arab genome and those of the other ethnic groups.", {"entities": []}], ["Available evidence concerning the association between indoor air pollution (IAP) from biomass and solid fuel combustion and preeclampsia/eclampsia is not available in developing countries.", {"entities": [[137, 146, "DISEASE"]]}], ["We investigated the association between exposure to IAP from biomass and solid fuel combustion and symptoms of preeclampsia/eclampsia in Indian women by analyzing cross-sectional data from India's third National Family Health Survey (NFHS-3, 2005\u20132006).", {"entities": [[124, 133, "DISEASE"]]}], ["Self-reported symptoms of preeclampsia/eclampsia during pregnancy such as convulsions (not from fever), swelling of legs, body or face, excessive fatigue or vision difficulty during daylight, were obtained from 39\u00a0657 women aged 15\u201349\u00a0years who had a live birth in the previous 5\u00a0years.", {"entities": [[39, 48, "DISEASE"]]}], ["Effects of exposure to cooking smoke, ascertained by type of fuel used for cooking on preeclampsia/eclampsia risk, were estimated using logistic regression after adjusting for various confounders.", {"entities": [[99, 108, "DISEASE"]]}], ["Results indicate that women living in households using biomass and solid fuels have two times higher likelihood of reporting preeclampsia/eclampsia symptoms than do those living in households using cleaner fuels (OR\u00a0=\u00a02.21; 95%: 1.26\u20133.87; P \u00a0=\u00a00.006), even after controlling for the effects of a number of potentially confounding factors.", {"entities": [[138, 147, "DISEASE"]]}], ["This study is the first to empirically estimate the associations of IAP from biomass and solid fuel combustion and reported symptoms suggestive of preeclampsia/eclampsia in a large nationally representative sample of Indian women and we observed increased risk.", {"entities": [[160, 169, "DISEASE"]]}], ["These findings have important program and policy implications for countries such as India, where large proportions of the population rely on polluting biomass fuels for cooking and space heating.", {"entities": []}], ["More epidemiological research with detailed exposure assessments and clinical measures of preeclampsia/eclampsia is needed in a developing country setting to validate these findings.", {"entities": [[103, 112, "DISEASE"]]}], ["Microscopic colitis (MC) induces gastrointestinal symptoms, which are partly overlapping with irritable bowel syndrome (IBS), predominately in middle-aged and elderly women.", {"entities": [[94, 118, "DISEASE"], [110, 118, "DISEASE"]]}], ["The etiology is unknown, but association with smoking has been found.", {"entities": []}], ["The aim of this study was to examine whether the increased risk for smokers to develop MC is a true association, or rather the result of confounding factors.", {"entities": []}], ["Therefore, patients suffering from MC and population-based controls from the same geographic area were studied regarding smoking- and alcohol habits, and other simultaneous, lifestyle factors, concerning the clinical expression of the disease.", {"entities": []}], ["Women at the age of 73 years or younger, who had been treated for biopsy-verified MC at any of the Departments of Gastroenterology in Sk\u00e5ne, between 2002 and 2010, were invited to the study (240 patients).", {"entities": []}], ["Women (737) from the population-based prospective cohort study, Malm\u00f6 Diet and Cancer Study (MDCS), served as controls.", {"entities": []}], ["A self-administered questionnaire about lifestyle factors, gastrointestinal symptoms, medical conditions and medication at the time for the study was sent by post.", {"entities": []}], ["Altogether, 131 women with MC could be included after age-matching with controls (median age 56 years) and exclusion of secondary MC.", {"entities": []}], ["Patients were divided into persistent MC (MC1) and transient MC (MC2).", {"entities": []}], ["Past smoking was associated with increased risk to develop MC2 (OR\u2009=\u20092.67, 95 CI\u2009=\u20091.15\u20136.23), whereas current smoking was associated with increased risk to develop MC1 (OR\u2009=\u20093.18, 95 CI\u2009=\u20091.57\u20136.42).", {"entities": []}], ["Concomitant symptoms of IBS were associated with smoking (OR\u2009=\u20094.24, 95 CI\u2009=\u20091.92\u20139.32).", {"entities": []}], ["Alcohol drinking had no association with MC or IBS.", {"entities": []}], ["The results suggest that past smoking is associated with transient MC, whereas current smoking is associated with persistent MC.", {"entities": []}], ["Smoking is associated with MC patients with concomitant IBS-like symptoms.", {"entities": []}], ["In recent times, increased attention has been given to evaluating the efficacy of phage therapy, especially in scenarios where the bacterial infectious agent of interest is highly antibiotic resistant.", {"entities": []}], ["In this regard, phage therapy is especially applicable to infections caused by the Burkholderia cepacia complex (BCC) since members of the BCC are antibiotic pan-resistant.", {"entities": []}], ["Current studies in BCC phage therapy are unique from many other avenues of phage therapy research in that the investigation is not only comprised of phage isolation, in vitro phage characterization and assessment of in vivo infection model efficacy, but also adapting aerosol drug delivery techniques to aerosol phage formulation delivery and storage.", {"entities": []}], ["Two simples scoring systems for a self-completed postal respiratory questionnaire were developed to identify adults who may have obstructive airways disease.", {"entities": []}], ["The objective of this study was to validate these scoring systems.", {"entities": []}], ["A two-stage design was used.", {"entities": []}], ["All adults in two practice populations were sent the questionnaire and a stratified random sample of respondents was selected to undergo full clinical evaluation.", {"entities": []}], ["Three respiratory physicians reviewed the results of each evaluation.", {"entities": []}], ["A majority decision was reached as to whether the subject merited a trial of obstructive airways disease medication.", {"entities": []}], ["This clinical decision was compared with two scoring systems based on the questionnaire in order to determine their positive predictive value, sensitivity and specificity.", {"entities": []}], ["The PPV (positive predictive value) of the first scoring system was 75.1% (95% CI 68.6\u201382.3), whilst that of the second system was 82.3% (95% CI 75.9\u201389.2).", {"entities": []}], ["The more stringent second system had the greater specificity, 97.1% (95% CI 96.0\u201398.2) versus 95.3% (95% CI 94.0\u201396.7), but poorer sensitivity 46.9% (95% CI 33.0\u201366.8) versus 50.3% (95% CI 35.3\u201371.6).", {"entities": []}], ["This scoring system based on the number of symptoms/risk factors reported via a postal questionnaire could be used to identify adults who would benefit from a trial of treatment for obstructive airways disease.", {"entities": []}], ["Stress is a powerful modulator of neuroendocrine, behavioral, and immunological functions.", {"entities": []}], ["So far, the molecular mechanisms of response to stressors still remain elusive.", {"entities": []}], ["In the current study, after 10 days of repeated chronic stress (hot-dry environment and electric foot-shock), a murine model of combined-stress (CS) was created in the SPF Wistar rats.", {"entities": [[145, 147, "GENE"]]}], ["Meanwhile, we established an ulcerative-colitis (UC) rat model induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol enema according to previous studies.", {"entities": []}], ["The blood, hypothalamus, and colon tissues of these rats from CS, normal control (NC), UC and sham (SH) groups, were collected for further investigations.", {"entities": [[62, 64, "GENE"]]}], ["Comparing to the NC group, the serum levels of T3, T4, fT3 and fT4 were obviously decreased in the CS group after chronic stress, indicating that thyroid dysfunction was induced by long-term combined stress.", {"entities": [[99, 101, "GENE"]]}], ["Moreover, the application of RNA-seq and subsequent analyses revealed that neurological disorder and immunosuppression were also caused in the hypothalamus and colon tissues, respectively.", {"entities": []}], ["Comparing with SH group, besides the induced colon inflammation, thyroid dysfuntion and neurological disorder were also produced in the UC group, suggesting that hypothalamic-pituitary-thyroid (HPT) axis and gastrointestinal system might not function in isolation, but rather, have intricate crosstalks.", {"entities": []}], ["In recent decades, considerable progress in diagnosis and treatment of patients with intoxication-type inborn errors of metabolism (IT-IEM) such as urea cycle disorders (UCD), organic acidurias (OA), maple syrup urine disease (MSUD), or tyrosinemia type 1 (TYR 1) has resulted in a growing group of long-term survivors.", {"entities": [[237, 248, "DISEASE"], [200, 225, "DISEASE"], [257, 260, "GENE"]]}], ["However, IT-IEM still require intense patient and caregiver effort in terms of strict dietetic and pharmacological treatment, and the threat of metabolic crises is always present.", {"entities": []}], ["Furthermore, crises can affect the central nervous system (CNS), leading to cognitive, behavioural and psychiatric sequelae.", {"entities": []}], ["Consequently, the well-being of the patients warrants consideration from both a medical and a psychosocial viewpoint by assessing health-related quality of life (HrQoL), psychological adjustment, and adaptive functioning.", {"entities": []}], ["To date, an overview of findings on these topics for IT-IEM is lacking.", {"entities": []}], ["We therefore aimed to systematically review the research on HrQoL, psychological adjustment, and adaptive functioning in patients with IT-IEM.", {"entities": []}], ["Relevant databases were searched with predefined keywords.", {"entities": []}], ["Study selection was conducted in two steps based on predefined criteria.", {"entities": []}], ["Two independent reviewers completed the selection and data extraction.", {"entities": []}], ["Eleven articles met the inclusion criteria.", {"entities": []}], ["Studies were of varying methodological quality and used different assessment measures.", {"entities": []}], ["Findings on HrQoL were inconsistent, with some showing lower and others showing higher or equal HrQoL for IT-IEM patients compared to norms.", {"entities": []}], ["Findings on psychological adjustment and adaptive functioning were more consistent, showing mostly either no difference or worse adjustment of IT-IEM patients compared to norms.", {"entities": []}], ["Single medical risk factors for HrQoL, psychological adjustment, or adaptive functioning have been addressed, while psychosocial risk factors have not been addressed.", {"entities": []}], ["Data on HrQoL, psychological adjustment, and adaptive functioning for IT-IEM are sparse.", {"entities": []}], ["Studies are inconsistent in their methodological approaches, assessment instruments and norm populations.", {"entities": []}], ["A disease-specific standard assessment procedure for HrQoL is not available.", {"entities": []}], ["Psychosocial risk factors for HrQoL, psychological adjustment, or adaptive functioning have not been investigated.", {"entities": []}], ["Considering psychosocial variables and their corresponding risk factors for IT-IEM would allow evaluation of outcomes and treatments as well as the planning of effective social and psychological interventions to enhance the patients\u2019 HrQoL.", {"entities": []}], ["Individualized Medicine aims at providing optimal treatment for an individual patient at a given time based on his specific genetic and molecular characteristics.", {"entities": []}], ["This requires excellent clinical stratification of patients as well as the availability of genomic data and biomarkers as prerequisites for the development of novel diagnostic tools and therapeutic strategies.", {"entities": []}], ["The University Medicine Greifswald, Germany, has launched the \u201cGreifswald Approach to Individualized Medicine\u201d (GANI_MED) project to address major challenges of Individualized Medicine.", {"entities": []}], ["Herein, we describe the implementation of the scientific and clinical infrastructure that allows future translation of findings relevant to Individualized Medicine into clinical practice.", {"entities": []}], ["Clinical patient cohorts (N\u2009>\u20095,000) with an emphasis on metabolic and cardiovascular diseases are being established following a standardized protocol for the assessment of medical history, laboratory biomarkers, and the collection of various biosamples for bio-banking purposes.", {"entities": []}], ["A multi-omics based biomarker assessment including genome-wide genotyping, transcriptome, metabolome, and proteome analyses complements the multi-level approach of GANI_MED.", {"entities": []}], ["Comparisons with the general background population as characterized by our Study of Health in Pomerania (SHIP) are performed.", {"entities": []}], ["A central data management structure has been implemented to capture and integrate all relevant clinical data for research purposes.", {"entities": []}], ["Ethical research projects on informed consent procedures, reporting of incidental findings, and economic evaluations were launched in parallel.", {"entities": []}], ["Structured light plethysmography ( SLP ) is a noncontact, noninvasive, respiratory measurement technique, which uses a structured pattern of light and two cameras to track displacement of the thoraco\u2013abdominal wall during tidal breathing.", {"entities": []}], ["The primary objective of this study was to examine agreement between tidal breathing parameters measured simultaneously for 45\u00a0sec using pneumotachography and SLP in a group of 20 participants with a range of respiratory patterns (\u201cprimary cohort\u201d).", {"entities": []}], ["To examine repeatability of the agreement, an additional 21 healthy subjects (\u201crepeatability cohort\u201d) were measured twice during resting breathing and once during increased respiratory rate ( RR ).", {"entities": []}], ["Breath\u2010by\u2010breath and averaged RR , inspiratory time ( tI ), expiratory time ( tE ), total breath time ( tT ot), tI / tE , tI / tT ot, and IE 50 (inspiratory to expiratory flow measured at 50% of tidal volume) were calculated.", {"entities": []}], ["Bland\u2013Altman plots were used to assess the agreement.", {"entities": []}], ["In the primary cohort, breath\u2010by\u2010breath agreement for RR was \u00b11.44\u00a0breaths per minute (brpm).", {"entities": []}], ["tI , tE , and tT ot agreed to \u00b10.22, \u00b10.29, and \u00b10.32\u00a0sec, respectively, and tI / tE , tI / tT ot, and IE 50/ IE 50 SLP to \u00b10.16, \u00b10.05, and \u00b10.55, respectively.", {"entities": []}], ["When averaged, agreement for RR was \u00b10.19\u00a0brpm.", {"entities": []}], ["tI , tE , and tT ot were within \u00b10.16, \u00b10.16, and \u00b10.07\u00a0sec, respectively, and tI / tE , tI / tT ot, and IE 50 were within \u00b10.09, \u00b10.03, and \u00b10.25, respectively.", {"entities": []}], ["A comparison of resting breathing demonstrated that breath\u2010by\u2010breath and averaged agreements for all seven parameters were repeatable ( P \u00a0>\u00a00.05).", {"entities": []}], ["With increased RR , agreement improved for tI , tE , and tT ot ( P \u00a0\u2264\u00a00.01), did not differ for tI / tE , tI / tT ot, and IE 50 ( P \u00a0>\u00a00.05) and reduced for breath\u2010by\u2010breath ( P \u00a0<\u00a00.05) but not averaged RR ( P \u00a0>\u00a00.05).", {"entities": []}], ["Inflammatory bowel diseases (IBD) have become highly prevalent in developed countries.", {"entities": []}], ["Environmentally triggered exaggerated immune responses against the intestinal microbiome are thought to mediate the disorders.", {"entities": []}], ["The potential dietary origins of the disease group have been implicated.", {"entities": []}], ["However, the effects of environmental influences on prenatal developmental programming in respect to orchestrating postnatal microbiome composition and predilection towards mammalian colitis have not been examined.", {"entities": []}], ["We tested how transient prenatal exposure to methyl donor micronutrient (MD) supplemented diets may impact predilection towards IBD in a murine dextran sulfate sodium (DSS) colitis model.", {"entities": []}], ["Prenatal MD supplementation was sufficient to modulate colonic mucosal Ppara expression (3.2 fold increase; p=0.022) and worsen DSS colitis in young adulthood.", {"entities": [[71, 76, "GENE"]]}], ["The prenatal dietary exposure shifted the postnatal colonic mucosal and cecal content microbiomes.", {"entities": []}], ["Transfer of the gut microbiome from prenatally MD supplemented young adult animals into germ free mice resulted in increased colitis susceptibility in the recipients compared to controls.", {"entities": []}], ["Therefore, the prenatal dietary intervention induced the postnatal nurturing of a colitogenic microbiome.", {"entities": []}], ["Our results show that prenatal nutritional programming can modulate the mammalian host to harbor a colitogenic microbiome.", {"entities": []}], ["These findings may be relevant for the nutritional developmental origins of IBD.", {"entities": []}], ["Data on growth and sexual maturation among boys from the rural Western Cape in South Africa is limited.", {"entities": []}], ["A cross-sectional study of 269 school boys was conducted testing for serum luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone, sex hormone binding globulin (SHBG) and estradiol (E2); height, weight and body mass index (BMI); sexual maturity (using Tanner Stages) and a questionnaire (demographic and medical history).", {"entities": [[181, 185, "GENE"]]}], ["The median age at pubertal onset (Tanner Stage 2) and Tanner Stage 5 was 11.6 and 14.7 years, respectively.", {"entities": []}], ["The median testicular volume was 5.5 mL at Tanner Stage 2 increasing from 2.5 mL at Tanner Stage 1 to 14.7 mL at Tanner Stage 5.", {"entities": []}], ["Height and weight measurements were <25th & 50th percentile references at Tanner Stages 1\u20133.", {"entities": []}], ["Controlling for confounders, serum FSH and LH increased ( p < 0.05) from Tanner Stage 1 to 4 (by 4.1 and 3 mL respectively), and serum testosterone and estradiol increased after Tanner Stage 2 (by 12.7 nmol/L and 59.5 pmol/L respectively).", {"entities": []}], ["These results indicate some delays in pubertal development of boys in the rural Western Cape when compared to boys from other settings possibly due to nutritional, socio-economic and environmental exposures.", {"entities": []}], ["Changes in serum hormone levels were consistent with other populations.", {"entities": []}], ["Initiatives to improve nutrition amongst Western Cape rural communities are recommended.", {"entities": []}], ["Lung macrophages (LMs) are essential immune effector cells that are pivotal in both innate and adaptive immune responses to inhaled foreign matter.", {"entities": []}], ["They either reside within the airways and lung tissues (from early life) or are derived from blood monocytes.", {"entities": []}], ["Similar to macrophages in other organs and tissues, LMs have natural plasticity and can change phenotype and function depending largely on the microenvironment they reside in.", {"entities": []}], ["Phenotype changes in lung tissue macrophages have been implicated in chronic inflammatory responses and disease progression of various chronic lung diseases, including Chronic Obstructive Pulmonary Disease (COPD).", {"entities": []}], ["LMs have a wide variety of functional properties that include phagocytosis (inorganic particulate matter and organic particles, such as viruses/bacteria/fungi), the processing of phagocytosed material, and the production of signaling mediators.", {"entities": []}], ["Functioning as janitors of the airways, they also play a key role in removing dead and dying cells, as well as cell debris (efferocytic functions).", {"entities": []}], ["We herein review changes in LM phenotypes during chronic lung disease, focusing on COPD, as well as changes in their functional properties as a result of such shifts.", {"entities": [[57, 69, "DISEASE"]]}], ["Targeting molecular pathways involved in LM phenotypic shifts could potentially allow for future targeted therapeutic interventions in several diseases, such as COPD.", {"entities": []}], ["To determine whether inpatient sleep duration and efficiency are associated with a greater risk of hyperglycemia in hospitalized patients with and without diabetes.", {"entities": [[99, 112, "DISEASE"]]}], ["In this retrospective analysis of a prospective cohort study, medical inpatients \u226550 years of age were interviewed, and their charts were reviewed to obtain demographic data and diagnosis.", {"entities": []}], ["Using World Health Organization criteria, patients were categorized as having normal blood glucose, impaired fasting blood glucose, or hyperglycemia based on morning glucose from the electronic health record.", {"entities": [[135, 148, "DISEASE"]]}], ["Wrist actigraphy measured sleep.", {"entities": []}], ["Multivariable ordinal logistic regression models, controlling for subject random effects, tested the association between inpatient sleep duration and proportional odds of hyperglycemia versus impaired fasting blood glucose or impaired fasting blood glucose versus normal blood glucose in hospitalized adults.", {"entities": [[171, 184, "DISEASE"]]}], ["A total of 212 patients (60% female and 74% African American) were enrolled.", {"entities": []}], ["Roughly one-third (73, 34%) had diabetes.", {"entities": []}], ["Objective inpatient sleep measures did not differ between patients with or without diabetes.", {"entities": []}], ["In ordinal logistic regression models, each additional hour of in-hospital sleep was associated with an 11% (odds ratio 0.89 [95% CI 0.80, 0.99]; P = 0.043) lower proportional odds of a higher glucose category the next morning (hyperglycemia vs. elevated and elevated vs. normal).", {"entities": [[228, 241, "DISEASE"]]}], ["Every 10% increase in sleep efficiency was associated with an 18% lower proportional odds of a higher glucose category (odds ratio 0.82 [95% CI 0.74, 0.89]; P < 0.001).", {"entities": []}], ["Among medical inpatients, both shorter sleep duration and worse sleep efficiency were independently associated with greater proportional odds of hyperglycemia and impaired fasting glucose.", {"entities": [[145, 158, "DISEASE"]]}], ["Acute respiratory tract infections (ARTI) are an important public health problem.", {"entities": []}], ["Improved identification of risk factors might enable targeted intervention.", {"entities": []}], ["Therefore we carried out a case-control study with the aim of identifying environmental risk factors for ARTI consultations in the Dutch general population.", {"entities": []}], ["A subset of patients visiting their GP in the period of 2000\u20132003 with an ARTI (cases) and age-matched controls (visiting for other complaints) were included in a case-control study.", {"entities": []}], ["They were asked to complete a questionnaire about potential risk factors.", {"entities": []}], ["Conditional logistic regression was used to calculate odds ratio's (OR) and 95% confidence intervals (CI) to estimate the independent effect of potential risk factors.", {"entities": []}], ["A total of 493 matched pairs of case and control subjects were enrolled.", {"entities": []}], ["Exposure to persons with respiratory complaints, both inside and outside the household, was found to be an independent risk factor for visiting a GP with an ARTI (respectively OR adj = 1.9 and OR adj = 3.7).", {"entities": []}], ["Participants exposed to dampness or mould at home (OR adj =0.5) were significantly less likely to visit their GP.", {"entities": []}], ["In accordance with the general risk of consultations for ARTI, participants with a laboratory-confirmed ARTI who were exposed to persons with respiratory complaints outside the household were also significantly more likely to visit their GP (OR adj =2.5).", {"entities": []}], ["This study confirmed that heterogeneity in the general population as well as in pathogens causing ARTI makes it complicated to detect associations between potential risk factors and respiratory infections.", {"entities": []}], ["Whereas it may be difficult to intervene on the risk posed by exposure to persons with respiratory complaints, transmission of ARTI in the general population might be reduced by improved hygienic conditions.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease characterized by breathing difficulty as a consequence of narrowed airways.", {"entities": [[57, 69, "DISEASE"]]}], ["Previous studies have shown that COPD is correlated with neutrophil infiltration into the airways through chemotactic migration.", {"entities": []}], ["However, whether neutrophil chemotaxis can be used to characterize and diagnose COPD is not well established.", {"entities": []}], ["In the present study, we developed a microfluidic platform for evaluating neutrophil chemotaxis to sputum samples from COPD patients.", {"entities": []}], ["Our results show increased neutrophil chemotaxis to COPD sputum compared to control sputum from healthy individuals.", {"entities": []}], ["The level of COPD sputum induced neutrophil chemotaxis was correlated with the patient\u2019s spirometry data.", {"entities": []}], ["The cell morphology of neutrophils in a COPD sputum gradient is similar to the morphology displayed by neutrophils exposed to an IL-8 gradient, but not a fMLP gradient.", {"entities": []}], ["In competing gradients of COPD sputum and fMLP, neutrophils chemotaxis and cell morphology are dominated by fMLP.", {"entities": []}], ["Passive smoking unfavorably affects pregnancy, child birth and child health.", {"entities": []}], ["Passive smoking associates with still-birth, premature birth as well as acute respiratory infection, asthma, disorder in red blood cell metabolism in children.", {"entities": [[101, 107, "DISEASE"]]}], ["This study examined the effects of passive smoking on anemia in young children in Jordan.", {"entities": [[54, 60, "DISEASE"]]}], ["The analysis based on the information from 740 children aged 0\u201335 months that were tested for hemoglobin levels included in the 2002 Jordan Population and Family Health Survey.", {"entities": []}], ["This study used multivariate logistic regression method to analyze the effect of passive smoking on anemia in young children in Jordan, controlling for a number of risk factors and confounding factors for anemia.", {"entities": [[100, 106, "DISEASE"], [205, 211, "DISEASE"]]}], ["Results indicated that independent of other risk factors and confounding factors, anemia in young children was strongly positively associated with exposure to passive smoking from both parents (OR= 2.99, p < 0.01).", {"entities": [[82, 88, "DISEASE"]]}], ["Severely undernourished children were at higher risk of anemia independent of passive smoking and other risk factors (OR= 5.29, p < 0.05).", {"entities": [[56, 62, "DISEASE"]]}], ["Children age 24\u201335 months, children born to mothers age 35\u201349, and children lived in households with a hygienic toilet facility were less likely to suffer from anemia.", {"entities": [[160, 166, "DISEASE"]]}], ["Passive smoking from both parents was strongly positively associated with anemia in young children in Jordan independent of other risk factors and confounding factors.", {"entities": [[74, 80, "DISEASE"]]}], ["The results support the importance of smoking prevention during and after pregnancy that prevent childhood anemia and others morbidities in young children.", {"entities": [[107, 113, "DISEASE"]]}], ["Diabetes mellitus is a highly prevalent condition in Malaysia, increasing from 11.6% in 2006 to 15.2% in 2011 among individuals 18 years and above.", {"entities": []}], ["Co-morbid depression in diabetics is associated with hyperglycemia, diabetic complications and increased health care costs.", {"entities": [[53, 66, "DISEASE"]]}], ["The aims of this study are to determine the prevalence and predictors of depression, anxiety and stress symptoms in Type II diabetics attending government primary care facilities in the urban area of Klang Valley, Malaysia.", {"entities": []}], ["The study was cross sectional in design and carried out in 12 randomly selected primary care government clinics in the Klang Valley, Malaysia.", {"entities": []}], ["A total of 2508 eligible consenting respondents participated in the study.", {"entities": []}], ["The Depression, Anxiety and Stress Scale (DASS) 21 questionnaire was used to measure depression, anxiety and stress symptoms.", {"entities": []}], ["Data was analyzed using the SPSS version 16 software using both descriptive and inferential statistics.", {"entities": []}], ["The prevalence of depression, anxiety and stress symptoms among Type II diabetics were 11.5%, 30.5% and 12.5% respectively.", {"entities": []}], ["Using multiple logistic regression, females, Asian Indians, marital status (never married, divorced/widowed/separated), a family history of psychiatric illness, less than 2 years duration of diabetes and current alcohol consumption were found to be significant predictors of depression.", {"entities": []}], ["For anxiety, unemployment, housewives, HbA1c level of more than 8.5%, a family history of psychiatric illness, life events and lack of physical activity were independent risk factors.", {"entities": []}], ["Stress was significantly associated with females, HbA1c level of more than 8.5%, presence of co-morbidity, a family history of psychiatric illness, life events and current alcohol consumption.", {"entities": []}], ["For depression (adjusted OR 2.8, 95% CI 1.1; 7.0), anxiety (adjusted OR 2.4, 95% CI 1.1;5.5) and stress (adjusted OR 4.2, 95% CI 1.8; 9.8), a family history of psychiatric illness was the strongest predictor.", {"entities": []}], ["We found the prevalence of depression, anxiety and stress symptoms to be high among Type II diabetics, with almost a third being classified as anxious.", {"entities": []}], ["Screening of high risk Type II diabetics for depression, anxiety and stress symptoms in the primary care setting is recommended at regular intervals.", {"entities": []}], ["Sequential cohort design (SCD) applying matching for propensity scores (PS) in accrual periods has been proposed to mitigate bias caused by channeling when calendar time is a proxy for strong confounders.", {"entities": [[26, 29, "GENE"]]}], ["We studied the channeling of patients according to atorvastatin and simvastatin initiation in Finland, starting from the market introduction of atorvastatin in 1998, and explored the SCD PS approach to analyzing the comparative effectiveness of atorvastatin versus simvastatin in the prevention of cardiovascular events (CVE).", {"entities": [[183, 186, "GENE"]]}], ["Initiators of atorvastatin or simvastatin use in the 45\u201375-year age range in 1998\u20132006 were characterized by their propensity of receiving atorvastatin over simvastatin, as estimated for 17 six-month periods.", {"entities": []}], ["Atorvastatin (10 mg) and simvastatin (20 mg) initiators were matched 1\u22361 on the PS, as estimated for the whole cohort and within each period.", {"entities": []}], ["Cox regression models were fitted conventionally, and also for the PS matched cohort and the periodically PS matched cohort, to estimate the hazard ratios (HR) for CVEs.", {"entities": [[156, 158, "GENE"]]}], ["Atorvastatin (10 mg) was associated with a 11%\u201312% lower incidence of CVE in comparison with simvastatin (20 mg).", {"entities": []}], ["The HR estimates were the same for a conventional Cox model (0.88, 95% confidence interval 0.85\u20130.91), for the analysis in which the PS was used to match across all periods and the Cox model was adjusted for strong confounders (0.89, 0.85\u20130.92), and for the analysis in which PS matching was applied within sequential periods (0.88, 0.84\u20130.92).", {"entities": [[4, 6, "GENE"]]}], ["The HR from a traditional PS matched analysis was 0.80 (0.77\u20130.83).", {"entities": [[4, 6, "GENE"]]}], ["The SCD PS approach produced effect estimates similar to those obtained in matching for PS within the whole cohort and adjusting the outcome model for strong confounders, but at the cost of efficiency.", {"entities": [[4, 7, "GENE"]]}], ["A traditional PS matched analysis without further adjustment in the outcome model produced estimates further away from unity.", {"entities": []}], ["The objective of this study was to evaluate the association between falls and obesity using Asian body mass index (BMI) classifications.", {"entities": [[78, 85, "DISEASE"]]}], ["Using the data from the Korean community health survey in 2011, a total of 229,226 participants ranging from 19 to 106 years old were included in this study.", {"entities": []}], ["The BMI groups were classified as underweight (<18.5), healthy (18.5\u200a\u2264\u200aBMI\u200a<\u200a23), overweight (23\u200a\u2264\u200aBMI\u200a<25), and obese (\u226525) using Asian BMI classifications.", {"entities": []}], ["The associations between BMI groups and falls (\u22651 time or \u22652 times per year) were analyzed using multiple logistic regression analyses with complex sampling.", {"entities": []}], ["A subgroup analysis was conducted according to age (19\u201340, 41\u201360, and \u226561 years) and the location of the fall (indoor and outdoor).", {"entities": []}], ["Physical activity, household income, education level, alcohol consumption, smoking, stress level, and medical comorbidities were adjusted as confounders.", {"entities": []}], ["In total, 16.8% and 6.1% of the participants experienced falls \u22651 time and \u22652 times per year, respectively.", {"entities": []}], ["Compared to the healthy weight group, the other BMI groups showed a significant U-shaped relationship with falls \u22651 time (AOR underweight\u200a=\u200a1.12, 95% CI [confidence interval]\u200a=\u200a1.05\u20131.19; AOR obese\u200a=\u200a1.06, 95% CI\u200a=\u200a1.02\u20131.10, P \u200a<\u200a0.001) and \u22652 times (AOR underweight\u200a=\u200a1.14, 95% CI\u200a=\u200a1.04\u20131.26; AOR obese\u200a=\u200a1.04, 95% CI\u200a=\u200a0.99\u20131.10, P \u200a<\u200a0.001).", {"entities": []}], ["Obese status was significantly associated with falls (\u22651 fall per year) in all age groups, whereas being underweight was significantly associated with falls in the 19 to 40 year age group only.", {"entities": []}], ["In conclusion, both underweight and obese statuses were significantly associated with falls in this adult Korean population.", {"entities": []}], ["However, the relationship between BMI group and falls varied according to age and the location of the falls.", {"entities": []}], ["Quality-of-life (QoL) scores in chronic obstructive pulmonary disease (COPD) have a weak relationship with physiologic impairment.", {"entities": [[32, 69, "DISEASE"]]}], ["We investigated factors associated with poor QoL, focusing on psychological measures potentially amenable to intervention.", {"entities": []}], ["We utilized a pre-existing Birmingham (UK) COPD cohort to assess factors associated with QoL impairment (COPD Assessment Test [CAT] scores).", {"entities": []}], ["Univariate and multivariate regression models were constructed from three categories of variables: demographic, lung function/COPD-related symptoms, and psychosocial/behavioral factors.", {"entities": []}], ["Analyses were based on self-report questionnaire data from 735 participants.", {"entities": []}], ["The multivariate model of variables independently associated with CAT included depression, dysfunctional breathing symptoms (Nijmegen score), and illness perception, in addition to COPD symptoms (wheeze, cough), exercise capacity, breathlessness, exacerbations, and deprivation; this model explained 72% of CAT score variation.", {"entities": []}], ["In a dominance analysis assessing the relative contribution of variables, similar contributions were made by breathlessness (20.2%), illness perception (19.8%), dysfunctional breathing symptoms (17.5%), and depression (12.5%) with other variables contributing <5%.", {"entities": []}], ["Psychological factors significantly contribute to disease-specific QoL impairment in COPD, and potentially explain the mismatch between objective physiologic impairment and patients\u2019 experience of their disease.", {"entities": []}], ["Interventions targeting psychological factors, illness perception, and dysfunctional breathing should be assessed.", {"entities": []}], ["Among patients with non-cystic fibrosis bronchiectasis, 1\u201318% have an underlying diagnosis of primary ciliary dyskinesia (PCD) and it is suspected that there is under-recognition of this disease.", {"entities": [[94, 120, "DISEASE"], [40, 54, "DISEASE"], [24, 39, "DISEASE"]]}], ["Our intention was to evaluate the specific features of PCD seen on computed tomography (CT) in the cohort of bronchiectasis in order to facilitate the diagnosis.", {"entities": [[109, 123, "DISEASE"]]}], ["One hundred and twenty-one CTs performed in patients with bronchiectasis were scored for the involvement, type, and lobar distribution of bronchiectasis, bronchial dilatation, and bronchial wall thickening.", {"entities": [[58, 72, "DISEASE"], [138, 152, "DISEASE"]]}], ["Later, associated findings such as mucus plugging, tree in bud, consolidations, ground glass opacities, interlobular thickening, intralobular lines, situs inversus, emphysema, mosaic attenuation, and atelectasis were registered.", {"entities": [[149, 163, "DISEASE"]]}], ["Patients with PCD (n = 46) were compared to patients with other underlying diseases (n = 75).", {"entities": []}], ["In patients with PCD, the extent and severity of the bronchiectasis and bronchial wall thickness were significantly lower in the upper lung lobes (p<0.001-p = 0.011).", {"entities": [[53, 67, "DISEASE"]]}], ["The lobar distribution differed significantly with a predominance in the middle and lower lobes in patients with PCD (<0.001).", {"entities": []}], ["Significantly more common in patients with PCD were mucous plugging (p = 0.001), tree in bud (p <0.001), atelectasis (p = 0.009), and a history of resection of a middle or lower lobe (p = 0.047).", {"entities": []}], ["Less common were emphysematous (p = 0.003) and fibrotic (p<0.001) changes.", {"entities": []}], ["A situs inversus (Kartagener\u2019s Syndrome) was only seen in patients with PCD (17%, p <0.001).", {"entities": [[2, 16, "DISEASE"]]}], ["Typical imaging features in PCD include a predominance of bronchiectasis in the middle and lower lobes, severe tree in bud pattern, mucous plugging, and atelectasis.", {"entities": [[58, 72, "DISEASE"]]}], ["These findings may help practitioners to identify patients with bronchiectasis in whom further work-up for PCD is called for.", {"entities": [[64, 78, "DISEASE"]]}], ["There have been many epidemiological and clinical researches on chronic fatigue (CF) and chronic fatigue syndrome (CFS) since the 1990s, but such studies have been quite limited in Korea.", {"entities": [[89, 113, "DISEASE"], [105, 113, "DISEASE"]]}], ["The aim of this study was to investigate the point prevalence of CF and CFS in patients who visited community-based eight primary care clinics in Korea.", {"entities": []}], ["The study subjects were 1,648 patients aged 18 yr and over who visited one of eight primary care clinics in Korea between the 7th and 17th of May 2001.", {"entities": []}], ["The physicians determined the status of the subjects through fatigue-related questionnaires, medical history, physical examination, and laboratory tests.", {"entities": []}], ["The subjects were categorized into no fatigue, prolonged fatigue, CF and then CF were further classified to medically explained CF (Physical CF and Psychological CF) and medically unexplained CF (CFS and idiopathic chronic fatigue).", {"entities": []}], ["The point prevalence of CF and CFS were 8.4% (95% CI 7.1-9.7%) and 0.6% (95% CI 0.2-1.0%).", {"entities": []}], ["Medically explained CF was 80.5% of CF, of which 57.1% had psychological causes.", {"entities": []}], ["The clinical characteristics of CFS were distinguished from explained CF.", {"entities": []}], ["CF was common but CFS was rare in community-based primary care settings in Korea.", {"entities": []}], ["Mitogen-activated protein kinase (MAPK) signaling is involved in a variety of cellular functions.", {"entities": []}], ["MAPK-dependent functions rely on phosphorylation of target proteins such as mitogen- and stress-activated protein kinase 1 (MSK1).", {"entities": []}], ["MSK1 participates in the early gene expression and in the production of pro- and anti-inflammatory cytokines.", {"entities": []}], ["However, the role of MSK1 in neutrophil recruitment remains elusive.", {"entities": []}], ["Here, we show that chemokine macrophage inflammatory protein-2 (CXCL2) enhances neutrophil MSK1 expression.", {"entities": [[64, 69, "GENE"]]}], ["Using intravital microscopy and time-lapsed video analysis of cremasteric microvasculature in mice, we studied the effect of pharmacological suppression of MSK1 by SB-747651A on CXCL2-elicited neutrophil recruitment.", {"entities": []}], ["SB-747651A treatment enhanced CXCL2-induced neutrophil adhesion while temporally attenuating neutrophil emigration.", {"entities": []}], ["CXCL2-induced intraluminal crawling was reduced following SB-747651A treatment.", {"entities": []}], ["Fluorescence-activated cell sorting analysis of integrin expression revealed that SB-747651A treatment attenuated neutrophil integrin \u03b1 M \u03b2 2 (Mac-1) expression following CXCL2 stimulation.", {"entities": [[171, 176, "GENE"]]}], ["Both the transmigration time and detachment time of neutrophils from the venule were increased following SB-747651A treatment.", {"entities": []}], ["It also decreased the velocity of neutrophil migration in cremasteric tissue in CXCL2 chemotactic gradient.", {"entities": [[80, 85, "GENE"]]}], ["SB-747651A treatment enhanced the extravasation of neutrophils in mouse peritoneal cavity not at 1\u20132 h but at 3\u20134 h following CXCL2 stimulation.", {"entities": [[126, 131, "GENE"]]}], ["Collectively, our data suggest that inhibition of MSK1 by SB-747651A treatment affects CXCL2-induced neutrophil recruitment by modulating various steps of the recruitment cascade in vivo.", {"entities": []}], ["Improvements in asthma diagnosis and management require deeper understanding of the heterogeneity of the complex airway inflammation.", {"entities": [[16, 22, "DISEASE"]]}], ["We hypothesise that differences in the two major inflammatory phenotypes of asthma; eosinophilic and neutrophilic asthma, will be reflected in the lung protein expression profile of murine asthma models and can be delineated using proteomics of bronchoalveolar lavage (BAL).", {"entities": [[76, 82, "DISEASE"], [114, 120, "DISEASE"], [189, 195, "DISEASE"]]}], ["BAL from mice challenged with ovalbumin (OVA/OVA) alone (standard model of asthma, here considered eosinophilic) or OVA in combination with endotoxin (OVA/LPS, model of neutrophilic asthma) was analysed using liquid chromatography coupled to high resolution mass spectrometry, and compared with steroid-treated animals and healthy controls.", {"entities": [[75, 81, "DISEASE"], [182, 188, "DISEASE"]]}], ["In addition, conventional inflammatory markers were analysed using multiplexed ELISA (Bio-Plex\u2122 assay).", {"entities": []}], ["Multivariate statistics was performed on integrative proteomic fingerprints using principal component analysis.", {"entities": []}], ["Proteomic data were complemented with lung mechanics and BAL cell counts.", {"entities": []}], ["Several of the analysed proteins displayed significant differences between the controls and either or both of the two models reflecting eosinophilic and neutrophilic asthma.", {"entities": [[166, 172, "DISEASE"]]}], ["Most of the proteins found with mass spectrometry analysis displayed a considerable increase in neutrophilic asthma compared with the other groups.", {"entities": [[109, 115, "DISEASE"]]}], ["Conversely, the larger number of the inflammatory markers analysed with Bio-Plex\u2122 analysis were found to be increased in the eosinophilic model.", {"entities": []}], ["In addition, major inflammation markers were correlated to peripheral airway closure, while commonly used asthma biomarkers only reflect central inflammation.", {"entities": [[106, 112, "DISEASE"]]}], ["Our data suggest that the commercial markers we are currently relying on to diagnose asthma subtypes are not giving us comprehensive or specific enough information.", {"entities": [[85, 91, "DISEASE"]]}], ["The analysed protein profiles allowed to discriminate the two models and may add useful information for characterization of different asthma phenotypes.", {"entities": [[134, 140, "DISEASE"]]}], ["The quality-adjusted life-year (QALY) is a recognised outcome measure in health economic evaluations.", {"entities": []}], ["QALY incorporates individual preferences and identifies health gains by combining mortality and morbidity into one single index number.", {"entities": []}], ["A literature review was conducted to examine and discuss the use of QALYs to measure outcomes in telehealth evaluations.", {"entities": []}], ["Evaluations were identified via a literature search in all relevant databases.", {"entities": []}], ["Only economic evaluations measuring both costs and QALYs using primary patient level data of two or more alternatives were included.", {"entities": []}], ["A total of 17 economic evaluations estimating QALYs were identified.", {"entities": []}], ["All evaluations used validated generic health related-quality of life (HRQoL) instruments to describe health states.", {"entities": []}], ["They used accepted methods for transforming the quality scores into utility values.", {"entities": []}], ["The methodology used varied between the evaluations.", {"entities": []}], ["The evaluations used four different preference measures (EQ-5D, SF-6D, QWB and HUI3), and utility scores were elicited from the general population.", {"entities": []}], ["Most studies reported the methodology used in calculating QALYs.", {"entities": []}], ["The evaluations were less transparent in reporting utility weights at different time points and variability around utilities and QALYs.", {"entities": []}], ["Few made adjustments for differences in baseline utilities.", {"entities": []}], ["The QALYs gained in the reviewed evaluations varied from 0.001 to 0.118 in implying a small but positive effect of telehealth intervention on patient\u2019s health.", {"entities": []}], ["The evaluations reported mixed cost-effectiveness results.", {"entities": []}], ["The use of QALYs in telehealth evaluations has increased over the last few years.", {"entities": []}], ["Different methodologies and utility measures have been used to calculate QALYs.", {"entities": []}], ["A more harmonised methodology and utility measure is needed to ensure comparability across telehealth evaluations.", {"entities": []}], ["To assess bias and generalizability of results in randomized controlled trials (RCT), investigators compare participants to non-participants or early- to late-participants.", {"entities": []}], ["Comparisons can also inform the recruitment approach, especially when working with challenging populations, such as urban adolescents.", {"entities": []}], ["In this paper, we describe characteristics by participant status of urban teens eligible to participate in a RCT of a school-based, web-based asthma management program.", {"entities": [[142, 148, "DISEASE"]]}], ["The denominator for this analysis was all students found to be eligible to participate in the RCT.", {"entities": []}], ["Data were analyzed for participants and non-participants of the RCT, as well as for students that enrolled during the initially scheduled recruitment period (early-participants) and persons that delayed enrollment until the following fall when recruitment was re-opened to increase sample size (late-participants).", {"entities": []}], ["Full Time Equivalents (FTEs) of staff associated with recruitment were estimated.", {"entities": []}], ["Of 1668 teens eligible for the RCT, 386 enrolled early, and 36 enrolled late, leaving 1246 non-participants.", {"entities": []}], ["Participants were younger (p < 0.01), more likely to be diagnosed, use asthma medication, and have moderate-to-severe disease than non-participants, odds ratios (95% Confidence Intervals) = 2.1(1.7-2.8), 1.7(1.3-2.1), 1.4(1.0-1.8), respectively.", {"entities": [[71, 77, "DISEASE"]]}], ["ORs were elevated for the association of late-participation with Medicaid enrollment, 1.9(0.7-5.1) and extrinsic motivation to enroll, 1.7(0.6-5.0).", {"entities": []}], ["Late-participation was inversely related to study compliance for teens and caregivers, ORs ranging from 0.1 to 0.3 (all p-values < 0.01).", {"entities": []}], ["Early- and late-participants required 0.45 FTEs/100 and 3.3 FTEs/100, respectively.", {"entities": []}], ["Recruitment messages attracted youth with moderate-to-severe asthma, but extending enrollment was costly, resulting in potentially less motivated, and certainly less compliant, participants.", {"entities": [[61, 67, "DISEASE"]]}], ["Investigators must balance internal versus external validity in the decision to extend recruitment.", {"entities": []}], ["Gains in sample size and external validity may be offset by the cost of additional staff time and the threat to internal validity caused by lower participant follow-up.", {"entities": []}], ["ClinicalTrials.gov: NCT00201058", {"entities": []}], ["Asian dust events result from displacement of atmospheric pollutants from the Chinese and Mongolian deserts, causing associated health issues throughout Northeast Asia.", {"entities": []}], ["We investigated the relationship between skin symptoms in Asian dust events and contact allergy to Asian dust and associated metals.", {"entities": []}], ["Increases in atmospheric levels of heavy metals such as Ni, Al, and Fe occurred during the severe Asian dust event on March 21, 2010.", {"entities": []}], ["We conducted a case\u2013control study (n = 62) with patch testing to compare skin symptoms on an Asian dust day with metal allergic reactions.", {"entities": []}], ["Skin symptoms were observed in 18/62 subjects.", {"entities": []}], ["Nine subjects with skin symptoms (group A) and 11 without (group B) were patch tested for six metals and Asian dust particles.", {"entities": []}], ["Metal and dust samples were applied to the subjects\u2019 backs for 2 days and the reactions were scored according to the International Contact Dermatitis Research Group guidelines.", {"entities": []}], ["Differences in the positive rates between the groups were analyzed.", {"entities": []}], ["Skin reactions to ferric chloride ( p = 0.015), aluminum chloride ( p = 0.047), nickel sulfate ( p = 0.008), and Asian dust particles ( p = 0.047) were more common in group A than in group B.", {"entities": []}], ["Skin symptoms during Asian dust events may be allergic reactions to Asian dust particle-bound metals.", {"entities": []}], ["Among the properties that are common to complex systems, the presence of critical thresholds in the dynamics of the system is one of the most important.", {"entities": []}], ["Recently, there has been interest in the universalities that occur in the behavior of systems near critical points.", {"entities": []}], ["These universal properties make it possible to estimate how far a system is from a critical threshold.", {"entities": []}], ["Several early-warning signals have been reported in time series representing systems near catastrophic shifts.", {"entities": []}], ["The proper understanding of these early-warnings may allow the prediction and perhaps control of these dramatic shifts in a wide variety of systems.", {"entities": []}], ["In this paper we analyze this universal behavior for a system that is a paradigm of phase transitions, the Ising model.", {"entities": []}], ["We study the behavior of the early-warning signals and the way the temporal correlations of the system increase when the system is near the critical point.", {"entities": []}], ["The aim of this study was to assess cross-sectional and longitudinal correlations between uEPX and other markers of asthma control and eosinophilic airway inflammation.", {"entities": [[116, 122, "DISEASE"]]}], ["We measured uEPX at baseline, after 1\u2009year and after 2\u2009years in 205 atopic asthmatic children using inhaled fluticasone.", {"entities": []}], ["At the same time points, we assessed symptom scores (2 weeks diary card), lung function (forced expiratory volume in one second (FEV 1 )), airway hyperresponsiveness (AHR), and percentage eosinophils in induced sputum (% eos).", {"entities": [[129, 132, "GENE"], [167, 170, "GENE"]]}], ["We found negative correlations between uEPX and FEV 1 at baseline ( r = \u22120.18, P = 0.01), after 1 year ( r = \u22120.25, P < 0.01) and after 2 years ( r = \u22120.21, P = 0.02).", {"entities": [[48, 51, "GENE"]]}], ["Within-patient changes of uEPX showed a negative association with FEV 1 changes (at 1\u2009year: r = \u22120.24, P = 0.01; at 2\u2009years: r = \u22120.21, P = 0.03).", {"entities": [[66, 69, "GENE"]]}], ["Within-patient changes from baseline of uEPX correlated with changes in % eos.", {"entities": []}], ["No relations were found between uEPX and symptoms.", {"entities": []}], ["Conclusion .", {"entities": []}], ["In this population of children with atopic asthma, uEPX correlated with FEV 1 and % eos, and within-subjects changes in uEPX correlated with changes in FEV 1 and % eos.", {"entities": [[43, 49, "DISEASE"], [72, 75, "GENE"], [152, 155, "GENE"], [72, 75, "GENE"], [152, 155, "GENE"]]}], ["As the associations were weak and the scatter of uEPX wide, it seems unlikely that uEPX will be useful as a biomarker for monitoring asthma control in the individual child.", {"entities": [[133, 139, "DISEASE"]]}], ["Allergic conjunctivitis (AC) is a common condition, especially in childhood.", {"entities": [[9, 23, "DISEASE"]]}], ["The extent to which it occurs concurrently with or independently from allergic rhinitis (AR) has not been well described.", {"entities": [[70, 87, "DISEASE"], [79, 87, "DISEASE"]]}], ["To examine the inter-relationship between rhinitis and conjunctivitis and the epidemiological risk factors for these conditions in a rural UK population.", {"entities": [[42, 50, "DISEASE"], [55, 69, "DISEASE"]]}], ["Cross-sectional study of rural school children (aged 5\u201311 years).", {"entities": []}], ["Parental questionnaires were used to diagnose allergic outcomes (including conjunctivitis, rhinitis and rhinoconjunctivitis), and to collect data on atopic history, demographic and environmental exposures.", {"entities": [[91, 99, "DISEASE"], [75, 89, "DISEASE"]]}], ["Odds ratios of allergic outcome by exposure were examined adjusted for age, sex, breastfeeding, family history of allergy, number of older and younger siblings.", {"entities": []}], ["Prevalence of conjunctivitis was 17.5%, rhinitis 15.1% and rhinoconjunctivitis 13.0%.", {"entities": [[40, 48, "DISEASE"], [14, 28, "DISEASE"]]}], ["Seasonality of symptoms varied by condition: 64.7% of those with conjunctivitis had seasonal symptoms (April-Sept only), 46.7% of those with rhinitis and 92.2% of those with rhinoconjunctivitis.", {"entities": [[141, 149, "DISEASE"], [65, 79, "DISEASE"]]}], ["Living on a farm consistently reduced the risk of conjunctivitis (odds ratio 0.47, 95%CI 0.29\u20130.79, p = 0.004), rhinitis (OR 0.57, 95%CI 0.33\u20131.01, p = 0.05) and rhinoconjunctivitis (OR 0.57, 95%CI 0.32\u20131.03, p = 0.06).", {"entities": [[112, 120, "DISEASE"], [50, 64, "DISEASE"]]}], ["Exposure to farm animals (particularly in early life), current consumption of unpasteurised milk and playing in a barn or stable significantly reduced the risk of all three conditions.", {"entities": []}], ["More children had parent-reported conjunctivitis than rhinitis.", {"entities": [[54, 62, "DISEASE"], [34, 48, "DISEASE"]]}], ["The majority of children with either condition also reported symptoms with the other condition.", {"entities": []}], ["Farmers\u2019 children have less eye and/or nasal symptoms.", {"entities": []}], ["A number of farming variables linked with the farm microbial environment are likely to be mediating the protective effect.", {"entities": []}], ["A survey of Western Australia's general practitioners' (GPs') knowledge and practices relating to genital chlamydia infection was conducted in mid-2005, prior to a multi-media campaign which encouraged 15\u201324 year olds to seek chlamydia testing through their general practitioner (GP).", {"entities": []}], ["The survey aimed to raise GPs' awareness of chlamydia in preparation for the campaign and to establish a baseline measure of their chlamydia-related knowledge and practices.", {"entities": []}], ["All 2038 GPs registered on the Australian Medical Publishing Company's database as practising in Western Australia were sent a survey which covered clinical features of chlamydia, investigations, treatment and public health issues; 576 (29%) responded.", {"entities": []}], ["Most GPs were aware of chlamydia being common in the 20\u201324 year old age group, but less than half were aware that it is common in 15\u201319 year olds.", {"entities": []}], ["GPs missed many opportunities for chlamydia testing in patients likely to be at risk of STIs, largely because they thought the patient would be embarrassed.", {"entities": []}], ["It is of concern that public health responsibilities in relation to chlamydia, ie notification and contact tracing, were not undertaken by all GPs.", {"entities": []}], ["Australia is currently piloting chlamydia screening.", {"entities": []}], ["For this to be successful, GPs will need to maintain current knowledge and clinical suspicion about chlamydia, and be comfortable in asking and receiving information about sexual behaviours.", {"entities": []}], ["Only then will GPs have a significant impact on curbing Australia's ever-increasing rates of chlamydia.", {"entities": []}], ["This study aimed to establish mechanistic links between the aging-associated changes in the functional status of mast cells and the altered responses of mesenteric tissue and mesenteric lymphatic vessels (MLVs) to acute inflammation.", {"entities": []}], ["We used an in vivo model of acute peritoneal inflammation induced by lipopolysaccharide treatment of adult (9-month) and aged (24-month) F-344 rats.", {"entities": []}], ["We analyzed contractility of isolated MLVs, mast cell activation, activation of nuclear factor-\u03baB (NF-\u03baB) without and with stabilization of mast cells by cromolyn or blockade of all types of histamine receptors and production of 27 major pro-inflammatory cytokines in adult and aged perilymphatic mesenteric tissues and blood.", {"entities": []}], ["We found that the reactivity of aged contracting lymphatic vessels to LPS-induced acute inflammation was abolished and that activated mast cells trigger NF-\u03baB signaling in the mesentery through release of histamine.", {"entities": []}], ["The aging-associated basal activation of mesenteric mast cells limits acute inflammatory NF-\u03baB activation in aged mesentery.", {"entities": []}], ["We conclude that proper functioning of the mast cell/histamine/NF-\u03baB axis is necessary for reactions of the lymphatic vessels to acute inflammatory stimuli as well as for interaction and trafficking of immune cells near and within the collecting lymphatics.", {"entities": []}], ["Unlike the 2014 guidelines, the 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines have removed lung function from the risk assessment algorithm of patients with COPD.", {"entities": []}], ["The aim of this investigation was to analyze the proportion of subjects who would change to a lower risk group when applying GOLD A total of 571 subjects with physician-diagnosed and spirometry-verified COPD were included in the present study.", {"entities": []}], ["The data consisted of measurements of lung function, inflammatory markers, together with questionnaires that covered comorbidities, COPD symptoms and medication.", {"entities": []}], ["From group C, 53% of the subjects would be reclassified to the lower risk group A, and from group D, 47% of the subjects would be reclassified to the lower risk group B when using GOLD p -values were <0.05.", {"entities": []}], ["The removal of spirometry from risk assessment in GOLD", {"entities": []}], ["Green tea polyphenols have emerged over the past two decades as an important dietary factor for health promotion.", {"entities": []}], ["There is considerable evidence that tea polyphenols, in particular (\u2212)-epigallocatechin-3-gallate (EGCG) inhibit carcinogenesis.", {"entities": []}], ["However, the mechanisms for the cancer-preventive activity of EGCG are not completely characterized and many features remain to be elucidated.", {"entities": [[32, 38, "DISEASE"]]}], ["Recently we have identified a cell-surface EGCG receptor and the relating molecules that confer EGCG responsiveness to many cancer cells at physiological concentrations.", {"entities": [[124, 130, "DISEASE"]]}], ["Here, we review some of the reported mechanisms for the cancer chemopreventive action of EGCG and provide an overview of several molecules that sense and manage the physiological functions of EGCG.", {"entities": [[56, 62, "DISEASE"]]}], ["Parasitic infections have been shown to have deleterious effects on host nutritional status.", {"entities": []}], ["In addition, although helmintic infection can modulate the host inflammatory response directed against the parasite, a causal association between helminths and allergy remains uncertain.", {"entities": []}], ["The present study was therefore designed to evaluate the relationship between nutritional status, parasite infection and prevalence of allergy among school children.", {"entities": []}], ["A cross sectional study was performed involving school children in two elementary schools in Gondar, Ethiopia.", {"entities": []}], ["Nutritional status of these children was determined using anthropometric parameters (weight-for-age, height-for-age and BMI-for-age).", {"entities": []}], ["Epi-Info software was used to calculate z-scores.", {"entities": []}], ["Stool samples were examined using standard parasitological procedures.", {"entities": []}], ["The serum IgE levels were quantified by total IgE ELISA kit following the manufacturer\u2019s instruction.", {"entities": []}], ["A total of 405 children (with mean age of 12.09.1\u2009\u00b1\u20092.54 years) completed a self-administered allergy questionnaire and provided stool samples for analysis.", {"entities": []}], ["Overall prevalence of underweight, stunting and thinness/wasting was 15.1%, 25.2%, 8.9%, respectively.", {"entities": []}], ["Of the total, 22.7% were found to be positive for intestinal parasites.", {"entities": []}], ["The most prevalent intestinal parasite detected was Ascaris lumbricoides (31/405, 7.6%).", {"entities": []}], ["There was no statistically significant association between prevalence of malnutrition and the prevalence of parasitic infections.", {"entities": []}], ["Median total serum IgE level was 344 IU/ml (IQR 117\u20132076, n\u2009=\u200980) and 610 IU/ml (143\u20131833, n\u2009=\u200920), respectively, in children without and with intestinal parasite infection (Z\u2009=\u2009\u22120.198, P\u2009>\u20090.8).", {"entities": []}], ["The prevalence of self reported allergy among the subset was 8%.", {"entities": []}], ["IgE concentration was not associated either with the presence of parasitic infection or history of allergy.", {"entities": []}], ["The prevalence of malnutrition, intestinal parasitism and allergy was not negligible in this population.", {"entities": []}], ["In addition, there was no significant association between the prevalence of allergy and their nutritional status, and parasite infection.", {"entities": []}], ["Further research prospective observational and intervention studies are required to address the question of causality between nutritional factors, parasites, and allergy.", {"entities": []}], ["The fractional concentration of exhaled nitric oxide (FeNO) is a biomarker of airway inflammation that has proved to be useful in investigations of genetic and epigenetic airway susceptibility to ambient air pollutants.", {"entities": []}], ["For example, susceptibility to airway inflammation from exposure to particulate matter with aerodynamic diameter\u00a0<\u00a0=2.5\u00a0\u03bcm (PM 2.5 ) varies by haplotypes and promoter region methylation in inducible nitric oxide synthase (iNOS encoded by NOS2).", {"entities": [[238, 242, "GENE"]]}], ["We hypothesized that PM2.5 susceptibility associated with these epigenetic and genetic variants may be greater in children with high FeNO from inflamed airways.", {"entities": []}], ["In this study, we investigated genetic and epigenetic susceptibility to airborne particulate matter by examining whether the joint effects of PM2.5, NOS2 haplotypes and iNOS promoter methylation significantly vary across the distribution of FeNO in school children.", {"entities": [[149, 153, "GENE"]]}], ["The study included 940 school children in the southern California Children\u2019s Health Study who provided concurrent buccal samples and FeNO measurements.", {"entities": []}], ["We used quantile regression to examine susceptibility by estimating the quantile-specific joint effects of PM 2.5 , NOS2 haplotype and methylation on FeNO.", {"entities": [[116, 120, "GENE"]]}], ["We discovered striking differences in susceptibility to PM 2.5 in school children.", {"entities": []}], ["The joint effects of short-term PM 2.5 exposure, NOS2 haplotypes and methylation across the FeNO distribution were significantly larger in the upper tail of the FeNO distribution, with little association in its lower tail, especially among children with asthma and Hispanic white children.", {"entities": [[254, 260, "DISEASE"], [49, 53, "GENE"]]}], ["School-aged children with higher FeNO have greater genetic and epigenetic susceptibility to PM 2.5 , highlighting the importance of investigating effects across the entire distribution of FeNO.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-017-0285-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["During the 2009 H1N1 pandemic the Danish National board of Health carried out massive public hygiene campaigns to limit spread of disease.", {"entities": []}], ["We aimed to investigate whether this resulted in lower incidences of communicable diseases in the paediatric population.", {"entities": []}], ["The study compared annual hospitalization rates for childhood infections from 2005 to 2011.", {"entities": []}], ["Admission rates for infections were higher during the year of the pandemic compared to the rest of the period.", {"entities": []}], ["There were no indications of a preventive effect by the hygiene campaign on incidence of severe common childhood infections.", {"entities": []}], ["Chronic diseases and multimorbidity are common and expected to rise over the coming years.", {"entities": []}], ["The objective of this study is to examine the time trend in the prevalence of chronic diseases and multimorbidity over the period 2001 till 2011 in the Netherlands, and the extent to which this can be ascribed to the aging of the population.", {"entities": []}], ["Monitoring study, using two data sources: 1) medical records of patients listed in a nationally representative network of general practices over the period 2002\u20132011, and 2) national health interview surveys over the period 2001\u20132011.", {"entities": []}], ["Regression models were used to study trends in the prevalence-rates over time, with and without standardization for age.", {"entities": []}], ["An increase from 34.9% to 41.8% (p<0.01) in the prevalence of chronic diseases was observed in the general practice registration over the period 2004\u20132011 and from 41.0% to 46.6% (p<0.01) based on self-reported diseases over the period 2001\u20132011.", {"entities": []}], ["Multimorbidity increased from 12.7% to 16.2% (p<0.01) and from 14.3% to 17.5% (p<0.01), respectively.", {"entities": []}], ["Aging of the population explained part of these trends: about one-fifth based on general practice data, and one-third for chronic diseases and half of the trend for multimorbidity based on health surveys.", {"entities": []}], ["The prevalence of chronic diseases and multimorbidity increased over the period 2001\u20132011.", {"entities": []}], ["Aging of the population only explained part of the increase, implying that other factors such as health care and society-related developments are responsible for a substantial part of this rise.", {"entities": []}], ["Attention\u2010Deficit/Hyperactivity Disorder ( ADHD ) is a common neurodevelopmental disorder starting in childhood that may persist into adulthood.", {"entities": []}], ["It can be managed through carefully monitored medication and nonpharmacological interventions.", {"entities": []}], ["Access to care for children at risk of ADHD varies both within and between countries.", {"entities": []}], ["A systematic literature review was conducted to investigate the research evidence related to factors which influence children accessing services for ADHD .", {"entities": []}], ["Studies investigating access to care for children at risk of ADHD were identified through electronic searches of the international peer\u2010reviewed and grey literature.", {"entities": []}], ["Databases were searched from inception till 30th April 2012.", {"entities": []}], ["This identified 23,156 articles which were subjected to three levels of screening (title, abstract and full text) by a minimum of two independent reviewers.", {"entities": []}], ["Due to the heterogeneity in the study designs, a narrative approach was used to present the findings.", {"entities": []}], ["Twenty\u2010seven papers met the inclusion criteria; these were grouped into four main themes, with some papers being included in more than one.", {"entities": []}], ["These were wider determinants (10 papers); identification of need (9 papers); entry and continuity of care (13 papers) and interventions to improve access (4 papers).", {"entities": []}], ["Barriers and facilitators to access were found to operate at the individual, organisational and societal level.", {"entities": []}], ["Limited evidence of effective interventions to improve access was identified.", {"entities": []}], ["This review explored the multilayered obstacles in the pathway to care for children at risk of ADHD and the lack of evidence\u2010based interventions designed to address these issues, thereby indicating areas for service development and further evaluative research.", {"entities": []}], ["Older patients are at an increased risk of developing adverse drug reactions (ADR).", {"entities": []}], ["Of particular concern are the oldest old, which constitute an increasingly growing population.", {"entities": []}], ["Having a validated clinical tool to identify those older patients at risk of developing an ADR during hospital stay would enable healthcare staff to put measures in place to reduce the risk of such an event developing.", {"entities": []}], ["The current study aimed to (1) develop and (2) validate an ADR risk prediction model.", {"entities": []}], ["We used a combination of univariate analysis and multivariate binary logistic regression to identify clinical risk factors for developing an ADR in a population of older people from a UK teaching hospital.", {"entities": []}], ["The final ADR risk model was then validated in a European population (European dataset).", {"entities": []}], ["Six-hundred-ninety patients (median age 85 years) were enrolled in the development stage of the study.", {"entities": []}], ["Ninety-five reports of ADR were confirmed by independent review in these patients.", {"entities": []}], ["Five clinical variables were identified through multivariate analysis and included in our final model; each variable was attributed a score of 1.", {"entities": []}], ["Internal validation produced an AUROC of 0.74, a sensitivity of 80%, and specificity of 55%.", {"entities": []}], ["During the external validation stage the AUROC was 0.73, with sensitivity and specificity values of 84% and 43% respectively.", {"entities": []}], ["We have developed and successfully validated a simple model to use ADR risk score in a population of patients with a median age of 85, i.e.", {"entities": []}], ["the oldest old.", {"entities": []}], ["The model is based on 5 clinical variables (\u22658 drugs, hyperlipidaemia, raised white cell count, use of anti-diabetic agents, length of stay \u226512 days), some of which have not been previously reported.", {"entities": []}], ["To examine the psychometric properties of the Injection Pen Assessment Questionnaire (IPAQ) including the following: 1) item and scale characteristics (e.g., frequencies, item distributions, and factor structure), 2) reliability, and 3) validity.", {"entities": []}], ["Focus groups and one-on-one dyad interviews guided the development of the IPAQ.", {"entities": []}], ["The IPAQ was subsequently tested in 136 parent\u2013child dyads in a Phase 3, 2-month, open-label, multicenter trial for a new Genotropin\u00ae disposable pen.", {"entities": []}], ["Factor analysis was performed to inform the development of a scoring algorithm, and reliability and validity of the IPAQ were evaluated using the data from this two months study.", {"entities": []}], ["Psychometric analyses were conducted separately for each injection pen.", {"entities": []}], ["Confirmatory factor analysis provides evidence supporting a second order factor solution for four subscales and a total IPAQ score.", {"entities": []}], ["These factor analysis results support the conceptual framework developed from previous qualitative research in patient dyads using the reusable pen.", {"entities": []}], ["However, the IPAQ subscales did not consistently meet acceptable internal consistency reliability for some group level comparisons.", {"entities": []}], ["Cronbach\u2019s alphas for the total IPAQ score for both pens were 0.85, exceeding acceptable levels of reliability for group comparisons.", {"entities": []}], ["The total IPAQ score is a useful measure for evaluating ease of use and preference for injection pens in clinical trials among patient dyads receiving hGH.", {"entities": []}], ["The psychometric properties of the individual subscales, mainly the lower internal consistency reliability of some of the subscales and the predictive validity findings, do not support the use of subscale scores alone as a primary endpoint.", {"entities": []}], ["Spirometry values may be expressed as T -scores in standard deviation units relative to a reference in a young, normal population as an analogy to the T -score for bone mineral density.", {"entities": []}], ["This study was performed to develop the spirometry T -score.", {"entities": []}], ["T -scores were calculated from lambda-mu-sigma-derived Z-scores using a young, normal age reference.", {"entities": []}], ["Three outcomes of all-cause death, respiratory death, and COPD death were evaluated in 9,101 US subjects followed for 10 years; an outcome of COPD-related health care utilization (COPD utilization) was evaluated in 1,894 Korean subjects followed for 4 years.", {"entities": []}], ["The probability of all-cause death appeared to remain nearly zero until \u22121 of forced expiratory volume in 1 second (FEV 1 ) T -score but increased steeply where FEV 1 T -score reached below \u22122.5.", {"entities": [[116, 119, "GENE"], [161, 164, "GENE"], [116, 119, "GENE"], [161, 164, "GENE"]]}], ["Survival curves for all-cause death, respiratory death, COPD death, and COPD utilization differed significantly among the groups when stratified by FEV 1 T -score ( P <0.001).", {"entities": [[148, 151, "GENE"]]}], ["The adjusted hazard ratios of the FEV 1 T -score for the four outcomes were 0.54 (95% confidence interval, 0.48\u20130.60), 0.43 (95% CI: 0.37\u20130.50), 0.30 (95% CI: 0.24\u20130.37), and 0.69 (95% CI: 0.59\u20130.81), respectively, adjusting for covariates ( P <0.001).", {"entities": [[34, 37, "GENE"]]}], ["The spirometry T -score could predict all-cause death, respiratory death, COPD death, and COPD utilization.", {"entities": []}], ["Twist 1 is highly expressed in adipose tissue and has been associated with obesity and related disorders.", {"entities": [[75, 82, "DISEASE"]]}], ["However, the molecular function of Twist 1 in adipose tissue is unclear.", {"entities": []}], ["Twist 1 has been implicated in cell lineage determination and differentiation.", {"entities": []}], ["Therefore, we investigated both the role of Twist 1 in adipocyte precursor mobilization and the relationship of Twist 1 with other molecular determinants of adipocyte differentiation.", {"entities": []}], ["We examined Twist 1 mRNA and protein expression in subcutaneous adipose tissues from diet-induced obese C57/BL6 mice and Wistar rats and in obese patients undergoing liposuction or adipose transplant surgeries.", {"entities": []}], ["Twist 1 expression was measured on days 0, 2, 4, 8, and 12 of 3T3-L1 differentiation in vitro.", {"entities": []}], ["The role of Twist 1 in adipogenesis was explored using retroviral interference of Twist 1 expression.", {"entities": []}], ["Adipokine secretion was evaluated using a RayBio\u00ae Biotin Label-based Adipokine Array.", {"entities": []}], ["Twist 1 mRNA and protein levels were reduced in diet-induced obese mice and rats and in obese humans.", {"entities": []}], ["Twist 1 was upregulated during 3T3-L1 preadipocyte differentiation in vitro, beginning from the fourth day of differentiation induction.", {"entities": []}], ["Retroviral interference of Twist 1 expression did not significantly impair lipid formation; however, retroviral interference induced PPAR\u03b3 mRNA and protein expression on day 4 of differentiation induction.", {"entities": []}], ["Adipokine array analyses revealed increased secretion of CXCR4 (19.55-fold), VEGFR1 (92.13-fold), L-21 R (63.55-fold), and IL-12 R beta 1 (59.66-fold) and decreased secretion of VEGFR3 (0.01-fold), TSLP R (0.071-fold), MIP-1 gamma (0.069-fold), TNF RI/TNFRSF1A (0.09-fold), and MFG-E8 (0.06-fold).", {"entities": [[57, 62, "GENE"], [198, 202, "GENE"], [245, 248, "GENE"]]}], ["Twist 1 is a regulator of adipocyte gene expression although it is not likely to regulate differentiation.", {"entities": []}], ["We identified PPAR\u03b3 as a potential target of Twist 1 and found variation in the secretion of multiple adipokines, which might indicate a prospective mechanism linking Twist 1 expression with obesity or associated diseases.", {"entities": [[191, 198, "DISEASE"]]}], ["We report the case of an 82-year-old patient, hospitalized for malaise.", {"entities": []}], ["Her clothes were infested by numerous insects and the entomological analysis identified them as being Cimex lectularius (bed bugs).", {"entities": []}], ["The history of the patient highlighted severe cognitive impairment.", {"entities": []}], ["The biological assessment initially showed a profound microcytic, aregenerative, iron deficiency anemia.", {"entities": [[86, 103, "DISEASE"], [81, 103, "DISEASE"], [97, 103, "DISEASE"]]}], ["A vitamin B12 deficiency due to pernicious anemia (positive intrinsic factor antibodies) was also highlighted, but this was not enough to explain the anemia without macrocytosis.", {"entities": [[32, 49, "DISEASE"], [43, 49, "DISEASE"], [150, 156, "DISEASE"]]}], ["Laboratory tests, endoscopy and a CT scan eliminated a tumor etiology responsible for occult bleeding.", {"entities": []}], ["The patient had a mild itchy rash which was linked to the massive colonization by the bed bugs.", {"entities": []}], ["The C. lectularius bite is most often considered benign because it is not a vector of infectious agents.", {"entities": []}], ["Far from trivial, a massive human colonization by bed bugs may cause such a hematic depletion that severe microcytic anemia may result.", {"entities": [[117, 123, "DISEASE"], [106, 123, "DISEASE"]]}], ["Prostaglandin (PG) E 2 exhibits an anti-fibrotic effect in the lung in response to inflammatory reactions and is a high-affinity substrate of PG transporter (SLCO2A1).", {"entities": [[158, 165, "GENE"]]}], ["The present study aimed to evaluate the pathophysiological relevance of SLCO2A1 to bleomycin (BLM)-induced pulmonary fibrosis in mice.", {"entities": [[107, 125, "DISEASE"], [72, 79, "GENE"], [94, 97, "GENE"]]}], ["Immunohistochemical analysis indicated that Slco2a1 protein was expressed in airway and alveolar type I (ATI) and II (ATII) epithelial cells, and electron-microscopic immunohistochemistry further demonstrated cell surface expression of Slco2a1 in ATI cells in wild type (WT) C57BL/6 mice.", {"entities": [[44, 51, "GENE"], [236, 243, "GENE"], [44, 51, "GENE"], [236, 243, "GENE"]]}], ["PGE 2 uptake activity was abrogated in ATI-like cells from Slco2a1 -deficient ( Slco2a1 2 concentrations in lung tissues were lower in Slco2a1 Slco2a1 Slco2a1 2 levels were higher in bronchoalveolar lavage fluid, but lower in lung tissues of Slco2a1 Slco2a1 Slco2a1 2 disposition is largely regulated by SLCO2A1, demonstrating that SLCO2A1 plays a critical role in protecting the lung from BLM-induced fibrosis.", {"entities": [[59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"], [59, 66, "GENE"], [80, 87, "GENE"], [135, 142, "GENE"], [143, 150, "GENE"], [151, 158, "GENE"], [242, 249, "GENE"], [250, 257, "GENE"], [258, 265, "GENE"], [304, 311, "GENE"], [332, 339, "GENE"]]}], ["Questionnaires are available to identify patients at risk for several chronic diseases, including COPD, but are infrequently utilized in primary care.", {"entities": []}], ["COPD is often underdiagnosed, while at the same time the US Preventive Services Task Force recommends against spirometric screening for COPD in asymptomatic adults.", {"entities": []}], ["Use of a symptom-based questionnaire and subsequent handheld spirometric device depending on the answers to the questionnaire is a promising approach to identify patients at risk for COPD.", {"entities": []}], ["Screening, Evaluating and Assessing Rate CHanges of diagnosing respiratory conditions in primary care 1 (SEARCH I) was a prospective cluster-randomized study in 168 US primary care practices evaluating the effect of the COPD-Population Screener (COPD-PS\u2122) questionnaire.", {"entities": []}], ["The effect of this questionnaire alone or sequentially with the handheld copd-6", {"entities": []}], ["The P2X 7 receptor binds extracellular ATP to mediate numerous inflammatory responses and is considered a potential biomarker and therapeutic target for diverse inflammatory and neurological diseases.", {"entities": []}], ["P2X 7 contains many single nucleotide polymorphisms, including several mutations located within its intracellular C-terminal trafficking domain.", {"entities": []}], ["Mutations within the trafficking domain result in attenuated receptor activity and cell surface presentation, but the mechanisms by which amino acid changes within this region promote altered P2X 7 function have not been elucidated.", {"entities": []}], ["We analyzed the amino acid sequence of P2X 7 for any potential trafficking signals and found that P2X 7 contains putative Arg-X-Arg ER retention sequences.", {"entities": []}], ["Alanine substitutions near or within these sequences were constructed, and we determined that single mutation of R574 and R578 but not R576 or K579 attenuates P2X 7 -stimulated activation of ERK1/2 and induction of the transcription factors FosB and \u0394FosB.", {"entities": [[241, 245, "GENE"]]}], ["We found that mutation of R578 within the trafficking domain to the naturally occurring Gln substitution disrupts P2X 7 localization at the plasma membrane and results in R578Q displaying a higher apparent molecular weight in comparison to wild-type receptor.", {"entities": []}], ["We used the glycosidase endoglycosidase H to determine that this difference in mass is due in part to the R578Q mutant possessing a larger mass of oligosaccharides, indicative of improper N-linked glycosylation addition and/or trimming.", {"entities": []}], ["Chemical cross-linking experiments were also performed and suggest that the R578Q variant also does not form trimers as well as wild-type receptor, a function required for its full activity.", {"entities": []}], ["These data demonstrate the distal C-terminus of P2X 7 is important for oligomerization and post-translational modification of the receptor, providing a mechanism by which mutations in the trafficking domain disrupt P2X 7 activity and localization at the plasma membrane.", {"entities": []}], ["To evaluate the hypoallergenicity of an extensively hydrolysed (EH) casein formula supplemented with Lactobacillus rhamnosus GG (LGG).", {"entities": []}], ["A prospective, randomised, double-blind, placebo-controlled crossover trial.", {"entities": []}], ["Two study sites in Italy and The Netherlands.", {"entities": []}], ["Children with documented cow's milk allergy were eligible for inclusion in this trial.", {"entities": []}], ["After a 7-day period of strict avoidance of cow's milk protein and other suspected food allergens, participants were tested with an EH casein formula with demonstrated hypoallergenicity (control, EHF) and a formula of the same composition with LGG added at 10 Clinical assessment of any adverse reactions to ingestion of study formulae during the DBPCFC.", {"entities": [[196, 199, "GENE"]]}], ["For all participants with confirmed cow's milk allergy (n=31), the DBPCFC and open challenge were classified as negative.", {"entities": []}], ["The EH casein formula supplemented with LGG is hypoallergenic and can be recommended for infants and children allergic to cow's milk who require an alternative to formulae containing intact cow's milk protein.", {"entities": []}], ["http://ClinicalTrials.gov Identifier: NCT01181297.", {"entities": []}], ["Hypoallergenic extensively hydrolysed (EH) cow's milk-based or amino acid-based formulae are recommended for management of cow's milk allergy in formula-fed infants.", {"entities": []}], ["Although Lactobacillus rhamnosus GG (LGG) has over 25\u2005years of safe use as a dietary probiotic, the safety and hypoallergenic status of EH casein formula supplemented with LGG has not yet been demonstrated.", {"entities": []}], ["Supplementing the EH casein formula with LGG to provide additional benefits does not change its hypoallergenic status.", {"entities": []}], ["The LGG-supplemented EH formula can be safely used for management of cow's milk allergy in infants and children.", {"entities": []}], ["Testing the LGG-supplemented EH formula in a properly designed double-blind placebo-controlled food challenge in accordance with accepted European Society of Pediatric Gastroenterology and Nutrition (ESPGHAN) and American Academy of Pediatrics standards to establish hypoallergenicity is a major strength of this study.", {"entities": []}], ["One limitation is the potentially low novelty of our finding.", {"entities": []}], ["Because LGG is the most used dietary probiotic, accumulated safety data for LGG as a stand-alone dietary supplement in infants and adults are available.", {"entities": []}], ["Graft-versus-host disease (GvHD) is a key contributor to the morbidity and mortality after allogeneic hematopoetic stem cell transplantation (HSCT).", {"entities": []}], ["Regulatory Foxp3 reg ) suppress conventional T cell activation and can control GvHD.", {"entities": [[11, 16, "GENE"]]}], ["In our previous work, we demonstrate that a basic mechanism of T reg mediated suppression occurs by the transfer of cyclic adenosine monophosphate (cAMP) to responder cells.", {"entities": []}], ["Whether this mechanism is relevant for T reg mediated suppression of GvHD is currently unknown.", {"entities": []}], ["To address this question, bone marrow and T cells from C57BL/6 mice were transferred into lethally irradiated BALB/c recipients, and the course of GvHD and survival were monitored.", {"entities": []}], ["Transplanted recipients developed severe GvHD that was strongly ameliorated by the transfer of donor T reg cells.", {"entities": []}], ["Towards the underlying mechanisms, in vitro studies revealed that T reg communicated with DCs via gap junctions, resulting in functional inactivation of DC by a metabolic pathway involving cAMP that is modulated by the phosphodiesterase (PDE) 4 inhibitor rolipram.", {"entities": []}], ["PDE2 or PDE3 inhibitors as well as rolipram suppressed allogeneic T cell activation, indirectly by enhancing T reg mediated suppression of DC activation and directly by inhibiting responder T cell proliferation.", {"entities": []}], ["In line with this, we observed a cooperative suppression of GvHD upon T reg transfer and additional rolipram treatment.", {"entities": []}], ["In conclusion, we propose that an important pathway of T reg mediated control of GvHD is based on a cAMP dependent mechanism.", {"entities": []}], ["These data provide the basis for future concepts to manipulate allogeneic T cell responses to prevent GvHD.", {"entities": []}], ["Background: Chronic inflammatory disorders have been increasing in incidence over the past decades following geographical patterns of industrialization.", {"entities": []}], ["Fetal exposure to maternal inflammation may alter organ functions and the offspring's disease risk.", {"entities": []}], ["We studied the development of genetically-driven ileitis and colitis in response to maternal inflammation using mouse models.", {"entities": []}], ["Methods: Disease susceptible ( Tnf IL 10 Tnf IL 10 Results: Disease severity, the number of infiltrated neutrophils as well as Tnf and Il12p40 mRNA expression were independent of maternal inflammation in the offspring of mouse models for ileitis ( Tnf IL 10 Tnf Conclusions: Disease risk and activity in mouse models of chronic ileitis and colitis was independent of the fetal exposure to maternal inflammation.", {"entities": [[31, 34, "GENE"], [41, 44, "GENE"], [127, 130, "GENE"], [248, 251, "GENE"], [258, 261, "GENE"], [31, 34, "GENE"], [41, 44, "GENE"], [127, 130, "GENE"], [248, 251, "GENE"], [258, 261, "GENE"], [31, 34, "GENE"], [41, 44, "GENE"], [127, 130, "GENE"], [248, 251, "GENE"], [258, 261, "GENE"], [31, 34, "GENE"], [41, 44, "GENE"], [127, 130, "GENE"], [248, 251, "GENE"], [258, 261, "GENE"], [31, 34, "GENE"], [41, 44, "GENE"], [127, 130, "GENE"], [248, 251, "GENE"], [258, 261, "GENE"]]}], ["Likewise, maternal inflammation did not alter the diversity and composition of offspring's caecal microbiota, clearly demonstrating that changes of the gene expression program in the fetal gut epithelium were not relevant for the development of chronic inflammatory disorders in the gut.", {"entities": []}], ["Acrolein is a highly reactive \u03b1,\u03b2 unsaturated aldehyde and respiratory irritant.", {"entities": []}], ["Acrolein is formed during combustion (e.g., burning tobacco or biomass), during high-temperature cooking of foods, and in vivo as a product of oxidative stress and polyamine metabolism.", {"entities": []}], ["No biomonitoring reference data have been reported to characterize acrolein exposure for the U.S. population.", {"entities": []}], ["Our goals were to a ) evaluate two acrolein metabolites in urine\u2014 N -acetyl- S -(3-hydroxypropyl)- l -cysteine (3HPMA) and N -acetyl- S -(2-carboxyethyl)- l -cysteine (CEMA)\u2014as biomarkers of exposure to acrolein for the U.S. population by age, sex, race, and smoking status; and b ) assess tobacco smoke as a predictor of acrolein exposure.", {"entities": []}], ["We analyzed urine from National Health and Nutrition Examination Survey (NHANES 2005\u20132006) participants \u2265 12 years old ( n = 2,866) for 3HPMA and CEMA using ultra-high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC/ESI-MSMS).", {"entities": []}], ["Sample-weighted linear regression models stratified for non-tobacco users versus tobacco smokers (as defined by serum cotinine and self-report) characterized the association of urinary 3HPMA and CEMA with tobacco smoke exposure, adjusting for urinary creatinine, sex, age, and race/ethnicity.", {"entities": []}], ["3HPMA and CEMA levels were higher among tobacco smokers (cigarettes, cigars, and pipe users) than among non-tobacco users.", {"entities": []}], ["The median 3HPMA levels for tobacco smokers and non-tobacco users were 1,089 and 219 \u03bcg/g creatinine, respectively.", {"entities": []}], ["Similarly, median CEMA levels were 203 \u03bcg/g creatinine for tobacco smokers and 78.8 \u03bcg/g creatinine for non-tobacco users.", {"entities": []}], ["Regression analysis showed that serum cotinine was a significant positive predictor ( p < 0.0001) of both 3HPMA and CEMA among tobacco smokers.", {"entities": []}], ["Tobacco smoke was a significant predictor of acrolein exposure in the U.S. population.", {"entities": []}], ["Alwis KU, deCastro BR, Morrow JC, Blount BC.", {"entities": []}], ["Acrolein exposure in U.S. tobacco smokers and non-tobacco users: NHANES 2005\u20132006.", {"entities": []}], ["Environ Health Perspect 123:1302\u20131308;\u2002 http://dx.doi.org/10.1289/ehp.1409251", {"entities": []}], ["Gamma gap is the difference in total serum proteins and albumin and an elevated gamma gap is related to infections, malignancy, and rheumatic diseases.", {"entities": []}], ["An elevated gamma gap is also associated with higher mortality due to the correlation with inflammatory status.", {"entities": []}], ["The study aimed to utilize mid-arm muscle circumference (MAMC) to assist in predicting all-cause mortality, cancer mortality, and cardiovascular mortality in people with elevated gamma gaps.", {"entities": [[108, 114, "DISEASE"]]}], ["Data were obtained from the third U.S. National Health and Nutrition Examination Survey (1988\u20131994), which contained 14,011 adults aged 20 to 90 years during up to 14.3 years of follow-up.", {"entities": []}], ["The Primary analysis examined MAMC in tertiles and revealed the demographic and characteristics of the study population.", {"entities": []}], ["Receiver operating characteristic curve analysis was used and the most suitable cut-off point of gamma gap was 3.65 g/dl.", {"entities": []}], ["The secondary analysis employed Cox proportional hazards models stratified by age, gender and body mass index to evaluate the hazard ratios for all-cause mortality, cancer mortality, and cardiovascular mortality associated with the MAMC.", {"entities": [[165, 171, "DISEASE"]]}], ["As the MAMC tertiles increased in group with gamma gap \u2265 3.65 g/dl, individuals with elder age (60\u201390 years), normal range of body mass index (19\u201324.9 kg/m", {"entities": []}], ["Attention and interest in the use of complementary and alternative medicine (CAM) has been reignited globally, most especially in patients with chronic diseases.", {"entities": []}], ["Sickle cell disease (SCD) is one of such chronic diseases associated with devastating clinical and psychosocial consequences, thus leading those affected to seek alternative treatment apart from orthodox medicine.", {"entities": [[21, 24, "GENE"]]}], ["Hence, this study aimed to determine the prevalence, pattern and tolerability of the use of CAM in patients with SCD in the Lagos University Teaching Hospital (LUTH).", {"entities": [[113, 116, "GENE"]]}], ["This was a cross-sectional survey of 200 respondents with SCD attending the hematology clinics of the Lagos University Teaching Hospital over a period of 3\u00a0months.", {"entities": [[58, 61, "GENE"]]}], ["Data on socio-demographic characteristic, clinical profile, the types and sources of CAM used were collected using a well structured pretested questionnaire.", {"entities": []}], ["The data obtained were analyzed using Statistical Package for Social Sciences (SPSS\u00ae) version 17.", {"entities": []}], ["Of the 200 patients who participated in the study, 113; 56.5% were males and 87; 43.5% were females.", {"entities": []}], ["Majority of the SCD patients were 1\u201310\u00a0years old and their mean age was 18.8\u00a0\u00b1\u00a014.39\u00a0years.", {"entities": [[16, 19, "GENE"]]}], ["CAM was reportedly used by 88.5% of the respondents.", {"entities": []}], ["Biological (herbal) products 156; 62.9% were the most commonly used CAM, followed by alternative medical systems 52; 20.9% and mind-body interventions 30; 12.1%.", {"entities": []}], ["Relations, friends and neighbors influenced 85.2% of CAM users by recommending CAM to them.", {"entities": []}], ["Tolerability of CAM was perceived to be excellent as only 33 (18.6%) of the respondents abandoned the use of CAM.", {"entities": []}], ["Comparing CAM users and CAM non-users, there was no statistical significant difference in the proportion of those >18\u00a0years (45.76% vs 52.17%; p \u00a0=\u00a00.658), those who experienced two or more crises (51.41% vs 34.78%; p \u00a0=\u00a00.183), and those with stable haemoglobin concentration of >7\u00a0g/dL (15.81% vs 8.69%; p \u00a0=\u00a00.539) More patients among CAM non-users (91.30%) significantly spend over 3000 Naira (USD 15) per month on medicine than CAM users (4.51%) ( p \u00a0<\u00a00.001).", {"entities": []}], ["CAM use is highly prevalent among adults with sickle cell diseases in Nigeria.", {"entities": []}], ["CAM is well tolerated and relatively affordable by these patients.", {"entities": []}], ["Clinician awareness and understanding of the factors influencing the use of CAM and the potential herbal-orthodox medicine interaction are crucial during hospital treatment of these patients.", {"entities": []}], ["MicroRNAs (miRNAs or miRs) are small, non-coding RNA molecules that play significant roles in numerous diseases.", {"entities": []}], ["However, there is limited information regarding the plasma expression of miRNAs in patients with primary biliary cirrhosis (PBC) as well as the potential role of miRNAs in the development of PBC.", {"entities": [[97, 122, "DISEASE"]]}], ["miRNA microarray analysis was performed using plasma obtaind from three patients with PBC and three healthy controls.", {"entities": []}], ["Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to confirm the differential expression of miRNAs in the plasma and peripheral blood mononuclear cells (PBMCs) isolated from 20 patients with PBC, 20 patients with chronic hepatitis B (CHB) and 20 healthy controls.", {"entities": [[256, 265, "DISEASE"]]}], ["These miRNAs in PBMCs and plasma were validated by linear regression analyses.", {"entities": []}], ["The T cell subset frequency was analyzed by flow cytometry.", {"entities": []}], ["Correlations between altered miRNA expression and the frequency of the T cell subsets were determined by linear regression analyses.", {"entities": []}], ["The co-expression of miRNAs and IL-17A was examined using fluorescence in situ hybridization (FISH) and immunohistochemistry.", {"entities": []}], ["The microarray analysis identified sixteen miRNAs that were differentially expressed.", {"entities": []}], ["Four miRNAs were validated by RT-qPCR.", {"entities": []}], ["The expression pattern of miR-572 and miR-92a in the PBMCs correlated with the expression pattern in plasma.", {"entities": [[26, 33, "GENE"], [38, 45, "GENE"]]}], ["We also found that miR-92a expression closely correlated with the frequency of a subset of IL-17-producing T helper cells (Th17), and that miR-92a was co-expressed with IL-17A in patients with PBC.", {"entities": [[19, 26, "GENE"], [139, 146, "GENE"], [19, 26, "GENE"], [139, 146, "GENE"]]}], ["Taken together, these findings revealed that plasma from patients with PBC has a unique miRNA expression profile.", {"entities": []}], ["Moreover, miR-92a may play an important role in the pathogenesis of PBC by regulating Th17 cell differentiation.", {"entities": [[10, 17, "GENE"]]}], ["The recently described IL-33 acts as a pro-inflammatory cytokine, inducing the expression of multiple responses in the target cells.", {"entities": []}], ["Although a nuclear localization of IL-33 has been described, its exact functional relevance is presently unknown.", {"entities": []}], ["The present study was conducted to analyze the effects of IL-33 on the TNF-\u03b1 induced synthesis of the pro-inflammatory mediators IL-6, IL-8, and monocyte chemotactic protein-1 (MCP-1) and the pro-destructive molecules matrix metalloproteinase-1 (MMP-1), MMP-3, and TIMP-1 of rheumatoid arthritis synovial fibroblast (RA-SFs) using RNA overexpression and silencing.", {"entities": [[275, 295, "DISEASE"], [286, 295, "DISEASE"]]}], ["TNF-\u03b1 significantly induced IL-33 mRNA expression and protein synthesis in RA-SFs.", {"entities": []}], ["TNF-\u03b1-induced IL-33 protein expression was mediated via p38 signaling.", {"entities": []}], ["Immunohistochemistry for IL-33 clearly showed that nuclear translocation of IL-33 was induced in TNF-\u03b1 stimulated RA-SFs.", {"entities": []}], ["IL-33 overexpression enhanced TNF-\u03b1-induced pro-inflammatory and pro-destructive functions in RA-SFs.", {"entities": []}], ["IL-33 silencing significantly downregulated TNF-\u03b1-induced pro-inflammatory functions, whereas TNF-\u03b1-induced pro-destructive functions were less influenced by IL-33 silencing.", {"entities": []}], ["This study identifies IL-33 as a critical regulator/enhancer of TNF-\u03b1-induced functions in RA-SFs, pointing to a central role of this cytokine in the perpetuation of pro-inflammatory and pro-destructive processes in rheumatoid arthritis (RA) and other inflammatory and degenerative diseases.", {"entities": [[216, 236, "DISEASE"], [227, 236, "DISEASE"]]}], ["Background .", {"entities": []}], ["Entonox (N 2 O 2 ) which is an inhalational gas for relieving labor pain is commonly used intermittently; however some women are interested in continuous breathing in face mask.", {"entities": []}], ["So we decided to compare the complications induced by two methods to find out whether it is safe to permit the mothers to use Entonox continuously or not.", {"entities": []}], ["Patients and Methods .", {"entities": []}], ["This randomized clinical trial was performed in Mobini Hospital, Sabzevar, Iran.", {"entities": []}], ["50 parturients used Entonox intermittently and 50 cases used it continuously during labor.", {"entities": []}], ["Then obstetrical outcomes were analyzed in two groups by spss 17 software, t -test, and Chi P < 0.05 was considered significant.", {"entities": []}], ["This study showed the mean duration of second stage of labor had no significant difference ( P = 0.3).", {"entities": []}], ["Perineal laceration was less in continuous group significantly ( P = 0.04).", {"entities": []}], ["Assisted vaginal birth was not different significantly ( P = 0.4).", {"entities": []}], ["Uterine atony had no significant difference in two groups ( P = 0.2).", {"entities": []}], ["Maternal collaboration in pushing and satisfaction were higher in continuous group significantly ( P = 0.03), ( P < 0.0001).", {"entities": []}], ["Apgar score of neonates at first and fifth minute was acceptable and not different significantly in two groups ( P = 0.3).", {"entities": []}], ["Conclusions .", {"entities": []}], ["Our study demonstrated continuous method is also safe.", {"entities": []}], ["So, it seems reasonable to set mothers free to choose the desired method of Entonox usage.", {"entities": []}], ["The exact molecular mechanism that mediates hypoxia-induced pulmonary fibrosis needs to be further clarified.", {"entities": [[60, 78, "DISEASE"]]}], ["The aim of this study was to explore the effect and underlying mechanism of angiotensin II (Ang II) on collagen synthesis in hypoxic human lung fibroblast (HLF) cells.", {"entities": [[92, 95, "GENE"], [156, 159, "GENE"]]}], ["The HLF-1 cell line was used for in vitro studies.", {"entities": []}], ["Angiotensinogen (AGT), angiotensin converting enzyme (ACE), angiotensin II type 1 receptor (AT1R) and angiotensin II type 2 receptor (AT2R) expression levels in human lung fibroblasts were analysed using real-time polymerase chain reaction (RT-PCR) after hypoxic treatment.", {"entities": [[17, 20, "GENE"]]}], ["Additionally, the collagen type I (Col-I), AT1R and nuclear factor \u03baappaB (NF-\u03baB) protein expression levels were detected using Western blot analysis, and NF-\u03baB nuclear translocation was measured using immunofluorescence localization analysis.", {"entities": []}], ["Ang II levels in HLF-1 cells were measured with an enzyme-linked immunosorbent assay (ELISA).", {"entities": [[0, 3, "GENE"]]}], ["We found that hypoxia increased Col-I mRNA and protein expression in HLF-1 cells, and this effect could be inhibited by an AT1R or AT2R inhibitor.", {"entities": []}], ["The levels of NF-\u03baB, RAS components and Ang II production in HLF-1 cells were significantly increased after the hypoxia exposure.", {"entities": [[40, 43, "GENE"]]}], ["Hypoxia or Ang II increased NF-\u03baB-p50 protein expression in HLF-1 cells, and the special effect could be inhibited by telmisartan (TST), an AT1R inhibitor, and partially inhibited by PD123319, an AT2R inhibitor.", {"entities": [[11, 14, "GENE"]]}], ["Importantly, hypoxia-induced NF-\u03baB nuclear translocation could be nearly completely inhibited by an AT1R or AT2R inhibitor.", {"entities": []}], ["Furthermore pyrrolidine dithiocarbamate (PDTC), a NF-\u03baB blocker, abolished the expression of hypoxia-induced AT1R and Col-I in HLF-1 cells.", {"entities": []}], ["Our results indicate that Ang II-mediated NF-\u03baB signalling via ATR is involved in hypoxia-induced collagen synthesis in human lung fibroblasts.", {"entities": [[26, 29, "GENE"], [63, 66, "GENE"]]}], ["Candida sp.", {"entities": []}], ["have been responsible for an increasing number of infections, especially in patients with immunodeficiency.", {"entities": []}], ["Species-specific differentiation of Candida sp.", {"entities": []}], ["is difficult in routine diagnosis.", {"entities": []}], ["This identification can have a highly significant association in therapy and prophylaxis.", {"entities": []}], ["This work has shown a new application of the terminal restriction fragment length polymorphism (t-RFLP) method in the molecular identification of six species of Candida , which are the most common causes of fungal infections.", {"entities": []}], ["Specific for fungi homocitrate synthase gene was chosen as a molecular target for amplification.", {"entities": []}], ["The use of three restriction enzymes, Dra I, Rsa I, and Bgl II, for amplicon digestion can generate species-specific fluorescence labeled DNA fragment profiles, which can be used to determine the diagnostic algorithm.", {"entities": []}], ["The designed method can be a cost-efficient high-throughput molecular technique for the identification of six clinically important Candida species.", {"entities": []}], ["There is a growing appreciation by the biomedical community that studying the impact of sex and gender on health, aging, and disease will lead to improvements in human health.", {"entities": []}], ["Sex- and gender-based comparisons can inform research on disease mechanisms and the development of new therapeutics as well as enhance scientific rigor and reproducibility.", {"entities": []}], ["This review will assist basic researchers, clinical investigators, as well as epidemiologists, population, and social scientists by providing an annotated bibliography of currently available resource tools on how to consider sex and gender as independent variables in research design and methodology.", {"entities": []}], ["These resources will assist investigators applying for funding from the National Institutes of Health since all grant applicants will be required (as of January 25, 2016) to address the role of sex as a biological variable in vertebrate animal and human studies.", {"entities": []}], ["The primary aim of the present study was to investigate if exposure to dust from absorbent hygiene products containing superabsorbent polymer is related to symptoms from the airways and from the eyes.", {"entities": []}], ["The secondary aim was to estimate the current exposure to superabsorbent polymer among production and maintenance workers in a plant producing hygiene products.", {"entities": []}], ["The cohort comprised 1043 workers of whom 689 were exposed to super absorbent polymer and 804 were exposed to paper dust (overlapping groups).", {"entities": []}], ["There was 186 workers not exposed to either superabsorbent polymer or to paper dust They were investigated with a comprehensive questionnaire about exposure, asthma, rhinitis and symptoms from eyes and airways.", {"entities": [[166, 174, "DISEASE"], [158, 164, "DISEASE"]]}], ["The results were analyzed with logistic regression models adjusting for sex, age, atopy and smoking habits.", {"entities": []}], ["An aerosol sampler equipped with a polytetrafluoroethylene filter with 1 \u03bcm pore size was used for personal samplings in order to measure inhalable dust and superabsorbent polymer.", {"entities": []}], ["The prevalence of nasal crusts (OR 1.4, 95% CI 1.01-2.0) and nose-bleeding (OR 1.7, 95% CI 1.2-2.4) was increased among the paper dust exposed workers (adjusted for superabsorbent polymer exposure).", {"entities": []}], ["There were no significant effects associated with exposure to superabsorbent polymer (adjusted for paper dust exposure).", {"entities": []}], ["The average exposure to inhalable levels of total dust (paper dust) varied between 0.40 and 1.37 mg/m In conclusion, our study shows that workers manufacturing diapers in the hygiene industry have an increased prevalence of symptoms from the nose, especially nose-bleeding.", {"entities": []}], ["There was no relation between exposure to superabsorbent polymer and symptoms from eyes, nose or respiratory tract, but exposure to paper dust was associated with nose-bleeding and nasal crusts.", {"entities": []}], ["This group of workers had also a considerable exposure to superabsorbent polymer dust.", {"entities": []}], ["In India, private pharmacies are ubiquitous yet critical establishments that facilitate community access to medicines.", {"entities": []}], ["These are often the first points of treatment seeking in parts of India and other low income settings around the world.", {"entities": []}], ["The characteristics of these pharmacies including their location, drug availability, human resources and infrastructure have not been studied before.", {"entities": []}], ["Given the ubiquity and popularity of private pharmacies in India, such information would be useful to harness the potential of these pharmacies to deliver desirable public health outcomes, to facilitate regulation and to involve in initiatives pertaining to rational drug use.", {"entities": []}], ["This study was a cross sectional survey that mapped private pharmacies in one district on a geographic information system and described relevant characteristics of these units.", {"entities": []}], ["This study of pharmacies was a part of larger cross sectional survey carried out to map all the health care providers in Ujjain district (population 1.9 million), Central India, on a geographic information system.", {"entities": []}], ["Their location vis-\u00e0-vis formal providers of health services were studied.", {"entities": []}], ["Other characteristics like human resources, infrastructure, clients and availability of tracer drugs were also surveyed.", {"entities": []}], ["A total 475 private pharmacies were identified in the district.", {"entities": []}], ["Three-quarter were in urban areas, where they were concentrated around physician practices.", {"entities": []}], ["In rural areas, pharmacies were located along the main roads.", {"entities": []}], ["A majority of pharmacies simultaneously retailed medicines from multiple systems of medicine.", {"entities": []}], ["Tracer parenteral antibiotics and injectable steroids were available in 83.7% and 88.7% pharmacies respectively.", {"entities": []}], ["The proportion of clients without prescription was 39.04%.", {"entities": []}], ["Only 11.58% of staff had formal pharmacist qualifications.", {"entities": []}], ["Power outages were a significant challenge.", {"entities": []}], ["This is the first mapping of pharmacies & their characteristics in India.", {"entities": []}], ["It provides evidence of the urban dominance and close relationship between healthcare provider location and pharmacy location.", {"entities": []}], ["The implications of this relationship are discussed.", {"entities": []}], ["The study reports a lack of qualified staff in the presence of a high proportion of clients attending without a prescription.", {"entities": []}], ["The study highlights the need for the better implementation of regulation.", {"entities": []}], ["Besides facilitating regulation & partnerships, the data also provides a sampling frame for future interventional studies on these pharmacies.", {"entities": []}], ["The Notch pathway plays a role in the processes of cell proliferation, differentiation, and apoptosis, which affect the development and function of various organs.", {"entities": []}], ["Dendritic cells (DCs), as professional antigen-presenting cells (APCs), induce T cell activation and promote T cell differentiation by antigen stimulation.", {"entities": [[65, 69, "GENE"]]}], ["Research has shown that Notch ligand delta-like 4 (Dll4) in APCs is associated with stimulation of a Th1-type response.", {"entities": [[51, 55, "GENE"], [60, 64, "GENE"]]}], ["However, the regulatory roles of Dll4 in the activation and function of DCs have yet to be clearly elucidated.", {"entities": [[33, 37, "GENE"]]}], ["In this study, we demonstrated that activation of Dll4-pretreated bone marrow-derived DCs by performing ovalbumin (OVA) stimulation expressed a high level of interleukin (IL)-10 without diminishing IL-12 production.", {"entities": []}], ["By contrast, the proinflammatory cytokines, IL-1\u03b2, IL-6, and tumor necrosis factor (TNF)-\u03b1, decreased in Dll4-pretreated DCs by performing either lipopolysaccharide (LPS) or OVA stimulation.", {"entities": [[84, 87, "GENE"]]}], ["Compared to fully mature DCs, lower levels of MHC class II CD40 and higher levels of CD80 and CD86 molecules were expressed in these semi-mature like DCs.", {"entities": [[59, 63, "GENE"], [85, 89, "GENE"], [94, 98, "GENE"]]}], ["Dll4 Notch signaling also enhanced Notch ligand mRNA expression of Dll1, Dll4, and Jagged1 in DCs.", {"entities": [[0, 4, "GENE"], [73, 77, "GENE"], [67, 71, "GENE"], [0, 4, "GENE"], [73, 77, "GENE"]]}], ["Dll4-modified DCs exhibited a reduced capacity to stimulate the proliferation of OVA-specific CD4 2a antibody production, lower eotaxin, keratinocyte-derived chemokine (KC), IL-5, and IL-13 release in bronchial alveolar lavage fluid, attenuated airway hyper-responsiveness, and promoted higher IL-10 and interferon (IFN)-\u03b3 production in the spleen.", {"entities": [[94, 97, "GENE"]]}], ["In summary, our findings elucidate the new role of Dll4 in the phenotype and function of DCs and provide a novel approach for manipulating T cell-driven deleterious immune diseases.", {"entities": [[51, 55, "GENE"]]}], ["Consuming a high-fat meal (HFM) may lead to postprandial lipemia (PPL) and inflammation.", {"entities": [[66, 69, "GENE"]]}], ["Postprandial exercise has been shown to effectively attenuate PPL.", {"entities": [[62, 65, "GENE"]]}], ["However, little is known about the impact of postprandial exercise on systemic inflammation and whether PPL and inflammation are associated.", {"entities": [[104, 107, "GENE"]]}], ["The purpose of this study was to determine whether moderate intensity exercise performed 60\u00a0min following a true-to-life HFM would attenuate PPL and inflammation.", {"entities": [[141, 144, "GENE"]]}], ["Thirty-nine young adults (18\u201340\u00a0year) with no known metabolic disease were randomized to either a control group (CON) who remained sedentary during the postprandial period or an exercise (EX) group who walked at 60\u00a0% VO 2peak to expend\u2009\u2248\u20095\u00a0kcal/kgbw one-hour following the HFM.", {"entities": []}], ["Participants consumed a HFM of 10\u00a0kcal/kgbw and blood draws were performed immediately before, 2\u00a0h and 4\u00a0h post-HFM.", {"entities": []}], ["At baseline, there were no differences between EX and CON groups for any metabolic or inflammatory markers ( p \u2009>\u20090.05).", {"entities": []}], ["Postprandial triglycerides (TRG) increased from baseline to 4\u00a0h in the EX and CON groups ( p \u2009<\u20090.001), with no differences between groups ( p \u2009=\u20090.871).", {"entities": []}], ["High density lipoprotein cholesterol (HDL-C) decreased in both groups across time ( p \u2009<\u20090.001) with no differences between groups ( p \u2009=\u20090.137).", {"entities": []}], ["Interleukin-6 (IL-6) was significant as a quadratic function over time ( p \u2009=\u20090.005), decreasing from baseline to 2\u00a0h then increasing and returning to baseline at 4\u00a0h in all participants with no difference between groups ( p \u2009=\u20090.276).", {"entities": []}], ["Tumor necrosis factor-alpha (TNF-\u03b1) was not different from baseline to 4\u00a0h between groups ( p \u2009>\u20090.05).", {"entities": []}], ["There was an increase in soluble vascular adhesion molecule (sVCAM-1) from baseline to 4\u00a0h ( p \u2009=\u20090.027) for all participants along with a group x time interaction ( p \u2009=\u20090.020).", {"entities": []}], ["Changes in TRG were associated with changes in interleukin-10 (IL-10) from 0 to 2\u00a0h ( p \u2009=\u20090.007), but were not associated with changes in any other inflammatory marker in the postprandial period ( p \u2009>\u20090.05).", {"entities": []}], ["Despite significant increases in PPL following a HFM, moderate intensity exercise in the postprandial period did not mitigate the PPL nor the inflammatory response to the HFM.", {"entities": [[33, 36, "GENE"], [130, 133, "GENE"], [33, 36, "GENE"], [130, 133, "GENE"]]}], ["These results indicate that in populations with low metabolic risk, PPL and inflammation following a HFM may not be directly related.", {"entities": [[68, 71, "GENE"]]}], ["Intestinal parasitic infections are a public health problem in developing countries such as Mexico.", {"entities": []}], ["As a result, two governmental programmes have been implemented: a) \"National Deworming Campaign\" and b) \"Opportunities\" aimed at maternal care.", {"entities": []}], ["However, both programmes are developed separately and their impact is still unknown.", {"entities": []}], ["We independently investigated whether a variety of socio-economic factors, including maternal education and employment levels, were associated with intestinal parasite infection in rural school children.", {"entities": []}], ["This cross-sectional study was conducted in 12 rural communities in two Mexican states.", {"entities": []}], ["The study sites and populations were selected on the basis of the following traits: a) presence of activities by the national administration of albendazole, b) high rates of intestinal parasitism, c) little access to medical examination, and d) a population having less than 2,500 inhabitants.", {"entities": []}], ["A total of 507 schoolchildren (mean age 8.2 years) were recruited and 1,521 stool samples collected (3 per child).", {"entities": []}], ["Socio-economic information was obtained by an oral questionnaire.", {"entities": []}], ["Regression modelling was used to determine the association of socio-economic indicators and intestinal parasitism.", {"entities": []}], ["More than half of the schoolchildren showed poliparasitism (52%) and protozoan infections (65%).", {"entities": []}], ["The prevalence of helminth infections was higher in children from Oaxaca (53%) than in those from Sinaloa (33%) (p < 0.0001).", {"entities": []}], ["Giardia duodenalis and Hymenolepis nana showed a high prevalence in both states.", {"entities": []}], ["Ascaris lumbricoides , Trichuris trichiura and Entamoeba hystolitica/dispar showed low prevalence.", {"entities": []}], ["Children from lower-income families and with unemployed and less educated mothers showed higher risk of intestinal parasitism (odds ratio (OR) 6.0, 95% confidence interval (CI) 1.6\u201322.6; OR 4.5, 95% CI 2.5\u20138.2; OR 3.3, 95% CI 1.5\u20137.4 respectively).", {"entities": []}], ["Defecation in open areas was also a high risk factor for infection (OR 2.4, 95% CI 2.0\u20133.0).", {"entities": []}], ["Intestinal parasitism remains an important public health problem in Sinaloa (north-western Mexico) and Oaxaca (south-eastern Mexico).", {"entities": []}], ["Lower income, defecation in open areas, employment status and a lower education level of mothers were the significant factors related to these infections.", {"entities": []}], ["We conclude that mothers should be involved in health initiatives to control intestinal parasitism in Mexico.", {"entities": []}], ["Health literacy (HL) refers to the ability to obtain, process, and understand basic health information and services, and is thus needed to make appropriate health decisions.", {"entities": []}], ["The Newest Vital Sign (NVS) is comprised of 6 questions about an ice cream nutrition label and assesses HL numeracy skills.", {"entities": []}], ["We developed a Japanese version of the NVS (NVS-J) and evaluated the validity and reliability of the NVS-J in patients with chronic pain.", {"entities": []}], ["The translation of the original NVS into Japanese was achieved as per the published guidelines.", {"entities": []}], ["An observational study was subsequently performed to evaluate the validity and reliability of the NVS-J in 43 Japanese patients suffering from chronic pain.", {"entities": []}], ["Factor analysis with promax rotation, using the Kaiser criterion (eigenvalues \u22651.0), and a scree plot revealed that the main component of the NVS-J consists of three determinative factors, and each factor consists of two NVS-J items.", {"entities": []}], ["The criterion-related validity of the total NVS-J score was significantly correlated with the total score of Ishikawa et al.", {"entities": []}], ["'s self-rated HL Questionnaire, the clinical global assessment of comprehensive HL level, cognitive function, and the Brinkman index.", {"entities": []}], ["In addition, Cronbach's coefficient for the total score of the NVS-J was adequate (alpha\u200a=\u200a0.72).", {"entities": []}], ["This study demonstrated that the NVS-J has good validity and reliability.", {"entities": []}], ["Further, the NVS-J consists of three determinative factors: \u201cbasic numeracy ability,\u201d \u201ccomplex numeracy ability,\u201d and \u201cserious-minded ability.\u201d These three HL abilities comprise a 3-step hierarchical structure.", {"entities": []}], ["Adequate HL should be promoted in chronic pain patients to enable coping, improve functioning, and increase activities of daily living (ADLs) and quality of life (QOL).", {"entities": []}], ["Objective To assess the receipt of effective healthcare interventions in England by adults aged 50 or more with serious health conditions.", {"entities": []}], ["Design National structured survey questionnaire with face to face interviews covering medical panel endorsed quality of care indicators for both publicly and privately provided care.", {"entities": []}], ["Setting Private households across England.", {"entities": []}], ["Participants 8688 participants in the English longitudinal study of ageing, of whom 4417 reported diagnoses of one or more of 13 conditions.", {"entities": []}], ["Main outcome measures Percentage of indicated interventions received by eligible participants for 32 clinical indicators and seven questions on patient centred care, and aggregate scores.", {"entities": []}], ["Results Participants were eligible for 19\u2009082 items of indicated care.", {"entities": []}], ["Receipt of indicated care varied substantially by condition.", {"entities": []}], ["The percentage of indicated care received by eligible participants was highest for ischaemic heart disease (83%, 95% confidence interval 80% to 86%), followed by hearing problems (79%, 77% to 81%), pain management (78%, 73% to 83%), diabetes (74%, 72% to 76%), smoking cessation (74%, 71% to 76%), hypertension (72%, 69% to 76%), stroke (65%, 54% to 76%), depression (64%, 57% to 70%), patient centred care (58%, 57% to 60%), poor vision (58%, 54% to 63%), osteoporosis (53%, 49% to 57%), urinary incontinence (51%, 47% to 54%), falls management (44%, 37% to 51%), osteoarthritis (29%, 26% to 32%), and overall (62%, 62% to 63%).", {"entities": [[298, 310, "DISEASE"], [93, 106, "DISEASE"], [457, 469, "DISEASE"], [565, 579, "DISEASE"]]}], ["Substantially more indicated care was received for general medical (74%, 73% to 76%) than for geriatric conditions (57%, 55% to 58%), and for conditions included in the general practice pay for performance contract (75%, 73% to 76%) than excluded from it (58%, 56% to 59%).", {"entities": []}], ["Conclusions Shortfalls in receipt of basic recommended care by adults aged 50 or more with common health conditions in England were most noticeable in areas associated with disability and frailty, but few areas were exempt.", {"entities": []}], ["Efforts to improve care have substantial scope to achieve better health outcomes and particularly need to include chronic conditions that affect quality of life of older people.", {"entities": []}], ["Even though it has been suggested that antiretroviral therapy has an impact on severe hypovitaminosis D (SHD) in HIV infected patients, it could be speculated that the different levels of residual inflammation on HAART (Highly Active Anti Retroviral Therapy) could contribute to SHD and aggravate bone catabolism in these patients.", {"entities": [[105, 108, "GENE"], [279, 282, "GENE"], [105, 108, "GENE"], [279, 282, "GENE"]]}], ["A cross-sectional study was carried out in an unselected cohort of 263 HIV infected outpatients consulting during Spring 2010.", {"entities": []}], ["Clinical examinations were performed and medical history, food habits, sun exposure and addictions were collected.", {"entities": []}], ["Fasting blood samples were taken for immunological, virological, inflammation, endocrine and bone markers evaluations.", {"entities": []}], ["Ninety-five (36%) patients had SHD.", {"entities": [[31, 34, "GENE"]]}], ["In univariate analysis, a significant and positive association was found between SHD and IL6 (p = 0.001), hsCRP (p = 0.04), increased serum C-Telopeptides X (CTX) (p = 0.005) and Parathyroid Hormon (PTH) (p < 0.0001) levels.", {"entities": [[81, 84, "GENE"], [89, 92, "GENE"], [199, 202, "GENE"]]}], ["In multivariate analysis, SHD deficiency correlated significantly with increased IL-6, high serum CTX levels, lower mean daily exposure to the sun, current or past smoking, hepatitis C, and functional status (falls), but not with the time spent on the current HAART (by specific drug or overall).", {"entities": [[173, 182, "DISEASE"], [26, 29, "GENE"]]}], ["SHD is frequent and correlates with inflammation in HIV infected patients.", {"entities": [[0, 3, "GENE"]]}], ["Since SHD is also associated with falls and increased bone catabolism, it may be of interest to take into account not only the type of antiretroviral therapy but also the residual inflammation on HAART in order to assess functional and bone risks.", {"entities": [[6, 9, "GENE"]]}], ["This finding also suggests that vitamin D supplementation may be beneficial in these HIV-infected patients.", {"entities": []}], ["Multiple imputation is a reliable tool to deal with missing data and is becoming increasingly popular in biostatistics.", {"entities": []}], ["However, building a model with interactions that are not specified a priori , in the presence of missing data, presents a challenge.", {"entities": []}], ["On the one hand, the interactions are needed to impute the data, while on the other hand, the data is needed to identify the interactions.", {"entities": []}], ["The objective of this study was to present a way in which this challenge can be addressed.", {"entities": []}], ["This paper investigates two strategies in which model development with interactions is achieved using a single data set generated from the Expectation Maximization (EM) algorithm.", {"entities": []}], ["Imputation using both the fully conditional specification approach and the multivariate normal approach is carried out and results are compared.", {"entities": []}], ["The strategies are illustrated with data from a study of ambient pollution and childhood asthma in Durban, South Africa.", {"entities": [[89, 95, "DISEASE"]]}], ["The different approaches to model building and imputation yielded similar results despite the data being mainly categorical.", {"entities": []}], ["Both strategies investigated for building the model using the multivariate normal imputed data resulted in the identical set of variables and interactions being identified; while models built using data imputed by fully conditional specification were marginally different for the two strategies.", {"entities": []}], ["It was found that, for both imputation approaches, model building with backward elimination applied to the initial EM data set was easier to implement, and produced good results, compared to those from a complete case analysis.", {"entities": []}], ["Developing a predictive model including interactions with data that suffers from missingness is easily done by identifying significant interactions and then applying backward elimination to a single data set imputed from the EM algorithm.", {"entities": []}], ["It is hoped that this idea can be further developed and, by addressing this practical dilemma, there will be increased adoption of multiple imputation in medical research when data suffers from missingness.", {"entities": []}], ["Understanding the characteristics of Chinese American smokers with medical conditions and factors associated with their tobacco-use behaviors will guide effective cessation programs.", {"entities": []}], ["In 2008, the authors described socio-demographic profiles of Chinese smokers with medical conditions treated during the period 2002\u20132006, documented their tobacco-use behaviors (i.e., average daily cigarette use, nicotine dependence, and number of past-year quit attempts), and drew comparisons between subjects recruited from hospitals (IP) and ambulatory settings (OP).", {"entities": [[213, 232, "DISEASE"]]}], ["Compared to OP, IP were significantly older, less educated, less acculturated, and more likely to be retired.", {"entities": []}], ["Of the two groups, IP had poorer disease profiles, smoked less (4.4 vs. 11.9 cigarettes per day), and had lower nicotine-addiction scores (5.5 vs. 6.7).", {"entities": []}], ["There was no difference between groups in past-year quit attempts.", {"entities": []}], ["After adjustments, the data revealed that being employed and OP was associated with higher average daily cigarette use; IP were less nicotine dependent than OP; and for both groups, years of smoking was negatively associated with past-year quit attempts.", {"entities": []}], ["Our study suggests that, more than acculturation level, health status influences the Chinese smoker\u2019s level of cigarette use and nicotine addiction.", {"entities": []}], ["Given the severity of their disease profiles, IP should be aggressively targeted for intervention, as they are more likely to be light smokers and to be less nicotine dependent than OP.", {"entities": []}], ["Future tobacco treatment studies should pay attention to health status among smokers in health-care settings in order to provide a more accurate assessment of treatment needs and of barriers to successful smoking cessation.", {"entities": []}], ["Lymphocytes from patients with neoplastic disease were tested for sensitization to encephalitogenic factor (EF) by the macrophage migration inhibition test.", {"entities": []}], ["Sensitization to EF was demonstrated in 71% of patients with various forms of neoplastic disease.", {"entities": []}], ["Sensitization to EF was also demonstrated for 31% of subjects with no evidence of neoplastic disease; these included patients with warts, chronic bronchitis and hernias.", {"entities": [[146, 156, "DISEASE"]]}], ["In contrast, healthy subjects showed no sensitization to myelin basic protein.", {"entities": []}], ["These observations suggest that sensitization to EF may not be confined to patients with neoplastic disease.", {"entities": []}], ["Lymphocytes from hamsters bearing a transplanted virus induced tumour were sensitized to EF prepared from both human and hamster brain.", {"entities": []}], ["Sensitization was also seen in hamsters infected with influenza virus but not in animals with acute tubular necrosis produced by glycerol treatment.", {"entities": [[54, 63, "DISEASE"]]}], ["The development of an animal model system provides a method for the investigation of possible mechanisms of sensitization.", {"entities": []}], ["Evidence suggests that gender differences exist in the severity of many immunological diseases and their response to glucocorticosteroid treatment.", {"entities": []}], ["In this report, we have used a murine model of ovalbumin-induced lung inflammation to address whether gender could affect the systemic response, airway inflammation and hyperreactivity and their responses to budesonide.", {"entities": []}], ["Following an acute ovalbumin challenge, actively sensitised BALB/c mice developed a time-dependent increase in interleukin-4 and interleukin-5 production and inflammatory cell influx into bronchoalveolar lavage fluid.", {"entities": []}], ["Apart from an increased number of lymphocytes in female mice at day 3 post-challenge, none of the above parameters were affected by gender.", {"entities": []}], ["Blood leukocyte numbers were also unaffected, whereas a two-fold increase in total serum immunoglobulin E was observed in female mice.", {"entities": []}], ["Budesonide, given intranasally, did not affect the blood parameters, but dose-dependently inhibited the pulmonary inflammation and airway hyperreactivity in both male and female mice.", {"entities": []}], ["Female mice were slightly less sensitive to budesonide's inhibitory action on interleukin-5 production and the development of airway hyperreactivity.", {"entities": []}], ["Our results suggest that, apart from a 2-fold increase in serum immunoglobulin E levels observed in female mice, gender is not a major factor in the present murine model of ovalbumin-induced lung inflammation.", {"entities": []}], ["In contrast, gender might slightly influence the potency of test compounds such as steroids.", {"entities": []}], ["Neolitsea species, medicinal plants belonging to Lauraceae, contain rich alkaloids, steroids, sesquiterpenoids, and triterpenoids which possess antimicrobial, antioxidant, and anti-inflammatory bioactivities.", {"entities": []}], ["However, species differences in the immunomodulatory effects and evidence pertaining to the effects of Neolitsea species on adaptive immunity are scarce.", {"entities": []}], ["This study aimed to evaluate the immunomodulatory properties of ten Taiwanese Neolitsea plants on T helper (Th) cell functionality, especially Th1 and Th2.", {"entities": []}], ["Most of the 29 crude extracts of Neolitsea were not toxic to splenocytes, except N. buisanensis roots.", {"entities": []}], ["N. aciculata and N. villosa leaf extracts possessed differential immunomodulatory effects on Th1/Th2 balance.", {"entities": []}], ["N. aciculata var.", {"entities": []}], ["variabillima and N. hiiranensis leaf extracts attenuated both Th1 and Th2 cytokines while N. konishii dramatically suppressed IFN- \u03b3 production.", {"entities": []}], ["As N. aciculata var.", {"entities": []}], ["variabillima and N. konishii leaf extracts significantly attenuated Th1 functionality, we further evaluated their effects on CD4 cells under CD3/CD28 stimulation.", {"entities": [[125, 128, "GENE"]]}], ["N. aciculata var.", {"entities": []}], ["variabillima significantly suppressed IFN- \u03b3 , IL-10, and IL-17, demonstrating the broad suppressive effects on T helper cells; N. konishii significantly suppressed IFN- \u03b3 and IL-10 production, while the production of IL-17 was not altered.", {"entities": []}], ["Collectively, these data demonstrated that leaf extracts of Taiwanese Neolitsea species contain phytochemicals with potentials to be developed as selective immunomodulators.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is characterized by lung and systemic inflammation as well as airway goblet cell hyperplasia (GCH).", {"entities": []}], ["Mucin production is activated in part by stimulation of the epidermal growth factor (EGF) receptor pathway through neutrophils and macrophages.", {"entities": [[85, 88, "GENE"]]}], ["How circulating cytokine levels relate to GCH is not clear.", {"entities": []}], ["We performed phlebotomy and bronchoscopy on 25 subjects (six nonsmokers, 11 healthy smokers, and eight COPD subjects FEV 1 30\u201360\u00a0%).", {"entities": [[117, 120, "GENE"]]}], ["Six endobronchial biopsies per subject were performed.", {"entities": []}], ["GCH was measured by measuring mucin volume density (MVD) using stereological techniques on periodic acid fast-Schiff stained samples.", {"entities": [[52, 55, "GENE"]]}], ["We measured the levels of chemokines CXCL8/IL-8, CCL2/MCP-1, CCL7/MCP-3, CCL22/MCD, CCL3/MIP-1\u03b1, and CCL4/MIP-1\u03b2, and the cytokines IL-1, IL-4, IL-6, IL-9, IL-17, EGF, and vascular endothelial growth factor (VEGF).", {"entities": [[163, 166, "GENE"]]}], ["Differences between groups were assessed using one-way ANOVA, t test, or Chi squared test.", {"entities": []}], ["Post hoc tests after ANOVA were performed using Bonferroni correction.", {"entities": []}], ["MVD was highest in healthy smokers (27.78\u2009\u00b1\u200910.24\u00a0\u03bcL/mm p \u2009=\u20090.216) and nonsmokers (3.42\u2009\u00b1\u20093.07\u00a0\u03bcL/mm p <0.0001).", {"entities": [[0, 3, "GENE"]]}], ["Plasma CXCL8 was highest in healthy smokers (11.05\u2009\u00b1\u20098.92\u00a0pg/mL) compared to nonsmokers (1.20\u2009\u00b1\u200921.92\u00a0pg/mL, p \u2009=\u20090.047) and COPD subjects (6.01\u2009\u00b1\u20095.90\u00a0pg/mL, p \u2009=\u20090.366).", {"entities": []}], ["CCL22 and CCL4 followed the same trends.", {"entities": [[0, 5, "GENE"], [10, 14, "GENE"]]}], ["There were no significant differences in the other cytokines measured.", {"entities": []}], ["When the subjects were divided into current smokers (healthy smokers and COPD current smokers) and non/ex-smokers (nonsmokers and COPD ex-smokers), plasma CXCL8, CCL22, CCL4, and MVD were greater in current smokers.", {"entities": [[162, 167, "GENE"], [169, 173, "GENE"], [179, 182, "GENE"]]}], ["No differences in other cytokines were seen.", {"entities": []}], ["Plasma CXCL8 moderately correlated with MVD ( r \u2009=\u20090.552, p \u2009=\u20090.003).", {"entities": [[40, 43, "GENE"]]}], ["In this small cohort, circulating levels of the chemokines CXCL8, CCL4, and CCL22, as well as MVD, attain the highest levels in healthy smokers compared to nonsmokers and COPD subjects.", {"entities": [[66, 70, "GENE"], [76, 81, "GENE"], [94, 97, "GENE"]]}], ["These findings seem to be driven by current smoking and are independent of airflow obstruction.", {"entities": []}], ["These data suggest that smoking upregulates a systemic pattern of neutrophil and macrophage chemoattractant expression, and this correlates significantly with the development of goblet cell hyperplasia.", {"entities": []}], ["Inflammation of cartilage is a primary symptom for knee-joint osteoarthritis.", {"entities": [[62, 76, "DISEASE"]]}], ["Matrix metalloproteinases (MMPs) are known to play an important role in the articular cartilage destruction related to osteoarthritis.", {"entities": [[119, 133, "DISEASE"]]}], ["Naringenin is a plant-derived flavonoid known for its anti-inflammatory properties.", {"entities": []}], ["We studied the effect of naringenin on the transcriptional expression, secretion and enzymatic activity of MMP-3 in vivo in the murine monosodium iodoacetate (MIA) osteoarthritis model.", {"entities": [[164, 178, "DISEASE"], [159, 162, "GENE"]]}], ["The assessment of pain behavior was also performed in the MIA rats.", {"entities": [[58, 61, "GENE"]]}], ["The destruction of knee-joint tissues was analyzed microscopically.", {"entities": []}], ["Moreover, the effect of naringenin was also studied in vitro in IL-1\u03b2 activated articular chondrocytes.", {"entities": []}], ["The transcriptional expression of MMP-3, MMP-1, MMP-13, thrombospondin motifs (ADAMTS-4) and ADAMTS-5 was also studied in primary cultured chondrocytes of rats.", {"entities": []}], ["Naringenin caused significant reduction in pain behavior and showed marked improvement in the tissue morphology of MIA rats.", {"entities": [[115, 118, "GENE"]]}], ["Moreover, a significant inhibition of MMP-3 expression in MIA rats was observed upon treatment with naringenin.", {"entities": [[58, 61, "GENE"]]}], ["In the in vitro tests, naringenin caused a significant reduction in the transcriptional expression, secretion and enzymatic activity of the studied degradative enzymes.", {"entities": []}], ["The NF-\u03baB pathway was also found to be inhibited upon treatment with naringenin in vitro .", {"entities": []}], ["Overall, the study suggests that naringenin alleviated pain and regulated the production of matrix-metalloproteinases via regulation of NF-\u03baB pathway.", {"entities": []}], ["Thus, naringenin could be a potent therapeutic option for the treatment of osteoarthritis.", {"entities": [[75, 89, "DISEASE"]]}], ["Adoptive transfer of in vivo\u2013primed CD8 EFF ) cells restores airway hyperresponsiveness (AHR) and airway inflammation in CD8-deficient (CD8 EFF cells compared with central memory CD8 EFF cells with a \u03b3-secretase inhibitor (GSI) strongly inhibited Notch signaling in these cells, and after adoptive transfer, GSI-treated T EFF cells failed to restore AHR and airway inflammation in sensitized and challenged recipient CD8 EFF cells.", {"entities": [[89, 92, "GENE"], [350, 353, "GENE"], [89, 92, "GENE"], [350, 353, "GENE"]]}], ["Treatment of sensitized and challenged WT mice with Delta1-Fc resulted in decreased AHR and airway inflammation accompanied by higher levels of interferon \u03b3 in bronchoalveolar lavage fluid.", {"entities": [[84, 87, "GENE"]]}], ["These results demonstrate a role for Notch in skewing the T cell response from a T helper (Th)2 to a Th1 phenotype as a consequence of the inhibition of Notch receptor activation and the up-regulation of the Notch ligand Delta1.", {"entities": []}], ["These data are the first to show a functional role for Notch in the challenge phase of CD8", {"entities": []}], ["Although differences in immunological responses between populations have been found in terms of vaccine efficacy, immune responses to infections and prevalence of chronic inflammatory diseases, the mechanisms responsible for these differences are not well understood.", {"entities": []}], ["Therefore, innate cytokine responses mediated by various classes of pattern-recognition receptors including Toll-like receptors (TLR), C-type lectin receptors (CLRs) and nucleotide-binding oligomerisation domain-like receptors (NLRs) were compared between Dutch (European), semi-urban and rural Gabonese (African) children.", {"entities": []}], ["Whole blood was stimulated for 24 hours and the pro-inflammatory tumor necrosis factor (TNF) and the anti-inflammatory/regulatory interleukin-10 (IL-10) cytokines in culture supernatant were measured by enzyme-linked immunosorbent assay (ELISA).", {"entities": [[88, 91, "GENE"]]}], ["Gabonese children had a lower pro-inflammatory response to poly(I:C) (TLR3 ligand), but a higher pro-inflammatory response to FSL-1 (TLR2/6 ligand), Pam3 (TLR2/1 ligand) and LPS (TLR4 ligand) compared to Dutch children.", {"entities": [[70, 74, "GENE"], [179, 183, "GENE"]]}], ["Anti-inflammatory responses to Pam3 were also higher in Gabonese children.", {"entities": []}], ["Non-TLR ligands did not induce substantial cytokine production on their own.", {"entities": []}], ["Interaction between various TLR and non-TLR receptors was further assessed, but no differences were found between the three populations.", {"entities": []}], ["In conclusion, using a field applicable assay, significant differences were observed in cytokine responses between European and African children to TLR ligands, but not to non-TLR ligands.", {"entities": []}], ["The existence of pronounced differences in health outcomes between US populations is a problem of moral significance and public health urgency.", {"entities": []}], ["Pursuing research on genetic contributors to such disparities, despite striking data on the fundamental role of social factors, has been controversial.", {"entities": []}], ["Still, advances in genomic science are providing an understanding of disease biology at a level of precision not previously possible.", {"entities": []}], ["The potential for genomic strategies to help in addressing population-level disparities therefore needs to be carefully evaluated.", {"entities": []}], ["Using 3 examples from current research, we argue that the best way to maximize the benefits of population-based genomic investigations, and mitigate potential harms, is to direct research away from the identification of genetic causes of disparities and instead focus on applying genomic methodologies to the development of clinical and public health tools with the potential to ameliorate healthcare inequities, direct population-level health interventions or inform public policy.", {"entities": []}], ["Such a transformation will require close collaboration between transdisciplinary teams and community members as well as a reorientation of current research objectives to better align genomic discovery efforts with public health priorities and well-recognized barriers to fair health care delivery.", {"entities": []}], ["Oral lichen planus (OLP) decreases the quality of life because it can cause spontaneous pain during eating and tooth-brushing and an uncomfortable feeling in the mouth.", {"entities": [[5, 18, "DISEASE"]]}], ["In addition, OLP may be associated with HCV-related liver disease.", {"entities": [[52, 65, "DISEASE"]]}], ["We investigated the visual analogue scale (VAS) and effects of oral care gel, REFRECARE-H Nine OLP patients (mean age 67.9 \u00b1 7.6 years) with HCV-related liver diseases were recruited and their VAS score determined along with a biochemical examination of the blood.", {"entities": []}], ["Types of OLP included erosive (6 patients) and reticular (3).", {"entities": []}], ["REFRECARE-H REFRECARE-H", {"entities": []}], ["Numerous studies have investigated the association between eosinophilia and clinical outcome of patients with chronic obstructive pulmonary disease (COPD) but the evidence is conflicting.", {"entities": [[110, 147, "DISEASE"], [59, 71, "DISEASE"]]}], ["We conducted a pooled analysis of outcome measures comparing eosinophilic and non-eosinophilic COPD patients.", {"entities": []}], ["We searched articles indexed in four databases using Medical Subject Heading or Title and Abstract words including COAD, COPD, eosinophil, eosinophilia, eosinopenia from inception to December 2016.", {"entities": [[139, 151, "DISEASE"]]}], ["Observational studies and randomized controlled trials with parallel groups comparing COPD patients with and without eosinophilia were included.", {"entities": [[117, 129, "DISEASE"]]}], ["Comparing to the non-eosinophilic group, those with eosinophilic COPD had a similar risk for exacerbation in 12 months [Odds ratio\u2009=\u20091.07, 95% confidence interval (CI) 0.86\u20131.32, P \u2009=\u20090.55] and in-hospital mortality [OR\u2009=\u20090.52, 95% CI 0.25\u20131.07].", {"entities": []}], ["Eosinophilia was associated with reduced length of hospital stay ( P \u2009=\u20090.04).", {"entities": [[0, 12, "DISEASE"]]}], ["Subsequent to therapeutic interventions, eosinophilic outpatients performed better in pulmonary function tests [Mean Difference\u2009=\u20091.64, 95% CI 0.05\u20133.23, P \u2009<\u20090.001].", {"entities": []}], ["Inclusion of hospitalized patients nullified the effect.", {"entities": []}], ["Improvement of quality of life was observed in eosinophilic subjects [Standardized Mean Difference\u2009=\u20091.83, 95% CI 0.02\u20133.64, P \u2009=\u20090.05], independent of hospitalization status.", {"entities": []}], ["In conclusion, blood eosinophilia may be predictive of favorable response to steroidal and bronchodilator therapies in patients with stable COPD.", {"entities": [[21, 33, "DISEASE"]]}], ["This study aimed to evaluate the effects of a high refined carbohydrate diet and pulmonary inflammatory response in C57BL/6 mice exposed to cigarette smoke (CS).", {"entities": [[157, 159, "GENE"]]}], ["Twenty-four male mice were divided into four groups: control group (CG), which received a standard diet; cigarette smoke group (CSG), which was exposed to CS; a high refined carbohydrate diet group (RG), which received a high refined carbohydrate diet; and a high refined carbohydrates diet and cigarette smoke group (RCSG), which received a high refined carbohydrate diet and was exposed to CS.", {"entities": [[155, 157, "GENE"], [392, 394, "GENE"], [155, 157, "GENE"], [392, 394, "GENE"]]}], ["The animals were monitored for food intake and body weight gain for 12 weeks.", {"entities": []}], ["After this period, the CSG and RCSG were exposed to CS for five consecutive days.", {"entities": [[52, 54, "GENE"]]}], ["At the end of the experimental protocol, all animals were euthanized for subsequent analyses.", {"entities": []}], ["There was an increase of inflammatory cells in the bronchoalveolar lavage fluid (BALF) of CSG compared to CG and RCSG compared to CG, CSG, and RG.", {"entities": []}], ["In addition, in the BALF, there was an increase of tumor necrosis factor alpha in RCSG compared to CG, CSG, and RG; interferon gamma increase in RCSG compared to the CSG; and increase in interleukin-10 in RCSG compared to CG and RG.", {"entities": []}], ["Lipid peroxidation increased in RCSG compared to CG, CSG, and RG.", {"entities": []}], ["Furthermore, the oxidation of proteins increased in CSG compared to CG.", {"entities": []}], ["The analysis of oxidative stress showed an increase in superoxide dismutase in RCSG compared to CG, CSG, and RG and an increase in the catalase activity in RCSG compared with CG.", {"entities": []}], ["In addition, there was a decrease in the glutathione reduced/glutathione total ratio of CSG, RG, and RCSG compared to CG.", {"entities": []}], ["Therefore, the administration of a high refined carbohydrate diet promoted an increase in pulmonary inflammation and oxidative stress in mice exposed to CS.", {"entities": [[153, 155, "GENE"]]}], ["Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung infections have critical consequences on mortality and morbidity in humans.", {"entities": [[37, 74, "DISEASE"], [29, 35, "DISEASE"]]}], ["The aims of the present study were to examine the mechanisms by which CXCL12 affects MUC1 transcription and airway inflammation, which depend on activator of G-protein signaling (AGS) 3 and to identify specific molecules that suppress CXCL12-induced airway inflammation by acting on G-protein-coupled receptors.", {"entities": [[70, 76, "GENE"], [235, 241, "GENE"], [85, 89, "GENE"]]}], ["Herein, AGS3 suppresses CXCL12-mediated upregulation of MUC1 and TNF\u03b1 by regulating G\u03b1 i .", {"entities": [[56, 60, "GENE"]]}], ["We found that the G-protein regulatory (GPR) motif peptide in AGS3 binds to G\u03b1 i and downregulates MUC1 expression; in contrast, this motif upregulates TNF\u03b1 expression.", {"entities": [[99, 103, "GENE"]]}], ["Mutated GPR Q34A peptide increased the expression of MUC1 and TGF\u03b2 but decreased the expression of TNF\u03b1 and IL-6.", {"entities": [[53, 57, "GENE"]]}], ["Moreover, CXCR4-induced dendritic extensions in 2D and 3D matrix cultures were inhibited by the GPR Q34A peptide compared with a wild-type GPR peptide.", {"entities": []}], ["The GPR Q34A peptide also inhibited CXCL12-induced morphological changes and inflammatory cell infiltration in the mouse lung, and production of inflammatory cytokines in bronchoalveolar lavage (BAL) fluid and the lungs.", {"entities": []}], ["Our data indicate that the GPR motif of AGS3 is critical for regulating MUC1/Muc1 expression and cytokine production in the inflammatory microenvironment.", {"entities": []}], ["The correlation between low socioeconomic status (SES) and poor health outcome or higher risk of disease has been consistently reported by many epidemiological studies across various race/ancestry groups.", {"entities": []}], ["However, the biological mechanisms linking low SES to disease and/or disease risk factors are not well understood and remain relatively under-studied.", {"entities": []}], ["The analysis of the blood transcriptome is a promising window for elucidating how social and environmental factors influence the molecular networks governing health and disease.", {"entities": []}], ["To further define the mechanistic pathways between social determinants and health, this study examined the impact of SES on the blood transcriptome in a sample of African-Americans.", {"entities": []}], ["An integrative approach leveraging three complementary methods (Weighted Gene Co-expression Network Analysis, Random Forest and Differential Expression) was adopted to identify the most predictive and robust transcriptome pathways associated with SES.", {"entities": []}], ["We analyzed the expression of 15079 genes (RNA-seq) from whole blood across 36 samples.", {"entities": []}], ["The results revealed a cluster of 141 co-expressed genes over-expressed in the low SES group.", {"entities": []}], ["Three pro-inflammatory pathways (IL-8 Signaling, NF-\u03baB Signaling and Dendritic Cell Maturation) are activated in this module and over-expressed in low SES.", {"entities": []}], ["Random Forest analysis revealed 55 of the 141 genes that, collectively, predict SES with an area under the curve of 0.85.", {"entities": []}], ["One third of the 141 genes are significantly over-expressed in the low SES group.", {"entities": []}], ["Lower SES has consistently been linked to many social and environmental conditions acting as stressors and known to be correlated with vulnerability to chronic illnesses (e.g.", {"entities": []}], ["asthma, diabetes) associated with a chronic inflammatory state.", {"entities": [[0, 6, "DISEASE"]]}], ["Our unbiased analysis of the blood transcriptome in African-Americans revealed evidence of a robust molecular signature of increased inflammation associated with low SES.", {"entities": []}], ["The results provide a plausible link between the social factors and chronic inflammation.", {"entities": []}], ["The arts are powerful, accessible forms of communication that have the potential to impart knowledge by attracting interest and developing meaningful connections.", {"entities": []}], ["Knowledge translation aims to reduce the \u2018evidence-practice\u2019 gap by developing, implementing and evaluating strategies designed to enhance awareness and promote behavior change congruent with research evidence.", {"entities": []}], ["Increasingly, innovative approaches such as narrative storytelling and other arts-based interventions are being investigated to bridge the growing gap between practice and research.", {"entities": []}], ["This study is the first to systematically identify and synthesize current research on narrative storytelling and visual art to translate and disseminate health research.", {"entities": []}], ["A health research librarian will develop and implement search strategies designed to identify relevant evidence.", {"entities": []}], ["Studies will be included if they are primary research employing narrative storytelling and/or visual art as a knowledge translation strategy in healthcare.", {"entities": []}], ["Two reviewers will independently perform study selection, quality assessment, and data extraction using standard forms.", {"entities": []}], ["Disagreements will be resolved through discussion or third party adjudication.", {"entities": []}], ["Data will be grouped and analyzed by research design, type of knowledge translation strategy (that is, a narrative or visual-arts-based approach), and target audience.", {"entities": []}], ["An overall synthesis across all studies will be conducted.", {"entities": []}], ["The findings from this research project will describe the \u2018state of the science\u2019 regarding the use of narrative storytelling and visual art as knowledge translation strategies.", {"entities": []}], ["This systematic review will provide critical information for: (1) researchers conducting knowledge translation intervention studies; (2) nursing, medicine, and allied healthcare professionals; (3) healthcare consumers, including patients and families; and (4) decision makers and knowledge users who are charged to increase use of the latest research in healthcare settings.", {"entities": []}], ["Indoor microbial contamination due to excess moisture is an important contributor to human illness in both residential and occupational settings.", {"entities": []}], ["However, the census of microorganisms in the indoor environment is limited by the use of selective, culture-based detection techniques.", {"entities": []}], ["By using clone library sequencing of full-length internal transcribed spacer region combined with quantitative polymerase chain reaction (qPCR) for 69 fungal species or assay groups and cultivation, we have been able to generate a more comprehensive description of the total indoor mycoflora.", {"entities": []}], ["Using this suite of methods, we assessed the impact of moisture damage on the fungal community composition of settled dust and building material samples (n = 8 and 16, correspondingly).", {"entities": []}], ["Water-damaged buildings (n = 2) were examined pre- and post- remediation, and compared with undamaged reference buildings (n = 2).", {"entities": []}], ["Culture-dependent and independent methods were consistent in the dominant fungal taxa in dust, but sequencing revealed a five to ten times higher diversity at the genus level than culture or qPCR.", {"entities": []}], ["Previously unknown, verified fungal phylotypes were detected in dust, accounting for 12% of all diversity.", {"entities": []}], ["Fungal diversity, especially within classes Dothideomycetes and Agaricomycetes tended to be higher in the water damaged buildings.", {"entities": []}], ["Fungal phylotypes detected in building materials were present in dust samples, but their proportion of total fungi was similar for damaged and reference buildings.", {"entities": []}], ["The quantitative correlation between clone library phylotype frequencies and qPCR counts was moderate (r = 0.59, p < 0.01).", {"entities": []}], ["We examined a small number of target buildings and found indications of elevated fungal diversity associated with water damage.", {"entities": []}], ["Some of the fungi in dust were attributable to building growth, but more information on the material-associated communities is needed in order to understand the dynamics of microbial communities between building structures and dust.", {"entities": []}], ["The sequencing-based method proved indispensable for describing the true fungal diversity in indoor environments.", {"entities": []}], ["However, making conclusions concerning the effect of building conditions on building mycobiota using this methodology was complicated by the wide natural diversity in the dust samples, the incomplete knowledge of material-associated fungi fungi and the semiquantitative nature of sequencing based methods.", {"entities": []}], ["The link between concentrations of particulate matter (PM) and respiratory morbidity has been investigated in numerous studies.", {"entities": []}], ["The aim of this study was to analyze the role of different particle size fractions with respect to respiratory health in Beijing, China.", {"entities": []}], ["Data on particle size distributions from 3 nm to 1 \u03bcm; PM 10 (PM \u2264 10 \u03bcm), nitrogen dioxide (NO 2 ), and sulfur dioxide concentrations; and meteorologic variables were collected daily from March 2004 to December 2006.", {"entities": []}], ["Concurrently, daily counts of emergency room visits (ERV) for respiratory diseases were obtained from the Peking University Third Hospital.", {"entities": []}], ["We estimated pollutant effects in single- and two-pollutant generalized additive models, controlling for meteorologic and other time-varying covariates.", {"entities": []}], ["Time-delayed associations were estimated using polynomial distributed lag, cumulative effects, and single lag models.", {"entities": []}], ["Associations of respiratory ERV with NO 2 concentrations and 100\u20131,000 nm particle number or surface area concentrations were of similar magnitude\u2014that is, approximately 5% increase in respiratory ERV with an interquartile range increase in air pollution concentration.", {"entities": []}], ["In general, particles < 50 nm were not positively associated with ERV, whereas particles 50\u2013100 nm were adversely associated with respiratory ERV, both being fractions of ultrafine particles.", {"entities": []}], ["Effect estimates from two-pollutant models were most consistent for NO 2 .", {"entities": []}], ["Present levels of air pollution in Beijing were adversely associated with respiratory ERV.", {"entities": []}], ["NO 2 concentrations seemed to be a better surrogate for evaluating overall respiratory health effects of ambient air pollution than PM 10 or particle number concentrations in Beijing.", {"entities": []}], ["Poor adherence to inhaled medications in COPD patients seems to be associated with an increased risk of death and hospitalization.", {"entities": []}], ["Knowing the determinants of nonadherence to inhaled medications is important for creating interventions to improve adherence.", {"entities": []}], ["To identify disease-specific and health-related quality of life (HRQoL) factors, associated with adherence to inhaled corticosteroids (ICS) and tiotropium in COPD patients.", {"entities": []}], ["Adherence of 795 patients was recorded over 3 years and was deemed optimal at >75%\u2013\u2264125%, suboptimal at \u226550%\u2013<75%, and poor at <50% (underuse) or >125% (overuse).", {"entities": []}], ["Health-related quality of life was measured with the Clinical COPD Questionnaire and the EuroQol-5D questionnaire.", {"entities": []}], ["Patients with a higher forced expiratory volume in 1 second (FEV 1 )/vital capacity (VC) (odds ratio [OR] =1.03) and \u22651 hospitalizations in the year prior to inclusion in this study (OR =2.67) had an increased risk of suboptimal adherence to ICS instead of optimal adherence.", {"entities": [[61, 64, "GENE"]]}], ["An increased risk of underuse was predicted by a higher FEV 1 /VC (OR =1.05).", {"entities": [[56, 59, "GENE"]]}], ["Predictors for the risk of overuse were a lower FEV 1 (OR =0.49), higher scores on Clinical COPD Questionnaire-question 3 (anxiety for dyspnea) (OR =1.26), and current smoking (OR =1.73).", {"entities": [[48, 51, "GENE"]]}], ["Regarding tiotropium, predictors for suboptimal use were a higher FEV 1 /VC (OR =1.03) and the inability to perform usual activities as asked by the EuroQol-5D questionnaire (OR =3.09).", {"entities": [[66, 69, "GENE"]]}], ["A higher FEV 1 /VC also was a predictor for the risk of underuse compared to optimal adherence (OR =1.03).", {"entities": [[9, 12, "GENE"]]}], ["The risk of overuse increased again with higher scores on Clinical COPD Questionnaire-question 3 (OR =1.46).", {"entities": []}], ["Several disease-specific and quality of life factors are related to ICS and tiotropium adherence, but a clear profile of a nonadherent patient cannot yet be outlined.", {"entities": []}], ["Overusers of ICS and tiotropium experience more anxiety.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) share molecular mechanisms that cause the pathological symptoms they have in common.", {"entities": [[49, 64, "DISEASE"]]}], ["Here, we review evidence suggesting that hyperactivity of the EGFR/ADAM17 axis plays a role in the development of chronic lung disease in both CF and COPD.", {"entities": [[122, 134, "DISEASE"]]}], ["The ubiquitous transmembrane protease A disintegrin and metalloprotease 17 (ADAM17) forms a functional unit with the EGF receptor (EGFR), in a feedback loop interaction labeled the ADAM17/EGFR axis.", {"entities": [[76, 82, "GENE"], [181, 187, "GENE"], [117, 120, "GENE"], [131, 135, "GENE"], [188, 192, "GENE"]]}], ["In airway epithelial cells, ADAM17 sheds multiple soluble signaling proteins by proteolysis, including EGFR ligands such as amphiregulin (AREG), and proinflammatory mediators such as the interleukin 6 coreceptor (IL-6R).", {"entities": [[28, 34, "GENE"], [103, 107, "GENE"], [138, 142, "GENE"]]}], ["This activity can be enhanced by injury, toxins, and receptor-mediated external triggers.", {"entities": []}], ["In addition to intracellular kinases, the extracellular glutathione-dependent redox potential controls ADAM17 shedding.", {"entities": [[103, 109, "GENE"]]}], ["Thus, the epithelial ADAM17/EGFR axis serves as a receptor of incoming luminal stress signals, relaying these to neighboring and underlying cells, which plays an important role in the resolution of lung injury and inflammation.", {"entities": []}], ["We review evidence that congenital CFTR deficiency in CF and reduced CFTR activity in chronic COPD may cause enhanced ADAM17/EGFR signaling through a defect in glutathione secretion.", {"entities": [[35, 39, "GENE"], [69, 73, "GENE"], [35, 39, "GENE"], [69, 73, "GENE"]]}], ["In future studies, these complex interactions and the options for pharmaceutical interventions will be further investigated.", {"entities": []}], ["Detection of interacting risk factors for complex traits is challenging.", {"entities": []}], ["The choice of an appropriate method, sample size, and allocation of cases and controls are serious concerns.", {"entities": []}], ["To provide empirical guidelines for planning such studies and data analyses, we investigated the performance of the multifactor dimensionality reduction (MDR) and generalized MDR (GMDR) methods under various experimental scenarios.", {"entities": []}], ["We developed the mathematical expectation of accuracy and used it as an indicator parameter to perform a gene-gene interaction study.", {"entities": []}], ["We then examined the statistical power of GMDR and MDR within the plausible range of accuracy (0.50\u223c0.65) reported in the literature.", {"entities": []}], ["The GMDR with covariate adjustment had a power of>80% in a case-control design with a sample size of\u22652000, with theoretical accuracy ranging from 0.56 to 0.62.", {"entities": []}], ["However, when the accuracy was<0.56, a sample size of\u22654000 was required to have sufficient power.", {"entities": []}], ["In our simulations, the GMDR outperformed the MDR under all models with accuracy ranging from 0.56\u223c0.62 for a sample size of 1000\u20132000.", {"entities": []}], ["However, the two methods performed similarly when the accuracy was outside this range or the sample was significantly larger.", {"entities": []}], ["We conclude that with adjustment of a covariate, GMDR performs better than MDR and a sample size of 1000\u223c2000 is reasonably large for detecting gene-gene interactions in the range of effect size reported by the current literature; whereas larger sample size is required for more subtle interactions with accuracy<0.56.", {"entities": []}], ["To describe demographic characteristics, surgical results, postoperative complications, and overall survival rates in surgically treated patients with lung metastases.", {"entities": []}], ["This was a retrospective analysis of 119 patients who underwent a total of 154 lung metastasis resections between 1997 and 2011.", {"entities": []}], ["Among the 119 patients, 68 (57.1%) were male and 108 (90.8%) were White.", {"entities": []}], ["The median age was 52 years (range, 15-75 years).", {"entities": []}], ["In this sample, 63 patients (52.9%) presented with comorbidities, the most common being systemic arterial hypertension (69.8%) and diabetes (19.0%).", {"entities": [[106, 118, "DISEASE"]]}], ["Primary colorectal tumors (47.9%) and musculoskeletal tumors (21.8%) were the main sites of origin of the metastases.", {"entities": []}], ["Approximately 24% of the patients underwent more than one resection of the lesions, and 71% had adjuvant treatment prior to metastasectomy.", {"entities": []}], ["The rate of lung metastasis recurrence was 19.3%, and the median disease-free interval was 23 months.", {"entities": []}], ["The main surgical access used was thoracotomy (78%), and the most common approach was wedge resection with segmentectomy (51%).", {"entities": []}], ["The rate of postoperative complications was 22%, and perioperative mortality was 1.9%.", {"entities": []}], ["The overall survival rates at 12, 36, 60, and 120 months were 96%, 77%, 56%, and 39%, respectively.", {"entities": []}], ["A Cox analysis confirmed that complications within the first 30 postoperative days were associated with poor prognosis (hazard ratio = 1.81; 95% CI: 1.09-3.06; p = 0.02).", {"entities": []}], ["Surgical treatment of lung metastases is safe and effective, with good overall survival, especially in patients with fewer metastases.", {"entities": []}], ["Descrever caracter\u00edsticas demogr\u00e1ficas, resultados operat\u00f3rios, complica\u00e7\u00f5es p\u00f3s-operat\u00f3rias e taxa de sobrevida global em pacientes com met\u00e1stases pulmonares tratados cirurgicamente.", {"entities": []}], ["An\u00e1lise retrospectiva de 119 pacientes submetidos a um total de 154 cirurgias de ressec\u00e7\u00e3o de met\u00e1stase pulmonar entre 1997 e 2011.", {"entities": []}], ["Do total de 119 pacientes, 68 (57,1%) eram do sexo masculino, e 108 (90,8%) eram brancos.", {"entities": []}], ["A mediana de idade foi de 52 anos (varia\u00e7\u00e3o, 15-75 anos).", {"entities": []}], ["Nessa amostra, 63 pacientes (52,9%) apresentaram comorbidades, sendo as mais frequentes hipertens\u00e3o arterial sist\u00eamica (69,8%) e diabetes (19,0%).", {"entities": []}], ["Tumores prim\u00e1rios colorretais (47,9%) e musculoesquel\u00e9ticos (21,8%) foram os principais s\u00edtios de origem das met\u00e1stases.", {"entities": []}], ["Aproximadamente 24% dos pacientes foram submetidos a mais de uma ressec\u00e7\u00e3o das les\u00f5es, e 71% fizeram tratamento adjuvante pr\u00e9vio \u00e0 metastasectomia.", {"entities": []}], ["A taxa de recidiva de met\u00e1stase pulmonar foi de 19,3%.", {"entities": []}], ["A mediana do intervalo livre de doen\u00e7a foi de 23 meses.", {"entities": []}], ["A principal via de acesso usada foi toracotomia (78%), e o tipo de ressec\u00e7\u00e3o mais frequente foi em cunha e segmentectomia (51%).", {"entities": []}], ["O \u00edndice de complica\u00e7\u00f5es p\u00f3s-operat\u00f3rias foi de 22% e o de mortalidade perioperat\u00f3ria foi de 1,9%.", {"entities": []}], ["As taxas de sobrevida global em 12, 36, 60 e 120 meses foram, respectivamente, de 96%, 77%, 56% e 39%.", {"entities": []}], ["A an\u00e1lise de Cox confirmou que complica\u00e7\u00f5es nos primeiros 30 dias p\u00f3s-operat\u00f3rios associaram-se a pior progn\u00f3stico ( hazard ratio = 1,81; IC95%: 1,09-3,06; p = 0,02).", {"entities": []}], ["O tratamento cir\u00fargico das met\u00e1stases pulmonares oriundas de diferentes s\u00edtios tumorais \u00e9 efetivo e seguro, com boa sobrevida global, especialmente nos casos com um menor n\u00famero de les\u00f5es pulmonares.", {"entities": []}], ["Accurate and high-throughput technologies are needed for identification of new therapeutic targets and for optimizing therapy in inflammatory bowel disease.", {"entities": [[129, 155, "DISEASE"]]}], ["Our aim was to assess multi-analyte protein-based assays of cytokines/chemokines using Luminex technology.", {"entities": []}], ["We have reported that Luminex-based profiling was useful in assessing response to L-arginine therapy in the mouse model of dextran sulfate sodium colitis.", {"entities": []}], ["Therefore, we studied prospectively collected samples from ulcerative colitis (UC) patients and control subjects.", {"entities": [[59, 77, "DISEASE"]]}], ["Serum, colon biopsies, and clinical information were obtained from subjects undergoing colonoscopy for evaluation of UC or for non-UC indications.", {"entities": []}], ["In total, 38 normal controls and 137 UC cases completed the study.", {"entities": []}], ["Histologic disease severity and the Mayo Disease Activity Index (DAI) were assessed.", {"entities": []}], ["Serum and colonic tissue cytokine/chemokine profiles were measured by Luminex-based multiplex testing of 42 analytes.", {"entities": []}], ["Only eotaxin-1 and G-CSF were increased in serum of patients with histologically active UC vs. controls.", {"entities": []}], ["While 13 cytokines/chemokines were increased in active UC vs. controls in tissues, only eotaxin-1 was increased in all levels of active disease in both serum and tissue.", {"entities": []}], ["In tissues, eotaxin-1 correlated with the DAI and with eosinophil counts.", {"entities": []}], ["Increased eotaxin-1 levels were confirmed by real-time PCR.", {"entities": []}], ["Tissue eotaxin-1 levels were also increased in experimental murine colitis induced by dextran sulfate sodium, oxazolone, or Citrobacter rodentium , but not in murine Helicobacter pylori infection.", {"entities": []}], ["Our data implicate eotaxin-1 as an etiologic factor and therapeutic target in UC, and indicate that Luminex-based assays may be useful to assess IBD pathogenesis and to select patients for anti-cytokine/chemokine therapies.", {"entities": []}], ["To examine if pulmonary P-glycoprotein (P-gp) is functional in an intact lung; impeding the pulmonary absorption and increasing lung retention of P-gp substrates administered into the airways.", {"entities": []}], ["Using calculated physico-chemical properties alone build a predictive Quantitative Structure-Activity Relationship (QSAR) model distinguishing whether a substrate\u2019s pulmonary absorption would be limited by P-gp or not.", {"entities": []}], ["A panel of 18 P-gp substrates were administered into the airways of an isolated perfused mouse lung (IPML) model derived from Mdr1a / Mdr1b knockout mice.", {"entities": []}], ["Parallel intestinal absorption studies were performed.", {"entities": []}], ["Substrate physico-chemical profiling was undertaken.", {"entities": []}], ["Using multivariate analysis a QSAR model was established.", {"entities": []}], ["A subset of P-gp substrates (10/18) displayed pulmonary kinetics influenced by lung P-gp.", {"entities": []}], ["These substrates possessed distinct physico-chemical properties to those P-gp substrates unaffected by P-gp (8/18).", {"entities": []}], ["Differential outcomes were not related to different intrinsic P-gp transporter kinetics.", {"entities": []}], ["In the lung, in contrast to intestine, a higher degree of non-polar character is required of a P-gp substrate before the net effects of efflux become evident.", {"entities": []}], ["The QSAR predictive model was applied to 129 substrates including eight marketed inhaled drugs, all these inhaled drugs were predicted to display P-gp dependent pulmonary disposition.", {"entities": []}], ["Lung P-gp can affect the pulmonary kinetics of a subset of P-gp substrates.", {"entities": []}], ["Physico-chemical relationships determining the significance of P-gp to absorption in the lung are different to those operative in the intestine.", {"entities": []}], ["Our QSAR framework may assist profiling of inhaled drug discovery candidates that are also P-gp substrates.", {"entities": []}], ["The potential for P-gp mediated pulmonary disposition exists in the clinic.", {"entities": []}], ["The online version of this article (doi:10.1007/s11095-017-2220-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Large-scale cohort studies are currently being designed to investigate the human microbiome in health and disease.", {"entities": []}], ["Adequate sampling strategies are required to limit bias due to shifts in microbial communities during sampling and storage.", {"entities": []}], ["Therefore, we examined the impact of different sampling and storage conditions on the stability of fecal microbial communities in healthy and diseased subjects.", {"entities": []}], ["Fecal samples from 10 healthy controls, 10 irritable bowel syndrome and 8 inflammatory bowel disease patients were collected on site, aliquoted immediately after defecation and stored at -80\u00b0C, -20\u00b0C for 1 week, at +4\u00b0C or room temperature for 24 hours.", {"entities": [[74, 100, "DISEASE"], [43, 67, "DISEASE"], [59, 67, "DISEASE"]]}], ["Fecal transport swabs (FecalSwab, Copan) were collected and stored for 48-72 hours at room temperature.", {"entities": []}], ["We used pyrosequencing of the 16S gene to investigate the stability of microbial communities.", {"entities": []}], ["Alpha diversity did not differ between all storage methods and -80\u00b0C, except for the fecal swabs.", {"entities": []}], ["UPGMA clustering and principal coordinate analysis showed significant clustering by test subject (p<0.001) but not by storage method.", {"entities": []}], ["Bray-Curtis dissimilarity and (un)weighted UniFrac showed a significant higher distance between fecal swabs and -80\u00b0C versus the other methods and -80\u00b0C samples (p<0.009).", {"entities": []}], ["The relative abundance of Ruminococcus and Enterobacteriaceae did not differ between the storage methods versus -80\u00b0C, but was higher in fecal swabs (p<0.05).", {"entities": []}], ["Storage up to 24 hours (at +4\u00b0C or room temperature) or freezing at -20\u00b0C did not significantly alter the fecal microbial community structure compared to direct freezing of samples from healthy subjects and patients with gastrointestinal disorders.", {"entities": []}], ["Chinese marine materia medica (CMMM) is a vital part of traditional Chinese medicine (TCM).", {"entities": []}], ["Compared with terrestrial TCM, CMMM, derived from specific marine habitats, possesses peculiar chemical components with unique structures reflecting as potent pharmacological activities, distinct drug properties and functions.", {"entities": []}], ["Nowadays, CMMM appears to be especially effective in treating such difficult diseases as cancers, diabetes, cardio-cerebrovascular diseases, immunodeficiency diseases and senile dementia, and therefore has become an important medicinal resource for the research and development of new drugs.", {"entities": [[178, 186, "DISEASE"]]}], ["In recent years, such development has attracted wide attention in the field of medicine.", {"entities": []}], ["In this study, the CMMM resources in China were systematically investigated and evaluated.", {"entities": []}], ["It was found that the historic experiences of Chinese people using CMMM have continuously accumulated over a period of more than 3600 years, and that the achievements of the research on modern CMMM are especially outstanding.", {"entities": []}], ["By June 2015, 725 kinds of CMMMs from Chinese coastal sea areas have been identified and recorded, covering 1552 organisms and minerals.", {"entities": []}], ["More than 3100 traditional prescriptions containing CMMMs have been imparted and inherited.", {"entities": []}], ["However, the number of CMMMs is less than the 8188 terrestrial TCMs, from more than 12,100 medicinal terrestrial plants, animals and minerals.", {"entities": []}], ["In the future, the research and development of CMMM should focus on the channel entries (TCM drug properties), compatibility, effective ingredients, acting mechanisms, drug metabolism and quality standard.", {"entities": []}], ["This study reveals the high potential of CMMM development.", {"entities": []}], ["In the aftermath of the Icelandic volcano Grimsv\u00f6tn\u2019s eruption on 21 May 2011, volcanic ash reached Northern Europe.", {"entities": []}], ["Elevated levels of ambient particles (PM) were registered in mid Sweden.", {"entities": []}], ["The aim of the present study was to investigate if the Grimsv\u00f6tn eruption had an effect on mortality in Sweden.", {"entities": []}], ["Based on PM measurements at 16 sites across Sweden, data were classified into an ash exposed data set (Ash area) and an unexposed data set (No ash area).", {"entities": []}], ["Data on daily all-cause mortality were obtained from Statistics Sweden for the time period 1 April through 31 July 2011.", {"entities": []}], ["Mortality ratios were calculated as the ratio between the daily number of deaths in the Ash area and the No ash area.", {"entities": []}], ["The exposure period was defined as the week following the days with elevated particle concentrations, namely 24 May through 31 May.", {"entities": []}], ["The control period was defined as 1 April through 23 May and 1 June through 31 July.", {"entities": []}], ["There was no absolute increase in mortality during the exposure period.", {"entities": []}], ["However, during the exposure period the mean mortality ratio was 2.42 compared with 2.17 during the control period, implying a relatively higher number of deaths in the Ash area than in the No ash area.", {"entities": []}], ["The differences in ratios were mostly due to a single day, 31 May, and were not statistically significant when tested with a Mann-Whitney non-parametric test ( p > 0.3).", {"entities": []}], ["The statistical power was low with only 8 days in the exposure period (24 May through 31 May).", {"entities": []}], ["Assuming that the observed relative differences were not due to chance, the results would imply an increase of 128 deaths during the exposure period 24\u201331 May.", {"entities": []}], ["If 31 May was excluded, the number of extra deaths was reduced to 20.", {"entities": []}], ["The results of the present study are contradicting and inconclusive, but may indicate that all-cause mortality was increased by the ash-fall from the Grimsv\u00f6tn eruption.", {"entities": []}], ["Meta-analysis or pooled analysis of data from neighboring countries might make it possible to reach sufficient statistical power to study effects of the Grimsv\u00f6tn ash on morbidity and mortality.", {"entities": []}], ["Such studies would be of particular importance for European societies preparing for future large scale volcanic eruptions in Iceland.", {"entities": []}], ["Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infections.", {"entities": []}], ["Immunity to RSV is initiated upon detection of the virus by pattern recognition receptors, such as RIG-I-like receptors.", {"entities": []}], ["RIG-I-like receptors signal via MAVS to induce the synthesis of proinflammatory mediators, including type I interferons (IFNs), which trigger and shape antiviral responses and protect cells from infection.", {"entities": [[32, 36, "GENE"]]}], ["Alveolar macrophages (AMs) are amongst the first cells to encounter invading viruses and the ones producing type I IFNs.", {"entities": []}], ["However, it is unclear whether IFNs act to prevent AMs from serving as vehicles for viral replication.", {"entities": []}], ["In this study, primary AMs from MAVS ( Mavs Ifnar1 Mavs Ifnar1 Mavs Ifnar1", {"entities": [[32, 36, "GENE"], [39, 43, "GENE"], [51, 55, "GENE"], [63, 67, "GENE"], [32, 36, "GENE"], [39, 43, "GENE"], [51, 55, "GENE"], [63, 67, "GENE"], [44, 50, "GENE"], [56, 62, "GENE"], [68, 74, "GENE"], [32, 36, "GENE"], [39, 43, "GENE"], [51, 55, "GENE"], [63, 67, "GENE"], [44, 50, "GENE"], [56, 62, "GENE"], [68, 74, "GENE"], [32, 36, "GENE"], [39, 43, "GENE"], [51, 55, "GENE"], [63, 67, "GENE"], [44, 50, "GENE"], [56, 62, "GENE"], [68, 74, "GENE"]]}], ["Periostin is an extracellular matrix protein highly expressed in collagen-rich tissues subjected to continuous mechanical stress.", {"entities": []}], ["Functionally, periostin is involved in tissue remodeling and its altered function is associated to numerous pathological processes.", {"entities": []}], ["In orthodontics, periostin plays key roles in the maintenance of dental tissues and it is mainly expressed in those areas where tension or pressing forces are taking place.", {"entities": []}], ["In this regard, high expression of periostin is essential to promote migration and proliferation of periodontal ligament fibroblasts.", {"entities": []}], ["However little is known about the participation of periostin in migration and adhesion processes of bone remodeling cells.", {"entities": []}], ["In this work we employ the mouse pre-osteoblastic MC3T3-E1 and the macrophage-like RAW 264.7 cell lines to overexpress periostin and perform different cell-based assays to study changes in cell behavior.", {"entities": []}], ["Our data indicate that periostin overexpression not only increases adhesion capacity of MC3T3-E1 cells to different matrix proteins but also hampers their migratory capacity.", {"entities": []}], ["Changes on RNA expression profile of MC3T3-E1 cells upon periostin overexpression have been also analyzed, highlighting the alteration of genes implicated in processes such as cell migration, adhesion or bone metabolism but not in bone differentiation.", {"entities": []}], ["Overall, our work provides new evidence on the impact of periostin in osteoblasts physiology.", {"entities": []}], ["Asthma is a heterogeneous disease and development of novel therapeutics requires an understanding of pathophysiologic phenotypes.", {"entities": [[0, 6, "DISEASE"]]}], ["The purpose of the ADEPT study was to correlate clinical features and biomarkers with molecular characteristics, by profiling asthma (NCT01274507).", {"entities": [[126, 132, "DISEASE"]]}], ["This report presents for the first time the study design, and characteristics of the recruited subjects.", {"entities": []}], ["Patients with a range of asthma severity and healthy non-atopic controls were enrolled.", {"entities": [[25, 31, "DISEASE"]]}], ["The asthmatic subjects were followed for 12\u00a0months.", {"entities": []}], ["Assessments included history, patient questionnaires, spirometry, airway hyper-responsiveness to methacholine, fractional exhaled nitric oxide (FENO), and biomarkers measured in induced sputum, blood, and bronchoscopy samples.", {"entities": []}], ["All subjects underwent sputum induction and 30 subjects/cohort had bronchoscopy.", {"entities": []}], ["Mild ( n \u2009=\u200952), moderate ( n \u2009=\u200955), severe ( n \u2009=\u200951) asthma cohorts and 30 healthy controls were enrolled from North America and Western Europe.", {"entities": [[56, 62, "DISEASE"]]}], ["Airflow obstruction, bronchodilator response and airways hyperresponsiveness increased with asthma severity, and severe asthma subjects had reduced forced vital capacity.", {"entities": [[92, 98, "DISEASE"], [120, 126, "DISEASE"]]}], ["Asthma control questionnaire-7 (ACQ7) scores worsened with asthma severity.", {"entities": [[0, 6, "DISEASE"], [59, 65, "DISEASE"]]}], ["In the asthmatics, mean values for all clinical and biomarker characteristics were stable over 12\u00a0months although individual variability was evident.", {"entities": []}], ["FENO and blood eosinophils did not differ by asthma severity.", {"entities": [[45, 51, "DISEASE"]]}], ["Induced sputum eosinophils but not neutrophils were lower in mild compared to the moderate and severe asthma cohorts.", {"entities": [[102, 108, "DISEASE"]]}], ["The ADEPT study successfully enrolled asthmatics across a spectrum of severity and non-atopic controls.", {"entities": []}], ["Clinical characteristics were related to asthma severity and in general asthma characteristics e.g.", {"entities": [[41, 47, "DISEASE"], [72, 78, "DISEASE"]]}], ["lung function, were stable over 12\u00a0months.", {"entities": []}], ["Use of the ADEPT data should prove useful in defining biological phenotypes to facilitate personalized therapeutic approaches.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0299-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Fibrosis involves increasing amounts of scar tissue appearing in a tissue, but what drives this is unclear.", {"entities": []}], ["In fibrotic lesions in human and mouse lungs, we found extensive desialylation of glycoconjugates, and upregulation of sialidases.", {"entities": []}], ["The fibrosis-associated cytokine TGF-\u03b21 upregulates sialidases in human airway epithelium cells, lung fibroblasts, and immune system cells.", {"entities": []}], ["Conversely, addition of sialidases to human peripheral blood mononuclear cells induces accumulation of extracellular TGF-\u03b21, forming what appears to be a sialidase - TGF-\u03b21 - sialidase positive feedback loop.", {"entities": []}], ["Monocyte-derived cells called fibrocytes also activate fibroblasts, and we found that sialidases potentiate fibrocyte differentiation.", {"entities": []}], ["A sialylated glycoprotein called serum amyloid P (SAP) inhibits fibrocyte differentiation, and sialidases attenuate SAP function.", {"entities": []}], ["Injections of the sialidase inhibitors DANA and oseltamivir (Tamiflu) starting either 1\u2009day or 10 days after bleomycin strongly attenuate pulmonary fibrosis in the mouse bleomycin model, and by breaking the feedback loop, cause a downregulation of sialidase and TGF-\u03b21 accumulation.", {"entities": [[138, 156, "DISEASE"]]}], ["Together, these results suggest that a positive feedback loop involving sialidases potentiates fibrosis, and suggest that sialidase inhibitors could be useful for the treatment of fibrosis.", {"entities": []}], ["Stereotactic ablative body radiation (SABR) is a novel and sophisticated radiation modality that involves the irradiation of extracranial tumors through precise and very high doses in patients with oligometastatic lung disease and primary lung tumors.", {"entities": [[214, 226, "DISEASE"]]}], ["A 52-year-old female with subclinical idiopathic interstitial lung disease (ILD) and oligometastatic lung disease from squamous urethral cancer who was treated with SABR for a metastatic lesion located in the right lower pulmonary lobe.", {"entities": [[49, 74, "DISEASE"], [62, 74, "DISEASE"], [101, 113, "DISEASE"], [137, 143, "DISEASE"]]}], ["The patient received a hypo-fractionated course of SABR.", {"entities": []}], ["A 3D-conformal multifield technique was used with six coplanar and one non-coplanar statics beams.", {"entities": []}], ["A 48\u00a0Gy total dose in three fractions over six days was prescribed to the 95% of the PTV.", {"entities": []}], ["The presence of idiopathic ILD and other identifiable underlying lung conditions were not taken into account as a constraint to prescribe a different than standard total dose or fractionation schedule.", {"entities": []}], ["Six months after the SABR treatment, a CT-scan showed the presence of a pneumomediastinum with air outside the bronchial tree and within the subcutaneous tissue without co-existing pneumothorax.", {"entities": [[181, 193, "DISEASE"]]}], ["To our knowledge, this is the first case of pneumomediastinum appearing 6\u00a0months after SABR treatment for a lung metastasis located in the perihiliar/central tumors region as defined by the RTOG protocols as the proximal bronchial tree.", {"entities": []}], ["Radiation oncologist should be aware of the potential risk of severe lung toxicity caused by SABR in patients with ILD, especially when chemotherapy-induced pulmonary toxicity is administered in a short time interval.", {"entities": []}], ["Children and elderly individuals are often infected easily and repeatedly with human respiratory syncytial virus (HRSV); however, the features of recurrent infection in the same individual are defined poorly.", {"entities": []}], ["To clarify the clinical significance of repeated HRSV infections in relation to subgroup epidemiology, this study performed prospective and longitudinal analyses in children with lower respiratory tract infections over 20 consecutive epidemics between 1985 and 2005 at a pediatric outpatient clinic in Kawasaki, Japan.", {"entities": []}], ["HRSV infections were confirmed by 2 types of reverse-transcription PCR.", {"entities": []}], ["Samples obtained from patients with repeated infections were subjected to sequence analysis and cloning analysis.", {"entities": []}], ["A total of 1,312 lower respiratory tract infections observed in 1,010 patients were diagnosed as HRSV infections.", {"entities": []}], ["Repeated HRSV infections occurred in 208 of the 1,010 patients.", {"entities": []}], ["Analysis of the patients with repeated infections revealed that children were often infected multiple times even within a single short epidemic.", {"entities": []}], ["Some patients were re-infected with strains having the same or virtually identical N gene sequences.", {"entities": []}], ["In patients infected more than 4 times, cloning analysis revealed more frequent dual infections with both subgroups (23.8%).", {"entities": []}], ["The HRSV-A subgroup caused subsequent homologous infections more frequently than did HRSV-B; furthermore, HRSV-A infections provided no protection from a second homologous infection.", {"entities": []}], ["In contrast, HRSV-B infections offered significant protection against a second homologous infection.", {"entities": []}], ["Statistical analysis revealed alleviation of symptoms with a reduced rate of dyspnoeic attacks only in the group re-infected with homologous HRSV-A strains.", {"entities": []}], ["Thus, this study elucidates new clinical features of recurrent HRSV infection.", {"entities": []}], ["Virol 86: 1629\u20131638, 2014 .", {"entities": []}], ["In severe asthma, bronchodilator- and steroid-insensitive airflow obstruction develops through unknown mechanisms characterized by increased lung airway smooth muscle (ASM) mass and stiffness.", {"entities": [[10, 16, "DISEASE"]]}], ["We explored the role of a Regulator of G-protein Signaling protein (RGS4) in the ASM hyperplasia and reduced contractile capacity characteristic of advanced asthma.", {"entities": [[157, 163, "DISEASE"], [68, 72, "GENE"]]}], ["Using immunocytochemical staining, ASM expression of RGS4 was determined in endobronchial biopsies from healthy subjects and those from subjects with mild, moderate and severe asthma.", {"entities": [[176, 182, "DISEASE"], [53, 57, "GENE"]]}], ["Cell proliferation assays, agonist-induced calcium mobilization and bronchoconstriction were determined in cultured human ASM cells and in human precision cut lung slices.", {"entities": []}], ["Using gain- and loss-of-function approaches, the precise role of RGS proteins was determined in stimulating human ASM proliferation and inhibiting bronchoconstriction.", {"entities": []}], ["RGS4 expression was restricted to a subpopulation of ASM and was specifically upregulated by mitogens, which induced a hyperproliferative and hypocontractile ASM phenotype similar to that observed in recalcitrant asthma.", {"entities": [[213, 219, "DISEASE"], [0, 4, "GENE"]]}], ["RGS4 expression was markedly increased in bronchial smooth muscle of patients with severe asthma, and expression correlated significantly with reduced pulmonary function.", {"entities": [[90, 96, "DISEASE"], [0, 4, "GENE"]]}], ["Whereas RGS4 inhibited G protein-coupled receptor (GPCR)-mediated bronchoconstriction, unexpectedly RGS4 was required for PDGF-induced proliferation and sustained activation of PI3K, a mitogenic signaling molecule that regulates ASM proliferation.", {"entities": [[8, 12, "GENE"], [100, 104, "GENE"], [8, 12, "GENE"], [100, 104, "GENE"]]}], ["These studies indicate that increased RGS4 expression promotes a phenotypic switch of ASM, evoking irreversible airway obstruction in subjects with severe asthma.", {"entities": [[155, 161, "DISEASE"], [38, 42, "GENE"]]}], ["It is beneficial for health care institutions to monitor physician prescribing patterns to ensure that high-quality and cost-effective care is being provided to patients.", {"entities": []}], ["However, detecting treatment patterns within an institution is challenging, given that medications and conditions are often not explicitly linked in the health record.", {"entities": []}], ["Here we demonstrate the use of statistical methods together with data from the electronic health care record (EHR) to analyze prescribing patterns at an institution.", {"entities": []}], ["As a demonstration of our method, which is based on regression, we collect EHR data from outpatient notes and use a case/control study design to determine the medications that are associated with hypertension.", {"entities": [[196, 208, "DISEASE"]]}], ["We also use regression to determine which conditions are associated with a preferential use of one or more classes of hypertension agents.", {"entities": [[118, 130, "DISEASE"]]}], ["Finally, we compare our method to methods based on tabulation.", {"entities": []}], ["Our results show that regression methods provide more reasonable and useful results than tabulation, and successfully distinguish between medications that treat hypertension and medications that do not.", {"entities": [[161, 173, "DISEASE"]]}], ["These methods also provide insight into in which circumstances certain drugs are preferred over others.", {"entities": []}], ["Our method can be used by health care institutions to monitor physician prescribing patterns and ensure the appropriateness of treatment.", {"entities": []}], ["France has recently witnessed a nationwide outbreak of measles.", {"entities": [[55, 62, "DISEASE"]]}], ["Data on severe forms of measles in adults are lacking.", {"entities": [[24, 31, "DISEASE"]]}], ["We sought to describe the epidemiologic, clinical, treatment, and prognostic aspects of the disease in adult patients who required admission to an intensive care unit (ICU).", {"entities": []}], ["We performed a retrospective analysis of a cohort of 36 adults admitted to a total of 64 ICUs throughout France for complications of measles from January 1, 2009, to December 31, 2011.", {"entities": [[133, 140, "DISEASE"]]}], ["All cases of measles were confirmed by serologic testing and/or reverse transcription polymerase chain reaction.", {"entities": [[13, 20, "DISEASE"]]}], ["The cohort consisted of 21 male and 15 female patients, with a median age of 29.2 years (25th\u201375th interquartile range [IQR], 27.2\u201334.2 yr) and a median Simplified Acute Physiology Score (SAPS II) of 13 (IQR, 9\u201318).", {"entities": []}], ["Among the 26 patients whose measles vaccination status was documented, none had received 2 injections.", {"entities": [[28, 35, "DISEASE"]]}], ["One patient had developed measles during childhood.", {"entities": [[26, 33, "DISEASE"]]}], ["Underlying comorbid conditions included chronic respiratory disease in 9 patients, immunosuppression in 7 patients, and obesity in 3 patients, while measles affected 5 pregnant women.", {"entities": [[149, 156, "DISEASE"], [120, 127, "DISEASE"]]}], ["Respiratory complications induced by measles infection led to ICU admission in 32 cases, and measles-related neurologic complications led to ICU admission in 2 cases.", {"entities": [[37, 44, "DISEASE"], [93, 100, "DISEASE"]]}], ["Two patients were admitted due to concurrent respiratory and neurologic complications.", {"entities": []}], ["Bacterial superinfection of measles-related airway infection was suspected in 28 patients and was documented in 8.", {"entities": [[28, 35, "DISEASE"]]}], ["Four cases of community-acquired pneumonia, 6 cases of ventilator-associated pneumonia, 1 case of tracheobronchitis, and 2 cases of sinusitis were microbiologically substantiated.", {"entities": [[33, 42, "DISEASE"], [77, 86, "DISEASE"], [132, 141, "DISEASE"]]}], ["Of 11 patients who required mechanical ventilation, 9 developed acute respiratory distress syndrome (ARDS).", {"entities": [[91, 99, "DISEASE"]]}], ["Among the patients with ARDS, extraalveolar air leak complications occurred in 4 cases.", {"entities": []}], ["Five patients died, all of whom were severely immunocompromised.", {"entities": []}], ["On follow-up, 1 patient had severe chronic respiratory failure related to lung fibrosis, and 2 patients had mild lower limb paraparesis along with bladder dysfunction, both of which were ascribable to measles-induced encephalitis and myelitis.", {"entities": [[201, 208, "DISEASE"], [43, 62, "DISEASE"], [234, 242, "DISEASE"], [217, 229, "DISEASE"]]}], ["Among the 5 pregnant patients, the course of measles infection was uneventful, albeit 1 patient underwent emergent cesarean delivery because of fetal growth restriction.", {"entities": [[45, 52, "DISEASE"]]}], ["Measles is a disease with protean and potentially deceptive clinical manifestations, especially in the immunocompromised patient.", {"entities": [[0, 7, "DISEASE"]]}], ["Measles-associated pneumonitis and its complications, and less commonly postinfectious encephalomyelitis, are the main source of morbidity and mortality.", {"entities": [[0, 7, "DISEASE"], [87, 104, "DISEASE"]]}], ["In contrast with the usually benign course of the disease in immunocompetent patients, measles occurring in immunocompromised patients gives rise to lethal complications including ARDS, with or without bacterial superinfection.", {"entities": [[87, 94, "DISEASE"]]}], ["Other patients potentially at high risk for severe measles are young adults and pregnant women.", {"entities": [[51, 58, "DISEASE"]]}], ["Measles pneumonitis may predispose to air leak disease in patients using mechanical ventilation.", {"entities": [[0, 7, "DISEASE"]]}], ["To date, vaccination remains the most potent tool to control measles infection.", {"entities": [[61, 68, "DISEASE"]]}], ["Although many human diseases have a genetic component involving many loci, the majority of studies are statistically underpowered to isolate the many contributing variants, raising the question of the existence of alternate processes to identify disease mutations.", {"entities": []}], ["To address this question, we collect ancestral transcription factor binding sites disrupted by an individual\u2019s variants and then look for their most significant congregation next to a group of functionally related genes.", {"entities": []}], ["Strikingly, when the method is applied to five different full human genomes, the top enriched function for each is invariably reflective of their very different medical histories.", {"entities": []}], ["For example, our method implicates \u201cabnormal cardiac output\u201d for a patient with a longstanding family history of heart disease, \u201cdecreased circulating sodium level\u201d for an individual with hypertension, and other biologically appealing links for medical histories spanning narcolepsy to axonal neuropathy.", {"entities": [[188, 200, "DISEASE"], [272, 282, "DISEASE"], [113, 126, "DISEASE"], [293, 303, "DISEASE"], [286, 303, "DISEASE"]]}], ["Our results suggest that erosion of gene regulation by mutation load significantly contributes to observed heritable phenotypes that manifest in the medical history.", {"entities": []}], ["The test we developed exposes a hitherto hidden layer of personal variants that promise to shed new light on human disease penetrance, expressivity and the sensitivity with which we can detect them.", {"entities": []}], ["A central goal of personal genomics is to interpret an individual\u2019s genome to identify variants that confer disease risk, an aim that has far-reaching implications for personalized, precision medicine.", {"entities": []}], ["Here, we leverage next generation sequencing, health records, and functional genome annotations to develop statistical methods that predict disease risk from a single genome.", {"entities": []}], ["Motivated by the fact that about 90% of genome-wide association study disease-associated variants lie in the non-coding genome, we identify personal variants that mutate conserved transcription factor binding sites.", {"entities": []}], ["To identify if such non-coding personal variants collectively dysregulate a key biological process, we employ the enrichment analysis tool GREAT to identify if a person\u2019s noncoding mutations are over-represented in the regulatory domains of genes involved in a common biological pathway.", {"entities": []}], ["Notably, in five unrelated genomes we analyzed, the most statistically significant, seemingly dysregulated pathway is indicative of that person\u2019s medical history, ranging from neuropathy to heart disease.", {"entities": [[190, 203, "DISEASE"], [176, 186, "DISEASE"]]}], ["Statistical analysis confirms that associations from our predicted pathway to an individual\u2019s medical record are rigorous and significant in the context of the un-phenotyped, race-matched 1,000 Genomes cohort.", {"entities": []}], ["As such, we present a novel method that leverages the contribution of multifactorial non-coding variation to predict disease risk in individual genomes.", {"entities": []}], ["Traffic-related air pollution is related with asthma, and this association may be modified by genetic factors.", {"entities": [[46, 52, "DISEASE"]]}], ["We investigated the role of genetic polymorphisms potentially modifying the association between home outdoor levels of modeled nitrogen dioxide and asthma.", {"entities": [[148, 154, "DISEASE"]]}], ["Adults from 13 cities of the second European Community Respiratory Health Survey (ECRHS II) were included ( n = 2,920), for whom both DNA and outdoor NO 2 estimates were available.", {"entities": []}], ["Home addresses were geocoded and linked to modeled outdoor NO 2 estimates, as a marker of local traffic-related pollution.", {"entities": []}], ["We examined asthma prevalence and evaluated polymorphisms in genes involved in oxidative stress pathways [gluthatione S -transferases M1 ( GSTM1 ), T1 ( GSTT1 ), and P1 ( GSTP1 ) and NAD(P)H:quinine oxidoreductase ( NQO1 )], inflammatory response [tumor necrosis factor \u03b1 ( TNFA )], immunologic response [Toll-like receptor 4 ( TLR4 )], and airway reactivity [adrenergic receptor \u03b22 ( ADRB2 )].", {"entities": [[12, 18, "DISEASE"], [139, 144, "GENE"], [153, 158, "GENE"], [171, 176, "GENE"], [216, 220, "GENE"], [328, 332, "GENE"], [385, 390, "GENE"]]}], ["The association between modeled NO 2 and asthma prevalence was significant for carriers of the most common genotypes of NQO1 rs2917666 [odds ratio (OR) = 1.54; 95% confidence interval (CI), 1.10\u20132.24], TNFA rs2844484 (OR = 2.02; 95% CI, 1.30\u20133.27).", {"entities": [[41, 47, "DISEASE"], [120, 124, "GENE"]]}], ["For new-onset asthma, the effect of NO 2 was significant for the most common genotype of NQO1 rs2917666 (OR = 1.52; 95% CI, 1.09\u20132.16).", {"entities": [[14, 20, "DISEASE"], [89, 93, "GENE"]]}], ["A significant interaction was found between NQO1 rs2917666 and NO 2 for asthma prevalence ( p = 0.02) and new-onset asthma ( p = 0.04).", {"entities": [[72, 78, "DISEASE"], [116, 122, "DISEASE"], [44, 48, "GENE"]]}], ["Genetic polymorphisms in the NQO1 gene are related to asthma susceptibility among persons exposed to local traffic-related air pollution.", {"entities": [[54, 60, "DISEASE"], [29, 33, "GENE"]]}], ["This points to the importance of antioxidant pathways in the protection against the effects of air pollution on asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["Hydrogen sulfide (H 2 S), together with nitric oxide (NO) and carbon monoxide (CO), belongs to a family of endogenous signaling mediators termed \u201cgasotransmitters\u201d.", {"entities": []}], ["Recent studies suggest that H 2 S modulates many cellular processes and it has been recognized to play a central role in inflammation, in the cardiovascular and nervous systems.", {"entities": []}], ["By infecting monocytes/macrophages with Mycoplasma fermentans (M.F.", {"entities": []}], ["), a well-known pro-inflammatory agent, we evaluated the effects of H 2 S. M.F.-infected cells were analyzed by ELISA and real time RT-PCR to detect the M.F.", {"entities": []}], ["effects on MCP-1 and on MMP-12 expression.", {"entities": []}], ["The role of two different H 2 S donors (NaHS and GYY4137) on MF-infected cells was determined by treating infected cells with H 2 S and then testing the culture supernatants for MCP-1 and on MMP-12 production by ELISA assay.", {"entities": []}], ["In order to identify the pathway/s mediating H 2 S- anti-inflammatory activity, cells were also treated with specific pharmaceutical inhibitors.", {"entities": []}], ["Cytoplasmic and nuclear accumulation of NF-\u03baB heterodimers was analyzed.", {"entities": []}], ["We show that H 2 S was able to reduce the production of pro-inflammatory cytokine MCP-1, that was induced in monocytes/macrophages during M.F.", {"entities": []}], ["Moreover, MCP-1 was induced by M.F.", {"entities": []}], ["through Toll-like receptor (TLR)-mediated nuclear factor-\u03baB (NF-\u03baB) activation, as demonstrated by the fact that TLR inhibitors TIRAP and MyD88 and NF-\u03baB inhibitor IKK were able to block the cytokine production.", {"entities": [[128, 133, "GENE"], [138, 143, "GENE"]]}], ["In contrast H 2 S treatment of M.F.", {"entities": []}], ["infected macrophages reduced nuclear accumulation of NF-\u03baB heterodimer p65/p52.", {"entities": []}], ["Our data demonstrate that under the present conditions H 2 S is effective in reducing Mycoplasma-induced inflammation by targeting the NF-\u03baB pathway.", {"entities": []}], ["This supports further studies for possible clinical applications.", {"entities": []}], ["The Asp358Ala variant in the interleukin-6 receptor ( IL-6R ) gene has been implicated in asthma, autoimmune and cardiovascular disorders, but its role in other respiratory conditions such as chronic obstructive pulmonary disease (COPD) has not been investigated.", {"entities": [[192, 229, "DISEASE"], [90, 96, "DISEASE"]]}], ["The aims of this study were to evaluate whether there is an association between Asp358Ala and COPD or asthma risk, and to explore the role of the Asp358Ala variant in sIL-6R shedding from neutrophils and its pro-inflammatory effects in the lung.", {"entities": [[102, 108, "DISEASE"]]}], ["We undertook logistic regression using data from the UK Biobank and the ECLIPSE COPD cohort.", {"entities": []}], ["Results were meta-analyzed with summary data from a further three COPD cohorts (7,519 total cases and 35,653 total controls), showing no association between Asp358Ala and COPD (OR\u2009=\u20091.02 [95% CI: 0.96, 1.07]).", {"entities": []}], ["Data from the UK Biobank showed a positive association between the Asp358Ala variant and atopic asthma (OR\u2009=\u20091.07 [1.01, 1.13]).", {"entities": [[96, 102, "DISEASE"]]}], ["In a series of in vitro studies using blood samples from 37 participants, we found that shedding of sIL-6R from neutrophils was greater in carriers of the Asp358Ala minor allele than in non-carriers.", {"entities": []}], ["Human pulmonary artery endothelial cells cultured with serum from homozygous carriers showed an increase in MCP-1 release in carriers of the minor allele, with the difference eliminated upon addition of tocilizumab.", {"entities": []}], ["In conclusion, there is evidence that neutrophils may be an important source of sIL-6R in the lungs, and the Asp358Ala variant may have pro-inflammatory effects in lung cells.", {"entities": []}], ["However, we were unable to identify evidence for an association between Asp358Ala and COPD.", {"entities": []}], ["Microparticles (MPs) are small membrane fragments shed from normal as well as activated, apoptotic or injured cells.", {"entities": []}], ["Emerging evidence implicates MPs as a causal and/or contributing factor in altering normal vascular cell phenotype through initiation of proinflammatory signal transduction events and paracrine delivery of proteins, mRNA and miRNA.", {"entities": []}], ["However, little is known regarding the mechanism by which MPs influence these events.", {"entities": []}], ["Caveolae are important membrane microdomains that function as centers of signal transduction and endocytosis.", {"entities": []}], ["Here, we tested the concept that the MP-induced pro-inflammatory phenotype shift in endothelial cells (ECs) depends on caveolae.", {"entities": []}], ["Consistent with previous reports, MP challenge activated ECs as evidenced by upregulation of intracellular adhesion molecule-1 (ICAM-1) expression.", {"entities": []}], ["ICAM-1 upregulation was mediated by activation of NF-\u03baB, Poly [ADP-ribose] polymerase 1 (PARP-1) and the epidermal growth factor receptor (EGFR).", {"entities": [[139, 143, "GENE"]]}], ["This response was absent in ECs lacking caveolin-1/caveolae.", {"entities": []}], ["To test whether caveolae-mediated endocytosis, a dynamin-2 dependent process, is a feature of the proinflammatory response, EC\u2019s were pretreated with the dynamin-2 inhibitor dynasore.", {"entities": []}], ["Similar to observations in cells lacking caveolin-1, inhibition of endocytosis significantly attenuated MPs effects including, EGFR phosphorylation, activation of NF-\u03baB and upregulation of ICAM-1 expression.", {"entities": [[127, 131, "GENE"]]}], ["Thus, our results indicate that caveolae play a role in mediating the pro-inflammatory signaling pathways which lead to EC activation in response to MPs.", {"entities": []}], ["Introduction: Metabolic syndrome represents a cluster of related metabolic abnormalities, including central obesity, hypertension, dyslipidemia, hyperglycemia, and insulin resistance, with central obesity and insulin resistance in particular recognized as causative factors.", {"entities": [[117, 129, "DISEASE"], [108, 115, "DISEASE"], [197, 204, "DISEASE"], [24, 32, "DISEASE"], [145, 158, "DISEASE"]]}], ["These metabolic derangements present significant risk factors for cardiovascular disease, which is commonly recognized as the primary clinical outcome, although other outcomes are possible.", {"entities": []}], ["Metabolic syndrome is a progressive condition that encompasses a wide array of disorders with specific metabolic abnormalities presenting at different times.", {"entities": [[10, 18, "DISEASE"]]}], ["These abnormalities can be detected and monitored via serum biomarkers.", {"entities": []}], ["This review will compile a list of promising biomarkers that are associated with metabolic syndrome and this panel can aid in early detection and management of metabolic syndrome in high risk populations, such as in West Virginia.", {"entities": [[91, 99, "DISEASE"], [170, 178, "DISEASE"]]}], ["Methods: A literature review was conducted using PubMed, Science Direct, and Google Scholar to search for markers related to metabolic syndrome.", {"entities": [[135, 143, "DISEASE"]]}], ["Biomarkers searched included adipokines (leptin, adiponectin), neuropeptides (ghrelin), pro-inflammatory cytokines (IL-6, TNF-\u03b1), anti-inflammatory cytokines (IL-10), markers of antioxidant status (OxLDL, PON-1, uric acid), and prothrombic factors (PAI-1).", {"entities": []}], ["Results: According to the literature, the concentrations of pro-inflammatory cytokines (IL-6, TNF-\u03b1), markers of pro-oxidant status (OxLDL, uric acid), and prothrombic factors (PAI-1) were elevated in metabolic syndrome.", {"entities": [[211, 219, "DISEASE"]]}], ["Additionally, leptin concentrations were found to be elevated in metabolic syndrome as well, likely due to leptin resistance.", {"entities": [[75, 83, "DISEASE"]]}], ["In contrast, concentrations of anti-inflammatory cytokines (IL-10), ghrelin, adiponectin, and antioxidant factors (PON-1) were decreased in metabolic syndrome, and these decreases also correlated with specific disorders within the cluster.", {"entities": [[150, 158, "DISEASE"]]}], ["Conclusion: Based on the evidence presented within the literature, the aforementioned biomarkers correlate significantly with metabolic syndrome and could provide a minimally-invasive means for early detection and specific treatment of these disorders.", {"entities": [[136, 144, "DISEASE"]]}], ["Further research is encouraged to determine the efficacy of applying these biomarkers to diagnosis and treatment in a clinical setting.", {"entities": []}], ["It has been suggested that neutrophils may be involved in the late- phase reaction of immunoglobulin E (IgE)-dependent hypersensitivity states.", {"entities": []}], ["However, the identity of neutrophil-associated molecules inducing the release of mediators remains unclear.", {"entities": []}], ["In this report, we demonstrate that human neutrophils from normal donors or from patients with inflammatory disorders could bind myeloma IgE proteins, especially after desialylation.", {"entities": [[129, 136, "DISEASE"]]}], ["Northern blot, immunoprecipitation, and flow cytometry analyses revealed that neutrophils did not express Fc epsilon RII/CD23, but rather Mac-2/epsilon binding protein (BP), belonging to the S-type lectin family.", {"entities": []}], ["Similarly to IgA used as positive control, myeloma IgE proteins, as well as polyclonal IgE antibodies with or without antibody specificity, were both capable of inducing a neutrophil respiratory burst.", {"entities": [[43, 50, "DISEASE"]]}], ["Anti-Mac-2 but not anti-CD23 mAb strongly decreased the IgE-dependent activation of neutrophils, induced either by the specific antigen or by anti-IgE antibodies.", {"entities": []}], ["These findings open new perspectives on the functional role of neutrophils in IgE- associated diseases including allergic states or parasitic infections.", {"entities": []}], ["Several recent clinical studies have implied a role for the receptor for advanced glycation end products (RAGE) and its variants in chronic obstructive pulmonary disease (COPD).", {"entities": [[132, 169, "DISEASE"]]}], ["In this study we have defined a role for RAGE in the pathogenesis of emphysema in mice.", {"entities": []}], ["RAGE deficient mice (RAGE-/-) exposed to chronic cigarette smoke were significantly protected from smoke induced emphysema as determined by airspace enlargement and had no significant reduction in lung tissue elastance when compared to their air exposed controls contrary to their wild type littermates.", {"entities": []}], ["The progression of emphysema has been largely attributed to an increased inflammatory cell-mediated elastolysis.", {"entities": []}], ["Acute cigarette smoke exposure in RAGE-/- mice revealed an impaired early recruitment of neutrophils, approximately a 6-fold decrease compared to wild type mice.", {"entities": []}], ["Hence, impaired neutrophil recruitment with continued cigarette smoke exposure reduces elastolysis and consequent emphysema.", {"entities": []}], ["The cytokines interleukin (IL)-7 and thymic stromal lymphopoietin (TSLP) signal through the IL-7R subunit and play proinflammatory roles in experimental arthritis and rheumatoid arthritis (RA).", {"entities": [[167, 187, "DISEASE"], [153, 162, "DISEASE"], [178, 187, "DISEASE"], [67, 71, "GENE"]]}], ["We evaluated the effect of inhibition of IL-7R- and TSLPR-signalling as well as simultaneous inhibition of IL-7R- and TSLPR-signalling in murine experimental arthritis.", {"entities": [[158, 167, "DISEASE"]]}], ["In addition, the effects of IL-7 and TSLP in human RA dendritic cell (DC)/T-cell co-cultures were studied.", {"entities": [[37, 41, "GENE"]]}], ["Arthritis was induced with proteoglycan in wildtype mice (WT) and in mice deficient for the TSLP receptor subunit (TSLPR-/-).", {"entities": [[0, 9, "DISEASE"], [92, 96, "GENE"]]}], ["Both mice genotypes were treated with anti-IL-7R or phosphate buffered saline.", {"entities": []}], ["Arthritis severity was assessed and local and circulating cytokines were measured.", {"entities": [[0, 9, "DISEASE"]]}], ["Autologous CD1c-positive DCs and CD4 T-cells were isolated from peripheral blood of RA patients and were co-cultured in the presence of IL-7, TSLP or both and proliferation and cytokine production were assessed.", {"entities": [[33, 36, "GENE"], [142, 146, "GENE"]]}], ["Arthritis severity and immunopathology were decreased in WT mice treated with anti-IL-7R, in TSLPR-/- mice, and the most robustly in TSLPR-/- mice treated with anti-IL-7R.", {"entities": [[0, 9, "DISEASE"]]}], ["This was associated with strongly decreased levels of IL-17, IL-6 and CD40L.", {"entities": []}], ["In human DC/T-cell co-cultures, TSLP and IL-7 additively increased T-cell proliferation and production of Th17-associated cytokines, chemokines and tissue destruction factors.", {"entities": [[32, 36, "GENE"]]}], ["TSLP and IL-7 have an additive effect on the production of Th17-cytokines in a human in vitro model, and enhance arthritis in mice linked with enhanced inflammation and immunopathology.", {"entities": [[113, 122, "DISEASE"], [0, 4, "GENE"]]}], ["As both cytokines signal via the IL-7R, these data urge for IL-7R-targeting to prevent the activity of both cytokines in RA.", {"entities": []}], ["We performed a cross-sectional study including 533 individuals (median age 61) from the highly TBE endemic \u00c5land Islands in the archipelago between Sweden and Finland.", {"entities": []}], ["Blood samples, questionnaires and vaccination records were obtained from all study participants.", {"entities": []}], ["The aim was to investigate if there was any association between TBEV antibody titer and 12 health-related factors.", {"entities": []}], ["Measurement of TBEV IgG antibodies was performed using two commercial ELISA assays (Enzygnost and Immunozym), and a third in-house rapid fluorescent focus inhibition test was used to measure TBEV neutralizing antibodies.", {"entities": []}], ["The age of the individual and the number of vaccine doses were the two most important factors determining the immunological response to vaccination.", {"entities": []}], ["The response to each vaccine dose declined linearly with increased age.", {"entities": []}], ["A 35 year age difference corresponds to a vaccine dose increment from 3 to 4 to achieve the same immunological response.", {"entities": []}], ["Participants previously vaccinated against other flaviviruses had lower odds of being seropositive for neutralizing TBEV antibodies on average, while participants with self-reported asthma had higher odds of being seropositive.", {"entities": [[182, 188, "DISEASE"]]}], ["By comparing the 3 serological assays we show that the Enzygnost and Immunozym assay differ due to choice of cutoffs, but not in overall accuracy.", {"entities": []}], ["Intracellular pathogens have devised various mechanisms to subvert the host immune response in order to survive and replicate in host cells.", {"entities": []}], ["Here, we studied the infection of human blood monocytes with the intracellular pathogen C. pneumoniae and the effect on cytokine and chemokine profiles in comparison to stimulation with LPS.", {"entities": []}], ["Monocytes purified from peripheral blood mononuclear cells by negative depletion were infected with C. pneumoniae .", {"entities": []}], ["While immunofluorescence confirmed the presence of chlamydial lipopolysaccharide (LPS) in the cytoplasm of infected monocytes, real-time PCR did not provide evidence for replication of the intracellular pathogen.", {"entities": []}], ["Complementary to PCR, C. pneumoniae infection was confirmed by an oligonucleotide DNA microarray for the detection of intracellular pathogens.", {"entities": []}], ["Raman microspectroscopy revealed different molecular fingerprints for infected and non-infected monocytes, which were mainly due to changes in lipid and fatty acid content.", {"entities": []}], ["Stimulation of monocytes with C. pneumoniae or with LPS induced similar profiles of tumor necrosis factor-alpha (TNF-\u03b1) and interleukin (IL)-6, but higher levels of IL-1\u03b2, IL-12p40 and IL-12p70 for C. pneumoniae which were statistically significant.", {"entities": []}], ["C. pneumoniae also induced release of the chemokines MCP-1, MIP-1\u03b1 and MIP-1\u03b2, and CXCL-8, which correlated with TNF-\u03b1 secretion.", {"entities": []}], ["Infection of human blood monocytes with intracellular pathogens triggers altered cytokine and chemokine pattern as compared to stimulation with extracellular ligands such as LPS.", {"entities": []}], ["Complementing conventional methods, an oligonucleotide DNA microarray for the detection of intracellular pathogens as well as Raman microspectroscopy provide useful tools to trace monocyte infection.", {"entities": []}], ["The online version of this article (doi:10.1186/s12865-014-0060-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["During acute viral infections such as influenza, humans often experience not only transient fever, but also prolonged fatigue or depressive feelings with a decrease in social activity for days or weeks.", {"entities": [[38, 47, "DISEASE"]]}], ["These feelings are thought to be due to neuroinflammation in the brain.", {"entities": []}], ["Recent studies have suggested that chronic neuroinflammation is a precipitating event of various neurological disorders, but the mechanism determining the duration of neuroinflammation has not been elucidated.", {"entities": []}], ["In this study, neuroinflammation was induced by intraperitoneal injection of polyriboinosinic:polyribocytidylic acid (poly I:C), a Toll-like receptor-3 agonist that mimics viral infection in male Sprague-Dawley rats, and then investigated how the neuroinflammation shift from acute to the chronic state.", {"entities": []}], ["The rats showed transient fever and prolonged suppression of spontaneous activity for several days following poly I:C injection.", {"entities": []}], ["NS-398, a cyclooxygenase-2 inhibitor, completely prevented fever, but did not improve spontaneous activity, indicating that suppression of spontaneous activity was not induced by the arachidonate cascade that generated the fever.", {"entities": []}], ["The animals overexpressed interleukin (IL)-1\u03b2 and IL-1 receptor antagonist (IL-1ra) in the brain including the cerebral cortex.", {"entities": []}], ["Blocking the IL-1 receptor in the brain by intracerebroventricular (i.c.v.)", {"entities": []}], ["infusion of recombinant IL-1ra completely blocked the poly I:C-induced suppression of spontaneous activity and attenuated amplification of brain interferon (IFN)-\u03b1 expression, which has been reported to produce fatigue-like behavior by suppressing the serotonergic system.", {"entities": []}], ["Furthermore, i.c.v.", {"entities": []}], ["infusion of neutralizing antibody for IL-1ra prolonged recovery from suppression of spontaneous activity.", {"entities": []}], ["Our findings indicated that IL-1\u03b2 is the key trigger of neuroinflammation and that IL-1ra prevents the neuroinflammation entering the chronic state.", {"entities": []}], ["The identification of causes of genetic diseases has been carried out by several approaches with increasing complexity.", {"entities": []}], ["Innovation of genetic methodologies leads to the production of large amounts of data that needs the support of statistical and computational methods to be correctly processed.", {"entities": []}], ["The aim of the paper is to provide an overview of statistical and computational methods paying attention to methods for the sequence analysis and complex diseases.", {"entities": []}], ["Obesity is a major health problem and an immense economic burden on the health care systems both in the United States and the rest of the world.", {"entities": [[0, 7, "DISEASE"]]}], ["The prevalence of obesity in children and adults in the United States has increased dramatically over the past decade.", {"entities": [[18, 25, "DISEASE"]]}], ["Besides environmental factors, genetic factors are known to play an important role in the pathogenesis of obesity.", {"entities": [[106, 113, "DISEASE"]]}], ["Genome-wide association studies (GWAS) have revealed strongly associated genomic variants associated with most common disorders; indeed there is general consensus on these findings from generally positive replication outcomes by independent groups.", {"entities": []}], ["To date, there have been only a few GWAS-related reports for childhood obesity specifically, with studies primarily uncovering loci in the adult setting instead.", {"entities": [[71, 78, "DISEASE"]]}], ["It is clear that a number of loci previously reported from GWAS analyses of adult BMI and/or obesity also play a role in childhood obesity.", {"entities": [[93, 100, "DISEASE"], [131, 138, "DISEASE"]]}], ["Aspirin is a primary antiplatelet agent for the secondary prevention of ischemic stroke.", {"entities": []}], ["However, if aspirin fails to inhibit platelet function, as is expected in acute ischemic stroke (AIS), it may increase the rate of early clinical events.", {"entities": []}], ["Therefore, we sought to determine whether aspirin resistance in the acute stage was associated with early radiological events, including new ischemic lesions (NILs).", {"entities": []}], ["This study was a single-center, prospective, observational study conducted between April 2012 and May 2013.", {"entities": []}], ["Aspirin 300 mg was initially administered followed by maintenance doses of 100 mg daily.", {"entities": []}], ["The acute aspirin reaction unit (aARU) was consistently measured after 3 hours of aspirin loading.", {"entities": []}], ["An aARU value \u2265550 IU was defined as biological aspirin resistance (BAR).", {"entities": []}], ["NILs on follow-up diffusion-weighted imaging (DWI) were defined as lesions separate from index lesions, which were not detected on the initial DWI.", {"entities": []}], ["A total of 367 patients were analyzed in this study.", {"entities": []}], ["BAR in aARU was detected in 60 patients (16.3%).", {"entities": []}], ["On follow-up DWI, 81 patients (22.1%) had NILs, which were frequently in the same territory as the index lesions (79%), pial infarcts (61.7%), and located within the cortex (59.3%).", {"entities": []}], ["BAR was independently associated with NILs on follow-up DWI (adjusted OR 2.00, 95% CIs 1.01\u20133.96; p = 0.047).", {"entities": []}], ["In conclusion, BAR in aARU could be associated with NILs on follow-up DWI in AIS.", {"entities": []}], ["Therefore, a further prospective study with a longer follow-up period is necessary to evaluate the clinical implications of aARU in AIS.", {"entities": []}], ["Exposure to airborne particles has a major impact on global health.", {"entities": []}], ["The probability of these particles to deposit in the respiratory tract during breathing is essential for their toxic effects.", {"entities": []}], ["Observations have shown that there is a substantial variability in deposition between subjects, not only due to respiratory diseases, but also among individuals with healthy lungs.", {"entities": []}], ["The factors determining this variability are, however, not fully understood.", {"entities": []}], ["In this study we experimentally investigate factors that determine individual differences in the respiratory tract depositions of inhaled particles for healthy subjects at relaxed breathing.", {"entities": []}], ["The study covers particles of diameters 15\u20135000\u00a0nm and includes 67 subjects aged 7\u201370 years.", {"entities": []}], ["A comprehensive examination of lung function was performed for all subjects.", {"entities": []}], ["Principal component analyses and multiple regression analyses were used to explore the relationships between subject characteristics and particle deposition.", {"entities": []}], ["A large individual variability in respiratory tract deposition efficiency was found.", {"entities": []}], ["Individuals with high deposition of a certain particle size generally had high deposition for all particles <3500\u00a0nm.", {"entities": []}], ["The individual variability was explained by two factors: breathing pattern, and lung structural and functional properties.", {"entities": []}], ["The most important predictors were found to be breathing frequency and anatomical airway dead space.", {"entities": []}], ["We also present a linear regression model describing the deposition based on four variables: tidal volume, breathing frequency, anatomical dead space and resistance of the respiratory system (the latter measured with impulse oscillometry).", {"entities": []}], ["To understand why some individuals are more susceptible to airborne particles we must understand, and take into account, the individual variability in the probability of particles to deposit in the respiratory tract by considering not only breathing patterns but also adequate measures of relevant structural and functional properties.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-017-0190-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements.", {"entities": []}], ["The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date.", {"entities": []}], ["This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK.", {"entities": []}], ["The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including \u2018other\u2019) for the government, charity and private sectors.", {"entities": []}], ["The VECM model describes the relationship between public (i.e.", {"entities": []}], ["government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements.", {"entities": []}], ["There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure.", {"entities": []}], ["A 1\u00a0% increase in public sector expenditure is associated in the best-fit model with a 0.81\u00a0% increase in private sector expenditure.", {"entities": []}], ["Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68.", {"entities": []}], ["Overall, every additional \u00a31 of public research expenditure is associated with an additional \u00a30.83\u2013\u00a31.07 of private sector R&D spend in the UK; 44\u00a0% of that additional private sector expenditure occurs within 1\u00a0year, with the remainder accumulating over decades.", {"entities": []}], ["This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15\u201318\u00a0%.", {"entities": []}], ["When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24\u201328\u00a0%.", {"entities": [[102, 108, "DISEASE"]]}], ["Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK.", {"entities": []}], ["The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5\u00a0% real annual rate of return required by the UK government to public investments generally.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-016-0564-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study aims to evaluate the acute effects of an oscillating positive expiratory pressure device (flutter) on airways resistance in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[149, 186, "DISEASE"]]}], ["Randomized crossover study: 15 COPD outpatients from Asthma Lab\u2013Royal Brompton Hospital underwent spirometry, impulse oscillometry (IOS) for respiratory resistance (R) and reactance (X), and fraction exhaled nitric oxide (FeNO) measures.", {"entities": []}], ["Thirty minutes of flutter exercises: a \u201cflutter-sham\u201d procedure was used as a control, and airway responses after a short-acting bronchodilator were also assessed.", {"entities": []}], ["Respiratory system resistance (R): in COPD patients an increase in X5insp (\u22120.21 to \u22120.33\u200akPa/L/s) and Fres (24.95 to 26.16\u200aHz) occurred immediately after flutter exercises without bronchodilator.", {"entities": []}], ["Following 20 min of rest, a decrease in the R5, \u0394R5, R20, X5, and Ax was observed, with R5, R20, and X5 values lower than baseline, with a moderate effect size; there were no changes in FeNO levels or spirometry.", {"entities": []}], ["The use of flutter can decrease the respiratory system resistance and reactance and expiratory flow limitation in stable COPD patients with small amounts of secretions.", {"entities": []}], ["High salt (HS) intake may elevate blood pressure (BP), also in animals without genetic salt sensitivity.", {"entities": []}], ["The development of salt-dependent hypertension could be mediated by endogenous vasoactive agents; here we examined the role of vasodilator epoxyeicosatrienoic acids (EETs) and vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE).", {"entities": [[34, 46, "DISEASE"]]}], ["In conscious Wistar rats on HS diet systolic BP (SBP) was examined after chronic elevation of EETs using 4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid ( c -AUCB), a blocker of soluble epoxide hydrolase, or after inhibition of 20-HETE with 1-aminobenzotriazole (ABT).", {"entities": []}], ["Thereafter, in acute experiments the responses of renal artery blood flow (Transonic probe) and renal regional perfusion (laser-Doppler) to intrarenal acetylcholine (ACh) or norepinephrine were determined.", {"entities": []}], ["HS diet increased urinary 20-HETE excretion.", {"entities": []}], ["The SBP increase was not reduced by c -AUCB but prevented by ABT until day 5 of HS exposure.", {"entities": []}], ["Renal vasomotor responses to ACh or norepinephrine were similar on standard and HS diet.", {"entities": []}], ["ABT but not c -AUCB abolished the responses to ACh.", {"entities": []}], ["20-HETE seems to mediate the early-phase HS diet-induced BP increase while EETs are not engaged in the process.", {"entities": []}], ["Since HS exposure did not alter renal vasodilator responses to Ach, endothelial dysfunction is not a critical factor in the mechanism of salt-induced blood pressure elevation.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is a progressive airway disease characterised by neutrophilic airway inflammation or bronchitis.", {"entities": [[130, 140, "DISEASE"]]}], ["Neutrophilic bronchitis is associated with both bacterial colonisation and lung function decline and is common in exacerbations of COPD.", {"entities": [[13, 23, "DISEASE"]]}], ["Despite current available therapies to control inflammation, neutrophilic bronchitis remains common.", {"entities": [[74, 84, "DISEASE"]]}], ["This study tested the hypothesis that azithromycin treatment, as an add-on to standard medication, would significantly reduce airway neutrophil and neutrophils chemokine (CXCL8) levels, as well as bacterial load.", {"entities": []}], ["We conducted a randomised, double-blind, placebo-controlled study in COPD participants with stable neutrophilic bronchitis.", {"entities": [[112, 122, "DISEASE"]]}], ["Eligible participants (n\u200a=\u200a30) were randomised to azithromycin 250 mg daily or placebo for 12 weeks in addition to their standard respiratory medications.", {"entities": []}], ["Sputum was induced at screening, randomisation and monthly for a 12 week treatment period and processed for differential cell counts, CXCL8 and neutrophil elastase assessment.", {"entities": []}], ["Quantitative bacteriology was assessed in sputum samples at randomisation and the end of treatment visit.", {"entities": []}], ["Severe exacerbations where symptoms increased requiring unscheduled treatment were recorded during the 12 week treatment period and for 14 weeks following treatment.", {"entities": []}], ["A sub-group of participants underwent chest computed tomography scans (n\u200a=\u200a15).", {"entities": []}], ["Nine participants with neutrophilic bronchitis had a potentially pathogenic bacteria isolated and the median total bacterial load of all participants was 5.22\u00d710 In stable COPD with neutrophilic bronchitis, add-on azithromycin therapy showed a trend to reduced severe exacerbations sputum neutrophils, CXCL8 levels and bacterial load.", {"entities": [[36, 46, "DISEASE"], [195, 205, "DISEASE"]]}], ["Future studies with a larger sample size are warranted.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry ACTRN12609000259246", {"entities": []}], ["Mast cells and basophils depend on aggregation of the high-affinity IgE receptor, FceRI, to initiate secretion.", {"entities": []}], ["A variety of studies have shown that FceRI densities vary 100 fold among subjects\u2019 basophils and it has been speculated that high densities might be responsible for unusual behaviors of the cells, notably sensitivity to certain monomeric IgE antibodies or spontaneous release.", {"entities": []}], ["These studies experimentally examined the density dependence of spontaneous release and signaling element expression in subjects\u2019 basophils with FceRI densities ranging from approximately 6000 to 600,000 per cell.", {"entities": []}], ["Through the use of numerical simulation, this study examined the expectations for spontaneous receptor aggregation and aggregate persistence at densities of FceRI ranging from 5000 to 500,000.", {"entities": []}], ["Experimentally, FceRI density was not associated with greater spontaneous histamine release even when secretion was enhanced by the inclusion of deuterium oxide in the buffers.", {"entities": []}], ["There was also no association of 15 activating or de-activating signaling elements with FceRI density.", {"entities": []}], ["The numerical simulations demonstrated that at densities of \u2248500,000 receptors, 13% of receptors were involved in transient aggregates at any given moment but that these aggregates rarely persisted for greater than 10 milliseconds.", {"entities": []}], ["In contrast, a weak linear antigen aggregator, with ligand affinities known to induce secretion, would generate aggregates persisting for an average of \u224860 milliseconds.", {"entities": []}], ["These results suggest that although a high density of FceRI likely produces a large number of transient aggregates, these aggregates do not persist long enough to induce signaling that results in secretion and do not induce the cells to alter their expression of several signaling elements known to be important in regulating secretion from human basophils.", {"entities": []}], ["The results set some boundaries on the aggregation requirements for inducing histamine release from human basophils.", {"entities": []}], ["Waste management, namely, collection, transport, sorting and processing, and disposal, is an issue of social concern owing to its environmental impact and effects on public health.", {"entities": []}], ["In fact, waste management activities are carried out according to procedures that can have various negative effects on the environment and, potentially, on human health.", {"entities": []}], ["The aim of our study was to assess the potential effects on respiratory health of this exposure in workers in the waste management and disposal field, as compared with a group of workers with no occupational exposure to outdoor pollutants.", {"entities": []}], ["The sample consisted of a total of 124 subjects, 63 waste collectors, and 61 office clerks.", {"entities": []}], ["Informed consent was obtained from all subjects before inclusion in the study.", {"entities": []}], ["The entire study population underwent pulmonary function assessments with spirometry and completed two validated questionnaires for the diagnosis of rhinitis and chronic bronchitis.", {"entities": [[149, 157, "DISEASE"], [170, 180, "DISEASE"]]}], ["Statistical analyses were performed using STATA 13.", {"entities": []}], ["Spirometry showed a statistically significant reduction in the mean Tiffenau Index values in the exposed workers, as compared with the controls, after adjusting for the confounding factors of age, BMI, and smoking habit.", {"entities": []}], ["Similarly, the mean FEV1 values were lower in the exposed workers than in the controls, this difference being again statistically significant.", {"entities": []}], ["The FVC differences measured in the two groups were not found to be statistically significant.", {"entities": []}], ["We ran a cross-sectional study to investigate the respiratory health of a group of workers in the solid waste collection and disposal field as compared with a group of office workers.", {"entities": []}], ["In agreement with most of the data in the literature, our findings support the existence of a prevalence of respiratory deficits in waste disposal workers.", {"entities": []}], ["Our data suggest the importance of adopting preventive measures, such as wearing specific individual protection devices, to protect this particular category of workers from adverse effects on respiratory health.", {"entities": []}], ["The glucocorticoid receptor gene (NR3C1) has been suggested as a candidate gene affecting juvenile idiopathic arthritis (JIA) course and prognosis.", {"entities": [[110, 119, "DISEASE"], [34, 39, "GENE"]]}], ["The purpose of this study is to investigate the glucocorticoid receptor gene Bcl I polymorphism (rs41423247) in JIA patients, the gene's role in susceptibility to juvenile idiopathic arthritis, and its associations with JIA activity, course and bone mineralization.", {"entities": [[183, 192, "DISEASE"]]}], ["One hundred twenty-two Caucasian children with JIA and 143 healthy ethnically matched controls were studied.", {"entities": []}], ["We checked markers of clinical and laboratory activity: morning stiffness, Ritchie Articular Index (RAI), swollen joint count (SJC), tender joint count (TJC), physician's visual analog scale (VAS), hemoglobin level (Hb), leukocyte count (L), platelet count (Pl), Westergren erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), albumin, DAS and DAS28.", {"entities": [[332, 335, "GENE"]]}], ["Bone mineralization was measured by dual-energy X-ray absorptiometry (DXA) of lumbar spine L1-L4.", {"entities": []}], ["Assessments of bone metabolism included osteocalcin, C-terminal telopeptide (CTT), parathyroid hormone (PTH), total and ionized calcium, inorganic phosphate and total alkaline phosphatase (TAP).", {"entities": [[104, 107, "GENE"]]}], ["Bcl I polymorphism was genotyped by polymerase chain reaction restriction fragment length polymorphism.", {"entities": []}], ["No association was observed between glucocorticoid receptor gene polymorphism and the presence or absence of JIA.", {"entities": []}], ["In girls with JIA, the presence of the G allele was associated with an unfavorable arthritis course, a younger age of onset of arthritis (p = 0.0017), and higher inflammatory activity.", {"entities": [[83, 92, "DISEASE"], [127, 136, "DISEASE"]]}], ["The higher inflammatory activity was demonstrated by the following: increased time of morning stiffness (p = 0.02), VAS (p = 0.014), RAI (p = 0.048), DAS (p = 0.035), DAS28 (p = 0.05), Pl (p = 0.003), L (p = 0.046), CRP (p = 0.01).", {"entities": [[216, 219, "GENE"]]}], ["In addition, these patients had bone metabolism disturbances as follows: decreased BA (p = 0.0001), BMC (p = 0.00007), BMD (0.005) and Z score (p = 0.002); and higher levels of osteocalcin (p = 0.03), CTT (p = 0.036), TAP activity (p = 0.01) and ionized calcium (p = 0.017).", {"entities": []}], ["In boys with JIA, no significant differences were observed related to the polymorphic alleles or genotypes.", {"entities": []}], ["We suggest that G allele and the GG genotype of the glucocorticoid receptor gene Bcl I polymorphism contribute to an unfavorable course and low bone mineral density in girls with JIA.", {"entities": []}], ["Cell wounding is an important driver of the innate immune response of ventilator-injured lungs.", {"entities": []}], ["We had previously shown that the majority of wounded alveolus resident cells repair and survive deformation induced insults.", {"entities": []}], ["This is important insofar as wounded and repaired cells may contribute to injurious deformation responses commonly referred to as biotrauma.", {"entities": []}], ["The central hypothesis of this communication states that extracellular adenosine-5\u2032 triphosphate (ATP) promotes the repair of wounded alveolus resident cells by a P2Y2-Receptor dependent mechanism.", {"entities": []}], ["Using primary type 1 alveolar epithelial rat cell models subjected to micropuncture injury and/or deforming stress we show that 1) stretch causes a dose dependent increase in cell injury and ATP media concentrations; 2) enzymatic depletion of extracellular ATP reduces the probability of stretch induced wound repair; 3) enriching extracellular ATP concentrations facilitates wound repair; 4) purinergic effects on cell repair are mediated by ATP and not by one of its metabolites; and 5) ATP mediated cell salvage depends at least in part on P2Y2-R activation.", {"entities": []}], ["While rescuing cells from wounding induced death may seem appealing, it is possible that survivors of membrane wounding become governors of a sustained pro-inflammatory state and thereby perpetuate and worsen organ function in the early stages of lung injury syndromes.", {"entities": []}], ["Means to uncouple P2Y2-R mediated cytoprotection from P2Y2-R mediated inflammation and to test the preclinical efficacy of such an undertaking deserve to be explored.", {"entities": []}], ["Dendritic cells (DCs) are important immune cells linking innate and adaptive immune responses.", {"entities": []}], ["DCs encounter various self and non-self antigens present in the environment and induce different types of antigen specific adaptive immune responses.", {"entities": []}], ["DCs can be classified into lymphoid tissue-resident DCs, migratory DCs, non-lymphoid resident DCs, and monocyte derived DCs (moDCs).", {"entities": []}], ["Recent work has also established that DCs consist of developmentally and functionally distinct subsets that differentially regulate T lymphocyte function.", {"entities": []}], ["The development of different DC subsets has been found to be regulated by a network of different cytokines and transcriptional factors.", {"entities": []}], ["Moreover, the response of DC is tightly regulated to maintain the homeostasis of immune system.", {"entities": []}], ["MicroRNAs (miRNAs) are an important class of cellular regulators that modulate gene expression and thereby influence cell fate and function.", {"entities": []}], ["In the immune system, miRNAs act at checkpoints during hematopoietic development and cell subset differentiation, they modulate effector cell function, and are implicated in the maintenance of homeostasis.", {"entities": []}], ["DCs are also regulated by miRNAs.", {"entities": []}], ["In the past decade, much progress has been made to understand the role of miRNAs in regulating the development and function of DCs.", {"entities": []}], ["In this review, we summarize the origin and distribution of different mouse DC subsets in both lymphoid and non-lymphoid tissues.", {"entities": []}], ["The DC subsets identified in human are also described.", {"entities": []}], ["Recent progress on the function of miRNAs in the development and activation of DCs and their functional relevance to autoimmune diseases are discussed.", {"entities": []}], ["NF- \u03ba B comprises a family of transcription factors that are critically involved in various inflammatory processes.", {"entities": []}], ["In this paper, the role of NF- \u03ba B in inflammation and atherosclerosis and the regulation of the NF- \u03ba B signaling pathway are summarized.", {"entities": [[55, 70, "DISEASE"]]}], ["The structure, function, and regulation of the NF- \u03ba B inhibitors, I \u03ba B \u03b1 and I \u03ba B \u03b2 , are reviewed.", {"entities": []}], ["The regulation of NF- \u03ba B activity by glucocorticoid receptor (GR) signaling and I \u03ba B \u03b1 sumoylation is also discussed.", {"entities": []}], ["This paper focuses on the recently reported regulatory function that adipocyte enhancer-binding protein 1 (AEBP1) exerts on NF- \u03ba B transcriptional activity in macrophages, in which AEBP1 manifests itself as a potent modulator of NF- \u03ba B via physical interaction with I \u03ba B \u03b1 and a critical mediator of inflammation.", {"entities": [[107, 112, "GENE"], [182, 187, "GENE"], [107, 112, "GENE"], [182, 187, "GENE"]]}], ["Finally, we summarize the regulatory roles that recently identified I \u03ba B \u03b1 -interacting proteins play in NF- \u03ba B signaling.", {"entities": []}], ["Based on its proinflammatory roles in macrophages, AEBP1 is anticipated to serve as a therapeutic target towards the treatment of various inflammatory conditions and disorders.", {"entities": [[51, 56, "GENE"]]}], ["Community-acquired pneumonia (CAP) is one of the leading causes of death worldwide.", {"entities": [[19, 28, "DISEASE"]]}], ["Cytokines are involved in the pathogenesis of CAP.", {"entities": []}], ["To date, only a few studies concerned the association of interleukin-10 (IL-10) gene polymorphisms with CAP.", {"entities": []}], ["In this study, we aimed to investigate whether the -1082(G/A) polymorphism in the promoter region of the IL-10 gene is involved in susceptibility to and the outcome of CAP, and we also measured the serum level of IL-10 to assess its relation to such polymorphism.", {"entities": []}], ["This was a case\u2013control study included 100 patients with CAP, and matched with age, gender, and ethnicity of 100 healthy control children.", {"entities": []}], ["IL-10 -1082(G/A) gene polymorphism was genotyped by polymerase chain reaction-restriction fragment length polymorphism, while the serum IL-10 levels were measured by ELISA method.", {"entities": []}], ["Compared to the controls subjects, the frequencies of the IL-10 -1082 AA genotype and A allele were observed to be overrepresented in patients with CAP (51%; odds ratio [OR] = 2.8; 95% confidence interval [CI]: 1.5\u20135.3 for the AA genotype; P \u200a<\u200a0.01) and (70%; OR: 1.95; 95% CI: 1.27\u20133.00 for the A allele; P \u200a<\u200a0.01, respectively).", {"entities": []}], ["We found that patients with the GG genotype had significantly higher serum IL-10 levels (46.7\u200a\u00b1\u200a9.5\u200apg/mL) compared to those with AG genotype (21.8\u200a\u00b1\u200a4.5\u200apg/mL) and AA genotype (11.5\u200a\u00b1\u200a3.3\u200apg/mL); P \u200a<\u200a0.01, respectively.", {"entities": []}], ["Our data revealed a significant positive association between the -1082 GG genotype and susceptibility to severe sepsis, acute respiratory failure, and hospital mortality (OR: 3.8; 95% CI: 1.3\u201311.2; P \u200a<\u200a0.01).", {"entities": [[126, 145, "DISEASE"]]}], ["We demonstrate for the first time, to the best of our knowledge, that IL-10 -1082 (G/A) gene polymorphism may contribute to susceptibility to CAP in Egyptian children.", {"entities": []}], ["Moreover, we observed that the presence of a G allele or GG genotype at the -1082 position of the promoter region of the IL-10 gene constitute risk factors for developing severe sepsis, acute respiratory failure, and hospital mortality among patients with CAP.", {"entities": [[192, 211, "DISEASE"]]}], ["The respiratory mucosa is a major coordinator of the inflammatory response in chronic airway diseases, including asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[124, 161, "DISEASE"], [113, 119, "DISEASE"]]}], ["Signals produced by the chronic inflammatory process induce epithelial mesenchymal transition (EMT) that dramatically alters the epithelial cell phenotype.", {"entities": []}], ["The effects of EMT on epigenetic reprogramming and the activation of transcriptional networks are known, its effects on the innate inflammatory response are underexplored.", {"entities": []}], ["We used a multiplex gene expression profiling platform to investigate the perturbations of the innate pathways induced by TGF \u03b2 in a primary airway epithelial cell model of EMT.", {"entities": []}], ["EMT had dramatic effects on the induction of the innate pathway and the coupling interval of the canonical and noncanonical NF- \u03ba B pathways.", {"entities": []}], ["Simulation experiments demonstrate that rapid, coordinated cap-independent translation of TRAF-1 and NF- \u03ba B2 is required to reduce the noncanonical pathway coupling interval.", {"entities": []}], ["Experiments using amantadine confirmed the prediction that TRAF-1 and NF- \u03ba B2/p100 production is mediated by an IRES-dependent mechanism.", {"entities": []}], ["These data indicate that the epigenetic changes produced by EMT induce dynamic state changes of the innate signaling pathway.", {"entities": []}], ["Further applications of systems approaches will provide understanding of this complex phenotype through deterministic modeling and multidimensional (genomic and proteomic) profiling.", {"entities": []}], ["Greece has one of the highest rates of smoking and chronic obstructive pulmonary disease (COPD) in Europe.", {"entities": [[51, 88, "DISEASE"]]}], ["The study aimed to record both the disease characteristics among a sample of Greek COPD patients and the nationwide rates of newly diagnosed COPD cases.", {"entities": []}], ["In this noninterventional, epidemiological cross-sectional study, a representative nationwide sample of 45 respiratory centers provided data on the following: 1) the demographic and clinical characteristics of COPD patients and 2) newly diagnosed COPD cases monitored over a period of 6 months by each physician.", {"entities": []}], ["Data from 6,125 COPD patients were collected.", {"entities": []}], ["Advanced age (median age: 68 years), male predominance (71.3%), largely overweight status with median body mass index (BMI) =27.5 kg/m P -values <0.001).", {"entities": []}], ["A total of 61.3% of the patients received medication, mostly bronchodilators (64.4%) and fixed-dose combinations of long-acting \u03b2 2 -agonists and inhaled corticosteroids (39.9%), while 35.9% reported taking medication on demand.", {"entities": []}], ["The majority (81.1%) of patients reported a preference for fewer inhalations of their bronchodilator therapy.", {"entities": []}], ["Based on the mixed-effect Poisson model, the rate of newly diagnosed COPD cases was estimated to be 18.2% (95% confidence interval: 14.9\u201322.3) per pulmonologist/3 months.", {"entities": []}], ["Of those newly diagnosed, the majority of patients had mild or moderate airflow limitation (78.2%).", {"entities": []}], ["The Greek Obstructive Lung Disease Epidemiology and health ecoNomics study reflected the real-life profile of COPD patients and provided evidence on the profile of new COPD cases in Greece.", {"entities": []}], ["Various demographic factors were delineated, which can assist in designing more effective diagnostic and management strategies for COPD in Greece.", {"entities": []}], ["Japanese cedar pollinosis (JCP) is an important illness caused by the inhalation of airborne allergenic cedar pollens, which are dispersed in the early spring throughout the Japanese islands.", {"entities": []}], ["However, associations between pollen exposures and the prevalence or severity of allergic symptoms are largely unknown, due to a lack of understanding regarding personal pollen exposures in relation to indoor and outdoor concentrations.", {"entities": []}], ["This study aims to examine the relationships among indoor, outdoor, and personal airborne Japanese cedar pollen counts.", {"entities": []}], ["We conducted a 4-year monitoring campaign to quantify indoor, outdoor, and personal airborne cedar pollen counts, where the personal passive settling sampler that has been previously validated against a volumetric sampler was used to count airborne pollen grains.", {"entities": []}], ["A total of 256 sets of indoor, outdoor, and personal samples (768 samples) were collected from 9 subjects.", {"entities": []}], ["Medians of the seasonally-integrated indoor-to-outdoor, personal-to-outdoor, and personal-to-indoor ratios of airborne pollen counts measured for 9 subjects were 0.08, 0.10, and 1.19, respectively.", {"entities": []}], ["A greater correlation was observed between the personal and indoor counts ( r = 0.89) than between the personal and outdoor counts ( r = 0.71), suggesting a potential inaccuracy in the use of outdoor counts as a basis for estimating personal exposures.", {"entities": []}], ["The personal pollen counts differed substantially among the human subjects (49% geometric coefficient of variation), in part due to the variability in the indoor counts that have been found as major determinants of the personal pollen counts.", {"entities": []}], ["The findings of this study highlight the need for pollen monitoring in proximity to human subjects to better understand the relationships between pollen exposures and the prevalence or severity of pollen allergy.", {"entities": []}], ["Computer-based decision support systems are a promising method for incorporating research evidence into clinical practice.", {"entities": []}], ["However, evidence is still scant on how such information technology solutions work in primary healthcare when support is provided across many health problems.", {"entities": []}], ["In Finland, we designed a trial where a set of evidence-based, patient-specific reminders was introduced into the local Electronic Patient Record (EPR) system.", {"entities": []}], ["The aim was to measure the effects of such reminders on patient care.", {"entities": []}], ["The hypothesis was that the total number of triggered reminders would decrease in the intervention group compared with the control group, indicating an improvement in patient care.", {"entities": []}], ["From July 2009 to October 2010 all the patients of one health center were randomized to an intervention or a control group.", {"entities": []}], ["The intervention consisted of patient-specific reminders concerning 59 different health conditions triggered when the healthcare professional (HCP) opened and used the EPR.", {"entities": []}], ["In the intervention group, the triggered reminders were shown to the HCP; in the control group, the triggered reminders were not shown.", {"entities": []}], ["The primary outcome measure was the change in the number of reminders triggered over 12 months.", {"entities": []}], ["We developed a unique data gathering method, the Repeated Study Virtual Health Check (RSVHC), and used Generalized Estimation Equations (GEE) for analysing the incidence rate ratio, which is a measure of the relative difference in percentage change in the numbers of reminders triggered in the intervention group and the control group.", {"entities": []}], ["In total, 13,588 participants were randomized and included.", {"entities": []}], ["Contrary to our expectation, the total number of reminders triggered increased in both the intervention and the control groups.", {"entities": []}], ["The primary outcome measure did not show a significant difference between the groups.", {"entities": []}], ["However, with the inclusion of patients followed up over only six months, the total number of reminders increased significantly less in the intervention group than in the control group when the confounding factors (age, gender, number of diagnoses and medications) were controlled for.", {"entities": []}], ["Computerized, tailored reminders in primary care did not decrease during the 12 months of follow-up time after the introduction of a patient-specific decision support system.", {"entities": []}], ["ClinicalTrial.gov NCT00915304", {"entities": []}], ["Biyeom-Tang, a medicine prescribed by oriental clinics, has been used for the treatment of the allergic rhinitis (AR).", {"entities": [[95, 112, "DISEASE"], [104, 112, "DISEASE"]]}], ["In the present study, an ethanol extract of Biyeom-Tang (EBT) was investigated for anti-allergic properties on bone-marrow derived mast cells (BMMC) and in vivo models.", {"entities": []}], ["The anti-allergic properties of EBT were evaluated by measuring \u03b2-Hex release and the production of prostaglandin D 2 (PGD 2 ) and leukotriene C 4 (LTC 4 ) on BMMC in vitro and PCA and OVA-induced AR models in vivo .", {"entities": [[119, 122, "GENE"]]}], ["EBT strongly inhibited a degranulation reaction in a dose dependent manner with an IC 50 value of 35.6 \u03bcg/ml.", {"entities": []}], ["In addition, the generation of PGD 2 and LTC 4 was inhibited in BMMC in a concentration-dependent manner with IC 50 values of 7.0 \u03bcg/ml and 10.9 \u03bcg/ml, respectively.", {"entities": [[31, 34, "GENE"]]}], ["When administrated orally, EBT ameliorated the mast cell-mediated PCA reaction.", {"entities": []}], ["In the OVA-induced AR model, the increased levels of IgE were reduced by EBT.", {"entities": []}], ["The levels of cytokines, such as IL-4, IL-5, IL-10, and IL-13 decreased in the splenocytes of EBT-treated mice.", {"entities": []}], ["The histological analysis shows that the infiltration of inflammatory cells increased by OVA-sensitization was also reduced.", {"entities": []}], ["Taken together, these results suggested that EBT has anti-allergic and anti-inflammatory effects in vitro and in vivo models.", {"entities": []}], ["Churg-Strauss Syndrome (CSS) is rare in children.", {"entities": []}], ["It consists of a small- and medium-sized vessel vasculitis, with skin and peripheral nerve involvement.", {"entities": [[48, 58, "DISEASE"]]}], ["It is characterized by eosinophilia, extravascular necrotizing granuloma, and eosinophilic infiltration of multiple organs particularly the lungs, but may also involve the gastrointestinal tract, the heart, and the kidneys.", {"entities": [[23, 35, "DISEASE"]]}], ["The condition is usually associated with a preceding history of asthma or allergic sinusitis.", {"entities": [[83, 92, "DISEASE"], [64, 70, "DISEASE"]]}], ["It has rarely been reported in children, where most of the cases had pre-existing asthma, allergic rhinitis, or atopic disease.", {"entities": [[90, 107, "DISEASE"], [99, 107, "DISEASE"], [82, 88, "DISEASE"]]}], ["We report a 10-year-old Arab girl proven to have CSS, with no history of asthma or allergic rhinitis, who presented with tender cutaneous nodules of lower extremities, foot drop, and peripheral eosinophilia, without any clinical respiratory symptoms or signs.", {"entities": [[83, 100, "DISEASE"], [92, 100, "DISEASE"], [194, 206, "DISEASE"], [73, 79, "DISEASE"]]}], [": To determine whether a restrictive pattern on spirometry is associated with the level of physical activity in daily life (PADL), as well as with cardiovascular disease (CVD) risk factors, in asymptomatic adults.", {"entities": []}], [": A total of 374 participants (mean age, 41 \u00b1 14 years) underwent spirometry, which included the determination of FVC and FEV 1 .", {"entities": [[122, 125, "GENE"]]}], ["A restrictive pattern on spirometry was defined as an FEV 1 /FVC ratio > 0.7 and an FVC < 80% of the predicted value.", {"entities": [[54, 57, "GENE"]]}], ["After conducting demographic, anthropometric, and CVD risk assessments, we evaluated body composition, muscle function, and postural balance, as well as performing cardiopulmonary exercise testing and administering the six-minute walk test.", {"entities": []}], ["The PADL was quantified with a triaxial accelerometer.", {"entities": []}], [": A restrictive pattern on spirometry was found in 10% of the subjects.", {"entities": []}], ["After multivariate logistic regression, adjusted for confounders (PADL and cardiorespiratory fitness), the following variables retained significance (OR; 95% CI) as predictors of a restrictive pattern: systemic arterial hypertension (17.5; 1.65-184.8), smoking (11.6; 1.56-87.5), physical inactivity (8.1; 1.43-46.4), larger center-of-pressure area while standing on a force platform (1.34; 1.05-1.71); and dyslipidemia (1.89; 1.12-1.98).", {"entities": [[220, 232, "DISEASE"]]}], [": A restrictive pattern on spirometry appears to be common in asymptomatic adults.", {"entities": []}], ["We found that CVD risk factors, especially systemic arterial hypertension, smoking, and physical inactivity, were directly associated with a restrictive pattern, even when the analysis was adjusted for PADL and cardiorespiratory fitness.", {"entities": [[61, 73, "DISEASE"]]}], ["Longitudinal studies are needed in order to improve understanding of the etiology of a restrictive pattern as well as to aid in the design of preventive strategies.", {"entities": []}], [": Determinar se o dist\u00farbio ventilat\u00f3rio restritivo (DVR) sugerido por espirometria est\u00e1 associado ao n\u00edvel de atividade f\u00edsica na vida di\u00e1ria (AFVD), assim como a fatores de risco para doen\u00e7a cardiovascular (DCV), em adultos assintom\u00e1ticos.", {"entities": [[67, 70, "GENE"]]}], [": Um total de 374 participantes (m\u00e9dia de idade, 41 \u00b1 14 anos) realizou espirometria, que incluiu a determina\u00e7\u00e3o de CVF e VEF 1 .", {"entities": []}], ["O DVR foi definido como a rela\u00e7\u00e3o VEF 1 /CVF > 0,7 e CVF < 80% do valor previsto.", {"entities": []}], ["Ap\u00f3s a coleta de dados demogr\u00e1ficos, dados antropom\u00e9tricos e dados relacionados aos fatores de risco para DCV, foram avaliados composi\u00e7\u00e3o corporal, fun\u00e7\u00e3o muscular e equil\u00edbrio postural, assim como realizados teste cardiopulmonar e teste de caminhada de seis minutos.", {"entities": []}], ["O n\u00edvel de AFVD foi medido por um aceler\u00f4metro triaxial.", {"entities": [[27, 30, "GENE"]]}], [": O DVR sugerido por espirometria foi encontrado em 10% dos indiv\u00edduos.", {"entities": [[17, 20, "GENE"]]}], ["Ap\u00f3s a regress\u00e3o log\u00edstica multivariada, ajustada para os fatores de confus\u00e3o (AFVD e aptid\u00e3o cardiorrespirat\u00f3ria), as seguintes vari\u00e1veis permaneceram significativas (OR; IC95%) como preditoras de DVR: hipertens\u00e3o arterial sist\u00eamica (17,5; 1,65-184,8), tabagismo (11,6; 1,56-87,5), inatividade f\u00edsica (8,1; 1,43-46,4), maior \u00e1rea do centro de press\u00e3o durante apoio bipodal em plataforma de for\u00e7a (1,34; 1,05-1,71) e dislipidemia (1,89; 1,12-1,98).", {"entities": []}], [": O DVR sugerido por espirometria parece ser um achado comum em adultos assintom\u00e1ticos.", {"entities": [[17, 20, "GENE"]]}], ["Fatores de risco para DCV, principalmente hipertens\u00e3o arterial sist\u00eamica, tabagismo e sedentarismo, foram diretamente associados ao DVR, mesmo quando a an\u00e1lise foi ajustada para AFVD e aptid\u00e3o cardiorrespirat\u00f3ria.", {"entities": []}], ["Estudos longitudinais s\u00e3o necess\u00e1rios para melhorar a compreens\u00e3o da etiologia do DVR, bem como para auxiliar na concep\u00e7\u00e3o de estrat\u00e9gias preventivas.", {"entities": []}], ["To address the lack of research on the pulmonary health effects of ozone and fine particulate matter (\u2264 2.5 \u03bcm in aerodynamic diameter; PM 2.5 ) on individuals who recreate in the Great Smoky Mountains National Park (USA) and to replicate a study performed at Mt.", {"entities": []}], ["Washington, New Hampshire (USA), we conducted an observational study of adult (18\u201382 years of age) day hikers of the Charlies Bunion trail during 71 days of fall 2002 and summer 2003.", {"entities": []}], ["Volunteer hikers performed pre- and posthike pulmonary function tests (spirometry), and we continuously monitored ambient O 3 , PM 2.5 , temperature, and relative humidity at the trailhead.", {"entities": []}], ["Of the 817 hikers who participated, 354 (43%) met inclusion criteria (nonsmokers and no use of bronchodilators within 48 hr) and gave acceptable and reproducible spirometry.", {"entities": [[121, 123, "GENE"]]}], ["For these 354 hikers, we calculated the posthike percentage change in forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV 1 ), FVC/FEV 1 , peak expiratory flow, and mean flow rate between 25 and 75% of the FVC and regressed each separately against pollutant (O 3 or PM 2.5 ) concentration, adjusting for age, sex, hours hiked, smoking status (former vs. never), history of asthma or wheeze symptoms, hike load, reaching the summit, and mean daily temperature.", {"entities": [[389, 395, "DISEASE"], [134, 137, "GENE"], [147, 150, "GENE"]]}], ["O 3 and PM 2.5 concentrations measured during the study were below the current federal standards, and we found no significant associations of acute changes in pulmonary function with either pollutant.", {"entities": []}], ["These findings are contrasted with those in the Mt.", {"entities": []}], ["Washington study to examine the hypothesis that pulmonary health effects are associated with exposure to O 3 and PM 2.5 in healthy adults engaged in moderate exercise.", {"entities": []}], ["Using a strict subject selection procedure, we tested in High and Low Hypnotizable subjects (HHs and LHs) whether treatments of hypoalgesia and hyperalgesia, as compared to a relaxation-control, differentially affected subjective pain ratings and somatosensory event-related potentials (SERPs) during painful electric stimulation.", {"entities": []}], ["Treatments were administered in waking and hypnosis conditions.", {"entities": []}], ["LHs showed little differentiation in pain and distress ratings between hypoalgesia and hyperalgesia treatments, whereas HHs showed a greater spread in the instructed direction.", {"entities": []}], ["HHs had larger prefrontal N140 and P200 waves of the SERPs during hypnotic hyperalgesia as compared to relaxation-control treatment.", {"entities": []}], ["Importantly, HHs showed significant smaller frontocentral N140 and frontotemporal P200 waves during hypnotic hypoalgesia.", {"entities": []}], ["LHs did not show significant differences for these SERP waves among treatments in both waking and hypnosis conditions.", {"entities": []}], ["Source localization (sLORETA) method revealed significant activations of the bilateral primary somatosensory (BA3), middle frontal gyrus (BA6) and anterior cingulate cortices (BA24).", {"entities": []}], ["Activity of these contralateral regions significantly correlated with subjective numerical pain scores for control treatment in waking condition.", {"entities": []}], ["Moreover, multivariate regression analyses distinguished the contralateral BA3 as the only region reflecting a stable pattern of pain coding changes across all treatments in waking and hypnosis conditions.", {"entities": []}], ["More direct testing showed that hypnosis reduced the strength of the association of pain modulation and brain activity changes at BA3.", {"entities": []}], ["sLORETA in HHs revealed, for the N140 wave, that during hypnotic hyperalgesia, there was an increased activity within medial, supramarginal and superior frontal gyri, and cingulated gyrus (BA32), while for the P200 wave, activity was increased in the superior (BA22), middle (BA37), inferior temporal (BA19) gyri and superior parietal lobule (BA7).", {"entities": []}], ["Hypnotic hypoalgesia in HHs, for N140 wave, showed reduced activity within medial and superior frontal gyri (BA9,8), paraippocampal gyrus (BA34), and postcentral gyrus (BA1), while for the P200, activity was reduced within middle and superior frontal gyri (BA9 and BA10), anterior cingulate (BA33), cuneus (BA19) and sub-lobar insula (BA13).", {"entities": []}], ["These findings demonstrate that hypnotic suggestions can exert a top-down modulatory effect on attention/preconscious brain processes involved in pain perception.", {"entities": []}], ["Background: Identifying risk factors for adverse health outcomes in children is important.", {"entities": []}], ["The intrauterine environment plays a pivotal role for health and disease across life.", {"entities": []}], ["Objectives: We conducted a comprehensive study to determine whether common psychosocial stress during pregnancy is a risk factor for a wide spectrum of pediatric diseases in the offspring.", {"entities": []}], ["Methods: The study was conducted using prospective data in a population-based sample of mothers with live singleton births ( n = 66,203; 71.4% of those eligible) from the Danish National Birth Cohort.", {"entities": []}], ["We estimated the association between maternal stress during pregnancy (classified based on two a priori \u2013defined indicators of common stress forms, life stress and emotional stress) and offspring diseases during childhood (grouped into 16 categories of diagnoses from the International Classification of Diseases, 10th Revision , based on data from national registries), controlling for maternal stress after pregnancy.", {"entities": []}], ["Results: Median age at end of follow-up was 6.2 (range, 3.6\u20138.9) years.", {"entities": []}], ["Life stress (highest compared with lowest quartile) was associated with an increased risk of conditions originating in the perinatal period [odds ratio (OR) = 1.13; 95% confidence interval (CI): 1.06, 1.21] and congenital malformations (OR=1.17; CI: 1.06, 1.28) and of the first diagnosis of infection [hazard ratio (HR) = 1.28; CI: 1.17, 1.39], mental disorders (age 0\u20132.5 years: HR = 2.03; CI: 1.32, 3.14), and eye (age 0\u20134.5 years: HR = 1.27; CI: 1.06, 1.53), ear (HR = 1.36; CI: 1.23, 1.51), respiratory (HR = 1.27; CI; 1.19, 1.35), digestive (HR = 1.23; CI: 1.11, 1.37), skin (HR = 1.24; CI: 1.09, 1.43), musculoskeletal (HR = 1.15; CI: 1.01\u20131.30), and genitourinary diseases (HR = 1.25; CI; 1.08, 1.45).", {"entities": [[317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"], [317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"], [317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"], [317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"], [317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"], [317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"], [317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"], [317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"], [317, 319, "GENE"], [381, 383, "GENE"], [435, 437, "GENE"], [468, 470, "GENE"], [509, 511, "GENE"], [548, 550, "GENE"], [582, 584, "GENE"], [627, 629, "GENE"], [682, 684, "GENE"]]}], ["Emotional stress was associated with an increased risk for the first diagnosis of infection (HR = 1.09; CI: 1.01, 1.18) and a decreased risk for the first diagnosis of endocrine (HR = 0.81; CI; 0.67, 0.99), eye (HR = 0.84; CI; 0.71, 0.99), and circulatory diseases (age 0\u20133 years: HR = 0.63; CI: 0.42, 0.95).", {"entities": [[93, 95, "GENE"], [179, 181, "GENE"], [212, 214, "GENE"], [281, 283, "GENE"], [93, 95, "GENE"], [179, 181, "GENE"], [212, 214, "GENE"], [281, 283, "GENE"], [93, 95, "GENE"], [179, 181, "GENE"], [212, 214, "GENE"], [281, 283, "GENE"], [93, 95, "GENE"], [179, 181, "GENE"], [212, 214, "GENE"], [281, 283, "GENE"]]}], ["Conclusions: Maternal life stress during pregnancy may be a common risk factor for impaired child health.", {"entities": []}], ["The results suggest new approaches to reduce childhood diseases.", {"entities": []}], ["Neutrophil extracellular traps (NETs) have recently been implicated in a number of autoimmune conditions, including rheumatoid arthritis (RA).", {"entities": [[116, 136, "DISEASE"], [127, 136, "DISEASE"]]}], ["We examined the underlying signaling pathways triggering enhanced NETosis in RA and ascertained whether the products of NETosis had diagnostic implications or usefulness.", {"entities": []}], ["Neutrophils were isolated from RA patients with active disease and from controls.", {"entities": []}], ["Spontaneous NET formation from RA and control neutrophils was assessed in vitro with microscopy and enzyme-linked immunosorbent assay (ELISA) for NETosis-derived products.", {"entities": []}], ["The analysis of the signal-transduction cascade included reactive oxygen species (ROS) production, myeloperoxidase (MPO), neutrophil elastase (NE), peptidyl arginine deiminase 4 (PAD4), and citrullinated histone 3 (citH3).", {"entities": [[116, 119, "GENE"]]}], ["NET formation was studied in response to serum and synovial fluid and immunoglobulin G (IgG) depleted and reconstituted serum.", {"entities": []}], ["Serum was analyzed for NETosis-derived products, for which receiver operator characteristic (ROC) curves were calculated.", {"entities": []}], ["Neutrophils from RA cases exhibited increased spontaneous NET formation in vitro , associated with elevated ROS production, enhanced NE and MPO expression, nuclear translocation of PAD4, PAD4-mediated citrullination of H3, and altered nuclear morphology.", {"entities": [[140, 143, "GENE"]]}], ["NET formation in both anti-citrullinated peptide antibody (ACPA)-positive and -negative RA was abolished by IgG depletion, but restored only with ACPA-positive IgG.", {"entities": []}], ["NETosis-derived products in RA serum demonstrated diagnostic potential, the ROC area under the curve for cell-free nucleosomes being >97%, with a sensitivity of 91% and a specificity of 92%.", {"entities": []}], ["No significant difference was observed between ACPA-positive and -negative cases.", {"entities": []}], ["Signaling elements associated with the extrusion of NETs are significantly enhanced to promote NETosis in RA compared with healthy controls.", {"entities": []}], ["NETosis depended on the presence of ACPA in ACPA-positive RA serum.", {"entities": []}], ["The quantitation of NETosis-derived products, such as cell-free nucleosomes in serum, may be a useful complementary tool to discriminate between healthy controls and RA cases.", {"entities": []}], ["Prior reports suggest a link between gonadotropin-releasing hormone (GnRH) and gastrointestinal function.", {"entities": []}], ["The aim of the study was to prospectively investigate women subjected to in vitro fertilization (IVF) using the GnRH analog buserelin, taking into account gastrointestinal symptoms and antibody development against buserelin, GnRH, luteinizing hormone (LH), and their receptors.", {"entities": []}], ["Gastrointestinal symptoms were registered by the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS) before and after IVF treatment, and five years later.", {"entities": []}], ["Health-related quality of life was evaluated by the 36-item Short-Form questionnaire (SF-36).", {"entities": []}], ["ELISA was used for antibody analyses before and after treatment.", {"entities": []}], ["Data were compared with women from the general population.", {"entities": []}], ["In total, 124 patients were investigated before and after IVF, and 62 were re-evaluated after five years.", {"entities": []}], ["Buserelin treatment led to significant impairment of constipation (p\u2009=\u20090.004), nausea and vomiting (p\u2009=\u20090.035), psychological well-being (p\u2009=\u20090.000), and the intestinal symptoms\u2019 influence on daily life (p\u2009=\u20090.027).", {"entities": [[53, 65, "DISEASE"]]}], ["At 5-year follow-up, abdominal pain was worsened (p\u2009=\u20090.041), but psychological well-being was improved (p\u2009=\u20090.036), compared to prior treatment, and 15% had an observable deterioration in gastrointestinal symptoms.", {"entities": []}], ["None developed severe dysmotility.", {"entities": []}], ["Patients had higher prevalence of IgG antibodies against LH (p\u2009=\u20090.001) and its receptor (p\u2009=\u20090.016), and IgM antibodies against the GnRH receptor (p\u2009=\u20090.001) prior treatment compared with controls, but no antibody development was observed after IVF.", {"entities": []}], ["Patients experience gastrointestinal symptoms during buserelin treatment, and abdominal pain is still increased after five years, but buserelin does not increase antibody formation against GnRH, LH or their receptors.", {"entities": []}], ["The role of the immune system in neuropsychiatric diseases, including autism spectrum disorder (ASD), has long been hypothesized.", {"entities": [[70, 94, "DISEASE"]]}], ["This hypothesis has mainly been supported by family cohort studies and the immunological abnormalities found in ASD patients, but had limited findings in genetic association testing.", {"entities": []}], ["Two cross-disorder genetic association tests were performed on the genome-wide data sets of ASD and six autoimmune disorders.", {"entities": []}], ["In the polygenic score test, we examined whether ASD risk alleles with low effect sizes work collectively in specific autoimmune disorders and show significant association statistics.", {"entities": []}], ["In the genetic variation score test, we tested whether allele-specific associations between ASD and autoimmune disorders can be found using nominally significant single-nucleotide polymorphisms.", {"entities": []}], ["In both tests, we found that ASD is probabilistically linked to ankylosing spondylitis (AS) and multiple sclerosis (MS).", {"entities": [[75, 86, "DISEASE"], [96, 114, "DISEASE"], [64, 86, "DISEASE"]]}], ["Association coefficients showed that ASD and AS were positively associated, meaning that autism susceptibility alleles may have a similar collective effect in AS.", {"entities": []}], ["The association coefficients were negative between ASD and MS.", {"entities": []}], ["Significant associations between ASD and two autoimmune disorders were identified.", {"entities": []}], ["This genetic association supports the idea that specific immunological abnormalities may underlie the etiology of autism, at least in a number of cases.", {"entities": []}], ["Preeclampsia is a complex heterogeneous disease commonly defined by new-onset hypertension and proteinuria in pregnancy.", {"entities": [[78, 90, "DISEASE"], [95, 106, "DISEASE"]]}], ["Women experiencing preeclampsia have increased risk for cardiovascular diseases (CVD) later in life.", {"entities": []}], ["Preeclampsia and CVD share risk factors and pathophysiologic mechanisms, including dysregulated inflammation and raised blood pressure.", {"entities": []}], ["Despite commonalities, little is known about the contribution of shared genes (pleiotropy) to these diseases.", {"entities": []}], ["This study aimed to investigate whether genetic risk factors for hypertension or inflammation are pleiotropic by also being associated with preeclampsia.", {"entities": [[65, 77, "DISEASE"]]}], ["We genotyped 122 single nucleotide polymorphisms (SNPs) in women with preeclampsia ( n \u200a=\u200a1006) and nonpreeclamptic controls ( n \u200a=\u200a816) from the Norwegian HUNT Study.", {"entities": []}], ["SNPs were chosen on the basis of previously reported associations with either nongestational hypertension or inflammation in genome-wide association studies.", {"entities": [[93, 105, "DISEASE"]]}], ["The SNPs were tested for association with preeclampsia in a multiple logistic regression model.", {"entities": []}], ["The minor ( G ) allele of the intronic SNP rs17367504 in the gene methylenetetrahydrofolate reductase ( MTHFR ) was associated with a protective effect on preeclampsia (odds ratio 0.65, 95% confidence interval 0.53\u20130.80) in the Norwegian cohort.", {"entities": [[104, 109, "GENE"]]}], ["This association did not replicate in an Australian preeclampsia case\u2013control cohort ( P \u200a=\u200a0.68, odds ratio 1.05, 95% confidence interval 0.83\u20131.32, minor allele frequency\u200a=\u200a0.15).", {"entities": []}], ["MTHFR is important for regulating transmethylation processes and is involved in regulation of folate metabolism.", {"entities": [[0, 5, "GENE"]]}], ["The G allele of rs17367504 has previously been shown to protect against nongestational hypertension.", {"entities": [[87, 99, "DISEASE"]]}], ["Our study suggests a novel association between this allele and reduced risk for preeclampsia.", {"entities": []}], ["This is the first study associating the minor (G) allele of a SNP within the MTHFR gene with a protective effect on preeclampsia, and in doing so identifying a possible pleiotropic protective effect on preeclampsia and hypertension.", {"entities": [[219, 231, "DISEASE"], [77, 82, "GENE"]]}], ["We constructed job-exposure profiles and assessed quality of health care in 39 of 47 current and former workers from a nuclear installation in the Negev whose files were referred to us for assessment of a possible work-related aspect of their tumors.", {"entities": []}], ["The workers, all male except one, began employment at various times from the reactor construction and were engaged in different tasks in laboratory research, construction, maintenance, and service.", {"entities": []}], ["Of those workers still living the average age was 57.9 years, with a range from 42 to 77 years of age.", {"entities": []}], ["The average age at the time of death for the deceased workers was 57.3 years, with a range from 41 to 69 years of age, Information on past exposures to radiation and chemical agents came from employee records dosimetry, and interviews.", {"entities": []}], ["Personal monitoring (urine assays) in 29 workers indicated the presence of various radionuclides, with higher levels found in persons with work histories in laboratory/research and development and technical/inspector job categories compared to those in administrative/service job categories.", {"entities": []}], ["Among the 39 workers, latency between onset of exposure and first appearance of illness from tumor was 24.2 years, with a range of 5 to 34 years.", {"entities": []}], ["Tumor distribution for these workers was as follows: hematolymphatic (n = 11 workers), gastrointestinal (n = 9), breast (n = 1 [male]), renal-urogenital (n = 8), skin (n = 1), and pulmonary (n = 8 [5 known smokers]).", {"entities": []}], ["For all tumors except those of the respiratory tract, the first diagnosis was made more frequently in those patients under the age of 55.", {"entities": []}], ["Observed/expected comparisons for tumor proportional incidence showed excess fractions of blood tumors in persons < 55 and > 55 years of age.", {"entities": []}], ["Ratios were greater than unity for blood, breast (n = 1), gastrointestinal, and urogenital tumors in patients < 55 years of age and pulmonary tumors in persons > 55 years of age.", {"entities": []}], ["The odds ratio for smoking history in patients with lung tumors compared to those with other tumors was 4.8.", {"entities": []}], ["Nonmalignant conditions appeared at relatively younger ages.", {"entities": []}], ["After the exposure episodes two children with major congenital anomalies were born to wives of the workers; one anomaly was fatal.", {"entities": []}], ["Not all patients were first diagnosed for cancer following referral from the plant medical service, and delays between warning signs and symptoms and medical evaluation occurred in some.", {"entities": [[42, 48, "DISEASE"]]}], ["Although we lacked data on cancer incidence and population at risk, our findings suggest that earlier official assessments of risk should be reconsidered.", {"entities": [[27, 33, "DISEASE"]]}], ["There is a need for population-based monitoring of risk to nuclear industry workers, external quality control of their medical surveillance and care, and improvements in information delivery.", {"entities": []}], ["Human immunodeficiency virus (HIV)-1 infectivity requires actin-dependent clustering of host lipid raft\u2013associated receptors, a process that might be linked to Rho guanosine triphosphatase (GTPase) activation.", {"entities": []}], ["Rho GTPase activity can be negatively regulated by statins, a family of drugs used to treat hypercholesterolemia in man.", {"entities": []}], ["Statins mediate inhibition of Rho GTPases by impeding prenylation of small G proteins through blockade of 3-hydroxy-3-methylglutaryl coenzyme A reductase.", {"entities": []}], ["We show that statins decreased viral load and increased CD4 l -mevalonate or of geranylgeranylpyrophosphate, but not by cholesterol.", {"entities": [[56, 59, "GENE"]]}], ["Cell treatment with a geranylgeranyl transferase inhibitor, but not a farnesyl transferase inhibitor, specifically inhibited entry of HIV-1\u2013pseudotyped viruses.", {"entities": []}], ["Statins blocked Rho-A activation induced by HIV-1 binding to target cells, and expression of the dominant negative mutant RhoN19 inhibited HIV-1 envelope fusion with target cell membranes, reducing cell infection rates.", {"entities": []}], ["We suggest that statins have direct anti\u2013HIV-1 effects by targeting Rho.", {"entities": []}], ["The prevalence of chronic suppurative lung disease (CSLD) and bronchiectasis unrelated to cystic fibrosis (CF) among Indigenous children in Australia, New Zealand and Alaska is very high.", {"entities": [[62, 76, "DISEASE"], [90, 105, "DISEASE"], [38, 50, "DISEASE"]]}], ["Antibiotics are a major component of treatment and are used both on a short or long-term basis.", {"entities": []}], ["One aim of long-term or maintenance antibiotics is to reduce the frequency of acute pulmonary exacerbations and symptoms.", {"entities": []}], ["However, there are few studies investigating the efficacy of long-term antibiotic use for CSLD and non-CF bronchiectasis among children.", {"entities": [[106, 120, "DISEASE"]]}], ["This study tests the hypothesis that azithromycin administered once a week as maintenance antibiotic treatment will reduce the rate of pulmonary exacerbations in Indigenous children with bronchiectasis.", {"entities": [[187, 201, "DISEASE"]]}], ["We are conducting a multicentre, randomised, double-blind, placebo controlled clinical trial in Australia and New Zealand.", {"entities": []}], ["Inclusion criteria are: Aboriginal, Torres Strait Islander, Maori or Pacific Island children aged 1 to 8\u2009years, diagnosed with bronchiectasis (or probable bronchiectasis) with no underlying disease identified (such as CF or primary immunodeficiency), and having had at least one episode of pulmonary exacerbation in the last 12\u2009months.", {"entities": [[127, 141, "DISEASE"], [155, 169, "DISEASE"]]}], ["After informed consent, children are randomised to receive either azithromycin (30\u2009mg/kg once a week) or placebo (once a week) for 12\u201324\u2009months from study entry.", {"entities": []}], ["Primary outcomes are the rate of pulmonary exacerbations and time to pulmonary exacerbation determined by review of patient medical records.", {"entities": []}], ["Secondary outcomes include length and severity of pulmonary exacerbation episodes, changes in growth, school loss, respiratory symptoms, forced expiratory volume in 1-second (FEV 1 ; for children \u22656\u2009years), and sputum characteristics.", {"entities": [[175, 178, "GENE"]]}], ["Safety endpoints include serious adverse events.", {"entities": []}], ["Antibiotic resistance in respiratory bacterial pathogens colonising the nasopharynx is monitored.", {"entities": []}], ["Data derived from medical records and clinical assessments every 3 to 4\u2009months for up to 24\u2009months from study entry are recorded on standardised forms.", {"entities": []}], ["Should this trial demonstrate that azithromycin is efficacious in reducing the number of pulmonary exacerbations, it will provide a much-needed rationale for the use of long-term antibiotics in the medical management of bronchiectasis in Indigenous children.", {"entities": [[220, 234, "DISEASE"]]}], ["Australian New Zealand Clinical Trials Registry: ACTRN12610000383066", {"entities": []}], ["Health systems throughout the world, whether in developed or developing countries, are struggling with the challenge of how to manage health-care delivery in conditions of resource constraint.", {"entities": []}], ["The availability and utilization of various health care equipments at all levels of the health care system has been emphasized for effective and efficient service delivery.", {"entities": []}], ["In Ethiopia lack of proper management of medical equipment limited the capacity of health institutions to deliver adequate health care.", {"entities": []}], ["The main objective of this study was to assess availability and utilization of medical devices and identify reported reasons that affect availability and utilization of medical devices among hospitals in Jimma Zone.", {"entities": []}], ["A cross-sectional multiple case-study using mixed quantitative and qualitative methods was used.", {"entities": []}], ["Three hospitals of Jimma Zone were included in the study.", {"entities": []}], ["Adapted and pre-tested structured English version checklist for availability and utilization of medical equipment and document review as well as interview guide for in-depth interview were used for data collection.", {"entities": []}], ["Data were collected by observation of availability of the devices, interviewing selected professionals and document review of health care services using devices in the study hospitals.", {"entities": []}], ["Data were analyzed using SPSS 16.0 statistical software.", {"entities": []}], ["Descriptive analysis was made to determine the availability and functional status of medical devices.", {"entities": []}], ["For qualitative part responses were transcribed, categorized and thematically analyzed.", {"entities": []}], ["Observation and interview using checklist showed that 299 medical devices were available in the three hospitals among which, 196 (65.6\u00a0%) of them were available in Jimma University Specialized Hospital whereas, 57 (19.0\u00a0%) and 46 (15.4\u00a0%) were available in Limu Genet hospital and Shenen Gibe hospital respectively.", {"entities": []}], ["Among 196 available medical devices in JUSH, 127 (64.8\u00a0%) were functional and the rest; 63 (32.1\u00a0%) and 6 (3.1\u00a0%) were not functional and not in use respectively.", {"entities": []}], ["Similarly, 28 (60.9\u00a0%) and 30 (52.6\u00a0%) of the devices in Shenen Gibe hospital and LGH respectively were functional.", {"entities": []}], ["More than a third of medical devices in the three study hospitals were not functional.", {"entities": []}], ["Purchasing devices with bids and preference for cheap price, lack of training on how to operate devices, less sense of accountability, power interruption, staff work overload and lack of maintenance experts, and inappropriate referral system were among the reported reasons for influencing availability and utilization of medical devices.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-016-1523-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Prior literature identified the use of Performance Measurement Systems (PMS) as crucial in addressing improved processes of care.", {"entities": []}], ["Moreover, a strategic use of PMS has been found to enhance quality, compared to non-strategic use, although a clear understanding of this linkage is still to be achieved.", {"entities": []}], ["This paper deals with the test of direct and indirect models related to the link between the strategic use of PMS and the level of improved processes in health care organizations.", {"entities": []}], ["Indirect models were mediated by the degree of perceived managerial discretion.", {"entities": []}], ["A PLS analysis on a survey of 97 Italian managers working for health care organizations in the Lombardy region was conducted.", {"entities": []}], ["The response rate was 77.6%.", {"entities": []}], ["The strategic use of PMS in health care organizations directly and significantly ( p \u2009<\u20090.001) enhances performance in terms of improved processes.", {"entities": []}], ["Perceived managerial discretion is positively and significantly ( p \u2009<\u20090.001) affected by the strategic use of PMS, whereas the mediation effect is non-significant.", {"entities": []}], ["This study contributes to the literature investigating the design and implementation of a non-financial measurement tool, such as the non-financial information included into a balanced scorecard (BSC), in health care organizations.", {"entities": []}], ["Managers in health care organizations can benefit from the strategic use of PMS to effectively allocate their time to strategic opportunities and threats, which might arise and affect organizational, output-related performance, such as improving processes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-017-2022-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Modulation of the A type \u03b3-aminobutyric acid receptors (GABA A R) is one of the major drug targets for neurological and psychological diseases.", {"entities": []}], ["The natural flavonoid compound luteolin (2-(3,4-Dihydroxyphenyl)- 5,7-dihydroxy-4-chromenone) has been reported to have antidepressant, antinociceptive, and anxiolytic-like effects, which possibly involve the mechanisms of modulating GABA signaling.", {"entities": []}], ["However, as yet detailed studies of the pharmacological effects of luteolin are still lacking, we investigated the effects of luteolin on recombinant and endogenous GABA A R-mediated current responses by electrophysiological approaches.", {"entities": []}], ["Our results showed that luteolin inhibited GABA-mediated currents and slowed the activation kinetics of recombinant \u03b11\u03b22, \u03b11\u03b22\u03b32, \u03b15\u03b22, and \u03b15\u03b22\u03b32 receptors with different degrees of potency and efficacy.", {"entities": []}], ["The modulatory effect of luteolin was likely dependent on the subunit composition of the receptor complex: the \u03b1\u03b2 receptors were more sensitive than the \u03b1\u03b2\u03b3 receptors.", {"entities": []}], ["In hippocampal pyramidal neurons, luteolin significantly reduced the amplitude and slowed the rise time of miniature inhibitory postsynaptic currents (mIPSCs).", {"entities": []}], ["However, GABA A R-mediated tonic currents were not significantly influenced by luteolin.", {"entities": []}], ["These data suggested that luteolin has negative modulatory effects on both recombinant and endogenous GABA A Rs and inhibits phasic rather than tonic inhibition in hippocampus.", {"entities": []}], ["The immunosuppression and immune dysregulation that follows severe injury includes type 2 immune responses manifested by elevations in interleukin (IL) 4, IL5, and IL13 early after injury.", {"entities": [[155, 158, "GENE"], [164, 168, "GENE"]]}], ["We hypothesized that IL33, an alarmin released early after tissue injury and a known regulator of type 2 immunity, contributes to the early type 2 immune responses after systemic injury.", {"entities": [[21, 25, "GENE"]]}], ["Blunt trauma patients admitted to the trauma intensive care unit of a level I trauma center were enrolled in an observational study that included frequent blood sampling.", {"entities": []}], ["Dynamic changes in IL33 and soluble suppression of tumorigenicity 2 (sST2) levels were measured in the plasma and correlated with levels of the type 2 cytokines and nosocomial infection.", {"entities": [[19, 23, "GENE"]]}], ["Based on the observations in humans, mechanistic experiments were designed in a mouse model of resuscitated hemorrhagic shock and tissue trauma (HS/T).", {"entities": []}], ["These experiments utilized wild-type C57BL/6 mice, IL33 Severely injured human blunt trauma patients ( n = 472, average injury severity score [ISS] = 20.2) exhibited elevations in plasma IL33 levels upon admission and over time that correlated positively with increases in IL4, IL5, and IL13 ( P < 0.0001).", {"entities": [[51, 55, "GENE"], [187, 191, "GENE"], [51, 55, "GENE"], [187, 191, "GENE"], [273, 276, "GENE"], [278, 281, "GENE"], [287, 291, "GENE"]]}], ["sST2 levels also increased after injury but in a delayed manner compared with IL33.", {"entities": [[78, 82, "GENE"]]}], ["The increases in IL33 and sST2 were significantly greater in patients that developed nosocomial infection and organ dysfunction than similarly injured patients that did not ( P < 0.05).", {"entities": [[17, 21, "GENE"]]}], ["Mechanistic studies were carried out in a mouse model of HS/T that recapitulated the early increase in IL33 and delayed increase in sST2 in the plasma ( P < 0.005).", {"entities": [[103, 107, "GENE"]]}], ["These studies identified a pathway where IL33 induces ILC2 activation in the lung within hours of HS/T.", {"entities": [[41, 45, "GENE"]]}], ["ILC2 IL5 up-regulation induces further IL5 expression by CXCR2 These results suggest that IL33 may initiate early detrimental type 2 immune responses after trauma through ILC2 regulation of neutrophil IL5 production.", {"entities": [[5, 8, "GENE"], [39, 42, "GENE"], [201, 204, "GENE"], [5, 8, "GENE"], [39, 42, "GENE"], [201, 204, "GENE"], [57, 62, "GENE"], [90, 94, "GENE"], [5, 8, "GENE"], [39, 42, "GENE"], [201, 204, "GENE"]]}], ["This IL33\u2013ILC2\u2013IL5\u2013neutrophil axis defines a novel regulatory role for ILC2 in acute lung injury that could be targeted in trauma patients prone to early lung dysfunction.", {"entities": []}], ["In a reverse translation study from a human cohort to a mouse trauma model, Timothy Billiar and colleagues investigate the factors mediating immune dysregulation after severe injury.", {"entities": []}], ["The factors that initiate immune dysregulation after severe injury, including the skewing of the immune system towards type 2 responses, are unknown.", {"entities": []}], ["Our aim was to determine if interleukin (IL) 33, an alarmin released after tissue injury and a regulator of type 2 immunity, contributes to the early type 2 immune responses after systemic injury.", {"entities": []}], ["We measured IL33 and its soluble receptor, soluble suppression of tumorigenicity 2 (sST2), an endogenous antagonist of IL33, in the blood of 472 multiply injured trauma patients.", {"entities": [[12, 16, "GENE"], [119, 123, "GENE"], [12, 16, "GENE"], [119, 123, "GENE"]]}], ["IL33 levels were already markedly elevated on the first blood draw after injury and correlated with increases in IL4, IL5, and IL13 as well as nosocomial infections.", {"entities": [[0, 4, "GENE"], [113, 116, "GENE"], [118, 121, "GENE"], [127, 131, "GENE"]]}], ["Reverse translation experiments using a mouse model of hemorrhagic shock and tissue trauma were carried out to understand the functional link between IL33 and the type 2 cytokine, IL5.", {"entities": [[150, 154, "GENE"], [180, 183, "GENE"]]}], ["IL33 was shown to activate a resident set of innate lymphocytes (group 2 innate lymphoid cells [ILC2]) in the lungs to produce IL5, further leading to neutrophil IL5 production.", {"entities": [[0, 4, "GENE"], [127, 130, "GENE"], [162, 165, "GENE"], [127, 130, "GENE"], [162, 165, "GENE"]]}], ["These findings demonstrate the utility of using reverse translation of observations made in humans into mechanistic experimental models that recapitulate key components of the clinical response.", {"entities": []}], ["IL33 and one of its target cells, ILC2, are identified for the first time as regulators of the early type 2 immune responses after severe injury.", {"entities": [[0, 4, "GENE"]]}], ["The findings include a previously unsuspected role for ILC2 in the regulation of neutrophils and acute lung injury.", {"entities": []}], ["The findings identify IL33, IL5, or their receptors as potential targets to block early lung injury after polytrauma.", {"entities": [[22, 26, "GENE"], [28, 31, "GENE"]]}], ["Mycobacterium tuberculosis (Mtb) infections are still a major cause of death among all infectious diseases.", {"entities": [[14, 26, "DISEASE"]]}], ["Although 99% of individuals infected with Mtb develop a CD4 Here we tested the stimulatory capacity of selective Mtb antigens on human monocyte-derived dendritic cell (DC) maturation and cytokine production.", {"entities": [[56, 59, "GENE"]]}], ["DC maturation markers CD80, CD86 and CD83 were readily upregulated by H37Ra- and H37Rv-associated antigens, the 30-kDa (from Ag85 B complex) and 38-KDa Mtb antigens only partially induced these markers.", {"entities": [[22, 26, "GENE"], [28, 32, "GENE"], [37, 41, "GENE"]]}], ["All Mtb antigens induced variable levels of IL-6 and low levels of IL-10, there was no release of IL-12p70 detectable.", {"entities": []}], ["Substantial IL-12p40 production was restricted to LPS or H37Ra and H37Rv preparations.", {"entities": []}], ["Although the proliferation levels of primary T cell responses were comparable using all the differentially stimulated DC, the 30-kDa and 38-kDa antigens showed a bias towards IL-4 secretion of polarized CD4 Together our data indicate that 30-kDa and 38-kDa Mtb antigens induced only partial DC maturation shifting immune responses towards a Th2 profile.", {"entities": [[203, 206, "GENE"]]}], ["Gastroesophageal reflux disease (GERD) and Barrett\u2019s Esophagus (BE), which are\u00a0prevalent in the World Trade Center (WTC) exposed and general populations, negatively impact quality of life and cost of healthcare.", {"entities": []}], ["GERD, a risk factor of BE, is linked to obstructive airways disease (OAD).", {"entities": []}], ["We aim to identify serum biomarkers of GERD/BE, and assess the respiratory and clinical phenotype of a longitudinal cohort of never-smoking, male, WTC-exposed rescue workers presenting with pulmonary symptoms.", {"entities": []}], ["Biomarkers collected soon after WTC-exposure were evaluated in optimized predictive models of GERD/BE.", {"entities": []}], ["In the WTC-exposed cohort, the prevalence of BE is at least 6 times higher than in the general population.", {"entities": []}], ["GERD/BE cases had similar lung function, D LCO , bronchodilator response and long-acting \u03b2-agonist use compared to controls.", {"entities": []}], ["In confounder-adjusted regression models, TNF-\u03b1\u2009\u2265\u20096\u2009pg/mL predicted both GERD and BE.", {"entities": []}], ["GERD was also predicted by C-peptide\u2009\u2265\u2009360\u2009pg/mL, while BE was predicted by fractalkine\u2009\u2265\u2009250\u2009pg/mL and IP-10\u2009\u2265\u2009290\u2009pg/mL.", {"entities": []}], ["Finally, participants with GERD had significantly increased use of short-acting \u03b2-agonist compared to controls.", {"entities": []}], ["Overall, biomarkers sampled prior to GERD/BE presentation showed strong predictive abilities of disease development.", {"entities": []}], ["This study frames future investigations to further our understanding of aerodigestive pathology due to particulate matter exposure.", {"entities": []}], ["The effectiveness of weight loss therapies is commonly measured using body mass index and other obesity-related variables.", {"entities": [[96, 103, "DISEASE"]]}], ["Although these data are often stored in electronic health records (EHRs) and potentially very accessible, few studies on obesity and weight loss have used data derived from EHRs.", {"entities": [[121, 128, "DISEASE"]]}], ["We developed processes for obtaining data from the EHR in order to construct a database on patients undergoing Roux-en-Y gastric bypass (RYGB) surgery.", {"entities": []}], ["Clinical data obtained as part of standard of care in a bariatric surgery program at an integrated health delivery system were extracted from the EHR and deposited into a data warehouse.", {"entities": []}], ["Data files were extracted, cleaned, and stored in research datasets.", {"entities": []}], ["To illustrate the utility of the data, Kaplan-Meier analysis was used to estimate length of post-operative follow-up.", {"entities": []}], ["Demographic, laboratory, medication, co-morbidity, and survey data were obtained from 2028 patients who had undergone RYGB at the same institution since 2004.", {"entities": []}], ["Pre-and post-operative diagnostic and prescribing information were available on all patients, while survey laboratory data were available on a majority of patients.", {"entities": []}], ["The number of patients with post-operative laboratory test results varied by test.", {"entities": []}], ["Based on Kaplan-Meier estimates, over 74% of patients had post-operative weight data available at 4 years.", {"entities": []}], ["A variety of EHR-derived data related to obesity can be efficiently obtained and used to study important outcomes following RYGB.", {"entities": [[41, 48, "DISEASE"]]}], ["There are no approved therapeutics for the treatment of dengue disease despite the global prevalence of dengue virus (DENV) and its mosquito vectors.", {"entities": [[56, 70, "DISEASE"]]}], ["DENV infections can lead to vascular complications, hemorrhage, and shock due to the ability of DENV to infect a variety of immune and nonimmune cell populations.", {"entities": []}], ["Increasingly, studies have implicated the host response as a major contributor to severe disease.", {"entities": []}], ["Inflammatory products of various cell types, including responding T cells, mast cells (MCs), and infected monocytes, can contribute to immune pathology.", {"entities": []}], ["In this study, we show that the host response to DENV infection in immunocompetent mice recapitulates transcriptional changes that have been described in human studies.", {"entities": []}], ["We found that DENV infection strongly induced metabolic dysregulation, complement signaling, and inflammation.", {"entities": []}], ["DENV also affected the immune cell content of the spleen and liver, enhancing NK, NKT, and CD8 IMPORTANCE Dengue virus (DENV), which causes febrile illness, is transmitted by mosquito vectors throughout tropical and subtropical regions of the world.", {"entities": []}], ["Symptoms of DENV infection involve damage to blood vessels and, in rare cases, hemorrhage and shock.", {"entities": []}], ["Currently, there are no targeted therapies to treat DENV infection, but it is thought that drugs that target the host immune response may be effective in limiting symptoms that result from excessive inflammation.", {"entities": []}], ["In this study, we measured the host transcriptional response to infection in multiple DENV target organs using a mouse model of disease.", {"entities": []}], ["We found that DENV infection induced metabolic dysregulation and inflammatory responses and affected the immune cell content of the spleen and liver.", {"entities": []}], ["The use of the mast cell stabilization drug ketotifen reversed many of these responses and induced additional changes in the transcriptome and immune cell repertoire that contribute to decreased dengue disease.", {"entities": [[195, 209, "DISEASE"]]}], ["The 2010 Census revealed the population of Latino and Asian children grew by 5.5 million, while the population of white children declined by 4.3 million from 2000-2010, and minority children will outnumber white children by 2020.", {"entities": []}], ["No prior analyses, however, have examined time trends in racial/ethnic disparities in children\u2019s health and healthcare.", {"entities": []}], ["The study objectives were to identify racial/ethnic disparities in medical and oral health, access to care, and use of services in US children, and determine whether these disparities have changed over time.", {"entities": []}], ["The 2003 and 2007 National Surveys of Children\u2019s Health were nationally representative telephone surveys of parents of 193,995 children 0-17 years old (N\u2009=\u2009102,353 in 2003 and N\u2009=\u200991,642 in 2007).", {"entities": []}], ["Thirty-four disparities indicators were examined for white, African-American, Latino, Asian/Pacific-Islander, American Indian/Alaskan Native, and multiracial children.", {"entities": []}], ["Multivariable analyses were performed to adjust for nine relevant covariates, and Z-scores to examine time trends.", {"entities": []}], ["Eighteen disparities occurred in 2007 for \u22651 minority group.", {"entities": []}], ["The number of indicators for which at least one racial/ethnic group experienced disparities did not significantly change between 2003-2007, nor did the total number of specific disparities (46 in 2007).", {"entities": []}], ["The disparities for one subcategory (use of services), however, did decrease (by 82%).", {"entities": []}], ["Although 15 disparities decreased over time, two worsened, and 10 new disparities arose.", {"entities": []}], ["Minority children continue to experience multiple disparities in medical and oral health and healthcare.", {"entities": []}], ["Most disparities persisted over time.", {"entities": []}], ["Although disparities in use of services decreased, 10 new disparities arose in 2007.", {"entities": []}], ["Study findings suggest that urgent policy solutions are needed to eliminate these disparities, including collecting racial/ethnic and language data on all patients, monitoring and publicly disclosing disparities data annually, providing health-insurance coverage and medical and dental homes for all children, making disparities part of the national healthcare quality discussion, ensuring all children receive needed pediatric specialty care, and more research and innovative solutions.", {"entities": []}], ["COPD is characterized by progressive airflow obstruction which does not fully reverse to inhaled or oral pharmacotherapy.", {"entities": []}], ["The management of patients with COPD has taken a totally new direction over the past 20 years, thank to the use of novel therapies aimed to improve and modify the natural history of COPD.", {"entities": []}], ["Long-acting bronchodilators, including long-acting \u03b2 2 -agonists (LABAs), were introduced several years ago in order to enhance improvements in lung function, health status related quality of life, and reduce the rate of exacerbations.", {"entities": []}], ["These effects can be boosted by the combination of LABAs with long-acting anticholinergic, and/or with inhaled corticosteroids.", {"entities": []}], ["Inhaled LABAs are commonly well tolerated although adverse effects such as tremor and palpitations are occasionally troublesome.", {"entities": []}], ["We describe the case of a 28-year-old-male with no significant medical history who presented with right-sided hemiparesis, bruits over the carotid and subclavian arteries and an elevated erythrocyte sedimentation rate.", {"entities": []}], ["Imaging studies revealed a middle cerebral artery thrombus and inflammatory changes of the carotid and subclavian arteries and aorta.", {"entities": []}], ["The diagnosis of Takayasu\u2019s arteritis was made and the patient was started on steroids and immunomodulators with good clinical response.", {"entities": []}], ["Mainly based on evidence of success in adults, various medications are commonly used to prevent pediatric migraines.", {"entities": []}], ["Topiramate has been approved for migraine prevention in children as young as 12\u00a0years of age.", {"entities": [[33, 41, "DISEASE"]]}], ["In this meta-analysis, we aimed to assess the currently published data pertaining to the efficacy of topiramate for migraine prevention in patients less than 18\u00a0years of age.", {"entities": [[116, 124, "DISEASE"]]}], ["We searched PubMed/Medline, Embase and the Cochrane Library (from inception to April 2017) for randomized controlled trials (RCTs) published in English.", {"entities": []}], ["Two independent investigators performed data extraction and quality evaluation using the Cochrane Collaboration\u2019s tool.", {"entities": []}], ["The data extracted were analyzed by Review Manager 5.3 software.", {"entities": []}], ["A total of four RCTs matching the inclusion criteria were included, with an aggregate of 465 patients.", {"entities": []}], ["Of these patients, 329 were included in the topiramate group, and 136 were included in the placebo group.", {"entities": []}], ["This meta-analysis revealed that compared with placebo, topiramate failed to decrease the number of patients experiencing a\u00a0\u2265\u00a050% relative reduction in headache frequency ( n \u00a0=\u00a0465, RR\u00a0=\u00a01.26, 95% CI\u00a0=\u00a0[0.94,1.67], Z\u00a0=\u00a01.55, P \u00a0=\u00a00.12) or the number of headache days ( n \u00a0=\u00a0465, MD\u00a0=\u00a0\u22120.77, 95% CI\u00a0=\u00a0[\u22122.31,0.76], Z\u00a0=\u00a00.99, P \u00a0=\u00a00.32) but did reduce PedMIDAS scores ( n \u00a0=\u00a0205, MD\u00a0=\u00a0\u22129.02, 95% CI\u00a0=\u00a0[\u221217.34, \u22120.70], Z\u00a0=\u00a02.13, P \u00a0=\u00a00.03).", {"entities": []}], ["Higher rates of side effects and adverse events in the topiramate group than in the placebo group were observed in the included trials.", {"entities": []}], ["Topiramate may not achieve a more effective clinical trial endpoint than placebo in the prevention of migraines in patients less than 18\u00a0years of age, and topiramate may lead to more side effects or adverse events in the included patients.", {"entities": []}], ["IL-17 plays an important role in autoimmunity, promoting autoimmunity, inflammation and invasion in multiple sclerosis, rheumatoid arthritis and type I diabetes.", {"entities": [[100, 118, "DISEASE"], [120, 140, "DISEASE"], [131, 140, "DISEASE"]]}], ["The role of IL-17 in cancer is unclear, however, as there are few studies examining IL-17 protein expression in cancer.", {"entities": [[21, 27, "DISEASE"], [112, 118, "DISEASE"]]}], ["We therefore examined IL-17 protein expression in human breast cancer and modelled its potential biological significance in vitro .", {"entities": [[56, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["Immunohistochemistry was used to determine IL-17 expression in breast cancers.", {"entities": []}], ["Matrigel invasion assays were employed to examine the effect of IL-17 on cancer cell invasion by a panel of breast cancer cell lines.", {"entities": [[108, 121, "DISEASE"], [73, 79, "DISEASE"], [115, 121, "DISEASE"]]}], ["The role of matrix metalloproteinases (MMPs) was investigated with selective antagonists and immunoassays for MMP-2, MMP-3, MMP-9 and tissue inhibitor of MMP.", {"entities": []}], ["IL-17-expressing cells with macrophage morphology were identified in the peritumoural area of a proportion of patients (8/19 patients).", {"entities": []}], ["Macrophages were confirmed by CD68 staining on serial sections.", {"entities": [[30, 34, "GENE"]]}], ["With the exception of occasional lymphocytes, one patient with rare multinucleate giant cells and one patient with occasional expression of IL-17 in tumour cells, no other IL-17-positive cells were detected.", {"entities": []}], ["Addition of IL-17 to cell lines in vitro stimulated marked invasion of Matrigel.", {"entities": []}], ["In contrast, IL-17 did not promote the invasion of MCF7 or T47D cell lines.", {"entities": []}], ["Invasion was initially thought to be dependent on MMPs, as evidenced by the broad-spectrum MMP inhibitor GM6001 and selective antagonists of MMP-2/MMP-9 and MMP-3.", {"entities": []}], ["Measurement of MMP-2, MMP-3 and MMP-9, and tissue inhibitor of MMP 1 secretion, failed to reveal any changes in expression following IL-17 exposure.", {"entities": []}], ["In contrast, TNF promoted secretion of MMPs but IL-17 did not augment TNF, indicating that IL-17 acts via an independent mechanism.", {"entities": [[13, 16, "GENE"], [70, 73, "GENE"], [13, 16, "GENE"], [70, 73, "GENE"]]}], ["The present study is the first to describe in situ expression of IL-17 protein in human breast tumours and to propose a direct association between IL-17 and breast cancer invasion.", {"entities": [[157, 170, "DISEASE"], [164, 170, "DISEASE"]]}], ["The precise effectors of IL-17-dependent invasion remain to be characterised but could include a range of proteases such as a disintegrin and metalloproteinase protein or astacins.", {"entities": []}], ["Nevertheless, this work identifies a novel potential mechanism for breast cancer invasion and tumour progression, the prognostic implication of which is currently under investigation.", {"entities": [[67, 80, "DISEASE"], [74, 80, "DISEASE"]]}], ["Various polymorphisms in toll-like receptor (TLR) genes have been identified and associated with susceptibility to various malignancies, such as gastric carcinoma (GC), breast cancer, and prostate cancer.", {"entities": [[153, 162, "DISEASE"], [169, 182, "DISEASE"], [176, 182, "DISEASE"], [197, 203, "DISEASE"], [188, 203, "DISEASE"], [164, 166, "GENE"]]}], ["However, little is known about the polymorphisms of TLR genes and the susceptibility to GC in Northern China, especially to Epstein\u2013Barr virus-associated GC (EBVaGC).", {"entities": [[88, 90, "GENE"], [154, 156, "GENE"], [88, 90, "GENE"], [154, 156, "GENE"]]}], ["We focused on the association with susceptibility to GC, especially to EBVaGC.", {"entities": [[53, 55, "GENE"]]}], ["Polymorphisms of the TLR2, 3, 4 , and 9 genes were measured in 52 cases of EBVaGC and 157 cases of EBV-negative GC (EBVnGC).", {"entities": [[21, 25, "GENE"], [112, 114, "GENE"]]}], ["Ninety-four peripheral blood samples from healthy individuals were also examined.", {"entities": []}], ["For the TLR2 gene (196 to 174 del), there was no significant difference between the GC group and control group in genotype, but there was a significant difference in the del allele.", {"entities": [[8, 12, "GENE"], [84, 86, "GENE"]]}], ["As for the TLR3 gene (c. 1377C/T), there were significant differences between the GC group and the control group in both genotype and allelic frequency.", {"entities": [[11, 15, "GENE"], [82, 84, "GENE"]]}], ["No SNPs single nucleotide polymorphisms (SNPs) were found in the TLR4 gene at the sites Asp299Gly and Thr399Ile.", {"entities": [[65, 69, "GENE"]]}], ["As for TLR9 1486T/C (rs187084) and C2848T (rs352140), there was also no association between the GC group and control.", {"entities": [[7, 11, "GENE"], [96, 98, "GENE"]]}], ["In all of the indicators, there were no significant differences between EBVaGCs and EBVnGCs.", {"entities": []}], ["The TLR3 gene (c. 1377C/T) polymorphisms and the del allele of the TLR2 gene (196 to 174) were both associated with susceptibility to GC in Shangdong Province of Northern China.", {"entities": [[4, 8, "GENE"], [67, 71, "GENE"], [134, 136, "GENE"]]}], ["There was no interaction between EBV and TLR gene polymorphisms in EBVaGC.", {"entities": []}], ["Having been a national advocate for the use of patient reported outcome measures (PROMs) in Child and Adolescent Mental Health Services (CAMHS) in the UK for the last decade, I have become increasingly concerned that unless the potential iatrogenic impact of widespread policy requirement for use of PROMs (Department of Health, Children and Young People\u2019s Health Outcomes Strategy,", {"entities": []}], ["People\u2019s perceptions of and attitudes towards pollution are critical for reducing exposure among people and can also influence the response to interventions that are aimed at encouraging behaviour change.", {"entities": []}], ["This study assessed the perceptions and attitudes of residents in two slums in Nairobi regarding air pollution.", {"entities": []}], ["We conducted focus group discussions with residents aged 18\u00a0years and above using an emergent design in the formulation of the study guide.", {"entities": []}], ["A thematic approach was used in data analysis.", {"entities": []}], ["The discussions revealed that the two communities experience air pollution arising mainly from industries and dump sites.", {"entities": []}], ["There was an apparent disconnect between knowledge and practice, with individuals engaging in practices that placed them at high risk of exposure to air pollution.", {"entities": []}], ["Residents appear to have rationalized the situation in which they live in and were resigned to these conditions.", {"entities": []}], ["Consequently, they expressed lack of agency in addressing prevalent air pollution within their communities.", {"entities": []}], ["Community-wide education on air pollution and related health effects together with the measures needed to reduce exposure to air pollution are necessary towards reducing air pollution impacts.", {"entities": []}], ["A similar city-wide study is recommended to enable comparison of perceptions along socio-economic groups and neighbourhoods.", {"entities": []}], ["Women are more frequently affected by chronic conditions and disability than men.", {"entities": []}], ["Although some of these sex differences have been in part attributed to biological susceptibility, social determinants of health and other factors, these gaps have not been fully explained in the current literature.", {"entities": []}], ["This chapter presents comparisons of hospitalization rates, and the prevalence of chronic conditions and physical disability between Canadian women and men and between various subgroups of women, adjusting for selected risk factors.", {"entities": []}], ["The Canadian Hospital Morbidity Database (2000\u20132001) and Canadian Community Health Survey (2000\u20132001) were used to examine inpatient hospital morbidity, prevalence of chronic conditions and disability.", {"entities": []}], ["Hospitalization rates were 20% higher among women than men.", {"entities": []}], ["This was due to the large number of hospitalizations for pregnancies and childbirth.", {"entities": []}], ["When \"normal\" deliveries were excluded, hospitalization rates remained higher among women.", {"entities": []}], ["Women had slightly lower rates of hospitalizations for ambulatory-care sensitive conditions than men.", {"entities": []}], ["Prevalence of activity limitation (mild and severe) was higher among women than men, and differences remained after adjusting for age, chronic conditions, socio-economic status, and smoking.", {"entities": []}], ["Women who reported a disability were less likely than men to be in a partnered relationship, have less tangible social support, and have lower income and employment rates.", {"entities": []}], ["The impact of morbidity and disability on Canadian women is substantial.", {"entities": []}], ["These results identify areas for interventions among more vulnerable subgroups, and point to the need for further research in the area of risk factors for the prevention of morbidity and disability in the population.", {"entities": []}], ["In idiopathic pulmonary arterial hypertension (IPAH), peripheral airway obstruction is frequent.", {"entities": [[33, 45, "DISEASE"]]}], ["This is partially attributed to the mediator dysbalance, particularly an excess of endothelin-1 (ET-1), to increased pulmonary vascular and airway tonus and to local inflammation.", {"entities": []}], ["Bosentan (ET-1 receptor antagonist) improves pulmonary hemodynamics, exercise limitation, and disease severity in IPAH.", {"entities": []}], ["We hypothesized that bosentan might affect airway obstruction.", {"entities": []}], ["In 32 IPAH-patients (19 female, WHO functional class II (n = 10), III (n = 22); (data presented as mean \u00b1 standard deviation) pulmonary vascular resistance (11 \u00b1 5 Wood units), lung function, 6 minute walk test (6-MWT; 364 \u00b1 363.7 (range 179.0-627.0) m), systolic pulmonary artery pressure, sPAP, 79 \u00b1 19 mmHg), and NT-proBNP serum levels (1427 \u00b1 2162.7 (range 59.3-10342.0) ng/L) were measured at baseline, after 3 and 12 months of oral bosentan (125 mg twice per day).", {"entities": []}], ["At baseline, maximal expiratory flow at 50 and 25% vital capacity were reduced to 65 \u00b1 25 and 45 \u00b1 24% predicted.", {"entities": []}], ["Total lung capacity was 95.6 \u00b1 12.5% predicted and residual volume was 109 \u00b1 21.4% predicted.", {"entities": []}], ["During 3 and 12 months of treatment, 6-MWT increased by 32 \u00b1 19 and 53 \u00b1 69 m, respectively; p < 0.01; whereas sPAP decreased by 7 \u00b1 14 and 10 \u00b1 19 mmHg, respectively; p < 0.05.", {"entities": []}], ["NT-proBNP serum levels tended to be reduced by 123 \u00b1 327 and by 529 \u00b1 1942 ng/L; p = 0.11).", {"entities": []}], ["There was no difference in expiratory flows or lung volumes during 3 and 12 months.", {"entities": []}], ["This study gives first evidence in IPAH, that during long-term bosentan, improvement of hemodynamics, functional parameters or serum biomarker occur independently from persisting peripheral airway obstruction.", {"entities": []}], ["Aquaporins (AQP) are water channel proteins and the genes coding for AQP2 , AQP5 , and AQP6 are clustered in 12q13.", {"entities": [[69, 73, "GENE"], [76, 80, "GENE"], [87, 91, "GENE"]]}], ["Since AQP5 is expressed in serous acinar cells of salivary glands, we investigated its involvement in caries.", {"entities": [[6, 10, "GENE"]]}], ["DNA samples from 1,383 individuals from six groups were studied.", {"entities": []}], ["Genotypes of eight single nucleotide polymorphisms covering the aquaporin locus were tested for association with caries experience.", {"entities": []}], ["Interaction with genes involved in enamel formation was tested.", {"entities": []}], ["The association between enamel microhardness at baseline, after creation of artificial caries lesion, and after exposure to fluoride and the genetic markers in AQP5 was tested.", {"entities": [[160, 164, "GENE"]]}], ["Finally, AQP5 expression in human whole saliva, after exposure to fluoride in a mammary gland cell line, which is known to express AQP5, and in Wistar rats was also verified.", {"entities": [[9, 13, "GENE"], [131, 135, "GENE"], [9, 13, "GENE"], [131, 135, "GENE"]]}], ["Nominal associations were found between caries experience and markers in the AQP5 locus.", {"entities": [[77, 81, "GENE"]]}], ["Since these associations suggested that AQP5 may be inhibited by levels of fluoride in the drinking water that cause fluorosis, we showed that fluoride levels above optimal levels change AQP5 expression in humans, cell lines, and rats.", {"entities": [[40, 44, "GENE"], [187, 191, "GENE"], [40, 44, "GENE"], [187, 191, "GENE"]]}], ["We have shown that AQP5 is involved in the pathogenesis of caries and likely interacts with fluoride.", {"entities": [[19, 23, "GENE"]]}], ["Over three-quarter of the world's population is using herbal medicines with an increasing trend globally.", {"entities": []}], ["Herbal medicines may be beneficial but are not completely harmless.", {"entities": []}], ["This study aimed to assess the extent of use and the general knowledge of the benefits and safety of herbal medicines among urban residents in Lagos, Nigeria.", {"entities": []}], ["The study involved 388 participants recruited by cluster and random sampling techniques.", {"entities": []}], ["Participants were interviewed with a structured open- and close-ended questionnaire.", {"entities": []}], ["The information obtained comprises the demography and types of herbal medicines used by the respondents; indications for their use; the sources, benefits and adverse effects of the herbal medicines they used.", {"entities": []}], ["A total of 12 herbal medicines (crude or refined) were used by the respondents, either alone or in combination with other herbal medicines.", {"entities": []}], ["Herbal medicines were reportedly used by 259 (66.8%) respondents.", {"entities": []}], ["'Agbo jedi-jedi' (35%) was the most frequently used herbal medicine preparation, followed by 'agbo-iba' (27.5%) and Oroki herbal mixture Herbal medicine is popular among the respondents but they appear to be ignorant of its potential toxicities.", {"entities": []}], ["It may be necessary to evaluate the safety, efficacy and quality of herbal medicines and their products through randomised clinical trial studies.", {"entities": []}], ["Public enlightenment programme about safe use of herbal medicines may be necessary as a means of minimizing the potential adverse effects.", {"entities": []}], ["To compare clinical and demographic characteristics, resource utilization and costs of chronic obstructive pulmonary disease (COPD) patients prior to initiating budesonide\u2013formoterol combination (BFC) or tiotropium-maintenance therapy.", {"entities": [[87, 124, "DISEASE"]]}], ["This cross-sectional study used claims-based diagnosis to identify COPD patients in the HealthCore Integrated Research Database who initiated BFC or tiotropium therapy between March 1, 2009 and January 31, 2012 (intake period); the index date was defined as the initial prescription fill for either agent.", {"entities": []}], ["Patients diagnosed with respiratory tract cancer or receiving inhaled corticosteroids/long-acting \u03b2 2 -adrenergic agonists or tiotropium in 12 months prior to index date were excluded.", {"entities": [[42, 48, "DISEASE"]]}], ["Categorical variables were evaluated with \u03c7 Overall, 6,940 BFC and 10,831 tiotropium patients were identified.", {"entities": []}], ["The BFC group was younger (mean age 64 versus 67 years), with a greater proportion of females (54% versus 51%).", {"entities": []}], ["BFC-treated patients had more comorbid respiratory conditions, including asthma (25% versus 13%), but fewer comorbid cardiovascular conditions, including atherosclerosis (7% versus 10%) and myocardial infarction (4% versus 6%).", {"entities": [[154, 169, "DISEASE"], [190, 211, "DISEASE"], [73, 79, "DISEASE"]]}], ["A greater proportion of BFC patients received prior respiratory medication, including oral corticosteroids (46% versus 35%) and short-acting \u03b2 2 -agonists (44% versus 35%).", {"entities": []}], ["Tiotropium-treated patients had a greater mean number of COPD-related outpatient visits (4.6 versus 4.1).", {"entities": []}], ["BFC-treated patients had lower total all-cause ($17,259 versus $17,926) and COPD-related ($1,718 versus $1,930) health care costs, driven by lower all-cause and COPD-related inpatient expenditures.", {"entities": []}], ["Initiators of BFC or tiotropium showed differences in clinical and demographic characteristics and health care utilization and costs prior to starting COPD maintenance therapy.", {"entities": []}], ["To investigate whether lipoxin A 4 (LXA 4 ) increases expression of heme oxygenase-1(HO-1) in cardiomyocytes, whether LXA 4 -induced HO-1 protects cardiomyocytes against hypoxia/reoxygenation (H/R) injury, and what are the mechanisms involved in the LXA 4 -induced HO-1 induction.", {"entities": []}], ["Rat cardiomyocytes were exposed to H/R injury with or without preincubation with LXA 4 or HO-1 inhibitor ZnPP-IX or various signal molecule inhibitors.", {"entities": []}], ["Expressions of HO-1 protein and mRNA were analyzed by using Western blot and RT-PCR respectively.", {"entities": []}], ["Activity of nuclear factor E2-related factor 2 (Nrf2) binding to the HO-1 E1 enhancer was assessed by chromatin immunoprecipitation.", {"entities": []}], ["Nrf2 binding to the HO-1 antioxidant responsive element (ARE) were measured by using electrophoretic mobility shift assay.", {"entities": []}], ["Pretreatment of the cells undergoing H/R lesion with LXA 4 significantly reduced the lactate dehydrogenase and creatine kinase productions, increased the cell viability, and increased the expressions of HO-1 protein and mRNA and HO-1 promoter activity.", {"entities": []}], ["HO-1 inhibition abolished the protective role of LXA 4 on the cells undergoing H/R lesion.", {"entities": []}], ["LXA 4 increased p38 mitogen-activated protein kinase (p38 MAPK) activation, nuclear translocation of Nrf2, Nrf2 binding to the HO-1 ARE and E1 enhancer in cardiomyocytes with or without H/R exposure.", {"entities": []}], ["The protection role of LXA 4 against H/R injury of cardiomyocytes is related to upregulation of HO-1, via activation of p38 MAPK pathway and nuclear translocation of Nrf2 and Nrf2 binding to the HO-1 ARE and E1 enhancer, but not via activation of phosphatidyinositol-3-kinase or extracellular signal-regulated kinase pathway.", {"entities": []}], ["The National Institute of Environmental Health Sciences (NIEHS) is the leading biomedical research institution in the United States whose mission is to support research that seeks to understand how environmental exposures affect human health.", {"entities": []}], ["NIEHS possesses a longstanding interest in the health effects of agrochemical and other environmental exposures in rural America, including pesticides, to farmers and their families and to migrant farmworkers and their families.", {"entities": []}], ["In recent years, NIEHS has begun augmenting traditional basic science investigations with innovative programs that translate findings from the laboratory to affected populations.", {"entities": []}], ["It is through community-based participatory research that NIEHS strives to advance the public health field by fostering the development of culturally relevant interventions that will reduce exposures to environmental contaminants and the risk of environmentally induced disease.", {"entities": []}], ["In this article, we describe the translational research program at NIEHS as it relates to the NIEHS mission and highlight activities pertinent to the health of rural communities, especially underserved populations.", {"entities": []}], ["We provide an overview of NIEHS-supported projects addressing health concerns of Native American and rural African-American communities in addition to farmworkers.", {"entities": []}], ["We conclude with a discussion of future plans for community-based participatory research at NIEHS.", {"entities": []}], ["Although numerous studies examine catastrophic health expenditures (CHE) worldwide, most focus on whole populations rather than specific vulnerable groups.", {"entities": []}], ["This study analyzes the extent, associated factors and inequality of CHE in elderly household with chronic disease patients in China.", {"entities": []}], ["Data were obtained from a nationally representative elderly household survey\u2014the China Health and Retirement Longitudinal Study\u2014that was conducted by the National School of Development of Peking University in 2011.", {"entities": []}], ["An elderly household with chronic disease patients is defined by\u2009\u2265\u20091 chronic disease patient who is\u2009\u2265\u200945\u00a0years of age.", {"entities": []}], ["CHE was measured according to the proportion of out-of-pocket health payments to non-food household expenditures.", {"entities": []}], ["The associated factors of CHE were estimated using ordinary least square and logistic regression modeling.", {"entities": []}], ["CHE inequality was measured according to the concentration index (CI) and its decomposition.", {"entities": []}], ["CHE incidence and intensity were relatively high among elderly households with chronic disease patients.", {"entities": []}], ["The main associated factors of CHE include household size, having members\u2009>\u200965\u00a0years, having members with\u2009\u2265\u20092 chronic diseases, per capita income, and elderly household members demonstrating healthcare-seeking behaviors.", {"entities": []}], ["Healthcare insurance did not significantly affect CHE risk.", {"entities": []}], ["Disproportionate concentration of CHE was noted among elderly households, and poor elderly households demonstrated a higher probability of experiencing CHE.", {"entities": []}], ["Factors such as household size, per capita income, having members\u2009>\u200965\u00a0years, and having members with\u2009\u2265\u20092 chronic diseases are major and positive contributors to CHE inequality.", {"entities": []}], ["Some inpatient and outpatient services are negatively contributed to CHE inequality,suggesting that the unequal usage of such services reduces CHE inequality among elderly households with chronic disease patients.", {"entities": []}], ["Policy efforts should focus on improving financial protection and relieving the economic burden of disease in elderly households.", {"entities": []}], ["The government should increase income subsidies and optimize social health insurance programs, thereby reducing CHE and alleviating CHE inequality among elderly households in China.", {"entities": []}], ["An association between mast cells and tumor angiogenesis is known to exist, but the exact role that mast cells play in this process is still unclear.", {"entities": []}], ["It is thought that the mediators released by mast cells are important in neovascularization.", {"entities": []}], ["However, it is not known how individual mediators are involved in this process.", {"entities": []}], ["The major constituents of mast cell secretory granules are the mast cell specific proteases chymase, tryptase, and carboxypeptidase A3.", {"entities": []}], ["Several previous studies aimed to understand the way in which specific mast cell granule constituents act to induce tumor angiogenesis.", {"entities": []}], ["A body of evidence indicates that mast cell proteases are the pivotal players in inducing tumor angiogenesis.", {"entities": []}], ["In this review, the likely mechanisms by which tryptase and chymase can act directly or indirectly to induce tumor angiogenesis are discussed.", {"entities": []}], ["Finally, information presented here in this review indicates that mast cell proteases significantly influence angiogenesis thus affecting tumor growth and progression.", {"entities": []}], ["This also suggests that these proteases could serve as novel therapeutic targets for the treatment of various types of cancer.", {"entities": [[119, 125, "DISEASE"]]}], ["To compare the effectiveness of rituximab (RTX) or a second anti\u2013tumor necrosis factor (anti-TNF) therapy in rheumatoid arthritis (RA) patients who had failed their first anti-TNF and switched to either RTX or a second anti-TNF, in routine clinical practice.", {"entities": [[109, 129, "DISEASE"], [120, 129, "DISEASE"]]}], ["RA patients were registered with the British Society for Rheumatology Biologics Register.", {"entities": []}], ["Response to treatment 6 months after switching was assessed using European League Against Rheumatism (EULAR) criteria and improvements in a Health Assessment Questionnaire (HAQ) score (0.22 unit or more).", {"entities": []}], ["Regression analyses were used to compare EULAR response and improvement in HAQ score between the 2 groups, adjusting for propensity scores.", {"entities": []}], ["In total, 1,328 patients were included in the analysis of EULAR response, and 937 patients were included in the analysis of HAQ scores.", {"entities": []}], ["Six months after switching, 54.8% of patients who switched to RTX were EULAR responders compared to 47.3% of those who switched to a second anti-TNF.", {"entities": []}], ["A total of 38.4% of RTX patients achieved a clinically important improvement in HAQ score compared to 29.6% in anti-TNF patients.", {"entities": []}], ["After adjustment using propensity scores, patients who switched to RTX were significantly more likely to achieve EULAR response (odds ratio [OR] 1.31; 95% confidence interval [95% CI] 1.02, 1.69) compared to those who switched to an alternative anti-TNF.", {"entities": []}], ["RTX patients were also significantly more likely to achieve improvements in HAQ score (OR 1.49; 95% CI 1.07, 2.08).", {"entities": []}], ["The results suggest that switching to RTX may be of more benefit than switching to an alternative anti-TNF therapy after failing the first anti-TNF therapy in RA patients.", {"entities": []}], ["We previously demonstrated that infusion of an intestinal peptide called xenin-25 (Xen) amplifies the effects of glucose-dependent insulinotropic polypeptide (GIP) on insulin secretion rates (ISRs) and plasma glucagon levels in humans.", {"entities": []}], ["However, these effects of Xen, but not GIP, were blunted in humans with type 2 diabetes.", {"entities": []}], ["Thus, Xen rather than GIP signaling to islets fails early during development of type 2 diabetes.", {"entities": []}], ["The current crossover study determines if cholinergic signaling relays the effects of Xen on insulin and glucagon release in humans as in mice.", {"entities": []}], ["Fasted subjects with impaired glucose tolerance were studied.", {"entities": []}], ["On eight separate occasions, each person underwent a single graded glucose infusion- two each with infusion of albumin, Xen, GIP, and GIP plus Xen.", {"entities": []}], ["Each infusate was administered \u00b1 atropine.", {"entities": []}], ["Heart rate and plasma glucose, insulin, C-peptide, glucagon, and pancreatic polypeptide (PP) levels were measured.", {"entities": []}], ["ISRs were calculated from C-peptide levels.", {"entities": []}], ["All peptides profoundly increased PP responses.", {"entities": []}], ["From 0 to 40 min, peptide(s) infusions had little effect on plasma glucose concentrations.", {"entities": []}], ["However, GIP, but not Xen, rapidly and transiently increased ISRs and glucagon levels.", {"entities": []}], ["Both responses were further amplified when Xen was co-administered with GIP.", {"entities": []}], ["From 40 to 240 min, glucose levels and ISRs continually increased while glucagon concentrations declined, regardless of infusate.", {"entities": []}], ["Atropine increased resting heart rate and blocked all PP responses but did not affect ISRs or plasma glucagon levels during any of the peptide infusions.", {"entities": []}], ["Thus, cholinergic signaling mediates the effects of Xen on insulin and glucagon release in mice but not humans.", {"entities": []}], ["A component of particulate matter (PM) air pollution that may provide one biologically plausible pathway for the observed PM air pollution-health effect associations is aerosol acidity (H(+)).", {"entities": []}], ["An increasing number of observational studies have demonstrated associations between H(+) and increased adverse health effects in the United States and abroad.", {"entities": []}], ["Although studies have shown significant H(+) associations with increased morbidity in the United States, similar associations have yet to be shown with daily mortality.", {"entities": []}], ["We considered a 2.5-year record of daily H(+) and sulfate measurements (May 1988-October 1990) collected in the Buffalo, New York, region in a time-series analysis of respiratory, circulatory, and total daily mortality and hospital admissions.", {"entities": []}], ["Other copollutants considered included particulate matter [less than/equal to] 10 microm in aerodynamic diameter, coefficient of haze, ozone, carbon monoxide, sulfur dioxide, and nitrogen dioxide.", {"entities": []}], ["Various modeling techniques were applied to control for confounding of effect estimates due to seasonality, weather, and day-of-week effects.", {"entities": []}], ["We found multiple significant pollutant-health effect associations--most strongly between SO(4)(2-) and respiratory hospital admissions (as indicated by its t-statistic).", {"entities": []}], ["Additionally, H(+) and SO(4)(2-) demonstrated the most coherent associations with both respiratory hospital admissions [H(+): relative risk (RR) = 1.", {"entities": []}], ["31; 95% confidence interval (CI), 1.14-1.51; and SO(4)(2-): RR = 1.", {"entities": []}], ["18, CI, 1.09-1.28] and respiratory mortality (H(+): RR = 1.55, CI, 1.", {"entities": []}], ["09-2.20; and SO(4)(2-): RR = 1.24, CI, 1.01-1.52).", {"entities": []}], ["Thus, acidic sulfate aerosols represent a component of PM air pollution that may contribute to the previously noted adverse effects of PM mass on human health, and the associations demonstrated in this study support the need for further investigations into the potential health effects of acidic aerosols.", {"entities": []}], ["Subepithelial fibrosis is a characteristic hallmark of airway remodeling in asthma.", {"entities": [[76, 82, "DISEASE"]]}], ["A critical regulator of fibrosis, transforming growth factor \u03b2 (TGF-\u03b2), can induce airway remodeling in epithelial cells through induction of epithelial-mesenchymal transition (EMT).", {"entities": []}], ["Vitamin D has immunomodulatory functions, however, its effect on controlling subepithelial fibrosis is not known.", {"entities": []}], ["Human bronchial epithelial cells (BEAS-2B) were exposed to calcitriol followed by stimulation with TGF-\u03b21 or TGF-\u03b22.", {"entities": []}], ["The protein expression and mRNA transcripts for E-cadherin, Snail, vimentin, and N-cadherin were analyzed by Western blot and qPCR.", {"entities": []}], ["An invasion assay and scratch wound assay were performed to identify the migratory properties of the cells following treatments.", {"entities": []}], ["TGF-\u03b21 decreased E-cadherin expression and increased protein expression and mRNA transcripts of Snail, vimentin, and N-cadherin together with increased cell invasion and migration.", {"entities": []}], ["TGF-\u03b22 elicited migratory response similar to TGF-\u03b21 but induced the expression of EMT markers differently from that by TGF-\u03b21.", {"entities": []}], ["Calcitriol attenuated TGF-\u03b21- and TGF-\u03b22-induced cell motility.", {"entities": []}], ["Also, calcitriol inhibited the expression of EMT markers in TGF-\u03b21-treated epithelial cells with less effect on TGF-\u03b22.", {"entities": []}], ["These data suggest that calcitriol inhibits both migration and invasion induced by TGF-\u03b21 and TGF-\u03b22 in human airway epithelial cells.", {"entities": []}], ["However, the regulatory effect of vitamin D in epithelial-mesenchymal transition was more effective to TGF-\u03b21-induced changes.", {"entities": []}], ["Thus, calcitriol could be a potential therapeutic agent in the prevention and management of subepithelial fibrosis and airway remodeling.", {"entities": []}], ["This review considers the molecular toxicology of combustion-derived nanoparticles (CDNP) following inhalation exposure.", {"entities": []}], ["CDNP originate from a number of sources and in this review we consider diesel soot, welding fume, carbon black and coal fly ash.", {"entities": []}], ["A substantial literature demonstrates that these pose a hazard to the lungs through their potential to cause oxidative stress, inflammation and cancer; they also have the potential to redistribute to other organs following pulmonary deposition.", {"entities": [[144, 150, "DISEASE"]]}], ["These different CDNP show considerable heterogeneity in composition and solubility, meaning that oxidative stress may originate from different components depending on the particle under consideration.", {"entities": []}], ["Key CDNP-associated properties of large surface area and the presence of metals and organics all have the potential to produce oxidative stress.", {"entities": []}], ["CDNP may also exert genotoxic effects, depending on their composition.", {"entities": []}], ["CDNP and their components also have the potential to translocate to the brain and also the blood, and thereby reach other targets such as the cardiovascular system, spleen and liver.", {"entities": []}], ["CDNP therefore can be seen as a group of particulate toxins unified by a common mechanism of injury and properties of translocation which have the potential to mediate a range of adverse effects in the lungs and other organs and warrant further research.", {"entities": []}], ["The Florence Statement on Triclosan and Triclocarban documents a consensus of more than 200 scientists and medical professionals on the hazards of and lack of demonstrated benefit from common uses of triclosan and triclocarban.", {"entities": []}], ["These chemicals may be used in thousands of personal care and consumer products as well as in building materials.", {"entities": []}], ["Based on extensive peer-reviewed research, this statement concludes that triclosan and triclocarban are environmentally persistent endocrine disruptors that bioaccumulate in and are toxic to aquatic and other organisms.", {"entities": []}], ["Evidence of other hazards to humans and ecosystems from triclosan and triclocarban is presented along with recommendations intended to prevent future harm from triclosan, triclocarban, and antimicrobial substances with similar properties and effects.", {"entities": []}], ["Because antimicrobials can have unintended adverse health and environmental impacts, they should only be used when they provide an evidence-based health benefit.", {"entities": []}], ["Greater transparency is needed in product formulations, and before an antimicrobial is incorporated into a product, the long-term health and ecological impacts should be evaluated.", {"entities": []}], ["https://doi.org/10.1289/EHP1788", {"entities": []}], ["In 2009 a new influenza serotype (AH1N1) was identified in Mexico that spread rapidly generating worldwide alarm.", {"entities": [[14, 23, "DISEASE"]]}], ["San Luis Potosi (SLP) was the third state with more cases reported in that year.", {"entities": []}], ["The clinical identification of this flu posed a challenge to medical staff.", {"entities": []}], ["This study aimed at estimating the AH1N1 infection, hospitalization and mortality rates, and at identifying related clinical features in persons who received medical care during the influenza pandemic.", {"entities": [[182, 191, "DISEASE"]]}], ["Retrospective study with persons with flu-like illness who received public or private medical care in SLP from 15.03.09 to 30.10.09.", {"entities": []}], ["Physicians purposely recorded many clinical variables.", {"entities": []}], ["Samples from pharyngeal exudate or bronchoalveolar lavage were taken to diagnose AH1N1 using real-time PCR.", {"entities": []}], ["Clinical predictors were identified using multivariate logistic regression with infection as a dependent variable.", {"entities": []}], ["Odds ratios (OR) with 95% confidence intervals (CI) were computed.", {"entities": []}], ["Analyses were stratified by age group based on the distribution of positive cases.", {"entities": []}], ["From the 6922 persons with flu symptoms 6158 had available laboratory results from which 44.9% turned out to be positive for AH1N1.", {"entities": []}], ["From those, 5.8% were hospitalized and 0.7% died.", {"entities": []}], ["Most positive cases were aged 5\u201314 years and, in this subgroup, older age was positively associated with A H1N1 infection (95% CI 1.05-1.1); conversely, in patients aged 15 years or more, older age was negatively associated with the infection (95% CI 0.97-0.98).", {"entities": []}], ["Fever was related in those aged 15 years or more (95% CI 1.4-3.5), and headache (95% CI 1.2-2.2) only in the 0\u201314 years group.", {"entities": []}], ["Clear rhinorrhea and cough were positively related in both groups (p\u2009<\u20090.05).", {"entities": []}], ["Arthralgia, dyspnea and vaccination history were related to lesser risk in persons aged 15 years or more, just as dyspnea, purulent rhinorrhea and leukocytosis were in the 0\u201314 years group.", {"entities": []}], ["This study identified various signs and symptoms for the clinical diagnosis of AH1N1 influenza and revealed that some of them can be age-specific.", {"entities": [[85, 94, "DISEASE"]]}], ["A universal pH indicator is used to fabricate a fiber optic ammonia sensor.", {"entities": []}], ["The advantage of this pH indicator is that it exhibits sensitivity to ammonia over a broad wavelength range.", {"entities": []}], ["This provides a differential response, with a valley around 500 nm and a peak around 650 nm, which allows us to perform ratiometric measurements.", {"entities": []}], ["The ratiometric measurements provide not only an enhanced signal, but can also eliminate any external disturbance due to humidity or temperature fluctuations.", {"entities": []}], ["In addition, the indicator is embedded in a hydrophobic and gas permeable polyurethane film named Tecoflex", {"entities": []}], ["The objective was to evaluate the efficacy of MP \u2010AzeFlu (Dymista vs fluticasone propionate ( FP ), (both 1 spray/nostril bid), in children with allergic rhinitis ( AR ).", {"entities": [[145, 162, "DISEASE"], [154, 162, "DISEASE"]]}], ["MP \u2010AzeFlu combines azelastine hydrochloride, FP and a novel formulation in a single spray.", {"entities": []}], ["Children were randomized in a 3 : 1 ratio to MP \u2010AzeFlu or FP in this open\u2010label, 3\u2010month study.", {"entities": []}], ["Efficacy was assessed in children aged \u2265 6 to <12 years ( MP \u2010AzeFlu: n = 264; FP : n = 89), using a 4\u2010point symptom severity rating scale from 0 to 3 (0 = no symptoms; 3 = severe symptoms).", {"entities": []}], ["Over the 3\u2010month period, MP \u2010AzeFlu\u2010treated children experienced significantly greater symptom relief than FP\u2010treated children (Diff: \u22120.14; 95% CI : \u22120.28, \u22120.01; P = 0.04), noted from the first day (particularly the first 7 days) and sustained for 90 days.", {"entities": []}], ["More MP \u2010AzeFlu children achieved symptom\u2010free or mild symptom severity status, and did so up to 16 days faster than FP .", {"entities": []}], ["MP \u2010AzeFlu provides significantly greater, more rapid and clinically relevant symptom relief than FP in children with AR .", {"entities": []}], ["Secondhand smoke (SHS) is a major contributor to indoor air pollution.", {"entities": []}], ["Because it contains respiratory irritants, it may adversely influence the clinical course of persons with chronic obstructive pulmonary disease (COPD).", {"entities": [[106, 143, "DISEASE"]]}], ["We used data from nonsmoking members of the FLOW cohort of COPD (n = 809) to elucidate the impact of SHS exposure on health status and exacerbations (requiring emergency department visits or hospitalization).", {"entities": []}], ["SHS exposure was measured by a validated survey instrument (hours of exposure during the past week).", {"entities": []}], ["Physical health status was measured by the SF-12 Physical Component Summary Score and disease-specific health-related quality of life (HRQL) by the Airways Questionnaire 20-R. Health care utilization for COPD was determined from Kaiser Permanente Northern California computerized databases.", {"entities": []}], ["Compared to no SHS exposure, higher level SHS exposure was associated with poorer physical health status (mean score decrement \u22121.78 points; 95% confidence interval [CI] \u22123.48 to \u22120.074 points) after controlling for potential confounders.", {"entities": []}], ["Higher level SHS exposure was also related to poorer disease-specific HRQL (mean score increment 0.63; 95% CI 0.016 to 1.25) and less distance walked during the Six-Minute Walk test (mean decrement \u221250 feet; 95% CI \u2212102 to 1.9).", {"entities": []}], ["Both lower level and higher level SHS exposure was related to increased risk of emergency department (ED) visits (hazard ratio [HR] 1.40; 95% CI 0.96 to 2.05 and HR 1.41; 95% CI 0.94 to 2.13).", {"entities": [[128, 130, "GENE"], [162, 164, "GENE"], [128, 130, "GENE"], [162, 164, "GENE"]]}], ["Lower level and higher level SHS exposure were associated with a greater risk of hospital-based care for COPD, which was a composite endpoint of either ED visits or hospitalizations for COPD (HR 1.52; 95% CI 1.06 to 2.18 and HR 1.40; 95% CI 0.94 to 2.10, respectively).", {"entities": [[192, 194, "GENE"], [225, 227, "GENE"], [192, 194, "GENE"], [225, 227, "GENE"]]}], ["In conclusion, SHS was associated with poorer health status and a greater risk of COPD exacerbation.", {"entities": []}], ["COPD patients may comprise a vulnerable population for the health effects of SHS.", {"entities": []}], ["Background Asthma exacerbations are seasonal with the greatest risk in elementary-age students occurring shortly after returning to school following summer break.", {"entities": [[11, 17, "DISEASE"]]}], ["Recent research suggests that this seasonality in children is primarily related to viral respiratory tract infections.", {"entities": []}], ["Regular hand washing is the most effective method to prevent the spread of viral respiratory infections; unfortunately, achieving hand washing recommendations in schools is difficult.", {"entities": []}], ["Therefore, we designed a study to evaluate the effect of hand sanitizer use in elementary schools on exacerbations among children with asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["Purpose To describe the process of redesigning the trial in response to changes in the safety profile of the hand sanitizer as well as changes in hand hygiene practice in the schools.", {"entities": []}], ["Methods The original trial was a randomized, longitudinal, subject-blinded, placebo-controlled, community-based crossover trial.", {"entities": []}], ["The primary aim was to evaluate the incremental effectiveness of hand sanitizer use in addition to usual hand hygiene practices to decrease asthma exacerbations in elementary-age children.", {"entities": [[140, 146, "DISEASE"]]}], ["Three events occurred that required major modifications to the original study protocol: (1) safety concerns arose regarding the hand sanitizer\u2019s active ingredient; (2) no substitute placebo hand sanitizer was available; and (3) community preferences changed regarding hand hygiene practices in the schools.", {"entities": []}], ["Results The revised protocol is a randomized, longitudinal, community-based crossover trial.", {"entities": []}], ["The primary aim is to evaluate the incremental effectiveness of a two-step hand hygiene process (hand hygiene education plus institutionally provided alcohol-based hand sanitizer) versus usual care to decrease asthma exacerbations.", {"entities": [[210, 216, "DISEASE"]]}], ["Enrollment was completed in May 2009 with 527 students from 30 schools.", {"entities": []}], ["The intervention began in August 2009 and will continue through May 2011.", {"entities": []}], ["Study results should be available at the end of 2011.", {"entities": []}], ["Limitations The changed design does not allow us to directly measure the effectiveness of hand sanitizer use as a supplement to traditional hand washing practices.", {"entities": []}], ["Conclusions The need to balance a rigorous study design with one that is acceptable to the community requires investigators to be actively involved with community collaborators and able to adapt study protocols to fit changing community practices.", {"entities": []}], ["The purpose of this study was to evaluate the clinical benefits and safety of the long-term use of macrolides in patients with non-cystic fibrosis (non-CF) bronchiectasis.", {"entities": [[156, 170, "DISEASE"], [131, 146, "DISEASE"]]}], ["Embase, Pubmed, the Cochrane Library and Web of Science databases were searched from inception up to March 2014.", {"entities": []}], ["The primary outcome was the improvement of exacerbations of bronchiectasis.", {"entities": [[60, 74, "DISEASE"]]}], ["Secondary endpoints included changes of microbiology, lung function, quality of life, sputum volume, adverse events and macrolide resistance.", {"entities": []}], ["The literature search yielded 139 studies, ten of which containing 601 patients were included in this meta-analysis.", {"entities": []}], ["Macrolides showed a statistically-significant improvement in reducing acute exacerbations per patient during follow-up treatment (RR\u2009=\u20090.55, 95% CI: 0.47, 0.64, P\u2009<\u20090.001), increasing the number of patients free from exacerbations (OR\u2009=\u20092.81, 95% CI: 1.85, 4.26, P\u2009<\u20090.001), and prolonging time to a first exacerbation (HR\u2009=\u20090.38, 95% CI: 0.28, 0.53, P\u2009<\u20090.001).", {"entities": [[320, 322, "GENE"]]}], ["Macrolides maintenance treatment was superior to control with respect to attenuating FEV1 decline (p\u2009=\u20090.02), improving sputum volume (p\u2009=\u20090.009) and SGRQ total scores (p\u2009=\u20090.02), but showed a higher risk of adverse events, especially diarrhea (OR\u2009=\u20095.36; 95% CI: 2.06, 13.98, P\u2009=\u20090.0006).", {"entities": [[235, 243, "DISEASE"]]}], ["Eradication of pathogens was improved in the macrolide group (OR\u2009=\u20091.76, 95% CI: 0.91, 3.41, P\u2009=\u20090.09), while pathogen resistance caused by macrolides dramatically increased (OR\u2009=\u200916.83, 95% CI: 7.26, 38.99, P\u2009<\u20090.001).", {"entities": []}], ["The new appearance of a microbiologic profile or participant withdrawal due to adverse events showed no significant differences between the two groups.", {"entities": []}], ["In patients with non-CF bronchiectasis, macrolide maintenance treatment can effectively reduce frequency of exacerbations, attenuate lung function decline, decrease sputum volume, improve quality of life, but may be accompanied with increased adverse events (especially diarrhea) and pathogen resistance.", {"entities": [[24, 38, "DISEASE"], [270, 278, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12879-015-0872-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, is the most common complication in extreme premature infants (born before 28 weeks gestation).", {"entities": [[46, 58, "DISEASE"]]}], ["Despite advances in perinatal care, modern clinical management remains devoid of therapies specifically promoting lung repair and lung growth.", {"entities": []}], ["Recent progress in stem cell biology has uncovered the promise of stem/progenitor cells to repair damaged organs.", {"entities": []}], ["Contrary to the original theory that stem cells engraft and repopulate the damaged organ, evidence suggests that stem cells act via a paracrine mechanism.", {"entities": []}], ["This review highlights the pre-clinical evidence for the therapeutic potential of cell-based therapies in animal models of neonatal chronic lung injury and the multiple therapeutic avenues offered by soluble stem cell-derived factors.", {"entities": []}], ["\u03b2 2 -adrenergic receptor (\u03b2 2 AR) agonists (\u03b2 2 -agonist) are the most commonly used therapy for acute relief in asthma, but chronic use of these bronchodilators paradoxically exacerbates airway hyper-responsiveness.", {"entities": [[113, 119, "DISEASE"]]}], ["Activation of \u03b2ARs by \u03b2-agonist leads to desensitization (inactivation) by phosphorylation through G-protein coupled receptor kinases (GRKs) which mediate \u03b2-arrestin binding and \u03b2AR internalization.", {"entities": []}], ["Resensitization occurs by dephosphorylation of the endosomal \u03b2ARs which recycle back to the plasma membrane as agonist-ready receptors.", {"entities": []}], ["To determine whether the loss in \u03b2-agonist response in asthma is due to altered \u03b2AR desensitization and/or resensitization, we used primary human airway smooth muscle cells (HASMCs) isolated from the lungs of non-asthmatic and fatal-asthmatic subjects.", {"entities": [[55, 61, "DISEASE"]]}], ["Asthmatic HASMCs have diminished adenylyl cyclase activity and cAMP response to \u03b2-agonist as compared to non-asthmatic HASMCs.", {"entities": []}], ["Confocal microscopy showed significant accumulation of phosphorylated \u03b2 2 ARs in asthmatic HASMCs.", {"entities": []}], ["Systematic analysis of desensitization components including GRKs and \u03b2-arrestin showed no appreciable differences between asthmatic and non-asthmatic HASMCs.", {"entities": []}], ["However, asthmatic HASMC showed significant increase in PI3K\u03b3 activity and was associated with reduction in PP2A activity.", {"entities": []}], ["Since reduction in PP2A activity could alter receptor resensitization, endosomal fractions were isolated to assess the agonist ready \u03b2 2 ARs as a measure of resensitization.", {"entities": []}], ["Despite significant accumulation of \u03b2 2 ARs in the endosomes of asthmatic HASMCs, endosomal \u03b2 2 ARs cannot robustly activate adenylyl cyclase.", {"entities": []}], ["Furthermore, endosomes from asthmatic HASMCs are associated with significant increase in PI3K\u03b3 and reduced PP2A activity that inhibits \u03b2 2 AR resensitization.", {"entities": []}], ["Our study shows that resensitization, a process considered to be a homeostasis maintaining passive process is inhibited in asthmatic HASMCs contributing to \u03b2 2 AR dysfunction which may underlie asthma pathophysiology and loss in asthma control.", {"entities": [[194, 200, "DISEASE"], [229, 235, "DISEASE"]]}], ["There is a marked growth in the number of homebound older adults, due mainly to increased life expectancy.", {"entities": []}], ["Although this group has special characteristics and needs, it has not been properly studied.", {"entities": []}], ["This study thus aimed to measure the prevalence of homebound status in a community-dwelling population, and its association with both socio-demographic, medical and functional characteristics and the use of health care and social services.", {"entities": []}], ["We used instruments coming under the WHO International Classification of Functioning (ICF) framework to carry out a cross-sectional study on populations aged 50 years and over in the province of Zaragoza (Spain), covering a total of 1622 participants.", {"entities": []}], ["Persons who reported severe or extreme difficulty in getting out of the house in the last 30 days were deemed to be homebound.", {"entities": []}], ["We studied associations between homebound status and several relevant variables in a group of 790 subjects who tested positive to the WHODAS-12 disability screening tool.", {"entities": []}], ["Prevalence of homebound status was 9.8 % (95 % CI: 8.4 to 11.3 %).", {"entities": []}], ["Homebound participants tended to be older, female and display a lower educational level, a higher number of diseases, poorer cognition and a higher degree of disability.", {"entities": []}], ["In fully adjusted models including disability as measured with the ICF-Checklist, the associated variables (odds ratios and [95 % confidence intervals]) were: female gender (3.75 [2.10\u20136.68]); urban population (2.36 [1.30\u20134.29]); WHODAS-12 disability (6.27 [2.56\u201315.40]); depressive symptoms (2.95 [1.86\u20134.68]); moderate pain (2.37 [1.30\u20134.31] and severe pain (3.03 [1.31\u20137.01]), as compared to the group with no/mild pain; hospital admissions in the previous 3 months (2.98 [1.25\u20137.11]); and diabetes (1.87 [1.03\u20133.41]).", {"entities": []}], ["Adjustment for ICF-Checklist disability had a notable impact on most associations.", {"entities": []}], ["The study shows that homebound status is a common problem in our setting, and that being disabled is its main determinant.", {"entities": []}], ["Socio-demographic characteristics, barriers and chronic diseases can also be assumed to be playing a role in the onset of this condition, indicating the need for further research, including longitudinal studies on its incidence and associated factors.", {"entities": []}], ["Leukotriene (LT) C 4 and its metabolites, LTD 4 and LTE 4 , are involved in the pathobiology of bronchial asthma.", {"entities": [[106, 112, "DISEASE"], [13, 15, "GENE"]]}], ["LTC 4 synthase is the nuclear membrane-embedded enzyme responsible for LTC 4 biosynthesis, catalyzing the conjugation of two substrates that have considerably different water solubility; that amphipathic LTA 4 as a derivative of arachidonic acid and a water-soluble glutathione (GSH).", {"entities": [[204, 207, "GENE"]]}], ["A previous crystal structure revealed important details of GSH binding and implied a GSH activating function for Arg-104.", {"entities": []}], ["In addition, Arg-31 was also proposed to participate in the catalysis based on the putative LTA 4 binding model.", {"entities": [[92, 95, "GENE"]]}], ["In this study enzymatic assay with mutant enzymes demonstrates that Arg-104 is required for the binding and activation of GSH and that Arg-31 is needed for catalysis probably by activating the epoxide group of LTA 4 .", {"entities": [[210, 213, "GENE"]]}], ["Calcium signaling in phagocytes is essential for cellular activation, migration and the potential resolution of infection or inflammation.", {"entities": []}], ["The generation of reactive oxygen species (ROS) via activation of NADPH (nicotinamide adenine dinucleotide phosphate-) oxidase activity in macrophages has been linked to altered intracellular calcium concentrations.", {"entities": []}], ["Because of its role as an oxidative stress sensor in phagocytes, we investigated the function of the cation channel transient receptor potential melastatin 2 (TRPM2) in macrophages during oxidative stress responses induced by Helicobacter pylori infection.", {"entities": [[159, 164, "GENE"]]}], ["We show that Trpm2 mice, when chronically infected with H. pylori , exhibit increased gastric inflammation and decreased bacterial colonization compared with WT mice.", {"entities": [[13, 18, "GENE"]]}], ["The absence of TRPM2 triggers greater macrophage production of inflammatory mediators and promotes classically activated macrophage M1 polarization in response to H. pylori .", {"entities": [[15, 20, "GENE"]]}], ["TRPM2-deficient macrophages upon H. pylori stimulation are unable to control intracellular calcium levels, which results in calcium overloading.", {"entities": []}], ["Furthermore, increased intracellular calcium in TRPM2 H. pylori gastric colonization while increasing inflammation in the gastric mucosa.", {"entities": [[48, 53, "GENE"]]}], ["The majority of the global population cannot afford existing asthma pharmacotherapy.", {"entities": [[61, 67, "DISEASE"]]}], ["Physical training as an airway anti-inflammatory therapy for asthma could potentially be a non-invasive, easily available, affordable, and healthy treatment modality.", {"entities": [[61, 67, "DISEASE"]]}], ["However, effects of physical training on airway inflammation in asthma are currently inconclusive.", {"entities": [[64, 70, "DISEASE"]]}], ["The main objective of this review is to summarize the effects of physical training on airway inflammation in asthmatics.", {"entities": []}], ["A peer reviewed search was applied to Medline, Embase, Web of Science, Cochrane, and DARE databases.", {"entities": []}], ["We included all observational epidemiological research studies and RCTs.", {"entities": []}], ["Studies evaluating at least one marker of airway inflammation in asthmatics after a period of physical training were selected.", {"entities": []}], ["Data extraction was performed in a blinded fashion.", {"entities": []}], ["We decided a priori to avoid pooling of the data in anticipation of heterogeneity of the studies, specifically heterogeneity of airway inflammatory markers studied as outcome measures.", {"entities": []}], ["From the initial 2635 studies; 23 studies (16 RCTs and 7 prospective cohort studies) were included.", {"entities": []}], ["Study sizes were generally small (median sample size\u2009=\u200930).", {"entities": []}], ["There was a reduction in C-reactive protein, malondialdehyde, nitric oxide, sputum cell counts and IgE in asthmatics with physical training.", {"entities": []}], ["Mixed results were observed after training for fractional excretion of nitric oxide and bronchial hyperresponsiveness.", {"entities": []}], ["The data was not pooled owing to significant heterogeneity between studies, and a funnel plot tests for publication bias were not performed because there were less than 10 studies for almost all outcome measures.", {"entities": []}], ["Physical training intervention type, duration, intensity, frequency, primary outcome measures, methods of assessing outcome measures, and study designs were heterogeneous.", {"entities": []}], ["Due to reporting issues, lack of information and heterogeneity there was no definite conclusion; however, some findings suggest physical training may reduce airway inflammation in asthmatics.", {"entities": []}], ["Long-acting bronchodilator monotherapy (long-acting \u03b2 2 -agonist [LABA] or long-acting muscarinic antagonist [LAMA]) is extensively used for treatment of patients with chronic obstructive pulmonary disease (COPD) with mild-to-moderate airflow limitation.", {"entities": [[168, 205, "DISEASE"]]}], ["However, a substantial number of patients remain symptomatic despite treatment with a single bronchodilator, necessitating a change in therapy.", {"entities": []}], ["This 12-week, randomized, multicenter, open-label, phase IV study aims to show that the once-daily indacaterol/glycopyrronium (IND/GLY) 110/50 \u03bcg fixed-dose LABA/LAMA combination results in an improved lung function in symptomatic patients with mild-to-moderate COPD who switch from once-daily tiotropium 18 \u03bcg.", {"entities": []}], ["The study aims to enroll a total of 404 symptomatic patients in Korea with mild-to-moderate COPD who received tiotropium for at least 12 weeks prior to the study initiation.", {"entities": []}], ["The primary objective of this study is to demonstrate the superiority of IND/GLY over tiotropium in terms of trough forced expiratory volume in 1 second (FEV 1 ) following 12 weeks of treatment.", {"entities": [[154, 157, "GENE"]]}], ["Secondary endpoints include the pre-dose trough FEV 1 after 4 weeks of treatment, transition dyspnea index (TDI) total score, COPD assessment test (CAT) total score, and rescue medication use following the 12-week treatment, and safety assessment over the 12-week treatment.", {"entities": [[48, 51, "GENE"]]}], ["This study intends to establish the use of LABA/LAMA combination therapy in symptomatic patients with mild-to-moderate COPD by demonstrating the superiority of IND/GLY over tiotropium monotherapy.", {"entities": []}], ["ClinicalTrials.gov, NCT02566031 .", {"entities": []}], ["Registered on 10 August 2015.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-1800-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["One quality indicator of hospital care, which can be used to judge the process of care, is the prevalence of hospital readmission because it reflects the impact of hospital care on the patient\u2019s condition after discharge.", {"entities": []}], ["The purposes of the study were to measure the prevalence of hospital readmissions, to identify possible factors that influence such readmission and to measure the prevalence of readmissions potentially avoidable in Italy.", {"entities": []}], ["A sample of 2289 medical records of patients aged 18 and over admitted for medical or surgical illness at one 502-bed community non-teaching hospital were randomly selected.", {"entities": []}], ["A total of 2252 patients were included in the final analysis, equaling a response rate of 98.4%.", {"entities": []}], ["The overall hospital readmission prevalence within 30 days of discharge was 10.2%.", {"entities": []}], ["Multivariate logistic regression analysis revealed that the proportion of patients readmitted within 30 days of discharge significantly increased regardless of Charlson et al.", {"entities": []}], ["comorbidity score, among unemployed or retired patients, and in patients in general surgery.", {"entities": []}], ["A total of 43.7% hospital readmissions were judged to be potentially avoidable.", {"entities": []}], ["Multivariate logistic regression analysis showed that potentially avoidable readmissions were significantly higher in general surgery, in patients referred to hospital by an emergency department physician, and in those with a shortened time between discharge and readmission.", {"entities": []}], ["Additional research on intervention or bundle of interventions applicable to acute inpatient populations that aim to reduce potentially avoidable readmissions is strongly needed, and health care providers are urged to implement evidence-based programs for more cost-effective delivery of health care.", {"entities": []}], ["This paper is based on an ethnobotanical investigation that focused on the traditional medicinal plants used by local Maonan people to treat human diseases in Maonan concentration regions.", {"entities": []}], ["The Maonan people have relied on traditional medicine since ancient times, especially medicinal plants.", {"entities": []}], ["The aim of this study is to document medicinal plants used by the Maonans and to report the status of medicinal plants and associated traditional knowledge.", {"entities": []}], ["Ethnobotanical data were collected from June 2012 to September 2014 in Huanjiang Maonan Autonomous County, northern Guangxi, southwest China.", {"entities": []}], ["In total, 118 knowledgeable informants were interviewed.", {"entities": []}], ["Following statistically sampling method, eighteen villages from 5 townships were selected to conduct field investigations.", {"entities": []}], ["Information was collected through the approache of participatory observation, semi-structured interviews, ranking exercises, key informant interviews, focus group discussions, and participatory rural appraisals.", {"entities": []}], ["A total of 368 medicinal plant species were investigated and documented together with their medicinal uses by the Maonans, most of which were obtained from the wild ecosystems.", {"entities": []}], ["The plants were used to treat 95 human diseases.", {"entities": []}], ["Grinding was a widely used method to prepare traditional herbal medicines.", {"entities": []}], ["There were significant relationships between gender and age, and between gender and informants\u2019 knowledge of medicinal plant use.", {"entities": []}], ["Deforestation for agricultural purposes was identified as the most destructive factor of medicinal plants, followed by drought and over-harvest.", {"entities": []}], ["The species diversity of medicinal plants used by the Maonans in the study area was very rich.", {"entities": []}], ["Medicinal plants played a significant role in healing various human disorders in the Maonan communities.", {"entities": []}], ["However, the conflicts between traditional inheriting system and recent socio-economic changes (and other factors) resulted in the reduction or loss of both medicinal plants and associated indigenous knowledge.", {"entities": []}], ["Thus, conservation efforts and policies, and innovation of inheriting system are necessary for protecting the medicinal plants and associated indigenous knowledge.", {"entities": []}], ["Awareness is also needed to be raised among local Maonans focusing on sustainable utilization and management of both medicinal plants and traditional knowledge.", {"entities": []}], ["Headache and facial pain are among the most common, disabling and costly disorders in Europe.", {"entities": []}], ["Correct diagnosis and treatment is important for achieving a high quality of care.", {"entities": []}], ["As a national organisation whose role is to educate and advocate for the needs of patients with primary headaches, the Danish Headache Society has set up a task force to develop a set of guidelines for the diagnosis, organisation and treatment of the most common types of headaches and for trigeminal neuralgia in Denmark.", {"entities": [[290, 310, "DISEASE"]]}], ["The guideline was published in Danish in 2010 and has been a great success.", {"entities": []}], ["The Danish Headache Society decided to translate and publish our guideline in English to stimulate the discussion on optimal organisation and treatment of headache disorders and to encourage other national headache authorities to produce their own guidelines.", {"entities": []}], ["The recommendations regarding the most common primary headaches and trigeminal neuralgia are largely in accordance with the European guidelines produced by the European Federation of Neurological Societies.", {"entities": [[68, 88, "DISEASE"]]}], ["The guideline provides a practical tool for use in daily clinical practice for primary care physicians, neurologists with a common interest in headache, as well as other health-care professionals treating headache patients.", {"entities": []}], ["The guideline first describes how to examine and diagnose the headache patient and how headache treatment is organised in Denmark.", {"entities": []}], ["This description is followed by individual sections on the characteristics, diagnosis, differential diagnosis and treatment of each of the major headache disorders and trigeminal neuralgia.", {"entities": [[168, 188, "DISEASE"]]}], ["The guideline includes many tables to facilitate a quick overview.", {"entities": []}], ["Finally, the particular problems regarding headache in children and headache in relation to female hormones and pregnancy are described.", {"entities": []}], ["Although research suggests that patients prefer a shared decision making (SDM) experience when making healthcare decisions, clinicians do not routinely implement SDM into their practice and training programs are needed.", {"entities": []}], ["Using a novel case-based strategy, we developed and pilot tested an online educational program to promote shared decision making (SDM) by primary care clinicians.", {"entities": []}], ["A three-phased approach was used: 1) development of a conceptual model of the SDM process; 2) development of an online teaching case utilizing the Design A Case (DAC) authoring template, a well-tested process used to create peer-reviewed web-based clinical cases across all levels of healthcare training; and 3) pilot testing of the case.", {"entities": []}], ["Participants were clinician members affiliated with several primary care research networks across the United States who answered an invitation email.", {"entities": []}], ["The case used prostate cancer screening as the clinical context and was delivered online.", {"entities": [[23, 29, "DISEASE"], [14, 29, "DISEASE"]]}], ["Post-intervention ratings of clinicians\u2019 general knowledge of SDM, knowledge of specific SDM steps, confidence in and intention to perform SDM steps were also collected online.", {"entities": []}], ["Seventy-nine clinicians initially volunteered to participate in the study, of which 49 completed the case and provided evaluations.", {"entities": []}], ["Forty-three clinicians (87.8%) reported the case met all the learning objectives, and 47 (95.9%) indicated the case was relevant for other equipoise decisions.", {"entities": []}], ["Thirty-one clinicians (63.3%) accessed supplementary information via links provided in the case.", {"entities": []}], ["After viewing the case, knowledge of SDM was high (over 90% correctly identified the steps in a SDM process).", {"entities": []}], ["Determining a patient\u2019s preferred role in making the decision (62.5% very confident) and exploring a patient\u2019s values (65.3% very confident) about the decisions were areas where clinician confidence was lowest.", {"entities": []}], ["More than 70% of the clinicians intended to perform SDM in the future.", {"entities": []}], ["A comprehensive model of the SDM process was used to design a case-based approach to teaching SDM skills to primary care clinicians.", {"entities": []}], ["The case was favorably rated in this pilot study.", {"entities": []}], ["Clinician skills training for helping patients clarify their values and for assessing patients\u2019 desire for involvement in decision making remain significant challenges and should be a focus of future comparative studies.", {"entities": []}], ["The online version of this article (doi:10.1186/1472-6947-14-95) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Current health policies emphasize the need for an equitable doctor-patient relationship, and this requires a certain level of patient empowerment.", {"entities": []}], ["However, a systematic review of the empirical evidence on how empowerment affects medication adherence\u2014the extent to which patients follow the physician\u2019s prescription of medication intake\u2014is still missing.", {"entities": []}], ["The goal of this systematic review is to sum up current state-of-the-art knowledge concerning the relationship between patient empowerment and medication adherence across medical conditions.", {"entities": []}], ["As our conceptualization defines health locus of control and self-efficacy as being crucial components of empowerment, we explored the relationship between these two constructs and medication adherence.", {"entities": []}], ["Relevant studies were retrieved through a comprehensive search of Medline and PsychINFO databases (1967 to 2017).", {"entities": []}], ["In total, 4903 publications were identified.", {"entities": []}], ["After applying inclusion and exclusion criteria and quality assessment, 154 articles were deemed relevant.", {"entities": []}], ["Peer-reviewed articles, written in English, addressing the relationship between empowerment (predictor) and medication adherence (outcome) were included.", {"entities": []}], ["High levels of self-efficacy and Internal Health Locus of Control are consistently found to promote medication adherence.", {"entities": []}], ["External control dimensions were found to have mainly negative (Chance and God attributed control beliefs) or ambiguous (Powerful others attributed control beliefs) links to adherence, except for Doctor Health Locus of Control which had a positive association with medication adherence.", {"entities": []}], ["To fully capture how health locus of control dimensions influence medication adherence, the interaction between the sub-dimensions and the attitudinal symmetry between the doctor and patient, regarding the patient\u2019s control over the disease management, can provide promising new alternatives.", {"entities": []}], ["The beneficial effect of patients\u2019 high internal and concurrent physician-attributed control beliefs suggests that a so-called \u201cjoint empowerment\u201d approach can be suitable in order to foster medication adherence, enabling us to address the question of control as a versatile component in the doctor-patient relationship.", {"entities": []}], ["Over the past two decades, the study of chronic cocaine and crack cocaine exposure in the pediatric population has been focused on the potential adverse effects, especially in the prenatal period and early childhood.", {"entities": []}], ["Non-invasive biological matrices have become an essential tool for the assessment of a long-term history of drug of abuse exposure.", {"entities": []}], ["We analyze the significance of different biomarker values in hair after chronic crack exposure in a two-year-old Caucasian girl and her parents, who are self-reported crack smokers.", {"entities": []}], ["The level of benzoylecgonine, the principal metabolite of cocaine, was determined in segmented hair samples (0 cm to 3 cm from the scalp, and > 3 cm from the scalp) following washing to exclude external contamination.", {"entities": []}], ["Benzoylecgonine was detectable in high concentrations in the child's hair, at 1.9 ng/mg and 7.04 ng/mg, respectively.", {"entities": []}], ["Benzoylecgonine was also present in the maternal and paternal hair samples at 7.88 ng/mg and 6.39 ng/mg, and 13.06 ng/mg and 12.97 ng/mg, respectively.", {"entities": []}], ["Based on the data from this case and from previously published poisoning cases, as well as on the experience of our research group, we conclude that, using similar matrices for the study of chronic drug exposure, children present with a higher cocaine concentration in hair and they experience more serious deleterious acute effects, probably due to a different and slower cocaine metabolism.", {"entities": []}], ["Consequently, children must be not exposed to secondhand crack smoke under any circumstance.", {"entities": []}], ["Toll-like receptors (TLRs) recognize molecular patterns preferentially expressed by pathogens.", {"entities": []}], ["In endosomes, TLR9 is activated by unmethylated bacterial DNA, resulting in proinflammatory cytokine secretion via the adaptor protein MyD88.", {"entities": [[14, 18, "GENE"], [135, 140, "GENE"]]}], ["We demonstrate that CpG oligonucleotides activate a TLR9-independent pathway initiated by two Src family kinases, Hck and Lyn, which trigger a tyrosine phosphorylation\u2013mediated signaling cascade.", {"entities": [[94, 97, "GENE"], [114, 117, "GENE"], [122, 125, "GENE"]]}], ["This cascade induces actin cytoskeleton reorganization, resulting in cell spreading, adhesion, and motility.", {"entities": []}], ["CpG-induced actin polymerization originates at the plasma membrane, rather than in endosomes.", {"entities": []}], ["Chloroquine, an inhibitor of CpG-triggered cytokine secretion, blocked TLR9/MyD88-dependent cytokine secretion as expected but failed to inhibit CpG-induced Src family kinase activation and its dependent cellular responses.", {"entities": [[157, 160, "GENE"]]}], ["Knock down of Src family kinase expression or the use of specific kinase inhibitors blocked MyD88-dependent signaling and cytokine secretion, providing evidence that tyrosine phosphorylation is both CpG induced and an upstream requirement for the engagement of TLR9.", {"entities": [[14, 17, "GENE"], [261, 265, "GENE"]]}], ["The Src family pathway intersects the TLR9\u2013MyD88 pathway by promoting the tyrosine phosphorylation of TLR9 and the recruitment of Syk to this receptor.", {"entities": [[4, 7, "GENE"], [38, 42, "GENE"], [102, 106, "GENE"], [130, 133, "GENE"]]}], ["Inequalities in health have been identified for lesbian, gay, and bisexual (LGB) populations nationally.", {"entities": []}], ["Policies in the U.S. South offer fewer protections for LGB people than in other regions, yet, limited data exist for this region.", {"entities": []}], ["North Carolina (NC) BRFSS data from 2011 to 2014 were combined (LGB n = 604; heterosexual n = 33,170) and analyzed using SAS survey procedures to estimate health characteristics by sexual orientation within gender.", {"entities": []}], ["Many examined indicators were not different by sexual orientation, however, other results were significant and consistent with findings from state population surveys in other regions of the country.", {"entities": []}], ["Both genders showed inequities in mental health, having over twice the odds of five or more poor mental health days in the past month and of having ever been diagnosed with a depressive disorder.", {"entities": []}], ["Sexual minority women had higher odds compared with heterosexual women for ever having smoked cigarettes, current smoking, exposure to secondhand smoke both in the workplace and at home, and both alcohol risk factors, binge and heavy drinking.", {"entities": []}], ["Being part of the LGB population in NC is associated with worse health.", {"entities": []}], ["The implementation of anti-LGB policies in the NC warrants ongoing monitoring of LGB health inequities in NC and in other southeastern states for potential effects on the health and well-being of sexual minorities.", {"entities": []}], ["This study aims to investigate the prevalence of self-reported food hypersensitivity, (SFH), the characteristics of women with SFH, and whether SFH is associated with multiple health complaints among the participants of the Norwegian Women and Cancer study (NOWAC).", {"entities": []}], ["We conducted a cross-sectional study among 64,316 women aged 41\u201376 years.", {"entities": []}], ["The women were randomly selected from the Norwegian Central Person Register.", {"entities": []}], ["Information on SFH and all covariates except age and place of residence was collected by questionnaires in 2002\u20132005.", {"entities": []}], ["The prevalence of SFH in our study sample was 6.8% (95% confidence interval: 6.7\u20137.0).", {"entities": []}], ["Logistic regression analysis showed a negative association between SFH and age (odds ratio [OR] 0.97).", {"entities": []}], ["The odds of SFH increased among women living in or near urban centers, women with more than 9 years of education, women who did not have full-time work, women who had experienced poor economic conditions in childhood, those living without a partner, and those who did not consume alcohol or smoke (OR varied from 1.10 to 1.70).", {"entities": []}], ["Women with a low body mass index had higher odds of SFH (OR 1.37) than those with a moderate body mass index.", {"entities": []}], ["SFH was positively associated with poor self-perceived health (OR 2.56).", {"entities": []}], ["The odds of SFH increased with the number of concurrent health complaints, with an OR for 5\u20136 comorbidities of 4.93.", {"entities": []}], ["We found an association between SFH, poor health, and different socio demographic and lifestyle characteristics.", {"entities": []}], ["Women with SFH had increased odds of reporting multiple health complaints.", {"entities": []}], ["I used generalized additive models to analyze the time-series of daily total nonaccidental and cause-specific (cardiovascular, cerebrovascular, and chronic obstructive pulmonary disease) deaths over the period 1987-1995 in three major U.S. metropolitan areas: Cook County, Los Angeles County, and Maricopa County.", {"entities": [[148, 185, "DISEASE"]]}], ["In all three counties I had monitoring information on particulate matter [less than/equal to] 10 microm (PM(10)), carbon monoxide, sulfur dioxide, nitrogen dioxide, and ozone.", {"entities": []}], ["In Los Angeles, monitoring information on particulate matter [less than/equal to] 2.5 microm (PM(2.5)) was available as well.", {"entities": []}], ["I present the results of both single and multi-pollutant analyses.", {"entities": []}], ["Air pollution was associated with each of the mortality end points.", {"entities": []}], ["With respect to the individual components of the pollution mix, the results indicate considerable heterogeneity of air pollution effects in the different geographic locations.", {"entities": []}], ["In general, the gases, particularly CO, but not ozone, were much more strongly associated with mortality than was particulate matter.", {"entities": []}], ["This association was particularly striking in Los Angeles County.", {"entities": []}], ["Animal and cross-sectional epidemiological studies suggest a link between air pollution and diabetes, whereas the limited prospective data show mixed results.", {"entities": []}], ["We studied the association between long-term exposure to traffic-related air pollution and incidence of diabetes.", {"entities": []}], ["We followed 57,053 participants of the Danish Diet, Cancer, and Health cohort in the Danish National Diabetes Register between baseline (1993\u20131997) and 27 June 2006.", {"entities": []}], ["We estimated the mean levels of nitrogen dioxide (NO 2 ) at the residential addresses of the cohort participants since 1971 and modeled the association between NO 2 and diabetes incidence with a Cox regression model, separately for two definitions of diabetes: all cases and a more strict definition where unconfirmed cases were excluded.", {"entities": []}], ["Over a mean follow-up of 9.7 years of 51,818 eligible subjects, there were 4,040 (7.8%) incident diabetes cases in total and 2,877 (5.5%) with confirmed diagnoses.", {"entities": []}], ["Air pollution was not associated with all diabetes cases (hazard ratio 1.00 [95% CI 0.97\u20131.04] per interquartile range of 4.9 \u03bcg/m 2 levels since 1971), but a borderline statistically significant association was detected with confirmed cases of diabetes (1.04 [1.00\u20131.08]).", {"entities": []}], ["Among confirmed diabetes cases, effects were significantly enhanced in nonsmokers (1.12 [1.05\u20131.20]) and physically active people (1.10 [1.03\u20131.16]).", {"entities": []}], ["Long-term exposure to traffic-related air pollution may contribute to the development of diabetes, especially in individuals with a healthy lifestyle, nonsmokers, and physically active individuals.", {"entities": []}], ["Health impact assessments (HIA) use information on exposure, baseline mortality/morbidity and exposure-response functions from epidemiological studies in order to quantify the health impacts of existing situations and/or alternative scenarios.", {"entities": []}], ["The aim of this study was to improve HIA methods for air pollution studies in situations where exposures can be estimated using GIS with high spatial resolution and dispersion modeling approaches.", {"entities": []}], ["Tallinn was divided into 84 sections according to neighborhoods, with a total population of approx.", {"entities": []}], ["390 000 persons.", {"entities": []}], ["Actual baseline rates for total mortality and hospitalization with cardiovascular and respiratory diagnosis were identified.", {"entities": []}], ["The exposure to fine particles (PM 2.5 ) from local emissions was defined as the modeled annual levels.", {"entities": []}], ["The model validation and morbidity assessment were based on 2006 PM 10 or PM 2.5 levels at 3 monitoring stations.", {"entities": []}], ["The exposure-response coefficients used were for total mortality 6.2% (95% CI 1.6\u201311%) per 10 \u03bcg/m 2.5 concentration and for the assessment of respiratory and cardiovascular hospitalizations 1.14% (95% CI 0.62\u20131.67%) and 0.73% (95% CI 0.47\u20130.93%) per 10 \u03bcg/m 10 .", {"entities": []}], ["The direct costs related to morbidity were calculated according to hospital treatment expenses in 2005 and the cost of premature deaths using the concept of Value of Life Year (VOLY).", {"entities": []}], ["The annual population-weighted-modeled exposure to locally emitted PM 2.5 in Tallinn was 11.6 \u03bcg/m Sectioning the city for analysis and using GIS systems can help to improve the accuracy of air pollution health impact estimations, especially in study areas with poor air pollution monitoring data but available dispersion models.", {"entities": []}], ["Patients across North America are using complementary and alternative medicine (CAM) with increasing frequency as part of their management of many different health conditions.", {"entities": []}], ["The objective of this study was to develop a guide for academic health sciences centers that may wish to consider starting an integrative medicine program.", {"entities": []}], ["We queried North American leaders in the field of integrative medicine to identify initial sites.", {"entities": []}], ["Key stakeholders at each of the initial sites visited were then asked to identify additional potential study sites (snowball sampling), until no new sites were identified.", {"entities": []}], ["We conducted structured interviews to identify critical factors associated with success and failure in each of four domains: research, education, clinical care, and administration.", {"entities": []}], ["During the interviews, field notes were recorded independently by at least two investigators.", {"entities": []}], ["Team meetings were held after each visit to reach consensus on the information recorded and to ensure that it was as complete as possible.", {"entities": []}], ["Content analysis techniques were used to identify key themes that emerged from the field notes.", {"entities": []}], ["We identified ten leading North American integrative medical centers, and visited nine during 2002\u20132003.", {"entities": []}], ["The centers visited suggested that the initiation of an integrative medicine program requires a significant initial outlay of funding and a motivated \"champion\".", {"entities": []}], ["The centers had important information to share regarding credentialing, medico-legal issues and billing for clinical programs; identifying researchers and research projects for a successful research program; and strategies for implementing flexible educational initiatives and establishing a functional administrative structure.", {"entities": []}], ["Important lessons can be learned from academic integrative programs already in existence.", {"entities": []}], ["Such initiatives are timely and feasible in a variety of different ways and in a variety of settings.", {"entities": []}], ["Thrombin activates protease-activated receptor (PAR)-1 and induces a myofibroblast phenotype in normal lung fibroblasts.", {"entities": []}], ["The origins of myofibroblasts are resident fibroblasts, fibrocytes, and epithelial-mesenchymal transition (EMT).", {"entities": []}], ["We investigated the effects of thrombin, an important mediator of interstitial lung fibrosis, on EMT in A549 human alveolar epithelial cells.", {"entities": []}], ["We show that thrombin induced EMT and collagen I secretion through the activation of PAR-1, and PKC and ERK1/2 phosphorylation in A549 cells.", {"entities": []}], ["These effects were largely prevented by a specific PAR-1 antagonist, short interfering RNA (siRNA) directed against PAR-1, or specific PKC\u03b1/\u03b2, \u03b4, and \u03b5 inhibitors.", {"entities": []}], ["These data indicated that interaction with thrombin and alveolar epithelial cells might directly contribute to the pathogenesis of pulmonary fibrosis through EMT.", {"entities": [[131, 149, "DISEASE"]]}], ["Targeting PAR-1 on the pulmonary epithelium or specific inhibitors to PKC\u03b1/\u03b2, \u03b4, and \u03b5 might stop the fibrotic processes in human idiopathic pulmonary fibrosis by preventing thrombin-induced EMT.", {"entities": [[141, 159, "DISEASE"], [130, 159, "DISEASE"]]}], ["Flecainide is a use\u2010dependent blocker of cardiac Na We compared the ability of fully charged (QX\u2010FL) and neutral (NU\u2010FL) derivatives of flecainide to block individual recombinant human RyR2 channels incorporated into planar phospholipid bilayers, and their effects on the properties of Ca Both QX\u2010FL and NU\u2010FL were partial blockers of the non\u2010physiological cytosolic to luminal flux of cations through RyR2 channels but were significantly less effective than flecainide.", {"entities": [[185, 189, "GENE"], [402, 406, "GENE"], [185, 189, "GENE"], [402, 406, "GENE"]]}], ["None of the compounds influenced the physiologically relevant luminal to cytosol cation flux through RyR2 channels.", {"entities": [[101, 105, "GENE"]]}], ["Intracellular flecainide or QX\u2010FL, but not NU\u2010FL, reduced Ca Given its inability to block physiologically relevant cation flux through RyR2 channels, and its lack of efficacy in blocking the cytosolic\u2010to\u2010luminal current, the effect of QX\u2010FL on Ca", {"entities": [[135, 139, "GENE"]]}], ["Aged subjects display increased susceptibility to mucosal diseases.", {"entities": []}], ["Retinoic Acid (RA) plays a major role in inducing tolerance in the mucosa.", {"entities": []}], ["RA acts on Dendritic cells (DCs) to induce mucosal tolerance.", {"entities": []}], ["Here we compared the response of DCs from aged and young individuals to RA with a view to understand the role of DCs in age-associated increased susceptibility to mucosal diseases.", {"entities": []}], ["Our investigations revealed that compared to young DCs, RA stimulated DCs from aged subjects are defective in inducing IL-10 and T regulatory cells.", {"entities": []}], ["Examinations of the underlying mechanisms indicated that RA exposure led to the upregulation of CD141 and GARP on DCs which rendered the DCs tolerogenic.", {"entities": []}], ["This prospective cohort study aimed to identify symptom and patient factors that influence time to lung cancer diagnosis and stage at diagnosis.", {"entities": [[99, 110, "DISEASE"], [104, 110, "DISEASE"]]}], ["Data relating to symptoms were collected from patients upon referral with symptoms suspicious of lung cancer in two English regions; we also examined primary care and hospital records for diagnostic routes and diagnoses.", {"entities": [[97, 108, "DISEASE"], [102, 108, "DISEASE"]]}], ["Descriptive and regression analyses were used to investigate associations between symptoms and patient factors with diagnostic intervals and stage.", {"entities": []}], ["Among 963 participants, 15.9% were diagnosed with primary lung cancer, 5.9% with other thoracic malignancies and 78.2% with non-malignant conditions.", {"entities": [[58, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["Only half the cohort had an isolated first symptom (475, 49.3%); synchronous first symptoms were common.", {"entities": []}], ["Haemoptysis, reported by 21.6% of cases, was the only initial symptom associated with cancer.", {"entities": [[86, 92, "DISEASE"]]}], ["Diagnostic intervals were shorter for cancer than non-cancer diagnoses (91 vs 124 days, P =0.037) and for late-stage than early-stage cancer (106 vs 168 days, P =0.02).", {"entities": [[38, 44, "DISEASE"], [54, 60, "DISEASE"], [134, 140, "DISEASE"]]}], ["Chest/shoulder pain was the only first symptom with a shorter diagnostic interval for cancer compared with non-cancer diagnoses ( P =0.003).", {"entities": [[86, 92, "DISEASE"], [111, 117, "DISEASE"]]}], ["Haemoptysis is the strongest symptom predictor of lung cancer but occurs in only a fifth of patients.", {"entities": [[50, 61, "DISEASE"], [55, 61, "DISEASE"]]}], ["Programmes for expediting earlier diagnosis need to focus on multiple symptoms and their evolution.", {"entities": []}], ["Thymic stromal lymphoproetin (TSLP) is a cytokine secreted by the airway epithelium in response to respiratory viruses and it is known to promote allergic Th2 responses in asthma.", {"entities": [[172, 178, "DISEASE"], [30, 34, "GENE"]]}], ["This study investigated whether virally-induced secretion of TSLP is directional in nature (apical vs. basolateral) and/or if there are TSLP-mediated effects occurring at both sides of the bronchial epithelial barrier in the asthmatic state.", {"entities": [[61, 65, "GENE"], [136, 140, "GENE"]]}], ["Primary human bronchial epithelial cells (HBEC) from control (n\u200a=\u200a3) and asthmatic (n\u200a=\u200a3) donors were differentiated into polarized respiratory tract epithelium under air-liquid interface (ALI) conditions and treated apically with dsRNA (viral surrogate) or TSLP.", {"entities": [[259, 263, "GENE"]]}], ["Sub-epithelial effects of TSLP were examined in human airway smooth muscle cells (HASMC) from normal (n\u200a=\u200a3) and asthmatic (n\u200a=\u200a3) donors.", {"entities": [[26, 30, "GENE"]]}], ["Clinical experiments examined nasal airway secretions obtained from asthmatic children during naturally occurring rhinovirus-induced exacerbations (n\u200a=\u200a20) vs. non-asthmatic uninfected controls (n\u200a=\u200a20).", {"entities": []}], ["Protein levels of TSLP, CCL11/eotaxin-1, CCL17/TARC, CCL22/MDC, TNF-\u03b1 and CXCL8 were determined with a multiplex magnetic bead assay.", {"entities": [[18, 22, "GENE"]]}], ["Our data demonstrate that: 1) Asthmatic HBEC exhibit an exaggerated apical, but not basal, secretion of TSLP after dsRNA exposure; 2) TSLP exposure induces unidirectional (apical) secretion of CCL11/eotaxin-1 in asthmatic HBEC and enhanced CCL11/eotaxin-1 secretion in asthmatic HASMC; 3) Rhinovirus-induced asthma exacerbations in children are associated with in vivo airway secretion of TSLP and CCL11/eotaxin-1.", {"entities": [[308, 314, "DISEASE"], [104, 108, "GENE"], [134, 138, "GENE"], [389, 393, "GENE"], [104, 108, "GENE"], [134, 138, "GENE"], [389, 393, "GENE"], [104, 108, "GENE"], [134, 138, "GENE"], [389, 393, "GENE"]]}], ["There are virally-induced TSLP-driven secretory immune responses at both sides of the bronchial epithelial barrier characterized by enhanced CCL11/eotaxin-1 secretion in asthmatic airways.", {"entities": []}], ["These results suggest a new model of TSLP-mediated eosinophilic responses in the asthmatic airway during viral-induced exacerbations.", {"entities": []}], ["Asthma is a heterogeneous disease whose etiology is poorly understood but is likely to involve innate responses to inhaled microbial components that are found in allergens.", {"entities": [[0, 6, "DISEASE"]]}], ["The influence of these components on pulmonary inflammation has been largely studied in the context of individual agonists, despite knowledge that they can have synergistic effects when used in combination.", {"entities": []}], ["Here we have explored the effects of LPS and \u03b2-glucan, two commonly-encountered microbial agonists, on the pathogenesis of allergic and non-allergic respiratory responses to house dust mite allergen.", {"entities": []}], ["Notably, sensitization with these microbial components in combination acted synergistically to promote robust neutrophilic inflammation, which involved both Dectin-1 and TLR-4.", {"entities": []}], ["This pulmonary neutrophilic inflammation was corticosteroid-refractory, resembling that found in patients with severe asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["Thus our results provide key new insights into how microbial components influence the development of respiratory pathology.", {"entities": []}], ["Lung T lymphocytes are important in pulmonary immunity and inflammation.", {"entities": []}], ["It has been difficult to study these cells due to contamination with other cell types, mainly alveolar macrophages.", {"entities": []}], ["We have developed a novel method for isolating lung T cells from lung resection tissue, using a combination of approaches.", {"entities": []}], ["Firstly the lung tissue was finely chopped and filtered through a nylon mesh.", {"entities": []}], ["Lymphocytic cells were enriched by Percoll density centrifugation and the T cells purified using human CD3 microbeads, resulting in 90.5%\u00a0\u00b1\u00a01.9% ( n \u00a0=\u00a011) pure lymphocytes.", {"entities": []}], ["The T cell yield from the crude cell preparation was 10.8\u00a0\u00b1\u00a02.1% and viability, calculated using propidium iodide (PI) staining and trypan blue, was typically over 95%.", {"entities": []}], ["The purification process did not affect expression of CD69 or CD103, nor was there a difference in the proportion of CD4 and CD8 cells between the starting population and the purified cells.", {"entities": [[54, 58, "GENE"], [117, 120, "GENE"]]}], ["Microarray analysis and real time RT-PCR revealed upregulation of GAPDH and CXCR6 of the lung T cells as compared to blood-derived T cells.", {"entities": [[66, 71, "GENE"], [76, 81, "GENE"]]}], ["This technique highly enriches lung T cells to allow detailed investigation of the biology of these cells.", {"entities": []}], ["The use of complementary and alternative medicines (CAM) and CAM practitioners is common, most frequently for the management of musculoskeletal conditions.", {"entities": []}], ["Knowledge is limited about the use of CAM practitioners by older people, and specifically those with other long term or chronic conditions.", {"entities": []}], ["In 2011 we conducted an Australia wide survey targeting older adults aged over 50\u00a0years (n\u2009=\u20092540).", {"entities": []}], ["Participants were asked to identify their chronic conditions, and from which health professionals they had \u2018received advice or treatment from in the last 3\u00a0months\u2019, including \u2018complementary health practitioners, e.g.", {"entities": []}], ["naturopath\u2019.", {"entities": []}], ["Descriptive analyses were undertaken using SPSS and STATA software.", {"entities": []}], ["Overall, 8.8% of respondents reported seeing a CAM practitioner in the past three months, 12.1% of women and 3.9% of men; the vast majority also consulting medical practitioners in the same period.", {"entities": []}], ["Respondents were more likely to report consulting a CAM practitioner if they had musculoskeletal conditions (osteoporosis, arthritis), pain, or depression/anxiety.", {"entities": [[109, 121, "DISEASE"], [123, 132, "DISEASE"]]}], ["Respondents with diabetes, hypertension and asthma were least likely to report consulting a CAM practitioner.", {"entities": [[27, 39, "DISEASE"], [44, 50, "DISEASE"]]}], ["Those over 80 reported lower use of CAM practitioners than younger respondents.", {"entities": []}], ["CAM practitioner use in a general older population was not associated with the number of chronic conditions reported, or with the socio-economic level of residence of the respondent.", {"entities": []}], ["Substantial numbers of older Australians with chronic conditions seek advice from CAM practitioners, particularly those with pain related conditions, but less often with conditions where there are clear treatment guidelines using conventional medicine, such as with diabetes, hypertension and asthma.", {"entities": [[276, 288, "DISEASE"], [293, 299, "DISEASE"]]}], ["Given the policy emphasis on better coordination of care for people with chronic conditions, these findings point to the importance of communication and integration of health services and suggest that the concept of the \u2018treating team\u2019 needs a broad interpretation.", {"entities": []}], ["Chitooligosaccharides (CHOS) are homo- or heterooligomers of N -acetylglucosamine and D -glucosamine.", {"entities": []}], ["CHOS can be produced using chitin or chitosan as a starting material, using enzymatic conversions, chemical methods or combinations thereof.", {"entities": []}], ["Production of well-defined CHOS-mixtures, or even pure CHOS, is of great interest since these oligosaccharides are thought to have several interesting bioactivities.", {"entities": []}], ["Understanding the mechanisms underlying these bioactivities is of major importance.", {"entities": []}], ["However, so far in-depth knowledge on the mode-of-action of CHOS is scarce, one major reason being that most published studies are done with badly characterized heterogeneous mixtures of CHOS.", {"entities": []}], ["Production of CHOS that are well-defined in terms of length, degree of N -acetylation, and sequence is not straightforward.", {"entities": []}], ["Here we provide an overview of techniques that may be used to produce and characterize reasonably well-defined CHOS fractions.", {"entities": []}], ["We also present possible medical applications of CHOS, including tumor growth inhibition and inhibition of T H 2-induced inflammation in asthma, as well as use as a bone-strengthener in osteoporosis, a vector for gene delivery, an antibacterial agent, an antifungal agent, an anti-malaria agent, or a hemostatic agent in wound-dressings.", {"entities": [[281, 288, "DISEASE"], [186, 198, "DISEASE"], [137, 143, "DISEASE"]]}], ["By using well-defined CHOS-mixtures it will become possible to obtain a better understanding of the mechanisms underlying these bioactivities.", {"entities": []}], ["Tobacco smoke and genetic susceptibility are risk factors for asthma and wheezing.", {"entities": [[62, 68, "DISEASE"]]}], ["The aim of this study was to investigate whether there is a combined effect of interleukin-13 gene ( IL13 ) polymorphisms and tobacco smoke on persistent childhood wheezing and asthma.", {"entities": [[177, 183, "DISEASE"], [101, 105, "GENE"]]}], ["In the Isle of Wight birth cohort (UK, 1989\u20131999), five IL13 single nucleotide polymorphisms (SNPs): rs1800925 (-1112C/T), rs2066960, rs1295686, rs20541 (R130Q) and rs1295685 were genotyped.", {"entities": [[56, 60, "GENE"]]}], ["Parents were asked whether their children had wheezed in the last 12 months at ages 1, 2, 4 and 10 years.", {"entities": []}], ["Children who reported wheeze in the first 4 years of life and also had wheezing at age 10 were classified as early-onset persistent wheeze phenotype; non-wheezers never wheezed up to age 10.", {"entities": []}], ["Persistent asthma was defined as having a diagnosis of asthma both during the first four years of life and at age 10.", {"entities": [[11, 17, "DISEASE"], [55, 61, "DISEASE"]]}], ["Logistic regression methods were used to analyze data on 791 children with complete information.", {"entities": []}], ["Potential confounders were gender, birth weight, duration of breast feeding, and household cat or dog present during pregnancy.", {"entities": []}], ["Maternal smoking during pregnancy was associated with early-onset persistent wheeze (OR 2.93, p < 0.0001); polymorphisms in IL13 were not (OR 1.15, p = 0.60 for the common haplotype pair).", {"entities": [[124, 128, "GENE"]]}], ["However, the effect of maternal smoking during pregnancy was stronger in children with the common IL13 haplotype pair compared to those without it (OR 5.58 and OR 1.29, respectively; p for interaction = 0.014).", {"entities": [[98, 102, "GENE"]]}], ["Single SNP analysis revealed a similar statistical significance for rs20541 ( p for interaction = 0.02).", {"entities": []}], ["Comparable results were observed for persistent childhood asthma ( p for interaction = 0.03).", {"entities": [[58, 64, "DISEASE"]]}], ["This is the first report that shows a combined effect of in utero exposure to smoking and IL13 on asthma phenotypes in childhood.", {"entities": [[98, 104, "DISEASE"], [90, 94, "GENE"]]}], ["The results emphasize that genetic studies need to take environmental exposures into account, since they may explain contradictory findings.", {"entities": []}], ["To determine the vaccination rates in pediatric immunosuppression-dependent inflammatory bowel disease (IBD) and review the safety and efficacy of vaccinations in this population.", {"entities": [[76, 102, "DISEASE"]]}], ["The electronic medical records from October 2009 to December 2015 of patients diagnosed with IBD at 10 years of age or younger and prescribed anti-tumor necrosis factor alpha (anti-TNF-\u03b1) therapy were reviewed for clinical history, medication history, vaccination history, and hepatitis B and varicella titers.", {"entities": [[277, 286, "DISEASE"]]}], ["Literature discussing vaccination response in IBD patients were identified through search of the MEDLINE database and reviewed using the key words \u201cinflammatory bowel disease\u201d, \u201cimmunization\u201d, \u201cvaccination\u201d, \u201cpneumococcal\u201d, \u201cvaricella\u201d, and \u201chepatitis B\u201d.", {"entities": [[148, 174, "DISEASE"], [242, 251, "DISEASE"]]}], ["Non-human and non-English language studies were excluded.", {"entities": []}], ["Search results were reviewed by authors to select articles that addressed safety and efficacy of immunizations in inflammatory bowel disease.", {"entities": [[114, 140, "DISEASE"]]}], ["A total of 51 patients diagnosed with IBD prior to the age of 10 and receiving anti-TNF-\u03b1 therapy were identified.", {"entities": []}], ["Thirty-three percent of patients (17/51) had incomplete or no documentation of vaccinations.", {"entities": []}], ["Sixteen case reports, cohort studies, cross-sectional studies, and randomized trials were determined through review of the literature to describe the safety and efficacy of hepatitis B, pneumococcal, and varicella immunizations in adult and pediatric patients with IBD.", {"entities": [[173, 182, "DISEASE"]]}], ["These studies showed that patients safely tolerated the vaccines without significant adverse effects.", {"entities": []}], ["Importantly, IBD patients receiving immunosuppressive medications, particularly anti-TNF-\u03b1 treatment, have decreased vaccine response compared to controls.", {"entities": []}], ["However, the majority of patients are still able to achieve protective levels of specific antibodies.", {"entities": []}], ["Immunizations have been shown to be well-tolerated and protective immunity can be achieved in patients with IBD requiring immunosuppressive therapy.", {"entities": []}], ["This study was designed to determine the ancestral composition of a multi-ethnic sample collected for studies of drug addictions in New York City and Las Vegas, and to examine the reliability of self-identified ethnicity and three-generation family history data.", {"entities": []}], ["Ancestry biographical scores for seven clusters corresponding to world major geographical regions were obtained using STRUCTURE, based on genotypes of 168 ancestry informative markers (AIMs), for a sample of 1,291 African Americans (AA), European Americans (EA), and Hispanic Americans (HA) along with data from 1,051 HGDP-CEPH \u2018diversity panel\u2019 as a reference.", {"entities": []}], ["Self-identified ethnicity and family history data, obtained in an interview, were accurate in identifying the individual major ancestry in the AA and the EA samples (approximately 99% and 95%, respectively) but were not useful for the HA sample and could not predict the extent of admixture in any group.", {"entities": []}], ["The mean proportions of the combined clusters corresponding to European and Middle Eastern populations in the AA sample, revealed by AIMs analysis, were 0.13.", {"entities": []}], ["The HA subjects, predominantly Puerto Ricans, showed a highly variable hybrid contribution pattern of clusters corresponding to Europe (0.27), Middle East (0.27), Africa (0.20), and Central Asia (0.14).", {"entities": []}], ["The effect of admixture on allele frequencies is demonstrated for two single-nucleotide polymorphisms (118A\u2009>\u2009G, 17\u2009C\u2009>\u2009T) of the mu opioid receptor gene ( OPRM1 ).", {"entities": [[156, 161, "GENE"]]}], ["This study reiterates the importance of AIMs in defining ancestry, especially in admixed populations.", {"entities": []}], ["Asthma exacerbation may require a visit to the emergency room as well as hospitalization and can occasionally be fatal.", {"entities": [[0, 6, "DISEASE"]]}], ["However, there is limited information about the prognostic factors for asthma exacerbation requiring hospitalization, and no methods are available to predict an inpatient\u2019s prognosis.", {"entities": [[71, 77, "DISEASE"]]}], ["We investigated the clinical features and factors affecting in-hospital mortality of patients with asthma exacerbation and generated a nomogram to predict in-hospital death using a national inpatient database in Japan.", {"entities": [[99, 105, "DISEASE"]]}], ["We retrospectively collected data concerning hospitalization of adult patients with asthma exacerbation between July 2010 and March 2013 using the Japanese Diagnosis Procedure Combination database.", {"entities": [[84, 90, "DISEASE"]]}], ["We recorded patient characteristics and performed Cox proportional hazards regression analysis to assess the factors associated with all-cause in-hospital mortality.", {"entities": []}], ["Then, we constructed a nomogram to predict in-hospital death.", {"entities": []}], ["A total of 19,684 patients with asthma exacerbation were identified; their mean age was 58.8\u00a0years (standard deviation, 19.7\u00a0years) and median length of hospital stay was 8\u00a0days (interquartile range, 5\u201312\u00a0days).", {"entities": [[32, 38, "DISEASE"]]}], ["Among study patients, 118 died in the hospital (0.6%).", {"entities": []}], ["Factors associated with higher in-hospital mortality included older age, male sex, reduced level of consciousness, pneumonia, and heart failure.", {"entities": [[115, 124, "DISEASE"]]}], ["A nomogram was generated to predict the in-hospital death based on the existence of seven variables at admission.", {"entities": []}], ["The nomogram allowed us to estimate the probability of in-hospital death, and the calibration plot based on these results was well fitted to predict the in-hospital prognosis.", {"entities": []}], ["Our nomogram allows physicians to predict individual risk of in-hospital death in patients with asthma exacerbation.", {"entities": [[96, 102, "DISEASE"]]}], ["T cell recruitment to elicit contact sensitivity (CS) requires a CS-initiating process mediated by B-1 cells that produce IgM, which activates complement to promote T cell passage into the tissues.", {"entities": [[50, 52, "GENE"], [65, 67, "GENE"]]}], ["We now show that V\u03b114i NKT cells induce B-1 cell activation likely by releasing IL-4 early postimmunization.", {"entities": []}], ["The CS initiation process is absent in J\u03b118", {"entities": [[4, 6, "GENE"]]}], ["The serotonin transporter (SERT) gene-linked polymorphic region (5-HTTLPR) has been implicated in moderating the link between life stress and depression.", {"entities": []}], ["However, respective molecular pathways of gene\u2013environment (GxE) interaction are largely unknown.", {"entities": []}], ["Sustained alterations in SERT gene expression profiles, possibly mediated by epigenetic modifications, are a frequent correlate of depression and may thus constitute a putative mediator of GxE interaction.", {"entities": []}], ["Here, we aimed to investigate joint effects of 5-HTTLPR and self-reported environmental adversity throughout the lifespan (prenatal, early and recent stress/trauma) on in vivo SERT mRNA expression in peripheral blood cells.", {"entities": []}], ["To further evaluate whether environmentally induced changes in SERT expression are mediated by epigenetic modifications, we analyzed 83 CpG sites within a 799-bp promoter-associated CpG island of the SERT gene using the highly sensitive method of bisulfite pyrosequencing.", {"entities": []}], ["Participants were 133 healthy young adults.", {"entities": []}], ["Our findings show that both the 5-HTTLPR S allele and maternal prenatal stress/child maltreatment are associated with reduced in vivo SERT mRNA expression in an additive manner.", {"entities": []}], ["Remarkably, individuals carrying both the genetic and the environmental risk factors exhibited 32.8% (prenatal stress) and 56.3% (child maltreatment) lower SERT mRNA levels compared with those without any risk factor.", {"entities": []}], ["Our data further indicated that changes in SERT mRNA levels were unlikely to be mediated by DNA methylation profiles within the SERT CpG island.", {"entities": []}], ["It is thus conceivable that the persistent changes in SERT expression may in turn relate to altered serotonergic functioning and possibly convey differential disease vulnerability associated with 5-HTTLPR and early adversity.", {"entities": []}], ["We assessed the effect of information sources on Ebola-specific knowledge and behavior during the 2014\u20132015 Ebola virus disease outbreak in Sierra Leone.", {"entities": []}], ["We pooled data from 4 population-based knowledge, attitude, and practice surveys (August, October, and December 2014 and July 2015), with a total of 10,604 respondents.", {"entities": []}], ["We created composite variables for exposures (information sources: electronic, print, new media, government, community) and outcomes (knowledge and misconceptions, protective and risk behavior) and tested associations by using logistic regression within multilevel modeling.", {"entities": []}], ["Exposure to information sources was associated with higher knowledge and protective behaviors.", {"entities": []}], ["However, apart from print media, exposure to information sources was also linked to misconceptions and risk behavior, but with weaker associations observed.", {"entities": []}], ["Knowledge and protective behavior were associated with the outbreak level, most strongly after the peak, whereas risk behavior was seen at all levels of the outbreak.", {"entities": []}], ["In future outbreaks, close attention should be paid to dissemination of information.", {"entities": []}], ["A helium-oxygen gas mixture (heliox) has low gas density and low \t\t\t\tturbulence and resistance through narrowed airways.", {"entities": []}], ["The effects of heliox on \t\t\t\tpulmonary mechanics following severe methacholine-induced bronchospasm were \t\t\t\tinvestigated and compared to those of a nitrogen-oxygen gas mixture (nitrox) in \t\t\t\tan innovative pediatric porcine, independent lung, mechanical ventilation \t\t\t\tmodel.", {"entities": []}], ["All of the lungs showed evidence of severe bronchospasm after \t\t\t\tmethacholine challenge.", {"entities": []}], ["Prospective definition of 'heliox response' \t\t\t\twas a 15% or greater improvement in lung function in the lung receiving heliox \t\t\t\tcompared with the matched lung receiving nitrox.", {"entities": []}], ["Seven out of 10 pigs responded \t\t\t\tto heliox therapy with respect to resistance and eight out of 10 pigs responded \t\t\t\tto heliox therapy with respect to compliance and tidal volume ( P \t\t\t\t< 0.03).", {"entities": []}], ["After crossover from nitrox to heliox, eight out of eight lungs \t\t\t\tsignificantly improved with respect to tidal volume, resistance and compliance \t\t\t\t( P < 0.001).", {"entities": []}], ["After crossover from heliox to nitrox all eight lungs \t\t\t\tshowed a significant increase in resistance and a significant decrease in tidal \t\t\t\tvolume ( P < 0.001).", {"entities": []}], ["In a pediatric porcine model of acute, severe methacholine-induced \t\t\t\tbronchospasm and independent lung mechanical ventilation, administration of \t\t\t\theliox improves pulmonary mechanics, gas flow, and ventilation.", {"entities": []}], ["Administration \t\t\t\tof heliox should be considered for support of pediatric patients with acute, \t\t\t\tsevere bronchospasm requiring mechanical ventilation through small artificial \t\t\t\tairways.", {"entities": []}], ["Whether non-communicable diseases (NCDs) are diseases of poverty or affluence in low-and-middle income countries has been vigorously debated.", {"entities": []}], ["Most analyses of NCDs have used self-reported data, which is biased by differential access to healthcare services between groups of different socioeconomic status (SES).", {"entities": []}], ["We sought to compare self-reported diagnoses versus standardised measures of NCD prevalence across SES groups in India.", {"entities": []}], ["We calculated age-adjusted prevalence rates of common NCDs from the Study on Global Ageing and Adult Health, a nationally representative cross-sectional survey.", {"entities": []}], ["We compared self-reported diagnoses to standardized measures of disease for five NCDs.", {"entities": []}], ["We calculated wealth-related and education-related disparities in NCD prevalence by calculating concentration index (C), which ranges from \u22121 to +1 (concentration of disease among lower and higher SES groups, respectively).", {"entities": []}], ["NCD prevalence was higher (range 5.2 to 19.1%) for standardised measures than self-reported diagnoses (range 3.1 to 9.4%).", {"entities": []}], ["Several NCDs were particularly concentrated among higher SES groups according to self-reported diagnoses (C srd ) but were concentrated either among lower SES groups or showed no strong socioeconomic gradient using standardized measures (C sm ): age-standardised wealth-related C: angina C srd 0.02 vs. C sm \u2212 0.17; asthma and lung diseases C srd \u2212 0.05 vs. C sm \u2212 0.04 ( age-standardised education-related C srd 0.04 vs. C sm \u2212 0.05); vision problems C srd 0.07 vs. C sm \u2212 0.05; depression C srd 0.07 vs. C sm \u2212 0.13 .", {"entities": [[316, 322, "DISEASE"]]}], ["Indicating similar trends of standardized measures detecting more cases among low SES, concentration of hypertension declined among higher SES (C srd 0.19 vs. C sm 0.03).", {"entities": [[104, 116, "DISEASE"]]}], ["The socio-economic patterning of NCD prevalence differs markedly when assessed by standardized criteria versus self-reported diagnoses.", {"entities": []}], ["NCDs in India are not necessarily diseases of affluence but also of poverty, indicating likely under-diagnosis and under-reporting of diseases among the poor.", {"entities": []}], ["Standardized measures should be used, wherever feasible, to estimate the true prevalence of NCDs.", {"entities": []}], ["This study was undertaken to assess the potential impact of maternal exposures to polychlorinated biphenyl (PCB), dichlorodiphenyl dichloroethylene (DDE) and methylmercury on the secondary sex ratios (the ratio of male to female live births) over a span of 23\u00a0years.", {"entities": []}], ["The study includes prospective data from three Faroese birth cohorts, with a total of 2,152 healthy mother\u2013child dyads recruited between 1986 and 2009.", {"entities": []}], ["The Faroe Islands is a subarctic fishing community, where pilot whale meat and blubber are part of the traditional marine diet.", {"entities": []}], ["Exposures were measured in maternal hair, serum or umbilical cord blood.", {"entities": []}], ["Confounder adjusted logistic regression models were used to assess the associations between maternal exposures and the secondary sex ratio.", {"entities": []}], ["A doubling in \u03a3PCB, p,p\u2019 -DDE and mercury concentrations were associated with increased odds by 8% (95% CI = 0\u201316%), 7% (95% CI = 0\u201314%) and 9% (95% CI = 2\u201317%), respectively, of giving birth to a boy.", {"entities": []}], ["In conclusion, maternal exposure to \u03a3PCB, DDE and methylmercury was associated with a slightly increased secondary sex ratio.", {"entities": []}], ["The impact of paternal exposures could not be taken into account and deserves attention.", {"entities": []}], ["The Near-Road Exposures and Effects of Urban Air Pollutants Study (NEXUS) investigated the impact of exposure to traffic-related air pollution on the respiratory health of asthmatic children in Detroit, Michigan.", {"entities": []}], ["Since indoor mold exposure may also contribute to asthma, floor dust samples were collected in participants homes ( n = 112) to assess mold contamination using the Environmental Relative Moldiness Index (ERMI).", {"entities": [[50, 56, "DISEASE"]]}], ["The repeatability of the ERMI over time, as well as ERMI differences between rooms and dust collection methods, was evaluated for insights into the application of the ERMI metric.", {"entities": []}], ["ERMI values for the standard settled floor dust samples had a mean \u00b1 standard deviation of 14.5 \u00b1 7.9, indicating high levels of mold contamination.", {"entities": []}], ["ERMI values for samples collected from the same home 1 to 7 months apart ( n = 52) were consistent and without systematic bias.", {"entities": []}], ["ERMI values for separate bedroom and living room samples were highly correlated ( r = 0.69, n = 66).", {"entities": []}], ["Vacuum bag dust ERMI values were lower than for floor dust but correlated ( r = 0.58, n = 28).", {"entities": []}], ["These results support the use of the ERMI to evaluate residential mold exposure as a confounder in air pollution health effects studies.", {"entities": []}], ["Patients with respiratory diseases, such as chronic obstructive pulmonary disease (COPD), may have swallowing dysfunction.", {"entities": [[44, 81, "DISEASE"]]}], ["The aim of this investigation was to evaluate the oral and pharyngeal phases of swallowing in patients with COPD.", {"entities": []}], ["We studied 16 patients with clinical manifestations and pulmonary function tests diagnosis of COPD (mean age: 68 years) and 15 nonsmoking healthy volunteers (mean age: 65 years) with normal pulmonary function tests.", {"entities": []}], ["All subjects were submitted to clinical and videofluoroscopic evaluation of swallowing.", {"entities": []}], ["Each subject performed in duplicate swallows of 5 mL and 10 mL of liquid bolus, paste bolus, and a solid bolus.", {"entities": []}], ["In general, the duration of the events of the pharyngeal phase of swallowing was longer in COPD patients than controls.", {"entities": []}], ["The difference was significant in the laryngeal vestibular closure, hyoid movement, and pharyngeal transit with swallows of both volumes of liquid bolus; in oral\u2013pharyngeal transit with 5 mL paste bolus; and in pharyngeal and oral\u2013pharyngeal transit with solid bolus.", {"entities": []}], ["The difference between the duration of maximal laryngeal elevation and the duration of pharyngeal transit was higher in control subjects than in patients with COPD.", {"entities": []}], ["The results suggested that patients with COPD have a longer pharyngeal swallowing phase than normal subjects, which is associated with a decrease in the difference between the duration of maximal laryngeal elevation and the duration of pharyngeal transit.", {"entities": []}], ["Interleukin 4 (IL-4) induces B-cell differentiation and survival of chronic lymphocytic leukemia (CLL) cells.", {"entities": [[68, 96, "DISEASE"], [88, 96, "DISEASE"]]}], ["MicroRNAs (miRNAs) regulate mRNA and protein expression, and several miRNAs, deregulated in CLL, might play roles as oncogenes or tumor suppressors.", {"entities": []}], ["We have studied the miRNA profile of CLL, and its response to IL-4, by oligonucleotide microarrays, resulting in the detection of a set of 129 mature miRNAs consistently expressed in CLL, which included 41 differentially expressed compared to normal B cells (NBC), and 6 significantly underexpressed in ZAP-70 positive patients.", {"entities": []}], ["IL-4 stimulation brought about up-regulation of the 5p and 3p mature variants of the miR-21 gene, which maps immediately downstream to the VMP1 gene, and of the mature forms generated from the miR-362 (3p and 5p), miR-500a (3p), miR-502 (3p), and miR-532 (3p and 5p) genes, which map within the third intron of the CLCN5 gene.", {"entities": [[85, 91, "GENE"], [315, 320, "GENE"]]}], ["Both genes are in turn regulated by IL-4, suggesting that these miRNAs were regulated by IL-4 as passengers from their carrier genes.", {"entities": []}], ["Their levels of up-regulation by IL-4 significantly correlated with cytoprotection.", {"entities": []}], ["MiR-21 has been reported to be leukemogenic, associated to bad prognosis in CLL, and the miRNA more frequently overexpressed in human cancer.", {"entities": [[134, 140, "DISEASE"], [0, 6, "GENE"]]}], ["Up-regulation by IL-4 of miR-21 and the miRNAs hosted in the CLCN5 locus may contribute to evasion of apoptosis of CLL cells.", {"entities": [[25, 31, "GENE"], [61, 66, "GENE"]]}], ["These findings indicate that the IL-4 pathway and the miRNAs induced by IL-4 are promising targets for the development of novel therapies in CLL.", {"entities": []}], ["The pleiotropic cytokine interleukin 4 (IL-4) has been shown to regulate many processes thought to be important in the allergic diathesis.", {"entities": []}], ["To determine the mechanism(s) by which IL-4 mediates allergic airway responses to inhaled allergens, we compared the effects of antigen sensitization and challenge on the development of allergic airway responses in mice in which the gene for the signal transducer and activator of transcription factor 6 (Stat6) was disrupted to those of their wild-type littermates.", {"entities": [[305, 310, "GENE"]]}], ["Strikingly, Stat6-deficient mice failed to develop airway hyperresponsiveness (AHR), which was observed in their wild-type littermates after allergen provocation.", {"entities": [[79, 82, "GENE"]]}], ["Moreover, antigen-induced increases in mucus-containing cells were found to be completely Stat6 dependent.", {"entities": [[90, 95, "GENE"]]}], ["Consistent with the lack of Th2 cytokine responses in Stat6-deficient mice, no ovalbumin-specific immunoglobulin (Ig)E was detected in their serum.", {"entities": []}], ["In contrast, Stat6 signaling only partially mediated antigen-induced eosinophilia with no role in vascular adhesion molecule 1 expression.", {"entities": [[69, 81, "DISEASE"], [13, 18, "GENE"]]}], ["These results indicate that Stat6 signal transduction is critical in the development of allergen-induced AHR and that agents that specifically inhibit this pathway may provide a novel strategy for the treatment of allergic disorders.", {"entities": [[28, 33, "GENE"], [105, 108, "GENE"]]}], ["To correlate the serum levels of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule-1 (ICAM-1) with the severity of retinopathy and disruption of the external limiting membrane (ELM) and inner segment-outer segment (IS-OS) junction in type 2 diabetes mellitus (DM).", {"entities": [[269, 286, "DISEASE"], [262, 286, "DISEASE"]]}], ["Study subjects included patients with type 2 DM [diabetes mellitus with no retinopathy (No DR; n=19); non-proliferative diabetic retinopathy (NPDR; n=19); proliferative diabetic retinopathy (PDR; n=20)] and healthy controls (n=19) between the ages of 40 and 65 years.", {"entities": [[120, 140, "DISEASE"], [169, 189, "DISEASE"], [106, 140, "DISEASE"], [155, 189, "DISEASE"], [49, 66, "DISEASE"]]}], ["Disruption of the ELM and the IS-OS junction was graded by spectral domain optical coherence tomography as follows: grade 0\u2014no disruption of ELM and IS-OS junction; grade 1\u2014ELM disrupted, inner segment-outer segment (IS-OS) junction intact; grade 2\u2014both ELM and IS-OS junction disrupted.", {"entities": []}], ["The serum levels of VEGF and ICAM-1were analyzed using the standard protocol.", {"entities": []}], ["A significant difference was found between the serum levels of VEGF and ICAM-1 and the various study groups (p<0.001).", {"entities": []}], ["A positive correlation was found between the grade of disruption and the levels of VEGF (r=0.45, p<0.0001) and ICAM-1 (r=0.40, p=0.0003).", {"entities": []}], ["A significant positive correlation was found between logMAR visual acuity and grade of disruption (r=0.85, p<0.0001).", {"entities": []}], ["An increase in serum VEGF and ICAM-1 levels is associated with an increase in the severity of diabetic retinopathy and the grade of ELM and IS-OS junction disruption.", {"entities": [[94, 114, "DISEASE"]]}], ["Please cite this paper as: Burns et\u00a0al.", {"entities": []}], ["(2011) Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings.", {"entities": [[44, 59, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(3), 218\u2013223.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Viral detection from different respiratory sample types in children with cystic fibrosis (CF) is facilitated by available molecular methods, but optimum sampling strategies have not been identified.", {"entities": [[85, 100, "DISEASE"]]}], ["In addition, associations between viral detection and respiratory symptoms are not well described.", {"entities": []}], ["Objectives\u2002 Study goals were to compare molecular detection of viruses from concurrent upper airway and sputum samples in children with CF and to describe relative frequency of respiratory viral infections and identify potential clinical associations.", {"entities": []}], ["Methods\u2002 We conducted a 2\u2010year prospective surveillance study in 44 children with CF aged 6\u201318\u2003years.", {"entities": []}], ["Upper airway and sputum samples were collected quarterly and during pulmonary exacerbations and tested for respiratory syncytial virus (RSV), influenza viruses, parainfluenza viruses types 1\u20134, human metapneumovirus, coronaviruses, rhinoviruses, and adenoviruses.", {"entities": [[142, 151, "DISEASE"]]}], ["Physical exams and symptom surveys were used to identify respiratory signs and symptoms.", {"entities": []}], ["Results\u2002 Upper airway samples were collected at 359 visits; concordance of PCR\u2010based viral detection was examined in a subset of paired upper airway and sputum samples from 21 participants at 92 visits.", {"entities": []}], ["Rhinovirus was the most commonly detected virus (23\u00b71% overall), and rhinovirus detection was the same for both sample types (21\u00b77% each).", {"entities": []}], ["Sensitivity and specificity for the detection of rhinovirus in sputum relative to upper airway sampling were 70% and 91\u00b77%, respectively.", {"entities": []}], ["Respiratory symptoms associated with rhinovirus detection included increased cough, increased nasal congestion, increased sputum production, and wheezing.", {"entities": []}], ["Conclusions\u2002 A relatively high frequency of rhinovirus detection was observed by either upper airway or sputum samples, and clinical findings suggest a significant\u2010associated symptom burden.", {"entities": []}], ["Glucocorticoid resistance (GCR), i .", {"entities": []}], ["unresponsiveness to the beneficial anti-inflammatory activities of the glucocorticoid receptor (GR), poses a serious problem in the treatment of inflammatory diseases.", {"entities": []}], ["One possible solution to try and overcome GCR, is to identify molecules that prevent or revert GCR by hyper-stimulating the biological activity of the GR.", {"entities": []}], ["To this purpose, we screened for compounds that potentiate the dexamethasone (Dex)-induced transcriptional activity of GR.", {"entities": []}], ["To monitor GR transcriptional activity, the screen was performed using the lung epithelial cell line A549 in which a glucocorticoid responsive element (GRE) coupled to a luciferase reporter gene construct was stably integrated.", {"entities": []}], ["Histone deacetylase inhibitors (HDACi) such as Vorinostat and Belinostat are two broad-spectrum HDACi that strongly increased the Dex-induced luciferase expression in our screening system.", {"entities": []}], ["In sharp contrast herewith, results from a genome-wide transcriptome analysis of Dex-induced transcripts using RNAseq, revealed that Belinostat impairs the ability of GR to transactivate target genes.", {"entities": []}], ["The stimulatory effect of Belinostat in the luciferase screen further depends on the nature of the reporter construct.", {"entities": []}], ["In conclusion, a profound discrepancy was observed between HDACi effects on two different synthetic promoter-luciferase reporter systems.", {"entities": []}], ["The favorable effect of HDACi on gene expression should be evaluated with care, when considering them as potential therapeutic agents.", {"entities": []}], ["GEO accession number GSE96649.", {"entities": []}], ["Indoor mold growth has recently become a concern in the legal world in regards to insurance litigation.", {"entities": []}], ["Hazardous mold exposure to humans has been linked to many acute and chronic adverse health effects including death.", {"entities": []}], ["As it grows, mold produces several types of primary and secondary metabolites, including microbial volatile organic compounds (MVOCs).", {"entities": []}], ["Microbial volatile organic compound emission may be used as a preliminary indication of a mold infestation that is invisible to the unaided eye.", {"entities": []}], ["The objective of the study is to identify the unique odor signatures of three species of molds, Aspergillus versicolor , Penicillium chrysogenum , and Stachybotrys chartarum by SPME-GC/MS analysis.", {"entities": []}], ["Determining the compounds that are emitted by the selected species has made it possible to conduct validation studies of canine detection of these mold species through a series of field tests.", {"entities": []}], ["Chronic neutrophilic inflammation is a poorly understood feature in a variety of diseases with notable worldwide morbidity and mortality.", {"entities": []}], ["We have recently characterized N-acetyl Pro-Gly-Pro (Ac-PGP) as an important neutrophil (PMN) chemoattractant in chronic inflammation generated from the breakdown of collagen by the actions of MMP-9.", {"entities": []}], ["MMP-9 is present in the granules of PMNs and is differentially released during inflammation but whether Ac-PGP contributes to this ongoing proteolytic activity in chronic neutrophilic inflammation is currently unknown.", {"entities": []}], ["Utilizing isolated primary blood PMNs from human donors, we found that Ac-PGP induces significant release of MMP-9 and concurrently activates the ERK1/2 MAPK pathway.", {"entities": []}], ["This MMP-9 release is attenuated by an inhibitor of ERK1/2 MAPK and upstream blockade of CXCR1 and CXCR2 receptors with repertaxin leads to decreased MMP-9 release and ERK 1/2 MAPK activation.", {"entities": [[89, 94, "GENE"], [99, 104, "GENE"]]}], ["Supernatants obtained from PMNs stimulated by Ac-PGP generate more Ac-PGP when incubated with intact collagen ex vivo ; this effect is inhibited by an ERK1/2 pathway inhibitor.", {"entities": []}], ["Finally, clinical samples from individuals with CF demonstrate a notable correlation between Ac-PGP (as measured by liquid chromatography-tandem mass spectrometry) and MMP-9 levels even when accounting for total PMN burden.", {"entities": []}], ["These data indicate that ECM-derived Ac-PGP could result in a feed-forward cycle by releasing MMP-9 from activated PMNs through the ligation of CXCR1 and CXCR2 and subsequent activation of the ERK1/2 MAPK, highlighting for the first time a matrix-derived chemokine (matrikine) augmenting its generation through a discrete receptor/intracellular signaling pathway.", {"entities": [[144, 149, "GENE"], [154, 159, "GENE"]]}], ["These findings have notable implications to the development unrelenting chronic PMN inflammation in human disease.", {"entities": []}], ["Extravasation and luminal entry of plasma occurs continuously in the nose.", {"entities": []}], ["This process is markedly facilitated in patients with symptomatic allergic rhinitis, resulting in an increased secretion of proteins.", {"entities": [[66, 83, "DISEASE"], [75, 83, "DISEASE"]]}], ["Identification of these proteins is an important step in the understanding of the pathological mechanisms in allergic diseases.", {"entities": []}], ["DNA microarrays have recently made it possible to compare mRNA profiles of lavage fluids from healthy and diseased patients, whereas information on the protein level is still lacking.", {"entities": []}], ["Nasal lavage fluid was collected from 11 patients with symptomatic allergic rhinitis and 11 healthy volunteers.", {"entities": [[67, 84, "DISEASE"], [76, 84, "DISEASE"]]}], ["2-dimensional gel electrophoresis was used to separate proteins in the lavage fluids.", {"entities": []}], ["Protein spots were picked from the gels and identified using mass spectrometry and database search.", {"entities": []}], ["Selected proteins were confirmed with western blot.", {"entities": []}], ["61 spots were identified, of which 21 were separate proteins.", {"entities": []}], ["6 of these proteins (psoriasin, galectin-3, alpha enolase, intersectin-2, Wnt-2B and hypothetical protein MGC33648) had not previously been described in nasal lavage fluids.", {"entities": []}], ["The levels of psoriasin were markedly down-regulated in allergic individuals.", {"entities": []}], ["Prolactin-inducible protein was also found to be down-regulated, whereas different fragments of albumin together with Ig gamma 2 chain c region, transthyretin and splice isoform 1 of Wnt-2B were up-regulated among the allergic patients.", {"entities": []}], ["The identification of proteins in nasal lavage fluid with 2-dimensional gelelectrophoresis in combination with mass spectrometry is a novel tool to profile protein expression in allergic rhinitis and it might prove useful in the hunt for new therapeutic targets or diagnostic markers for allergic diseases.", {"entities": [[178, 195, "DISEASE"], [187, 195, "DISEASE"]]}], ["Psoriasin is a potent chemotactic factor and its down-regulation during inflammation might be of importance for the outcome of the disease.", {"entities": []}], ["Previous genetic analysis has shown that a deletion in the complement component 5 gene-coding region renders mice more susceptible to allergen-induced airway hyperresponsiveness (AHR) due to reduced IL-12 production.", {"entities": [[179, 182, "GENE"]]}], ["We investigated the role of complement in a murine model of asthma-like pulmonary inflammation.", {"entities": [[60, 66, "DISEASE"]]}], ["In order to evaluate the role of complement B10 mice either sufficient or deficient in C5 were studied.", {"entities": [[87, 89, "GENE"]]}], ["Both groups of mice immunized and challenged with a house dust extract (HDE) containing high levels of cockroach allergens.", {"entities": []}], ["Airways hyper-reactivity was determined with whole-body plesthysmography.", {"entities": []}], ["Bronchoalveolar lavage (BAL) was performed to determine pulmonary cellular recruitment and measure inflammatory mediators.", {"entities": []}], ["Lung homogenates were assayed for mediators and plasma levels of IgE determined.", {"entities": []}], ["Pulmonary histology was also evaluated.", {"entities": []}], ["C5-deficient mice showed enhanced AHR to methylcholine challenge, 474% and 91% increase above baseline Penh in C5-deficient and C5-sufficient mice respectively, p < 0.001.", {"entities": [[34, 37, "GENE"]]}], ["IL-12 levels in the lung homogenate (LH) were only slightly reduced and BAL IL-12 was comparable in C5-sufficient and C5-deficient mice.", {"entities": []}], ["However, C5-deficient mice had significantly higher cysteinyl-leukotriene levels in the BAL fluid, 1913 +/- 246 pg/ml in C5d and 756 +/- 232 pg/ml in C5-sufficient, p = 0.003.", {"entities": []}], ["These data demonstrate that C5-deficient mice show enhanced AHR due to increased production of cysteinyl-leukotrienes.", {"entities": [[60, 63, "GENE"]]}], ["Non-communicable diseases (NCDs) disproportionately affect low- and lower-middle income countries (LLMICs) where 80% of global NCD related deaths occur.", {"entities": []}], ["LLMICs are the primary focus of interventions to address development and poverty indicators.", {"entities": []}], ["We aimed to synthesise the evidence of these interventions' impact on the four primary NCDs (cardiovascular disease, diabetes, chronic respiratory disease and cancer) and their common behavioural risk factors (unhealthy diets, physical inactivity, tobacco and alcohol use).", {"entities": [[159, 165, "DISEASE"]]}], ["We systematically searched four online databases (Medline, Embase, Web of Science and Global Health) for primary research conducted in LLMICS, published between January 1st 1990 and February 15th 2016.", {"entities": []}], ["Studies involved development or poverty interventions which reported on outcomes relating to NCDs.", {"entities": []}], ["We extracted summary level data on study design, population, health outcomes and potential confounders.", {"entities": []}], ["From 6383 search results, 29 studies from 24 LLMICs published between 1999 and 2015 met our inclusion criteria.", {"entities": []}], ["The quality of included studies was limited and heterogeneity of outcome measures required narrative synthesis.", {"entities": []}], ["One study measured impact on NCD prevalence, one physical activity and 27 dietary components.", {"entities": []}], ["The majority of papers (23), involved agricultural interventions.", {"entities": []}], ["Primary outcome measures tended to focus on undernutrition.", {"entities": []}], ["Intensive agricultural interventions were associated with improved calorie, vitamin, fruit and vegetable intake.", {"entities": []}], ["However, positive impacts were reliant on participant's land ownership, infection status and limited in generalisability.", {"entities": []}], ["Just three studies measured adult obesity; two indicated increased income and consequential food affordability had the potential to increase obesity.", {"entities": [[34, 41, "DISEASE"], [141, 148, "DISEASE"]]}], ["Overall, there was poor alignment between included studies outcome measures and the key policy options and objectives of the Global Action Plan on NCDs.", {"entities": []}], ["Though many interventions addressing poverty and development have great potential to impact on NCD prevalence and risk, most fail to measure or report these outcomes.", {"entities": []}], ["Current evidence is limited to behavioural risk factors, namely diet and suggests a positive impact of agricultural-based food security programmes on dietary indicators.", {"entities": []}], ["However, studies investigating the impact of improved income on obesity tend to show an increased risk.", {"entities": [[64, 71, "DISEASE"]]}], ["Embedding NCD impact evaluation into development programmes is crucial in the context of the Sustainable Development Goals and the rapid epidemiological transitions facing LLMICs.", {"entities": []}], ["Epidemiological studies have suggested that the recent increase in the incidence and severity of immunoglobulin (Ig)E-mediated allergic disorders is inversely correlated with Mycobacterium bovis bacillus Calmette Guerin (BCG) vaccination; however, the underlying mechanisms remain uncertain.", {"entities": []}], ["Here, we demonstrate that natural killer T (NKT) cells in mice and humans play a crucial role in the BCG-induced suppression of IgE responses.", {"entities": []}], ["BCG-activated murine V\u03b114 NKT cells, but not conventional CD4 T cells, selectively express high levels of interleukin (IL)-21, which preferentially induces apoptosis in B\u025b cells.", {"entities": [[58, 61, "GENE"]]}], ["Signaling from the IL-21 receptor increases the formation of a complex between Bcl-2 and the proapoptotic molecule Bcl-2\u2013modifying factor, resulting in B\u025b cell apoptosis.", {"entities": []}], ["Similarly, BCG vaccination induces IL-21 expression by human peripheral blood mononuclear cells (PBMCs) in a partially NKT cell\u2013dependent fashion.", {"entities": []}], ["BCG-activated PBMCs significantly reduce IgE production by human B cells.", {"entities": []}], ["These findings provide new insight into the therapeutic effect of BCG in allergic diseases.", {"entities": []}], ["Epidemiological studies of health effects of long-term exposure to outdoor air pollution rely on different exposure assessment methods.", {"entities": []}], ["This review discusses widely used methods with a special focus on new developments.", {"entities": []}], ["New data and study designs have been applied, including satellite measurements of fine particles and nitrogen dioxide (NO 2 ).", {"entities": []}], ["The methods to apply satellite data for epidemiological studies are improving rapidly and have already contributed significantly to national-, continental- and global-scale models.", {"entities": []}], ["Spatiotemporal models have been developed allowing more detailed temporal resolution compared to spatial models.", {"entities": []}], ["The development of hybrid models combining dispersion models, satellite observations, land use and surface monitoring has improved models substantially.", {"entities": []}], ["Mobile monitoring designs to develop models for long-term UFP exposure have been conducted.", {"entities": []}], ["Methods to assess long-term exposure to outdoor air pollution have improved significantly over the past decade.", {"entities": []}], ["Application of satellite data and mobile monitoring designs is promising new methods.", {"entities": []}], ["This study aims to investigate the association between prenatal exposure to terbutaline and other \u03b22 adrenergic receptor (B2AR) agonists and autism spectrum disorders (ASDs).", {"entities": []}], ["The methodology used is a case\u2013control study among children born from 1995 to 1999 at Kaiser Permanente Northern California hospitals.", {"entities": []}], ["Cases ( n \u2009=\u2009291) were children with an ASD diagnosis; controls ( n \u2009=\u2009284) were children without ASDs, randomly sampled and frequency-matched to cases on sex, birth year, and delivery hospital.", {"entities": []}], ["Exposure to B2AR agonists during 30\u00a0days prior to conception and each trimester of pregnancy was ascertained from prenatal medical records and health plan databases.", {"entities": []}], ["The frequency of exposure to any B2AR agonist during pregnancy was similar for mothers of children with ASD and mothers of controls (18.9% vs. 14.8%, P \u2009=\u20090.19).", {"entities": []}], ["Exposure to B2AR agonists other than terbutaline was not associated with an increased risk for ASDs.", {"entities": []}], ["However, terbutaline exposure for >2\u00a0days during the third trimester was associated with more than a fourfold increased risk for ASDs independent of indication although the limited sample size resulted in an imprecise and nonsignificant effect estimate (OR adj \u2009=\u20094.4; 95% confidence interval, 0.8\u201324.6).", {"entities": []}], ["This analysis does not offer evidence linking B2AR exposure in pregnancy with autism risk.", {"entities": []}], ["However, exposure to terbutaline during the third trimester for >2\u00a0days may be associated with an increased risk of autism.", {"entities": []}], ["Should this result be confirmed in larger samples, it would point to late pregnancy as an etiologic window of interest in autism risk factor research.", {"entities": []}], ["Globally, noncommunicable chronic diseases such as Type-2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD) are posing a major threat to the world.", {"entities": []}], ["T2DM is known to potentiate CAD which had led to the coining of a new clinical entity named diabetic CAD (DM-CAD), leading to excessive morbidity and mortality.", {"entities": []}], ["The synergistic interaction between these two comorbidities is through sterile inflammation which is now being addressed as metabolic inflammation or metainflammation, which plays a pivotal role during both early and late stages of T2DM and also serves as a link between T2DM and CAD.", {"entities": []}], ["This review summarises the current concepts on the role played by both innate and adaptive immune responses in setting up metainflammation in DM-CAD.", {"entities": []}], ["More specifically, the role played by innate pattern recognition receptors (PRRs) like Toll-like receptors (TLRs), NOD1-like receptors (NLRs), Rig-1-like receptors (RLRs), and C-type lectin like receptors (CLRs) and metabolic endotoxemia in fuelling metainflammation in DM-CAD would be discussed.", {"entities": []}], ["Further, the role played by adaptive immune cells (Th1, Th2, Th17, and Th9 cells) in fuelling metainflammation in DM-CAD will also be discussed.", {"entities": []}], ["Rhaponticum carthamoides has a long tradition of use in Siberian folk medicine.", {"entities": []}], ["The roots and rhizomes of this species are used in various dietary supplements or nutraceutical preparations to increase energy level or eliminate physical weakness.", {"entities": []}], ["This is the first report to reveal the protective and DNA repair stimulating abilities of R. carthamoides root extracts in Chinese hamster ovary (CHO) cells exposed to an oxidative agent.", {"entities": []}], ["Both transformed root extract (TR extract) and extract of soil-grown plant roots (NR extract) may be responsible for stimulating CHO cells to repair oxidatively induced DNA damage, but CHO cells stimulated with extract from the transformed roots demonstrated significantly stronger properties than cells treated with the soil-grown plant root extract.", {"entities": []}], ["These differences in biological activity may be attributed to the differences in the content of phenolic compounds in these root extracts.", {"entities": []}], ["Preincubation of the CHO cells with TR and NR extracts showed an increase in gene expression and protein levels of catalase ( CAT ) and superoxide dismutase ( SOD2) .", {"entities": [[159, 163, "GENE"]]}], ["R. carthamoides may possess antioxidant properties that protect CHO cells against oxidative stress.", {"entities": []}], ["Shah Ebrahim and colleagues argue that more research on non-communicable diseases (NCDs) in both high-income countries and low- and middle-income countries can result in mutual benefits and will help better address the growing burden of NCDs.", {"entities": []}], ["The selective enzyme inhibitors genistein and Ro 31-8220 were used to assess the importance of protein tyrosine kinase (PTK) and protein kinase C (PKC), respectively, in N-formyl-methionyl-leucyl-phenylalanine (FMLP) induced generation of superoxide anion and thromboxane B 2 (TXB 2 ) in guinea-pig alveolar macrophages (AM).", {"entities": []}], ["Genistein (3\u2013100 \u03bcM) dose dependently inhibited FMLP (3 nM) induced superoxide generation in non-primed AM and TXB 2 release in non-primed or in lipopolysaccharide (LPS) (10 ng/ml) primed AM to a level > 80% but had litle effect up to 100 \u03bcM on phorbol myristate acetate (PMA) (10 nM) induced superoxide release.", {"entities": []}], ["Ro 31-8220 inhibited PMA induced superoxide generation (IC 50 0.21 \u00b1 0.10 \u03bcM) but had no effect on or potentiated (at 3 and 10 \u03bcM) FMLP responses in non-primed AM.", {"entities": []}], ["In contrast, when present during LPS priming as well as during FMLP challenge Ro 31-8220 (10 \u03bcM) inhibited primed TXB 2 release by > 80%.", {"entities": []}], ["The results indicate that PTK activation is required for the generation of these inflammatory mediators by FMLP in AM.", {"entities": []}], ["PKC activation appears to be required for LPS priming but not for transducing the FMLP signal; rather, PKC activation may modulate the signal by a negative feedback mechanism.", {"entities": []}], ["The use of oral corticosteroids as treatment of COPD exacerbations in primary care is well established and evidence-based.", {"entities": []}], ["However, the most appropriate dosage regimen has not been determined and remains controversial.", {"entities": []}], ["Corticosteroid therapy is associated with a number of undesirable side effects, including hyperglycaemias, so differences in prescribing might be relevant.", {"entities": []}], ["This study examines the differences between GPs in dosage and duration of prednisolone treatment in patients with a COPD exacerbation.", {"entities": []}], ["It also investigates the number of general practitioners (GPs) who adjust their treatment according to the presence of diabetic co-morbidity.", {"entities": []}], ["Cross-sectional study among 219 GPs and 25 GPs in training, located in the Northern part of the Netherlands.", {"entities": []}], ["The response rate was 69%.", {"entities": []}], ["Nearly every GP prescribed a continuous dose of prednisolone 30 mg per day.", {"entities": []}], ["Among GPs there were substantial differences in treatment duration.", {"entities": []}], ["GPs prescribed courses of five, seven, ten, or fourteen days.", {"entities": []}], ["A course of seven days was most common.", {"entities": []}], ["The duration of treatment depended on exacerbation and disease severity.", {"entities": []}], ["A course of five days was especially prescribed in case of a less severe exacerbation.", {"entities": []}], ["In a more severe exacerbation duration of seven to fourteen days was more common.", {"entities": []}], ["Hardly any GP adjusted treatment to the presence of diabetic co-morbidity.", {"entities": []}], ["Under normal conditions GPs prescribe prednisolone quite uniformly, within the range of the current Dutch guidelines.", {"entities": []}], ["There is insufficient guidance regarding how to adjust corticosteroid treatment to exacerbation severity, disease severity and the presence of diabetic co-morbidity.", {"entities": []}], ["Under these circumstances, there is a substantial variation in treatment duration.", {"entities": []}], ["Hypertensive mice that express the human renin and angiotensinogen genes are used as a model for human hypertension because they develop hypertension secondary to increased renin-angiotensin system activity.", {"entities": [[103, 115, "DISEASE"], [137, 149, "DISEASE"]]}], ["Our study investigated the cellular localization and distribution of COX-1, COX-2, mPGES-1, and mPGES-2 in organ tissues from a mouse model of human hypertension.", {"entities": [[149, 161, "DISEASE"]]}], ["Male ( n = 15) and female ( n = 15) double transgenic mice (h-Ang 204/1 h-Ren 9) were used in the study.", {"entities": []}], ["Lung, kidney, and heart tissues were obtained from mice at necropsy and fixed in 10% neutral buffered formalin followed by embedding in paraffin wax.", {"entities": []}], ["Cut sections were stained immunohistochemically with antibodies to COX-1, COX-2, mPGES-1, and mPGES-2 and analyzed by light microscopy.", {"entities": []}], ["Renal expression of COX-1 was the highest in the distal convoluted tubules, cortical collecting ducts, and medullary collecting ducts; while proximal convoluted tubules lacked COX-1 expression.", {"entities": []}], ["Bronchial and bronchiolar epithelial cells, alveolar macrophages, and cardiac vascular endothelial cells also had strong COX-1 expression, with other renal, pulmonary, or cardiac microanatomic locations having mild-to-moderate expression.", {"entities": []}], ["mPGES-2 expression was strong in the bronchial and bronchiolar epithelial cells, mild to moderate in various renal microanatomic locations, and absent in cardiac tissues.", {"entities": []}], ["COX-2 expression was strong in the proximal and distal convoluted tubules, alveolar macrophages, and bronchial and bronchiolar epithelial cells.", {"entities": []}], ["Marked mPGES-1 was present only in bronchial and bronchiolar epithelial cells; while mild-to-moderate expression was present in other pulmonary, renal, or cardiac microanatomic locations.", {"entities": []}], ["Expression of these molecules was similar between males and females.", {"entities": []}], ["Our work suggests that in hypertensive mice, there are (a) significant microanatomic variations in the pulmonary, renal, and cardiac distribution and cellular localization of COX-1, COX-2, mPGES-1, and mPGES-2, and (b) no differences in expression between genders.", {"entities": []}], ["This study investigates factors affecting older persons' state of loneliness in multiethnic Malaysia using data from the 2004 Malaysian Population and Family Survey, the first nationally representative sample in Malaysia.", {"entities": []}], ["The study sample was extracted to include Malays, Chinese, Indians and other Indigenous groups aged 60 and above, and who had children ( n = 1791).", {"entities": []}], ["Cross tabulations and ordinal logistic regression methods were used in the analysis.", {"entities": []}], ["Among the ethnic groups, older Malays were more likely than their Chinese and Indian counterparts to experience loneliness.", {"entities": []}], ["Loneliness was found to be associated with age, marital status, education level, sources of income, health status, and physical limitations.", {"entities": []}], ["Among older people, feelings of loneliness were inversely related with coresidence with adult children and participation in religious activities.", {"entities": []}], ["Sociodemographic changes have eroded the traditional family support system for the elderly, while social security remains inadequate.", {"entities": []}], ["This study shows the important role of family in alleviating loneliness among older people.", {"entities": []}], ["Hence the need to promote and facilitate coresidence, as well as participation in religious activities, and a healthy lifestyle as a priority strategy is in line with the objectives of the National Policy for the Older People.", {"entities": []}], ["Osteonecrosis of the femoral head (ONFH) is a common hip joint disease, and steroid-induced ONFH accounts for a large number of cases.", {"entities": []}], ["Here, we examined eight previously-identified single-nucleotide polymorphisms (SNPs) in the MPP2 and MPP9 genes of 285 steroid-induced ONFH patients and 507 healthy controls from northern China to determine whether these SNPs were associated with the risk of developing steroid-induced ONFH.", {"entities": [[92, 96, "GENE"]]}], ["Chi-squared tests and genetic model and haplotype analyses were used to evaluate associations.", {"entities": []}], ["The rs2274755 SNP in MMP9 was associated with a decreased risk of steroid-induced ONFH in the allele, dominant, and additive models.", {"entities": [[21, 25, "GENE"]]}], ["Additionally, the \u201cCGC\u201d MMP9 haplotype was associated with a 0.69-fold decrease in the risk of steroid-induced ONFH.", {"entities": [[24, 28, "GENE"]]}], ["Although additional, larger population-based studies are needed to confirm these findings, our results reveal for the first time an association between a MMP9 SNP at the rs2274755 locus and a decreased risk of steroid-induced ONFH in a northern Chinese population.", {"entities": [[154, 158, "GENE"]]}], ["Most people prefer home palliation but die in an institution.", {"entities": []}], ["Some experience decisional conflict when weighing options regarding place of care.", {"entities": []}], ["Clinicians can identify patients' decisional needs and provide decision support, yet generally lack skills and confidence in doing so.", {"entities": []}], ["This study aims to determine whether the quality of clinicians' decision support can be improved with a brief, theory-based, skills-building intervention.", {"entities": []}], ["The Ottawa Decision Support Framework (ODSF) guides an evidence based, practical approach to assist clinicians in providing high-quality decision support.", {"entities": []}], ["The ODSF proposes that decisional needs [personal uncertainty, knowledge, values clarity, support, personal characteristics] strongly influence the quality of decisions patients make.", {"entities": []}], ["Clinicians can improve decision quality by providing decision support to address decisional needs [clarify decisional needs, provide facts and probabilities, clarify values, support/guide deliberation, monitor/facilitate progress].", {"entities": []}], ["The efficacy of a brief education intervention will be assessed in a two-phase study.", {"entities": []}], ["In phase one a focused needs assessment will be conducted with key informants.", {"entities": []}], ["Phase two is a randomized control trial where clinicians will be randomly allocated to an intervention or control group.", {"entities": []}], ["The intervention, informed by the needs assessment, knowledge transfer best practices and the ODSF, comprises an online tutorial; an interactive skills building workshop; a decision support protocol; performance feedback, and educational outreach.", {"entities": []}], ["Participants will be assessed: a) at baseline (quality of decision support); b) after the tutorial (knowledge); and c) four weeks after the other interventions (quality of decision support, intention to incorporate decision support into practice and perceived usefulness of intervention components).", {"entities": []}], ["Between group differences in the primary outcome (quality of decision support scores) will be analyzed using ANOVA.", {"entities": []}], ["Few studies have investigated the efficacy of an evidence-based, theory guided intervention aimed at assisting clinicians to strengthen their patient decision support skills.", {"entities": []}], ["Expanding our understanding of how clinicians can best support palliative patients' decision-making will help to inform best practices in patient-centered palliative care.", {"entities": []}], ["There is potential transferability of lessons learned to other care situations such as chronic condition management, advance directives and anticipatory care planning.", {"entities": []}], ["Should the efficacy evaluation reveal clear improvements in the quality of decision support provided by clinicians who received the intervention, a larger scale implementation and effectiveness trial will be considered.", {"entities": []}], ["This study is registered as NCT00614003", {"entities": []}], ["This prospective study used data from the BRISA Cohort, S\u00e3o Lu\u00eds, Brazil (n\u2009=\u20091140) and analyzed associations between environmental factors up to the first 1000 days of life and \u201cChildhood Asthma Symptoms\u201d.", {"entities": [[189, 195, "DISEASE"]]}], ["\u201cChildhood Asthma Symptoms\u201d was a latent variable based on the number of wheezing episodes, emergency care visit due to wheezing, diagnosis of asthma and diagnosis of rhinitis.", {"entities": [[167, 175, "DISEASE"], [11, 17, "DISEASE"], [143, 149, "DISEASE"]]}], ["A theoretical model that included prenatal factors (socioeconomic status, pregestational body mass index-BMI, soft drink and junk food consumption), birth factors (gestational age, smoking and diseases during pregnancy, birth weight and type of delivery), first year of life factors (breastfeeding, environmental aeroallergens and respiratory diseases) and BMI z-score in the second year of life, was analyzed by structural equation modeling.", {"entities": []}], ["High pregestational BMI, high soft drink consumption, cesarean section without labor, chill in the first three months of life, carpeted floor and child\u2019s exposure to tobacco were associated with higher values of \u201cChildhood Asthma Symptoms\u201d.", {"entities": [[223, 229, "DISEASE"]]}], ["In contrast, high birth weight, breastfeeding and infant\u2019s age were associated with lower values of \u201cChildhood Asthma Symptoms\u201d.", {"entities": [[111, 117, "DISEASE"]]}], ["These findings support the hypothesis that environmental factors that are present before conception and up to the first 1000 days of life are associated with asthma.", {"entities": [[158, 164, "DISEASE"]]}], ["To examine the trend of \"mobile only\" households, and households that have a mobile phone or landline telephone listed in the telephone directory, and to describe these groups by various socio-demographic and health indicators.", {"entities": []}], ["Representative face-to-face population health surveys of South Australians, aged 15 years and over, were conducted in 1999, 2004, 2006, 2007 and 2008 (n = 14285, response rates = 51.9% to 70.6%).", {"entities": []}], ["Self-reported information on mobile phone ownership and usage (1999 to 2008) and listings in White Pages telephone directory (2006 to 2008), and landline telephone connection and listings in the White Pages (1999 to 2008), was provided by participants.", {"entities": []}], ["Additional information was collected on self-reported health conditions and health-related risk behaviours.", {"entities": []}], ["Mobile only households have been steadily increasing from 1.4% in 1999 to 8.7% in 2008.", {"entities": []}], ["In terms of sampling frame for telephone surveys, 68.7% of South Australian households in 2008 had at least a mobile phone or landline telephone listed in the White Pages (73.8% in 2006; 71.5% in 2007).", {"entities": []}], ["The proportion of mobile only households was highest among young people, unemployed, people who were separated, divorced or never married, low income households, low SES areas, rural areas, current smokers, current asthma or people in the normal weight range.", {"entities": [[215, 221, "DISEASE"]]}], ["The proportion with landlines or mobiles telephone numbers listed in the White Pages telephone directory was highest among older people, married or in a defacto relationship or widowed, low SES areas, rural areas, people classified as overweight, or those diagnosed with arthritis or osteoporosis.", {"entities": [[284, 296, "DISEASE"], [271, 280, "DISEASE"]]}], ["The rate of mobile only households has been increasing in Australia and is following worldwide trends, but has not reached the high levels seen internationally (12% to 52%).", {"entities": []}], ["In general, the impact of mobile telephones on current sampling frames (exclusion or non-listing of mobile only households or not listed in the White Pages directory) may have a low impact on health estimates obtained using telephone surveys.", {"entities": []}], ["However, researchers need to be aware that mobile only households are distinctly different to households with a landline connection, and the increase in the number of mobile-only households is not uniform across all groups in the community.", {"entities": []}], ["Listing in the White Pages directory continues to decrease and only a small proportion of mobile only households are listed.", {"entities": []}], ["Researchers need to be aware of these telephone sampling issues when considering telephone surveys.", {"entities": []}], ["Obese, older adults often have multiple chronic conditions resulting in multiple health care encounters.", {"entities": []}], ["However, their satisfaction and experiences with care are not well understood.", {"entities": []}], ["The objective of this study was to examine the independent impact of obesity on patient satisfaction and experiences with care in adults 65\u00a0years of age and older with Medigap insurance.", {"entities": [[69, 76, "DISEASE"]]}], ["Surveys were mailed to 53,286 randomly chosen adults with an AARP\u00ae Medicare Supplement Insurance Plan insured by UnitedHealthcare Insurance Company (for New York residents, UnitedHealthcare Insurance Company of New York) in 10 states.", {"entities": []}], ["Following adjustment for non-response bias, multivariate regression modeling was used to adjust for demographic, socioeconomic and health status differences to estimate the independent impact of weight on satisfaction and experiences with care.", {"entities": []}], ["Outcome variables included four global and four composite measures of satisfaction and experiences with care.", {"entities": []}], ["21.4% of the respondents were obese.", {"entities": []}], ["Relative to normal weight, obesity was significantly associated with higher patient satisfaction and better experiences with care in seven of the eight ratings measured.", {"entities": [[27, 34, "DISEASE"]]}], ["Obese individuals were more satisfied and had better experiences with care.", {"entities": []}], ["Obese individuals had more office visits and discussions about nutrition, exercise and medical checks.", {"entities": []}], ["This may have led to increased attentiveness to care, explaining the increase in satisfaction and better experiences with care.", {"entities": []}], ["Given the high level of satisfaction and experiences with care in older, obese adults, opportunities exist for clinicians to address weight concerns in this population.", {"entities": []}], ["Health state valuation exercises can be conducted online, but the quality of data generated is unclear.", {"entities": []}], ["To investigate whether responses to binary choice health state valuation questions differ by administration mode: online versus face to face.", {"entities": []}], ["Identical surveys including demographic, self-reported health status, and seven types of binary choice valuation questions were administered in online and computer-assisted personal interview (CAPI) settings.", {"entities": []}], ["Samples were recruited following procedures employed in typical online or CAPI studies.", {"entities": []}], ["Analysis included descriptive comparisons of the distribution of responses across the binary options and probit regression to explain the propensity to choose one option across modes of administration, controlling for background characteristics.", {"entities": []}], ["Overall, 422 (221 online; 201 CAPI) respondents completed a survey.", {"entities": []}], ["There were no overall age or sex differences.", {"entities": []}], ["Online respondents were educated to a higher level than were the CAPI sample and general population, and employment status differed.", {"entities": []}], ["CAPI respondents reported significantly better general health and health/life satisfaction.", {"entities": []}], ["CAPI took significantly longer to complete.", {"entities": []}], ["There was no effect of the mode of administration on responses to the valuation questions, and this was replicated when demographic differences were controlled.", {"entities": []}], ["The findings suggest that both modes may be equally valid for health state valuation studies using binary choice methods (e.g., discrete choice experiments).", {"entities": []}], ["There are some differences between the observable characteristics of the samples, and the groups may differ further in terms of unobservable characteristics.", {"entities": []}], ["When designing health state valuation studies, the advantages and disadvantages of both approaches must be considered.", {"entities": []}], ["Intestinal microbiota plays an important role in the human health.", {"entities": []}], ["It is involved in the digestion and protects the host against external pathogens.", {"entities": []}], ["Examination of the intestinal microbiome interactions is required for understanding of the community influence on host health.", {"entities": []}], ["Studies of the microbiome can provide insight on methods of improving health, including specific clinical procedures for individual microbial community composition modification and microbiota correction by colonizing with new bacterial species or dietary changes.", {"entities": []}], ["In this work we report an agent-based model of interactions between two bacterial species and between species and the gut.", {"entities": []}], ["The model is based on reactions describing bacterial fermentation of polysaccharides to acetate and propionate and fermentation of acetate to butyrate.", {"entities": []}], ["Antibiotic treatment was chosen as disturbance factor and used to investigate stability of the system.", {"entities": []}], ["System recovery after antibiotic treatment was analyzed as dependence on quantity of feedback interactions inside the community, therapy duration and amount of antibiotics.", {"entities": []}], ["Bacterial species are known to mutate and acquire resistance to the antibiotics.", {"entities": []}], ["The ability to mutate was considered to be a stochastic process, under this suggestion ratio of sensitive to resistant bacteria was calculated during antibiotic therapy and recovery.", {"entities": []}], ["The model confirms a hypothesis of feedbacks mechanisms necessity for providing functionality and stability of the system after disturbance.", {"entities": []}], ["High fraction of bacterial community was shown to mutate during antibiotic treatment, though sensitive strains could become dominating after recovery.", {"entities": []}], ["The recovery of sensitive strains is explained by fitness cost of the resistance.", {"entities": []}], ["The model demonstrates not only quantitative dynamics of bacterial species, but also gives an ability to observe the emergent spatial structure and its alteration, depending on various feedback mechanisms.", {"entities": []}], ["Visual version of the model shows that spatial structure is a key factor, which helps bacteria to survive and to adapt to changed environmental conditions.", {"entities": []}], ["E-learning is a candidate tool for clinical practice guidelines (CPG) implementation due to its versatility, universal access and low costs.", {"entities": []}], ["We aimed to assess the impact of a five-module e-learning course about CPG for acute gastroenteritis (AGE) on physicians\u2019 knowledge and clinical practice.", {"entities": [[85, 100, "DISEASE"]]}], ["This work was conceived as a pre/post single-arm intervention study.", {"entities": []}], ["Physicians from 11 European countries registered for the online course.", {"entities": []}], ["Personal data, pre- and post-course questionnaires and clinical data about 3 to 5 children with AGE managed by each physician before and after the course were collected.", {"entities": []}], ["Primary outcome measures included the proportion of participants fully adherent to CPG and number of patients managed with full adherence.", {"entities": []}], ["Among the 149 physicians who signed up for the e-learning course, 59 took the course and reported on their case management of 519 children <5 years of age who were referred to their practice because of AGE (281 and 264 children seen before and after the course, respectively).", {"entities": []}], ["The course improved knowledge scores (pre-course 8.6 \u00b1 2.7 versus post-course 12.8 \u00b1 2.1, P < 0.001), average adherence (from 87.0 \u00b1 7.7% to 90.6 \u00b1 7.1%, P = 0.001) and the number of patients managed in full adherence with the guidelines (from 33.6 \u00b1 31.7% to 43.9 \u00b1 36.1%, P = 0.037).", {"entities": []}], ["E-learning is effective in increasing knowledge and improving clinical practice in paediatric AGE and is an effective tool for implementing clinical practice guidelines.", {"entities": []}], ["It is well established that there is a link between inflammation and depression, with several studies reporting increased circulating levels of the pro-inflammatory cytokine, interleukin-6 ( IL6 ), in depressed individuals.", {"entities": [[191, 194, "GENE"]]}], ["Peripheral epigenetic marks, including DNA methylation, hold promise as biomarkers for a range of complex conditions, with potential to inform diagnosis and tailor interventions.", {"entities": []}], ["The aim of this study was to determine whether individuals with depression display differential methylation of the IL6 gene promoter compared to individuals without depression.", {"entities": [[115, 118, "GENE"]]}], ["The ESPRIT study of later life neuropsychiatric disorders used a random sampling framework to select non-institutionalised participants aged \u226565\u00a0years and over living in the Montpellier region of France.", {"entities": []}], ["Major depressive disorder (MDD) was assessed using the Mini International Neuropsychiatric Interview (MINI) according to DSM-IV criteria.", {"entities": []}], ["High levels of depressive symptoms were defined as a score of \u226516 on the Centre for Epidemiologic Studies Depression Scale (CES-D).", {"entities": []}], ["IL6 promoter DNA methylation was measured on a sub-sample of 380 participants who provided buccal samples.", {"entities": [[0, 3, "GENE"]]}], ["Individuals with depression (current MDD or high depressive symptoms) had lower IL6 methylation levels at one of the four sites investigated, however the effect size was small (\u2206 2.4%, SE 0.009, p \u00a0=\u00a00.006).", {"entities": [[80, 83, "GENE"]]}], ["Interestingly, antidepressant use was independently associated with higher IL-6 methylation at the same site (\u2206 4.6%, SE 0.019, p \u00a0=\u00a00.015).", {"entities": []}], ["In multivariate linear regression analyses adjusting for covariates, including sex and smoking status, these associations remained.", {"entities": []}], ["There was no effect modification when considering IL6 genotype.", {"entities": [[50, 53, "GENE"]]}], ["This study presents evidence that IL6 methylation may be a marker of depression status in older individuals, however further work is now needed to replicate these findings and to assess the association with inflammatory status of individuals.", {"entities": [[34, 37, "GENE"]]}], ["Antidepressant drugs are the mainstay of drug therapy for sustained remission of symptoms.", {"entities": []}], ["However, the clinical results are not encouraging.", {"entities": []}], ["This lack of response could be due, among other causes, to factors that alter the metabolism of the antidepressant drug.", {"entities": []}], ["Objective: to evaluate the impact of concomitant administration of CYP2D6 inhibitors or substrates on the efficacy, tolerability and costs of patients treated with venlafaxine for major depressive disorder in clinical practice.", {"entities": [[180, 205, "DISEASE"], [67, 73, "GENE"]]}], ["We designed an observational study using the medical records of outpatients.", {"entities": []}], ["Subjects aged \u226518 years who started taking venlafaxine during 2008\u20132010 were included.", {"entities": []}], ["Three study groups were considered: no combinations (reference), venlafaxine-substrate, and venlafaxine-inhibitor.", {"entities": []}], ["The follow-up period was 12 months.", {"entities": []}], ["The main variables were: demographic data, comorbidity, remission (Hamilton <7), response to treatment, adverse events and costs.", {"entities": []}], ["The statistical analysis included logistic regression models and ANCOVA, with p values <0.05 considered significant.", {"entities": []}], ["A total of 1,115 subjects were recruited.", {"entities": []}], ["The mean age was 61.7 years and 75.1% were female.", {"entities": []}], ["Approximately 33.3% (95% CI: 30.5 to 36.1) were receiving some kind of drug combination (venlafaxine-substrate: 23.0%, and venlafaxine-inhibitor: 10.3%).", {"entities": []}], ["Compared with the venlafaxine-substrate and venlafaxine-inhibitor groups, patients not taking concomitant drugs had a better response to therapy (49.1% vs. 39.9% and 34.3%, p<0.01), greater remission of symptoms (59.9% vs. 50.2% and 43.8%, p<0.001), fewer adverse events (1.9% vs. 7.0% and 6.1%, p<0.05) and a lower mean adjusted cost (\u20ac2,881.7 vs. \u20ac4,963.3 and \u20ac7,389.1, p<0.001), respectively.", {"entities": []}], ["All cost components showed these differences.", {"entities": []}], ["The patients treated with venlafaxine alone showed a better response to anti-depressant treatment, greater remission of symptoms, a lower incidence of adverse events and lower healthcare costs.", {"entities": []}], ["Pulmonary tuberculosis, the most common clinical form of mycobacterial diseases, is a granulomatous disease of the lungs caused by Mycobaterium tuberculosis .", {"entities": [[10, 22, "DISEASE"], [144, 156, "DISEASE"]]}], ["A number of genes have been identified in studies of diverse origins to be important in tuberculosis.", {"entities": [[88, 100, "DISEASE"]]}], ["Of these, both tumor necrosis factor \u03b1 (TNF-\u03b1) and lymphotoxin \u03b1 (LT-\u03b1) play important immunoregulatory roles.", {"entities": []}], ["To investigate the association of TNF polymorphisms with tuberculosis in the Asian Indians, we genotyped five potentially functional promoter polymorphisms in the TNFA gene and a LTA_NcoI polymorphism (+252 position) of the LTA gene in a clinically well-defined cohort of North-Indian patients with tuberculosis (N = 185) and their regional controls (N = 155).", {"entities": [[57, 69, "DISEASE"], [299, 311, "DISEASE"], [34, 37, "GENE"], [224, 227, "GENE"]]}], ["Serum TNF-\u03b1 (sTNF-\u03b1) levels were measured and correlated with genotypes and haplotypes.", {"entities": []}], ["The comparison of the allele frequencies for the various loci investigated revealed no significant differences between the tuberculosis patients and controls.", {"entities": [[123, 135, "DISEASE"]]}], ["Also, when the patients were sub-grouped into minimal, moderately advanced and far advanced disease on the basis of chest radiographs, TST and the presence/absence of cavitary lesions, none of the polymorphisms showed a significant association with any of the patient sub-groups.", {"entities": []}], ["Although a significant difference was observed in the serum TNF-\u03b1 levels in the patients and the controls, none of the investigated polymorphisms were found to affect the sTNF-\u03b1 levels.", {"entities": []}], ["Interestingly, it was observed that patients with minimal severity were associated with lower log sTNF-\u03b1 levels when compared to the patients with moderately advanced and far advanced severity.", {"entities": []}], ["However, none of these differences were found to be statistically significant.", {"entities": []}], ["Furthermore, when haplotypes were analyzed, no significant difference was observed.", {"entities": []}], ["Thus, our findings exclude the TNF genes as major risk factor for tuberculosis in the North Indians.", {"entities": [[66, 78, "DISEASE"], [31, 34, "GENE"]]}], ["Airway remodelling describes the histopathological changes leading to fixed airway obstruction in patients with asthma and includes extra-cellular matrix (ECM) deposition.", {"entities": [[112, 118, "DISEASE"]]}], ["Matrix metalloproteinase-1 (MMP-1) is present in remodelled airways but its relationship with ECM proteins and the resulting functional consequences are unknown.", {"entities": []}], ["We used airway smooth muscle cells (ASM) and bronchial biopsies from control donors and patients with asthma to examine the regulation of MMP-1 by ECM in ASM cells and the effect of MMP-1 on ASM contraction.", {"entities": [[102, 108, "DISEASE"]]}], ["Collagen-I and tenascin-C induced MMP-1 protein expression, which for tenascin-C, was greater in asthma derived ASM cells.", {"entities": [[97, 103, "DISEASE"]]}], ["Tenascin-C induced MMP-1 expression was dependent on ERK1/2, JNK and p38 MAPK activation and attenuated by function blocking antibodies against the \u03b21 and \u03b23 integrin subunits.", {"entities": []}], ["Tenascin-C and MMP-1 were not expressed in normal airways but co-localised in the ASM bundles and reticular basement membrane of patients with asthma.", {"entities": [[143, 149, "DISEASE"]]}], ["Further, ECM from asthma derived ASM cells stimulated MMP-1 expression to a greater degree than ECM from normal ASM.", {"entities": [[18, 24, "DISEASE"]]}], ["Bradykinin induced contraction of ASM cells seeded in 3D collagen gels was reduced by the MMP inhibitor ilomastat and by siRNA knockdown of MMP-1.", {"entities": []}], ["In summary, the induction of MMP-1 in ASM cells by tenascin-C occurs in part via integrin mediated MAPK signalling.", {"entities": []}], ["MMP-1 and tenascin-C are co-localised in the smooth muscle bundles of patients with asthma where this interaction may contribute to enhanced airway contraction.", {"entities": [[84, 90, "DISEASE"]]}], ["Our findings suggest that ECM changes in airway remodelling via MMP-1 could contribute to an environment promoting greater airway narrowing in response to broncho-constrictor stimuli and worsening asthma symptoms.", {"entities": [[197, 203, "DISEASE"]]}], ["The long-term consequences of chronic pain and/or stiffness from the musculoskeletal system (musculoskeletal complaints: MSCs) have not been well explored.", {"entities": []}], ["The aims of this study were to investigate whether MSCs reported at baseline influence all-cause and cause-specific mortality during 21 years follow-up of a general Northern Norwegian adult population.", {"entities": []}], ["A total of 26,977 men and women aged 25\u201397 years who participated in the 1994\u20131995 survey of the Troms\u00f8 study (response rate 77%) were included in the present prospective cohort study.", {"entities": []}], ["Baseline data were collected from the 1994\u20131995 survey and information on death and emigration was taken from the National Register of Norway.", {"entities": []}], ["Cox regression analyses were performed to examine if MSCs predicted risk of mortality.", {"entities": []}], ["5693 (21.1%) participants died during follow-up.", {"entities": []}], ["Mean time between entry into the survey and death or emigration was 18.6 years (standard deviation 4.87) for all-cause mortality.", {"entities": []}], ["There was an increased risk of death among those with MSCs at baseline in the crude Cox regression model.", {"entities": []}], ["However, the multivariable model revealed no significant association between MSCs at baseline and all-cause mortality by sex (women: hazard ratio [HR] = 0.93, 95% confidence interval [CI]: 0.85\u20131.01; men: HR = 0.93, 95%CI: 0.85\u20131.01).", {"entities": [[147, 149, "GENE"], [205, 207, "GENE"], [147, 149, "GENE"], [205, 207, "GENE"]]}], ["Furthermore, no significant associations were found between widespread MSCs at baseline and all-cause mortality in multivariable models (women: HR = 0.90, 95%CI: 0.80\u20131.01; men HR = 0.87, 95%CI: 0.76\u20131.00).", {"entities": [[144, 146, "GENE"], [177, 179, "GENE"], [144, 146, "GENE"], [177, 179, "GENE"]]}], ["Analyses on cause-specific mortality did not reveal any significant results.", {"entities": []}], ["MSCs are not independently associated with increased risk of death from cardiovascular disease, cancer, or death from all causes.", {"entities": [[96, 102, "DISEASE"]]}], ["Telehealth services based on at-home monitoring of vital signs and the administration of clinical questionnaires are being increasingly used to manage chronic disease in the community, but few statistically robust studies are available in Australia to evaluate a wide range of health and socio-economic outcomes.", {"entities": []}], ["The objectives of this study are to use robust statistical methods to research the impact of at home telemonitoring on health care outcomes, acceptability of telemonitoring to patients, carers and clinicians and to identify workplace cultural factors and capacity for organisational change management that will impact on large scale national deployment of telehealth services.", {"entities": []}], ["Additionally, to develop advanced modelling and data analytics tools to risk stratify patients on a daily basis to automatically identify exacerbations of their chronic conditions.", {"entities": []}], ["A clinical trial is proposed at five locations in five states and territories along the Eastern Seaboard of Australia.", {"entities": []}], ["Each site will have 25 Test patients and 50 case matched control patients.", {"entities": []}], ["All participants will be selected based on clinical criteria of at least two hospitalisations in the previous year or four or more admissions over the last five years for a range of one or more chronic conditions.", {"entities": []}], ["Control patients are matched according to age, sex, major diagnosis and their Socio-Economic Indexes for Areas (SEIFA).", {"entities": []}], ["The Trial Design is an Intervention control study based on the Before-After-Control-Impact (BACI) design.", {"entities": []}], ["Our preliminary data indicates that most outcome variables before and after the intervention are not stationary, and accordingly we model this behaviour using linear mixed-effects (lme) models which can flexibly model within-group correlation often present in longitudinal data with repeated measures.", {"entities": []}], ["We expect reduced incidence of unscheduled hospitalisation as well as improvement in the management of chronically ill patients, leading to better and more cost effective care.", {"entities": []}], ["Advanced data analytics together with clinical decision support will allow telehealth to be deployed in very large numbers nationally without placing an excessive workload on the monitoring facility or the patient's own clinicians.", {"entities": []}], ["Registered with Australian New Zealand Clinical Trial Registry on 1 ACTRN12613000635763", {"entities": []}], ["The mTOR pathway has been implicated in immune functions; however, its role in asthma is not well understood.", {"entities": [[79, 85, "DISEASE"], [4, 8, "GENE"]]}], ["We found that patients experiencing an asthma attack, when compared with patients in asthma remission, showed significantly elevated serum mTOR pathway activation, increased Th17 cells and IL-4, and decreased Treg cells and IFN-\u03b3.", {"entities": [[39, 45, "DISEASE"], [85, 91, "DISEASE"], [139, 143, "GENE"]]}], ["In patients experiencing asthma, mTOR activation was positively correlated with the loss of Th17/Treg and Th1/Th2 balance.", {"entities": [[25, 31, "DISEASE"], [33, 37, "GENE"]]}], ["The role of mTOR in asthma was further confirmed using an ovalbumin-induced asthmatic mouse model.", {"entities": [[20, 26, "DISEASE"], [12, 16, "GENE"]]}], ["The mTOR pathway was activated in asthmatic mice, demonstrated by elevated levels of p-PI3K, p-Akt, p-mTOR, and p-p70S6k, and this activation was significantly reduced by treatment with budenoside or mTOR pathway inhibitors.", {"entities": [[4, 8, "GENE"], [102, 106, "GENE"], [200, 204, "GENE"], [4, 8, "GENE"], [102, 106, "GENE"], [200, 204, "GENE"]]}], ["Moreover, mTOR pathway inhibitor treatment reduced asthmatic markers and reversed the Th17/Treg and Th1/Th2 imbalances in asthmatic mice.", {"entities": [[10, 14, "GENE"]]}], ["Finally, different mTOR pathway inhibitor treatments have different inhibitory effects on signaling molecules in asthmatic mice.", {"entities": [[19, 23, "GENE"]]}], ["In summary, mTOR is activated during asthma onset and suppressed during asthma remission, and inhibiting the mTOR pathway in asthmatic mice alleviates asthmatic markers and restores the balances of Th17/Treg and Th1/Th2 cytokines.", {"entities": [[37, 43, "DISEASE"], [72, 78, "DISEASE"], [12, 16, "GENE"], [109, 113, "GENE"], [12, 16, "GENE"], [109, 113, "GENE"]]}], ["These data strongly suggest a critical requirement for mTOR pathway activation in asthma onset, suggesting potential targets for asthma treatments.", {"entities": [[82, 88, "DISEASE"], [129, 135, "DISEASE"], [55, 59, "GENE"]]}], ["The Delhi State Drug Policy was adopted in 1994 following which the first Essential Medicines List (EML) was developed in 1996.", {"entities": []}], ["The Delhi State Essential Medicines Formulary was brought out in 1997.", {"entities": []}], ["A need was felt to revise the formulary to match with the EML as the EML is renewed every 2 years.", {"entities": []}], ["A survey was undertaken to elicit the opinions of the doctors practicing in the state on the usefulness of the formulary before revising and printing the updated version.", {"entities": []}], ["The survey covered dispensaries, 10\u201320 bedded hospitals, 100-bedded hospitals and two tertiary care hospitals.", {"entities": []}], ["Discussions were focused on questionnaires on attitudes toward adopting Essential Medicines Formulary using a 10-point scale.", {"entities": []}], ["Of the 200 doctors approached, only 90 doctors completed the questionnaire.", {"entities": []}], ["Sixty-nine respondents (76.6%) had received the copy of the formulary.", {"entities": []}], ["Most practitioners welcomed the formulary and were satisfied with the coverage and selection of the medicines.", {"entities": []}], ["Most respondents (76.9%) agreed that a well-developed formulary would improve the quality of the public health care system, although they had reservations about the authority, relevance and effect on professional autonomy.", {"entities": []}], ["About 74% of the respondents used the formulary in clinical practice as a source of medicine information, which makes its regular revision necessary.", {"entities": []}], ["Obesity increases the risk of colon cancer.", {"entities": [[0, 7, "DISEASE"], [30, 42, "DISEASE"], [36, 42, "DISEASE"]]}], ["It is also known that most colorectal cancers develop from adenomatous polyps.", {"entities": []}], ["However, the effects of obesity and adipokines on colonic polyp formation are unknown.", {"entities": [[24, 31, "DISEASE"]]}], ["To determine if BMI, waist circumference or adipokines are associated with colon polyps in males, 126 asymptomatic men (48\u201365 yr) were recruited at time of colonoscopy, and anthropometric measures as well as blood were collected.", {"entities": []}], ["Odds ratios were determined using polytomous logistic regression for polyp number (0 or \u22653) and polyp type (no polyp, hyperplastic polyp, tubular adenoma).", {"entities": [[146, 153, "DISEASE"]]}], ["41% of the men in our study were obese (BMI \u226530).", {"entities": []}], ["The odds of an obese individual having \u22653 polyps was 6.5 (CI: 1.3\u201333.0) times greater than those of a lean (BMI<25) individual.", {"entities": []}], ["Additionally, relative to lean individuals, obese individuals were 7.8 (CI: 2.0\u201330.8) times more likely to have a tubular adenoma than no polyp.", {"entities": [[122, 129, "DISEASE"]]}], ["As BMI category increased, participants were 2.9 (CI: 1.5\u20135.4) times more likely to have a tubular adenoma than no polyps.", {"entities": [[99, 106, "DISEASE"]]}], ["Serum leptin, IP-10 and TNF-\u03b1 were significantly associated with tubular adenoma presence.", {"entities": [[73, 80, "DISEASE"]]}], ["Serum leptin and IP-10 were significantly associated with increased likelihood of \u22653 polyps, and TNF-\u03b1 showed a trend (p\u200a=\u200a0.09).", {"entities": []}], ["Obese men are more likely to have at least three polyps and adenomas.", {"entities": []}], ["This cross-sectional study provides evidence that colonoscopy should be recommended for obese, white males.", {"entities": []}], ["Gemstones have been in use as part of alternative and complementary medicine for years.", {"entities": []}], ["However, our understanding of the perceived healing powers of gemstones is limited.", {"entities": []}], ["An extensive literature search revealed that there is a dearth of validated information on this subject.", {"entities": []}], ["This study was therefore undertaken to explore the various aspects of the knowledge, attitudes, and practices of the public towards gemstone therapeutics.", {"entities": []}], ["A survey was performed in the Community Health Centre of a tertiary care teaching hospital in Pakistan.", {"entities": []}], ["Data collection was done via a face-to-face interview based on a structured, pre-tested questionnaire.", {"entities": []}], ["Participants included all willing persons between 18\u201375 years of age approached prior to their appointments at the Community Health Centre.", {"entities": []}], ["The survey response rate was 86% (400/465).", {"entities": []}], ["More than half (63%) of the study population was aware of the use of gemstone therapy.", {"entities": []}], ["One hundred fifty-six individuals believed that gemstone use impacts health.", {"entities": []}], ["Of this group, 39% believed that gemstone use increases physical strength.", {"entities": []}], ["62% believed that gemstone use is based on superstitious beliefs, whereas 28% opined that it is based on religious beliefs.", {"entities": []}], ["38% had used gemstones therapeutics formerly, while 24% were current users.", {"entities": []}], ["Multiple logistic regression analysis revealed that age status and education status were significant (p < 0.05) independent predictors for both awareness of gemstone therapy and the belief that gemstone use impacts health.", {"entities": []}], ["The elderly (aged 51\u201361) were 5.9-times more likely to believe that gemstones had an impact on health than the younger population (aged 18\u201328 years).", {"entities": []}], ["(Adjusted Odd's Ratio = 5.9 [95% Confidence Interval = 2.9\u201311.9]).", {"entities": []}], ["More than half of our sample population is aware of the use of the gemstones for their various effects.", {"entities": []}], ["Willingness to use gemstones is associated with the beliefs about the impact of gemstone therapy on health.", {"entities": []}], ["Friends and family seem to be the major role players influencing people's willingness to use gemstones.", {"entities": []}], ["CAM modalities should be recognized and considered as an important therapeutic option.", {"entities": []}], ["We feel that gemstone therapy is a relatively unexplored area and more studies should, therefore, be conducted to gather more validated information on the subject.", {"entities": []}], ["Telecare is increasingly recognized as an essential tool for a contemporary twenty-first century health care system even though the evidence is still emerging on its effectiveness.", {"entities": []}], ["The need to find delivery models like telecare that improve both the convenience and value of care is universal, but particularly pressing for countries like the U.S. and Israel who are facing rising costs related to the needs of individuals with multiple complex conditions.", {"entities": []}], ["This commentary provides highlights of the current state of practice and policy for telecare and the challenges that remain ahead as it is adopted into the mainstream.", {"entities": []}], ["Lung cancer is the leading cause of cancer mortality worldwide.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [36, 42, "DISEASE"]]}], ["Helicobacter pylori ( H. pylori ) is a risk factor for distal stomach cancer, and a few small studies have suggested that H. pylori may be a potential risk factor for lung cancer.", {"entities": [[167, 178, "DISEASE"], [62, 76, "DISEASE"], [70, 76, "DISEASE"], [172, 178, "DISEASE"]]}], ["To test this hypothesis, we conducted a study of 350 lung adenocarcinoma cases, 350 squamous cell carcinoma cases, and 700 controls nested within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC) cohort of male Finnish smokers.", {"entities": [[58, 72, "DISEASE"], [53, 72, "DISEASE"], [98, 107, "DISEASE"], [84, 107, "DISEASE"], [182, 188, "DISEASE"]]}], ["Controls were one-to-one matched by age and date of baseline serum draw.", {"entities": []}], ["Using enzyme-linked immunosorbent assays to detect immunoglobulin G antibodies against H. pylori whole-cell and cytotoxin-associated gene (CagA) antigens, we calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) for associations between H. pylori seropositivity and lung cancer risk using conditional logistic regression.", {"entities": [[280, 291, "DISEASE"], [285, 291, "DISEASE"]]}], ["H. pylori seropositivity was detected in 79.7% of cases and 78.5% of controls.", {"entities": []}], ["After adjusting for pack-years and cigarettes smoked per day, H. pylori seropositivity was not associated with either adenocarcinoma (OR: 1.1, 95% CI: 0.75\u20131.6) or squamous cell carcinoma (OR: 1.1, 95% CI: 0.77\u20131.7).", {"entities": [[118, 132, "DISEASE"], [178, 187, "DISEASE"], [164, 187, "DISEASE"]]}], ["Results were similar for CagA-negative and CagA-positive H. pylori seropositivity.", {"entities": []}], ["Despite earlier small studies suggesting that H. pylori may contribute to lung carcinogenesis, H. pylori seropositivity does not appear to be associated with lung cancer.", {"entities": [[158, 169, "DISEASE"], [163, 169, "DISEASE"]]}], ["We report a case of a 15-year-old boy with autoimmune hepatitis lacking common serologic markers and normal gammaglobulinemia associated with immune thrombocytopenia and family history of psoriasis.", {"entities": [[188, 197, "DISEASE"], [43, 63, "DISEASE"], [149, 165, "DISEASE"], [54, 63, "DISEASE"]]}], ["He presented to our department with a 4-year history of a cervical posterior lymphadenopathy and recent petechiae.", {"entities": []}], ["Previous laboratory results 6 months before already showed hepatocellular injury.", {"entities": []}], ["After exclusion of other causes, the diagnosis of autoimmune hepatitis was made based on clinical grounds, associated immune disorder and histological features of liver biopsy.", {"entities": [[50, 70, "DISEASE"], [61, 70, "DISEASE"]]}], ["The authors alert for this atypical presentation of autoimmune hepatitis and associated immune thrombocytopenia.", {"entities": [[52, 72, "DISEASE"], [95, 111, "DISEASE"], [63, 72, "DISEASE"]]}], ["Mechanical ventilation (MV) may amplify the lung-specific inflammatory response in preinjured lungs by elevating cytokine release and augmenting damage to the alveolar integrity.", {"entities": []}], ["In this study, we test the hypothesis that MV exerts different negative impacts on inflammatory response at different time points of postlung injury.", {"entities": []}], ["Basic lung injury was induced by cecal ligation and puncture (CLP) surgery in rats.", {"entities": []}], ["Physiological indexes including blood gases were monitored during MV and samples were assessed following each experiment.", {"entities": []}], ["Low V T (tidal volume) MV caused a slight increase in cytokine release and tissue damage at day 1 and day 4 after sepsis induced lung injury, while cytokine release from the lungs in the two moderately ventilated V T groups was amplified.", {"entities": []}], ["Interestingly, in the two groups where rats received low V T MV, we found that infiltration of inflammatory cells was only profound at day 4 after CLP.", {"entities": []}], ["Marked elevation of protein leakage indicated a compromise in alveolar integrity in rats that received moderate V T MV at day 4 following CLP, correlating with architectural damage to the alveoli.", {"entities": []}], ["Our study indicates that preinjured lungs are more sensitive to mechanical MV at later phases of sepsis, and this situation may be a result of differing immune status.", {"entities": []}], ["Chronic inflammation in visceral adipose tissue is considered a key element for induction of insulin resistance in obesity.", {"entities": [[115, 122, "DISEASE"]]}], ["CD40 is required for efficient systemic adaptive immune responses and is implicated in various inflammatory conditions.", {"entities": [[0, 4, "GENE"]]}], ["However, its role in modulating immunity in the microanatomical niches of adipose tissue remains largely undefined.", {"entities": []}], ["Here, we show that, in contrast to its well-documented costimulatory effects, CD40 regulates development of insulin resistance in a diet-induced obesity (DIO) mouse model by ameliorating local inflammation in adipose tissues.", {"entities": [[145, 152, "DISEASE"], [78, 82, "GENE"]]}], ["CD40 deficiency (CD40KO) resulted in greater body weight gain, more severe inflammation in epididymal adipose tissue (EAT), and aggravated insulin resistance in response to DIO.", {"entities": [[0, 4, "GENE"]]}], ["Interestingly, we found that CD40KO CD8", {"entities": []}], ["Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) aggravates the overall severity in COPD patients, resulting in severe morbidity and mortality.", {"entities": [[22, 59, "DISEASE"]]}], ["However, there are no objective biomarkers currently available to predict the development of AECOPD.", {"entities": []}], ["Several studies have indicated that galectin-3 (Gal-3) is involved in diseases characterized by excessive inflammatory response and fibrosis.", {"entities": []}], ["The objective of this study was to examine the dynamic changes of Gal-3 in acute exacerbation and convalescence phases of COPD.", {"entities": []}], ["Serum levels of Gal-3, high sensitivity C-reactive protein (hsCRP), and prohormone of brain natriuretic peptide (pro-BNP) were determined using multiplex enzyme-linked immunosorbent assay kits.", {"entities": []}], ["Serum levels of Gal-3 in 44 patients with COPD were further analyzed and correlated with the parameters of lung function and the biomarkers of systemic inflammation.", {"entities": []}], ["The mean level of serum Gal-3 was significantly higher in acute exacerbation of COPD compared with the level in COPD convalescence phase (32.10\u00b19.83 versus 29.02\u00b18.68 ng/mL, p <0.01).", {"entities": []}], ["Serum levels of Gal-3 positively correlated with hsCRP (r=0.354, p =0.018 for total patients) and pro-BNP (r=0.319, p =0.035 for total patients) in AECOPD.", {"entities": []}], ["In addition, the level of Gal-3 was the highest in the current smoker group, and the lowest in the never-smoker group in either the acute exacerbation phase (33.91\u00b13.55 versus 29.12\u00b111.73 ng/mL, p =0.036) or the convalescence phase (30.94\u00b13.40 versus 27.76\u00b19.68 ng/mL, p =0.045) of COPD.", {"entities": []}], ["Our results indicated that serum Gal-3 is increased in AECOPD patients, which is also positively associated with systemic inflammation and smoking in patients with COPD, suggesting that Gal-3 might be a valuable biomarker for AECOPD.", {"entities": []}], ["Despite its widespread use in pulmonary fibrosis research, the bleomycin mouse model has not been thoroughly validated from a pulmonary functional standpoint using new technologies.", {"entities": [[30, 48, "DISEASE"]]}], ["Purpose of this study was to systematically assess the functional alterations induced in murine lungs by fibrogenic agent bleomycin and to compare the forced oscillation technique with quasi-static pressure-volume curves in mice following bleomycin exposure.", {"entities": []}], ["Single intratracheal injections of saline (50 \u03bcL) or bleomycin (2 mg/Kg in 50 \u03bcL saline) were administered to C57BL/6 ( n = 40) and Balb/c ( n = 32) mice.", {"entities": []}], ["Injury/fibrosis score, tissue volume density (TVD), collagen content, airway resistance ( R N ), tissue damping ( G ) and elastance coefficient ( H ), hysteresivity ( \u03b7 ), and area of pressure-volume curve (PV-A) were determined after 7 and 21 days (inflammation and fibrosis stage, respectively).", {"entities": []}], ["Statistical hypothesis testing was performed using one-way ANOVA with LSD post hoc tests.", {"entities": []}], ["Both C57BL/6 and Balb/c mice developed weight loss and lung inflammation after bleomycin.", {"entities": []}], ["However, only C57BL/6 mice displayed cachexia and fibrosis, evidenced by increased fibrosis score, TVD, and collagen.", {"entities": []}], ["At day 7, PV-A increased significantly and G and H non-significantly in bleomycin-exposed C57BL/6 mice compared to saline controls and further increase in all parameters was documented at day 21.", {"entities": []}], ["G and H , but not PV-A, correlated well with the presence of fibrosis based on histology, TVD and collagen.", {"entities": []}], ["In Balb/c mice, no change in collagen content, histology score, TVD, H and G was noted following bleomycin exposure, yet PV-A increased significantly compared to saline controls.", {"entities": []}], ["Lung dysfunction in the bleomycin model is more pronounced during the fibrosis stage rather than the inflammation stage.", {"entities": []}], ["Forced oscillation mechanics are accurate indicators of experimental bleomycin-induced lung fibrosis.", {"entities": []}], ["Quasi-static PV-curves may be more sensitive than forced oscillations at detecting inflammation and fibrosis.", {"entities": []}], ["As bioaerosol research attracts increasing attention, there is a need for additional efforts that focus on method development to deal with different environmental samples.", {"entities": []}], ["Bioaerosol environmental samples typically have very low biomass concentrations in the air, which often leaves researchers with limited options in choosing the downstream analysis steps, especially when culture-independent methods are intended.", {"entities": []}], ["This study investigates the impacts of three important factors that can influence the performance of culture-independent DNA-based analysis in dealing with bioaerosol environmental samples engaged in this study.", {"entities": []}], ["The factors are: 1) enhanced high temperature sonication during DNA extraction; 2) effect of sampling duration on DNA recoverability; and 3) an alternative method for concentrating composite samples.", {"entities": []}], ["In this study, DNA extracted from samples was analysed using the Qubit fluorometer (for direct total DNA measurement) and quantitative polymerase chain reaction (qPCR).", {"entities": []}], ["The findings suggest that additional lysis from high temperature sonication is crucial: DNA yields from both high and low biomass samples increased up to 600% when the protocol included 30-min sonication at 65\u00b0C.", {"entities": []}], ["Long air sampling duration on a filter media was shown to have a negative impact on DNA recoverability with up to 98% of DNA lost over a 20-h sampling period.", {"entities": []}], ["Pooling DNA from separate samples during extraction was proven to be feasible with margins of error below 30%.", {"entities": []}], ["Before this study, there had been no research evaluating the relationship between a lysosomal exoglycosidase profile and secretory function in the salivary glands of rats with streptozotocin- (STZ-) induced type 1 diabetes.", {"entities": []}], ["In our work, rats were divided into 4 groups of 8 animals each: control groups (C2, C4) and diabetic groups (STZ2, STZ4).", {"entities": [[80, 82, "GENE"]]}], ["The secretory function of salivary glands\u2014nonstimulated and stimulated salivary flow, \u03b1 -amylase, total protein\u2014and salivary exoglycosidase activities\u2014N-acetyl- \u03b2 -hexosaminidase (HEX, HEX A, and HEX B), \u03b2 -glucuronidase, \u03b1 -fucosidase, \u03b2 -galactosidase, and \u03b1 -mannosidase\u2014was estimated both in the parotid and submandibular glands of STZ-diabetic and control rats.", {"entities": []}], ["The study has demonstrated that the activity of most salivary exoglycosidases is significantly higher in the parotid and submandibular glands of STZ-diabetic rats as compared to the healthy controls and that it increases as the disease progresses.", {"entities": []}], ["Reduced secretory function of diabetic salivary glands was also observed.", {"entities": []}], ["A significant inverse correlation between HEX B, \u03b1 -amylase activity, and stimulated salivary flow in diabetic parotid gland has also been shown.", {"entities": []}], ["Summarizing, STZ-induced diabetes leads to a change in the lysosomal exoglycosidase profile and reduced function of the salivary glands.", {"entities": []}], ["Although primary health care, and in particular, general practice will be at the frontline in the response to pandemic influenza, there are no frameworks to guide systematic planning for this task or to appraise available plans for their relevance to general practice.", {"entities": [[119, 128, "DISEASE"]]}], ["We aimed to develop a framework that will facilitate planning for general practice, and used it to appraise pandemic plans from Australia, England, USA, New Zealand and Canada.", {"entities": []}], ["We adapted the Haddon matrix to develop the framework, populating its cells through a multi-method study that incorporated the peer-reviewed and grey literature, interviews with general practitioners, practice nurses and senior decision-makers, and desktop simulation exercises.", {"entities": []}], ["We used the framework to analyse 89 publicly-available jurisdictional plans at similar managerial levels in the five countries.", {"entities": []}], ["The framework identifies four functional domains: clinical care for influenza and other needs, public health responsibilities, the internal environment and the macro-environment of general practice.", {"entities": [[68, 77, "DISEASE"]]}], ["No plan addressed all four domains.", {"entities": []}], ["Most plans either ignored or were sketchy about non-influenza clinical needs, and about the contribution of general practice to public health beyond surveillance.", {"entities": [[52, 61, "DISEASE"]]}], ["Collaborations between general practices were addressed in few plans, and inter-relationships with the broader health system, even less frequently.", {"entities": []}], ["This is the first study to provide a framework to guide general practice planning for pandemic influenza.", {"entities": [[95, 104, "DISEASE"]]}], ["The framework helped identify critical shortcomings in available plans.", {"entities": []}], ["Engaging general practice effectively in planning is challenging, particularly where governance structures for primary health care are weak.", {"entities": []}], ["We identify implications for practice and for research.", {"entities": []}], ["Obesity-related eating behaviors (OREB) are associated with higher energy intake.", {"entities": []}], ["Total energy intake can be decomposed into the following constituents: food portion size, food energy density, the number of eating occasions, and the energy intake from energy-rich beverages.", {"entities": []}], ["To our knowledge this is the first study to examine the association between the OREB and these energy components.", {"entities": []}], ["Data were taken from a cross-sectional study conducted in 2008\u20132010 among 11,546 individuals representative of the Spanish population aged \u226518 years.", {"entities": []}], ["Information was obtained on the following 8 self-reported OREB: not planning how much to eat before sitting down, eating precooked/canned food or snacks bought at vending machines or at fast-food restaurants, not choosing low-energy foods, not removing visible fat from meat or skin from chicken, and eating while watching TV.", {"entities": []}], ["Usual diet was assessed with a validated diet history.", {"entities": []}], ["Analyses were performed with linear regression with adjustment for main confounders.", {"entities": []}], ["Compared to individuals with \u22641 OREB, those with \u22655 OREB had a higher food energy density (\u03b2 0.10; 95% CI 0.08, 0.12 kcal/g/day; p-trend<0.001) and a higher consumption of sugary drinks (\u03b2 7; 95% CI \u22127, 20 ml/day; p-trend<0.05) and of alcoholic beverages (\u03b2 24; 95% CI 10, 38 ml/day; p-trend<0.001).", {"entities": []}], ["Specifically, a higher number of OREB was associated with higher intake of dairy products and red meat, and with lower consumption of fresh fruit, oily fish and white meat.", {"entities": []}], ["No association was found between the number of OREB and food portion size or the number of eating occasions.", {"entities": []}], ["OREB were associated with higher food energy density and higher consumption of sugary and alcoholic beverages.", {"entities": []}], ["Avoiding OREB may prove difficult because they are firmly socially rooted, but these results may nevertheless serve to palliate the undesirable effects of OREB by reducing the associated energy intake.", {"entities": []}], ["Problem-based learning is recognised as promoting integration of knowledge and fostering a deeper approach to life-long learning, but is associated with significant resource implications.", {"entities": []}], ["In order to encourage second year undergraduate medical students to integrate their pharmacological knowledge in a professionally relevant clinical context, with limited staff resources, we developed a novel clustered PBL approach.", {"entities": []}], ["This paper utilises preliminary data from both the facilitator and student viewpoint to determine whether the use of this novel methodology is feasible with large groups of students.", {"entities": []}], ["Students were divided into 16 groups (20\u201321 students/group) and were allocated a PBL facilitator.", {"entities": []}], ["Each group was then divided into seven subgroups, or clusters, of 2 or 3 students wh each cluster being allocated a specific case.", {"entities": []}], ["Each cluster was then provided with more detailed clinical information and studied an individual and distinct case-study.", {"entities": []}], ["An electronic questionnaire was used to evaluate both student and facilitator perception of this clustered PBL format, with each being asked to rate the content, structure, facilitator effectiveness, and their personal view of the wider learning experience.", {"entities": []}], ["Despite initial misgivings, facilitators managed this more complex clustered PBL methodology effectively within the time restraints and reported that they enjoyed the process.", {"entities": []}], ["They felt that the cases effectively illustrated medical concepts and fitted and reinforced the students' pharmacological knowledge, but were less convinced that the scenario motivated students to use additional resources or stimulated their interest in pharmacology.", {"entities": []}], ["Student feedback was broadly similar to that of the facilitators; although they were more positive about the scenario stimulating the use of additional resources and an interest in pharmacology.", {"entities": []}], ["This clustered PBL methodology can be successfully used with larger groups of students.", {"entities": []}], ["The key to success lies with challenging and well situated clinically relevant cases together with enthusiastic facilitators.", {"entities": []}], ["Facilitator enjoyment of the PBL process may be related to adequate training and previous PBL experience, rather than academic background.", {"entities": []}], ["The smaller number of facilitators required using this clustered PBL approach allows for facilitators with 'a belief in the philosophy of PBL' to volunteer which would again impact on the success of the process.", {"entities": []}], ["There are limited data regarding the prevalence and risk factors relating to hypovitaminosis D in children of Thailand, a tropical country with abundant sunlight.", {"entities": []}], ["The objective of this study was to assess the prevalence of hypovitaminosis D and examine factors associated with hypovitaminosis D in school-aged children in Bangkok, Thailand \u2013 a centrally located capital city.", {"entities": []}], ["This cross-sectional study evaluated 159 healthy children (33.3% boys and 66.7% girls), aged 6 to 12\u00a0years, in Bangkok, Thailand (located at 13.45\u00b0N).", {"entities": []}], ["Fasting plasma samples were examined for total 25-hydroxyvitamin D [25(OH)D] using electrochemiluminescence immunoassay.", {"entities": []}], ["Demographic characteristics (age, sex, household income), past medical history (birth weight, allergic diseases, hospitalization), amount of sun exposure, anthropometric data, and selected biochemical tests were used to investigate for factors associated with hypovitaminosis D. Overall, the mean\u2009\u00b1\u2009SD level of plasma 25(OH)D was 64.0\u2009\u00b1\u200915.1\u00a0nmol/L.", {"entities": []}], ["Hypovitaminosis D (<\u200975\u00a0nmol/L) was presented in 79.2% of subjects.", {"entities": []}], ["Of these, the prevalence of vitamin D insufficiency and vitamin D deficiency were 59.7% and 19.5%, respectively.", {"entities": []}], ["In univariate analysis, children with hypovitaminosis D (<\u200975\u00a0nmol/L) had a higher mean body mass index (BMI) percentile than the vitamin D-sufficient group (56.7\u2009\u00b1\u200933.9 vs. 42.6\u2009\u00b1\u200936.0; P -value\u2009=\u20090.04).", {"entities": []}], ["Plasma PTH levels in the children with hypovitaminosis D were significantly higher than in the children with normal levels of vitamin D (4.34\u2009\u00b1\u20091.38 vs 3.78\u2009\u00b1\u20091.25 pmol/L; P -value\u2009=\u20090.04).", {"entities": [[7, 10, "GENE"]]}], ["In multivariate analysis, high BMI percentile and high PTH concentration were the parameters associated with 25(OH)D level\u2009<\u200975\u00a0nmol/L.", {"entities": [[55, 58, "GENE"]]}], ["The prevalence of hypovitaminosis D in healthy Thai children is very high, despite their exposure to sunlight, and that prevalence increases in children with a high BMI percentile.", {"entities": []}], ["As a result, a formal recommendation for vitamin D supplementation in Thai children should be considered.", {"entities": []}], ["This paper describes evidence-based kernels, fundamental units of behavioral influence that appear to underlie effective prevention and treatment for children, adults, and families.", {"entities": []}], ["A kernel is a behavior\u2013influence procedure shown through experimental analysis to affect a specific behavior and that is indivisible in the sense that removing any of its components would render it inert.", {"entities": []}], ["Existing evidence shows that a variety of kernels can influence behavior in context, and some evidence suggests that frequent use or sufficient use of some kernels may produce longer lasting behavioral shifts.", {"entities": []}], ["The analysis of kernels could contribute to an empirically based theory of behavioral influence, augment existing prevention or treatment efforts, facilitate the dissemination of effective prevention and treatment practices, clarify the active ingredients in existing interventions, and contribute to efficiently developing interventions that are more effective.", {"entities": []}], ["Kernels involve one or more of the following mechanisms of behavior influence: reinforcement, altering antecedents, changing verbal relational responding, or changing physiological states directly.", {"entities": []}], ["The paper describes 52 of these kernels, and details practical, theoretical, and research implications, including calling for a national database of kernels that influence human behavior.", {"entities": []}], ["Hematopoietic cells normally require cell extrinsic signals to maintain metabolism and survival.", {"entities": []}], ["In contrast, cancer cells can express constitutively active oncogenic kinases such as BCR-Abl that promote these processes independent of extrinsic growth factors.", {"entities": [[13, 19, "DISEASE"]]}], ["When cells receive insufficient growth signals or when oncogenic kinases are inhibited, glucose metabolism decreases and the self-digestive process of autophagy is elevated to degrade bulk cytoplasm and organelles.", {"entities": []}], ["While autophagy has been proposed to provide a cell-intrinsic nutrient supply for mitochondrial oxidative metabolism and to maintain cellular homeostasis through degradation of damaged organelles or protein aggregates, its acute role in growth factor deprivation or inhibition of oncogenic kinases remains poorly understood.", {"entities": []}], ["We therefore developed a growth factor-dependent hematopoietic cell culture model in which autophagy can be acutely disrupted through conditional Cre-mediated excision of the autophagy-essential gene Atg3.", {"entities": [[200, 204, "GENE"]]}], ["Treated cells rapidly lost their ability to perform autophagy and underwent cell cycle arrest and apoptosis.", {"entities": []}], ["While Atg3 was essential for optimal upregulation of mitochondrial oxidative pathways in growth factor withdrawal, this metabolic contribution of autophagy did not appear critical for cell survival, as provision of exogenous pyruvate or lipids could not completely rescue Atg3-deficiency.", {"entities": [[6, 10, "GENE"], [272, 276, "GENE"]]}], ["Instead, autophagy suppressed a stress response that otherwise led to p53 phosphorylation and upregulation of p21 and the pro-apoptotic Bcl-2 family protein Puma.", {"entities": []}], ["Importantly, BCR-Abl-expressing cells had low basal levels of autophagy but were highly dependent on this process, and rapidly underwent apoptosis upon disruption of autophagy through Atg3 deletion or treatment with chemical autophagy inhibitors.", {"entities": [[184, 188, "GENE"]]}], ["This dependence on autophagy extended in vivo, as Atg3 deletion also prevented BCR-Abl-mediated leukemogenesis in a cell transfer model.", {"entities": [[50, 54, "GENE"]]}], ["Together these data demonstrate a critical role for autophagy to mitigate cell stress, and that cells expressing the oncogenic kinase BCR-Abl appear particularly dependent on autophagy for cell survival and leukemogenesis.", {"entities": []}], ["Management of the critically ill pregnant woman is complicated by potential adverse effects of both maternal illness and ICU interventions on the fetus.", {"entities": []}], ["This paper reviews the potential risks to the fetus of maternal critical illness, including shock, hypoxemia, and fever, as well as the effects of critical care management, such as drug therapy and radiological investigations.", {"entities": []}], ["The authors\u2019 recommended approach to management is provided.", {"entities": []}], ["Prior publications and new data presented identify that there is insufficient information to prognosticate accurately on fetal outcome after maternal critical illness, although maternal shock, hypoxemia and early gestational age are likely significant risk factors.", {"entities": []}], ["Copper oxide nanomaterials (CuO NMs) are exploited in a diverse array of products including antimicrobials, inks, cosmetics, textiles and food contact materials.", {"entities": [[32, 35, "GENE"]]}], ["There is therefore a need to assess the toxicity of CuO NMs to the gastrointestinal (GI) tract since exposure could occur via direct oral ingestion, mucocillary clearance (following inhalation) or hand to mouth contact.", {"entities": [[56, 59, "GENE"]]}], ["Undifferentiated Caco-2 intestinal cells were exposed to CuO NMs (10\u00a0nm) at concentrations ranging from 0.37 to 78.13\u00a0\u03bcg/cm 4 ), which informed the selection of concentrations for further studies.", {"entities": [[61, 64, "GENE"]]}], ["The differentiation status of cells and the impact of CuO NMs and CuSO 4 on the integrity of the differentiated Caco-2 cell monolayer were assessed by measurement of trans-epithelial electrical resistance (TEER), staining for Zonula occludens-1 (ZO-1) and imaging of cell morphology using scanning electron microscopy (SEM).", {"entities": [[58, 61, "GENE"]]}], ["The impact of CuO NMs and CuSO 4 on the viability of differentiated cells was performed via assessment of cell number (DAPI staining), and visualisation of cell morphology (light microscopy).", {"entities": [[18, 21, "GENE"]]}], ["Interleukin-8 (IL-8) production by undifferentiated and differentiated Caco-2 cells following exposure to CuO NMs and CuSO 4 was determined using an ELISA.", {"entities": [[110, 113, "GENE"]]}], ["The copper concentration in the cell lysate, apical and basolateral compartments were measured with Inductive Coupled Plasma Optical Emission Spectrometry (ICP-OES) and used to calculate the apparent permeability coefficient (P app ); a measure of barrier permeability to CuO NMs.", {"entities": [[228, 231, "GENE"], [276, 279, "GENE"]]}], ["For all experiments, CuSO 4 was used as an ionic control.", {"entities": []}], ["CuO NMs and CuSO 4 caused a concentration dependent decrease in cell viability in undifferentiated cells.", {"entities": [[4, 7, "GENE"]]}], ["CuO NMs and CuSO 4 translocated across the differentiated Caco-2 cell monolayer.", {"entities": [[4, 7, "GENE"]]}], ["CuO NM mediated IL-8 production was over 2-fold higher in undifferentiated cells.", {"entities": []}], ["A reduction in cell viability in differentiated cells was not responsible for the lower level of cytokine production observed.", {"entities": []}], ["Both CuO NMs and CuSO 4 decreased TEER values to a similar extent, and caused tight junction dysfunction (ZO-1 staining), suggesting that barrier integrity was disrupted.", {"entities": [[9, 12, "GENE"]]}], ["CuO NMs and CuSO 4 stimulated IL-8 production by Caco-2 cells, decreased barrier integrity and thereby increased the P app and translocation of Cu.", {"entities": [[4, 7, "GENE"], [119, 122, "GENE"]]}], ["There was no significant enhancement in potency of the CuO NMs compared to CuSO 4 .", {"entities": [[59, 62, "GENE"]]}], ["Differentiated Caco-2 cells were identified as a powerful model to assess the impacts of ingested NMs on the GI tract.", {"entities": [[98, 101, "GENE"]]}], ["The online version of this article (doi:10.1186/s12989-017-0211-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Exercise is a recommended \u2018core\u2019 treatment for chronic knee pain (CKP), however it appears to be underused by general practitioners (GPs).", {"entities": []}], ["While behavioural theories suggest that attitudes and beliefs influence behaviours, no single theory reliably predicts GPs\u2019 behaviours.", {"entities": []}], ["A theoretical analysis framework, developed from sociocognitive theories, was used to underpin investigation of the key influences associated with GPs\u2019 use of exercise for patients with CKP, to inform future interventions to optimise GPs\u2019 use of exercise.", {"entities": []}], ["A cross-sectional postal questionnaire survey investigated UK GPs\u2019 reported use of exercise based on a patient case vignette.", {"entities": []}], ["Factors influencing GPs\u2019 exercise use (behaviour) were examined using attitude statements, free-text questions and multiple response option questions related to factors within the analysis framework.", {"entities": []}], ["Unadjusted logistic regression analyses explored the associations between GPs\u2019 attitudes/beliefs and behaviour.", {"entities": []}], ["From a total sample of 5000 GPs, 835 (17%) returned a questionnaire.", {"entities": []}], ["Most respondents ( n \u2009=\u2009729, 87%) reported that they would use exercise.", {"entities": []}], ["Factors significantly associated with exercise use (OR (95% CI)) included GPs\u2019 beliefs about their role (belief that GPs should give information on type, duration and frequency of exercise (30.71 (5.02,188.01)), beliefs about consequences (agreement that knee problems are improved by local (3.23 (1.94,5.39)) and general exercise (2.63 (1.38,5.02))), moral norm (agreement that GPs should prescribe all patients local (3.08 (1.96,4.83)) and general exercise (2.63 (1.45,4.76))), and GP-related beliefs about capabilities (prior experience of insufficient expertise to give detailed exercise information (0.50 (0.33,0.76)).", {"entities": []}], ["Whilst perceived time limitations were not associated with exercise use (1.00 (0.33,3.01)), GPs who disagreed that they experienced time limitations were more likely to suggest general (2.17 (1.04,4.55)), or demonstrate local (2.16 (1.06,4.42)), exercises.", {"entities": []}], ["GPs\u2019 attitudes and beliefs are associated with their use of exercise for patients with CKP, particularly beliefs about role, responsibilities and skills in initiating exercise, and about the efficacy of exercise.", {"entities": []}], ["Although the low response risks response bias, these results can inform future interventions to optimise GPs\u2019 behaviour.", {"entities": []}], ["The role of GP uncertainty and influences on clinical decision-making need further exploration, thus an amended analysis framework is suggested, which should be tested in future research.", {"entities": []}], ["The online version of this article (doi:10.1186/s12875-016-0570-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Type I hypersensitivity is an allergic reaction characterized by the overactivity of the immune system provoked by normally harmless substances.", {"entities": []}], ["Glucocorticoids, anti-histamines, or mast cell stabilizers are the choices of treatment for type I hypersensitivity.", {"entities": []}], ["Even though these drugs have the anti-allergic effect, they can have several side effects in prolong use.", {"entities": []}], ["Cedrol is the main bioactive compound of Cedrus atlantica with anti-tumor, anti-oxidative, and platelet-activating factor inhibiting properties.", {"entities": []}], ["In this study, the preparation and anti-anaphylactic effect of cedrol-loaded nanostructured lipid carriers (NLCs) were evaluated.", {"entities": []}], ["NLCs were prepared using Compritol d -\u03b1-tocopherylpolyethyleneglycol 1000 succinate, soya lecithin, and sodium deoxycholate as nanoparticle stabilizers.", {"entities": []}], ["The average diameter of cedrol-NLCs (CR-NLCs) was 71.2 nm (NLC-C 1 ) and 91.93 nm (NLC-C 2 ).", {"entities": []}], ["The particle had negative zeta potential values of \u221231.9 mV (NLC-C 1 ) and \u221244.5 mV (NLC-C 2 ).", {"entities": []}], ["Type I anaphylactoid reaction in the animal model is significantly reduced by cedrol and cedrol-NLC.", {"entities": []}], ["This in vivo activity of cedrol resulted that cedrol suppressed compound 48/80-induced peritoneal mast cell degranulation and histamine release from mast cells.", {"entities": []}], ["Furthermore, compound 48/80-evoked Ca 2 was found to be 11.5-fold greater than both prednisolone and cromolyn sodium.", {"entities": []}], ["Administration of CR-NLC 24 hours before the onset of anaphylaxis can prevent an anaphylactoid reaction.", {"entities": []}], ["NLCs could be a promising vehicle for the oral delivery of cedrol to protect anaphylactic reactions.", {"entities": []}], ["Atopic dermatitis among children is an important issue due to relapses and skin manifestations.", {"entities": [[0, 17, "DISEASE"], [7, 17, "DISEASE"]]}], ["Traditional Chinese medicine (TCM) is commonly used to treat children with atopic dermatitis.", {"entities": [[75, 92, "DISEASE"], [82, 92, "DISEASE"]]}], ["The aim of this study was to investigate the characteristics and TCM prescriptions of patients with atopic dermatitis using a nationwide database.", {"entities": [[100, 117, "DISEASE"], [107, 117, "DISEASE"]]}], ["Children younger than 12\u00a0years of age diagnosed with atopic dermatitis, defined as ICD-9-CM codes 691.8 and 692.x, were identified from the database.", {"entities": [[53, 70, "DISEASE"], [60, 70, "DISEASE"]]}], ["Data on age, diagnosis codes, area of residence and use of corticosteroids of the TCM users were recorded.", {"entities": []}], ["Association rule mining was used to analyze the prescriptions used for atopic dermatitis.", {"entities": [[71, 88, "DISEASE"], [78, 88, "DISEASE"]]}], ["We identified 13,646 children with atopic dermatitis using TCM in 2007.", {"entities": [[35, 52, "DISEASE"], [42, 52, "DISEASE"]]}], ["Female gender (OR: 0.83 for male gender), adolescence (OR: 10.0, 95\u00a0% CI: 8.88\u201311.15) and allergic rhinitis (OR: 2.44, 95\u00a0% CI: 2.10\u20132.85) were associated with the use of TCM.", {"entities": [[90, 107, "DISEASE"], [99, 107, "DISEASE"]]}], ["Fewer of the TCM users were prescribed with corticosteroids (35.8\u00a0% of all TCM users), but the TCM users had a higher rate of long-term topical corticosteroid therapy (10.6\u00a0% for TCM users versus 2.0\u00a0% for those who did not use TCM).", {"entities": []}], ["Chinese herbal medicine (CHM) was used by 93.7\u00a0% of all TCM users in 36,398 prescriptions.", {"entities": [[25, 28, "GENE"]]}], ["On average, 5.6 kinds of CHM were used in combination.", {"entities": [[25, 28, "GENE"]]}], ["The relationship between the CHMs constituted a network, in which Xiao-Feng-San was the core treatment for atopic dermatitis.", {"entities": [[107, 124, "DISEASE"], [114, 124, "DISEASE"]]}], ["In this study, we described the characteristics of children with atopic dermatitis who use TCM in Taiwan.", {"entities": [[65, 82, "DISEASE"], [72, 82, "DISEASE"]]}], ["and identified the core CHM treatment.", {"entities": [[24, 27, "GENE"]]}], ["Further research on the safety and efficacy of this treatment are still needed.", {"entities": []}], ["Serum albumin (Alb) is the most abundant protein in blood plasma.", {"entities": []}], ["Alb reacts with many carcinogens and/or their electrophilic metabolites.", {"entities": []}], ["Studies conducted over 20 years ago showed that Alb forms adducts with the human carcinogens aflatoxin B 1 and benzene, which were successfully used as biomarkers in molecular epidemiology studies designed to address the role of these chemicals in cancer risk.", {"entities": [[248, 254, "DISEASE"]]}], ["Alb forms adducts with many therapeutic drugs or their reactive metabolites such as \u03b2-lactam antibiotics, acetylsalicylic acid, acetaminophen, nonsteroidal anti-inflammatory drugs, chemotherapeutic agents, and antiretroviral therapy drugs.", {"entities": []}], ["The identification and characterization of the adduct structures formed with Alb have served to understand the generation of reactive metabolites and to predict idiosyncratic drug reactions and toxicities.", {"entities": []}], ["The reaction of candidate drugs with Alb is now exploited as part of the battery of screening tools to assess the potential toxicities of drugs.", {"entities": []}], ["The use of gas chromatography-mass spectrometry, liquid chromatography, or liquid chromatography-mass spectrometry (LC-MS) enabled the identification and quantification of multiple types of Alb xenobiotic adducts in animals and humans during the past three decades.", {"entities": []}], ["In this perspective, we highlight the history of Alb as a target protein for adduction to environmental and dietary genotoxicants, pesticides, and herbicides, common classes of medicinal drugs, and endogenous electrophiles, and the emerging analytical mass spectrometry technologies to identify Alb-toxicant adducts in humans.", {"entities": []}], ["The aim of the study was to evaluate the presence and spectrum of cardiac abnormalities identified by cardiac magnetic resonance (CMR) in subjects in clinical remission of Churg\u2013Strauss syndrome (CSS) and granulomatosis with polyangiitis (Wegener\u2019s) (WG) with normal ECG and transthoracic echocardiography (TTE).", {"entities": [[186, 194, "DISEASE"]]}], ["Eleven (7 females, 4 males, mean age 42.4\u00a0\u00b1\u00a09.6\u00a0years) CSS and 10 (4 females, 6 males, mean age 45.3\u00a0\u00b1\u00a010.9\u00a0years) WG patients in clinical remission with normal ECG and TTE underwent CMR.", {"entities": []}], ["Segmental peak-systolic myocardial strain (\u03b5 ps ) was measured using feature tracking cine-sequence based technique.", {"entities": []}], ["Left ventricular (LV) ejection fraction, end-diastolic volume and myocardial mass indexes were 66.2\u00a0\u00b1\u00a05.8\u00a0%, 66.1\u00a0\u00b1\u00a06.6\u00a0ml/m ps and myocardial late gadolinium enhancement (LGE) (6 subendocardial, 10 midwall, 8 subepicardial) areas.", {"entities": []}], ["In CSS and WG subjects with LVLGE lesions the mean LVLGE extent was 2.0\u00a0\u00b1\u00a01.6\u00a0% and 2.3\u00a0\u00b1\u00a01.5\u00a0% ( p \u00a0=\u00a00.65), respectively.", {"entities": []}], ["Segmental \u03b5 ps was decreased longitudinally (\u221211.8\u00a0\u00b1\u00a05.6\u00a0%) for subendocardial LGE, radially (13.7\u00a0\u00b1\u00a08.7\u00a0%) for subepicardial LGE, and circumferentially (\u221216.6\u00a0\u00b1\u00a04.2\u00a0%), longitudinally (\u221213.2\u00a0\u00b1\u00a05.5\u00a0%) and radially (18.8\u00a0\u00b1\u00a08.1\u00a0%) for midwall LGE, if compared to longitudinal (\u221222.7\u00a0\u00b1\u00a05.1\u00a0%), circumferential (\u221223.6\u00a0\u00b1\u00a05.6\u00a0%) and radial (34.2\u00a0\u00b1\u00a015.7\u00a0%) \u03b5 ps in controls (11 females, 10 males, mean age 43.9\u00a0\u00b1\u00a010.5\u00a0years) (all p \u00a0<\u00a00.01).", {"entities": []}], ["Despite clinical remission, normal ECG and TTE, most CSS and WG patients demonstrate decreased segmental \u03b5 ps and non-ischemic LGE lesions without signs of myocarditis.", {"entities": [[156, 167, "DISEASE"]]}], ["To assess the reasons for low influenza vaccination coverage in Poland, including knowledge of influenza and attitudes toward influenza vaccination.", {"entities": [[30, 39, "DISEASE"], [95, 104, "DISEASE"], [126, 135, "DISEASE"]]}], ["This was a cross-sectional, anonymous, self-administered survey in primary care patients in Lodzkie voivodship (central Poland).", {"entities": []}], ["The study participants were adults who visited their primary care physicians for various reasons from January 1 to April 30, 2007.", {"entities": []}], ["Six hundred and forty participants completed the survey.", {"entities": []}], ["In 12 months before the study, 20.8% participants had received influenza vaccination.", {"entities": [[63, 72, "DISEASE"]]}], ["The most common reasons listed by those who had not been vaccinated were good health (27.6%), lack of trust in vaccination effectiveness (16.8%), and the cost of vaccination (9.7%).", {"entities": []}], ["The most common source of information about influenza vaccination were primary care physicians (46.6%).", {"entities": [[44, 53, "DISEASE"]]}], ["Despite reasonably good knowledge of influenza, as many as approximately 20% of participants could not point out any differences between influenza and other viral respiratory tract infections.", {"entities": [[37, 46, "DISEASE"], [137, 146, "DISEASE"]]}], ["The main reasons for low influenza vaccination coverage in Poland were patients\u2019 misconceptions and the cost of vaccination.", {"entities": [[25, 34, "DISEASE"]]}], ["Therefore, free-of-charge vaccination and more effective informational campaigns are needed, with special focus on high-risk groups.", {"entities": []}], ["We investigated the role of interleukin-33 (IL-33) in airway inflammation in an experimental model of an acute exacerbation of chronic asthma, which reproduces many of the features of the human disease.", {"entities": [[135, 141, "DISEASE"]]}], ["Systemically sensitized female BALB/c mice were challenged with a low mass concentration of aerosolized ovalbumin for 4 weeks to induce chronic asthmatic inflammation and then received a single moderate-level challenge to trigger acute airway inflammation simulating an asthmatic exacerbation.", {"entities": []}], ["The inflammatory response and expression of cytokines and activation markers by alveolar macrophages (AM) were assessed, as was the effect of pretreatment with a neutralizing antibody to IL-33.", {"entities": []}], ["Compared to chronically challenged mice, AM from an acute exacerbation exhibited significantly enhanced expression of markers of alternative activation, together with enhanced expression of proinflammatory cytokines and of cell surface proteins associated with antigen presentation.", {"entities": []}], ["In parallel, there was markedly increased expression of both mRNA and immunoreactivity for IL-33 in the airways.", {"entities": []}], ["Neutralization of IL-33 significantly decreased both airway inflammation and the expression of proinflammatory cytokines by AM.", {"entities": []}], ["Collectively, these data indicate that in this model of an acute exacerbation of chronic asthma, IL-33 drives activation of AM and has an important role in the pathogenesis of airway inflammation.", {"entities": [[89, 95, "DISEASE"]]}], ["Local policy makers increasingly need information on health-related indicators at smaller geographic levels like districts or neighbourhoods.", {"entities": []}], ["Although more large data sources have become available, direct estimates of the prevalence of a health-related indicator cannot be produced for neighbourhoods for which only small samples or no samples are available.", {"entities": []}], ["Small area estimation provides a solution, but unit-level models for binary-valued outcomes that can handle both non-linear effects of the predictors and spatially correlated random effects in a unified framework are rarely encountered.", {"entities": []}], ["We used data on 26 binary-valued health-related indicators collected on 387,195 persons in the Netherlands.", {"entities": []}], ["We associated the health-related indicators at the individual level with a set of 12 predictors obtained from national registry data.", {"entities": []}], ["We formulated a structured additive regression model for small area estimation.", {"entities": []}], ["The model captured potential non-linear relations between the predictors and the outcome through additive terms in a functional form using penalized splines and included a term that accounted for spatially correlated heterogeneity between neighbourhoods.", {"entities": []}], ["The registry data were used to predict individual outcomes which in turn are aggregated into higher geographical levels, i.e.", {"entities": []}], ["neighbourhoods.", {"entities": []}], ["We validated our method by comparing the estimated prevalences with observed prevalences at the individual level and by comparing the estimated prevalences with direct estimates obtained by weighting methods at municipality level.", {"entities": []}], ["We estimated the prevalence of the 26 health-related indicators for 415 municipalities, 2599 districts and 11,432 neighbourhoods in the Netherlands.", {"entities": []}], ["We illustrate our method on overweight data and show that there are distinct geographic patterns in the overweight prevalence.", {"entities": []}], ["Calibration plots show that the estimated prevalences agree very well with observed prevalences at the individual level.", {"entities": []}], ["The estimated prevalences agree reasonably well with the direct estimates at the municipal level.", {"entities": []}], ["Structured additive regression is a useful tool to provide small area estimates in a unified framework.", {"entities": []}], ["We are able to produce valid nationwide small area estimates of 26 health-related indicators at neighbourhood level in the Netherlands.", {"entities": []}], ["The results can be used for local policy makers to make appropriate health policy decisions.", {"entities": []}], ["To assess the relationship between socioeconomic deprivation and health-related quality of life in urban neighbourhoods, using a multilevel approach.", {"entities": []}], ["Of the population-based cohort EPIPorto, 1154 georeferenced participants completed the 36-Item Short-Form Health Survey.", {"entities": []}], ["Neighbourhood socioeconomic deprivation classes were estimated using latent-class analysis.", {"entities": []}], ["Multilevel models measured clustering and contextual effects of neighbourhood deprivation on physical and mental HRQoL.", {"entities": []}], ["Residents from the least deprived neighbourhoods had higher physical HRQoL.", {"entities": []}], ["Neighbourhood socioeconomic deprivation together with individual-level variables (age, gender and education) and health-related factors (smoking, alcohol consumption, sedentariness and chronic diseases) explained 98% of the total between-neighbourhood variance.", {"entities": []}], ["Neighbourhood socioeconomic deprivation was significantly associated with physical health when comparing least and most deprived neighbourhoods (class 2\u2014beta coefficient: -0.60; 95% confidence interval:-1.76;-0.56; class 3 \u2013beta coefficient: -2.28; 95% confidence interval:-3.96;-0.60), and as neighbourhood deprivation increases, a decrease in all values of physical health dimensions (physical functioning, role physical, bodily pain and general health) was also observed.", {"entities": []}], ["Regarding the mental health dimension, no neighbourhood clustering or contextual effects were found.", {"entities": []}], ["However, as neighbourhood deprivation increases, the values of vitality and role emotional dimensions significantly decreased.", {"entities": []}], ["Neighbourhood socioeconomic deprivation is associated with HRQoL, affecting particularly physical health.", {"entities": []}], ["This study suggests that to improve HRQoL, people and places should be targeted simultaneously.", {"entities": []}], ["With the current wealth of new inhalers available and insurance policy driven inhaler switching, the need for insights in optimal education on inhaler use is more evident than ever.", {"entities": []}], ["We aimed to systematically review educational inhalation technique interventions, to assess their overall effectiveness, and identify main drivers of success.", {"entities": []}], ["Medline, Embase and CINAHL databases were searched for randomised controlled trials on educational inhalation technique interventions.", {"entities": []}], ["Inclusion eligibility, quality appraisal (Cochrane\u2019s risk of bias tool) and data extraction were performed by two independent reviewers.", {"entities": []}], ["Regression analyses were performed to identify characteristics contributing to inhaler technique improvement.", {"entities": []}], ["Thirty-seven of the 39 interventions included (95%) indicated statistically significant improvement of inhaler technique.", {"entities": []}], ["However, average follow-up time was relatively short (5 months), 28% lacked clinical relevant endpoints and all lacked cost-effectiveness estimates.", {"entities": []}], ["Poor initial technique, number of inhalation procedure steps, setting (outpatient clinics performing best), and time elapsed since intervention (all, p \u2009<\u20090.05), were shown to have an impact on effectiveness of the intervention, explaining up to 91% of the effectiveness variation.", {"entities": []}], ["Other factors, such as disease (asthma vs. chronic obstructive pulmonary disease), education group size (individual vs. group training) and inhaler type (dry powder inhalers vs. pressurised metered dose inhalers) did not play a significant role.", {"entities": [[43, 80, "DISEASE"], [32, 38, "DISEASE"]]}], ["Notably, there was a trend ( p \u2009=\u20090.06) towards interventions in adults being more effective than those in children and the intervention effect seemed to wane over time.", {"entities": []}], ["In conclusion, educational interventions to improve inhaler technique are effective on the short-term.", {"entities": []}], ["Periodical intervention reinforcement and longer follow-up studies, including clinical relevant endpoints and cost-effectiveness, are recommended.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by chronic bronchitis, emphysema and irreversible airflow limitation.", {"entities": [[73, 83, "DISEASE"]]}], ["These changes are thought to be due to oxidative stress and an imbalance of proteases and antiproteases.", {"entities": []}], ["Quercetin, a plant flavonoid, is a potent antioxidant and anti-inflammatory agent.", {"entities": []}], ["We hypothesized that quercetin reduces lung inflammation and improves lung function in elastase/lipopolysaccharide (LPS)-exposed mice which show typical features of COPD, including airways inflammation, goblet cell metaplasia, and emphysema.", {"entities": []}], ["Mice treated with elastase and LPS once a week for 4 weeks were subsequently administered 0.5 mg of quercetin dihydrate or 50% propylene glycol (vehicle) by gavage for 10 days.", {"entities": []}], ["Lungs were examined for elastance, oxidative stress, inflammation, and matrix metalloproteinase (MMP) activity.", {"entities": []}], ["Effects of quercetin on MMP transcription and activity were examined in LPS-exposed murine macrophages.", {"entities": []}], ["Quercetin-treated, elastase/LPS-exposed mice showed improved elastic recoil and decreased alveolar chord length compared to vehicle-treated controls.", {"entities": []}], ["Quercetin-treated mice showed decreased levels of thiobarbituric acid reactive substances, a measure of lipid peroxidation caused by oxidative stress.", {"entities": []}], ["Quercetin also reduced lung inflammation, goblet cell metaplasia, and mRNA expression of pro-inflammatory cytokines and muc5AC.", {"entities": []}], ["Quercetin treatment decreased the expression and activity of MMP9 and MMP12 in vivo and in vitro , while increasing expression of the histone deacetylase Sirt-1 and suppressing MMP promoter H4 acetylation.", {"entities": [[61, 65, "GENE"], [70, 75, "GENE"]]}], ["Finally, co-treatment with the Sirt-1 inhibitor sirtinol blocked the effects of quercetin on the lung phenotype.", {"entities": []}], ["Quercetin prevents progression of emphysema in elastase/LPS-treated mice by reducing oxidative stress, lung inflammation and expression of MMP9 and MMP12.", {"entities": [[139, 143, "GENE"], [148, 153, "GENE"]]}], ["Good communication is a crucial element of good clinical care, and it is important to provide appropriate consultation skills teaching in undergraduate medical training to ensure that doctors have the necessary skills to communicate effectively with patients and other key stakeholders.", {"entities": []}], ["This article aims to provide research evidence of the acceptability of a longitudinal consultation skills strand in an undergraduate medical course, as assessed by a cross-sectional evaluation of students' perceptions of their teaching and learning experiences.", {"entities": []}], ["A structured questionnaire was used to collect student views.", {"entities": []}], ["The questionnaire comprised two parts: 16 closed questions to evaluate content and process of teaching and 5 open-ended questions.", {"entities": []}], ["Questionnaires were completed at the end of each consultation skills session across all year groups during the 2006-7 academic year (5 sessions in Year 1, 3 in Year 2, 3 in Year 3, 10 in Year 4 and 10 in Year 5).", {"entities": []}], ["2519 questionnaires were returned in total.", {"entities": []}], ["Students rated Tutor Facilitation most favourably, followed by Teaching, then Practice & Feedback, with suitability of the Rooms being most poorly rated.", {"entities": []}], ["All years listed the following as important aspects they had learnt during the session: \u2022 how to structure the consultation \u2022 importance of patient-centredness \u2022 aspects of professionalism (including recognising own limits, being prepared, generally acting professionally).", {"entities": []}], ["All years also noted that the sessions had increased their confidence, particularly through practice.", {"entities": []}], ["Our results suggest that a longitudinal and integrated approach to teaching consultation skills using a well structured model such as Calgary-Cambridge, facilitates and consolidates learning of desired process skills, increases student confidence, encourages integration of process and content, and reinforces appreciation of patient-centredness and professionalism.", {"entities": []}], ["Airway microbiota dynamics during lower respiratory infection (LRI) are still poorly understood due, in part, to insufficient longitudinal studies and lack of uncontaminated lower airways samples.", {"entities": []}], ["Furthermore, the similarity between upper and lower airway microbiomes is still under debate.", {"entities": []}], ["Here we compare the diversity and temporal dynamics of microbiotas directly sampled from the trachea via tracheostomy in patients with (YLRI) and without (NLRI) lower respiratory infections.", {"entities": []}], ["We prospectively collected 127 tracheal aspirates across four consecutive meteorological seasons (quarters) from 40 patients, of whom 20 developed LRIs and 20 remained healthy.", {"entities": []}], ["All aspirates were collected when patients had no LRI.", {"entities": []}], ["We generated 16S rRNA-based microbial profiles (~250 bp) in a MiSeq platform and analyzed them using Mothur and the SILVAv123 database.", {"entities": []}], ["Differences in microbial diversity and taxon normalized (via negative binomial distribution) abundances were assessed using linear mixed effects models and multivariate analysis of variance.", {"entities": []}], ["Alpha-diversity (ACE, Fisher and phylogenetic diversity) and beta-diversity (Bray-Curtis, Jaccard and Unifrac distances) indices varied significantly (P<0.05) between NLRI and YLRI microbiotas from tracheostomised patients.", {"entities": []}], ["Additionally, Haemophilus was significantly (P = 0.009) more abundant in YLRI patients than in NLRI patients, while Acinetobacter , Corynebacterium and Pseudomonas (P<0.05) showed the inverse relationship.", {"entities": []}], ["We did not detect significant differences in diversity and bacterial abundance among seasons.", {"entities": []}], ["This result disagrees with previous evidence suggesting seasonal variation in airway microbiotas.", {"entities": []}], ["Further study is needed to address the interaction between microbes and LRI during times of health and disease.", {"entities": []}], ["The potential effects of combinations of dilute whole diesel exhaust (DE) and ozone (O 3 ), each a common component of ambient airborne pollutant mixtures, on lung function were examined.", {"entities": []}], ["Healthy young human volunteers were exposed for 2\u00a0hr to pollutants while exercising (~50\u00a0L/min) intermittently on two consecutive days.", {"entities": [[50, 52, "GENE"]]}], ["Day 1 exposures were either to filtered air, DE (300 \u03bcg/m 3 (0.300\u00a0ppm), or the combination of both pollutants.", {"entities": []}], ["On Day 2 all exposures were to O 3 (0.300\u00a0ppm), and Day 3 served as a followup observation day.", {"entities": []}], ["Lung function was assessed by spirometry just prior to, immediately after, and up to 4\u00a0hr post-exposure on each exposure day.", {"entities": [[87, 89, "GENE"]]}], ["Functional pulmonary responses to the pollutants were also characterized based on stratification by glutathione S-transferase mu 1 (GSTM1) genotype.", {"entities": [[132, 137, "GENE"]]}], ["On Day 1, exposure to air or DE did not change FEV1 or FVC in the subject population (n\u2009=\u200915).", {"entities": []}], ["The co-exposure to O 3 and DE decreased FEV1 (17.6%) to a greater extent than O 3 alone (9.9%).", {"entities": []}], ["To test for synergistic exposure effects, i.e., in a greater than additive fashion, FEV1 changes post individual O 3 and DE exposures were summed together and compared to the combined DE and O 3 exposure; the p value was 0.057.", {"entities": []}], ["On Day 2, subjects who received DE exposure on Day 1 had a larger FEV1 decrement (14.7%) immediately after the O 3 exposure than the individuals\u2019 matched response following a Day 1 air exposure (10.9%).", {"entities": []}], ["GSTM1 genotype did not affect the magnitude of lung function changes in a significant fashion.", {"entities": [[0, 5, "GENE"]]}], ["These data suggest that altered respiratory responses to the combination of O 3 and DE exposure can be observed showing a greater than additive manner.", {"entities": []}], ["In addition, O 3 -induced lung function decrements are greater with a prior exposure to DE compared to a prior exposure to filtered air.", {"entities": []}], ["Based on the joint occurrence of these pollutants in the ambient environment, the potential exists for interactions in more than an additive fashion affecting lung physiological processes.", {"entities": []}], ["Free radicals-induced neurodegeneration is one of the many causes of Parkinson\u2019s disease (PD).", {"entities": []}], ["This study investigated the neuroprotective effects of flavonol isoquercitrin against toxicity induced by 6-hydroxy-dopamine (6-OHDA) in rat pheochromocytoma (PC12) cells.", {"entities": []}], ["PC12 cells were pretreated with different concentrations of isoquercitrin for 4, 8 and 12 hours and incubated with 6-OHDA for 24 hours to induce oxidative cell damage.", {"entities": []}], ["A significant cytoprotective activity was observed in isoquercitrin pre-treated cells in a dose-dependent manner.", {"entities": []}], ["There was a significant increase (P < 0.01) in the antioxidant enzymes namely superoxide dismutase, catalase, glutathione peroxidase, and glutathione in isoquercitrin pretreated cells compared to cells incubated with 6-OHDA alone.", {"entities": []}], ["Isoquercitrin significantly reduced (P < 0.01) lipid peroxidation in 6-OHDA treated cells.", {"entities": []}], ["These results suggested that isoquercitrin protects PC 12 cells against 6-OHDA\u2013induced oxidative stress.", {"entities": [[52, 54, "GENE"]]}], ["The present study suggests the protective role of isoquercitrin on 6-hydroxydopamine-induced toxicity by virtue of its antioxidant potential.", {"entities": []}], ["Isoquercitrin could be a potential therapeutic agent against neurodegeneration in Parkinson\u2019s disease.", {"entities": []}], ["Interleukin (IL)-13, a T-helper type 2 cytokine, plays a critical role in the development of chronic obstructive pulmonary disease (COPD).", {"entities": [[93, 130, "DISEASE"]]}], ["This meta-analysis was performed to assess the association of IL-13 \u22121112 C/T promoter polymorphism with COPD susceptibility.", {"entities": []}], ["Published case-control studies from Pubmed and China National Knowledge Infrastructure (CNKI) databases were retrieved.", {"entities": []}], ["Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated.", {"entities": []}], ["Eight case-control studies in seven articles were included in this meta-analysis.", {"entities": []}], ["Pooled effect size showed IL-13 \u22121112 C/T was associated with COPD susceptibility in a codominant genetic model (TT vs CT, OR: 1.82, 95% CI: 1.14\u20132.92 and TT vs CC, OR: 2.02, 95% CI: 1.10\u20133.72), indicating individuals with TT genotype had an increased risk for COPD compared with those with CT or CC genotype.", {"entities": []}], ["According to ethnicity, results indicated IL-13 \u22121112 C/T was correlated with COPD susceptibility in Arabians (TT vs CT, OR: 2.94, 95% CI: 1.03\u20138.42 and TT vs CC, OR: 3.05, 95% CI: 1.08\u20138.59).", {"entities": []}], ["Moreover, after excluding the study without Hardy-Weinberg equilibrium, the pooled results were robust and no publication bias was found in this study.", {"entities": []}], ["This meta-analysis suggests IL-13 \u22121112 C/T promoter polymorphism is associated with the risk of COPD in Arabians.", {"entities": []}], ["The prevalence and severity of asthma has increased in the last 20 years, and the greatest increase has been seen among children and young adults living in U.S. inner cities.", {"entities": [[31, 37, "DISEASE"]]}], ["The reasons for this increase are obviously complex, but include environmental exposures to allergens and pollutants, changing patterns of medication, and the psychosocial stresses of living in poor inner-city neighborhoods.", {"entities": []}], ["This paper presents an overview of environmental, immunologic, and genetic factors associated with asthma morbidity and mortality.", {"entities": [[99, 105, "DISEASE"]]}], ["This overview can be used to provide a framework for designing an interdisciplinary research program to address the complexities of asthma etiology and exacerbation.", {"entities": [[132, 138, "DISEASE"]]}], ["The strongest epidemiologic association has been found between asthma morbidity and the exposure of immunologically sensitive asthmatic patients to airborne allergens.", {"entities": [[63, 69, "DISEASE"]]}], ["Our current understanding of the process of sensitization suggests that there is a strong genetic predisposition to form IgE to allergenic proteins on airborne particles.", {"entities": []}], ["Much of this work has been conducted with animal models, but in a number of instances, specific confirmation has been reported in humans.", {"entities": []}], ["Sensitized individuals respond to inhaled exposure with immediate mast-cell dependent inflammation that may be augmented by pollutant particles, especially diesel exhaust particles.", {"entities": []}], ["Relatively little is known about the methods of assessing exposure to airborne pollutants, especially biologically active particulates.", {"entities": []}], ["However, to examine the relationship of morbidity in genetically predisposed individuals, it will be important to determine the most relevant method of making this assessment.", {"entities": []}], ["Obstructive sleep apnea syndrome (OSAS) is strongly associated with the increasing prevalence of cerebrovascular events and metabolic syndrome.", {"entities": [[24, 32, "DISEASE"], [134, 142, "DISEASE"]]}], ["A growing number of studies have shown OSAS is an independent factor for insulin resistance, glucose intolerance and type2 diabetes.", {"entities": [[93, 112, "DISEASE"]]}], ["However, relationship of OSAS with dysglycemia is complex and still remains poorly understood.", {"entities": []}], ["Glucose transporter 4 (GLUT4) gene is Human and rodents\u2019 main glucose transporter sensitive to insulin, and therefore confirmation of candidate gene polymorphisms and association with OSAS is needed.", {"entities": []}], ["Aim of our study was to assess whether GLUT4 gene polymorphisms are associated with OSAS.", {"entities": []}], ["Patients hospitalized at People\u2019s Hospital of Xinjiang were selected from January to December 2010.", {"entities": []}], ["A total of 568 Han subjects who possibly exist OSAS base on a\u00a0history\u00a0and physical\u00a0examination were completed the polysomnography, 412of whom (72.5%) were diagnosed with OSAS, and 156 individuals were confirmed without OSAS (27.5%).", {"entities": []}], ["96 severe OSAS patients chosen from OSAS were used for DNA sequencing in functional domain.", {"entities": []}], ["Blood samples were collected from all subjects and genotyping was performed on DNA extracted from blood cells.", {"entities": []}], ["We performed GLUT4 genome sequencing, found 4 mutated sites.", {"entities": []}], ["And finally selected three mutated sites such as rs5415, rs4517 and rs5435, according to principle of linkage disequilibrium ( r P > 0.05).", {"entities": []}], ["Our study demonstrated a significant association of GLUT4 SNPrs5417 allele with OSAS, compared with controls ( P < 0.05).", {"entities": []}], ["Haplotype H1 (TCC) and H3 (CCC) defined as SNPrs5415, rs4517 and rs5435 are marginally associated with OSAS ( P < 0.05).", {"entities": []}], ["Frequencies of C haplotype of rs5417 in OSAS were higher than in controls.", {"entities": []}], ["After adjustment for confounding factors, (AC + AA) genotype significantly reduces prevalence of OSAS, compared with CC genotype.", {"entities": []}], ["Level of awake blood oxygen and lowest blood oxygen of (AA + AC) genotype was significantly superior to those of CC genotype.", {"entities": []}], ["Our study demonstrates GLUT4 gene SNPrs5417 is associated with OSAS in hypertensive population.", {"entities": []}], ["Carriers of AA + AC have less prevalence of obstructive sleep apnea syndrome than that of CC carriers.", {"entities": [[68, 76, "DISEASE"]]}], ["Linear mixed models (LMMs) are a powerful and established tool for studying genotype\u2013phenotype relationships.", {"entities": []}], ["A limitation of the LMM is that the model assumes Gaussian distributed residuals, a requirement that rarely holds in practice.", {"entities": []}], ["Violations of this assumption can lead to false conclusions and loss in power.", {"entities": []}], ["To mitigate this problem, it is common practice to pre-process the phenotypic values to make them as Gaussian as possible, for instance by applying logarithmic or other nonlinear transformations.", {"entities": []}], ["Unfortunately, different phenotypes require different transformations, and choosing an appropriate transformation is challenging and subjective.", {"entities": []}], ["Here we present an extension of the LMM that estimates an optimal transformation from the observed data.", {"entities": []}], ["In simulations and applications to real data from human, mouse and yeast, we show that using transformations inferred by our model increases power in genome-wide association studies and increases the accuracy of heritability estimation and phenotype prediction.", {"entities": []}], ["Linear mixed models (LMMs) provide a powerful method for studying genotype\u2013phenotype associations.", {"entities": []}], ["Here the authors present a LMM application that estimates an optimal transformation from observed data and increases the accuracy of heritability estimation and phenotype prediction.", {"entities": []}], ["With a secular trend of increasing colorectal cancer (CRC) screening, concerns about disparities in CRC screening also have been rising.", {"entities": [[35, 52, "DISEASE"], [46, 52, "DISEASE"]]}], ["It is unclear if CRC screening varies geographically, if area-level poverty rate affects CRC screening, and if individual-level characteristics mediate the area-level effects on CRC screening.", {"entities": []}], ["Using 2006 Missouri Behavioral Risk Factor Surveillance System (BRFSS) data, a multilevel study was conducted to examine geographic variation and the effect of area-level poverty rate on CRC screening use among persons age 50 or older.", {"entities": []}], ["Individuals were nested within ZIP codes (ZIP5 areas), which in turn, were nested within aggregations of ZIP codes (ZIP3 areas).", {"entities": []}], ["Six groups of individual-level covariates were considered as potential mediators.", {"entities": []}], ["An estimated 51.8% of Missourians aged 50 or older adhered to CRC screening recommendations.", {"entities": []}], ["Nearly 15% of the total variation in CRC screening lay between ZIP5 areas.", {"entities": []}], ["Persons residing in ZIP5 areas with \u2265 10% of poverty rate had lower odds of CRC screening use than those residing in ZIP5 areas with <10% poverty rate (unadjusted odds ratio [OR], 0.69; 95% confidence interval [95% CI], 0.58\u20130.81; adjusted OR, 0.81; 95% CI, 0.67\u20130.98).", {"entities": []}], ["Persons who resided in ZIP3 areas with \u2265 20% poverty rate also had lower odds of following CRC screening guidelines than those residing in ZIP3 areas with <20% poverty rate (unadjusted OR, 0.66; 95% CI, 0.52\u20130.83; adjusted OR, 0.64; 95% CI, 0.50\u20130.83).", {"entities": []}], ["Obesity, history of depression/anxiety and access to care were associated with CRC screening, but did not mediate the effect of area-level poverty on CRC screening.", {"entities": []}], ["Large geographic variation of CRC screening exists in Missouri.", {"entities": []}], ["Area-level poverty rate, independent of individual-level characteristics, is a significant predictor of CRC screening, but it only explains a small portion of the geographic heterogeneity of CRC screening.", {"entities": []}], ["Individual-level factors we examined do not mediate the effect of the area-level poverty rate on CRC screening.", {"entities": []}], ["Future studies should identify other area- and individual-level characteristics associated with CRC screening in Missouri.", {"entities": []}], ["Endogenous biological clocks enable living species to acquire some independence in relation to time.", {"entities": []}], ["They improve the efficiency of biological systems, by allowing them to anticipate future constraints on major physyological systems and cell energy metabolism.", {"entities": []}], ["The temporal organization of a giwen biological function can be impaired in its coordination with astronomical time or with other biological function.", {"entities": []}], ["There are also external conditions that influence biological clocks.", {"entities": []}], ["This temporal organization is complex, and it is possible that a series of psychiatric disorders and syndromes involve primary or secondary changes in biological clocks: seasonal and other mood disorders, premenstrual syndromes, social jet lag, free-running rhythms, and several sleep disorders are among them.", {"entities": []}], ["In this review, we describe the main concepts relevant to chronobiology and explore the relevance of knowledge about biological clocks to the clinical practice of psychiatry", {"entities": []}], ["To compare lung function of extremely preterm (EP)-born infants with and without bronchopulmonary dysplasia (BPD) with that of healthy term-born infants, and to determine which perinatal characteristics were associated with lung function at term and how predictive these measurements were for later respiratory health in EP-born infants.", {"entities": []}], ["Perinatal variables were recorded prospectively, and tidal breathing parameters were measured at term-equivalent age using electromagnetic inductance plethysmography.", {"entities": []}], ["Respiratory morbidity was defined by hospital readmissions and/or treatment with asthma medications during the first year of life.", {"entities": [[81, 87, "DISEASE"]]}], ["Fifty-two EP-born infants (mean gestational age 26 Lung function measured at term-equivalent age was strikingly abnormal in EP-born infants, irrespective of BPD.", {"entities": []}], ["Tidal breathing parameters may be of value in predicting future pulmonary health in infants born premature.", {"entities": []}], ["NCT01150396; Results.", {"entities": []}], ["The variability of repeated house dust mite (HDM) allergen determinations at the same site within 3-24 months was evaluated on previously collected samples.", {"entities": []}], ["Between two and four repeated measurements of Der p 1, a major allergen of Dermatophagoides pteronyssinus and Der f 1, a major allergen of D. farinae, on 46 carpets and 31 mattresses were analyzed.", {"entities": []}], ["In 90% of carpets and mattresses, HDM allergen concentrations were clinically relevant (at least one measurement >0.1 microg Der p 1 + Der f 1/g dust).", {"entities": []}], ["The coefficients of variation (CVs) for allergen concentrations in repeated samples over time (55.3-82.0% for the two allergens in beds and carpets) were clearly greater than the CVs for multiple samples collected at the same time (4.0-32.6%).", {"entities": []}], ["Determination of allergen mass per square meter of surface instead of concentration per gram of dust resulted in an even greater CV (72.3-86.7%).", {"entities": []}], ["The 95% range of expected values was about 10-fold above and below the result of a single determination.", {"entities": []}], ["We conclude that single determinations of HDM allergen in dust give very limited information about long-term exposure of an individual to the allergen.", {"entities": []}], ["Repeated measurements are recommended.", {"entities": []}], ["Studies of factors that affect HDM allergen exposure must be planned with appropriate sample sizes.", {"entities": []}], ["Exhaled breath condensate (EBC) has been increasingly used as a new and non-invasive method to study airway inflammation.", {"entities": []}], ["In this study we have compared the concentrations of lipid mediators in EBCwith concentrations in bronchoalveolar lavage fluid (BALF).", {"entities": []}], ["We included 37 patients undergoing bronchoscopy (12 sarcoidosis, 12 COPD, 6 lung cancer, 5 chronic cough, 1 Wegener\u2019s granulomatosis, 1 sclerodermia).", {"entities": [[76, 87, "DISEASE"], [52, 63, "DISEASE"], [81, 87, "DISEASE"]]}], ["Patients were not allowed to have exacerbation or any change in concomitant medication for at least 4 weeks prior to the study.", {"entities": []}], ["In all patients, EBC was collected immediately prior to the bronchoscopy.", {"entities": []}], ["The levels of cys-LTs, LTB 4 , 8-isoprostane were significantly higher in BALF compared to EBC (p < 0.0001, p < 0.001, p < 0.0001 for cys-LTs, LTB4, 8-isoprostane respectively).", {"entities": [[23, 26, "GENE"]]}], ["Moreover, there was a strong positive correlation between both leukotriene B 4 and 8-isoprostane in BALF and EBC ( r = 0.53 and r = 0.79, p < 0.01, respectively) in patients with sarcoidosis and COPD but there was no correlation between eicosanoids BALF and EBC in patients with chronic cough and lung cancer.", {"entities": [[297, 308, "DISEASE"], [179, 190, "DISEASE"], [302, 308, "DISEASE"]]}], ["This is the first study to compare EBC and BALF in different lung diseases which demonstrated significant correlations between the levels of eicosanoids in BALF and EBCin patientswith COPD and sarcoidosis.", {"entities": [[193, 204, "DISEASE"]]}], ["EBC may be useful inmeasuring inflammation in several inflammatory lung diseases.", {"entities": []}], ["Developing recommendations for prostate cancer prevention requires identification of modifiable risk factors.", {"entities": [[40, 46, "DISEASE"], [31, 46, "DISEASE"]]}], ["Maternal exposure to high-fat diet (HFD) initiates a broad array of second-generation adult disorders in murine models and humans.", {"entities": []}], ["Here, we investigate whether maternal HFD in mice affects incidence of prostate hyperplasia in offspring.", {"entities": []}], ["Using three independent assays, we demonstrate that maternal HFD is sufficient to initiate prostate hyperproliferation in adult male offspring.", {"entities": []}], ["HFD-exposed prostate tissues do not increase in size, but instead concomitantly up-regulate apoptosis.", {"entities": []}], ["Maternal HFD-induced phenotypes are focally present in young adult subjects and greatly exacerbated in aged subjects.", {"entities": []}], ["HFD-exposed prostate tissues additionally exhibit increased levels of activated Akt and deactivated Pten.", {"entities": [[100, 104, "GENE"]]}], ["Taken together, we conclude that maternal HFD diet is a candidate modifiable risk factor for prostate cancer initiation in later life.", {"entities": [[102, 108, "DISEASE"], [93, 108, "DISEASE"]]}], ["Experience of stress may lead to increased electromyography (EMG) activity in specific muscles compared to a non-stressful situation.", {"entities": []}], ["The main aim of this study was to develop and validate a stress-EMG paradigm in which a single uncontrollable and unpredictable nociceptive stimulus was presented.", {"entities": []}], ["EMG activity of the trapezius muscles was the response of interest.", {"entities": []}], ["In addition to linear time effects, non-linear EMG time courses were also examined.", {"entities": []}], ["Taking into account the hierarchical structure of the dataset, a multilevel random regression model was applied.", {"entities": []}], ["The stress paradigm, executed in N\u200a=\u200a70 subjects, consisted of a 3-minute baseline measurement, a 3-minute pre-stimulus stress period and a 2-minute post-stimulus phase.", {"entities": []}], ["Subjects were unaware of the precise moment of stimulus delivery and its intensity level.", {"entities": []}], ["EMG activity during the entire experiment was conform a priori expectations: the pre-stimulus phase showed a significantly higher mean EMG activity level compared to the other two phases, and an immediate EMG response to the stimulus was demonstrated.", {"entities": []}], ["In addition, the analyses revealed significant non-linear EMG time courses in all three phases.", {"entities": []}], ["Linear and quadratic EMG time courses were significantly modified by subjective anticipatory stress level, measured just before the start of the stress task.", {"entities": []}], ["Linking subjective anticipatory stress to EMG stress reactivity revealed that subjects with a high anticipatory stress level responded with more EMG activity during the pre-stimulus stress phase, whereas subjects with a low stress level showed an inverse effect.", {"entities": []}], ["Results suggest that the stress paradigm presented here is a valid test to quantify individual differences in stress susceptibility.", {"entities": []}], ["Further studies with this paradigm are required to demonstrate its potential use in mechanistic clinical studies.", {"entities": []}], ["Since 1987, the World Health Organization (WHO) carried out global surveys on polychlorinated dibenzo- p -dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs) in human milk.", {"entities": []}], ["This study presents a review of the three most recent surveys from 2000 to 2010, including DDT.", {"entities": []}], ["The objective was to identify global quantitative differences and provide baseline information for 52 countries or provide time-trends for countries with previous data.", {"entities": []}], ["Individual human milk samples were collected following a WHO-designed procedure and combined to form a national pooled sample.", {"entities": []}], ["Here, we report global levels for PCDDs, PCDFs, PCBs and the sum of o , p \u2032-DDT, p , p \u2032-DDT, o , p \u2032-DDE, p , p \u2032-DDE, o , p \u2032-DDD and p , p \u2032-DDD ( \u03a3 DDTs).", {"entities": []}], ["A concise risk\u2013benefit evaluation related to human milk contamination with these persistent organic pollutants (POPs) was also done.", {"entities": []}], ["Large global and regional differences were observed.", {"entities": []}], ["Levels of PCDDs and PCDFs were highest in India and some European and African countries.", {"entities": []}], ["PCB levels were highest in East and West Europe.", {"entities": []}], ["The highest levels of \u03a3 DDTs were found in less industrialized countries.", {"entities": []}], ["A temporal downward trend for PCDDs, PCDFs and PCBs is indicated.", {"entities": []}], ["A risk\u2013benefit assessment indicates that human milk levels of PCDDs, PCDFs and PCBs are still significantly above those considered toxicologically safe, while \u03a3 DDTs are below or around those considered safe.", {"entities": []}], ["With respect to potential adverse health effects, a more dominant role of in utero exposure versus lactational exposure is indicated.", {"entities": []}], ["If potential adverse effects are balanced against positive health aspects for (breastfed) infants, the advantages of breastfeeding far outweigh the possible disadvantages.", {"entities": []}], ["Our observations provide a strong argument to plea for further global source-directed measures to reduce human exposure further to dioxin-like compounds.", {"entities": []}], ["Despite the availability of evidence-based guidelines for conservative treatment of osteoarthritis (OA), management is often confined to the use of analgesics and waiting for eventual total joint replacement.", {"entities": [[84, 98, "DISEASE"]]}], ["This suggests a gap in knowledge for persons with OA regarding the many different treatments available to them.", {"entities": []}], ["Our objective was to evaluate outcomes after usage of a Web-based resource called My Joint Pain that contains tailored, evidence-based information and tools aimed to improve self-management of OA on self-management and change in knowledge.", {"entities": []}], ["A quasi-experimental design was used to evaluate the My Joint Pain website intervention over a 12-month period.", {"entities": []}], ["The intervention provided participants with general and user-specific information, monthly assessments with validated instruments, and progress-tracking tools.", {"entities": []}], ["A nationwide convenience sample of 195 participants with self-assessed hip and/or knee OA completed both baseline and 12-month questionnaires (users: n=104; nonusers: n=91).", {"entities": []}], ["The primary outcome measure was the Health Evaluation Impact Questionnaire (heiQ) to evaluate 8 different domains (health-directed activity, positive and active engagement in life, emotional distress, self-monitoring and insight, constructive attitudes and approaches, skill and technique acquisition, social integration and support, health service navigation) and the secondary outcome measure was the 17-item Osteoarthritis Quality Indicator (OAQI) questionnaire to evaluate the change in appropriateness of care received by participants.", {"entities": [[411, 425, "DISEASE"]]}], ["Independent t tests were used to compare changes between groups for the heiQ and chi-square tests to identify changes within and between groups from baseline to 12 months for each OAQI item.", {"entities": []}], ["Baseline demographics between groups were similar for gender (152/195, 77.9% female), age (mean 60, SD 9 years) and body mass index (mean 31.1, SD 6.8 kg/m P =.03), lifestyle (absolute change score=16%, P =.02), and physical activity (absolute change score=11%, P =.04), with no significant improvements for the nonusers.", {"entities": []}], ["Following 12 months of exposure to the website, there were significant improvements for users compared to nonusers in self-management (absolute change score 15% vs 2%, P =.001) and weight reduction (absolute change scores 3% vs \u20136%, P =.03) measured on the OAQI.", {"entities": []}], ["The My Joint Pain Web resource does not significantly improve overall heiQ, but does improve other important aspects of quality of care in people with hip and/or knee OA.", {"entities": []}], ["Further work is required to improve engagement with the website and the quality of information delivered in order to provide a greater impact.", {"entities": []}], ["Stress is considered a causal factor in many diseases, allergic disease being one of them.", {"entities": []}], ["The prevalence of allergic disease is increasing in Korea, but the relationship between allergic symptoms and stress is not empirically well known.", {"entities": []}], ["We aimed to evaluate the relationship between allergy-related symptoms and stress in children and adolescents.", {"entities": []}], ["We investigated 698 children and adolescents living in Gwangyang Bay, Korea, using a multi-stage cluster sampling method.", {"entities": []}], ["Using the International Study of Asthma and Allergies in Childhood and the Psychosocial Well-being Index, these subjects were surveyed on allergy-related symptoms and psychosocial stressors in their lives, respectively.", {"entities": []}], ["We used a multivariate logistic analysis for odds ratios for the complaint rate of allergic symptoms, after adjusting for age, gender, household income, body mass index, and residence.", {"entities": []}], ["After adjustments, lifetime rhinitis (odds ratio [OR], 1.024), rhinoconjunctivitis (OR, 1.090), diagnosis of itchy eczema (OR, 1.040), treatment of itchy eczema (OR, 1.049), 12-month allergic conjunctivitis (OR, 1.026), diagnosis of allergic conjunctivitis (OR, 1.031), and treatment of allergic conjunctivitis (OR, 1.034) were found to be significantly associated with stress.", {"entities": [[28, 36, "DISEASE"], [183, 206, "DISEASE"], [233, 256, "DISEASE"], [287, 310, "DISEASE"], [192, 206, "DISEASE"], [242, 256, "DISEASE"], [296, 310, "DISEASE"]]}], ["Our results support the notion that there is a relationship between stress and allergic symptoms in children and adolescents.", {"entities": []}], ["Further research into any causal relationship between stress and allergies, as well as preventative public health plans for decreasing stress in children and adolescents are needed.", {"entities": []}], ["Interactions between the immune system and skin bacteria are of major importance in the pathophysiology of atopic dermatitis (AD), yet our understanding of them is limited.", {"entities": [[107, 124, "DISEASE"], [114, 124, "DISEASE"]]}], ["From a cohort of very young AD children (1 to 3 years old), sensitized to Dermatophagoides pteronyssinus allergens (Der p), we conducted culturomic analysis of skin microbiota, cutaneous transcript profiling and quantification of anti-Der p CD4 S .", {"entities": [[241, 244, "GENE"]]}], ["aureus in inflamed skin of AD patients was associated with a high IgE response, increased expression of inflammatory and Th2/Th22 transcripts and the prevalence of a peripheral Th2 anti-Der p response.", {"entities": []}], ["Monocyte-derived dendritic cells (moDC) exposed to the S .", {"entities": []}], ["aureus and S .", {"entities": []}], ["epidermidis secretomes were found to release pro-inflammatory IFN-\u03b3 and anti-inflammatory IL-10, respectively.", {"entities": []}], ["Allogeneic moDC exposed to the S .", {"entities": []}], ["aureus secretome also induced the proliferation of CD4 S .", {"entities": [[51, 54, "GENE"]]}], ["epidermidis secretome.", {"entities": []}], ["In addition, whereas the S .", {"entities": []}], ["epidermidis secretome promoted the activity of regulatory T cells (Treg) in suppressing the proliferation of conventional CD4 S .", {"entities": [[122, 125, "GENE"]]}], ["aureus secretome.", {"entities": []}], ["We therefore conclude that S .", {"entities": []}], ["aureus may cause and promote inflammation in the skin of AD children through concomitant Th2 activation and the silencing of resident Treg cells.", {"entities": []}], ["Commensals such as S .", {"entities": []}], ["epidermidis may counteract these effects by inducing the release of IL-10 by skin dendritic cells.", {"entities": []}], ["Streptococcus pneumoniae is the bacterial agent which most frequently causes pneumonia.", {"entities": [[77, 86, "DISEASE"]]}], ["In some Scandinavian countries, this infection is treated with penicillin V since the resistances of pneumococci to this antibiotic are low.", {"entities": []}], ["Four reasons justify the undertaking of this study; firstly, the cut-off points which determine whether a pneumococcus is susceptible or resistant to penicillin have changed in 2008 and according to some studies published recently the pneumococcal resistances to penicillin in Spain have fallen drastically, with only 0.9% of the strains being resistant to oral penicillin (minimum inhibitory concentration>2\u00a0\u03bcg/ml); secondly, there is no correlation between pneumococcal infection by a strain resistant to penicillin and therapeutic failure in pneumonia; thirdly, the use of narrow-spectrum antibiotics is urgently needed because of the dearth of new antimicrobials and the link observed between consumption of broad-spectrum antibiotics and emergence and spread of antibacterial resistance; and fourthly, no clinical study comparing amoxicillin and penicillin V in pneumonia in adults has been published.", {"entities": [[545, 554, "DISEASE"], [867, 876, "DISEASE"]]}], ["Our aim is to determine whether high-dose penicillin V is as effective as high-dose amoxicillin for the treatment of uncomplicated community-acquired pneumonia.", {"entities": [[150, 159, "DISEASE"]]}], ["We will perform a parallel group, randomised, double-blind, trial in primary healthcare centres in Spain.", {"entities": []}], ["Patients aged 18 to 65 without significant associated comorbidity attending the physician with signs and symptoms of lower respiratory tract infection and radiological confirmation of the diagnosis of pneumonia will be randomly assigned to either penicillin V 1.6 million units thrice-daily during 10\u00a0days or amoxicillin 1,000\u00a0mg thrice-daily during 10\u00a0days.", {"entities": [[201, 210, "DISEASE"]]}], ["The main outcome will be clinical cure at 14\u00a0days, defined as absence of fever, resolution or improvement of cough, improvement of general wellbeing and resolution or reduction of crackles indicating that no other antimicrobial treatment will be necessary.", {"entities": []}], ["Any clinical result other than the anterior will be considered as treatment failure.", {"entities": []}], ["A total of 210 patients will be recruited to detect a non-inferiority margin of 15% between the two treatments with a minimum power of 80% considering an alpha error of 2.5% for a unilateral hypothesis and maximum possible losses of 15%.", {"entities": []}], ["This pragmatic trial addresses the long-standing hypothesis that the administration of high doses of a narrow-spectrum antibiotic (penicillin V) in patients with non-severe pneumonia attended in the community is not less effective than high doses of amoxicillin (treatment currently recommended) in patients under the age of 65\u00a0years.", {"entities": [[173, 182, "DISEASE"]]}], ["EudraCT number 2012-003511-63 .", {"entities": []}], ["Studies have shown diverse strength of evidence for the associations between air pollutants and childhood asthma, but these associations have scarcely been documented in the early life.", {"entities": [[106, 112, "DISEASE"]]}], ["The purpose of this study was to evaluate the impacts of various air pollutants on the development of asthma phenotypes in the first year of life.", {"entities": [[102, 108, "DISEASE"]]}], ["Adjusted odds ratios were estimated to assess the relationships between exposures to air pollutants and single and multi-dimensional asthma phenotypes in the first year of life in children of the EDEN mother-child cohort study (n\u2009=\u20091,765 mother-child pairs).", {"entities": [[133, 139, "DISEASE"]]}], ["The Generalized Estimating Equation (GEE) model was used to determine the associations between prenatal maternal smoking and in utero exposure to traffic-related air pollution and asthma phenotypes (data were collected when children were at birth, and at 4, 8 and 12\u00a0months of age).", {"entities": [[180, 186, "DISEASE"]]}], ["Adjusted Population Attributable Risk (aPAR) was estimated to measure the impacts of air pollutants on health outcomes.", {"entities": []}], ["In the first year of life, both single and multi-dimensional asthma phenotypes were positively related to heavy parental smoking, traffic-related air pollution and dampness, but negatively associated with contact with cats and domestic wood heating.", {"entities": [[61, 67, "DISEASE"]]}], ["Adjusted odds ratios (aORs) for traffic-related air pollution were the highest [1.71 (95% Confidence Interval (CI): 1.08-2.72) for ever doctor-diagnosed asthma, 1.44 (95% CI: 1.05-1.99) for bronchiolitis with wheezing, 2.01 (95% CI: 1.23-3.30) for doctor-diagnosed asthma with a history of bronchiolitis].", {"entities": [[153, 159, "DISEASE"], [265, 271, "DISEASE"], [190, 203, "DISEASE"], [290, 303, "DISEASE"]]}], ["The aPARs based on these aORs were 13.52%, 9.39%, and 17.78%, respectively.", {"entities": []}], ["Results persisted for prenatal maternal smoking and in utero exposure to traffic-related air pollution, although statistically significant associations were observed only with the asthma phenotype of ever bronchiolitis.", {"entities": [[180, 186, "DISEASE"], [205, 218, "DISEASE"]]}], ["After adjusting for potential confounders, traffic-related air pollution in utero life and in the first year of life, had a greater impact on the development of asthma phenotypes compared to other factors.", {"entities": [[161, 167, "DISEASE"]]}], ["To estimate the prevalence of emergency cases reporting to Primary Health Care centers (PHC), Jeddah, Saudi Arabia and to explore the barriers facing PHC physicians when dealing with such emergency cases.", {"entities": []}], ["A cross-sectional analytic study, where all physicians working in the PHC of the Ministry of Health (MOH) in Jeddah; were invited to participate (n=247).", {"entities": []}], ["The study period was from July 2013 till December 2013.", {"entities": []}], ["Data were collected through two sources.", {"entities": []}], ["1- A self-administered questionnaire used to determine the physicians\u2019 perceived competence when dealing with emergency cases.", {"entities": []}], ["2- A structured observation sheet used to evaluate availability of equipment, drugs, ambulances and other supporting facilities required to deal with emergency cases.", {"entities": []}], ["The response rate was 83.4%.", {"entities": []}], ["The physicians\u2019 age ranged between 25 and 60 years with a mean \u00b1SD of 34.4\u00b17.5 years.", {"entities": []}], ["Majority of them (83.5%) did not attend ATLS courses at all whereas 60.7% never attended ACLS courses.", {"entities": []}], ["The majority (97.1%) had however attended BLS courses.", {"entities": []}], ["Physicians in the age group 36-45 years, non-Saudi, those who had SBFM, those who reported experience in working in emergency departments and physicians who reported more working years in PHCCs (>5 years) had a significant higher score of perceived level of competence in performing emergency skill scale than others (P<0.05).", {"entities": []}], ["The prevalence of emergency cases attending PHC in Jeddah (2013) was 5.2%.", {"entities": []}], ["Emergency services at PHC in Jeddah are functioning reasonably well, but require fine tuning of services and an upgrade in their quality.", {"entities": []}], ["Gout is a self-limiting, auto-inflammatory arthritis induced by the deposition of monosodium urate crystals in the synovial fluid and periarticular tissues.", {"entities": [[43, 52, "DISEASE"], [0, 4, "DISEASE"]]}], ["The aim of this study was to investigate the associations between genetic variants in the interleukin (IL) and interleukin receptor (ILR) genes IL-33 , IL-1RL1 , IL-23R , and signal transducer and activator of transcription 4 ( STAT4 ) and susceptibility to gout in Chinese Han male individuals.", {"entities": [[258, 262, "DISEASE"], [228, 233, "GENE"]]}], ["The genetic distributions of rs3939286 in IL-33 , rs13015714 in IL-1RL1 , rs10889677 in IL-23R , and rs7574865 in STAT4 were detected in 1100 men with gout and 1227 ethnically matched controls, using Taqman allelic discrimination real-time polymerase chain reaction (PCR).", {"entities": [[151, 155, "DISEASE"], [114, 119, "GENE"]]}], ["Differences in these polymorphisms between the groups were investigated using \u03c7 IL-23R may be involved in the development of gout in Chinese Han male individuals.", {"entities": [[125, 129, "DISEASE"]]}], ["However, further studies in other ethnic groups are needed to confirm these results.", {"entities": []}], ["Knowledge about psychometric properties of the Pediatric Quality of Life Inventory (PedsQL) in the Netherlands is limited and Dutch reference data are lacking.", {"entities": []}], ["Aim of the current study is to collect Dutch reference data of the PedsQL and subsequently assess reliability, socio-demographic within-group differences and construct validity.", {"entities": []}], ["In this study the PedsQL was administered to Dutch children aged 5 to 18 years.", {"entities": []}], ["A socio-demographic questionnaire was completed as well.", {"entities": []}], ["The sample consisted of three age groups: 5-7 years (parent proxy report), 8-12 years and 13-18 years (child self report).", {"entities": []}], ["Analysis was performed with SPSS 16.0.2.", {"entities": []}], ["A reliability analysis was done using Cronbach's alpha coefficient.", {"entities": []}], ["Socio-demographic within-group differences were assessed by means of an ANOVA with post hoc Bonferroni correction and t-tests.", {"entities": []}], ["Subsequently, construct validity was determined by t-tests and effect sizes.", {"entities": []}], ["For 496 children PedsQL reference data were collected.", {"entities": []}], ["PedsQL total scores were 84.18 (group 5-7), 82.11 (group 8-12) and 82.24 (group 13-18).", {"entities": []}], ["Internal consistency coefficients ranged from .53 to .85.", {"entities": []}], ["Socio-demographic within-group differences demonstrated that, in group 8-12, children of parents born in the Netherlands had significantly lower scores on several PedsQL subscales, compared to children of parents born in another country.", {"entities": []}], ["With respect to construct validity, healthy children of group 5-7 and 13-18 scored significantly higher than children with a chronic health condition on all subscales, except for emotional functioning.", {"entities": []}], ["In group 5-7, the PedsQL total score for healthy children was 85.31, whereas the same age group with a chronic health condition scored 78.80.", {"entities": []}], ["Effect sizes in this group varied from 0.58 to 0.88.", {"entities": []}], ["With respect to group 13-18, healthy children obtained a PedsQL total score of 83.14 and children suffering from a chronic health condition 77.09.", {"entities": []}], ["Effect sizes in this group varied from 0.45 to 0.67.", {"entities": []}], ["No significant differences were found in group 8-12 regarding health.", {"entities": []}], ["The Dutch version of the PedsQL has adequate psychometric properties and can be used as a health related quality of life instrument in paediatric research in the Netherlands.", {"entities": []}], ["Data from Washington State's work-related asthma surveillance system were used to characterize isocyanate-induced asthma cases occurring from 1999 through 2010.", {"entities": [[42, 48, "DISEASE"], [114, 120, "DISEASE"]]}], ["Injured worker interviews and medical records were used to describe the industry, job title, work process, workers\u2019 compensation cost, and exposure trends associated with 27 cases of isocyanate-induced asthma.", {"entities": [[202, 208, "DISEASE"]]}], ["The majority (81%) of cases were classified within the surveillance system as new-onset asthma while 19% were classified as work-aggravated asthma.", {"entities": [[88, 94, "DISEASE"], [140, 146, "DISEASE"]]}], ["The workers\u2019 compensation cost for isocyanate-induced asthma cases was $1.7 million; this was 14% of the total claims cost for all claims in the asthma surveillance system.", {"entities": [[54, 60, "DISEASE"], [145, 151, "DISEASE"]]}], ["The majority of cases (48%) occurred from paint processes, followed by foam application or foam manufacturing (22%).", {"entities": []}], ["Nine of the asthma cases associated with spray application occurred during application to large or awkward-shaped objects.", {"entities": [[12, 18, "DISEASE"]]}], ["Six workers who did not directly handle isocyanates (indirect exposure) developed new-onset asthma.", {"entities": [[92, 98, "DISEASE"]]}], ["Two cases suggest that skin contact and processes secondary to the isocyanate spray application, such as cleanup, contributed to immune sensitization.", {"entities": []}], ["Surveillance data provide insight for the prevention of isocyanate-induced respiratory disease.", {"entities": []}], ["Key observations are made regarding the development of work-related asthma in association with a) paint application on large objects difficult to ventilate, b) indirect exposure to isocyanates, c) exposure during secondary or cleanup processes, and d) reports of dermal exposure.", {"entities": [[68, 74, "DISEASE"]]}], ["To systematically review the literature and determine frequencies of adverse drug events (ADE) associated with pediatric asthma medications.", {"entities": [[121, 127, "DISEASE"]]}], ["Following PRISMA guidelines, we systematically searched six bibliographic databases between January 1991 and January 2017.", {"entities": []}], ["Study eligibility, data extraction and quality assessment were independently completed and verified by two reviewers.", {"entities": []}], ["We included randomized control trials (RCT), case-control, cohort, or quasi-experimental studies where the primary objective was identifying ADE in children 1 month\u2013 18 years old exposed to commercial asthma medications.", {"entities": [[201, 207, "DISEASE"]]}], ["The primary outcome was ADE frequency.", {"entities": []}], ["Our search identified 14,540 citations.", {"entities": []}], ["46 studies were included: 24 RCT, 15 cohort, 4 RCT pooled analyses, 1 case-control, 1 open-label trial and 1 quasi-experimental study.", {"entities": []}], ["Studies examined the following drug classes: inhaled corticosteroids (ICS) (n = 24), short-acting beta-agonists (n = 10), long-acting beta-agonists (LABA) (n = 3), ICS + LABA (n = 3), Leukotriene Receptor Antagonists (n = 3) and others (n = 3).", {"entities": []}], ["29 studies occurred in North America, and 29 were industry funded.", {"entities": []}], ["We report a detailed index of 406 ADE descriptions and frequencies organized by drug class.", {"entities": []}], ["The majority of data focuses on ICS, with 174 ADE affecting 13 organ systems including adrenal and growth suppression.", {"entities": []}], ["We observed serious ADE, although they were rare, with frequency ranging between 0.9\u20136% per drug.", {"entities": []}], ["There were no confirmed deaths, except for 13 potential deaths in a LABA study including combined adult and pediatric participants.", {"entities": []}], ["We identified substantial methodological concerns, particularly with identifying ADE and determining severity.", {"entities": []}], ["No studies utilized available standardized causality, severity or preventability assessments.", {"entities": []}], ["The majority of studies focus on ICS, with adrenal and growth suppression described.", {"entities": []}], ["Serious ADE are relatively uncommon, with no confirmed pediatric deaths.", {"entities": []}], ["We identify substantial methodological concerns, highlighting need for standardization with future research examining pediatric asthma medication safety.", {"entities": [[128, 134, "DISEASE"]]}], ["This study was performed to assess the early diagnostic, risk stratification, and prognostic value of the angiopoietin-2/angiopoietin-1 ratio (Ang-2/Ang-1) and angiopoietin-1/tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2 ratio (Ang-1/Tie-2) and to compare these factors with procalcitonin (PCT) and the Mortality in Emergency Department Sepsis (MEDS) score in patients with early sepsis in the emergency department (ED).", {"entities": []}], ["Consecutive patients with sepsis (n\u2009=\u2009440) were enrolled in this study.", {"entities": []}], ["They fulfilled the systemic inflammatory response syndrome (SIRS) criteria and were admitted to the ED of Beijing Chao-yang Hospital between August 2014 and February 2015.", {"entities": [[50, 58, "DISEASE"]]}], ["The control group consisted of 55 healthy blood donors.", {"entities": []}], ["The patients were categorized into four groups: SIRS, sepsis, severe sepsis, and septic shock.", {"entities": []}], ["Serum Ang-1, Ang-2, Tie-2, and PCT were measured, and the MEDS score was calculated upon ED arrival.", {"entities": []}], ["The prognostic values of Ang-2/Ang-1, Ang-1/Tie-2, Ang-1, Ang-2, and Tie-2 were compared with the PCT and MEDS scores.", {"entities": []}], ["All patients were followed for 28\u00a0days.", {"entities": []}], ["Upon admission, the median levels of the serum Ang-2 level and Ang-2/Ang-1 ratio increased and the serum Ang-1 levels and Ang-1/Tie-2 ratios decreased with the severity of sepsis.", {"entities": []}], ["The areas under the receiver operating characteristic curves of the Ang-2/Ang-1 and Ang-1/Tie-2 ratios were greater than those of the Ang-1, Ang-2, and PCT levels and MEDS scores in the diagnosis and prediction of 28-day mortality due to sepsis.", {"entities": []}], ["Ang-2/Ang-1 was significantly higher and Ang-1/Tie-2 was significantly lower in nonsurvivors than in survivors at the 28-day follow-up examination.", {"entities": []}], ["Ang-2/Ang-1, Ang-1/Tie-2, and MEDS score were found to be independent predictors of 28-day mortality in patients with sepsis.", {"entities": []}], ["The levels of serum Ang-1, Ang-2, and Tie-2 were positively correlated with each other.", {"entities": []}], ["The ratios of Ang-2/Ang-1 and Ang-1/Tie-2 were positively and negatively correlated, respectively, with the MEDS score in every septic group.", {"entities": []}], ["The Ang-2/Ang-1 and Ang-1/Tie-2 ratios are valuable for risk stratification in patients with sepsis and are associated with the poor clinical outcome of early sepsis in the ED.", {"entities": []}], ["Close to one third of patients with major depression show increases in pro-inflammatory cytokines, which are in turn associated with risk for inflammatory disease.", {"entities": []}], ["Genetic variants that enhance immune reactivity may thus enhance inflammatory and depressive reactions to stress.", {"entities": []}], ["The aim of the present study was to investigate a trio of functional SNPs in the promoter regions of IL6 (-174G>C, rs1800795), IL1\u03b2 (-511C>T, rs16944), and TNF (-308G>A, rs1800629) as moderators of the relationship between chronic stress exposure and elevations in depressive symptoms.", {"entities": [[101, 104, "GENE"], [156, 159, "GENE"]]}], ["Participants were 444 Australian youth (mean age = 20.12) whose exposure to chronic stress in the past 6 months was assessed using the semi-structured UCLA Life Stress Interview, and who completed the Beck Depression Inventory II at ages 15 and 20.", {"entities": []}], ["Between ages 22 and 25, all participants in the selected sample provided blood samples for genotyping.", {"entities": []}], ["In line with a hypothesized moderation effect, -174G allele carriers at IL6 had fewer depressive symptoms following interpersonal stress, relative to C/C homozygotes with equal interpersonal stress exposure.", {"entities": [[72, 75, "GENE"]]}], ["However, IL6 genotype did not moderate the effects of non-interpersonal stress exposure (i.e., financial, work and health-related difficulties) on depression.", {"entities": [[9, 12, "GENE"]]}], ["Also in line with hypotheses, the -511C allele in IL1\u03b2 , previously associated with higher IL-1\u03b2 expression, was associated with more severe depression following chronic interpersonal stress exposure, relative to T/T homozygotes.", {"entities": []}], ["Again, the moderating effect was specific to interpersonal stressors and did not generalize to non-interpersonal stress.", {"entities": []}], ["TNF was not a moderator of the effects of either interpersonal or non-interpersonal stress on later depression outcomes.", {"entities": [[0, 3, "GENE"]]}], ["Findings were consistent with the hypothesis that pro-inflammatory genetic variation increases the risk of stress-induced depression.", {"entities": []}], ["The present results provide evidence of a genetic mechanism contributing to individual differences in depressive symptomatology following interpersonal stress exposure.", {"entities": []}], ["Mastitis and accompanying pain have been associated with the cessation of breastfeeding.", {"entities": [[0, 8, "DISEASE"]]}], ["Mastitis is an inflammatory condition of the breast and may be a result of decreased immunity and a lowered resistance to infection.", {"entities": [[0, 8, "DISEASE"]]}], ["Mastitis affects up to one in five breastfeeding women with most episodes occurring in the first 6\u20138 weeks postpartum.", {"entities": [[0, 8, "DISEASE"]]}], ["Antibiotics are often used in the treatment of mastitis, but have not been popular or proven effective as a preventative agent.", {"entities": [[47, 55, "DISEASE"]]}], ["The WHO has highlighted significant concerns relating to adverse harms of antibiotic use with the production of antibiotic-resistant strains of disease organisms.", {"entities": []}], ["Increasing research suggests that specific probiotic bacteria possess significant anti-inflammatory properties and supports their potential use as immunomodulatory agents.", {"entities": []}], ["While animal studies have shown promising results in the use of probiotics for preventing mastitis, their use in human trials has had limited investigation.", {"entities": [[90, 98, "DISEASE"]]}], ["The aim of this study is to evaluate the effectiveness of oral probiotics for the prevention of mastitis in breastfeeding women.", {"entities": [[96, 104, "DISEASE"]]}], ["APProve (C A n P robiotics Im Prove Breastfeeding Outcomes?)", {"entities": []}], ["is a double-blind randomised controlled trial designed to assess outcomes between breastfeeding women ingesting a probiotic versus a placebo daily for 8\u00a0weeks following birth.", {"entities": []}], ["A total of 600 women (300 to each arm) who intend to breastfeed will be randomised after the birth of a term, healthy infant.", {"entities": []}], ["Daily and weekly surveys for 8\u00a0weeks and follow-up surveys at 2, 6 and 12\u00a0months after birth will assess the primary outcome of mastitis in the first 8\u00a0weeks following birth as well as secondary maternal outcomes of breastfeeding duration (total/partial), antibiotic use, maternal health and well-being, and treatment compliance; and infant outcomes including gastroenteritis, infant health and well-being and growth and development.", {"entities": [[128, 136, "DISEASE"], [360, 375, "DISEASE"]]}], ["The acceptability and compliance using a novel mobile phone application system will also be evaluated.", {"entities": []}], ["There is an urgent need to explore safe and effective alternatives for preventing mastitis in breastfeeding women.", {"entities": [[82, 90, "DISEASE"]]}], ["This trial seeks to provide evidence for such an alternative in the form of probiotics, which may also increase breastfeeding duration, providing long-term health, cognitive and developmental benefits for children.", {"entities": []}], ["Decreased antibiotic usage also benefits the community and health system.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry: ACTRN12615000923561 .", {"entities": []}], ["Date of registration: 4th September, 2015, retrospectively registered.", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-017-1330-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Advancements in phosphodiesterase (PDE)-targeted therapies have shown promise in recent years for treating patients with a variety of autoimmune diseases.", {"entities": []}], ["This review summarizes the development of PDE4 inhibitors and the associated literature with a focus on treatments for autoimmune diseases.", {"entities": []}], ["After the initial investigations of the prototypic PDE inhibitor, rolipram, more selective inhibitors targeting the PDE4 isozyme have been developed.", {"entities": []}], ["With phase II and phase III clinical trials currently underway to evaluate the safety and efficacy of the latest generation of PDE4 inhibitors, namely apremilast, a new class of treatments may be around the corner for patients suffering from chronic, autoimmune diseases.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease is one of the commonest respiratory diseases in the United Kingdom, accounting for 10\u00a0% of unplanned hospital admissions each year.", {"entities": []}], ["Nearly a third of these admitted patients are re-admitted to hospital within 28\u00a0days of discharge.", {"entities": []}], ["Whilst there is a move within the NHS to ensure that people with long-term conditions receive more co-ordinated care, there is little research evidence to support an optimum approach to this in COPD.", {"entities": [[34, 37, "GENE"]]}], ["This study aims to evaluate the effectiveness of introducing standardised packages of care i.e.", {"entities": []}], ["care bundles, for patients with acute exacerbations of COPD as a means of improving hospital care and reducing re-admissions.", {"entities": []}], ["This mixed-methods evaluation will use a controlled before-and-after design to examine the effect of, and costs associated with, implementing care bundles for patients admitted to hospital with an acute exacerbation of COPD, compared with usual care.", {"entities": []}], ["It will quantitatively measure a range of patient and organisational outcomes for two groups of hospitals - those who deliver care using COPD care bundles, and those who deliver care without the use of COPD care bundles.", {"entities": []}], ["These care bundles may be provided for patients with COPD following admission, prior to discharge or at both points in the care pathway.", {"entities": []}], ["The primary outcome will be re-admission to hospital within 28\u00a0days of discharge, although the study will additionally investigate a number of secondary outcomes including length of stay, total bed days, in-hospital mortality, costs of care and patient / carer experience.", {"entities": []}], ["A series of nested qualitative case studies will explore in detail the context and process of care as well as the impact of COPD bundles on staff, patients and carers.", {"entities": []}], ["The results of the study will provide information about the effectiveness of care bundles as a way of managing in-hospital care for patients with an acute exacerbation of COPD.", {"entities": []}], ["Given the number of unplanned hospital admissions for this patient group and their rate of subsequent re-admission, it is hoped that this evaluation will make a timely contribution to the evidence on care provision, to the benefit of patients, clinicians, managers and policy-makers.", {"entities": []}], ["International Standard Randomised Controlled Trials \u2013 ISRCTN13022442 - 11 February 2015", {"entities": []}], ["Healthy condition and chronic diseases may be associated with microbiota composition and its properties.", {"entities": []}], ["The prevalence of respiratory haemophili with respect to their phenotypes including the ability to biofilm formation in patients with sarcoidosis was assayed.", {"entities": [[134, 145, "DISEASE"]]}], ["Nasopharynx and sputum specimens were taken in 31 patients with sarcoidosis (average age 42.6\u2009\u00b1\u200913), and nasopharynx specimens were taken in 37 healthy people (average age 44.6\u2009\u00b1\u200911.6).", {"entities": [[64, 75, "DISEASE"]]}], ["Haemophili were identified by API-NH microtest and by the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) system.", {"entities": []}], ["Biofilm was visualised by crystal violet staining and confocal scanning laser microscopy (CSLM).", {"entities": []}], ["The statistical analysis was performed with Statgraphics Plus for Windows.", {"entities": []}], ["In total, 30/31 patients with sarcoidosis and 31/37 healthy people were colonized by Haemophilus influenzae (6/30 vs. 1/31) and Haemophilus parainfluenzae (28/30 vs. 31/31) in the nasopharynx.", {"entities": [[30, 41, "DISEASE"]]}], ["The overall number of nasopharyngeal haemophili isolates was 59 in patients with sarcoidosis and 67 in healthy volunteers ( H. influenzae 6/59 vs. 1/67, P\u2009= \u20090.05; H. parainfluenzae 47/59 vs. 65/67, P\u2009= \u20090.0032).", {"entities": [[81, 92, "DISEASE"]]}], ["Moreover, the decreased number of H. parainfluenzae biofilm-producing isolates was shown in nasopharyngeal samples in patients with sarcoidosis as compared to healthy people (19/31 vs. 57/65, P\u2009= \u20090.006), especially with respect to isolates classified as strong and very strong biofilm-producers (8/31 vs. 39/65, P\u2009= \u20090.002).", {"entities": [[132, 143, "DISEASE"]]}], ["The obtained data suggest that the qualitative and quantitative changes within the respiratory microbiota concerning the overall prevalence of H. influenzae together with the decreased number of H. parainfluenzae strains and the decreased rate of H. parainfluenzae biofilm-producing isolates as compared to healthy people may be associated with sarcoidosis.", {"entities": [[345, 356, "DISEASE"]]}], ["There is paucity of information on epidemiology of mental disability in India.", {"entities": []}], ["The objective of this study was to assess mental disability, and to study the association between sociodemographic and comorbid chronic conditions with mental disability.", {"entities": []}], ["This community-based cross-sectional study was conducted among \u22655 years age group in an urban area attached to a Tertiary Care Medical Institute in Puducherry, India.", {"entities": []}], ["Mental disability was assessed using Indian Disability Evaluation and Assessment Scale.", {"entities": []}], ["Chronic morbid conditions and other associated factors were collected using pretested questionnaire.", {"entities": []}], ["Univariate and multiple logistic regression analysis.", {"entities": []}], ["About 2537 subjects were covered with a response rate of 94.1%.", {"entities": []}], ["Overall, the prevalence of mental disability was found to be 7.1% (181/2537).", {"entities": []}], ["Among them, majority had mild mental disability (151, 83.4%), followed by moderate (21, 11.6%), severe (8, 4.4%), and profound (1, 0.6%) mental disability.", {"entities": []}], ["Univariate analysis showed that age group status, marital status, education level, occupation, family type, religion, hypertension, joint pain, backache, current smoking, current alcohol use, and conflicts were associated with mental disability ( P < 0.05).", {"entities": [[118, 130, "DISEASE"]]}], ["Multiple logistic regression analysis showed that male gender (adjusted odds ratio [AOR] =2.064), widowed status (AOR = 27.022), separated/divorced status (AOR = 16.674), currently married status (AOR = 18.487), being illiterate (AOR = 4.352), having 1 Mental disability is more common in this area.", {"entities": []}], ["Males, lesser education level, skilled or unskilled occupation, nuclear family, and conflicts were associated with mental disability after adjusting other variables.", {"entities": []}], ["Multicentric cross-sectional analytical studies will explore the mental disability burden and its associated factors at regional or country level.", {"entities": []}], ["Simulations can provide tremendous insight into atomistic details of biological mechanisms, but micro- to milliseconds timescales are historically only accessible on dedicated supercomputers.", {"entities": []}], ["We demonstrate that cloud computing is a viable alternative, bringing long-timescale processes within reach of a broader community.", {"entities": []}], ["We used Google's Exacycle cloud computing platform to simulate 2 milliseconds of dynamics of the \u03b22 adrenergic receptor \u2014 a major drug target G protein-coupled receptor (GPCR).", {"entities": []}], ["Markov state models aggregate independent simulations into a single statistical model that is validated by previous computational and experimental results.", {"entities": []}], ["Moreover, our models provide an atomistic description of the activation of a GPCR, revealing multiple activation pathways.", {"entities": []}], ["Agonists and inverse agonists interact differentially with these pathways, with profound implications for drug design", {"entities": []}], ["Preterm delivery and preeclampsia are common adverse pregnancy outcomes that have been inconsistently associated with ambient air pollutant exposures.", {"entities": []}], ["We aimed to prospectively examine relations between exposures to ambient carbon monoxide (CO) and fine particulate matter [\u2264 2.5 \u03bcm in aerodynamic diameter (PM 2.5 )] and risks of preeclampsia and preterm delivery.", {"entities": []}], ["We used data from 3,509 western Washington women who delivered infants between 1996 and 2006.", {"entities": []}], ["We predicted ambient CO and PM 2.5 exposures using regression models based on regional air pollutant monitoring data.", {"entities": []}], ["Models contained predictor terms for year, month, weather, and land use characteristics.", {"entities": []}], ["We evaluated several exposure windows, including prepregnancy, early pregnancy, the first two trimesters, the last month, and the last 3 months of pregnancy.", {"entities": []}], ["Outcomes were identified using abstracted maternal medical record data.", {"entities": []}], ["Covariate information was obtained from maternal interviews.", {"entities": []}], ["Predicted periconceptional CO exposure was significantly associated with preeclampsia after adjustment for maternal characteristics and season of conception [adjusted odds ratio (OR) per 0.1 ppm = 1.07; 95% confidence interval (CI), 1.02\u20131.13].", {"entities": []}], ["However, further adjustment for year of conception essentially nullified the association (adjusted OR = 0.98; 95% CI, 0.91\u20131.06).", {"entities": []}], ["Associations between PM 2.5 and preeclampsia were nonsignificant and weaker than associations estimated for CO, and neither air pollutant was strongly associated with preterm delivery.", {"entities": []}], ["Patterns were similar across all exposure windows.", {"entities": []}], ["Because both CO concentrations and preeclampsia incidence declined during the study period, secular changes in another preeclampsia risk factor may explain the association observed here.", {"entities": []}], ["We saw little evidence of other associations with preeclampsia or preterm delivery in this setting.", {"entities": []}], ["The variation of immune cell activities over time is an immanent property of the human immune system, as can be measured by the stimulated secretion of cytokines in cell cultures.", {"entities": []}], ["However, inter-individual variability is considerably higher.", {"entities": []}], ["Especially the latter is the major reason why it has not been possible to establish international standard values for cytokines as was possible for other parameters, such as leukocyte sub-population numbers.", {"entities": []}], ["In this trial, a highly standardized whole-blood culture model (TrueCulture\u00ae), developed to characterise drug effects on cells of the human immune system in clinical trials, was used to analyse cytokine patterns in the blood samples of 12 healthy subjects over a period of one month.", {"entities": []}], ["After an overnight fast, 12 healthy subjects donated blood three times a week on three consecutive days over a period of 4\u2009weeks.", {"entities": []}], ["TruCulture\u00ae blood collection and whole-blood culture systems were used to measure whole-blood leukocyte stimulation.", {"entities": []}], ["The levels of IL-2, IL-5, IL-13, IL-6, IL-8, IL-10, IFN\u03b3, and MCP-1 in the culture supernatants were quantified by sandwich ELISA.", {"entities": []}], ["The pattern of cytokine concentrations in the supernatants of the stimulated whole-blood cultures was highly individual, but considerably stable over the whole observation period of 4\u2009weeks.", {"entities": []}], ["By using TruCulture\u00ae it seems feasible to determine subject-specific cytokine reference patterns, for example under healthy conditions, or before starting an experimental treatment, e.g.", {"entities": []}], ["during a clinical trial, against which changes in the behaviour of the immune system can be detected more accurately in future.", {"entities": []}], ["Although recent studies have reported that mitochondria are putative oxygen sensors underlying hypoxic pulmonary vasoconstriction, little is known concerning the sirtuin 1 (SIRT1)-mediated mitochondrial biogenesis regulatory program in pulmonary arteriolar smooth muscle cells (PASMCs) during hypoxia/reoxygenation (H/R).", {"entities": [[173, 178, "GENE"]]}], ["We investigated the epigenetic regulatory mechanism of mitochondrial biogenesis and function in human PASMCs during H/R.", {"entities": []}], ["Human PASMCs were exposed to hypoxia of 24\u201348 h and reoxygenation of 24\u201348 h. The expression of SIRT1 was reduced in a time-dependent manner.", {"entities": [[96, 101, "GENE"]]}], ["Mitochondrial transcription factor A (TFAM) expression was increased during hypoxia and decreased during reoxygenation, while the release of TFAM was increased in a time-dependent manner.", {"entities": [[38, 42, "GENE"], [141, 145, "GENE"], [38, 42, "GENE"], [141, 145, "GENE"]]}], ["Lentiviral overexpression of SIRT1 preserved SIRT3 deacetylase activity in human PASMCs exposed to H/R.", {"entities": [[29, 34, "GENE"], [45, 50, "GENE"]]}], ["Knockdown of PGC-1\u03b1 suppressed the effect of SIRT1 on SIRT3 activity.", {"entities": [[45, 50, "GENE"], [54, 59, "GENE"]]}], ["Knockdown of SIRT3 abrogated SIRT1-mediated deacetylation of cyclophilin D (CyPD).", {"entities": [[13, 18, "GENE"]]}], ["Notably, knockdown of SIRT3 or PGC-1\u03b1 suppressed the incremental effect of SIRT1 on mitochondrial TFAM, mitochondrial DNA (mtDNA) content and cellular ATP levels.", {"entities": [[22, 27, "GENE"], [75, 80, "GENE"], [98, 102, "GENE"]]}], ["Importantly, polydatin restored SIRT1 levels in human PASMCs exposed to H/R.", {"entities": [[32, 37, "GENE"]]}], ["Knockdown of SIRT1 suppressed the effect of polydatin on mitochondrial TFAM, mtDNA content and cellular ATP levels.", {"entities": [[13, 18, "GENE"], [71, 75, "GENE"]]}], ["In conclusion, SIRT1 expression is decreased in human PASMCs during H/R.", {"entities": [[15, 20, "GENE"]]}], ["TFAM expression in mitochondria is reduced and the release of TFAM is increased by H/R.", {"entities": [[0, 4, "GENE"], [62, 66, "GENE"], [0, 4, "GENE"], [62, 66, "GENE"]]}], ["PGC-1\u03b1/SIRT3/CyPD mediates the protective effect of SIRT1 on expression and release of TFAM and mitochondrial biogenesis and function.", {"entities": [[52, 57, "GENE"], [87, 91, "GENE"]]}], ["Polydatin improves mitochondrial biogenesis and function by enhancing SIRT1 expression in hypoxic human PASMCs.", {"entities": [[70, 75, "GENE"]]}], ["The aim of this study, conducted in Europe, was to develop a validated risk factor based model to predict RSV-related hospitalisation in premature infants born 33\u201335 weeks' gestational age (GA).", {"entities": []}], ["The predictive model was developed using risk factors captured in the Spanish FLIP dataset, a case-control study of 183 premature infants born between 33\u201335 weeks' GA who were hospitalised with RSV, and 371 age-matched controls.", {"entities": []}], ["The model was validated internally by 100-fold bootstrapping.", {"entities": []}], ["Discriminant function analysis was used to analyse combinations of risk factors to predict RSV hospitalisation.", {"entities": []}], ["Successive models were chosen that had the highest probability for discriminating between hospitalised and non-hospitalised infants.", {"entities": []}], ["Receiver operating characteristic (ROC) curves were plotted.", {"entities": []}], ["An initial 15 variable model was produced with a discriminant function of 72% and an area under the ROC curve of 0.795.", {"entities": []}], ["A step-wise reduction exercise, alongside recalculations of some variables, produced a final model consisting of 7 variables: birth \u00b1 10 weeks of start of season, birth weight, breast feeding for \u2264 2 months, siblings \u2265 2 years, family members with atopy, family members with wheeze, and gender.", {"entities": []}], ["The discrimination of this model was 71% and the area under the ROC curve was 0.791.", {"entities": []}], ["At the 0.75 sensitivity intercept, the false positive fraction was 0.33.", {"entities": []}], ["The 100-fold bootstrapping resulted in a mean discriminant function of 72% (standard deviation: 2.18) and a median area under the ROC curve of 0.785 (range: 0.768\u20130.790), indicating a good internal validation.", {"entities": []}], ["The calculated NNT for intervention to treat all at risk patients with a 75% level of protection was 11.7 (95% confidence interval: 9.5\u201313.6).", {"entities": [[15, 18, "GENE"]]}], ["A robust model based on seven risk factors was developed, which is able to predict which premature infants born between 33\u201335 weeks' GA are at highest risk of hospitalisation from RSV.", {"entities": []}], ["The model could be used to optimise prophylaxis with palivizumab across Europe.", {"entities": []}], ["Streptococcus infections are still one of the important problems facing contemporary medicine.", {"entities": []}], ["As the World Health Organization (WHO) warns, Streptococcus pneumoniae is responsible for the highest number of pneumonia cases all over the world.", {"entities": [[112, 121, "DISEASE"]]}], ["Despite an increasing number of pneumococcal vaccinations, incidences of disease connected to this pathogen\u2019s infection stay at the same level, which is related to a constantly increasing number of infections caused by nonvaccinal serotypes.", {"entities": []}], ["Unfortunately, the pathogenicity of bacteria of the Streptococcus genus is also connected to species considered to be physiological flora in humans or animals and, additionally, new species exhibiting pathogenic potential have been discovered.", {"entities": []}], ["This paper presents an opinion concerning the epidemiology of streptococci infections based on case studies and other publications devoted to this problem.", {"entities": []}], ["It also sheds new light based on recent reports on the prevention of protective vaccinations application in the case of streptococci infections.", {"entities": []}], ["Respiratory viruses often have been studied in children with respiratory tract infection (RTI), but less knowledge exists about viruses in asymptomatic children.", {"entities": []}], ["We have studied the occurrence of a broad panel of respiratory viruses in apparently healthy children attending day care, taking into account the influence of possible confounding factors, such as age, clinical signs of respiratory tract infection (RTI), location (day-care section) and season.", {"entities": []}], ["We have studied 161 children in two day-care centers, each with separate sections for younger and older children, during four autumn and winter visits over a two-year period.", {"entities": []}], ["A total of 355 clinical examinations were performed, and 343 nasopharyngeal samples (NPS) were analyzed by semi-quantitative, real-time, polymerase chain reaction (PCR) tests for 19 respiratory pathogens.", {"entities": [[85, 88, "GENE"]]}], ["Forty-three percent of all NPS were PCR-positive for \u2265 1 of 13 virus species, with high species variation during visits.", {"entities": [[27, 30, "GENE"]]}], ["Rhinovirus 26% (88/343 NPS), enterovirus 12% (40/343) and parechovirus 9% (30/343) were detected in every visit, and the rates varied in relation to age, day-care section and season.", {"entities": [[23, 26, "GENE"]]}], ["Ten other viruses were detected in \u2264 3% of the NPS.", {"entities": [[47, 50, "GENE"]]}], ["Generally, viruses occurred together in the NPS.", {"entities": [[44, 47, "GENE"]]}], ["In 24% (79/331) of the clinical examinations with available NPS, the children had clear signs of RTI, while in 41% (135/331) they had mild signs, and in 35% (117/331) the children had no signs of RTI.", {"entities": [[60, 63, "GENE"]]}], ["Moreover, viruses were found in 70% (55/79) of children with clear signs of RTI, in 41% (55/135) with mild signs and in 30% (35/117) without any signs of RTI (p < 0.001).", {"entities": []}], ["Positive PCR tests for respiratory viruses, particularly picornaviruses, were frequently detected in apparently healthy children attending day care.", {"entities": []}], ["Virus detection rates were related to age, presence of clinical signs of RTI, location in day care and season.", {"entities": []}], ["IgE-mediated food allergy is an important health concern with increasing prevalence worldwide.", {"entities": [[13, 25, "DISEASE"]]}], ["Manifestations of IgE-mediated food allergy include urticaria, angioedema, pruritus, difficulty in breathing, laryngeal oedema, vomiting, diarrhoea and/or hypotension within minutes to two hours of the offending food's ingestion.", {"entities": [[52, 61, "DISEASE"], [31, 43, "DISEASE"], [63, 73, "DISEASE"]]}], ["Diagnosis requires both a careful history and supportive testing with laboratory studies and possibly oral food challenges.", {"entities": []}], ["Current treatment of food allergy focuses on avoidance of the allergen and prompt emergency management of reactions.", {"entities": [[21, 33, "DISEASE"]]}], ["Epinephrine autoinjectors are provided to patients for the treatment of severe reactions.", {"entities": []}], ["More research is needed to determine the optimal timing with which to introduce common allergens into a child's diet to possibly prevent the development of food allergy.", {"entities": [[156, 168, "DISEASE"]]}], ["Novel therapies are under investigation given the difficulty of allergen avoidance and the potentially fatal nature of reactions.", {"entities": []}], ["Both allergen specific therapies such as oral, sublingual and epicutaneous immunotherapy and allergen non-specific therapies such the Chinese herbal formula FAHF-2 and omalizumab show promise though more data on efficacy and long-term safety are needed before these therapies become mainstream.", {"entities": []}], ["The epidermis forms a critical barrier that is maintained by orchestrated programs of proliferation, differentiation, and cell death.", {"entities": []}], ["Gene mutations that disturb this turnover process may cause skin diseases.", {"entities": []}], ["Human GASDERMIN A ( GSDMA ) is frequently silenced in gastric cancer cell lines and its overexpression has been reported to induce apoptosis.", {"entities": [[62, 68, "DISEASE"], [20, 25, "GENE"]]}], ["GSDMA has also been linked with airway hyperresponsiveness in genetic association studies.", {"entities": [[0, 5, "GENE"]]}], ["The function of GSDMA in the skin was deduced by dominant mutations in mouse gasdermin A3 ( Gsdma3 ), which caused skin inflammation and hair loss.", {"entities": [[16, 21, "GENE"]]}], ["However, the mechanism for the autosomal dominance of Gsdma3 mutations and the mode of Gsdma3\u2019s action remain unanswered.", {"entities": []}], ["We demonstrated a novel function of Gsdma3 in modulating mitochondrial oxidative stress.", {"entities": []}], ["We showed that Gsdma3 is regulated by intramolecular fold-back inhibition, which is disrupted by dominant mutations in the C-terminal domain.", {"entities": []}], ["The unmasked N-terminal domain of Gsdma3 associates with Hsp90 and is delivered to mitochondrial via mitochondrial importer receptor Tom70, where it interacts with the mitochondrial chaperone Trap1 and causes increased production of mitochondrial reactive oxygen species (ROS), dissipation of mitochondrial membrane potential, and mitochondrial permeability transition (MPT).", {"entities": [[192, 197, "GENE"]]}], ["Overexpression of the C-terminal domain of Gsdma3 as well as pharmacological interventions of mitochondrial translocation, ROS production, and MPT pore opening alleviate the cell death induced by Gsdma3 mutants.", {"entities": []}], ["Our results indicate that the genetic mutations in the C-terminal domain of Gsdma3 are gain-of-function mutations which unmask the N-terminal functional domain of Gsdma3.", {"entities": []}], ["Gsdma3 regulates mitochondrial oxidative stress through mitochondrial targeting.", {"entities": []}], ["Since mitochondrial ROS has been shown to promote epidermal differentiation, we hypothesize that Gsdma3 regulates context-dependent response of keratinocytes to differentiation and cell death signals by impinging on mitochondria.", {"entities": []}], ["The online version of this article (doi:10.1186/s12929-015-0152-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This review covers the histopathology and pathogenesis of non-infectious inflammatory diseases of the sinonasal tract, in particular, sarcoidosis, granulomatous vasculitides Wegener, Churg\u2013Strauss), relapsing polychondritis, eosinophilic angiocentric fibrosis, chronic rhinosinusitis and nasal perforations.", {"entities": [[199, 223, "DISEASE"], [134, 145, "DISEASE"]]}], ["Molecular associations and mechanisms are emphasised to assist pathologists to put their observations into the context of clinical, genetic and environmental influences on patients\u2019 diseases.", {"entities": []}], ["While seasonal influenza vaccination is recommended for individuals with asthma, uptake in this population is low.", {"entities": [[15, 24, "DISEASE"], [73, 79, "DISEASE"]]}], ["We examined how self-rated health impacts reasons for not being immunized against influenza in Canadian adults with asthma, focusing on those who have never been immunized.", {"entities": [[82, 91, "DISEASE"], [116, 122, "DISEASE"]]}], ["We pooled four cycles of the Canadian Community Health Survey (cycles 3.1(2005), 2007/08, 2009/10 and 2011/12), grouping individuals by whether their reasons for not having been vaccinated were perceptual or technical.", {"entities": []}], ["We used a multivariable logistic regression model, adjusted for confounders, to quantify the relationship between self-rated health and their reported reasons for not vaccinating.", {"entities": []}], ["Among the 9,836 respondents, 84.4% cited perceptual barriers as a reason for not being vaccinated.", {"entities": []}], ["After adjusting for socio-demographic characteristics and province of residence, we determined that reporting perceptual barriers was associated with self-rated health status, with the adjusted odds ratios ranging from 1.42 (95%CI: 0.97, 2.09) to 2.64 (95%CI: 1.74, 3.99) for fair and excellent health versus poor health, respectively.", {"entities": []}], ["Each increase in self-rated health category was associated with greater odds of citing a perceptual rather than technical barrier as a reason for non-vaccination.", {"entities": []}], ["Self-reported health influences people\u2019s perception of the need for influenza vaccination.", {"entities": [[68, 77, "DISEASE"]]}], ["Viewing the results through the lens of the precaution adoption process model suggests that personalizing communication around both the risk of influenza and the effectiveness of the vaccine may improve uptake amongst adults with asthma.", {"entities": [[144, 153, "DISEASE"], [230, 236, "DISEASE"]]}], ["Fine airborne particulate matter (PM 2.5 ) has adverse effects on human health.", {"entities": []}], ["Assessing the long-term effects of PM 2.5 exposure on human health and ecology is often limited by a lack of reliable PM 2.5 measurements.", {"entities": []}], ["In Taipei, PM 2.5 levels were not systematically measured until August, 2005.", {"entities": []}], ["Due to the popularity of geographic information systems (GIS), the landuse regression method has been widely used in the spatial estimation of PM concentrations.", {"entities": []}], ["This method accounts for the potential contributing factors of the local environment, such as traffic volume.", {"entities": []}], ["Geostatistical methods, on other hand, account for the spatiotemporal dependence among the observations of ambient pollutants.", {"entities": []}], ["This study assesses the performance of the landuse regression model for the spatiotemporal estimation of PM 2.5 in the Taipei area.", {"entities": []}], ["Specifically, this study integrates the landuse regression model with the geostatistical approach within the framework of the Bayesian maximum entropy (BME) method.", {"entities": []}], ["The resulting epistemic framework can assimilate knowledge bases including: (a) empirical-based spatial trends of PM concentration based on landuse regression, (b) the spatio-temporal dependence among PM observation information, and (c) site-specific PM observations.", {"entities": []}], ["The proposed approach performs the spatiotemporal estimation of PM 2.5 levels in the Taipei area (Taiwan) from 2005\u20132007.", {"entities": []}], ["Numerous studies have revealed an association between particulate matter (PM) and emergency room (ER) visits, although few studies have investigated the association between health and PM components.", {"entities": []}], ["The present study evaluated the associations of ER visits for cardiovascular and respiratory diseases with PM 2.5 components, including organic carbon (OC), elemental carbon (EC), and ion species (SO 4 3 4 4 4 3 4", {"entities": []}], ["To investigate the relationship between overweight and erosive esophagitis (EE) in a non-obese Taiwanese population.", {"entities": [[63, 74, "DISEASE"]]}], ["A total of 7,352 subjects (non-obese, 5,826; obese, 1,526) from a health examination center at National Cheng Kung University Hospital were enrolled.", {"entities": []}], ["Central obesity was defined by a waist circumference (WC) \u226590 cm in male and 80 cm in female.", {"entities": [[8, 15, "DISEASE"]]}], ["Overweight was defined as body mass index (BMI) of 24\u201326.9 kg/m There were significant differences in the prevalence of central obesity and different BMI status between subjects with and without EE in total and non-obese population.", {"entities": [[128, 135, "DISEASE"]]}], ["In total population, multivariate analyses revealed central obesity (OR, 1.17, 95% CI, 1.02\u20131.34, p \u200a=\u200a0.021) and being obese (OR, 1.28, 95% CI, 1.07\u20131.52, p \u200a=\u200a0.007)/overweight (OR, 1.25, 95% CI, 1.08\u20131.45, p \u200a=\u200a0.003) had positive associations with EE in different model, respectively.", {"entities": [[60, 67, "DISEASE"]]}], ["When considering the joint effect of central obesity and BMI status, overweight (OR, 1.22; 95% CI, 1.04\u20131.44; p \u200a=\u200a0.016) remained as an independent associated factor of EE but central obesity (OR, 1.06; 95% CI, 0.89\u20131.26; p \u200a=\u200a0.549)/being obese (OR, 1.22; 95% CI, 0.98\u20131.53; p \u200a=\u200a0.082) did not.", {"entities": [[45, 52, "DISEASE"], [185, 192, "DISEASE"]]}], ["As for non-obese group, separate model showed central obesity (OR, 1.19, 95% CI, 1.00\u20131.40, p \u200a=\u200a0.046) and overweight (OR, 1.24; 95% CI, 1.07\u20131.44, p \u200a=\u200a0.005) was positively associated with EE, respectively.", {"entities": [[54, 61, "DISEASE"]]}], ["However, being overweight (OR, 1.20; 95% CI, 1.02\u20131.42, p \u200a=\u200a0.030) but not central obesity (OR, 1.08; 95% CI, 0.90\u20131.31; p \u200a=\u200a0.398) was positively related to EE with considering the effect of overweight and central obesity simultaneously.", {"entities": [[84, 91, "DISEASE"], [217, 224, "DISEASE"]]}], ["Overweight effect on EE was more detrimental than central obesity in non-obese subjects.", {"entities": [[58, 65, "DISEASE"]]}], ["In addition, male gender, hiatus hernia and alcohol use were also associated with increased risk of EE.", {"entities": [[26, 39, "DISEASE"]]}], ["To fully understand human biology and link genotype to phenotype, the phase of DNA variants must be known.", {"entities": []}], ["Here we present a comprehensive analysis of haplotype-resolved genomes to assess the nature and variation of haplotypes and their pairs, diplotypes, in European population samples.", {"entities": []}], ["We use a set of 14 haplotype-resolved genomes generated by fosmid clone-based sequencing, complemented and expanded by up to 372 statistically resolved genomes from the 1000 Genomes Project.", {"entities": []}], ["We find immense diversity of both haploid and diploid gene forms, up to 4.1 and 3.9 million corresponding to 249 and 235 per gene on average.", {"entities": []}], ["Less than 15% of autosomal genes have a predominant form.", {"entities": []}], ["We describe a \u2018common diplotypic proteome\u2019, a set of 4,269 genes encoding two different proteins in over 30% of genomes.", {"entities": []}], ["We show moreover an abundance of cis configurations of mutations in the 386 genomes with an average cis / trans ratio of 60:40, and distinguishable classes of cis - versus trans -abundant genes.", {"entities": []}], ["This work identifies key features characterizing the diplotypic nature of human genomes and provides a conceptual and analytical framework, rich resources and novel hypotheses on the functional importance of diploidy.", {"entities": []}], ["Knowing which genetic variants exist on either parental chromosome requires diploid human genomes to be phased.", {"entities": []}], ["Here the authors generate haplotype-resolved genomes and identify a large diversity of haploid and diploid gene forms, a common diplotypic proteome, and an abundance of cis configurations of mutations, highlighting the functional importance of diploidy.", {"entities": []}], ["The present study tested the hypothesis that patients with Crohn\u2019s disease (CD) have a higher prevalence and risk for caries compared to people without CD.", {"entities": []}], ["Patients with CD were divided into groups; 71 patients (50.7\u00b113.9 years) who had gone through resective intestinal surgery and 79 patients (42.0\u00b114.4 years) who had not.", {"entities": []}], ["The patients were compared to 75 controls (48.6\u00b113.4 years) regarding DMF-T and DMF-S, Lactobacilli (LB), Streptococcus mutans (SM), salivary flow and dental plaque.", {"entities": []}], ["Statistical methods including ANOVA or Chi-square test for calculation of demographic differences between groups, analysis of covariance (ANCOVA) to compare the clinical variable and Post hoc analyses were done with Fischers Least Significant Difference test or Chi-square.", {"entities": []}], ["Non-parametric Spearman\u2019s correlation matrix coefficient was estimated between clinical variables and disease duration.", {"entities": []}], ["CD patients who had been subjected to resective surgery had a higher DMF-S score (50.7 versus 36.5; p \u200a=\u200a0.01) compared to the control group after adjusting for age, gender and smoking.", {"entities": []}], ["These patients had higher counts of SM (1.5 versus 0.9; p \u200a=\u200a0.04) and LB (10000.0 versus 1000.0; p \u200a=\u200a0.01), and more dental plaque (53.7 versus 22.6; p \u200a=\u200a0.001).", {"entities": []}], ["CD patients reported a more frequent consumption of sweetened drinks between meals compared to controls ( p \u200a=\u200a0.001).", {"entities": []}], ["The present study shows that patients with CD who had undergone resective surgery had a higher DMFs score, and higher salivary counts of Lactobacilli and Streptococcus mutans compared to the control group.", {"entities": []}], ["The most important feature of abdominal aortic aneurysm (AAA) pathogenesis is an enzymatic degradation of elastic lamellae and extracellular matrix proteins particularly with participation of matrix metalloproteinases.", {"entities": [[30, 55, "DISEASE"], [40, 55, "DISEASE"]]}], ["Plasmin, which is responsible for the dissolution of fibrin in blood vessels, plays also a key role in the cascade for activation of the metalloproteinases.", {"entities": []}], ["The purpose of this study was to evaluate the influence of selected polymorphisms in genes coding for tissue plasminogen activator (\u22127351 C/T polymorphism), urokinase-type plasminogen activator (1788 C/T polymorphism) and plasminogen activator inhibitor 1 (\u2212675 4G/5G and \u2212844 G/A polymorphism) on the susceptibility to AAA.", {"entities": []}], ["We performed a case\u2013control study of 153 polish patients hospitalized due to AAA and compared them with matched healthy control subjects.", {"entities": []}], ["The polymorphisms were ascertained through genotyping by polymerase chain reaction and restriction digestion of amplified fragments or through high-resolution melting analysis.", {"entities": []}], ["In this study we have found lower frequency of wild-type GG genotype of the \u2212844G/A PAI - 1 polymorphism in cases than in controls, what may suggest the protective effect of this genotype for the risk of AAA development.", {"entities": []}], ["None of the remaining polymorphisms tested were associated with AAA occurrence.", {"entities": []}], ["One of the hallmarks of HIV-1 disease is the association of heightened CD4 Brugia malayi (BmA) and excretory-secretory product 62 (ES-62) from Acanthocheilonema viteae on HIV-1 infection in vitro .", {"entities": [[71, 74, "GENE"]]}], ["Neither BmA nor ES-62 influenced HIV-1 replication in CD4 trans -infection of CD4", {"entities": [[54, 57, "GENE"], [78, 81, "GENE"], [54, 57, "GENE"], [78, 81, "GENE"]]}], ["Asthma, a chronic inflammatory airway disease, is typified by high levels of T H 2-cytokines and excessive generation of reactive nitrogen and oxygen species, which contribute to bronchial epithelial injury and airway remodeling.", {"entities": [[0, 6, "DISEASE"]]}], ["While immune function plays a major role in the pathogenesis of the disease, accumulating evidence suggests that altered cellular metabolism is a key determinant in the predisposition and disease progression of asthma.", {"entities": [[211, 217, "DISEASE"]]}], ["Further, several studies demonstrate altered mitochondrial function in asthmatic airways and suggest that these changes may be systemic.", {"entities": []}], ["However, it is unknown whether systemic metabolic changes can be detected in circulating cells in asthmatic patients.", {"entities": []}], ["Platelets are easily accessible blood cells that are known to propagate airway inflammation in asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["Here we perform a bioenergetic screen of platelets from asthmatic and healthy individuals and demonstrate that asthmatic platelets show a decreased reliance on glycolytic processes and have increased tricarboxylic acid cycle activity.", {"entities": []}], ["These data demonstrate a systemic alteration in asthma and are consistent with prior reports suggesting that oxidative phosphorylation is more efficient asthmatic individuals.", {"entities": [[48, 54, "DISEASE"]]}], ["The implications for this potential metabolic shift will be discussed in the context of increased oxidative stress and hypoxic adaptation of asthmatic patients.", {"entities": []}], ["Further, these data suggest that platelets are potentially a good model for the monitoring of bioenergetic changes in asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["Thymus-derived regulatory T cells (T regs ) mediate dominant peripheral tolerance and treat experimental colitis.", {"entities": []}], ["T regs can be expanded from patient blood and were safely used in recent phase 1 studies in graft versus host disease and type 1 diabetes.", {"entities": []}], ["T reg cell therapy is also conceptually attractive for Crohn's disease (CD).", {"entities": []}], ["However, barriers exist to this approach.", {"entities": []}], ["The stability of T regs expanded from Crohn's blood is unknown.", {"entities": []}], ["The potential for adoptively transferred T regs to express interleukin-17 and exacerbate Crohn's lesions is of concern.", {"entities": []}], ["Mucosal T cells are resistant to T reg -mediated suppression in active CD.", {"entities": []}], ["The capacity for expanded T regs to home to gut and lymphoid tissue is unknown.", {"entities": []}], ["To define the optimum population for T reg cell therapy in CD, CD4 reg subsets were isolated from patients\u2019 blood and expanded in vitro using a workflow that can be readily transferred to a good manufacturing practice background.", {"entities": [[63, 66, "GENE"]]}], ["T regs can be expanded from the blood of patients with CD to potential target dose within 22\u201324\u2005days.", {"entities": []}], ["Expanded CD45RA regs have an epigenetically stable FOXP3 locus and do not convert to a Th17 phenotype in vitro, in contrast to CD45RA regs .", {"entities": [[51, 56, "GENE"]]}], ["CD45RA regs highly express \u03b1 4 \u03b2 7 integrin, CD62L and CC motif receptor 7 (CCR7).", {"entities": [[76, 80, "GENE"]]}], ["CD45RA regs also home to human small bowel in a C.B-17 severe combined immune deficiency (SCID) xenotransplant model.", {"entities": []}], ["Importantly, in vitro expansion enhances the suppressive ability of CD45RA regs .", {"entities": []}], ["These cells also suppress activation of lamina propria and mesenteric lymph node lymphocytes isolated from inflamed Crohn's mucosa.", {"entities": []}], ["CD4 regs may be the most appropriate population from which to expand T regs for autologous T reg therapy for CD, paving the way for future clinical trials.", {"entities": [[0, 3, "GENE"]]}], ["Background: Fine particulate matter (PM) air pollution is associated with numerous adverse health effects, including increased blood pressure (BP) and vascular dysfunction.", {"entities": []}], ["Coarse PM substantially contributes to global air pollution, yet differs in characteristics from fine particles and is currently not regulated.", {"entities": []}], ["However, the cardiovascular (CV) impacts of coarse PM exposure remain largely unknown.", {"entities": []}], ["Objectives: Our goal was to elucidate whether coarse PM, like fine PM, is itself capable of eliciting adverse CV responses.", {"entities": []}], ["Methods: We performed a randomized double-blind crossover study in which 32 healthy adults (25.9 \u00b1 6.6 years of age) were exposed to concentrated ambient coarse particles (CAP; 76.2 \u00b1 51.5 \u03bcg/m Results: Both systolic (mean difference = 0.32 mmHg; 95% CI: 0.05, 0.58; p = 0.021) and diastolic BP (0.27 mmHg; 95% CI: 0.003, 0.53; p = 0.05) linearly increased per 10 min of exposure during the inhalation of coarse CAP when compared with changes during FA exposure.", {"entities": []}], ["Heart rate was on average higher (4.1 bpm; 95% CI: 3.06, 5.12; p < 0.0001) and the ratio of low-to-high frequency heart rate variability increased (0.24; 95% CI: 0.07, 0.41; p = 0.007) during coarse particle versus FA exposure.", {"entities": []}], ["Other outcomes (brachial flow-mediated dilatation, microvascular reactive hyperemia index, aortic hemodynamics, pulse wave velocity) were not differentially altered by the exposures.", {"entities": []}], ["Conclusions: Inhalation of coarse PM from a rural location is associated with a rapid elevation in BP and heart rate during exposure, likely due to the triggering of autonomic imbalance.", {"entities": []}], ["These findings add mechanistic evidence supporting the biological plausibility that coarse particles could contribute to the triggering of acute CV events.", {"entities": []}], ["Citation: Brook RD, Bard RL, Morishita M, Dvonch JT, Wang L, Yang HY, Spino C, Mukherjee B, Kaplan MJ, Yalavarthi S, Oral EA, Ajluni N, Sun Q, Brook JR, Harkema J, Rajagopalan S. 2014.", {"entities": [[16, 18, "GENE"]]}], ["Hemodynamic, autonomic, and vascular effects of exposure to coarse particulate matter air pollution from a rural location.", {"entities": []}], ["Environ Health Perspect 122:624\u2013630;\u2002 http://dx.doi.org/10.1289/ehp.1306595", {"entities": []}], ["Variations in mitochondrial DNA (mtDNA) and abnormalities in the complement pathways have been implicated in the pathogenesis of age-related macular degeneration (AMD).", {"entities": [[141, 161, "DISEASE"]]}], ["This study was designed to determine the effects of mtDNA from AMD subjects on the complement pathway.", {"entities": []}], ["Transmitochondrial cybrids were prepared by fusing platelets from AMD and age-matched Normal subjects with Rho 0 (lacking mtDNA) human ARPE-19 cells.", {"entities": []}], ["Quantitative PCR and Western blotting were performed to examine gene and protein expression profiles, respectively, of complement markers in these cybrids.", {"entities": []}], ["Bioenergetic profiles of Normal and AMD cybrids were examined using the Seahorse XF24 flux analyzer.", {"entities": []}], ["Significant decreases in the gene and protein expression of complement inhibitors, along with significantly higher levels of complement activators, were found in AMD cybrids compared to Older-Normal cybrids.", {"entities": []}], ["Seahorse flux data demonstrated that the bioenergetic profiles for Older-Normal and Older-AMD cybrid samples were similar to each other but were lower compared to Young-Normal cybrid samples.", {"entities": []}], ["In summary, since all cybrids had identical nuclei and differed only in mtDNA content, the observed changes in components of complement pathways can be attributed to mtDNA variations in the AMD subjects, suggesting that mitochondrial genome and retrograde signaling play critical roles in this disease.", {"entities": []}], ["Furthermore, the similar bioenergetic profiles of AMD and Older-Normal cybrids indicate that the signaling between mitochondria and nuclei are probably not via a respiratory pathway.", {"entities": []}], ["To determine the reliability of a rapid hematology stain for the cytological analysis of induced sputum samples.", {"entities": []}], ["This was a cross-sectional study comparing the standard technique (May-Gr\u00fcnwald-Giemsa stain) with a rapid hematology stain (Diff-Quik).", {"entities": []}], ["Of the 50 subjects included in the study, 21 had asthma, 19 had COPD, and 10 were healthy (controls).", {"entities": [[49, 55, "DISEASE"]]}], ["From the induced sputum samples collected, we prepared four slides: two were stained with May-Gr\u00fcnwald-Giemsa, and two were stained with Diff-Quik.", {"entities": []}], ["The slides were read independently by two trained researchers blinded to the identification of the slides.", {"entities": []}], ["The reliability for cell counting using the two techniques was evaluated by determining the intraclass correlation coefficients (ICCs) for intraobserver and interobserver agreement.", {"entities": []}], ["Agreement in the identification of neutrophilic and eosinophilic sputum between the observers and between the stains was evaluated with kappa statistics.", {"entities": []}], ["In our comparison of the two staining techniques, the ICCs indicated almost perfect interobserver agreement for neutrophil, eosinophil, and macrophage counts (ICC: 0.98-1.00), as well as substantial agreement for lymphocyte counts (ICC: 0.76-0.83).", {"entities": []}], ["Intraobserver agreement was almost perfect for neutrophil, eosinophil, and macrophage counts (ICC: 0.96-0.99), whereas it was moderate to substantial for lymphocyte counts (ICC = 0.65 and 0.75 for the two observers, respectively).", {"entities": []}], ["Interobserver agreement for the identification of eosinophilic and neutrophilic sputum using the two techniques ranged from substantial to almost perfect (kappa range: 0.91-1.00).", {"entities": []}], ["The use of Diff-Quik can be considered a reliable alternative for the processing of sputum samples.", {"entities": []}], ["Determinar a confiabilidade da colora\u00e7\u00e3o hematol\u00f3gica r\u00e1pida para a an\u00e1lise do escarro induzido.", {"entities": []}], ["Estudo transversal comparando a t\u00e9cnica padr\u00e3o (colora\u00e7\u00e3o May-Gr\u00fcnwald-Giemsa) com a colora\u00e7\u00e3o hematol\u00f3gica r\u00e1pida (pan\u00f3tico r\u00e1pido).", {"entities": []}], ["Participaram do estudo 50 indiv\u00edduos (21 asm\u00e1ticos, 19 portadores de DPOC e 10 controles).", {"entities": []}], ["Ap\u00f3s a coleta do escarro induzido, foram preparadas 4 l\u00e2minas, sendo 2 coradas por May-Gr\u00fcnwald-Giemsa e 2 por pan\u00f3tico r\u00e1pido.", {"entities": [[79, 82, "GENE"], [107, 110, "GENE"], [79, 82, "GENE"], [107, 110, "GENE"]]}], ["As l\u00e2minas foram lidas de forma independente por dois pesquisadores capacitados para o exame de escarro induzido e cegados para a identifica\u00e7\u00e3o das l\u00e2minas.", {"entities": [[45, 48, "GENE"]]}], ["A confiabilidade para as contagens celulares dos dois m\u00e9todos foi avaliada pela determina\u00e7\u00e3o dos coeficientes de correla\u00e7\u00e3o intraclasse (CCI) para as concord\u00e2ncias intraobservador e interobservador.", {"entities": []}], ["As concord\u00e2ncias na identifica\u00e7\u00e3o de escarro neutrof\u00edlico e eosinof\u00edlico entre observadores e entre as duas colora\u00e7\u00f5es foram calculadas por estat\u00edstica kappa.", {"entities": [[136, 139, "GENE"]]}], ["Nas duas colora\u00e7\u00f5es, os CCI apontaram concord\u00e2ncia interobservador quase perfeita para as contagens de neutr\u00f3filos, eosin\u00f3filos e macr\u00f3fagos (varia\u00e7\u00e3o do CCI: 0,98-1,00) e substancial para as contagens de linf\u00f3citos (varia\u00e7\u00e3o do CCI: 0,76-0,83).", {"entities": []}], ["Na an\u00e1lise intraobservador, a concord\u00e2ncia foi quase perfeita para as contagens de neutr\u00f3filos, eosin\u00f3filos e macr\u00f3fagos (varia\u00e7\u00e3o do CCI: 0,96-0,99) e de moderada a substancial para as contagens de linf\u00f3citos (CCI = 0,65 e 0,75 para observadores 1 e 2, respectivamente).", {"entities": []}], ["A concord\u00e2ncia interobservador na identifica\u00e7\u00e3o de escarro eosinof\u00edlico e neutrof\u00edlico para os dois m\u00e9todos de colora\u00e7\u00e3o variou entre substancial e quase perfeita (varia\u00e7\u00e3o kappa: 0,91-1,00).", {"entities": []}], ["O pan\u00f3tico r\u00e1pido pode ser considerado uma alternativa confi\u00e1vel para o processamento de amostras de escarro.", {"entities": []}], ["The wild tobacco species Nicotiana attenuata has been intensively used as a model plant to study its interaction with insect herbivores and pollinators in nature, however very little is known about its native pathogen community.", {"entities": []}], ["We describe a fungal disease outbreak in a native N. attenuata population comprising 873 plants growing in an area of about 1500 m N. attenuata pathogens were isolated from diseased plants, characterized genetically, chemotaxonomically and morphologically, revealing several isolates of the ascomycete genera Fusarium and Alternaria, that differed in the type and strength of the disease symptoms they caused in bioassays on either detached leaves or intact soil-grown plants.", {"entities": []}], ["These isolates and the bioassays will empower the study of N. attenuata -pathogen interactions in a realistic ecological context.", {"entities": []}], ["Receptors for advanced glycation end-products (RAGE) are cell-surface receptors expressed by alveolar type I (ATI) epithelial cells and are implicated in mechanisms of alveolar development and sustained pulmonary inflammation.", {"entities": []}], ["In the present study, we tested the hypothesis that diesel particulate matter (DPM) up-regulates RAGE in rat ATI-like R3/1 cells and human primary small airway epithelial cells (SAECs), leading to an inflammatory response.", {"entities": []}], ["Using real-time reverse transcriptase polymerase chain reaction and immunoblotting, we found that RAGE mRNA and protein are up-regulated in cells exposed to DPM for 2 hr.", {"entities": [[167, 169, "GENE"]]}], ["Use of a luciferase reporter containing nuclear factor-\u03baB (NF-\u03baB) response elements revealed decreased NF-\u03baB activation in cells transfected with small interfering RNA (siRNA) for RAGE (siRAGE) before DPM exposure compared with cells transfected with scrambled control siRNA (siControl).", {"entities": []}], ["In addition, immunostaining revealed diminished nuclear translocation of NF-\u03baB in DPM-exposed cells transfected with siRAGE compared with cells transfected with siControl before DPM stimulation.", {"entities": []}], ["Enzyme-linked immunosorbent assay demonstrated that in R3/1 cells DPM induced secretion of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), two cytokines induced by NF-\u03baB and associated with leukocyte chemotaxis during an inflammatory response.", {"entities": []}], ["Incorporating siRAGE was sufficient to significantly decrease DPM-induced MCP-1 and IL-8 secretion compared with cells transfected with siControl.", {"entities": []}], ["These data offer novel insights into potential mechanisms whereby RAGE influences pulmonary inflammation exacerbated by DPM exposure.", {"entities": []}], ["Further research may demonstrate that molecules involved in RAGE signaling are potential targets in lessening the degree of particulate matter-induced exacerbations of inflammatory lung disease.", {"entities": [[181, 193, "DISEASE"]]}], ["There is increased recognition of the importance of breastfeeding at a national level as evidenced by the increased number of Canadian mothers initiating breastfeeding.", {"entities": []}], ["However, adolescent mothers (<19\u2009years), compared to all other mothers, have lower rates of breastfeeding initiation and duration.", {"entities": []}], ["The purpose of this study was to examine the facilitating influences and barriers to initiating, and continuing breastfeeding, as perceived by adolescent mothers in Durham Region, Ontario, Canada.", {"entities": []}], ["The principles of interpretive description guided this qualitative study.", {"entities": []}], ["A purposeful, homogenous sample of 16 adolescent mothers (15\u201319\u2009years) were recruited to complete individual, semi-structured, face-to-face interviews.", {"entities": []}], ["Conventional content analysis was used to code data, identify concepts and synthesize them into overall themes.", {"entities": []}], ["Adolescent mothers in this study expressed that the decision to breastfeed was made prenatally and while partner and family member opinions about breastfeeding initiation were influential, the decision was made independently.", {"entities": []}], ["Mothers were primarily motivated to initiate breastfeeding due to the health benefits for the infant.", {"entities": []}], ["Lower breastfeeding duration rates were found among mothers who decided to only \u201ctry\u201d breastfeeding when compared to the mothers who committed to breastfeeding.", {"entities": []}], ["Influences on continued breastfeeding included: 1) the impact of breastfeeding on social and intimate relationships; 2) the availability of social support; 3) the physical demands of breastfeeding; 4) mothers\u2019 knowledge of breastfeeding practices and benefits; and 5) mothers\u2019 perceived sense of comfort in breastfeeding.", {"entities": []}], ["The results of this study provide health care providers new conceptual insight and understanding of the factors that influence adolescents\u2019 decisions to \u201ctry\u201d breastfeeding and to continue providing breastmilk to their infants.", {"entities": []}], ["Professional implications drawn from this study include active engagement of adolescents in the pre and postnatal periods, including early assessment of potential barriers surrounding breastfeeding decisions.", {"entities": []}], ["This early professional interaction highlights the professional as a form of support, and allows for sharing of evidence-informed breastfeeding information and practical breastfeeding skills.", {"entities": []}], ["Inclusion of adolescents\u2019 positive social support networks should be emphasized in professional breastfeeding support.", {"entities": []}], ["Motivational interviewing is a promising prenatal strategy to influence behavior change and reduce ambivalence in decision-making about breastfeeding, creating opportunities for health care providers to tailor interventions.", {"entities": []}], ["Asthma-COPD ovelap (ACO) is an umbrella term that encompasses patients with COPD and eosinophilic inflammation (e-COPD) and smoking asthmatics with non-fully reversible airflow obstruction (SA).", {"entities": [[0, 6, "DISEASE"]]}], ["We compared the clinical characteristics and the inflammatory profile of e-COPD and SA.", {"entities": []}], ["Patients classified as e-COPD were older and more often male and showed significantly impaired pulmonary function (likely explained by a heavier smoking habit).", {"entities": []}], ["On the contrary, SA had more atopic features, more reversibility of airflow obstruction and higher IgE levels.", {"entities": []}], ["The concentrations of IL-5, IL-13, IL-8, IL-6, TNF-\u03b1, IL17 in serum were similar between the 2 groups.", {"entities": []}], ["However, Th2-related biomarkers (periostin, FeNO and blood eosinophils) shower higher median values in e-COPD patients.", {"entities": []}], ["Our findings reinforce the notion that ACO is a heterogeneous disorder and, as a consequence, it might be unacceptable to offer the same treatment for two related but different conditions.", {"entities": []}], ["Previous research shows that existing asthma quality of life questionnaires fail to measure the burden of oral corticosteroids that can be used to treat severe asthma, and are therefore not fit for purpose for severe asthma according to the USA\u2019s Federal Drug Authority\u2019s (FDA) criteria for content validity.", {"entities": [[38, 44, "DISEASE"], [160, 166, "DISEASE"], [217, 223, "DISEASE"]]}], ["Patient input and documentation of that input is key to achieving content validity according to FDA guidelines.", {"entities": []}], ["This paper describes the process of constructing a new questionnaire to measure the burden of asthma symptoms and burden of treatment in severe asthma, using criteria specified by the FDA.", {"entities": [[94, 100, "DISEASE"], [144, 150, "DISEASE"]]}], ["A draft severe asthma questionnaire (SAQ) was constructed using qualitative input from severe asthma patients who took part in an earlier study.", {"entities": [[15, 21, "DISEASE"], [94, 100, "DISEASE"]]}], ["The aim of this study was to improve that draft questionnaire using a further group of patients.", {"entities": []}], ["In four iterative focus groups, 16 people with severe asthma completed the draft questionnaire, discussed the wording and structure and suggested changes that were incorporated into the final version.", {"entities": [[54, 60, "DISEASE"]]}], ["The original intention to ask patients to identify whether problems were caused by asthma symptoms or side effects of medication was abandoned as the attribution of cause was found to be difficult and inconsistent.", {"entities": [[83, 89, "DISEASE"]]}], ["The recall period of 2 weeks was acceptable but fails to reflect the patients\u2019 desire to express the variability of severe asthma.", {"entities": [[123, 129, "DISEASE"]]}], ["Patients suggested improvements to the wording of the draft questionnaire, including splitting some items in two, combining two items in one, and changes to some of the words in individual items and the response scale.", {"entities": []}], ["The final version of the questionnaire was substantially different from one constructed using only qualitative reports from patients about the quality of life deficits of severe asthma.", {"entities": [[178, 184, "DISEASE"]]}], ["Patients make a valuable contribution to the questionnaire if they are asked to comment and improve an initial draft and where patients are treated as partners in the process of questionnaire construction, rather than only as a source of information to experts who construct the questionnaire.", {"entities": []}], ["The chemokines CCL21 and CCL19, and cell bound TNF family ligand lymphotoxin beta (LT\u03b2), have been associated with numerous chronic inflammatory diseases.", {"entities": [[15, 20, "GENE"], [25, 30, "GENE"], [47, 50, "GENE"]]}], ["A general role in chronic inflammatory diseases cannot be assumed however; in the case of allergic inflammatory disease, CCL21/CCL19 and LT\u03b2 have not been associated with the induction, recruitment, or effector function of Th2 cells nor dendritic cells to the lung.", {"entities": []}], ["We have examined the induction of allergic inflammatory lung disease in mice deficient in CCL21/CCL19 or LT\u03b2 and found that both kinds of mice can develop allergic lung inflammation.", {"entities": [[56, 68, "DISEASE"]]}], ["To control for effects of priming differences in knockout mice, adoptive transfers of Th2 cells were also performed, and they showed that such effector cells had equivalent effects on airway hyper-responsiveness in both knockout background recipients.", {"entities": []}], ["Moreover, class II positive antigen presenting cells (B cells and CD11c+ dendritic cells) showed normal recruitment to the peribronchial spaces along with CD4 T cells.", {"entities": [[155, 158, "GENE"]]}], ["Thus, the induction of allergic responses and recruitment of both effector Th2 cells and antigen presenting cells to lung peribronchial spaces can develop independently of CCL21/CCL19 and LT\u03b2.", {"entities": []}], ["With the advancement of systems biology research, we have already seen great progress in pharmacology studies, especially in network pharmacology.", {"entities": []}], ["Network pharmacology has been proven to be effective for establishing the \u201ccompounds-proteins/genes-diseases\u201d network, and revealing the regulation principles of small molecules in a high-throughput manner, thus would be very effective for the analysis of drug combinations, especially for TCM preparations.", {"entities": []}], ["In this work, we have proposed the TCM-Mesh system, which records TCM-related information collected from various resources and could serve for network pharmacology analysis for TCM preparations in a high-throughput manner (http://mesh.tcm.microbioinformatics.org/).", {"entities": []}], ["Currently, the database contains 6,235 herbs, 383,840 compounds, 14,298 genes, 6,204 diseases, 144,723 gene-disease associations, 3,440,231 pairs of gene interactions, 163,221 side effect records and 71 toxic records, and web-based software construct a network between herbs and treated diseases, which will help to understand the underlying mechanisms for TCM preparations at molecular levels.", {"entities": []}], ["We have used 1,293 FDA-approved drugs, as well as compounds from an herbal material Panax ginseng and a patented drug Liuwei Dihuang Wan (LDW) for evaluating our database.", {"entities": []}], ["By comparison of different databases, as well as checking against literature, we have demonstrated the completeness, effectiveness, and accuracy of our database.", {"entities": []}], ["To determine whether the presence of hypercapnia on admission in adult patients admitted to a university-based hospital in Karachi, Pakistan with community-acquired pneumonia (CAP) correlates with an increased length of hospital stay and severity compared with no hypercapnia on admission.", {"entities": [[165, 174, "DISEASE"]]}], ["A prospective observational study.", {"entities": []}], ["Tertiary care hospital in Karachi, Pakistan.", {"entities": []}], ["Patients who met the inclusion criteria were enrolled in the study.", {"entities": []}], ["The severity of pneumonia was assessed by CURB-65 and PSI scores.", {"entities": [[16, 25, "DISEASE"]]}], ["An arterial blood gas analysis was obtained within 24\u2009hours of admission.", {"entities": []}], ["Based on arterial PaCO 2 levels, patients were divided into three groups: hypocapnic (PaCO 2 <35\u2009mm Hg), hypercapnic (PaCO 2 >45\u2009mm Hg) and normocapnic (PaCO 2 <35\u201345\u2009mm Hg).", {"entities": []}], ["The primary outcome was the association of hypercapnia on admission with mean length of hospital stay.", {"entities": []}], ["Secondary outcomes were the need for mechanical ventilation, ICU admission and in-hospital mortality.", {"entities": []}], ["A total of 295 patients of mean age 60.20\u00b117.0 years (157 (53.22%) men) were enrolled over a 1-year period.", {"entities": []}], ["Hypocapnia was found in 181 (61.35%) and hypercapnia in 57 (19.32%) patients.", {"entities": []}], ["Hypercapnic patients had a longer hospital stay (mean 9.27\u00b17.57\u2009days), increased requirement for non-invasive mechanical ventilation (NIMV) on admission (n=45 (78.94%)) and longer mean time to clinical stability (4.39\u00b12.0\u2009days) compared with the other groups.", {"entities": []}], ["Overall mortality was 41 (13.89%), but there was no statistically significant difference in mortality (p=0.35) and ICU admission (p=0.37) between the three groups.", {"entities": []}], ["On multivariable analysis, increased length of hospital stay was associated with NIMV use, ICU admission, hypercapnia and normocapnia.", {"entities": []}], ["Hypercapnia on admission is associated with severity of CAP, longer time to clinical stability, increased length of hospital stay and need for NIMV.", {"entities": []}], ["It should be considered as an important criterion to label the severity of the illness and also a determinant of patients who will require a higher level of hospital care.", {"entities": []}], ["However, further validation is required.", {"entities": []}], ["Ciclesonide is a novel inhaled corticosteroid for the treatment of airway inflammation.", {"entities": []}], ["In this study we investigated uptake and in vitro metabolism of ciclesonide in human alveolar type II epithelial cells (A549).", {"entities": []}], ["Ciclesonide uptake was compared with fluticasone propionate, an inhaled corticosteroid that is not metabolized in lung tissue.", {"entities": []}], ["A549 cells were incubated with 2 \u00d7 10 in vitro metabolism.", {"entities": []}], ["High performance liquid chromatography with tandem mass spectrometry was used to measure the concentrations of both corticosteroids and metabolites.", {"entities": []}], ["At all time points the mean intracellular concentration was higher for ciclesonide when compared with fluticasone propionate.", {"entities": []}], ["Activation of ciclesonide to desisobutyryl-ciclesonide (des-CIC) was confirmed and conjugates of des-CIC with fatty acids were detected.", {"entities": []}], ["The intracellular concentration of ciclesonide decreased over time, whereas the concentration of des-CIC remained relatively stable: 2.27 to 3.19 pmol/dish between 3 and 24 h. The concentration of des-CIC fatty acid conjugates increased over time, with des-CIC-oleate being the main metabolite.", {"entities": []}], ["Uptake of ciclesonide into A549 cells was more efficient than that of the less lipophilic fluticasone propionate.", {"entities": []}], ["Intracellular concentrations of the pharmacologically active metabolite des-CIC were maintained for up to 24 h. The local anti-inflammatory activity of ciclesonide in the lung may be prolonged by the slow release of active drug from the depot of fatty acid esters.", {"entities": []}], ["The halogen bond occurs when there is evidence of a net attractive interaction between an electrophilic region associated with a halogen atom in a molecular entity and a nucleophilic region in another, or the same, molecular entity.", {"entities": []}], ["In this fairly extensive review, after a brief history of the interaction, we will provide the reader with a snapshot of where the research on the halogen bond is now, and, perhaps, where it is going.", {"entities": []}], ["The specific advantages brought up by a design based on the use of the halogen bond will be demonstrated in quite different fields spanning from material sciences to biomolecular recognition and drug design.", {"entities": []}], ["Understanding the processes across childhood and adolescence that affect later life inequalities depends on many variables for a large number of individuals measured over substantial time periods.", {"entities": []}], ["Linkable administrative data were used to generate birth cohorts and to study pathways of inequity in childhood and early adolescence leading to differences in educational attainment.", {"entities": []}], ["Advantages and disadvantages of using large administrative data bases for such research were highlighted.", {"entities": []}], ["Children born in Manitoba, Canada between 1982 and 1995 were followed until age 19 (N = 89,763), with many time-invariant measures serving as controls.", {"entities": []}], ["Five time-varying predictors of high school graduation\u2014three social and two health\u2014were modelled using logistic regression and a framework for examining predictors across the life course.", {"entities": []}], ["For each time-varying predictor, six temporal patterns were tested: full, accumulation of risk, sensitive period, and three critical period models.", {"entities": []}], ["Predictors measured in early adolescence generated the highest odds ratios, suggesting the importance of adolescence.", {"entities": []}], ["Full models provided the best fit for the three time-varying social measures.", {"entities": []}], ["Residence in a low-income neighborhood was a particularly influential predictor of not graduating from high school.", {"entities": []}], ["The transmission of risk across developmental periods was also highlighted; exposure in one period had significant implications for subsequent life stages.", {"entities": []}], ["This study advances life course epidemiology, using administrative data to clarify the relationships among several measures of social behavior, cognitive development, and health.", {"entities": []}], ["Analyses of temporal patterns can be useful in studying such other outcomes as educational achievement, teen pregnancy, and workforce participation.", {"entities": []}], ["In 2001 Health Canada responded to a series of Ontario court decisions by creating the Marihuana Medical Access Division (MMAD) and the Marihuana Medical Access Regulations (MMAR).", {"entities": []}], ["Although Health Canada has conducted a small number of stakeholder consultations, the federal government has never polled federally authorized cannabis patients.", {"entities": []}], ["This study is an attempt to learn more about patient needs, challenges and experiences with the MMAD.", {"entities": []}], ["Launched in the spring of 2007, Quality of Service Assessment of Health Canada's Medical Cannabis Policy and Program pairs a 50 question online survey addressing the personal experiences of patients in the federal cannabis program with 25 semi-guided interviews.", {"entities": []}], ["Data gathering for this study took place from April 2007 to Jan. 2008, eventually garnering survey responses from 100 federally-authorized users, which at the time represented about 5% of the patients enrolled in Health Canada's program.", {"entities": []}], ["This paper presents the results of the survey portion of the study.", {"entities": []}], ["8% of respondents report getting their cannabis from Health Canada, while 66% grow it for themselves.", {"entities": []}], [">50% report that they frequent compassion clubs or dispensaries, which remain illegal and unregulated in Canada.", {"entities": []}], ["81% of patients would chose certified organic methods of cultivation; >90% state that not all strains are equally effective at relieving symptoms, and 97% would prefer to obtain cannabis from a source where multiple strains are available.", {"entities": []}], ["Of the 48 patients polled that had tried the Health Canada cannabis supply, >75% rank it as either \"1\" or \"2\" on a scale of 1-10 (with \"1\" being \"very poor\", and 10 being \"excellent\").", {"entities": []}], ["72% of respondents report they are either \"somewhat\" or \"totally unsatisfied\" with Canada's medical cannabis program.", {"entities": []}], ["These survey results and relevant court decisions suggest that the MMAR are not meeting the needs of most of the nation's medical cannabis patient community.", {"entities": []}], ["It is hoped this research will help inform policy changes that will better address the needs of Canada's critically and chronically ill medical cannabis patient population, including the integration of community-based dispensaries into this novel healthcare delivery model.", {"entities": []}], ["Using a randomized controlled trial, Marc Lallemant and colleagues ask if a CD4-based monitoring and treatment switching strategy provides a similar clinical outcome compared to the standard viral load-based strategy for adults with HIV in Thailand.", {"entities": []}], ["Please see later in the article for the Editors' Summary Viral load (VL) is recommended for monitoring the response to highly active antiretroviral therapy (HAART) but is not routinely available in most low- and middle-income countries.", {"entities": []}], ["The purpose of the study was to determine whether a CD4-based monitoring and switching strategy would provide a similar clinical outcome compared to the standard VL-based strategy in Thailand.", {"entities": []}], ["The Programs for HIV Prevention and Treatment (PHPT-3) non-inferiority randomized clinical trial compared a treatment switching strategy based on CD4-only (CD4) monitoring versus viral-load (VL).", {"entities": [[146, 149, "GENE"], [156, 159, "GENE"]]}], ["Consenting participants were antiretroviral-na\u00efve HIV-infected adults (CD4 count 50\u2013250/mm p \u200a=\u200a0.097).", {"entities": [[71, 74, "GENE"]]}], ["Median time from treatment initiation to switch was 11.7 months (7.7\u201319.4) in VL and 24.7 months (15.9\u201335.0) in CD4 ( p \u200a=\u200a0.001).", {"entities": [[112, 115, "GENE"]]}], ["The median duration of viremia >400 copies/ml at switch was 7.2 months (5.8\u20138.0) in VL versus 15.8 months (8.5\u201320.4) in CD4 ( p \u200a=\u200a0.002).", {"entities": [[120, 123, "GENE"]]}], ["FDO scores were not significantly different at time of switch.", {"entities": []}], ["No adverse events related to the monitoring strategy were reported.", {"entities": []}], ["The 3-year rates of clinical failure and loss of treatment options did not differ between strategies although the longer-term consequences of CD4 monitoring would need to be investigated.", {"entities": [[142, 145, "GENE"]]}], ["These results provide reassurance to treatment programs currently based on CD4 monitoring as VL measurement becomes more affordable and feasible in resource-limited settings.", {"entities": [[75, 78, "GENE"]]}], ["ClinicalTrials.gov NCT00162682 Please see later in the article for the Editors' Summary About 34 million people (most of them living in low-and middle-income countries) are currently infected with HIV, the virus that causes AIDS.", {"entities": []}], ["HIV infection leads to the destruction of immune system cells (including CD4 cells, a type of white blood cell), leaving infected individuals susceptible to other infections.", {"entities": [[73, 76, "GENE"]]}], ["Early in the AIDS epidemic, most HIV-infected individuals died within 10 years of infection.", {"entities": []}], ["Then, in 1996, highly active antiretroviral therapy (HAART)\u2014combined drugs regimens that suppress viral replication and allow restoration of the immune system\u2014became available.", {"entities": []}], ["For people living in affluent countries, HIV/AIDS became a chronic condition but, because HAART was expensive, HIV/AIDS remained a fatal illness for people living in resource-limited countries.", {"entities": []}], ["In 2003, the international community declared HIV/AIDS a global health emergency and, in 2006, it set the target of achieving universal global access to HAART by 2010.", {"entities": []}], ["By the end of 2011, 8 million of the estimated 14.8 million people in need of HAART in low- and middle-income countries were receiving treatment.", {"entities": []}], ["At the time this trial was conceived, national and international recommendations were that HIV-positive individuals should start HAART when their CD4 count fell below 200 cells/mm The researchers assigned about 700 HIV-positive adults who were beginning HAART for the first time to have their CD4 count (CD4 arm) or their CD4 count and viral load (VL arm) determined every 3 months.", {"entities": [[146, 149, "GENE"], [293, 296, "GENE"], [304, 307, "GENE"], [322, 325, "GENE"], [146, 149, "GENE"], [293, 296, "GENE"], [304, 307, "GENE"], [322, 325, "GENE"], [146, 149, "GENE"], [293, 296, "GENE"], [304, 307, "GENE"], [322, 325, "GENE"], [146, 149, "GENE"], [293, 296, "GENE"], [304, 307, "GENE"], [322, 325, "GENE"]]}], ["Participants were switched to a second-line therapy if their CD4 count declined by more than 30% from their peak CD4 count (CD4 arm) or if a viral load of more than 400 copies/ml was recorded (VL arm).", {"entities": [[61, 64, "GENE"], [113, 116, "GENE"], [124, 127, "GENE"], [61, 64, "GENE"], [113, 116, "GENE"], [124, 127, "GENE"], [61, 64, "GENE"], [113, 116, "GENE"], [124, 127, "GENE"]]}], ["The 3-year cumulative risk of clinical failure (defined as death, a new AIDS-defining event, or a CD4 count of less than 50 cells/mm These findings suggest that, in Thailand, a CD4 switching strategy is non-inferior in terms of clinical outcomes among HIV-positive adults 3 years after beginning HAART when compared to the recommended viral load-based switching strategy and that there is no difference between the strategies in terms of viral suppression and immune restoration after 3-years follow-up.", {"entities": [[98, 101, "GENE"], [177, 180, "GENE"], [98, 101, "GENE"], [177, 180, "GENE"]]}], ["Importantly, however, even though patients in the CD4 arm spent longer with a high viral load than patients in the VL arm, the emergence of HIV mutants resistant to antiretroviral drugs was similar in the two arms.", {"entities": [[50, 53, "GENE"]]}], ["Although these findings provide no information about the long-term outcomes of the two monitoring strategies and may not be generalizable to routine care settings, they nevertheless provide reassurance that using CD4 counts alone to monitor HAART in HIV treatment programs in resource-limited settings is an appropriate strategy to use as viral load measurement becomes more affordable and feasible in these settings.", {"entities": [[213, 216, "GENE"]]}], ["Please access these websites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001494 .", {"entities": []}], ["The World Health Organization provides information on all aspects of HIV/AIDS (in several languages); its 2010 recommendations for antiretroviral therapy for HIV infection in adults and adolescents are available as well as the June 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach The 2012 UNAIDS World AIDS Day Report provides up-to-date information about the AIDS epidemic and efforts to halt it Information is available from the US National Institute of Allergy and Infectious Diseases on HIV infection and AIDS NAM/aidsmap provides basic information about HIV/AIDS and summaries of recent research findings on HIV care and treatment Information is available from Avert , an international AIDS charity on many aspects of HIV/AIDS, including information on the global HIV/AIDS epidemic , on HIV and AIDS in Thailand , on universal access to AIDS treatment , and on starting, monitoring and switching HIV treatment (in English and Spanish) The UK National Health Service Choices website provides information (including personal stories) about HIV and AIDS More information about this trial (the PHPT-3 trial) is available Patient stories about living with HIV/AIDS are available through Avert ; the nonprofit website Healthtalkonline also provides personal stories about living with HIV, including stories about HIV treatment", {"entities": []}], ["Allergies to certain fruits such as banana, avocado, chestnut and kiwi are described in 30\u201370% of latex-allergic patients.", {"entities": []}], ["This association is attributed to the cross-reactivity between the major latex allergen hevein and hevein-like domains (HLDs) from fruit class I chitinases.", {"entities": []}], ["We aimed to assess the extent of cross-reactivity between hevein and HLDs using sera from latex-allergic patients with and without plant food allergy.", {"entities": [[137, 149, "DISEASE"]]}], ["Hevein and HLDs of latex, banana, and avocado chitinases were expressed in Escherichia coli as fusion proteins with the maltose-binding protein and purified by affinity chromatography.", {"entities": []}], ["IgE binding to these proteins was studied in sera from 59 latex-allergic patients and 20 banana-allergic patients without latex allergy by ELISA and ELISA inhibition.", {"entities": []}], ["Additionally, 16,408 allergic patients\u2019 sera were tested for IgE binding to hevein, latex chitinase, and wheat germ agglutinin using an allergen microarray.", {"entities": []}], ["Hevein-specific IgE was detected in 34/59 (58%) latex-allergic patients\u2019 sera.", {"entities": []}], ["HLDs of latex, banana, and avocado chitinases were recognized by 21 (36%), 20 (34%), and 9 (15%) sera, respectively.", {"entities": []}], ["In contrast, only one of 20 banana-allergic patients without latex allergy was sensitized to chitinase HLDs.", {"entities": []}], ["In most tested latex-allergic patients\u2019 sera, IgE binding to hevein was only partially reduced by preincubation with HLDs.", {"entities": []}], ["Among hevein-sensitized, latex-allergic patients, the percentage of plant food allergy (15/34\u00a0=\u00a044%) was equal to latex-allergic patients without hevein sensitization (11/25\u00a0=\u00a044%).", {"entities": [[74, 86, "DISEASE"]]}], ["In the general allergic population, 230 of 16,408 sera (1.4%) reacted to hevein and/or a hevein-like allergen.", {"entities": []}], ["Of these, 128 sera showed an isolated sensitization to hevein, whereas only 17 bound to latex chitinase or wheat germ agglutinin without hevein sensitization.", {"entities": []}], ["In conclusion, the IgE response to HLDs is elicited by hevein as sensitizing allergen in most cases.", {"entities": []}], ["Despite considerable cross-reactivity between these allergens, no correlation between latex-associated plant food allergy and sensitization to hevein or HLDs was found.", {"entities": [[109, 121, "DISEASE"]]}], ["Haemophilus influenzae is the most common colonizing bacteria of the bronchial tree in chronic obstructive pulmonary disease (COPD), and positive cultures for this potentially pathogenic microorganism (PPM) has been associated with local inflammation changes that may influence the relationships between H. influenzae and the bronchial mucosa.", {"entities": [[87, 124, "DISEASE"]]}], ["A cross-sectional analysis of stable COPD patients enrolled in the Phenotype and Course of Chronic Obstructive Pulmonary Disease (PAC-COPD) Study, focusing on bronchial colonization by H. influenzae, was performed.", {"entities": [[91, 128, "DISEASE"]]}], ["Specific IgA against the PPM was measured by optical density, and metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) using ELISA in sputum samples.", {"entities": []}], ["Levels in patients colonized by H. influenzae and non-colonized patients were compared.", {"entities": []}], ["Sputum supernatant for the measurement of specific IgA against H. influenzae was available from 54 stable COPD patients, who showed levels of specific IgA significantly lower in colonized (n=21) than in non-colonized patients (n=33) (15 [4-37] versus 31 [10-75], p=0.033, Mann-Whitney U test).", {"entities": []}], ["Proenzyme MMP-9 was measured in 44 patients, and it was higher in colonized (n=12, 1903 [1488-6699] ng/ml) than in non-colonized patients (n=32, 639 [373-972] ng/ml) (p<0.001, Mann-Whitney U test).", {"entities": []}], ["Active form of MMP-9 was also higher in colonized (126 [25-277] ng/ml) than in non-colonized patients (39 [14-68] ng/ml) (p=0.021, Mann-Whitney U test), and the molar ratio between proenzyme MMP-9 and TIMP-1 was above 1 (2.1 [0.1-12.5]) in colonized patients, significantly higher than the ratio found in non-colonized patients (0.2 [0.08-0.5]) (p=0.030, Mann-Whitney U test).", {"entities": []}], ["Clinically stable COPD patients colonized by H. influenzae had lower levels of specific IgA against the microorganism and higher values of the active form of MMP-9 in their sputum supernatant than non-colonized patients.", {"entities": []}], ["Bronchial colonization by H. influenzae may cause structural changes in the extracellular matrix through a defective defense and the production of active metalloproteinases.", {"entities": []}], ["Health risk factors such as body mass index (BMI) and serum cholesterol are associated with many common diseases.", {"entities": []}], ["It often remains unclear whether the risk factors are cause or consequence of disease, or whether the associations are the result of confounding.", {"entities": []}], ["We develop and apply a method (called GSMR) that performs a multi-SNP Mendelian randomization analysis using summary-level data from genome-wide association studies to test the causal associations of BMI, waist-to-hip ratio, serum cholesterols, blood pressures, height, and years of schooling (EduYears) with common diseases (sample sizes of up to 405,072).", {"entities": []}], ["We identify a number of causal associations including a protective effect of LDL-cholesterol against type-2 diabetes (T2D) that might explain the side effects of statins on T2D, a protective effect of EduYears against Alzheimer\u2019s disease, and bidirectional associations with opposite effects (e.g., higher BMI increases the risk of T2D but the effect of T2D on BMI is negative).", {"entities": []}], ["Genetic methods are useful to test whether risk factors are causal for or consequence of disease.", {"entities": []}], ["Here, Zhu et al.", {"entities": []}], ["develop a generalized summary-based Mendelian Randomization (GSMR) method which uses summary-level data from GWAS to test for causal associations of health risk factors with common diseases.", {"entities": []}], ["T cells and B cells participate in the pathogenesis of COPD.", {"entities": []}], ["Currently, NK cells and NKT cells have gained increasing attention.", {"entities": []}], ["In the present study, 19 COPD patients and 12 healthy nonsmokers (HNS) were recruited, and their pulmonary function was assessed.", {"entities": []}], ["The frequencies of CD3 \u03b3 \u03b3 -secreting NK and NKT-like cells were less in COPD patients.", {"entities": []}], ["The frequencies of CD158a and CD158b on NK cells and CD158b on NKT-like cells were greater.", {"entities": []}], ["The frequency of CD158b 1 % prediction and FEV 1 /FVC.", {"entities": [[43, 46, "GENE"]]}], ["Our data indicate that COPD patients have immune dysfunction, and higher frequencies of inhibitory NK cells and NKT-like cells may participate in the pathogenesis of COPD.", {"entities": []}], ["G-protein-coupled receptor (GPCR) signaling modulates the expression of cytokines that are drug targets for immune disorders.", {"entities": []}], ["However, although GPCRs are common targets for other diseases, there are few GPCR-based pharmaceuticals for inflammation.", {"entities": []}], ["The purpose of this study was to determine whether targeting G-protein \u03b2\u03b3 (G\u03b2\u03b3) complexes could provide a useful new approach for modulating interleukin 2 (IL-2) levels in CD4 1 and G\u03b2 2 mRNA accounted for >99% of G\u03b2 mRNA, and small interfering RNA (siRNA)-mediated silencing of G\u03b2 1 but not G\u03b2 2 enhanced TCR-stimulated IL-2 mRNA increases.", {"entities": [[172, 175, "GENE"]]}], ["Blocking G\u03b2\u03b3 enhanced TCR-stimulated increases in IL-2 transcription without affecting IL-2 mRNA stability.", {"entities": []}], ["Blocking G\u03b2\u03b3 also enhanced TCR-stimulated increases in nuclear localization of nuclear factor of activated T cells 1 (NFAT1), NFAT transcriptional activity, and levels of intracellular Ca", {"entities": []}], ["Over 9.6 million ED visits occur annually for abdominal pain in the US, but little is known about the medical outcomes of these patients based on demographics.", {"entities": []}], ["We aimed to identify disparities in outcomes among children presenting to the ED with abdominal pain linked to race and SES.", {"entities": []}], ["Data from 4.2 million pediatric encounters of abdominal pain were analyzed from 43 tertiary US children\u2019s hospitals, including 2.0 million encounters in the emergency department during 2004-2011.", {"entities": []}], ["Abdominal pain was categorized as functional or organic abdominal pain.", {"entities": []}], ["Appendicitis (with and without perforation) was used as a surrogate for abdominal pain requiring emergent care.", {"entities": [[0, 12, "DISEASE"]]}], ["Multivariate analysis estimated likelihood of hospitalizations, radiologic imaging, ICU admissions, appendicitis, appendicitis with perforation, and time to surgery and hospital discharge.", {"entities": [[100, 112, "DISEASE"], [114, 126, "DISEASE"]]}], ["Black and low income children had increased odds of perforated appendicitis (aOR, 1.42, 95% CI, 1.32- 1.53; aOR, 1.20, 95% CI 1.14 \u2013 1.25).", {"entities": [[63, 75, "DISEASE"]]}], ["Blacks had increased odds of an ICU admission (aOR, 1.92, 95% CI 1.53 - 2.42) and longer lengths of stay (aHR, 0.91, 95% CI 0.86 \u2013 0.96) than Whites.", {"entities": [[106, 109, "GENE"]]}], ["Minorities and low income also had lower rates of imaging for their appendicitis, including CT scans.", {"entities": [[68, 80, "DISEASE"]]}], ["The combined effect of race and income on perforated appendicitis, hospitalization, and time to surgery was greater than either separately.", {"entities": [[53, 65, "DISEASE"]]}], ["Based on race and SES, disparity of health outcomes exists in the acute ED setting among children presenting with abdominal pain, with differences in appendicitis with perforation, length of stay, and time until surgery.", {"entities": [[150, 162, "DISEASE"]]}], ["This study examines health behaviors of breast cancer survivors with hypertension and compares them with those of non-cancer individuals with hypertension.", {"entities": [[69, 81, "DISEASE"], [142, 154, "DISEASE"], [40, 53, "DISEASE"], [47, 53, "DISEASE"], [118, 124, "DISEASE"]]}], ["In this cross-sectional study, a total of 10,996 hypertensive adults (\u2265 19 years) who participated in the 2005-2012 Korean National Health and Nutrition Examination Survey (KNHANES) were considered.", {"entities": []}], ["Data on alcohol consumption, smoking, physical activity, antihypertensive medication adherence, self-reported diet control, and sodium intake were collected through self-report questionnaire.", {"entities": []}], ["A total of 64 breast cancer survivors with hypertension and 10,932 non-cancer participants with hypertension were identified.", {"entities": [[43, 55, "DISEASE"], [96, 108, "DISEASE"], [14, 27, "DISEASE"], [21, 27, "DISEASE"], [71, 77, "DISEASE"]]}], ["To better compare health behaviors of the two groups, 56 breast cancer survivors and 280 non-cancer participants were selected through the 1:5 nearest available matching based on estimated propensity scores.", {"entities": [[57, 70, "DISEASE"], [64, 70, "DISEASE"], [93, 99, "DISEASE"]]}], ["Multivariate analysis was conducted to determine any differences between the two groups.", {"entities": []}], ["According to multivariate analysis, breast cancer survivors with hypertension (n = 56) were significantly less likely to consume alcohol (odds ratio (OR): 3.75; 95% confidence interval (CI): 1.06-13.29) but significantly more likely to have sodium intake of more than 2400 mg (OR: 2.98; 95% CI: 1.27-6.97) than the propensity-matched control group (n = 280).", {"entities": [[65, 77, "DISEASE"], [36, 49, "DISEASE"], [43, 49, "DISEASE"]]}], ["There was no significant difference in other health behaviors between the two groups.", {"entities": []}], ["Breast cancer survivors require active interventions for healthy behaviors related to the management of comorbid conditions such as hypertension to reduce the risk of cardiovascular disease and improve their overall survival rate.", {"entities": [[132, 144, "DISEASE"], [0, 13, "DISEASE"], [7, 13, "DISEASE"]]}], ["Neovascular age-related macular degeneration is the leading cause of irreversible blindness in people 50 years of age or older in the developed world.", {"entities": [[82, 91, "DISEASE"], [24, 44, "DISEASE"]]}], ["As in other chronic diseases, several effective treatments are available, but in clinical daily practice there is an evidence performance gap.", {"entities": []}], ["The Chronic Care Model represents an evidence-based framework for the care of chronically ill patients and aims at closing that gap.", {"entities": []}], ["However, no data are available regarding patients with neovascular age-related macular degeneration.", {"entities": [[79, 99, "DISEASE"]]}], ["CHARMED is a multicenter randomized controlled trial.", {"entities": []}], ["The study challenges the hypothesis that the implementation of core elements of the Chronic Care Model (patient empowerment, delivering evidence based information, clinical information system, reminder system with structured follow up and frequent monitoring) via a specially trained Chronic Care Coach in Swiss centres for neovascular age-related macular degeneration results in better visual acuity (primary outcome) and an increased disease specific quality of life (secondary outcome) in patients with neovascular age-related macular degeneration.", {"entities": [[348, 368, "DISEASE"], [530, 550, "DISEASE"]]}], ["According to the power calculation, a total sample size of 352 patients is needed (drop out rate of 25%).", {"entities": []}], ["14 specialised medical doctors from leading ophtalmologic centres in Switzerland will include 25 patients.", {"entities": []}], ["In each centre, a Chronic Care Coach will provide disease specific care according to the Chronic Care Model for intervention group.", {"entities": []}], ["Patients from the control group will be treated as usual.", {"entities": []}], ["Baseline measurements will be taken in month III - XII, starting in March 2011.", {"entities": []}], ["Follow-up data will be collected after 6 months and 1 year.", {"entities": []}], ["Multiple studies have shown that implementing Chronic Care Model elements improve clinical outcomes as well as process parameters in different chronic diseases as osteoarthritis, depression or e.g.", {"entities": [[163, 177, "DISEASE"]]}], ["the cardiovascular risk profile of diabetes patients.", {"entities": []}], ["This study will be the first to assess this approach in neovascular age-related macular degeneration.", {"entities": [[80, 100, "DISEASE"]]}], ["If our hypothesis will be confirmed, the implementation of this approach in routine care for patients with with neovascular age-related macular degeneration should be considered.", {"entities": [[136, 156, "DISEASE"]]}], ["Current controlled trials ISRCTN32507927 .", {"entities": []}], ["The INSIG2 rs7566605 polymorphism was identified for obesity (BMI\u226530 kg/m A polymorphism of the INSIG2 gene was identified as being associated with obesity in one of the first genome-wide association studies.", {"entities": [[53, 60, "DISEASE"], [148, 155, "DISEASE"], [4, 10, "GENE"], [96, 102, "GENE"], [4, 10, "GENE"], [96, 102, "GENE"]]}], ["However, this association has since then been highly debated upon inconsistent subsequent reports.", {"entities": []}], ["We collected association information from 34 studies including a total of 74,000 participants.", {"entities": []}], ["In a meta-analysis of the 27 studies including 66,000 Caucasian adults, we found no overall association of this polymorphism rs7566605 with obesity, comparing subjects with a body-mass-index (BMI)\u226530 kg/m", {"entities": [[140, 147, "DISEASE"]]}], ["The prevalence of high levels of circulating ACTH-like immunoactivity was determined in 134 patients with lung cancer, using reference ranges from 52 age- and sex-matched patients with non-malignant lung disease.", {"entities": [[106, 117, "DISEASE"], [199, 211, "DISEASE"], [111, 117, "DISEASE"]]}], ["Two studies used ACTH radioimmunoassays with different specificities.", {"entities": []}], ["Study A used an unextracted plasma or serum assay for total ACTH immunoactivity.", {"entities": []}], ["High serum ACTH levels occurred in 24% of patients with small-cell carcinoma and 3% of patients with non-small-cell cancer.", {"entities": [[67, 76, "DISEASE"], [116, 122, "DISEASE"]]}], ["In patients with small-cell carcinoma, levels were high in 12% with limited disease and 32% with extensive disease.", {"entities": [[28, 37, "DISEASE"]]}], ["Study B used an ACTH assay after plasma extraction by porous glass, which measured mainly regular 1-39 ACTH.", {"entities": []}], ["Here no lung-cancer patient had levels above the reference range, suggesting that the high levels in Study A may be due to plasma ACTH components which are poorly extracted by porous glass.", {"entities": [[13, 19, "DISEASE"]]}], ["It is concluded that high circulating ACTH immunoactivity occurs in a minority of patients with lung cancer, particularly those with extensive small-cell carcinoma.", {"entities": [[96, 107, "DISEASE"], [154, 163, "DISEASE"], [101, 107, "DISEASE"]]}], ["Indirect evidence suggests that the high ACTH levels detected with assays for total ACTH are due to molecular forms other than 1-39 ACTH, probably high-mol.-wt species.", {"entities": []}], ["The purpose of this research was to fully explore the impact of endpoint type (primary vs. nonprimary) on decisions related to patient-reported outcome (PRO) labeling claims supported by PRO measures and to determine if nonprimary PRO endpoints are being fully optimized.", {"entities": []}], ["This review examines the use of PROs as both primary and nonprimary endpoints in support of demonstration of treatment benefit of new molecular entities (NMEs) and biologic license applications (BLAs) in the United States in the years 2000 to 2012.", {"entities": []}], ["All NMEs and BLAs approved by the Food and Drug Administration (FDA) between January 2000 and June 2012 were identified using the FDA Drug Approval Reports Web page.", {"entities": []}], ["Generic products granted tentative approvals were excluded.", {"entities": []}], ["For all identified products, medical review sections from publicly available drug approval packages were reviewed to identify PRO endpoint status.", {"entities": []}], ["Product labels (indication, clinical trials sections) were reviewed to determine the number and type of PRO claim.", {"entities": []}], ["A total of 308 NMEs/BLAs were identified.", {"entities": []}], ["Of these, 70 NMEs/BLAs (23%) were granted PRO claims.", {"entities": []}], ["The majority of product claims were for disease- or condition-specific signs and symptoms.", {"entities": []}], ["Of the 70 products with PRO claims, a PRO was a primary endpoint for the vast majority (57 [81%]).", {"entities": []}], ["A total of 19 of the 70 products were granted a PRO claim based on a nonprimary endpoint.", {"entities": []}], ["While nonprimary endpoints were used most often to support claims of improved signs or symptoms, nonprimary endpoints were much more likely to support claims of higher order impacts.", {"entities": []}], ["Successful PRO labeling claims are typically based on primary endpoints assessing signs and symptoms.", {"entities": []}], ["Based on this research, studies with PROs as primary endpoints are far more likely to facilitate positive regulatory review and acceptance of PROs in support of labeling claims.", {"entities": []}], ["Although inclusion of PROs as nonprimary endpoints in clinical trials has its challenges, recent PRO labels granted by the FDA show that they can indeed be candidates for PRO labeling claims as long as they are supported by evidence.", {"entities": []}], ["Chronic kidney disease (CKD) is an increasing and global health problem with a great economic burden for healthcare system.", {"entities": [[8, 22, "DISEASE"]]}], ["Therefore to slow down the progression of this condition is a main objective in nephrology.", {"entities": []}], ["It has been extensively reported that microinflammation, immune system deregulation, and oxidative stress contribute to CKD progression.", {"entities": []}], ["Additionally, dialysis worsens this clinical condition because of the contact of blood with bioincompatible dialytic devices.", {"entities": []}], ["Numerous studies have shown the close link between immune system impairment and CKD but most have been performed using classical biomolecular strategies.", {"entities": []}], ["These methodologies are limited in their ability to discover new elements and enable measuring the simultaneous influence of multiple factors.", {"entities": []}], ["The \u201comics\u201d techniques could overcome these gaps.", {"entities": []}], ["For example, transcriptomics has revealed that mitochondria and inflammasome have a role in pathogenesis of CKD and are pivotal elements in the cellular alterations leading to systemic complications.", {"entities": []}], ["We believe that a larger employment of this technique, together with other \u201comics\u201d methodologies, could help clinicians to obtain new pathogenetic insights, novel diagnostic biomarkers, and therapeutic targets.", {"entities": []}], ["Finally, transcriptomics could allow clinicians to personalize therapeutic strategies according to individual genetic background (nutrigenomic and pharmacogenomic).", {"entities": []}], ["In this review, we analyzed the available transcriptomic studies involving CKD patients.", {"entities": []}], ["In the United States, a medical home model has been shown to improve the outcomes for children with special health care needs.", {"entities": []}], ["As part of this model, primary care physicians provide comprehensive medical care that includes identification of delayed and/or atypical development in children and coordination of care with specialists.", {"entities": []}], ["However, it is not clear if families of children with Autism Spectrum Disorder (ASD) rely on the medical home model for care of their child to the same extent as families of children with other special health care needs.", {"entities": []}], ["This study aims to add to the understanding of medical care for children with ASD by examining the referral source for specialty care.", {"entities": []}], ["This retrospective study was accomplished by evaluating parent completed intake data for children with ASD compared to those with other neurological disorders in a single physician Pediatric Neurology Practice at a major urban medical center in Northern New Jersey.", {"entities": []}], ["To account for referral bias, a similar comparison study was conducted using a multispecialty ASD practice at the same medical center.", {"entities": []}], ["Parent reported \"source of referral\" and \"reason for the referral\" of 189 ASD children and 108 non-ASD neurological disordered children were analyzed.", {"entities": []}], ["The specialty evaluations of ASD were predominantly parent initiated.", {"entities": []}], ["There were significantly less referrals received from primary care physicians for children with ASD compared to children with other neurodevelopmental disorders.", {"entities": []}], ["Requirement of an insurance referral was not associated with a primary care physician prompted specialty visit.We identified different patterns of referral to our specialty clinics for children with ASD vs. children with other neurolodevelopmental disorders.", {"entities": []}], ["The majority of the families of children with ASD evaluated at our autism center did not indicate that a primary care physician initiated the specialty referral.", {"entities": []}], ["This study suggests that families of children with ASD interface differently with the primary care provider than families of children with other neurological disorders.", {"entities": []}], ["Exposure to air pollution is associated with increased morbidity from cardiovascular diseases, lung cancer, respiratory and allergic diseases.", {"entities": [[95, 106, "DISEASE"], [100, 106, "DISEASE"]]}], ["The aim of this study was to investigate allergic diseases in 111 traffic wardens compared to a control group of 101 administrative employees.", {"entities": []}], ["All participating subjects underwent a physical examination, in which a complete medical history was taken and a dedicated allergological questionnaire administered.", {"entities": []}], ["Spirometry, Specific IgE dosage (RAST) and skin prick tests (SPT) were done.", {"entities": []}], ["Diagnostic investigations such as the nasal cytology, a specific nasal provocation test and rhinomanometry were also performed.", {"entities": []}], ["Statistical analyses were performed using STATA version 11.", {"entities": []}], ["The percentage of subjects with a diagnosis of allergy was higher in the exposed workers than in the controls.", {"entities": []}], ["As regards the clinical tests, the positivity was higher for the group of exposed subjects.", {"entities": []}], ["Among the exposed workers, those who worked on foot or motorcycle had a higher positivity in clinical trials compared to the traffic wardens who used the car.", {"entities": []}], ["Our study showed a higher percentage of allergic subjects in the group of workers exposed to outdoor pollutants than in the controls.", {"entities": []}], ["These results suggest that allergological tests should be included in the health surveillance protocols for workers exposed to outdoor pollutants.", {"entities": []}], ["In this prospective study, 87 children were followed up from birth to 14\u00a0months with data on maternal vitamin D status during the pregnancy.", {"entities": []}], ["Postnatal vitamin D supplementation improved vitamin D status but only partly eliminated the differences in bone variables induced by maternal vitamin D status during the fetal period.", {"entities": []}], ["Intrauterine nutritional deficits may have permanent consequences despite improved nutritional status postnatally.", {"entities": []}], ["We evaluated the role of prenatal and postnatal vitamin D status on bone parameters in early infancy.", {"entities": []}], ["Eighty-seven children were followed from birth to 14\u00a0months.", {"entities": []}], ["Background data were collected with a questionnaire and a 3-day food record.", {"entities": []}], ["At 14\u00a0months bone variables were measured with peripheral computed tomography (pQCT) from the left tibia.", {"entities": []}], ["Serum 25-OHD and bone turnover markers were determined.", {"entities": []}], ["Findings were compared with maternal vitamin D status during pregnancy.", {"entities": []}], ["The children were divided into two groups based on vitamin D status during pregnancy.", {"entities": []}], ["Despite discrepant S-25-OHD at baseline (median 36.3 vs. 52.5\u00a0nmol/l, p \u2009<\u20090.001), the values at 14\u00a0months were similar (63 vs. 66\u00a0nmol/l, p \u2009=\u20090.58) in Low D and High D. Serum 25-OHD increased more in Low D ( p \u2009<\u20090.001) despite similar total intake of vitamin D (mean 12.3\u00a0\u03bcg/day).", {"entities": []}], ["In Low D, tibial bone mineral content (BMC) was lower at birth but BMC gain was greater (multivariate analysis of variance [MANOVA]; p \u2009=\u20090.032) resulting in similar BMC at 14\u00a0months in the two groups.", {"entities": []}], ["In High D, tibial total bone cross-sectional area was higher at baseline; the difference persisted at 14\u00a0months (MANOVA; p \u2009=\u20090.068).", {"entities": []}], ["Bone mineral density (BMD) and \u0394BMD were similar in the two groups.", {"entities": []}], ["Postnatal vitamin D supplementation improved vitamin D status but only partly eliminated the differences in bone variables induced by maternal vitamin D status during the fetal period.", {"entities": []}], ["Further attention should be paid to improving vitamin D status during pregnancy.", {"entities": []}], ["The expression of facial asymmetries has been recurrently related with poverty and/or disadvantaged socioeconomic status.", {"entities": []}], ["Departing from the developmental instability theory, previous approaches attempted to test the statistical relationship between the stress experienced by individuals grown in poor conditions and an increase in facial and corporal asymmetry.", {"entities": []}], ["Here we aim to further evaluate such hypothesis on a large sample of admixed Latin Americans individuals by exploring if low socioeconomic status individuals tend to exhibit greater facial fluctuating asymmetry values.", {"entities": []}], ["To do so, we implement Procrustes analysis of variance and Hierarchical Linear Modelling (HLM) to estimate potential associations between facial fluctuating asymmetry values and socioeconomic status.", {"entities": []}], ["We report significant relationships between facial fluctuating asymmetry values and age, sex, and genetic ancestry, while socioeconomic status failed to exhibit any strong statistical relationship with facial asymmetry.", {"entities": []}], ["These results are persistent after the effect of heterozygosity (a proxy for genetic ancestry) is controlled in the model.", {"entities": []}], ["Our results indicate that, at least on the studied sample, there is no relationship between socioeconomic stress (as intended as low socioeconomic status) and facial asymmetries.", {"entities": []}], ["Previous studies have shown that treatment with ergocalciferol in patients with CKD stage 3 + 4 is not effective with less than 33% of patients achieving a 25-OH vitamin D target of >30 ng/ml.", {"entities": []}], ["The aim of this study was to test the response to cholecalciferol in CKD.", {"entities": []}], ["We attempted to replete 25-OH vitamin D to a target level of 40\u201360 ng/ml using the response to treatment and PTH suppression as an outcome measure.", {"entities": [[109, 112, "GENE"]]}], ["This retrospective cohort study identified patients (Stages 2\u20135 and Transplant) from 2001\u20132010 who registered at the Chronic Kidney Disease Clinic.", {"entities": []}], ["Patients received cholecalciferol 10,000 IU capsules weekly as initial therapy.", {"entities": []}], ["When levels above 40 ng/ml were not achieved, doses were titrated up to a maximum of 50,000 IU weekly.", {"entities": []}], ["Active vitamin D analogs were also used in some Stage 4\u20135 CKD patients per practice guidelines.", {"entities": []}], ["Patients reaching at least one level of 40 ng/mL were designated RESPONDER, and if no level above 40 ng/mL they were designated NON-RESPONDER.", {"entities": []}], ["Patients were followed for at least 6 months and up to 5 years.", {"entities": []}], ["352 patients were included with a mean follow up of 2.4 years.", {"entities": []}], ["Of the CKD patients, the initial 25-OH vitamin D in the NON-RESPONDER group was lower than the RESPONDER group (18 vs. 23 ng/ml) (p = 0.03).", {"entities": []}], ["Among all patients, the initial eGFR in the RESPONDER group was significantly higher than the NON-RESPONDER group (36 vs. 30 ml/min/1.73 m CKD patients treated with cholecalciferol experience treatment resistance in raising vitamin D levels to a pre-selected target level.", {"entities": [[32, 36, "GENE"]]}], ["The mechanism of vitamin D resistance remains unknown and is associated with progressive loss of eGFR.", {"entities": [[97, 101, "GENE"]]}], ["Proteinuria modifies but does not account for the vitamin D resistance.", {"entities": []}], ["The 7.5% carbon dioxide (CO 2 ) inhalation model is used to provoke acute anxiety, for example to investigate the effects of anxiety on cognitive processes, or the efficacy of novel anxiolytic agents.", {"entities": []}], ["However, little is known about the relationship of baseline anxiety sensitivity or trait anxiety (i.e., anxiety proneness), with an individual\u2019s response to the 7.5% CO 2 challenge.", {"entities": []}], ["We examined data from a number of 7.5% CO 2 challenge studies to determine whether anxiety proneness was related to subjective or physiological response.", {"entities": []}], ["Our findings indicate anxiety proneness is associated with greater subjective and physiological responses.", {"entities": []}], ["However, anxiety-prone individuals also have a greater subjective response to the placebo (medical air) condition.", {"entities": []}], ["This suggests that anxiety-prone individuals not only respond more strongly to the 7.5% CO 2 challenge, but also to medical air.", {"entities": []}], ["Implications for the design and conduct of 7.5% CO 2 challenge studies are discussed.", {"entities": []}], ["Polyphenols, widely found in edible plants, influence the immune system.", {"entities": []}], ["Nevertheless, the immunomodulatory properties of hesperidin, the predominant flavanone in oranges, have not been deeply studied.", {"entities": []}], ["To establish the effect of hesperidin on in vivo immune response, two different conditions of immune system stimulations in Lewis rats were applied.", {"entities": []}], ["In the first experimental design, rats were intraperitoneally immunized with ovalbumin (OVA) plus Bordetella pertussis toxin and alum as the adjuvants, and orally given 100 or 200 mg/kg hesperidin.", {"entities": [[109, 118, "DISEASE"]]}], ["In the second experimental design, rats were orally sensitized with OVA together with cholera toxin and fed a diet containing 0.5% hesperidin.", {"entities": [[86, 93, "DISEASE"]]}], ["In the first approach, hesperidin administration changed mesenteric lymph node lymphocyte (MLNL) composition, increasing the TCR\u03b1\u03b2+ cell percentage and decreasing that of B lymphocytes.", {"entities": []}], ["Furthermore, hesperidin enhanced the interferon (IFN)-\u03b3 production in stimulated MLNL.", {"entities": []}], ["In the second approach, hesperidin intake modified the lymphocyte composition in the intestinal epithelium (TCR\u03b3\u03b4+ cells) and the lamina propria (TCR\u03b3\u03b4+, CD45RA+, natural killer, natural killer T, TCR\u03b1\u03b2+CD4+, and TCR\u03b1\u03b2+CD8+ cells).", {"entities": []}], ["Nevertheless, hesperidin did not modify the level of serum anti-OVA antibodies in either study.", {"entities": []}], ["In conclusion, hesperidin does possess immunoregulatory properties in the intestinal immune response, but this effect is not able to influence the synthesis of specific antibodies.", {"entities": []}], ["\"Phosphatase and tensin homolog deleted on chromosome 10\" (PTEN) is mostly considered to be a cancer-related gene, and has been suggested to be a new pathway of pathogenesis of asthma.", {"entities": [[177, 183, "DISEASE"], [94, 100, "DISEASE"], [59, 63, "GENE"]]}], ["The purpose of this study was to investigate the effects of the glucocorticoid, dexamethasone, on PTEN regulation.", {"entities": [[98, 102, "GENE"]]}], ["OVA-challenged mice were used as an asthma model to investigate the effect of dexamethasone on PTEN regulation.", {"entities": [[36, 42, "DISEASE"], [95, 99, "GENE"]]}], ["Immunohistochemistry was used to detect expression levels of PTEN protein in lung tissues.", {"entities": [[61, 65, "GENE"]]}], ["The human A549 cell line was used to explore the possible mechanism of action of dexamethasone on human PTEN regulation in vitro .", {"entities": [[104, 108, "GENE"]]}], ["A luciferase reporter construct under the control of PTEN promoter was used to confirm transcriptional regulation in response to dexamethasone.", {"entities": [[53, 57, "GENE"]]}], ["PTEN protein was found to be expressed at low levels in lung tissues in asthmatic mice; but the expression was restored after treatment with dexamethasone.", {"entities": [[0, 4, "GENE"]]}], ["In A549 cells, human PTEN was up-regulated by dexamethasone treatment.", {"entities": [[21, 25, "GENE"]]}], ["The promoter-reporter construct confirmed that dexamethasone could regulate human PTEN transcription.", {"entities": [[82, 86, "GENE"]]}], ["Treatment with the histone deacetylase inhibitor, TSA, could increase PTEN expression in A549 cells, while inhibition of histone acetylase (HAT) by anacardic acid attenuated dexamethasone-induced PTEN expression.", {"entities": [[70, 74, "GENE"], [196, 200, "GENE"], [70, 74, "GENE"], [196, 200, "GENE"]]}], ["Based on the data a new mechanism is proposed where glucocorticoids treat asthma partly through up-regulation of PTEN expression.", {"entities": [[74, 80, "DISEASE"], [113, 117, "GENE"]]}], ["The in vitro studies also suggest that the PTEN pathway may be involved in human asthma.", {"entities": [[81, 87, "DISEASE"], [43, 47, "GENE"]]}], ["We are in the midst of a digital revolution in health care, although the application of new and useful technology in routine clinical practice is variable.", {"entities": []}], ["The Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly (CATCH ME) Consortium, in collaboration with the European Society of Cardiology (ESC), has funded the creation of two applications (apps) in atrial fibrillation (AF) for use in smartphones and tablets.", {"entities": []}], ["The patient app aims to enhance patient education, improve communication between patients and health care professionals, and encourage active patient involvement in the management of their condition.", {"entities": [[12, 15, "GENE"]]}], ["The health care professional app is designed as an interactive management tool incorporating the new ESC Practice Guidelines on AF and supported by the European Heart Rhythm Association (EHRA), with the aim of improving best practice approaches for the care of patients with AF.", {"entities": [[29, 32, "GENE"]]}], ["Both stand-alone apps are now freely available for Android and iOS devices though the Google Play, Amazon, and Apple stores.", {"entities": []}], ["In this article, we outline the rationale for the design and implementation of these apps.", {"entities": []}], ["Our objective is to demonstrate the value of integrating novel digital technology into clinical practice, with the potential for patient engagement, optimization of pharmacological and interventional therapy in AF, and ultimately to improve patient outcomes.", {"entities": []}], ["CD163 is a macrophage scavenger receptor with anti-inflammatory and pro-inflammatory functions.", {"entities": [[0, 5, "GENE"]]}], ["Here, we report that alveolar macrophages (AM\u03a6s) from asthmatic subjects had reduced cell surface expression of CD163, which suggested that CD163 might modulate the pathogenesis of asthma.", {"entities": [[181, 187, "DISEASE"], [112, 117, "GENE"], [140, 145, "GENE"], [112, 117, "GENE"], [140, 145, "GENE"]]}], ["Consistent with this, house dust mite (HDM)-challenged Cd163 Cd163 Dermatophagoides ptyeronyssinus peptidase 1 (Der p1).", {"entities": [[55, 60, "GENE"], [61, 66, "GENE"], [55, 60, "GENE"], [61, 66, "GENE"]]}], ["Der p1-challenged Cd163 Cd163 Cd163 Cd163 Cd163", {"entities": [[18, 23, "GENE"], [24, 29, "GENE"], [30, 35, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [18, 23, "GENE"], [24, 29, "GENE"], [30, 35, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [18, 23, "GENE"], [24, 29, "GENE"], [30, 35, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [18, 23, "GENE"], [24, 29, "GENE"], [30, 35, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"], [18, 23, "GENE"], [24, 29, "GENE"], [30, 35, "GENE"], [36, 41, "GENE"], [42, 47, "GENE"]]}], ["Seasonal variations in mood and behaviour, termed seasonality, are commonly reported in the general population.", {"entities": []}], ["As a part of a large cross-sectional health survey in Hordaland, Norway, we investigated the relationship between seasonality, objective health measurements and health behaviours.", {"entities": []}], ["A total of 11,545 subjects between 40\u201344 years old participated, completing the Global Seasonality Score, measuring seasonality.", {"entities": []}], ["Waist/hip circumference, BMI and blood pressure were measured, and blood samples were analyzed for total cholesterol, HDL cholesterol, triglycerides and glucose.", {"entities": []}], ["Subjects also completed a questionnaire on miscellaneous health behaviours (exercise, smoking, alcohol consumption).", {"entities": []}], ["Hierarchical linear regression analyses were used to investigate associations between seasonality and objective health measurements, while binary logistic regression was used for analysing associations between seasonality and health behaviours.", {"entities": []}], ["Analyses were adjusted for sociodemographic factors, month of questionnaire completion and sleep duration.", {"entities": []}], ["Seasonality was positively associated with high waist-hip-ratio, BMI, triglyceride levels, and in men high total cholesterol.", {"entities": []}], ["Seasonality was negatively associated with HDL cholesterol.", {"entities": []}], ["In women seasonality was negatively associated with prevalence of exercise and positively associated with daily cigarette smoking.", {"entities": []}], ["High seasonality was associated with objective health risk factors and in women also with health behaviours associated with an increased risk for cardiovascular disease.", {"entities": []}], ["Ameba-associated microorganisms should be suspected when conventional microbiologic test results are negative.", {"entities": []}], ["To elucidate the role of ameba-associated microorganisms (AAMs) as etiologic agents of pneumonia, we screened for Legionella spp., Parachlamydia acanthamoeba , Afipia sp., Bosea spp., Bradyrhizobium spp., Mesorhizobium amorphae , Rasbo bacterium , Azorhizobium caulinodans , Acanthamoeba polyphaga mimivirus , and conventional microorganisms in 210 pneumonia patients in intensive-care units by using culture, polymerase chain reaction, and serologic testing.", {"entities": [[87, 96, "DISEASE"], [349, 358, "DISEASE"]]}], ["These resulted in 59 diagnoses in 40 patients.", {"entities": []}], ["AAMs and non-AAMs were implicated in 10.5% of the patients.", {"entities": []}], ["The infectious agents were identified in 15 patients: Acanthamoeba polyphaga mimivirus , 8; Legionella pneumophila , 3; L .", {"entities": []}], ["anisa , 1; Parachlamydia sp., 1; Bosea massiliensis , L .", {"entities": []}], ["worsleiensis , L .", {"entities": []}], ["quinlivanii , and L .", {"entities": []}], ["rubrilucens , 1; and M .", {"entities": []}], ["amorphae and R .", {"entities": []}], ["bacterium , 1.", {"entities": []}], ["polyphaga mimivirus was the fourth most common etiologic agent, with a higher seroprevalence than noted in healthy controls.", {"entities": []}], ["This finding suggested its clinical relevance.", {"entities": []}], ["Therefore, AAM might cause nosocomial pneumonia and should be suspected when conventional microbiologic results are negative.", {"entities": [[38, 47, "DISEASE"]]}], ["Most epidemiological studies on pediatric asthma rely on the report of \"wheezing\" in questionnaires.", {"entities": [[42, 48, "DISEASE"]]}], ["Our aim was to investigate the understanding of this term by parents and health professionals.", {"entities": []}], ["A cross-sectional survey was carried out in hospital and community settings within the south of Portugal.", {"entities": []}], ["Parents or caregivers self-completed a written questionnaire with information on social characteristics and respiratory history.", {"entities": []}], ["Multiple choice questions assessed their understanding of \"wheezing\".", {"entities": []}], ["Health professionals (physicians, nurses and physiotherapists) were given an adapted version.", {"entities": []}], ["We used bivariate analysis and multivariate models to study associations between definitions of \"wheezing\" and participants' characteristics.", {"entities": []}], ["Questionnaires from 425 parents and 299 health professionals were included.", {"entities": []}], ["The term \"wheezing\" was not recognized by 34% of parents, more frequently those who were younger (OR 0.4 per 10-year increment, 95% CI 0.3-0.7), had lower education (OR 3.3, 95% CI 1.5-7.4), and whose children had no history of respiratory disease (OR 4.6, 95% CI 2.5-8.7) (all ORs adjusted).", {"entities": []}], ["31% of parents familiar with \"wheezing\" either did not identify it as a sound, or did not locate it to the chest, while tactile (40%) and visual (34%) cues to identify \"wheezing\" were frequently used.", {"entities": []}], ["Nurses reported using visual stimuli and overall assessments more often than physicians (p < 0.01).", {"entities": []}], ["The geographical location was independently associated with how parents recognized and described \"wheezing\".", {"entities": []}], ["Different meanings for \"wheezing\" are recognized in Portuguese language and may be influenced by education, respiratory history and regional terminology.", {"entities": []}], ["These findings are likely applicable to other non-English languages, and suggest the need for more accurate questionnaires and additional objective measurement instruments to study the epidemiology of wheezing disorders.", {"entities": []}], ["Preventive nebulization of mucolytic agents and bronchodilating drugs is a strategy aimed at the prevention of sputum plugging, and therefore atelectasis and pneumonia, in intubated and ventilated intensive care unit (ICU) patients.", {"entities": [[158, 167, "DISEASE"]]}], ["The present trial aims to compare a strategy using the preventive nebulization of acetylcysteine and salbutamol with nebulization on indication in intubated and ventilated ICU patients.", {"entities": []}], ["The preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE) trial is a national multicenter open-label, two-armed, randomized controlled non-inferiority trial in the Netherlands.", {"entities": []}], ["Nine hundred and fifty intubated and ventilated ICU patients with an anticipated duration of invasive ventilation of more than 24 hours will be randomly assigned to receive either a strategy consisting of preventive nebulization of acetylcysteine and salbutamol or a strategy consisting of nebulization of acetylcysteine and/or salbutamol on indication.", {"entities": []}], ["The primary endpoint is the number of ventilator-free days and surviving on day 28.", {"entities": []}], ["Secondary endpoints include ICU and hospital length of stay, ICU and hospital mortality, the occurrence of predefined pulmonary complications (acute respiratory distress syndrome, pneumonia, large atelectasis and pneumothorax), and the occurrence of predefined side effects of the intervention.", {"entities": [[180, 189, "DISEASE"], [170, 178, "DISEASE"], [213, 225, "DISEASE"]]}], ["Related healthcare costs will be estimated in a cost-benefit and budget-impact analysis.", {"entities": []}], ["The NEBULAE trial is the first randomized controlled trial powered to investigate whether preventive nebulization of acetylcysteine and salbutamol shortens the duration of ventilation in critically ill patients.", {"entities": []}], ["NCT02159196 , registered on 6 June 2014.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-015-0865-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cellular damage induced by free-radicals like Reactive Oxygen and Nitrogen Species (ROS and RNS) has been implicated in several disorders and diseases, including ageing.", {"entities": []}], ["Hence naturally occurring anti-oxidant rich-herbs play a vital role in combating these conditions.", {"entities": []}], ["The present study was carried out to investigate the in vitro free-radical quenching capacity of a known Ayurvedic poly-herbal formulation called Vayasthapana Rasayana.", {"entities": []}], ["Methanol extracts of Vayasthapana Rasayana formulation (VRF) were studied for in vitro total antioxidant activity along with phenolic content and reducing power.", {"entities": []}], ["In vitro assays like DPPH, FRAP, ABTS scavenging to evaluate radical quenching potential were performed.", {"entities": []}], ["The formulation has shown 94% at 0.1 mg/ml DPPH free-radical scavenging activity as against 84% at 0.1 mg/ml for standard ascorbic acid (IC 50 value 5.51 \u03bcg/ml for VRF and 39 \u03bcg/ml for standard).", {"entities": []}], ["It has a significant higher ferric reducing potential also (OD 0.87 at 700 nm & 0.21 at 0.1 mg/ml for VRF and standard, respectively).", {"entities": []}], ["The total phenolic content (gallic acid equivalent) of the VRF is 8.3 mg per g of dry mass.", {"entities": []}], ["Total antioxidant capacity of the formulation, estimated by FRAP was 1150 \u00b1 5 \u03bcM Fe(II)/g dry mass.", {"entities": []}], ["ABTS radical scavenging activity of VRF was 69.55 \u00b1 0.21% at 100 \u03bcg/ml concentration with a IC 50 value of 69.87 \u03bcg/ml as against 9% and 95% by ascorbic acid and Trolox (at 70.452 \u03bcg/ml and 0.250 \u03bcg/ml concentrations, respectively).", {"entities": []}], ["In Indian traditional Ayurvedic system, use of VRF is in regular practice for mainly combating age-related disorders and diseases as many of the components of the Rasayana are known for their free-radical scavenging activity.", {"entities": []}], ["This study has validated the potential use of VRF as an anti-oxidant to fight age-related problems.", {"entities": []}], ["Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns and their activation leads to the induction of effector genes involving inflammatory cytokines that may have contribute to controlling parasite growth and disease pathogenesis.", {"entities": []}], ["The current immunogenetic study was designed to analyse the key components of innate immunity, TLRs and TIRAP (Toll-interleukin-1 receptor domain-containing adaptor protein), also known as MAL (MYD88 adaptor-like), in Iranian patients with mild malaria.", {"entities": [[245, 252, "DISEASE"], [104, 109, "GENE"], [194, 199, "GENE"]]}], ["The tlr - 4 (D299G and T399I), tlr-9 (T-1486C and T-1237C) and tirap (S180L) genes were assessed in 640 Baluchi individuals (320 Plasmodium falciparum -infected and 320 non-infected, median age of 28 years) from malaria-endemic regions using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods.", {"entities": [[212, 219, "DISEASE"], [63, 68, "GENE"]]}], ["Common tlr-4 SNPs and promoter SNPs of tlr-9 were distributed among P. falciparum -infected and non-infected groups ( P > 0.05) that showed no association of these variants with mild clinical manifestation.", {"entities": []}], ["The comparison of the tirap S180L genotypes between patients with mild malaria and those healthy individuals showed that the frequency of heterozygosity was significantly higher in infected than non-infected individuals (33.8 vs. 25.6; OR, 1.479; 95% CI, 1.051-2.081; P = 0.024).", {"entities": [[71, 78, "DISEASE"], [22, 27, "GENE"]]}], ["The result also revealed a significant association of tirap S180L ( P < 0.05) with development of mild malaria, which is common in Baluchi populations, who are living in malaria hypoendemic region of Iran but not in African populations (0%-6%).", {"entities": [[103, 110, "DISEASE"], [170, 177, "DISEASE"], [54, 59, "GENE"]]}], ["These data point towards the need for addressing the exact role of TLRs in contributing to human genetic factors in malaria susceptibility/resistance/severity within different malaria settings in the world.", {"entities": [[116, 123, "DISEASE"], [176, 183, "DISEASE"]]}], ["Significant event analysis (SEA) is promoted as a team-based approach to enhancing patient safety through reflective learning.", {"entities": []}], ["Evidence of SEA participation is required for appraisal and contractual purposes in UK general practice.", {"entities": []}], ["A voluntary educational model in the west of Scotland enables general practitioners (GPs) and doctors-in-training to submit SEA reports for feedback from trained peers.", {"entities": []}], ["We reviewed reports to identify the range of safety issues analysed, learning needs raised and actions taken by GP teams.", {"entities": []}], ["Content analysis of SEA reports submitted in an 18 month period between 2005 and 2007.", {"entities": []}], ["191 SEA reports were reviewed.", {"entities": []}], ["48 described patient harm (25.1%).", {"entities": []}], ["A further 109 reports (57.1%) outlined circumstances that had the potential to cause patient harm.", {"entities": []}], ["Individual 'error' was cited as the most common reason for event occurrence (32.5%).", {"entities": []}], ["Learning opportunities were identified in 182 reports (95.3%) but were often non-specific professional issues not shared with the wider practice team.", {"entities": []}], ["154 SEA reports (80.1%) described actions taken to improve practice systems or professional behaviour.", {"entities": []}], ["However, non-medical staff were less likely to be involved in the changes resulting from event analyses describing patient harm (p < 0.05) The study provides some evidence of the potential of SEA to improve healthcare quality and safety.", {"entities": []}], ["If applied rigorously, GP teams and doctors in training can use the technique to investigate and learn from a wide variety of quality issues including those resulting in patient harm.", {"entities": []}], ["This leads to reported change but it is unclear if such improvement is sustained.", {"entities": []}], ["ICD-9 codes collected automatically in a syndromic system are sensitive and specific in detecting outbreaks caused by respiratory viruses.", {"entities": []}], ["With the spread of avian influenza, use of automated data streams to rapidly detect and track human influenza cases has increased.", {"entities": [[25, 34, "DISEASE"], [100, 109, "DISEASE"], [19, 34, "DISEASE"]]}], ["We performed correlation analyses to determine whether International Classification of Diseases, Ninth Revision (ICD-9), groupings used to detect influenzalike illness (ILI) within an automated syndromic system correlate with respiratory virus laboratory test results in the same population (r = 0.71 or 0.86, depending on group).", {"entities": []}], ["We used temporal and signal-to-noise analysis to identify 2 subsets of ICD-9 codes that most accurately represent ILI trends, compared nationwide sentinel ILI surveillance data from the Centers for Disease Control and Prevention with the automated data (r = 0.97), and found the most sensitive set of ICD-9 codes for respiratory illness surveillance.", {"entities": []}], ["Our results demonstrate a method for selecting the best group of ICD-9 codes to assist system developers and health officials who are interpreting similar data for daily public health activities.", {"entities": []}], ["Antidepressants are commonly prescribed during pregnancy; however, there are inconsistent data on the safety of these medications during the prenatal period.", {"entities": []}], ["To address this gap, this study will investigate short-term and long-term neurodevelopmental, physical and mental health, and educational outcomes of children who have been exposed to selective serotonin reuptake inhibitors (SSRIs) or selective serotonin norepinephrine reuptake inhibitors (SNRIs) and/or maternal depression during pregnancy.", {"entities": []}], ["Administrative data will be linked to generate 4 population-based exposed groups from all children born in Manitoba between 1996 and 2014 whose mother had at least 2 prescriptions for either an SSRI or SNRI: (1) throughout the prenatal period (beginning of pregnancy until birth); (2) in the first trimester (\u226414\u2005weeks gestation); (3) in the second trimester (15\u201326\u2005weeks gestation); (4) in the third trimester (\u226527\u2005weeks gestation) and 1 population-based unexposed group consisting of children whose mothers had a diagnosis of mood or anxiety disorder during pregnancy but did not use antidepressants.", {"entities": [[536, 552, "DISEASE"]]}], ["Propensity scores and inverse probability treatment weights will be used to adjust for confounding.", {"entities": []}], ["Multivariate regression modelling will determine whether, compared with untreated mood/anxiety disorder, prenatal exposure to antidepressant medications is associated with: (1) adverse birth and neonatal outcomes, including: preterm birth, low birth weight, low Apgar scores, respiratory distress, congenital malformations and persistent pulmonary hypertension; (2) adverse early childhood outcomes, including: early childhood education challenges, diagnosis of neurodevelopmental disorders and diagnosis of mental disorders.", {"entities": [[348, 360, "DISEASE"], [87, 103, "DISEASE"], [338, 360, "DISEASE"]]}], ["We will determine if exposure effects differ between SSRIs and SRNIs, and determine if exposure effects differ between gestation timing of exposure to antidepressants.", {"entities": []}], ["Ethical approval was obtained from the University of Manitoba Health Research Ethics Board.", {"entities": []}], ["Dissemination of results will include engagement of stakeholders and patients, writing of reports for policymakers and patients, and publication of scientific papers.", {"entities": []}], ["The survival time in nursing homes (NHs) in Alzheimer\u2019s disease (AD) might be affected by sociodemographic/clinical characteristics, rate of disease progression, and use of specific medications and community-based services.", {"entities": [[36, 39, "GENE"]]}], ["Whether different aspects of cholinesterase inhibitor (ChEI) therapy modify time spent in NHs is unclear.", {"entities": [[90, 93, "GENE"]]}], ["Therefore, we examined the relationship between these potential predictors and survival time in NHs.", {"entities": [[96, 99, "GENE"]]}], ["This prospective, multicenter study of ChEI treatment in clinical practice included 220 deceased patients clinically diagnosed with mild-to-moderate AD who were admitted to NHs during the study.", {"entities": [[173, 176, "GENE"]]}], ["Cognitive and activities of daily living (ADL) performance, ChEI dose, and amount of services used/week were evaluated every 6\u00a0months over 3\u00a0years.", {"entities": []}], ["Dates of nursing-home placement (NHP) and death were recorded.", {"entities": []}], ["Variables that determined survival time in NHs were analyzed using general linear models.", {"entities": [[43, 46, "GENE"]]}], ["The mean survival time in NHs was 4.06\u00a0years (men, 2.78\u00a0years; women, 4.53\u00a0years; P \u2009<\u20090.001).", {"entities": [[26, 29, "GENE"]]}], ["The multivariate model showed that a shorter stay in NHs was associated with the interaction term male living with a family member, use of antihypertensive/cardiac therapy or anxiolytics/sedatives/hypnotics, and worse basic ADL at NHP, but not with age or cognitive and instrumental ADL capacities.", {"entities": [[53, 56, "GENE"]]}], ["Increased community-based care did not reduce the survival time in NHs among individuals with AD.", {"entities": [[67, 70, "GENE"]]}], ["Men living with family spent significantly less time in NHs compared with the corresponding women, which suggests that the situation of female spouses of AD patients may need attention and possibly support.", {"entities": [[56, 59, "GENE"]]}], ["There was no indication that different aspects of ChEI therapy, e.g., drug type, dose, or duration, alter survival time in NHs.", {"entities": [[123, 126, "GENE"]]}], ["Blastocystis is a highly prevalent anaerobic eukaryotic parasite of humans and animals that is associated with various gastrointestinal and extraintestinal disorders.", {"entities": []}], ["Epidemiological studies have identified different subtypes but no one subtype has been definitively correlated with disease.", {"entities": []}], ["Here we report the 18.8 Mb genome sequence of a Blastocystis subtype 7 isolate, which is the smallest stramenopile genome sequenced to date.", {"entities": [[24, 26, "GENE"]]}], ["The genome is highly compact and contains intriguing rearrangements.", {"entities": []}], ["Comparisons with other available stramenopile genomes (plant pathogenic oomycete and diatom genomes) revealed effector proteins potentially involved in the adaptation to the intestinal environment, which were likely acquired via horizontal gene transfer.", {"entities": []}], ["Moreover, Blastocystis living in anaerobic conditions harbors mitochondria-like organelles.", {"entities": []}], ["An incomplete oxidative phosphorylation chain, a partial Krebs cycle, amino acid and fatty acid metabolisms and an iron-sulfur cluster assembly are all predicted to occur in these organelles.", {"entities": []}], ["Predicted secretory proteins possess putative activities that may alter host physiology, such as proteases, protease-inhibitors, immunophilins and glycosyltransferases.", {"entities": []}], ["This parasite also possesses the enzymatic machinery to tolerate oxidative bursts resulting from its own metabolism or induced by the host immune system.", {"entities": []}], ["This study provides insights into the genome architecture of this unusual stramenopile.", {"entities": []}], ["It also proposes candidate genes with which to study the physiopathology of this parasite and thus may lead to further investigations into Blastocystis -host interactions.", {"entities": []}], ["Sleep disorders are prevalent medical disorders in patients with rheumatoid arthritis (RA).", {"entities": [[65, 85, "DISEASE"], [76, 85, "DISEASE"]]}], ["However, whether patients with RA are at an increased risk of developing obstructive sleep apnoea (OSA) is unclear.", {"entities": []}], ["Using population-based retrospective cohort study to examine the risk of OSA in patients with RA.", {"entities": []}], ["We used claims data of the National Health Insurance Research Database (NHIRD) of Taiwan.", {"entities": []}], ["We identified a RA cohort with 33\u2005418 patients newly diagnosed in 2000\u20132010 and a randomly selected non-RA comparison cohort with 33\u2005418 individuals frequency matched by sex, age and diagnosis year.", {"entities": []}], ["Incident OSA was estimated by the end of 2011.", {"entities": []}], ["The HRs of OSA were calculated using the Cox proportional hazards regression analysis.", {"entities": []}], ["The overall incidence rate of OSA was 75% greater in the RA cohort than in the non-RA cohort (3.04 vs 1.73/10\u2005000 person-years, p<0.001), with an adjusted HR (aHR) of 1.75 (95% CI 1.18 to 2.60).", {"entities": [[155, 157, "GENE"], [159, 162, "GENE"]]}], ["Stratified analyses by sex, age group and comorbidity revealed that the incidence rates of OSA associated with RA were higher in all subgroups.", {"entities": []}], ["This population-based retrospective cohort study suggested that patients with RA should be monitored for the risk of developing OSA.", {"entities": []}], ["Semaphorins are a large family of secreted and membrane-associated proteins necessary for wiring of the brain.", {"entities": []}], ["Semaphorin 5A (SEMA5A) acts as a bifunctional guidance cue, exerting both attractive and inhibitory effects on developing axons.", {"entities": [[15, 21, "GENE"]]}], ["Previous studies have suggested that SEMA5A could be a susceptibility gene for autism spectrum disorders (ASDs).", {"entities": [[37, 43, "GENE"]]}], ["We first identified a de novo translocation t(5;22)(p15.3;q11.21) in a patient with ASD and intellectual disability (ID).", {"entities": [[92, 115, "DISEASE"]]}], ["At the translocation breakpoint on chromosome 5, we observed a 861-kb deletion encompassing the end of the SEMA5A gene.", {"entities": [[107, 113, "GENE"]]}], ["We delineated the breakpoint by NGS and observed that no gene was disrupted on chromosome 22.", {"entities": []}], ["We then used Sanger sequencing to search for deleterious variants affecting SEMA5A in 142 patients with ASD.", {"entities": [[76, 82, "GENE"]]}], ["We also identified two independent heterozygous variants located in a conserved functional domain of the protein.", {"entities": []}], ["Both variants were maternally inherited and predicted as deleterious.", {"entities": []}], ["Our genetic screens identified the first case of a de novo SEMA5A microdeletion in a patient with ASD and ID.", {"entities": [[59, 65, "GENE"]]}], ["Although our study alone cannot formally associate SEMA5A with susceptibility to ASD, it provides additional evidence that Semaphorin dysfunction could lead to ASD and ID.", {"entities": [[51, 57, "GENE"]]}], ["Further studies on Semaphorins are warranted to better understand the role of this family of genes in susceptibility to neurodevelopmental disorders.", {"entities": []}], ["The pathophysiology of autistic spectrum disorder (ASD) is not fully understood and there are no diagnostic or predictive biomarkers.", {"entities": []}], ["Glycosylation modified as many as 70% of all human proteins can sensitively reflect various pathological changes.", {"entities": []}], ["However, little is known about the alterations of glycosylation and glycoproteins in ASD.", {"entities": []}], ["In this study, serum glycopattern and the maackia amurensis lectin-II binding glycoproteins (MBGs) in 65 children with ASD and 65 age-matched typically developing (TD) children were compared by using lectin microarrays and lectin-magnetic particle conjugate-assisted LC-MS/MS analyses.", {"entities": []}], ["Expression of Sia\u03b12-3\u2009Gal/GalNAc was significantly increased in pooled (fold change\u2009=\u20093.33, p \u2009<\u20090.001) and individual ( p \u2009=\u20090.009) serum samples from ASD versus TD children.", {"entities": []}], ["A total of 194 and 217 MGBs were identified from TD and ASD sera respectively, of which 74 proteins were specially identified or up-regulated in ASD.", {"entities": []}], ["Bioinformatic analysis revealed abnormal complement cascade and aberrant regulation of response-to-stimulus that might be novel makers or markers for ASD.", {"entities": []}], ["Moreover, increase of APOD \u03b12-3 sialoglycosylation could sensitively and specifically distinguish ASD samples from TD samples (AUC is 0.88).", {"entities": []}], ["In conclusion, alteration of MBGs expression and their sialoglycosylation may serve as potential biomarkers for diagnosis of ASD, and provide useful information for investigations into the pathogenesis of ASD.", {"entities": []}], ["PA-824 is a novel bicyclic nitroimidazole anti-tuberculosis (TB) drug.", {"entities": [[47, 59, "DISEASE"]]}], ["Cordyceps sinensis (Berk.)", {"entities": []}], ["(CS) was proven to be a good immunomodulatory compound.", {"entities": [[1, 3, "GENE"]]}], ["This research aimed to investigate the effect of CS on PA-824 in Mycobacterium tuberculosis ( M.tb ) infected mice (female CBA/J mice, 6 to 8 weeks of age and 20\u00b12 g of weight).", {"entities": [[79, 91, "DISEASE"], [49, 51, "GENE"]]}], ["Mice were randomly assigned to 4 groups: PA-824, CS, PA-824+CS, and control.", {"entities": [[49, 51, "GENE"], [60, 62, "GENE"]]}], ["To verify the effect of PA-824 and CS on M.tb , after drug administration, mice lungs were harvested and bacterial colony formations were measured.", {"entities": [[35, 37, "GENE"]]}], ["Cells were isolated from infected lungs and spleens to analyze the percentage of CD4 M.tb infected mice than PA-824 alone.", {"entities": [[81, 84, "GENE"]]}], ["In conclusion, CS has the potential to be an effective adjuvant in TB treatment.", {"entities": [[15, 17, "GENE"]]}], ["Activin-A is a pleiotropic cytokine that participates in developmental, inflammatory, and tissue repair processes.", {"entities": []}], ["Still, its effects on T helper (Th) cell\u2013mediated immunity, critical for allergic and autoimmune diseases, are elusive.", {"entities": []}], ["We provide evidence that endogenously produced activin-A suppresses antigen-specific Th2 responses and protects against airway hyperresponsiveness and allergic airway disease in mice.", {"entities": []}], ["Importantly, we reveal that activin-A exerts suppressive function through induction of antigen-specific regulatory T cells that suppress Th2 responses in vitro and upon transfer in vivo.", {"entities": []}], ["In fact, activin-A also suppresses Th1-driven responses, pointing to a broader immunoregulatory function.", {"entities": []}], ["Blockade of interleukin 10 and transforming growth factor \u03b21 reverses activin-A\u2013induced suppression.", {"entities": []}], ["Remarkably, transfer of activin-A\u2013induced antigen-specific regulatory T cells confers protection against allergic airway disease.", {"entities": []}], ["This beneficial effect is associated with dramatically decreased maturation of draining lymph node dendritic cells.", {"entities": []}], ["Therapeutic administration of recombinant activin-A during pulmonary allergen challenge suppresses Th2 responses and protects from allergic disease.", {"entities": []}], ["Finally, we demonstrate that immune cells infiltrating the lungs from individuals with active allergic asthma, and thus nonregulated inflammatory response, exhibit significantly decreased expression of activin-A's responsive elements.", {"entities": [[94, 109, "DISEASE"], [103, 109, "DISEASE"]]}], ["Our results uncover activin-A as a novel suppressive factor for Th immunity and a critical controller of allergic airway disease.", {"entities": []}], ["Researchers in clinical and pharmacoepidemiology fields have adopted information technology (IT) and electronic data capture, but these remain underused despite the benefits.", {"entities": []}], ["This review discusses electronic case report forms and electronic data capture, specifically within pharmacoepidemiology and clinical research.", {"entities": []}], ["The review used PubMed and the Institute of Electrical and Electronic Engineers library.", {"entities": []}], ["Search terms used were agreed by the authors and documented.", {"entities": []}], ["PubMed is medical and health based, whereas Institute of Electrical and Electronic Engineers is technology based.", {"entities": []}], ["The review focuses on electronic case report forms and electronic data capture, but briefly considers other relevant topics; consent, ethics and security.", {"entities": []}], ["There were 1126 papers found using the search terms.", {"entities": []}], ["Manual filtering and reviewing of abstracts further condensed this number to 136 relevant manuscripts.", {"entities": []}], ["The papers were further categorized: 17 contained study data; 40 observational data; 27 anecdotal data; 47 covering methodology or design of systems; one case study; one literature review; two feasibility studies; and one cost analysis.", {"entities": []}], ["Electronic case report forms, electronic data capture and IT in general are viewed with enthusiasm and are seen as a cost\u2010effective means of improving research efficiency, educating participants and improving trial recruitment, provided concerns about how data will be protected from misuse can be addressed.", {"entities": []}], ["Clear operational guidelines and best practises are key for healthcare providers, and researchers adopting IT, and further work is needed on improving integration of new technologies with current systems.", {"entities": []}], ["A robust method of evaluation for technical innovation is required.", {"entities": []}], ["Antibiotic treatment of community-acquired pneumonia (CAP) in children remains mostly empirical because clinical and paraclinical findings poorly discriminate the principal causes of CAP.", {"entities": [[43, 52, "DISEASE"]]}], ["Fast response to beta-lactam treatment can be considered a proxy of pneumococcal aetiology.", {"entities": []}], ["We aimed to identify the best biological predictor of response to beta-lactam therapy in children hospitalized for CAP.", {"entities": []}], ["A retrospective, single-centre cohort study included all consecutive patients 1 month to 16 years old hospitalized in a teaching hospital in Paris, France, because of CAP empirically treated with a beta-lactam alone from 2003 to 2010.", {"entities": []}], ["Uni- and multivariate analyses were used to study the ability of routine biological parameters available in the Emergency Department to predict a favourable response to beta-lactam (defined as apyrexia within 48 hours of treatment onset).", {"entities": []}], ["Among the 125 included patients, 85% (106) showed a favourable response to beta-lactam.", {"entities": []}], ["In multivariate logistic regression, we found procalcitonin (PCT) the only independent predictor of apyrexia (p\u200a=\u200a0.008).", {"entities": []}], ["The adjusted odds ratio for the decadic logarithm of PCT was 4.3 (95% CI 1.5\u201312.7).", {"entities": []}], ["At \u22653 ng/mL, PCT had 55.7% sensitivity (45.7\u201365.3), 78.9% specificity (54.4\u201393.9), 93.7% positive predictive value (84.5\u201398.2), 24.2% negative predictive value (14.2\u201336.7), 2.64 positive likelihood ratio (1.09\u20136.42) and 0.56 negative likelihood ratio (0.41\u20130.77).", {"entities": []}], ["In the 4 children with a PCT level \u22653 ng/mL and who showed no response to beta-lactam treatment, secondary pleural effusion had developed in 3, and viral co-infection was documented in 1.", {"entities": []}], ["PCT is the best independent biologic predictor of favourable response to beta-lactam therapy in children hospitalized for CAP.", {"entities": []}], ["Thus, a high PCT level is highly suggestive of pneumococcal aetiology.", {"entities": []}], ["However, a 3-ng/mL cut-off does not seem compatible with daily medical practice, and additional research is needed to further define the role of PCT in managing CAP in children.", {"entities": []}], ["It has been established that patients with chronic rhinosinusitis with nasal polyps (CRSwNP) often have co-existing asthma.", {"entities": [[116, 122, "DISEASE"]]}], ["We aimed to test two hypotheses: (i) upper and lower airway inflammation in CRSwNP is uniform in agreement with the united airways concept; and (ii) bronchial inflammation exists in all CRSwNP patients irrespective of clinical asthma status.", {"entities": [[227, 233, "DISEASE"]]}], ["We collected biopsies from nasal polyps, inferior turbinates and bronchi of 27 CRSwNP patients and 6 controls.", {"entities": []}], ["All participants were evaluated for lower airway disease according to international guidelines.", {"entities": []}], ["Inflammatory cytokines were investigated using a Th1/Th2 assay including 14 chemokines and cytokines; tissue concentrations were normalized according to tissue weight and total protein concentration.", {"entities": []}], ["Individual cytokines and multivariate inflammatory profiles were compared between biopsy sites and between patients and controls.", {"entities": []}], ["We found significantly higher concentrations of Th2 cytokines in nasal polyps compared to inferior turbinate and bronchial biopsies.", {"entities": []}], ["In addition, we showed that the inflammatory profile of nasal polyps and bronchial biopsies correlated significantly (p<0.01).", {"entities": []}], ["From the Th2 cytokines measured, IL-13 was significantly increased in bronchial biopsies from CRSwNP patients with, but not without asthma.", {"entities": [[132, 138, "DISEASE"]]}], ["Our findings support the united airways concept; however, we did not find evidence for subclinical bronchial inflammation in CRSwNP patients without asthma.", {"entities": [[149, 155, "DISEASE"]]}], ["Finally, this study indicates for the first time that nasal polyps potentially play an important role in the airway inflammation rather than being a secondary phenomenon.", {"entities": []}], ["The onset of plastic bronchitis (PB) can be debilitating in survivors of Fontan surgery.", {"entities": [[21, 31, "DISEASE"]]}], ["The rarity of this complication makes designing studies to understand risk factors for PB challenging.", {"entities": []}], ["This 2\u2010center case\u2010control study aimed to describe patient outcomes and to assess the association of antecedent patient factors with PB development.", {"entities": []}], ["Using center registries, PB patients (n=25) were matched 1:2 to non\u2010PB Fontans (n=43) by date of Fontan surgery and center.", {"entities": []}], ["The groups were compared for baseline characteristics.", {"entities": []}], ["Association of patient characteristics with PB was assessed using logistic regression and of potential risk factors with onset of PB using time\u2010to\u2010event analyses.", {"entities": []}], ["The median time from Fontan to PB diagnosis was 2.5 years.", {"entities": []}], ["Overall, 12/25 PB patients died or underwent heart transplant; the median transplant\u2010free survival was 8.3 years after diagnosis.", {"entities": []}], ["Factors associated with developing PB included post\u2010surgical chylothorax (44% PB versus 10% control; odds ratio [OR] 7.3; P =0.003), chest tube (CT) duration at stage 2 ( P =0.04) and Fontan ( P =0.004), and postoperative ascites (36% PB versus 12% control; OR 4.2; P =0.003).", {"entities": []}], ["CT drainage >13 days at Fontan was associated with earlier PB onset ( P =0.04).", {"entities": []}], ["Early\u2010onset PB was associated with an increased risk of death (OR 5.0; P =0.002).", {"entities": []}], ["PB is a life\u2010threatening disorder.", {"entities": []}], ["A longer duration of CT drainage after surgery, chylothorax, and development of ascites are all associated with developing PB.", {"entities": []}], ["Understanding the pathophysiology of peri\u2010operative complications in individual patients and using targeted interventions may delay the onset of the PB phenotype.", {"entities": []}], ["Particulate air pollution is linked to impaired respiratory health.", {"entities": []}], ["We analyzed particle emissions from common indoor sources (candles burning (CB), toasting bread (TB), frying sausages (FS)) and lung function in 55 healthy volunteers (mean age 33.0 years) in a randomized cross-over controlled exposure study.", {"entities": []}], ["Lung-deposited particle surface area concentration (PSC), size-specific particle number concentration (PNC) up to 10 \u00b5m, and particle mass concentration (PMC) of PM 1 , PM 2.5 and PM 10 were determined during exposure (2 h).", {"entities": []}], ["FEV 1 , FVC and MEF 25 %\u201375% was measured before, 4 h and 24 h after exposure.", {"entities": [[0, 3, "GENE"]]}], ["Wilcoxon-rank sum tests (comparing exposure scenarios) and mixed linear regression using particle concentrations and adjusting for personal characteristics, travel time and transportation means before exposure sessions were performed.", {"entities": []}], ["While no effect was seen comparing the exposure scenarios and in the unadjusted model, inverse associations were found for PMC from CB and FS in relation to FEV 1 and MEF 25 %\u201375% .", {"entities": [[157, 160, "GENE"]]}], ["with a change in 10 \u00b5g/m 2.5 from CB being associated with a change in FEV 1 of \u221219 mL (95%-confidence interval:\u221243; 5) after 4 h. PMC from TB and PNC of UFP were not associated with lung function changes, but PSC from CB was.", {"entities": [[71, 74, "GENE"]]}], ["Elevated indoor fine particles from certain sources may be associated with small decreases in lung function in healthy adults.", {"entities": []}], ["In 2010, the World Health Organization released benchmarks for training in osteopathy in which they considered cranial osteopathy as an important osteopathic skill.", {"entities": []}], ["However, the evidence supporting the reliability of diagnosis and the efficacy of treatment in this field appears scientifically weak and inconsistent.", {"entities": []}], ["To identify and critically evaluate the scientific literature dealing with the reliability of diagnosis and the clinical efficacy of techniques and therapeutic strategies used in cranial osteopathy.", {"entities": []}], ["Relevant keywords were used to search the electronic databases MEDLINE, PEDro, OSTMED.DR, Cochrane Library, and in Google Scholar, Journal of American Osteopathy Association and International Journal of Osteopathic Medicine websites.", {"entities": []}], ["Searches were conducted up to end June 2016 with no date restriction as to when the studies were completed.", {"entities": []}], ["As a complementary approach we explored the bibliography of included articles and consulted available previous reviews dealing with this topic.", {"entities": []}], ["Regarding diagnostic processes in cranial osteopathy, we analyzed studies that compared the results obtained by at least two examiners or by the same examiner on at least two occasions.", {"entities": []}], ["For efficacy studies, only randomized-controlled-trials or crossover-studies were eligible.", {"entities": []}], ["We excluded articles that were not in English or French, and for which the full-text version was not openly available.", {"entities": []}], ["We also excluded studies with unsuitable study design, in which there was no clear indication of the use of techniques or therapeutic strategies concerning the cranial field, looked at combined treatments, used a non-human examiner and subjects or used healthy subjects for efficacy studies.", {"entities": []}], ["There was no restriction regarding the type of disease.", {"entities": []}], ["In our electronic search we found 1280 references concerning reliability of diagnosis studies plus four references via our complementary strategy.", {"entities": []}], ["Based on the title 18 articles were selected for analysis.", {"entities": []}], ["Nine were retained after applying our exclusion criteria.", {"entities": []}], ["Regarding efficacy, we extracted 556 references from the databases plus 14 references through our complementary strategy.", {"entities": []}], ["Based on the title 46 articles were selected.", {"entities": []}], ["Thirty two articles were not retained on the grounds of our exclusion criteria.", {"entities": []}], ["Risk of bias in reliability studies was assessed using a modified version of the quality appraisal tool for studies of diagnostic reliability.", {"entities": []}], ["The methodological quality of the efficacy studies was assessed using the Cochrane risk of bias tool.", {"entities": []}], ["Two screeners conducted these analyses.", {"entities": []}], ["For reliability studies, our analysis leads us to conclude that the diagnostic procedures used in cranial osteopathy are unreliable in many ways.", {"entities": []}], ["For efficacy studies, the Cochrane risk of bias tool we used shows that 2 studies had a high risk of bias, 9 were rated as having major doubt regarding risk of bias and 3 had a low risk of bias.", {"entities": []}], ["In the 3 studies with a low risk of bias alternative interpretations of the results, such as a non-specific effect of treatment, were not considered.", {"entities": []}], ["Our results demonstrate, consistently with those of previous reviews, that methodologically strong evidence on the reliability of diagnostic procedures and the efficacy of techniques and therapeutic strategies in cranial osteopathy is almost non-existent.", {"entities": []}], ["Neutrophil infiltration constitutes the first step in wound healing, although their timely clearance by macrophage engulfment, or efferocytosis, is critical for efficient tissue repair.", {"entities": []}], ["However, the specific mechanism for neutrophil clearance in wound healing remains undefined.", {"entities": []}], ["Here we uncover a key role for CCN1 in neutrophil efferocytosis by acting as a bridging molecule that binds phosphatidylserine, the \u201ceat-me\u201d signal on apoptotic cells, and integrins \u03b1 v \u03b2 3 /\u03b1 v \u03b2 5 in macrophages to trigger efferocytosis.", {"entities": []}], ["Both knockin mice expressing a mutant CCN1 that is unable to bind \u03b1 v \u03b2 3 /\u03b1 v \u03b2 5 and mice with Ccn1 knockdown are defective in neutrophil efferocytosis, resulting in exuberant neutrophil accumulation and delayed healing.", {"entities": []}], ["Treatment of wounds with CCN1 accelerates neutrophil clearance in both Ccn1 knockin mice and diabetic Lepr mice, which suffer from neutrophil persistence and impaired healing.", {"entities": [[102, 106, "GENE"]]}], ["These findings establish CCN1 as a critical opsonin in skin injury and suggest a therapeutic potential for CCN1 in certain types of non-healing wounds.", {"entities": []}], ["Respiratory viruses invade the upper airway of the lung, triggering a potent immune response that often exacerbates preexisting conditions such as asthma and COPD.", {"entities": [[147, 153, "DISEASE"]]}], ["Poly(I:C) is a synthetic analog of viral dsRNA that induces the characteristic inflammatory response associated with viral infection, such as loss of epithelial integrity, and increased production of mucus and inflammatory cytokines.", {"entities": []}], ["Here, we explore the mechanistic responses to poly(I:C) in a well-defined primary normal human bronchial epithelial (NHBE) model that recapitulates in vivo functions and responses.", {"entities": []}], ["We developed functional and quantifiable methods to evaluate the physiology of our model in both healthy and inflamed states.", {"entities": []}], ["Through gene and protein expression, we validated the differentiation state and population of essential cell subtypes (i.e., ciliated, goblet, club, and basal cells) as compared to the human lung.", {"entities": []}], ["Assays for total mucus production, cytokine secretion, and barrier function were used to evaluate in vitro physiology and response to viral insult.", {"entities": []}], ["Cells were treated apically with poly(I:C) and evaluated 48\u00a0h after induction.", {"entities": []}], ["Results revealed a dose-dependent increase in goblet cell differentiation, as well as, an increase in mucus production relative to controls.", {"entities": []}], ["There was also a dose-dependent increase in secretion of IL-6, IL-8, TNF- \u03b1, and RANTES.", {"entities": []}], ["Epithelial barrier function, as measured by TEER, was maintained at 1501\u00a0\u00b1\u00a0355\u00a0\u03a9*cm\u00b2 postdifferentiation, but dropped significantly when challenged with poly(I:C).", {"entities": []}], ["This study provides first steps toward a well-characterized model with defined functional methods for understanding dsRNA stimulated inflammatory responses in a physiologically relevant manner.", {"entities": []}], ["The stress response is a critical factor in the training of equine athletes; it is important for performance and for protection of the animal against physio-pathological disorders.", {"entities": []}], ["In this study, the molecular mechanisms involved in the response to acute and strenuous exercise were investigated using peripheral blood mononuclear cells (PBMCs).", {"entities": []}], ["Quantitative real-time PCR (qRT-PCR) was used to detect modifications in transcription levels of the genes for matrix metalloproteinase-1 ( MMP-1 ) and interleukin 8 ( IL-8 ), which were derived from previous genome-wide expression analysis.", {"entities": []}], ["Significant up-regulation of these two genes was found in 10 horses that had completed a race of 90\u2013120 km in a time-course experimental design.", {"entities": []}], ["These results suggest that MMP-1 and IL-8 are both involved in the exercise-induced stress response, and this represents a starting point from which to understand the adaptive responses to this phenomenon.", {"entities": []}], ["The respiratory pathogen nontypeable Haemophilus influenzae (NTHi) is an important cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) that requires efficient treatments.", {"entities": [[114, 151, "DISEASE"]]}], ["A previous screening for host genes differentially expressed upon NTHi infection identified sirtuin-1, which encodes a NAD-dependent deacetylase protective against emphysema and is activated by resveratrol.", {"entities": []}], ["This polyphenol concomitantly reduces NTHi viability, therefore highlighting its therapeutic potential against NTHi infection at the COPD airway.", {"entities": []}], ["In this study, resveratrol antimicrobial effect on NTHi was shown to be bacteriostatic and did not induce resistance development in vitro .", {"entities": []}], ["Analysis of modulatory properties on the NTHi-host airway epithelial interplay showed that resveratrol modulates bacterial invasion but not subcellular location, reduces inflammation without targeting phosphodiesterase 4B gene expression, and dampens \u03b2 defensin-2 gene expression in infected cells.", {"entities": []}], ["Moreover, resveratrol therapeutics against NTHi was evaluated in vivo on mouse respiratory and zebrafish septicemia infection model systems, showing to decrease NTHi viability in a dose-dependent manner and reduce airway inflammation upon infection, and to have a significant bacterial clearing effect without signs of host toxicity, respectively.", {"entities": []}], ["This study presents resveratrol as a therapeutic of particular translational significance due to the attractiveness of targeting both infection and overactive inflammation at the COPD airway.", {"entities": []}], ["Smoke-free legislation was introduced in Wales in April 2007.", {"entities": []}], ["In response to concerns regarding potential displacement of smoking into the home following legislation, this study assessed changes in secondhand smoke (SHS) exposure amongst non-smoking children.", {"entities": []}], ["Approximately 1,750 year 6 (aged 10-11) children from 75 Welsh primary schools were included in cross-sectional surveys immediately pre-legislation and one year later.", {"entities": []}], ["Participants completed self-report questionnaires and provided saliva samples for cotinine assay.", {"entities": []}], ["Regression analyses assessed the impact of legislation on children's SHS exposure at the population level, and amongst subgroups defined by parental figures who smoke within the home.", {"entities": []}], ["Geometric mean salivary cotinine concentrations were 0.17 ng/ml (95% CI 0.15,0.20) pre-legislation and 0.15 ng/ml (95% CI 0.13,0.17), post-legislation, although this change was not statistically significant.", {"entities": []}], ["Significant movement was however observed from the middle (0.10-0.50 ng/ml) to lower tertile, though not from the higher end (>0.51 ng/ml) to the middle.", {"entities": []}], ["Reported exposure to SHS was greatest within the home.", {"entities": []}], ["Home-based exposure did not change significantly post-legislation.", {"entities": []}], ["Reported exposure in caf\u00e9s or restaurants, buses and trains, and indoor leisure facilities fell significantly.", {"entities": []}], ["The proportion of children reporting that parent figures smoked in the home declined (P = 0.03), with children with no parent figures who smoke in the home significantly more likely to provide saliva with cotinine concentrations of <0.10 ng/ml post-legislation.", {"entities": []}], ["Amongst children with no parent figures who smoke in the home, the likelihood of 'not knowing' or 'never' being in a place where people were smoking increased post-legislation.", {"entities": []}], ["Smoke-free legislation in Wales did not increase SHS exposure in homes of children aged 10-11.", {"entities": []}], ["Reported SHS exposure in public places fell significantly.", {"entities": []}], ["The home remained the main source of children's SHS exposure.", {"entities": []}], ["The legislation was associated with an unexpected reduction in cotinine levels among children with lower SHS exposure pre-legislation.", {"entities": []}], ["The findings indicate positive rather than harmful effects of legislation on children's SHS exposure, but highlight the need for further action to protect those children most exposed to SHS.", {"entities": []}], ["This work is about gas biosensing with a cytochrome c biosensor.", {"entities": []}], ["Emphasis is put on the analysis of the sensing process and a mathematical model to make predictions about the biosensor response.", {"entities": []}], ["Reliable predictions about biosensor responses can provide valuable information and facilitate biosensor development, particularly at an early development stage.", {"entities": []}], ["The sensing process comprises several individual steps, such as phase partition equilibrium, intermediate reactions, mass-transport, and reaction kinetics, which take place in and between the gas and liquid phases.", {"entities": []}], ["A quantitative description of each step was worked out and finally combined into a mathematical model.", {"entities": []}], ["The applicability of the model was demonstrated for a particular example of methanethiol gas detection by a cytochrome c biosensor.", {"entities": []}], ["The model allowed us to predict the optical readout response of the biosensor from tabulated data and data obtained in simple liquid phase experiments.", {"entities": []}], ["The prediction was experimentally verified with a planar three-electrode electro-optical cytochrome c biosensor in contact with methanethiol gas in a gas tight spectroelectrochemical measurement cell.", {"entities": []}], ["The primary aim was to examine possible differences in telomere length between primary health care patients, with depression, anxiety or stress and adjustment disorders, and healthy controls.", {"entities": []}], ["The second aim was to examine the association between telomere length and baseline characteristics in the patients.", {"entities": []}], ["The third aim was to examine the potential effects of the 8-week treatments (mindfulness-based group therapy or treatment as usual, i.e.", {"entities": []}], ["mostly cognitive-based therapy) on telomere length, and to examine whether there was a difference in the potential effect on telomere length between the two groups.", {"entities": []}], ["A total of 501 individuals including 181 patients (aged 20\u201364\u00a0years), with depression, anxiety and stress and adjustment disorders, and 320 healthy controls (aged 19\u201370\u00a0years) were recruited in the study.", {"entities": []}], ["Patient data were collected from a randomized controlled trial comparing mindfulness-based group therapy with treatment as usual.", {"entities": []}], ["We isolated genomic DNA from blood samples, collected at baseline and after the 8-week follow-up.", {"entities": []}], ["Telomere length was measured by quantitative real-time (qRT)-PCR.", {"entities": []}], ["Telomere length was significantly shorter in the patients (mean\u00a0=\u00a00.77\u00a0\u00b1\u00a00.12,), compared to the controls (mean\u00a0=\u00a00.81\u00a0\u00b1\u00a00.14) ( p \u00a0=\u00a00.006).", {"entities": []}], ["The difference in telomere length remained significant after controlling for age and sex.", {"entities": []}], ["Old age, male sex and being overweight were associated with shorter telomere length.", {"entities": []}], ["There was no significant difference in telomere length between baseline and at the 8-week follow-up in any of the treatment groups and no difference between the two groups.", {"entities": []}], ["Our findings confirm that telomere length, as compared with healthy controls, is shortened in patients with depression, anxiety and stress and adjustment disorders.", {"entities": []}], ["In both groups (mindfulness-based group therapy or treatment as usual), the telomere length remained unchanged after the 8-week treatment/follow-up and there was no difference between the two groups.", {"entities": []}], ["(ClinicalTrials.gov ID: NCT01476371 ) Registered November 11, 2011.", {"entities": []}], ["The online version of this article (doi:10.1186/s12888-017-1308-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Chronic Care Model (CCM) has achieved widespread acceptance and reflects the core elements of patient-centred care in chronic diseases such as cardiovascular diseases (CVD).", {"entities": []}], ["In the Netherlands the extent to which CVD patients receive care congruent with the CCM is unknown.", {"entities": []}], ["The main objectives of this study were to validate the 20-item Patient Assessment of Chronic Illness Care (PACIC) and the 11-item (PACIC-S) in the Netherlands among CVD patients and investigate the validity, reliability, and sensitivity to change of both instruments.", {"entities": []}], ["The Dutch version of the PACIC and PACIC-S were tested among 1484 CVD patients (out of 2760; response rate 54%) enrolled in Disease Management Programmes (DMPs) at T0 and 1167 respondents (out of 2545; response rate\u2009=\u200946%) at T1.", {"entities": []}], ["Five hundred-eighty-five CVD patients filled in the questionnaire at both T0 and T1.", {"entities": []}], ["We tested the instrument by means of structural equation modeling, and examined its construct validity, reliability and sensitivity to change.", {"entities": []}], ["Reliability of the instrument was assessed by determining the statistical coherence of the scaled items.", {"entities": []}], ["Internal consistency of the subscales was assessed by calculating Cronbach\u2019s alphas and correlations between the PACIC and PACIC-S. We investigated the sensitivity to change of the original PACIC and the PACIC-S with paired t-tests among CVD patients in DMPs who filled in the questionnaire at both T0 and T1 (N\u2009=\u2009585).", {"entities": []}], ["The confirmatory factor analyses revealed good indices of fit with the PACIC and PACIC-S. Internal consistency as represented by Cronbach\u2019s alphas were also good.", {"entities": []}], ["Correlations between the PACIC and PACIC-S subscales were excellent: 0.98 at both T0 and T1.", {"entities": []}], ["Paired t-tests results show that the PACIC and PACIC-S improved significantly over time ( p \u2009<\u20090.01).", {"entities": []}], ["The psychometric properties of the Dutch PACIC and PACIC-S were satisfactory and it is sensitive to change, rendering it a valid and reliable instrument for assessing chronic illness care among CVD patients.", {"entities": []}], ["Tobacco smoke exposure in adults is linked to adverse anaesthetic and surgical outcomes.", {"entities": []}], ["Environmental tobacco smoke (ETS) exposure, including passive smoking, causes a number of known harms in children, but there is no established evidence review on its impact on intraoperative and postoperative outcomes.", {"entities": []}], ["To undertake a systematic review of the impact of ETS on the paediatric surgical pathway and to establish if there is evidence of anaesthetic, intraoperative and postoperative harm.", {"entities": []}], ["Children aged 0\u201318\u2005years undergoing anaesthetic or surgical procedures, any country, English language papers.", {"entities": []}], ["ETS exposure assessed via questioning, observation or biological marker.", {"entities": []}], ["Frequency of respiratory and other adverse events during anaesthesia, surgery and recovery, and longer term surgical outcomes.", {"entities": []}], ["28 relevant studies were identified; 15 considered anaesthetic outcomes, 12 surgical outcomes, and 1 a secondary outcome.", {"entities": []}], ["There was sufficient evidence to demonstrate that environmental smoke exposure significantly increased risk of perianaesthetic respiratory adverse events (Pooled risk ratio 2.52 CI 95% 1.68 to 3.77), and some evidence that ear and sinus surgery outcomes were poorer for children exposed to ETS.", {"entities": []}], ["ETS exposure increases the risk of anaesthetic complications and some negative surgical outcomes in children, and this should be considered when planning surgery.", {"entities": []}], ["Research is required to demonstrate whether changes in household smoking behaviour prior to surgery reduces risk of adverse outcomes, and to close the evidence gap around other outcomes such as wound healing and respiratory infections.", {"entities": []}], ["Review registration number 42014014557.", {"entities": []}], ["Long-standing randomised controlled trial (RCT) evidence indicates that asthma action plans can improve patient outcomes.", {"entities": [[72, 78, "DISEASE"]]}], ["Internationally, however, these plans are seldom issued by professionals or used by patients/carers.", {"entities": []}], ["To understand how the benefits of such plans might be realised clinically, we previously investigated barriers and facilitators to their implementation in a systematic review of relevant RCTs and synthesised qualitative studies exploring professional and patient/carer views.", {"entities": []}], ["Our final step was to integrate these two separate studies.", {"entities": []}], ["First, a theoretical model of action plan implementation was proposed, derived from our synthesis of 19 qualitative studies, identifying elements which, if incorporated into future interventions, could promote their use.", {"entities": []}], ["Second, 14 RCTs included in the quantitative synthesis were re-analysed to assess the extent to which these elements were present within their interventions (that is, \u2018strong\u2019, \u2018weak\u2019 or \u2018no\u2019 presence) and with what effect.", {"entities": []}], ["Matrices charted each element\u2019s presence and strength, facilitating analysis of element presence and action plan implementation.", {"entities": []}], ["Four elements (professional education, patient/carer education, (patient/carer and professional) partnership working and communication) were identified in our model as likely to promote asthma plan use.", {"entities": [[186, 192, "DISEASE"]]}], ["Thirteen interventions reporting increased action plan implementation contained all four elements, with two or more strongly present.", {"entities": []}], ["One intervention reporting no effect on action plan implementation contained only weakly present elements.", {"entities": []}], ["Intervention effectiveness was reported using a narrow range of criteria which did not fully reflect the four elements.", {"entities": []}], ["For example, no study assessed whether jointly developed action plans increased use.", {"entities": []}], ["Whilst important from the professional and patient/carer perspectives, the integral role of these elements in intervention delivery and their effect on study outcomes was under-acknowledged in these RCTs.", {"entities": []}], ["Our novel approach provides an evidence-base for future action plan interventions.", {"entities": []}], ["Such interventions need to ensure all elements in our implementation model (patient/carer and professional education to support development of effective partnership working and communication) are strongly present within them and a wider range of criteria better reflecting the realities of clinical practice and living with asthma are used to measure their effectiveness.", {"entities": [[324, 330, "DISEASE"]]}], ["We now intend to test such a complex intervention using a cluster trial design.", {"entities": []}], ["Carbon-based nanomaterials (CBN), such as graphene nanosheets (GNS) and multiwalled carbon nanotubes (MWCNT), have been proposed for potential nanomedicine applications such as biomedical devices and carriers for drug delivery.", {"entities": [[63, 66, "GENE"]]}], ["However, our current understanding regarding the systemic toxicity of these CBN through intravenous (iv) injection is limited.", {"entities": []}], ["In this study, we compare the immune response resulting from GNS and MWCNT exposure.", {"entities": [[61, 64, "GENE"]]}], ["We hypothesize that iv administration of GNS and MWCNT would result in divergent systemic inflammatory responses due to physicochemical differences between these two CBN.", {"entities": [[41, 44, "GENE"]]}], ["In the lungs of C57BL/6 mice, GNS actuate a Th2 immune response 1 day following iv administration, which consists of neutrophilic influx and a significant increase in interleukin (IL)-5, IL-13, IL-33, and its soluble receptor (sST2) in the bronchoalveolar lavage fluid.", {"entities": [[30, 33, "GENE"]]}], ["MWCNT elicited a significant increase in the messenger ribonucleic acid expression of cytokines in the spleen including IL-4 and IL-33, which are associated with an increase in splenic cell differentiation (CD)4", {"entities": []}], ["Genome-wide association studies (GWAS) have identified loci reproducibly associated with inflammatory bowel disease (IBD) and other immune-mediated diseases; however, the molecular mechanisms underlying most of genetic susceptibility remain undefined.", {"entities": [[89, 115, "DISEASE"]]}], ["Expressional quantitative trait loci (eQTL) of disease-relevant tissue can be employed in order to elucidate the genes and pathways affected by disease-specific genetic variance.", {"entities": []}], ["In this study, we derived eQTLs for human whole blood and intestine tissues of anti-tumor necrosis factor-resistant Crohn's disease (CD) patients.", {"entities": []}], ["We interpreted these eQTLs in the context of published IBD GWAS hits to inform on the disease process.", {"entities": []}], ["At 10% false discovery rate, we discovered that 5,174 genes in blood and 2,063 genes in the intestine were controlled by a nearby single-nucleotide polymorphism (SNP) (i.e., cis-eQTL), among which 1,360 were shared between the two tissues.", {"entities": []}], ["A large fraction of the identified eQTLs were supported by the regulomeDB database, showing that the eQTLs reside in regulatory elements (odds ratio; OR=3.44 and 3.24 for blood and intestine eQTLs, respectively) as opposed to protein-coding regions.", {"entities": []}], ["Published IBD GWAS hits as a whole were enriched for blood and intestine eQTLs (OR=2.88 and 2.05; and P value=2.51E-9 and 0.013, respectively), thereby linking genetic susceptibility to control of gene expression in these tissues.", {"entities": []}], ["Through a systematic search, we used eQTL data to inform 109 out of 372 IBD GWAS SNPs documented in National Human Genome Research Institute catalog, and we categorized the genes influenced by eQTLs according to their functions.", {"entities": []}], ["Many of these genes have experimentally validated roles in specific cell types contributing to intestinal inflammation.", {"entities": []}], ["The blood and intestine eQTLs described in this study represent a powerful tool to link GWAS loci to a regulatory function and thus elucidate the mechanisms underlying the genetic loci associated with IBD and related conditions.", {"entities": []}], ["Overall, our eQTL discovery approach empirically identifies the disease-associated variants including their impact on the direction and extent of expression changes in the context of disease-relevant cellular pathways in order to infer the functional outcome of this aspect of genetic susceptibility.", {"entities": []}], ["This paper aims to systematically review observational studies that have analysed whether depressive symptoms in the community are associated with higher general hospital admissions, longer hospital stays and increased risk of re-admission.", {"entities": []}], ["We identified prospective studies that looked at depressive symptoms in the community as a risk factor for non-psychiatric general hospital admissions, length of stay or risk of re-admission.", {"entities": []}], ["The search was carried out on MEDLINE, PsycINFO, Cochrane Library Database, and followed up with contact with authors and scanning of reference lists.", {"entities": []}], ["Eleven studies fulfilled our inclusion and exclusion criteria, and all were deemed to be of moderate to high quality.", {"entities": []}], ["Meta-analysis of seven studies with relevant data suggested that depressive symptoms may be a predictor of subsequent admission to a general hospital in unadjusted analyses (RR\u00a0=\u00a01.36, 95% CI: 1.28\u20131.44), but findings after adjustment for confounding variables were inconsistent.", {"entities": []}], ["The narrative synthesis also reported depressive symptoms to be independently associated with longer length of stay, and higher re-admission risk.", {"entities": []}], ["Depressive symptoms are associated with a higher risk of hospitalisation, longer length of stay and a higher re-admission risk.", {"entities": []}], ["Some of these associations may be mediated by other factors, and should be explored in more details.", {"entities": []}], ["\u2022 We reviewed the relationship between depression and non-psychiatric hospitalisation.", {"entities": []}], ["\u2022 Depressive symptoms were associated with hospitalisation (RR\u00a0=\u00a01.4, 95% CI: 1.3\u20131.4).", {"entities": []}], ["\u2022 Adjustment for confounders reduced the magnitude of associations.", {"entities": []}], ["\u2022 Depression was also associated with longer length of stay and re-admission.", {"entities": []}], ["We reviewed the relationship between depression and non-psychiatric hospitalisation.", {"entities": []}], ["Depressive symptoms were associated with hospitalisation (RR\u00a0=\u00a01.4, 95% CI: 1.3\u20131.4).", {"entities": []}], ["Adjustment for confounders reduced the magnitude of associations.", {"entities": []}], ["Depression was also associated with longer length of stay and re-admission.", {"entities": []}], ["To assess the effectiveness of geriatric interventions, The Older Persons and Informal Caregivers Survey \u2013 Composite Endpoint (TOPICS-CEP) has been developed based on health valuations of older persons and informal caregivers.", {"entities": []}], ["This study explored the influence of the raters\u2019 age on the preference weights of TOPICS-CEP\u2019s components.", {"entities": []}], ["A vignette study was conducted with 200 raters (mean age \u00b1 standard deviation: 72.5\u00b111.8 years; 66.5% female).", {"entities": []}], ["Profiles of older persons were used to obtain the preference weights for all TOPICS-CEP components: morbidity, functional limitations, emotional well-being, pain experience, cognitive functioning, social functioning, self-perceived health, and self-perceived quality of life.", {"entities": []}], ["The raters assessed the general wellbeing of these vignettes on a 0\u201310 scale.", {"entities": []}], ["Mixed linear regression analysis with interaction terms was used to explore the effects of raters\u2019 age on the preference weights.", {"entities": []}], ["Interaction effects between age and the TOPICS-CEP components showed that older raters gave significantly ( P <0.05) more weight to functional limitations and social functioning and less to morbidities and pain experience, compared to younger raters.", {"entities": []}], ["Researchers examining effectiveness in elderly care need to consider the discrepancies between health valuations of younger olds and older olds when selecting or establishing outcome measures.", {"entities": []}], ["In clinical decision making, health care professionals need to be aware of this discrepancy as well.", {"entities": []}], ["For this reason we highly recommend shared decision making in geriatric care.", {"entities": []}], ["This study aimed to determine the performance and long-term outcomes of therapeutic ERCP in very old patients.", {"entities": []}], ["Patients aged or over 90 (Group A, n = 78) and consecutive sex-matched controls (Group B, n = 312) under 65 selected were compared.", {"entities": []}], ["More patients in Group A had chronic concomitant diseases, but the success and complication rates were comparable.", {"entities": []}], ["The follow-up of 61 patients (78.2%) in Group A were done, with a mean period of 27.5 (3\u201354) months.", {"entities": []}], ["Seven patients survived; the main causes of death for the other patients were concomitant diseases (n = 43) and primary diseases (n = 11).", {"entities": []}], ["In patients with choledocholithiasis, cases with complete extractions of stones in bile ducts survived longer than those without (30 vs. 24 months, P < 0.001).", {"entities": [[17, 36, "DISEASE"]]}], ["Therapeutic ERCP in patients aged 90 years or older is effective and safe.", {"entities": []}], ["In patients with choledocholithiasis, complete clearance of stones is associated with longer survival time.", {"entities": [[17, 36, "DISEASE"]]}], ["Although tuberculosis (TB) causes more deaths than any other pathogen, most infected individuals harbor the pathogen without signs of disease.", {"entities": [[9, 21, "DISEASE"]]}], ["We explored the metabolome of >400 small molecules in serum of uninfected individuals, latently infected healthy individuals and patients with active TB.", {"entities": []}], ["We identified changes in amino acid, lipid and nucleotide metabolism pathways, providing evidence for anti-inflammatory metabolomic changes in TB.", {"entities": []}], ["Metabolic profiles indicate increased activity of indoleamine 2,3 dioxygenase 1 (IDO1), decreased phospholipase activity, increased abundance of adenosine metabolism products, as well as indicators of fibrotic lesions in active disease as compared to latent infection.", {"entities": [[81, 85, "GENE"]]}], ["Consistent with our predictions, we experimentally demonstrate TB-induced IDO1 activity.", {"entities": [[74, 78, "GENE"]]}], ["Furthermore, we demonstrate a link between metabolic profiles and cytokine signaling.", {"entities": []}], ["Finally, we show that 20 metabolites are sufficient for robust discrimination of TB patients from healthy individuals.", {"entities": []}], ["Our results provide specific insights into the biology of TB and pave the way for the rational development of metabolic biomarkers for TB.", {"entities": []}], ["The associations between ozone concentrations measured outdoors and both morbidity and mortality may be partially due to indoor exposures to ozone and ozone-initiated oxidation products.", {"entities": []}], ["In this article I examine the contributions of such indoor exposures to overall ozone-related health effects by extensive review of the literature as well as further analyses of published data.", {"entities": []}], ["Daily inhalation intakes of indoor ozone (micrograms per day) are estimated to be between 25 and 60% of total daily ozone intake.", {"entities": []}], ["This is especially noteworthy in light of recent work indicating little, if any, threshold for ozone\u2019s impact on mortality.", {"entities": []}], ["Additionally, the present study estimates that average daily indoor intakes of ozone oxidation products are roughly one-third to twice the indoor inhalation intake of ozone alone.", {"entities": []}], ["Some of these oxidation products are known or suspected to adversely affect human health (e.g., formaldehyde, acrolein, hydroperoxides, fine and ultrafine particles).", {"entities": []}], ["Indirect evidence supports connections between morbidity/mortality and exposures to indoor ozone and its oxidation products.", {"entities": []}], ["For example, cities with stronger associations between outdoor ozone and mortality tend to have residences that are older and less likely to have central air conditioning, which implies greater transport of ozone from outdoors to indoors.", {"entities": []}], ["Indoor exposures to ozone and its oxidation products can be reduced by filtering ozone from ventilation air and limiting the indoor use of products and materials whose emissions react with ozone.", {"entities": []}], ["Such steps might be especially valuable in schools, hospitals, and childcare centers in regions that routinely experience elevated outdoor ozone concentrations.", {"entities": []}], ["Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole.", {"entities": []}], ["Here we describe a cohort of 167 patients with primary or secondary antibody deficiencies on immunoglobulin (Ig)-replacement treatment.", {"entities": []}], ["The demographics, causes of immunodeficiency, diagnostic delay, clinical and laboratory features, and infection frequency were analysed retrospectively.", {"entities": []}], ["Chemotherapy for B cell lymphoma and the use of Rituximab, corticosteroids or immunosuppressive medications were the most common causes of secondary antibody deficiency in this cohort.", {"entities": [[24, 32, "DISEASE"]]}], ["There was no difference in diagnostic delay or bronchiectasis between primary and secondary antibody deficiency patients, and both groups experienced disorders associated with immune dysregulation.", {"entities": [[47, 61, "DISEASE"]]}], ["Secondary antibody deficiency patients had similar baseline levels of serum IgG, but higher IgM and IgA, and a higher frequency of switched memory B cells than primary antibody deficiency patients.", {"entities": []}], ["Serious and non-serious infections before and after Ig-replacement were also compared in both groups.", {"entities": []}], ["Although secondary antibody deficiency patients had more serious infections before initiation of Ig-replacement, treatment resulted in a significant reduction of serious and non-serious infections in both primary and secondary antibody deficiency patients.", {"entities": []}], ["Patients with secondary antibody deficiency experience similar delays in diagnosis as primary antibody deficiency patients and can also benefit from immunoglobulin-replacement treatment.", {"entities": []}], ["Boswellic acids mixture of triterpenic acids obtained from the oleo gum resin of Boswellia serrata and known for its effectiveness in the treatment of chronic inflammatory disease including peritumor edema.", {"entities": []}], ["Boswellic acids have been extensively studied for a number of activities including anti inflammatory, antitumor, immunomodulatory, and inflammatory bowel diseases.", {"entities": []}], ["The present study describes the antimicrobial activities of boswellic acid molecules against oral cavity pathogens.", {"entities": []}], ["Acetyl-11-keto-\u03b2-boswellic acid (AKBA), which exhibited the most potent antibacterial activity, was further evaluated in time kill studies, mutation prevention frequency, postantibiotic effect (PAE) and biofilm susceptibility assay against oral cavity pathogens.", {"entities": []}], ["AKBA exhibited an inhibitory effect on all the oral cavity pathogens tested (MIC of 2-4 \u03bcg/ml).", {"entities": []}], ["It exhibited concentration dependent killing of S treptococcus mutans ATCC 25175 up to 8 \u00d7 MIC and also prevented the emergence of mutants of S.mutans ATCC 25175 at 8\u00d7 MIC.", {"entities": []}], ["AKBA demonstrated postantibiotic effect (PAE) of 5.7 \u00b1 0.1 h at 2 \u00d7 MIC.", {"entities": []}], ["Furthermore, AKBA inhibited the formation of biofilms generated by S.mutans and Actinomyces viscosus and also reduced the preformed biofilms by these bacteria.", {"entities": []}], ["AKBA can be useful compound for the development of antibacterial agent against oral pathogens and it has great potential for use in mouthwash for preventing and treating oral infections.", {"entities": []}], ["Objectives were to assess and estimate an association between exposure to ground-level ozone and emergency department (ED) visits for cellulitis.", {"entities": [[134, 144, "DISEASE"]]}], ["All ED visits for cellulitis in Edmonton, Canada, in the period April 1992\u2013March 2002 (N = 69,547) were examined.", {"entities": [[18, 28, "DISEASE"]]}], ["Case-crossover design was applied to estimate odds ratio (OR, and 95% confidence interval) per one interquartile range (IQR) increase in ozone concentration (IQR = 14.0 ppb).", {"entities": []}], ["Delay of ED visit relating to exposure was probed using 0- to 5-day exposure lags.", {"entities": []}], ["For all patients in the all months (January\u2013December) and lags 0 to 2 days, OR = 1.05 (1.02, 1.07).", {"entities": []}], ["For male patients during the cold months (October\u2013March): OR = 1.05 (1.02, 1.09) for lags 0 and 2 and OR = 1.06 (1.02, 1.10) for lag 3.", {"entities": []}], ["For female patients in the warm months (April\u2013September): OR = 1.12 (1.06, 1.18) for lags 1 and 2.", {"entities": []}], ["Cellulitis developing on uncovered (more exposed) skin was analyzed separately, observed effects being stronger.", {"entities": [[0, 10, "DISEASE"]]}], ["Cellulitis may be associated with exposure to ambient ground level ozone; the exposure may facilitate cellulitis infection and aggravate acute symptoms.", {"entities": [[0, 10, "DISEASE"], [102, 112, "DISEASE"]]}], ["A significant percentage of lung adenocarcinomas have a driver mutation.", {"entities": []}], ["To date, there has been no assessment of the prevalence of such mutations in a Middle Eastern population.", {"entities": []}], ["The present multicenter prospective study of formalin fixed paraffin embedded (FFPE) tissues from patients diagnosed with lung adenocarcinoma was performed to assess the prevalence of EGFR and ALK mutations in the Levant.", {"entities": [[127, 141, "DISEASE"], [122, 141, "DISEASE"], [184, 188, "GENE"]]}], ["Patients of Middle Eastern origin with lung adenocarcinomas at 10 sites in Lebanon, Jordan and Iraq were prospectively enrolled.", {"entities": []}], ["Tumors were tested for EGFR by PCR and for EML4-ALK translocation by fluorescence in situ hybridization (FISH).", {"entities": [[23, 27, "GENE"]]}], ["A total of 210 patients were enrolled, 139 (66.2%) males and 71 females (33.8%), with a mean age of 63.4 years.", {"entities": []}], ["EGFR testing of 205 (97.6%) demonstrated the wild type in 173 (84.4%) and mutated forms in 32 (15.6%).", {"entities": [[0, 4, "GENE"]]}], ["Some 46.9% of EGFR positive patients were non-smokers and 62.5% were females as opposed to 22.4% and 33.8%, respectively, in the general population.", {"entities": [[14, 18, "GENE"]]}], ["As for the EML4-ALK translocation, testing in 157 (74.8%) cases gave negative results in 154 (98.1%), only 3 being positive (1.9%), 2 being females and 2 non-smokers.", {"entities": []}], ["Our study established a 15.6% EGFR mutation rate in lung adenocarcinomas with ALK translocation mutations in only 1.9%, as compared to a 15-20% and 5%, respectively, in the Western literature.", {"entities": [[30, 34, "GENE"]]}], ["The efficacy of inhaled corticosteroids (ICSs)/long-acting beta2-agonist (LABA) treatment in patients with asthma\u2013chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) compared to patients with COPD alone has rarely been examined.", {"entities": [[114, 151, "DISEASE"], [167, 175, "DISEASE"], [107, 113, "DISEASE"]]}], ["This study aimed to evaluate the clinical efficacy for the improvement of lung function after ICS/LABA treatment in patients with ACOS compared to COPD alone patients.", {"entities": []}], ["Patients with stable COPD were selected from the Korean Obstructive Lung Disease (KOLD) cohort.", {"entities": []}], ["Subjects began a 3-month ICS/LABA treatment after a washout period.", {"entities": []}], ["ACOS was defined when the patients had 1) a personal history of asthma, irrespective of age, and wheezing in the last 12 months in a self-reported survey and 2) a positive bronchodilator response.", {"entities": [[64, 70, "DISEASE"]]}], ["Among 152 eligible COPD patients, 45 (29.6%) fulfilled the criteria for ACOS.", {"entities": []}], ["After a 3-month treatment with ICS/LABA, the increase in forced expiratory volume in 1 second (FEV 1 ) was significantly greater in ACOS patients than in those with COPD alone (240.2\u00b133.5 vs 124.6\u00b119.8 mL, P =0.002).", {"entities": [[95, 98, "GENE"]]}], ["This increase in FEV 1 persisted even after adjustment for confounding factors (adjusted P =0.002).", {"entities": [[17, 20, "GENE"]]}], ["According to severity of baseline FEV 1 , the ACOS group showed a significantly greater increase in FEV 1 than the COPD-alone group in patients with mild-to-moderate airflow limitation (223.2\u00b142.9 vs 84.6\u00b125.3 mL, P =0.005), whereas there was no statistically significant difference in patients with severe to very severe airflow limitation.", {"entities": [[34, 37, "GENE"], [100, 103, "GENE"], [34, 37, "GENE"], [100, 103, "GENE"]]}], ["This study provides clinical evidence that ACOS patients with mild-to-moderate airflow limitation showed a greater response in lung function after 3 months of ICS/LABA combination treatment.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) represents a major global cause of disability and death.", {"entities": []}], ["COPD is currently the fourth most common global cause of death and also exerts an enormous toll on patients quality of life.", {"entities": []}], ["The present database analysis aimed to identify clinical trials using fixed combination therapies that have assessed the impact on the patients quality of life.", {"entities": []}], ["Within the different studies, questionnaires including the George\u2019s Respiratory Questionnaire (SGRQ) the Chronic Respiratory Disease Questionnaire (CRDQ) and the Clinical COPD Questionnaire (CCQ) were used and differing results in quality of life were obtained when combination therapies such as fluticasone/salmeterol or fluticasone/salmeterol were compared with monotherapies.", {"entities": []}], ["While there were some differences in favor of combination therapies reported when the combination therapy was compared to inhaled steroid monotherapy there were no consistent differences when combination therapies were compared to bronchodilator monotherapies.", {"entities": []}], ["Future trials will lead to a proof-of-principle stage concerning the use of combination therapies.", {"entities": []}], ["Heterozygous mutations of SFTPC , the gene encoding surfactant protein C (SP-C), cause sporadic and familial interstitial lung disease (ILD) in children and adults.", {"entities": [[109, 134, "DISEASE"], [122, 134, "DISEASE"], [26, 31, "GENE"]]}], ["The most frequent SFTPC mutation in ILD patients leads to a threonine for isoleucine substitution at position 73 (I73T) of the SP-C preprotein (proSP-C), however little is known about the cellular consequences of SP-C To address this, we stably expressed SP-C We show that I73T mutation leads to impaired processing of proSP-C in alveolar type II cells, alters their stress tolerance and surfactant lipid composition, and activates cells of the immune system.", {"entities": [[18, 23, "GENE"]]}], ["In addition, we show that some of the mentioned cellular aspects behind the disease can be modulated by application of pharmaceutical drugs commonly applied in the ILD therapy.", {"entities": []}], ["Endothelial cells (EC) are involved in regulating several aspects of lipid metabolism, with recent research revealing the clinicopathological significance of interactions between EC and lipids.", {"entities": []}], ["Induced pluripotent stem cells (iPSC) have various possible medical uses, so understanding the metabolism of these cells is important.", {"entities": []}], ["In this study, endothelial phenotype cells generated from human iPSC formed cell networks in co-culture with fibroblasts.", {"entities": []}], ["Changes of plasmalogen lipids and sphingomyelins in endothelial phenotype cells generated from human iPSC were investigated by reverse-phase ultra-high-pressure liquid chromatography mass spectrometry (UHPLC-MS/MS) analysis.", {"entities": []}], ["The levels of plasmalogen phosphatidylethanolamines (38:5) and (38:4) increased during differentiation of EC, while sphingomyelin levels decreased transiently.", {"entities": []}], ["These changes of plasmalogen lipids and sphingomyelins may have physiological significance for EC and could be used as markers of differentiation.", {"entities": []}], ["People with chronic epilepsy (PWE) often make costly but clinically unnecessary emergency department (ED) visits.", {"entities": []}], ["Offering them and their carers a self-management intervention that improves confidence and ability to manage seizures may lead to fewer visits.", {"entities": []}], ["As no such intervention currently exists, we describe a project to develop and pilot one.", {"entities": []}], ["To develop the intervention, an existing group-based seizure management course that has been offered by the Epilepsy Society within the voluntary sector to a broader audience will be adapted.", {"entities": []}], ["Feedback from PWE, carers and representatives from the main groups caring for PWE will help refine the course so that it addresses the needs of ED attendees.", {"entities": []}], ["Its behaviour change potential will also be optimised.", {"entities": []}], ["A pilot randomised controlled trial will then be completed.", {"entities": []}], ["80 PWE aged \u226516 who have visited the ED in the prior 12\u2005months on \u22652 occasions, along with one of their family members or friends, will be recruited from three NHS EDs.", {"entities": [[160, 163, "GENE"]]}], ["Dyads will be randomised to receive the intervention or treatment as usual alone.", {"entities": []}], ["The proposed primary outcome is ED use in the 12\u2005months following randomisation.", {"entities": []}], ["For the pilot, this will be measured using routine hospital data.", {"entities": []}], ["Secondary outcomes will be measured by patients and carers completing questionnaires 3, 6 and 12\u2005months postrandomisation.", {"entities": []}], ["Rates of recruitment, retention and unblinding will be calculated, along with the ED event rate in the control group and an estimate of the intervention's effect on the outcome measures.", {"entities": []}], ["Ethical approval: NRES Committee North West\u2014Liverpool East (Reference number 15/NW/0225).", {"entities": []}], ["The project's findings will provide robust evidence on the acceptability of seizure management training and on the optimal design of a future definitive trial.", {"entities": []}], ["The findings will be published in peer-reviewed journals and presented at conferences.", {"entities": []}], ["ISRCTN13\u2005871\u2005327.", {"entities": []}], ["Since persulfate salts are an important cause of occupational asthma (OA), we aimed to study the persistence of respiratory symptoms after a single exposure to ammonium persulfate (AP) in AP-sensitized mice.", {"entities": [[62, 68, "DISEASE"]]}], ["BALB/c mice received dermal applications of AP or dimethylsulfoxide (DMSO) on days 1 and 8.", {"entities": []}], ["On day 15, they received a single nasal instillation of AP or saline.", {"entities": []}], ["Airway hyperresponsiveness (AHR) was assessed using methacholine provocation, while pulmonary inflammation was evaluated in bronchoalveolar lavage (BAL), and total serum immunoglobulin E (IgE), IgG1 and IgG2a were measured in blood at 1, 4, 8, 24 hours and 4, 8, 15 days after the single exposure to the causal agent.", {"entities": [[28, 31, "GENE"]]}], ["Histological studies of lungs were assessed.", {"entities": []}], ["AP-treated mice showed a sustained increase in AHR, lasting up to 4 days after the challenge.", {"entities": [[47, 50, "GENE"]]}], ["There was a significant increase in the percentage of neutrophils 8 hours after the challenge, which persisted for 24 hours in AP-treated mice.", {"entities": []}], ["The extent of airway inflammation was also seen in the histological analysis of the lungs from challenged mice.", {"entities": []}], ["Slight increases in total serum IgE 4 days after the challenge were found, while IgG gradually increased further 4 to 15 days after the AP challenge in AP-sensitized mice.", {"entities": []}], ["In AP-sensitized mice, an Ig-independent response is induced after AP challenge.", {"entities": []}], ["AHR appears immediately, but airway neutrophil inflammation appears later.", {"entities": [[0, 3, "GENE"]]}], ["This response decreases in time; at early stages only respiratory and inflammatory responses decrease, but later on immunological response decreases as well.", {"entities": []}], ["To explore the association between unexpected potentially disruptive life events in a patient or family member that may challenge an individual's ability to take medications as prescribed and the discontinuation of evidence-based medications for common, chronic conditions.", {"entities": []}], ["Understanding the relationship between medication adherence and life stressors, especially those that can be identified using administrative data, may help identify patients at risk of non-adherence.", {"entities": []}], ["Observational self-controlled case-crossover design.", {"entities": []}], ["Individuals in a nationally representative US commercial health insurance database.", {"entities": []}], ["Adult individuals who initiated an oral hypoglycaemic, antihypertensive and/or statin and subsequently stopped the medication for \u226590\u2005days.", {"entities": []}], ["Potentially disruptive life events among patients and their family members measured in the 30\u2005days just before the medication was discontinued (\u2018hazard period\u2019) compared with the 30\u2005days before this period (\u2018control period\u2019).", {"entities": []}], ["These events included personal injury, hospitalisation, emergency room visits, changes in insurance coverage, acute stress or acute anxiety.", {"entities": []}], ["Among the 326\u2005519 patients meeting study criteria who discontinued their chronic disease medications, 88\u2005896 (27.2%) experienced at least one potentially disruptive life event.", {"entities": []}], ["Newly experiencing an injury (OR: 1.26, 95% CI 1.12 to 1.42), an emergency room visit (OR: 1.19, 95% CI 1.13 to 1.26) and acute stress (OR: 1.19, 95% CI 1.08 to 1.31) were associated with discontinuation.", {"entities": []}], ["Life events among patients\u2019 family members did not appear to be associated with medication discontinuation or occurred less frequently just prior to discontinuation.", {"entities": []}], ["Potentially disruptive life events among individuals identified using routinely collected claims data are associated with discontinuation of chronic disease medications.", {"entities": []}], ["Awareness of these events may help providers or payers identify patients at risk of non-adherence to maximise patient outcomes.", {"entities": []}], ["The causative micro-organism in community-acquired pneumonia (CAP) is often difficult to predict.", {"entities": [[51, 60, "DISEASE"]]}], ["Different studies have examined chronic morbidity and clinical symptoms as predictors for microbial aetiology of pneumonia.", {"entities": [[113, 122, "DISEASE"]]}], ["The aim of our study was to assess whether prior outpatient antimicrobial treatment is predictive for determining the microbial aetiology of CAP.", {"entities": []}], ["This was a hospital-based prospective observational study including all patients admitted with CAP between 1 October 2004 and 1 August 2006.", {"entities": []}], ["Microbial investigations included sputum, blood culture, sputum PCR, antigen testing and serology.", {"entities": []}], ["Exposure to antimicrobial drugs prior to hospital admission was ascertained through community pharmacy dispensing records.", {"entities": []}], ["Multivariate logistic regression analysis was conducted to assess whether prior outpatient antimicrobial treatment is a predictor of microbial aetiology.", {"entities": []}], ["Patient demographics, co-morbidities and pneumonia severity were considered to be other potential predictors.", {"entities": [[41, 50, "DISEASE"]]}], ["Overall, 201 patients were included in the study.", {"entities": []}], ["The microbial aetiology was determined in 64% of the patients.", {"entities": []}], ["The five most prevalent pathogens were Streptococcus pneumoniae , Heamophilus influenzae , Legionella spp.", {"entities": []}], [", Mycoplasma pneumoniae and Influenza virus A+B.", {"entities": [[28, 37, "DISEASE"]]}], ["Forty-seven of the patients (23%) had received initial antimicrobial treatment as outpatients.", {"entities": []}], ["Multivariate analyses revealed that initial outpatient beta-lactam treatment was associated with a threefold increased chance of finding atypical pathogens and a threefold decreased probability of pneumococcal infection; the corresponding odds ratios were 3.51 (95% CI 1.25\u20139.99) and 0.30 (95% CI 0.10\u20130.90), respectively.", {"entities": []}], ["Patients who received macrolides prior to hospitalisation had an increased probability of viral pneumonia.", {"entities": [[96, 105, "DISEASE"], [90, 105, "DISEASE"]]}], ["Prior outpatient antimicrobial therapy has a predictive value in the diagnostic workup aimed at identifying the causative pathogen and planning corresponding antimicrobial treatment in patients hospitalised for pneumonia.", {"entities": [[211, 220, "DISEASE"]]}], ["During inflammation, leukocytes leave the circulation and cross the endothelium to fight invading pathogens in underlying tissues.", {"entities": []}], ["This process is known as leukocyte transendothelial migration.", {"entities": []}], ["Two routes for leukocytes to cross the endothelial monolayer have been described: the paracellular route, i.e., through the cell-cell junctions and the transcellular route, i.e., through the endothelial cell body.", {"entities": []}], ["However, it has been technically difficult to discriminate between the para- and transcellular route.", {"entities": []}], ["We developed a simple in vitro assay to study the distribution of endogenous VE-cadherin and PECAM-1 during neutrophil transendothelial migration under physiological flow conditions.", {"entities": []}], ["Prior to neutrophil perfusion, endothelial cells were briefly treated with fluorescently-labeled antibodies against VE-cadherin and PECAM-1.", {"entities": []}], ["These antibodies did not interfere with the function of both proteins, as was determined by electrical cell-substrate impedance sensing and FRAP measurements.", {"entities": []}], ["Using this assay, we were able to follow the distribution of endogenous VE-cadherin and PECAM-1 during transendothelial migration under flow conditions and discriminate between the para- and transcellular migration routes of the leukocytes across the endothelium.", {"entities": []}], ["Procalcitonin (PCT) is helpful for diagnosing bacterial infections.", {"entities": []}], ["The diagnostic utility of PCT has not been examined thoroughly in critically ill patients with suspected H1N1 influenza.", {"entities": [[110, 119, "DISEASE"]]}], ["Clinical characteristics and PCT were prospectively assessed in 46 patients with pneumonia admitted to medical ICUs during the 2009 and 2010 influenza seasons.", {"entities": [[141, 150, "DISEASE"], [81, 90, "DISEASE"]]}], ["An individual patient data meta-analysis was performed by combining our data with data from five other studies on the diagnostic utility of PCT in ICU patients with suspected 2009 pandemic influenza A(H1N1) virus infection identified by performing a systematic literature search.", {"entities": [[189, 198, "DISEASE"]]}], ["PCT levels, measured within 24\u00a0hours of ICU admission, were significantly elevated in patients with bacterial pneumonia (isolated or coinfection with H1N1; n \u2009=\u200977) (median\u2009=\u20096.2\u00a0\u03bcg/L, interquartile range (IQR)\u2009=\u20090.9 to 20) than in patients with isolated H1N1 influenza pneumonia ( n \u2009=\u200984; median\u2009=\u20090.56\u00a0\u03bcg/L, IQR\u2009=\u20090.18 to 3.33).", {"entities": [[260, 269, "DISEASE"], [110, 119, "DISEASE"], [270, 279, "DISEASE"], [100, 119, "DISEASE"]]}], ["The area under the curve of the receiver operating characteristic curve of PCT was 0.72 (95% confidence interval (CI)\u2009=\u20090.64 to 0.80; P \u2009<\u20090.0001) for diagnosis of bacterial pneumonia, but increased to 0.76 (95% CI\u2009=\u20090.68 to 0.85; P \u2009<\u20090.0001) when patients with hospital-acquired pneumonia and immune-compromising disorders were excluded.", {"entities": [[174, 183, "DISEASE"], [281, 290, "DISEASE"], [164, 183, "DISEASE"]]}], ["PCT at a cut-off of 0.5 \u03bcg/L had a sensitivity (95% CI) and a negative predictive value of 80.5% (69.9 to 88.7) and 73.2% (59.7 to 84.2) for diagnosis of bacterial pneumonia, respectively, which increased to 85.5% (73.3 to 93.5) and 82.2% (68.0 to 92.0) in patients without hospital acquired pneumonia or immune-compromising disorder.", {"entities": [[164, 173, "DISEASE"], [292, 301, "DISEASE"], [154, 173, "DISEASE"]]}], ["In critically ill patients with pneumonia during the influenza season, PCT is a reasonably accurate marker for detection of bacterial pneumonia, particularly in patients with community-acquired disease and without immune-compromising disorders, but it might not be sufficient as a stand-alone marker for withholding antibiotic treatment.", {"entities": [[53, 62, "DISEASE"], [32, 41, "DISEASE"], [134, 143, "DISEASE"], [124, 143, "DISEASE"]]}], ["In this review, O\u2019Neill and Pearce discuss recent intriguing findings on metabolic changes regulating the function of macrophages and dendritic cells.", {"entities": []}], ["Recent studies on intracellular metabolism in dendritic cells (DCs) and macrophages provide new insights on the functioning of these critical controllers of innate and adaptive immunity.", {"entities": []}], ["Both cell types undergo profound metabolic reprogramming in response to environmental cues, such as hypoxia or nutrient alterations, but importantly also in response to danger signals and cytokines.", {"entities": []}], ["Metabolites such as succinate and citrate have a direct impact on the functioning of macrophages.", {"entities": []}], ["Immunogenicity and tolerogenicity of DCs is also determined by anabolic and catabolic processes, respectively.", {"entities": []}], ["These findings provide new prospects for therapeutic manipulation in inflammatory diseases and cancer.", {"entities": [[95, 101, "DISEASE"]]}], ["The role of interferon-\u03b3 release assay (IGRA) in monitoring responses to anti-tuberculosis (TB) treatment is not clear.", {"entities": [[78, 90, "DISEASE"]]}], ["We evaluated the results of the QuantiFERON-TB Gold In-tube (QFT-GIT) assay over time during the anti-TB treatment of adults with no underlying disease.", {"entities": []}], ["We enrolled soldiers who were newly diagnosed with active TB and admitted to the central referral military hospital in South Korea between May 1, 2008 and September 30, 2009.", {"entities": []}], ["For each participant, we preformed QFT-GIT assay before treatment (baseline) and at 1, 3, and 6 months after initiating anti-TB medication.", {"entities": []}], ["Of 67 eligible patients, 59 (88.1%) completed the study protocol.", {"entities": []}], ["All participants were males who were human immunodeficiency virus (HIV)-negative and had no chronic diseases.", {"entities": []}], ["Their median age was 21 years (range, 20-48).", {"entities": []}], ["Initially, 57 (96.6%) patients had positive QFT-GIT results, and 53 (89.8%), 42 (71.2%), and 39 (66.1%) had positive QFT-GIT results at 1, 3, and 6 months, respectively.", {"entities": []}], ["The IFN-\u03b3 level at baseline was 5.31 \u00b1 5.34 IU/ml, and the levels at 1, 3, and 6 months were 3.95 \u00b1 4.30, 1.82 \u00b1 2.14, and 1.50 \u00b1 2.12 IU/ml, respectively.", {"entities": []}], ["All patients had clinical and radiologic improvements after treatment and were cured.", {"entities": []}], ["A lower IFN-\u03b3 level, C-reactive protein \u2265 3 mg/dl, and the presence of fever (\u2265 38.3\u00b0C) at diagnosis were associated with negative reversion of the QFT-GIT assay.", {"entities": []}], ["Although the IFN-\u03b3 level measured by QFT-GIT assay decreased after successful anti-TB treatment in most participants, less than half of them exhibited QFT-GIT reversion.", {"entities": []}], ["Thus, the reversion to negativity of the QFT-GIT assay may not be a good surrogate for treatment response in otherwise healthy young patients with TB.", {"entities": []}], ["In recent years, Islamic terrorism has manifested itself with an unexpectedly destructive force.", {"entities": []}], ["Despite the fact that Islamic terrorism commences locally in most cases, it has spread its terror worldwide.", {"entities": []}], ["In August 2014, when troops of the self-proclaimed \u2018Islamic State\u2019 conquered areas of northern Iraq, they turned on the long-established religious minorities in the area with tremendous brutality, especially towards the Yazidis.", {"entities": []}], ["Vast numbers of men were executed, and women and children were abducted and willfully subjected to sexual violence.", {"entities": []}], ["With the aim of systematic destruction of the Yazidi community, the religious minority was to be eliminated and the will of the victims broken.", {"entities": []}], ["The medical and mental health issues arising from the combination of subjective, collective, and cultural traumatization, as well as the subsequent migrant and refugee crisis, are therefore extraordinary and require novel and wise concepts of integrated medical care.", {"entities": []}], ["We aimed to systematically evaluate evidence on the effectiveness of Lactobacillus reuteri DSM 17938 ( L. reuteri ) for treating and preventing diseases in infants and children.", {"entities": []}], ["MEDLINE and the Cochrane Library were searched in December 2013, with no language restrictions, for relevant randomized controlled trials (RCTs) and meta-analyses.", {"entities": []}], ["The search was updated in April 2014.", {"entities": []}], ["One systematic review and 14 RCTs met the inclusion criteria.", {"entities": []}], ["The use of L. reuteri may be considered in the management of acute gastroenteritis as an adjunct to rehydration.", {"entities": [[67, 82, "DISEASE"]]}], ["There is some evidence that L. reuteri is effective in reducing the incidence of diarrhea in children attending day care centers.", {"entities": [[81, 89, "DISEASE"]]}], ["There is no evidence of effectiveness of L. reuteri in preventing nosocomial diarrhea in children.", {"entities": [[77, 85, "DISEASE"]]}], ["The administration of L. reuteri is likely to reduce crying time in infants with infantile colic in exclusively or predominantly exclusively breast-fed infants, but not in formula-fed infants.", {"entities": []}], ["More studies are needed.", {"entities": []}], ["Preliminary data suggest that L. reuteri may be effective in the prevention of some functional gastrointestinal disorders, such as colic and regurgitation.", {"entities": []}], ["This innovative approach needs further evaluation by an independent research team.", {"entities": []}], ["Preliminary evidence provides a rationale for further assessing the efficacy of L. reuteri for treating functional constipation or functional abdominal pain.", {"entities": [[115, 127, "DISEASE"]]}], ["However, it is too soon to recommend the routine use of L. reuteri for these conditions.", {"entities": []}], ["There are no safety concerns with regard to the use of L. reuteri in nonimmunocompromised subjects.", {"entities": []}], ["There are also data to support the safety of using L. reuteri in preterm infants.", {"entities": []}], ["Conclusion : Our results precisely define current evidence on the effects of the administration of L. reuteri DSM 17938 to the pediatric population.", {"entities": []}], ["Spirulina platensis (SP) is a blue-green microalga that has recently raised attention not only as a nutritional component, but also as a source of bioactivities that have therapeutic effects and may find application in medicine, including cancer treatment.", {"entities": [[239, 245, "DISEASE"]]}], ["In the present study we determined the cytotoxic effect of S. platensis filtrates (SPF) on human colon cancer cell line Caco-2.", {"entities": [[97, 109, "DISEASE"], [103, 109, "DISEASE"]]}], ["Three concentrations of SPF were tested\u20141.25%, 2.5%, and 5% ( v / v ).", {"entities": []}], ["We have found that the highest concentration of SPF exerts the strongest anti-proliferative and pro-apoptotic effect on Caco-2 cultures.", {"entities": []}], ["The SPF negatively affected the morphology of Caco-2 causing colony shrinking and significant inhibition of metabolic and proliferative activity of cells.", {"entities": []}], ["The wound-healing assay showed that the SPF impaired migratory capabilities of Caco-2.", {"entities": []}], ["This observation was consistent with lowered mRNA levels for metalloproteinases.", {"entities": []}], ["Furthermore, SPF decreased the transcript level of pro-survival genes (cyclin D1, surviving, and c-Myc) and reduced the autocrine secretion of Wnt-10b.", {"entities": []}], ["The cytotoxic effect of SPF involved the modulation of the Bax and Bcl-2 ratio and a decrease of mitochondrial activity, and was related with increased levels of intracellular reactive oxygen species (ROS) and nitric oxide (NO).", {"entities": [[59, 62, "GENE"]]}], ["Moreover, the SPF also caused an increased number of cells in the apoptotic sub-G0 phase and up-regulated expression of mir-145, simultaneously decreasing expression of mir-17 and 146.", {"entities": [[120, 127, "GENE"], [169, 175, "GENE"]]}], ["Obtained results indicate that SPF can be considered as an agent with anti-cancer properties that may be used for colon cancer prevention and treatment.", {"entities": [[114, 126, "DISEASE"], [75, 81, "DISEASE"], [120, 126, "DISEASE"]]}], ["To synthesise the existing published literature on the perceptions of general practitioners (GPs) or their equivalent on the clinical management of multimorbidity and determine targets for future research that aims to improve clinical care in multimorbidity.", {"entities": []}], ["Systematic review and metaethnographic synthesis of primary studies that used qualitative methods to explore GPs\u2019 experiences of clinical management of multimorbidity or multiple chronic diseases.", {"entities": []}], ["EMBASE, MEDLINE, CINAHL, PsycInfo, Academic Search Complete, SocIndex, Social Science Full Text and digital theses/online libraries (database inception to September 2012) to identify literature using qualitative methods (focus groups or interviews).", {"entities": []}], ["The 7-step metaethnographic approach described by Noblit and Hare, which involves cross-interpretation between studies while preserving the context of the primary data.", {"entities": []}], ["Of 1805 articles identified, 37 were reviewed in detail and 10 were included, using a total of 275 GPs in 7 different countries.", {"entities": []}], ["Four areas of difficulty specific to the management of multimorbidity emerged from these papers: disorganisation and fragmentation of healthcare; the inadequacy of guidelines and evidence-based medicine; challenges in delivering patient-centred care; and barriers to shared decision-making.", {"entities": []}], ["A \u2018line of argument\u2019 was drawn which described GPs\u2019 sense of isolation in decision-making for multimorbid patients.", {"entities": []}], ["This systematic review shows that the problem areas for GPs in the management of multimorbidity may be classified into four domains.", {"entities": []}], ["There will be no \u2018one size fits all\u2019 intervention for multimorbidity but these domains may be useful targets to guide the development of interventions that will assist and improve the provision of care to multimorbid patients.", {"entities": []}], ["Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) are present in a subset of aquaporin-4 (AQP4)-IgG-negative patients with optic neuritis (ON) and/or myelitis.", {"entities": [[136, 144, "DISEASE"], [157, 165, "DISEASE"], [130, 144, "DISEASE"], [97, 101, "GENE"]]}], ["Little is known so far about brainstem involvement in MOG-IgG-positive patients.", {"entities": []}], ["To investigate the frequency, clinical and paraclinical features, course, outcome, and prognostic implications of brainstem involvement in MOG-IgG-positive ON and/or myelitis.", {"entities": [[166, 174, "DISEASE"]]}], ["Retrospective case study.", {"entities": []}], ["Among 50 patients with MOG-IgG-positive ON and/or myelitis, 15 (30\u00a0%) with a history of brainstem encephalitis were identified.", {"entities": [[50, 58, "DISEASE"], [98, 110, "DISEASE"]]}], ["All were negative for AQP4-IgG.", {"entities": []}], ["Symptoms included respiratory insufficiency, intractable nausea and vomiting (INV), dysarthria, dysphagia, impaired cough reflex, oculomotor nerve palsy and diplopia, nystagmus, internuclear ophthalmoplegia (INO), facial nerve paresis, trigeminal hypesthesia/dysesthesia, vertigo, hearing loss, balance difficulties, and gait and limb ataxia; brainstem involvement was asymptomatic in three cases.", {"entities": [[191, 206, "DISEASE"], [178, 206, "DISEASE"]]}], ["Brainstem inflammation was already present at or very shortly after disease onset in 7/15 (47\u00a0%) patients.", {"entities": []}], ["16/21 (76.2\u00a0%) brainstem attacks were accompanied by acute myelitis and/or ON.", {"entities": [[59, 67, "DISEASE"]]}], ["Lesions were located in the pons (11/13), medulla oblongata (8/14), mesencephalon (cerebral peduncles; 2/14), and cerebellar peduncles (5/14), were adjacent to the fourth ventricle in 2/12, and periaqueductal in 1/12; some had concomitant diencephalic (2/13) or cerebellar lesions (1/14).", {"entities": []}], ["MRI or laboratory signs of blood-brain barrier damage were present in 5/12.", {"entities": []}], ["Cerebrospinal fluid pleocytosis was found in 11/14 cases, with neutrophils in 7/11 (3-34\u00a0% of all CSF white blood cells), and oligoclonal bands in 4/14.", {"entities": []}], ["Attacks were preceded by acute infection or vaccination in 5/15 (33.3\u00a0%).", {"entities": []}], ["A history of teratoma was noted in one case.", {"entities": [[13, 21, "DISEASE"]]}], ["The disease followed a relapsing course in 13/15 (87\u00a0%); the brainstem was involved more than once in 6.", {"entities": []}], ["Immunosuppression was not always effective in preventing relapses.", {"entities": []}], ["Interferon-beta was followed by new attacks in two patients.", {"entities": []}], ["While one patient died from central hypoventilation, partial or complete recovery was achieved in the remainder following treatment with high-dose steroids and/or plasma exchange.", {"entities": []}], ["Brainstem involvement was associated with a more aggressive general disease course (higher relapse rate, more myelitis attacks, more frequently supratentorial brain lesions, worse EDSS at last follow-up).", {"entities": [[110, 118, "DISEASE"]]}], ["Brainstem involvement is present in around one third of MOG-IgG-positive patients with ON and/or myelitis.", {"entities": [[97, 105, "DISEASE"]]}], ["Clinical manifestations are diverse and may include symptoms typically seen in AQP4-IgG-positive neuromyelitis optica, such as INV and respiratory insufficiency, or in multiple sclerosis, such as INO.", {"entities": [[168, 186, "DISEASE"], [97, 117, "DISEASE"]]}], ["As MOG-IgG-positive brainstem encephalitis may take a serious or even fatal course, particular attention should be paid to signs or symptoms of additional brainstem involvement in patients presenting with MOG-IgG-positive ON and/or myelitis.", {"entities": [[232, 240, "DISEASE"], [30, 42, "DISEASE"]]}], ["Harm reduction is a health-centred approach that seeks to reduce the health and social harms associated with high-risk behaviors, such as illicit drug use.", {"entities": []}], ["The objective of this study is to determine the association between the beliefs of a group of adult, male prisoners in Iran about the transmission of HIV and their high-risk practices while in prison.", {"entities": []}], ["A cross-sectional study was conducted in 2004.", {"entities": []}], ["The study population was a random selection of 100 men incarcerated at Rajaei-Shahr prison.", {"entities": []}], ["The data were collected through a self-administered questionnaire.", {"entities": []}], ["Focus group discussions were held at the prison to guide the design of the questionnaire.", {"entities": []}], ["The relationship between components of the Health Belief Model (HBM) and prisoners' risky HIV-related behaviors was examined.", {"entities": []}], ["Calculating Pearson's correlation coefficient, a significant, positive association was found between the benefit component of the HBM and prisoners not engaging in HIV high-risk behaviors.", {"entities": []}], ["Educational harm reduction initiatives that promote the effectiveness of strategies designed to reduce the risk of HIV transmission may decrease prisoners' high-risk behaviors.", {"entities": []}], ["This finding provides initial support for the Iran prison system's current offering of HIV/AIDS harm reduction programming and suggests the need to offer increased education about the effectiveness of HIV prevention practices.", {"entities": []}], ["In British Columbia (BC), Canada, neuraminidase inhibitors (NIs) were publicly funded during the 2009 A(H1N1)pdm09 pandemic for treatment of high-risk patients and/or anyone with moderate-to-severe illness.", {"entities": []}], ["We assessed antiviral effectiveness (AVE) against hospitalization in that context.", {"entities": []}], ["A population-based cohort study was conducted using linked administrative data.", {"entities": []}], ["The cohort included all individuals living in BC during the study period (1 September to 31 December 2009) with a diagnostic code consistent with influenza or pandemic H1N1.", {"entities": [[146, 155, "DISEASE"]]}], ["The main study period pertained to the second-wave A(H1N1)pdm09 circulation (1 October to 31 December 2009), with sensitivity analyses around the more specific pandemic peak (18 October to 7 November).", {"entities": []}], ["Exposure was defined by same-day NI prescription.", {"entities": []}], ["The main outcome was all-cause hospitalization within 14 days of the outpatient influenza diagnosis.", {"entities": [[80, 89, "DISEASE"]]}], ["Cox proportional hazards models assessed AVE with 1\u200a:\u200a1 propensity-score matching and covariate adjustment.", {"entities": []}], ["After matching, there were 304/58\u200a061 NI-exposed and 345/58\u200a061 unexposed patients hospitalized during the main study period.", {"entities": []}], ["The very young [<6 months (35.0; 95% CI 16.7\u201373.4)], the old [65\u201379 years (13.7; 95% CI 10.1\u201318.6)] and the very old [\u226580 years (38.7; 95% CI 26.6\u201356.5)] had the highest hospitalization rate per 1000 patients overall.", {"entities": []}], ["Fully adjusted AVE against all-cause hospitalization during the main study period was 16% (95% CI 2%\u201328%), similar to the pandemic peak (15%; 95% CI \u22124%\u201330%).", {"entities": []}], ["The use of NIs was associated with modest protection against hospitalization during the 2009 pandemic, but appeared underutilized in affected age groups with the highest hospitalization risk.", {"entities": []}], ["To create a self-reported, internet-based questionnaire for the assessment of suicide risk in children and adolescents.", {"entities": []}], ["As part of the EU project \u2018Suicidality: Treatment Occurring in Paediatrics\u2019 (STOP project), we developed web-based Patient Reported Outcome Measures (PROMs) for children and adolescents and for proxy reports by parents and clinicians in order to assess suicidality.", {"entities": []}], ["Based on a literature review, expert panels and focus groups of patients, we developed the items of the STOP Suicidality Assessment Scale (STOP-SAS) in Spanish and English, translated it into four more languages, and optimized it for web-based presentation using the HealthTracker The STOP-SAS comprises 19 items in its adolescent, parent, and clinician versions, and 14 items in its children\u2019s version.", {"entities": []}], ["Good internal consistency was found for adolescents (Cronbach\u2019s alpha: 0.965), children (Cronbach\u2019s alpha: 0.922), parents (Cronbach\u2019s alpha: 0.951) and clinicians (Cronbach\u2019s alpha: 0.955) versions.", {"entities": []}], ["A strong correlation was found between the STOP-SAS and the C-SSRS for adolescents (r:0.670), parents (r:0.548), clinicians (r:0.863) and children (r:0.654).", {"entities": []}], ["The ROC area was good for clinicians\u2019 (0.917), adolescents\u2019 (0.834) and parents\u2019 (0.756) versions but only fair (0.683) for children\u2019s version.", {"entities": []}], ["The STOP-SAS is a comprehensive, web-based PROM developed on the HealthTracker", {"entities": []}], ["Phthalates are ubiquitous in the environment, but concentrations in multiple media from breast-feeding U.S. women have not been evaluated.", {"entities": []}], ["The objective of this study was to accurately measure and compare the concentrations of oxidative monoester phthalate metabolites in milk and surrogate fluids (serum, saliva, and urine) of 33 lactating North Carolina women.", {"entities": []}], ["We analyzed serum, saliva, urine, and milk for the oxidative phthalate metabolites mono(3-carboxypropyl) phthalate, mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2-ethyl-5-hydroxyhexyl) phthalate, and mono(2-ethyl-5-oxohexyl) phthalate using isotope-dilution high-performance liquid chromatography tandem mass spectroscopy.", {"entities": []}], ["Because only urine lacks esterases, we analyzed it for the hydrolytic phthalate monoesters.", {"entities": []}], ["We detected phthalate metabolites in few milk (< 10%) and saliva samples.", {"entities": []}], ["MECPP was detected in > 80% of serum samples, but other metabolites were less common (3\u201322%).", {"entities": []}], ["Seven of the 10 urinary metabolites were detectable in \u2265 85% of samples.", {"entities": []}], ["Monoethyl phthalate had the highest mean concentration in urine.", {"entities": []}], ["Metabolite concentrations differed by body fluid (urine > serum > milk and saliva).", {"entities": []}], ["Questionnaire data suggest that frequent nail polish use, immunoglobulin A, and fasting serum glucose and triglyceride levels were increased among women with higher concentrations of urinary and/or serum phthalate metabolites; motor vehicle age was inversely correlated with certain urinary phthalate concentrations.", {"entities": []}], ["Our data suggest that phthalate metabolites are most frequently detected in urine of lactating women and are less often detected in serum, milk, or saliva.", {"entities": []}], ["Urinary phthalate concentrations reflect maternal exposure and do not represent the concentrations of oxidative metabolites in other body fluids, especially milk.", {"entities": []}], ["Birch pollen associated allergy to mung bean sprouts is caused by cross-reactivity between the birch pollen allergen Bet v 1 and the mung bean allergen Vig r 1.", {"entities": []}], ["We aimed to determine the allergenicity of the cytokinin-specific binding protein from mung bean (Vig r 6), another allergen related to Bet v 1 with only 31% sequence identity.", {"entities": []}], ["Bet v 1, Gly m 4, Vig r 1, and Vig r 6 were produced in Escherichia coli .", {"entities": []}], ["In an ELISA, 73 and 32% of Bet v 1-sensitized birch-allergic patients\u2019 sera ( n = 60) showed IgE binding to Vig r 1 and Vig r 6, respectively.", {"entities": []}], ["Of 19 patients who reported allergic reactions or had positive prick-to-prick tests to mung bean sprouts, 79% showed IgE binding to Vig r 1 and 63% showed IgE binding to Vig r 6.", {"entities": []}], ["Bet v 1 completely inhibited IgE binding to both mung bean allergens.", {"entities": []}], ["Vig r 6 showed partial cross-reactivity with Vig r 1 and activated basophils sensitized with mung bean allergic patients\u2019 sera.", {"entities": []}], ["We demonstrated IgE cross-reactivity despite low sequence identity between Vig r 6 and other Bet v 1-related allergens.", {"entities": []}], ["Thus, IgE binding to Vig r 6 may contribute to birch pollinosis-associated mung bean sprout allergy.", {"entities": []}], ["The last few years have seen a rapid expansion in the use and availability of ablation techniques with hundreds of papers published.", {"entities": []}], ["Radiofrequency remains the front-runner in terms of cost, ease of set-up, versatility and flexibility but other techniques are catching up.", {"entities": []}], ["Ablation with cryotherapy and microwave, which were previously only available at open laparotomy due to the large size of the probes, are now readily performed percutaneously, with a predictable reduction in morbidity.", {"entities": []}], ["Ablation is now accepted as the first line of treatment in patients with limited volume hepatocellular carcinoma who are not candidates for transplantation.", {"entities": [[88, 112, "DISEASE"], [103, 112, "DISEASE"]]}], ["There is continuing debate in most other areas but the evidence is increasing for an important role in liver metastases, renal carcinoma, inoperable lung tumours and some bone tumours.", {"entities": [[121, 136, "DISEASE"], [127, 136, "DISEASE"]]}], ["Although pulmonary rehabilitation (PR) is associated with significant clinical benefits in chronic obstructive pulmonary disease (COPD) and has been recommended by guidelines, PR with conventional exercise training has not been widely applied in the clinic because of its inherent limitations.", {"entities": [[91, 128, "DISEASE"]]}], ["Alternative exercise such as Tai Chi has been investigated and the results are promising.", {"entities": []}], ["However, the strengths and weaknesses of the exercise modality of Tai Chi, conventional PR and a combination of Tai Chi and conventional PR and the possible mechanisms underlying Tai Chi exercise remain unclear.", {"entities": []}], ["This study aims to address the above research gaps in a well-designed clinical trial.", {"entities": []}], ["This study is a single-blind, randomised controlled trial.", {"entities": []}], ["Participants with stable COPD will be recruited and randomly assigned to one of four groups receiving Tai Chi exercise, conventional PR using a total body recumbent stepper (TBRS), combined Tai Chi and TBRS, or usual care (control) in a 1:1:1:1 ratio.", {"entities": []}], ["Participants will perform 30\u2005min of supervised exercise three times a week for 8\u2005weeks; they will receive sequential follow-ups until 12\u2005months after recruitment.", {"entities": []}], ["The primary outcome will be health-related quality of life as measured by the St George's Respiratory Questionnaire.", {"entities": []}], ["Secondary outcomes will include 6\u2005min walking distance, pulmonary function, the modified Medical Research Council Dyspnoea Scale, the COPD Assessment Test, the Hospital Anxiety and Depression Scale, the Berg Balance Scale, exacerbation frequency during the study period, and systemic inflammatory and immune markers.", {"entities": []}], ["Ethics approval has been granted by the Clinical Trial and Biomedical Ethics Committee of West China Hospital of Sichuan University (No TCM-2015-82).", {"entities": []}], ["Written informed consent will be obtained from each participant before any procedures are performed.", {"entities": []}], ["The study findings will be published in peer-reviewed journals and presented at national and international conferences.", {"entities": []}], ["ChiCTR-IOR-15006874; Pre-results.", {"entities": []}], ["A skin-derived cytokine with high systemic availability provides a mechanistic explanation for atopic march and highlights a potential therapeutic target for preventing the development of asthma among people with atopic dermatitis.", {"entities": [[213, 230, "DISEASE"], [188, 194, "DISEASE"], [220, 230, "DISEASE"]]}], ["Asthma is a common allergic lung disease frequently affecting individuals with a prior history of eczema/atopic dermatitis (AD); however, the mechanism underlying the progression from AD to asthma (the so-called \u201catopic march\u201d) is unclear.", {"entities": [[105, 122, "DISEASE"], [0, 6, "DISEASE"], [190, 196, "DISEASE"], [28, 40, "DISEASE"], [112, 122, "DISEASE"]]}], ["Here we show that, like humans with AD, mice with skin-barrier defects develop AD-like skin inflammation and are susceptible to allergic asthma.", {"entities": [[128, 143, "DISEASE"], [137, 143, "DISEASE"]]}], ["Furthermore, we show that thymic stromal lymphopoietin (TSLP), overexpressed by skin keratinocytes, is the systemic driver of this bronchial hyper-responsiveness.", {"entities": [[56, 60, "GENE"]]}], ["As an AD-like model, we used mice with keratinocyte-specific deletion of RBP-j that sustained high systemic levels of TSLP.", {"entities": [[118, 122, "GENE"]]}], ["Antigen-induced allergic challenge to the lung airways of RBP-j\u2013deficient animals resulted in a severe asthmatic phenotype not seen in similarly treated wild-type littermates.", {"entities": []}], ["Elimination of TSLP signaling in these animals blocked the atopic march, demonstrating that high serum TSLP levels were required to sensitize the lung to allergic inflammation.", {"entities": [[15, 19, "GENE"], [103, 107, "GENE"], [15, 19, "GENE"], [103, 107, "GENE"]]}], ["Furthermore, we analyzed outbred K14-TSLP mice that maintained high systemic levels of TSLP without developing any skin pathology.", {"entities": [[37, 41, "GENE"], [87, 91, "GENE"]]}], ["Importantly, epidermal-derived TSLP was sufficient to trigger the atopic march, sensitizing the lung airways to inhaled allergens in the absence of epicutaneous sensitization.", {"entities": [[31, 35, "GENE"]]}], ["Based on these findings, we propose that in addition to early treatment of the primary skin-barrier defects, selective inhibition of systemic TSLP may be the key to blocking the development of asthma in AD patients.", {"entities": [[193, 199, "DISEASE"], [142, 146, "GENE"]]}], ["Eczema (atopic dermatitis) is a common allergic skin inflammation that has a particularly high prevalence among children.", {"entities": [[8, 25, "DISEASE"], [15, 25, "DISEASE"]]}], ["Importantly, a large proportion of people suffering from eczema go on to develop asthma later in life.", {"entities": [[81, 87, "DISEASE"]]}], ["Although the susceptibility of eczema patients to asthma is well documented, the mechanism that mediates \u201catopic march\u201d\u2014the progression from eczema to asthma\u2014is unclear.", {"entities": [[50, 56, "DISEASE"], [151, 157, "DISEASE"]]}], ["We used genetic engineering to generate mice with chronic skin-barrier defects and a subsequent eczema-like disorder.", {"entities": []}], ["With these mice, we were able to investigate how skin-specific defects predisposed the lungs to allergic asthma.", {"entities": [[96, 111, "DISEASE"], [105, 111, "DISEASE"]]}], ["We identified thymic stromal lymphopoietin (TSLP), a cytokine that is secreted by barrier-defective skin into the systemic circulation, as the agent sensitizing the lung to allergens.", {"entities": [[44, 48, "GENE"]]}], ["We demonstrated that high systemic levels of skin-derived TSLP were both required and sufficient to render lung airways hypersensitive to allergens.", {"entities": [[58, 62, "GENE"]]}], ["Thus, these data suggest that early treatment of skin-barrier defects to prevent TSLP overexpression, and systemic inhibition of TSLP, may be crucial in preventing the progression from eczema to asthma.", {"entities": [[195, 201, "DISEASE"], [81, 85, "GENE"], [129, 133, "GENE"], [81, 85, "GENE"], [129, 133, "GENE"]]}], ["The incidence of food hypersensitivity and food allergies is on the rise and new treatment approaches are needed.", {"entities": []}], ["We investigated whether N. sativa , one of its components, thymoquinone, or synthetic opioid receptor (OR)-agonists can alleviate food allergy.", {"entities": [[130, 142, "DISEASE"]]}], ["Hence, ovalbumin (OVA) -sensitized BALB/c -mice were pre-treated either with a hexanic N. sativa seed extract, thymoquinone, kappa- (U50'4889) or mu-OR-agonists (DAMGO) and subsequently challenged intra-gastrically with OVA.", {"entities": []}], ["All 4 treatments significantly decreased clinical scores of OVA-induced diarrhea.", {"entities": [[72, 80, "DISEASE"]]}], ["N. sativa seed extract, thymoquinone, and U50'488 also decreased intestinal mast cell numbers and plasma mouse mast cell protease-1 (MMCP-1).", {"entities": []}], ["DAMGO, in contrast, had no effect on mast cell parameters but decreased IFN\u03b3, IL-4, IL-5, and IL-10 concentration after ex vivo re-stimulation of mesenteric lymphocytes.", {"entities": []}], ["The effects on allergy symptoms were reversible by OR-antagonist pre-treatment, whereas most of the effects on immunological parameter were not.", {"entities": []}], ["We demonstrate that N. sativa seed extract significantly improves symptoms and immune parameters in murine OVA-induced allergic diarrhea; this effect is at least partially mediated by thymoquinone.", {"entities": [[128, 136, "DISEASE"]]}], ["ORs may also be involved and could be a new target for intestinal allergy symptom alleviation.", {"entities": []}], ["N. sativa seed extract seems to be a promising candidate for nutritional interventions in humans with food allergy.", {"entities": [[102, 114, "DISEASE"]]}], ["Infectious agents, often through complex systems, likely determine more chronic diseases than is currently appreciated.", {"entities": []}], ["Evidence now confirms that noncommunicable chronic diseases can stem from infectious agents.", {"entities": []}], ["Furthermore, at least 13 of 39 recently described infectious agents induce chronic syndromes.", {"entities": []}], ["Identifying the relationships can affect health across populations, creating opportunities to reduce the impact of chronic disease by preventing or treating infection.", {"entities": []}], ["As the concept is progressively accepted, advances in laboratory technology and epidemiology facilitate the detection of noncultivable, novel, and even recognized microbial origins.", {"entities": []}], ["A spectrum of diverse pathogens and chronic syndromes emerges, with a range of pathways from exposure to chronic illness or disability.", {"entities": []}], ["Complex systems of changing human behavioral traits superimposed on human, microbial, and environmental factors often determine risk for exposure and chronic outcome.", {"entities": []}], ["Yet the strength of causal evidence varies widely, and detecting a microbe does not prove causality.", {"entities": []}], ["Nevertheless, infectious agents likely determine more cancers, immune-mediated syndromes, neurodevelopmental disorders, and other chronic conditions than currently appreciated.", {"entities": []}], ["An important issue in the target identification for the drug design is the tissue-specific effect of inhibition of target genes.", {"entities": []}], ["The task of assessing the tissue-specific effect in suppressing gene activity is especially relevant in the studies of the brain, because a significant variability in gene expression levels among different areas of the brain was well documented.", {"entities": []}], ["A method is proposed for constructing statistical models to predict the potential effect of the knockout of target genes on the expression of genes involved in the regulation of apoptosis in various brain regions.", {"entities": []}], ["The model connects the expression of the objective group of genes with expression of the target gene by means of machine learning models trained on available expression data.", {"entities": []}], ["Information about the interactions between target and objective genes is determined by reconstruction of target-centric gene network.", {"entities": []}], ["STRING and ANDSystem databases are used for the reconstruction of gene networks.", {"entities": []}], ["The developed models have been used to analyse gene knockout effects of more than 7,500 target genes on the expression of 1,900 objective genes associated with the Gene Ontology category \"apoptotic process\".", {"entities": []}], ["The tissue-specific effect was calculated for 12 main anatomical structures of the human brain.", {"entities": []}], ["Initial values of gene expression in these anatomical structures were taken from the Allen Brain Atlas database.", {"entities": []}], ["The results of the predictions of the effect of suppressing the activity of target genes on apoptosis, calculated on average for all brain structures, were in good agreement with experimental data on siRNA-inhibition.", {"entities": []}], ["This theoretical paper presents an approach that can be used to assess tissue-specific gene knockout effect on gene expression of the studied biological process in various structures of the brain.", {"entities": []}], ["Genes that, according to the predictions of the model, have the highest values of tissue-specific effects on the apoptosis network can be considered as potential pharmacological targets for the development of drugs that would potentially have strong effect on the specific area of the brain and a much weaker effect on other brain structures.", {"entities": []}], ["Further experiments should be provided in order to confirm the potential findings of the method.", {"entities": []}], ["A report on the eighth annual meeting of the Human Genome Organization (HGM2003), Cancun, Mexico, 27-30 April 2003.", {"entities": []}], ["A report on the eighth annual meeting of the Human Genome Organization (HGM2003), Cancun, Mexico, 27-30 April 2003.", {"entities": []}], ["The aims of this study were to determine the utilization of mental health services (MHSs) by adults with a depressive mood and to identify the influencing sociodemographic factors, using a nationwide representative Korean sample.", {"entities": []}], ["The study included 2735 subjects, aged 19\u00a0years or older, who had experienced a depressive mood continuously for over 2\u00a0weeks within the previous year, using the data from the KNHANES IV (Fourth Korea National Health and Nutrition Examination Survey), which was performed between 2007 and 2009, and involved a nationally representative sample of the Korean community population who were visited at home.", {"entities": []}], ["A multivariate logistic regression analysis was used to estimate the adjusted odd ratios (ORs) and 95% confidence intervals (CIs) for the use of MHSs, which was defined as using healthcare institutions, consulting services, and inpatient or outpatient treatments due to mental health problems.", {"entities": []}], ["MHSs had been used by 9.6% of the subjects with a depressive mood.", {"entities": []}], ["The use of the MHSs was significantly associated with age, education level, and employment status, after adjusting for sociodemographic and health-related factors.", {"entities": []}], ["Specifically, the OR for the nonuse of MHSs by the elderly (\u226565\u00a0years) relative to subjects aged 19\u201334 years was 2.55 (95% CI\u2009=\u20091.13\u20135.76), subjects with a lower education level were less likely to use MHSs compared to those with a higher education level (7\u20139 years, OR\u2009=\u20092.35, 95% CI\u2009=\u20091.19\u20134.64; 10\u201312 years, OR\u2009=\u20091.66, 95% CI\u2009=\u20091.07\u20132.56; \u226513\u00a0years, reference), and the OR of unemployed relative to employed was 0.47 (95% CI\u2009=\u20090.32\u20130.67).", {"entities": []}], ["Among Korean adults with a depressive mood, the elderly, those with a lower education level, and the employed are less likely to use MHSs.", {"entities": []}], ["These findings suggest that mental health policies should be made based on the characteristics of the population in order to reduce untreated patients with depression.", {"entities": []}], ["Greater resources and attention to identifying and treating depression in older, less educated, and employed adults are warranted.", {"entities": []}], ["Intestinal epithelial cells (IECs) produce thymic stromal lymphopoietin (TSLP); however, the in vivo influence of TSLP\u2013TSLP receptor (TSLPR) interactions on immunity and inflammation in the intestine remains unclear.", {"entities": [[73, 77, "GENE"], [114, 118, "GENE"], [119, 123, "GENE"]]}], ["We show that TSLP\u2013TSLPR interactions are critical for immunity to the intestinal pathogen Trichuris .", {"entities": []}], ["Monoclonal antibody\u2013mediated neutralization of TSLP or deletion of the TSLPR in normally resistant mice resulted in defective expression of Th2 cytokines and persistent infection.", {"entities": [[47, 51, "GENE"]]}], ["Susceptibility was accompanied by elevated expression of interleukin (IL) 12/23p40, interferon (IFN) \u03b3, and IL-17A, and development of severe intestinal inflammation.", {"entities": []}], ["Critically, neutralization of IFN-\u03b3 in Trichuris -infected TSLPR", {"entities": []}], ["Although the prevalence of gastroesophageal reflux disease (GERD) is relatively low in Korean population, the number is increasing.", {"entities": [[27, 58, "DISEASE"]]}], ["The aim of this study is to analyze our experience with laparoscopic Nissen fundoplication.", {"entities": []}], ["From Sep. 2003 to Mar.", {"entities": []}], ["2008, 31 adult Korean patients diagnosed with GERD underwent laparoscopic Nissen fundoplication.", {"entities": []}], ["A 360\u00b0 fundoplication was carried out in all patients.", {"entities": []}], ["There were 19 males and 12 females with an average age of 46.8 \u00b1 17.0 years.", {"entities": []}], ["Typical symptoms were present in 15 (48%) of patients, and atypical symptoms in 16 (51.6%).", {"entities": []}], ["Both typical and atypical symptoms were present in 4 of patients (12.9%).", {"entities": []}], ["Preoperative studies showed hiatal hernias in 13 patients (41.9%), Barrett's esophagus in 10 (32.3%), and reflux esophagitis in 18 (58.1%).", {"entities": [[113, 124, "DISEASE"]]}], ["Mean DeMeester score was 17.4 \u00b1 16.7, mean operative time 206.1 \u00b1 47.8 min and mean hospital stay 5.2 \u00b1 2.1 days.", {"entities": []}], ["Perioperative complications occurred in 5 patients (16.1%), including gastric perforation, subcutaneous emphysema, atelectasis, and prolonged ileus.", {"entities": [[142, 147, "DISEASE"]]}], ["Gastroesophageal junction stenoses with subsequent endoscopic balloon dilations were required in 5 patients (16.1%).", {"entities": []}], ["After surgery, symptoms were completely controlled in 17 patients (54.8%), partially improved in 12 patients (38.7%) and not controlled in 2 patients (6.5%).", {"entities": []}], ["In our series, 93.5% of patients had either complete or partial remission of symptom after laparoscopic Nissen fundoplication.", {"entities": []}], ["Atypical symptoms were more predominant in our Korean patients.", {"entities": []}], ["Laparoscopic Nissen fundoplication is an efficacious method of controlling symptoms of GERD, even for those who have atypical symptoms.", {"entities": []}], ["Understanding factors associated with the inappropriate or excessive use of short-acting beta agonists (SABA) can help develop better policies.", {"entities": []}], ["We used British Columbian (BC)\u2018s administrative health data (1997\u20132014) to create a retrospective cohort of asthma patients aged between 14 and 55\u00a0years.", {"entities": [[108, 114, "DISEASE"]]}], ["The primary and secondary outcomes were, respectively, inappropriate and excessive use of SABA based on a previously validated definition.", {"entities": []}], ["Exposures were categorised into groups comprising socio-demographic variables, indicators of type and quality of asthma care, and burden of comorbid conditions.", {"entities": [[113, 119, "DISEASE"]]}], ["343,520 individuals (56.3% female, average age 30.5) satisfied the asthma case definition, contributing 2.6 million person-years.", {"entities": [[67, 73, "DISEASE"]]}], ["7.3% of person-years were categorised as inappropriate SABA use and 0.9% as excessive use.", {"entities": []}], ["Several factors were associated with lower likelihood of inappropriate use, including female sex, higher socio-economic status, higher continuity of care, having received pulmonary function test in the previous year, visited a specialist in the previous year, and the use of inhaled corticosteroids in the previous year.", {"entities": []}], ["An asthma-related outpatient visit to a general practitioner in the previous year was associated with a higher likelihood of inappropriate SABA use.", {"entities": [[3, 9, "DISEASE"]]}], ["Similar associations were found for excessive SABA use with the exception that visit to respirologist and the use of systemic corticosteroids were associated with increased likelihood of excessive use.", {"entities": []}], ["Despite proven safety issues, inappropriate SABA use is still prevalent.", {"entities": []}], ["Several factors belonging to patients\u2019 characteristics and type/quality of care were associated with inappropriate use of SABAs and can be used to risk-stratify patients for targeted attempts to reduce this preventable cause of adverse asthma outcomes.", {"entities": [[236, 242, "DISEASE"]]}], ["The online version of this article (10.1186/s12890-018-0598-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This population-based cross-sectional study examined the prevalence and risk factors of suboptimal vitamin D levels (assessed using circulating 25-hydroxycholecalciferol (25(OH)D)) in a multi-ethnic sample of Asian adults.", {"entities": []}], ["Plasma 25(OH)D concentration of 1139 Chinese, Malay and Indians (40\u201380 years) were stratified into normal (\u226530 ng/mL), and suboptimal (including insufficiency and deficiency, <30 ng/mL) based on the 2011 Endocrine Society Clinical Practice Guidelines.", {"entities": []}], ["Logistic regression models were used to assess the associations of demographic, lifestyle and clinical risk factors with the outcome.", {"entities": []}], ["Of the 1139 participants, 25(OH)D concentration was suboptimal in 76.1%.", {"entities": []}], ["In multivariable models, age \u226465 years (compared to age >65 years), Malay and Indian ethnicities (compared to Chinese ethnicity), and higher body mass index, HbA1c, education and income levels were associated with suboptimal 25(OH)D concentration ( p < 0.05).", {"entities": []}], ["In a population-based sample of Asian adults, approximately 75% had suboptimal 25(OH)D concentration.", {"entities": []}], ["Targeted interventions and stricter reinforcements of existing guidelines for vitamin D supplementation are needed for groups at risk of vitamin D insufficiency/deficiency.", {"entities": []}], ["The applicability of international risk scores in heart surgery (HS) is not well defined in centers outside of North America and Europe.", {"entities": []}], ["To evaluate the capacity of the Parsonnet Bernstein 2000 (BP) and EuroSCORE (ES) in predicting in-hospital mortality (IHM) in patients undergoing HS at a reference hospital in Brazil and to identify risk predictors (RP).", {"entities": []}], ["Retrospective cohort study of 1,065 patients, with 60.3% patients underwent coronary artery bypass grafting (CABG), 32.7%, valve surgery and 7.0%, CABG combined with valve surgery.", {"entities": []}], ["Additive and logistic scores models, the area under the ROC (Receiver Operating Characteristic) curve (AUC) and the standardized mortality ratio (SMR) were calculated.", {"entities": []}], ["Multivariate logistic regression was performed to identify the RP.", {"entities": []}], ["Overall mortality was 7.8%.", {"entities": []}], ["The baseline characteristics of the patients were significantly different in relation to BP and ES.", {"entities": []}], ["AUCs of the logistic and additive BP were 0.72 (95% CI, from 0.66 to 0.78 p = 0.74), and of ES they were 0.73 (95% CI; 0.67 to 0.79 p = 0.80).", {"entities": []}], ["The calculation of the SMR in BP was 1.59 (95% CI; 1.27 to 1.99) and in ES, 1.43 (95% CI; 1.14 to 1.79).", {"entities": []}], ["Seven RP of IHM were identified: age, serum creatinine > 2.26 mg/dL, active endocarditis, systolic pulmonary arterial pressure > 60 mmHg, one or more previous HS, CABG combined with valve surgery and diabetes mellitus.", {"entities": [[76, 88, "DISEASE"], [200, 217, "DISEASE"]]}], ["Local scores, based on the real situation of local populations, must be developed for better assessment of risk in cardiac surgery.", {"entities": []}], ["Health seeking behavior of people around the globe is affected by different socio-cultural and economic factors.", {"entities": []}], ["In Ethiopia, people living in rural areas in particular, are noted for their use of medicinal plants as a major component of their health care option.", {"entities": []}], ["This study was conducted to document ethnopharmacological information of the Hamer semi-pastoralists ethnic group in southwestern Ethiopia.", {"entities": []}], ["A cross-sectional study was carried out whereby information on demographic characteristics, prevalence of perceived illnesses, factors associated with preference of health care seeking options, medicinal plants used and hoarded as well as some healers\u2019 socio-economic characteristics were collected using two sets of semi-structured questionnaires \u2013 one for household (HH) heads and the other for traditional healers supplemented by focus group discussions (FGDs).", {"entities": []}], ["Households were selected using a cluster sampling followed by systematic sampling techniques; whereas healers and FGD participants were purposively selected with the assistance of local leaders and elders from the community.", {"entities": []}], ["The study revealed that the use of traditional medicine among the Hamer ethnic group is very high.", {"entities": []}], ["Females preferred traditional medicine more than males.", {"entities": []}], ["The main reasons for this preference include effectiveness, low cost and ease of availability.", {"entities": []}], ["Malaria ( gebeze ) was the most frequently occurring illness in the area identified by all FGD participants.", {"entities": []}], ["A total of 60 different medicinal plants were reported [34 by HH respondents, 14 by traditional healers and 12 by both].", {"entities": []}], ["Fifty-one medicinal plants were fully identified, 3 at generic level and 6 have not yet been identified.", {"entities": []}], ["It can be concluded that traditional medical practices, particularly herbal aspect, is widely used by the Hamer ethnic group, although health seeking behavior of the community is affected by different socio-economic and cultural factors.", {"entities": []}], ["The online version of this article (doi:10.1186/s13002-016-0107-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Sex and sex hormones play a major role in lung physiology.", {"entities": []}], ["It has been proposed that the ratio of the second to fourth digits (digit ratio) is correlated with fetal sex hormones.", {"entities": []}], ["We therefore hypothesized that digit ratio might help predict lung function.", {"entities": []}], ["We investigated the relationship between digit ratio and pulmonary function test (PFT) findings.", {"entities": []}], ["A total of 245 South Korean patients (162 male, 83 female) aged from 34 to 90 years who were hospitalized for urological surgery were prospectively enrolled.", {"entities": []}], ["Before administering the PFTs, the lengths of the second and fourth digits of the right hand were measured by a single investigator using a digital Vernier caliper.", {"entities": []}], ["In males ( n = 162), univariate and multivariate analysis using linear regression models showed that digit ratio was a significant predictive factor of forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) (FVC: r = 0.156, P = 0.047; FEV1: r = 0.160, P = 0.042).", {"entities": []}], ["In male ever-smokers ( n = 69), lung functions (FVC and FEV1) were correlated with smoking exposure rather than digit ratio.", {"entities": []}], ["In female never-smokers ( n = 83), lung functions (FEV1 and FEV1/FVC ratio) were positively correlated with digit ratio on univariate analysis (FEV1: r = 0.242, P = 0.027; FEV1/FVC ratio: r = 0.245, P = 0.026).", {"entities": []}], ["Patients with lower digit ratios tend to have decreased lung function.", {"entities": []}], ["These results suggest that digit ratio is a predictor of airway function.", {"entities": []}], ["Parallel changes in body shape may evolve in response to similar environmental conditions, but whether such parallel phenotypic changes share a common genetic basis is still debated.", {"entities": []}], ["The goal of this study was to assess whether parallel phenotypic changes could be explained by genetic parallelism, multiple genetic routes, or both.", {"entities": []}], ["We first provide evidence for parallelism in fish shape by using geometric morphometrics among 300 fish representing five species pairs of Lake Whitefish.", {"entities": []}], ["Using a genetic map comprising 3438 restriction site\u2212associated DNA sequencing single-nucleotide polymorphisms, we then identified quantitative trait loci underlying body shape traits in a backcross family reared in the laboratory.", {"entities": []}], ["A total of 138 body shape quantitative trait loci were identified in this cross, thus revealing a highly polygenic architecture of body shape in Lake Whitefish.", {"entities": []}], ["Third, we tested for evidence of genetic parallelism among independent wild populations using both a single-locus method (outlier analysis) and a polygenic approach (analysis of covariation among markers).", {"entities": []}], ["The single-locus approach provided limited evidence for genetic parallelism.", {"entities": []}], ["However, the polygenic analysis revealed genetic parallelism for three of the five lakes, which differed from the two other lakes.", {"entities": []}], ["These results provide evidence for both genetic parallelism and multiple genetic routes underlying parallel phenotypic evolution in fish shape among populations occupying similar ecological niches.", {"entities": []}], ["Weekly influenza-like illness (ILI) consultation rates are an integral part of influenza surveillance.", {"entities": [[7, 16, "DISEASE"], [79, 88, "DISEASE"]]}], ["However, in most health care settings, only a small proportion of true influenza cases are clinically diagnosed as influenza or ILI.", {"entities": [[71, 80, "DISEASE"], [115, 124, "DISEASE"]]}], ["The primary objective of this study was to estimate the number and rate of visits to the emergency department (ED) that are attributable to seasonal and pandemic influenza and to describe the effect of influenza on the ED by age, diagnostic categories, and visit disposition.", {"entities": [[162, 171, "DISEASE"], [202, 211, "DISEASE"]]}], ["A secondary objective was to assess the weekly \u201creal-time\u201d time series of ILI ED visits as an indicator of the full burden due to influenza.", {"entities": [[130, 139, "DISEASE"]]}], ["The authors performed an ecologic analysis of ED records extracted from the National Ambulatory Care Reporting System (NARCS) database for the province of Ontario, Canada, from September 2003 to March 2010 and stratified by diagnostic characteristics (International Classification of Diseases, 10th Revision [ICD-10]), age, and visit disposition.", {"entities": []}], ["A regression model was used to estimate the seasonal baseline.", {"entities": []}], ["The weekly number of influenza-attributable ED visits was calculated as the difference between the weekly number of visits predicted by the statistical model and the estimated baseline.", {"entities": [[21, 30, "DISEASE"]]}], ["The estimated rate of ED visits attributable to influenza was elevated during the H1N1/2009 pandemic period at 1,000 per 100,000 (95% confidence interval [CI] = 920 to 1,100) population compared to an average annual rate of 500 per 100,000 (95% CI = 450 to 550) for seasonal influenza.", {"entities": [[48, 57, "DISEASE"], [275, 284, "DISEASE"]]}], ["ILI or influenza was clinically diagnosed in one of 2.6 (38%) and one of 14 (7%) of these visits, respectively.", {"entities": [[7, 16, "DISEASE"]]}], ["While the ILI or clinical influenza diagnosis was the diagnosis most specific to influenza, only 87% and 58% of the clinically diagnosed ILI or influenza visits for pandemic and seasonal influenza, respectively, were likely directly due to an influenza infection.", {"entities": [[26, 35, "DISEASE"], [81, 90, "DISEASE"], [144, 153, "DISEASE"], [187, 196, "DISEASE"], [243, 252, "DISEASE"]]}], ["Rates for ILI ED visits were highest for younger age groups, while the likelihood of admission to hospital was highest in older persons.", {"entities": []}], ["During periods of seasonal influenza activity, there was a significant increase in the number of persons who registered with nonrespiratory complaints, but left without being seen.", {"entities": [[27, 36, "DISEASE"]]}], ["This effect was more pronounced during the 2009 pandemic.", {"entities": []}], ["The ratio of influenza-attributed respiratory visits to influenza-attributed ILI visits varied from 2.4:1 for the fall H1N1/2009 wave to 9:1 for the 2003/04 influenza A(H3N2) season and 28:1 for the 2007/08 H1N1 season.", {"entities": [[13, 22, "DISEASE"], [56, 65, "DISEASE"], [157, 166, "DISEASE"]]}], ["Influenza appears to have had a much larger effect on ED visits than was captured by clinical diagnoses of influenza or ILI.", {"entities": [[0, 9, "DISEASE"], [107, 116, "DISEASE"]]}], ["Throughout the study period, ILI ED visits were strongly associated with excess respiratory complaints.", {"entities": []}], ["However, the relationship between ILI ED visits and the estimated effect of influenza on ED visits was not consistent enough from year to year to predict the effect of influenza on the ED or downstream in-hospital resource requirements.", {"entities": [[76, 85, "DISEASE"], [168, 177, "DISEASE"]]}], ["There are disproportionately higher rates of overweight and obesity in poor rural communities but studies exploring children\u2019s health-related behaviors that may assist in designing effective interventions are limited.", {"entities": [[60, 67, "DISEASE"]]}], ["We examined the association between overweight and obesity prevalence of 401 ethnically/racially diverse, rural school-aged children and healthy-lifestyle behaviors: improving diet quality, obtaining adequate sleep, limiting screen-time viewing, and consulting a physician about a child\u2019s weight.", {"entities": [[51, 58, "DISEASE"]]}], ["A cross-sectional analysis was conducted on a sample of school-aged children (6\u201311 years) in rural regions of California, Kentucky, Mississippi, and South Carolina participating in CHANGE (Creating Healthy, Active, and Nurturing Growing-up Environments) Program, created by Save the Children, an independent organization that works with communities to improve overall child health, with the objective to reduce unhealthy weight gain in these school-aged children (grades 1\u20136) in rural America.", {"entities": []}], ["After measuring children\u2019s height and weight, we17 assessed overweight and obesity (BMI \u2265 85th percentile) associations with these behaviors: improving diet quality18 (\u2265 2 servings of fruits and vegetables/day), reducing whole milk, sweetened beverage consumption/day; obtaining19 adequate night-time sleep on weekdays (\u2265 10 hours/night); limiting screen-time (i.e., television, video, computer,20 videogame) viewing on weekdays (\u2264 2 hours/day); and consulting a physician about weight.", {"entities": [[75, 82, "DISEASE"]]}], ["Analyses were adjusted 21 for state of residence, children's race/ethnicity, gender, age, and government assistance.", {"entities": []}], ["Overweight or obesity prevalence was 37 percent in Mississippi and nearly 60 percent in Kentucky.", {"entities": [[14, 21, "DISEASE"]]}], ["Adjusting for covariates, obese children were twice as likely to eat \u2265 2 servings of vegetables per day (OR=2.0,95% CI 1.1-3.4), less likely to consume whole milk (OR=0.4,95% CI 0.2-0.70), Their parents are more likely to be told by their doctor that their child was obese (OR=108.0,95% CI 21.9-541.6), and less likely to report talking to their child about fruits and vegetables a lot/sometimes vs. not very much/never (OR=0.4, 95%CI 0.2-0.98) compared to the parents of healthy-weight children.", {"entities": []}], ["Rural children are not meeting recommendations to improve diet, reduce screen time and obtain adequate sleep.", {"entities": []}], ["Although we expected obese children to be more likely to engage in unhealthy behaviors, we found the opposite to be true.", {"entities": []}], ["It is possible that these groups of respondent parents were highly aware of their weight status and have been advised to change their children\u2019s health behaviors.", {"entities": []}], ["Perhaps given the opportunity to participate in an intervention study in combination with a physician recommendation could have resulted in actual behavior change.", {"entities": []}], ["Obesity is associated with morbidity, mortality, and increased health care costs.", {"entities": [[0, 7, "DISEASE"]]}], ["Few studies have examined the impact of obesity on outpatient office visits.", {"entities": [[40, 47, "DISEASE"]]}], ["The purpose of this study was to determine if outpatient visits by obese persons required more time with the provider and more prescription medication management compared to visits made by non-obese persons.", {"entities": []}], ["Obesity status was determined for 9,280 patient visits made by persons aged 18 years or older in the 2006 National Ambulatory Medical Care Survey.", {"entities": [[0, 7, "DISEASE"]]}], ["Multivariate analyses compared obese and non-obese visits, stratified by sex, for duration of the visit and the number of medications mentioned at the visit.", {"entities": []}], ["Average duration of visit was higher among visits with patients determined to be obese.", {"entities": []}], ["However, these differences were not considered significant after statistical testing.", {"entities": []}], ["Visits made by obese female patients were significantly more likely to involve more than two prescription medications (OR 1.26, 95% CI 1.05 - 1.51) and visits made by obese male patients were significantly more likely to involve more than two prescription medications (OR 1.46, 95% CI 1.16 - 1.83) as compared to visits made by non-obese patients.", {"entities": []}], ["Time spent with the provider was found to be greater among visits with obese patients, but not significantly different from visits with non-obese patients.", {"entities": []}], ["The number of medications for each visit was found to be significantly greater for visits where the patient was considered to be obese.", {"entities": []}], ["Increased time for the visit and increased numbers of medication for each visit translate into increased costs.", {"entities": []}], ["These findings document the impact of obesity on our health care system and have great implications on medical care cost and planning.", {"entities": [[38, 45, "DISEASE"]]}], ["Activated microglia can exert either neurotoxic or neuroprotective effects, and they play pivotal roles in the pathogenesis and progression of various neurological diseases.", {"entities": []}], ["In this study, we used cDNA microarrays to show that interleukin-19 (IL-19), an IL-10 family cytokine, is markedly upregulated in activated microglia.", {"entities": []}], ["Furthermore, we found that microglia are the only cells in the nervous system that express the IL-19 receptor, a heterodimer of the IL-20R\u03b1 and IL-20R\u03b2 subunits.", {"entities": []}], ["IL-19 deficiency increased the production of such pro-inflammatory cytokines as IL-6 and tumor necrosis factor-\u03b1 in activated microglia, and IL-19 treatment suppressed this effect.", {"entities": []}], ["Moreover, in a mouse model of Alzheimer\u2019s disease, we observed upregulation of IL-19 in affected areas in association with disease progression.", {"entities": []}], ["Our findings demonstrate that IL-19 is an anti-inflammatory cytokine, produced by activated microglia, that acts negatively on microglia in an autocrine manner.", {"entities": []}], ["Thus, microglia may self-limit their inflammatory response by producing the negative regulator IL-19.", {"entities": []}], ["Sub-Saharan African populations are growing in many European countries.", {"entities": []}], ["Data on the health of these populations are rare.", {"entities": []}], ["Additionally, many sub-Saharan African migrants are confronted with issues of low socio-economic status, acculturation and language difficulties, which may hamper their access to health care.", {"entities": []}], ["Despite the identification of some of those barriers, little is known about the enabling factors.", {"entities": []}], ["Knowledge about the enablers and barriers in access to healthcare experienced is important in addressing their health needs and promoting healthcare access.", {"entities": []}], ["This study aimed to investigate the enabling factors as well as barriers in access to the Dutch healthcare system among the largest sub-Saharan African migrant group (Ghanaians) living in Amsterdam, the Netherlands.", {"entities": []}], ["Six focus groups were conducted from November 2009 to February 2010.", {"entities": []}], ["A semi-structured interview guideline was used.", {"entities": []}], ["Discussions were conducted in English or Twi (Ghanaian dialect), recorded and transcribed verbatim.", {"entities": []}], ["Analysis was based on the Andersen model of healthcare utilisation using MAXQDA software.", {"entities": []}], ["Knowledge and perceived quality of the health system, awareness of diseases, family and community support, community initiatives and availability of social support were the main enablers to the healthcare system.", {"entities": []}], ["Difficulties with the Dutch language and mistrust in health care providers were major barriers in access to healthcare.", {"entities": []}], ["Access to healthcare is facilitated mainly by knowledge of and the perceived efficiency and quality of the Dutch healthcare system.", {"entities": []}], ["However, poor Dutch language proficiency and mistrust in health care providers appear to be important barriers in accessing healthcare.", {"entities": []}], ["The enablers and barriers identified by this study provide useful information for promoting healthcare access among this and similar Sub-Saharan African communities.", {"entities": []}], ["Population based studies are important for prevalence, incidence and association studies, but their external validity might be threatened by decreasing participation rates.", {"entities": []}], ["The 50 807 participants in the third survey of the HUNT Study (HUNT3, 2006-08), represented 54% of the invited, necessitating a nonparticipation study.", {"entities": []}], ["Questionnaire data from HUNT3 were compared with data collected from several sources: a short questionnaire to nonparticipants, anonymous data on specific diagnoses and prescribed medication extracted from randomly selected general practices, registry data from Statistics Norway on socioeconomic factors and mortality, and from the Norwegian Prescription Database on drug consumption.", {"entities": []}], ["Participation rates for HUNT3 depended on age, sex and type of symptoms and diseases, but only small changes were found in the overall prevalence estimates when including data from 6922 nonparticipants.", {"entities": []}], ["Among nonparticipants, the prevalences of cardiovascular diseases, diabetes mellitus and psychiatric disorders were higher both in nonparticipant data and data extracted from general practice, compared to that reported by participants, whilst the opposite pattern was found, at least among persons younger than 80 years, for urine incontinence, musculoskeletal pain and headache.", {"entities": [[67, 84, "DISEASE"]]}], ["Registry data showed that the nonparticipants had lower socioeconomic status and a higher mortality than participants.", {"entities": []}], ["Nonparticipants had lower socioeconomic status, higher mortality and showed higher prevalences of several chronic diseases, whilst opposite patterns were found for common problems like musculoskeletal pain, urine incontinence and headache.", {"entities": []}], ["The impact on associations should be analyzed for each diagnosis, and data making such analyses possible are provided in the present paper.", {"entities": []}], ["We evaluated the effects of T helper cell differentiation in a mite-allergic animal model treated with inhaled heparins of different molecular weight.", {"entities": []}], ["BALB/c mice were divided into four groups: 1.", {"entities": []}], ["Control, 2.", {"entities": []}], ["Mite intratracheal (mIT), 3.", {"entities": []}], ["Inhaled heparin (hIN), 4.", {"entities": []}], ["Inhaled low-molecular-weight heparin (lmwhIN).", {"entities": []}], ["Groups 2, 3, and 4 were sensitized twice with Der p allergen subcutaneously on day 1 and day 8.", {"entities": []}], ["Der p allergen was administered intratracheally on day 15.", {"entities": []}], ["Groups 3 and 4 were treated with heparin or low-molecular-weight (lmw) heparin intranasally from day 1 to 22.", {"entities": []}], ["Splenocytes from sacrificed mice stimulated with 16 \u00b5g/ml of Der p were cultured for 72 hours.", {"entities": []}], ["Supernatants of splenocyte were collected to analyze the effect of Interleukin (IL)17-A/F, Interferon(IFN)-\u03b3, IL-4, IL-13, and IL-10.", {"entities": []}], ["Serum was also collected for Der P-specific IgE level on day 23.", {"entities": []}], ["Total RNA was extracted from spleen tissue for mRNA expression.", {"entities": []}], ["Gene expression of Foxp3, IL-10 IFN-\u03b3, GATA3, IL-5, and ROR\u03b3t were analyzed.", {"entities": [[19, 24, "GENE"], [39, 44, "GENE"]]}], ["Both hIN and lmwhIN groups had lower serum IgE level than that of the mIT group (both p<0.0001).", {"entities": []}], ["Both hIN and lmwhIN groups showed significantly decreased transcripts of GATA-3, IFN-\u03b3, IL-5, and ROR\u03b3t mRNA in their spleen.", {"entities": []}], ["Regarding the supernatant of splenocyte culture stimulated with Der p, compared with the mIT group, there were significant decreases in IL-17A/F, IFN-\u03b3, IL-4, IL-13, and IL-10 secretion in inhaled hIN and lmwhIN groups.", {"entities": []}], ["From this balb/c mice study, the analyses of mRNA and cytokines revealed that both intranasal heparin and lmw heparin treatment decreased the expression of Th1, Th2, and Th17 in spleen.", {"entities": []}], ["The underlying mechanism(s) warrant further studies.", {"entities": []}], ["We examined the neuroprotective efficacy of docosahexaenoic acid (DHA), an omega-3 essential fatty acid family member, in acute ischemic stroke; studied the therapeutic window; and investigated whether DHA administration after an ischemic stroke is able to salvage the penumbra.", {"entities": []}], ["In each series described below, SD rats underwent 2\u00a0h of middle cerebral artery occlusion (MCAo).", {"entities": [[64, 89, "DISEASE"]]}], ["In series 1, DHA or saline was administered i.v.", {"entities": []}], ["at 3, 4, 5, or 6\u00a0h after stroke.", {"entities": []}], ["In series 2, MRI was conducted on days\u00a01, 3 and 7.", {"entities": []}], ["In series 3, DHA or saline was administered at 3\u00a0h, and lipidomic analysis was conducted on day\u00a03.", {"entities": []}], ["Treatment with DHA significantly improved behavior and reduced total infarct volume by a mean of 40% when administered at 3\u00a0h, by 66% at 4\u00a0h, and by 59% at 5\u00a0h. Total lesion volumes computed from T2-weighted images were reduced in the DHA group at all time points.", {"entities": []}], ["Lipidomic analysis showed that DHA treatment potentiates neuroprotectin D1 (NPD1) synthesis in the penumbra 3\u00a0days after MCAo.", {"entities": []}], ["DHA administration provides neurobehavioral recovery, reduces brain infarction and edema, and activates NPD1 synthesis in the penumbra when administered up to 5\u00a0h after focal cerebral ischemia in rats.", {"entities": [[62, 78, "DISEASE"], [184, 192, "DISEASE"]]}], ["Catharanthus roseus (L.) known as Madagascar periwinkle (MP) is a legendary medicinal plant mostly because of possessing two invaluable antitumor terpenoid indole alkaloids (TIAs), vincristine and vinblastine.", {"entities": []}], ["The plant has also high aesthetic value as an evergreen ornamental that yields prolific blooms of splendid colors.", {"entities": []}], ["The plant possesses yet another unique characteristic as an amiable experimental host for the maintenance of the smallest bacteria found on earth, the phytoplasmas and spiroplasmas, and serves as a model for their study.", {"entities": []}], ["Botanical information with respect to synonyms, vernacular names, cultivars, floral morphology, and reproduction adds to understanding of the plant while the geography and ecology of periwinkle illustrate the organism's ubiquity.", {"entities": []}], ["Good agronomic practices ensure generous propagation of healthy plants that serve as a source of bioactive compounds and multitudinous horticultural applications.", {"entities": []}], ["The correlation between genetic diversity, variants, and TIA production exists.", {"entities": []}], ["MP is afflicted with a whole range of diseases that have to be properly managed.", {"entities": []}], ["The ethnobotanical significance of MP is exemplified by its international usage as a traditional remedy for abundant ailments and not only for cancer.", {"entities": [[143, 149, "DISEASE"]]}], ["TIAs are present only in micro quantities in the plant and are highly poisonous per se rendering a challenge for researchers to increase yield and reduce toxicity.", {"entities": []}], ["Although drug fever may develop after administration of the drug by various routes, it has not been reported with antibiotic-loaded bone cement.", {"entities": []}], ["Here, a case of drug fever induced by piperacillin/tazobactam loaded into bone cement is reported.", {"entities": []}], ["A 72-yr-old woman presented with fever that developed two weeks after insertion of bone cement loaded with antibiotics including piperacillin/tazobactam into the knee joint for infectious arthritis.", {"entities": [[188, 197, "DISEASE"]]}], ["The fever was associated with a skin rash and blood eosinophilia.", {"entities": [[52, 64, "DISEASE"]]}], ["The work-up of the fever excluded several causes.", {"entities": []}], ["Drug provocation test demonstrated that the piperacillin/tazobactam, which had been loaded in the bone cement, was the cause of the fever.", {"entities": []}], ["The findings of this case suggest that drug fever can be induced by any drug placed and released continuously within the body.", {"entities": []}], ["Therefore, the evaluation for possible drug fever should include all drugs the patient has been exposed to regardless of the route of administration.", {"entities": []}], ["School-age children are important drivers of annual influenza epidemics yet influenza vaccination coverage of this population is low despite universal publicly funded influenza vaccination in Alberta, Canada.", {"entities": [[52, 61, "DISEASE"], [76, 85, "DISEASE"], [167, 176, "DISEASE"]]}], ["Immunizing children at school may potentially increase vaccine uptake.", {"entities": []}], ["As parents are a key stakeholder group for such a program, it is important to consider their concerns.", {"entities": []}], ["We explored parents\u2019 perspectives on the acceptability of adding an annual influenza immunization to the immunization program that is currently delivered in Alberta schools, and obtained suggestions for structuring such a program.", {"entities": [[75, 84, "DISEASE"]]}], ["Forty-eight parents of children aged 5-18 years participated in 9 focus groups.", {"entities": []}], ["Participants lived in urban areas of the Alberta Health Services Calgary Zone.", {"entities": []}], ["Three major themes emerged: Advantages of school-based influenza vaccination (SBIV), Disadvantages of SBIV, and Implications for program design & delivery.", {"entities": [[55, 64, "DISEASE"]]}], ["Advantages were perceived to occur for different populations: children (e.g.", {"entities": []}], ["emotional support), families (e.g.", {"entities": []}], ["convenience), the community (e.g.", {"entities": []}], ["benefits for school and multicultural communities), the health sector (e.g.", {"entities": []}], ["reductions in costs due to burden of illness) and to society at large (e.g.", {"entities": []}], ["indirect conduit of information about health services, building structure for pandemic preparedness, building healthy lifestyles).", {"entities": []}], ["Disadvantages, however, might also occur for children (e.g.", {"entities": []}], ["older children less likely to be immunized), families (e.g.", {"entities": []}], ["communication challenges, perceived loss of parental control over information, choices and decisions) and the education sector (loss of instructional time).", {"entities": []}], ["Nine second-level themes emerged within the major theme of Implications for program design & delivery: program goals/objectives, consent process, stakeholder consultation, age-appropriate program, education, communication, logistics, immunizing agent, and clinic process.", {"entities": []}], ["Parents perceived advantages and disadvantages to delivering annual seasonal influenza immunizations to children at school.", {"entities": [[77, 86, "DISEASE"]]}], ["Their input gives a framework of issues to address in order to construct robust, acceptable programs for delivering influenza or other vaccines in schools.", {"entities": [[116, 125, "DISEASE"]]}], ["The aim of this study was to extend previous findings and determine the value of prompt initiation of maintenance treatment (MT) following COPD exacerbations requiring hospitalization or an emergency department (ED) visit.", {"entities": []}], ["Administrative claims data (collected between January 1, 2009 and June 30, 2012) from an employer-sponsored commercially insured population were retrospectively used to identify patients with a COPD exacerbation resulting in hospitalization or an ED visit.", {"entities": []}], ["Patients initiating approved MT for COPD within 30 days of discharge/diagnosis (prompt) were compared with those initiating MT within 31\u2013180 days (delayed).", {"entities": []}], ["COPD-related total, medical, and prescription drug costs during a 1-year follow-up period were evaluated using semilog ordinary least square regressions, controlling for baseline characteristics plus COPD-related costs from the previous year.", {"entities": []}], ["The odds and number of subsequent COPD-related exacerbations during the follow-up were compared between the prompt and delayed cohorts using logistic regression and zero-inflated negative binomial models, respectively.", {"entities": []}], ["A total of 6,521 patients with a COPD-related hospitalization or an ED visit were included, of whom 4,555 received prompt MT and 1,966 received delayed MT.", {"entities": []}], ["Adjusted COPD-related total and medical costs were significantly lower for the prompt MT than the delayed MT cohorts (US$3,931 vs US$4,857 and US$2,327 vs US$3,087, respectively; both P <0.010), as were COPD-related prescription costs (US$1,526 vs US$1,683, P <0.010) during the 1-year follow-up period.", {"entities": []}], ["Patients receiving delayed MT were 68% more likely to have a subsequent exacerbation requiring hospitalization and 80% more likely to have an exacerbation requiring an ED visit.", {"entities": []}], ["Prompt initiation of MT following a COPD-related hospitalization or an ED visit was associated with a significant reduction in COPD-related costs and odds of exacerbation in the following year compared with delayed initiation.", {"entities": []}], ["GSK256066 is a selective phosphodiesterase 4 inhibitor that can be given by inhalation, minimising the potential for side effects.", {"entities": []}], ["We evaluated the effects of GSK256066 on airway responses to allergen challenge in mild asthmatics.", {"entities": []}], ["In a randomised, double blind, cross-over study, 24 steroid naive atopic asthmatics with both early (EAR) and late (LAR) responses to inhaled allergen received inhaled GSK256066 87.5 mcg once per day and placebo for 7 days, followed by allergen challenge.", {"entities": []}], ["Methacholine reactivity was measured 24 h post-allergen.", {"entities": []}], ["Plasma pharmacokinetics were measured.", {"entities": []}], ["The primary endpoint was the effect on LAR.", {"entities": []}], ["GSK256066 significantly reduced the LAR, attenuating the fall in minimum and weighted mean FEV1 by 26.2% (p = 0.007) and 34.3% (p = 0.005) respectively compared to placebo.", {"entities": []}], ["GSK256066 significantly reduced the EAR, inhibiting the fall in minimum and weighted mean FEV1 by 40.9% (p = 0.014) and 57.2% (p = 0.014) respectively compared to placebo.", {"entities": []}], ["There was no effect on pre-allergen FEV1 or methacholine reactivity post allergen.", {"entities": []}], ["GSK256066 was well tolerated, with low systemic exposure; plasma levels were not measurable after 4 hours in the majority of subjects.", {"entities": []}], ["GSK256066 demonstrated a protective effect on the EAR and LAR.", {"entities": []}], ["This is the first inhaled PDE4 inhibitor to show therapeutic potential in asthma.", {"entities": [[74, 80, "DISEASE"]]}], ["This study is registered on clinicaltrials.gov NCT00380354", {"entities": []}], ["In order to validate its antiseptic and anticancer properties with respect to traditional uses, we have screened for the first time the antimicrobial activity of aerial parts of M. vulgare L. essential oil against different pathogenic microorganisms and the cytotoxic activity against HeLa cell lines.", {"entities": []}], ["The agar disk diffusion method was used to study the antibacterial activity of M. vulgare essential oil against 12 bacterial and 4 fungi strains.", {"entities": []}], ["The disc diameters of zone of inhibition (DD), the minimum inhibitory concentrations (MIC) and the concentration inhibiting 50% (IC 50 ) were investigated to characterize the antimicrobial activities of this essential oil.", {"entities": []}], ["The in vitro cytotoxicity of M. vulgare essential oil was examined using a modified MTT assay; the viability and the IC 50 were used to evaluate this test.", {"entities": []}], ["The antimicrobial activity of the essential oil was investigated in order to evaluate its efficacy against the different tested microorganisms.", {"entities": []}], ["The present results results showed a significant activity against microorganisms especially Gram (+) bacteria with inhibition zones and minimal inhibitory concentration values in the range of 6.6-25.2 mm and 1120-2600 \u03bcg/ml, respectively, whereas Gram (-) bacteria exhibited a higher resistance.", {"entities": []}], ["As far as the antifungal activity, among four strains tested, Botrytis cinerea exhibited the strongest activity with inhibition zones of 12.6 mm.", {"entities": []}], ["However, Fusarium solani, Penicillium digitatum and Aspergillus niger were less sensitive to M. vulgare essential oil.", {"entities": []}], ["About the citotoxicity assay, this finding indicate the capability of this essential oil to inhibited the proliferation of HeLa cell lines under some conditions with IC 50 value of 0.258 \u03bcg/ml.", {"entities": []}], ["This investigation showed that the M. vulgare essential oil has a potent antimicrobial activity against some Gram (+) pathogenic bacteria and Botrytis cinerea fungi.", {"entities": []}], ["The present studies confirm the use of this essential oil as anticancer agent.", {"entities": []}], ["Further research is required to evaluate the practical values of therapeutic applications.", {"entities": []}], ["Rheumatoid arthritis (RA) and its accepted animal model, murine collagen-induced arthritis (CIA), are classic autoimmune inflammatory diseases which require proinflammatory cytokine production for pathogenesis.", {"entities": [[11, 20, "DISEASE"], [81, 90, "DISEASE"]]}], ["We and others have previously used N, N-dimethylglycine (DMG) and extracts from the New Zealand green-lipped mussel Perna canaliculus (Perna) as potent immunomodulators to modify ongoing immune and/or inflammatory responses.", {"entities": []}], ["In our initial studies, we treated lipopolysaccahride (LPS) stimulated THP-1 monocytes in vitro with increasing concentrations of Perna extract or DMG.", {"entities": []}], ["Additionally, we treated rat peripheral blood neutrophils with increasing concentrations of Perna extract and measured superoxide burst.", {"entities": []}], ["In subsequent in vivo experiments, CIA was induced by administration of type II collagen; rats were prophylactically treated with either Perna or DMG, and then followed for disease severity.", {"entities": []}], ["Finally, to test whether Perna and/or DMG could block or inhibit an ongoing pathologic disease process, we induced CIA in mice and treated them therapeutically with either of the two immunomodulators.", {"entities": []}], ["Following LPS stimulation of THP-1 monocytes, we observed dose-dependent reductions in TNF-\u03b1 and IL-12p40 production in Perna treated cultures.", {"entities": []}], ["DMG treatment, however, showed significant increases in both of these cytokines in the range of 0.001\u20131 \u03bcM.", {"entities": []}], ["We also demonstrate that in vitro neutrophil superoxide burst activity is dose-dependently reduced in the presence of Perna.", {"entities": []}], ["Significant reductions in disease incidence, onset, and severity of CIA in rats were noted following prophylactic treatment with either of the two immunomodulators.", {"entities": []}], ["More importantly, amelioration of mouse CIA was observed following therapeutic administration of Perna.", {"entities": []}], ["In contrast, DMG appeared to have little effect in mice and may act in a species-specific manner.", {"entities": []}], ["These data suggest that Perna, and perhaps DMG, may be useful supplements to the treatment of RA in humans.", {"entities": []}], ["Asthma prevalence in children has increased 58% since 1980.", {"entities": [[0, 6, "DISEASE"]]}], ["Mortality has increased by 78%.", {"entities": []}], ["The burden of the disease is most acute in urban areas and racial/ethnic minority populations.", {"entities": []}], ["Hospitalization and morbidity rates for nonwhites are more than twice those for whites.", {"entities": []}], ["Asthma is characterized by recurrent wheezing, breathlessness, chest tightness, and coughing.", {"entities": [[0, 6, "DISEASE"]]}], ["Research in the past decade has revealed the importance of inflammation of the airways in asthma and clinical treatment to reduce chronic inflammation.", {"entities": [[90, 96, "DISEASE"]]}], ["Asthma is associated with production of IgE to common environmental allergens including house dust mite, animal dander, cockroach, fungal spores, and pollens.", {"entities": [[0, 6, "DISEASE"]]}], ["Some interventions to reduce symptoms through control of dust mite and animal dander have had positive results.", {"entities": []}], ["Control of symptoms through interventions to reduce exposures to cockroach antigen has not been reported.", {"entities": []}], ["Studies illustrating causal effects between outdoor air pollution and asthma prevalence are scant.", {"entities": [[70, 76, "DISEASE"]]}], ["Increases in asthma prevalence have occurred at the same time as general improvements in air quality.", {"entities": [[13, 19, "DISEASE"]]}], ["However, air quality appears to exacerbate symptoms in the child who already has the disease.", {"entities": []}], ["Decreased pulmonary function has been associated with exposure to particulates and bronchial hyperresponsiveness to smoke, SO(2) and NO(2).", {"entities": []}], ["Symptoms have been correlated with increased levels of respirable particulates, ozone, and SO(2).", {"entities": []}], ["Interventions that reduce the negative outcomes in asthma associated with outdoor environmental factors have not been reported.", {"entities": [[51, 57, "DISEASE"]]}], ["Control of asthma in children will entail the collaborative efforts of patients, family, clinical professionals, and school personnel, as well as community-wide environmental control measures and conducive national and local policies based on sound research.", {"entities": [[11, 17, "DISEASE"]]}], ["The aim of this study was to investigate the relationship between urinary eosinophil protein X (uEPX) and asthma symptoms, lung function, and other markers of eosinophilic airway inflammation in asthmatic school children.", {"entities": [[106, 112, "DISEASE"]]}], ["A cross-sectional study was performed in 180 steroid dependent atopic children with stable moderately severe asthma, who were stable on 200 or 500 \u03bc g of fluticasone per day.", {"entities": [[109, 115, "DISEASE"]]}], ["uEPX was measured in a single sample of urine and was normalized for creatinine concentration (uEPX/c).", {"entities": []}], ["Symptom scores were kept on a diary card.", {"entities": []}], ["FEV 1 and PD 20 methacholine were measured.", {"entities": [[0, 3, "GENE"]]}], ["Sputum induction was performed in 49 and FE NO levels measured in 24 children.", {"entities": []}], ["We found an inverse correlation between uEPX/c and FEV 1 ( r = \u2212.20, P = .01) and a borderline significant correlation between uEPX/c and PD 20 methacholine ( r = \u2212.15, P = .06).", {"entities": [[51, 54, "GENE"]]}], ["Symptom score, %eosinophils and ECP in induced sputum and FE NO levels did not correlate with uEPX/c.", {"entities": []}], ["Conclusion .", {"entities": []}], ["uEPX/c levels did not correlate with established markers of asthma severity and eosinophilic airway inflammation in atopic asthmatic children.", {"entities": [[60, 66, "DISEASE"]]}], ["Exacerbation-associated health-related quality of life (HRQoL) in patients with severe and very severe chronic obstructive pulmonary disease (COPD) is ill-defined.", {"entities": [[103, 140, "DISEASE"]]}], ["This study describes patterns, HRQoL, and the work productivity impact of COPD-related moderate and SEV exacerbations in patients with SEV/VSEV COPD, focusing on the chronic bronchitis subtype.", {"entities": [[174, 184, "DISEASE"]]}], ["A US sample of SEV and VSEV COPD patients with recent moderate or SEV exacerbation was recruited.", {"entities": []}], ["Along with the demographic and clinical data collected from medical records, patients reported on exacerbation frequency, health-related quality of life (HRQoL) (using the St George\u2019s Respiratory Questionnaire for COPD [SGRQ-C] and the European Quality of Life-5 Dimensions [EQ-5D]\u2122 index), and work productivity and activity impairment (using the Work Productivity and Activity Impairment Questionnaire \u2013 Specific Health Problem [WPAI-SHP]).", {"entities": []}], ["The HRQoL-related impacts of exacerbation frequency, time since exacerbation, and last exacerbation severity were evaluated via linear regressions.", {"entities": []}], ["A total of 314 patients (190 SEV/124 VSEV, mean age =68.0 years, 51% male, 28% current smokers) were included.", {"entities": []}], ["In the previous 12 months, patients reported an average of 1.8 moderate exacerbations and 0.9 SEV exacerbations.", {"entities": []}], ["Overall, 16% of patients were employed and reported a high percentage of overall work impairment (42.4% \u00b1 31.1%).", {"entities": []}], ["Activity impairment was positively associated with recent exacerbation severity (SEV 64.6% \u00b1 26.8% versus moderate 55.6% \u00b1 28.2%) ( P =0.006).", {"entities": []}], ["The HRQoL was significantly worse for SEV versus VSEV COPD (EQ-5D: 0.62 \u00b1 0.23 versus 0.70 \u00b1 0.17, respectively, and SGRQ-C: 70.1 \u00b1 21.3 versus 61.1 \u00b1 19.0, respectively) ( P <0.001).", {"entities": []}], ["Worse current HRQoL was reported by patients with a SEV versus moderate recent exacerbation (EQ-5D: 0.63 \u00b1 0.21 versus 0.70 \u00b1 0.20, respectively) ( P =0.003); SGRQ-C: 70.3 \u00b1 19.9 versus 61.7 \u00b1 20.1, respectively ( P <0.001).", {"entities": []}], ["One additional exacerbation in the previous 12 months was associated with a 2.4-point SGRQ-C increase and a 0.02-point EQ-5D index decrease.", {"entities": []}], ["The severity and frequency of COPD-related moderate/SEV exacerbations in SEV and VSEV COPD patients were positively associated with poor HRQoL and work productivity and activity impairment.", {"entities": []}], ["Occupational asthma is induced by many agents, including herbal materials, that are exposed in working places.", {"entities": [[13, 19, "DISEASE"]]}], ["Although there are a few case reports for occupational allergy induced by herbal materials, there is none for that induced by Wonji ( Polygala tenuifolia ).", {"entities": []}], ["This study was conducted to evaluate clinical characteristics and immunologic mechanism of Wonji-induced asthma in a exposed-worker.", {"entities": [[105, 111, "DISEASE"]]}], ["A patient who complained of asthma and rhinitis symptoms, and who had worked in a herbal manufacturing factory for 8 yr, underwent a skin prick test with crude extract of Wonji under the impression of occupational asthma induced by the agent.", {"entities": [[39, 47, "DISEASE"], [28, 34, "DISEASE"], [214, 220, "DISEASE"]]}], ["The patient had a strong positive response to the extract on the skin prick test.", {"entities": []}], ["Allergen bronchial challenge to the extract demonstrated a typical dual response.", {"entities": []}], ["Serum specific IgE level to the extract was higher in the patient than in healthy controls, and ELISA inhibition test revealed complete inhibition of IgE binding with the extract, but no inhibition with Der p 2 or mugwort extracts.", {"entities": []}], ["Six IgE binding components to the extract (10, 25, 28, 36, 50, and 90 kDa) were detected using SDS-PAGE and immunoblot analysis.", {"entities": []}], ["These findings suggest that Polygala tenuifolia , a herbal material, can induce IgE-mediated bronchoconstriction in exposed workers.", {"entities": []}], ["An enzyme-based electrochemical biosensor was investigated for the analysis of Sunset Yellow synthetic food dye.", {"entities": []}], ["A glassy carbon electrode was coated with a poly(acrylamide- co -ethyl methacrylate) membrane to immobilize laccase using a single-step photopolymerization procedure.", {"entities": []}], ["Poly(acrylamide- co -ethyl methacrylate) membrane was demonstrated to have acceptable water absorption and suitable for biosensor application.", {"entities": []}], ["Sunset Yellow biosensor exhibited a linear response range from 0.08 to 10.00 \u00b5M with a detection limit of 0.02 \u00b5M.", {"entities": []}], ["This biosensor was successfully used to determine Sunset Yellow in soft drinks with recoveries of 99.0\u2013101.6%.", {"entities": []}], ["The method was validated using high-performance liquid chromatography, indicating the biosensor can be as a promising alternative method for Sunset Yellow detection.", {"entities": []}], ["An association between chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) has been described, mainly due to smoking and corticosteroid use.", {"entities": [[23, 60, "DISEASE"], [72, 84, "DISEASE"]]}], ["Whether inhaled corticosteroid (ICS) therapy is associated with an increased risk of TB remains unclear.", {"entities": []}], ["We selected COPD cases by using six diagnostic scenarios and control subjects from a nationwide health insurance database, and applied time-dependent Cox regression analysis to identify the risk factors for TB.", {"entities": []}], ["Among 1,000,000 beneficiaries, 23,594 COPD cases and 47,188 non-COPD control subjects were selected.", {"entities": []}], ["Cox regression analysis revealed that age, male gender, diabetes mellitus, end-stage renal disease, and cirrhosis, as well as COPD (hazard ratio = 2.468 [2.205\u20132.762]) were independent risk factors for TB.", {"entities": [[56, 73, "DISEASE"]]}], ["Among the COPD cases, those who developed TB received more oral corticosteroids and oral \u03b2-agonists.", {"entities": []}], ["Time-dependent Cox regression analysis revealed that age, male gender, diabetes mellitus, low income, oral corticosteroid dose, and oral \u03b2-agonist dose, but not ICS dose, were independent risk factors for TB.", {"entities": [[71, 88, "DISEASE"]]}], ["The identified risk factors and their hazard ratios were similar among the COPD cases selected using different scenarios.", {"entities": []}], ["Keeping a high suspicion and regularly monitoring for the development of pulmonary TB in COPD patients are necessary, especially for those receiving higher doses of oral corticosteroids and other COPD medications.", {"entities": []}], ["Although ICS therapy has been shown to predispose COPD patients to pneumonia in large randomized clinical trials, it does not increase the risk of TB in real world practice.", {"entities": [[67, 76, "DISEASE"]]}], ["Introduction .", {"entities": []}], ["The transcription factor NFE2-related factor 2 (Nrf2) is a central regulator of antioxidant and detoxification gene expression in response to electrophilic or oxidative stress.", {"entities": []}], ["Nrf2 has recently been shown to cross-talk with metabolic pathways, and its gene deletion protected mice from high-fat-diet-(HFD-) induced obesity and insulin resistance.", {"entities": [[139, 146, "DISEASE"]]}], ["This study aimed to identify potential Nrf2-regulated genes of metabolic interest by comparing gene expression profiles of livers of wild-type (WT) versus Nrf2 knockout (Nrf2-KO) mice after a long-term HFD.", {"entities": []}], ["WT and Nrf2-KO mice were fed an HFD for 180 days; total RNA was prepared from liver and used for microarray analysis and quantitative real-time RT-PCR (qRT-PCR).", {"entities": []}], ["The microarray analysis identified 601 genes that were differentially expressed between WT and Nrf2-KO mice after long-term HFD.", {"entities": []}], ["Selected genes, including ones known to be involved in metabolic regulation, were prioritized for verification by qRT-PCR: Cyp7a1 and Fabp5 were significantly overexpressed in Nrf2-KO mice; in contrast, Car , Cyp2b10 , Lipocalin 13 , Aquaporin 8 , Cbr3 , Me1 , and Nqo1 were significantly underexpressed in Nrf2-KO mice.", {"entities": [[123, 129, "GENE"], [134, 139, "GENE"], [248, 252, "GENE"], [255, 258, "GENE"], [265, 269, "GENE"]]}], ["Conclusion .", {"entities": []}], ["Transcriptome profiling after HFD-induced obesity confirms that Nrf2 is implicated in liver metabolic gene networks.", {"entities": [[42, 49, "DISEASE"]]}], ["The specific genes identified here may provide insights into Nrf2-dependent mechanisms of metabolic regulation.", {"entities": []}], ["Our environment poses a constant threat to our health.", {"entities": []}], ["To survive, all organisms must be able to discriminate between good (food ingredients and microbes that help digest our food) and bad (pathogenic microbes, viruses and toxins).", {"entities": []}], ["In vertebrates, discrimination between beneficial and harmful antigens mainly occurs at the mucosal surfaces of the respiratory, digestive, urinary and genital tract.", {"entities": []}], ["Here, an extensive network of cells and organs form the basis of what we have come to know as the mucosal immune system.", {"entities": []}], ["The mucosal immune system is composed of a single epithelial cell layer protected by a mucus layer.", {"entities": []}], ["Different immune cells monitor the baso-lateral side of the epithelial cells and dispersed secondary lymphoid organs, such as Peyer\u2019s patches and isolated lymphoid follicles are equipped with immune cells able to mount appropriate and specific responses.", {"entities": []}], ["This review will focus on the current knowledge on host, dietary and bacterial-derived factors that shape the mucosal immune system before and after birth.", {"entities": []}], ["We will discuss current knowledge on fetal immunity (both responsiveness and lymphoid organ development) as well as the impact of diet and microbial colonization on neonatal immunity and disease susceptibility.", {"entities": []}], ["Lastly, inflammatory bowel disease will be discussed as an example of how the composition of the microbiota might predispose to disease later in life.", {"entities": [[8, 34, "DISEASE"]]}], ["A fundamental understanding of the mechanisms involved in mucosal immune development and tolerance will aid nutritional intervention strategies to improve health in neonatal and adult life.", {"entities": []}], ["Exacerbations of asthma are linked to significant decline in lung function and are often poorly controlled by corticosteroid treatment.", {"entities": [[17, 23, "DISEASE"]]}], ["Clinical investigations indicate that viral and bacterial infections play crucial roles in the onset of steroid-resistant inflammation and airways hyperresponsiveness (AHR) that are hallmark features of exacerbations.", {"entities": [[168, 171, "GENE"]]}], ["We have previously shown that interferon \u03b3 (IFN\u03b3) and lipopolysaccharide (LPS) cooperatively activate pulmonary macrophages and induce steroid-resistant airway inflammation and AHR in mouse models.", {"entities": [[177, 180, "GENE"]]}], ["Furthermore, we have established a mouse model of respiratory syncytial virus (RSV)-induced exacerbation of asthma, which exhibits macrophage-dependent, steroid-resistant lung disease.", {"entities": [[108, 114, "DISEASE"], [171, 183, "DISEASE"]]}], ["Emerging evidence has demonstrated a key role for bromo- and extra-terminal (BET) proteins in the regulation of inflammatory gene expression in macrophages.", {"entities": []}], ["We hypothesised that BET proteins may be involved in the regulation of AHR and airway inflammation in our steroid-resistant exacerbation models.", {"entities": [[71, 74, "GENE"]]}], ["We investigated the effects of a BET inhibitor (I-BET-762) on the development of steroid-resistant AHR and airway inflammation in two mouse models.", {"entities": [[99, 102, "GENE"]]}], ["I-BET-762 administration decreased macrophage and neutrophil infiltration into the airways, and suppressed key inflammatory cytokines in both models.", {"entities": []}], ["I-BET treatment also suppressed key inflammatory cytokines linked to the development of steroid-resistant inflammation such as monocyte chemoattractant protein 1 (MCP-1), keratinocyte-derived protein chemokine (KC), IFN\u03b3, and interleukin 27 (IL-27).", {"entities": []}], ["Attenuation of inflammation was associated with suppression of AHR.", {"entities": [[63, 66, "GENE"]]}], ["Our results suggest that BET proteins play an important role in the regulation of steroid-resistant exacerbations of airway inflammation and AHR.", {"entities": [[141, 144, "GENE"]]}], ["BET proteins may be potential targets for the development of future therapies to treat steroid-resistant inflammatory components of asthma.", {"entities": [[132, 138, "DISEASE"]]}], ["Mediators of inflammation, oxidative stress, and chemoattractants drive the hypoxemic mechanisms that accompany pulmonary fibrosis.", {"entities": [[112, 130, "DISEASE"]]}], ["Patients with idiopathic pulmonary fibrosis commonly have obstructive sleep apnea, which potentiates the hypoxic stimuli for oxidative stress, culminating in systemic inflammation and generalized vascular endothelial damage.", {"entities": [[25, 43, "DISEASE"], [14, 43, "DISEASE"]]}], ["Comorbidities like pulmonary hypertension, obesity, gastroesophageal reflux disease, and hypoxic pulmonary vasoconstriction contribute to chronic hypoxemia leading to the release of proinflammatory cytokines that may propagate clinical deterioration and alter the pulmonary fibrotic pathway.", {"entities": [[29, 41, "DISEASE"], [43, 50, "DISEASE"], [19, 41, "DISEASE"], [52, 83, "DISEASE"]]}], ["Tissue inhibitor of metalloproteinase (TIMP-1), interleukin- (IL-) 1 \u03b1 , cytokine-induced neutrophil chemoattractant (CINC-1, CINC-2 \u03b1 / \u03b2 ), lipopolysaccharide induced CXC chemokine (LIX), monokine induced by gamma interferon (MIG-1), macrophage inflammatory protein- (MIP-) 1 \u03b1 , MIP-3 \u03b1 , and nuclear factor- (NF-) \u03ba B appear to mediate disease progression.", {"entities": []}], ["Adipocytes may induce hypoxia inducible factor (HIF) 1 \u03b1 production; GERD is associated with increased levels of lactate dehydrogenase (LDH), alkaline phosphatase (ALP), and tumor necrosis factor alpha (TNF- \u03b1 ); pulmonary artery myocytes often exhibit increased cytosolic free Ca2+.", {"entities": []}], ["Protein kinase C (PKC) mediated upregulation of TNF- \u03b1 and IL-1 \u03b2 also occurs in the pulmonary arteries.", {"entities": []}], ["Increased understanding of the inflammatory mechanisms driving hypoxemia in pulmonary fibrosis and obstructive sleep apnea may potentiate the identification of appropriate therapeutic targets for developing effective therapies.", {"entities": [[76, 94, "DISEASE"]]}], ["Pregnant women have been identified as a group at risk, both for respiratory complications than for the admissions to the Intensive Care Unit (ICU) during the 2009 H1N1 influenza pandemic (pdm).", {"entities": [[169, 178, "DISEASE"]]}], ["The purpose of this prospective register-based cohort-study was to characterize the clinical virulence of the pdm (H1N1/09)v during pregnancy in La R\u00e9union.", {"entities": []}], ["Over a twelve-week pdm wave (13 July to 3 October 2009), 294 pregnant women presented with an influenza-like illness (ILI) to one of the three maternity departments of the South Reunion area, Indian Ocean.", {"entities": [[94, 103, "DISEASE"]]}], ["Out of these, 278 were checked by RT-PCR for influenza viruses (157 positive and 121 negative, of whom, 141 with pdm flu and 132 with ILIs of non pdm origin, 5 untyped).", {"entities": [[45, 54, "DISEASE"]]}], ["The median body temperature was higher in women experiencing pdm flu than in those with non pdm ILI (38.9\u00b0C versus 38.3\u00b0C, P <0.0001), without evidence linked to circulating viremia.", {"entities": []}], ["Oseltamivir was given for 86% of pdm flu cases in a median time inferior than 48 hrs (range 0\u20137 days).", {"entities": []}], ["The hospitalization rate for pdm flu was of 60% and not associated with underlying conditions.", {"entities": []}], ["Six viral pneumonia and fourteen asthma attacks were observed among 84 hospitalized pdm flu cases, of whom, only one led to the ICU for an acute lung injury.", {"entities": [[10, 19, "DISEASE"], [33, 39, "DISEASE"], [4, 19, "DISEASE"]]}], ["No maternal death occurred during the pdm wave.", {"entities": []}], ["None adverse pregnancy outcome was associated with pdm flu.", {"entities": []}], ["No congenital birth defect, nor early-onset neonatal influenza infection was attributable to pdm flu exposure.", {"entities": [[53, 62, "DISEASE"]]}], ["This report mitigates substantially the presumed severity of pandemic H1N1/09 influenza infection during pregnancy.", {"entities": [[78, 87, "DISEASE"]]}], ["The reasons for which the clinical burden of H1N1/09 influenza virus may differ worldwide raise questions about a differential local viral-strain effect and public health preparedness, notably in timely access to special care and antiviral treatments.", {"entities": [[53, 62, "DISEASE"]]}], ["Nitric oxide synthase (NOS) is a biomarker/target in sepsis.", {"entities": []}], ["NOS activity is driven by amino acids, which cycle to regulate the substrate L-arginine in parallel with cycles which regulate the endogenous inhibitors ADMA and L-NMMA.", {"entities": []}], ["The relationship between amines and the consequence of plasma changes on iNOS activity in early sepsis is not known.", {"entities": []}], ["Our objective was to apply a metabolomics approach to determine the influence of sepsis on a full array of amines and what consequence these changes may have on predicted iNOS activity.", {"entities": []}], ["34 amino acids were measured using ultra purification mass spectrometry in the plasma of septic patients (n = 38) taken at the time of diagnosis and 24\u201372 hours post diagnosis and of healthy volunteers (n = 21).", {"entities": []}], ["L-arginine and methylarginines were measured using liquid-chromatography mass spectrometry and ELISA.", {"entities": []}], ["A top down approach was also taken to examine the most changed metabolic pathways by Ingenuity Pathway Analysis.", {"entities": []}], ["The iNOS supporting capacity of plasma was determined using a mouse macrophage cell-based bioassay.", {"entities": []}], ["Of all the amines measured 22, including L-arginine and ADMA, displayed significant differences in samples from patients with sepsis.", {"entities": []}], ["The functional consequence of increased ADMA and decreased L-arginine in context of all cumulative metabolic changes in plasma resulted in reduced iNOS supporting activity associated with sepsis.", {"entities": []}], ["In early sepsis profound changes in amine levels were defined by dominant changes in the iNOS canonical pathway resulting in functionally meaningful changes in the ability of plasma to regulate iNOS activity ex vivo .", {"entities": []}], ["To quantify bias related to specific methodological characteristics in child-relevant randomized controlled trials (RCTs).", {"entities": []}], ["Meta-epidemiological study.", {"entities": []}], ["We identified systematic reviews containing a meta-analysis with 10\u201340 RCTs that were relevant to child health in the Cochrane Database of Systematic Reviews.", {"entities": []}], ["Two reviewers independently assessed RCTs using items in the Cochrane Risk of Bias tool and other study factors.", {"entities": []}], ["We used meta-epidemiological methods to assess for differences in effect estimates between studies classified as high/unclear vs. low risk of bias.", {"entities": []}], ["We included 287 RCTs from 17 meta-analyses.", {"entities": []}], ["The proportion of studies at high/unclear risk of bias was: 79% sequence generation, 83% allocation concealment, 67% blinding of participants, 47% blinding of outcome assessment, 49% incomplete outcome data, 32% selective outcome reporting, 44% other sources of bias, 97% overall risk of bias, 56% funding, 35% baseline imbalance, 13% blocked randomization in unblinded trials, and 1% early stopping for benefit.", {"entities": []}], ["We found no significant differences in effect estimates for studies that were high/unclear vs. low risk of bias for any of the risk of bias domains, overall risk of bias, or other study factors.", {"entities": []}], ["We found no differences in effect estimates between studies based on risk of bias.", {"entities": []}], ["A potential explanation is the number of trials included, in particular the small number of studies with low risk of bias.", {"entities": []}], ["Until further evidence is available, reviewers should not exclude RCTs from systematic reviews and meta-analyses based solely on risk of bias particularly in the area of child health.", {"entities": []}], ["Exosomes are membrane-enclosed vesicles actively released into the extracellular space, whose content reflect the physiological/pathological state of the cells they originate from.", {"entities": []}], ["These vesicles participate in cell-to-cell communication and transfer of biologically active proteins, lipids, and RNAs.", {"entities": []}], ["Their role in viral infections is just beginning to be appreciated.", {"entities": []}], ["RNA viruses are an important class of pathogens and affect millions of people worldwide.", {"entities": []}], ["Recent studies on Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), human T-cell lymphotropic virus (HTLV), and Dengue Virus (DENV) have demonstrated that exosomes released from infected cells harbor and deliver many regulatory factors including viral RNA and proteins, viral and cellular miRNA, and other host functional genetic elements to neighboring cells, helping to establish productive infections and modulating cellular responses.", {"entities": []}], ["Exosomes can either spread or limit an infection depending on the type of pathogen and target cells, and can be exploited as candidates for development of antiviral or vaccine treatments.", {"entities": []}], ["This review summarizes recent progress made in understanding the role of exosomes in RNA virus infections with an emphasis on their potential contribution to pathogenesis.", {"entities": []}], ["Cough is a protective reflex action that helps clear the respiratory tract which is continuously exposed to airborne environmental irritants.", {"entities": []}], ["However, chronic cough presents itself as a disease in its own right and despite its global occurrence; the molecular mechanisms responsible for cough are not completely understood.", {"entities": []}], ["Transient receptor potential ankyrin1 (TRPA1) is robustly expressed in the neuronal as well as non-neuronal cells of the respiratory tract and is a sensor of a wide range of environmental irritants.", {"entities": [[39, 44, "GENE"]]}], ["It is fast getting acceptance as a key biological sensor of a variety of pro-tussive agents often implicated in miscellaneous chronic cough conditions.", {"entities": []}], ["In the present study, we demonstrate in vitro direct functional activation of TRPA1 receptor by citric acid which is routinely used to evoke cough in preclinical and clinical studies.", {"entities": [[78, 83, "GENE"]]}], ["We also show for the first time that a potent and selective TRPA1 antagonist GRC 17536 inhibits citric acid induced cellular Ca in vitro and cough response induced in vivo by citric acid.", {"entities": [[60, 65, "GENE"]]}], ["Furthermore, we also show evidence for TRPA1 activation in vitro by the TLR4, TLR7 and TLR8 ligands which are implicated in bacterial/respiratory virus pathogenesis often resulting in chronic cough.", {"entities": [[39, 44, "GENE"], [72, 76, "GENE"], [78, 82, "GENE"], [87, 91, "GENE"]]}], ["In conclusion, this study highlights the potential utility of TRPA1 antagonist such as GRC 17536 in the treatment of miscellaneous chronic cough conditions arising due to diverse causes but commonly driven via TRPA1.", {"entities": [[62, 67, "GENE"], [210, 215, "GENE"], [62, 67, "GENE"], [210, 215, "GENE"]]}], ["In this article we describe a phenomenological lifeworld study based on the theory of communicative action of 13 women with noncommunicable disease (NCDs) in a rural area in South Africa.", {"entities": []}], ["The purpose of the study was to generate key concepts of health care access and the management of NCDs in a rural South African context.", {"entities": []}], ["The study employed a qualitative methodology with serial semistructured interviews.", {"entities": []}], ["We used a content analytical approach to analyse key themes and patterns in participants\u2019 narratives of NCDs and health care access.", {"entities": []}], ["The findings are reported by theme and include analyses of narrative sequences related to 1) family environment, 2) experiences of NCDs, 3) understandings of the causes of NCDs, 4) accessibility of formal health care services, 5) experiences of formal health care services, 6) treating NCDs, and 7) experiences of informal health care services.", {"entities": []}], ["The findings suggest that participation in the routines prescribed by formal health care services and reinforced by families and faith-based communities normalises the experience of NCDs to the extent that narratives of NCDs form the background, rather than the focus of broader illness narratives.", {"entities": []}], ["Such narratives rather tend to focus on significant life events and relationships.", {"entities": []}], ["The key features of the narratives include connections between social or autobiographical and biological understandings of NCDs, the appropriation of modern concepts of disease in illness narratives, and reflexive commentary on the modern features of NCDs.", {"entities": []}], ["In the context of such narrative expertise formal health care services have a high level of acceptability in this rural area.", {"entities": []}], ["Lifeworld analysis of health care access based on the theory of communicative action places consensual understandings of NCDs and their treatment as central to the health care experience.", {"entities": []}], ["Our findings suggest that such analyses can facilitate potential feedback processes between health care users and professionals which generate consensus as well as institutional reform within formal health care services.", {"entities": []}], ["To evaluate changes in influenza vaccination rates in healthy and at-risk children following the implementation of the UK's childhood influenza immunisation programme.", {"entities": [[23, 32, "DISEASE"], [134, 143, "DISEASE"]]}], ["Observational cohort study before and after initiation of the UK's childhood influenza immunisation programme over three influenza seasons (2012\u20132013, 2013\u20132014 and 2014\u20132015) using data from the Clinical Practice Research Datalink (CPRD).", {"entities": [[77, 86, "DISEASE"], [121, 130, "DISEASE"]]}], ["More than 500 primary care practices in the UK.", {"entities": []}], ["All individuals aged 2\u201317\u2005years on 1 September, with at least 12\u2005months of medical history documented in CPRD were retained in the analysis.", {"entities": []}], ["Starting in 2013\u20132014, all children aged 2 and 3\u2005years were offered influenza vaccination through general practice, and primary school-aged children were offered influenza vaccination in selected counties in England (described as pilot regions).", {"entities": [[68, 77, "DISEASE"], [162, 171, "DISEASE"]]}], ["The vaccination programme was extended to all children aged 4\u2005years in England in 2014\u20132015.", {"entities": []}], ["Cumulative vaccination rate from 1 September to 28 February of the next calendar year as assessed by a time-to-event statistical model (vaccination uptake).", {"entities": []}], ["Age group, sex, region and type of high-risk medical condition were assessed as predictors.", {"entities": []}], ["Vaccination uptake increased considerably from 2012\u20132013 to 2013\u20132014 in targeted children aged 2\u20133\u2005years, both in children with a high-risk medical condition (from 40.7% to 61.1%) and those without (from 1.0% to 43.0%).", {"entities": []}], ["Vaccination rates increased also, though less markedly, in older children.", {"entities": []}], ["In 2014\u20132015, vaccination rates remained higher than 40% in healthy children aged 2\u20133\u2005years, although they decreased slightly from 2013\u20132014 (from 43.0% to 41.8%).", {"entities": []}], ["Vaccination rates in older healthy children continued to increase, driven primarily by an increase in children aged 4\u2005years to 31.3% in 2014\u20132015.", {"entities": []}], ["The introduction of a universal childhood vaccination policy in the UK increased vaccination rates for targeted children, including those with high-risk conditions.", {"entities": []}], ["Settled dust has been used in studies to assess exposures to allergens and other biologically active components, but it has not been considered in the aggregate in relation to respiratory health outcomes in the general population.", {"entities": []}], ["We addressed whether total house dust weight, an index of total dust exposure, was associated with respiratory health outcomes in the National Survey of Lead and Allergens in Housing (1998\u20131999) (NSLAH).", {"entities": []}], ["NSLAH was a cross-sectional survey designed to represent permanently occupied housing units in the United States.", {"entities": []}], ["In each household, a questionnaire was administered and settled dust was vacuumed from five locations.", {"entities": []}], ["Linear regression models were used to identify predictors of dust weight; logistic regression models were used to examine the relationship between dust weight and asthma and wheeze.", {"entities": [[163, 169, "DISEASE"]]}], ["Dust weight samples were available for 829 households, and survey information was available for 2,456 participants (children and adults).", {"entities": []}], ["Lower income, older homes, household pets, having a smoker in the house, and less frequent cleaning predicted higher dust weight levels in U.S. households.", {"entities": []}], ["Higher levels of dust weight were associated with greater odds of current asthma and wheeze.", {"entities": [[74, 80, "DISEASE"]]}], ["The strongest associations were seen for wheeze [adjusted odds ratio (OR) = 1.99; 95% confidence interval (CI), 1.21\u20133.28 for bedroom bed dust; OR = 2.81; 95% CI, 1.52\u20135.21 for upholstery dust).", {"entities": []}], ["These associations persisted when adjusting for allergen and endotoxin exposures.", {"entities": []}], ["Dust weight, an index of total dust exposure in the home, may contribute to respiratory outcomes independently of the exposure to specific components.", {"entities": []}], ["Uncontrolled hypertension is a leading modifiable risk factor for cardiovascular disease morbidity and mortality.", {"entities": [[13, 25, "DISEASE"]]}], ["Data on adequacy of blood pressure control in Kenya is scarce.", {"entities": []}], ["This study aimed at assessing the level of blood pressure control among hypertensive patients on follow-up in a regional referral hospital.", {"entities": []}], ["Data regarding blood pressure, antihypertensive medication use, and comorbidities was abstracted from medical records of 452 hypertensive patients seen in Nyeri Provincial General Hospital between January and March 2013.", {"entities": []}], ["Adequate blood pressure control was defined as a systolic pressure < 140 mmHg (< 130 mmHg for diabetic hypertensive patients) and a diastolic pressure < 90 mmHg (< 80 mmHg for diabetic hypertensive patients).", {"entities": []}], ["Data was entered and analyzed using STATA 9 (StataCorp, Inc, Texas, USA).", {"entities": []}], ["Only 33.4% of patients had a blood pressure within the recommended limits.", {"entities": []}], ["In multivariate analysis, using a calcium channel blocker was significantly associated with good blood pressure control (OR, 2.1; 95% CI, 1.4, 3.3).", {"entities": []}], ["On the other hand, old age (\u2265 60 years), being diabetic, and the use of three or more antihypertensive drugs were associated with reduced odds of good blood pressure control (OR, 0.64; 95% CI, 0.43; OR, 0.54; 95% CI, 0.36, 0.81; and OR, 0.41; 95% CI, 0.26, 0.64, respectively).", {"entities": []}], ["Poorly controlled blood pressure is an important public health concern among hypertensive patients in this region.", {"entities": []}], ["Elderly patients, those with diabetes, and those on multidrug regimens are at higher risk for poor blood pressure control and warrant closer attention.", {"entities": []}], ["Mucosa-associated lymphoid tissue lymphoma is a common type of primary pulmonary carcinoma, but the presence of polypoid nodules is extremely rare.", {"entities": [[81, 90, "DISEASE"], [34, 42, "DISEASE"]]}], ["We herein report two cases with multiple nodules in the trachea.", {"entities": []}], ["One case involved polypoid nodules and airway stenosis mimicking asthma; the other case had concurrent nontuberculous mycobacterial infection.", {"entities": [[65, 71, "DISEASE"]]}], ["The diagnosis of both cases was confirmed by bronchoscopy.", {"entities": []}], ["The two cases were sensitive to radiotherapy and chemotherapy, respectively.", {"entities": []}], ["Evidence of epidemiological associations of vitamins and disease states have been found for nine vitamins.", {"entities": []}], ["In observational studies, people with a high intake of antioxidant vitamins by regular diet or as food supplements generally have a lower risk of major chronic disease, such as myocardial infarction or stroke, than people who are low consumers of antioxidant vitamins.", {"entities": [[177, 198, "DISEASE"]]}], ["Prospectively, folate appears to reduce the incidence of neural tube defects.", {"entities": []}], ["Vitamin D is associated with a decreased occurrence of fractures when taken with calcium.", {"entities": []}], ["Zinc, betacarotene, and vitamin E appear to slow the progression of macular degeneration, but do not reduce the incidence.", {"entities": [[68, 88, "DISEASE"]]}], ["Vitamin E and lycopene may decrease the risk of prostate cancer.", {"entities": [[57, 63, "DISEASE"], [48, 63, "DISEASE"]]}], ["In other randomized controlled trials, the apparent beneficial results of a high intake of antioxidant vitamins seen in observational studies have not been confirmed.", {"entities": []}], ["There is increasing concern from these trials that pharmacological supplementation of vitamins may be associated with a higher mortality risk.", {"entities": []}], ["With the advent of genome-wide association (GWA) studies, researchers are hoping that reliable genetic association of common human complex diseases/traits can be detected.", {"entities": []}], ["Currently, there is an increasing enthusiasm about GWA and a number of GWA studies have been published.", {"entities": []}], ["In the field a common practice is that replication should be used as the gold standard to validate an association finding.", {"entities": []}], ["In this article, based on empirical and theoretical data, we emphasize that replication of GWA findings can be quite difficult, and should not always be expected, even when true variants are identified.", {"entities": []}], ["The probability of replication becomes smaller with the increasing number of independent GWA studies if the power of individual replication studies is less than 100% (which is usually the case), and even a finding that is replicated may not necessarily be true.", {"entities": []}], ["We argue that the field may have unreasonably high expectations on success of replication.", {"entities": []}], ["We also wish to raise the question whether it is sufficient or necessary to treat replication as the ultimate and gold standard for defining true variants.", {"entities": []}], ["We finally discuss the usefulness of integrating evidence from multiple levels/sources such as genetic epidemiological studies (at the DNA level), gene expression studies (at the RNA level), proteomics (at the protein level), and follow-up molecular and cellular studies for eventual validation and illumination of the functional relevance of the genes uncovered.", {"entities": []}], ["Moringa stenopetala has been used in traditional health systems to treat diabetes mellitus.", {"entities": [[73, 90, "DISEASE"]]}], ["The aim of this study was to investigate the antidiabetic activity of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves in streptozotocin (STZ) induced diabetic rats.", {"entities": []}], ["The aqueous ethanol extract and n-butanol fraction of Moringa stenopetala leaves hydroalcoholic (500\u00a0mg/kg body weight) and metformin (150\u00a0mg/kg body weight) were administered to diabetic rats.", {"entities": []}], ["Blood glucose, lipid profiles, liver and kidney function were examined after 14\u00a0days of experiment.", {"entities": []}], ["Histopathological profile of the pancreas was also observed in diabetic rats at the end of study.", {"entities": []}], ["An oral sucrose challenge test was also carried out to assess the post prandial effect of the extract.", {"entities": []}], ["Oral administration of the aqueous ethanol and n-butanol extracts of Moringa stenopetala leaves (500\u00a0mg/kg body weight) and metformin (150\u00a0mg/kg) significantly reduced blood glucose level (P\u2009<\u20090.05), improved serum lipid profiles, liver enzymes and kidney functions in diabetic rats after 14\u00a0days.", {"entities": []}], ["The extracts also improved damage of islet of Langerhan\u2019s in diabetic rats.", {"entities": []}], ["The plant material reduced the post-prandial glucose level (P\u2009<\u20090.001) at the dose of 750\u00a0mg/kg.", {"entities": []}], ["These findings revealed that both the aqueous ethanol and n-butanol extracts of Moringa stenopetala leaves possess antihyperglycemic and antihyperlipidemic properties, and alleviate STZ-induced pancreatic damage in diabetic rats.", {"entities": []}], ["The beneficial effects of plant material in inhibition of diabetes-induced complications are being investigated.", {"entities": []}], ["Samsoeum (SSE), a traditional herbal formula, has been widely used to treat cough, fever, congestion, and emesis for centuries.", {"entities": []}], ["Recent studies have demonstrated that SSE retains potent pharmacological efficiency in anti-allergic and anti-inflammatory reactions.", {"entities": []}], ["However, the anti-cancer activity of SSE and its underlying mechanisms have not been studied.", {"entities": [[18, 24, "DISEASE"]]}], ["Thus, the present study was designed to determine the effect of SSE on cell death and elucidate its detailed mechanism.", {"entities": []}], ["Following SSE treatment, cell growth and cell death were measured using an MTT assay and trypan blue exclusion assay, respectively.", {"entities": []}], ["Cell cycle arrest and YO-PRO-1 uptake were assayed using flow cytometry, and LC3 redistribution was observed using confocal microscope.", {"entities": []}], ["The mechanisms of anti-cancer effect of SSE were investigated through western blot analysis.", {"entities": [[23, 29, "DISEASE"]]}], ["We initially found that SSE caused dose- and time-dependent cell death in cancer cells but not in normal primary hepatocytes.", {"entities": [[74, 80, "DISEASE"]]}], ["In addition, during early SSE treatment (6\u201312\u00a0h), cells were arrested in G 2 /M phase concomitant with up-regulation of p21 and p27 and down-regulation of cyclin D1 and cyclin B1, followed by an increase in apoptotic YO-PRO-1 (+) cells.", {"entities": []}], ["SSE also induced autophagy via up-regulation of Beclin-1 expression, conversion of microtubule-associated protein light chain 3 (LC3) I to LC3-II, and re-distribution of LC3, indicating autophagosome formation.", {"entities": []}], ["Moreover, the level of B-cell lymphoma 2 (Bcl-2), which is critical for cross-talk between apoptosis and autophagy, was significantly reduced in SSE-treated cells.", {"entities": [[30, 38, "DISEASE"]]}], ["Phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) was increased, followed by suppression of the protein kinase B/mammalian target of rapamycin (Akt/mTOR) pathway, and phosphorylation of mitogen-activated protein kinases (MAPKs) in response to SSE treatment.", {"entities": []}], ["In particular, among MAPKs inhibitors, only the c-Jun N-terminal kinase (JNK)-specific inhibitor SP600125 nearly blocked SSE-induced increases in Beclin-1, LC3-II, and Bax expression and decreases in Bcl-2 expression, indicating that JNK activation plays critical role in cell death caused by SSE.", {"entities": [[168, 171, "GENE"]]}], ["These findings suggest that SSE efficiently induces cancer cell death via apoptosis as well as autophagy through modification of the Akt/mTOR and JNK signaling pathways.", {"entities": [[52, 58, "DISEASE"]]}], ["SSE may be as a potent traditional herbal medicine for treating malignancies.", {"entities": []}], ["Standardized means to identify patients likely to benefit from language assistance are needed.", {"entities": []}], ["To evaluate the accuracy of the U.S. Census English proficiency question (Census-LEP) in predicting patients\u2019 ability to communicate effectively in English.", {"entities": []}], ["We investigated the sensitivity and specificity of the Census-LEP alone or in combination with a question on preferred language for medical care for predicting patient-reported ability to discuss symptoms and understand physician recommendations in English.", {"entities": []}], ["Three hundred and two patients > 18 who spoke Spanish and/or English recruited from a cardiology clinic and an inpatient general medical-surgical ward in 2004\u20132005.", {"entities": []}], ["One hundred ninety-eight (66%) participants reported speaking English less than \u201cvery well\u201d and 166 (55%) less than \u201cwell\u201d; 157 (52%) preferred receiving their medical care in Spanish.", {"entities": []}], ["Overall, 135 (45%) were able to discuss symptoms and 143 (48%) to understand physician recommendations in English.", {"entities": []}], ["The Census-LEP with a high-threshold (less than \u201cvery well\u201d) had the highest sensitivity for predicting effective communication (100% Discuss; 98.7% Understand), but the lowest specificity (72.6% Discuss; 67.1% Understand).", {"entities": []}], ["The composite measure of Census-LEP and preferred language for medical care provided a significant increase in specificity (91.9% Discuss; 83.9% Understand), with only a marginal decrease in sensitivity (99.4% Discuss; 96.7% Understand).", {"entities": []}], ["Using the Census-LEP item with a high-threshold of less than \u201cvery well\u201d as a screening question, followed by a language preference for medical care question, is recommended for inclusive and accurate identification of patients likely to benefit from language assistance.", {"entities": []}], ["(246 words)", {"entities": []}], ["Current COPD guidelines advocate a fixed < 0.70 FEV1/FVC cutpoint to define airflow obstruction.", {"entities": []}], ["We compared rate of lung function decline in respiratory symptomatic 40+ subjects who were 'obstructive' or 'non-obstructive' according to the fixed and/or age and gender specific lower limit of normal (LLN) FEV1/FVC cutpoints.", {"entities": []}], ["We studied 3,324 respiratory symptomatic subjects referred to primary care diagnostic centres for spirometry.", {"entities": []}], ["The cohort was subdivided into four categories based on presence or absence of obstruction according to the fixed and LLN FEV1/FVC cutpoints.", {"entities": []}], ["Postbronchodilator FEV1 decline served as primary outcome to compare subjects between the respective categories.", {"entities": []}], ["918 subjects were obstructive according to the fixed FEV1/FVC cutpoint; 389 (42%) of them were non-obstructive according to the LLN cutpoint.", {"entities": []}], ["In smokers, postbronchodilator FEV1 decline was 21 (SE 3) ml/year in those non-obstructive according to both cutpoints, 21 (7) ml/year in those obstructive according to the fixed but not according to the LLN cutpoint, and 50 (5) ml/year in those obstructive according to both cutpoints (p = 0.004).", {"entities": []}], ["This study showed that respiratory symptomatic 40+ smokers and non-smokers who show FEV1/FVC values below the fixed 0.70 cutpoint but above their age/gender specific LLN value did not show accelerated FEV1 decline, in contrast with those showing FEV1/FVC values below their LLN cutpoint.", {"entities": []}], ["Little is known about asthma control in adolescents who were exposed to the World Trade Center (WTC) attacks of 11 September 2001 and diagnosed with asthma after 9/11.", {"entities": [[22, 28, "DISEASE"], [149, 155, "DISEASE"]]}], ["This report examines asthma and asthma control 10\u201311 y after 9/11 among exposed adolescents.", {"entities": [[21, 27, "DISEASE"], [32, 38, "DISEASE"]]}], ["The WTC Health Registry adolescent Wave 3 survey (2011\u20132012) collected data on asthma diagnosed by a physician after 11 September 2001, extent of asthma control based on modified National Asthma Education and Prevention Program criteria, probable mental health conditions, and behavior problems.", {"entities": [[79, 85, "DISEASE"], [146, 152, "DISEASE"], [188, 194, "DISEASE"]]}], ["Parents reported healthcare needs and 9/11-exposures.", {"entities": []}], ["Logistic regression was used to evaluate associations between asthma and level of asthma control and 9/11-exposure, mental health and behavioral problems, and unmet healthcare needs.", {"entities": [[62, 68, "DISEASE"], [82, 88, "DISEASE"]]}], ["Poorly/very poorly controlled asthma was significantly associated with a household income of \u2264$75,000 (adjusted odds ratio (AOR): 3.0; 95% confidence interval (CI): 1.1\u20138.8), having unmet healthcare needs (AOR: 6.2; 95% CI: 1.4\u201327.1), and screening positive for at least one mental health condition (AOR: 5.0; 95% CI: 1.4\u201317.7), but not with behavioral problems.", {"entities": [[30, 36, "DISEASE"]]}], ["The impact of having at least one mental health condition on the level of asthma control was substantially greater in females than in males.", {"entities": [[74, 80, "DISEASE"]]}], ["Comprehensive care of post-9/11 asthma in adolescents should include management of mental health-related comorbidities.", {"entities": [[32, 38, "DISEASE"]]}], ["Determine what clinical role, if any, GM-CSF may have in the clinical treatment of sepsis in the adult patient.", {"entities": []}], ["Advancements in the management of sepsis have led to significant decreases in early mortality; however, sepsis remains a significant source of long-term mortality and disability which places strain on healthcare resources with a substantial growing economic impact.", {"entities": []}], ["Historically, early multiple organ failure (MOF) and death in patients with severe sepsis was thought to result from an exaggerated proinflammatory response called the systemic inflammatory response syndrome (SIRS).", {"entities": [[199, 207, "DISEASE"]]}], ["Numerous prospective randomized controlled trials (PRCTs) tested therapies aimed at decreasing the organ injury associated with an exaggerated inflammatory response.", {"entities": []}], ["With few exceptions, the results from these PRCTs have been disappointing, and currently no specific therapeutic agent is approved to counteract the early SIRS response in patients with severe sepsis.", {"entities": []}], ["It has long been recognized that there is a delayed immunosuppressive state that contributes to long-term morbidity.", {"entities": []}], ["However, recent findings now support a concurrent proinflammatory and anti-inflammatory response present throughout sepsis.", {"entities": []}], ["Multiple immunomodulating agents have been studied to combat the immunosuppressive phase of sepsis with the goal of decreasing secondary infection, reducing organ dysfunction, decreasing ICU stays, and improving survival.", {"entities": []}], ["Granulocyte-macrophage colony stimulating factor (GM-CSF), a myelopoietic growth factor currently used in patients with neutropenia secondary to chemotherapy-induced myelosuppression, has been studied as a potential immune-activating agent.", {"entities": [[120, 131, "DISEASE"]]}], ["The applicability of GM-CSF as a standard therapy for generalized sepsis is still largely understudied; however, small-scale studies available have demonstrated some improved recovery from infection, decreased hospital length of stay, decreased days requiring mechanical ventilation, and decreased medical costs.", {"entities": []}], ["Chronic inflammatory diseases (CID) are globally highly prevalent and characterized by severe pathological medical conditions.", {"entities": []}], ["Several trials were conducted aiming at measuring the effects of manipulative therapies on patients affected by CID.", {"entities": []}], ["The purpose of this review was to explore the extent to which osteopathic manipulative treatment (OMT) can be benefi-cial in medical conditions also classified as CID.", {"entities": []}], ["This review included any type of experimental study which enrolled sub-jects with CID comparing OMT with any type of control procedure.", {"entities": []}], ["The search was conducted on eight databases in January 2014 using a pragmatic literature search approach.", {"entities": []}], ["Two independent re-viewers conducted study selection and data extraction for each study.", {"entities": []}], ["The risk of bias was evaluated according to the Cochrane methods.", {"entities": []}], ["Heterogeneity was assessed and meta-analysis performed where possible.", {"entities": []}], ["10 studies met the inclusion criteria for this review enrolling 386 subjects.", {"entities": []}], ["The search identified six RCTs, one laboratory study, one cross-over pilot studies, one observation-al study and one case control pilot study.", {"entities": []}], ["Results suggest a potential effect of osteopathic medicine on patients with medical pathologies associated with CID (in particular Chronic Obstructive Pul-monary Disease (COPD), Irritable Bowel Syndrome, Asthma and Peripheral Arterial Disease) com-pared to no treatment or sham therapy although data remain elusive.", {"entities": []}], ["Moreover one study showed possible effects on arthritis rat model.", {"entities": [[46, 55, "DISEASE"]]}], ["Meta-analysis was performed for COPD studies only show-ing no effect of any type of OMT applied versus control.", {"entities": []}], ["No major side effects were reported by those receiving OMT.", {"entities": []}], ["The present systematic review showed inconsistent data on the effect of OMT in the treatment of medical conditions potentially associated with CID, however the OMT appears to be a safe approach.", {"entities": []}], ["Further more robust trials are needed to determine the direction and magnitude of the effect of OMT and to generalize favorable results.", {"entities": []}], ["Pregnancy-associated deaths are extremely rare in Germany.", {"entities": []}], ["Most deaths are from natural causes, and a range of causes are possible.", {"entities": []}], ["The deaths of 22 women who died of pregnancy-associated causes and who were autopsied in the Institute of Forensic Medicine of Justus-Liebig University Gie\u00dfen between 1992 and 2016 were analyzed.", {"entities": []}], ["The autopsy results and histological examinations for the majority of women who died of pregnancy-associated causes between 1992 and 2016 showed that they had died of natural causes, although complications of pregnancy were a leading cause of death.", {"entities": []}], ["The death of a pregnant woman should not automatically raise the suspicion of malpractice, although the question does arise in cases of bleeding complications only detected at very late stages.", {"entities": []}], ["Experts must prove that a real mistake was made during treatment and provide evidence of the causality between malpractice and patient death.", {"entities": []}], ["Particularly when well-known complications of pregnancy were present, this is only the case if poor monitoring resulted in the complication being detected too late or if treatment was not in accordance with accepted standards of care.", {"entities": []}], ["The majority of pregnancy-associated deaths are from natural causes and the death of a pregnant woman does not mean that medical malpractice was involved, although this accusation is often levelled in cases where rupture was not immediately diagnosed or in cases of fatal postpartum hemorrhage.", {"entities": []}], ["Hintergrund Schwangerschaftsassoziierte Todesf\u00e4lle sind in Deutschland sehr selten.", {"entities": []}], ["Zu erwarten ist ein differenziertes Todesursachenspektrum, es dominieren nat\u00fcrliche Todesursachen.", {"entities": []}], ["Keinesfalls bedeutet ein schwangerschaftsassoziierter Todesfall, dass Behandlungsfehlervorw\u00fcrfe begr\u00fcndet sind.", {"entities": []}], ["Methodik Analysiert wurde die in den Jahren 1992 bis 2016 im Institut f\u00fcr Rechtsmedizin der Justus-Liebig-Universit\u00e4t Giessen obduzierten schwangerschaftsassoziierten Todesf\u00e4lle.", {"entities": []}], ["Ergebnisse Bei der Mehrzahl der pr\u00e4sentierten 22\u2009Todesf\u00e4lle aus den Jahren 1992 bis 2016 im Zusammenhang mit einer Schwangerschaft konnten im Wege der Obduktion und nachfolgender insbesondere histologischer Untersuchungen nat\u00fcrliche Todesursachen nachgewiesen werden, auch wenn der Schwangerschaft eine krankheitsausl\u00f6sende Wirkung zukommt.", {"entities": []}], ["Schlussfolgerung Keineswegs muss die Tatsache des Todeseintritts automatisch einen Behandlungsfehlerverdacht induzieren, dies ist jedoch vor allem bei aufgetretenen und teilweise relativ sp\u00e4t erkannten Blutungskomplikationen der Fall.", {"entities": [[46, 49, "GENE"]]}], ["Gutachterlich muss dann der Behandlungsfehler als solches ebenso substanziiert dargelegt werden wie dessen Kausalit\u00e4t f\u00fcr den Todeseintritt.", {"entities": []}], ["Dies ist gerade bei bekannten und nicht ausschlie\u00dfbaren Komplikationen einer Schwangerschaft nur m\u00f6glich, wenn mangelhafte Kontrolle zu einem versp\u00e4teten Erkennen der Komplikation gef\u00fchrt hat oder auf eine Komplikation nicht lege artis reagiert wurde.", {"entities": []}], ["This study evaluated the action of Pfaffia paniculata K., Juglans regia L., and Rosmarius officinalis L. extracts against planktonic form and biofilm of Klebsiella pneumoniae (ATCC 4352).", {"entities": []}], ["Minimum inhibitory concentration (MIC) and minimum microbicidal concentration (MMC) values were determined for each extract by microdilution broth method, according to Clinical and Laboratory Standards Institute.", {"entities": []}], ["Next, antimicrobial activity of the extracts on biofilm was analyzed.", {"entities": []}], ["For this, standardized suspension at 10 K. pneumoniae was distributed into 96-well microplates ( n = 10) and after 48\u2009h at 37\u00b0C and biofilm was subjected to treatment for 5\u2009min with the extracts at a concentration of 200\u2009mg/mL.", {"entities": []}], ["ANOVA and Tukey tests (5%) were used to verify statistical significant reduction ( p < 0.05) of planktonic form and biofilm .", {"entities": []}], ["P paniculata K., R. officinalis L., and J. regia L. showed reductions in biomass of 55.6, 58.1, and 18.65% and cell viability reduction of 72.4, 65.1, and 31.5%, respectively.", {"entities": []}], ["The reduction obtained with P. paniculata and R. officinalis extracts was similar to the reduction obtained with chlorhexidine digluconate 2%.", {"entities": []}], ["In conclusion, all extracts have microbicidal action on the planktonic form but only P. paniculata K. and R. officinalis L. were effective against biofilm.", {"entities": []}], ["The combination of inhaled corticosteroids and long-acting \u03b2 2 -adrenoceptor agonists is increasingly used in chronic obstructive pulmonary disease (COPD).", {"entities": [[110, 147, "DISEASE"]]}], ["Recently, we have demonstrated that combination of salmeterol and fluticasone propionate (FP) additionally suppress the production of IL-8 by human monocyte.", {"entities": []}], ["In this study, the molecular mechanism behind the effectiveness of this combination therapy is investigated in human neutrophils.", {"entities": []}], ["Human neutrophils were preincubated with salmeterol or FP or the combination.", {"entities": []}], ["The amount of interleukin-8 (IL-8), elastase and matrix metalloproteinases (MMP)-2 and -9 releases, and reactive oxygen species (ROS) generation and expression of MAP kinase phosphatase (MKP-1) and glucocorticoid receptor (GR) were determined.", {"entities": []}], ["Cigarette smoke medium (CSM) induces an increased expression of CXC receptors and the production of ROS that may explain the strong production of IL-8 by neutrophils.", {"entities": []}], ["The expression of CXC receptors, the production of ROS, and the release of elastase and MMP-2 and -9 were not influenced by salmeterol, FP, or the combination.", {"entities": []}], ["Interestingly, the combination therapy had an additive suppressive effect on the CSM-induced production of IL-8.", {"entities": []}], ["The latter could be explained by an increased mRNA expression of MKP-1, the GR and an increased translocation of the GR to the nucleus.", {"entities": []}], ["This leads eventually to suppression of both the NF-\u03baB and MAPK pathways and, hence, to less IL-8 production by the neutrophil.", {"entities": []}], ["These data are in support for the use of a combination therapy in COPD patients.", {"entities": []}], ["Antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may present with pulmonary involvement ranging from mild to life-threatening disease such as diffuse alveolar hemorrhage.", {"entities": [[56, 66, "DISEASE"]]}], ["There is a paucity of information regarding morbidity outcomes for AAV subjects presenting with lung involvement.", {"entities": []}], ["This study determines the relationship between disease activity and damage in these subjects using the Birmingham Vasculitis Activity Score v 3 (BVAS 3) and Vasculitis Damage Index (VDI) respectively.", {"entities": [[114, 124, "DISEASE"], [157, 167, "DISEASE"]]}], ["151 patients with AAV were included with 59 presenting initially with pulmonary involvement.", {"entities": []}], ["The initial BVAS scores recorded at time of diagnosis were positively correlated with the final VDI scores at 24\u00a0months (p\u2009<\u20090.0001, rs\u2009=\u20090.5871).", {"entities": []}], ["No differences between BVAS and VDI scores were seen for both groups, however in the lung-involvement group only, BVAS scores were significantly higher at 6, 12 and 24\u00a0months whilst the VDI scores were significantly higher at 12 and 24\u00a0months.", {"entities": []}], ["Subjects presenting with pulmonary involvement had an increased likelihood for cardiovascular (OR 1.31, 95% CI 0.89, 1.54; p\u2009=\u20090.032) and renal (OR 1.32, 95% CI 1.22, 1.39; p\u2009=\u20090.005) involvement.", {"entities": []}], ["Subjects presenting with lung involvement with granulomatosis with polyangiitis and microscopic polyangiitis had 24-month VDI scores that were significantly higher (p\u2009=\u20090.027, p\u2009=\u20090.045), and more likely to develop pulmonary fibrosis (OR 1.79, 95% CI 1.48, 2.12; p\u2009<\u20090.001).", {"entities": [[215, 233, "DISEASE"]]}], ["AAV subjects with lung involvement at presentation had a higher disease activity and damage scores at 6, 12 and 24\u00a0months follow-up representing a considerable burden of disease despite improvement in overall survival due to the introduction of immunosuppressive therapy.", {"entities": []}], ["Genetic susceptibility to tobacco smoke might modify the effect of smoking on pregnancy outcomes.", {"entities": []}], ["We conducted a case\u2013control study of 543 women who delivered singleton live births in Kaunas (Lithuania), examining the association between low-level tobacco smoke exposure (mean: 4.8 cigarettes/day) during pregnancy, GSTT1 and GSTM1 polymorphisms and birthweight of the infant.", {"entities": [[218, 223, "GENE"], [228, 233, "GENE"]]}], ["Multiple linear-regression analysis was performed adjusting for gestational age, maternal education, family status, body mass index, blood pressure, and parity.", {"entities": []}], ["Subsequently, we tested for the interaction effect of maternal smoking, GSTT1 and GSTM1 genes polymorphisms with birthweight by adding all the product terms in the regression models.", {"entities": [[72, 77, "GENE"], [82, 87, "GENE"]]}], ["The findings suggested a birthweight reduction among light-smoking with the GSTT1\u2013null genotype (\u2212162.9 g, P = 0.041) and those with the GSTM1\u2013null genotype (\u2212118.7 g, P = 0.069).", {"entities": []}], ["When a combination of these genotypes was considered, birthweight was significantly lower for infants of smoking women the carriers of the double-null genotypes (\u2212311.2 g, P = 0.008).", {"entities": []}], ["The interaction effect of maternal smoking, GSTM1 and GSTT1 genotypes was marginally significant on birthweight (\u2212234.5 g, P = 0.078).", {"entities": [[44, 49, "GENE"], [54, 59, "GENE"]]}], ["Among non-smokers, genotype did not independently confer an adverse effect on infant birthweight.", {"entities": []}], ["The study shows the GSTT1\u2013null genotype, either presents only one or both with GSTM1\u2013null genotype in a single subject, have a modifying effect on birthweight among smoking women even though their smoking is low level.", {"entities": []}], ["Our data also indicate that identification of the group of susceptible subjects should be based on both environmental exposure and gene polymorphism.", {"entities": []}], ["Findings of this study add additional evidence on the interplay among two key GST genes and maternal smoking on birth weight of newborns.", {"entities": []}], ["Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network (SPSN) assessed interim 2016/17 influenza vaccine effectiveness (VE) against dominant influenza A(H3N2) viruses considered antigenically matched to the clade 3C.2a vaccine strain.", {"entities": [[118, 127, "DISEASE"], [172, 181, "DISEASE"]]}], ["Sequence analysis revealed substantial heterogeneity in emerging 3C.2a1 variants by province and over time.", {"entities": []}], ["Adjusted VE was 42% (95% confidence interval:\u200918\u201359%) overall, with variation by province.", {"entities": []}], ["Interim virological and VE findings reported here warrant further investigation to inform potential vaccine reformulation.", {"entities": []}], ["Common variable immunodeficiency is characterized by defective antibody production and recurrent pulmonary infections.", {"entities": []}], ["Intravenous immunoglobulin is the treatment of choice, but the effects of Intravenous immunoglobulin on pulmonary defense mechanisms are poorly understood.", {"entities": []}], ["The aim of this study was to verify the impact of intravenous immunoglobulin on the physical properties of the sputum and on inflammatory alterations in the airways of patients with Common variable immunodeficiency associated with bronchiectasis.", {"entities": [[231, 245, "DISEASE"]]}], ["The present study analyzed sputum physical properties, exhaled NO, inflammatory cells in the sputum, and IG titers in 7 patients with Common variable immunodeficiency and bronchiectasis with secretion, immediately before and 15 days after Intravenous immunoglobulin.", {"entities": [[171, 185, "DISEASE"]]}], ["A group of 6 patients with Common variable immunodeficiency and bronchiectasis but no sputum was also studied for comparison of the basal IgG level and blood count.", {"entities": [[64, 78, "DISEASE"]]}], ["The 13 patients were young (age=36\u00b117 years) and comprised predominantly of females (n=11).", {"entities": []}], ["Patients with secretion presented significantly decreased IgG and IgM levels.", {"entities": []}], ["Intravenous immunoglobulin was associated with a significant decrease in exhaled NO (54.7 vs. 40.1 ppb, p<0.05), sputum inflammatory cell counts (28.7 vs. 14.6 cells/mm We concluded that immunoglobulin administration in Common variable immunodeficiency patients results in significant improvement in indexes of inflammation of the airways with improvement in the transportability of the respiratory mucus by cough.", {"entities": []}], ["We performed a comparative literature review, to elucidate the major features of the Takotsubo (stress) cardiomyopathy (TCM) collected in last 25 years.", {"entities": [[104, 118, "DISEASE"]]}], ["TCM is characterized by left- or biventricular apical ballooning with a clinical presentation, electrocardiographic abnormalities, and biomarker profils similar to those seen in acute myocardial infarction.", {"entities": [[184, 205, "DISEASE"], [178, 205, "DISEASE"]]}], ["Epidemiological studies have shown that TCM is more common in postmenopausal women; however exact figures are not available.", {"entities": []}], ["The underlying aetiology is still largely undetermined.", {"entities": []}], ["Elevated catecholamine levels, lack of estrogen, disturbed myocardial fatty acid metabolism and plaque rupture with spontaneous thrombolysis are potentially discussed mechanisms responsible for inducing a prolonged stunned myocardium.", {"entities": []}], ["Strong emotional or physical stress is the most frequently described trigger in the literature.", {"entities": []}], ["Therapy recommendations include appropriate antiplatelet treatment, \u03b2-blockers and ACE inhibitors.", {"entities": []}], ["The abnormal kinetics usually resolve or improve within a month and carry a favorable prognosis in most cases.", {"entities": []}], ["However, all the suspected complications of an acute myocardial infarction, including cardiogenic shock or lethal arrhythmias, may still occur.", {"entities": [[53, 74, "DISEASE"], [47, 74, "DISEASE"]]}], ["The Federal Panel on Formaldehyde concluded that definitive experiments exist which demonstrate the mutagenicity and carcinogenicity of formaldehyde under laboratory conditions.", {"entities": []}], ["Formaldehyde induces both gene mutations and chromosomal aberrations in a variety of test systems.", {"entities": []}], ["Inhalation of formaldehyde causes cancer of the nose in rats.", {"entities": [[34, 40, "DISEASE"]]}], ["The concentrations of formaldehyde in inhaled air that caused nasal cancer in Fisher 344 rats are within the same order of magnitude as those to which humans may be exposed.", {"entities": [[68, 74, "DISEASE"]]}], ["The data presently available do not permit a direct assessment of the carcinogenicity of formaldehyde to man.", {"entities": []}], ["Epidemiologic studies on exposed human populations are in progress and may further clarify the situation.", {"entities": []}], ["Other experimental and human studies on toxic effects such as teratogenicity and reproductive disorders are as yet inadequate for a health risk assessment.", {"entities": []}], ["The CIIT 24 month study on animal carcinogenicity has not yet been completely evaluated.", {"entities": []}], ["Additional data are expected on the effects of prolonged exposure to lower doses of formaldehyde and on the possible carcinogenicity of formaldehyde in the mouse.", {"entities": []}], ["The panel recommends that, for a comprehensive health risk assessment, further experiments be conducted on the effects of other modes of exposure (ingestion and skin penetration), the effects in humans, and on the pharmacokinetics of formaldehyde in man and animals and the possible role for formaldehyde in reproductive and chronic respiratory disorders.", {"entities": []}], ["It is the conclusion of the panel that formaldehyde should be presumed to pose a carcinogenic risk to humans.", {"entities": []}], ["To study the activation of macrophage and upregulation of costimulatory molecule of CD40 in lipopolysaccharide- (LPS-) induced acute lung injury (ALI) model, and to investigate the pathogenecy of ALI, mice were randomly divided into two groups.", {"entities": [[84, 88, "GENE"]]}], ["ALI model was created by injecting 0.2\u2009mg/kg LPS in phosphate saline (PBS) in trachea.", {"entities": []}], ["The pathologic changes of mice lungs were observed by HE staining at 24 and 48 hours after LPS treatment, then the alveolar septum damage, abnormal contraction, alveolar space hyperemia, and neutrophils or other inflammatory cells infiltration in the LPS group, but not in the control group, were observed.", {"entities": []}], ["The expression of CD40 mRNA and CD40 protein molecules were higher in LPS group as compared to the control group by Northern blot and flow cytometry, respectively.", {"entities": [[18, 22, "GENE"], [32, 36, "GENE"], [18, 22, "GENE"], [32, 36, "GENE"]]}], ["Expression of Toll-like receptor-4 (TLR4) in activated macrophage (AM\u03a6) was higher in LPS group as compared to the control group by RT-PCR.", {"entities": [[36, 40, "GENE"]]}], ["The activation of NF- \u03ba B binding to NF- \u03ba B consensus oligos increased in LPS group by EMSA in macrophage.", {"entities": []}], ["The concentrations of TNF- \u03b1 , MIP-2, and IL-1 \u03b2 cytokines from bronchoalveolar lavage fluid (BALF) were increased significantly in LPS group as compared to the control group by ELISA.", {"entities": []}], ["The activation of AM and upregulation of costimulatory molecule CD40 induced all kinds of inflammatory cytokines releasing, then led to ALI.", {"entities": [[64, 68, "GENE"]]}], ["Therefore, both of them played vital role in the process of development of ALI.", {"entities": []}], ["The term \u2018emphysema\u2019 is generally used in a morphological sense, and therefore imaging modalities have an important role in diagnosing this disease.", {"entities": []}], ["In particular, high resolution computed tomography (HRCT) is a reliable tool for demonstrating the pathology of emphysema, even in subtle changes within secondary pulmonary lobules.", {"entities": []}], ["Generally, pulmonary emphysema is classified into three types related to the lobular anatomy: centrilobular emphysema, panlobular emphysema, and paraseptal emphysema.", {"entities": [[11, 30, "DISEASE"]]}], ["In this pictorial review, we discuss the radiological \u2013 pathological correlation in each type of pulmonary emphysema.", {"entities": [[97, 116, "DISEASE"]]}], ["HRCT of early centrilobular emphysema shows an evenly distributed centrilobular tiny areas of low attenuation with ill-defined borders.", {"entities": []}], ["With enlargement of the dilated airspace, the surrounding lung parenchyma is compressed, which enables observation of a clear border between the emphysematous area and the normal lung.", {"entities": []}], ["Because the disease progresses from the centrilobular portion, normal lung parenchyma in the perilobular portion tends to be preserved, even in a case of far-advanced pulmonary emphysema.", {"entities": [[167, 186, "DISEASE"]]}], ["In panlobular emphysema, HRCT shows either panlobular low attenuation or ill-defined diffuse low attenuation of the lung.", {"entities": []}], ["Paraseptal emphysema is characterized by subpleural well-defined cystic spaces.", {"entities": []}], ["Recent topics related to imaging of pulmonary emphysema will also be discussed, including morphometry of the airway in cases of chronic obstructive pulmonary disease, combined pulmonary fibrosis and pulmonary emphysema, and bronchogenic carcinoma associated with bullous lung disease.", {"entities": [[237, 246, "DISEASE"], [128, 165, "DISEASE"], [36, 55, "DISEASE"], [199, 218, "DISEASE"], [176, 194, "DISEASE"], [224, 246, "DISEASE"], [271, 283, "DISEASE"]]}], ["In a previous study, we demonstrated that asthma patients with signs of emphysema on quantitative computed tomography (CT) fulfill the diagnosis of asthma-COPD overlap syndrome (ACOS).", {"entities": [[168, 176, "DISEASE"], [42, 48, "DISEASE"], [148, 154, "DISEASE"]]}], ["However, quantitative CT measurements of emphysema are not routinely available for patients with chronic airway disease, which limits their application.", {"entities": []}], ["Spirometry was a widely used examination tool in clinical settings and shows emphysema as a sharp angle in the maximum expiratory flow volume (MEFV) curve, called the \u201cangle of collapse (AC)\u201d.", {"entities": [[143, 147, "GENE"]]}], ["The aim of this study was to investigate the value of the AC in the diagnosis of emphysema and ACOS.", {"entities": []}], ["This study included 716 participants: 151 asthma patients, 173 COPD patients, and 392 normal control subjects.", {"entities": [[42, 48, "DISEASE"]]}], ["All the participants underwent pulmonary function tests.", {"entities": []}], ["COPD and asthma patients also underwent quantitative CT measurements of emphysema.", {"entities": [[9, 15, "DISEASE"]]}], ["The AC was measured using computer models based on Matlab software.", {"entities": []}], ["The value of the AC in the diagnosis of emphysema and ACOS was evaluated using receiver-operating characteristic (ROC) curve analysis.", {"entities": []}], ["The AC of COPD patients was significantly lower than that of asthma patients and control subjects.", {"entities": [[61, 67, "DISEASE"]]}], ["The AC was significantly negatively correlated with emphysema index (EI; r =\u22120.666, P <0.001), and patients with high EI had a lower AC than those with low EI.", {"entities": []}], ["The ROC curve analysis showed that the AC had higher diagnostic efficiency for high EI (area under the curve =0.876) than did other spirometry parameters.", {"entities": []}], ["In asthma patients, using the AC \u2264137\u00b0 as a surrogate criterion for the diagnosis of ACOS, the sensitivity and specificity were 62.5% and 89.1%, respectively.", {"entities": [[3, 9, "DISEASE"]]}], ["The AC on the MEFV curve quantified by computer models correlates with the extent of emphysema.", {"entities": [[14, 18, "GENE"]]}], ["The AC may become a surrogate marker for the diagnosis of emphysema and help to diagnose ACOS.", {"entities": []}], ["Do men and women process and experience unpleasant bodily states differently?", {"entities": []}], ["We used fMRI to determine brain processing before, during and after an aversive respiratory stimulation.", {"entities": []}], ["No sex difference emerged during anticipation or stimulation.", {"entities": []}], ["However, after the offset of the stimulation, men but not women showed enhanced activation of brain regions that are important for interoception and reward processing.", {"entities": []}], ["Moreover, this activation was highest in those males who rated the preceding stimulation as most unpleasant.", {"entities": []}], ["These results indicate that men are particularly sensitive to reward associated with the termination of an aversive event, which may signal relief.", {"entities": []}], ["Dendritic cells (DCs) are the key initiators of T-helper (Th) 2 immune responses against the parasitic helminth Schistosoma mansoni .", {"entities": []}], ["Although the liver is one of the main sites of antigen deposition during infection with this parasite, it is not yet clear how distinct DC subtypes in this tissue respond to S. mansoni antigens in vivo , or how the liver microenvironment might influence DC function during establishment of the Th2 response.", {"entities": []}], ["In this study, we show that hepatic DC subsets undergo distinct activation processes in vivo following murine infection with S. mansoni .", {"entities": []}], ["Conventional DCs (cDCs) from schistosome-infected mice upregulated expression of the costimulatory molecule CD40 and were capable of priming naive CD4 in vivo depletion of pDCs revealed that this subset was dispensable for either maintenance or regulation of the hepatic Th2 effector response during acute S. mansoni infection.", {"entities": [[108, 112, "GENE"], [147, 150, "GENE"]]}], ["Our data provides strong evidence that S. mansoni infection favors the establishment of an immunogenic, rather than tolerogenic, liver microenvironment that conditions cDCs to initiate and maintain Th2 immunity in the context of ongoing antigen exposure.", {"entities": []}], ["It is known that respiratory muscles undergo adaptation in response to overload stimuli during exercise training in stable COPD patients, thus resulting in significant increase of respiratory muscle function as well as the individual\u2019s improvements.", {"entities": []}], ["The present article reviews the most updated evidence with regard to the use of respiratory muscle training (RMT) methods in COPD patients.", {"entities": []}], ["Basically, three types of RMT (resistive training, pressure threshold loading, and normocapnic hyperpnea) have been reported.", {"entities": []}], ["Frequency, duration, and intensity of exercise must be carefully considered for a training effect.", {"entities": []}], ["In contrast with the plentitude of existing data inherent to inspiratory muscle training (IMT), literature is still lacking in showing clinical and physiological studies related to expiratory muscle training (EMT).", {"entities": []}], ["In particular, while it seems that IMT is slightly superior to EMT in providing additional benefits other than respiratory muscle function such as a reduction in dyspnea, both the effects and the safety of EMT is still to be definitively elucidated in patients with COPD.", {"entities": []}], ["In North America and other industrialized countries, heart failure (HF) has become a national public health priority.", {"entities": []}], ["Studies indicate there is significant heterogeneity in approaches to treat and manage HF and suggest targeted changes in health care delivery are needed to reduce unnecessary health care utilization and to optimize patient outcomes.", {"entities": []}], ["Most recent published studies have reported on the care of HF patients in tertiary care hospitals and the perspective of non-specialist stakeholders on HF management, such as general practitioners and clinics or hospital administrators is rarely considered.", {"entities": []}], ["This study explores the current state of community-based HF care in Canada as experienced by various healthcare stakeholders providing or coordinating care to HF patients.", {"entities": []}], ["This study employed a qualitative exploratory research design consisting of semi-structured telephone interviews conducted with health care providers and health care administrators working outside of tertiary care in the four most populous Canadian provinces.", {"entities": []}], ["A modified thematic analysis process was used and the different data sources were triangulated.", {"entities": []}], ["Findings were collectively interpreted by the authors.", {"entities": []}], ["Twenty-eight participants were recruited in the study: eight cardiologists, five general practitioners/family physicians, eight nurse practitioners/registered nurses, four hospital pharmacists and three health care administrators/directors.", {"entities": []}], ["Participants reported a lack of stakeholder engagement throughout the continuum of care, which hinders the implementation of a coordinated approach to quality HF care.", {"entities": []}], ["Four substantive themes emerged that indicated challenges and gaps in the optimal treatment and management of HF in community settings: 1) challenges in the risk assessment and early diagnosis of HF, 2) challenges in ensuring efficient and consistent transition from acute care setting to the community, 3) challenges of primary care providers to optimally treat and manage HF patients, and 4) challenges in promoting a holistic approach in HF management.", {"entities": []}], ["As health systems evolve from tertiary-based care to community-based outpatient services for the management of chronic diseases, this study\u2019s findings pinpoint challenges that have been observed in the Canadian context and can stimulate and orient dialogue toward solutions for a more coordinated approach to improve the care of HF patients and reduce pressure on the healthcare system.", {"entities": []}], ["The impact of Obstructive sleep apnea (OSA) in worsening outcomes is profound, especially in the presence of comorbid conditions.", {"entities": []}], ["This study aimed to describe the proportion of patients at a high risk of OSA in our practice setting.", {"entities": []}], ["The STOP BANG questionnaire and the Epworth Sleepiness scale were used to assess for OSA risk and excessive daytime sleepiness respectively.", {"entities": []}], ["Hospitalized patients and out-patients were recruited.", {"entities": []}], ["Intergroup differences in continuous variables were compared using the analysis of variance.", {"entities": []}], ["The proportion of patients with high risk of OSA and excessive daytime sleepiness was presented as frequencies and group differences compared with the Pearson \u03c7 A total of 1100 patients (53.4% females) participated in the study.", {"entities": []}], ["Three hundred and ninety nine (36.3%) had a high risk of OSA, and 268 (24.4%) had excessive daytime sleepiness.", {"entities": []}], ["Of the participants with high OSA risk, 138 (34.6%) had excessive daytime sleepiness compared to 130 (18.5%) of those with low OSA risk (p).", {"entities": []}], ["A significant proportion of patients attending our tertiary care center are at high risk of OSA.", {"entities": []}], ["Synthesis of IL-1\u03b2 and TNF\u03b1 by human monocytesmacrophages was significantly inhibited by eleven bisbenzylisoquinolines and one half-molecule (benzylisoquinoline), with IC 50 values in the \u03bcM range.", {"entities": []}], ["The results indicate that these compounds may have value in the therapy of human diseases where these inflammatory cytokines have a central role in pathogenesis.", {"entities": []}], ["Multiple sclerosis ( MS ) is a chronic and progressive disease that causes stress due to its unpredictability and lack of definitive treatments.", {"entities": []}], ["This study examined the effects of an educational program using a transactional model to help women with MS cope with their disease.", {"entities": []}], ["In a randomized clinical trial, 80 female patients from the MS Society of Iran were randomized to the intervention ( n \u00a0=\u00a040) or a control group ( n \u00a0=\u00a040).", {"entities": []}], ["Outcomes were assessed using Cohen's Perceived Stress Scale ( PSS ) and the Jalowiec Coping Scale ( JCS ), which were completed by both groups at baseline, 1\u00a0month, and 3\u00a0months after the intervention.", {"entities": []}], ["The intervention consisted of six educational sessions administered over 2\u00a0months based on a transactional model.", {"entities": []}], ["The data were analyzed using repeated measures ANOVA .", {"entities": []}], ["Average PSS scores decreased significantly over time in the intervention group, while increasing in the control group.", {"entities": []}], ["Between\u2010group differences were significant at both 1\u2010month and 3\u2010month follow\u2010up ( p \u00a0<\u00a0.001).", {"entities": []}], ["Both problem\u2010focused and emotion\u2010focused coping styles improved over time in use and effectiveness in the intervention group, whereas little or no change occurred in these coping behaviors in the control group.", {"entities": []}], ["The transactional model\u2010based education program tested here was successful in reducing stress levels and increasing healthy coping styles in women with MS .", {"entities": []}], ["If these findings are replicated in future studies, widespread adoption of this program may help women with MS cope more successfully with their disease.", {"entities": []}], ["Histone deacetylases (HDAC) are key enzymes in the epigenetic control of gene expression.", {"entities": []}], ["Recently, inhibitors of class I and class II HDAC have been successfully employed for the treatment of different inflammatory diseases such as rheumatoid arthritis, colitis, airway inflammation and asthma.", {"entities": [[143, 163, "DISEASE"], [154, 163, "DISEASE"], [198, 204, "DISEASE"]]}], ["So far, little is known so far about a similar therapeutic effect of inhibitors specifically directed against sirtuins, the class III HDAC.", {"entities": []}], ["In this study, we investigated the expression and localization of endogenous sirtuins in primary human dermal microvascular endothelial cells (HDMEC), a cell type playing a key role in the development and maintenance of skin inflammation.", {"entities": []}], ["We then examined the biological activity of sirtinol, a specific sirtuin inhibitor, in HDMEC response to pro-inflammatory cytokines.", {"entities": []}], ["We found that, even though sirtinol treatment alone affected only long-term cell proliferation, it diminishes HDMEC inflammatory responses to tumor necrosis factor (TNF)\u03b1 and interleukin (IL)-1\u03b2.", {"entities": [[165, 168, "GENE"]]}], ["In fact, sirtinol significantly reduced membrane expression of adhesion molecules in TNF\u00e3- or IL-1\u03b2-stimulated cells, as well as the amount of CXCL10 and CCL2 released by HDMEC following TNF\u03b1 treatment.", {"entities": [[143, 149, "GENE"], [154, 158, "GENE"]]}], ["Notably, sirtinol drastically decreased monocyte adhesion on activated HDMEC.", {"entities": []}], ["Using selective inhibitors for Sirt1 and Sirt2, we showed a predominant involvement of Sirt1 inhibition in the modulation of adhesion molecule expression and monocyte adhesion on activated HDMEC.", {"entities": [[31, 36, "GENE"], [87, 92, "GENE"], [41, 46, "GENE"], [31, 36, "GENE"], [87, 92, "GENE"]]}], ["Finally, we demonstrated the in vivo expression of Sirt1 in the dermal vessels of normal and psoriatic skin.", {"entities": [[51, 56, "GENE"]]}], ["Altogether, these findings indicated that sirtuins may represent a promising therapeutic target for the treatment of inflammatory skin diseases characterized by a prominent microvessel involvement.", {"entities": []}], ["The Dunedin Multidisciplinary Health and Development Study began more than four decades ago.", {"entities": []}], ["Unusual at the time, it was founded as a multidisciplinary research enterprise, and was strongly supported by the Dunedin community, both professional and lay, in its early years.", {"entities": []}], ["Seven research themes have evolved over the past 40\u00a0years focusing on mental health and neuro-cognition, cardiovascular risk, respiratory health, oral health, sexual and reproductive health, and psychosocial functioning.", {"entities": []}], ["A seventh, more applied theme, seeks to maximise the value of the Study findings for New Zealand\u2019s indigenous people\u2014M\u0101ori (or tangata whenua transl people of the land).", {"entities": []}], ["The study has published over 1200 papers and reports to date, with almost 2/3 of these being in peer-reviewed journals.", {"entities": []}], ["Here we provide an overview of the study, its history, leadership structure, scientific approach, operational foci, and some recent examples of work that illustrate the following: (a) the value of multidisciplinary data; (b) how the study is well positioned to address contemporary issues; and (c) how research can simultaneously address multiple audiences\u2014from researchers and theoreticians to policy makers and practitioners.", {"entities": []}], ["Near-future research plans are described, and we end by reflecting upon the core aspects of the study that portend future useful contributions.", {"entities": []}], ["Classification of lung carcinoids into typical and atypical is a diagnostic challenge since no immunohistochemical tools are available to support pathologists in distinguishing between the two subtypes.", {"entities": []}], ["A differential diagnosis is essential for clinicians to correctly discuss therapy, prognosis and follow-up with patients.", {"entities": []}], ["Indeed, the distinction between the two typical and atypical subtypes on biopsies/cytological specimens is still unfeasible and sometimes limited also after radical surgeries.", {"entities": []}], ["By comparing the gene expression profile of typical (TC) and atypical carcinoids (AC), we intended to find genes specifically expressed in one of the two subtypes that could be used as diagnostic markers.", {"entities": []}], ["Expression profiling, with Affymetrix arrays, was performed on six typical and seven atypical samples.", {"entities": []}], ["Data were validated on an independent cohort of 29 tumours, by means of quantitative PCR and immunohistochemistry (IHC).", {"entities": []}], ["High-throughput gene expression profiling was successfully used to identify a gene signature specific for atypical lung carcinoids.", {"entities": []}], ["Among the 273 upregulated genes in the atypical vs typical subtype, GC (vitamin D-binding protein) and CEACAM1 (carcinoembryonic antigen family member) emerged as potent diagnostic markers.", {"entities": [[68, 70, "GENE"], [103, 110, "GENE"]]}], ["Quantitative PCR and IHC on a validation set of 17 ACs and 12 TCs confirmed their reproducibility and feasibility.", {"entities": []}], ["GC and CEACAM1 can distinguish between TC and AC, defining an IHC assay potentially useful for routine cytological and histochemical diagnostic procedures.", {"entities": [[0, 2, "GENE"], [7, 14, "GENE"]]}], ["The high sensitivity and reproducibility of this new diagnostic algorithm strongly support a further validation on a wider sample size.", {"entities": []}], ["To compare the effect of vitamin K 2 and risedronate on trabecular bone in glucocorticoid (GC)-treated rats.", {"entities": [[91, 93, "GENE"]]}], ["Forty-eight Sprague-Dawley female rats, 3 months of age, were randomized by the stratified weight method into 5 groups according to the following treatment schedule: age-matched control, GC administration, and GC administration with concomitant administration of vitamin K 2 , risedronate, or vitamin K 2 + risedronate.", {"entities": [[187, 189, "GENE"], [210, 212, "GENE"], [187, 189, "GENE"], [210, 212, "GENE"]]}], ["GC (methylprednisolone sodium succinate, 5.0 mg/kg) and risedronate (10 \u00b5g/kg) were administered subcutaneously three and five times a week, respectively.", {"entities": [[0, 2, "GENE"]]}], ["Vitamin K 2 (menatetrenone, 30 mg/kg) was administered orally three times a week.", {"entities": []}], ["At the end of the 8-week experiment, bone histomorphometric analysis was performed on trabecular bone of the tibial proximal metaphysis.", {"entities": []}], ["GC administration decreased trabecular bone mass compared with age-matched controls because of decreased bone formation (mineralizing surface, mineral apposition rate, and bone formation rate) and increased bone erosion.", {"entities": [[0, 2, "GENE"]]}], ["Vitamin K 2 attenuated GC-induced trabecular bone loss by preventing GC-induced decrease in bone formation (mineralizing surface) and subsequently reducing GC-induced increase in bone erosion.", {"entities": []}], ["Risedronate prevented GC-induced trabecular bone loss by preventing GC-induced increase in bone erosion although it also suppressed bone formation (mineralizing surface, mineral apposition rate, and bone formation rate).", {"entities": []}], ["Vitamin K 2 mildly attenuated suppression of bone formation (mineralizing surface) and bone erosion caused by risedronate without affecting trabecular bone mass when administered in combination.", {"entities": []}], ["The present study showed differential effect of vitamin K 2 and risedronate on trabecular bone in GC-treated rats.", {"entities": []}], ["Cross-linkage of the high-affinity immunoglobulin E (IgE) receptor (Fc\u025bRI) on mast cells by antigen ligation has a critical role in the pathology of IgE-dependent allergic disorders, such as anaphylaxis and asthma.", {"entities": [[207, 213, "DISEASE"]]}], ["Restraint of intracellular signal transduction pathways that promote release of mast cell-derived pro-inflammatory mediators is necessary to dampen activation and restore homoeostasis.", {"entities": []}], ["Here we show that the ligase Nedd4-2 and the adaptor Ndfip1 (Nedd4 family interacting protein 1) limit the intensity and duration of IgE-Fc\u025bRI-induced positive signal transduction by ubiquitinating phosphorylated Syk, a tyrosine kinase that is indispensable for downstream Fc\u025bRI signalosome activity.", {"entities": [[53, 59, "GENE"], [29, 34, "GENE"], [61, 66, "GENE"], [213, 216, "GENE"]]}], ["Importantly, loss of Nedd4-2 or Ndfip1 in mast cells results in exacerbated and prolonged IgE-mediated cutaneous anaphylaxis in vivo .", {"entities": [[32, 38, "GENE"]]}], ["Our findings reveal an important negative regulatory function for Nedd4-2 and Ndfip1 in IgE-dependent mast cell activity.", {"entities": [[78, 84, "GENE"]]}], ["Aberrant activation of the IgE receptor on mast cells leads to allergic responses.", {"entities": []}], ["Here, the authors identify an E3 ligase and adaptor protein that can reduce IgE signalling by targeting phosphorylated-Syk for degradation.", {"entities": []}], ["Evidence suggests that optimism may be protective for health during times of heightened stress, yet the mechanisms involved remain unclear.", {"entities": []}], ["In a double-blind placebo-controlled study, we recently showed that acute psychological stress and an immune stimulus (Typhim-Vi typhoid vaccine) synergistically increased serum levels of interleukin-6 (IL-6) and negative mood in 59 healthy men.", {"entities": []}], ["Here we carried out further analysis of this sample to investigate the relationship between dispositional optimism and stress-induced changes in immunity and mood.", {"entities": []}], ["Volunteers were randomly assigned to one of four experimental conditions in which they received either typhoid vaccine or saline placebo, and then rested or completed two mental tasks.", {"entities": []}], ["In the stress condition, optimism was inversely related to IL-6 responses, independent of age, BMI, trait CES-D depression and baseline IL-6.", {"entities": []}], ["This relationship was present across both stress groups (combining vaccine and placebo) and was not present in the vaccine/stress group alone, suggesting that optimism protects against the inflammatory effects of stress rather than vaccine per se.", {"entities": []}], ["Typhoid vaccine induced a significant increase in participants\u2019 circulating anti-Vi antibody levels.", {"entities": []}], ["Stress had no effect on antibody responses overall.", {"entities": []}], ["However, in the vaccine/stress group, there was a strong positive association between optimism and antibody responses, indicating that stress accentuated the antibody response to vaccine in optimists.", {"entities": []}], ["Across the complete sample, more optimistic individuals had smaller increases in negative mood and less reduction in mental vigour.", {"entities": []}], ["Together these findings suggest that optimism may promote health, by counteracting stress-induced increases in inflammation and boosting the adjuvant effects of acute stress.", {"entities": []}], ["Several respiratory diseases are associated with specific respiratory sounds.", {"entities": []}], ["In contrast to auscultation, computerized lung sound analysis is objective and can be performed continuously over an extended period.", {"entities": []}], ["Moreover, audio recordings can be stored.", {"entities": []}], ["Computerized lung sounds have rarely been assessed in neonates during the first year of life.", {"entities": []}], ["This study was designed to determine and validate optimal cut-off values for computerized wheeze detection, based on the assessment by trained clinicians of stored records of lung sounds, in infants aged <1\u00a0year.", {"entities": []}], ["Lung sounds in 120 sleeping infants, of median (interquartile range) postmenstrual age of 51 (44.5\u201367.5) weeks, were recorded on 144 test occasions by an automatic wheeze detection device (PulmoTrack\u00ae).", {"entities": []}], ["The records were retrospectively evaluated by three trained clinicians blinded to the results.", {"entities": []}], ["Optimal cut-off values for the automatically determined relative durations of inspiratory and expiratory wheezing were determined by receiver operating curve analysis, and sensitivity and specificity were calculated.", {"entities": []}], ["The optimal cut-off values for the automatically detected durations of inspiratory and expiratory wheezing were 2% and 3%, respectively.", {"entities": []}], ["These cutoffs had a sensitivity and specificity of 85.7% and 80.7%, respectively, for inspiratory wheezing and 84.6% and 82.5%, respectively, for expiratory wheezing.", {"entities": []}], ["Inter-observer reliability among the experts was moderate, with a Fleiss\u2019 Kappa (95% confidence interval) of 0.59 (0.57-0.62) for inspiratory and 0.54 (0.52 - 0.57) for expiratory wheezing.", {"entities": []}], ["Computerized wheeze detection is feasible during the first year of life.", {"entities": []}], ["This method is more objective and can be more readily standardized than subjective auscultation, providing quantitative and noninvasive information about the extent of wheezing.", {"entities": []}], ["Inhalation of antigen in atopic asthma induces early (EAR) and late asthmatic responses (LARs), inflammatory cell infiltration and airways hyperresponsiveness (AHR).", {"entities": [[32, 38, "DISEASE"], [89, 93, "GENE"], [160, 163, "GENE"]]}], ["Previously, we have established a protocol of sensitisation and subsequent ovalbumin (Ova) inhalation challenge in guinea-pigs which induced these 4 features (Smith & Broadley, 2007).", {"entities": []}], ["However, the responses of guinea-pigs to Ova challenge have recently declined, producing no LAR or AHR and diminished EAR and cells.", {"entities": [[99, 102, "GENE"]]}], ["By making cumulative modifications to the protocol, we sought to restore these features.", {"entities": []}], ["Guinea-pigs were sensitised with Ova (i.p.", {"entities": []}], ["100 or 150\u00a0\u03bcg) on days 1 and 5 or days 1, 4 and 7 and challenged with nebulised Ova (100 or 300\u00a0\u03bcg/ml, 1\u00a0h) on day 15.", {"entities": []}], ["Airway function was measured in conscious guinea-pigs by whole-body plethysmography to record specific airway conductance (sGaw).", {"entities": []}], ["Airway responsiveness to aerosolized histamine (0.3\u00a0mM) was determined before and 24\u00a0h after Ova challenge.", {"entities": []}], ["Bronchoalveolar lavage was performed for total and differential inflammatory cell counts.", {"entities": []}], ["Lung sections were stained for counting of eosinophils.", {"entities": []}], ["Lack of AHR and LAR with the original protocol was confirmed.", {"entities": [[8, 11, "GENE"]]}], ["Increasing the Ova challenge concentration from 100 to 300\u00a0\u03bcg/ml restored AHR and eosinophils and increased the peak of the EAR.", {"entities": [[74, 77, "GENE"]]}], ["Increasing the number of sensitisation injections from 2 to 3 did not alter the responses.", {"entities": []}], ["Increasing the Ova sensitisation concentration from 100 to 150\u00a0\u03bcg significantly increased total cells, particularly eosinophils.", {"entities": []}], ["A LAR was revealed and lymphocytes and eosinophils increased when either the Al(OH) 3 concentration was increased or the duration between the final sensitisation injection and Ova challenge was extended from 15 to 21\u00a0days.", {"entities": []}], ["This study has shown that declining allergic responses to Ova in guinea-pigs could be restored by increasing the sensitisation and challenge conditions.", {"entities": []}], ["It has also demonstrated an important dissociation between EAR, LAR, AHR and inflammation.", {"entities": [[69, 72, "GENE"]]}], ["Symptoms and prognosis of patients with rheumatoid arthritis (RA) have improved with more intensive therapy, including the biological disease-modifying anti-rheumatic drugs (bDMARDs).", {"entities": [[40, 60, "DISEASE"], [51, 60, "DISEASE"]]}], ["Real life data concerning how comorbidities are distributed among patients treated or not treated with bDMARDs are scarce.", {"entities": []}], ["Our objective was to investigate differences in comorbidity and health care consumption in RA patients, with and without bDMARDs.", {"entities": []}], ["This cross-sectional study was performed in the Southwestern part of Sweden.", {"entities": []}], ["Patients, aged\u2009\u2265\u200918\u00a0years and diagnosed with RA in secondary health care during 2009\u20132010, were identified in the regional health care database.", {"entities": []}], ["Aggregated data of comorbidity and health care consumption were retrieved between 2006 and 2010.", {"entities": []}], ["RA patients treated with bDMARDs on 31st December 2010 were identified in the Swedish Rheumatology Quality Register (SRQ), which includes the biologics register Anti-Rheumatic Therapy in Sweden (ARTIS).", {"entities": []}], ["Descriptive, comparative, univariate and multiple logistic regression analyses were used to identify factors associated with bDMARDs.", {"entities": []}], ["Seven thousand seven hundred and twelve (7712) RA patients were identified (age 64.8\u2009\u00b1\u200914.9\u00a0years, women 74.3%), of whom 1137 (14.7%) were treated with bDMARDs.", {"entities": []}], ["Overall, the most common comorbidities were infections (69.2%), hypertension (41.1%), chronic respiratory disease (15.3%), ischemic heart disease (14.0%) and malignancy (13.7%).", {"entities": [[64, 76, "DISEASE"], [123, 145, "DISEASE"], [132, 145, "DISEASE"]]}], ["Patients without bDMARDs were older and had more comorbidity.", {"entities": []}], ["In the multiple logistic regression analysis, older age, cerebrovascular and chronic respiratory disease, heart failure, depression and malignancy were all associated with no present bDMARDs.", {"entities": []}], ["Infections were associated with bDMARDs.", {"entities": []}], ["Patients treated with bDMARDs consumed more secondary outpatient care but less visits in primary health care compared to patients without bDMARDs.", {"entities": []}], ["Patients treated with bDMARDs versus no bDMARDs were younger and had significantly lower period prevalence for most common comorbidities, with the exception of infections.", {"entities": []}], ["Differences in comorbidities between RA patients with or without bDMARDs should be taken into consideration when evaluating effectiveness and safety of bDMARDs in ordinary care.", {"entities": []}], ["The online version of this article (doi:10.1186/s12891-016-1354-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objective .", {"entities": []}], ["To determine the prevalence of obesity and its risk factors in Turkish children.", {"entities": [[31, 38, "DISEASE"]]}], ["This cross-sectional survey was conducted on students including 1271 boys and 1206 girls selected from 20 secondary schools in Samsun, Turkey.", {"entities": []}], ["A predesigned questionnaire was used to elicit the information on individual characteristics.", {"entities": []}], ["The height and weight of students were measured in their classroom.", {"entities": []}], ["Obesity was defined as body mass index at or above the 95th percentile for age of the sex-specific CDC growth charts.", {"entities": [[0, 7, "DISEASE"]]}], ["The mean age was 12.8 \u00b1 0.9 years, and the prevalence of obesity was found at 10.3%.", {"entities": [[57, 64, "DISEASE"]]}], ["There were higher numbers of obese students in boys than in girls ( X P < 0.001).", {"entities": []}], ["The prevalence of obesity was 10.0% and 16.8% in public and private school students, respectively.", {"entities": [[18, 25, "DISEASE"]]}], ["The percentage of obese children in students who skipped breakfast was found to be higher than that in the group that consumed 3 meals a day regularly.", {"entities": []}], ["There was no difference at time spent in sedentary behavior except watching TV, and prevalence of obesity in the group of students watching television over 3 hours per day was higher than that in their counterparts ( X P < 0.01).", {"entities": [[98, 105, "DISEASE"]]}], ["The time of engagement in sports was lower in obese group statistically ( F = 8.9; P < 0.001).", {"entities": []}], ["Conclusion .", {"entities": []}], ["In order to prevent childhood obesity, monitoring children's lifestyle by parents is necessary.", {"entities": [[30, 37, "DISEASE"]]}], ["Evidence that experiences of nature can benefit people has accumulated rapidly.", {"entities": []}], ["Yet perhaps because of the domination of the visual sense in humans, most research has focused on the visual aspects of nature experiences.", {"entities": []}], ["However, humans are multisensory, and it seems likely that many benefits are delivered through the non-visual senses and these are potentially avenues through which a physiological mechanism could occur.", {"entities": []}], ["Here we review the evidence around these lesser studied sensory pathways\u2014through sound, smell, taste, touch, and three non-sensory pathways.", {"entities": []}], ["Natural sounds and smells underpin experiences of nature for many people, and this may well be rooted in evolutionary psychology.", {"entities": []}], ["Tactile experiences of nature, particularly beyond animal petting, are understudied yet potentially fundamentally important.", {"entities": []}], ["Tastes of nature, through growing and consuming natural foods, have been linked with a range of health and well-being benefits.", {"entities": []}], ["Beyond the five senses, evidence is emerging for other non-visual pathways for nature experiences to be effective.", {"entities": []}], ["These include ingestion or inhalation of phytoncides, negative air ions and microbes.", {"entities": []}], ["We conclude that (i) these non-visual avenues are potentially important for delivering benefits from nature experiences; (ii) the evidence base is relatively weak and often based on correlational studies; and (iii) deeper exploration of these sensory and non-sensory avenues is needed.", {"entities": []}], ["Prediction of new disease indications for approved drugs by computational methods has been based largely on the genomics signatures of drugs and diseases.", {"entities": []}], ["We propose a method for drug repositioning that uses the clinical signatures extracted from over 13 years of electronic medical records from a tertiary hospital, including >9.4\u2005M laboratory tests from >530,000 patients, in addition to diverse genomics signatures.", {"entities": []}], ["Cross-validation using over 17,000 known drug\u2013disease associations shows this approach outperforms various predictive models based on genomics signatures and a well-known \u201cguilt-by-association\u201d method.", {"entities": []}], ["Interestingly, the prediction suggests that terbutaline sulfate, which is widely used for asthma, is a promising candidate for amyotrophic lateral sclerosis for which there are few therapeutic options.", {"entities": [[127, 156, "DISEASE"], [139, 156, "DISEASE"], [90, 96, "DISEASE"]]}], ["In vivo tests using zebrafish models found that terbutaline sulfate prevents defects in axons and neuromuscular junction degeneration in a dose-dependent manner.", {"entities": []}], ["A therapeutic potential of terbutaline sulfate was also observed when axonal and neuromuscular junction degeneration have already occurred in zebrafish model.", {"entities": []}], ["Cotreatment with a \u03b2 2 -adrenergic receptor antagonist, butoxamine, suggests that the effect of terbutaline is mediated by activation of \u03b2 2 -adrenergic receptors.", {"entities": []}], ["Previous studies reported increased risk of cardiac events in subjects with fasting blood glucose (FBG) levels lower than the diagnostic threshold of diabetes mellitus.", {"entities": [[150, 167, "DISEASE"]]}], ["However, whether increased cardiac events in those with upper normal FBG is secondary to the shift of their cardiac sympathovagal balance towards sympathetic predominance is unknown.", {"entities": []}], ["To assess the association between FBG levels and cardiac autonomic modulation (CAM) in euglycaemic healthy subjects based on heart rate variability (HRV) derived indices.", {"entities": []}], ["The study enrolled 42 healthy young adults.", {"entities": []}], ["Following sociodemographic and clinical assessment, blood samples were collected to measure FBG levels.", {"entities": []}], ["Five minutes ECG recordings were performed to all participants to obtain frequency domain HRV measurements, namely the natural logarithm (Ln) of total power (LnTP), very low frequency (LnVLF), low frequency (LnLF) and high frequency (LnHF), low frequency/ high frequency ratio (LnLF/HF), normalized low frequency (LF Norm) and high frequency (HF Norm).", {"entities": []}], ["FBG levels correlated positively with LnHF ( r = 0.33, P = 0.031) and HF Norm ( r = 0.35, P = 0.025) and negatively with LF Norm ( r = -0.35, P = 0.025) and LnLF/HF ( r = -0.33, P = 0.035).", {"entities": []}], ["LnHF and HF Norm were significantly decreased in subjects with the lower (4.00 (1.34) ms The present study is the first to demonstrate that rise of blood glucose concentration, within physiological range, is associated with higher parasympathetic, but lower sympathetic CAM.", {"entities": []}], ["Further researches are needed to set out the glycemic threshold beyond which further increase in glucose level readjusts sympathovagal balance towards sympathetic predominance again.", {"entities": []}], ["Asthma and associated phenotypes are complex traits most probably caused by an interaction of multiple disease susceptibility genes and environmental factors.", {"entities": [[0, 6, "DISEASE"]]}], ["Major achievements have occurred in identifying chromosomal regions and polymorphisms in candidate genes linked to or associated with asthma, atopic dermatitis, IgE levels and response to asthma therapy.", {"entities": [[142, 159, "DISEASE"], [134, 140, "DISEASE"], [188, 194, "DISEASE"], [149, 159, "DISEASE"]]}], ["The aims of this review are to explain the methodology of genetic studies of multifactorial diseases, to summarize chromosomal regions and polymorphisms in candidate genes linked to or associated with asthma and associated traits, to list genetic alterations that may alter response to asthma therapy, and to outline genetic factors that may render individuals more susceptible to asthma and atopy due to environmental changes.", {"entities": [[201, 207, "DISEASE"], [286, 292, "DISEASE"], [381, 387, "DISEASE"]]}], ["There is consistent evidence that obesity is a correlate of mortality.", {"entities": [[34, 41, "DISEASE"]]}], ["Less information is available about the relation between body weight and the prevalence of diseases.", {"entities": []}], ["We investigated the prevalence of overweight and obesity and their relationship with 14 groups of chronic diseases in a Mediterranean population using data from the Italian National Survey collected in 1999\u20132000.", {"entities": [[49, 56, "DISEASE"]]}], ["A sample of 52,300 families was randomly selected using a complex stratified multistage design, within strata of geographical areas, municipalities, and household sizes, to produce estimates representative of the whole Italian population.", {"entities": []}], ["Data were collected by civil servants both with an interview and a self-reported questionnaire.", {"entities": []}], ["The present study documents an increase in the prevalence of overweight among Italian adults in the last decades and an increased prevalence of several chronic conditions in obese or overweight individuals.", {"entities": []}], ["A general pattern of a positive association between excess weight and chronic disease was observed for both sexes.", {"entities": []}], ["The ratio of the prevalences of cardiovascular diseases, diabetes and chronic respiratory diseases was higher in obese versus normal-weight individuals in the age group under 45 years.", {"entities": []}], ["To reduce the prevalence of chronic diseases a policy promoting a healthier individual lifestyle is becoming more and more desirable.", {"entities": []}], ["Previous studies have shown that phthalate exposure in childhood is associated with the development of respiratory problems.", {"entities": []}], ["However, few studies have assessed the relative impact of prenatal and postnatal exposure to phthalates on the development of asthma later in childhood.", {"entities": [[126, 132, "DISEASE"]]}], ["Therefore, we assessed the impact of prenatal and postnatal phthalate exposure on the development of asthma and wheezing using a Taiwanese birth cohort.", {"entities": [[101, 107, "DISEASE"]]}], ["A total of 430 pregnant women were recruited, and 171 (39.8%) of them had their children followed when they were aged 2, 5, and 8 years.", {"entities": []}], ["The International Study of Asthma and Allergies in Childhood questionnaire was used to assess asthma and wheezing symptoms and serum total immunoglobulin E levels were measured at 8 years of age.", {"entities": [[27, 33, "DISEASE"], [94, 100, "DISEASE"]]}], ["Urine samples were obtained from 136 women during their third trimester of pregnancy, 99 children at 2 years of age, and 110 children at 5 years.", {"entities": []}], ["Four common phthalate monoester metabolites in maternal and children\u2019s urine were measured using liquid chromatography-electrospray ionization-tandem mass spectrometry.", {"entities": []}], ["Maternal urinary mono-benzyl phthalate [MBzP] concentrations were associated with an increased occurrence of wheezing in boys at 8 years of age (odds ratio [OR] = 4.95 (95% CI 1.08\u201322.63)), for upper quintile compared to the others) after controlling for parental allergies and family members' smoking status.", {"entities": []}], ["Urinary mono-2-ethylhexyl phthalate [MEHP] levels over the quintile at 2-year-old were associated with increased asthma occurrence (adjusted OR = 6.14 (1.17\u201332.13)) in boys.", {"entities": [[113, 119, "DISEASE"]]}], ["Similarly, the sum of di-2-ethyl-hexyl phthalate [DEHP] metabolites at 5 years was associated with asthma in boys (adjusted OR = 4.36 (1.01\u201318.86)).", {"entities": [[99, 105, "DISEASE"]]}], ["Urinary MEHP in maternal and 5-year-old children urine were significantly associated with increased IgE in allergic children at 8 years.", {"entities": []}], ["Prenatal and postnatal exposure to phthalate was associated with the occurrence of asthma in children, particularly for boys.", {"entities": [[83, 89, "DISEASE"]]}], ["The Patient-Reported Outcomes Measurement Information System (PROMIS The translation was performed by FACITtrans using standardized PROMIS methodology and approved by the PROMIS Statistical Center.", {"entities": []}], ["The translation included four forward translations, two back-translations, three independent reviews (at least two Dutch, one Flemish), and pretesting in 24 children from the Netherlands and Flanders.", {"entities": []}], ["For some items, it was necessary to have separate translations for Dutch and Flemish: physical function\u2014mobility (three items), anger (one item), pain interference (two items), and asthma impact (one item).", {"entities": [[181, 187, "DISEASE"]]}], ["Challenges faced in the translation process included scarcity or overabundance of possible translations, unclear item descriptions, constructs broader/smaller in the target language, difficulties in rank ordering items, differences in unit of measurement, irrelevant items, or differences in performance of activities.", {"entities": []}], ["By addressing these challenges, acceptable translations were obtained for all items.", {"entities": []}], ["The Dutch\u2013Flemish PROMIS items are linguistically equivalent to the original USA version.", {"entities": []}], ["Short forms are now available for use, and entire item banks are ready for cross-cultural validation in the Netherlands and Flanders.", {"entities": []}], ["Obstructive sleep apnea and hypopnea syndrome is characterized by repeated airway collapse during sleep.", {"entities": [[37, 45, "DISEASE"]]}], ["The li-terature describes multiple causes of the disease.", {"entities": []}], ["The main cause is a reduction of the expansion forces of the pharyngeal dilator muscles, as in situations of genioglossal muscle dysfunction, and discoordination between the inspiratory activity of the muscle and respiratory effort, which play an important role in progression of the disease.", {"entities": []}], ["Other described causes are soft tissue disorders, such as macroglossia or tonsillar hypertrophy, and skeletal structural alterations such as micrognathia and retrognathia.", {"entities": []}], ["The syndrome is also more frequent in obese people, where the accumulation of fat in the neck region produces narrowing of the pharyngeal airway, thereby diminishing the passage of air.", {"entities": [[4, 12, "DISEASE"]]}], ["This review focuses on the pathogenesis, epidemiology, main features and diagnosis of the disease, and on its main forms of treatment.", {"entities": []}], ["Key words: Sleep apnea, obstructive sleep apnea, sleep apnea syndrome, obstructive sleep apnea syndrome.", {"entities": [[61, 69, "DISEASE"], [95, 103, "DISEASE"]]}], ["When health declines, older persons may benefit from an intervention program that strengthens their self-management and empowers them to keep in control of their own body and life.", {"entities": []}], ["Therefore we conducted a Randomized Controlled Trial using the Chronic Disease Self-Management Program (CDSMP) in a sample of 169 older persons in frail health and in need of elderly care.", {"entities": []}], ["We assessed psychological coping resources and wellbeing, pre- and posttreatment and at 6-month follow-up, and investigated whether specific subgroups would benefit in particular from the intervention.", {"entities": []}], ["The CDSMP appeared effective with respect to sense of mastery but only in the lower educated participants (p\u2009<\u2009.05).", {"entities": []}], ["Furthermore, the intervention stabilized valuation of life in participants, whereas in the controls valuation of life decreased.", {"entities": []}], ["The high appreciation score and low drop-out are indicative for the applicability of the CDSMP for this specific target group.", {"entities": []}], ["We recommend integration of the ingredients of the program into the daily healthcare practice of professionals working with vulnerable older persons.", {"entities": []}], ["This would involve professional guidance starting from interpersonal equality and emphasising a persons possibilities given their physical or cognitive limitations.", {"entities": []}], ["This will help older vulnerable persons to focus on their own attainable goals and to experience being successful.", {"entities": []}], ["The trial was registered in the Dutch Trial Register as NTR 1173 at 08-03-2008; \u2018Is selfmanagement benefical for well-being of average older persons?\u2019 http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1173", {"entities": []}], ["Pseudomyxoma peritonei (PMP, ORPHA26790) is a clinical syndrome characterized by progressive dissemination of mucinous tumors and mucinous ascites in the abdomen and pelvis.", {"entities": [[55, 63, "DISEASE"]]}], ["PMP is a rare disease with an estimated incidence of 1\u20132 out of a million.", {"entities": []}], ["Clinically, PMP usually presents with a variety of unspecific signs and symptoms, including abdominal pain and distention, ascites or even bowel obstruction.", {"entities": []}], ["It is also diagnosed incidentally at surgical or non-surgical investigations of the abdominopelvic viscera.", {"entities": []}], ["PMP is a neoplastic disease originating from a primary mucinous tumor of the appendix with a distinctive pattern of the peritoneal spread.", {"entities": []}], ["Computed tomography and histopathology are the most reliable diagnostic modalities.", {"entities": []}], ["The differential diagnosis of the disease includes secondary peritoneal carcinomatoses and some rare peritoneal conditions.", {"entities": []}], ["Optimal elimination of mucin and the mucin-secreting tumor comprises the current standard of care for PMP offered in specialized centers as visceral resections and peritonectomy combined with intraperitoneal chemotherapy.", {"entities": []}], ["This multidisciplinary approach has reportedly provided a median survival rate of 16.3\u00a0years, a median progression-free survival rate of 8.2\u00a0years and 10- and 15-year survival rates of 63% and 59%, respectively.", {"entities": []}], ["Despite its indolent, bland nature as a neoplasm, PMP is a debilitating condition that severely impacts quality of life.", {"entities": []}], ["It tends to be diagnosed at advanced stages and frequently recurs after treatment.", {"entities": []}], ["Being ignored in research, however, PMP remains a challenging, enigmatic entity.", {"entities": []}], ["Clinicopathological features of the PMP syndrome and its morbid complications closely correspond with the multifocal distribution of the secreted mucin collections and mucin-secreting implants.", {"entities": [[40, 48, "DISEASE"]]}], ["Novel strategies are thus required to facilitate macroscopic, as well as microscopic, elimination of mucin and its source as the key components of the disease.", {"entities": []}], ["In this regard, MUC2, MUC5AC and MUC5B have been found as the secreted mucins of relevance in PMP.", {"entities": [[16, 20, "GENE"], [33, 38, "GENE"]]}], ["Development of mucin-targeted therapies could be a promising avenue for future research which is addressed in this article.", {"entities": []}], ["Probabilistic Boolean network (PBN) modelling is a semi-quantitative approach widely used for the study of the topology and dynamic aspects of biological systems.", {"entities": []}], ["The combined use of rule-based representation and probability makes PBN appealing for large-scale modelling of biological networks where degrees of uncertainty need to be considered.", {"entities": []}], ["A considerable expansion of our knowledge in the field of theoretical research on PBN can be observed over the past few years, with a focus on network inference, network intervention and control.", {"entities": []}], ["With respect to areas of applications, PBN is mainly used for the study of gene regulatory networks though with an increasing emergence in signal transduction, metabolic, and also physiological networks.", {"entities": []}], ["At the same time, a number of computational tools, facilitating the modelling and analysis of PBNs, are continuously developed.", {"entities": []}], ["A concise yet comprehensive review of the state-of-the-art on PBN modelling is offered in this article, including a comparative discussion on PBN versus similar models with respect to concepts and biomedical applications.", {"entities": []}], ["Due to their many advantages, we consider PBN to stand as a suitable modelling framework for the description and analysis of complex biological systems, ranging from molecular to physiological levels.", {"entities": []}], ["The objective of this study was to examine the association between infection early in life and mental disorders among youth in the community.", {"entities": []}], ["Data were drawn from the MECA (Methods in Epidemiology of Child and Adolescent psychopathology), a community-based study of 1,285 youth in the United States conducted in 1992.", {"entities": []}], ["Multiple logistic regression analyses were used to investigate the association between parent/caregiver-reported infection early in life and DSM/DISC diagnoses of mental disorders at ages 9-17.", {"entities": []}], ["Infection early in life was associated with a significantly increased odds of major depression (OR = 3.9), social phobia (OR = 5.8), overanxious disorder (OR = 6.1), panic disorder (OR = 12.1), and oppositional defiant disorder (OR = 3.7).", {"entities": [[166, 180, "DISEASE"]]}], ["These findings are consistent with and extend previous results by providing new evidence suggesting a link between infection early in life and increased risk of depression and anxiety disorders among youth.", {"entities": []}], ["These results should be considered preliminary.", {"entities": []}], ["Replication of these findings with longitudinal epidemiologic data is needed.", {"entities": []}], ["Possible mechanisms are discussed.", {"entities": []}], ["This study attempted to estimate the utility weights for hypothetical chronic obstructive pulmonary disease (COPD) health states, including the effect of exacerbation, and based on utilities elicited from a representative sample using the time trade-off (TTO).", {"entities": [[70, 107, "DISEASE"]]}], ["A total of 200 study subjects were recruited using a quota sampling method in Seoul, Korea.", {"entities": []}], ["Ten COPD health profiles were described reflecting the severity of COPD and the extent of exacerbation.", {"entities": []}], ["Respondents evaluated each health state using a visual analogue scale and TTO during a personal interview.", {"entities": []}], ["TTO values were estimated using a linear mixed model, and the model performance was evaluated in terms of its predictive ability and goodness of fit.", {"entities": []}], ["The estimated TTO values were 0.824 in moderate, 0.646 in severe, and 0.305 in very severe COPD health states.", {"entities": []}], ["The estimated utility decrements in TTO varied from 0.082 for a non-serious exacerbation to 0.228 for one non-serious plus one serious exacerbation per year.", {"entities": []}], ["The mean absolute error of the TTO model was 0.008, and the generalized R The social preference of various COPD health states and the utility decrement due to exacerbation can be useful for the economic evaluation of COPD intervention in Korea.", {"entities": []}], ["The online version of this article (doi:10.1186/s12955-015-0228-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A recombinant live attenuated tetravalent dengue vaccine (CYD-TDV) has been shown to be efficacious in preventing virologically-confirmed dengue disease, severe dengue disease and dengue hospitalization in children aged 2\u201316 years in Asia and Latin America.", {"entities": [[138, 152, "DISEASE"], [161, 175, "DISEASE"]]}], ["We analyzed pooled safety data from 18 phase I, II and III clinical trials in which the dengue vaccine was administered to participants aged 2\u201360 years, including long-term safety follow-up in three efficacy trials.", {"entities": []}], ["The participants were analyzed according to their age at enrollment.", {"entities": []}], ["The percentage of participants aged 2\u201360 years reporting \u22651 solicited injection-site or systemic reactions was slightly higher in the CYD-TDV group than in the placebo group.", {"entities": []}], ["The most common solicited injection-site reactions were pain.", {"entities": []}], ["Headache and malaise were the most common solicited systemic reactions.", {"entities": []}], ["In both groups 0.3% of participants discontinued for safety reasons.", {"entities": []}], ["The most common unsolicited adverse events were injection-site reactions, gastrointestinal disorders, and infections.", {"entities": []}], ["Reactogenicity did not increase with successive doses of CYD-TDV.", {"entities": []}], ["The frequency and nature of SAEs occurring within 28 days of any dose were similar in the CYD-TDV and placebo groups and were common medical conditions that could be expected as a function of age.", {"entities": []}], ["Baseline dengue virus serostatus did not appear to influence the safety profile.", {"entities": []}], ["No vaccine-related anaphylactic reactions, neurotropic events or viscerotropic events were reported.", {"entities": []}], ["In year 3 after dose 1, an imbalance for dengue hospitalization, including for severe dengue, observed in participants aged <9 years in the CYD-TDV group compared with the placebo group was not observed for participants aged \u22659 years.", {"entities": []}], ["In Year 4, this imbalance in participants aged <9 years was less marked, giving an overall lower risk of dengue hospitalization or severe dengue from dose 1 to Year 4 in the CYD-TDV group.", {"entities": []}], ["These results have contributed to the definition of the target population for vaccination (\u22659 years old) for which CYD-TDV has a satisfactory safety profile.", {"entities": []}], ["Long-term safety will continue to be monitored in the ongoing follow-up of efficacy trials.", {"entities": []}], ["Safety and effectiveness in real-life settings will be assessed through post-licensure studies.", {"entities": []}], ["Dengue is a mosquito-borne viral infection in tropical and subtropical regions of the world that causes flu-like illness and, in severe cases, death.", {"entities": []}], ["Every year, 390 million dengue infections occur worldwide, and over 3.9 billion people are now at risk from the disease.", {"entities": []}], ["Although mosquito control and improved care have helped reduce dengue\u2019s impact, a vaccine is needed.", {"entities": []}], ["CYD-TDV, a live-attenuated vaccine, has been shown to be efficacious in preventing symptomatic virologically-confirmed dengue disease in children aged 2\u201316 years.", {"entities": [[119, 133, "DISEASE"]]}], ["To help establish its safety, we analyzed integrated data from available clinical trials, with emphasis on safety parameters suggested by the World Health Organization.", {"entities": []}], ["The analysis included data for 77,234 doses in 26,356 participants aged 2\u201360 years who have received \u22651 dose.", {"entities": []}], ["We found that the overall safety profile of the dengue vaccine is satisfactory.", {"entities": []}], ["The imbalance observed for dengue hospitalization and severe dengue observed in year 3 after the first dose in children aged <9 years who had received CYD-TDV vaccine was less marked in year 4.", {"entities": []}], ["This imbalance was not observed in participants aged \u22659 years in either year.", {"entities": []}], ["These results have contributed to the definition of the target population for vaccination, i.e.", {"entities": []}], ["\u22659 years old for which the CYD-TDV vaccine has a satisfactory safety profile.", {"entities": []}], ["Little is known about the association of the TIMD4 (T-cell immunoglobulin and mucin domain 4 gene)- HAVCR1 (hepatitis A virus cellular receptor 1) variants and lipid metabolism, the risk of coronary heart disease (CHD) and ischemic stroke (IS).", {"entities": [[199, 212, "DISEASE"], [190, 212, "DISEASE"], [108, 117, "DISEASE"], [45, 50, "GENE"], [100, 106, "GENE"]]}], ["The present study aimed to determine the TIMD4-HAVCR1 variants, their haplotypes and gene\u2013environment interactions on serum lipid levels, the risk of CHD and IS, and the lipid-lowering efficacy of atorvastatin in a southern Chinese Han population.", {"entities": []}], ["Genotypes of three variants in 622 controls, 579 CHD, and 546 IS patients were determined by the Snapshot technology.", {"entities": []}], ["Atorvastatin calcium tablet (20 mg/day) was given in 724 hyperlipidemic patients for 8 weeks after genotyping.", {"entities": []}], ["The rs12522248 genotypic and allelic frequencies were different between controls and patients, and were associated with the risk of CHD and IS.", {"entities": []}], ["The rs1501908G-rs12522248T-rs2036402T haplotype was associated with an increased risk of CHD; the G-C-T haplotype was associated with lower risk of CHD; and the C-C-C haplotype was associated with an increased risk of IS.", {"entities": []}], ["Variants and their haplotypes in controls were associated with triglyceride (rs1501908), low-density lipoprotein cholesterol (LDL-C, rs1501908, G-T-T), high-density lipoprotein cholesterol (HDL-C, rs12522248, C-C-C) and the ratio of total cholesterol (TC) to HDL-C (C-C-C).", {"entities": []}], ["Interactions of rs1501908- and rs2036402-alcohol (HDL-C); rs1501908- and rs12522248-high body mass index (hBMI, \u226524 kg/m TIMD4-HAVCR1 variants-atorvastatin on several lipid parameters were detected.", {"entities": []}], ["Interactions of rs12522248TC/CC-hBMI, G-T-T-, and C-C-C-smoking on the risk of CHD; and C-C-C-smoking, C-C-C-, and G-C-T-hBMI on the risk of IS were also observed.", {"entities": []}], ["These findings suggest that the TIMD4-HAVCR1 variants may be the genetic risk factors for CHD and IS.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) are often nonadherent with medications and have poor inhaler technique.", {"entities": [[14, 51, "DISEASE"]]}], ["Community pharmacists can help to improve health-related quality of life and overall outcomes in patients with COPD.", {"entities": []}], ["We aim to measure the effectiveness of a systematic, pharmacist-driven intervention on patients with diagnosed COPD.", {"entities": []}], ["This pragmatic, parallel-group, cluster randomized controlled trial is designed to determine the effectiveness of a multifactorial, pharmacist-led intervention on medication adherence, inhaler technique, health-related quality of life, health care resource utilization including COPD exacerbations, and use of medications.", {"entities": []}], ["Participating pharmacies in Newfoundland and Labrador (NL), Canada will be randomly assigned to either the intervention or the control group.", {"entities": []}], ["The intervention group will deliver an enhanced form of care that emphasizes COPD management.", {"entities": []}], ["The control group will provide usual care and a COPD education pamphlet.", {"entities": []}], ["Included patients will be aged 40 years or older, have a physician-confirmed diagnosis of COPD, and be able to answer questionnaires in English.", {"entities": []}], ["The primary outcomes are the between-group difference in the change from baseline to 6 months in medication adherence using the Medication Possession Ratio (MPR) and the Morisky Medication Adherence Scale (MMAS-8).", {"entities": []}], ["The secondary outcomes are also measured from baseline to 6 months, and include the proportion of patients with a clinically significant change in adherence, the proportion of patients defined as having \u201cgood adherence,\u201d the mean MPR between groups, quality of life as measured by the St. George\u2019s Respiratory Questionnaire, medication inhalation technique using a pharmacist-scored checklist, health care resource utilization and antibiotic and orally administered corticosteroid use for COPD exacerbations.", {"entities": []}], ["Differences between groups will be analyzed at the individual patient level while controlling for clustering effect.", {"entities": []}], ["A pharmacist-led COPD intervention has the potential to improve patient medication adherence, thus increasing quality of life, possibly decreasing pulmonary exacerbations and reducing utilization of acute health care resources.", {"entities": []}], ["Methods and results taken from this study could be used to enhance the delivery of COPD care by community pharmacists in a real-world setting.", {"entities": []}], ["This would serve to enhance COPD population health and quality of life.", {"entities": []}], ["International Standard Randomized Controlled Trial Number (ISRCTN) ISRCTN78138190 , registered on 3 February 2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-016-1623-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Purpose: To investigate the safety, tolerability, and pharmacokinetics of trabodenoson, a highly selective adenosine mimetic targeting the adenosine A 1 receptor.", {"entities": []}], ["Methods: In Part 1, 60 healthy adult volunteers were randomized to 14 days of twice-daily topical monocular application of placebo or trabodenoson (200, 400, 800, 1,600, 2,400, or 3,200\u2009\u03bcg).", {"entities": []}], ["In Part 2, 10 subjects were randomized to placebo or 8 escalating doses of bilateral trabodenoson (total daily doses: 1,800\u20136,400\u2009\u03bcg).", {"entities": []}], ["Results: The incidence of treatment-related adverse events in Part 1 was similar in the trabodenoson (27.8%) and placebo (25.0%) groups.", {"entities": []}], ["Most were mild in intensity.", {"entities": []}], ["The most common adverse events (AEs) for trabodenoson and placebo were headache (25.0% vs. 33%, respectively) and eye pain (11.1% vs. 4.2%, respectively).", {"entities": []}], ["Ocular AEs were infrequent (16.7% and 17.9%, respectively), were self-limited, lasted <24\u2009h, and were typically mild in intensity.", {"entities": []}], ["The most common ocular AE was eye pain (9.5% and 3.6%, respectively), with a single observation of ocular hyperemia (200\u2009\u03bcg trabodenoson).", {"entities": [[99, 115, "DISEASE"]]}], ["Trabodenoson was rapidly absorbed [median time to maximum concentration (t max ): \u223c0.08 to 0.27\u2009h] and eliminated (t \u00bd : 0.48\u20132.0\u2009h), with no evidence of drug accumulation.", {"entities": [[75, 78, "GENE"]]}], ["Systemic exposure to topical trabodenoson was dose related but not dose proportional, with a plateau effect at doses \u22652,400\u2009mg per eye.", {"entities": []}], ["No clinically significant treatment-related systemic AEs were observed, and increasing systemic exposure had no effect on heart rate or blood pressure.", {"entities": []}], ["Conclusions: Ocular doses of trabodenoson up to 3,200\u2009\u03bcg per eye were safe and well tolerated in the eye and resulted in no detectable systemic effects in healthy adult volunteers.", {"entities": []}], ["Accurate registration of adverse surgical outcomes is essential to detect areas for improvement of surgical care quality.", {"entities": []}], ["One reason for inaccurate adverse outcome registration may be the method to collect these outcomes.", {"entities": []}], ["The authors compared the completeness of the national complication registry database (LHCR) as used in our hospital with relevant information from other available resources.", {"entities": []}], ["Retrospective reliability analysis.", {"entities": []}], ["University hospital.", {"entities": []}], ["From the 3252 patients admitted to the surgical wards in 2010, the authors randomly selected a cohort of 180 cases, oversampling those with adverse outcomes.", {"entities": []}], ["The LHCR contains adverse outcomes as reported during morning hand-offs or in discharge letters.", {"entities": []}], ["The authors checked if the number and severity of adverse outcomes recorded in the LHCR agreed with those reported in morning hand-offs, discharge letters and medical and nursing files.", {"entities": []}], ["In 135 of 180 patients, all resources could be retrieved completely.", {"entities": []}], ["Fourteen per cent of the patients with adverse outcomes were not recorded in the LHCR.", {"entities": []}], ["Missing adverse outcomes were all reversible without the need for (re)operation, for example, postoperative pain, delirium or urinary tract complications.", {"entities": []}], ["Only 38% of these adverse outcomes were reported in the morning hand-offs and discharge letters but were best reported in the medical and nursing files.", {"entities": []}], ["Registration of surgical adverse outcomes appears largely depending on the reliability of the underlying sources.", {"entities": []}], ["For a more complete adverse outcome registration, the authors advocate a better hand-off and additional consultation of the patient's dossier.", {"entities": []}], ["This extra effort allows for improvement actions to eventually avoid \u2018mild\u2019 adverse outcomes patients perceive as important and undesirable.", {"entities": []}], ["How complete is the national surgical complication registry as applied in a university hospital?", {"entities": []}], ["Should we use more or other resources to achieve a more complete registry of adverse outcomes?", {"entities": []}], ["Registration of surgical adverse outcomes largely depends on the reliability of the underlying resources.", {"entities": []}], ["Better hand-off and additional consultation of the patient's dossier will increase the reliability.", {"entities": []}], ["This extra effort can help avoid \u2018mild\u2019 adverse outcomes patients perceive as important and undesirable.", {"entities": []}], ["Representative data set from a consistently used registry.", {"entities": []}], ["Only inhospital adverse outcomes were taken into account.", {"entities": []}], ["Obesity and accompanying metabolic disease is negatively correlated with lung health yet the exact mechanisms by which obesity affects the lung are not well characterized.", {"entities": [[0, 7, "DISEASE"], [119, 126, "DISEASE"]]}], ["Since obesity is associated with lung diseases as chronic bronchitis and asthma, we designed a series of experiments to measure changes in lung metabolism in mice fed obesogenic diets.", {"entities": [[6, 13, "DISEASE"], [73, 79, "DISEASE"], [58, 68, "DISEASE"]]}], ["Mice were fed either control or high fat/sugar diet (45%kcal fat/17%kcal sucrose), or very high fat diet (60%kcal fat/7% sucrose) for 150 days.", {"entities": []}], ["We performed untargeted metabolomics by GC-TOFMS and HILIC-QTOFMS and lipidomics by RPLC-QTOFMS to reveal global changes in lung metabolism resulting from obesity and diet composition.", {"entities": [[155, 162, "DISEASE"]]}], ["From a total of 447 detected metabolites, we found 91 metabolite and lipid species significantly altered in mouse lung tissues upon dietary treatments.", {"entities": []}], ["Significantly altered metabolites included complex lipids, free fatty acids, energy metabolites, amino acids and adenosine and NAD pathway members.", {"entities": []}], ["While some metabolites were altered in both obese groups compared to control, others were different between obesogenic diet groups.", {"entities": []}], ["Furthermore, a comparison of changes between lung, kidney and liver tissues indicated few metabolic changes were shared across organs, suggesting the lung is an independent metabolic organ.", {"entities": []}], ["These results indicate obesity and diet composition have direct mechanistic effects on composition of the lung metabolome, which may contribute to disease progression by lung-specific pathways.", {"entities": [[23, 30, "DISEASE"]]}], ["Animal model of cigarette smoke (CS) \u2013induced chronic obstructive pulmonary disease (COPD) is the primary testing methodology for drug therapies and studies on pathogenic mechanisms of disease.", {"entities": [[46, 83, "DISEASE"], [33, 35, "GENE"]]}], ["However, researchers have rarely run simultaneous or side-by-side tests of whole-body and nose-only CS exposure in building their mouse models of COPD.", {"entities": [[100, 102, "GENE"]]}], ["We compared and evaluated these two different methods of CS exposure, plus airway Lipopolysaccharides (LPS) inhalation, in building our COPD mouse model.", {"entities": [[57, 59, "GENE"]]}], ["Compared with the control group, CS exposed mice showed significant increased inspiratory resistance, functional residual capacity, right ventricular hypertrophy index, and total cell count in BALF.", {"entities": [[33, 35, "GENE"]]}], ["Moreover, histological staining exhibited goblet cell hyperplasia, lung inflammation, thickening of smooth muscle layer on bronchia, and lung angiogenesis in both methods of CS exposure.", {"entities": [[174, 176, "GENE"]]}], ["Our data indicated that a viable mouse model of COPD can be established by combining the results from whole-body CS exposure, nose-only CS exposure, and airway LPS inhalation testing.", {"entities": [[113, 115, "GENE"], [136, 138, "GENE"], [113, 115, "GENE"], [136, 138, "GENE"]]}], ["However, in our study, we also found that, given the same amount of particulate intake, changes in right ventricular pressure and intimal thickening of pulmonary small artery are a little more serious in nose-only CS exposure method than changes in the whole-body CS exposure method.", {"entities": [[214, 216, "GENE"], [264, 266, "GENE"], [214, 216, "GENE"], [264, 266, "GENE"]]}], ["Fibromyalgia is characterized by widespread pain and is often accompanied by accessory symptoms.", {"entities": [[0, 12, "DISEASE"]]}], ["There are limited treatment options for this condition in Japan.", {"entities": []}], ["Therefore, we conducted a phase III study to assess the efficacy and safety of duloxetine in Japanese patients with fibromyalgia.", {"entities": [[116, 128, "DISEASE"]]}], ["This randomized, double-blind, placebo-controlled, parallel-group trial was conducted in Japan.", {"entities": []}], ["Outpatients who met the American College of Rheumatology 1990 criteria for fibromyalgia and whose Brief Pain Inventory (BPI) average pain score was \u22654 were randomized to duloxetine 60\u00a0mg or placebo once daily for 14\u00a0weeks.", {"entities": [[75, 87, "DISEASE"], [120, 123, "GENE"]]}], ["The primary efficacy measure was the change in the BPI average pain score from baseline.", {"entities": [[51, 54, "GENE"]]}], ["Secondary efficacy, quality of life (QoL), and safety outcomes were also evaluated.", {"entities": []}], ["Mixed-effects model repeated-measures (MMRM) analysis and last observation carried forward (LOCF) analysis of covariance were used to evaluate the primary efficacy measure.", {"entities": []}], ["Overall, 393 patients were randomized to receive either duloxetine (n\u2009=\u2009196) or placebo (n\u2009=\u2009197).", {"entities": []}], ["The MMRM analysis revealed no significant difference between duloxetine and placebo regarding the change in BPI average pain scores at week 14.", {"entities": [[108, 111, "GENE"]]}], ["Based on LOCF analysis, a statistically significant improvement in the change in BPI average pain scores at week 14 was observed for patients treated with duloxetine compared with placebo.", {"entities": [[81, 84, "GENE"]]}], ["Duloxetine treatment was associated with improved outcomes in nearly all secondary and post hoc analyses.", {"entities": []}], ["The treatment was generally well tolerated.", {"entities": []}], ["Somnolence, nausea, and constipation were the most common treatment-emergent adverse events in the duloxetine group.", {"entities": [[24, 36, "DISEASE"]]}], ["The discontinuation rates due to treatment-emergent adverse events were similar in both groups.", {"entities": []}], ["Although the MMRM analysis did not demonstrate superiority of duloxetine over placebo, duloxetine treatment was associated with improved outcomes in secondary and post hoc analyses of the mean change in the BPI average pain score and most of the secondary outcomes, including analgesia and QoL.", {"entities": [[207, 210, "GENE"]]}], ["Duloxetine treatment was safe and well tolerated.", {"entities": []}], ["These results suggest that duloxetine treatment could be associated with improvements in pain relief and QoL in Japanese patients with fibromyalgia.", {"entities": [[135, 147, "DISEASE"]]}], ["ClinicalTrials.gov Identifier: NCT01552057 .", {"entities": []}], ["Registered 9 March 2012.", {"entities": []}], ["CD1d-deficiency results in a selective deletion of NKT cells in mice that is reported to prevent murine allergic airway disease (AAD).", {"entities": []}], ["Because we find 2\u20133 fold lower basal IL-4 production in CD1d", {"entities": [[56, 60, "GENE"]]}], ["Background: In air pollution time-series studies, the temporal pattern of the association of fine particulate matter (PM 2.5 ; particulate matter \u2264 2.5 \u00b5m in aerodynamic diameter) and health end points has been observed to vary by disease category.", {"entities": []}], ["The lag pattern of PM 2.5 chemical constituents has not been well investigated, largely because daily data have not been available.", {"entities": []}], ["Objectives: We explored the lag structure for hospital admissions using daily PM 2.5 chemical constituent data for 5 years in the Denver Aerosol Sources and Health (DASH) study.", {"entities": []}], ["Methods: We measured PM 2.5 constituents, including elemental carbon, organic carbon, sulfate, and nitrate, at a central residential site from 2003 through 2007 and linked these daily pollution data to daily hospital admission counts in the five-county Denver metropolitan area.", {"entities": []}], ["Total hospital admissions and subcategories of respiratory and cardiovascular admissions were examined.", {"entities": []}], ["We assessed the lag structure of relative risks (RRs) of hospital admissions for PM 2.5 and four constituents on the same day and from 1 to 14 previous days from a constrained distributed lag model; we adjusted for temperature, humidity, longer-term temporal trends, and day of week using a generalized additive model.", {"entities": []}], ["Results: RRs were generally larger at shorter lags for total cardiovascular admissions but at longer lags for total respiratory admissions.", {"entities": []}], ["The delayed lag pattern was particularly prominent for asthma.", {"entities": [[55, 61, "DISEASE"]]}], ["Elemental and organic carbon generally showed more immediate patterns, whereas sulfate and nitrate showed delayed patterns.", {"entities": []}], ["Conclusion: In general, PM 2.5 chemical constituents were found to have more immediate estimated effects on cardiovascular diseases and more delayed estimated effects on respiratory diseases, depending somewhat on the constituent.", {"entities": []}], ["To identify novel risk variants for chronic lymphocytic leukemia (CLL) we conducted a genome-wide association study of 299,983 tagging SNPs, with validation in four additional series totaling 2,503 cases and 5,789 controls.", {"entities": [[36, 64, "DISEASE"], [56, 64, "DISEASE"]]}], ["We identified four risk loci for CLL at 2q37.3 (rs757978, FARP2 ; odds ratio [OR] = 1.39; P = 2.11 x 10 P = 7.84 x 10 P = 4.74 x 10 P = 3.60 x 10 CPEB1 ; OR = 1.18; P = 3.67 x 10 P = 2.28 x 10", {"entities": [[58, 63, "GENE"], [146, 151, "GENE"]]}], ["The cause (or causes) of most cases of autism spectrum disorder is unknown.", {"entities": [[39, 63, "DISEASE"]]}], ["Evidence from epidemiological studies and work in animal models of neurodevelopmental disorders suggest that both genetic and environmental factors may be implicated.", {"entities": []}], ["The latter include gestational infection and immune activation.", {"entities": []}], ["In our cohort, high levels of antibodies to herpes simplex virus 2 at midpregnancy were associated with an elevated risk of autism spectrum disorder in male offspring.", {"entities": [[44, 58, "DISEASE"], [124, 148, "DISEASE"]]}], ["These findings provide support for the hypothesis that gestational infection may contribute to the pathogenesis of autism spectrum disorder and have the potential to drive new efforts to monitor women more closely for cryptic gestational infection and to implement suppressive therapy during pregnancy.", {"entities": [[115, 139, "DISEASE"]]}], ["Maternal infections during pregnancy are associated with risk of neurodevelopmental disorders, including autism spectrum disorders (ASDs).", {"entities": []}], ["Proposed pathogenetic mechanisms include fetal infection, placental inflammation, and maternal cytokines or antibodies that cross the placenta.", {"entities": []}], ["The Autism Birth Cohort comprises mothers, fathers, and offspring recruited in Norway in 1999 to 2008.", {"entities": []}], ["Through questionnaire screening, referrals, and linkages to a national patient registry, 442 mothers of children with ASD were identified, and 464 frequency-matched controls were selected.", {"entities": []}], ["Immunoglobulin G (IgG) antibodies to Toxoplasma gondii , rubella virus, cytomegalovirus (CMV), herpes simplex virus 1 (HSV-1), and HSV-2 in plasma collected at midpregnancy and after delivery were measured by multiplexed immunoassays.", {"entities": [[95, 109, "DISEASE"], [57, 64, "DISEASE"]]}], ["High levels of HSV-2 IgG antibodies in maternal midpregnancy plasma were associated with increased risk of ASD in male offspring (an increase in HSV-2 IgG levels from 240 to 640 arbitrary units/ml was associated with an odds ratio of 2.07; 95% confidence interval, 1.06 to 4.06; P = 0.03) when adjusted for parity and child\u2019s birth year.", {"entities": []}], ["No association was found between ASD and the presence of IgG antibodies to Toxoplasma gondii , rubella virus, CMV, or HSV-1.", {"entities": [[95, 102, "DISEASE"]]}], ["Additional studies are needed to test for replicability of risk and specificity of the sex effect and to examine risk associated with other infections.", {"entities": []}], ["IMPORTANCE The cause (or causes) of most cases of autism spectrum disorder is unknown.", {"entities": [[50, 74, "DISEASE"]]}], ["Evidence from epidemiological studies and work in animal models of neurodevelopmental disorders suggest that both genetic and environmental factors may be implicated.", {"entities": []}], ["The latter include gestational infection and immune activation.", {"entities": []}], ["In our cohort, high levels of antibodies to herpes simplex virus 2 at midpregnancy were associated with an elevated risk of autism spectrum disorder in male offspring.", {"entities": [[44, 58, "DISEASE"], [124, 148, "DISEASE"]]}], ["These findings provide support for the hypothesis that gestational infection may contribute to the pathogenesis of autism spectrum disorder and have the potential to drive new efforts to monitor women more closely for cryptic gestational infection and to implement suppressive therapy during pregnancy.", {"entities": [[115, 139, "DISEASE"]]}], ["Objective is to explore how multimorbidity is defined in the scientific literature, with a focus on the roles of diseases, risk factors, and symptoms in the definitions.", {"entities": []}], ["Design: Systematic review.", {"entities": []}], ["Methods: MEDLINE (PubMed), Embase, and The Cochrane Library were searched for relevant publications up until October 2013.", {"entities": []}], ["One author extracted the information.", {"entities": []}], ["Ambiguities were resolved, and consensus reached with one co-author.", {"entities": []}], ["Outcome measures were: cut-off point for the number of conditions included in the definitions of multimorbidity; setting; data sources; number, kind, duration, and severity of diagnoses, risk factors, and symptoms.", {"entities": []}], ["We reviewed 163 articles.", {"entities": []}], ["In 61 articles (37%), the cut-off point for multimorbidity was two or more conditions (diseases, risk factors, or symptoms).", {"entities": []}], ["The most frequently used setting was the general population (68 articles, 42%), and primary care (41 articles, 25%).", {"entities": []}], ["Sources of data were primarily self-reports (56 articles, 42%).", {"entities": []}], ["Out of the 163 articles selected, 115 had individually constructed multimorbidity definitions, and in these articles diseases occurred in all definitions, with diabetes as the most frequent.", {"entities": []}], ["Risk factors occurred in 98 (85%) and symptoms in 71 (62%) of the definitions.", {"entities": []}], ["The severity of conditions was used in 26 (23%) of the definitions, but in different ways.", {"entities": []}], ["The definition of multimorbidity is heterogeneous and risk factors are more often included than symptoms.", {"entities": []}], ["The severity of conditions is seldom included.", {"entities": []}], ["Since the number of people living with multimorbidity is increasing there is a need to develop a concept of multimorbidity that is more useful in daily clinical work.", {"entities": []}], ["Key points The increasing number of multimorbidity patients challenges the healthcare system.", {"entities": []}], ["The concept of multimorbidity needs further discussion in order to be implemented in daily clinical practice.", {"entities": []}], ["Many definitions of multimorbidity exist and most often a cut-off point of two or more is applied to a range of 4\u2013147 different conditions.", {"entities": []}], ["Diseases are included in all definitions of multimorbidity.", {"entities": []}], ["Risk factors are often included in existing definitions, whereas symptoms and the severity of the conditions are less frequently included.", {"entities": []}], ["The increasing number of multimorbidity patients challenges the healthcare system.", {"entities": []}], ["The concept of multimorbidity needs further discussion in order to be implemented in daily clinical practice.", {"entities": []}], ["Many definitions of multimorbidity exist and most often a cut-off point of two or more is applied to a range of 4\u2013147 different conditions.", {"entities": []}], ["Diseases are included in all definitions of multimorbidity.", {"entities": []}], ["Risk factors are often included in existing definitions, whereas symptoms and the severity of the conditions are less frequently included.", {"entities": []}], ["Netherton syndrome (NS) is a severe genetic skin disease with constant atopic manifestations that is caused by mutations in the serine protease inhibitor Kazal-type 5 ( SPINK5 ) gene, which encodes the protease inhibitor lymphoepithelial Kazal-type\u2013related inhibitor (LEKTI).", {"entities": [[10, 18, "DISEASE"], [44, 56, "DISEASE"], [169, 175, "GENE"]]}], ["Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases hyperactivity.", {"entities": []}], ["This skin barrier defect favors allergen absorption and is generally regarded as the underlying cause for atopy in NS.", {"entities": []}], ["We show for the first time that the pro-Th2 cytokine thymic stromal lymphopoietin (TSLP), the thymus and activation-regulated chemokine, and the macrophage-derived chemokine are overexpressed in LEKTI-deficient epidermis.", {"entities": [[83, 87, "GENE"]]}], ["This is part of an original biological cascade in which unregulated kallikrein (KLK) 5 directly activates proteinase-activated receptor 2 and induces nuclear factor \u03baB\u2013mediated overexpression of TSLP, intercellular adhesion molecule 1, tumor necrosis factor \u03b1, and IL8.", {"entities": [[195, 199, "GENE"], [265, 268, "GENE"]]}], ["This proinflammatory and proallergic pathway is independent of the primary epithelial failure and is activated under basal conditions in NS keratinocytes.", {"entities": []}], ["This cell-autonomous process is already established in the epidermis of Spink5 embryos, and the resulting proinflammatory microenvironment leads to eosinophilic and mast cell infiltration in a skin graft model in nude mice.", {"entities": [[72, 78, "GENE"]]}], ["Collectively, these data establish that uncontrolled KLK5 activity in NS epidermis can trigger atopic dermatitis (AD)\u2013like lesions, independently of the environment and the adaptive immune system.", {"entities": [[95, 112, "DISEASE"], [102, 112, "DISEASE"], [53, 57, "GENE"]]}], ["They illustrate the crucial role of protease signaling in skin inflammation and point to new therapeutic targets for NS as well as candidate genes for AD and atopy.", {"entities": []}], ["HLA-G plays a role in fetal-maternal tolerance as well as immunoregulation, and has been suggested to be involved in autoimmune diseases and cancers.", {"entities": [[0, 5, "GENE"]]}], ["HLA-G encodes two potentially functional polymorphisms in the 3\u2019 untranslated region, 14bp insertion/deletion (14bp indel, rs371194629) and a single nucleotide polymorphism rs1063320, previously reported to affect HLA-G expression level or splicing isoform and to be associated with susceptibility to systemic lupus erythematosus (SLE).", {"entities": [[310, 329, "DISEASE"], [301, 329, "DISEASE"], [0, 5, "GENE"], [214, 219, "GENE"], [0, 5, "GENE"], [214, 219, "GENE"]]}], ["However, the results of SLE association studies are inconsistent, probably due to the small sample size of each study and lack of consideration of linkage disequilibrium (LD) with HLA-class II haplotypes in each population.", {"entities": []}], ["In this study, we performed association studies of these polymorphisms on 843 patients with SLE and 778 healthy controls in a Japanese population, in many of whom HLA-DRB1 alleles have been genotyped at the four-digit level.", {"entities": [[163, 171, "GENE"]]}], ["LD was detected between DRB1*13 : 02 , protective against multiple autoimmune diseases in the Japanese, and the rs1063320 G ( D\u2019 = 0.86, r D\u2019 = 0.62, r DRB1*15 : 01 and HLA-G .", {"entities": [[169, 174, "GENE"]]}], ["Although significant association with overall SLE was not detected, 14bp ins allele was significantly associated with SLE with the age of onset <20 years, when compared with healthy controls (P = 0.0067, P FDR = 0.039, OR 1.44, additive model) or with SLE patients with the age of onset \u226520 (P = 0.033, P FDR = 0.0495, OR 2.09, additive model).", {"entities": [[73, 76, "GENE"]]}], ["This association remained significant after conditioning on DRB1*13 : 02 or DRB1*15 : 01 .", {"entities": []}], ["On the other hand, significant association was detected between rs1063320 C and anti-RNP antibody and anti-Sm antibody positive SLE, which was dependent on negative LD with DRB1*13 : 02 .", {"entities": []}], ["eQTL analysis showed reduced HLA-G mRNA level in 14bp ins/ins individuals.", {"entities": [[29, 34, "GENE"]]}], ["In conclusion, our observations showed that HLA-G 14bp ins allele represents a genetic contribution on early-onset SLE independent of DRB1 .", {"entities": [[44, 49, "GENE"], [55, 58, "GENE"], [134, 138, "GENE"]]}], ["Several studies have been conducted in recent years to evaluate the risk of type 2 diabetes mellitus (T2DM) and polymorphisms of interleukin (IL)-10.", {"entities": [[83, 100, "DISEASE"], [76, 100, "DISEASE"]]}], ["However, the results remain conflicting rather than conclusive.", {"entities": []}], ["This meta-analysis aimed to summarize the current evidence from case-control studies that evaluated this association.", {"entities": []}], ["We carried out a search in Medline, EMBASE, and the Chinese National Knowledge Infrastructure (CNKI) database for relevant studies.", {"entities": []}], ["Data were extracted using a standardized form and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the strength of the association.", {"entities": []}], ["10 studies were included in our meta-analysis and systemic review.", {"entities": []}], ["Our meta-analysis indicated that IL-10 \u22121082A/G polymorphism was associated with the risk of T2DM (GA vs. AA: OR\u200a=\u200a1.21, 95% CI\u200a=\u200a1.03\u20131.14; GA/GG vs. AA: OR\u200a=\u200a1.22, 95% CI\u200a=\u200a1.05\u20131.41), whereas there was no association between IL-10 \u2212592C/A (CC/CA vs. AA: OR\u200a=\u200a1.07, 95% CI\u200a=\u200a0.59\u20131.93) or -819C/T (CC/CT vs. TT: OR\u200a=\u200a0.93, 95% CI\u200a=\u200a0.49\u20131.75) polymorphism and T2DM risk was found in our study.", {"entities": []}], ["This meta-analysis provides strong evidence that IL-10 \u22121082A/G polymorphism associated with risk of T2DM.", {"entities": []}], ["However, no association of the IL-10 \u2212592C/A or \u2212819C/T polymorphism with T2DM risk was found.", {"entities": []}], ["Additional well-designed large studies were required for the validation of our results.", {"entities": []}], ["Perspectives on invasive and noninvasive ventilatory support for critically ill patients are evolving, as much evidence indicates that ventilation may have positive effects on patient survival and the quality of the care provided in intensive care units in Brazil.", {"entities": []}], ["For those reasons, the Brazilian Association of Intensive Care Medicine ( Associa\u00e7\u00e3o de Medicina Intensiva Brasileira - AMIB) and the Brazilian Thoracic Society ( Sociedade Brasileira de Pneumologia e Tisiologia - SBPT), represented by the Mechanical Ventilation Committee and the Commission of Intensive Therapy, respectively, decided to review the literature and draft recommendations for mechanical ventilation with the goal of creating a document for bedside guidance as to the best practices on mechanical ventilation available to their members.", {"entities": []}], ["The document was based on the available evidence regarding 29 subtopics selected as the most relevant for the subject of interest.", {"entities": []}], ["The project was developed in several stages, during which the selected topics were distributed among experts recommended by both societies with recent publications on the subject of interest and/or significant teaching and research activity in the field of mechanical ventilation in Brazil.", {"entities": []}], ["The experts were divided into pairs that were charged with performing a thorough review of the international literature on each topic.", {"entities": []}], ["All the experts met at the Forum on Mechanical Ventilation, which was held at the headquarters of AMIB in S\u00e3o Paulo on August 3 and 4, 2013, to collaboratively draft the final text corresponding to each sub-topic, which was presented to, appraised, discussed and approved in a plenary session that included all 58 participants and aimed to create the final document.", {"entities": []}], ["Despite depression being one of the most prevalent mental disorders in the world, access to treatment is still insufficient, especially in low- and middle-income countries.", {"entities": []}], ["The aim of this study is to investigate differences in access to treatment for depression according to socio-demographic characteristics, geographical area and multi-morbidity in a nationally representative sample of individuals with depression.", {"entities": []}], ["This study analyses data from the National Health Survey ( Pesquisa Nacional de Sa\u00fade \u2013 PNS), a Brazilian household-based nationwide survey, which comprises 60,202 adults (aged 18\u00a0years or older).", {"entities": []}], ["Depression was evaluated through the Patient Health Questionnaire-9 (PHQ-9).", {"entities": []}], ["Prevalence Ratios and corresponding 95\u00a0% confidence intervals (95%CI) were calculated using Poisson regression.", {"entities": []}], ["The general prevalence of depression was 7.9\u00a0% (95\u00a0% CI 7.5 to 8.3).", {"entities": []}], ["Among those with depression, 78.8\u00a0% did not receive any treatment, and 14.1\u00a0% received only pharmacotherapy.", {"entities": []}], ["Multivariable analyses showed that being female, white, aged between 30 and 69\u00a0years, living in regions other than the North, having higher education and having multi-morbidities were independently associated with higher likelihood of access to any treatment.", {"entities": []}], ["Most Brazilians with clinically relevant depressive symptoms are not receiving any treatment.", {"entities": []}], ["Access to care is unequal, with the poor and those living in low resource areas having higher difficulties to access mental health care.", {"entities": []}], ["Understanding these disparities is important for the provision of effective interventions aimed at reducing the prevalence of depression and inequities in access to mental health care.", {"entities": []}], ["There is some evidence that maternal smoking increases susceptibility to personal smoking\u2019s detrimental effects.", {"entities": []}], ["One might question whether early life disadvantage might influence susceptibility to occupational exposure.", {"entities": []}], ["In this cross-sectional study we investigated respiratory symptoms, asthma and self-reported chronic obstructive pulmonary disease (COPD) as related to working as a cleaner in Northern European populations, and whether early life factors influenced susceptibility to occupational cleaning\u2019s unhealthy effects.", {"entities": [[93, 130, "DISEASE"], [68, 74, "DISEASE"]]}], ["The RHINE III questionnaire study assessed occupational cleaning in 13,499 participants.", {"entities": []}], ["Associations with respiratory symptoms, asthma and self-reported COPD were analysed with multiple logistic regressions, adjusting for sex, age, smoking, educational level, parent\u00b4s educational level, BMI and participating centre.", {"entities": [[40, 46, "DISEASE"]]}], ["Interaction of occupational cleaning with early life disadvantage (maternal smoking, severe respiratory infection <5 years, born during winter months, maternal age at birth >35 years) was investigated.", {"entities": []}], ["Among 2138 ever-cleaners the risks of wheeze (OR 1.4, 95% CI 1.3\u20131.6), adult-onset asthma (1.5 [1.2\u20131.8]) and self-reported COPD (1.7 [1.3\u20132.2]) were increased.", {"entities": [[83, 89, "DISEASE"]]}], ["The risk increased with years in occupational cleaning (adult-onset asthma: \u22641 year 0.9 [0.7\u20131.3]; 1\u20134 years 1.5 [1.1\u20132.0]; \u22654 years 1.6 [1.2\u20132.1]).", {"entities": [[68, 74, "DISEASE"]]}], ["The association of wheeze with cleaning activity \u22654 years was significantly stronger for those with early life disadvantage than in those without (1.8 [1.5\u20132.3] vs. 1.3 [0.96\u20131.8]; p interaction 0.035).", {"entities": []}], ["Occupational cleaners had increased risk of asthma and self-reported COPD.", {"entities": [[44, 50, "DISEASE"]]}], ["Respiratory symptom risk was particularly increased in persons with factors suggestive of early life disadvantage.", {"entities": []}], ["We hypothesize that early life disadvantage may increase airway vulnerability to harmful exposure from cleaning agents later in life.", {"entities": []}], ["The fecal egg count reduction test (FECRT) is recommended to monitor drug efficacy against soil-transmitted helminths (STHs) in public health.", {"entities": []}], ["However, the impact of factors inherent to study design (sample size and detection limit of the fecal egg count (FEC) method) and host-parasite interactions (mean baseline FEC and aggregation of FEC across host population) on the reliability of FECRT is poorly understood.", {"entities": []}], ["A simulation study was performed in which FECRT was assessed under varying conditions of the aforementioned factors.", {"entities": []}], ["Classification trees were built to explore critical values for these factors required to obtain conclusive FECRT results.", {"entities": []}], ["The outcome of this analysis was subsequently validated on five efficacy trials across Africa, Asia, and Latin America.", {"entities": []}], ["Unsatisfactory (<85.0%) sensitivity and specificity results to detect reduced efficacy were found if sample sizes were small (<10) or if sample sizes were moderate (10\u201349) combined with highly aggregated FEC (k<0.25).", {"entities": []}], ["FECRT remained inconclusive under any evaluated condition for drug efficacies ranging from 87.5% to 92.5% for a reduced-efficacy-threshold of 90% and from 92.5% to 97.5% for a threshold of 95%.", {"entities": []}], ["The most discriminatory study design required 200 subjects independent of STH status (including subjects who are not excreting eggs).", {"entities": []}], ["For this sample size, the detection limit of the FEC method and the level of aggregation of the FEC did not affect the interpretation of the FECRT.", {"entities": []}], ["Only for a threshold of 90%, mean baseline FEC <150 eggs per gram of stool led to a reduced discriminatory power.", {"entities": []}], ["This study confirms that the interpretation of FECRT is affected by a complex interplay of factors inherent to both study design and host-parasite interactions.", {"entities": []}], ["The results also highlight that revision of the current World Health Organization guidelines to monitor drug efficacy is indicated.", {"entities": []}], ["We, therefore, propose novel guidelines to support future monitoring programs.", {"entities": []}], ["The reduction in number of eggs excreted in stools after drug administration is a primary parameter to monitor the efficacy of drugs against parasitic worms.", {"entities": []}], ["Guidelines on how to perform such a fecal egg count reduction test (FECRT) are provided by the World Health Organization.", {"entities": []}], ["However, it remains unclear to which extent these guidelines are cost-effective.", {"entities": []}], ["We, therefore, performed a simulation study in which the FECRT was performed under varying conditions to determine the critical values for sample size, the detection limit of the fecal egg count (FEC) method, mean baseline FEC, and variation of FEC across host population that allow for conclusive FECRT results.", {"entities": []}], ["The results revealed that a reliable monitoring system demands a sample size of 200 subjects and that in some cases FECRT results may be thwarted by low mean baseline FEC.", {"entities": []}], ["For this sample size, the detection of the FEC method or the variation of FEC across the host population did not affect the FECRT results.", {"entities": []}], ["Our findings underscore that the current guidelines are not cost-effective, demanding too much financial and technical resources.", {"entities": []}], ["We, therefore, propose novel guidelines to support future monitoring programs.", {"entities": []}], ["Interstitial cells of Cajal (ICC) are recognized as pacemaker cells for gastrointestinal movement and are suggested to be mediators of neuromuscular transmission.", {"entities": []}], ["Intestinal motility disturbances are often associated with a reduced number of ICC and/or ultrastructural damage, sometimes associated with immune cells.", {"entities": []}], ["Macrophages and mast cells in the intestinal muscularis externa of rodents can be found in close spatial contact with ICC.", {"entities": []}], ["Macrophages are a constant and regularly distributed cell population in the serosa and at the level of Auerbach\u2019s plexus (AP).", {"entities": []}], ["In human colon, ICC are in close contact with macrophages at the level of AP, suggesting functional interaction.", {"entities": []}], ["It has therefore been proposed that ICC and macrophages interact.", {"entities": []}], ["Macrophages and mast cells are considered to play important roles in the innate immune defence by producing pro-inflammatory mediators during classical activation, which may in itself result in damage to the tissue.", {"entities": []}], ["They also take part in alternative activation which is associated with anti-inflammatory mediators, tissue remodelling and homeostasis, cancer, helminth infections and immunophenotype switch.", {"entities": [[136, 142, "DISEASE"]]}], ["ICC become damaged under various circumstances \u2013 surgical resection, possibly post-operative ileus in rodents \u2013 where innate activation takes place, and in helminth infections \u2013 where alternative activation takes place.", {"entities": [[93, 98, "DISEASE"]]}], ["During alternative activation the muscularis macrophage can switch phenotype resulting in up-regulation of F4/80 and the mannose receptor.", {"entities": []}], ["In more chronic conditions such as Crohn\u2019s disease and achalasia, ICC and mast cells develop close spatial contacts and piecemeal degranulation is possibly triggered.", {"entities": [[55, 64, "DISEASE"]]}], ["Vaccine adverse events (VAEs) are adverse bodily changes occurring after vaccination.", {"entities": []}], ["Understanding the adverse event (AE) profiles is a crucial step to identify serious AEs.", {"entities": []}], ["Two different types of seasonal influenza vaccines have been used on the market: trivalent (killed) inactivated influenza vaccine (TIV) and trivalent live attenuated influenza vaccine (LAIV).", {"entities": [[32, 41, "DISEASE"], [112, 121, "DISEASE"], [166, 175, "DISEASE"]]}], ["Different adverse event profiles induced by these two groups of seasonal influenza vaccines were studied based on the data drawn from the CDC Vaccine Adverse Event Report System (VAERS).", {"entities": [[73, 82, "DISEASE"]]}], ["Extracted from VAERS were 37,621 AE reports for four TIVs (Afluria, Fluarix, Fluvirin, and Fluzone) and 3,707 AE reports for the only LAIV (FluMist).", {"entities": []}], ["The AE report data were analyzed by a novel combinatorial, ontology-based detection of AE method (CODAE).", {"entities": []}], ["CODAE detects AEs using Proportional Reporting Ratio (PRR), Chi-square significance test, and base level filtration, and groups identified AEs by ontology-based hierarchical classification.", {"entities": []}], ["In total, 48 TIV-enriched and 68 LAIV-enriched AEs were identified (PRR>2, Chi-square score >4, and the number of cases >0.2% of total reports).", {"entities": []}], ["These AE terms were classified using the Ontology of Adverse Events (OAE), MedDRA, and SNOMED-CT.", {"entities": []}], ["The OAE method provided better classification results than the two other methods.", {"entities": []}], ["Thirteen out of 48 TIV-enriched AEs were related to neurological and muscular processing such as paralysis, movement disorders, and muscular weakness.", {"entities": []}], ["In contrast, 15 out of 68 LAIV-enriched AEs were associated with inflammatory response and respiratory system disorders.", {"entities": []}], ["There were evidences of two severe adverse events (Guillain-Barre Syndrome and paralysis) present in TIV.", {"entities": []}], ["Although these severe adverse events were at low incidence rate, they were found to be more significantly enriched in TIV-vaccinated patients than LAIV-vaccinated patients.", {"entities": []}], ["Therefore, our novel combinatorial bioinformatics analysis discovered that LAIV had lower chance of inducing these two severe adverse events than TIV.", {"entities": []}], ["In addition, our meta-analysis found that all previously reported positive correlation between GBS and influenza vaccine immunization were based on trivalent influenza vaccines instead of monovalent influenza vaccines.", {"entities": [[103, 112, "DISEASE"], [158, 167, "DISEASE"], [199, 208, "DISEASE"]]}], ["Exposure to environmental polycyclic aromatic hydrocarbons (PAHs), such as benzo(a)pyrene (B(a)P), has been linked to several health-threatening risks.", {"entities": []}], ["PAHs were also shown to hinder adrenergic receptor (ADR) responses.", {"entities": []}], ["As we previously demonstrated that B(a)P can directly interact with the \u03b22ADR, we investigated here whether B(a)P could decrease \u03b22ADR responsiveness by triggering receptor desensitization phenomena.", {"entities": []}], ["We firstly showed that exposure to B(a)P reduced \u03b22ADR-mediated epinephrine-induced induction of NR4A gene mRNAs and of intracellular cAMP.", {"entities": []}], ["Analysis of \u03b22ADR protein expression demonstrated that B(a)P rapidly decreased membrane expression of \u03b22ADR with a subsequent degradation of receptor protein.", {"entities": []}], ["B(a)P exposure concomitantly rapidly increased the \u03b22ADR mRNA levels.", {"entities": []}], ["The use of the \u03b2-blockers, propranolol and ICI 118.551, demonstrated the involvement of \u03b22ADR itself in this increase.", {"entities": []}], ["However, sustained exposure to B(a)P induced a diminution of \u03b22ADR mRNA steady-state as a result of the acceleration of its degradation.", {"entities": []}], ["Together, these results show that, beside the well-known activation of the aryl hydrocarbon receptor, PAH deleterious effects may involve the dysfunction of adrenergic responses through, in part, the desensitization of \u03b22ADR.", {"entities": []}], ["This may be taken in consideration when \u03b22-agonists/antagonists are administered in patients exposed to important concentrations of PAHs, e.g .", {"entities": []}], ["in cigarette smokers.", {"entities": []}], ["Avian influenza A H5N1 is a virus with pandemic potential.", {"entities": [[6, 15, "DISEASE"]]}], ["Mucosal vaccines are attractive as they have the potential to block viruses at the site of entry, thereby preventing both disease and further transmission.", {"entities": []}], ["The intranasal route is safe for the administration of seasonal live-attenuated influenza vaccines, but may be less suitable for administration of pandemic vaccines.", {"entities": [[80, 89, "DISEASE"]]}], ["Research into novel mucosal routes is therefore needed.", {"entities": []}], ["In this study, a murine model was used to compare sublingual administration with intranasal and intramuscular administration of influenza H5N1 virosomes (2 \u00b5g haemagglutinin; HA) in combination with the mucosal adjuvant (3\u2032,5\u2032)-cyclic dimeric guanylic acid (c-di-GMP).", {"entities": [[128, 137, "DISEASE"]]}], ["We found that sublingual immunisation effectively induced local and systemic H5N1-specific humoral and cellular immune responses but that the magnitude of response was lower than after intranasal administration.", {"entities": []}], ["However, both the mucosal routes were superior to intramuscular immunisation for induction of local humoral and systemic cellular immune responses including high frequencies of splenic H5N1-specific multifunctional (IL-2", {"entities": []}], ["The regulation and function of IgE in healthy individuals and in antigen-na\u00efve animals is not well understood.", {"entities": []}], ["IL-33 administration increases serum IgE in mice with unknown mechanism.", {"entities": []}], ["We tested the hypothesis that IL-33 provides an antigen-independent stimulus for IgE production and mast cell degranulation.", {"entities": []}], ["IL-33 was administered to na\u00efve wild-type (WT), nude and ST2 IL-33 enhanced IgE production in na\u00efve WT, T-IL-4R\u03b1 IL-33 amplifies IgE synthesis and triggers anaphylaxis in na\u00efve mice via IL-4, independent of allergen.", {"entities": []}], ["IL-33 may play an important role in nonatopic allergy and idiopathic anaphylaxis.", {"entities": []}], ["Although personal cigarette smoking is the most important cause and modulator of chronic obstructive pulmonary disease (COPD), secondhand smoke (SHS) exposure could influence the course of the disease.", {"entities": [[81, 118, "DISEASE"]]}], ["Despite the importance of this question, the impact of SHS exposure on COPD health outcomes remains unknown.", {"entities": []}], ["We used data from two waves of a population-based multiwave U.S. cohort study of adults with COPD.", {"entities": []}], ["77 non-smoking respondents with a diagnosis of COPD completed direct SHS monitoring based on urine cotinine and a personal badge that measures nicotine.", {"entities": []}], ["We evaluated the longitudinal impact of SHS exposure on validated measures of COPD severity, physical health status, quality of life (QOL), and dyspnea measured at one year follow-up.", {"entities": []}], ["The highest level of SHS exposure, as measured by urine cotinine, was cross-sectionally associated with poorer COPD severity (mean score increment 4.7 pts; 95% CI 0.6 to 8.9) and dyspnea (1.0 pts; 95% CI 0.4 to 1.7) after controlling for covariates.", {"entities": [[151, 154, "GENE"], [192, 195, "GENE"], [151, 154, "GENE"], [192, 195, "GENE"]]}], ["In longitudinal analysis, the highest level of baseline cotinine was associated with worse COPD severity (4.7 points; 95% CI -0.1 to 9.4; p = 0.054), disease-specific QOL (2.9 pts; -0.16 to 5.9; p = 0.063), and dyspnea (0.9 pts; 95% CI 0.2 to 1.6 pts; p < 0.05), although the confidence intervals did not always exclude the no effect level.", {"entities": [[176, 179, "GENE"], [224, 227, "GENE"], [247, 250, "GENE"], [176, 179, "GENE"], [224, 227, "GENE"], [247, 250, "GENE"], [176, 179, "GENE"], [224, 227, "GENE"], [247, 250, "GENE"]]}], ["Directly measured SHS exposure appears to adversely influence health outcomes in COPD, independent of personal smoking.", {"entities": []}], ["Because SHS is a modifiable risk factor, clinicians should assess SHS exposure in their patients and counsel its avoidance.", {"entities": []}], ["In public health terms, the effects of SHS exposure on this vulnerable subpopulation provide a further rationale for laws prohibiting public smoking.", {"entities": []}], ["This paper reviews biofeedback research from the perspective of cybernetic/feedback theory and applies the theory to the behavioral treatment of psychosomatic disorders.", {"entities": []}], ["The concept of disregulation is used to elucidate how environmental factors can modulate the central nervous system and effect homeostatic, self-regulatory control of peripheral organs.", {"entities": []}], ["When feedback from peripheral organs is disrupted, it is hypothesized that disregulation occurs, leading to physiological instability and functional disease.", {"entities": []}], ["Within this framework, biofeedback provides a new feedback loop that can help individuals regain physiological self-control.", {"entities": []}], ["Basic research using biofeedback to enhance self-regulation of cardiovascular responses is reviewed.", {"entities": []}], ["The use of biofeedback in the behavioral treatment of disorders such as tension and migraine headache, hypertension, and epilepsy are selectively reviewed and critically evaluated.", {"entities": [[103, 115, "DISEASE"], [84, 92, "DISEASE"]]}], ["The need to consider feedback mechanisms in behavioral and biomedical approaches to treatment is highlighted.", {"entities": []}], ["Predictions regarding the potential inadvertent perpetuation of disregulation and disease through inappropriate biomedical intervention is also considered.", {"entities": []}], ["Understanding the dietary intakes of infants and toddlers is important because early life nutrition influences future health outcomes.", {"entities": []}], ["The aim of this study was to determine the dietary sources of total energy and 16 nutrients in a nationally representative sample of U.S. infants and toddlers aged 0\u201324 months.", {"entities": []}], ["Data from the 2005\u20132012 National Health and Nutrition Examination Survey were analyzed.", {"entities": []}], ["Dietary intake was assessed in 2740 subjects using one 24-h dietary recall.", {"entities": []}], ["The population proportion was used to determine the contribution of foods and beverages to nutrient intakes.", {"entities": []}], ["Overall infant formulas and baby foods were the leading sources of total energy and nutrients in infants aged 0\u201311.9 months.", {"entities": []}], ["In toddlers, the diversity of food groups contributing to nutrient intakes was much greater.", {"entities": []}], ["Important sources of total energy included milk, 100% juice and grain based mixed dishes.", {"entities": []}], ["A number of foods of low nutritional quality also contributed to energy intakes including sweet bakery products, sugar-sweetened beverages and savory snacks.", {"entities": []}], ["Overall non-flavored milks and ready-to-eat cereals were the most important contributors to micronutrient intakes.", {"entities": []}], ["In conclusion this information can be used to guide parents regarding appropriate food selection as well as inform targeted dietary strategies within public health initiatives to improve the diets of infants and toddlers.", {"entities": []}], ["This cross-sectional survey assessed and compared by country, the levels and correlates of 21 self-reported symptoms/health complaints.", {"entities": []}], ["We examined the associations between self-reported symptoms and perceived stress.", {"entities": []}], ["Data was collected from universities in the United Kingdom and Egypt (N = 3706 and 3271 undergraduates, respectively).", {"entities": []}], ["A self-administered questionnaire assessed a range of self-reported symptoms, perceived stress, sociodemographic (gender, age, marital status, year of study, living arrangements during semester, income sufficiency), lifestyle (tobacco smoking, illicit drug/s use, alcohol consumption frequency), and health variables (subjective health status, health awareness, BMI), along with religiosity, and quality of life.", {"entities": []}], ["Factor analysis categorized the 21 self-reported symptoms into four components.", {"entities": []}], ["Correlation analysis and linear regression tested the associations between the self-reported symptoms and stress.", {"entities": []}], ["Factor analysis of the health symptoms generated four symptom groups for each of the UK and Egypt (psychological; circulatory/breathing; gastrointestinal; and, pains/aches), and factor loadings were quite similar for both countries.", {"entities": []}], ["Whilst the two samples showed similarities as to the kind of symptoms most frequently reported by students, the Egyptian sample had significantly higher frequency than the UK for every symptom.", {"entities": []}], ["Frequent complaints (both countries) included difficulties to concentrate, fatigue, headaches, nervousness/anxiety, and back pain (UK) and mood swings (Egypt).", {"entities": []}], ["Significantly more Egyptian students reported \u22654 symptoms over the past year than the UK.", {"entities": []}], ["For each of the UK and Egypt, across each of the four symptom groups, there was a stepladder appearance whereby the frequency of symptoms increased with increasing quartiles of perceived stress.", {"entities": []}], ["Not controlling for other variables, for both countries, there were significant positive correlations between each of the four symptom groups and stress; the highest correlation was for psychological symptoms.", {"entities": []}], ["After controlling for sex, age country, and other symptom groups, stress was highly and significantly associated with psychological symptoms and also with pain & aches symptoms in both countries.", {"entities": []}], ["UK students were generally less stressed than their counterparts in Egypt.", {"entities": []}], ["Age and female gender were also associated with stress; the younger the student was the more likely to suffer from stress.", {"entities": []}], ["Interactions were not significant.", {"entities": []}], ["Across both countries, the levels of stress among students and the associations between perceived stress and health complaints suggest the need for a multiple approaches in order to understand the sources of stress; how college students experience stress; and, the coping mechanisms that different students employ to mitigate stress.", {"entities": []}], ["Interventions aimed at both preventing, treating and caring for students\u2019 distress, and also preventive strategies to help minimize the impact of stressful situations are required.", {"entities": []}], ["Strategies that address both physical and psychological complaints may be beneficial for this population.", {"entities": []}], ["Chemokine ( CC motif) ligand 18 ( CCL 18) is involved in remodeling of the tumor microenvironment and plays critical roles in oncogenesis, invasiveness, and metastasis.", {"entities": []}], ["We previously investigated the overexpression of CCL 18 in primary oral squamous cell carcinoma ( OSCC ) tissues and its association with advanced clinical stage in OSCC patients.", {"entities": [[86, 95, "DISEASE"], [72, 95, "DISEASE"]]}], ["However, the underlying mechanisms of this CCL 18\u2010derived activity remains unidentified.", {"entities": []}], ["This study showed exogenous CCL 18 increased cell migration and invasion and induced cell epithelial\u2013mesenchymal transition ( EMT ), and that E\u2010cadherin, an epithelial marker, decreased and N\u2010cadherin, a mesenchymal marker, increased, compared to negative control in OSCC cells.", {"entities": []}], ["Furthermore, we detected that CCL 18 induced the acquisition of cancer stem(\u2010like) cell characteristics in oral cancer cells, but also found a significantly positive correlation between the expression of CCL 18 and Bmi\u20101 ( P \u00a0<\u00a00.001) in OSCC surgical specimens by immunohistochemistry analysis.", {"entities": [[64, 70, "DISEASE"], [112, 118, "DISEASE"]]}], ["The expression of octamer\u2010binding transcription factor 4 and Bmi\u20101 were significantly upregulated, and proportions of aldehyde dehydrogenase CD 133 CCL 18\u2010treated cells compared to untreated cells.", {"entities": []}], ["Sphere formation ability was observably enhanced when cells were continually exposed to high levels of CCL 18.", {"entities": []}], ["Moreover, CCL 18 upregulated Slug expression by stimulating the mammalian target of rapamycin ( mTOR ) signaling pathway in OSCC cell lines.", {"entities": [[96, 100, "GENE"]]}], ["Inhibition of the mTOR pathway by INK 128, or Slug knockdown by RNA interference, reversed CCL 18\u2010induced EMT and the stemness response at both molecular and functional levels.", {"entities": [[18, 22, "GENE"]]}], ["In conclusion, our data suggested that CCL 18 upregulated Slug expression to promote EMT and stem cell\u2010like features by activating the mTOR pathway in oral cancer.", {"entities": [[156, 162, "DISEASE"], [135, 139, "GENE"]]}], ["These findings provide new potential targets for the early diagnosis and treatment of OSCC.", {"entities": []}], ["Introduction.", {"entities": []}], ["Malnutrition is one of the most important causes for improper physical and mental development of children.", {"entities": []}], ["Childhood obesity is a worldwide public health problem.", {"entities": [[10, 17, "DISEASE"]]}], ["The increasing prevalence of childhood obesity has become a growing matter of public health concern worldwide.", {"entities": [[39, 46, "DISEASE"]]}], ["The aim of the current study was to determine the prevalence of malnutrition and obesity in children under 5 years old in Salmas district.", {"entities": [[81, 88, "DISEASE"]]}], ["The current study is a cross-sectional study conducted on 902 of children under 5 years old to assess the nutritional status in Salmas district and performed from 16 until 30 October, 2011, with the cooperation of the Office of Community Nutrition Improvement and the United Nations Children's Fund.", {"entities": []}], ["ENA (Emergency Nutrition Assessment) and Spss software were used for data analysis.", {"entities": []}], ["49.6% of children were boys and 50.4% were girls.", {"entities": []}], ["The prevalence of malnutrition based on underweight, stunting, and wasting was estimated to be 2.3%, 7.3%, and 1.4% among children, respectively.", {"entities": []}], ["Stunting was more common in rural areas and this difference was significant ( P < 0.001).", {"entities": []}], ["Conclusion.", {"entities": []}], ["In this area stunting, overweight and obesity were the most important priorities that health officials must pay more attention to.", {"entities": [[38, 45, "DISEASE"]]}], ["ENA software has a special ability to determine the samples and clusters and is a simple, rapid, and accurate method, especially in epidemiological studies in the country, and can be a convenient tool and its use is suggested for the same studies.", {"entities": []}], ["Ovomucoid (OM) has two carbohydrate chains on each of the first and second domains and one in the third.", {"entities": []}], ["The contribution of the covalently bound carbohydrate chains to the overall OM allergenicity is controversial.", {"entities": []}], ["Another aspect directly related with the immunological properties of OM that has not been studied in depth is the importance of the carbohydrate chains on its digestibility.", {"entities": []}], ["The aim of the study was to assess the involvement of the carbohydrate moieties of OM in its digestibility and allergenic properties.", {"entities": []}], ["IgE-binding and basophil activation by glycosylated and enzymatically deglycosylated OM (dOM) were compared using blood from egg-allergic patients.", {"entities": []}], ["The peptides obtained after digestion using a physiologically relevant model were identified by RP-HPLC-MS/MS and the IgE-binding of the resulting fragments was evaluated by DOT-Blot.", {"entities": []}], ["No structural changes were observed after deglycosylation of OM.", {"entities": []}], ["80% of the patients showed lower IgE binding to dOM as compared with OM and, in some patients, IgE reactivity could not be inhibited by pre-incubation with dOM.", {"entities": []}], ["A subtle reduction in the percentage of activated basophils was observed when incubated with dOM as compared to OM.", {"entities": []}], ["Following simulated digestion, dOM was more extensively degraded than OM, particularly during the gastric phase and both, OM and dOM, yielded, after the duodenal phase, immunoreactive fragments that were totally or partially coincident with previously described epitopes.", {"entities": []}], ["& Clinical Relevance : this work demonstrated an enhanced IgE reactivity towards carbohydrate containing OM in some egg-allergic patients that could be attributed to cross-sensitization or sensitization to the glycosylated components.", {"entities": []}], ["The carbohydrate chains contributed to an increased resistance to proteolysis, and thus, to its allergenic potency.", {"entities": []}], ["Evaluation of the products of digestion of OM and dOM revealed the presence of high-frequency IgE-binding epitopes that could remain linked by disulphide bonds.", {"entities": []}], ["Some studies have reported a high prevalence of bronchiectasis in patients with uncontrolled asthma, but the factors associated with this condition are unknown.", {"entities": [[48, 62, "DISEASE"], [93, 99, "DISEASE"]]}], ["The objective of this study was to determine the prevalence of bronchiectasis in uncontrolled moderate-to-severe asthma and to identify risk factors and their correlation with bronchiectasis in these patients.", {"entities": [[63, 77, "DISEASE"], [176, 190, "DISEASE"], [113, 119, "DISEASE"]]}], ["This is a prospective study of data from consecutive patients with uncontrolled moderate-to-severe asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["Diagnosis of bronchiectasis was based on high-resolution computed tomography.", {"entities": [[13, 27, "DISEASE"]]}], ["A prognostic score was developed using a logistic regression model, which was used to determine the factors associated with bronchiectasis.", {"entities": [[124, 138, "DISEASE"]]}], ["A total of 398 patients (60% with severe asthma) were included.", {"entities": [[41, 47, "DISEASE"]]}], ["The prevalence of bronchiectasis was 28.4%.", {"entities": [[18, 32, "DISEASE"]]}], ["The presence of bronchiectasis was associated with a higher frequency of chronic expectoration (OR, 2.95; 95% CI, 1.49\u20135.84; p \u2009=\u20090.002), greater severity of asthma (OR, 2.43; 95% CI, 1.29\u20134.57; p \u2009=\u20090.006), at least one previous episode of pneumonia (OR, 2.42; 95% CI, 1.03\u20135.69; p \u2009=\u20090.044), and lower levels of FeNO (OR, 0.98; 95% CI, 0.97\u20130.99; p \u2009=\u20090.016).", {"entities": [[241, 250, "DISEASE"], [16, 30, "DISEASE"], [158, 164, "DISEASE"]]}], ["The NOPES score was developed on the basis of these variables (Fe NO [cut off point 20.5\u00a0ppb], P neumonia, E xpectoration and asthma S everity), and it ranges from 0 to 4 points, where 0 means \u201cno risk\u201d and 4 corresponds to \u201chigh risk\u201d.", {"entities": [[126, 132, "DISEASE"]]}], ["The NOPES score yielded an AUC-ROC of 70% for the diagnosis of bronchiectasis, with a specificity of 95%.", {"entities": [[63, 77, "DISEASE"]]}], ["Almost a third of the patients with uncontrolled moderate-to-severe asthma had bronchiectasis.", {"entities": [[79, 93, "DISEASE"], [68, 74, "DISEASE"]]}], ["Bronchiectasis was related to the severity of asthma, the presence of chronic expectoration, a previous history of pneumonia, and lower levels of FeNO.", {"entities": [[115, 124, "DISEASE"], [0, 14, "DISEASE"], [46, 52, "DISEASE"]]}], ["The NOPES score is an easy-to-use scoring system with a high prognostic value for bronchiectasis in patients with uncontrolled moderate-to-severe asthma.", {"entities": [[82, 96, "DISEASE"], [146, 152, "DISEASE"]]}], ["Tumours of the central nervous system are the second most common group of childhood cancers in 0\u201314\u00a0year olds (24% of total cancers) and represent a major diagnostic group in 15\u201324\u00a0year olds.", {"entities": []}], ["The pilot case\u2013control study aimed to establish methodologies for a future comprehensive aetiological investigation among children and young adults.", {"entities": []}], ["Eligible cases were newly diagnosed with an intracranial tumour of neuroepithelial tissue aged 0\u201324\u00a0years.", {"entities": []}], ["The pilot recruited patients through Leeds and Manchester Principal Treatment Centres.", {"entities": []}], ["Controls were drawn from general practice lists.", {"entities": []}], ["Controls were frequency matched by age and gender.", {"entities": []}], ["We interviewed 49 cases and 78 controls comprising 85% of the target sample size.", {"entities": []}], ["Response rates were 52% for cases and 32% for controls.", {"entities": []}], ["Completion of the questionnaire was successful, with a very small proportion of missing data being reported (5-10%).", {"entities": []}], ["The age distribution of cases and controls was similar with around three-quarters of interviewed subjects aged 0\u201314.", {"entities": []}], ["Half of cases and almost two-thirds of controls reported using a mobile phone with the majority starting between 10\u201314\u00a0years of age.", {"entities": []}], ["Prevalence of breastfeeding was lower in cases than controls (Odds Ratio 0.4; 95% CI 0.2-1.2), whilst cases were more likely to be delivered by caesarean section (OR 1.6; 95% CI 0.6-4.4).", {"entities": []}], ["Cases were significantly more likely to have a birthweight >\u20093.5\u00a0kg compared to controls.", {"entities": []}], ["Cases were also more likely to come from a family with 3 or more siblings than controls (OR 3.0; 95% CI 0.7-13.6).", {"entities": []}], ["The majority of participants (>80%) were in favour of taking either blood or saliva to aid molecular epidemiological research.", {"entities": []}], ["Successful methods were established for identifying and recruiting a high proportion of case subjects, exploiting strong links with the clinical teams at the treatment centres.", {"entities": []}], ["Control procedures proved more difficult to implement.", {"entities": []}], ["However, working closely with national clinical and professional research networks will enable improved control identification and recruitment, with good prospects for collecting biological samples in the future.", {"entities": []}], ["Pulmonary function measures obtained by spirometry are used to diagnose chronic obstructive pulmonary disease (COPD) and are highly heritable.", {"entities": [[72, 109, "DISEASE"]]}], ["We conducted genome-wide association (GWA) analyses (Affymetrix 100K SNP GeneChip) for measures of lung function in the Framingham Heart Study.", {"entities": []}], ["Ten spirometry phenotypes including percent of predicted measures, mean spirometry measures over two examinations, and rates of change based on forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC), forced expiratory flow from the 25 25\u201375 ), the FEV 1 /FVC ratio, and the FEF 25\u201375 /FVC ratio were examined.", {"entities": [[184, 187, "GENE"], [270, 273, "GENE"], [184, 187, "GENE"], [270, 273, "GENE"]]}], ["Percent predicted phenotypes were created using each participant's latest exam with spirometry.", {"entities": []}], ["Predicted lung function was estimated using models defined in the set of healthy never-smokers, and standardized residuals of percent predicted measures were created adjusting for smoking status, pack-years, and body mass index (BMI).", {"entities": []}], ["All modeling was performed stratified by sex and cohort.", {"entities": []}], ["Mean spirometry phenotypes were created using data from two examinations and adjusting for age, BMI, height, smoking and pack-years.", {"entities": []}], ["Change in pulmonary function over time was studied using two to four examinations with spirometry to calculate slopes, which were then adjusted for age, height, smoking and pack-years.", {"entities": []}], ["Analyses were restricted to 70,987 autosomal SNPs with minor allele frequency \u2265 10%, genotype call rate \u2265 80%, and Hardy-Weinberg equilibrium p-value \u2265 0.001.", {"entities": []}], ["A SNP in the interleukin 6 receptor ( IL6R ) on chromosome 1 was among the best results for percent predicted FEF 25\u201375 .", {"entities": [[38, 42, "GENE"]]}], ["A non-synonymous coding SNP in glutathione S-transferase omega 2 ( GSTO2 ) on chromosome 10 had top-ranked results studying the mean FEV 1 and FVC measurements from two examinations.", {"entities": [[67, 72, "GENE"], [133, 136, "GENE"]]}], ["SNPs nearby the SOD3 and vitamin D binding protein genes, candidate genes for COPD, exhibited association to percent predicted phenotypes.", {"entities": [[16, 20, "GENE"]]}], ["GSTO2 and IL6R are credible candidate genes for association to pulmonary function identified by GWA.", {"entities": [[0, 5, "GENE"], [10, 14, "GENE"]]}], ["These and other observed associations warrant replication studies.", {"entities": []}], ["This resource of GWA results for pulmonary function measures is publicly available at .", {"entities": []}], ["Chemical mediators of inflammation (CMI) are important in host defense against infection.", {"entities": []}], ["The reduced capacity of host to induce the secretion of these mediators following infection is one of the factors in host susceptibility to infection.", {"entities": []}], ["Boron, which has been suggested for its role in infection, is reported in this study to increase lymphocyte proliferation and the secretion of CMI by the lipopolysaccharide (LPS)-stimulated peritoneal macrophages in BALB/c mice.", {"entities": []}], ["Boron was administered to mice orally as borax at different doses for 10 consecutive days, followed by the stimulation of animals with ovalbumin and isolation of splenocytes for proliferation assay.", {"entities": []}], ["The lymphocyte subsets were determined by flow cytometry in spleen cell suspension.", {"entities": []}], ["The mediators of inflammation, TNF-\u03b1, IL-6, IL-1\u03b2 and nitric oxide (NO), were measured in culture supernatant of LPS-primed macrophages isolated from borax treated mice.", {"entities": []}], ["TNF and ILs were measured by ELISA.", {"entities": [[0, 3, "GENE"]]}], ["NO was determined by Griess test.", {"entities": []}], ["The expression of inducible nitric oxide synthase (iNOS) in macrophages was studied by confocal microscopy.", {"entities": []}], ["Results showed a significant increase in T and B cell populations, as indicated by an increase in CD4 and CD19, but not CD8, cells.", {"entities": [[98, 101, "GENE"], [106, 110, "GENE"]]}], ["Boron further stimulated the secretion of TNF-\u03b1, IL-6, IL-1\u03b2, NO and the expression of iNOS by the LPS-primed macrophages.", {"entities": []}], ["The effect was dose dependent and most significant at a dose level of 4.6 mg/kg b. wt.", {"entities": []}], ["Taken together, the study concludes that boron at physiological concentration induces lymphocyte proliferation and increases the synthesis and secretion of pro-inflammatory mediators by the LPS-primed macrophages, more specifically the M1 macrophages, possibly acting through Toll-like receptor.", {"entities": []}], ["The study implicates boron as a regulator of the immune and inflammatory reactions and macrophage polarization, thus playing an important role in augmenting host defense against infection, with possible role in cancer and other diseases.", {"entities": [[211, 217, "DISEASE"]]}], ["Arginine is an amino acid that serves as a substrate for the enzymes nitric oxide synthase (NOS) and arginase, leading to synthesis of NO and ornithine, respectively.", {"entities": []}], ["As such, arginine has the potential to influence diverse fundamental processes in the lung.", {"entities": []}], ["We used mice deficient in cationic amino acid transporter (CAT) 2 in models of allergic airway inflammation and pulmonary fibrosis.", {"entities": [[112, 130, "DISEASE"]]}], ["We report that the arginine transport protein CAT2 was over-expressed in the lung during the induction of allergic airway inflammation.", {"entities": []}], ["Furthermore, CAT2 mRNA was strongly induced by transgenically over-expressed IL-4, and allergen-induced expression was dependent upon signal-transducer-and-activator-of-transcription (STAT) 6.", {"entities": []}], ["In situ mRNA hybridization demonstrated marked staining of CAT2, predominantly in scattered mononuclear cells.", {"entities": []}], ["Analysis of allergic airway inflammation and bleomycin-induced inflammation in CAT2-deficient mice revealed that while inflammation was independent of CAT2 expression, bleomycin-induced fibrosis was dependent upon CAT2.", {"entities": []}], ["Mechanistic analysis revealed that arginase activity in macrophages was partly dependent on CAT2.", {"entities": []}], ["Taken together, these results identify CAT2 as a regulator of fibrotic responses in the lung.", {"entities": []}], ["Osteoarthritis (OA) has traditionally been considered a condition of older age.", {"entities": []}], ["However, younger people are also affected by hip and knee OA, often as a result of sporting and work-related injuries.", {"entities": []}], ["As OA studies have generally focused on older individuals, little is known about the experience of younger adults with hip or knee OA who can face a distinct set of pressures including work responsibilities and parenting roles.", {"entities": []}], ["This study aims to investigate well-being and work participation among younger people with hip or knee OA, as well as preferences for OA education and support.", {"entities": []}], ["200 people aged 20\u201355\u2005years with a diagnosis of hip and/or knee OA will be recruited for this cross-sectional study.", {"entities": []}], ["Participants will be recruited from three major public hospitals in the state of Victoria, Australia following screening of orthopaedic outpatient clinic lists and referrals, and through community-based advertisements.", {"entities": []}], ["A study questionnaire will be mailed to all participants and written informed consent obtained.", {"entities": []}], ["Validated measures of Health-Related Quality of Life (HRQoL), health status, psychological distress and work limitations will be used.", {"entities": []}], ["Information on health services use will be collected, in addition to information on the perceived utility and accessibility of a range of existing and proposed education and peer support models.", {"entities": []}], ["HRQoL data will be compared with Australian population norms using independent t tests, and associations between HRQoL, health status, psychological distress, work limitations and demographic factors will be evaluated using univariate and multivariate analyses.", {"entities": []}], ["Data on the perceived utility and accessibility of education and peer support models will be analysed descriptively.", {"entities": []}], ["Ethics approval for the study has been obtained.", {"entities": []}], ["The study findings will be submitted to peer-reviewed journals and arthritis consumer organisations for broader dissemination, and presented at national and international scientific meetings.", {"entities": [[67, 76, "DISEASE"]]}], ["The involvement of VSX1 gene for the genetic basis of keratoconus is unclear and controversial.", {"entities": [[54, 65, "DISEASE"], [19, 23, "GENE"]]}], ["The genetic screening of VSX1 from different ethnic populations can enlighten this subject.", {"entities": [[25, 29, "GENE"]]}], ["The aim of the present study is to investigate the role of VSX1 gene in patients with sporadic cases of keratoconus from South India.", {"entities": [[104, 115, "DISEASE"], [59, 63, "GENE"]]}], ["The VSX1 gene coding regions, including exon-intron boundaries were screened by direct sequencing analysis in 117 sporadic cases of keratoconus.", {"entities": [[132, 143, "DISEASE"], [4, 8, "GENE"]]}], ["The identified variations were also analyzed in 108 ethnic matched healthy blood donors.", {"entities": []}], ["In the VSX 1 gene screening, no pathogenic mutation was identified, whereas we could find the presence of four reported single nucleotide polymorphisms; c.546A>G (rs12480307), c.627+23G>A (rs6138482), c.627+84T>A (rs56157240) and c.504-24C>T (IVS3-24C) .", {"entities": []}], ["These variations were observed in similar frequency between cases and controls.", {"entities": []}], ["The lack of VSX1 pathogenic variations in a large number of unrelated sporadic keratoconus patients tend to omit its role, and corroborate the involvement of other genetic, environmental or behavioural factors in the development of this complex disorder.", {"entities": [[79, 90, "DISEASE"], [12, 16, "GENE"]]}], ["The only existing NVP-specific quality of life (QOL) questionnaire is the \"Health-Related Quality of Life for Nausea and Vomiting during Pregnancy\" (NVPQOL).", {"entities": []}], ["However, the reliability and validity of the NVPQOL have never been established.", {"entities": []}], ["In order to justify its usage, the internal consistency and criterion validity of the NVPQOL questionnaire must be ascertained.", {"entities": []}], ["A prospective observational study including pregnant women attending CHU Sainte-Justine or Ren\u00e9-Laennec clinics for their prenatal care was conducted from 2004 to 2006.", {"entities": []}], ["Women were eligible if they were \u2265 18 years of age and \u2264 16 weeks of gestation at the time of their first prenatal visit.", {"entities": []}], ["During this initial visit, women who reported NVP were also asked to complete the NVPQOL and the SF-12.", {"entities": []}], ["Cronbach's alpha coefficients were calculated as the measures of the internal consistency of the NVPQOL.", {"entities": []}], ["With respect to the criterion validity, linear regression models were built to measure the association between the NVPQOL and the SF-12 scores.", {"entities": []}], ["Of the 367 women included in the study, 288 (78.5%) reported NVP in the first trimester of pregnancy.", {"entities": []}], ["Among these women, the Cronbach's alpha coefficients were high for the complete NVPQOL questionnaire (\u03b1 = 0.98), and for the four distinct domains [physical symptoms and aggravating factors (\u03b1 = 0.90); fatigue (\u03b1 = 0.94); emotions (\u03b1 = 0.86); limitations (\u03b1 = 0.97)].", {"entities": []}], ["NVP-specific QOL as measured by the NVPQOL was significantly associated with physical and mental QOL as measured by the SF-12.", {"entities": []}], ["Our data suggest that the NVPQOL is a reliable and valid index to measure NVP-specific QOL in the first trimester of pregnancy.", {"entities": []}], ["No current patient-centred instrument captures all dimensions of physical activity in chronic obstructive pulmonary disease (COPD).", {"entities": [[86, 123, "DISEASE"]]}], ["Our objective was item reduction and initial validation of two instruments to measure physical activity in COPD.", {"entities": []}], ["Physical activity was assessed in a 6-week, randomised, two-way cross-over, multicentre study using PROactive draft questionnaires (daily and clinical visit versions) and two activity monitors.", {"entities": []}], ["Item reduction followed an iterative process including classical and Rasch model analyses, and input from patients and clinical experts.", {"entities": []}], ["236 COPD patients from five European centres were included.", {"entities": []}], ["Results indicated the concept of physical activity in COPD had two domains, labelled \u201camount\u201d and \u201cdifficulty\u201d.", {"entities": []}], ["After item reduction, the daily PROactive instrument comprised nine items and the clinical visit contained 14.", {"entities": []}], ["Both demonstrated good model fit (person separation index >0.7).", {"entities": []}], ["Confirmatory factor analysis supported the bidimensional structure.", {"entities": []}], ["Both instruments had good internal consistency (Cronbach's \u03b1>0.8), test\u2013retest reliability (intraclass correlation coefficient \u22650.9) and exhibited moderate-to-high correlations (r>0.6) with related constructs and very low correlations (r<0.3) with unrelated constructs, providing evidence for construct validity.", {"entities": []}], ["Daily and clinical visit \u201cPROactive physical activity in COPD\u201d instruments are hybrid tools combining a short patient-reported outcome questionnaire and two activity monitor variables which provide simple, valid and reliable measures of physical activity in COPD patients.", {"entities": []}], ["Both PROactive hybrid tools are simple, valid, and reliable measures of physical activity in COPD patients http://ow.ly/LJqP8", {"entities": []}], ["We examine the association between family structure and children\u2019s health care utilization, barriers to health care access, health, and schooling and cognitive outcomes and assess whether socioeconomic status (SES) accounts for those family structure differences.", {"entities": []}], ["We advance prior research by focusing on understudied but increasingly common family structures including single father families and five different family structures that include grandparents.", {"entities": []}], ["Our data on United States children aged birth through 17 (unweighted N\u2009=\u2009198,864) come from the 1997\u20132013 waves of the National Health Interview Survey, a nationally representative, publicly available, household-based sample.", {"entities": []}], ["We examine 17 outcomes across nine family structures, including married couple, cohabiting couple, single mother, and single father families, with and without grandparents, and skipped-generation families that include children and grandparents but not parents.", {"entities": []}], ["The SES measures include family income, home ownership, and parents\u2019 or grandparents\u2019 (depending on who is in the household) employment and education.", {"entities": []}], ["Compared to children living with married couples, children in single mother, extended single mother, and cohabiting couple families average poorer outcomes, but children in single father families sometimes average better health outcomes.", {"entities": []}], ["The presence of grandparents in single parent, cohabiting, or married couple families does not buffer children from adverse outcomes.", {"entities": []}], ["SES only partially explains family structure disparities in children\u2019s well-being.", {"entities": []}], ["All non-married couple family structures are associated with some adverse outcomes among children, but the degree of disadvantage varies across family structures.", {"entities": []}], ["Efforts to understand and improve child well-being might be most effective if they recognize the increasing diversity in children\u2019s living arrangements.", {"entities": []}], ["In type 2 diabetes, hyperglycemia, insulin resistance, increased inflammation, and oxidative stress were shown to be associated with the progressive deterioration of beta-cell function and mass.", {"entities": [[20, 33, "DISEASE"]]}], ["Short-chain fatty acids (SCFAs) are organic fatty acids produced in the distal gut by bacterial fermentation of macrofibrous material that might improve type 2 diabetes features.", {"entities": []}], ["Their main beneficial activities were identified in the decrease of serum levels of glucose, insulin resistance as well as inflammation, and increase in protective Glucagon-like peptide-1 (GLP-1) secretion.", {"entities": []}], ["In this review, we updated evidence on the effects of SCFAs potentially improving metabolic control in type 2 diabetes.", {"entities": []}], ["In this research, we investigated the public health risks associated with atmospheric exposure to PM 2.5 for different subpopulations (black, white, Hispanic, youth, adults, and elderly) in the Washington, DC area.", {"entities": []}], ["Washington, DC has long been considered a non-healthy place to live according to the American Lung Association due to its poor air quality.", {"entities": []}], ["This recognition clearly includes the negative PM-related human health effects within the region.", {"entities": []}], ["Specifically, DC fine particulate matter (PM 2.5 ) [or particulate matter with an aerodynamic diameter less than 2.5 \u03bcm] poses notable health risks to subpopulations having an annual mean value of 16.70 \u03bcg/m", {"entities": []}], ["Microglia mediate amyloid-beta peptide (A\u03b2)-induced neuroinflammation, which is one of the key events in the pathogenesis of Alzheimer\u2019s disease (AD).", {"entities": []}], ["Decoy receptor 3 (DcR3)/TNFRSF6B is a pleiotropic immunomodulator that promotes macrophage differentiation toward the M2 anti-inflammatory phenotype.", {"entities": []}], ["Based on its role as an immunosupressor, we examined whether DcR3 could alleviate neuroinflammation and AD-like deficits in the central nervous system.", {"entities": []}], ["We crossed human APP transgenic mice (line J20) with human DcR3 transgenic mice to generate wild-type, APP, DcR3, and APP/DcR3 mice for pathological analysis.", {"entities": [[17, 20, "GENE"], [103, 106, "GENE"], [118, 121, "GENE"], [17, 20, "GENE"], [103, 106, "GENE"], [118, 121, "GENE"]]}], ["The Morris water maze, fear conditioning test, open-field, and elevated-plus maze were used to access their cognitive behavioral changes.", {"entities": []}], ["Furthermore, the pathological and immune profiles were examined by immunostaining, ELISA, Q-PCR, and IP.", {"entities": []}], ["In vitro assays were designed to examine DcR3-mediated innate cytokine profile alteration and the potential protective mechanism.", {"entities": []}], ["We reported that DcR3 ameliorates hippocampus-dependent memory deficits and reduces amyloid plaque deposition in APP transgenic mouse.", {"entities": [[113, 116, "GENE"]]}], ["The protective mechanism of DcR3 mediates through interacting with heparan sulfate proteoglycans and activating IL-4 The neuroprotective effect of DcR3 is mediated via modulating microglia activation into anti-inflammatory M2a phenotype, and upregulating DcR3 expression in the brain may be a potential therapeutic approach for AD.", {"entities": []}], ["The online version of this article (doi:10.1186/s13024-017-0173-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mutation on both the copies of cystic fibrosis transmembrane conductance regulator ( CFTR ) gene results in cystic fibrosis (CF), which is a recessively transmitted genetic disorder.", {"entities": [[31, 46, "DISEASE"], [108, 123, "DISEASE"], [165, 181, "DISEASE"], [85, 89, "GENE"]]}], ["It is hypothesized that individuals heterozygous for CFTR gene mutation may develop obstructive pulmonary diseases like asthma.", {"entities": [[120, 126, "DISEASE"], [53, 57, "GENE"]]}], ["There is great heterogeneity in the phenotypic presentation and severity of CF lung disease.", {"entities": [[79, 91, "DISEASE"]]}], ["This could be due to genetic or environmental factors.", {"entities": []}], ["Several modifier genes have been identified which may directly or indirectly interact with CFTR pathway and affect the severity of disease.", {"entities": [[91, 95, "GENE"]]}], ["This review article discusses the information related to the association of CFTR gene mutation with asthma.", {"entities": [[100, 106, "DISEASE"], [76, 80, "GENE"]]}], ["Association between CFTR gene mutation and asthma is still unclear.", {"entities": [[43, 49, "DISEASE"], [20, 24, "GENE"]]}], ["Report ranges from studies showing positive or protective association to those showing no association.", {"entities": []}], ["Therefore, studies with sufficiently large sample size and detailed phenotype are required to define the potential contribution of CFTR in the pathogenesis of asthma.", {"entities": [[159, 165, "DISEASE"], [131, 135, "GENE"]]}], ["Ambient and indoor temperature affects thermal comfort and human health.", {"entities": []}], ["In a changing climate with a predicted change in temperature extremes, understanding indoor temperatures, both hot and cold, of different housing types is important.", {"entities": []}], ["This study aimed to assess the hourly, daily and monthly variation in indoor temperatures in different housing types, namely formal houses, informal houses, flats, government-built low-cost houses and old, apartheid era low-cost housing, in five impoverished urban communities in Johannesburg, South Africa.", {"entities": []}], ["During the cross-sectional survey of the Health, Environment and Development study data loggers were installed in 100 homes (20 per suburb) from February to May 2014.", {"entities": []}], ["Indoor temperature and relative humidity were recorded on an hourly basis.", {"entities": []}], ["Ambient outdoor temperatures were obtained from the nearest weather station.", {"entities": []}], ["Indoor and outdoor temperature and relative humidity levels were compared; and an inter-comparison between the different housing types were also made.", {"entities": []}], ["Apparent temperature was calculated to assess indoor thermal comfort.", {"entities": []}], ["Data from 59 retrieved loggers showed a significant difference in monthly mean indoor temperature between the five different housing types ( p < 0.0001).", {"entities": []}], ["Low cost government-built houses and informal settlement houses had the greatest variation in temperature and experienced temperatures between 4 and 5 \u00b0C warmer than outdoor temperatures.", {"entities": []}], ["Housing types occupied by poor communities experienced indoor temperature fluctuations often greater than that observed for ambient temperatures.", {"entities": []}], ["Families living in government-built low-cost and informally-constructed homes are the most at risk for indoor temperature extremes.", {"entities": []}], ["These types of housing should be prioritised for interventions aimed at assisting families to cope with extreme temperatures, gaining optimal thermal comfort and preventing temperature-related health effects.", {"entities": []}], ["Lactoferrin in commercial supplements is known to exert anti\u2010viral and anti\u2010allergic effects.", {"entities": []}], ["However, this is the first study to evaluate the induction of allergic airway inflammation in NC /Nga mice.", {"entities": []}], ["Human lactoferrin was administered intraperitoneally with aluminum oxide for sensitization.", {"entities": []}], ["Five days later, lactoferrin was inoculated intranasally for 5\u00a0days, and then on the 12th day, the single inoculation of lactoferrin intranasally was performed as a challenge.", {"entities": []}], ["On the 13th day, airway hypersensitivity was assessed ( AHR ), a bronchoalveolar fluid ( BALF ) cell analysis was conducted, serum IgE and serum lactoferrin\u2010specific IgG and IgE levels as well as the mRNA expression levels of cytokines and chemokines in the lung were measured, and a histopathological analysis of the lung was performed.", {"entities": [[56, 59, "GENE"]]}], ["Human lactoferrin increased AHR , the number of eosinophils in BALF , serum lactoferrin\u2010specific IgG levels, and the mRNA levels of IL \u201013, eotaxin 1, and eotaxin 2.", {"entities": [[28, 31, "GENE"]]}], ["Moreover, the accumulation of inflammatory cells around the bronchus and the immunohistochemical localization of arginase I and human lactoferrin were detected.", {"entities": []}], ["Collectively, these results indicate that human lactoferrin induced allergic airway inflammation in mice.", {"entities": []}], ["Therefore, the commercial use of human lactoferrin in supplements warrants more intensive study.", {"entities": []}], ["Nuclear factor (NF)-\u03baB is regarded as one of the most important transcription factors and plays an essential role in the transcriptional activation of pro-inflammatory cytokines, cell proliferation and survival.", {"entities": []}], ["NF-\u03baB can be activated via two distinct NF-\u03baB signal transduction pathways, the so-called canonical and non-canonical pathways, and has been demonstrated to play a key role in a wide range of inflammatory diseases and various types of cancer.", {"entities": [[235, 241, "DISEASE"]]}], ["Much effort has been put in strategies to inhibit NF-\u03baB activation, for example by the development of pharmacological compounds that selectively inhibit NF-\u03baB activity and therefore would be beneficial for immunotherapy of transplantation, autoimmune and allergic diseases, as well as an adjuvant approach in patients treated with chemotherapy for cancer.", {"entities": [[348, 354, "DISEASE"]]}], ["Gene therapy targeting NF-\u03baB is a promising new strategy with the potential of long-term effects and has been explored in a wide variety of diseases, ranging from cancer to transplantation medicine and autoimmune diseases.", {"entities": [[163, 169, "DISEASE"]]}], ["In this review we discuss recent progress made in the development of NF-\u03baB targeted gene therapy and the evolution towards clinical application.", {"entities": []}], ["Pulmonary diseases [asthma, chronic obstructive pulmonary disease (COPD), and tuberculosis (TB)] are associated with lung cancer mortality.", {"entities": [[117, 128, "DISEASE"], [28, 65, "DISEASE"], [78, 90, "DISEASE"], [20, 26, "DISEASE"], [122, 128, "DISEASE"]]}], ["However, the relationship between coexisting pulmonary diseases and survival in patients with lung squamous cell carcinoma (SqCC) has not been well defined.", {"entities": [[113, 122, "DISEASE"], [99, 122, "DISEASE"], [94, 122, "DISEASE"]]}], ["Patients newly diagnosed with SqCC between 2003 and 2008 were identified by linking the National Health Insurance Research Database and Taiwan Cancer Registry Database.", {"entities": [[143, 149, "DISEASE"]]}], ["Cases with SqCC were followed up until death, loss to follow-up, or study end in 2010.", {"entities": []}], ["Information on health status, date of death and the main causes of death was ascertained from the National Death Registry Database.", {"entities": []}], ["Cox proportional hazard regression was used to calculate the hazard ratio (HR) of coexisting asthma, COPD and/or TB.", {"entities": [[93, 99, "DISEASE"], [75, 77, "GENE"]]}], ["During the study period, a total of 5406 cases with SqCC were enrolled.", {"entities": []}], ["For all cause-mortality, HRs were 1.08 [95% confidence interval (CI), 0.99\u20131.18], 1.04 (95% CI, 0.97\u20131.12), and 1.14 (95% CI, 1.00\u20131.31) for individuals with asthma, COPD, and TB, respectively.", {"entities": [[158, 164, "DISEASE"]]}], ["Specifically, among men with coexisting pulmonary diseases, the HRs were 1.56 (95% CI, 1.23\u20131.97) and 1.11 (95% CI, 1.00\u20131.24) for individuals with asthma+COPD+TB and asthma+COPD, respectively.", {"entities": [[148, 154, "DISEASE"], [167, 173, "DISEASE"]]}], ["Among male patients with stage III SqCC, HRs were 3.41 (95%CI, 1.27\u20139.17) and 1.65 (95%CI, 1.10\u20132.47) for individuals with asthma+TB and asthma+COPD+TB, respectively.", {"entities": [[123, 129, "DISEASE"], [137, 143, "DISEASE"]]}], ["Among male patients with stage IV SqCC, HRs were 1.40 (95%CI, 1.00\u20131.97) and 1.25 (95%CI, 1.03\u20131.52) for individuals with asthma+ COPD+TB and asthma.", {"entities": [[122, 128, "DISEASE"], [142, 148, "DISEASE"]]}], ["Among female patients with stage I and II, HR was 0.19 (95%CI, 005\u20130.77) for individuals with asthma.", {"entities": [[94, 100, "DISEASE"], [43, 45, "GENE"]]}], ["Coexisting pulmonary diseases increased the risk of mortality from SqCC in male patients.", {"entities": []}], ["For female patients with early stage SqCC, pre-existing asthma decreased mortality.", {"entities": [[56, 62, "DISEASE"]]}], ["These patients deserve greater attention while undergoing cancer treatment.", {"entities": [[58, 64, "DISEASE"]]}], ["For almost 2000 years it has been recognized that aqueous extracts from pine cones possess medicinal properties beneficial for the treatment of a broad variety of diseases and conditions.", {"entities": []}], ["In this report, the ability of an orally administered poly phenylpropanoid-polysaccharide rich extract of pine cones (PPC) to suppress the generation of IgE and to significantly enhance antigen-specific cellular responses to a variety of vaccines was tested.", {"entities": []}], ["A variety of vaccine protocols were utilized to determine the affects of orally administered PPC on the Th1/Th2 cytokine balance, the production of IgE antibodies, and the generation of antigen-specific cytotoxic T cells.", {"entities": []}], ["The effect of PPC on the Th1/Th2 balance in aged mice was also investigated.", {"entities": []}], ["Oral delivery of PPC was found to significantly suppress serum IgE levels in na\u00efve mice and in mice sensitized to ovalbumin.", {"entities": []}], ["PPC was also found to enhance the generation of antigen-specific CD8 \u03b3 by antigen-stimulated splenocytes from PPC treated mice.", {"entities": []}], ["PPC also suppressed the Th2 response and enhanced the Th1 response of splenocytes from aged mice.", {"entities": []}], ["Oral delivery of PPC enhances the generation of an antigen-specific CD8", {"entities": []}], ["The gut is the largest endocrine organ of the body, with hormone-secreting enteroendocrine cells located along the length of the gastrointestinal epithelium.", {"entities": []}], ["Despite their physiological importance, enteroendocrine cells represent only a small fraction of the epithelial cell population and in the past, their characterization has presented a considerable challenge resulting in a reliance on cell line models.", {"entities": []}], ["Here, we provide a detailed protocol for the isolation and culture of mixed murine small intestinal cells.", {"entities": []}], ["These primary cultures have been used to identify the signaling pathways underlying the stimulation and inhibition of gut peptide secretion in response to a number of nutrients and neuropeptides as well as pharmacological agents.", {"entities": []}], ["Furthermore, in combination with the use of transgenic fluorescent reporter mice, we have demonstrated that these primary cultures become a powerful tool for the examination of fluorescently-tagged enteroendocrine cells at the intracellular level, using methods such as patch clamping and single-cell calcium and cAMP-FRET imaging.", {"entities": []}], ["The prevalence of asthma and allergic diseases has increased in industrialised countries, and it is known that rates vary according whether the area is urban or rural and to socio-economic status.", {"entities": [[18, 24, "DISEASE"]]}], ["Surveys conducted in some urban settings in Latin America found high prevalence rates, only exceeded by the rates observed in industrialised English-speaking countries.", {"entities": []}], ["It is likely that the marked changes in the environment, life style and living conditions in Latin America are responsible for these observations.", {"entities": []}], ["The understanding of the epidemiological and immunological changes that underlie the increase in asthma and allergic diseases in Latin America aimed by SCAALA studies in Brazil and Ecuador will be crucial for the identification of novel preventive interventions.", {"entities": [[97, 103, "DISEASE"]]}], ["The Salvador-SCAALA project described here is a longitudinal study involving children aged 4\u201311 years living in the city of Salvador, Northeastern Brazil.", {"entities": []}], ["Data on asthma and allergic diseases (rhinitis and eczema) and potential risk factors will be collected in successive surveys using standardised questionnaire.", {"entities": [[38, 46, "DISEASE"], [8, 14, "DISEASE"]]}], ["This will be completed with data on dust collection (to dust mite and endotoxin), skin test to most common allergens, stool examinations to helminth and parasites, blood samples (to infection, total and specific IgE, and immunological makers), formaldehyde, physical inspection to diagnoses of eczema, and anthropometric measures.", {"entities": []}], ["Data on earlier exposures when these children were 0\u20133 years old are available from a different project.", {"entities": []}], ["It is expected that knowledge generated may help identify public health interventions that may enable countries in LA to enjoy the benefits of a \"modern\" lifestyle while avoiding \u2013 or minimising \u2013 increases in morbidity caused by asthma and allergies.", {"entities": [[230, 236, "DISEASE"]]}], ["The use of antidepressants during pregnancy is common.", {"entities": []}], ["Some studies suggest an association between in utero exposure to antidepressants and the occurrence of pulmonary diseases like asthma later in life.", {"entities": [[127, 133, "DISEASE"]]}], ["Serotonin reuptake inhibitors (SSRIs) as well tricyclic antidepressants (TCAs) are thought to be involved in the development of the respiratory rhythm generator (RRG) and the maturation of the formation of surfactant.", {"entities": []}], ["In this study the use of drugs for pulmonary diseases in children who were exposed to antidepressants in utero were compared with non-exposed children.", {"entities": []}], ["The pharmacy prescription database IADB.nl was used for a cohort study in which the use of drugs for pulmonary disease in children after in utero exposure to antidepressants (TCAs, SSRIs) was compared with children with no antidepressant exposure in utero.", {"entities": []}], ["Drugs for pulmonary diseases were applied as a proxy for disturbed development of the respiratory tract.", {"entities": []}], ["A small though significant increase in the incidence risk ratio (IRR) of the use of drugs for pulmonary disease was found after any-time in utero exposure to SSRIs, adjusted for maternal use of antibiotics, of 1.17 (95\u00a0% CI 1.16\u20131.18).", {"entities": []}], ["An increase was also seen when we looked specifically for the use of SSRIs in at least the first trimester (IRR\u2009=\u20091.18, 95\u00a0% CI 1.17\u20131.20).", {"entities": []}], ["An increased IRR in the use of drugs for pulmonary disease was also seen when children were exposed to TCAs, but this was not statistically significant.", {"entities": []}], ["However, in both groups our sample size was rather small.", {"entities": []}], ["The effect size is modest and may also be confounded by maternal smoking.", {"entities": []}], ["In utero exposure to SSRIs leads to a statistically significant increase in the use of drugs for pulmonary diseases, especially when exposure occurred during the first trimester of pregnancy.", {"entities": []}], ["The increase in the use of drugs for pulmonary disease may also be related to other factors.", {"entities": []}], ["Therefore, further study is recommended.", {"entities": []}], ["We assessed vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza in children 6 months to 15 years of age in 22 hospitals in Japan during the 2013\u201314 season.", {"entities": [[88, 97, "DISEASE"]]}], ["Our study was conducted according to a test-negative case-control design based on influenza rapid diagnostic test (IRDT) results.", {"entities": [[82, 91, "DISEASE"]]}], ["Outpatients who came to our clinics with a fever of 38\u00b0C or over and had undergone an IRDT were enrolled in this study.", {"entities": []}], ["Patients with positive IRDT results were recorded as cases, and patients with negative results were recorded as controls.", {"entities": []}], ["Between November 2013 and March 2014, a total of 4727 pediatric patients (6 months to 15 years of age) were enrolled: 876 were positive for influenza A, 66 for A(H1N1)pdm09 and in the other 810 the subtype was unknown; 1405 were positive for influenza B; and 2445 were negative for influenza.", {"entities": [[140, 149, "DISEASE"], [242, 251, "DISEASE"], [282, 291, "DISEASE"]]}], ["Overall VE was 46% (95% confidence interval [CI], 39\u201352).", {"entities": []}], ["Adjusted VE against influenza A, influenza A(H1N1)pdm09, and influenza B was 63% (95% CI, 56\u201369), 77% (95% CI, 59\u201387), and 26% (95% CI, 14\u201336), respectively.", {"entities": [[20, 29, "DISEASE"], [33, 42, "DISEASE"], [61, 70, "DISEASE"]]}], ["Influenza vaccine was not effective against either influenza A or influenza B in infants 6 to 11 months of age.", {"entities": [[0, 9, "DISEASE"], [51, 60, "DISEASE"], [66, 75, "DISEASE"]]}], ["Two doses of influenza vaccine provided better protection against influenza A infection than a single dose did.", {"entities": [[13, 22, "DISEASE"], [66, 75, "DISEASE"]]}], ["VE against hospitalization influenza A infection was 76%.", {"entities": [[27, 36, "DISEASE"]]}], ["Influenza vaccine was effective against influenza A, especially against influenza A(H1N1)pdm09, but was much less effective against influenza B.", {"entities": [[0, 9, "DISEASE"], [40, 49, "DISEASE"], [72, 81, "DISEASE"], [132, 141, "DISEASE"]]}], ["The working group on tropospheric ozone of the Health Effects Institute has evaluated the need for epidemiologic studies on the health effects of ozone (O3) exposure.", {"entities": []}], ["This paper summarizes current data and identifies possible research questions.", {"entities": []}], ["The extent to which ozone exposure results in chronic health effects is largely undefined and is the central issue for epidemiologic studies.", {"entities": []}], ["Most current data focus on transient endpoints; the link between acute changes in symptoms and/or lung function and possible chronic effects has not been established.", {"entities": []}], ["Concepts of ozone-induced health effects have been extended to include processes of chronic disease (e.g., markers of ongoing inflammation and repair, markers of accelerated lung aging).", {"entities": []}], ["Traditional epidemiologic studies performed have focused only on accelerated lung aging and are limited by a number of methodologic problems.", {"entities": []}], ["Recent, very preliminary, studies suggest new opportunities for the use of human lung tissue and a variety biological response markers as part of epidemiologic studies.", {"entities": []}], ["The identification of sensitive subpopulations with regard to ozone-induced health effects has been studied incompletely and is important both in terms of study efficiency and mechanistic insight.", {"entities": []}], ["Methodologic advances in the reconstruction of past ozone exposure are seen as essential, as is the incorporation of emerging markers of biologic response to ozone into traditional epidemiologic study designs.", {"entities": []}], ["Finally, more data on the joint and independent contribution of other ambient air pollutants to putative ozone-induced health effects is warranted.", {"entities": []}], ["Adverse childhood experiences (ACEs) can affect people's health and wellbeing not only at the time the ACE is experienced, but also later in life.", {"entities": []}], ["The majority of studies on ACEs are carried out in high-income countries and little is known about its prevalence in low and middle-income countries.", {"entities": []}], ["Thus, the aim of this study was to assess the prevalence of ACEs, associations between ACEs and sociodemographic factors, and the interrelationship between types of ACEs in adolescents of a Brazilian birth cohort.", {"entities": []}], ["Data from 3,951 adolescents (78.4% of the original cohort) from the 1993 Pelotas Cohort were analyzed.", {"entities": []}], ["Seven types of ACEs were assessed in those up to 18 years old: physical abuse, sexual abuse, physical neglect, emotional neglect, domestic violence, parental separation and parental death.", {"entities": []}], ["The most common ACE was parental separation (42%), followed by emotional neglect (19.7%) and domestic violence (10.3%).", {"entities": []}], ["Approximately 85% of the adolescents experienced at least one ACE, and females reported a higher number of adversities.", {"entities": []}], ["Several socioeconomic, demographic and family-related characteristics were associated with the occurrence of ACEs, e.g.", {"entities": []}], ["non-white skin color, low family income, low maternal schooling, absence of mother's partner, maternal smoking, and poor maternal mental health.", {"entities": []}], ["A strong interrelationship was observed among the ACEs, indicating clustering of risk.", {"entities": []}], ["These aspects should be considered by health and social care professionals in the prevention and identification of childhood adversities.", {"entities": []}], ["Innate immunity receptors play a critical role in host defence, as well as in allergy and asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["The aim of this exploratory study was to evaluate whether there are associations between TLR7 rs179008, TLR8 rs2407992, TLR9 rs187084 or TLR10 rs4129009 polymorphisms and viral findings, clinical characteristics or subsequent wheezing in infants with bronchiolitis.", {"entities": [[251, 264, "DISEASE"], [89, 93, "GENE"], [104, 108, "GENE"], [120, 124, "GENE"], [137, 142, "GENE"]]}], ["In all, 135 full-term infants were hospitalized for bronchiolitis at age less than 6 months: 129 of them were followed-up until the age of 1.5 years.", {"entities": [[52, 65, "DISEASE"]]}], ["The outcome measures were repeated wheezing, use of inhaled corticosteroids, atopic dermatitis during the first 1.5 years of life and total serum immunoglobulin E (IgE).", {"entities": [[77, 94, "DISEASE"], [84, 94, "DISEASE"]]}], ["There were no significant associations between the genotypes or allele frequencies of TLR7 rs179008, TLR8 rs2407992, TLR9 rs187084 or TLR10 rs4129009 polymorphisms and clinical characteristics or the severity of bronchiolitis during hospitalization.", {"entities": [[212, 225, "DISEASE"], [86, 90, "GENE"], [101, 105, "GENE"], [117, 121, "GENE"], [134, 139, "GENE"]]}], ["During follow-up, repeated wheezing was more common in children with TLR9 rs187084 variant genotype CC (30.5%) than in children with TLR9 wild-type genotype TT (12.2%) (p\u2009=\u20090.02, aOR 2.73, 95% CI 1.02\u20137.29).", {"entities": [[69, 73, "GENE"], [133, 137, "GENE"], [69, 73, "GENE"], [133, 137, "GENE"]]}], ["The TLR10 rs4129009 minor allele G was associated with elevated total serum IgE.", {"entities": [[4, 9, "GENE"]]}], ["TLR9 rs187084 gene polymorphism may be associated with post-bronchiolitis wheezing, and TLR10 rs4129009 gene polymorphism may be associated with atopy.", {"entities": [[60, 73, "DISEASE"], [0, 4, "GENE"], [88, 93, "GENE"]]}], ["The study aims to investigate sleep duration in four different population groups in a national probability sample of older South Africans who participated in the Study of Global Ageing and Adult Health (SAGE) Wave 1.", {"entities": []}], ["A national population-based cross-sectional study with a sample of 3284 aged 50 years or older in South Africa was conducted in 2008.", {"entities": []}], ["The questionnaire included socio-demographic characteristics, health variables, and self-reported sleep duration.", {"entities": []}], ["Results indicate that White Africans compared to other population groups had the lowest mean sleep duration (7.88 h among men and 7.46 h among women).", {"entities": []}], ["The prevalence of short sleep was the highest among both men and women among the White African (18.8% in men and 16.9% in women) and Indian or Asian African population groups (14.5% in men and 17.1% in women), and lowest among both men and women in the Black African (7.0% in men and 6.5% in women) and multi-ancestry population groups (15.6% in men and 12.7% in women).", {"entities": []}], ["The prevalence of long sleep was among both men and women the highest in the Black African population group (56.2% in men and 58.5% in women), and the lowest in the White African population group (36.4% in men and 24.3% in women).", {"entities": []}], ["In a Poisson regression model, adjusted for sociodemographics and chronic disease status, coming from the male and female White African population group was associated with short sleep.", {"entities": []}], ["In addition, coming from the Indian or Asian African population group was associated with short sleep.", {"entities": []}], ["No population group differences were found regarding long sleep prevalence.", {"entities": []}], ["White Africans reported more short sleep duration than the other population groups, while there were no racial or ethnic differences in long sleep.", {"entities": []}], ["White Africans are more likely to have sleep durations that are associated with negative health outcomes.", {"entities": []}], ["An explanation of the high short sleep prevalence among White Africans may be related to their racial or ethnic minority status in South Africa.", {"entities": []}], ["Learning in small group tutorials is appreciated by students and effective in the acquisition of clinical problem-solving skills but poses financial and resource challenges.", {"entities": []}], ["Interactive seminars, which accommodate large groups, might be an alternative.", {"entities": []}], ["This study examines the educational effectiveness of small group tutorials and interactive seminars and students' preferences for and satisfaction with these formats.", {"entities": []}], ["Students in year three of the Leiden undergraduate medical curriculum, who agreed to participate in a randomized controlled trial (RCT, n = 107), were randomly allocated to small group tutorials (n = 53) or interactive seminars (n = 54).", {"entities": []}], ["Students who did not agree were free to choose either format (n = 105).", {"entities": []}], ["Educational effectiveness was measured by comparing the participants' results on the end-of-block test.", {"entities": []}], ["Data on students' reasons and satisfaction were collected by means of questionnaires.", {"entities": []}], ["Data was analyzed using student unpaired t test or chi-square test where appropriate.", {"entities": []}], ["There were no significant differences between the two educational formats in students' test grades.", {"entities": []}], ["Retention of knowledge through active participation was the most frequently cited reason for preferring small group tutorials, while a dislike of compulsory course components was mentioned more frequently by students preferring interactive seminars.", {"entities": []}], ["Small group tutorials led to greater satisfaction.", {"entities": []}], ["We found that small group tutorials leads to greater satisfaction but not to better learning results.", {"entities": []}], ["Interactive learning in large groups might be might be an effective alternative to small group tutorials in some cases and be offered as an option.", {"entities": []}], ["We report prospectively recorded observational data from consecutive cases in which the attending pre-hospital critical care anaesthesiologist considered performing pre-hospital advanced airway management but decided to withhold such interventions.", {"entities": []}], ["Anaesthesiologists from eight pre-hospital critical care teams in the Central Denmark Region (a mixed rural and urban region with 1.27 million inhabitants) registered data from February 1 We registered data from 1081 cases in which the pre-hospital critical care anaesthesiologists\u2019 considered performing pre-hospital advanced airway management.", {"entities": []}], ["The anaesthesiologists decided to withhold pre-hospital advanced airway management in 32.1% of these cases (n =\u2009347).", {"entities": []}], ["In 75.1% of these cases (n =\u2009257) pre-hospital advanced airway management were withheld because of the patient\u2019s condition and in 30.8% (n =\u2009107) because of patient co-morbidity.", {"entities": []}], ["The most frequently used alternative treatment was bag-mask ventilation, used in 82.7% of the cases (n =\u2009287).", {"entities": []}], ["Immediate complications related to the decision of not performing pre-hospital advanced airway management occurred in 0.6% of the cases (n =\u20092).", {"entities": []}], ["We have illustrated the complexity of the critical decision-making associated with pre-hospital advanced airway management.", {"entities": []}], ["This study is the first to identify the most common reasons why pre-hospital critical care anaesthesiologists sometimes choose to abstain from pre-hospital advanced airway management as well as the alternative treatment methods used.", {"entities": []}], ["Improved quality of care is a policy objective of health care systems around the world.", {"entities": []}], ["Implementation research is the scientific study of methods to promote the systematic uptake of clinical research findings into routine clinical practice, and hence to reduce inappropriate care.", {"entities": []}], ["It includes the study of influences on healthcare professionals' behaviour and methods to enable them to use research findings more effectively.", {"entities": []}], ["Cluster randomized trials represent the optimal design for evaluating the effectiveness of implementation strategies.", {"entities": []}], ["Various codes of medical ethics, such as the Nuremberg Code and the Declaration of Helsinki inform medical research, but their relevance to cluster randomised trials in implementation research is unclear.", {"entities": []}], ["This paper discusses the applicability of various ethical codes to obtaining consent in cluster trials in implementation research.", {"entities": []}], ["The appropriate application of biomedical codes to implementation research is not obvious.", {"entities": []}], ["Discussion of the nature and practice of informed consent in implementation research cluster trials must consider the levels at which consent can be sought, and for what purpose it can be sought.", {"entities": []}], ["The level at which an intervention is delivered can render the idea of patient level consent meaningless.", {"entities": []}], ["Careful consideration of the ownership of information, and rights of access to and exploitation of data is required.", {"entities": []}], ["For health care professionals and organizations, there is a balance between clinical freedom and responsibility to participate in research.", {"entities": []}], ["While ethical justification for clinical trials relies heavily on individual consent, for implementation research aspects of distributive justice, economics, and political philosophy underlie the debate.", {"entities": []}], ["Societies may need to trade off decisions on the choice between individualized consent and valid implementation research.", {"entities": []}], ["We suggest that social sciences codes could usefully inform the consideration of implementation research by members of Research Ethics Committees.", {"entities": []}], ["Community health centers are increasingly embracing the Patient Centered Medical Home (PCMH) model to improve quality, access to care, and patient experience while reducing healthcare costs.", {"entities": []}], ["Care coordination (CC) is an important element of the PCMH model, but implementation and measurability of CC remains a problem within the outpatient setting.", {"entities": []}], ["Assessing CC is an integral component of quality monitoring in health care systems.", {"entities": []}], ["This study developed and validated the Medical Home Care Coordination Survey (MHCCS), to fill the gap in assessing CC in primary care from the perspectives of patients and their primary healthcare teams.", {"entities": []}], ["We conducted a review of relevant literature and existing care coordination instruments identified by bibliographic search and contact with experts.", {"entities": []}], ["After identifying all care coordination domains that could be assessed by primary healthcare team members and patients, we developed a conceptual model.", {"entities": []}], ["Potentially appropriate items from existing published CC measures, along with newly developed items, were matched to each domain for inclusion.", {"entities": []}], ["A modified Delphi approach was used to establish content validity.", {"entities": []}], ["Primary survey data was collected from 232 patients with care transition and/or complex chronic illness needs from the Community Health Center, Inc. and from 164 staff members from 12 community health centers across the country via mail, phone and online survey.", {"entities": []}], ["The MHCCS was validated for internal consistency, reliability, discriminant and convergent validity.", {"entities": []}], ["This study was conducted at the Community Health Center, Inc. from January 15, 2012 to July 15, 2014.", {"entities": []}], ["The 13-item MHCCS - Patient and the 32-item MHCCS - Healthcare Team were developed and validated.", {"entities": []}], ["Exploratory Structural Equation Modeling was used to test the hypothesized domain structure.", {"entities": []}], ["Four CC domains were confirmed from the patient group and eight were confirmed from the primary healthcare team group.", {"entities": []}], ["All domains had high reliability (Cronbach\u2019s \u03b1 scores were above 0.8).", {"entities": []}], ["Patients experience the ultimate output of care coordination services, but primary healthcare staff members are best primed to perceive many of the structural elements of care coordination.", {"entities": []}], ["The proactive measurement and monitoring of the core domains from both perspectives provides a richer body of information for the continuous improvement of care coordination services.", {"entities": []}], ["The MHCCS shows promise as a valid and reliable assessment of these CC efforts.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-0893-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Airway remodelling, including smooth muscle remodelling, is a primary cause of airflow limitation in asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["Recent evidence links bronchoconstriction to airway remodelling in asthma.", {"entities": [[67, 73, "DISEASE"]]}], ["The mechanisms involved are poorly understood.", {"entities": []}], ["A possible player is the multifunctional cytokine TGF-\u03b2, which plays an important role in airway remodelling.", {"entities": []}], ["Guinea pig lung slices were used as an in vitro model to investigate mechanisms involved in bronchoconstriction-induced airway remodelling.", {"entities": []}], ["To address this aim, mechanical effects of bronchoconstricting stimuli on contractile protein expression and TGF-\u03b2 release were investigated.", {"entities": []}], ["Lung slices were viable for at least 48 h. Both methacholine and TGF-\u03b2 1 augmented the expression of contractile proteins (sm-\u03b1-actin, sm-myosin, calponin) after 48 h. Confocal fluorescence microscopy showed that increased sm-myosin expression was enhanced in the peripheral airways and the central airways.", {"entities": []}], ["Mechanistic studies demonstrated that methacholine-induced bronchoconstriction mediated the release of biologically active TGF-\u03b2, which caused the increased contractile protein expression, as inhibition of actin polymerization (latrunculin A) or TGF-\u03b2 receptor kinase (SB431542) prevented the methacholine effects, whereas other bronchoconstricting agents (histamine and KCl) mimicked the effects of methacholine.", {"entities": []}], ["Collectively, bronchoconstriction promotes the release of TGF-\u03b2, which induces airway smooth muscle remodelling.", {"entities": []}], ["This study shows that lung slices are a useful in vitro model to study mechanisms involved in airway remodelling.", {"entities": []}], ["Genome-wide association studies of asthma have identified a novel region containing ORMDL3 at chromosome 17q21 that is strongly associated with childhood-onset asthma and significantly linked to ORMDL3 transcript abundance.", {"entities": [[35, 41, "DISEASE"], [160, 166, "DISEASE"], [84, 90, "GENE"], [195, 201, "GENE"], [84, 90, "GENE"], [195, 201, "GENE"]]}], ["These results have been successfully replicated in childhood-onset asthma cohorts in several ethnic groups.", {"entities": [[67, 73, "DISEASE"]]}], ["In this study, we aimed to evaluate the association of polymorphisms in ORMDL3, GSDMB, ZPBP2 and IKZF3 and adult-onset asthma in a Chinese Han population.", {"entities": [[119, 125, "DISEASE"], [72, 78, "GENE"], [80, 85, "GENE"], [87, 92, "GENE"], [97, 102, "GENE"]]}], ["We genotyped 5 single nucleotide polymorphisms (SNPs) at chromosome 17q21 in 1,366 Han Chinese people comprising 710 patients with adult-onset asthma and 656 healthy controls.", {"entities": [[143, 149, "DISEASE"]]}], ["We compared the 2 groups in terms of allele and haplotype frequencies.", {"entities": []}], ["Transcript levels were measured in leukocytes from 61 asthma patients by quantitative real-time PCR.", {"entities": [[54, 60, "DISEASE"]]}], ["We found the 5 SNPs significantly associated with asthma (P<0.05), of which 2, rs11557467 and rs9303277, were strongly associated (P<0.001).", {"entities": [[50, 56, "DISEASE"]]}], ["Subjects carrying the G allele of rs11557467 or the C allele of rs9303277 showed increased risk of asthma (odds ratio [OR] 1.27, 95% confidence interval 1.07-1.51, P = 0.006, and OR 1.27, 1.07-1.49, P = 0.005, respectively), even after adjusting for age and sex.", {"entities": [[99, 105, "DISEASE"]]}], ["The risk of asthma was lower for carriers of the haplotype CTGTT (OR 0.81, 0.67-0.97, P = 0.02).", {"entities": [[12, 18, "DISEASE"]]}], ["The risk allele for each SNP was associated with increased expression of ORMDL3 and GSDMB in leukocytes (all p<0.05).", {"entities": [[73, 79, "GENE"], [84, 89, "GENE"]]}], ["Our replication study suggests that variants in 17q21 are significantly associated with risk of adult-onset asthma and gene expression in a Chinese Han population.", {"entities": [[108, 114, "DISEASE"]]}], ["Diabetes mellitus has high prevalence in the ageing population and is often accompanied by other comorbidities, such as Alzheimer's disease, and general disabilities, such as poor eyesight.", {"entities": []}], ["These comorbidities have redefined ways in which patients use mHealth apps, including diabetes apps.", {"entities": []}], ["The latter have proven benefits for monitoring blood glucose levels and insulin tracking in the general population.", {"entities": []}], ["In this paper, we analyse a diabetes monitoring app DeStress Assistant (DeSA), which was developed as a part of an EU project and tested in a hospital setting.", {"entities": [[48, 51, "GENE"]]}], ["Due to the increasing number of older adults, we wanted to ensure the app was suitable for that demographic.", {"entities": [[70, 73, "GENE"]]}], ["Based on a number of supervised tests, we show that the app, which was developed with the help of workshops and feedback from tech-savvy patients and clinicians, is difficult to use by elderly users.", {"entities": [[56, 59, "GENE"]]}], ["We demonstrate that with a small number of changes it is possible to raise the usability of the app in a number of categories.", {"entities": [[96, 99, "GENE"]]}], ["We summarise the lessons learned in the discussion.", {"entities": []}], ["Our findings demonstrate that special care needs to be taken when developing mHealth apps for the elderly population.", {"entities": []}], ["Preclinical data have shown that rilmenidine can regulate autophagy in models of Huntington\u2019s disease (HD), providing a potential route to alter the disease course in patients.", {"entities": []}], ["Consequently, a 2-year open-label study examining the tolerability and feasibility of rilmenidine in mild-moderate HD was undertaken.", {"entities": []}], ["18 non-demented patients with mild to moderate HD took daily doses of 1\u00a0mg Rilmenidine for 6\u00a0months and 2\u00a0mg for a further 18\u00a0months followed by a 3-month washout period.", {"entities": []}], ["The primary outcome was the number of withdrawals and serious adverse events.", {"entities": []}], ["Secondary outcomes included safety parameters and changes in disease-specific variables, such as motor, cognitive and functional performance, structural MRI and serum metabolomic analysis.", {"entities": []}], ["12 patients completed the study; reasons for withdrawal included problems tolerating study procedures (MRI, and venepuncture), depression requiring hospital admission and logistical reasons.", {"entities": []}], ["Three serious adverse events were recorded, including hospitalisation for depression, but none were thought to be drug-related.", {"entities": []}], ["Changes in secondary outcomes were analysed as the annual rate of change in the study group.", {"entities": []}], ["The overall change was comparable to changes seen in recent large observational studies in HD patients, though direct statistical comparisons to these studies were not made.", {"entities": []}], ["Chronic oral administration of rilmenidine is feasible and well-tolerated and future, larger, placebo-controlled, studies in HD are warranted.", {"entities": []}], ["Trial registration: EudraCT number 2009-018119-14.", {"entities": []}], ["The online version of this article (doi:10.1007/s00415-017-8647-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Glucosinolates are amino acids derived secondary metabolites, invariably present in Brassicales, which have huge health and agricultural benefits.", {"entities": []}], ["Sulphoraphane, the breakdown product of glucosinolate glucoraphanin is known to posses anti-cancer properties.", {"entities": [[92, 98, "DISEASE"]]}], ["AOP (2-oxoglutarate-dependent dioxygenases) or GSL-ALK enzyme catalyzes the conversion of desirable glucoraphanin to deleterious gluconapin and progoitrin, which are present in very high amounts in most of the cultivable Brassica species including Brassica juncea .", {"entities": []}], ["In this study we showed that B. juncea encodes four functional homologs of GSL-ALK gene and constitutive silencing of GSL-ALK homologs resulted in accumulation of glucoraphanin up to 43.11\u2009\u03bcmoles g GSL-ALK homologs.", {"entities": []}], ["Growth and other seed quality parameters of the transgenic lines did not show drastic difference, compared to the untransformed control.", {"entities": []}], ["High glucoraphanin lines also showed higher resistance towards stem rot pathogen Sclerotinia sclerotiorum .", {"entities": []}], ["Our results suggest that metabolic engineering of GSL-ALK has huge potential for enriching glucoraphanin content, and improve the oil quality and vegetable value of Brassica crops.", {"entities": []}], ["Alcoholic liver injury leads to serious complication including death.", {"entities": []}], ["The potential role of baicalin at the transcription level in mice model of alcohol injury is not known yet.", {"entities": []}], ["In this study, we examined the effect of baicalin against chronic plus binge ethanol model in mice and understanding the mechanism of protection.", {"entities": []}], ["Liver function, histology, steatosis, inflammation, NF- \u03ba B activity, oxidative stress sources, nuclear translocation of NRF2 transcription factor, and cell death were assessed.", {"entities": []}], ["Treatment with baicalin ameliorated ethanol-induced oxidative stress, inflammation, and cell death.", {"entities": []}], ["Baicalin attenuated ethanol-induced proinflammatory molecules such as TNF- \u03b1 , IL-1 \u03b2 , MIP-2, and MCP-1 and reversed redox-sensitive transcription factor NF- \u03ba B activation.", {"entities": []}], ["Baicalin also modulated Kupffer cell activation in vitro.", {"entities": []}], ["Baicalin inhibited ethanol-induced expression of reactive oxygen species (ROS) generating enzymes NOX2, p67phox, xanthine oxidase, and iNOS in addition to CYP2E1 activities.", {"entities": [[155, 161, "GENE"]]}], ["Baicalin also enhanced ethanol-induced NRF2 nuclear translocation and increased downstream target gene HO-1 as antioxidant defense.", {"entities": []}], ["Finally, baicalin reduced significant apoptotic and necrotic cell death.", {"entities": []}], ["Our study suggests that baicalin ameliorates chronic plus binge ethanol-induced liver injury involving molecular crosstalk of multiple pathways at the transcriptional level and through upregulation of antioxidant defense mechanism.", {"entities": []}], ["Pegylated-interferon- \u03b1 based therapy for the treatment of chronic hepatitis C (CHC) is considered suboptimal as not all patients respond to the treatment and it is associated with several side effects that could lead to dose reduction and/or termination of therapy.", {"entities": [[67, 76, "DISEASE"]]}], ["The currently used markers to monitor the response to treatment are based on viral kinetics and their performance in the prediction of treatment outcome is moderate and does not combine accuracy and their values have several limitations.", {"entities": []}], ["Hence, the development of new sensitive and specific predictor markers could provide a useful tool for the clinicians and healthcare providers, especially in the new era of interferon-free therapy, for the classification of patients according to their response to the standard therapy and only subscribing the novel directly acting antiviral drugs to those who are anticipated not to respond to the conventional therapy and/or have absolute contraindications for its use.", {"entities": []}], ["The importance of activins and follistatin in the regulation of immune system, liver biology, and pathology has recently emerged.", {"entities": []}], ["This review appraises the up-to-date knowledge regarding the role of activins and follistatin in liver biology and immune system and their role in the pathophysiology of CHC.", {"entities": []}], ["In 2011, the National Health Interview Survey (NHIS), an in-person household interview, revised the human immunodeficiency virus (HIV) section of the survey and the Behavioral Risk Factor Surveillance System (BRFSS), a telephone-based survey, added cellphone numbers to its sampling frame.", {"entities": []}], ["We sought to determine how these changes might affect assessment of HIV testing trends.", {"entities": []}], ["We used linear regression with pairwise contrasts with 2003-2013 data from NHIS and BRFSS to compare percentages of persons aged 18-64 years who reported HIV testing in landline versus cellphone-only households before and after 2011, when NHIS revised its in-person questionnaire and BRFSS added cellphone numbers to its telephone-based sample.", {"entities": []}], ["In NHIS, the percentage of persons in cellphone-only households increased 13-fold from 2003 to 2013.", {"entities": []}], ["The percentage ever tested for HIV was 6%\u201310% higher among persons in cellphone-only than landline households.", {"entities": []}], ["The percentage ever tested for HIV increased significantly from 40.2% in 2003 to 45.0% in 2010, but was significantly lower in 2011 (40.6%) and 2012 (39.7%).", {"entities": []}], ["In BRFSS, the percentage ever tested decreased significantly from 45.9% in 2003 to 40.2% in 2010, but increased to 42.9% in 2011 and 43.5% in 2013.", {"entities": []}], ["HIV testing estimates were lower after NHIS questionnaire changes but higher after BRFSS methodology changes.", {"entities": []}], ["Data before and after 2011 are not comparable, complicating assessment of trends.", {"entities": []}], ["Novel risk factors were associated with the 2009 pandemic A/H1N1 virus (pH1N1).", {"entities": []}], ["Ethnicity was among these risk factors.", {"entities": []}], ["Ethnic disparities in hospitalization and death due to pH1N1 were noted.", {"entities": []}], ["The purpose of this study is to determine whether there are ethnic disparities in acquiring the 2009 pandemic H1N1.", {"entities": []}], ["We conducted a test-negative case\u2013control study of the risk of pH1N1 infection using data from Ontario, Canada.", {"entities": []}], ["Cases were laboratory confirmed to have influenza using reverse-transcriptase polymerase chain reaction (RT-PCR), and controls were obtained from the same population and were RT-PCR negative.", {"entities": [[40, 49, "DISEASE"]]}], ["Multivariate logistic regression was used to determine the association between ethnicity and pH1N1 infection, while adjusting for demographic, clinical and ecological covariates.", {"entities": []}], ["Adult cases were more likely than controls to be self-classified as East/Southeast Asian (OR\u2009=\u20092.59, 95% CI 1.02-6.57), South Asian (OR\u2009=\u20096.22, 95% CI 2.01-19.24) and Black (OR\u2009=\u20099.72, 95% CI 2.29-41.27).", {"entities": []}], ["Pediatric cases were more likely to be self-identified as Black (OR\u2009=\u20096.43, 95% CI 1.83-22.59).", {"entities": []}], ["However, pediatric cases without risk factors for severe influenza infection were more likely to be South Asian (OR 2.92, 95% CI 1.11-7.68), Black (OR 16.02, 95% CI 2.85-89.92), and West Asian/Arab, Latin American or Multi-racial groups (OR 3.09 95% CI 1.06-9.00).", {"entities": [[57, 66, "DISEASE"]]}], ["pH1N1 cases were more likely to come from certain ethnic groups compared to test-negative controls.", {"entities": []}], ["Insights into whether these disparities arise due to social or biological factors are needed in order to understand what approaches can be taken to reduce the burden of a future influenza pandemic.", {"entities": [[178, 187, "DISEASE"]]}], ["The antipyretic analgesics, paracetamol, and non-steroidal anti-inflammatory agents NSAIDs are one of the most widely used classes of medications in children.", {"entities": []}], ["The aim of this review is to determine if there are any clinically relevant differences in safety between ibuprofen and paracetamol that may recommend one agent over the other in the management of fever and discomfort in children older than 3\u00a0months of age.", {"entities": []}], ["Prostanoids, including prostaglandins (PGs), thromboxanes (TXs), and prostacyclins, are synthesized from arachidonic acid (AA) by the action of Cyclooxygenase (COX) enzymes.", {"entities": []}], ["They are bioactive inflammatory lipid mediators that play a key role in immunity and immunopathology.", {"entities": []}], ["Prostanoids exert their effects on immune and inflammatory cells by binding to membrane receptors that are widely expressed throughout the immune system and act at multiple levels in innate and adaptive immunity.", {"entities": []}], ["The immunoregulatory role of prostanoids results from their ability to regulate cell-cell interaction, antigen presentation, cytokine production, cytokine receptor expression, differentiation, survival, apoptosis, cell-surface molecule levels, and cell migration in both autocrine and paracrine manners.", {"entities": []}], ["By acting on immune cells of both systems, prostanoids and their receptors have great impact on immune regulation and play a pivotal role in connecting innate and adaptive immunity.", {"entities": []}], ["This paper focuses on the immunobiology of prostanoid receptor signaling because of their potential clinical relevance for various disorders including inflammation, autoimmunity, and tumorigenesis.", {"entities": []}], ["We mainly discuss the effects of major COX metabolites, PGD2, PGE2, their signaling during dendritic cell (DC)-natural killer (NK) reciprocal crosstalk, DC-T cell interaction, and subsequent consequences on determining crucial aspects of innate and adaptive immunity in normal and pathological settings.", {"entities": []}], ["Obesity is a risk factor for the development of asthma.", {"entities": [[0, 7, "DISEASE"], [48, 54, "DISEASE"]]}], ["In patients with obesity the diagnosis of asthma is often based on symptoms, but without objective measurements.", {"entities": [[17, 24, "DISEASE"], [42, 48, "DISEASE"]]}], ["Nevertheless, obesity-associated asthma is recognized as a distinct asthma phenotype.", {"entities": [[14, 21, "DISEASE"], [33, 39, "DISEASE"], [68, 74, "DISEASE"]]}], ["Therefore, this study explores lung function and symptoms in asthma patients with and without obesity.", {"entities": [[94, 101, "DISEASE"], [61, 67, "DISEASE"]]}], ["The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort study with 6671 participants (aged 45\u201365\u00a0years) of whom 472 had asthma.", {"entities": [[32, 39, "DISEASE"], [145, 151, "DISEASE"]]}], ["Of this latter group, linear regression analysis was used to examine differences in lung function and symptoms between asthma patients with ( n \u2009=\u2009248) and without obesity ( n \u2009=\u2009224), and between asthma patients with and without increased Fe NO .", {"entities": [[164, 171, "DISEASE"], [119, 125, "DISEASE"], [197, 203, "DISEASE"]]}], ["Analyses were adjusted for confounders.", {"entities": []}], ["Asthma patients with obesity had lower predicted FEV 1 and FVC values than patients without obesity [adjusted mean difference (MD) -3.3% predicted, 95% CI -6.5, \u22120.2; adjusted MD \u22125.0% predicted, 95% CI -7.8, \u22122.1].", {"entities": [[21, 28, "DISEASE"], [92, 99, "DISEASE"], [0, 6, "DISEASE"], [49, 52, "GENE"]]}], ["The prevalence of symptoms was higher in patients with obesity.", {"entities": [[55, 62, "DISEASE"]]}], ["Asthma patients with obesity and with increased Fe NO had lower FEV 1 and FEV 1 /FVC values compared with those with low Fe NO (adjusted MD \u22126.9% predicted, 95% CI -11.7, \u22122.0; \u22122.4%, 95% CI -4.6, \u22120.2).", {"entities": [[21, 28, "DISEASE"], [0, 6, "DISEASE"], [64, 67, "GENE"], [74, 77, "GENE"], [64, 67, "GENE"], [74, 77, "GENE"]]}], ["Asthma patients with obesity had lower FEV 1 and FVC values than patients without obesity.", {"entities": [[21, 28, "DISEASE"], [82, 89, "DISEASE"], [0, 6, "DISEASE"], [39, 42, "GENE"]]}], ["This suggests that patients with obesity have restrictive lung function changes, rather than obstructive changes.", {"entities": [[33, 40, "DISEASE"]]}], ["Asthma patients with obesity and increased Fe NO showed more obstructive changes.", {"entities": [[21, 28, "DISEASE"], [0, 6, "DISEASE"]]}], ["Fe NO might help to identify patients with eosinophilic inflammation-driven asthma, whereas patients with low Fe NO might have an obesity-associated asthma phenotype in which symptoms are partly caused by the obesity.", {"entities": [[130, 137, "DISEASE"], [209, 216, "DISEASE"], [76, 82, "DISEASE"], [149, 155, "DISEASE"]]}], ["The online version of this article (10.1186/s12931-017-0684-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To establish Fe NO norms for healthy Tunisian adults aged 18\u201360 years and to prospectively assess their reliability.", {"entities": []}], ["This was a cross-sectional analytical study.", {"entities": []}], ["A convenience sample of healthy Tunisian adults was recruited.", {"entities": []}], ["Subjects responded to a medical questionnaire, and then Fe NO levels were measured by an online method (Medisoft, Sorinnes (Dinant), Belgium).", {"entities": []}], ["Clinical, anthropometric, and plethysmographic data were collected.", {"entities": []}], ["All analyses were performed on natural logarithm values of Fe NO .", {"entities": []}], ["257 adults (145 males) were retained.", {"entities": []}], ["The proposed reference equation to predict Fe NO value is lnFe NO (ppb) = 3.47\u22120.56\u00d7 height (m).", {"entities": []}], ["After the predicted Fe NO value for a given adult was computed, the upper limit of normal could be obtained by adding 0.60\u2009ppb.", {"entities": []}], ["The mean \u00b1 SD (minimum-maximum) of Fe NO (ppb) for the total sample was 13.54 \u00b1 4.87 (5.00\u201326.00).", {"entities": []}], ["For Tunisian and Arab adults of any age and height, any Fe NO value greater than 26.00\u2009ppb may be considered abnormal.", {"entities": []}], ["Finally, in an additional group of adults prospectively assessed, we found no adult with a Fe NO higher than 26.00\u2009ppb.", {"entities": []}], ["Conclusion .", {"entities": []}], ["The present Fe NO norms enrich the global repository of Fe NO norms that the clinician can use to choose the most appropriate norms.", {"entities": []}], ["There is an urgent need to prevent excessive pregnancy weight gain, a contributor to both maternal and child obesity.", {"entities": [[109, 116, "DISEASE"]]}], ["However, the majority of women had reported not being counseled to gain an appropriate amount of gestational weight by their health care providers.", {"entities": []}], ["We developed a knowledge translation (KT) tool designed to facilitate the clinical interaction between pregnant women and their health care providers (HCPs).", {"entities": []}], ["We piloted the tool on the impact on women\u2019s knowledge of gestational weight gain (GWG) goals, and evaluated its potential in promoting appropriate knowledge about GWG within the 2009 Institute of Medicine guidelines.", {"entities": []}], ["We conducted a prospective cohort study, comparing women\u2019s knowledge about GWG after the KT tool to women from the same clinics and care providers the year prior.", {"entities": []}], ["Our primary outcome was the proportion of women who reported receiving an appropriate GWG recommendation from their care provider.", {"entities": []}], ["We evaluated knowledge on a survey conducted at enrollment in the cohort at\u2009\u2264\u200920\u00a0weeks gestation and evaluated participant satisfaction with the KT tool in the third trimester.", {"entities": []}], ["We performed univariate and multivariable logistic regression analyses for differences in outcomes with historical controls from the same clinics.", {"entities": []}], ["Our a priori sample size calculation required 130 participants to demonstrate a 15% increase in reported counseling about gestational weight gain.", {"entities": []}], ["One hundred and forty-six women were recruited and 131 (90%) completed the enrollment survey.", {"entities": []}], ["Women who received the KT tool were more likely to report receiving a specific GWG recommendation from their HCP (adjusted odds ratio [AOR] 3.45, 95% confidence interval [CI] 2.22-5.37) and discussing GWG topics with their HCP (AOR 7.96, 95% CI 4.41-14.37), and believing that there were risks to their infants with inadequate GWG (AOR 2.48, 95% CI 1.14-5.37).", {"entities": []}], ["Half of women (49.5%) indicated that they would recommend the tool to a friend.", {"entities": []}], ["Women who received the KT tool reported receiving more counseling on GWG from their HCPs and were more aware of the risks of gaining outside appropriate GWG recommendations.", {"entities": []}], ["The association between GWG education and GWG requires further research.", {"entities": []}], ["Africa bears 24% of the global burden of disease but has only 3% of the world\u2019s health workers.", {"entities": []}], ["Substantial variation in health worker performance adds to the negative impact of this significant shortfall.", {"entities": []}], ["We therefore sought to identify interventions implemented in sub-Saharan African aiming to improve health worker performance and the contextual factors likely to influence local effectiveness.", {"entities": []}], ["A systematic search for randomised controlled trials of interventions to improve health worker performance undertaken in sub-Saharan Africa identified 41 eligible trials.", {"entities": []}], ["Data were extracted to define the interventions\u2019 components, calculate the absolute improvement in performance achieved, and document the likelihood of bias.", {"entities": []}], ["Within-study variability in effect was extracted where reported.", {"entities": []}], ["Statements about contextual factors likely to have modified effect were subjected to thematic analysis.", {"entities": []}], ["Interventions to improve health worker performance can be very effective.", {"entities": []}], ["Two of the three trials assessing mortality impact showed significant reductions in death rates (age<5 case fatality 5% versus 10%, p<0.01; maternal in-hospital mortality 6.8/1000 versus 10.3/1000; p<0.05).", {"entities": []}], ["Eight of twelve trials focusing on prescribing had a statistically significant positive effect, achieving an absolute improvement varying from 9% to 48%.", {"entities": []}], ["However, reported range of improvement between centres within trials varied substantially, in many cases exceeding the mean effect.", {"entities": []}], ["Nine contextual themes were identified as modifiers of intervention effect across studies; most frequently cited were supply-line failures, inadequate supervision or management, and failure to follow-up training interventions with ongoing support, in addition to staff turnover.", {"entities": []}], ["Interventions to improve performance of existing staff and service quality have the potential to improve patient care in underserved settings.", {"entities": []}], ["But in order to implement interventions effectively, policy makers need to understand and address the contextual factors which can contribute to differences in local effect.", {"entities": []}], ["Researchers therefore must recognise the importance of reporting how context may modify effect size.", {"entities": []}], ["Choosing the correct ventilator settings for the treatment of patients with respiratory tract disease is quite an important issue.", {"entities": []}], ["Since the task of specifying the parameters of ventilation equipment is entirely carried out by a physician, physician\u2019s knowledge and experience in the selection of these settings has a direct effect on the accuracy of his/her decisions.", {"entities": []}], ["Nowadays, decision support systems have been used for these kinds of operations to eliminate errors.", {"entities": []}], ["Our goal is to minimize errors in ventilation therapy and prevent deaths caused by incorrect configuration of ventilation devices.", {"entities": []}], ["The proposed system is designed to assist less experienced physicians working in the facilities without having lung mechanics like cottage hospitals.", {"entities": []}], ["This article describes a decision support system proposing the ventilator settings required to be applied in the treatment according to the patients\u2019 physiological information.", {"entities": []}], ["The proposed model has been designed to minimize the possibility of making a mistake and to encourage more efficient use of time in support of the decision making process while the physicians make critical decisions about the patient.", {"entities": []}], ["Artificial Neural Network (ANN) is implemented in order to calculate frequency, tidal volume, F i O 2 outputs, and this classification model has been used for estimation of pressure support / volume support outputs.", {"entities": []}], ["For the obtainment of the highest performance in both models, different configurations have been tried.", {"entities": []}], ["Various tests have been realized for training methods, and a number of hidden layers mostly affect factors regarding the performance of ANNs.", {"entities": []}], ["The physiological information of 158 respiratory patients over the age of 60 and were treated in three different hospitals between the years 2010 and 2012 has been used in the training and testing of the system.", {"entities": []}], ["The diagnosed disease, core body temperature, pulse, arterial systolic pressure, diastolic blood pressure, PEEP, P S O 2 , pH, p C O 2 , bicarbonate data as well as the frequency, tidal volume, F i O 2 , and pressure support / volume support values suitable for use in the ventilator device have been recommended to the physicians with an accuracy of 98,44%.", {"entities": []}], ["Performed experiments show that sequential order weight/bias training was found to be the most ideal ANN learning algorithm for regression model and Bayesian regulation backpropagation was found to be the most ideal ANN learning algorithm for classification models.", {"entities": []}], ["This article aims at making independent of the choice of parameters from physicians in the ventilator treatment of respiratory tract patients with proposed decision support system.", {"entities": []}], ["The rate of accuracy in prediction of systems increases with the use of data of more patients in training.", {"entities": []}], ["Therefore, non-physician operators can use systems in determination of ventilator settings in case of emergencies.", {"entities": []}], ["The long-term prognosis of chronic cough and its determinants need to be clarified.", {"entities": []}], ["This is a prospective, observational cohort study.", {"entities": []}], ["Eighty-nine unselected subjects with chronic (> 8\u00a0weeks\u2019 duration) cough were carefully investigated: Clinical examination, symptom questionnaire, Leicester Cough Questionnaire (LCQ), skin prick tests, ambulatory peak expiratory flow monitoring, spirometry before and after 0.4 mgs of salbutamol, exhaled nitric oxide concentration measurement, hypertonic saline cough provocation test, and histamine bronchial provocation test.", {"entities": []}], ["After five years, a letter was sent to the subjects containing questions about continuation of cough, smoking, indoor exposures, presence of co-morbidities, and current medication.", {"entities": []}], ["It also contained LCQ and Cough Clinic diagnostic questionnaire.", {"entities": []}], ["Sixty-eight subjects (76%) responded.", {"entities": []}], ["At five years, continuing regular cough was present in 31 (46%) of the subjects and continuing impairment in cough-related quality of life (less than 1.3 points\u2019 improvement in LCQ) in 32 (47%).", {"entities": []}], ["Continuing regular cough was associated with presence of chronic rhinitis or esophageal reflux disease, baseline mild airway responsiveness to histamine, and baseline strong cough responsiveness to hypertonic saline.", {"entities": [[65, 73, "DISEASE"], [57, 73, "DISEASE"]]}], ["Continuing impairment in cough-related quality of life was associated with high body mass index, absence of atopy, absence of pets, and high number of background disorders (esophageal reflux disease, asthma, or chronic rhinitis).", {"entities": [[219, 227, "DISEASE"], [211, 227, "DISEASE"], [200, 206, "DISEASE"]]}], ["Almost half of subjects with chronic cough suffered of the disorder at five years from initial assessment.", {"entities": []}], ["Several possible determinants of poor prognosis could be identified.", {"entities": []}], ["Symptoms, and especially those without clear underlying medical explanations, account for a large percentage of clinical encounters.", {"entities": []}], ["Many unexplained symptoms have been organized by patients and practitioners into syndromes such as chronic fatigue syndrome, multiple chemical sensitivity, sick building syndrome, Gulf War syndrome, and the like.", {"entities": [[99, 123, "DISEASE"], [115, 123, "DISEASE"], [170, 178, "DISEASE"], [189, 197, "DISEASE"], [156, 178, "DISEASE"], [125, 154, "DISEASE"]]}], ["All these syndromes are defined solely on the basis of symptoms rather than by medical signs.", {"entities": []}], ["Some of the above-described conditions overlap strongly with explained conditions such as asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["The relationship of such symptoms and syndromes to environmental exposure is often sharply debated, as is the distinction between the various syndromes.", {"entities": []}], ["This leads to problems of what type of research should be conducted and who should conduct it.", {"entities": []}], ["It is time to develop a comprehensive research agenda to sort out nomenclature, epidemiology, and environmental causation for these conditions, moving toward comprehensive and effective public health and clinical approaches.", {"entities": []}], ["This systematic review sought to identify the association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and function in people with chronic obstructive pulmonary disease (COPD).", {"entities": [[182, 219, "DISEASE"]]}], ["We searched electronic databases including PubMed, CINAHL, MEDLINE, EMBASE, The Cochrane Library, ProQuest Dissertations and Theses, Scopus, Google Scholar, Trove, and WHO International Clinical Trials Registry Platform and reference lists of retrieved articles published prior to August 2014.", {"entities": []}], ["We considered observational studies that evaluated dietary intake of omega-3 (eicosapentaenoic acid, docosahexaenoic acid or \u03b1-linolenic acid) and/or omega-6 fatty acids (\u03b3-linoleic acid or arachidonic acid), and experimental studies that evaluated omega-3 fatty acid supplementation (containing predominantly one or more omega-3 fatty acids) on airway and systemic inflammatory markers and/or functional capacity outcomes in people with COPD-related diagnoses.", {"entities": []}], ["Since statistical pooling was not possible, the findings were presented in narrative form including tables and figures to aid in data presentation when appropriate.", {"entities": []}], ["One 8-week randomized controlled trial conducted in 80 COPD patients in the Netherlands showed polyunsaturated fatty acid supplementation significantly improved exercise capacity compared with the control condition [between-group difference in mean peak workload was 9.7\u200aW (2.5\u201317.0; P \u200a=\u200a0.009); and mean duration was 4.3\u200amin (0.6\u20137.9; P \u200a=\u200a0.023)].", {"entities": []}], ["One cross-sectional study conducted in 250 COPD patients in Spain found associations of specific dietary omega-3 fatty acids with inflammation were inconsistent.", {"entities": []}], ["Limited evidence provides weak support for the use of omega-3 fatty acid supplementation for reducing chronic inflammation and some support for improving functional capacity in COPD patients.", {"entities": []}], ["There is no consistent evidence showing that low dietary intake of specific omega-3 fatty acids worsens inflammation and/or function.", {"entities": []}], ["More evidence is required before routinely incorporating this therapy within COPD management plans.", {"entities": []}], ["Regulatory B cells (Bregs) play a critical role in inflammation and autoimmune disease.", {"entities": []}], ["We characterized the role of Bregs in the progression of gastric cancer.", {"entities": [[65, 71, "DISEASE"]]}], ["We detected an increase in Bregs producing IL-10 both in peripheral blood mononuclear cells (PBMCs) and in gastric tumors.", {"entities": []}], ["Multicolor flow cytometry analysis revealed that a subset of CD19", {"entities": [[61, 65, "GENE"]]}], ["To assess the associations of obesity with newly diagnosed and previously known atopic disorders in Chinese adults.", {"entities": [[30, 37, "DISEASE"]]}], ["4,629 adults aged 18 years or older were recruited in Harbin, China.", {"entities": []}], ["Among them, 1,114 were previously diagnosed atopic cases, 1,298 were newly diagnosed cases, and 2,217 non-atopic controls.", {"entities": []}], ["Obesity and overweight are defined according to the criteria established by the Working Group on Obesity in China.", {"entities": [[0, 7, "DISEASE"], [97, 104, "DISEASE"]]}], ["The associations of obesity with known and newly diagnosed atopic disorders were assessed using logistic regressions.", {"entities": [[20, 27, "DISEASE"]]}], ["Obesity was significantly associated with known atopic disorders (adjusted OR\u2009=\u20092.41 (95% CI: 1.81, 3.22)).", {"entities": [[0, 7, "DISEASE"]]}], ["The association of obesity with newly diagnosed atopic cases was not as strong as that with known cases, and was not statistically significant (adjusted OR\u2009=\u20091.27 (95% CI: 0.94, 1.72)).", {"entities": [[19, 26, "DISEASE"]]}], ["The similar pattern was observed in different allergic diseases, gender and age stratifications.", {"entities": []}], ["The association between overweight and atopic diseases were not significant.", {"entities": []}], ["Obesity is strongly associated with previously diagnosed atopic cases but not so with newly diagnosed atopic cases in Chinese adults.", {"entities": [[0, 7, "DISEASE"]]}], ["It is likely that people with atopic disorders have a higher risk of developing obesity.", {"entities": [[80, 87, "DISEASE"]]}], ["Our findings are important for the management of atopic disorders and chronic disease prevention among atopic disease patients.", {"entities": []}], ["The aim of this study was to compare the immunologic response to a prime-boost immunization strategy combining the 13-valent conjugate pneumococcal vaccine (PCV13) with the 23-valent polysaccharide pneumococcal vaccine (PPSV23) versus the PPSV23 alone in HIV-infected adults.", {"entities": []}], ["HIV-infected adults were randomized to receive PCV13 at week 0 followed by PPSV23 at week 4 (n\u2009=\u200931, prime-boost group) or PPSV23 alone at week 4 (n\u2009=\u200933, PPSV23-alone group).", {"entities": []}], ["Serotype specific IgG geometric mean concentration (GMC) and functional oposonophagocytic (OPA) geometric mean titer (GMT) were compared for 12 pneumococcal serotypes shared by both vaccines at week 8 and week 28.", {"entities": []}], ["The prime-boost vaccine group were more likely to achieve a \u22652-fold increase in IgG GMC and a GMC >1\u2009ug/ml at week 8 (odds ratio (OR) 2.00, 95% confidence interval (CI) 1.46\u20132.74, p\u2009<\u20090.01) and week 28 (OR 1.95, 95% CI 1.40\u20132.70, p\u2009<\u20090.01).", {"entities": []}], ["Similarly, the prime-boost vaccine group were more likely to achieve a \u22654-fold increase in GMT at week 8 (OR 1.71, 95% CI 1.22\u20132.39, p\u2009<\u20090.01) and week 28 (OR 1.6, 95% CI 1.15\u20132.3, p\u2009<\u20090.01).", {"entities": []}], ["This study adds to evidence supporting current pneumococcal vaccination recommendations combining the conjugate and polysaccharide pneumococcal vaccines in the United States and Europe for HIV-infected individuals.", {"entities": []}], ["Concerns over the health effects of nanomaterials in the environment have created a need for microscopy methods capable of examining the biological interactions of nanoparticles (NP).", {"entities": []}], ["Unfortunately, NP are beyond the diffraction limit of resolution for conventional light microscopy (~200 nm).", {"entities": []}], ["Fluorescence and electron microscopy techniques commonly used to examine NP interactions with biological substrates have drawbacks that limit their usefulness in toxicological investigation of NP.", {"entities": []}], ["EM is labor intensive and slow, while fluorescence carries the risk of photobleaching the sample and has size resolution limits.", {"entities": []}], ["In addition, many relevant particles lack intrinsic fluorescence and therefore can not be detected in this manner.", {"entities": []}], ["To surmount these limitations, we evaluated the potential of a novel combination of darkfield and confocal laser scanning microscopy (DF-CLSM) for the efficient 3D detection of NP in human lung cells.", {"entities": []}], ["The DF-CLSM approach utilizes the contrast enhancements of darkfield microscopy to detect objects below the diffraction limit of 200 nm based on their light scattering properties and interfaces it with the power of confocal microscopy to resolve objects in the z-plane.", {"entities": []}], ["Validation of the DF-CLSM method using fluorescent polystyrene beads demonstrated spatial colocalization of particle fluorescence (Confocal) and scattered transmitted light (Darkfield) along the X, Y, and Z axes.", {"entities": []}], ["DF-CLSM imaging was able to detect and provide reasonable spatial locations of 27 nm TiO 2 particles in relation to the stained nuclei of exposed BEAS 2B cells.", {"entities": []}], ["Statistical analysis of particle proximity to cellular nuclei determined a significant difference between 5 min and 2 hr particle exposures suggesting a time-dependant internalization process.", {"entities": [[118, 120, "GENE"]]}], ["DF-CLSM microscopy is an alternative to current conventional light and electron microscopy methods that does not rely on particle fluorescence or contrast in electron density.", {"entities": []}], ["DF-CLSM is especially well suited to the task of establishing the spatial localization of nanoparticles within cells, a critical topic in nanotoxicology.", {"entities": []}], ["This technique has advantages to 2D darkfield microscopy as it visualizes nanoparticles in 3D using confocal microscopy.", {"entities": []}], ["Use of this technique should aid toxicological studies related to observation of NP interactions with biological endpoints at cellular and subcellular levels.", {"entities": []}], ["It is reported that the iron-responsive element-binding protein 2 (IREB2) gene rs2568494 polymorphism might be associated with COPD risk.", {"entities": [[67, 72, "GENE"]]}], ["The purpose of this meta-analysis was to collect all eligible studies to review the association between IREB2 gene rs2568494 polymorphism and susceptibility to COPD.", {"entities": [[104, 109, "GENE"]]}], ["We carried out a comprehensive document search of electronic databases of PubMed, MEDLIN, Web of Science, and included 4 eligible studies that examined the association between IREB2 rs2568494 polymorphism and COPD susceptibility.", {"entities": [[176, 181, "GENE"]]}], ["We performed a meta-analysis of these studies based on IREB2 rs2568494 genotypes.", {"entities": [[55, 60, "GENE"]]}], ["After meta-analysis with fixed or random effects, no significant associations were found under the heterozygote model (GG/GA; OR=0.908, 95%CI: 0.790\u20131.043; P =0.172), homozygote model (GG/AA; OR=0.880, 95%CI: 0.497\u20131.557; P =0.661), dominant model (GG/AA+GA; OR=0.941, 95%CI: 0.748\u20131.182; P =0.599), or allelic model (G/A; OR=0.953, 95%CI: 0.770\u20131.179; P =0.655).", {"entities": []}], ["However, we found a significant correlation under the recessive model (AA/GA+GG; OR=1.384, 95%CI: 1.092\u20131.755; P =0.007).", {"entities": []}], ["The current results revealed that there was significant association between IREB2 gene rs2568494 polymorphism with susceptibility to COPD; the presence of allelic A might a genetic factor conferring susceptibility to COPD.", {"entities": [[76, 81, "GENE"]]}], ["Mangiferin, a bioactive compound derived primarily from Anacardiaceae and Gentianaceae families and found in mangoes and honeybush tea, has been extensively studied for its therapeutic properties.", {"entities": []}], ["Mangiferin has shown promising chemotherapeutic and chemopreventative potential.", {"entities": []}], ["This review focuses on the effect of mangiferin on: (1) inflammation, with respect to NF\u03baB, PPAR\u04af and the immune system; (2) cell cycle, the MAPK pathway G 2 /M checkpoint; (3) proliferation and metastasis, and implications on \u03b2-catenin, MMPs, EMT, angiogenesis and tumour volume; (4) apoptosis, with a focus on Bax/Bcl ratios, intrinsic/extrinsic apoptotic pathways and telomerase activity; (5) oxidative stress, through Nrf2/ARE signalling, ROS elimination and catalase activity; and (6) efficacy of chemotherapeutic agents, such as oxaliplatin, etoposide and doxorubicin.", {"entities": []}], ["In addition, the need to enhance the bioavailability and delivery of mangiferin are briefly addressed, as well as the potential for toxicity.", {"entities": []}], ["To assess the occurrence of glaucoma, eyelid, corneal and macular disorders in a cohort of patients with obstructive sleep apnoea (OSA) diagnosed by overnight polysomnography and to investigate into the risk factors for the above eye diseases (EDs).", {"entities": [[28, 36, "DISEASE"]]}], ["Cross-sectional cohort study between 2014 and 2015.", {"entities": []}], ["Unit of Respiratory Medicine and Eye Clinic of the University of Verona.", {"entities": []}], ["431 consecutive patients were considered eligible.", {"entities": []}], ["Of these, 87 declined to participate, 35 were untraceable and 13 were deceased.", {"entities": []}], ["A complete ophthalmic evaluation of both eyes for each patient.", {"entities": []}], ["Best-corrected distance visual acuity, intraocular pressure, corneal, macular and optic nerve optical coherence tomography, ocular aberrometry, optic nerve laser polarimetry, visual field test, and eyelid examination.", {"entities": []}], ["296 patients aged 64.5\u00b112.8 years, 23% female and 77% male, underwent ophthalmic examination.", {"entities": []}], ["There was 56% (n=166) prevalence of eyelid disorders, 27% (n=80) of corneal disorders, 13% (n=39) of macular disorders and 11% (n=33) of glaucoma.", {"entities": [[137, 145, "DISEASE"]]}], ["Advancing age was not associated with the severity of OSA, while significant differences were found for gender, body mass index, Oxygen Desaturation Index, smoking habit, hypertension and diabetes.", {"entities": [[171, 183, "DISEASE"]]}], ["Severe OSA was significantly associated with glaucoma (OR, 95% CI 1.05 to 5.93, p=0.037).", {"entities": [[45, 53, "DISEASE"]]}], ["EDs were more prevalent in our patinets with OSA than in the general population.", {"entities": []}], ["Severe Apnoea/Hypopnoea Index level seemed to play a role as risk factor only for glaucoma.", {"entities": [[82, 90, "DISEASE"]]}], ["In mammalian systems RNA can move between cells via vesicles.", {"entities": []}], ["Here we demonstrate that the gastrointestinal nematode Heligmosomoides polygyrus , which infects mice, secretes vesicles containing microRNAs (miRNAs) and Y RNAs as well as a nematode Argonaute protein.", {"entities": []}], ["These vesicles are of intestinal origin and are enriched for homologues of mammalian exosome proteins.", {"entities": []}], ["Administration of the nematode exosomes to mice suppresses Type 2 innate responses and eosinophilia induced by the allergen Alternaria.", {"entities": [[87, 99, "DISEASE"]]}], ["Microarray analysis of mouse cells incubated with nematode exosomes in vitro identifies Il33r and Dusp1 as suppressed genes, and Dusp1 can be repressed by nematode miRNAs based on a reporter assay.", {"entities": [[98, 103, "GENE"], [129, 134, "GENE"], [98, 103, "GENE"], [129, 134, "GENE"]]}], ["We further identify miRNAs from the filarial nematode Litomosoides sigmodontis in the serum of infected mice, suggesting that miRNA secretion into host tissues is conserved among parasitic nematodes.", {"entities": []}], ["These results reveal exosomes as another mechanism by which helminths manipulate their hosts and provide a mechanistic framework for RNA transfer between animal species.", {"entities": []}], ["Mammalian cell-derived exosomes can carry RNA and proteins from cell to cell, but this mode of transport has not been shown in nematodes.", {"entities": []}], ["Here the authors show that a gastrointestinal parasite secretes exosomes that transfer microRNAs to mammalian cells and regulate innate immunity.", {"entities": []}], ["Introduction: The balance between regulatory T cells (Tregs) and effector T help cells (Th cells) is critical for the control of adaptive immune response during nerve transplantation.", {"entities": []}], ["However, whether the homeostasis of immune regulation between Tregs and Th cells requires toll-like receptor (TLR) signaling is unclear.", {"entities": []}], ["The aim of this study is to profile the distribution of spleen Tregs and Th cells in a mouse model of nerve xenografting in the TLR2 and NF-\u03baB gene knockout mice.", {"entities": [[128, 132, "GENE"]]}], ["Methods: The sciatic nerve was taken from a SD rat or an allogeneic mouse and transplanted to a right back leg of recipient C57BL/6, TLR2 Results: The results showed that Tregs were decreased after nerve xenografting in the recipient C57BL/6 mouse.", {"entities": [[133, 137, "GENE"]]}], ["In addition, nerve xenografting also increased the Th1 and Th17 but not the Th2 cell populations.", {"entities": []}], ["In contrast, amelioration of the Tregs elimination was found in TLR2 Conclusions: TLR signaling is involved in T cell population regulation during tissue transplantation.", {"entities": [[64, 68, "GENE"]]}], ["Knock-out of TLR2 and NF-\u03baB prevented Tregs elimination and inhibited Th1- and Th17-driven immune response after nerve xenografting.", {"entities": [[13, 17, "GENE"]]}], ["This study highlighted the potential of inhibiting TLR signaling to modulate T cell-mediated immune regulation to facilitate tolerance to nerve transplantation.", {"entities": []}], ["Elite athletes endeavour to train and compete even when ill or injured.", {"entities": []}], ["Their motivation may be intrinsic or due to coach and team pressures.", {"entities": []}], ["The sports medicine physician plays an important role to risk-manage the health of the competing athlete in partnership with the coach and other members of the support team.", {"entities": []}], ["The sports medicine physician needs to strike the right ethical and operational balance between health management and optimising performance.", {"entities": []}], ["It is necessary to revisit the popular delivery model of sports medicine and science services to elite athletes based on the current reductionist multispecialist system lacking in practice an integrated approach and effective communication.", {"entities": []}], ["Athlete and coach in isolation or with a member of the multidisciplinary support team, often not qualified or experienced to do so, decide on the utilisation of services and how to apply the recommendations.", {"entities": []}], ["We propose a new Integrated Performance Health Management and Coaching model based on the UK Athletics experience in preparation for the London Olympic and Paralympic Games.", {"entities": []}], ["The Medical and Coaching Teams are managed by qualified and experienced individuals operating in synergy towards a common performance goal, accountable to a Performance Director and ultimately to the Board of Directors.", {"entities": []}], ["We describe the systems, processes and implementation strategies to assist the athlete, coach and support teams to continuously monitor and manage athlete health and performance.", {"entities": []}], ["These systems facilitate a balanced approach to training and competing decisions, especially while the athlete is ill or injured.", {"entities": []}], ["They take into account the best medical advice and athlete preference.", {"entities": []}], ["This Integrated Performance Health Management and Coaching model underpinned the Track and Field Gold Medal performances at the London Olympic and Paralympic Games.", {"entities": []}], ["Elderly persons\u2019 perceived accessibility to railway traveling depends on their functional limitations/diseases, their functional abilities and their travel behaviors in interaction with the barriers encountered during whole trips.", {"entities": []}], ["A survey was conducted on a random sample of 1000 city residents (65\u201385 years old; 57% response rate).", {"entities": []}], ["The travels were perceived least accessible by respondents with severely reduced functional ability and by those with more than one functional limitation/disease (e.g., restricted mobility and chronic pain).", {"entities": []}], ["Those who traveled \u201coften\u201d, perceived the accessibility to be better than those who traveled less frequently.", {"entities": []}], ["For travelers with high functional ability, the main barriers to more frequent traveling were travel costs and low punctuality.", {"entities": []}], ["For those with low functional ability, one\u2019s own health was reported to be the main barrier.", {"entities": []}], ["Our results clarify the links among existing functional limitations/functional abilities, the barriers encountered, the travel behavior, and the overall accessibility to traveling.", {"entities": []}], ["By operationalizing the whole-trip concept as a chain of events, we deliver practical knowledge on vulnerable groups for decision-making to improve the transport environment for all.", {"entities": []}], ["Malaria-associated acute respiratory distress syndrome (MA-ARDS) is a potentially lethal complication of clinical malaria.", {"entities": [[46, 54, "DISEASE"], [0, 7, "DISEASE"], [114, 121, "DISEASE"]]}], ["Acute lung injury in MA-ARDS shares features with ARDS triggered by other causes, including alveolar inflammation and increased alveolar-capillary permeability, leading to leak of protein-rich pulmonary oedema fluid.", {"entities": []}], ["Mechanisms and physiologic alterations in MA-ARDS can be examined in murine models of this syndrome.", {"entities": [[91, 99, "DISEASE"]]}], ["Integrin \u03b1 D \u03b2 2 is a member of the leukocyte, or \u03b2 2 (CD18), sub-family of integrins, and emerging observations indicate that it has important activities in leukocyte adhesion, accumulation and signalling.", {"entities": []}], ["The goal was to perform analysis of the lungs of mice wild type C57Bl/6 (a D D C57BL/6 wild type (a D D Plasmodium berghei ANKA.", {"entities": []}], ["CD11d subunit expression RNA was measured by real-time polymerase chain reaction, vascular barrier integrity by Evans blue dye (EBD) exclusion and cytokines by ELISA.", {"entities": []}], ["Protein and leukocytes were measured in bronchoalveolar lavage fluid (BALF) samples.", {"entities": []}], ["Tissue cellularity was measured by the point-counting technique, F4/80 and VCAM-1 expression by immunohistochemistry.", {"entities": []}], ["Respiratory function was analysed by non-invasive BUXCO and mechanical ventilation.", {"entities": []}], ["Alveolar inflammation, vascular and interstitial accumulation of monocytes and macrophages, and disrupted alveolar-capillary barrier function with exudation of protein-rich pulmonary oedema fluid were present in P. berghei -infected wild type mice and were improved in \u03b1 D \u03b2 2 -deficient animals.", {"entities": []}], ["Key pro-inflammatory cytokines were also decreased in lung tissue from \u03b1 D The results indicate that \u03b1 D \u03b2 2 is an important inflammatory effector molecule in P. berghei -induced MA-ARDS, and that leukocyte integrins regulate critical inflammatory and pathophysiologic events in this model of complicated malaria.", {"entities": [[305, 312, "DISEASE"]]}], ["Genetic deletion of integrin subunit \u03b1 D in mice, leading to deficiency of integrin \u03b1 D \u03b2 2 , alters lung inflammation and acute lung injury in a mouse model of MA-ARDS caused by P. berghei .", {"entities": []}], ["Annually, 600\u2009000 deaths are attributed to exposure of non-smokers to secondhand smoke (SHS).", {"entities": []}], ["These include 165\u2009000 among children, about 60% of which occur in Africa and Southeast Asia.", {"entities": []}], ["As of 2017, only seven countries in the African region had comprehensive smoke-free legislation covering all public places.", {"entities": []}], ["Given the increasing prevalence of smoking in many low-income countries, preventing exposure to SHS is an urgent public health priority, particularly in Sub-Saharan Africa.", {"entities": []}], ["The objective of this study is to obtain a reliable and nationally representative estimate of the prevalence of exposure to SHS and to identify the major risk factors among young people in The Gambia.", {"entities": []}], ["We used a two-stage cluster random sampling to select students in secondary schools throughout The Gambia and a self-administered questionnaire to collect data on demographic characteristics and detailed indicators of exposure to SHS.", {"entities": []}], ["Of the 10\u2009392 eligible students, 10\u2009289 (99%; 55% girls and 44% boys, age 12\u201320 years) participated.", {"entities": []}], ["The proportion of students reporting any exposure to SHS was 97.0% (enclosed public places 59.2%, outdoor public places 61.4%, school 21.3% and home 38.2%), with 96.4% reporting some exposure outside the home.", {"entities": []}], ["Exposure to SHS in the home was more common in girls and among older students.", {"entities": []}], ["Parental education, living with parents and being sent to purchase cigarettes were associated with exposure to SHS both within and outside the home.", {"entities": []}], ["More than 50% of students supported public smoking ban in both enclosed and outdoor public places.", {"entities": []}], ["About 35% of students were unaware of the harmful effects of exposure to SHS.", {"entities": []}], ["Exposure to SHS is highly prevalent among students in The Gambia and occurs mostly outside of the home.", {"entities": []}], ["Interventions to reduce SHS exposure in students are urgently needed.", {"entities": []}], ["Caesarean section is a routine veterinary obstetrical procedure employed to alleviate dystocia in cattle.", {"entities": []}], ["However, CS, particularly before the onset of labour, is known to negatively affect neonatal respiration and metabolic adaptation in humans, though there is little published information for cattle.", {"entities": [[9, 11, "GENE"]]}], ["The aim of this study was to investigate the effect of elective caesarean section (ECS) or normal trans-vaginal (TV) delivery, on lung and jejunal gene expression profiles of neonatal calves.", {"entities": []}], ["Paternal half-sib Angus calves (gestation length 278\u00a0 + \u00a01.8 d) were delivered either transvaginally (TV; n \u2009=\u20098) or by elective caesarean section (ECS; n \u2009=\u20099) and immediately euthanized.", {"entities": []}], ["Lung and jejunum epithelial tissue was isolated and snap frozen.", {"entities": []}], ["Total RNA was extracted using Trizol reagent and reverse transcribed to generate cDNA.", {"entities": []}], ["For lung tissue, primers were designed to target genes involved in immunity, surfactant production, cellular detoxification, membrane transport and mucin production.", {"entities": []}], ["Primers for jejunum tissue were chosen to target mucin production, immunoglobulin uptake, cortisol reaction and membrane trafficking.", {"entities": []}], ["Quantitative real-time PCR reactions were performed and data were statistically analysed using mixed models ANOVA.", {"entities": []}], ["In lung tissue the expression of five genes were affected ( p \u2009<\u20090.05) by delivery method.", {"entities": []}], ["Four of these genes were present at lower ( LAP, CYP1A1, SCN11\u03b1 and SCN11\u03b2 ) and one ( MUC5AC ) at higher abundance in ECS compared with TV calves.", {"entities": [[49, 55, "GENE"]]}], ["In jejunal tissue, expression of TNF\u03b1, Il-1\u03b2 and 1\u00a0l-6 was higher in ECS compared with TV calves.", {"entities": []}], ["This novel study shows that ECS delivery affects the expression of key genes involved in the efficiency of the pulmonary liquid to air transition at birth, and may lead to an increased inflammatory response in jejunal tissue, which could compromise colostral immunoglobulin absorption.", {"entities": []}], ["These findings are important to our understanding of the viability and management of neonatal calves born through ECS.", {"entities": []}], ["Anisakidae larvae can cause anisakiasis when ingested by humans.", {"entities": [[28, 39, "DISEASE"]]}], ["Although several groups have reported a gastrointestinal Anisakis allergy among people in Spain and Japan, our report is the first to summarize the clinical features of 10 Anisakis allergy cases in Korea.", {"entities": []}], ["We enrolled 10 Korean patients (6 men and 4 women) who complained of aggravated allergic symptoms after ingesting raw fish or seafood.", {"entities": []}], ["Sensitization to Anisakis was confirmed by detecting serum specific IgE to Anisakis simplex .", {"entities": []}], ["The most common manifestation of anisakiasis was urticaria (100%), followed by abdominal pain (30%) and anaphylaxis (30%).", {"entities": [[33, 44, "DISEASE"], [49, 58, "DISEASE"]]}], ["All patients presenting with these symptoms also exhibited high serum specific IgE (0.45 to 100 kU/L) to A. simplex .", {"entities": []}], ["Nine patients (90%) exhibited atopy and increased total serum IgE levels.", {"entities": []}], ["The fish species suspected of carrying the Anisakis parasite were flatfish (40%), congers (40%), squid (30%), whelk (10%), and tuna (10%).", {"entities": []}], ["Anisakis simplex should be considered as a possible causative food allergen in adult patients presenting with urticaria, angioedema, and anaphylaxis following the consumption of raw fish or seafood.", {"entities": [[110, 119, "DISEASE"], [121, 131, "DISEASE"]]}], ["Ixodes scapularis is the most medically important tick species and transmits five of the 14 reportable human tick borne disease (TBD) agents in the USA.", {"entities": []}], ["This study describes LC-MS/MS identification of 582 tick- and 83 rabbit proteins in saliva of I .", {"entities": []}], ["scapularis ticks that fed for 24, 48, 72, 96, and 120 h, as well as engorged but not detached (BD), and spontaneously detached (SD).", {"entities": []}], ["The 582 tick proteins include proteases (5.7%), protease inhibitors (7.4%), unknown function proteins (22%), immunity/antimicrobial (2.6%), lipocalin (3.1%), heme/iron binding (2.6%), extracellular matrix/ cell adhesion (2.2%), oxidant metabolism/ detoxification (6%), transporter/ receptor related (3.2%), cytoskeletal (5.5%), and housekeeping-like (39.7%).", {"entities": []}], ["Notable observations include: (i) tick saliva proteins of unknown function accounting for >33% of total protein content, (ii) 79% of proteases are metalloproteases, (iii) 13% (76/582) of proteins in this study were found in saliva of other tick species and, (iv) ticks apparently selectively inject functionally similar but unique proteins every 24 h, which we speculate is the tick's antigenic variation equivalent strategy to protect important tick feeding functions from host immune system.", {"entities": []}], ["The host immune responses to proteins present in 24 h I .", {"entities": []}], ["scapularis saliva will not be effective at later feeding stages.", {"entities": []}], ["Rabbit proteins identified in our study suggest the tick's strategic use of host proteins to modulate the feeding site.", {"entities": []}], ["Notably fibrinogen, which is central to blood clotting and wound healing, was detected in high abundance in BD and SD saliva, when the tick is preparing to terminate feeding and detach from the host.", {"entities": []}], ["A remarkable tick adaptation is that the feeding lesion is completely healed when the tick detaches from the host.", {"entities": []}], ["Does the tick concentrate fibrinogen at the feeding site to aide in promoting healing of the feeding lesion?", {"entities": []}], ["Overall, these data provide broad insight into molecular mechanisms regulating different tick feeding phases.", {"entities": []}], ["These data set the foundation for in depth I .", {"entities": []}], ["scapularis tick feeding physiology and TBD transmission studies.", {"entities": []}], ["Ixodes scapularis , the blacklegged tick or the deer tick, is among the most medically important ticks that transmit human tick borne disease agents including the spirochaete Lyme disease agent.", {"entities": []}], ["To develop new tick control methods, a deeper understanding of how the tick feeds is needed.", {"entities": []}], ["We collected saliva from rabbit fed blacklegged ticks every 24 h through five days of feeding and towards the end of feeding.", {"entities": []}], ["We used novel proteomic technologies (Liquid Chromotography\u2013Tandem Mass Spectrometry) to sequence and identify proteins in tick saliva.", {"entities": []}], ["The main finding is that ticks apparently selectively inject functionally similar but unique proteins every 24 h, which we speculate is the tick's way to avoid the host's defense to protect important tick feeding functions from host immune system.", {"entities": []}], ["The host immune responses to proteins present in 24 h I .", {"entities": []}], ["scapularis saliva will not be effective at later feeding stages.", {"entities": []}], ["This will influence how to design effective anti-tick vaccine antigens to stop disease agent transmission.", {"entities": []}], ["This is the first comprehensive study of proteins in blacklegged tick saliva that provides insight into the molecular mechanisms that are at play at the tick feeding site every 24 h.", {"entities": []}], ["The immune response consists of two main components: humoral immunity represented by B lymphocytes and cellular immunity maintained by the T lymphocytes.", {"entities": []}], ["Immunoglobulins, produced by B\u2013 lymphocytes, are the main mediators of humoral immunity, and deficiencies at this level affect the body's response to infection.", {"entities": []}], ["Plasmocytes produce nine antibody izotypes: immunoglobulins G (IgG 1, lgG2, lgG3, lgG4), immunoglobulins M (IgM), immunoglobulins A (lgA1, lgA2), immunoglobulins D (IGD) and immunoglobulins E (IgE).", {"entities": []}], ["Primary hypogammaglobulinemias are characterized by the occurrence of recurrent infections and, paradoxically, by the occurrence of autoimmune diseases.", {"entities": []}], ["Characteristic for these diseases is that symptoms occur at 7\u20139 months after birth, when transplacental antibody titers transmitted from the mother decrease, and the infant's body is unable to synthesize them to normal levels.", {"entities": []}], ["Primary hypogammaglobulinemias are transmitted genetically, but mutations at the molecular level are still not fully understood.", {"entities": []}], ["The most common are: Bruton agammaglobulinemia , transient newborn hypogammaglobulinemia, selective immunoglobulin deficiency and variable common immunodeficiency.", {"entities": [[28, 46, "DISEASE"]]}], ["Treatment consists of monthly antibiotics and immunoglobulins, depending on antibody titers (except for IgA deficiency).", {"entities": []}], ["Altered kallikrein-related peptidase activity and bradykinin are associated with skin disorders in humans and mice under chronic inflammation conditions.", {"entities": []}], ["The bradykinin B1 receptor (B1R), also known as one of the G-protein-coupled receptor family and usually absent in intact tissues and upregulated during tissue injury, is responsible for vasodilation, capillary permeability, nociceptor sensitization, and pain; it is indispensable for physiopathological progress in chronic inflammation conditions, but its roles and effectors in the itching sensation of the allergic contact dermatitis model are poorly defined.", {"entities": [[418, 436, "DISEASE"], [409, 436, "DISEASE"], [426, 436, "DISEASE"]]}], ["We focused on incurable itching in a diphenylcyclopropenone (DCP) chronic inflammation experimental model.", {"entities": []}], ["Preventive treatment with the B1R antagonist R892 significantly suppressed spontaneous scratching, while the B2R selective antagonist did not.", {"entities": []}], ["B1R expression in the skin tissues of this model was detected using a quantitative, real-time polymerase chain reaction, Western blotting, and immunohistochemistry; B1R mRNA and protein levels were increased compared with a sham-treated control group.", {"entities": []}], ["A higher B1R IHC staining signal was observed in the keratinocytes in DCP-treated mice compared with a vehicle-treated group, so we studied the B1R function when superimposed on a protease-activated receptor 2 (PAR2) background, establishing B1R as a pivotal mediator of PAR2 function in HaCaT cell lines.", {"entities": []}], ["Our data provide evidence that B1R facilitates the chronic itching sensation related to keratinocytes in a DCP-treated chronic inflammation experimental model.", {"entities": []}], ["The microbial composition of the equine respiratory tract, and differences due to mild equine asthma (also called Inflammatory Airway Disease (IAD)) have not been reported.", {"entities": [[94, 100, "DISEASE"]]}], ["The primary treatment for control of IAD in horses are corticosteroids.", {"entities": []}], ["The objectives were to characterize the upper and lower respiratory tract microbiota associated with respiratory health and IAD, and to investigate the effects of dexamethasone on these bacterial communities using high throughput sequencing.", {"entities": []}], ["The respiratory microbiota of horses was dominated by four major phyla, Proteobacteria (43.85%), Actinobacteria (21.63%), Firmicutes (16.82%), and Bacteroidetes (13.24%).", {"entities": []}], ["Fifty genera had a relative abundance >\u20090.1%, with Sphingomonas and Pantoea being the most abundant.", {"entities": []}], ["The upper and lower respiratory tract microbiota differed in healthy horses, with a decrease in richness in the lower airways, and 2 OTUs that differed in abundance.", {"entities": []}], ["There was a separation between bacterial communities in the lower respiratory tract of healthy and IAD horses; 6 OTUs in the tracheal community had different abundance with disease status, with Streptococcus being increased in IAD horses.", {"entities": []}], ["Treatment with dexamethasone had an effect on the lower respiratory tract microbiota of both heathy and IAD horses, with 8 OTUs increasing in abundance (including Streptococcus ) and 1 OTU decreasing .", {"entities": []}], ["The lower respiratory tract microbiota differed between healthy and IAD horses.", {"entities": []}], ["Further research on the role of Streptococcus in IAD is warranted .", {"entities": []}], ["Dexamethasone treatment affected the lower respiratory tract microbiota, which suggests that control of bacterial overgrowth in IAD horses treated with dexamethasone could be part of the treatment strategy.", {"entities": []}], ["The online version of this article (doi:10.1186/s12866-017-1092-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Understanding the immune response upon infection with the filarial nematode Onchocerca volvulus and the mechanisms that evolved in this parasite to evade immune mediated elimination is essential to expand the toolbox available for diagnostics, therapeutics and vaccines development.", {"entities": []}], ["Using high-density peptide microarrays we scanned the proteome-wide linear epitope repertoire in Cameroonian onchocerciasis patients and healthy controls from Southern Africa which led to the identification of 249 immunodominant antigenic peptides.", {"entities": [[109, 123, "DISEASE"]]}], ["Motif analysis learned that 3 immunodominant motifs, encompassing 3 linear epitopes, are present in 70, 43, and 31 of these peptides, respectively and appear to be scattered over the entire proteome in seemingly non-related proteins.", {"entities": []}], ["These linear epitopes are shown to have an atypical isotype profile dominated by IgG1, IgG3, IgE and IgM, in contrast to the commonly observed IgG4 response in chronic active helminth infections.", {"entities": []}], ["The identification of these linear epitope motifs may lead to novel diagnostic development but further evaluation of cross-reactivity against common co-infecting human nematode infections will be needed.", {"entities": []}], ["Infection with the filarial parasite Onchocerca volvulus is the cause of river blindness.", {"entities": [[79, 88, "DISEASE"]]}], ["We analyzed the immune response against this parasite in infected individuals in order to identify linear epitopes.", {"entities": []}], ["Using high-density peptide microarrays we discovered three immunodominant motifs in the Onchocerca volvulus proteome that induce a broad IgG response, but the typical IgG4 immune response against parasites was absent.", {"entities": []}], ["Our study led to the identification of novel potential epitope sequences that can potentially be used for detection of infection with Onchocerca volvulus .", {"entities": []}], ["Peripheral neuropathy is a common dose-limiting toxicity for patients treated with paclitaxel.", {"entities": [[11, 21, "DISEASE"], [0, 21, "DISEASE"]]}], ["For most individuals there are no known risk factors that predispose patients to the adverse event, and pathogenesis for paclitaxel-induced peripheral neuropathy is unknown.", {"entities": [[151, 161, "DISEASE"], [140, 161, "DISEASE"]]}], ["Determining whether there is a heritable component to paclitaxel induced peripheral neuropathy would be valuable in guiding clinical decisions and may provide insight into treatment of and mechanisms for the toxicity.", {"entities": [[84, 94, "DISEASE"], [73, 94, "DISEASE"]]}], ["Using genotype and patient information from the paclitaxel arm of CALGB 40101 (Alliance), a phase III clinical trial evaluating adjuvant therapies for breast cancer in women, we estimated the variance in maximum grade and dose at first instance of sensory peripheral neuropathy.", {"entities": [[267, 277, "DISEASE"], [256, 277, "DISEASE"], [151, 164, "DISEASE"], [158, 164, "DISEASE"], [248, 277, "DISEASE"]]}], ["Our results suggest that paclitaxel-induced neuropathy has a heritable component, driven in part by genes involved in axon outgrowth.", {"entities": [[44, 54, "DISEASE"]]}], ["Disruption of axon outgrowth may be one of the mechanisms by which paclitaxel treatment results in sensory peripheral neuropathy in susceptible patients.", {"entities": [[118, 128, "DISEASE"], [107, 128, "DISEASE"], [99, 128, "DISEASE"]]}], ["Emissions of volatile organic compounds (VOCs) and carbonyls from three types of commercially available wallpapers ( i.e.", {"entities": []}], [", PVC-coated, paper-backed, natural material-coated) in Korea were evaluated using a 20 L small chamber.", {"entities": []}], ["A total of 332 products were tested for emission factors, frequencies of occurrence and composition ratios.", {"entities": []}], ["Toluene and formaldehyde concentrations were below Korean standard values for all products; however, the total VOC (TVOC) concentrations exceeded current standards (4.0 mg/m", {"entities": []}], ["Language concordance between physicians and patients may reduce barriers to care faced by patients with limited English proficiency (LEP).", {"entities": [[133, 136, "GENE"]]}], ["It is unclear whether physicians with fluency in non-English languages practice in areas with high concentrations of people with LEP.", {"entities": [[129, 132, "GENE"]]}], ["To investigate whether physician non-English language fluency is associated with practicing in areas with high concentrations of people with LEP.", {"entities": [[141, 144, "GENE"]]}], ["Cross-sectional cohort study.", {"entities": []}], ["A total of 61,138 practicing physicians no longer in training who participated in the California Medical Board Physician Licensure Survey from 2001\u20132007.", {"entities": []}], ["Self-reported language fluency in Spanish and Asian languages.", {"entities": []}], ["Physician practice ZIP code corresponding to: (1) high concentration of people with LEP and (2) high concentration of linguistically isolated households.", {"entities": [[84, 87, "GENE"]]}], ["Practice location ZIP code was geocoded with geographic medical service study designations.", {"entities": []}], ["We examined the unadjusted relationships between physician self-reported fluency in Spanish and selected Asian languages and practice location, stratified by race-ethnicity.", {"entities": []}], ["We used staged logistic multiple variable regression models to isolate the effect of self-reported language fluency on practice location controlling for age, gender, race-ethnicity, medical specialty, and international medical graduate status.", {"entities": []}], ["Physicians with self-reported fluency in Spanish or an Asian language were more likely to practice in linguistically designated areas in these respective languages compared to those without fluency.", {"entities": []}], ["Physician fluency in an Asian language [adjusted odds ratio (AOR)\u2009=\u20091.77; 95% confidence intervals (CI): 1.63\u20131.92] was independently associated with practicing in areas with a high number of LEP Asian speakers.", {"entities": [[192, 195, "GENE"]]}], ["A similar pattern was found for Spanish language fluency (AOR\u2009=\u20091.77; 95% CI: 1.43\u20131.82) and areas with high numbers of LEP Spanish-speakers.", {"entities": [[120, 123, "GENE"]]}], ["Latino and Asian race-ethnicity had the strongest effect on corresponding practice location, and this association was attenuated by language fluency.", {"entities": []}], ["Physicians who are fluent in Spanish or an Asian language are more likely to practice in geographic areas where their potential patients speak the corresponding language.", {"entities": []}], ["The aberrant immunity plays an important role in the pathogenesis of allergic diseases.", {"entities": []}], ["Micro RNAs (miR) are involved in regulating the immunity in the body.", {"entities": []}], ["This study aims to test a hypothesis that miR-146a induces the expression of interleukin (IL)-10 in monocytes (Mos).", {"entities": [[42, 50, "GENE"]]}], ["In this study, the levels of miR-146a were determined by real time RT-PCR.", {"entities": [[29, 37, "GENE"]]}], ["Respiratory syncytial virus (RSV) causes recurrent infections throughout life.", {"entities": []}], ["Vaccine development may depend upon understanding the molecular basis for induction of ineffective immunity.", {"entities": []}], ["Because dendritic cells (DCs) are critically involved in early responses to infection, their interaction with RSV may determine the immunological outcome of RSV infection.", {"entities": []}], ["Therefore, we investigated the ability of RSV to infect and activate primary mDCs and pDCs using recombinant RSV expressing green fluorescent protein (GFP).", {"entities": []}], ["At a multiplicity of infection of 5, initial studies demonstrated \u223c6.8% of mDC1 and \u223c0.9% pDCs were infected.", {"entities": [[75, 79, "GENE"]]}], ["We extended these studies to include CD1c", {"entities": [[37, 41, "GENE"]]}], ["Providing feedback is a technique to promote health behavior that is emphasized by behavior change theories.", {"entities": []}], ["However, these theories make contradicting predictions regarding the effect of the feedback sign\u2014that is, whether the feedback signals success or failure.", {"entities": []}], ["Thus, it is unclear whether positive or negative feedback leads to more favorable behavior change in a health behavior intervention.", {"entities": []}], ["The aim of this study was to examine the effect of the feedback sign in a health behavior change intervention.", {"entities": []}], ["Data from participants (N=1623) of a 6-month physical activity intervention was used.", {"entities": []}], ["Participants received a feedback email at the beginning of each month.", {"entities": []}], ["Feedback was either positive or negative depending on the participants\u2019 physical activity in the previous month.", {"entities": []}], ["In an exploratory analysis, change in monthly step count averages was used to evaluate the feedback effect.", {"entities": []}], ["The feedback sign did not predict the change in monthly step count averages over the course of the intervention ( b =\u221284.28, P =.28).", {"entities": []}], ["Descriptive differences between positive and negative feedback can be explained by regression to the mean.", {"entities": []}], ["The feedback sign might not influence the effect of monthly feedback emails sent out to participants of a large-scale physical activity intervention.", {"entities": []}], ["However, randomized studies are needed to further support this conclusion.", {"entities": []}], ["Limitations as well as opportunities for future research are discussed.", {"entities": []}], ["The presence of tangles composed of phosphorylated tau is one of the neuropathological hallmarks of Alzheimer's disease (AD).", {"entities": []}], ["Tau, a microtubule (MT)-associated protein, accumulates in AD potentially as a result of posttranslational modifications, such as hyperphosphorylation and conformational changes.", {"entities": []}], ["However, it has not been fully understood how tau accumulation and phosphorylation are deregulated.", {"entities": []}], ["In the present study, we identified a novel role of death-associated protein kinase 1 (DAPK1) in the regulation of the tau protein.", {"entities": [[87, 92, "GENE"]]}], ["We found that hippocampal DAPK1 expression is markedly increased in the brains of AD patients compared with age-matched normal subjects.", {"entities": [[26, 31, "GENE"]]}], ["DAPK1 overexpression increased tau protein stability and phosphorylation at multiple AD-related sites.", {"entities": [[0, 5, "GENE"]]}], ["In contrast, inhibition of DAPK1 by overexpression of a DAPK1 kinase-deficient mutant or by genetic knockout significantly decreased tau protein stability and abolished its phosphorylation in cell cultures and in mice.", {"entities": [[27, 32, "GENE"], [56, 61, "GENE"], [27, 32, "GENE"], [56, 61, "GENE"]]}], ["Mechanistically, DAPK1-enhanced tau protein stability was mediated by Ser71 phosphorylation of Pin1, a prolyl isomerase known to regulate tau protein stability, phosphorylation, and tau-related pathologies.", {"entities": [[95, 99, "GENE"]]}], ["In addition, inhibition of DAPK1 kinase activity significantly increased the assembly of MTs and accelerated nerve growth factor-mediated neurite outgrowth.", {"entities": [[27, 32, "GENE"]]}], ["Given that DAPK1 has been genetically linked to late onset AD, these results suggest that DAPK1 is a novel regulator of tau protein abundance, and that DAPK1 upregulation might contribute to tau-related pathologies in AD.", {"entities": [[11, 16, "GENE"], [90, 95, "GENE"], [152, 157, "GENE"], [11, 16, "GENE"], [90, 95, "GENE"], [152, 157, "GENE"], [11, 16, "GENE"], [90, 95, "GENE"], [152, 157, "GENE"]]}], ["Therefore, we offer that DAPK1 might be a novel therapeutic target for treating human AD and other tau-related pathologies.", {"entities": [[25, 30, "GENE"]]}], ["Chemokines are a family of small, highly conserved cytokines that mediate various biological processes, including chemotaxis, hematopoiesis, and angiogenesis, and that function by interacting with cell surface G-Protein Coupled Receptors (GPCRs).", {"entities": []}], ["Because of their significant involvement in various biological functions and pathologies, chemokines and their receptors have been the focus of therapeutic discovery for clinical intervention.", {"entities": []}], ["There are several sub-families of chemokines (e.g., CXC, CC, C, and CX3C) defined by the positions of sequentially conserved cysteine residues.", {"entities": []}], ["Even though all chemokines also have a highly conserved, three-stranded \u03b2-sheet/\u03b1-helix tertiary structural fold, their quarternary structures vary significantly with their sub-family.", {"entities": []}], ["Moreover, their conserved tertiary structures allow for subunit swapping within and between sub-family members, thus promoting the concept of a \u201cchemokine interactome\u201d.", {"entities": []}], ["This review is focused on structural aspects of CXC and CC chemokines, their functional synergy and ability to form heterodimers within the chemokine interactome, and some recent developments in structure-based chemokine-targeted drug discovery.", {"entities": []}], ["The balance between Th17 and T regulatory (T reg ) cells critically modulates immune homeostasis, with an inadequate T reg response contributing to inflammatory disease.", {"entities": []}], ["Using an unbiased chemical biology approach, we identified a novel role for the dual specificity tyrosine-phosphorylation-regulated kinase DYRK1A in regulating this balance.", {"entities": [[139, 145, "GENE"]]}], ["Inhibition of DYRK1A enhances T reg differentiation and impairs Th17 differentiation without affecting known pathways of T reg /Th17 differentiation.", {"entities": [[14, 20, "GENE"]]}], ["Thus, DYRK1A represents a novel mechanistic node at the branch point between commitment to either T reg or Th17 lineages.", {"entities": [[6, 12, "GENE"]]}], ["Importantly, both T reg cells generated using the DYRK1A inhibitor harmine and direct administration of harmine itself potently attenuate inflammation in multiple experimental models of systemic autoimmunity and mucosal inflammation.", {"entities": [[50, 56, "GENE"]]}], ["Our results identify DYRK1A as a physiologically relevant regulator of T reg cell differentiation and suggest a broader role for other DYRK family members in immune homeostasis.", {"entities": [[21, 27, "GENE"]]}], ["These results are discussed in the context of human diseases associated with dysregulated DYRK activity.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.05920.001 Inflammation is used by the immune system to protect and repair tissues after an injury or infection.", {"entities": []}], ["However, if inflammation is too strong, or goes on for too long, it can damage tissues.", {"entities": []}], ["This is seen in autoimmune diseases such as inflammatory bowel disease and type 1 diabetes.", {"entities": [[44, 70, "DISEASE"]]}], ["Therefore, precise regulation of the inflammatory response is essential for maintaining human health.", {"entities": []}], ["White blood cells known as T cells are central regulators of tissue inflammation.", {"entities": []}], ["To achieve this goal, they develop into subtypes with specialized roles.", {"entities": []}], ["For example, some T helper cells release chemical signals that trigger inflammation and other immune responses.", {"entities": []}], ["Regulatory T (T reg ) cells then shut down these immune responses once they are no longer needed.", {"entities": []}], ["Many autoimmune and other inflammatory diseases are thought to arise\u2014at least partially\u2014because T reg cells fail to stop the inflammatory response.", {"entities": []}], ["Boosting the number or the activity of T reg cells could therefore help to treat these diseases.", {"entities": []}], ["However, technical difficulties have made it difficult to investigate the genes and molecular pathways that control how this subtype of white blood cells develops.", {"entities": []}], ["Khor et al.", {"entities": []}], ["thought that discovering new chemicals that increase the number of T reg cells without harming them could help to identify the pathways that control their development.", {"entities": []}], ["Khor et al.", {"entities": []}], ["screened over 3000 chemicals, many of which are drugs currently approved for use in humans, for their effect on immature T cells that were taken from mice and grown in the laboratory.", {"entities": []}], ["This \u2018unbiased chemical biology\u2019 approach identified several chemicals that both encouraged the T cells to develop into T reg cells and reduced the numbers that became inflammation-promoting T helper cells.", {"entities": []}], ["Khor et al.", {"entities": []}], ["then focused on one of these chemicals, called harmine.", {"entities": []}], ["Tests in mice showed that harmine reduces the extent of experimentally induced inflammatory reactions.", {"entities": []}], ["T reg cells generated by treating immature T cells with harmine had the same effect.", {"entities": []}], ["Further experiments showed that harmine exerts these effects, at least in part, by inhibiting the activity of a protein called DYRK1A.", {"entities": [[127, 133, "GENE"]]}], ["When DYRK1A was removed from maturing mouse T cells grown in the laboratory, the T cells tended to develop into anti-inflammatory T reg cells.", {"entities": [[5, 11, "GENE"]]}], ["These findings therefore identify DYRK1A as part of a pathway that suppresses the development of T reg cells.", {"entities": [[34, 40, "GENE"]]}], ["It remains to be discovered how it does this, and whether other DYRK protein family members have similar roles.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.05920.002", {"entities": []}], ["Diabetes mellitus is a chronic disease that is associated with depression.", {"entities": [[0, 17, "DISEASE"]]}], ["Also, depression is common in adults with type 2 diabetes mellitus (T2DM).", {"entities": [[49, 66, "DISEASE"], [42, 66, "DISEASE"]]}], ["Translocator protein (18kDa) (TSPO) and allopregnanolone play an important role in the depression treatment.", {"entities": [[30, 34, "GENE"]]}], ["However, few studies have evaluated TSPO and allopregnanolone in the treatment of depression in T2DM.", {"entities": [[36, 40, "GENE"]]}], ["AC-5216, a ligand for TSPO, produces anxiolytic- and antidepressant-like effects in animal models.", {"entities": [[22, 26, "GENE"]]}], ["The present study aimed to explore antidepressant-like effects of AC-5216 on diabetic rats.", {"entities": []}], ["Following the development of diabetic model induced by high fat diet (HFD) feeding and streptozotocin (STZ), AC-5216 (0.3 and 1\u2009mg/kg, i.g.)", {"entities": []}], ["elicited the antidepressant-like effects in behavioral tests while these activities were blocked by TSPO antagonist PK11195 (3\u2009mg/kg, i.p.).", {"entities": [[100, 104, "GENE"]]}], ["The levels of allopregnanolone in the prefrontal cortex and hippocampus were increased by AC-5216 (0.3 and 1\u2009mg/kg, i.g.", {"entities": []}], ["), which was antagonized by PK11195 (3\u2009mg/kg, i.p.).", {"entities": []}], ["The increased plasma glucose (PG) and decreased insulin (INS) in HFD-STZ rats were reversed by AC-5216 (0.3 and 1\u2009mg/kg, i.g.).", {"entities": [[57, 60, "GENE"]]}], ["This study indicates that the antidepressant-like effects of AC-5216 on HFD-STZ rats, suggesting that TSPO may represent a novel therapeutic target for depression in T2DM.", {"entities": [[102, 106, "GENE"]]}], ["The \u03b2 2 -adrenergic receptor (\u03b2 2 AR) is expressed on numerous cell-types including airway smooth muscle cells and cardiomyocytes.", {"entities": []}], ["Drugs (agonists or antagonists) acting at these receptors for treatment of asthma, chronic obstructive pulmonary disease, and heart failure show substantial interindividual variability in response.", {"entities": [[83, 120, "DISEASE"], [75, 81, "DISEASE"]]}], ["The ADRB2 gene is polymorphic in noncoding and coding regions, but virtually all ADRB2 association studies have utilized the two common nonsynonymous coding SNPs, often reaching discrepant conclusions.", {"entities": [[4, 9, "GENE"], [81, 86, "GENE"], [4, 9, "GENE"], [81, 86, "GENE"]]}], ["We constructed the 8 common ADRB2 haplotypes derived from 26 polymorphisms in the promoter, 5\u2032UTR, coding, and 3\u2032UTR of the intronless ADRB2 gene.", {"entities": [[28, 33, "GENE"], [135, 140, "GENE"], [28, 33, "GENE"], [135, 140, "GENE"]]}], ["These were cloned into an expression construct lacking a vector-based promoter, so that \u03b2 2 AR expression was driven by its promoter, and steady state expression could be modified by polymorphisms throughout ADRB2 within a haplotype.", {"entities": [[208, 213, "GENE"]]}], ["\u201cWhole-gene\u201d transfections were performed with COS-7 cells and revealed 4 haplotypes with increased cell surface \u03b2 2 AR protein expression compared to the others.", {"entities": []}], ["Agonist-promoted downregulation of \u03b2 2 AR protein expression was also haplotype-dependent, and was found to be increased for 2 haplotypes.", {"entities": []}], ["A phylogenetic tree of the haplotypes was derived and annotated by cellular phenotypes, revealing a pattern potentially driven by expression.", {"entities": []}], ["Thus for obstructive lung disease, the initial bronchodilator response from intermittent administration of \u03b2-agonist may be influenced by certain \u03b2 2 AR haplotypes (expression phenotypes), while other haplotypes may influence tachyphylaxis during the response to chronic therapy (downregulation phenotypes).", {"entities": [[9, 33, "DISEASE"], [21, 33, "DISEASE"]]}], ["An ideal clinical outcome of high expression and less downregulation was found for two haplotypes.", {"entities": []}], ["Haplotypes may also affect heart failure antagonist therapy, where \u03b2 2 AR increase inotropy and are anti-apoptotic.", {"entities": []}], ["The haplotype-specific expression and regulation phenotypes found in this transfection-based system suggest that the density of genetic information in the form of these haplotypes, or haplotype-clusters with similar phenotypes can potentially provide greater discrimination of phenotype in human disease and pharmacogenomic association studies.", {"entities": []}], ["The consensus process was applied to addressing a public health topic; this was a novel endeavor.", {"entities": []}], ["The following question was addressed: What role, if any, should sentinel health events play in the decision-making process for identifying the effects of environmental exposure?", {"entities": []}], ["The panel developed three levels of sentinel health events lists: those that are clearly identifiable, those that are potential signs, and those that are indicators of body burdens.", {"entities": []}], ["Additionally, the panel developed several salient statements regarding the principles of environmental health surveillance and, especially, recommendations for future research.", {"entities": []}], ["Contractile forces are the end effectors of cell migration, division, morphogenesis, wound healing and cancer invasion.", {"entities": [[103, 109, "DISEASE"]]}], ["Here we report optogenetic tools to upregulate and downregulate such forces with high spatiotemporal accuracy.", {"entities": []}], ["The technology relies on controlling the subcellular activation of RhoA using the CRY2/CIBN light-gated dimerizer system.", {"entities": [[67, 71, "GENE"]]}], ["We fused the catalytic domain (DHPH domain) of the RhoA activator ARHGEF11 to CRY2-mCherry (optoGEF-RhoA) and engineered its binding partner CIBN to bind either to the plasma membrane or to the mitochondrial membrane.", {"entities": [[51, 55, "GENE"], [100, 104, "GENE"], [66, 74, "GENE"]]}], ["Translocation of optoGEF-RhoA to the plasma membrane causes a rapid and local increase in cellular traction, intercellular tension and tissue compaction.", {"entities": []}], ["By contrast, translocation of optoGEF-RhoA to mitochondria results in opposite changes in these physical properties.", {"entities": []}], ["Cellular changes in contractility are paralleled by modifications in the nuclear localization of the transcriptional regulator YAP, thus showing the ability of our approach to control mechanotransductory signalling pathways in time and space.", {"entities": []}], ["Cellular mechanical forces are regulated by Rho GTPases.", {"entities": []}], ["Here the authors develop an optogenetic system to control the spatiotemporal activity of RhoA, and show that directing a RhoA activator to the plasma membrane causes contraction and YAP nuclear localization, whereas directing it to the mitochondria causes relaxation.", {"entities": [[89, 93, "GENE"], [121, 125, "GENE"], [89, 93, "GENE"], [121, 125, "GENE"]]}], ["The aim of this report was to introduce a novel \u201ccore-membrane\u201d microgel drug-delivery device for spontaneously pulsed release without any external trigger.", {"entities": []}], ["The microgel core was prepared with alginate and chitosan.", {"entities": []}], ["The semipermeable membrane outside the microgel was made of polyelectrolytes including polycation poly(allylamine hydrochloride) and sodium polystyrene sulfonate.", {"entities": []}], ["The drug release of this novel system was governed by the swelling pressure of the core and the rupture of the outer membrane.", {"entities": []}], ["The size of the core-membrane microgel drug-delivery device was 452.90 \u00b1 2.71 \u03bcm.", {"entities": []}], ["The surface charge depended on the layer-by-layer coating of polyelectrolytes, with zeta potential of 38.6 \u00b1 1.4 mV.", {"entities": []}], ["The confocal microscope exhibited the layer-by-layer outer membrane and inner core.", {"entities": []}], ["The in vitro release profile showed that the content release remained low during the first 2.67 hours.", {"entities": []}], ["After this lag time, the cumulative release increased to 80% in the next 0.95 hours, which suggested a pulsed drug release.", {"entities": []}], ["The in vivo drug release in mice showed that the outer membrane was ruptured at approximately 3 to 4 hours, as drug was explosively released.", {"entities": []}], ["These data suggest that the encapsulated substance in the core-membrane microgel delivery device can achieve a massive drug release after outer membrane rupture.", {"entities": []}], ["This device was an effective system for pulsed drug delivery.", {"entities": []}], ["The interaction between galectin-9 and its receptor, Tim-3, triggers a series of signaling events that regulate immune responses.", {"entities": []}], ["The expression of galectin-9 has been shown to be increased in a variety of target cells of many different viruses, such as hepatitis C virus (HCV), hepatitis B virus (HBV), herpes simplex virus (HSV), influenza virus, dengue virus (DENV), and human immunodeficiency virus (HIV).", {"entities": [[174, 188, "DISEASE"], [202, 211, "DISEASE"], [124, 133, "DISEASE"], [149, 158, "DISEASE"]]}], ["This enhanced expression of galectin-9 following viral infection promotes significant changes in the behaviors of the virus-infected cells, and the resulting events tightly correlate with the immunopathogenesis of the viral disease.", {"entities": []}], ["Because the human immune response to different viral infections can vary, and the lack of appropriate treatment can have potentially fatal consequences, understanding the implications of galectin-9 is crucial for developing better methods for monitoring and treating viral infections.", {"entities": []}], ["This review seeks to address how we can apply the current understanding of galectin-9 function to better understand the pathogenesis of viral infection and better treat viral diseases.", {"entities": []}], ["According to traditional Chinese medicine (TCM) theory, a specific physiological and pathological relationship exists between the lungs and the large intestine.", {"entities": []}], ["The aim of this study is to delineate the association of chronic obstructive pulmonary disease (COPD) and hemorrhoids in order to verify the \u201cinterior\u2013exterior\u201d relationship between the lungs and the large intestine.", {"entities": [[57, 94, "DISEASE"]]}], ["A retrospective cohort study is conceived from the National Health Insurance Research Database, Taiwan.", {"entities": []}], ["The 2 samples (COPD cohort and non-COPD cohort) were selected from the 2000 to 2003 beneficiaries of the NHI, representing patients age 20 and older in Taiwan, with the follow-up ending on December 31, 2011.", {"entities": []}], ["The COPD cohort (n\u200a=\u200a51,506) includes every patient newly diagnosed as having Chronic Obstructive Pulmonary Disease (COPD, ICD-9-CM: 490\u2013492, 494, 496), who have made at least 2 confirmed visits to the hospital/clinic.", {"entities": [[78, 115, "DISEASE"]]}], ["The non-COPD cohort (n\u200a=\u200a103,012) includes patients without COPD and is selected via a 1:2 (COPD: non-COPD) matching by age group (per 5 years), gender, and index date (diagnosis date of COPD for the COPD cohort).", {"entities": []}], ["Compared with non-COPD cohorts, patients with COPD have a higher likelihood of having hemorrhoids and the age-, gender- and comorbidies-adjusted hazard ratio (HR) for hemorrhoids is 1.56 (95% confidence intervals [CI]:1.50\u20131.62).", {"entities": [[159, 161, "GENE"]]}], ["The adjusted HR of hemorrhoids for females is 0.79 (95% CI: 0.77\u20130.83), which is significantly less than that for males.", {"entities": [[13, 15, "GENE"]]}], ["The elderly groups, 40 to 59 years and aged 60 or above, have higher adjusted HRs than younger age groups (20\u201339 years), 1.19 (95% CI: 1.14\u20131.26), and 1.18 (95% CI: 1.12\u20131.24), respectively.", {"entities": []}], ["Patients with COPD may have a higher likelihood to have hemorrhoids in this retrospective cohort study.", {"entities": []}], ["This study verifies the fundamental theorem of TCM that there is a definite pathogenic association between the lungs and large intestine.", {"entities": []}], ["Of the eight epithelial cell types of the airway surface epithelium three are secretory, the mucous, serous and Clara cells: the first two are also found in the submucosal glands.", {"entities": []}], ["Organ culture results indicate that the pattern of control of the surface cells is different from that of the glands.", {"entities": []}], ["Our recent studies show that in the surface epithelium Clara and serous cells can quickly convert to mucous as do nonsecretory undifferentiated cells.", {"entities": []}], ["The balance between the various cell types changes with airway level.", {"entities": []}], ["The type of glycoprotein within the secretory granules is neutral or acid, sialylated or sulfated, and also shows a regional pattern.", {"entities": []}], ["Homeostasis is maintained in the normal but the equilibrium is quickly upset by a variety of irritants, infection of drugs.", {"entities": []}], ["Change in pattern of glycoprotein synthesis depends largely on change of granules.", {"entities": []}], ["The granules at the cell apex change first.", {"entities": []}], ["The nature and distribution of the various receptor binding sites is significant in patterns of control.", {"entities": []}], ["This lability occurs in an intact epithelium and whether or not mitotic activity is increased.", {"entities": []}], ["With irritation tolerance to stimulus develops.", {"entities": []}], ["Antiinflammatory agents can protect against some of these cellular and intracellular events.", {"entities": []}], ["Our organ culture studies and biochemical analysis of secretion complement the tissue studies.", {"entities": []}], ["Recent studies show that isoproterenol and salbutamol (a nonselective beta agonist and a selective beta 2, respectively) alter the normal mix of cell types and quickly, but that they have different regional specificity.", {"entities": []}], ["Eosinophilic gastroenteritis (EGE) is an uncommon disease characterized by eosinophilic infiltration of the gastrointestinal tract, which is usually associated with abdominal pain, diarrhea, ascites, and peripheral eosinophilia.", {"entities": [[181, 189, "DISEASE"], [13, 28, "DISEASE"], [215, 227, "DISEASE"]]}], ["Steroids remain the mainstay of treatment for EGE, but symptoms often recur when the dose is reduced.", {"entities": []}], ["Macrolides have immunomodulatory effects as well as antibacterial effects.", {"entities": []}], ["The immunomodulatory effect results in inhibition of T-lymphocyte proliferation and triggering of T-lymphocyte and eosinophil apoptosis.", {"entities": []}], ["Macrolides also have a steroid-sparing effect through their influence on steroid metabolism.", {"entities": []}], ["We report a rare case of EGE, which relapsed on steroid reduction but improved following clarithromycin treatment.", {"entities": []}], ["The Campanian Ignimbrite (CI) volcanic eruption was the most explosive in Europe in the last 200,000 years.", {"entities": []}], ["The event coincided with the onset of an extremely cold climatic phase known as Heinrich Event 4 (HE4) approximately 40,000 years ago.", {"entities": []}], ["Their combined effect may have exacerbated the severity of the climate through positive feedbacks across Europe and possibly globally.", {"entities": []}], ["The CI event is of particular interest not only to investigate the role of volcanism on climate forcing and palaeoenvironments, but also because its timing coincides with the arrival into Europe of anatomically modern humans, the demise of Neanderthals, and an associated major shift in lithic technology.", {"entities": []}], ["At this stage, however, the degree of interaction between these factors is poorly known, based on fragmentary and widely dispersed data points.", {"entities": []}], ["In this study we provide important new data from Eastern Europe which indicate that the magnitude of the CI eruption and impact of associated distal ash (tephra) deposits may have been substantially greater than existing models suggest.", {"entities": []}], ["The scale of the eruption is modelled by tephra distribution and thickness, supported by local data points.", {"entities": []}], ["CI ashfall extends as far as the Russian Plain, Eastern Mediterranean and northern Africa.", {"entities": []}], ["However, modelling input is limited by very few data points in Eastern Europe.", {"entities": []}], ["Here we investigate an unexpectedly thick CI tephra deposit in the southeast Romanian loess steppe, positively identified using geochemical and geochronological analyses.", {"entities": []}], ["We establish the tephra as a widespread primary deposit, which blanketed the topography both thickly and rapidly, with potentially catastrophic impacts on local ecosystems.", {"entities": []}], ["Our discovery not only highlights the need to reassess models for the magnitude of the eruption and its role in climatic transition, but also suggests that it may have substantially influenced hominin population and subsistence dynamics in a region strategic for human migration into Europe.", {"entities": []}], ["Experimental data suggest that asthma exacerbation by ambient air pollutants is enhanced by exposure to endotoxin and allergens; however, there is little supporting epidemiologic evidence.", {"entities": [[31, 37, "DISEASE"]]}], ["We evaluated whether the association of exposure to air pollution with annual prevalence of chronic cough, phlegm production, or bronchitis was modified by dog and cat ownership (indicators of allergen and endotoxin exposure).", {"entities": [[129, 139, "DISEASE"]]}], ["The study population consisted of 475 Southern California children with asthma from a longitudinal cohort of participants in the Children\u2019s Health Study.", {"entities": [[72, 78, "DISEASE"]]}], ["We estimated average annual ambient exposure to nitrogen dioxide, ozone, particulate matter < 10, 2.5, and 10\u20132.5 \u03bcm in aerodynamic diameter (PM 10 , PM 2.5 , and PM 10\u20132.5 , respectively), elemental and organic carbon, and acid vapor from monitoring stations in each of the 12 study communities.", {"entities": []}], ["Multivariate models were used to examine the effect of yearly variation of each pollutant.", {"entities": []}], ["Effects were scaled to the variability that is common for each pollutant in representative communities in Southern California.", {"entities": []}], ["Among children owning a dog, there were strong associations between bronchitic symptoms and all pollutants examined.", {"entities": []}], ["Odds ratios ranged from 1.30 per 4.2 \u03bcg/m 10\u20132.5 [95% confidence interval (CI), 0.91\u20131.87) to 1.91 per 1.2 \u03bcg/m Our results suggest that dog ownership, a source of residential exposure to endotoxin, may worsen the relationship between air pollution and respiratory symptoms in asthmatic children.", {"entities": []}], ["Atopic dermatitis (AD) is known to predate asthma and other atopic disorders described under the term \u201catopic march\u201d.", {"entities": [[43, 49, "DISEASE"], [7, 17, "DISEASE"]]}], ["However, this classic sequence is not always present and only a few studies have addressed children at risk of developing asthma.", {"entities": [[122, 128, "DISEASE"]]}], ["The objective of this study is to define early-onset AD phenotypes leading to asthma.", {"entities": [[78, 84, "DISEASE"]]}], ["We performed a cluster analysis with 9 variables of 214 infants with early-onset AD prospectively enrolled in the ORCA cohort and followed each year on the occurrence of asthma until the age of 6.", {"entities": [[170, 176, "DISEASE"]]}], ["We identified 3 clusters - cluster 1 (n = 94) with low to no sensitization to food (27.7%) or aeroallergens (10.6%) and moderate AD severity (SCORAD 25.29 +/- 14.6) called \u201cAD with low sensitization\u201d; - cluster 2 (n = 84) characterized by a higher AD severity (SCORAD 32.66+/-16.6) and frequent sensitization to food (98.9%) or aeroallergens (26.2%), most likely multiple (96.4% for food allergens), called \u201cAD with multiple sensitizations\u201d - cluster 3 (n = 36) with parental history, moderate AD severity (SCORAD 24.46+/-15.7), moderate rate of sensitization to food allergens (38.9%) (exclusively single) with no sensitization to aeroallergens, called \u201cAD with familial history of asthma\u201d.", {"entities": [[683, 689, "DISEASE"]]}], ["Percentages of children suffering from asthma at the age of 6 were higher in clusters 2 and 3 (36.1% and 33.3% respectively versus 14.9% in cluster 1, p<0.01).", {"entities": [[39, 45, "DISEASE"]]}], ["Two phenotypes in infants with early-onset AD convey a higher risk of developing asthma during childhood: multiple sensitization and familial history of asthma.", {"entities": [[81, 87, "DISEASE"], [153, 159, "DISEASE"]]}], ["NQO1 is an emerging and promising therapeutic target in cancer therapy.", {"entities": [[56, 62, "DISEASE"], [0, 4, "GENE"]]}], ["This study was to determine whether the anti-tumor effect of tanshinone IIA (TSA) is NQO1 dependent and to elucidate the underlying apoptotic cell death pathways.", {"entities": [[85, 89, "GENE"]]}], ["The A\u00e7a\u00ed (Acai) fruit is a popular nutritional supplement that purportedly enhances immune system function.", {"entities": []}], ["These anecdotal claims are supported by limited studies describing immune responses to the Acai polyphenol fraction.", {"entities": []}], ["Previously, we characterized \u03b3\u03b4 T cell responses to both polyphenol and polysaccharide fractions from several plant-derived nutritional supplements.", {"entities": []}], ["Similar polyphenol and polysaccharide fractions are found in Acai fruit.", {"entities": []}], ["Thus, we hypothesized that one or both of these fractions could activate \u03b3\u03b4 T cells.", {"entities": []}], ["Contrary to previous reports, we did not identify agonist activity in the polyphenol fraction; however, the Acai polysaccharide fraction induced robust \u03b3\u03b4 T cell stimulatory activity in human, mouse, and bovine PBMC cultures.", {"entities": []}], ["To characterize the immune response to Acai polysaccharides, we fractionated the crude polysaccharide preparation and tested these fractions for activity in human PBMC cultures.", {"entities": []}], ["The largest Acai polysaccharides were the most active in vitro as indicated by activation of myeloid and \u03b3\u03b4 T cells.", {"entities": []}], ["When delivered in vivo , Acai polysaccharide induced myeloid cell recruitment and IL-12 production.", {"entities": []}], ["These results define innate immune responses induced by the polysaccharide component of Acai and have implications for the treatment of asthma and infectious disease.", {"entities": [[136, 142, "DISEASE"]]}], ["A 41-year old female patient was admitted with acute onset of dyspnea and chest pain.", {"entities": []}], ["Previous history revealed asthma, chronic sinusitis and eosinophilic proctitis.", {"entities": [[69, 78, "DISEASE"], [42, 51, "DISEASE"], [26, 32, "DISEASE"]]}], ["Electrocardiogram showed anterior ST-segment elevations and inferior ST-segment depression.", {"entities": []}], ["Immediate heart catheterization revealed a distally occluded left anterior descending coronary artery, the occlusion being reversible after nitroglycerine.", {"entities": []}], ["Cardiac magnetic resonance imaging was consistent with perimyocarditis.", {"entities": []}], ["Hypereosinophilia and IgE elevation were present and Churg-strauss syndrome was diagnosed.", {"entities": [[67, 75, "DISEASE"]]}], ["Leprosy control is achieved through a fine-tuning of T H 1 and T H 2 immune response pattern balance.", {"entities": [[0, 7, "DISEASE"]]}], ["Given the increasing epidemiological overlay of HIV and M .", {"entities": []}], ["leprae infections, immune response in co-infected patients consists in an important contemporary issue.", {"entities": []}], ["Here we describe for the first time the innate lymphoid cells compartment in peripheral blood of leprosy and HIV/ M .", {"entities": [[97, 104, "DISEASE"]]}], ["leprae co-infected patients, and show that co-infection increases group 2 innate lymphoid whilst decreasing group 1 innate lymphoid cells frequencies and function.", {"entities": []}], ["Mycobacterium leprae is a clinical relevant pathogen that can lead to leprosy upon infection.", {"entities": [[70, 77, "DISEASE"]]}], ["This chronic infectious disease is characterized by the appearance of skin and peripheral nerve lesions.", {"entities": []}], ["Normally, a healthy immune system is able to control the infection and impede the generation of lesions.", {"entities": []}], ["However, immunosuppressive conditions may reduce the fitness of host\u2019s immune system, with consequences of disease progression and pathogen spreading.", {"entities": []}], ["HIV is the major cause of pathogen-associated immunodeficiency, and during the past decades, an epidemiological overlay of M .", {"entities": []}], ["leprae and HIV infections spectra has been observed.", {"entities": []}], ["Thus, the increase of co-infection cases raised the interest of the scientific community in this subject.", {"entities": []}], ["Accordingly, our group has previously shown that co-infected patients presented a shift in the type of cellular immune response.", {"entities": []}], ["Nevertheless, in the past few years a new group of innate lymphoid cells (ILCs) was shown to play an important role in the initiation and maintenance of effective immune responses.", {"entities": []}], ["Here we describe for the first time the circulating ILCs subsets in leprosy, HIV and M .", {"entities": [[68, 75, "DISEASE"]]}], ["leprae /HIV co-infected patients.", {"entities": []}], ["Additionally, we found that the co-infection scenario leads to a shift in different ILCs population, concordant with those observed previously for T lymphocytes and innate immunity cells.", {"entities": []}], ["Activation of the Toll-like receptor (TLR) signaling pathway through TLR4 may be important in the induction of protective immunity against Bordetella pertussis with TLR4-mediated activation of dendritic and B cells, induction of cytokine expression, and reversal of tolerance as crucial steps.", {"entities": [[150, 159, "DISEASE"], [69, 73, "GENE"], [165, 169, "GENE"]]}], ["We examined whether single nucleotide polymorphisms (SNPs) in genes of the TLR4 pathway and their interaction are associated with the response to whole-cell vaccine (WCV) pertussis vaccination in 490 one-year-old children.", {"entities": [[171, 180, "DISEASE"], [75, 79, "GENE"]]}], ["We analyzed associations of 75 haplotype-tagging SNPs in genes in the TLR4 signaling pathway with pertussis toxin (PT)-IgG titers.", {"entities": [[98, 107, "DISEASE"], [70, 74, "GENE"]]}], ["We found significant associations between the PT-IgG titer and SNPs in CD14 , TLR4 , TOLLIP , TIRAP , IRAK3 , IRAK4 , TICAM1 , and TNFRSF4 in one or more of the analyses.", {"entities": [[71, 75, "GENE"], [78, 82, "GENE"], [85, 91, "GENE"], [94, 99, "GENE"], [102, 107, "GENE"], [110, 115, "GENE"], [118, 124, "GENE"], [131, 138, "GENE"]]}], ["The strongest evidence for association was found for two SNPs (rs5744034 and rs5743894) in TOLLIP that were almost completely in linkage disequilibrium, provided statistically significant associations in all tests with the lowest p -values, and displayed a dominant mode of inheritance.", {"entities": [[91, 97, "GENE"]]}], ["However, none of these single gene associations would withstand correction for multiple testing.", {"entities": []}], ["In addition, Multifactor Dimensionality Reduction Analysis, an approach that does not need correction for multiple testing, showed significant and strong two and three locus interactions between SNPs in TOLLIP (rs4963060), TLR4 (rs6478317) and IRAK1 (rs1059703).", {"entities": [[203, 209, "GENE"], [223, 227, "GENE"], [244, 249, "GENE"]]}], ["We have identified significant interactions between genes in the TLR pathway in the induction of vaccine-induced immunity.", {"entities": []}], ["These interactions underline that these genes are functionally related and together form a true biological relationship in a protein-protein interaction network.", {"entities": []}], ["Practically all our findings may be explained by genetic variation in directly or indirectly interacting proteins at the extra- and intracytoplasmic sites of the cell membrane of antigen-presenting cells, B cells, or both.", {"entities": []}], ["Fine tuning of interacting proteins in the TLR pathway appears important for the induction of an optimal vaccine response.", {"entities": []}], ["The wealth of information concealed in a single human breath has been of interest for many years, promising not only disease detection, but also the monitoring of our general well-being.", {"entities": []}], ["Recent developments in the fields of nano-sensor arrays and MEMS have enabled once bulky artificial olfactory sensor systems, or so-called \u201celectronic noses\u201d, to become smaller, lower power and portable devices.", {"entities": []}], ["At the same time, wearable health monitoring devices are now available, although reliable breath sensing equipment is somewhat missing from the market of physical, rather than chemical sensor gadgets.", {"entities": []}], ["In this article, we report on the unprecedented rise in healthcare problems caused by an increasingly overweight population.", {"entities": []}], ["We first review recently-developed electronic noses for the detection of diseases by the analysis of basic volatile organic compounds (VOCs).", {"entities": []}], ["Then, we discuss the primary cause of obesity from over eating and the high calorific content of food.", {"entities": [[38, 45, "DISEASE"]]}], ["We present the need to measure our individual energy expenditure from our exhaled breath.", {"entities": []}], ["Finally, we consider the future for handheld or wearable devices to measure energy expenditure; and the potential of these devices to revolutionize healthcare, both at home and in hospitals.", {"entities": []}], ["Few studies have examined the broad health effects of occupational exposures in flight attendants apart from disease-specific morbidity and mortality studies.", {"entities": []}], ["We describe the health status of flight attendants and compare it to the U.S. population.", {"entities": []}], ["In addition, we explore whether the prevalence of major health conditions in flight attendants is associated with length of exposure to the aircraft environment using job tenure as a proxy.", {"entities": []}], ["We surveyed flight attendants from two domestic U.S. airlines in 2007 and compared the prevalence of their health conditions to contemporaneous cohorts in the National Health and Nutrition Survey (NHANES), 2005-2006 and 2007-2008.", {"entities": []}], ["We weighted the prevalence of flight attendant conditions to match the age distribution in the NHANES and compared the two populations stratified by gender using the Standardized Prevalence Ratio (SPR).", {"entities": [[197, 200, "GENE"]]}], ["For leading health conditions in flight attendants, we analyzed the association between job tenure and health outcomes in logistic regression models.", {"entities": []}], ["Compared to the NHANES population (n =5,713), flight attendants (n\u2009=\u20094,011) had about a 3-fold increase in the age-adjusted prevalence of chronic bronchitis despite considerably lower levels of smoking.", {"entities": [[146, 156, "DISEASE"]]}], ["In addition, the prevalence of cardiac disease in female flight attendants was 3.5 times greater than the general population while their prevalence of hypertension and being overweight was significantly lower.", {"entities": [[151, 163, "DISEASE"]]}], ["Flight attendants reported 2 to 5.7 times more sleep disorders, depression, and fatigue, than the general population.", {"entities": []}], ["Female flight attendants reported 34% more reproductive cancers.", {"entities": []}], ["Health conditions that increased with longer job tenure as a flight attendant were chronic bronchitis, heart disease in females, skin cancer, hearing loss, depression and anxiety, even after adjusting for age, gender, body mass index (BMI), education, and smoking.", {"entities": [[103, 116, "DISEASE"], [129, 140, "DISEASE"], [134, 140, "DISEASE"], [91, 101, "DISEASE"]]}], ["This study found higher rates of specific diseases in flight attendants than the general population.", {"entities": []}], ["Longer tenure appears to explain some of the higher disease prevalence.", {"entities": []}], ["Conclusions are limited by the cross-sectional design and recall bias.", {"entities": []}], ["Further study is needed to determine the source of risk and to elucidate specific exposure-disease relationships over time.", {"entities": []}], ["Annual epidemics of seasonal influenza occur during autumn and winter in temperate regions and have imposed substantial public health and economic burdens.", {"entities": [[29, 38, "DISEASE"]]}], ["At the global level, these epidemics cause about 3-5 million severe cases of illness and about 0.25-0.5 million deaths each year.", {"entities": []}], ["Although annual vaccination is the most effective way to prevent the disease and its severe outcomes, influenza vaccination coverage rates have been at suboptimal levels in many countries.", {"entities": [[102, 111, "DISEASE"]]}], ["For instance, the coverage rates among the elderly in 20 developed nations in 2008 ranged from 21% to 78% (median 65%).", {"entities": []}], ["In the U.S., influenza vaccination levels among elderly population appeared to reach a \"plateau\" of about 70% after the late 1990s, and levels among child populations have remained at less than 50%.", {"entities": [[13, 22, "DISEASE"]]}], ["In addition, disparities in the coverage rates across subpopulations within a country present another important public health issue.", {"entities": []}], ["New approaches are needed for countries striving both to improve their overall coverage rates and to eliminate disparities.", {"entities": []}], ["This review article aims to describe a broad conceptual framework of vaccination, and to illustrate four potential determinants of influenza vaccination based on empirical analyses of U.S. nationally representative populations.", {"entities": [[131, 140, "DISEASE"]]}], ["These determinants include the ongoing influenza epidemic level, mass media reporting on influenza-related topics, reimbursement rate for providers to administer influenza vaccination, and vaccine supply.", {"entities": [[39, 48, "DISEASE"], [89, 98, "DISEASE"], [162, 171, "DISEASE"]]}], ["It additionally proposes specific policy implications, derived from these empirical analyses, to improve the influenza vaccination coverage rate and associated disparities in the U.S., which could be generalizable to other countries.", {"entities": [[109, 118, "DISEASE"]]}], ["Despite its proven benefit in reducing child mortality and morbidity, the coverage of exclusive breastfeeding (EBF) remains sub-optimal.", {"entities": []}], ["In Ethiopia, about 52% of infants under six months of age were exclusively breastfed, implying the need for further identification of the barriers to optimal EBF practice.", {"entities": []}], ["Therefore, this study aimed to investigate EBF and its determinants in the predominantly rural northwest Ethiopia.", {"entities": []}], ["The study was conducted at the Dabat Health and Demographic Surveillance System (HDSS) site, which is located in Dabat District, northwest Ethiopia.", {"entities": []}], ["A total of 5,227 mothers with children under five years of age were included for analysis.", {"entities": []}], ["Multivariable binary logistic regression analysis was employed to identify factors associated with EBF.", {"entities": []}], ["The Adjusted Odds Ratio (AOR) with a 95% Confidence Interval (CI) was estimated to show the strength of association.", {"entities": []}], ["A P-value of <0.05 was used to declare statistical significance.", {"entities": []}], ["About 54.5% [95% CI: 51.9, 57.1] of the mothers practiced EBF.", {"entities": []}], ["Mothers' education [AOR = 2.10; 95% CI: 1.63, 2.71], age (20\u201335 years) [AOR = 1.39; CI: 1.07, 1.80], urban residence [AOR = 1.28; 95% CI: 1.07, 1.54], at least one ANC visit [AOR = 1.41; 95% CI: 1.23,1.61], initiation of breastfeeding within one hour of birth [AOR = 1.32; 95% CI: 1.15,1.50], richer household [AOR = 1.34; 95% CI: 1.07, 1.65], and withholding prelacteal feeds [AOR = 1.34; 95% CI: 1.17, 1.53] were found important determinants of EBF.", {"entities": []}], ["In this study area, the prevalence of EBF is lower than the national as well as the global recommendation for universal coverage of EBF.", {"entities": []}], ["Therefore, strengthening the implementation of Infant and Young Child Feeding strategy (IYCF) and maternal health care utilization are essential for stepping up EBF coverage.", {"entities": []}], ["Moreover, attention should be given to uneducated, rural resident, and adolescent mothers.", {"entities": []}], ["Postural control deficits have been suggested to be a major component of gait disorders in children with cerebral palsy.", {"entities": [[105, 119, "DISEASE"]]}], ["The purpose of this study was to investigate the relationship between postural stability and treadmill walking, in children with unilateral cerebral palsy, by defining dependence between the posturographic weight-bearing distribution and center of pressure (CoP) sway during quiet standing with Gillette Gait Index and the 16 distinct gait parameters that composed the Gillette Gait Index.", {"entities": [[140, 154, "DISEASE"]]}], ["Forty-five children with unilateral cerebral palsy from 7\u201312 years of age were included in this study.", {"entities": [[36, 50, "DISEASE"]]}], ["A posturographic procedure and 3-dimensional instrumented gait analysis was developed.", {"entities": []}], ["In general, across the entire tested group, the significant correlations concerned only the asymmetry of the weight bearing and a few of the distinct gait parameters that compose the Gillette Gait Index; moreover, correlation coefficients were low.", {"entities": []}], ["The division of subjects into two clinical subgroups: children that exhibited a tendency to overload (1) and to underload (2) the affected body side, modified the results of the explored relationships.", {"entities": []}], ["Our findings revealed that the difficulties experienced by children with hemiplegia while controlled in a standing position result from tendency to excessively or insufficiently load the affected lower limbs, and thus establishes a direct relationship with inadequate affected peak ankle DF in both stance and swing gait phases.", {"entities": [[73, 83, "DISEASE"]]}], ["Given the presented relationship between postural instability and deviation of the particular gait parameters in children with unilateral cerebral palsy, a follow-up study will be needed to determine the therapeutic approaches that will be most effective in promoting increased improvement in gait pattern, as well as the static and dynamic balance in standing.", {"entities": [[138, 152, "DISEASE"]]}], ["Atrial fibrillation is a common cardiac dysrhythmia, particularly in the elderly.", {"entities": []}], ["Recent studies have indicated a statistically significant seasonal component to atrial fibrillation hospitalizations.", {"entities": []}], ["We conducted a retrospective population cohort study using time series analysis to evaluate seasonal patterns of atrial fibrillation hospitalizations for the province of Ontario for the years 1988 to 2001.", {"entities": []}], ["Five different series methods were used to analyze the data, including spectral analysis, X11, R-Squared, autocorrelation function and monthly aggregation.", {"entities": []}], ["This study found evidence of weak seasonality, most apparent at aggregate levels including both ages and sexes.", {"entities": []}], ["There was dramatic increase in hospitalizations for atrial fibrillation over the years studied and an age dependent increase in rates per 100,000.", {"entities": []}], ["Overall, the magnitude of seasonal difference between peak and trough months is in the order of 1.4 admissions per 100,000 population.", {"entities": []}], ["The peaks for hospitalizations were predominantly in April, and the troughs in August.", {"entities": []}], ["Our study confirms statistical evidence of seasonality for atrial fibrillation hospitalizations.", {"entities": []}], ["This effect is small in absolute terms and likely not significant for policy or etiological research purposes.", {"entities": []}], ["Poor characterization of propofol pharmacokinetics and pharmacodynamics in the morbidly obese (MO) pediatric population poses dosing challenges.", {"entities": []}], ["This study was conducted to evaluate propofol total intravenous anesthesia (TIVA) in this population.", {"entities": []}], ["After IRB approval, a prospective study was conducted in 20 MO children and adolescents undergoing laparoscopic surgery under clinically titrated propofol TIVA.", {"entities": []}], ["Propofol doses/infusion rates, hemodynamic variables, times to induction and emergence, and postoperative occurrence of respiratory adverse events (RAE) were recorded, along with intraoperative blinded Bispectral Index/BIS and postoperative Ramsay sedation scores (RSS).", {"entities": []}], ["Study subjects completed awareness questionnaires on postoperative days 1 and 3.", {"entities": []}], ["Propofol concentrations were obtained at predetermined intra- and post-operative time points.", {"entities": []}], ["Study subjects ranged 9 \u2013 18\u00a0years (age) and 97 - 99.9% (BMI for age percentiles).", {"entities": []}], ["Average percentage variability of hemodynamic parameters from baseline was\u2009\u2248\u200920%.", {"entities": []}], ["Patients had consistently below target BIS values (BIS\u2009<\u200940 for >90% of maintenance phase), delayed emergence (25.8\u2009\u00b1\u200922\u00a0minutes), increased somnolence (RSS\u2009\u2265\u20094) in the first 30\u00a0minutes of recovery from anesthesia and 30% incidence of postoperative RAE, the odds for which increased by 14% per unit increase in BMI (p\u2009\u2264\u20090.05).", {"entities": []}], ["Mean propofol concentration was 6.2\u00a0mg/L during maintenance and 1.8\u00a0mg/L during emergence from anesthesia.", {"entities": []}], ["Our findings indicate clinical overestimation of propofol requirements and highlight the challenges of clinically titrated propofol TIVA in MO adolescents.", {"entities": []}], ["In this setting, it may be advantageous to titrate propofol to targeted BIS levels until more accurate weight-appropriate dosing regimens are developed, to minimize relative overdosing and its consequences.", {"entities": []}], ["Quadriceps function is an important measure in patients recovering postoperatively.", {"entities": []}], ["Traditionally, strength measures that require high levels of resistance are contraindicated during the early postoperative phase.", {"entities": []}], ["Thus it may be helpful to evaluate the utilization of other tools, such as ultrasound imaging, that allow for assessment during a position of low resistance.", {"entities": []}], ["The rectus femoris cross-sectional area (CSA) is affected by sex and body composition in healthy subjects.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["Thirty-two healthy subjects (16 women, 16 men), selected from a previously larger study, were chosen for analysis.", {"entities": []}], ["All subjects underwent a maximal volitional isometric contraction protocol from 0\u00b0 to 90\u00b0 of knee motion controlled by an isokinetic dynamometer.", {"entities": []}], ["In the contracted and resting positions, the rectus femoris CSA was measured at each angle using ultrasound imaging.", {"entities": []}], ["The contractile index (contracted \u2212 resting CSA) was calculated at each position.", {"entities": []}], ["Subjects were separated into 1 of 4 groups based on sex and fat percentage (low or high).", {"entities": []}], ["These data were analyzed using mixed-factor analysis of variance (group \u00d7 angle) for each variable, with a critical \u03b1 level of 0.05.", {"entities": []}], ["A significant interaction was noted for the CSA of the rectus femoris at rest ( P < 0.03) and during contraction ( P < 0.02).", {"entities": []}], ["For both variables, all groups performed similarly, with the exception of women with high body fat percentage.", {"entities": []}], ["No statistically significant interaction existed for the contractile index; however, a main effect for angle ( P < 0.01) was observed.", {"entities": []}], ["Rectus femoris CSA appears to depend on sex as well as the body composition of individuals.", {"entities": []}], ["Traditional subjective assessment measures of quadriceps strength and function have low reliability and functional validity.", {"entities": []}], ["With the improved feasibility of ultrasound imaging in the clinical setting, quadriceps size may be more accurately measured during the early postoperative stages.", {"entities": []}], ["The airway epithelium is altered in respiratory disease and is thought to contribute to disease etiology.", {"entities": []}], ["A caveat to disease research is that the technique of isolation of bronchial epithelial cells from patients is invasive and cells have a limited lifespan.", {"entities": []}], ["The aim of this study was to extensively characterize the plasticity of primary human bronchial epithelial cells that have been engineered to delay cell senescence including the ability of these cells to differentiate.", {"entities": []}], ["Cells were engineered to express BMI \u20101 or hTERT using viral vector systems.", {"entities": []}], ["Cells were characterized at passage (p) early (p5), mid (p10), and late (p15) stage for: BMI \u20101, p16, and CK 14 protein expression, viability and the ability to differentiate at air\u2013liquid interface ( ALI ), using a range of techniques including immunohistochemistry ( IHC ), immunofluorescence ( IF ), transepithelial electrical resistance ( TEER ), scanning electron microscopy ( SEM ), MUC 5 AC and beta tubulin ( BTUB ) staining.", {"entities": []}], ["BMI \u20101\u2010expressing cells maintained elevated levels of the BMI \u20101 protein and the epithelial marker CK 14 and showed a suppression of p16.", {"entities": []}], ["BMI \u20101\u2010expressing cells had a viability advantage, differentiated at ALI , and had a normal karyotype.", {"entities": []}], ["In contrast, hTERT \u2010expressing cells had a reduced viability, showed limited differentiation, and had an abnormal karyotype.", {"entities": []}], ["We therefore provide extensive characterization of the plasticity of BMI \u20101 expressing cells in the context of the ALI model.", {"entities": []}], ["These cells retain properties of wild\u2010type cells and may be useful to characterize respiratory disease mechanisms in\u00a0vitro over sustained periods.", {"entities": []}], ["Resistance to imatinib has been recurrently reported in systemic mastocytosis (SM) carrying exon 17 KIT mutations.", {"entities": [[65, 77, "DISEASE"], [56, 77, "DISEASE"]]}], ["We evaluated the efficacy and safety of imatinib therapy in 10 adult SM patients lacking exon 17 KIT mutations, 9 of which fulfilled criteria for well-differentiated SM (WDSM).", {"entities": []}], ["The World Health Organization 2008 disease categories among WDSM patients were mast cell (MC) leukemia ( n = 3), indolent SM ( n = 3) and cutaneous mastocytosis ( n = 3); the remainder case had SM associated with a clonal haematological non-MC disease.", {"entities": [[138, 160, "DISEASE"], [148, 160, "DISEASE"], [94, 102, "DISEASE"]]}], ["Patients were given imatinib for 12 months \u2212400 or 300 mg daily depending on the presence vs. absence of > 30% bone marrow (BM) MCs and/or signs of advanced disease\u2013.", {"entities": []}], ["Absence of exon 17 KIT mutations was confirmed in highly-purified BM MCs by peptide nucleic acid-mediated PCR, while mutations involving other exons were investigated by direct sequencing of purified BM MC DNA.", {"entities": []}], ["Complete response (CR) was defined as resolution of BM MC infiltration, skin lesions, organomegalies and MC-mediator release-associated symptoms, plus normalization of serum tryptase.", {"entities": []}], ["Criteria for partial response (PR) included \u2265 50% reduction in BM MC infiltration and improvement of skin lesions and/or organomegalies.", {"entities": []}], ["Treatment was well-tolerated with an overall response rate of 50%, including early and sustained CR in four patients, three of whom had extracellular mutations of KIT , and PR in one case.", {"entities": []}], ["This later patient and all non-responders ( n = 5) showed wild-type KIT .", {"entities": []}], ["These results together with previous data from the literature support the relevance of the KIT mutational status in selecting SM patients who are candidates for imatinib therapy.", {"entities": []}], ["Phagocytosis is a complex process that involves membranelipid remodeling and the attraction and retention of key effector proteins.", {"entities": []}], ["Phagosome phenotype depends on the type of receptor engaged and can be influenced by extracellular signals.", {"entities": []}], ["Interleukin 4 (IL-4) is a cytokine that induces the alternative activation of macrophages (M\u03a6s) upon prolonged exposure, triggering a different cell phenotype that has an altered phagocytic capacity.", {"entities": []}], ["In contrast, the direct effects of IL-4 during phagocytosis remain unknown.", {"entities": []}], ["Here, we investigate the impact of short-term IL-4 exposure (1 hour) during phagocytosis of IgG-opsonized yeast particles by M\u03a6s.", {"entities": []}], ["By time-lapse confocal microscopy of GFP-tagged lipid-sensing probes, we show that IL-4 increases the negative charge of the phagosomal membrane by prolonging the presence of the negatively charged second messenger PI(3,4,5)P3.", {"entities": []}], ["Biochemical assays reveal an enhanced PI3K/Akt activity upon phagocytosis in the presence of IL-4.", {"entities": []}], ["Blocking the specific class I PI3K after the onset of phagocytosis completely abrogates the IL-4-induced changes in lipid remodeling and concomitant membrane charge.", {"entities": []}], ["Finally, we show that IL-4 direct signaling leads to a significantly prolonged retention profile of the signaling molecules Rac1 and Rab5 to the phagosomal membrane in a PI3K-dependent manner.", {"entities": [[124, 128, "GENE"]]}], ["This protracted early phagosome phenotype suggests an altered maturation, which is supported by the delayed phagosome acidification measured in the presence of IL-4.", {"entities": []}], ["Our findings reveal that molecular differences in IL-4 levels, in the extracellular microenvironment, influence the coordination of lipid remodeling and protein recruitment, which determine phagosome phenotype and, eventually, fate.", {"entities": []}], ["Endosomal and phagosomal membranes provide topological constraints to signaling molecules.", {"entities": []}], ["Therefore, changes in the phagosome phenotype modulated by extracellular factors may represent an additional mechanism that regulates the outcome of phagocytosis and could have significant impact on the net biochemical output of a cell.", {"entities": []}], ["Orlistat is an anti-obesity drug licensed in the United Kingdom for 7 years.", {"entities": [[20, 27, "DISEASE"]]}], ["We present a case of a patient who developed pancreatitis four days after commencing orlistat.", {"entities": [[45, 57, "DISEASE"]]}], ["A 36 year old man presented to hospital with acute severe pancreatitis four days after starting a course of Orlistat, a lipase inhibitor used in the treatment of obesity.", {"entities": [[162, 169, "DISEASE"], [58, 70, "DISEASE"]]}], ["A diagnosis of drug related pancreatitis was made by exclusion of other causes of pancreatitis; he was a teetotaller, had a normal serum calcium, had no family history of pancreatitis or hyperlipidaemia, no history of trauma and had no evidence of gallstones on Computerised Tomography scan (CT).", {"entities": [[28, 40, "DISEASE"], [82, 94, "DISEASE"], [171, 183, "DISEASE"]]}], ["Orlistat was the only drug that had been started recently and has been associated with pancreatitis previously.", {"entities": [[87, 99, "DISEASE"]]}], ["We found no case reports of similar cases, however 99 cases of orlistat related pancreatitis have been reported to the Food and Drug Administration (FDA), but no causative link has been found in clinical trials by the drug company.", {"entities": [[80, 92, "DISEASE"]]}], ["It is therefore not on the list of possible complications or side effects of the drug.", {"entities": []}], ["The effects of the enforcement of a smoke-free workplace policy on health-related quality of life (HRQOL) among a healthy population are poorly understood.", {"entities": []}], ["The present study was undertaken to examine the effects of the enforcement of a smoke-free school policy on HRQOL among healthy non-smoking schoolteachers with respect to their exposure to passive smoke.", {"entities": []}], ["Two self-reported questionnaire surveys were conducted, the first before and the second after the enforcement of a total smoke-free public school policy in Nara City.", {"entities": []}], ["A total of 1534 teachers were invited from 62 schools, and their HRQOL was assessed using six domains extracted from the Medical Outcomes Survey Short Form-8 questionnaire (SF-8): general health perception (GH), role functioning-physical (RP), vitality (VT), social functioning (SF), mental health (MH), and role functioning-emotional (RE).", {"entities": []}], ["The participants were divided into two groups according to their exposure to environmental tobacco smoke (ETS) at baseline: participants not exposed to ETS at school (non-smokers), and participants exposed to ETS at school (passive smokers).", {"entities": []}], ["Changes in each SF-8 score were evaluated using paired t-tests for each group, and their inter-group differences were evaluated using multiple linear regression analyses adjusted for sex, age, school type, managerial position, and attitude towards a smoke-free policy.", {"entities": []}], ["After ineligible subjects were excluded, 689 teachers were included in the analyses.", {"entities": []}], ["The number of non-smokers and passive smokers was 447 and 242, respectively.", {"entities": []}], ["Significant changes in SF-8 scores were observed for MH (0.9; 95% confidence interval [CI], 0.2-1.5) and RE (0.7; 95% CI, 0.0-1.3) in non-smokers, and GH (2.2; 95% CI, 1.2-3.1), VT (1.8; 95% CI, 0.9-2.7), SF (2.7; 95% CI, 1.6-3.8), MH (2.0; 95% CI, 1.0-2.9), and RE (2.0; 95% CI, 1.2-2.8) in passive smokers.", {"entities": []}], ["In the multiple linear regression analyses, the net changes in the category scores of GH (1.8; 95% CI, 0.7-2.9), VT (1.4, 95% CI, 0.3-2.5), SF (2.5; 95% CI, 1.1-3.9), MH (1.2; 95% CI, 0.1-2.4) and RE (1.6; 95% CI, 0.5-2.7) in passive smokers significantly exceeded those in non-smokers.", {"entities": []}], ["A smoke-free school policy would improve the HRQOL of healthy non-smoking teachers who are exposed to ETS.", {"entities": []}], ["Hypertension is a prevalent cardiovascular disease risk factor among blacks and adolescent hypertension can progress into adulthood.", {"entities": [[0, 12, "DISEASE"], [91, 103, "DISEASE"]]}], ["To determine the prevalence of hypertension and prehypertension among secondary school adolescents in Enugu South East Nigeria.", {"entities": [[31, 43, "DISEASE"]]}], ["A study of 2694 adolescents aged 10-18\u00a0years in Enugu metropolis was carried out.", {"entities": []}], ["Socio-demographic profile anthropometric and blood pressure readings were obtained.", {"entities": []}], ["Derived measurements such as Prehypertension, hypertension and BMI were obtained.", {"entities": [[46, 58, "DISEASE"]]}], ["The results showed that the mean systolic blood pressure and diastolic blood pressure for males were 106.66+ 11.80\u00a0mmHg and 70.25\u2009+\u20097.34\u00a0mmHg respectively.", {"entities": []}], ["The mean SBP and DBP for females were 109.83+ 11.66\u00a0mmHg and 72.23\u2009+\u20098.26\u00a0mmHg respectively (p\u2009<\u20090.01).", {"entities": [[17, 20, "GENE"]]}], ["Blood pressure was found to increase with age.", {"entities": []}], ["Prevalence of hypertension and prehypertension was 5.4% and 17.3% respectively with a higher rate in females (6.9%) than males (3.8%).", {"entities": [[14, 26, "DISEASE"]]}], ["Prevalence of prehypertension among males and females were 14.3% and 20.1% respectively.", {"entities": []}], ["The prevalence of obesity was 1.9%.", {"entities": [[18, 25, "DISEASE"]]}], ["Modifiable risk factors exist among adolescents.", {"entities": []}], ["Early lifestyle modification and a strengthened school health are recommended.", {"entities": []}], ["Local health authorities need small-area estimates for prevalence of chronic diseases and health behaviors for multiple purposes.", {"entities": []}], ["We generated city-level and census-tract\u2013level prevalence estimates of 27 measures for the 500 largest US cities.", {"entities": []}], ["To validate the methodology, we constructed multilevel logistic regressions to predict 10 selected health indicators among adults aged 18 years or older by using 2013 Behavioral Risk Factor Surveillance System (BRFSS) data; we applied their predicted probabilities to census population data to generate city-level, neighborhood-level, and zip-code\u2013level estimates for the city of Boston, Massachusetts.", {"entities": []}], ["By comparing the predicted estimates with their corresponding direct estimates from a locally administered survey (Boston BRFSS 2010 and 2013), we found that our model-based estimates for most of the selected health indicators at the city level were close to the direct estimates from the local survey.", {"entities": []}], ["We also found strong correlation between the model-based estimates and direct survey estimates at neighborhood and zip code levels for most indicators.", {"entities": []}], ["Findings suggest that our model-based estimates are reliable and valid at the city level for certain health outcomes.", {"entities": []}], ["Local health authorities can use the neighborhood-level estimates if high quality local health survey data are not otherwise available.", {"entities": []}], ["Background: The link between body weight status and spinal diseases has been suggested by a number of cross-sectional and cohort studies with a limited range of patient populations.", {"entities": []}], ["No population-representative samples have been used to examine the link between obesity and spinal diseases.", {"entities": [[80, 87, "DISEASE"]]}], ["The present study is based on a nationally representative sample drawn from the Medical Expenditure Panel Survey.", {"entities": []}], ["Methods: Using the cross-sectional sample of the 2014 Medical Expenditure Panel Study, we built four weighted logistic regression analyses of the associations between body weight status and the following four spinal diseases: low back pain, spondylosis, other cervical disorders and intervertebral disc disorder (IDD).", {"entities": [[241, 252, "DISEASE"]]}], ["Each respondent\u2019s body weight status was used as the key independent variable with three categories: normal/underweight, overweight, and obese.", {"entities": []}], ["We controlled for marital status, gender, age, smoking status, household income, health insurance coverage, educational attainment and the use of health services for other major categories of diseases.", {"entities": []}], ["Results: A total sample of 23,048 respondents was used in our analysis.", {"entities": []}], ["Overweight and obese respondents, as compared to normal/underweight respondents, were more likely to develop lower back problems (Overweight: logged odds = 0.218, p < 0.01; Obese: logged odds = 0.395, p < 0.001) and IDD (Overweight: logged odds = 0.441, p < 0.05; Obese: logged odds = 0.528, p < 0.001).", {"entities": []}], ["The associations between bodyweight status and spondylitis were statistically insignificant (Overweight: logged odds = 0.281, p = 0.442; Obese: logged odds = 0.680, p = 0.104).", {"entities": [[47, 58, "DISEASE"]]}], ["The associations between body weight status and other cervical disorders (Overweight: logged odds = \u22120.116, p = 0.304; Obese: logged odds = \u22120.160, p = 0.865) were statistically insignificant.", {"entities": []}], ["Conclusions: As the first study using a national sample to study bodyweight and spinal diseases, our paper supports the hypothesis that obesity adds to the burden of low back pain and IDD.", {"entities": [[136, 143, "DISEASE"]]}], ["Longitudinal and interventional studies are needed to understand the specific mechanisms behind these positive associations.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is associated with increased lung cancer risk.", {"entities": [[74, 85, "DISEASE"], [79, 85, "DISEASE"]]}], ["We evaluated the association of statin use with lung cancer risk in COPD patients and identified which statins possess the highest chemopreventive potential.", {"entities": [[48, 59, "DISEASE"], [53, 59, "DISEASE"]]}], ["After adjustment for age, sex, CCI, diabetes, hypertension, dyslipidemia, urbanization level, and monthly income according to propensity scores, lung cancer risk in the statin users was lower than that in the statin nonusers (adjusted hazard ratio [aHR] = 0.37).", {"entities": [[46, 58, "DISEASE"], [145, 156, "DISEASE"], [150, 156, "DISEASE"], [249, 252, "GENE"]]}], ["Of the individual statins, lovastatin and fluvastatin did not reduce lung cancer risk significantly.", {"entities": [[69, 80, "DISEASE"], [74, 80, "DISEASE"]]}], ["By contrast, lung cancer risk in patients using rosuvastatin, simvastatin, atorvastatin, and pravastatin was significantly lower than that in statin nonusers (aHRs = 0.41, 0.44, 0.52, and 0.58, respectively).", {"entities": [[13, 24, "DISEASE"], [18, 24, "DISEASE"]]}], ["Statins dose-dependently reduced lung cancer risk in all subgroups and the main model with additional covariates (nonstatin drug use).", {"entities": [[33, 44, "DISEASE"], [38, 44, "DISEASE"]]}], ["The study cohort comprised all patients diagnosed with COPD at health care facilities in Taiwan ( n = 116,017) between January 1, 2001 and December 31, 2012.", {"entities": []}], ["Our final study cohort comprised 43,802 COPD patients: 10,086 used statins, whereas 33,716 did not.", {"entities": []}], ["Patients were followed up to assess lung cancer risk or protective factors.", {"entities": [[36, 47, "DISEASE"], [41, 47, "DISEASE"]]}], ["In addition, we also considered demographic characteristics, namely age, sex, comorbidities (diabetes, hypertension, dyslipidemia, and Charlson comorbidity index [CCI]), urbanization level, monthly income, and nonstatin drug use.", {"entities": [[103, 115, "DISEASE"]]}], ["The index date of statin use was the COPD confirmation date.", {"entities": []}], ["To examine the dose\u2013response relationship, we categorized statin use into four groups in each cohort: < 28, 28\u201390, 91\u2013365, and > 365 cumulative defined daily doses (cDDDs).", {"entities": []}], ["Patients receiving < 28 cDDDs were defined as nonstatin users.", {"entities": []}], ["Statins dose-dependently exert a significant chemopreventive effect against lung cancer in COPD patients.", {"entities": [[76, 87, "DISEASE"], [81, 87, "DISEASE"]]}], ["Rosuvastatin, simvastatin, and atorvastatin exhibited the highest chemopreventive potential.", {"entities": []}], ["Although many foods contain toxins as a naturally-occurring constituent or, are formed as the result of handling or processing, the incidence of adverse reactions to food is relatively low.", {"entities": []}], ["The low incidence of adverse effects is the result of some pragmatic solutions by the US Food and Drug Administration (FDA) and other regulatory agencies through the creative use of specifications, action levels, tolerances, warning labels and prohibitions.", {"entities": []}], ["Manufacturers have also played a role by setting limits on certain substances and developing mitigation procedures for process-induced toxins.", {"entities": []}], ["Regardless of measures taken by regulators and food producers to protect consumers from natural food toxins, consumption of small levels of these materials is unavoidable.", {"entities": []}], ["Although the risk for toxicity due to consumption of food toxins is fairly low, there is always the possibility of toxicity due to contamination, overconsumption, allergy or an unpredictable idiosyncratic response.", {"entities": []}], ["The purpose of this review is to provide a toxicological and regulatory overview of some of the toxins present in some commonly consumed foods, and where possible, discuss the steps that have been taken to reduce consumer exposure, many of which are possible because of the unique process of food regulation in the United States.", {"entities": []}], ["Metallic constituents contained in ambient particulate matter have been associated with adverse effects in a number of epidemiologic, in vitro, and in vivo studies.", {"entities": []}], ["Residual oil fly ash (ROFA) is a metallic by-product of the combustion of fossil fuel oil, which has been shown to induce a variety of proinflammatory responses in lung cells.", {"entities": []}], ["We have examined signaling pathways activated in response to ROFA exposure and recently reported that ROFA treatment activates multiple mitogen-activated protein (MAP) kinases in the rat lung.", {"entities": []}], ["In the present study we extended our investigations on the mechanism of toxicity of ROFA to include transcription factors whose activities are regulated by MAP kinases as well as possible effectors of transcriptional changes that mediate the effects of ROFA.", {"entities": []}], ["We applied immunohistochemical methods to detect ROFA-induced activation of nuclear factor-kappa B (NF kappa B), activating transcription factor-2 (ATF-2), c-Jun, and cAMP response element binding protein (CREB) in intact lung tissue and confirmed and characterized their functional activation using DNA binding assays.", {"entities": []}], ["We performed these studies using a perfused rabbit lung model that is devoid of blood elements in order to distinguish between intrinsic lung cell effects and effects that are secondary to inflammatory cell influx.", {"entities": []}], ["We report here that exposure to ROFA results in a rapid activation of all of the transcription factors studied by exerting direct effects on lung cells.", {"entities": []}], ["These findings validate the use of immunohistochemistry to detect transcription factor activation in vivo and demonstrate the utility of studying signaling changes in response to environmental exposures.", {"entities": []}], ["Previous studies have demonstrated that S .", {"entities": []}], ["mansoni infection and inoculation of the parasite eggs and antigens are able to modulate airways inflammation induced by OVA in mice.", {"entities": []}], ["This modulation was associated to an enhanced production of interleukin-10 and to an increased number of regulatory T cells.", {"entities": []}], ["mansoni schistosomulum is the first stage to come into contact with the host immune system and its tegument represents the host-parasite interface.", {"entities": []}], ["The schistosomula tegument (Smteg) has never been studied in the context of modulation of inflammatory disorders, although immune evasion mechanisms take place in this phase of infection to guarantee the persistence of the parasite in the host.", {"entities": []}], ["The aim of this study was to evaluate the Smteg ability to modulate inflammation in an experimental airway inflammation model induced by OVA and to characterize the immune factors involved in this modulation.", {"entities": []}], ["To achieve the objective, BALB/c mice were sensitized with ovalbumin (OVA) and then challenged with OVA aerosol after Smteg intraperitoneal inoculation.", {"entities": []}], ["Protein extravasation and inflammatory cells were assessed in bronchoalveolar lavage and IgE levels were measured in serum.", {"entities": []}], ["Additionally, lungs were excised for histopathological analyses, cytokine measurement and characterization of the cell populations.", {"entities": []}], ["Inoculation with Smteg led to a reduction in the protein levels in bronchoalveolar lavage (BAL) and eosinophils in both BAL and lung tissue.", {"entities": []}], ["In the lung tissue there was a reduction in inflammatory cells and collagen deposition as well as in IL-5, IL-13, IL-25 and CCL11 levels.", {"entities": [[124, 129, "GENE"]]}], ["Additionally, a decrease in specific anti-OVA IgE levels was observed.", {"entities": []}], ["The reduction observed in these inflammatory parameters was associated with increased levels of IL-10 in lung tissues.", {"entities": []}], ["Furthermore, Smteg/asthma mice showed high percentage of CD11b Taken together, these findings demonstrate that S .", {"entities": [[19, 25, "DISEASE"]]}], ["mansoni schistosomula tegument can modulates experimental airway inflammation.", {"entities": []}], ["China is reforming and restructuring its health insurance system to achieve the goal of universal coverage.", {"entities": []}], ["This study aims to understand the determinants of public, private and multiple insurance coverage among people of retirement-age in China.", {"entities": []}], ["We used data from the China Health and Retirement Longitudinal Survey 2011 and 2013, a nationally representative survey of Chinese people aged 45 and over.", {"entities": []}], ["Multinomial logit regression was performed to identify the determinants of public, private and multiple health insurance coverage.", {"entities": []}], ["We also conducted logit regression to examine the association between public insurance coverage and demand for private insurance.", {"entities": []}], ["In 2013, 94.5% of this population had at least one type of public insurance, and 12.2% purchased private insurance.", {"entities": []}], ["In general, we found that rural residents were less likely to be uninsured (Relative Risk Ratio (RRR) = 0.40, 95% Confidence Interval (CI): 0.34\u20130.47) and were less likely to buy private insurance (RRR = 0.22, 95% CI: 0.16\u20130.31).", {"entities": []}], ["But rural-to-urban migrants were more likely to be uninsured (RRR = 1.39, 95% CI: 1.24\u20131.57).", {"entities": []}], ["Public health insurance coverage may crowd out private insurance market (Odds Ratio = 0.55, 95% CI: 0.48\u20130.63), particularly among enrollees of Urban Resident Basic Medical Insurance.", {"entities": []}], ["There exists a huge socioeconomic disparity in both public and private insurance coverage.", {"entities": []}], ["The migrants, the poor and the vulnerable remained in the edge of the system.", {"entities": []}], ["The growing private insurance market did not provide sufficient financial protection and did not cover the people with the greatest need.", {"entities": []}], ["To achieve universal coverage and reduce socioeconomic disparity, China should integrate the urban and rural public insurance schemes across regions and remove the barriers for the middle-income and low-income to access private insurance.", {"entities": []}], ["Polymorphic inversions are a type of structural variants that are difficult to analyze owing to their balanced nature and the location of breakpoints within complex repeated regions.", {"entities": []}], ["So far, only a handful of inversions have been studied in detail in humans and current knowledge about their possible functional effects is still limited.", {"entities": []}], ["However, inversions have been related to phenotypic changes and adaptation in multiple species.", {"entities": []}], ["In this review, we summarize the evidences of the functional impact of inversions in the human genome.", {"entities": []}], ["First, given that inversions have been shown to inhibit recombination in heterokaryotes, chromosomes displaying different orientation are expected to evolve independently and this may lead to distinct gene-expression patterns.", {"entities": []}], ["Second, inversions have a role as disease-causing mutations both by directly affecting gene structure or regulation in different ways, and by predisposing to other secondary arrangements in the offspring of inversion carriers.", {"entities": []}], ["Finally, several inversions show signals of being selected during human evolution.", {"entities": []}], ["These findings illustrate the potential of inversions to have phenotypic consequences also in humans and emphasize the importance of their inclusion in genome-wide association studies.", {"entities": []}], ["Estimating learning outcome from comparative student self-ratings is a reliable and valid method to identify specific strengths and shortcomings in undergraduate medical curricula.", {"entities": []}], ["However, requiring students to complete two evaluation forms (i.e.", {"entities": []}], ["one before and one after teaching) might adversely affect response rates.", {"entities": []}], ["Alternatively, students could be asked to rate their initial performance level retrospectively.", {"entities": []}], ["This approach might threaten the validity of results due to response shift or effort justification bias.", {"entities": []}], ["Two consecutive cohorts of medical students enrolled in a six-week cardio-respiratory module were enrolled in this study.", {"entities": []}], ["In both cohorts, performance gain was estimated for 33 specific learning objectives.", {"entities": []}], ["In the first cohort, outcomes calculated from ratings provided before (pretest) and after (posttest) teaching were compared to outcomes derived from comparative self-ratings collected after teaching only (thentest and posttest).", {"entities": []}], ["In the second cohort, only thentests and posttests were used to calculate outcomes, but data collection tools differed with regard to item presentation.", {"entities": []}], ["In one group, thentest and posttest ratings were obtained sequentially on separate forms while in the other, both ratings were obtained simultaneously for each learning objective.", {"entities": []}], ["Using thentest ratings to calculate performance gain produced slightly higher values than using true pretest ratings.", {"entities": []}], ["Direct comparison of then- and posttest ratings also yielded slightly higher performance gain than sequential ratings, but this effect was negligibly small.", {"entities": []}], ["Given the small effect sizes, using thentests appears to be equivalent to using true pretest ratings.", {"entities": []}], ["Item presentation in the posttest does not significantly impact on results.", {"entities": []}], ["Previous research has generally indicated that disadvantaged socioeconomic groups tend to experience poor health-related quality of life (HRQoL).", {"entities": []}], ["In an effort to extend the literature, this study proposes that coping flexibility is a stress buffer that mitigates the adverse effects of low socioeconomic status (SES).", {"entities": []}], ["The participants comprised 150 Indians (53\u00a0% women; mean age\u2009=\u200936.38\u00a0years) from high, medium and low socioeconomic groups.", {"entities": []}], ["Their levels of perceived stress, coping flexibility, subjective SES and HRQoL were assessed individually through household interviews.", {"entities": []}], ["The findings provide support for the hypothesised moderating role of coping flexibility between subjective SES and HRQoL ( p \u2009<\u20090.001).", {"entities": []}], ["In the low SES group, participants higher in coping flexibility reported significantly better HRQoL than those lower in coping flexibility.", {"entities": []}], ["Moreover, coping flexibility moderated the association between perceived stress and HRQoL ( p \u2009=\u20090.001).", {"entities": []}], ["Of the participants who experienced higher levels of stress, those higher in coping flexibility reported better HRQoL than those lower in coping flexibility.", {"entities": []}], ["This study enriches the literature by revealing the beneficial role of coping flexibility on HRQoL among individuals low in SES.", {"entities": []}], ["These new findings highlight the potential importance of psychological interventions that strengthen the flexible coping skills of socioeconomically disadvantaged groups.", {"entities": []}], ["Since the Health Promotion Act was introduced in Korea in 1995, anti-smoking policies and regulations have undergone numerous revisions, and non-smoking areas have gradually been expanded.", {"entities": []}], ["The purpose of this study was to examine the impact of a partial legislative ban on adolescent exposure to secondhand smoke using objective urinary cotinine levels in a nationwide representative sample.", {"entities": []}], ["Urine cotinine levels were measured in the Korea National Health and Nutrition Examination Survey from 2008 to 2011.", {"entities": []}], ["This study was a trend analysis of 4\u2009years of national survey data from 2197 Korean youth aged 10\u201318 years.", {"entities": []}], ["Among non-smokers, the 75th percentile urinary cotinine level was estimated.", {"entities": []}], ["We also considered the number of household smokers.", {"entities": []}], ["The 75th percentile urine cotinine level of non-smokers showed a significant decreasing trend from 2008 to 2011, from 15.47 to 5.37\u2009ng/mL, respectively.", {"entities": []}], ["Urine cotinine did not decline significantly in non-smokers living with smokers during the study period.", {"entities": []}], ["The results did not show a statistically significant reduction in smoking rate in adolescents from 2008 to 2011, although there was a trend towards a decrease (p=0.081).", {"entities": []}], ["Based on urine cotinine levels, government-initiated anti-smoking policies have only been effective among highly exposed non-smoking adolescents during the study period.", {"entities": []}], ["Further study needs to evaluate whether or not the legislative ban affects domestic smoking exposure.", {"entities": []}], ["Allergen extracts are still widely used in allergy diagnosis as they are regarded as sensitive screening tools despite the fact that they may lack some minor allergens.", {"entities": []}], ["Another drawback of extracts is their low specificity, which is due to the presence of cross-reactive allergens.", {"entities": []}], ["Progress in allergen identification has disclosed a number of allergenic molecules of homologous sequence and structure which are present in different animal species.", {"entities": []}], ["This review summarizes recent advances in mammalian and fish allergen identification and focuses on their clinical relevance.", {"entities": []}], ["Serum albumins and parvalbumins are well-known animal panallergens.", {"entities": []}], ["More recently several members of the lipocalin family were found to be cross-reactive between furry animals whereas in fish, additional allergens, enolase, aldolase and collagen, were found to be important and cross-reactive allergens.", {"entities": []}], ["New epidemiological studies have analysed the prevalence and clinical relevance of mammalian and fish components.", {"entities": []}], ["Primary sensitization can be distinguished from cross-sensitization by using marker allergens.", {"entities": []}], ["Although substantial progress has been made in allergen identification, only few markers are commercially available for routine clinical practice.", {"entities": []}], ["Effective treatments are needed for idiopathic chronic rhinitis in dogs, but assessment of efficacy requires a practical, quantifiable method for assessing severity of disease.", {"entities": [[55, 63, "DISEASE"], [47, 63, "DISEASE"]]}], ["To develop and perform initial validity and reliability testing of an owner\u2010completed questionnaire for assessing clinical signs and dog and owner quality of life ( QOL ) in canine chronic rhinitis.", {"entities": [[189, 197, "DISEASE"], [181, 197, "DISEASE"]]}], ["Twenty\u2010two dogs with histopathologically confirmed chronic rhinitis and 72 healthy dogs.", {"entities": [[59, 67, "DISEASE"], [51, 67, "DISEASE"]]}], ["In this prospective study, an online questionnaire was created based on literature review and feedback from veterinarians, veterinary internists with respiratory expertise, and owners of dogs with rhinitis.", {"entities": [[197, 205, "DISEASE"]]}], ["Owners of affected dogs completed the questionnaire twice, 1 week apart, to test reliability.", {"entities": []}], ["Healthy dogs were assessed once.", {"entities": []}], ["Data were analyzed using the Rasch Rating Scale Model, and results were interpreted using Messick's framework for evaluating construct validity evidence.", {"entities": []}], ["Initial item generation resulted in 5 domains: nasal signs, paranasal signs, global rhinitis severity, and dog's and owner's QOL .", {"entities": [[84, 92, "DISEASE"]]}], ["A 25\u2010item questionnaire was developed using 5\u2010point Likert\u2010type scales.", {"entities": []}], ["No respondent found the questionnaire difficult to complete.", {"entities": []}], ["Strong psychometric evidence was available to support the substantive, generalizability, content, and structural aspects of construct validity.", {"entities": []}], ["Statistical differences were found between responses for affected and control dogs for all but 2 items.", {"entities": []}], ["These items were eliminated, resulting in the 23\u2010item Severity of Nasal Inflammatory Disease ( SNIFLD ) questionnaire.", {"entities": []}], ["The SNIFLD questionnaire provides a mechanism for repeated assessments of disease severity in dogs with chronic rhinitis.", {"entities": [[112, 120, "DISEASE"], [104, 120, "DISEASE"]]}], ["A systematic review and meta-analysis was conducted to evaluate the efficacy and safety of macrolide therapy in adults and children with bronchiectasis.", {"entities": [[137, 151, "DISEASE"]]}], ["We searched the PUBMED, EMBASE, CENTRAL databases to identify relevant studies.", {"entities": []}], ["Two reviewers evaluated the studies and extracted data independently.", {"entities": []}], ["The primary outcome was the number of bronchiectasis exacerbations.", {"entities": [[38, 52, "DISEASE"]]}], ["Secondary outcomes included exacerbation-related admissions, quality of life (QoL), spirometry, 6-minute walk test (6MWT) and adverse events.", {"entities": []}], ["Nine eligible trials with 559 participants were included.", {"entities": []}], ["Six were conducted on adults, and the remaining on children.", {"entities": []}], ["Macrolide therapy significantly reduced the number of patients experiencing one or more exacerbation in adults [risk ratio (RR)\u200a=\u200a0.59; 95% CI, 0.40 to 0.86; P\u200a=\u200a0.006; I 1 and FVC, were significantly improved in adults but not in children.", {"entities": []}], ["Macrolide therapy improved the QoL (WMD, \u22126.56; 95% CI, \u221211.99 to \u22121.12; P\u200a=\u200a0.02; I Macrolide maintenance therapy, both in adults and children, was effective and safe in reducing bronchiectasis exacerbations, but not the admissions for exacerbations.", {"entities": [[180, 194, "DISEASE"]]}], ["In addition, macrolide administration in adults was associated with improvement in QoL and spirometry, but not 6WMT.", {"entities": []}], ["Future studies are warranted to verify the optimal populations and clarify its potential effects on antimicrobial resistance.", {"entities": []}], ["Macrophages are key players involved in numerous pathophysiological pathways and an in-depth characterization of their gene regulatory networks can help in better understanding how their dysfunction may impact on human diseases.", {"entities": []}], ["We here conducted a cross-species network analysis of macrophage gene expression data between human and mouse to identify conserved networks across both species, and assessed whether such networks could reveal new disease-associated regulatory mechanisms.", {"entities": []}], ["From a sample of 684 individuals processed for genome-wide macrophage gene expression profiling, we identified 27 groups of coexpressed genes (modules).", {"entities": []}], ["Six modules were found preserved ( P < 10 trans -acting variant influencing (minimal P -value = 4.3 \u00d7 10 PARK2 participates to the regulatory networks associated with oxidative phosphorylation and suggested that PARK2 genetic variations could act as a trans regulator of OXPHOS gene macrophage expression in humans.", {"entities": [[105, 110, "GENE"], [212, 217, "GENE"], [105, 110, "GENE"], [212, 217, "GENE"]]}], ["Heavy traffic is a source of air pollution and a safety concern with important public health implications.", {"entities": []}], ["We investigated whether green space lowers child asthma risk by buffering the effects of heavy traffic and a lack of neighborhood safety.", {"entities": [[49, 55, "DISEASE"]]}], ["Multilevel models were used to analyze affirmative asthma cases in nationally representative cross-sectional data from 4447 children aged 6\u20137 years old in Australia.", {"entities": [[51, 57, "DISEASE"]]}], ["Case-finding was based upon a triangulation of affirmative responses to three questions on doctor-diagnosed asthma, asthma-related medications and illness with wheezing lasting for at least 1 week within the 12 months prior.", {"entities": [[108, 114, "DISEASE"], [116, 122, "DISEASE"]]}], ["Among children considered to be exposed to high traffic volumes and areas with 0 to 20% green space quantity, the odds ratio of affirmative asthma was 1.87 (95% CI 1.37 to 2.55).", {"entities": [[140, 146, "DISEASE"]]}], ["However, the association between heavy traffic and asthma was significantly lower for participants living in areas with over 40% green space coverage (odds ratio for interaction 0.32, 95% CI 0.12 to 0.84).", {"entities": [[51, 57, "DISEASE"]]}], ["No association between affirmative asthma and green space coverage was observed for participants not exposed to heavy traffic, nor for the area safety variable.", {"entities": [[35, 41, "DISEASE"]]}], ["Protecting existing and investing in new green space may help to promote child respiratory health through the buffering of traffic-related air pollution.", {"entities": []}], ["Patients with chronic conditions require ongoing care which not only necessitates support from health care providers outside appointments but also self-management.", {"entities": []}], ["Web-based tools for text-based patient-provider communication, such as secure messaging, allow for sharing of contextual information and personal narrative in a simple accessible medium, empowering patients and enabling their providers to address emerging care needs.", {"entities": []}], ["The objectives of this study were to (1) conduct a systematic search of the published literature and the Internet for Web-based tools for text-based communication between patients and providers; (2) map tool characteristics, their intended use, contexts in which they were used, and by whom; (3) describe the nature of their evaluation; and (4) understand the terminology used to describe the tools.", {"entities": []}], ["We conducted a scoping review using the MEDLINE (Medical Literature Analysis and Retrieval System Online) and EMBASE (Excerpta Medica Database) databases.", {"entities": []}], ["We summarized information on the characteristics of the tools (structure, functions, and communication paradigm), intended use, context and users, evaluation (study design and outcomes), and terminology.", {"entities": []}], ["We performed a parallel search of the Internet to compare with tools identified in the published literature.", {"entities": []}], ["We identified 54 papers describing 47 unique tools from 13 countries studied in the context of 68 chronic health conditions.", {"entities": []}], ["The majority of tools (77%, 36/47) had functions in addition to communication (eg, viewable care plan, symptom diary, or tracker).", {"entities": []}], ["Eight tools (17%, 8/47) were described as allowing patients to communicate with the team or multiple health care providers.", {"entities": []}], ["Most of the tools were intended to support communication regarding symptom reporting (49%, 23/47), and lifestyle or behavior modification (36%, 17/47).", {"entities": []}], ["The type of health care providers who used tools to communicate with patients were predominantly allied health professionals of various disciplines (30%, 14/47), nurses (23%, 11/47), and physicians (19%, 9/47), among others.", {"entities": []}], ["Over half (52%, 25/48) of the tools were evaluated in randomized controlled trials, and 23 tools (48%, 23/48) were evaluated in nonrandomized studies.", {"entities": []}], ["Terminology of tools varied by intervention type and functionality and did not consistently reflect a theme of communication.", {"entities": []}], ["The majority of tools found in the Internet search were patient portals from 6 developers; none were found among published articles.", {"entities": []}], ["Web-based tools for text-based patient-provider communication were identified from a wide variety of clinical contexts and with varied functionality.", {"entities": []}], ["Tools were most prevalent in contexts where intended use was self-management.", {"entities": []}], ["Few tools for team-based communication were found, but this may become increasingly important as chronic disease care becomes more interdisciplinary.", {"entities": []}], ["Since its discovery in 2005, human bocavirus type 1 has often been found in the upper airways of young children with respiratory disease.", {"entities": []}], ["But is this virus the cause of the respiratory disease or just an innocent bystander?", {"entities": []}], ["A unique study in Finland, which examined follow-up blood samples of 109 healthy children with no underlying illness starting at birth and until they were 13 years of age, found that acute bocavirus infection resulted in respiratory disease.", {"entities": []}], ["All children had been infected by age 6.", {"entities": []}], ["Most retained their antibodies to this virus; some lost them.", {"entities": []}], ["Children who were later re-exposed to bocavirus did not get sick from this virus.", {"entities": []}], ["Thus, human bocavirus type 1 is a major cause of respiratory disease in childhood.", {"entities": []}], ["Human bocavirus 1 (HBoV1) DNA is frequently detected in the upper airways of young children with respiratory symptoms.", {"entities": []}], ["Because of its persistence and frequent co-detection with other viruses, however, its etiologic role has remained controversial.", {"entities": []}], ["During 2009\u20132011, using HBoV1 IgM, IgG, and IgG-avidity enzyme immunoassays and quantitative PCR, we examined 1,952 serum samples collected consecutively at 3- to 6-month intervals from 109 constitutionally healthy children from infancy to early adolescence.", {"entities": []}], ["Primary HBoV1 infection, as indicated by seroconversion, appeared in 102 (94%) of 109 children at a mean age of 2.3 years; the remaining 7 children were IgG antibody positive from birth.", {"entities": []}], ["Subsequent secondary infections or IgG antibody increases were evident in 38 children and IgG reversions in 10.", {"entities": []}], ["Comparison of the seroconversion interval with the next sampling interval for clinical events indicated that HBoV1 primary infection, but not secondary immune response, was significantly associated with acute otitis media and respiratory illness.", {"entities": [[209, 221, "DISEASE"]]}], ["The prevalence of asthma and allergic diseases is disproportionately distributed among different populations, with an increasing trend observed in Western countries.", {"entities": [[18, 24, "DISEASE"]]}], ["Here we investigated how the environment affected genotype-phenotype association in a genetically homogeneous, but geographically separated population.", {"entities": []}], ["We evaluated 18 single nucleotide polymorphisms (SNPs) corresponding to 8 genes ( ADAM33 , ALOX5 , LT-\u03b1, LTC4S , NOS1, ORMDL3, TBXA2R and TNF-\u03b1 ), the lung function and five respiratory/allergic conditions (ever asthma, bronchitis, rhinitis, dermatitis and atopy) in two populations of Inuit residing either in the westernized environment of Denmark or in the rural area of Greenland.", {"entities": [[232, 240, "DISEASE"], [212, 218, "DISEASE"], [242, 252, "DISEASE"], [220, 230, "DISEASE"], [82, 88, "GENE"], [91, 96, "GENE"], [105, 110, "GENE"], [113, 117, "GENE"], [119, 125, "GENE"], [127, 133, "GENE"]]}], ["Our results showed that lung function was associated with genetic variants in ORMDL3 , with polymorphisms having a significant interaction with place of residence.", {"entities": [[78, 84, "GENE"]]}], ["LT-\u03b1 SNP rs909253 and rs1041981 were significantly associated with bronchitis risk.", {"entities": [[67, 77, "DISEASE"]]}], ["LT-\u03b1 SNP rs2844484 was related to dermatitis susceptibility and was significantly influenced by the place of residence.", {"entities": [[34, 44, "DISEASE"]]}], ["The observed gene-phenotype relationships were exclusively present in one population and absent in the other population.", {"entities": []}], ["We conclude that the genotype-phenotype associations relating to bronchitis and allergy susceptibility are dependent on the environment and that environmental factors/lifestyles modify genetic predisposition and change the genetic effects on diseases.", {"entities": [[65, 75, "DISEASE"]]}], ["Many benefits provided by the gut microbiota to the host rely on its intricate interactions with host cells.", {"entities": []}], ["Perturbations of the gut microbiota, termed gut dysbiosis, affect the interplay between the gut microbiota and host cells, resulting in dysregulation of inflammation that contributes to the pathogenesis of chronic inflammatory diseases, including inflammatory bowel disease, multiple sclerosis, allergic asthma and rheumatoid arthritis.", {"entities": [[247, 273, "DISEASE"], [275, 293, "DISEASE"], [315, 335, "DISEASE"], [295, 310, "DISEASE"], [326, 335, "DISEASE"], [304, 310, "DISEASE"]]}], ["In this review, we provide an overview of how gut bacteria modulates host metabolic and immune functions, summarize studies that examined the roles of gut dysbiosis in chronic inflammatory diseases, and finally discuss measures to correct gut dysbiosis as potential therapeutics for chronic inflammatory diseases.", {"entities": []}], ["A significant number of young people start smoking at an age of 13-15, which means that serious smoking-evoked changes may have been occurred by their twenties.", {"entities": []}], ["Surfactant proteins (SP) and matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) have been linked to cigarette smoke induced lung remodelling and chronic obstructive pulmonary disease (COPD).", {"entities": [[163, 200, "DISEASE"]]}], ["However, the level of these proteins has not been examined during ageing or in young individuals with short smoking histories.", {"entities": []}], ["Plasma levels of SP-A, SP-D, MMP-9, and TIMP-1 were measured by EIA/ELISA from young (18-23 years) non-smoking controls (YNS) (n = 36), smokers (YS) (n = 51), middle aged/elderly (37-77 years) non-smoking controls (ONS) (n = 40), smokers (OS) (n = 64) (FEV1/FVC >0.7 in all subjects) and patients with COPD (n = 44, 35-79 years).", {"entities": []}], ["Plasma levels of SP-A increased with age and in the older group in relation to smoking and COPD.", {"entities": []}], ["Plasma SP-D and MMP-9 levels did not change with age but were elevated in OS and COPD as compared to ONS.", {"entities": []}], ["The TIMP-1 level declined with age but increased in chronic smokers when compared to ONS.", {"entities": []}], ["The clearest correlations could be detected between plasma SP-A vs. age, pack years and FEV1/FVC.", {"entities": []}], ["The receiver operating characteristic (ROC) curve analysis revealed SP-A to be the best marker for discriminating between patients with COPD and the controls (area under ROC curve of 0.842; 95% confidence interval, 0.785-0.899; p < 0.001).", {"entities": []}], ["Age has a significant contribution to potential markers related to smoking and COPD; SP-A seems to be the best factor in differentiating COPD from the controls.", {"entities": []}], ["In this paper, we aim to discern how a mother\u2019s health and her socioeconomic determinants may influence her children\u2019s mental health.", {"entities": []}], ["In addition to this, we also evaluate the influence of other household characteristics and whether or not the economic downturn has heightened the effect a parent\u2019s social gradient has on their children\u2019s mental health.", {"entities": []}], ["We use samples comprised of 4-14-year-old minors from the 2006 Spanish National Health Survey (SNHS), undertaken prior to the crisis, and the 2011 SNHS, carried out during the crisis.", {"entities": []}], ["The participating children\u2019s mental health is assessed using the Strengths and Difficulties Questionnaire (SDQ).", {"entities": []}], ["Mixed models are used to evaluate the influence a mother\u2019s health and her socioeconomic status may have on her children\u2019s mental health.", {"entities": []}], ["We also add interactions to observe the effect specific socioeconomic determinants may have had during the economic downturn.", {"entities": []}], ["The risk of a child suffering from mental health disorders increases when their mother has mental health problems.", {"entities": []}], ["Socioeconomic determinants also play a role, as a low socioeconomic status (SES) increases the risk of a child exhibiting behavioural problems, being hyperactive or antisocial, whereas when a mother has attained a high level of education, this significantly reduces the probability of a child having mental health problems.", {"entities": []}], ["\u2018Homemaker\u2019 is the activity status most positively related to children\u2019s mental health.", {"entities": []}], ["The findings show that the Spanish economic downturn has not significantly changed children\u2019s mental health problems and the negative effects of low maternal SES are no greater than they were before the crisis.", {"entities": []}], ["The main difference in 2011, with respect to 2006, is that the risk of children suffering from mental health problems is higher when their parents are (long or short-term) unemployed.", {"entities": []}], ["In conclusion, both a mother\u2019s health and her socioeconomic status, as well as other household characteristics, are found to be related to her children\u2019s mental well-being.", {"entities": []}], ["Although the crisis has not significantly changed mental health disorders in children or the social gradient of parents in general, at-risk children are the most negatively affected in the Spanish economic downturn.", {"entities": []}], ["Migraine and temporomandibular disorders (TMDs) are reported to be associated.", {"entities": [[0, 8, "DISEASE"]]}], ["However, there are no reports on the association among migraines, TMDs and changes in body posture.", {"entities": []}], ["To assess changes in body posture in women suffering migraines with or without TMD compared with a control group.", {"entities": []}], ["Sixty-six women with a mean age of 18 to 45 years participated in this study.", {"entities": []}], ["The groups were composed of 22 volunteers with migraine and TMD (MTMD), 22 volunteers with migraines without TMD (MG) and 22 women in the control group (CG).", {"entities": [[47, 55, "DISEASE"]]}], ["Static posture was assessed by photogrammetry, and 19 angles were measured.", {"entities": []}], ["Postural asymmetry was observed in the face for 4 angles measured on the frontal plane in the MG group and for 4 angles of the trunk in the MG and MTMD groups with respect to CG.", {"entities": []}], ["However, for comparisons between MTMD and CG, clinical relevance was identified for two angles of the sagittal plane (Cervical and Lumbar Lordosis, Effect Size - ES - moderate: 0.53 and 0.60).", {"entities": []}], ["For comparisons between the MG and CG, the clinical relevance/potential was verified for three angles with moderate ES (ES>0.42).", {"entities": []}], ["The clinical relevance when comparing MTMD and CG was identified for four angles of facial symmetry head inclination (ES>0.54) and for two angles between MG and CG (ES>0.48).", {"entities": []}], ["The results demonstrated the presence of postural changes compared with a control group in women with migraines with or without TMD, and there were similar clinically relevant postural changes among the patients with migraines with and without TMD.", {"entities": []}], ["IFN\u03b3 induces cell death in epithelial cells, but the mediator for this death pathway has not been identified.", {"entities": []}], ["In this study, we find that expression of Bik/Blk/Nbk is increased in human airway epithelial cells (AECs [HAECs]) in response to IFN\u03b3.", {"entities": []}], ["Expression of Bik but not mutant BikL61G induces and loss of Bik suppresses IFN\u03b3-induced cell death in HAECs.", {"entities": [[14, 17, "GENE"], [61, 64, "GENE"], [14, 17, "GENE"], [61, 64, "GENE"]]}], ["IFN\u03b3 treatment and Bik expression increase cathepsin B and D messenger RNA levels and reduce levels of phospho\u2013extracellular regulated kinase 1/2 (ERK1/2) in the nuclei of bik compared with bik murine AECs.", {"entities": [[19, 22, "GENE"], [172, 175, "GENE"], [190, 193, "GENE"], [19, 22, "GENE"], [172, 175, "GENE"], [190, 193, "GENE"], [19, 22, "GENE"], [172, 175, "GENE"], [190, 193, "GENE"]]}], ["Bik but not BikL61G interacts with and suppresses nuclear translocation of phospho-ERK1/2, and suppression of ERK1/2 activation inhibits IFN\u03b3- and Bik-induced cell death.", {"entities": [[0, 3, "GENE"], [147, 150, "GENE"]]}], ["Furthermore, after prolonged exposure to allergen, hyperplastic epithelial cells persist longer, and nuclear phospho-ERK is more prevalent in airways of IFN\u03b3 or bik compared with wild-type mice.", {"entities": [[161, 164, "GENE"]]}], ["These results demonstrate that IFN\u03b3 requires Bik to suppress nuclear localization of phospho-ERK1/2 to channel cell death in AECs.", {"entities": [[45, 48, "GENE"]]}], ["The concentration of particles in the ambient air is associated with deaths from cardiovascular disease, and determining the biologic mechanisms involved has been identified as a high-priority research need.", {"entities": []}], ["Hypotheses have focused on the possibility of direct cardiac effects, or indirect effects related to inflammatory responses, including increased blood viscosity or increased blood coagulability.", {"entities": []}], ["Ultrafine particles (UFPs; those smaller than 100 nm) may be important in cardiovascular effects because of their very high deposition efficiency in the pulmonary region, and their high propensity to penetrate the epithelium and reach interstitial sites.", {"entities": []}], ["We have initiated human clinical studies of the health effects of UFPs using a mouthpiece exposure system.", {"entities": []}], ["Healthy, nonsmoking subjects 18-55 years of age are exposed at rest for 2 hr to 10 microg/m3 carbon UFPs and to filtered air as a control.", {"entities": [[74, 76, "GENE"]]}], ["Preliminary findings indicate a relatively high overall deposition fraction (0.66 +/- 0.12 by particle number) consistent with model predictions and an absence of particle-associated symptoms or changes in lung function.", {"entities": []}], ["Planned studies examine responses in susceptible subject groups, and the effects of particles of varying composition.", {"entities": []}], ["Human clinical studies using model particles will complement other approaches such as epidemiologic, animal exposure, and in vitro studies in determining the mechanisms for heath effects related to ambient particle exposure.", {"entities": []}], ["We analyzed whether further education in young adult and mid-life [adult educational mobility] influences physical functioning and depressive symptoms in women.", {"entities": []}], ["14247 women born 1973\u201378 (younger cohort) and 13715 women born 1946\u201351 (mid-aged cohort) from the Australian Longitudinal Study on Women\u2019s Health were followed for 14\u201316 years.", {"entities": []}], ["Measures were the Short-Form 36 Health Survey physical functioning subscale (SF-36 PF) and Centre for Epidemiologic Studies 10-item Depression Scale (CESD-10).", {"entities": []}], ["Linear mixed modelling, accounting for time varying covariates, assessed the influence of further education on physical functioning and depressive symptoms over time.", {"entities": []}], ["Sensitivity analysis to assess the impact of missing data was conducted using multiple imputation.", {"entities": []}], ["Compared to younger women with a pre-existing high level of education, women gaining further education (up to age 39 years) from low levels had lower SF-36 PF scores (poorer physical functioning) (fully adjusted beta estimates (95%CIs) -1.52 (-2.59, -0.44)) while those gaining further education from middle to high levels showed equivalent SF-36 PF scores (-0.08 (-0.61, 0.44)).", {"entities": []}], ["A similar pattern was shown for CESD-10 scores (0.78 (0.29, 1.25); -0.02 (-0.26, 0.21), respectively) where higher scores represented more depressive symptoms.", {"entities": []}], ["For mid-age women, further education from a middle to high level resulted in equivalent SF-36 PF scores (-0.61 (-1.93,0.71)) but higher CESD-10 scores (0.49 (0.11, 0.86)), compared to highly educated women.", {"entities": []}], ["Women who delay further education until they are aged between their 40s and 60s can improve or maintain their physical functioning but may have missed the critical time to minimise depressive symptomatology.", {"entities": []}], ["Public health policy should focus on encouraging women to upgrade their educational qualifications earlier in life in order to potentially offset the negative associations between their initial lower socio-economic position class of origin and their mental health.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disorder of the lung and whole body caused mainly by tobacco smoking.", {"entities": []}], ["Patients with advanced COPD are in a state of undernutrition, referred to as pulmonary cachexia; the exercise performance and quality of life (QOL) of these patients are deteriorated, the vital prognosis is unfavorable, and the medico-economic burden posed by poorly nourished COPD patients is high.", {"entities": []}], ["The mainstays of COPD treatment are pharmacotherapy, mainly with bronchodilators, and non-pharmacotherapeutic approaches such as respiratory rehabilitation and nutrition counseling.", {"entities": []}], ["Nutritional supplement therapy, consisting primarily of high calorie intake, has been demonstrated to be effective for maintaining and improving the muscle strength and exercise tolerance in poorly nourished COPD patients.", {"entities": []}], ["The efficacy of intake of various nutrients, besides a high calorie intake, for amelioration of the disease state of COPD has also been reported.", {"entities": []}], ["The roles of adipokines in the pathophysiology of COPD have begun to receive attention recently, and not only their regulatory effects on appetite and nutritional status, but also their influence on systemic inflammation have been increasingly clarified.", {"entities": []}], ["We review the papers on COPD and nutrition and discuss the role of nutritional supplement therapy in the treatment of COPD.", {"entities": []}], ["Adults born preterm at very low birth weight (VLBW, <1500 g) have elevated levels of risk factors for cardiovascular diseases and type 2 diabetes.", {"entities": []}], ["Preliminary observations suggest that this could partly be explained by lower rates of physical activity.", {"entities": []}], ["The aim of this study was to assess physical activity in healthy young adults born preterm at very low birth weight compared with term-born controls.", {"entities": []}], ["We studied 94 unimpaired young adults, aged 21\u201329 years, born at VLBW and 101 age-, sex-, and birth hospital-matched term-born controls from one regional center in Southern Finland.", {"entities": []}], ["The participants completed a validated 30-item 12-month physical activity questionnaire and the NEO-Personality Inventory based on the Big Five taxonomy, the most commonly used classification of personality traits.", {"entities": []}], ["Yearly frequency, total time, total volume and energy expenditure of conditioning and non-conditioning leisure-time physical activity (LTPA) and commuting physical activity were compared between VLBW and term-born subjects.", {"entities": []}], ["A subset of participants underwent dual-energy x-ray absorptiometry for body composition measurement.", {"entities": []}], ["Data were analyzed by multiple linear regression.", {"entities": []}], ["Compared with controls, VLBW participants had lower frequency [\u221238.5% (95% CI; \u221258.9, \u22127.7)], total time [\u221247.4% (95% CI; \u221271.2, \u22124.1)], total volume [\u221244.3% (95% CI; \u221265.8, \u22129.2)] and energy expenditure [\u221255.9% (95% CI; \u221278.6, \u22129.4)] of conditioning LTPA when adjusted for age, sex, body mass index, smoking, parental education and personality traits.", {"entities": []}], ["Adjusting for lean body mass instead of body mass index attenuated the difference.", {"entities": []}], ["There were no differences in non-conditioning LTPA or commuting physical activity.", {"entities": []}], ["Compared with term-born controls, unimpaired VLBW adults undertake less frequent LTPA with lower total time and volume of exercise resulting in lower energy expenditure.", {"entities": []}], ["Differences in personality that exist between the VLBW and term-born groups do not seem to explain this association.", {"entities": []}], ["Nitric oxide (NO) production plays a central role in conferring tolerance to hypoxia.", {"entities": []}], ["Tibetan highlanders, successful high-altitude dwellers for millennia, have higher circulating nitrate and exhaled NO (E NO ) levels than native lowlanders.", {"entities": []}], ["Since nitrate itself can reduce the oxygen cost of exercise in normoxia it may confer additional benefits at high altitude.", {"entities": []}], ["Xtreme Alps was a double-blinded randomised placebo-controlled trial to investigate how dietary nitrate supplementation affects physiological responses to hypoxia in 28 healthy adult volunteers resident at 4559\u202fm for 1 week; 14 receiving a beetroot-based high-nitrate supplement and 14 receiving a low-nitrate \u2018placebo\u2019 of matching appearance/taste.", {"entities": []}], ["E NO , vital signs and acute mountain sickness (AMS) severity were recorded at sea level (SL) and daily at altitude.", {"entities": []}], ["Moreover, standard spirometric values were recorded, and saliva and exhaled breath condensate (EBC) collected.", {"entities": []}], ["There was no significant difference in resting cardiorespiratory variables, peripheral oxygen saturation or AMS score with nitrate supplementation at SL or altitude.", {"entities": []}], ["Median E NO levels increased from 1.5/3.0\u202f\u202fmPa at SL, to 3.5/7.4\u202fmPa after 5 days at altitude (D5) in the low and high-nitrate groups, respectively (p\u202f=\u202f0.02).", {"entities": []}], ["EBC nitrite also rose significantly with dietary nitrate (p\u202f=\u202f0.004), 1.7\u20135.1\u202f\u202f\u03bcM\u202fat SL and 1.6\u20136.3\u202f\u03bcM\u202fat D5, and this rise appeared to be associated with increased levels of E NO .", {"entities": []}], ["However, no significant changes occurred to levels of EBC nitrate or nitrosation products (RXNO).", {"entities": []}], ["Median salivary nitrite/nitrate concentrations increased from 56.5/786\u202f\u03bcM to 333/5,194\u202f\u202f\u03bcM\u202f with nitrate supplementation\u00a0at SL, and changed to 85.6/641\u202f\u03bcM and 341/4,553\u202f\u03bcM on D5.", {"entities": []}], ["Salivary RXNO rose markedly with treatment at SL from 0.55\u202f\u03bcM to 5.70\u202f\u03bcM.", {"entities": []}], ["At D5 placebo salivary RXNO had increased to 1.90\u202f\u03bcM whilst treatment RXNO decreased to 3.26\u202f\u03bcM.", {"entities": []}], ["There was no association with changes in any observation variables or AMS score.", {"entities": []}], ["In conclusion, dietary nitrate supplementation is well tolerated at altitude and significantly increases pulmonary NO availability and both salivary and EBC NO metabolite concentrations.", {"entities": []}], ["Surprisingly, this is not associated with changes in hemodynamics, oxygen saturation or AMS development.", {"entities": []}], ["\u2022 Xtreme Alps is a randomised controlled field study of dietary nitrate at altitude.", {"entities": []}], ["\u2022 Nitrate increased levels of exhaled NO and salivary nitrite, nitrate & RXNO.", {"entities": []}], ["\u2022 Breath condensate nitrate, oxygen saturation and blood pressure did not change following dietary nitrate supplementation.", {"entities": []}], ["\u2022 Increases in exhaled NO correlated with increases in breath condensate nitrite.", {"entities": []}], ["\u2022 Dietary nitrate did not alter the incidence of Acute Mountain Sickness at 4559\u202fm. Xtreme Alps is a randomised controlled field study of dietary nitrate at altitude.", {"entities": []}], ["Nitrate increased levels of exhaled NO and salivary nitrite, nitrate & RXNO.", {"entities": []}], ["Breath condensate nitrate, oxygen saturation and blood pressure did not change following dietary nitrate supplementation.", {"entities": []}], ["Increases in exhaled NO correlated with increases in breath condensate nitrite.", {"entities": []}], ["Dietary nitrate did not alter the incidence of Acute Mountain Sickness at 4559\u202fm.", {"entities": []}], ["Colorectal cancer (CRC) is the most common cancer affecting both men and women.", {"entities": [[11, 17, "DISEASE"], [43, 49, "DISEASE"]]}], ["Survivors of CRC often experience various physical and psychological effects arising from CRC and its treatment.", {"entities": []}], ["These effects may last for many years and adversely affect QoL, and they may not be adequately addressed by standard specialist-based follow-up.", {"entities": []}], ["Optimal management of these effects should harness the expertise of both primary care and specialist care.", {"entities": []}], ["Shared models of care (involving both the patient\u2019s primary care physician [PCP] and specialist) have the potential to better support survivors and enhance health system efficiency.", {"entities": []}], ["SCORE (Shared care of Colorectal cancer survivors) is a multisite randomised controlled trial designed to optimise and operationalise a shared care model for survivors of CRC, to evaluate the acceptability of the intervention and study processes, and to collect preliminary data regarding the effects of shared care compared with usual care on a range of patient-reported outcomes.", {"entities": [[33, 39, "DISEASE"]]}], ["The primary outcome is QoL measured using the European Organisation for Research and Treatment of Cancer QLQ-C30 questionnaire.", {"entities": [[98, 104, "DISEASE"]]}], ["Secondary outcomes are satisfaction with care, unmet needs, continuity of care and health resource use.", {"entities": []}], ["The shared care model involves replacement of two routine specialist follow-up visits with PCP visits, as well as the provision of a tailored survivorship care plan and a survivorship booklet and DVD for CRC survivors.", {"entities": []}], ["All consenting patients will be randomised 1:1 to either shared care or usual care and will complete questionnaires at three time points over a 12-month period (baseline and at 6 and 12\u00a0months).", {"entities": []}], ["Health care resource use data will also be collected and used to evaluate costs.", {"entities": []}], ["The evaluation and implementation of models of care that are responsive to the holistic needs of cancer survivors while reducing the burden on acute care settings is an international priority.", {"entities": [[97, 103, "DISEASE"]]}], ["Shared care between specialists and PCPs has the potential to enhance patient care and outcomes for CRC survivors while offering improvements in health care resource efficiency.", {"entities": []}], ["If the findings of the present study show that the shared care intervention is acceptable and feasible for CRC survivors, the intervention may be readily expanded to other groups of cancer survivors.", {"entities": [[182, 188, "DISEASE"]]}], ["Australian New Zealand Clinical Trials Registry, ACTRN12617000004369p .", {"entities": []}], ["Registered on 3 January 2017; protocol version 4 approved 24 February 2017.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-2245-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Public health vaccination guidelines cannot be easily transferred to elite athletes.", {"entities": []}], ["An enhanced benefit from preventing even mild diseases is obvious but stronger interference from otherwise minor side effects has to be considered as well.", {"entities": []}], ["Thus, special vaccination guidelines for adult elite athletes are required.", {"entities": []}], ["In most of them, protection should be strived for against tetanus, diphtheria, pertussis, influenza, hepatitis A, hepatitis B, measles, mumps and varicella.", {"entities": [[127, 134, "DISEASE"], [67, 77, "DISEASE"], [90, 99, "DISEASE"], [58, 65, "DISEASE"], [79, 88, "DISEASE"], [101, 110, "DISEASE"], [114, 123, "DISEASE"], [136, 141, "DISEASE"]]}], ["When living or traveling to endemic areas, the athletes should be immune against tick-borne encephalitis, yellow fever, Japanese encephalitis, poliomyelitis, typhoid fever, and meningococcal disease.", {"entities": [[143, 156, "DISEASE"], [106, 118, "DISEASE"], [92, 104, "DISEASE"], [129, 141, "DISEASE"], [158, 171, "DISEASE"], [81, 104, "DISEASE"]]}], ["Vaccination against pneumococci and Haemophilus influenzae type b is only relevant in athletes with certain underlying disorders.", {"entities": []}], ["Rubella and papillomavirus vaccination might be considered after an individual risk\u2013benefit analysis.", {"entities": [[0, 7, "DISEASE"]]}], ["Other vaccinations such as cholera, rabies, herpes zoster, and Bacille Calmette\u2013Gu\u00e9rin (BCG) cannot be universally recommended for athletes at present.", {"entities": [[36, 42, "DISEASE"], [27, 34, "DISEASE"], [44, 57, "DISEASE"]]}], ["Only for a very few diseases, a determination of antibody titers is reasonable to avoid unnecessary vaccinations or to control efficacy of an individual\u2019s vaccination (especially for measles, mumps, rubella, varicella, hepatitis B and, partly, hepatitis A).", {"entities": [[183, 190, "DISEASE"], [219, 228, "DISEASE"], [244, 253, "DISEASE"], [199, 206, "DISEASE"], [192, 197, "DISEASE"]]}], ["Vaccinations should be scheduled in a way that possible side effects are least likely to occur in periods of competition.", {"entities": []}], ["Typically, vaccinations are well tolerated by elite athletes, and resulting antibody titers are not different from the general population.", {"entities": []}], ["Side effects might be reduced by an optimal selection of vaccines and an appropriate technique of administration.", {"entities": []}], ["Very few discipline-specific considerations apply to an athlete\u2019s vaccination schedule mainly from the competition and training pattern as well as from the typical geographical distribution of competitive sites.", {"entities": []}], ["There is growing interest in myeloid (my) dendritic cells (DC) as an alternative to monocyte-derived DC (moDC) for immunotherapy.", {"entities": []}], ["However, in contrast to moDC, little is known regarding the effect of malignancy on the function, abundance or use of intracellular signaling pathways in myDC.", {"entities": []}], ["Understanding the molecular detail of circulating myDC is therefore important for future use in advanced cancer.", {"entities": [[105, 111, "DISEASE"]]}], ["Advanced cancer patients had similar numbers of circulating myDC to cancer-free patients and healthy individuals, and secreted similar levels of IL-1\u03b2, IL-6, IL-10, IL-12 and IL-23.", {"entities": [[9, 15, "DISEASE"], [68, 74, "DISEASE"]]}], ["However, myDC from some patients failed to secrete the Th1-cytokine IL-12.", {"entities": []}], ["Surprisingly, inhibiting p38 (p38i) signaling (using BIRB0796 or SB203580) markedly increased IL-12 secretion by myDC.", {"entities": []}], ["This is in complete contrast to what is established for moDC where inhibiting p38 ablates IL-12.", {"entities": []}], ["Interestingly, this was specific to IL-12, since IL-10 was suppressed by p38i in both DC types.", {"entities": []}], ["The opposing effect of p38i on IL-12 was evident at the transcriptional level and in both DC types was mediated through the p38-MK2 pathway but did not involve differential phosphorylation of the distal Rsk kinase.", {"entities": []}], ["Importantly, where patient myDC did not secrete IL-12 (or after treatment with suppressive melanoma lysate), p38i restored IL-12 to normal levels.", {"entities": [[91, 99, "DISEASE"]]}], ["In contrast to p38, inhibiting the other MAPK pathways had similar consequences in both DC types.", {"entities": []}], ["We show for the first time the differential use of a major intracellular signaling pathway by myDC.", {"entities": []}], ["Importantly, there are sufficient circulating myDC in advanced cancer patients to consider development of adoptive immunotherapy.", {"entities": [[63, 69, "DISEASE"]]}], ["Dendritic cells (DCs) govern antigen specificity in T cells.", {"entities": []}], ["DCs also secrete cytokines that regulate T-cell responses.", {"entities": []}], ["This study explores the potential of circulating myeloid dendritic cells (myDC) for cancer immunotherapy.", {"entities": [[84, 90, "DISEASE"]]}], ["The authors examined intracellular signalling and cytokine secretion in myDCs, and found that when p38 MAPK is inhibited in these cells, IL-12p70 production is enhanced and IL-10 is suppressed.", {"entities": []}], ["In contrast, monocyte-derived DCs (moDCs) require p38 MAPK for IL-12p70 production.", {"entities": []}], ["These differences in intracellular signalling indicate that immunotherapy with myDCs may induce more potent anti-tumour immunity in combination with MAPK inhibitors.", {"entities": []}], ["Disruption of nasal epithelial tight junctions (TJs) and ciliary dysfunction are found in patients with chronic rhinosinusitis (CRS) and nasal polyps (NPs), along with an increase of p63-positive basal cells and histone deacetylase (HDAC) activity.", {"entities": [[151, 154, "GENE"]]}], ["To investigate these mechanisms, primary cultures of HNECs transfected with human telomerase reverse transcriptase (hTERT-HNECs) were transfected with siRNAs of TAp63 and \u0394Np63, treated with the NF-kB inhibitor curucumin and inhibitors of HDACs, and infected with respiratory syncytial virus (RSV).", {"entities": []}], ["In TERT-HNECs, knockdown of p63 by siRNAs of TAp63 and \u0394Np63, induced claudin-1 and -4 with Sp1 activity and enhanced barrier and fence functions.", {"entities": [[92, 95, "GENE"]]}], ["The knockdown of p63 enhanced the number of microvilli with the presence of cilia-like structures.", {"entities": []}], ["Treatment with curcumin and inhibitors of HDACs, or infection with RSV prevented expression of p63 with an increase of claudin-4 and the number of microvilli.", {"entities": []}], ["The knockdown or downregulation of p63 inhibited phospho-p38MAPK, and the p38MAPK inhibitor downregulated p63 and upregulated the barrier function.", {"entities": []}], ["Thus, epithelial barrier and ciliogenesis of nasal epithelium are regulated in a p63-negative manner in normal and upper airway diseases.", {"entities": []}], ["Understanding of the regulation of p63/p38 MAPK/NF-\u03baB may be important in the therapy for airway allergy and its drug delivery system.", {"entities": []}], ["The present study aimed to provide guidance for the selection of prosthodontic materials and the management of patients with a suspected metal allergy.", {"entities": []}], ["This included a comparison of the sensitivity of patients to alloys used in prescribed metal-containing prostheses, and correlation analysis between metal allergy and accompanying clinical symptoms of sensitized patients using a patch test.", {"entities": []}], ["The results from the patch test and metal component analyses were processed to reach a final diagnosis.", {"entities": []}], ["In the present study, four dental alloys were assessed.", {"entities": []}], ["Subsequent to polishing the surface of a metal restoration, the components were analyzed using an X-ray fluorescence microscopy and spectrometry.", {"entities": []}], ["Immunohistochemical analysis, reverse transcription-polymerase chain reaction and western blotting were used to detect the expression levels of human leukocyte antigen (HLA)-DR in gingival tissues affected by alloy restoration, and in normal gingival tissue samples.", {"entities": [[169, 172, "GENE"]]}], ["Positive allergens identified in the patch test were consistent with the components of the metal prostheses.", {"entities": []}], ["The prevalence of nickel (Ni) allergy was highest (22.8%), and women were significantly more allergic to palladium and Ni than men (P<0.05).", {"entities": []}], ["The protein and gene expression levels of HLA-DR in the Ni-chromium (Cr) prosthesis group were significantly higher, compared with those in the other groups (P<0.01); followed by cobalt-Cr alloy, gold alloy and titanium alloy.", {"entities": []}], ["In conclusion, dentists require an understanding of the corrosion and allergy rates of prescribed alloys, in order to reduce the risk of allergic reactions.", {"entities": []}], ["Patch testing for hypersensitive patients is recommended and caution is required when planning to use different alloys in the mouth.", {"entities": []}], ["Little data on UK prescribing patterns and treatment effectiveness for allergic rhinitis (AR) are available.", {"entities": [[71, 88, "DISEASE"], [80, 88, "DISEASE"]]}], ["We quantified unmet pharmacologic needs in AR by assessing AR treatment effectiveness based on the prescribing behaviour of UK general practitioners (GP) during two consecutive pollen seasons (2009 and 2010).", {"entities": []}], ["We conducted a retrospective observational study with the data from the Optimum Patient Care Research Database.", {"entities": []}], ["We assessed diagnoses and prescription data for patients with a recorded diagnosis of rhinitis who took rhinitis medication during the study period.", {"entities": [[86, 94, "DISEASE"], [104, 112, "DISEASE"]]}], ["We assessed the data from 25,069 patients in 2009 and 22,381 patients in 2010.", {"entities": []}], ["Monotherapy was the initial prescription of the season for 67% of patients with seasonal AR (SAR) and 77% of patients with nonseasonal upper airways disease (NSUAD), for both years.", {"entities": []}], ["Initial oral antihistamine (OAH) or intranasal corticosteroid (INS) monotherapy proved insufficient for >20% of SAR and >37% of NSUAD patients.", {"entities": [[63, 66, "GENE"]]}], ["Multiple therapy was the initial prescription for 33% of SAR and 23% of NSUAD in both years, rising to 45% and >50% by season end, respectively.", {"entities": []}], ["For NSUAD, dual-therapy prescriptions doubled and triple-therapy prescriptions almost tripled during both seasons.", {"entities": []}], ["Many patients revisited their GP regardless of initial prescription.", {"entities": []}], ["Initial OAH or INS monotherapy provides insufficient symptom control for many AR patients.", {"entities": [[15, 18, "GENE"]]}], ["GPs often prescribe multiple therapies at the start of the season, with co-prescription becoming more common as the season progresses.", {"entities": []}], ["However, patients prescribed multiple therapies frequently revisit their GP, presumably to adjust treatment.", {"entities": []}], ["These data suggest the need for more effective AR treatment and management strategies.", {"entities": []}], ["The Sahel region of West Africa has the highest bacterial meningitis attack and case fatality rate in the world.", {"entities": [[58, 68, "DISEASE"], [48, 68, "DISEASE"]]}], ["The effect of climatic factors on patterns of invasive respiratory bacterial disease is not well documented.", {"entities": []}], ["We aimed to assess the link between climatic factors and occurrence of invasive respiratory bacterial disease in a Sahel region of Niger.", {"entities": []}], ["We conducted daily disease surveillance and climatic monitoring over an 8-year period between January 1, 2003, and December 31, 2010, in Niamey, Niger, to determine risk factors for bacterial meningitis and invasive bacterial disease.", {"entities": [[192, 202, "DISEASE"], [182, 202, "DISEASE"]]}], ["We investigated the mechanistic effects of these factors on Streptococcus pneumoniae infection in mice.", {"entities": []}], ["High temperatures and low visibility (resulting from high concentrations of airborne dust) were identified as significant risk factors for bacterial meningitis.", {"entities": [[149, 159, "DISEASE"], [139, 159, "DISEASE"]]}], ["Dust inhalation or exposure to high temperatures promoted progression of stable asymptomatic pneumococcal nasopharyngeal carriage to pneumonia and invasive disease.", {"entities": [[133, 142, "DISEASE"]]}], ["Dust exposure significantly reduced phagocyte-mediated bacterial killing, and exposure to high temperatures increased release of the key pneumococcal toxin pneumolysin through increased bacterial autolysis.", {"entities": []}], ["Our findings show that climatic factors can have a substantial influence on infectious disease patterns, altering density of pneumococcal nasopharyngeal carriage, reducing phagocytic killing, and resulting in increased inflammation and tissue damage and consequent invasiveness.", {"entities": []}], ["Climatic surveillance should be used to forecast invasive bacterial disease epidemics, and simple control measures to reduce particulate inhalation might reduce the incidence of invasive bacterial disease in regions of the world exposed to high temperatures and increased airborne dust.", {"entities": []}], ["Neurofibrillary tangles, composed of hyperphosphorylated tau fibrils, are a pathological hallmark of Alzheimer's disease; the neurofibrillary tangle load correlates strongly with clinical progression of the disease.", {"entities": []}], ["A growing body of evidence indicates that tau oligomer formation precedes the appearance of neurofibrillary tangles and contributes to neuronal loss.", {"entities": []}], ["Here we show that tau oligomer formation can be inhibited by compounds whose chemical backbone includes 1,2-dihydroxybenzene.", {"entities": []}], ["Specifically, we demonstrate that 1,2-dihydroxybenzene-containing compounds bind to and cap cysteine residues of tau and prevent its aggregation by hindering interactions between tau molecules.", {"entities": []}], ["Further, we show that orally administered DL-isoproterenol, an adrenergic receptor agonist whose skeleton includes 1,2-dihydroxybenzene and which penetrates the brain, reduces the levels of detergent-insoluble tau, neuronal loss and reverses neurofibrillary tangle-associated brain dysfunction.", {"entities": []}], ["Thus, compounds that target the cysteine residues of tau may prove useful in halting the progression of Alzheimer's disease and other tauopathies.", {"entities": []}], ["Aggregation of microtubule associated protein tau is one of cause of neuronal loss in tauopathies including Alzheimer's disease.", {"entities": []}], ["Here, the authors show that compounds with a 1,2-dihydroxybenzene skeleton can modify cysteine residues in tau and block toxic tau aggregation.", {"entities": []}], ["Thomas Land and colleagues show that among Massachusetts Medicaid subscribers, use of a comprehensive tobacco cessation pharmacotherapy benefit was followed by a substantial decrease in claims for hospitalizations for acute myocardial infarction and acute coronary heart disease.", {"entities": [[265, 278, "DISEASE"], [256, 278, "DISEASE"], [224, 245, "DISEASE"], [218, 245, "DISEASE"]]}], ["Insurance coverage of tobacco cessation medications increases their use and reduces smoking prevalence in a population.", {"entities": []}], ["However, uncertainty about the impact of this coverage on health care utilization and costs is a barrier to the broader adoption of this policy, especially by publicly funded state Medicaid insurance programs.", {"entities": []}], ["Whether a publicly funded tobacco cessation benefit leads to decreased medical claims for tobacco-related diseases has not been studied.", {"entities": []}], ["We examined the experience of Massachusetts, whose Medicaid program adopted comprehensive coverage of tobacco cessation medications in July 2006.", {"entities": []}], ["Over 75,000 Medicaid subscribers used the benefit in the first 2.5 years.", {"entities": []}], ["On the basis of earlier secondary survey work, it was estimated that smoking prevalence declined among subscribers by 10% during this period.", {"entities": []}], ["Using claims data, we compared the probability of hospitalization prior to use of the tobacco cessation pharmacotherapy benefit with the probability of hospitalization after benefit use among Massachusetts Medicaid beneficiaries, adjusting for demographics, comorbidities, seasonality, influenza cases, and the implementation of the statewide smoke-free air law using generalized estimating equations.", {"entities": [[286, 295, "DISEASE"]]}], ["Statistically significant annualized declines of 46% (95% confidence interval 2%\u201370%) and 49% (95% confidence interval 6%\u201372%) were observed in hospital admissions for acute myocardial infarction and other acute coronary heart disease diagnoses, respectively.", {"entities": [[221, 234, "DISEASE"], [212, 234, "DISEASE"], [174, 195, "DISEASE"], [168, 195, "DISEASE"]]}], ["There were no significant decreases in hospitalizations rates for respiratory diagnoses or seven other diagnostic groups evaluated.", {"entities": []}], ["Among Massachusetts Medicaid subscribers, use of a comprehensive tobacco cessation pharmacotherapy benefit was associated with a significant decrease in claims for hospitalizations for acute myocardial infarction and acute coronary heart disease, but no significant change in hospital claims for other diagnoses.", {"entities": [[232, 245, "DISEASE"], [223, 245, "DISEASE"], [191, 212, "DISEASE"], [185, 212, "DISEASE"]]}], ["For low-income smokers, removing the barriers to the use of smoking cessation pharmacotherapy has the potential to decrease short-term utilization of hospital services.", {"entities": []}], ["Please see later in the article for the Editors' Summary Smoking is the leading preventable cause of death in the world.", {"entities": []}], ["Globally, it is responsible for one in ten deaths among adults.", {"entities": []}], ["In developed countries, the death toll is even higher\u2014in the USA and the UK, for example, one in five deaths are caused by cigarette smoking.", {"entities": []}], ["In the USA alone, where a fifth of adults smoke, smoking accounts for more than 400,000 deaths every year; globally, smoking causes 5 million deaths per year.", {"entities": []}], ["On average, smokers die 14 years earlier than nonsmokers, and half of all long-term smokers will die prematurely because of a smoking-related disease.", {"entities": []}], ["These diseases include lung cancer, other types of cancer, heart disease, stroke, and lung diseases such as chronic airway obstruction, bronchitis, and emphysema.", {"entities": [[23, 34, "DISEASE"], [59, 72, "DISEASE"], [28, 34, "DISEASE"], [51, 57, "DISEASE"], [136, 146, "DISEASE"]]}], ["And, for every smoker who dies from one of these smoking-related diseases, another 20 will develop at least one serious disease because of their addiction to tobacco.", {"entities": []}], ["About half of US smokers try to quit each year but most of these attempts fail.", {"entities": []}], ["Many experts believe that counseling and/or treatment with tobacco cessation medications such as nicotine replacement products help smokers to quit.", {"entities": []}], ["In the USA, where health care is paid for through private or state health insurance, there is some evidence that insurance coverage of tobacco cessation medications increases their use and reduces smoking prevalence.", {"entities": []}], ["However, smoking cessation treatment is poorly covered by US health insurance programs, largely because of uncertainty about the impact of such coverage on health care costs.", {"entities": []}], ["It is unknown, for example, whether the introduction of publicly funded tobacco cessation benefits decreases claims for treatment for tobacco-related diseases.", {"entities": []}], ["In this longitudinal study (a study that follows a group of individuals over a period of time), the researchers ask whether the adoption of comprehensive coverage of tobacco cessation medications by the Massachusetts Medicaid program (MassHealth) in July 2006 has affected claims for treatment for tobacco-related diseases.", {"entities": []}], ["During its first two and half years, more than 75,000 MassHealth subscribers used the tobacco cessation medication benefit and smoking prevalence among subscribers declined by approximately 10% (38.3% to 28.8%).", {"entities": []}], ["The researchers used MassHealth claims data and a statistical method called generalized estimating equations to compare the probability of hospitalization prior to the use of tobacco cessation medication benefit with the probability of hospitalization after benefit use among MassHealth subscribers.", {"entities": []}], ["After adjusting for other factors that might have affected hospitalization such as influenza outbreaks and the implementation of the Massachusetts Smoke-Free Workplace Law in July 2004, there was a statistically significant annualized decline in hospital admissions for heart attack of 46% after use of the tobacco cessation medication benefit.", {"entities": [[83, 92, "DISEASE"]]}], ["That is, the calculated annual rate of admissions for heart attacks was 46% lower after use of the benefit than before among MassHealth beneficiaries.", {"entities": []}], ["There was also a 49% annualized decline in admissions for coronary atherosclerosis, another smoking-related heart disease.", {"entities": [[67, 82, "DISEASE"], [108, 121, "DISEASE"]]}], ["There were no significant changes in hospitalization rates for lung diseases (including asthma, pneumonia, and chronic airway obstruction) or for seven other diagnostic groups.", {"entities": [[96, 105, "DISEASE"], [88, 94, "DISEASE"]]}], ["These findings show that, among MassHealth subscribers, the use of a tobacco cessation medication benefit was followed by a significant decrease in claims for hospitalization for heart attack and for coronary atherosclerosis but not for other diseases.", {"entities": [[209, 224, "DISEASE"]]}], ["It does not, however, show that the reduced claims for hospitalization were associated with a reduction in smoking because smoking cessation was not recorded by MassHealth.", {"entities": []}], ["Furthermore, it is possible that the people who used the tobacco cessation medication benefit shared other characteristics that reduced their chances of hospitalization for heart disease.", {"entities": [[173, 186, "DISEASE"]]}], ["For example, people using tobacco cessation medication might have been more likely to adhere to prescription schedules for medications such as statins that would also reduce their risk of heart disease.", {"entities": [[188, 201, "DISEASE"]]}], ["Finally, these findings might be unique to Massachusetts, so similar studies need to be undertaken in other states.", {"entities": []}], ["Nevertheless, the results of this study suggest that, for low-income smokers, removing financial barriers to the use of smoking cessation medications has the potential to produce short-term decreases in the use of hospital services that will, hopefully, outweigh the costs of comprehensive tobacco cessation medication benefits.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1000375 .", {"entities": []}], ["The US Centers for Disease Control and Prevention Office on Smoking and Health has information on all aspects of smoking and health, including advice on how to quit The UK National Health Service Choices Web site provides advice about quitting smoking ; more advice on quitting is provided by Smokefree The American Heart Association provides information on heart disease, including advice on how to quit smoking (in several languages) Information about MassHealth is available, including information on smoking and tobacco use prevention", {"entities": [[358, 371, "DISEASE"]]}], ["Clinical practice guidelines (CPGs) recommend pharmacologic treatments for clinical conditions, and drug structured product labels (SPLs) summarize approved treatment indications.", {"entities": []}], ["Both resources are intended to promote evidence-based medical practices and guide clinicians\u2019 prescribing decisions.", {"entities": []}], ["However, it is unclear how well CPG recommendations about pharmacologic therapies match SPL indications for recommended drugs.", {"entities": []}], ["In this study, we perform text mining of CPG summaries to examine drug-disease associations in CPG recommendations and in SPL treatment indications for 15 common chronic conditions.", {"entities": []}], ["We constructed an initial text corpus of guideline summaries from the National Guideline Clearinghouse (NGC) from a set of manually selected ICD-9 codes for each of the 15 conditions.", {"entities": []}], ["We obtained 377 relevant guideline summaries and their Major Recommendations section, which excludes guidelines for pediatric patients, pregnant or breastfeeding women, or for medical diagnoses not meeting inclusion criteria.", {"entities": []}], ["A vocabulary of drug terms was derived from five medical taxonomies.", {"entities": []}], ["We used named entity recognition, in combination with dictionary-based and ontology-based methods, to identify drug term occurrences in the text corpus and construct drug-disease associations.", {"entities": []}], ["The ATC (Anatomical Therapeutic Chemical Classification) was utilized to perform drug name and drug class matching to construct the drug-disease associations from CPGs.", {"entities": []}], ["We then obtained drug-disease associations from SPLs using conditions mentioned in their Indications section in SIDER.", {"entities": []}], ["The primary outcomes were the frequency of drug-disease associations in CPGs and SPLs, and the frequency of overlap between the two sets of drug-disease associations, with and without using taxonomic information from ATC.", {"entities": []}], ["Without taxonomic information, we identified 1444 drug-disease associations across CPGs and SPLs for 15 common chronic conditions.", {"entities": []}], ["Of these, 195 drug-disease associations overlapped between CPGs and SPLs, 917 associations occurred in CPGs only and 332 associations occurred in SPLs only.", {"entities": []}], ["With taxonomic information, 859 unique drug-disease associations were identified, of which 152 of these drug-disease associations overlapped between CPGs and SPLs, 541 associations occurred in CPGs only, and 166 associations occurred in SPLs only.", {"entities": []}], ["Our results suggest that CPG-recommended pharmacologic therapies and SPL indications do not overlap frequently when identifying drug-disease associations using named entity recognition, although incorporating taxonomic relationships between drug names and drug classes into the approach improves the overlap.", {"entities": []}], ["This has important implications in practice because conflicting or inconsistent evidence may complicate clinical decision making and implementation or measurement of best practices.", {"entities": []}], ["One of the unmet needs for asthma management is a new therapeutic agent with both anti-inflammatory and anti-smooth muscle (ASM) remodeling effects.", {"entities": [[27, 33, "DISEASE"]]}], ["The mannose receptor (MR) family plays an important role in allergen uptake and processing of major allergens Der p 1 and Fel d 1.", {"entities": []}], ["We have previously reported that ASM cells express a mannose receptor (ASM-MR) and that mannan derived from Saccharomyces cerevisiae (SC-MN) inhibits mannosyl-rich lysosomal hydrolase-induced bovine ASM cell proliferation.", {"entities": []}], ["Using a humanized transgenic mouse strain (huASM-MRC2) expressing the human MRC2 receptor in a SM tissue-specific manner, we have demonstrated that ASM hyperplasia/hypertrophy can occur as early as 15 days after allergen challenge in this mouse model and this phenomenon is preventable with SC-MN treatment.", {"entities": [[49, 53, "GENE"], [76, 80, "GENE"]]}], ["This proof-of-concept study would facilitate future development of a potential asthma therapeutic agent with dual function of anti-inflammatory and anti-smooth muscle remodeling effects.", {"entities": [[79, 85, "DISEASE"]]}], ["The 21 The conferences were organized with a focus on antibody engineering only on the first day and a joint engineering/therapeutics session on the last day.", {"entities": []}], ["Delegates could select from presentations that occurred in two simultaneous sessions on days 2 and 3.", {"entities": []}], ["Day 1 included presentations on neutralizing antibodies and the identification of vaccine targets, as well as a historical overview of 20 years of phage display utilization.", {"entities": []}], ["Topics presented in the Antibody Engineering sessions on day 2 and 3 included antibody biosynthesis, structure and stability; antibodies in a complex environment; antibody half-life; and targeted nanoparticle therapeutics.", {"entities": []}], ["In the Antibody Therapeutics sessions on days 2 and 3, preclinical and early stage development and clinical updates of antibody therapeutics, including TRX518, SYM004, MM111, PRO140, CVX-241, ASG-5ME, U3-1287 (AMG888), R1507 and trastuzumab emtansine, were discussed and perspectives were provided on the development of biosimilar and biobetter antibodies, including coverage of regulatory and intellectual property issues.", {"entities": []}], ["The joint engineering/therapeutics session on the last day focused on bispecific and next-generation antibodies.", {"entities": []}], ["Summaries of most of the presentations are included here, but, due to the large number of speakers, it was not possible to include summaries for every presentation.", {"entities": []}], ["Delegates enjoyed the splendid views of the San Diego Bay and proximity to the Gaslamp Quarter provided by the venue.", {"entities": []}], ["The history of residential schools has been identified as having long lasting and intergenerational effects on the physical and mental well-being of Indigenous populations in Canada.", {"entities": []}], ["Our objective was to identify the extent and range of research on residential school attendance on specific health outcomes and the populations affected.", {"entities": []}], ["A scoping review of the empirical peer-reviewed literature was conducted, following the methodological framework of Arksey and O\u2019Malley (2005).", {"entities": []}], ["For this review, nine databases were used: Bibliography of Native North Americans, Canadian Health Research Collection, CINAHL, Google Scholar, Indigenous Studies Portal, PubMed, Scopus, Statistics Canada, and Web of Science.", {"entities": []}], ["Citations that did not focus on health and residential school among a Canadian Indigenous population were excluded.", {"entities": []}], ["Papers were coded using the following categories: Indigenous identity group, geography, age-sex, residential school attendance, and health status.", {"entities": []}], ["Sixty-one articles were selected for inclusion in the review.", {"entities": []}], ["Most focused on the impacts of residential schooling among First Nations, but some included M\u00e9tis and Inuit.", {"entities": []}], ["Physical health outcomes linked to residential schooling included poorer general and self-rated health, increased rates of chronic and infectious diseases.", {"entities": []}], ["Effects on mental and emotional well-being included mental distress, depression, addictive behaviours and substance mis-use, stress, and suicidal behaviours.", {"entities": []}], ["The empirical literature can be seen as further documenting the negative health effects of residential schooling, both among former residential school attendees and subsequent generations.", {"entities": []}], ["Future empirical research should focus on developing a clearer understanding of the aetiology of these effects, and particularly on identifying the characteristics that lead people and communities to be resilient to them.", {"entities": []}], ["There is growing interest in quantifying vascular cell and tissue stiffness.", {"entities": []}], ["Most measurement approaches, however, are incapable of assessing stiffness in the presence of physiological flows.", {"entities": []}], ["We developed a microfluidic approach which allows measurement of shear modulus ( G ) during flow.", {"entities": []}], ["The design included a chamber with glass windows allowing imaging with upright or inverted microscopes.", {"entities": []}], ["Flow was controlled gravitationally to push culture media through the chamber.", {"entities": []}], ["Fluorescent beads were conjugated to the sample surface and imaged before and during flow.", {"entities": []}], ["Bead displacements were calculated from images and G was computed as the ratio of imposed shear stress to measured shear strain.", {"entities": []}], ["Fluid-structure simulations showed that shear stress on the surface did not depend on sample stiffness.", {"entities": []}], ["Our approach was verified by measuring the moduli of polyacrylamide gels of known stiffness.", {"entities": []}], ["In human\u00a0pulmonary microvascular endothelial cells, G was 20.4\u2009\u00b1\u200912\u2009Pa and decreased by 20% and 22% with increasing shear stress and inhibition of non-muscle myosin II motors, respectively.", {"entities": []}], ["The G showed a larger intra- than inter-cellular variability and it was mostly determined by the cytosol.", {"entities": []}], ["Our shear modulus microscopy can thus map the spatial distribution of G of soft materials including gels, cells and tissues while allowing the visualization of microscopic structures such as the cytoskeleleton.", {"entities": []}], ["Medication nonadherence is a major obstacle to better control of glucose, blood pressure (BP), and LDL cholesterol in adults with diabetes.", {"entities": []}], ["Inexpensive effective strategies to increase medication adherence are needed.", {"entities": []}], ["In a pragmatic randomized trial, we randomly assigned 2,378 adults with diabetes mellitus who had recently been prescribed a new class of medication for treating elevated levels of glycated hemoglobin (A1C) \u22658% (64 mmol/mol), BP \u2265140/90 mmHg, or LDL cholesterol \u2265100 mg/dL, to receive 1 ) one scripted telephone call from a diabetes educator or clinical pharmacist to identify and address nonadherence to the new medication or 2 ) usual care.", {"entities": [[72, 89, "DISEASE"]]}], ["Hierarchical linear and logistic regression models were used to assess the impact on 1 ) the first medication fill within 60 days of the prescription; 2 ) two or more medication fills within 180 days of the prescription; and 3 ) clinically significant improvement in levels of A1C, BP, or LDL cholesterol.", {"entities": []}], ["Of the 2,378 subjects, 89.3% in the intervention group and 87.4% in the usual-care group had sufficient data to analyze study outcomes.", {"entities": []}], ["In intent-to-treat analyses, intervention was not associated with significant improvement in primary adherence, medication persistence, or intermediate outcomes of care.", {"entities": []}], ["Results were similar across subgroups of patients defined by age, sex, race/ethnicity, and study site, and when limiting the analysis to those who completed the intended intervention.", {"entities": []}], ["This low-intensity intervention did not significantly improve medication adherence or control of glucose, BP, or LDL cholesterol.", {"entities": []}], ["Wide use of this strategy does not appear to be warranted; alternative approaches to identify and improve medication adherence and persistence are needed.", {"entities": []}], ["The involvement of secretoglobins (SCGBs) other than SCGB1A1 (Clara cell 10-kDa protein, CC10) in human airway diseases remains unexplored.", {"entities": [[53, 60, "GENE"]]}], ["Among those SCGBs, SCGB3A2 (uteroglobin-related protein 1, UGRP1) is particularly interesting, given its structure and function similarities with SCGB1A1 (CC10).", {"entities": [[19, 26, "GENE"], [146, 153, "GENE"]]}], ["The aim of this study was to investigate the expression regulation of SCGBs other than SCGB1A1 (CC10) in human upper airway, and their potential involvement, particularly that of SCGB3A2 (UGRP1), in chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP).", {"entities": [[87, 94, "GENE"], [179, 186, "GENE"]]}], ["Eight SCGB family members including SCGB3A2 (UGRP1), SCGB1C1 (ligand binding protein RYD5), SCGB1D1 (lipophilin A), SCGB1D2 (lipophilin B), SCGB1D4 (interferon-\u03b3 inducible SCGB), SCGB2A1 (mammaglobin 2), SCGB2A2 (mammaglobin 1), and SCGB3A1 (uteroglobin-related protein 2) were studied.", {"entities": [[36, 43, "GENE"], [53, 60, "GENE"], [92, 99, "GENE"], [116, 123, "GENE"], [140, 147, "GENE"], [179, 186, "GENE"], [204, 211, "GENE"], [233, 240, "GENE"]]}], ["The regulation of SCGBs mRNA expression in normal nasal mucosa by proinflammatory, Th1, and Th2 cytokines was studied through nasal explant culture.", {"entities": []}], ["SCGBs mRNA expression levels in CRSsNP and CRSwNP patients and controls were compared.", {"entities": []}], ["The mRNA levels were detected by means of quantitative reverse transcriptase-polymerase chain reaction.", {"entities": []}], ["The protein expression of SCGB3A2 (UGRP1) was analyzed using immunohistochemistry.", {"entities": [[26, 33, "GENE"]]}], ["The expression of SCGBs except SCGB1D2 (lipophilin B) could be found in upper airway and be differentially regulated by different cytokines.", {"entities": [[31, 38, "GENE"]]}], ["SCGB3A2 (UGRP1) mRNA expression was induced by Th1 cytokine, but suppressed by proinflammatory and Th2 cytokines.", {"entities": [[0, 7, "GENE"]]}], ["SCGBs mRNA expression was altered in CRS; particularly, SCGB3A2 (UGRP1) protein and mRNA expression was markedly decreased in both CRSsNP and CRSwNP and its protein levels inversely correlated with the number of total infiltrating cells, preoperative sinonasal CT scores, and postoperative endoscopy and symptom scores.", {"entities": [[56, 63, "GENE"]]}], ["SCGBs except SCGB1D2 (lipophilin B) are expressed in human upper airway and their expression can be differentially regulated by inflammatory cytokines.", {"entities": [[13, 20, "GENE"]]}], ["SCGBs mRNA expression is altered in CRS.", {"entities": []}], ["Reduced production of UGRP1, which is likely due, at least in part, to a local cytokine environment, may contribute to the hyper-inflammation in CRS and correlates with response to surgery.", {"entities": []}], ["There is abundant evidence that low socioeconomic status (SES) is associated with worse health outcomes among people with Rheumatoid Arthritis (RA); however, the influence of socioeconomic disadvantage in early life has yet to be studied within that population.", {"entities": []}], ["Data originated from the cross-sectional arm of the Consortium Evaluation of African-Americans with Rheumatoid Arthritis (CLEAR II), which recruited African-Americans with RA from six sites in the Southeastern United States.", {"entities": []}], ["We used linear regression models to evaluate associations of parental homeownership status and educational level at participant time of birth with participant-reported fatigue (Visual Analog scale, cm), pain (Visual Analog scale, cm), disability (Health Assessment Questionnaire) and helplessness (Rheumatology Attitudes Index), independently of participant homeownership status and educational level.", {"entities": []}], ["Models included random effects to account for intra-site correlations, and were adjusted for variables identified using backward selection, from: age, disease-duration, sex, medication use, body-mass index, smoking history.", {"entities": []}], ["Our sample included 516 CLEAR II participants with full data on demographics and covariates.", {"entities": []}], ["89\u00a0% of participants were women, the mean age was 54.7\u00a0years and mean disease duration was 10.8\u00a0years.", {"entities": []}], ["In age adjusted models, parental non-homeownership was associated with greater fatigue (\u03b2\u2009=\u20090.75, 95\u00a0% CI\u2009=\u20090.36\u20131.14), disability (\u03b2\u2009=\u20090.12, 95\u00a0% CI\u2009=\u20090.04\u20130.19) and helplessness (\u03b2\u2009=\u20090.12, 95\u00a0% CI\u2009=\u20090.03\u20130.21), independently of participant homeownership and education; parental education had a further small influence on self-reported fatigue (\u03b2\u2009=\u20090.20, 95\u00a0% CI\u2009=\u20090.15\u20130.24).", {"entities": []}], ["Parental homeownership, and to a small extent parental education, had modest but meaningful relationships with self-reported health among CLEAR II participants.", {"entities": []}], ["The online version of this article (doi:10.1186/s12891-016-0882-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study describes specific patterns of elevated inflammatory proteins in clinical subtypes of myasthenia gravis (MG) patients.", {"entities": [[97, 114, "DISEASE"]]}], ["MG is a chronic, autoimmune neuromuscular disease with antibodies most commonly targeting the acetylcholine receptors (AChRab), which causes fluctuating skeletal muscle fatigue.", {"entities": [[28, 49, "DISEASE"]]}], ["MG pathophysiology includes a strong component of inflammation, and a large proportion of patients with early onset MG additionally present thymus hyperplasia.", {"entities": []}], ["Due to the fluctuating nature and heterogeneity of the disease, there is a great need for objective biomarkers as well as novel potential inflammatory targets.", {"entities": []}], ["We examined the sera of 45 MG patients (40 AChRab seropositive and 5 AChRab seronegative), investigating 92 proteins associated with inflammation.", {"entities": []}], ["Eleven of the analysed proteins were significantly elevated compared to healthy controls, out of which the three most significant were: matrix metalloproteinase 10 (MMP-10; p\u2009=\u20090.0004), transforming growth factor alpha (TGF-\u03b1; p\u2009=\u20090.0017) and extracellular newly identified receptor for advanced glycation end-products binding protein (EN-RAGE) (also known as protein S100-A12; p\u2009=\u20090.0054).", {"entities": []}], ["Further, levels of MMP-10, C-X-C motif ligand 1 (CXCL1) and brain derived neurotrophic factor (BDNF) differed between early and late onset MG.", {"entities": [[49, 54, "GENE"], [95, 99, "GENE"]]}], ["These novel targets provide valuable additional insight into the systemic inflammatory response in MG.", {"entities": []}], ["Given the increasing importance of patient-reported outcomes (PRO) in quality medical care, we examined the value and feasibility of an innovative method for assessing patients\u2019 illness perceptions, represented in drawings made by patients with COPD of their lungs.", {"entities": []}], ["The aim of our study was: to study patients\u2019 representation of COPD as reflected in their drawings of their lungs; and to examine scores on a validated measure that assesses illness perceptions (ie, Brief Illness Perception Questionnaire [B-IPQ]).", {"entities": []}], ["One hundred outpatients with COPD, mean age 70 years, selected from a pharmacy database, participated and 98 filled out the B-IPQ.", {"entities": []}], ["Eighty-seven patients completed the drawing task.", {"entities": []}], ["The illness perceptions as reflected in the responses to the B-IPQ scales represented a quite optimistic view of COPD and its consequences.", {"entities": []}], ["The drawings of the lungs reflected a considerable discordance between patients\u2019 representations and medically accepted representations of lungs of a person with COPD.", {"entities": []}], ["Assessing illness perceptions in clinical care and research about COPD offers opportunities to identify goals for patient education and self-management.", {"entities": []}], ["Inviting patients to draw their illness is an innovative and promising approach to assessing PRO.", {"entities": []}], ["Reducing maternal mortality remains a major challenge for health care systems worldwide.", {"entities": []}], ["The factors related to maternal mortality were extensively researched, and maternal death clusters around labour, delivery and the immediate postpartum period.", {"entities": []}], ["Studies on the quality of maternal care in academic medical centre settings in low income countries are uncommon.", {"entities": []}], ["A retrospective cohort study of maternal deaths was conducted in an academic public tertiary hospital in Yogyakarta, and maternal near misses were used as controls.", {"entities": []}], ["Data were obtained from medical records from February 1, 2011 to September 30, 2012.", {"entities": []}], ["Three groups of variables were measured: (1) timeliness of care, (2) adherence to a standard of process indicators, and (3) associated extraneous variables.", {"entities": []}], ["Variables were analysed using logistic regression to explore their effects on maternal mortality.", {"entities": []}], ["The mean of triage response time and obstetric resident response time were longer in maternal deaths (8\u2009\u00b1\u20093.59 and 36.17\u2009\u00b1\u200923.48\u00a0min respectively) compared to near misses (1.29\u2009\u00b1\u20090.24 and 18.78\u2009\u00b1\u20094.85\u00a0min respectively).", {"entities": []}], ["Near misses more frequently received oxytocin treatment than the maternal deaths (OR 0.13; 95%CI 0.02\u20130.77).", {"entities": []}], ["Magnesium sulfate treatment in severe-preeclampsia or eclampsia was less given in maternal deaths although insignificant statistically (OR 0.19; 95% CI 0.03\u20131.47).", {"entities": [[54, 63, "DISEASE"]]}], ["Prophylactic antibiotic was also more frequently given in near misses than in maternal deaths though insignificant statistically (OR 0.3; 95% CI 0.06\u20131.56).", {"entities": []}], ["Extraneous variables, such as caesarean sections were less performed in maternal deaths (OR 0.15; 95% CI 0.04\u20130.51), vaginal deliveries were more frequent in maternal deaths (OR 3.47; 95% CI 1.05\u201311.54), and more women in near misses were referred from other health care facilities (OR 0.09; 95% CI 0.01\u20130.91).", {"entities": []}], ["The near misses had relatively received better quality of care compared to the maternal deaths.", {"entities": []}], ["The near misses had received faster response time and better treatments.", {"entities": []}], ["Timely referral systems enabled benefits to prevent maternal death.", {"entities": []}], ["Forced expiratory volume in one second (FEV 1 ) is used to diagnose and establish a prognosis in chronic obstructive pulmonary disease (COPD).", {"entities": [[97, 134, "DISEASE"], [40, 43, "GENE"]]}], ["Using multi-dimensional scores improves this predictive capacity.Two instruments, the BODE-index ( B ody mass index, O bstruction, D yspnea, E xercise capacity) and the HADO-score ( H ealth, A ctivity, D yspnea, O bstruction), were compared in the prediction of mortality among COPD patients.", {"entities": []}], ["This is a prospective longitudinal study.", {"entities": []}], ["During one year (2003 to 2004), 543 consecutively COPD patients were recruited in five outpatient clinics and followed for three years.", {"entities": []}], ["The endpoints were all-causes and respiratory mortality.", {"entities": []}], ["In the multivariate analysis of patients with FEV 1 < 50%, no significant differences were observed in all-cause or respiratory mortality across HADO categories, while significant differences were observed between patients with a lower BODE (less severe disease) and those with a higher BODE (greater severity).", {"entities": [[46, 49, "GENE"]]}], ["Among patients with FEV 1 \u2265 50%, statistically significant differences were observed across HADO categories for all-cause and respiratory mortality, while differences were observed across BODE categories only in all-cause mortality.", {"entities": [[20, 23, "GENE"]]}], ["HADO-score and BODE-index were good predictors of all-cause and respiratory mortality in the entire cohort.", {"entities": []}], ["In patients with severe COPD (FEV 1 < 50%) the BODE index was a better predictor of mortality whereas in patients with mild or moderate COPD (FEV 1 \u2265 50%), the HADO-score was as good a predictor of respiratory mortality as the BODE-index.", {"entities": [[30, 33, "GENE"], [142, 145, "GENE"], [30, 33, "GENE"], [142, 145, "GENE"]]}], ["These differences suggest that the HADO-score and BODE-index could be used for different patient populations and at different healthcare levels, but can be used complementarily.", {"entities": []}], ["Out-of-pocket (OOP) medical expenses often lead to catastrophic expenditure and impoverishment in low- and middle-income countries.", {"entities": []}], ["Yet, there has been no systematic examination of which specific diseases and conditions (e.g., tuberculosis, cardiovascular disease) drive medical impoverishment, defined as OOP direct medical costs pushing households into poverty.", {"entities": [[95, 107, "DISEASE"]]}], ["We used a cost and epidemiological model to propose an assessment of the burden of medical impoverishment in Ethiopia, i.e., the number of households crossing a poverty line due to excessive OOP direct medical expenses.", {"entities": []}], ["We utilized disease-specific mortality estimates from the Global Burden of Disease study, epidemiological and cost inputs from surveys, and secondary data from the literature to produce a count of poverty cases due to OOP direct medical costs per specific condition.", {"entities": []}], ["In Ethiopia, in 2013, and among 20 leading causes of mortality, we estimated the burden of impoverishment due to OOP direct medical costs to be of about 350,000 poverty cases.", {"entities": []}], ["The top three causes of medical impoverishment were diarrhea, lower respiratory infections, and road injury, accounting for 75\u00a0% of all poverty cases.", {"entities": [[52, 60, "DISEASE"]]}], ["We present a preliminary attempt for the estimation of the burden of medical impoverishment by cause for high mortality conditions.", {"entities": []}], ["In Ethiopia, medical impoverishment was notably associated with illness occurrence and health services utilization.", {"entities": []}], ["Although currently used estimates are sensitive to health services utilization, a systematic breakdown of impoverishment due to OOP direct medical costs by cause can provide important information for the promotion of financial risk protection and equity, and subsequent design of health policies toward universal health coverage, reduction of direct OOP payments, and poverty alleviation.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-016-0697-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Using geographic information systems (GIS) and routinely collected data, we explored whether childhood residence near busy roads was associated with asthma in a low-income population in San Diego County, California.", {"entities": [[149, 155, "DISEASE"]]}], ["We examined the locations of residences of 5,996 children [less than/equal to] 14 years of age who were diagnosed with asthma in 1993 and compared them to a random control series of nonrespiratory diagnoses (n = 2,284).", {"entities": [[119, 125, "DISEASE"]]}], ["Locations of the children's residences were linked to traffic count data at streets within 550 ft. We also examined the number of medical care visits in 1993 for children with asthma to determine if the number of visits was related to traffic flow.", {"entities": [[176, 182, "DISEASE"]]}], ["Analysis of the distribution of cases and controls by quintiles and by the 90th, 95th, and 99th percentiles of traffic flow at the highest traffic street, nearest street, and total of all streets within a 550-ft buffer region did not show any significantly elevated odds ratios.", {"entities": []}], ["However, among cases, those residing near high traffic flows (measured at the nearest street) were more likely than those residing near lower traffic flows to have two or more medical care visits for asthma than to have only one visit for asthma during the year.", {"entities": [[200, 206, "DISEASE"], [239, 245, "DISEASE"]]}], ["The results of this exploratory study suggest that higher traffic flows may be related to an increase in repeated medical visits for asthmatic children.", {"entities": []}], ["Repeated exposure to particulate matter and other air pollutants from traffic exhaust may aggravate asthmatic symptoms in individuals already diagnosed with asthma.", {"entities": [[157, 163, "DISEASE"]]}], ["While constantly rising, the prevalence of allergies is globally one of the highest among chronic diseases.", {"entities": []}], ["Current treatments of allergic diseases include the application of anti-histamines, immunotherapy, steroids, and anti-immunoglobulin E (IgE) antibodies.", {"entities": []}], ["Here we report mammalian cells engineered with a synthetic signaling cascade able to monitor extracellular pathophysiological levels of interleukin 4 and interleukin 13, two main cytokines orchestrating allergic inflammation.", {"entities": []}], ["Upon activation of transgenic cells by these cytokines, designed ankyrin repeat protein (DARPin) E2_79, a non-immunogenic protein binding human IgE, is secreted in a precisely controlled and reversible manner.", {"entities": []}], ["Using human whole blood cell culturing, we demonstrate that the mammalian dual T helper 2 cytokine sensor produces sufficient levels of DARPin E2_79 to dampen histamine release in allergic subjects exposed to allergens.", {"entities": []}], ["Hence, therapeutic gene networks monitoring disease-associated cytokines coupled with in situ production, secretion and systemic delivery of immunomodulatory biologics may foster advances in the treatment of allergies.", {"entities": []}], ["The standard treatment for an allergic response is anti-histamines, steroids and anti-IgE antibodies.", {"entities": []}], ["Here the authors present a genetic circuit that senses IL-4 and IL-13 and responses with DARPin production to bind IgE.", {"entities": []}], ["We designed and validated a rule-based expert system to identify influenza like illness (ILI) from routinely recorded general practice clinical narrative to aid a larger retrospective research study into the impact of the 2009 influenza pandemic in New Zealand.", {"entities": [[65, 74, "DISEASE"], [227, 236, "DISEASE"]]}], ["Rules were assessed using pattern matching heuristics on routine clinical narrative.", {"entities": []}], ["The system was trained using data from 623 clinical encounters and validated using a clinical expert as a gold standard against a mutually exclusive set of 901 records.", {"entities": []}], ["We calculated a 98.2\u00a0% specificity and 90.2\u00a0% sensitivity across an ILI incidence of 12.4\u00a0% measured against clinical expert classification.", {"entities": []}], ["Peak problem list identification of ILI by clinical coding in any month was 9.2\u00a0% of all detected ILI presentations.", {"entities": []}], ["Our system addressed an unusual problem domain for clinical narrative classification; using notational, unstructured, clinician entered information in a community care setting.", {"entities": []}], ["It performed well compared with other approaches and domains.", {"entities": []}], ["It has potential applications in real-time surveillance of disease, and in assisted problem list coding for clinicians.", {"entities": []}], ["Our system identified ILI presentation with sufficient accuracy for use at a population level in the wider research study.", {"entities": []}], ["The peak coding of 9.2\u00a0% illustrated the need for automated coding of unstructured narrative in our study.", {"entities": []}], ["Urotensin II (UII) is a potent vasoconstrictor peptide, which signals through a G-protein coupled receptor (GPCR) known as GPR14 or urotensin receptor (UTR).", {"entities": []}], ["UII exerts a broad spectrum of actions in several systems such as vascular cell, heart muscle or pancreas, where it inhibits insulin release.", {"entities": []}], ["Given the reported role of UII in insulin secretion, we have performed a genetic association analysis of the UTS2 gene and flanking regions with biochemical parameters related to insulin resistance (fasting glucose, glucose 2 hours after a glucose overload, fasting insulin and insulin resistance estimated as HOMA).", {"entities": [[109, 113, "GENE"]]}], ["We have identified several polymorphisms associated with the analysed clinical traits, not only at the UTS2 gene, but also in thePER3 gene, located upstream from UTS2.", {"entities": [[103, 107, "GENE"], [162, 166, "GENE"], [103, 107, "GENE"], [162, 166, "GENE"]]}], ["Our results are compatible with a role for UII in glucose homeostasis and diabetes although we cannot rule out the possibility that PER3 gene may underlie the reported associations.", {"entities": [[132, 136, "GENE"]]}], ["The purpose was to analyse the properties of two models for the assessment of return to work after sickness certification, a manual one based on clinical judgement including non-measurable information (\u2018gut feeling\u2019), and a computer-based one.", {"entities": []}], ["All subjects aged 18 to 63 years, sickness-certified at a primary health care centre in Sweden during 8 months ( n = 943), and followed up for 3 years.", {"entities": []}], ["Baseline information included age, sex, occupational status, sickness certification diagnosis, full-time or part-time current sick-leave, and sick-leave days during the past year.", {"entities": []}], ["Follow-up information included first and last day of each occurring sick spell.", {"entities": []}], ["In the manual model all subjects were classified, based on baseline information and gut feeling, into a high-risk ( n = 447) or a low-risk group ( n = 496) regarding not returning to work when the present certificate expired.", {"entities": []}], ["It was evaluated with a Cox\u2019s analysis, including time and return to work as dependent variables and risk group assignment as the independent variable, while in the computer-based model the baseline variables were entered as independent variables.", {"entities": []}], ["Concordance between actual return to work and return to work predicted by the analysis model was 73%\u201376% during the first 28\u2013180 days in the manual model, and approximately 10% units higher in the computer-based model.", {"entities": []}], ["Based on the latter, three nomograms were constructed providing detailed information on the probability of return to work.", {"entities": []}], ["The computer-based model had a higher precision and gave more detailed information than the manual model.", {"entities": []}], ["The syndromic primary immunodeficiencies are disorders in which not only the immune system but also other organ systems are affected.", {"entities": []}], ["Other features most commonly involve the ectodermal, skeletal, nervous, and gastrointestinal systems.", {"entities": []}], ["Key in identifying syndromic immunodeficiencies is the awareness that increased susceptibility to infections or immune dysregulation in a patient known to have other symptoms or special features may hint at an underlying genetic syndrome.", {"entities": [[229, 237, "DISEASE"]]}], ["Because the extraimmune clinical features can be highly variable, it is more difficult establishing the correct diagnosis.", {"entities": []}], ["Nevertheless, correct diagnosis at an early age is important because of the possible treatment options.", {"entities": []}], ["Therefore, diagnostic work-up is best performed in a center with extensive expertise in this field, having immunologists and clinical geneticists, as well as adequate support from a specialized laboratory at hand.", {"entities": []}], ["This paper provides the general pediatrician with the main clinical features that are crucial for the recognition of these syndromes.", {"entities": []}], ["To study the influence of adolescence characteristics on asthma management.", {"entities": [[57, 63, "DISEASE"]]}], ["This was a qualitative study conducted in the city of Divin\u00f3polis, Minas Gerais, Southeast Brazil.", {"entities": []}], ["Data were collected through semistructured interviews guided by a questionnaire with seven asthmatic adolescents followed-up in the primary public health care service of the city.", {"entities": []}], ["Using content analysis, three thematic categories were observed in the adolescents' responses: 1) family relationships in the treatment of asthma in adolescence; 2) the asthmatic adolescents and their peers; and 3) the role of the school for the asthmatic adolescents.", {"entities": [[139, 145, "DISEASE"]]}], ["The results demonstrated that peers, family, and school should be more valued by health professionals and by health care services when treating asthmatic adolescents, as these social relationships are closely associated with the adolescent and have an important role in asthma management.", {"entities": [[270, 276, "DISEASE"]]}], ["Attempts to meet the demands of adolescents contribute to improve asthma management.", {"entities": [[66, 72, "DISEASE"]]}], ["Conhecer a influ\u00eancia das caracter\u00edsticas da fase da adolesc\u00eancia no manejo da asma.", {"entities": []}], ["Trata-se de um estudo descritivo de abordagem qualitativa realizado no munic\u00edpio de Divin\u00f3polis, regi\u00e3o centro-oeste de Minas Gerais.", {"entities": []}], ["Os dados foram coletados por meio de entrevistas semiestruturadas orientadas por um roteiro de perguntas junto a sete adolescentes asm\u00e1ticos atendidos na rede de aten\u00e7\u00e3o prim\u00e1ria \u00e0 sa\u00fade municipal.", {"entities": [[25, 28, "GENE"], [77, 80, "GENE"], [25, 28, "GENE"], [77, 80, "GENE"]]}], ["Por meio da an\u00e1lise de conte\u00fado na modalidade tem\u00e1tica foram constru\u00eddas tr\u00eas categorias anal\u00edticas: 1) As rela\u00e7\u00f5es familiares no tratamento da asma na adolesc\u00eancia; 2) O adolescente asm\u00e1tico e seu grupo; e 3) O papel da escola junto aos adolescentes asm\u00e1ticos.", {"entities": [[0, 3, "GENE"]]}], ["Os resultados mostraram que o grupo de pares, a fam\u00edlia e a escola devem ser mais valorizados pelos profissionais e pelos servi\u00e7os de sa\u00fade, pois essas inst\u00e2ncias se relacionam intimamente com o adolescente e t\u00eam pap\u00e9is importantes no tratamento da asma.", {"entities": []}], ["A tentativa de atender \u00e0s demandas do adolescente contribui para a melhoria do manejo da asma.", {"entities": []}], ["Cystic fibrosis (CF) lung disease is characterized by persistent inflammation.", {"entities": [[0, 15, "DISEASE"], [21, 33, "DISEASE"]]}], ["Antiinflammatory drugs, such as corticosteroids and ibuprofen, have proved to slow the decline of pulmonary function although their use is limited because of frequent adverse events.", {"entities": []}], ["We hypothesized that colchicine could be an alternative treatment because of its antiinflammatory properties and upregulatory effect on cystic fibrosis transmembrane regulator (CFTR) closely related proteins.", {"entities": [[136, 151, "DISEASE"], [177, 181, "GENE"]]}], ["We herein present results obtained in an open study of eight CF children treated with colchicine for at least 6 months.", {"entities": []}], ["Clinical status was better in all patients and respiratory function tests significantly improved in five.", {"entities": []}], ["Median duration of antibiotherapy decreased significantly.", {"entities": []}], ["These preliminary results support our hypothesis of a beneficial effect of colchicine in CF patients and stress the need for a controlled therapeutic trial.", {"entities": []}], ["Sleep deprivation is common in critically ill patients in intensive care units (ICU).", {"entities": []}], ["It can result in delirium, difficulty weaning, repeated nosocomial infections, prolonged ICU length of stay and increased ICU mortality.", {"entities": []}], ["Melatonin, a physiological sleep regulator, is well known to benefit sleep quality in certain people, but evidence for the effectiveness in ICU sleep disturbance is limited.", {"entities": []}], ["This study has a prospective, randomized, double-blind, controlled, parallel-group design.", {"entities": []}], ["Eligible patients are randomly assigned to one of the two treatment study groups, labelled the \u2018melatonin group\u2019 or the \u2018placebo group\u2019.", {"entities": []}], ["A dose of 3\u00a0mg of oral melatonin or placebo is administered at 9:00\u00a0pm on four consecutive days.", {"entities": []}], ["Earplugs and eye masks are made available to every participant.", {"entities": []}], ["We plan to enrol 198 patients.", {"entities": []}], ["The primary outcome is the objective sleep quality measured by the 24-hour polysomnography.", {"entities": []}], ["The secondary outcomes are the subjective sleep quality assessed by the Richards Campbell Sleep Questionnaire, the anxiety level evaluated by the Visual Analogue Scale-Anxiety, the number of delirium-free days in 8 and 28\u00a0days, the number of ventilation-free days in 28\u00a0days, the number of antibiotic-free days, ICU length of stay, the overall ICU mortality in 28\u00a0days and the incidence and severity of the side effects of melatonin in ICU patients.", {"entities": []}], ["Additionally, the body stress levels, oxidative stress levels and inflammation levels are obtained via measuring the plasma melatonin, cortisone, norepinephrine, malonaldehyde(MDA), superoxide dismutase(SOD), interleukin-6 (IL-6) and interleukin-8 (IL-8)concentrations.", {"entities": []}], ["The proposed study will be the first randomized controlled study to use the polysomnography, which is the gold standard of assessing sleep quality, to evaluate the effect of melatonin on the sleep quality and circadian rhythms of ICU patients.", {"entities": []}], ["The results may recommend a new treatment for ICU patients with sleep deprivation that is safe, effective and easily implementable in daily practice.", {"entities": []}], ["This study was registered with ClinicalTrials (NCT; registration number: ChiCTR-TRC-14004319 ) on 4 March 2013.", {"entities": []}], ["To evaluate the efficacy of using topical cyclosporin A 0.05% (Restasis) for the treatment of paediatric allergic conjunctivitis.", {"entities": [[105, 128, "DISEASE"], [114, 128, "DISEASE"]]}], ["This retrospective study included consecutive cases of paediatric allergic conjunctivitis treated with Restasis between 2010 and 2013.", {"entities": [[66, 89, "DISEASE"], [75, 89, "DISEASE"]]}], ["Subjects with follow-up time less than 3 months after using Restasis were excluded.", {"entities": []}], ["Itch severity score, symptom score, and sign score were compared before (baseline) and 3 months after using Restasis.", {"entities": []}], ["In 27 eyes of 14 patients (mean age 10.8 \u00b1 3.2 years), 44.4% had allergic conjunctivitis, 33.3% had vernal keratoconjunctivitis, and 22.2% had atopic keratoconjunctivitis.", {"entities": [[65, 88, "DISEASE"], [107, 127, "DISEASE"], [150, 170, "DISEASE"], [74, 88, "DISEASE"]]}], ["The mean duration of ocular symptoms was 20.4 \u00b1 13.2 months.", {"entities": []}], ["92.6% of subjects were using steroid eye drop before Restasis.", {"entities": []}], ["After 3 months of topical Restasis, there were statistically significant reductions in the symptom, sign, and itch severity scores compared with baseline (all P \u2264 0.001) and 78.6% of subjects were able to be tapered off steroid eye drops.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Topical Restasis was effective and safe in significantly reducing ocular itchiness, sign, and symptom scores at 3 months after use in paediatric allergic ocular conditions.", {"entities": []}], ["Oxidative stress is considered as a major risk factor that contributes to increased lipid peroxidation and declined antioxidants in some degenerative diseases.", {"entities": []}], ["Glycyrrhizin is widely used to cure allergic diseases due to its medicinal properties.", {"entities": []}], ["In the present study, we evaluated the role of glycyrrhizin on lipid peroxidation and antioxidant status in the blood and nasal mucosa of allergic rhinitis (AR) mice.", {"entities": [[138, 155, "DISEASE"], [147, 155, "DISEASE"]]}], ["Mice were divided into six groups: normal control mice, model control (MC) mice, three glycyrrhizin-treated mice groups and lycopene-treated mice.", {"entities": []}], ["Sensitization-associated increase in lipid peroxidation was observed in the blood and nasal mucosa of MC mice.", {"entities": []}], ["Activities of antioxidant enzymes like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), total antioxidant capacity (TAOC) and levels of glutathione (GSH) were found to be significantly decreased in the blood and nasal mucosa in MC mice when compared to normal control mice.", {"entities": []}], ["However, normalized lipid peroxidation and antioxidant defenses were reported in the glycyrrhizin-treated and lycopene-treated mice.", {"entities": []}], ["Moreover, glycyrrhizin treatment still enhanced IFN-\u03b3 and reduced IL-4 levels in glycyrrhizin-treated mice.", {"entities": []}], ["These findings demonstrated that glycyrrhizin treatment enhanced the antioxidant status and decreased the incidence of free radical-induced lipid peroxidation and improved immunity activities in the blood and nasal mucosa of AR mice.", {"entities": []}], ["Elucidation of the pathogenesis and effective treatment of autism spectrum disorders is one of the challenges today.", {"entities": []}], ["In this study, we examine hair zinc concentrations for 1,967 children with autistic disorders (1,553 males and 414 females), and show considerable association with zinc deficiency.", {"entities": []}], ["Histogram of hair zinc concentration was non-symmetric with tailing in lower range, and 584 subjects were found to have lower zinc concentrations than \u22122 standard deviation level of its reference range (86.3\u2013193ppm).", {"entities": []}], ["The incidence rate of zinc deficiency in infant group aged 0\u20133 year-old was estimated 43.5 % in male and 52.5 % in female.", {"entities": []}], ["The lowest zinc concentration of 10.7\u2005ppm was detected in a 2-year-old boy, corresponding to about 1/12 of the control mean level.", {"entities": []}], ["These findings suggest that infantile zinc deficiency may epigenetically contribute to the pathogenesis of autism and nutritional approach may yield a novel hope for its treatment and prevention.", {"entities": []}], ["We have developed a process for transcriptome analysis of bacterial communities that accommodates both intact and fragmented starting RNA and combines efficient rRNA removal with strand-specific RNA-seq.", {"entities": []}], ["We applied this approach to an RNA mixture derived from three diverse cultured bacterial species and to RNA isolated from clinical stool samples.", {"entities": []}], ["The resulting expression profiles were highly reproducible, enriched up to 40-fold for non-rRNA transcripts, and correlated well with profiles representing undepleted total RNA.", {"entities": []}], ["Fungi can undergo autophagic- or apoptotic-type programmed cell death (PCD) on exposure to antifungal agents, developmental signals, and stress factors.", {"entities": []}], ["Filamentous fungi can also exhibit a form of cell death called heterokaryon incompatibility (HI) triggered by fusion between two genetically incompatible individuals.", {"entities": []}], ["With the availability of recently sequenced genomes of Aspergillus fumigatus and several related species, we were able to define putative components of fungi-specific death pathways and the ancestral core apoptotic machinery shared by all fungi and metazoa.", {"entities": []}], ["Phylogenetic profiling of HI-associated proteins from four Aspergilli and seven other fungal species revealed lineage-specific protein families, orphan genes, and core genes conserved across all fungi and metazoa.", {"entities": []}], ["The Aspergilli-specific domain architectures include NACHT family NTPases, which may function as key integrators of stress and nutrient availability signals.", {"entities": []}], ["They are often found fused to putative effector domains such as Pfs, SesB/LipA, and a newly identified domain, HET-s/LopB.", {"entities": []}], ["Many putative HI inducers and mediators are specific to filamentous fungi and not found in unicellular yeasts.", {"entities": []}], ["In addition to their role in HI, several of them appear to be involved in regulation of cell cycle, development and sexual differentiation.", {"entities": []}], ["Finally, the Aspergilli possess many putative downstream components of the mammalian apoptotic machinery including several proteins not found in the model yeast, Saccharomyces cerevisiae .", {"entities": []}], ["Our analysis identified more than 100 putative PCD associated genes in the Aspergilli, which may help expand the range of currently available treatments for aspergillosis and other invasive fungal diseases.", {"entities": [[157, 170, "DISEASE"]]}], ["The list includes species-specific protein families as well as conserved core components of the ancestral PCD machinery shared by fungi and metazoa.", {"entities": []}], ["Omran's theory explains changing disease patterns over time predominantly from infectious to chronic noncommunicable diseases (NCDs).", {"entities": []}], ["India's epidemiological transition is characterized by dual burden of diseases.", {"entities": []}], ["Kumar addressed low mortality and high morbidity in Kerala, which seems also to be true for India as a country in the current demographic scenario.", {"entities": []}], ["NSS data (1986\u20131987, 1995\u20131996, 2004) and aggregated data on causes of death provided by Registrar General India (RGI) were used to examine the structural changes in morbidity and causes of death.", {"entities": []}], ["A zero-inflated poisson (ZIP) regression model and a beta-binomial model were used to corroborate the mounting age pattern of morbidity.", {"entities": []}], ["Measures, namely the 25th and 75th percentiles of age-at-death and modal age-at-death, were used to examine the advances in mortality transition.", {"entities": []}], ["This study addressed the advances in epidemiological transition via exploring the structural changes in pattern of diseases and progress in mortality transition.", {"entities": []}], ["The burden of NCDs has been increasing in old age without replacing the burden of communicable diseases.", {"entities": []}], ["The manifold rise of chronic diseases in recent decades justifies the death toll and is responsible for transformation in the age pattern of morbidity.", {"entities": []}], ["Over time, deaths have been concentrated near the modal age-at-death.", {"entities": []}], ["Modal age-at-death increased linearly by 5 years for females ( r r India experiences a dual burden of diseases associated with a remarkable transformation in the age pattern of morbidity and mortality, contemporaneous with structural changes in disease patterns.", {"entities": []}], ["Continued progress in the pattern of diseases and mortality transition, accompanied by a linear rise in e x , unravels a compelling variation in advances found so far in epidemiological transition witnessed by the developed nations, with similar matrices for India.", {"entities": []}], ["Bronchiectasis is characterized by pathological and irreversible bronchial dilatation caused by the inefficient mucus and microorganism clearance and progression of inflammatory processes.", {"entities": [[0, 14, "DISEASE"]]}], ["The most frequent characteristic is the increase in bronchial mucus production resulting in slower transport and damage to the mucociliary transport.", {"entities": []}], ["To evaluate the effects of exercise on mucus transport, inflammation, and resistance of the respiratory and autonomic nervous systems and subsequent effects on quality of life in patients with bronchiectasis who are enrolled in a pulmonary rehabilitation program.", {"entities": [[193, 207, "DISEASE"]]}], ["Sixty subjects of both sexes between 18 and 60 years (30 volunteers with clinically stable bronchiectasis and 30 healthy volunteers) will be included.", {"entities": [[91, 105, "DISEASE"]]}], ["Participants with chronic obstructive pulmonary disease, decompensated cardiovascular or metabolic diseases, neuromuscular and musculoskeletal diseases, and active smokers will be excluded.", {"entities": [[18, 55, "DISEASE"]]}], ["Volunteers will be randomly allocated to the pulmonary rehabilitation or control groups.", {"entities": []}], ["The primary outcomes will be nasal transport time as evaluated by nasal saccharin transport time, analysis of nasal lavage, enzyme immunoassay of exhaled expiration, and analysis of the mucus properties.", {"entities": []}], ["The secondary outcomes will include pulmonary function tests, impulse oscillometry, heart rate variability analysis, and quality of life questionnaires.", {"entities": []}], ["In addition to the benefits for patients already described in the literature, the additional benefit of mucus removal may contribute to optimizing treatments and better control of the disease.", {"entities": []}], ["This protocol could provide new information about the unclear mechanisms regarding exercise to aid in the removal of secretions.", {"entities": []}], ["Asthma is a complex disease presenting with variable symptoms which are sometimes hard to control.", {"entities": [[0, 6, "DISEASE"]]}], ["The purpose of the study was to describe the prevalence of asthma symptoms, use of asthma medications and allergic sensitization in subjects with asthma.", {"entities": [[59, 65, "DISEASE"], [83, 89, "DISEASE"], [146, 152, "DISEASE"]]}], ["We also related those indices to the level of asthma control, lung function and in particular, cough.", {"entities": [[46, 52, "DISEASE"]]}], ["An extensive questionnaire was sent to randomly selected adults from the West Sweden region.", {"entities": []}], ["Clinical examinations and interview were performed in a subset.", {"entities": []}], ["Of the participants, 744 were defined as having an ongoing asthma - reported ever having asthma or physician diagnosed asthma and one of the following \u2013 use of asthma medications, recurrent wheeze or attacks of shortness of breath with or without wheeze in the last 12\u00a0months.", {"entities": [[59, 65, "DISEASE"], [89, 95, "DISEASE"], [119, 125, "DISEASE"], [160, 166, "DISEASE"]]}], ["A respiratory disease-free control group of 847 subjects was also described.", {"entities": []}], ["According to GINA guidelines, 40.6% of the asthmatics had partly controlled and 17.8% had uncontrolled asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["Asthmatic subjects reported significantly more symptoms in the last 12\u00a0months than the control group \u2013 wheezing (79.4 vs 9.2%), shortness of breath (36.1 vs 2.5%), wheezing with shortness of breath (58.7 vs 1.3%).", {"entities": []}], ["Important complaints were morning cough (42.5 vs 15.5%), cough with sputum production (36.1 vs 6.8%) and longstanding cough (32.5 vs 11.1%), which bothered two thirds of the uncontrolled and one third of partly controlled subjects.", {"entities": []}], ["Asthma medications were used by 87.5% of the asthmatics, although around 30% of them who had insufficiently controlled disease used only short-acting beta-agonists.", {"entities": [[0, 6, "DISEASE"]]}], ["Asthmatics also had lower lung function, reacted to lower doses of methacholine that the controls and 13.6% of them had a FEV1/FVC ratio below 0.7.", {"entities": []}], ["Allergic rhinitis was reported by 73.8% of the asthmatics and they were more frequently sensitized to several common allergens.", {"entities": [[9, 17, "DISEASE"]]}], ["Approximately 60% of asthmatics from this population-based study had insufficiently controlled asthma and persistent complaints, despite a high use of asthma medications.", {"entities": [[95, 101, "DISEASE"], [151, 157, "DISEASE"]]}], ["These self-reported symptoms were supported by clinical examination data.", {"entities": []}], ["Increased cough frequency is an indicator of a more severe and difficult to control disease and should be considered when asthma is characterized.", {"entities": [[122, 128, "DISEASE"]]}], ["Qingfei Xiaoyan Wan (QFXY), a traditional Chinese formula, is widely used for relieving cough, asthma, upper respiratory tract infection, bronchitis, pneumonia, and etc.", {"entities": [[150, 159, "DISEASE"], [95, 101, "DISEASE"], [138, 148, "DISEASE"]]}], ["Comparing with other anti-asthma drugs, it is characterised with moderate and persistent efficacy as well as few side effects, however, the underlying action mechanism still remains elusive.", {"entities": [[26, 32, "DISEASE"]]}], ["This study aimed to identify QFXY multi-target network regulation as an asthma controller.", {"entities": [[72, 78, "DISEASE"]]}], ["This study established asthma model induced by histamine phosphate and acetylcholine chloride (His&Ach) in guinea pigs, which then were administered orally with QFXY.", {"entities": [[23, 29, "DISEASE"]]}], ["Hematoxylin-Eosin staining sections were applied for evaluating QFXY effect.", {"entities": []}], ["In both Model and QFXY groups, customized microarrays and 2D electrophoresis were adopted to detect differentially expressed genes (diff genes) and proteins (diff proteins) respectively, and some diff proteins were identified with MALDI-TOF/MS.", {"entities": []}], ["The checked diff genes and proteins underwent Cluster, GO and KEGG analysis.", {"entities": []}], ["Based on GAD and HPRD databases, QFXY-asthma target regulation network was constructed.", {"entities": [[38, 44, "DISEASE"]]}], ["His&Ach-induced asthma model of guinea pigs was established.", {"entities": [[16, 22, "DISEASE"]]}], ["HE sections presented anti-inflammation and anti-remodelling effects of QFXY.", {"entities": []}], ["Comparing with the Model group, 55 diff genes and 6 diff proteins were identified in QFXY group.", {"entities": []}], ["Validation by qPCR and Western blot showed the microarray and 2D data reliable.", {"entities": []}], ["Furthermore, QFXY-asthma target regulation network was achieved.", {"entities": [[18, 24, "DISEASE"]]}], ["A primarily combined genomic and proteomic screening of QFXY targets displayed a series of candidate genes and proteins, which indicated that the effect of QFXY relied on the combined mechanism, anti-inflammation and anti-remodelling, as well as influencing signal transduction in vivo.", {"entities": []}], ["Supplemental Digital Content is Available in the Text.", {"entities": []}], ["Some sickle cell anemia (SCA) patients suffer significantly worse phenotypes than others.", {"entities": [[5, 23, "DISEASE"], [17, 23, "DISEASE"]]}], ["Causes of such disparities are incompletely understood.", {"entities": []}], ["Comorbid chronic inflammation likely is a factor.", {"entities": []}], ["Recently, mast cell (MC) activation (creating an inflammatory state) was found to be a significant factor in sickle pathobiology and pain in a murine SCA model.", {"entities": []}], ["Also, a new realm of relatively noncytoproliferative MC disease termed MC activation syndrome (MCAS) has been identified recently.", {"entities": [[85, 93, "DISEASE"]]}], ["MCAS has not previously been described in SCA.", {"entities": []}], ["Some SCA patients experience pain patterns and other morbidities more congruent with MCAS than traditional SCA pathobiology (eg, vasoocclusion).", {"entities": []}], ["Presented here are 32 poor-phenotype SCA patients who met MCAS diagnostic criteria; all improved with MCAS-targeted therapy.", {"entities": []}], ["As hydroxyurea benefits some MCAS patients (particularly SCA-like pain), its benefit in SCA may be partly attributable to treatment of unrecognized MCAS.", {"entities": []}], ["Further study will better characterize MCAS in SCA and identify optimal therapy.", {"entities": []}], ["Asthma is a chronic inflammatory airways disease in which respiratory viral infections frequently trigger exacerbations.", {"entities": [[0, 6, "DISEASE"]]}], ["Current treatment of asthma with combinations of inhaled corticosteroids and long acting beta2 agonists improves asthma control and reduces exacerbations but what impact this might have on innate anti-viral immunity is unclear.", {"entities": [[21, 27, "DISEASE"], [113, 119, "DISEASE"]]}], ["We investigated the in vitro effects of asthma drugs on innate anti-viral immunity.", {"entities": [[40, 46, "DISEASE"]]}], ["Peripheral blood mononuclear cells (PBMC) from healthy and asthmatic donors were cultured for 24 hours with the Toll-like receptor 7 agonist, imiquimod, or rhinovirus 16 (RV16) in the presence of budesonide and/or formoterol.", {"entities": []}], ["Production of proinflammatory cytokines and expression of anti-viral intracellular signalling molecules were measured by ELISA and RT-PCR respectively.", {"entities": []}], ["In PBMC from healthy donors, budesonide alone inhibited IP-10 and IL-6 production induced by imiquimod in a concentration-dependent manner and the degree of inhibition was amplified when budesonide and formoterol were used in combination.", {"entities": []}], ["Formoterol alone had little effect on these parameters, except at high concentrations (10 in vitro studies demonstrate that combinations of drugs commonly used in asthma therapy inhibit both early pro-inflammatory cytokines and key aspects of the type I IFN pathway.", {"entities": [[163, 169, "DISEASE"]]}], ["These findings suggest that budesonide and formoterol curtail excessive inflammation induced by rhinovirus infections in patients with asthma, but whether this inhibits viral clearance in vivo remains to be determined.", {"entities": [[135, 141, "DISEASE"]]}], ["The U.S. is experiencing unprecedented movement away from coal and, to a lesser degree, oil.", {"entities": []}], ["Burdened low-income communities and people of color could experience health benefits from reductions in air and water pollution, yet these same groups could suffer harm if transitions lack broad public input or if policies prioritize elite or corporate interests.", {"entities": []}], ["This paper highlights how U.S. energy transitions build from, and contribute to, environmental injustices.", {"entities": []}], ["Energy justice requires not only ending disproportionate harm, it also entails involvement in the design of solutions and fair distribution of benefits, such as green jobs and clean air.", {"entities": []}], ["To what extent does the confluence of state, civic, and market processes assure \u201cjust\u201d transitions to clean, low-carbon energy production involving equitable distribution of costs, benefits, and decision-making power?", {"entities": []}], ["To explore this question we assess trends with (1) fossil fuel divestment; (2) carbon taxes and social cost of carbon measurements; (3) cap-and-trade; (4) renewable energy; and (5) energy efficiency.", {"entities": []}], ["Current research demonstrates opportunities and pitfalls in each area with mixed or partial energy justice consequences, leading to our call for greater attention to the specifics of distributive justice , procedural justice , and recognition justice in research, policy, and action.", {"entities": []}], ["Illustrative energy transition case studies suggest the feasibility and benefit of empowering approaches, but also indicate there can be conflict between \u201cgreen\u201d and \u201cjust\u201d, as evident though stark inequities in clean energy initiatives.", {"entities": []}], ["To identify positive pathways forward, we compile priorities for an energy justice research agenda based on interactive and participatory practices aligning advocacy, activism, and academics.", {"entities": []}], ["Chronic lung inflammation is accepted as being associated with the development of lung cancer caused by nickel exposure.", {"entities": [[82, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["Therefore, identifying the molecular mechanisms that lead to a nickel-induced sustained inflammatory microenvironment that causes transformation of human bronchial epithelial cells is of high significance.", {"entities": []}], ["In the current studies, we identified SQSTM1/p62 as a novel nickel-upregulated protein that is important for nickel-induced inflammatory TNF expression, subsequently resulting in transformation of human bronchial epithelial cells.", {"entities": [[137, 140, "GENE"]]}], ["We found that nickel exposure induced SQSTM1 protein upregulation in human lung epithelial cells in vitro and in mouse lung tissues in vivo .", {"entities": [[38, 44, "GENE"]]}], ["The SQSTM1 upregulation was also observed in human lung squamous cell carcinoma.", {"entities": [[70, 79, "DISEASE"], [56, 79, "DISEASE"], [51, 79, "DISEASE"], [4, 10, "GENE"]]}], ["Further studies revealed that the knockdown of SQSTM1 expression dramatically inhibited transformation of human lung epithelial cells upon chronic nickel exposure, whereas ectopic expression of SQSTM1 promoted such transformation.", {"entities": [[47, 53, "GENE"], [194, 200, "GENE"], [47, 53, "GENE"], [194, 200, "GENE"]]}], ["Mechanistic studies showed that the SQSTM1 upregulation by nickel was the compromised result of upregulating SQSTM1 mRNA transcription and promoting SQSTM1 protein degradation.", {"entities": [[36, 42, "GENE"], [109, 115, "GENE"], [149, 155, "GENE"], [36, 42, "GENE"], [109, 115, "GENE"], [149, 155, "GENE"], [36, 42, "GENE"], [109, 115, "GENE"], [149, 155, "GENE"]]}], ["We demonstrated that nickel-initiated SQSTM1 protein degradation is mediated by macroautophagy/autophagy via an MTOR-ULK1-BECN1 axis, whereas RELA is important for SQSTM1 transcriptional upregulation following nickel exposure.", {"entities": [[38, 44, "GENE"], [164, 170, "GENE"], [142, 146, "GENE"], [38, 44, "GENE"], [164, 170, "GENE"]]}], ["Furthermore, SQSTM1 upregulation exhibited its promotion of nickel-induced cell transformation through exerting an impetus for nickel-induced inflammatory TNF mRNA stability.", {"entities": [[13, 19, "GENE"], [155, 158, "GENE"]]}], ["Consistently, the MTOR-ULK1-BECN1 autophagic cascade acted as an inhibitory effect on nickel-induced TNF expression and cell transformation.", {"entities": [[101, 104, "GENE"]]}], ["Collectively, our results demonstrate a novel SQSTM1 regulatory network that promotes a nickel-induced tumorigenic effect in human bronchial epithelial cells, which is negatively controlled by an autophagic cascade following nickel exposure.", {"entities": [[46, 52, "GENE"]]}], ["Current guidelines recommend tailored interventions to optimise knee osteoarthritis (OA) management.", {"entities": [[69, 83, "DISEASE"]]}], ["However, models of care still have a \u2018one size fits all\u2019 approach, which is suboptimal as it ignores patient heterogeneity.", {"entities": []}], ["This study aims to compare a stepped care strategy with standard care for overweight and obese persons with medial tibiofemoral OA.", {"entities": []}], ["Participants will be randomised into two groups (85 each).", {"entities": []}], ["The intervention will receive a diet and exercise programme for 18 weeks in the first step of the study.", {"entities": []}], ["Disease remission will then be assessed using the Patient Acceptable Symptom State (PASS).", {"entities": []}], ["PASS is defined as the highest level of symptom beyond which patients consider themselves well and takes into account pain intensity, patient\u2019s global assessment of disease activity and degree of functional impairment.", {"entities": []}], ["In the second step, participants in remission will continue with diet and exercise.", {"entities": []}], ["If remission is not achieved, participants will be assigned in a hierarchical order to cognitive behavioural therapy, knee brace or muscle strengthening for 12 weeks.", {"entities": []}], ["The intervention will be decided based on their clinical presentation for symptoms of depression and varus malalignment.", {"entities": []}], ["Participants without depression or varus malalignment will undertake a muscle strengthening programme.", {"entities": []}], ["The control group will receive educational material related to OA management.", {"entities": []}], ["Main inclusion criteria are age \u226550 years, radiographic medial tibiofemoral OA, body mass index (BMI) \u226528\u2009kg/m The local ethics committee approved this protocol (HREC/14/HAWKE/381).", {"entities": []}], ["Dissemination will occur through presentations at international conferences and publication in peer-reviewed journals.", {"entities": []}], ["ACTRN12615000227594 .", {"entities": []}], ["Nickel nanoparticles (NiNPs) are increasingly used in a variety of industrial applications, including the manufacturing of multi-walled carbon nanotubes (MWCNTs).", {"entities": []}], ["While occupational nickel exposure is a known cause of pulmonary alveolitis, fibrosis, and cancer, the health risks of NiNPs are not well understood, especially in susceptible individuals such as asthmatics.", {"entities": [[91, 97, "DISEASE"]]}], ["The T-box transcription factor Tbx21 (T-bet) maintains Th1 cell development and loss of T-bet is associated with a shift towards Th2 type allergic airway inflammation that characterizes asthma.", {"entities": [[186, 192, "DISEASE"], [31, 36, "GENE"]]}], ["The purpose of this study was to determine the role of T-bet in susceptibility to lung remodeling by NiNPs or MWCNTs.", {"entities": []}], ["Wild-type (WT) and T-bet Morphometry of alcian-blue/periodic acid Schiff (AB/PAS)-stained lung tissue showed that NiNPs significantly increased mucous cell metaplasia in T-bet These findings identify T-bet as a potentially important susceptibility factor for NiNP exposure and to a lesser extent for MWCNT exposure, and suggests that individuals with asthma are at greater risk.", {"entities": [[351, 357, "DISEASE"]]}], ["Interleukin-2 inducible tyrosine kinase (ITK) is expressed in T cells and plays a critical role in signalling through the T cell receptor.", {"entities": [[41, 44, "GENE"]]}], ["Evidence, mainly from knockout mice, has suggested that ITK plays a particularly important function in Th2 cells and this has prompted significant efforts to discover ITK inhibitors for the treatment of allergic disease.", {"entities": [[56, 59, "GENE"], [167, 170, "GENE"], [56, 59, "GENE"], [167, 170, "GENE"]]}], ["However, ITK is known to have functions outside of its kinase domain and in general kinase knockouts are often not good models for the behaviour of small molecule inhibitors.", {"entities": [[9, 12, "GENE"]]}], ["Consequently we have developed a transgenic mouse where the wild type Itk allele has been replaced by a kinase dead Itk allele containing an inactivating K390R point mutation ( Itk -KD mice).", {"entities": [[70, 73, "GENE"], [116, 119, "GENE"], [177, 180, "GENE"], [70, 73, "GENE"], [116, 119, "GENE"], [177, 180, "GENE"], [70, 73, "GENE"], [116, 119, "GENE"], [177, 180, "GENE"]]}], ["We have characterised the immune phenotype of these naive mice and their responses to airway inflammation.", {"entities": []}], ["Unlike Itk knockout ( Itk ) mice, T-cells from Itk -KD mice can polymerise actin in response to CD3 activation.", {"entities": [[7, 10, "GENE"], [22, 25, "GENE"], [47, 50, "GENE"], [7, 10, "GENE"], [22, 25, "GENE"], [47, 50, "GENE"], [7, 10, "GENE"], [22, 25, "GENE"], [47, 50, "GENE"]]}], ["The lymph nodes from Itk -KD mice showed more prominent germinal centres than wild type mice and serum antibody levels were significantly abnormal.", {"entities": [[21, 24, "GENE"]]}], ["Unlike the Itk , \u03b3\u03b4 T cells in the spleens of the Itk -KD mice had an impaired ability to secrete Th2 cytokines in response to anti-CD3 stimulation whilst the expression of ICOS was not significantly different to wild type.", {"entities": [[11, 14, "GENE"], [50, 53, "GENE"], [11, 14, "GENE"], [50, 53, "GENE"], [173, 177, "GENE"]]}], ["However ICOS expression is markedly increased on \u03b1\u03b2CD3 Itk -KD compared to WT mice.", {"entities": [[8, 12, "GENE"], [55, 58, "GENE"]]}], ["The Itk -KD mice were largely protected from inflammatory symptoms in an Ovalbumin model of airway inflammation.", {"entities": [[4, 7, "GENE"]]}], ["Consequently, our studies have revealed many similarities but some differences between Itk and Itk -KD transgenic mice.", {"entities": [[87, 90, "GENE"], [95, 98, "GENE"], [87, 90, "GENE"], [95, 98, "GENE"]]}], ["The abnormal antibody response and enhanced ICOS expression on CD3+ cells has implications for the consideration of ITK as a therapeutic target.", {"entities": [[44, 48, "GENE"], [116, 119, "GENE"]]}], ["Bariatric surgery is the most effective current treatment for severe obesity.", {"entities": [[69, 76, "DISEASE"]]}], ["Capacity to perform surgery within Canada\u2019s public health system is limited and potential candidates face protracted wait times.", {"entities": []}], ["A better understanding of the gaps between demand for surgery and the capacity to provide it is required.", {"entities": []}], ["The purpose of this study was to quantify and characterize the bariatric surgery-eligible population in Canada in comparison to surgery-ineligible subjects and surgical recipients.", {"entities": []}], ["Data from adult (age\u2009>\u200920) respondents of the 2007\u201309 nationally representative Canadian Health Measures Survey (CHMS) were analyzed to estimate the prevalence and characteristics of the surgery-eligible and ineligible populations.", {"entities": []}], ["Federally mandated administrative healthcare data (2007\u201308) were used to characterize surgical recipients.", {"entities": []}], ["In 2007\u201309, an estimated 1.5 million obese Canadian adults met eligibility criteria for bariatric surgery.", {"entities": []}], ["19.2 million were surgery-ineligible (3.4 million obese and 15.8 million non-obese).", {"entities": []}], ["Surgery-eligible Canadians had a mean BMI of 40.1\u2009kg/m The proportion of bariatric surgery-eligible Canadians that undergo publicly funded bariatric surgery is very low.", {"entities": []}], ["There are notable differences in sociodemographic profiles and prevalence of comorbidities between surgery-eligible subjects and surgical recipients.", {"entities": []}], ["Supplemental Digital Content is available in the text Short-acting \u03b2 2 -agonists (SABA) are widely used in the emergency department (ED) to treat patients with decompensated chronic obstructive pulmonary disease (COPD).", {"entities": [[174, 211, "DISEASE"]]}], ["We sought to model the effectiveness of nebulized SABA (terbutaline) on clinically relevant parameters associated with a reduction in work of breathing or respiratory muscle fatigue in decompensated COPD patients admitted to the ED.", {"entities": []}], ["Forty consecutive decompensated COPD patients (having received at least one dose of nebulized terbutaline during their stay in the ED) were included in an observational cohort study.", {"entities": []}], ["The terbutaline dose received at time t was expressed as cumulative dose and as a rate (mg/day).", {"entities": []}], ["The associations between the terbutaline dose and time-dependent outcome parameters (respiratory rate, heart rate, arterial blood gases, and, as a marker of terbutaline's systemic effect, serum potassium) were analyzed using a nonlinear, mixed-effects model.", {"entities": []}], ["The effect of various covariates influencing terbutaline's effectiveness (baseline characteristics and concomitant treatments) was assessed on the model.", {"entities": []}], ["Among the investigated patients, a total of 377 time-dependent observations were available for analysis.", {"entities": []}], ["Neither the cumulative dose nor the dose rate at time t significantly influenced the arterial blood gas parameters or heart rate.", {"entities": []}], ["The cumulative dose of terbutaline was associated with a lower serum potassium level ( P \u200a<\u200a0.001) and, less significantly, a lower respiratory frequency ( P \u200a=\u200a0.036).", {"entities": []}], ["In a tertile analysis, the need for post-ED hospitalization was not associated with the cumulative dose or dose rate of terbutaline.", {"entities": []}], ["Overall, the results of our modeling study strongly suggest that terbutaline dose did not influence time-dependent outcomes other than serum potassium, and thus call into question the systematic administration of inhaled SABA to patients admitted to the ED for decompensated COPD.", {"entities": []}], ["The definition of new markers of local and systemic inflammation of chronic obstructive pulmonary disease (COPD) is one of the priority directions in the study of pathogenesis and diagnostic methods improvement for this disease.", {"entities": [[68, 105, "DISEASE"]]}], ["We investigated 91 patients with COPD and 21 healthy nonsmokers.", {"entities": []}], ["The levels of soluble CD25, CD38, CD8, and HLA-I-CD8 molecules in the blood serum and exhaled breath condensate (EBC) in moderate-to-severe COPD patients during exacerbation and stable phase were studied.", {"entities": [[28, 32, "GENE"]]}], ["An unidirectional change in the content of sCD25, sCD38, and sCD8 molecules with increasing severity of COPD was detected.", {"entities": []}], ["The correlations between the parameters of lung function and sCD8, sCD25, and sHLA-I-CD8 levels in the blood serum and EBC were discovered in patients with severe COPD.", {"entities": []}], ["The findings suggest a pathogenetic role of the investigated soluble molecules of the COPD development and allow considering the content of sCD8, sCD25, and sHLA-I-CD8 molecules as additional novel systemic and endobronchial markers of the progression of chronic inflammation of this disease.", {"entities": []}], ["Alcohol disrupts the intestinal mucosal barrier by inducing metabolic and functional changes in epithelial cells.", {"entities": []}], ["Recently, we showed that neuropeptide S (NPS) decreases duodenal motility and increases mucosal paracellular permeability, suggesting a role of NPS in the pathogenesis of disorders and dysfunctions in the small intestine.", {"entities": [[41, 44, "GENE"], [144, 147, "GENE"], [41, 44, "GENE"], [144, 147, "GENE"]]}], ["The aim of the present study was to investigate the effects of NPS on ethanol- and HCl-induced changes of duodenal mucosal barrier function and motility.", {"entities": [[63, 66, "GENE"]]}], ["Rats were anaesthetized with thiobarbiturate, and a 30-mm segment of the proximal duodenum with an intact blood supply was perfused in situ .", {"entities": []}], ["The effects on duodenal bicarbonate secretion, the blood-to-lumen clearance of", {"entities": []}], ["Respiratory syncytial virus (RSV) causes significant infant morbidity and mortality.", {"entities": []}], ["For decades severe RSV-induced disease was thought to result from an uncontrolled host response to viral replication, but recent work suggests that a strong innate immune response early in infection is protective.", {"entities": []}], ["To shed light on host-virus interactions and the viral determinants of disease, copy numbers of five RSV genes (NS1, NS2, N, G, F) were measured by quantitative real-time polymerase chain reaction (qPCR) in nasal wash samples from children with RSV-associated bronchiolitis.", {"entities": [[260, 273, "DISEASE"]]}], ["Correlations were sought with host cytokines/chemokines and biomarkers.", {"entities": []}], ["Associations with disposition from the emergency department (hospitalized or sent home) and pulse oximetry O 2 saturation levels were also sought.", {"entities": []}], ["Additionally, RNase P copy number was measured and used to normalize nasal wash data.", {"entities": []}], ["RSV gene copy numbers were found to significantly correlate with both cytokine/chemokine and biomarker levels; and RNase P-normalized viral gene copy numbers (NS1, NS2, N and G) were significantly higher in infants with less severe disease.", {"entities": []}], ["Moreover, three of the normalized viral gene copy numbers (NS1, NS2, and N) correlated significantly with arterial O 2 saturation levels.", {"entities": []}], ["The data support a model where a higher viral load early in infection can promote a robust innate immune response that protects against progression into hypoxic RSV-induced lower respiratory tract illness.", {"entities": []}], ["Neuronal plasticity is a fundamental factor in cognitive outcome following traumatic brain injury.", {"entities": []}], ["Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, plays an important role in this process.", {"entities": [[35, 39, "GENE"]]}], ["While there are many ways to measure cognitive outcome, general cognitive intelligence is a strong predictor of everyday decision-making, occupational attainment, social mobility and job performance.", {"entities": []}], ["Thus it is an excellent measure of cognitive outcome following traumatic brain injury (TBI).", {"entities": []}], ["Although the importance of the single-nucleotide polymorphisms polymorphism on cognitive function has been previously addressed, its role in recovery of general intelligence following TBI is unknown.", {"entities": []}], ["We genotyped male Caucasian Vietnam combat veterans with focal penetrating TBI (pTBI) (n\u200a=\u200a109) and non-head injured controls (n\u200a=\u200a38) for 7 BDNF single-nucleotide polymorphisms.", {"entities": [[141, 145, "GENE"]]}], ["Subjects were administrated the Armed Forces Qualification Test (AFQT) at three different time periods: pre-injury on induction into the military, Phase II (10\u201315 years post-injury, and Phase III (30\u201335 years post-injury).", {"entities": []}], ["Two single-nucleotide polymorphisms, rs7124442 and rs1519480, were significantly associated with post-injury recovery of general cognitive intelligence with the most pronounced effect at the Phase II time point, indicating lesion-induced plasticity.", {"entities": []}], ["The genotypes accounted for 5% of the variance of the AFQT scores, independently of other significant predictors such as pre-injury intelligence and percentage of brain volume loss.", {"entities": []}], ["These data indicate that genetic variations in BDNF play a significant role in lesion-induced recovery following pTBI.", {"entities": [[47, 51, "GENE"]]}], ["Identifying the underlying mechanism of this brain-derived neurotrophic factor effect could provide insight into an important aspect of post-traumatic cognitive recovery.", {"entities": []}], ["To assess the incidence of Chlamydia pneumoniae respiratory tract infection in children and adolescents in the Lower Silesia Region in Poland in 2009.", {"entities": []}], ["641 throat swabs obtained from 326 girls and 315 boys, aged 11 months to 18 years, were assessed diagnostically.", {"entities": []}], ["The patients enrolled into the study were treated on an outpatient basis due to various, non-specific respiratory ailments.", {"entities": []}], ["The most common presenting clinical symptom of a respiratory problem was dry cough, which occurred in 295 studied subjects, followed by runny nose and cough with discharge in 176 subjects, and other minor symptoms in 35 subjects.", {"entities": []}], ["The assessment was conducted by an indirect immunofluorescence antibody (IFA) Chlamydia Testing kit (Cellabs, Sydney, Australia).", {"entities": []}], ["Overall, Chlamydia infection was detected in the respiratory tract in 43.1% (276/641) of the children, with no clear gender differences.", {"entities": []}], ["Of the 295 subjects presenting with dry cough, 122 (41.4%) had positive tests for Chlamydia .", {"entities": []}], ["Of the 176 subjects with runny nose and cough and the 35 subjects with other symptoms, 83 (47.2%) and 8 (22.9%) had positive tests for Chlamydia , respectively.", {"entities": []}], ["In the asymptomatic children who had direct contact with a Chlamydia infected person, there were 29.6% (8/27) positively tested cases, whereas in the children presenting symptoms, the percentage of positive tests was 48.3% (29/60).", {"entities": []}], ["In children living in the Lower Silesia Region of Poland, there is a substantial ~50% rate of Chlamydia infection, transmitted via airborne droplets.", {"entities": []}], ["The finding of Chlamydia infection should be the signal for testing other subjects from the child's closest environment.", {"entities": []}], ["In the Pneumonia Etiology Research for Child Health study, abnormal chest radiographs (CXRs) in cases were associated with hypoxemia, crackles, tachypnea, and fever.", {"entities": [[7, 16, "DISEASE"]]}], ["Overall, 54% of CXRs were abnormal (site range, 35%\u201364%).", {"entities": []}], ["Consolidation on CXR was associated with an increased risk of mortality.", {"entities": []}], ["Chest radiographs (CXRs) are frequently used to assess pneumonia cases.", {"entities": [[55, 64, "DISEASE"]]}], ["Variations in CXR appearances between epidemiological settings and their correlation with clinical signs are not well documented.", {"entities": []}], ["The Pneumonia Etiology Research for Child Health project enrolled 4232 cases of hospitalized World Health Organization (WHO)\u2013defined severe and very severe pneumonia from 9 sites in 7 countries (Bangladesh, the Gambia, Kenya, Mali, South Africa, Thailand, and Zambia).", {"entities": [[4, 13, "DISEASE"], [156, 165, "DISEASE"]]}], ["At admission, each case underwent a standardized assessment of clinical signs and pneumonia risk factors by trained health personnel, and a CXR was taken that was interpreted using the standardized WHO methodology.", {"entities": [[82, 91, "DISEASE"]]}], ["CXRs were categorized as abnormal (consolidation and/or other infiltrate), normal, or uninterpretable.", {"entities": []}], ["CXRs were interpretable in 3587 (85%) cases, of which 1935 (54%) were abnormal (site range, 35%\u201364%).", {"entities": []}], ["Cases with abnormal CXRs were more likely than those with normal CXRs to have hypoxemia (45% vs 26%), crackles (69% vs 62%), tachypnea (85% vs 80%), or fever (20% vs 16%) and less likely to have wheeze (30% vs 38%; all P < .05).", {"entities": []}], ["CXR consolidation was associated with a higher case fatality ratio at 30-day follow-up (13.5%) compared to other infiltrate (4.7%) or normal (4.9%) CXRs.", {"entities": []}], ["Clinically diagnosed pneumonia cases with abnormal CXRs were more likely to have signs typically associated with pneumonia.", {"entities": [[21, 30, "DISEASE"], [113, 122, "DISEASE"]]}], ["However, CXR-normal cases were common, and clinical signs considered indicative of pneumonia were present in substantial proportions of these cases.", {"entities": [[83, 92, "DISEASE"]]}], ["CXR-consolidation cases represent a group with an increased likelihood of death at 30 days post-discharge.", {"entities": []}], ["We investigated whether cysteinyl leukotrienes (cysLT) are intracrine signal transducers that regulate human eosinophil degranulation mechanisms.", {"entities": []}], ["Interleukin (IL)-16, eotaxin, and RANTES stimulate vesicular transport\u2013mediated release of preformed, granule-derived IL-4 and RANTES from eosinophils and the synthesis at intracellular lipid bodies of LTC 4 , the dominant 5-lipoxygenase\u2013derived eicosanoid in eosinophils.", {"entities": []}], ["5-Lipoxygenase inhibitors blocked IL-16\u2013, eotaxin-, and RANTES-induced IL-4 release; but neither exogenous LTC 4 , LTD 4 , nor LTE 4 elicited IL-4 release.", {"entities": []}], ["Only after membrane permeabilization enabled cysLTs to enter eosinophils did LTC 4 and LTD 4 stimulate IL-4, but not RANTES, release.", {"entities": []}], ["LTC 4 -elicited IL-4 release was pertussis toxin inhibitable, but inhibitors of the two known G protein\u2013coupled cysLT receptors (cysLTRs) (CysLT1 and CysLT2) did not block LTC 4 -elicited IL-4 release.", {"entities": [[33, 42, "DISEASE"]]}], ["LTC 4 was 10-fold more potent than LTD 4 and at low concentrations (0.3\u20133 nM) elicited, and at higher concentrations (>3 nM) inhibited, IL-4 release from permeabilized eosinophils.", {"entities": []}], ["Likewise with intact eosinophils, LTC 4 export inhibitors, which increased intracellular LTC 4 , inhibited eotaxin-elicited IL-4 release.", {"entities": []}], ["Thus, LTC 4 acts, via an intracellular cysLTR distinct from CysLT1 or CysLT2, as a signal transducer to selectively regulate IL-4 release.", {"entities": []}], ["These results demonstrate that LTC 4 , well recognized as a paracrine mediator, may also dynamically govern inflammatory and immune responses as an intracrine mediator of eosinophil cytokine secretion.", {"entities": []}], ["The adverse effects of petrodiesel exhaust exposure on the cardiovascular and respiratory systems are well recognized.", {"entities": []}], ["While biofuels such as rapeseed methyl ester (RME) biodiesel may have ecological advantages, the exhaust generated may cause adverse health effects.", {"entities": []}], ["In the current study, we investigated the responses of bioactive lipid mediators in human airways after biodiesel exhaust exposure using lipidomic profiling methods.", {"entities": []}], ["Lipid mediator levels in lung lavage were assessed following 1-h biodiesel exhaust (average particulate matter concentration, 159\u00a0\u03bcg/m N -acylethanolamines, and related lipid metabolites in the collected BW and BAL samples.", {"entities": []}], ["Six lipids in the human lung lavage samples were altered following biodiesel exhaust exposure, three from BAL samples and three from BW samples.", {"entities": []}], ["Of these, elevated levels of PGE 2 , 12,13-DiHOME, and 13-HODE, all of which were found in BAL samples, reached Bonferroni-corrected significance.", {"entities": []}], ["This is the first study in humans reporting responses of bioactive lipids following biodiesel exhaust exposure and the most pronounced responses were seen in the more peripheral and alveolar lung compartments, reflected by BAL collection.", {"entities": []}], ["Since the responsiveness and diagnostic value of a subset of the studied lipid metabolites were established in lavage fluids, we conclude that our mass spectrometry profiling method is useful to assess effects of human exposure to vehicle exhaust.", {"entities": []}], ["The online version of this article (doi:10.1007/s00216-017-0243-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to assess the prevalence of (unknown) heart failure and left ventricular dysfunction in older patients with type 2 diabetes.", {"entities": []}], ["In total, 605 patients aged 60\u00a0years or over with type 2 diabetes in the south west of the Netherlands participated in this cross-sectional study (response rate 48.7%), including 24 with a cardiologist-confirmed diagnosis of heart failure.", {"entities": []}], ["Between February 2009 and March 2010, the patients without known heart failure underwent a standardised diagnostic work-up, including medical history, physical examination, ECG and echocardiography.", {"entities": []}], ["An expert panel used the criteria of the European Society of Cardiology to diagnose heart failure.", {"entities": []}], ["Of the 581 patients studied, 161 (27.7%; 95% CI 24.1%, 31.4%) were found to have previously unknown heart failure: 28 (4.8%; 95% CI 3.1%, 6.6%) with reduced ejection fraction, and 133 (22.9%; 95% CI 19.5%, 26.3%) with preserved ejection fraction.", {"entities": []}], ["The prevalence of heart failure increased steeply with age.", {"entities": []}], ["Heart failure with preserved ejection fraction was more common in women.", {"entities": []}], ["Left ventricular dysfunction was diagnosed in 150 patients (25.8%; 95% CI 22.3%, 29.4%); 146 (25.1%; 95% CI 21.6%, 28.7%) had diastolic dysfunction.", {"entities": []}], ["This is the first epidemiological study that provides exact prevalence estimates of (previously unknown) heart failure and left ventricular dysfunction in a representative sample of patients with type 2 diabetes.", {"entities": []}], ["Previously unknown heart failure and left ventricular dysfunction are highly prevalent.", {"entities": []}], ["Physicians should pay special attention to \u2018unmasking\u2019 these patients.", {"entities": []}], ["Early-life exposure to estrogenic compounds affects the development of the reproductive system in rodent models and humans.", {"entities": []}], ["Soy products, which contain phytoestrogens such as genistein, are one source of exposure in infants fed soy formula, and they result in high serum concentrations.", {"entities": []}], ["Our goal was to determine whether soy exposure is associated with differential DNA methylation in vaginal cells from soy-fed infant girls.", {"entities": []}], ["Using the Illumina HumanMethylation450 BeadChip, we evaluated epigenome-wide DNA methylation in vaginal cells from four soy formula\u2013fed and six cow formula\u2013fed girls from the Infant Feeding and Early Development (IFED) study.", {"entities": []}], ["Using pyrosequencing we followed up the two most differentially methylated sites in 214 vaginal cell samples serially collected between birth and 9 months of age from 50 girls (28 soy formula\u2013fed and 22 cow formula\u2013fed).", {"entities": []}], ["With a mouse model, we examined the effect of neonatal exposure to genistein on gene specific mRNA levels in vaginal tissue.", {"entities": []}], ["The epigenome-wide scan suggested differences in methylation between soy formula\u2013fed and cow formula\u2013fed infants at three CpGs in the gene proline rich 5 like ( PRR5L ) ( p < 10 Prr5l mRNA levels compared to controls.", {"entities": [[161, 166, "GENE"], [178, 183, "GENE"], [161, 166, "GENE"], [178, 183, "GENE"]]}], ["Girls fed soy formula have altered DNA methylation in vaginal cell DNA which may be associated with decreased expression of an estrogen-responsive gene.", {"entities": []}], ["Harlid S, Adgent M, Jefferson WN, Panduri V, Umbach DM, Xu Z, Stallings VA, Williams CJ, Rogan WJ, Taylor JA.", {"entities": []}], ["Soy formula and epigenetic modifications: analysis of vaginal epithelial cells from infant girls in the IFED study.", {"entities": []}], ["Environ Health Perspect 125:447\u2013452; http://dx.doi.org/10.1289/EHP428", {"entities": []}], ["Omega\u20103 polyunsaturated fatty acid ( PUFA ) may benefit humans and animals with chronic inflammatory diseases.", {"entities": []}], ["Omega\u20103 PUFA supplementation improves clinical signs, lung function, and airway inflammation in horses with recurrent airway obstruction ( RAO ) and inflammatory airway disease ( IAD ).", {"entities": []}], ["Eight research horses and 35 client\u2010owned horses.", {"entities": []}], ["A pilot study examined the dose of PUFA that can alter plasma PUFA composition.", {"entities": []}], ["Then, a randomized, controlled clinical trial was performed in horses with RAO and IAD .", {"entities": []}], ["Horses were fed a complete pelleted diet with no hay and randomly assigned to 1 of 3 daily treatments for 2\u00a0months: 30 or 60\u00a0g of the supplement or 30\u00a0g of placebo.", {"entities": []}], ["Clinical signs, lung function, plasma PUFA composition, and bronchoalveolar lavage fluid ( BALF ) cytology were evaluated.", {"entities": []}], ["Data were expressed as median (25\u201375th percentiles).", {"entities": []}], ["P \u00a0<\u00a0.05 was considered significant.", {"entities": []}], ["Polyunsaturated fatty acid supplementation resulted in increased plasma docosahexaenoic acid ( DHA ) that peaked at 4\u00a0weeks.", {"entities": []}], ["Clinical improvement was noted in all horses involved in the clinical trial, but the group that received PUFA had greater improvement in clinical signs (cough score improved 60%), lung function (respiratory effort decreased 48%), and BALF (neutrophils decreased from 23 to 9%) when compared to placebo (cough score improved 33%, respiratory effort decreased 27%, BALF neutrophils increased from 11 to 17%; P \u00a0<\u00a0.05).", {"entities": []}], ["Feeding horses with RAO and IAD a PUFA supplement containing 1.5\u20133\u00a0g DHA for 2\u00a0months provides an additional benefit to low\u2010dust diet.", {"entities": []}], ["Background.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a common, smoking-related lung disease.", {"entities": [[74, 86, "DISEASE"]]}], ["Patients with COPD frequently suffer disease exacerbations induced by bacterial respiratory infections, suggestive of impaired innate immunity.", {"entities": []}], ["Low-dose oxygen is a mainstay of therapy during COPD exacerbations; yet we understand little about whether oxygen can modulate the effects of cigarette smoke on lung immunity.", {"entities": []}], ["Wild-type mice were exposed to cigarette smoke for 5 weeks, followed by intratracheal instillation of Pseudomonas aeruginosa (PAO1) and 21% or 35\u201340% oxygen.", {"entities": []}], ["After two days, lungs were harvested for PAO1 CFUs, and bronchoalveolar fluid was sampled for inflammatory markers.", {"entities": []}], ["In culture, macrophages were exposed to cigarette smoke and oxygen (40%) for 24 hours and then incubated with PAO1, followed by quantification of bacterial phagocytosis and inflammatory markers.", {"entities": []}], ["Mice exposed to 35\u201340% oxygen after cigarette smoke and PAO1 had improved survival and reduced lung CFUs and inflammation.", {"entities": []}], ["Macrophages from these mice expressed less TNF- \u03b1 and more scavenger receptors.", {"entities": []}], ["In culture, macrophages exposed to cigarette smoke and oxygen also demonstrated decreased TNF- \u03b1 secretion and enhanced phagocytosis of PAO1 bacteria.", {"entities": []}], ["Conclusions.", {"entities": []}], ["Our findings demonstrate a novel, protective role for low-dose oxygen following cigarette smoke and bacteria exposure that may be mediated by enhanced macrophage phagocytosis.", {"entities": []}], ["Fertility traits in humans are heritable, however, little is known about the genes that influence reproductive outcomes or the genetic variants that contribute to differences in these traits between individuals, particularly women.", {"entities": []}], ["To address this gap in knowledge, we performed an unbiased genome-wide expression quantitative trait locus (eQTL) mapping study to identify common regulatory (expression) single nucleotide polymorphisms (eSNPs) in mid-secretory endometrium.", {"entities": []}], ["We identified 423 cis-eQTLs for 132 genes that were significant at a false discovery rate (FDR) of 1%.", {"entities": []}], ["After pruning for strong LD ( r TAP2 gene ( P = 1.3x10 HLA-F gene ( P = 4.0x10 Little is known about the genetics of female fertility.", {"entities": [[32, 36, "GENE"], [55, 60, "GENE"]]}], ["In this study, we addressed this gap in knowledge by first searching for genetic variants that regulate gene expression in uterine endometrial cells, and then testing those functional variants for associations with the length of time to pregnancy in fertile women.", {"entities": []}], ["Two functional genetic variants were associated with time to pregnancy in women after correcting for multiple testing.", {"entities": []}], ["Those variants were each associated with the expression of genes in the HLA region, HLA-F and TAP2 , which are have not previously been implicated female fertility.", {"entities": [[72, 75, "GENE"], [84, 87, "GENE"], [84, 89, "GENE"], [94, 98, "GENE"]]}], ["The association between HLA-F and TAP2 genotypes on the length of time to pregnancy was replicated in an independent cohort of women.", {"entities": [[24, 29, "GENE"], [34, 38, "GENE"]]}], ["Because HLA-F and TAP2 are involved in immune processes, these results suggest their role in specific immune regulation in the endometrium during implantation.", {"entities": [[8, 13, "GENE"], [18, 22, "GENE"]]}], ["Future studies will characterize these molecules in the implantation process and their potential as drug targets for treatment of conditions related to implantation failure.", {"entities": []}], ["Reviews indicate that the quality of reporting of randomised controlled trials (RCTs) in the medical literature is less than optimal, poor to moderate, and require improving.", {"entities": []}], ["However, the reporting quality of chiropractic RCTs is unknown.", {"entities": []}], ["As a result, the aim of this study was to assess the reporting quality of chiropractic RCTs and identify factors associated with better reporting quality.", {"entities": []}], ["We hypothesized that quality of reporting of RCTs was influenced by industry funding, positive findings, larger sample sizes, latter year of publication and publication in non-chiropractic journals.", {"entities": []}], ["RCTs published between 2005 and 2014 were sourced from clinical trial registers, PubMed and the Cochrane Reviews.", {"entities": []}], ["RCTs were included if they involved high-velocity, low-amplitude (HVLA) spinal and/or extremity manipulation and were conducted by a chiropractor or within a chiropractic department.", {"entities": []}], ["Data extraction, and reviews were conducted by all authors independently.", {"entities": []}], ["Disagreements were resolved by consensus.", {"entities": []}], ["Outcomes: a 39-point overall quality of reporting score checklist was developed based on the CONSORT 2010 and CONSORT for Non-Pharmacological Treatments statements.", {"entities": []}], ["Four key methodological items, based on allocation concealment, blinding of participants and assessors, and use of intention-to-treat analysis (ITT) were also investigated.", {"entities": []}], ["Thirty-five RCTs were included.", {"entities": []}], ["The overall quality of reporting score ranged between 10 and 33 (median score 26.0; IQR\u2009=\u20098.00).", {"entities": []}], ["Allocation concealment, blinding of participants and assessors and ITT analysis were reported in 31 (87\u00a0%), 16 (46\u00a0%), 25 (71\u00a0%) and 21 (60\u00a0%) of the 35 RCTs respectively.", {"entities": []}], ["Items most underreported were from the CONSORT for Non-Pharmacological Treatments statement.", {"entities": []}], ["Multivariate regression analysis, revealed that year of publication (t 32 \u2009=\u20095.17, p \u2009=\u20090.000, 95\u00a0% CI: 0.76, 1.76), and sample size (t 32 \u2009=\u20093.01, p \u2009=\u20090.005, 95\u00a0% CI: 1.36, 7.02), were the only two factors associated with reporting quality.", {"entities": []}], ["The overall quality of reporting RCTs in chiropractic ranged from poor to excellent, improving between 2005 and 2014.", {"entities": []}], ["This study suggests that quality of reporting, was influenced by year of publication and sample size but not journal type, funding source or outcome positivity.", {"entities": []}], ["Reporting of some key methodological items and uptake of items from the CONSORT Extension for Non-Pharmacological Treatments items was suboptimal.", {"entities": []}], ["Future recommendations were made.", {"entities": []}], ["The online version of this article (doi:10.1186/s12998-016-0099-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Here, we aimed to examine the associations between levels of serum 25-hydroxyvitamin D [25(OH)D] and inflammatory cytokines in healthy Japanese adults.", {"entities": []}], ["A total of 95 healthy adults (61 women; age range 21\u201369 years) participated in our study.", {"entities": []}], ["Fasting blood samples were analyzed for 25(OH)D, 1,25-dihydroxyvitamin D [1,25(OH) 2 D], interferon-\u03b3 (IFN-\u03b3), interleukin-6 (IL-6), and interleukin-17 (IL-17) levels using enzyme-linked immunosorbent assays kits.", {"entities": []}], ["Total percent body fat was determined by dual energy X-ray absorptiometry (DXA).", {"entities": []}], ["Moderate to vigorous physical activity (MVPA) was assessed objectively using an activity monitor for 7 days.", {"entities": []}], ["The mean 25(OH)D concentration was 34.7 nmol/L, and 83 subjects had 25(OH)D concentrations less than 50 nmol/L.", {"entities": []}], ["Multiple linear regression analysis revealed that serum 25(OH)D level was positively related to plasma IL-17 level (\u03b2 = 0.26, p = 0.025), after adjustment for gender, age, vitamin D intake, alcohol consumption, smoking status, and percent body fat.", {"entities": []}], ["This relationship remained statistically significant (\u03b2 = 0.28, p = 0.019) even after additional adjustment for MVPA.", {"entities": []}], ["However, no significant association was found between serum 25(OH)D level and plasma IFN-\u03b3 or IL-6 levels.", {"entities": []}], ["In conclusion, this study identified a high prevalence of vitamin D deficiency in healthy Japanese adults.", {"entities": []}], ["Serum 25(OH)D level was positively related to IL-17 level, independent of physical activity.", {"entities": []}], ["Animal models of human inflammatory diseases have limited predictive quality for human clinical trials for various reasons including species specific activation mechanisms and the immunological background of the animals which markedly differs from the genetically heterogeneous and often aged patient population.", {"entities": []}], ["Development of an animal model allowing for testing therapeutics targeting pathways involved in the development of Atopic Dermatitis (AD) with better translatability to the patient.", {"entities": []}], ["NOD-scid IL2R \u03b3 in vitro analysis.", {"entities": []}], ["hIgE secretion was induced by IL-4 and inhibited by the IL-4 antagonist Pitrakinra in vivo when formulated with methylcellulose.", {"entities": []}], ["B-cells proliferated in response to IL-4 in vivo ; the effect was abrogated by Pitrakinra.", {"entities": []}], ["IL-4 shifted CD4 : CD8 ratios in vitro and in vivo when hPBMC derived from healthy volunteers were used.", {"entities": [[13, 16, "GENE"]]}], ["Pitrakinra reversed the effect.", {"entities": []}], ["Human PBMC derived from patients with AD remained inert and engrafted mice reflected the individual responses observed in vitro .", {"entities": []}], ["NOD-scid IL2R \u03b3 in vitro studies.", {"entities": []}], ["Thus, studies in this model might provide data with better translatability from bench to bedside.", {"entities": []}], ["The inappropriate use of emergency room (ER) service by patients with non-urgent health problems is a worldwide problem.", {"entities": []}], ["Inappropriate ER use makes it difficult to guarantee access for real emergency cases, decreases readiness for care, produces negative spillover effects on the quality of emergency services, and raises overall costs.", {"entities": []}], ["We conducted a cross-sectional study in a medium-sized city in southern Brazil.", {"entities": []}], ["The urgency of the presenting complaint was defined according to the Hospital Urgencies Appropriateness Protocol (HUAP).", {"entities": []}], ["Multivariable Poisson regression was carried out to examine factors associated with inappropriate ER use.", {"entities": []}], ["The study interviewed 1,647 patients over a consecutive 13-day sampling period.", {"entities": []}], ["The prevalence of inappropriate ER use was 24.2% (95% CI 22.1\u201326.3).", {"entities": []}], ["Inappropriate ER use was inversely associated with age (P = 0.001), longer stay in the waiting room, longer duration of symptoms and morning shift.", {"entities": []}], ["However, the determinants of inappropriate ER use differed according age groups (P value for interaction = 0.04).", {"entities": []}], ["Within the younger age-group (15\u201349 years), inappropriate ER use was higher among females, patients who reported visiting the ER because there was no other place to go, patients reporting that the doctor at the regular place of care refused to attend to them without a prior appointment, and individuals who reported that the PHC clinic which they use is open for shorter periods during the day.", {"entities": []}], ["Among older patients (50+ years), those with highest level of education, absence of self-reported chronic diseases and lack of social support were more likely to engage in higher inappropriate ER use.", {"entities": []}], ["Efforts should be made to redirect inappropriate ER demand.", {"entities": []}], ["Besides expanding access to, and improving the quality of primary and secondary care, it is important to mobilize social support for older patients, to enhance the relationship between different levels of care, as well as to develop campaigns to educate the public about the appropriate use of medical services.", {"entities": []}], ["Mindfulness Based Stress Reduction (MBSR) is a secular form of meditation training.", {"entities": []}], ["The vast majority of the extant literature investigating the health effects of mindfulness interventions relies on wait-list control comparisons.", {"entities": []}], ["Previous studies have found that meditation training over several months is associated with improvements in cognitive control and attention.", {"entities": []}], ["We used a visual continuous performance task (CPT) to test the effects of eight weeks of mindfulness training on sustained attention by comparing MBSR to the Health Enhancement Program (HEP), a structurally equivalent, active control condition in a randomized, longitudinal design (ClinicalTrials.gov, NCT01301105) focusing on a non-clinical population typical of MBSR participants.", {"entities": []}], ["Researchers were blind to group assignment.", {"entities": []}], ["63 community participants were randomized to either MBSR (n\u200a=\u200a31) or HEP (n\u200a=\u200a32).", {"entities": []}], ["CPT analyses were conducted on 29 MBSR participants and 25 HEP participants.", {"entities": []}], ["We predicted that MBSR would improve visual discrimination ability and sustained attention over time on the CPT compared to HEP, with more home practice associated with greater improvements.", {"entities": []}], ["Our hypotheses were not confirmed but we did find some evidence for improved visual discrimination similar to effects in partial replication of other research.", {"entities": []}], ["Our study had sufficient power to demonstrate that intervention groups do not differ in their improvement over time in sustained attention performance.", {"entities": []}], ["One of our primary predictions concerning the effects of intervention on attentional fatigue was significant but not interpretable.", {"entities": []}], ["Attentional sensitivity is not affected by mindfulness practice as taught in MBSR, but it is unclear whether mindfulness might positively affect another aspect of attention, vigilance.", {"entities": []}], ["These results also highlight the relevant procedural modifications required by future research to correctly investigate the role of sustained attention in similar samples.", {"entities": []}], ["ClinicalTrials.gov, NCT01301105", {"entities": []}], ["Post\u2010pneumonectomy syndrome ( PPS ) is a rare syndrome characterized by trachea\u2010bronchial stenosis and severe dyspnea.", {"entities": [[19, 27, "DISEASE"], [46, 54, "DISEASE"]]}], ["In this study, we retrospectively evaluated the clinical outcomes in patients who underwent placement of tissue expanders for PPS .", {"entities": []}], ["Data from patients who underwent placement of tissue expanders for PPS were analyzed for preoperative characteristics, surgical techniques, and postoperative outcomes.", {"entities": []}], ["Between 1997 and 2014, a total of 10 patients were treated for PPS by tissue expanders.", {"entities": []}], ["The median age of the 10 patients was 45 years (range, 16\u201370).", {"entities": []}], ["Four patients had undergone right pneumonectomy, three patients had undergone left pneumonectomy, and three patients had post\u2010pneumonectomy\u2010like syndrome.", {"entities": [[145, 153, "DISEASE"]]}], ["Preoperatively, seven patients initially received high oxygen therapy for hypoxemia but progressed to respiratory failure, and three patients required mechanical ventilator support.", {"entities": [[102, 121, "DISEASE"]]}], ["Among these three patients, one required intraoperative extracorporeal membrane oxygenation support because of sudden cardiac arrest during preparation for surgery.", {"entities": []}], ["The median follow\u2010up was 59.5 months (range, 2\u2013204).", {"entities": []}], ["The median interval between pneumonectomy and repositioning was 13 months (range, 8\u2013581).", {"entities": []}], ["Two patients underwent placement of a single tissue expander, and two tissue expanders were placed in eight of the 10 patients.", {"entities": []}], ["The median volume of tissue expanders inflated with saline was 450\u2009cc (range, 60\u2013850\u2009cc) per tissue expander.", {"entities": []}], ["There was no perioperative mortality in our study.", {"entities": []}], ["Complications occurred in four patients (40%).", {"entities": []}], ["Repositioning of the mediastinum with placement of a saline filled tissue expander for PPS is very effective for the relief of symptoms, with low mortality.", {"entities": []}], ["T helper cell type 1 (Th1) and 2 (Th2) are central to immune regulation.", {"entities": []}], ["However, no stable cell surface marker capable of distinguishing and separating these two subsets of CD4 Leishmania major infection in BALB/c mice and exacerbated collagen-induced arthritis in DBA/1 mice.", {"entities": [[180, 189, "DISEASE"], [101, 104, "GENE"]]}], ["Thus, ST2L is a stable marker distinguishing Th2s from Th1s and is also associated with Th2 functions.", {"entities": []}], ["Hence, it may be a target for therapeutic intervention.", {"entities": []}], ["Epigenetics underlying refractory epilepsy is poorly understood, especially in patients without distinctive genetic alterations.", {"entities": []}], ["DNA methylation may affect gene expression in epilepsy without affecting DNA sequences.", {"entities": []}], ["Herein, we analyzed genome-wide DNA methylation and gene expression in brain tissues of 10 patients with refractory epilepsy using methylated DNA immunoprecipitation linked with sequencing and mRNA Sequencing.", {"entities": []}], ["Diverse distribution of differentially methylated genes was found in X chromosome, while differentially methylated genes appeared rarely in Y chromosome.", {"entities": []}], ["62 differentially expressed genes, such as MMP19, AZGP1, DES, and LGR6 were correlated with refractory epilepsy for the first time.", {"entities": [[43, 48, "GENE"], [50, 55, "GENE"], [57, 60, "GENE"], [66, 70, "GENE"]]}], ["Although general trends of differentially enriched gene ontology terms and Kyoto Encyclopedia of Genes and Genome pathways in this study are consistent with previous researches, differences also exist in many specific gene ontology terms and Kyoto Encyclopedia of Genes and Genome pathways.", {"entities": []}], ["These findings provide a new genome-wide profiling of DNA methylation and gene expression in brain tissues of patients with refractory epilepsy, which may provide a basis for further study on the etiology and mechanisms of refractory epilepsy.", {"entities": []}], ["There is general consensus that appropriate development and use of information and communication technologies (ICT) are crucial in the delivery of effective primary care (PC).", {"entities": [[171, 173, "GENE"]]}], ["Several countries are defining policies to support and promote a structural change of the health care system through the introduction of ICT.", {"entities": []}], ["This study analyses the state of development of basic ICT in PC systems of 31 European countries with the aim to describe the extent of, and main purposes for, computer use by General Practitioners (GPs) across Europe.", {"entities": [[61, 63, "GENE"]]}], ["Additionally, trends over time have been analysed.", {"entities": []}], ["Descriptive statistical analysis was performed on data from the QUALICOPC (Quality and Costs of Primary Care in Europe) survey, to describe the geographic differences in the general use of computer, and in specific computerized clinical functions for different health-related purposes such as prescribing, medication checking, generating health records and research for medical information on the Internet.", {"entities": []}], ["While all the countries have achieved a near-universal adoption of a computer in their primary care practices, with only a few countries near or under the boundary of 90\u00a0%, the computerisation of primary care clinical functions presents a wide variability of adoption within and among countries and, in several cases (such as in the southern and central-eastern Europe), a large room for improvement.", {"entities": []}], ["At European level, more efforts could be done to support southern and central-eastern Europe in closing the gap in adoption and use of ICT in PC.", {"entities": [[142, 144, "GENE"]]}], ["In particular, more attention seems to be need on the current usages of the computer in PC, by focusing policies and actions on the improvement of the appropriate usages that can impact on quality and costs of PC and can facilitate an interconnected health care system.", {"entities": [[88, 90, "GENE"], [210, 212, "GENE"], [88, 90, "GENE"], [210, 212, "GENE"]]}], ["However, policies and investments seem necessary but not sufficient to achieve these goals.", {"entities": []}], ["Organizational, behavioural and also networking aspects should be taken in consideration.", {"entities": []}], ["Chick embryonic stem cells (cESCs) can be derived from cells obtained from stage X embryos (blastoderm stage); these have the ability to contribute to all somatic lineages in chimaeras, but not to the germ line.", {"entities": []}], ["However, lines of stem cells that are able to contribute to the germ line can be established from chick primordial germ cells (cPGCs) and embryonic germ cells (cEGCs).", {"entities": []}], ["This review provides information on avian stem cells, emphasizing different sources of cells and current methods for derivation and culture of pluripotent cells from chick embryos.", {"entities": []}], ["We also review technologies for isolation and derivation of chicken germ cells and the production of transgenic birds.", {"entities": []}], ["\u2022 Chick embryonic stem cells (cESCs) can be derived from a variety of sources.", {"entities": []}], ["\u2022 cESCs can contribute to all somatic cell types but not to the germ line.", {"entities": []}], ["\u2022 germ cells can be isolated from early embryos, embryonic blood and gonads.", {"entities": []}], ["\u2022 germ cells can establish self-renewing lines and contribute to the germline.", {"entities": []}], ["Chick embryonic stem cells (cESCs) can be derived from a variety of sources.", {"entities": []}], ["cESCs can contribute to all somatic cell types but not to the germ line.", {"entities": []}], ["germ cells can be isolated from early embryos, embryonic blood and gonads.", {"entities": []}], ["germ cells can establish self-renewing lines and contribute to the germline.", {"entities": []}], ["Early hospital readmissions, defined as rehospitalization within 30 days from a previous discharge, represent an economic and social burden for public health management.", {"entities": []}], ["As data about early readmission in Italy are scarce, we aimed to relate the phenomenon of 30-day readmission to factors identified at the time of emergency department (ED) visits in subjects admitted to medical wards of a general hospital in Italy.", {"entities": []}], ["We performed a retrospective 30-month observational study, evaluating all patients admitted to the Department of Medicine of the Hospital of Ferrara, Italy.", {"entities": []}], ["Our study compared early and late readmission: patients were evaluated on the basis of the ED admission diagnosis and classified differently on the basis of a concordant or discordant readmission diagnosis in respect to the diagnosis of a first hospitalization.", {"entities": []}], ["Out of 13,237 patients admitted during the study period, 3,631 (27.4%) were readmitted; of those, 656 were 30-day rehospitalizations (5% of total admissions).", {"entities": []}], ["Early rehospitalization occurred 12 days (median) later than previous discharge.", {"entities": []}], ["The most frequent causes of rehospitalization were cardiovascular disease (CVD) in 29.3% and pulmonary disease (PD) in 29.7% of cases.", {"entities": []}], ["Patients admitted with the same diagnosis were younger, had lower length of stay (LOS) and higher prevalence of CVD, PD and cancer.", {"entities": [[124, 130, "DISEASE"]]}], ["Age, CVD and PD were independently associated with 30-day readmission with concordant diagnosis and kidney disease with 30-day rehospitalization with a discordant diagnosis.", {"entities": [[100, 114, "DISEASE"]]}], ["Comorbid patients are at higher risk for 30-day readmission.", {"entities": []}], ["Reduction of LOS, especially in elderly subjects, could increase early rehospitalization rates.", {"entities": []}], ["Cathepsins S (CatS) has been implicated in numerous tumourigenic processes and here we document for the first time its involvement in CCL2 regulation within the tumour microenvironment.", {"entities": [[134, 138, "GENE"]]}], ["Analysis of syngeneic tumours highlighted reduced infiltrating macrophages in CatS depleted tumours.", {"entities": []}], ["Interrogation of tumours and serum revealed genetic ablation of CatS leads to the depletion of several pro-inflammatory chemokines, most notably, CCL2.", {"entities": [[146, 150, "GENE"]]}], ["This observation was validated in vitro , where shRNA depletion of CatS resulted in reduced CCL2 expression.", {"entities": [[92, 96, "GENE"]]}], ["This regulation is transcriptionally mediated, as evident from RT-PCR analysis and CCL2 promoter studies.", {"entities": [[83, 87, "GENE"]]}], ["We revealed that CatS regulation of CCL2 is modulated through CD74 (also known as the invariant chain), a known substrate of CatS and a mediator of NFkB activity.", {"entities": [[36, 40, "GENE"], [62, 66, "GENE"]]}], ["Furthermore, CatS and CCL2 show a strong clinical correlation in brain, breast and colon tumours.", {"entities": [[22, 26, "GENE"]]}], ["In summary, these results highlight a novel mechanism by which CatS controls CCL2, which may present a useful pharmacodynamic marker for CatS inhibition.", {"entities": [[77, 81, "GENE"]]}], ["The biological basis of pain in chronic pancreatitis is poorly understood.", {"entities": [[40, 52, "DISEASE"]]}], ["Mast cells have been implicated in the pathogenesis of pain in other conditions.", {"entities": []}], ["We hypothesized that mast cells play a role in the pain of chronic pancreatitis.", {"entities": [[67, 79, "DISEASE"]]}], ["We examined the association of pain with mast cells in autopsy specimens of patients with painful chronic pancreatitis.", {"entities": [[106, 118, "DISEASE"]]}], ["We explored our hypothesis further using an experimental model of trinitrobenzene sulfonic acid (TNBS) -induced chronic pancreatitis in both wild type (WT) and mast cell deficient mice (MCDM).", {"entities": [[120, 132, "DISEASE"]]}], ["Archival tissues with histological diagnoses of chronic pancreatitis were identified and clinical records reviewed for presence or absence of reported pain in humans.", {"entities": [[56, 68, "DISEASE"]]}], ["Mast cells were counted.", {"entities": []}], ["The presence of pain was assessed using von Frey Filaments (VFF) to measure abdominal withdrawal responses in both WT and MCDM mice with and without chronic pancreatitis.", {"entities": [[157, 169, "DISEASE"]]}], ["Humans with painful chronic pancreatitis demonstrated a 3.5-fold increase in pancreatic mast cells as compared with those with painless chronic pancreatitis.", {"entities": [[28, 40, "DISEASE"], [144, 156, "DISEASE"]]}], ["WT mice with chronic pancreatitis were significantly more sensitive as assessed by VFF pain testing of the abdomen when compared with MCDM.", {"entities": [[21, 33, "DISEASE"]]}], ["Humans with painful chronic pancreatitis have an increased number of pancreatic mast cells as compared with those with painless chronic pancreatitis.", {"entities": [[28, 40, "DISEASE"], [136, 148, "DISEASE"]]}], ["MCDM are less sensitive to mechanical stimulation of the abdomen after induction of chronic pancreatitis as compared with WT.", {"entities": [[92, 104, "DISEASE"]]}], ["Mast cells may play an important role in the pathogenesis of pain in chronic pancreatitis.", {"entities": [[77, 89, "DISEASE"]]}], ["Patients with distinctive morphotype were more susceptible to nontuberculous mycobacterial lung disease (NTM-LD).", {"entities": [[91, 103, "DISEASE"]]}], ["However, little is known about the association between body morphotype and progression of NTM-LD.", {"entities": []}], ["The aim of this study was to elucidate predictors of NTM-LD progression, focusing on body morphotype and composition.", {"entities": []}], ["Data from patients with NTM-LD who participated in NTM cohort which started in 1 July 2011 were analyzed.", {"entities": [[24, 27, "GENE"], [51, 54, "GENE"]]}], ["Patients with more than 6\u00a0months of follow up were included for analysis.", {"entities": []}], ["NTM-LD progression was defined as clinician-initiated anti-NTM treatment, based on symptomatic and radiologic aggravation.", {"entities": []}], ["Body morphotype and composition was measured at entry to the cohort using bioelectrical impedance analysis.", {"entities": []}], ["NTM-LD progressed in 47 out of 150 patients with more than 6\u00a0months of follow up.", {"entities": []}], ["Patients with middle (adjusted hazard ratio [aHR], 2.758; 95% confidence interval [CI], 1.112\u20136.843) or lowest tertile (aHR, 3.084; 95% CI, 1.241\u20137.668) of abdominal fat ratio had a higher risk of disease progression compared with the highest tertile.", {"entities": [[45, 48, "GENE"], [120, 123, "GENE"], [45, 48, "GENE"], [120, 123, "GENE"]]}], ["Other predictors for disease progression were presence of cavity on chest computed tomography (aHR, 4.577; 95% CI, 2.364\u20138.861), and serum albumin level <3.5\u00a0g/dL (aHR, 12.943; 95% CI, 2.588\u201364.718).", {"entities": [[95, 98, "GENE"], [164, 167, "GENE"], [95, 98, "GENE"], [164, 167, "GENE"]]}], ["Progression of NTM-LD is associated with body composition.", {"entities": []}], ["Lower abdominal fat ratio is an independent predictor of NTM-LD progression.", {"entities": []}], ["ClinicalTrials.gov, NCT01616745 Registered 25 March 2012", {"entities": []}], ["Allergy is commoner in developed than in developing countries.", {"entities": []}], ["Chronic worm infections show inverse associations with allergy, and prenatal exposures may be critical to allergy risk.", {"entities": []}], ["To determine whether anthelminthic treatment during pregnancy increases the risk of allergy in infancy.", {"entities": []}], ["A randomised, double-blind, placebo-controlled trial on treatment in pregnancy with albendazole versus placebo and praziquantel versus placebo was conducted in Uganda, with a 2 \u00d7 2 factorial design; 2507 women were enrolled; infants\u2019 allergy events were recorded prospectively.", {"entities": []}], ["The main outcome was doctor-diagnosed infantile eczema.", {"entities": []}], ["Worms were detected in 68% of women before treatment.", {"entities": []}], ["Doctor-diagnosed infantile eczema incidence was 10.4/100 infant years.", {"entities": []}], ["Maternal albendazole treatment was associated with a significantly increased risk of eczema [Cox HR (95% CI), p: 1.82 (1.26\u20132.64), 0.002]; this effect was slightly stronger among infants whose mothers had no albendazole-susceptible worms than among infants whose mothers had such worms, although this difference was not statistically significant.", {"entities": [[97, 99, "GENE"]]}], ["Praziquantel showed no effect overall but was associated with increased risk among infants of mothers with Schistosoma mansoni [2.65 (1.16\u20136.08), interaction p = 0.02].", {"entities": []}], ["In a sample of infants, skin prick test reactivity and allergen-specific IgE were both associated with doctor-diagnosed eczema, indicating atopic aetiology.", {"entities": []}], ["Albendazole was also strongly associated with reported recurrent wheeze [1.58 (1.13\u20132.22), 0.008]; praziquantel showed no effect.", {"entities": []}], ["The detrimental effects of treatment suggest that exposure to maternal worm infections in utero may protect against eczema and wheeze in infancy.", {"entities": []}], ["The results for albendazole are also consistent with a direct drug effect.", {"entities": []}], ["Further studies are required to investigate mechanisms of these effects, possible benefits of worms or worm products in primary prevention of allergy, and the possibility that routine deworming during pregnancy may promote allergic disease in the offspring.", {"entities": []}], ["Despite chemotherapy, patients with cured pulmonary tuberculosis may result in lung functional impairment.", {"entities": [[52, 64, "DISEASE"], [42, 64, "DISEASE"]]}], ["To evaluate a novel scoring system based on the degree of radiographic abnormalities and related spirometric values in patients with cured pulmonary tuberculosis.", {"entities": [[149, 161, "DISEASE"], [139, 161, "DISEASE"]]}], ["One hundred and twenty seven patients with cured pulmonary tuberculosis were prospectively enrolled in a referral hospital specializing in respiratory diseases.", {"entities": [[59, 71, "DISEASE"], [49, 71, "DISEASE"]]}], ["Spirometry was performed and the extent of radiographic abnormalities was evaluated twice by each of two readers to generate a novel quantitative score.", {"entities": []}], ["Scoring reproducibility was analyzed by the intra-class correlation coefficient (ICC) and the Bland-Altman method.", {"entities": []}], ["Multiple linear regression models were performed to assess the association of the extent of radiographic abnormalities with spirometric values.", {"entities": []}], ["The intra-observer agreement for scoring of radiographic abnormalities (SRA) showed an ICC of 0.81 (CI:95%, 0.67\u20130.95) and 0.78 (CI:95%, 0.65\u20130.92), for reader 1 and 2, respectively.", {"entities": []}], ["Inter-observer reproducibility for the first measurement was 0.83 (CI:95%, 0.71\u20130.95), and for the second measurement was 0.74 (CI:95%, 0.58\u20130.90).", {"entities": []}], ["The Bland-Altman analysis of the intra-observer agreement showed a mean bias of 0.87% and -0.55% and an inter-observer agreement of -0.35% and -1.78%, indicating a minor average systematic variability.", {"entities": []}], ["After adjustment for age, gender, height, smoking status, pack-years of smoking, and degree of dyspnea, the scoring degree of radiographic abnormalities was significantly and negatively associated with absolute and percent predicted values of FVC: -0.07 (CI:95%, -0.01 to -0.04); -2.48 (CI:95%, -3.45 to -1.50); and FEV 1 -0.07 (CI:95%, -0.10 to -0.05); -2.92 (CI:95%, -3.87 to -1.97) respectively, in the patients studied.", {"entities": [[316, 319, "GENE"]]}], ["The extent of radiographic abnormalities, as evaluated through our novel scoring system, was inversely associated with spirometric values, and exhibited good reliability and reproducibility.", {"entities": []}], ["As intra-observer and inter-observer agreement of the SRA varied from good to excellent, the use of SRA in this setting appears acceptable.", {"entities": []}], ["White blood cell (WBC) count is a common clinical measure from complete blood count assays, and it varies widely among healthy individuals.", {"entities": []}], ["Total WBC count and its constituent subtypes have been shown to be moderately heritable, with the heritability estimates varying across cell types.", {"entities": []}], ["We studied 19,509 subjects from seven cohorts in a discovery analysis, and 11,823 subjects from ten cohorts for replication analyses, to determine genetic factors influencing variability within the normal hematological range for total WBC count and five WBC subtype measures.", {"entities": []}], ["Cohort specific data was supplied by the CHARGE, HeamGen, and INGI consortia, as well as independent collaborative studies.", {"entities": []}], ["We identified and replicated ten associations with total WBC count and five WBC subtypes at seven different genomic loci (total WBC count\u20146p21 in the HLA region, 17q21 near ORMDL3 , and CSF3 ; neutrophil count\u201417q21; basophil count- 3p21 near RPN1 and C3orf27 ; lymphocyte count\u20146p21, 19p13 at EPS15L1 ; monocyte count\u20142q31 at ITGA4 , 3q21, 8q24 an intergenic region, 9q31 near EDG2 ), including three previously reported associations and seven novel associations.", {"entities": [[150, 153, "GENE"], [173, 179, "GENE"], [186, 190, "GENE"], [243, 247, "GENE"], [294, 301, "GENE"], [327, 332, "GENE"]]}], ["To investigate functional relationships among variants contributing to variability in the six WBC traits, we utilized gene expression- and pathways-based analyses.", {"entities": []}], ["We implemented gene-clustering algorithms to evaluate functional connectivity among implicated loci and showed functional relationships across cell types.", {"entities": []}], ["Gene expression data from whole blood was utilized to show that significant biological consequences can be extracted from our genome-wide analyses, with effect estimates for significant loci from the meta-analyses being highly corellated with the proximal gene expression.", {"entities": []}], ["In addition, collaborative efforts between the groups contributing to this study and related studies conducted by the COGENT and RIKEN groups allowed for the examination of effect homogeneity for genome-wide significant associations across populations of diverse ancestral backgrounds.", {"entities": []}], ["WBC traits are highly variable, moderately heritable, and commonly assayed as part of clinical complete blood count (CBC) examinations.", {"entities": []}], ["The counts of constituent cell subtypes comprising the WBC count measure are assayed as part of a standard clinical WBC differential test.", {"entities": []}], ["In this study we employed meta-analytic techniques and identified ten associations with WBC measures at seven genomic loci in a large sample set of over 31,000 participants.", {"entities": []}], ["Cohort specific data was supplied by the CHARGE, HeamGen, and INGI consortia, as well as independent collaborative studies.", {"entities": []}], ["We confirm previous associations of WBC traits with three loci and identified seven novel loci.", {"entities": []}], ["We also utilize a number of additional analytic methods to infer the functional relatedness of independently implicated loci across WBC phenotypes, as well as investigate direct functional consequences of these loci through analyses of genomic variation affecting the expression of proximal genes in samples of whole blood.", {"entities": []}], ["In addition, subsequent collaborative efforts with studies of WBC traits in African-American and Japanese cohorts allowed for the investigation of the effects of these genomic variants across populations of diverse continental ancestries.", {"entities": []}], ["Tumor metastasis plays a major role in the morbidity and mortality of cancer patients.", {"entities": [[70, 76, "DISEASE"]]}], ["Among solid tumors that undergo metastasis, there is often a predilection to metastasize to a particular organ with, for example, prostate cancer preferentially metastasizing to bones and colon cancer preferentially metastasizing to the liver.", {"entities": [[188, 200, "DISEASE"], [139, 145, "DISEASE"], [194, 200, "DISEASE"], [130, 145, "DISEASE"]]}], ["Although many factors are thought to be important in establishing permissiveness for metastasis, the reasons for organ-specific predilection of each tumor are not understood.", {"entities": []}], ["Using a B16 murine melanoma model, we tested the hypothesis that organ-specific NK cell subsets play a critical role in organ-specific metastasis of this tumor.", {"entities": [[19, 27, "DISEASE"]]}], ["Melanoma cells, given intravenously, readily colonized the lungs but not the liver.", {"entities": [[0, 8, "DISEASE"]]}], ["NK cell depletion (either iatrogenically or by using genetically targeted mice) resulted in substantial hepatic metastasis.", {"entities": []}], ["Analysis of NK cell subsets, defined by the differential expression of a combination of CD27 and CD11b, indicated a significant difference in the distribution of NK cell subsets in the lung and liver with the mature subset being dominant in the lung and the immature subset being dominant in the liver.", {"entities": [[88, 92, "GENE"]]}], ["Several experimental approaches, including adoptive transfer, clearly indicated that the immature hepatic NK cell subset, CD27+ CD11b\u2013, was protective against liver metastasis; this subset mediated its protection by a perforin-dependent cytotoxic mechanism.", {"entities": []}], ["In contrast, the more mature NK cell subsets were more efficient at reducing pulmonary tumor load.", {"entities": []}], ["These data indicate that organ-specific immune responses may play a pivotal role in determining the permissiveness of a given organ for the establishment of a metastatic niche.", {"entities": []}], ["Pulmonary metastases are the major cause of death of osteosarcoma (OS) patients.", {"entities": [[53, 65, "DISEASE"]]}], ["Endothelin-1 (ET-1) reportedly plays an important role in OS metastasis.", {"entities": []}], ["In the present study, we for the first time explored the association of ET-1 SNPs with the risk of pulmonary metastatic OS.", {"entities": []}], ["We genotyped three SNPs (rs1800541, rs2070699 and rs5370) in the ET-1 gene in a case-control study, using 260 pairs of age-, sex-, residence area- and tumor location-matched subjects.", {"entities": []}], ["Patients with pulmonary metastatic OS and patients with localized high-grade (stage IIB) OS were enrolled as cases and controls, respectively.", {"entities": []}], ["The G allele at rs1800541 was found associated with reduced risk of pulmonary metastatic OS after adjustment for body mass index, systolic blood pressure, diastolic blood pressure and the plasma ET-1 level ( P =10 P =0.15; adjusted OR, 1.15; 95% CI, 0.87-1.50).", {"entities": []}], ["The mRNA and the secreted protein levels of ET-1 in primary OS cell cultures (POCCs) established from surgically resected primary OS in the rs1800541 TT homozygotes were higher than those from the TG heterozygotes ( P <0.05), who in turn showed higher ET-1 mRNA and secreted ET-1 levels than the GG homozygotes ( P <0.05).", {"entities": [[197, 199, "GENE"]]}], ["In the control subjects, the rs1800541 TT homozygotes showed an 18.4% relapse rate, significantly higher than that of the GG homozygotes (0%) ( P <0.01).", {"entities": []}], ["On the other hand, the GG homozygotes showed a 71.4% complete recovery rate, significantly higher than that of the TG heterozygotes (7.3%) and the TT homozygotes (0%) ( P <0.01).", {"entities": [[115, 117, "GENE"]]}], ["This study provides the first evidence of an association between the ET-1 gene SNPs and the risk of pulmonary metastatic OS.", {"entities": []}], ["Relationship between low-level air pollution and stroke is conflicting.", {"entities": []}], ["This study was conducted to document the relationship between outdoor air pollution and ischaemic stroke occurrence.", {"entities": []}], ["Time-stratified case-crossover analysis.", {"entities": []}], ["University Hospital of Nice, France.", {"entities": []}], ["All consecutive patients with ischaemic stroke living in Nice admitted in the University Hospital of Nice (France) between January 2007 and December 2011.", {"entities": []}], ["Association (adjusted OR) between daily levels of outdoor pollutants (ozone (O 3 ), nitrogen dioxide (NO 2 ), particulate matter (PM10) and sulfur dioxide (SO 2 )) and ischaemic stroke occurrence.", {"entities": []}], ["1729 patients with ischaemic stroke (mean age: 76.1\u00b114.0\u2005years; men: 46.7%) were enrolled.", {"entities": []}], ["No significant association was found between stroke occurrence and short-term effects of all pollutants tested.", {"entities": []}], ["In stratified analysis, we observed significant associations only between recurrent (n=280) and large artery ischaemic stroke (n=578) onset and short-term effect of O 3 exposure.", {"entities": []}], ["For an increase of 10\u2005\u00b5g/m 3 level, recurrent stroke risk (mean D-1, D-2 and D-3 lag) was increased by 12.1% (95% CI 1.5% to 23.9%) and large artery stroke risk (mean D-3 and D-4 lag) was increased by 8% (95% CI 2.0% to 16.6%).", {"entities": []}], ["Linear dose\u2013response relationship for both subgroups was found.", {"entities": []}], ["Our results confirm the relationship between low-level O 3 exposure and ischaemic stroke in high vascular risk subgroup with linear exposure\u2013response relation, independently of other pollutants and meteorological parameters.", {"entities": []}], ["The physiopathological processes underlying this association between ischaemic stroke and O 3 exposure remain to be investigated.", {"entities": []}], ["The aim of the paper was to asses the relationship between socioeconomic status, the prevalence of allergy and physical development.", {"entities": []}], ["The data were obtained from 478 female students and 195 male students aged 19-24.", {"entities": []}], ["The prevalence of allergy in the group surveyed was 14.6% (14.6% in women and 14.4% in men).", {"entities": []}], ["Allergic diseases were more frequent in students of high socioeconomic status.", {"entities": []}], ["The results of the analysis of variance did not show any significant differences in anthropometric characteristics between students with and without allergies.", {"entities": []}], ["However, women and men with allergies diagnosed are on average shorter than people without allergies.", {"entities": []}], ["The dependency is also visible after adjusting for socioeconomic status.", {"entities": []}], ["As for the equal status groups, the people with allergies are always shorter than those without allergies.", {"entities": []}], ["Summarizing, the results of the tests presented indicate that allergic diseases may affect the growing process.", {"entities": []}], ["However, upon providing appropriate conditions, the growth of children with allergy is not different from the control population.", {"entities": []}], ["The Enterovirus genus of the Picornaviridae family comprises many important human pathogens, including polioviruses, rhinovirus, enterovirus A71, and enterovirus D68.", {"entities": []}], ["They cause a wide variety of diseases, ranging from mild to severe life-threatening diseases.", {"entities": []}], ["Currently, no effective vaccine is available against enteroviruses except for poliovirus.", {"entities": []}], ["Enteroviruses subvert the autophagic machinery to benefit their assembly, maturation, and exit from host.", {"entities": []}], ["Some enteroviruses spread between cells via a process described as autophagosome-mediated exit without lysis (AWOL).", {"entities": []}], ["The early and late phases of autophagy are regulated through various lipids and their metabolizing enzymes.", {"entities": []}], ["Some of these lipids and enzymes are specifically regulated by enteroviruses.", {"entities": []}], ["In the present review, we summarize the current understanding of the regulation of autophagic machinery by enteroviruses, and provide updates on recent developments in this field.", {"entities": []}], ["The management and treatment of adult asthma has been associated with utilization of health services.", {"entities": [[38, 44, "DISEASE"]]}], ["Objectives : First, to investigate the likelihood of health service utilization, including primary care, emergency department, and hospital stays, among persons diagnosed with an asthma condition relative to those that do not have an asthma condition.", {"entities": [[179, 185, "DISEASE"], [234, 240, "DISEASE"]]}], ["Second, to examine the likelihood of poor physical health among asthma respondents relative to those that do not have an asthma condition.", {"entities": [[64, 70, "DISEASE"], [121, 127, "DISEASE"]]}], ["Third, to demonstrate that these relationships vary with frequency of utilization.", {"entities": []}], ["Fourth, to discuss the magnitude of differences in frequent utilization between asthma and non-asthma respondents.", {"entities": [[80, 86, "DISEASE"], [95, 101, "DISEASE"]]}], ["Data Source : Data is derived from a random, stratified sampling of Hampton Roads adults, 18 years and older ( n = 1678).", {"entities": []}], ["Study Design : Study participants are interviewed to identify asthma diagnosis, access to primary care, frequency of emergency department utilization, hospital admissions, and days of poor physical health.", {"entities": [[62, 68, "DISEASE"]]}], ["Odds-ratios establish relationships with the covariates on the outcome variable.", {"entities": []}], ["Findings : Those with asthma are found more likely (OR 1.50, 95% CI 1.05\u20132.15) to report poor physical health relative to non-asthma study participants.", {"entities": [[22, 28, "DISEASE"], [126, 132, "DISEASE"]]}], ["Further, asthma respondents are found more likely (OR 4.23, 95% CI 1.56\u201311.69) to frequently utilize primary care that may be associated with the management of the condition and are also more likely to utilize treatment services, such as the emergency department (OR 1.87, 95% CI 1.32\u20132.65) and hospitalization (OR 2.21, 95% CI 1.39\u20133.50), associated with acute and episodic care.", {"entities": [[9, 15, "DISEASE"]]}], ["Further, it is a novel finding that these likelihoods increase with frequency of utilization for emergency department visits and hospital stays.", {"entities": []}], ["Conclusion : Continuity in care and better management of the diseases may result in less demand for emergency department services and hospitalization.", {"entities": []}], ["Health care systems need to recognize that asthma patients are increasingly more likely to be characterized as frequent utilizers of both primary and emergency department care as the threshold for what constitutes frequent utilization increases.", {"entities": [[43, 49, "DISEASE"]]}], ["Investments in prevention and better management of the chronic condition may result in less demand for acute care services, especially among high frequency utilizers.", {"entities": []}], ["Smoking, poor diet, and physical inactivity account for as much as 60% of cancer risk.", {"entities": [[74, 80, "DISEASE"]]}], ["Latinos experience profound disparities in health behaviors, as well as the cancers associated with them.", {"entities": []}], ["Currently, there is a dearth of controlled trials addressing these health behaviors among Latinos.", {"entities": []}], ["Further, to the best of our knowledge, no studies address all three behaviors simultaneously, are culturally sensitive, and are guided by formative work with the target population.", {"entities": []}], ["Latinos represent 14% of the U.S. population and are the fastest growing minority group in the country.", {"entities": []}], ["Efforts to intervene on these important lifestyle factors among Latinos may accelerate the elimination of cancer-related health disparities.", {"entities": [[106, 112, "DISEASE"]]}], ["The proposed study will evaluate the efficacy of an evidence-based and theoretically-driven Motivation And Problem Solving (MAPS) intervention, adapted and culturally-tailored for reducing cancer risk related to smoking, poor diet, and physical inactivity among high-risk Mexican-origin smokers who are overweight/obese (n\u2009=\u2009400).", {"entities": [[189, 195, "DISEASE"]]}], ["Participants will be randomly assigned to one of two groups: Health Education (HE) or MAPS (HE\u2009+\u2009up to 18 MAPS counseling calls over 18\u2009months).", {"entities": []}], ["Primary outcomes are smoking status, servings of fruits and vegetables, and both self-reported and objectively measured physical activity.", {"entities": []}], ["Outcome assessments will occur at baseline, 6\u2009months, 12\u2009months, and 18\u2009months.", {"entities": []}], ["The current study will contribute to a very limited evidence base on multiple risk factor intervention studies on Mexican-origin individuals and has the potential to inform both future research and practice related to reducing cancer risk disparities.", {"entities": [[227, 233, "DISEASE"]]}], ["An effective program targeting multiple cancer risk behaviors modeled after chronic care programs has the potential to make a large public health impact because of the dearth of evidence-based interventions for Latinos and the extended period of support that is provided in such a program.", {"entities": [[40, 46, "DISEASE"]]}], ["National Institutes of Health Clinical Trials Registry # NCT01504919", {"entities": []}], ["Inequalities between men and women in morbidity and mortality show a contrast, which has been called gender paradox.", {"entities": []}], ["Most studies evaluating this paradox were conducted in high-income countries and, until now, few investigations have been performed in Brazil.", {"entities": []}], ["This study aims to estimate the magnitude of inequalities between adult men and women in several dimensions: demographic and socioeconomic, health behaviors, morbidity, use of health services and mortality.", {"entities": []}], ["The data were obtained from population-based household survey carried out in Campinas (Campinas Health Survey 2008/09) corresponding to 957 people, and data from the Mortality Information System (MIS) between 2009 and 2011.", {"entities": []}], ["Prevalences and prevalence ratios were analyzed in order to verify the differences between men and women regarding socioeconomic and demographic variables, health behaviors, morbidities and consultations in the last two weeks.", {"entities": []}], ["Mortality rates and the ratio between coefficients considering the underlying causes of death were calculated.", {"entities": []}], ["Women had a greater disadvantage in socioeconomic indicators, chronic diseases diagnosed by a health professional and referred health problems as well as make more use of health services, while men presented higher frequency of most unhealthy behaviors and excessive mortality for all causes investigated.", {"entities": []}], ["The findings contribute to the discussion of gender paradox and demonstrate the need to employ health actions that consider the differences between men and women in the various health dimensions analyzed.", {"entities": []}], ["The premature male mortality from preventable causes was outstanding, making clear the need for more effective prevention and health promotion directed to this segment of the population.", {"entities": []}], ["Evidence suggests disparities in quality of care (QoC) indicators based on sex exist in adults diagnosed with diabetes; however, this research is limited.", {"entities": []}], ["Therefore, the objective of this research study was to assess differences in QOC indicators in a nationally representative sample of men and women with diabetes.", {"entities": []}], ["Cross-sectional study of 17,702 men and women (\u226518\u00a0years of age) with diabetes from the 2002\u20132011 Medical Expenditure Panel Survey Household Component.", {"entities": []}], ["Sex was the main predictor variable, and the dependent variables were five binary indicators to measure QOC, which included testing of hemoglobin A1c, examining feet annually, getting eyes dilated, checking blood pressure, and visiting the doctor annually.", {"entities": []}], ["Sample demographics by sex were assessed.", {"entities": []}], ["Unadjusted analyses were computed for descriptive statistics by sex and proportions of QOC indicators over time.", {"entities": []}], ["Logistic regression evaluated associations between QOC indicators and sex, while controlling for sociodemographic characteristics, time, and comorbid conditions.", {"entities": []}], ["Approximately 44% and 56% of the sample was comprised of men and women, respectively.", {"entities": []}], ["Unadjusted analyses showed significant differences in A1c testing ( p \u2009<\u20090.001) and foot examinations ( p \u2009=\u20090.002) for the entire sample, and significant differences in A1c testing ( p \u2009=\u20090.027), foot examinations ( p \u2009=\u20090.01), and dilated eye exams ( p \u2009=\u20090.026) among men and A1c testing ( p \u2009<\u20090.001) among women overtime.", {"entities": []}], ["Adjusted analyses found women to be significantly more likely to have dilated eye examinations during a given year (OR\u2009=\u20091.14; 95% CI 1.04, 1.24), to get their blood pressure checked by a doctor in a given year (OR\u2009=\u20091.44; 95% CI 1.13, 1.84), and to visit a doctor annually (OR\u2009=\u20091.39; 95% CI 1.22, 1.58) compared to men.", {"entities": []}], ["In this sample of adults with diabetes, women had significantly higher odds of receiving quality of care compared to men.", {"entities": []}], ["These findings suggest the importance of educating patients about appropriate metrics of diabetes management, especially men, and the need for continuous empowerment of women to receive proper and optimal care.", {"entities": []}], ["Additional research is needed to identify causes and reduce sex and gender disparities associated with diabetes quality of care.", {"entities": []}], ["Orosomucoid 1-like 3 (ORMDL3) gene was strongly linked with the development of asthma in genetic association studies, and its expression could be significantly induced by allergen in airway epithelial cells of mice.", {"entities": [[79, 85, "DISEASE"], [22, 28, "GENE"]]}], ["However, the expression mechanism of ORMDL3 was still unclear.", {"entities": [[37, 43, "GENE"]]}], ["Here we have identified and characterized the mouse ORMDL3 gene promoter.", {"entities": [[52, 58, "GENE"]]}], ["Deletion constructs of the 5\u2032 \ufb02anking region were fused to a luciferase reporter gene.", {"entities": []}], ["After transient transfection in mouse fibroblast cell line NIH3T3, a CRE (\u221227/\u221220) binding CREB was identified in the core promoter region.", {"entities": []}], ["Deletion or mutation of the CRE consensus sequence resulted in a significant loss of the promoter activity.", {"entities": []}], ["EMSA and ChIP assays demonstrated the binding of CREB to the core promoter.", {"entities": []}], ["Knocking down endogenous CREB led to a reduction in ORMDL3 expression.", {"entities": [[52, 58, "GENE"]]}], ["Conversely, overexpression of CREB up-regulated ORMDL3 expression.", {"entities": [[48, 54, "GENE"]]}], ["Moreover, forskolin, a PKA activator, could facilitate the phosphorylation of CREB, which in turn heightens ORMDL3 expression.", {"entities": [[108, 114, "GENE"]]}], ["H-89, a PKA-specific inhibitor, could significantly inhibit ORMDL3 expression.", {"entities": [[60, 66, "GENE"]]}], ["This study delineates the characterization of mouse ORMDL3 gene promoter and shows signaling pathway cAMP/PKA/CREB plays an important role in regulating ORMDL3 expression, which will be helpful for future animal model studies regarding the regulation or function of ORMDL3 gene.", {"entities": [[52, 58, "GENE"], [153, 159, "GENE"], [266, 272, "GENE"], [52, 58, "GENE"], [153, 159, "GENE"], [266, 272, "GENE"], [52, 58, "GENE"], [153, 159, "GENE"], [266, 272, "GENE"]]}], ["Acute bronchiolitis is the commonest cause of hospitalisation in infancy.", {"entities": [[6, 19, "DISEASE"]]}], ["Currently management consists of supportive care and oxygen.", {"entities": []}], ["A Cochrane review concluded that, \u201cnebulised 3\u00a0% saline may significantly reduce the length of hospital stay\u201d.", {"entities": []}], ["We conducted a systematic review of controlled trials of nebulised hypertonic saline (HS) for infants hospitalised with primary acute bronchiolitis.", {"entities": [[134, 147, "DISEASE"]]}], ["Searches to January 2015 involved: Cochrane Central Register of Controlled Trials; Ovid MEDLINE; Embase; Google Scholar; Web of Science; and, a variety of trials registers.", {"entities": []}], ["We hand searched Chest, Paediatrics and Journal of Paediatrics on 14 January 2015.", {"entities": []}], ["Reference lists of eligible trial publications were checked.", {"entities": []}], ["Randomised or quasi-randomised trials which compared HS versus either normal saline (+/\u2212 adjunct treatment) or no treatment were included.", {"entities": []}], ["Eligible studies involved children less than 2\u00a0years old hospitalised due to the first episode of acute bronchiolitis.", {"entities": [[104, 117, "DISEASE"]]}], ["Two reviewers extracted data to calculate mean differences (MD) and 95\u00a0% Confidence Intervals (CIs) for length of hospital stay (LoS\u2014primary outcome), Clinical Severity Score (CSS) and Serious Adverse Events (SAEs).", {"entities": []}], ["Meta-analysis was undertaken using a fixed effect model, supplemented with additional sensitivity analyses.", {"entities": []}], ["We investigated statistical heterogeneity using I Fifteen trials were included in the systematic review ( n \u2009=\u20091922), HS reduced mean LoS by 0.36, (95\u00a0% CI 0.50 to 0.22) days, but with considerable heterogeneity (I n \u2009=\u2009516; MD \u22121.36, CI \u22121.52, \u22121.20].", {"entities": []}], ["One trial reported one possible intervention related SAE, no other studies described intervention related SAEs.", {"entities": []}], ["There is disparity between the overall combined effect on LoS as compared with the negative results from the largest and most precise trials.", {"entities": []}], ["Together with high levels of heterogeneity, this means that neither individual trials nor pooled estimates provide a firm evidence-base for routine use of HS in inpatient acute bronchiolitis.", {"entities": [[177, 190, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12890-015-0140-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Liver fibrosis is an excessive wound-healing reaction that requires the participation of inflammatory cells and hepatic stellate cells (HSCs).", {"entities": []}], ["The pathogenesis of liver fibrosis caused by viruses and alcohol has been well characterized, but the molecular mechanisms underlying liver fibrosis induced by the liver fluke Clonorchis sinensis are poorly understood.", {"entities": []}], ["Lysophospholipase A (LysoPLA), which deacylates lysophospholipids, plays a critical role in mediating the virulence and pathogenesis of parasites and fungi; however, the roles of C. sinensis lysophospholipase A ( Cs LysoPLA) in C. sinensis -induced liver fibrosis remain unknown.", {"entities": [[213, 215, "GENE"]]}], ["A mouse macrophage cell line (RAW264.7) was cultured and treated with Cs LysoPLA.", {"entities": [[70, 72, "GENE"]]}], ["IL-25 and members of its associated signaling pathway were detected by performing quantitative real-time PCR, Western blotting and immunofluorescent staining.", {"entities": []}], ["A human hepatic stellate cell line (LX-2) was cultured and exposed to IL-25.", {"entities": []}], ["LX-2 cell activation markers were examined via quantitative real-time PCR, Western blotting and immunofluorescent staining.", {"entities": []}], ["Migration was analyzed in transwell plates.", {"entities": []}], ["Treating RAW264.7 cells with Cs LysoPLA significantly induced IL-25 expression.", {"entities": [[29, 31, "GENE"]]}], ["Elevated PKA, B-Raf, and ERK1/2 mRNA levels and phosphorylated B-Raf and ERK1/2 were detected in Cs LysoPLA-stimulated RAW264.7 cells.", {"entities": [[97, 99, "GENE"]]}], ["The PKA inhibitor H-89 weakened B-Raf and ERK1/2 phosphorylation whereas the AKT activator SC79 attenuated ERK1/2 phosphorylation in RAW264.7 cells.", {"entities": []}], ["Both H-89 and SC79 inhibited Cs LysoPLA-induced IL-25 upregulation.", {"entities": [[29, 31, "GENE"]]}], ["In addition, stimulation of LX-2 cells with IL-25 upregulated the expression of mesenchymal cell markers, including \u03b1-smooth muscle actin (\u03b1-SMA) and collagen type I (Collagen-I), and promoted cell migration.", {"entities": []}], ["Cs LysoPLA activates HSCs by upregulating IL-25 in macrophages through the PKA-dependent B-Raf/ERK1/2 pathway and potentially promotes hepatic fibrosis during C. sinensis infection.", {"entities": [[0, 2, "GENE"]]}], ["In the recent years, the number of drug\u2010 and multi\u2010drug\u2010resistant microbial strains has increased rapidly.", {"entities": []}], ["Therefore, the need to identify innovative approaches for development of novel anti\u2010infectives and new therapeutic targets is of high priority in global health care.", {"entities": []}], ["The detection of small RNAs (sRNAs) in bacteria has attracted considerable attention as an emerging class of new gene expression regulators.", {"entities": []}], ["Several experimental technologies to predict sRNA have been established for the Gram\u2010negative model organism Escherichia coli .", {"entities": []}], ["In many respects, sRNA screens in this model system have set a blueprint for the global and functional identification of sRNAs for Gram\u2010positive microbes, but the functional role of sRNAs in colonization and pathogenicity for Listeria monocytogenes , Staphylococcus aureus , Streptococcus pyogenes , Enterococcus faecalis and Clostridium difficile is almost completely unknown.", {"entities": []}], ["Here, we report the current knowledge about the sRNAs of these socioeconomically relevant Gram\u2010positive pathogens, overview the state\u2010of\u2010the\u2010art high\u2010throughput sRNA screening methods and summarize bioinformatics approaches for genome\u2010wide sRNA identification and target prediction.", {"entities": []}], ["Finally, we discuss the use of modified peptide nucleic acids (PNAs) as a novel tool to inactivate potential sRNA and their applications in rapid and specific detection of pathogenic bacteria.", {"entities": []}], ["Studies of potential adverse effects of traffic related air pollution (TRAP) on allergic disease have had mixed findings.", {"entities": []}], ["Nutritional studies to examine whether fish oil supplementation may protect against development of allergic disease through their anti-inflammatory actions have also had mixed findings.", {"entities": []}], ["Extremely few studies to date have considered whether air pollution and dietary factors such as fish oil intake may interact, which was the rationale for this study.", {"entities": []}], ["We conducted a secondary analysis of the Childhood Asthma Prevention Study (CAPS) birth cohort, where children were randomised to fish oil supplementation or placebo from early life to age 5\u00a0years.", {"entities": [[76, 80, "GENE"]]}], ["We examined interactions between supplementation and TRAP (using weighted road density at place of residence as our measure of traffic related air pollution exposure) with allergic disease and lung function outcomes at age 5 and 8\u00a0years.", {"entities": []}], ["Outcome information was available on approximately 400 children (~\u200970% of the original birth cohort).", {"entities": []}], ["Statistically significant interactions between fish oil supplementation and TRAP were seen for house dust mite (HDM), inhalant and all-allergen skin prick tests (SPTs) and for HDM-specific interleukin-5 response at age 5.", {"entities": []}], ["Adjusting for relevant confounders, relative risks (RRs) for positive HDM SPT were RR 1.74 (95% CI 1.22\u20132.48) per 100\u00a0m local road or 33.3\u00a0m of motorway within 50\u00a0m of the home for those randomised to the control group and 1.03 (0.76\u20131.41) for those randomised to receive the fish oil supplement.", {"entities": []}], ["The risk differential was highest in an analysis restricted to those who did not change address between ages 5 and 8\u00a0years.", {"entities": []}], ["In this sub-group, supplementation also protected against the effect of traffic exposure on pre-bronchodilator FEV 1 /FVC ratio.", {"entities": [[111, 114, "GENE"]]}], ["Results suggest that fish oil supplementation may protect against pro-allergic sensitisation effects of TRAP exposure.", {"entities": []}], ["Strengths of this analysis are that supplementation was randomised and independent of TRAP exposure, however, findings need to be confirmed in a larger experimental study with the interaction investigated as a primary hypothesis, potentially also exploring epigenetic mechanisms.", {"entities": []}], ["More generally, studies of adverse health effects of air pollution may benefit from considering potential effect modification by diet and other factors.", {"entities": []}], ["Australia New Zealand Clinical Trial Registry.", {"entities": []}], ["www.anzctr.org.au Registration: ACTRN12605000042640 , Date: 26th July 2005.", {"entities": []}], ["Retrospectively registered, trial commenced prior to registry availability.", {"entities": []}], ["The online version of this article (10.1186/s12940-018-0370-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Infection of the lung with Pseudomonas aeruginosa results in upregulation of nitric oxide synthases (NOS) and arginase expression, and both enzymes compete for L-arginine as substrate.", {"entities": []}], ["Nitric oxide (NO) production may be regulated by arginase as it controls L-arginine availability for NOS.", {"entities": []}], ["We here studied the effect of systemic arginase inhibition on pulmonary L-arginine metabolism in Pseudomonas pneumonia in the mouse.", {"entities": [[109, 118, "DISEASE"]]}], ["Mice (C57BL/6, 8\u201310 weeks old, female) underwent direct tracheal instillation of Pseudomonas (PAO-1)-coated agar beads and were treated by repeated intra-peritoneal injections of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) or PBS until lungs were harvested on day 3 of the infection.", {"entities": []}], ["L-arginine metabolites were quantified using liquid chromatography-tandem mass spectrometry, NO metabolites nitrate and nitrite by Griess reagent and cytokines by ELISA.", {"entities": []}], ["NO metabolite concentrations (48.5\u00b12.9 vs. 10.9\u00b12.3 \u00b5M, p<0.0001), as well as L-ornithine (29.6\u00b11.7 vs 2.3\u00b10.4 \u00b5M, p<0.0001), the product of arginase activity, were increased in Pseudomonas infected lungs compared to na\u00efve controls.", {"entities": []}], ["Concentrations of the NOS inhibitor asymmetric dimethylarginine (ADMA) were also increased (0.44\u00b10.02 vs. 0.16\u00b10.01 \u00b5M, p<0.0001).", {"entities": []}], ["Arginase inhibition in the infected animals resulted in a significant decrease in L-ornithine (14.6\u00b11.6 \u00b5M, p<0.0001) but increase in L-arginine concentration (p<0.001), L-arginine/ADMA ratio (p<0.001), L-arginine availability for NOS (p<0.001), and NO metabolite concentrations (67.3\u00b15.7 \u00b5M, p<0.05).", {"entities": []}], ["Arginase inhibitor treatment also resulted in an increase in NO metabolite levels in animals following intratracheal injection of LPS (p\u200a=\u200a0.015).", {"entities": []}], ["Arginase inhibition was not associated with an increase in inflammatory markers (IFN-\u03b3, IL-1\u03b2, IL-6, MIP-2, KC or TNF-\u03b1) in lung.", {"entities": []}], ["Concentrations of the L-ornithine-dependent polyamines putrescine, spermidine and spermine were increased in Pseudomonas infected lungs (p<0.001, respectively) but were unaffected by ABH treatment.", {"entities": []}], ["Systemic arginase inhibition with ABH during Pseudomonas pneumonia in mice results in an increase in pulmonary NO formation but no pro-inflammatory effect.", {"entities": [[57, 66, "DISEASE"]]}], ["Carbon black nanoparticles (CBNP) are mainly composed of carbon, with a small amount of other elements (including hydrogen and oxygen).", {"entities": []}], ["The toxicity of CBNP has been attributed to their large surface area, and through adsorbing intrinsically toxic substances, such as polycyclic aromatic hydrocarbons (PAH).", {"entities": []}], ["It is not clear whether a PAH surface coating changes the toxicological properties of CBNP by influencing their physicochemical properties, through the specific toxicity of the surface-bound PAH, or by a combination of both.", {"entities": []}], ["Printex IL-8/KC mRNA expression were determined in A549 and bronchial epithelial cells (16HBE14o-, Calu-3), mouse intrapulmonary airways and tracheal epithelial cells.", {"entities": []}], ["Overall toxicity was tested in a rat inhalation study according to Organization for Economic Co-operation and Development (OECD) criteria.", {"entities": []}], ["Effects on cytochrome monooxygenase ( Cyp ) mRNA expression, cell viability and mucociliary clearance were determined in acute exposure models using explanted murine trachea.", {"entities": []}], ["All particles had similar primary particle size, shape, hydrodynamic diameter and \u03b6-potential.", {"entities": []}], ["All PAH-containing particles had a comparable specific surface area that was approximately one third that of P90.", {"entities": []}], ["AS-PAH contained a mixture of PAH with expected higher toxicity than BaP or 9NA.", {"entities": []}], ["PAH-coating reduced some effects of P90 such as IL-8 mRNA expression and oxidative stress in A549 cells, granulocyte influx in the in vivo OECD experiment, and agglomeration of P90 and mucus release in the murine trachea ex vivo.", {"entities": []}], ["Furthermore, P90-BaP decreased particle transport speed compared to P90 at 10\u00a0\u03bcg/ml.", {"entities": []}], ["In contrast, PAH-coating induced IL-8 mRNA expression in bronchial epithelial cell lines, and Cyp mRNA expression and apoptosis in tracheal epithelial cells.", {"entities": []}], ["In line with the higher toxicity compared to P90-BaP and P90-9NA, AS-PAH had the strongest biological effects both ex vivo and in vivo .", {"entities": []}], ["Our results demonstrate that the biological effect of CBNP is determined by a combination of specific surface area and surface-bound PAH, and varies in different target cells.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-017-0189-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mucus hypersecretion is a distinguished feature of chronic inflammatory airway diseases.", {"entities": []}], ["Interestingly, in this condition thyroid function is impaired with decreased level of triiodothyronine (T3), indicating potential link between low level of T3 and mucus hypersecretion.", {"entities": []}], ["But the underlying mechanisms are poorly understood.", {"entities": []}], ["In this study we aimed to elucidate the effect of T3 on MUC5AC secretion in human bronchial epithelial HBE16 cells and further investigate how T3 regulates MUC5AC gene expression at transcriptional level.", {"entities": []}], ["By RT-PCR and ELISA we showed that T3 inhibited MUC5AC mRNA expression and protein secretion in HBE16 cells.", {"entities": []}], ["Furthermore, luciferase assay and site-directed mutagenesis analysis demonstrated that T3 repressed MUC5AC expression at transcriptional level and the mechanism might partly lie in the specific inhibition of Sp1 binding to the promoter.", {"entities": [[208, 211, "GENE"]]}], ["Our results suggest that decreased T3 level leads to the release of repression of MUC5AC expression and thus contributes to mucus hypersecretion.", {"entities": []}], ["Ill health in early life has a significant negative impact on school grades, grade repetition, educational level, and labor market outcomes.", {"entities": []}], ["However, less is known about qualitative socio-economic consequences of a health shock in childhood or adolescence.", {"entities": []}], ["We investigate the relationship between onset of type 1 diabetes up to age 15 and the probability of choosing and completing a health-oriented path at upper secondary and university level of education.", {"entities": []}], ["We analyze the Swedish Childhood Diabetes Register, the National Educational Register, and other population registers in Sweden for 2756 people with type 1 diabetes and 10,020 matched population controls.", {"entities": []}], ["Educational decisions are modeled as unsorted series of binary choices to assess the choice of educational field as a potential mechanism linking early life health to adult outcomes.", {"entities": []}], ["The analyses reject the hypothesis of no systematic differences in choice of educational field between people with and without type 1 diabetes at both levels.", {"entities": []}], ["The results are robust to selection on ability proxies and across sensitivity analysis.", {"entities": []}], ["We conclude that the observed pro health-oriented educational choices among people with type 1 diabetes in our data are consistent with disease onset in childhood and adolescence having qualitative impact on life-course choices.", {"entities": []}], ["To assess the prevalence and risk factors of overweight (OW) and obesity (OB) by BMI and abdominal obesity (AO) by waist-to-height ratio, (WHtR) among the Balearic Islands' adult population.", {"entities": [[65, 72, "DISEASE"], [99, 106, "DISEASE"]]}], ["Cross-sectional nutritional survey carried out in the Balearic Islands (2009-2010).", {"entities": []}], ["A random sample (n = 1,081) of young (18-35 years) and middle-aged adults (36-55 years) were interviewed and anthropometrically measured.", {"entities": []}], ["OW (BMI 25.0-29.9 kg/m The overall prevalence of OW/OB and AO was 29.4% (95% confidence interval (95% CI) 26.9-32.3%), 11.2% (95% CI 9.5-13.2%) and 33.1% (95% CI 30.4-36.0%), respectively.", {"entities": []}], ["Men showed higher prevalence of OW (35.9%, 95% CI 31.6-40.5%) and AO (37.9%, 95% CI 33.6-42.5%) than women (OW 24.9%, 95% CI 21.7-28.4%; AO 29.7%, 95%CI 26.2-33.4%).", {"entities": []}], ["Overall prevalence of OB was 11.8% (95% CI 9.1-15.1%) in men and 10.8% (95% CI 8.6-13.5%) in women.", {"entities": []}], ["Age and no leisure-time physical activity (LTPA) were main risk factors associated with OW/OB and AO.", {"entities": []}], ["Living with at least one child at home and to be married in men as well as to be unemployed, to be born in South America, and a low level of education in women were associated with AO.", {"entities": []}], ["Men showed higher prevalence of OW and AO than women.", {"entities": []}], ["In both sexes, age is the main risk factor associated with OW/OB and AO; in men also the absence of LTPA plays a significant role.", {"entities": []}], ["Krasnoyarsk region is a territory with the widespread risk factors for chronic obstructive pulmonary disease (COPD) such as tobacco smoke, air pollution, and occupational exposure.", {"entities": [[71, 108, "DISEASE"]]}], ["An assessment of COPD prevalence based on medical diagnosis statistics underestimates the true COPD prevalence.", {"entities": []}], ["This study aims to evaluate how medical examinations may increase the accuracy of estimates of COPD prevalence.", {"entities": []}], ["True COPD prevalence was estimated as a number of patients with the established disease diagnosis supplemented by the additional disease cases detected during medical examinations per 1,000 inhabitants of the region.", {"entities": []}], ["Official medical statistics data and the data collected from the Global Alliance against Chronic Respiratory Diseases program 2011 among 15,000 inhabitants of the region aged 18 years and older were analyzed.", {"entities": []}], ["This study revealed the COPD cases without official medical diagnosis.", {"entities": []}], ["The true prevalence of COPD is estimated to be two times higher than the prevalence estimates based on medical diagnosis statistics.", {"entities": []}], ["Undiagnosed and untreated cases of COPD result in severe COPD forms as well as addition of severe comorbidities.", {"entities": []}], ["Because of this, there is an increase in the index of potential years of life lost.", {"entities": []}], ["Conducting special medical examinations may increase the number of COPD cases detected at the early stages of the disease.", {"entities": []}], ["This, in turn, may reduce the overall burden of the disease for the population of the region.", {"entities": []}], ["To describe and evaluate the use of cognitive-based behaviour change techniques as interventions to improve medication adherence.", {"entities": []}], ["Systematic review and meta-analysis of interventions to improve medication adherence.", {"entities": []}], ["Search of the MEDLINE, EMBASE, PsycINFO, CINAHL and The Cochrane Library databases from the earliest year to April 2013 without language restriction.", {"entities": []}], ["References of included studies were also screened to identify further relevant articles.", {"entities": []}], ["We used predefined criteria to select randomised controlled trials describing a medication adherence intervention that used Motivational Interviewing (MI) or other cognitive-based techniques.", {"entities": []}], ["Data were extracted and risk of bias was assessed by two independent reviewers.", {"entities": []}], ["We conducted the meta-analysis using a random effects model and Hedges\u2019 g as the measure of effect size.", {"entities": []}], ["We included 26 studies (5216 participants) in the meta-analysis.", {"entities": []}], ["Interventions most commonly used MI, but many used techniques such as aiming to increase the patient's confidence and sense of self-efficacy, encouraging support-seeking behaviours and challenging negative thoughts, which were not specifically categorised.", {"entities": []}], ["Interventions were most commonly delivered from community-based settings by routine healthcare providers such as general practitioners and nurses.", {"entities": []}], ["An effect size (95% CI) of 0.34 (0.23 to 0.46) was calculated and was statistically significant (p\u2009<\u20090.001).", {"entities": []}], ["Heterogeneity was high with an I Cognitive-based behaviour change techniques are effective interventions eliciting improvements in medication adherence that are likely to be greater than the behavioural and educational interventions largely used in current practice.", {"entities": []}], ["Subgroup analyses suggest that these interventions are amenable to use across different populations and in differing manners without loss of efficacy.", {"entities": []}], ["These factors may facilitate incorporation of these techniques into routine care.", {"entities": []}], ["A large proportion of people living with hip or knee pain do not consult health care professionals.", {"entities": []}], ["Pain severity is often believed to be the main reason for help seeking in this population; however the evidence for this is contradictory.", {"entities": []}], ["This study explores the importance of several potential risk factors on help seeking across different practitioner groups, among adults living with chronic hip or knee pain in a large community sample.", {"entities": []}], ["Health care utilization, defined as having seen a family doctor (GP) during the past 12 months; or an allied health professional (AHP) or alternative therapist during the past 3 months, was assessed in a community based sample aged 35 or over and reporting pain in hip or knee.", {"entities": []}], ["Adjusted odds ratios were determined for social deprivation, rurality, pain severity, mobility, anxiety/depression, co-morbidities, and body mass index.", {"entities": []}], ["Of 1119 persons reporting hip or knee pain, 52% had pain in both sites.", {"entities": []}], ["Twenty-five percent of them had seen a doctor only, 3% an AHP only, and 4% an alternative therapist only.", {"entities": []}], ["Thirteen percent had seen more than one category of health care professionals, and 55% had not seen any health care professional.", {"entities": []}], ["In the multivariate model, factors associated with consulting a GP were mobility problems (OR 2.62 (1.64-4.17)), urban living (OR 2.40 (1.14-5.04) and pain severity (1.28 (1.13-1.44)).", {"entities": []}], ["There was also some evidence that obesity was associated with increased consultation (OR 1.72 (1.00-2.93)).", {"entities": [[34, 41, "DISEASE"]]}], ["Factors were similar for consultation with a combination of several health care professionals.", {"entities": []}], ["In contrast, seeing an alternative therapist was negatively associated with pain severity, anxiety and mobility problems (adjusting for age and sex).", {"entities": []}], ["Disability appears to be a more important determinant of help-seeking than pain severity or anxiety and depression, for adults with chronic pain in hip or knee.", {"entities": []}], ["The determinants of seeking help from alternative practitioners are different from determinants of consulting GPs, AHPs or a combination of different health care providers.", {"entities": []}], ["ICAM-1 is a major receptor for ~60% of human rhinoviruses, and non-typeable Haemophilus influenzae , two major pathogens in COPD.", {"entities": []}], ["Increased cell-surface expression of ICAM-1 in response to tobacco smoke exposure has been suggested.", {"entities": []}], ["We have investigated epithelial ICAM-1 expression in both the large and small airways, and lung parenchyma in smoking-related chronic airflow limitation (CAL) patients.", {"entities": []}], ["We evaluated epithelial ICAM-1 expression in resected lung tissue: 8 smokers with normal spirometry (NLFS); 29 CAL patients (10 small-airway disease; 9 COPD-smokers; 10 COPD ex-smokers); Controls (NC): 15 normal airway/lung tissues.", {"entities": []}], ["Immunostaining with anti-ICAM-1 monoclonal antibody was quantified with computerized image analysis.", {"entities": []}], ["The percent and type of cells expressing ICAM-1 in large and small airway epithelium and parenchyma were enumerated, plus percentage of epithelial goblet and submucosal glands positive for ICAM- 1.", {"entities": []}], ["A major increase in ICAM-1 expression in epithelial cells was found in both large ( p \u2009<\u20090.006) and small airways ( p \u2009<\u20090.004) of CAL subjects compared to NC, with NLFS being intermediate.", {"entities": []}], ["In the CAL group, both basal and luminal areas stained heavily for ICAM-1, so did goblet cells and sub-mucosal glands, however in either NC or NLFS subjects, only epithelial cell luminal surfaces stained.", {"entities": []}], ["ICAM-1 expression on alveolar pneumocytes (mainly type II) was slightly increased in CAL and NLFS ( p \u2009<\u20090.01).", {"entities": []}], ["Pack-years of smoking correlated with ICAM-1 expression ( r \u2009=\u20090.49; p \u2009<\u20090.03).", {"entities": []}], ["Airway ICAM-1 expression is markedly upregulated in CAL group, which could be crucial in rhinoviral and NTHi infections.", {"entities": []}], ["The parenchymal ICAM-1 is affected by smoking, with no further enhancement in CAL subjects.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0483-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["CD69 is rapidly upregulated on T cells upon activation.", {"entities": [[0, 4, "GENE"]]}], ["In this work we show that this is also the case for CD69 expression on dendritic cells (DC).", {"entities": [[52, 56, "GENE"]]}], ["Thus, the expression kinetics of CD69 on both cell types is reminiscent of the one of costimulatory molecules.", {"entities": [[33, 37, "GENE"]]}], ["Using mouse models of transgenic T cells, we aimed at evaluating the effect of monoclonal antibody (MAb)-based targeting and gene deficiency of CD69 expressed by either DC or T cells on the extent of antigen (Ag)-specific T cell priming, which could be the result of a putative role in costimulation as well as on DC maturation and Ag-processing and presentation.", {"entities": [[144, 148, "GENE"]]}], ["CD69 targeting or deficiency of DC did not affect their expression of costimulatory molecules nor their capacity to induce Ag-specific T cell proliferation in in vitro assays.", {"entities": [[0, 4, "GENE"]]}], ["Also, CD69 targeting or deficiency of transgenic T cells did not affect the minimal proliferative dose for different peptide agonists in vitro .", {"entities": [[6, 10, "GENE"]]}], ["In in vivo models of transgenic T cell transfer and local Ag injection, CD69 deficiency of transferred T cells did not affect the extent of the proliferative response in Ag-draining lymph nodes (LN).", {"entities": [[72, 76, "GENE"]]}], ["In agreement with these results, CD69 MAb targeting or gene deficiency of Vaccinia-virus (VACV) infected mice did not affect the endogenous formation of virus-specific CD8", {"entities": [[33, 37, "GENE"]]}], ["Magnesium was reported to reduce both the anesthetic requirements and the period needed to reach a bi-spectral index value of 60 when used intra-operatively (Br J Anaesth 83:302-20, 1999; Anesth Analg 20:1273-5, 1988; Br J Anaesth 89:594-8, 2002; Anesth Analg 87:206-10, 1998; Br J Anaesth 89:594-8, 2002; Br J Anaesth 94:438-41, 2005) and to minimize the emergence agitation (Anaesthesia 61:1058-63, 2006).", {"entities": []}], ["Previous studies examined the influence of magnesium on the anesthetic requirements while the bi-spectral Index values were kept within a constant range.", {"entities": []}], ["We evaluated the effect of intraoperative magnesium on the bi-spectral index values during pediatric anesthesia while we kept other anesthetic variables unchanged.", {"entities": []}], ["Eighty pediatric patients with ASA physical status I, age 2\u20138 years and scheduled for minor infra-umbilical elective procedures included in a prospective randomized controlled study.", {"entities": []}], ["We randomly divided patients into two groups.", {"entities": []}], ["Group I (40 patients); received a bolus dose 50\u00a0mg/kg of magnesium sulphate followed by an infusion at rate of 15\u00a0mg/kg/h throughout the procedure.", {"entities": []}], ["Group II (40 patients); received the same amount in the form of ringer acetate for blinding.", {"entities": []}], ["We compared between the groups regarding: 1) BIS values.", {"entities": []}], ["2) Hemodynamic parameters.", {"entities": []}], ["3) Arterial oxygen saturation 4) End-tidal CO2 5) Respiratory rate and 6) Tidal volume.", {"entities": []}], ["Magnesium group (Group I) showed significantly lower BIS values and shorter time to achieve BIS values below 60.", {"entities": []}], ["Respiratory parameters (tidal volume and respiratory rate) were significantly lower in the magnesium group.", {"entities": []}], ["Otherwise, no significant differences between the study group and the control group were detected.", {"entities": []}], ["Our study has the advantage of evaluating the direct effect of magnesium sulphate on the Bi-spectral index scale with keeping other intraoperative factors almost constant (as the type of operations, induction and maintenance techniques, end-tidal anesthetic concentration, analgesia and mode of ventilation) for accurate assessment.", {"entities": []}], ["Magnesium produced significantly lower BIS values, less time to reach BIS values below 60, lower tidal volume and lower respiratory rate during pediatric general anesthesia.", {"entities": []}], ["Pan African Clinical Trial Registry, www.pactr.org , PACTR201312000666231 .", {"entities": []}], ["Registered at 6 October 2013.", {"entities": []}], ["The treatment of chronic obstructive pulmonary disease (COPD) involves different care providers across care sites.", {"entities": [[17, 54, "DISEASE"]]}], ["This fragmentation of care increases the morbidity and mortality burden, as well as acute health services use.", {"entities": []}], ["The COPD-Integrated Care Pathway (ICP) was designed and implemented to integrate the care across different sites from primary care to acute hospital and home.", {"entities": []}], ["It aims to reduce the prevalence of COPD among the population in the catchment, reduce risk of hospital admissions, delay or prevent the progression of the disease and reduce mortality rate by adopting a coordinated and multidisciplinary approach to the management of the patients\u2019 medical conditions.", {"entities": []}], ["This study on the COPD-ICP programme is undertaken to determine the impact on processes of care, clinical outcomes and acute care utilisation.", {"entities": []}], ["This will be a retrospective, pre-post, matched-groups study to evaluate the effectiveness of the COPD-ICP programme in improving clinical outcomes and reducing healthcare costs.", {"entities": []}], ["Programme enrolees (intervention group) and non-enrolees (comparator group) will be matched using propensity scores.", {"entities": []}], ["Administratively, we set 30% as our target for proportion admission difference between programme and non-programme patients.", {"entities": []}], ["A sample size of 62 patients in each group will be needed for statistical comparisons to be made at 90% power.", {"entities": []}], ["Adherence with recommended care elements will be measured at baseline and quarterly during 1-year follow-up.", {"entities": []}], ["Risk of COPD-related hospitalisations as primary outcome, healthcare costs, disease progression and 1-year mortality during 1-year follow-up will be compared between the groups using generalised linear regression models.", {"entities": []}], ["This protocol describes the implementation and proposed evaluation of the COPD-ICP programme.", {"entities": []}], ["The described study has received ethical approval from the NHG Domain Specific Review Board (DSRB Ref: 2013/01200).", {"entities": []}], ["Results of the study will be reported through peer-review publications and presentations at healthcare conferences.", {"entities": []}], ["Maternal asthma is the most common chronic disease complicating pregnancy and is a risk factor for bronchiolitis in infancy.", {"entities": [[9, 15, "DISEASE"], [99, 112, "DISEASE"]]}], ["Recurrent episodes of bronchiolitis are strongly associated with the development of childhood asthma.", {"entities": [[94, 100, "DISEASE"], [22, 35, "DISEASE"]]}], ["We conducted a follow-up study of infants born to women with asthma who completed a double-blind randomised controlled trial during pregnancy.", {"entities": [[61, 67, "DISEASE"]]}], ["In this trial, pregnant women with asthma were assigned to treatment adjustment by an algorithm using clinical symptoms (clinical group) or the fraction of exhaled nitric oxide (FeNO group) and we showed that the FeNO group had significantly lower asthma exacerbation rates in pregnancy.", {"entities": [[35, 41, "DISEASE"], [248, 254, "DISEASE"]]}], ["146 infants attended the 12-month follow-up visit.", {"entities": []}], ["Infants born to mothers from the FeNO group were significantly less likely to have recurrent episodes of bronchiolitis in the first year of life (OR 0.08, 95% CI 0.01 to 0.62; p=0.016) as compared with the clinical group.", {"entities": [[105, 118, "DISEASE"]]}], ["Optimised management of asthma during pregnancy may reduce recurrent episodes of bronchiolitis in infancy, which could potentially modulate the risk to develop or the severity of emerging childhood asthma.", {"entities": [[24, 30, "DISEASE"], [198, 204, "DISEASE"], [81, 94, "DISEASE"]]}], ["COPD patients are often prescribed multiple medications for their respiratory disease and comorbidities.", {"entities": []}], ["This can lead to complex medication regimens resulting in poor adherence, medication errors, and drug\u2013drug interactions.", {"entities": []}], ["The relationship between clinical outcomes and medication burden beyond medication count in COPD is largely unknown.", {"entities": []}], ["The aim of this study was to explore the relationships of medication burden in COPD with clinical outcomes, comorbidities, and multidimensional indices.", {"entities": []}], ["In a cross-sectional study, COPD patients (n=222) were assessed for demographic information, comorbidities, medication use, and clinical outcomes.", {"entities": []}], ["Complexity of medication regimens was quantified using the validated medication regimen complexity index (MRCI).", {"entities": []}], ["Participants (58.6% males) had a mean (SD) age of 69.1 (8.3) years with a postbronchodilator forced expiratory volume in 1 second % predicted of 56.5 (20.4) and a median of five comorbidities.", {"entities": []}], ["The median ( q 1, q 3) total MRCI score was 24 (18.5, 31).", {"entities": []}], ["COPD-specific medication regimens were more complex than those of non-COPD medications (median MRCI: 14.5 versus 9, respectively; P <0.0001).", {"entities": []}], ["Complex dosage formulations contributed the most to higher MRCI scores of COPD-specific medications while dosing frequency primarily drove the complexity associated with non-COPD medications.", {"entities": []}], ["Participants in Global Initiative for Chronic Obstructive Lung Disease quadrant D had the highest median MRCI score for COPD medications (15.5) compared to those in quadrants A (13.5; P =0.0001) and B (12.5; P <0.0001).", {"entities": []}], ["Increased complexity of COPD-specific treatments showed significant but weak correlations with lower lung function and 6-minute walk distance, higher St George\u2019s Respiratory Questionnaire and COPD assessment test scores, and higher number of prior year COPD exacerbations and hospitalizations.", {"entities": []}], ["Comorbid cardiovascular, gastrointestinal, or metabolic diseases individually contributed to higher total MRCI scores and/or medication counts for all medications.", {"entities": []}], ["Charlson Comorbidity Index and COPD-specific comorbidity test showed the highest degree of correlation with total MRCI score ( \u03c1 =0.289 and \u03c1 =0.326; P <0.0001, respectively).", {"entities": []}], ["In COPD patients, complex medication regimens are associated with disease severity and specific class of comorbidities.", {"entities": []}], ["B cells participate in immune surveillance in human circulation and tissues, including tumors such as melanoma.", {"entities": [[102, 110, "DISEASE"]]}], ["By contrast, the role of humoral responses in cutaneous immunity is underappreciated.", {"entities": []}], ["We report circulating skin-homing CD22+CLA+B cells in healthy volunteers and melanoma patients (n\u2009=\u200973) and CD22+ cells in melanoma and normal skin samples (n\u2009=\u2009189).", {"entities": [[77, 85, "DISEASE"], [123, 131, "DISEASE"]]}], ["Normal and malignant skin featured mature IgG and CD22 mRNA, alongside mRNA for the transiently-expressed enzyme Activation-induced cytidine Deaminase (AID).", {"entities": [[50, 54, "GENE"]]}], ["Gene expression analyses of publically-available data (n\u2009=\u2009234 GEO, n\u2009=\u2009384 TCGA) confirmed heightened humoral responses (CD20, CD22, AID) in melanoma.", {"entities": [[142, 150, "DISEASE"], [128, 132, "GENE"]]}], ["Analyses of 51 melanoma-associated and 29 normal skin-derived IgG sequence repertoires revealed lower IgG1/IgG total representation compared with antibodies from circulating B cells.", {"entities": [[15, 23, "DISEASE"]]}], ["Consistent with AID, comparable somatic hypermutation frequencies and class-switching indicated affinity-matured antibodies in normal and malignant skin.", {"entities": []}], ["A melanoma-associated antibody subset featured shorter complementarity-determining (CDR3) regions relative to those from circulating B cells.", {"entities": [[2, 10, "DISEASE"]]}], ["Clonal amplification in melanoma-associated antibodies and homology modeling indicated differential potential antigen recognition profiles between normal skin and melanoma sequences, suggesting distinct antibody repertoires.", {"entities": [[24, 32, "DISEASE"], [163, 171, "DISEASE"]]}], ["Evidence for IgG-expressing B cells, class switching and antibody maturation in normal and malignant skin and clonally-expanded antibodies in melanoma, support the involvement of mature B cells in cutaneous immunity.", {"entities": [[142, 150, "DISEASE"]]}], ["Long term pulmonary exposure to crystalline silica leads to silicosis that manifests progressive interstitial fibrosis, eventually leading to respiratory failure and death.", {"entities": [[142, 161, "DISEASE"], [60, 69, "DISEASE"]]}], ["Despite efforts to eliminate silicosis, clinical cases continue to occur in both developing and developed countries.", {"entities": [[29, 38, "DISEASE"]]}], ["The exact mechanisms of crystalline silica-induced pulmonary fibrosis remain elusive.", {"entities": [[51, 69, "DISEASE"]]}], ["Herein, we find that 4-1BB is induced in response to crystalline silica injury in lungs and that it is highly expressed during development of experimental silicosis.", {"entities": [[155, 164, "DISEASE"]]}], ["Therefore, we explore the role of 4-1BB pathway during crystalline silica-induced lung injury and find that a specific inhibitor blocking the pathway could effectively alleviate crystalline silica-induced lung inflammation and subsequent pulmonary fibrosis in vivo.", {"entities": [[238, 256, "DISEASE"]]}], ["Compared to controls, the treated mice exhibited reduced Th1 and Th17 responses.", {"entities": []}], ["The concentrations of pro-inflammatory cytokines in bronchoalveolar lavage fluid (BALF), including tumor necrosis factor (TNF)-\u03b1, interferon (IFN)-\u03b3 and interleukin (IL)-17A following crystalline silica challenge were also reduced in inhibitor-treated mice.", {"entities": [[122, 125, "GENE"]]}], ["Although there was no significant alteration in Th2 cytokines of IL-4 and IL-13, another type of pro-fibrogenic cell, regulatory T cell (Treg) was significantly affected.", {"entities": []}], ["In addition, one of the major participants in fibrogenesis, fibrocyte recruited less due to the blockade.", {"entities": []}], ["Furthermore, we demonstrated the decreased fibrocyte recruitment was associated with chemokine reductions in lung.", {"entities": []}], ["Our study discovers the 4-1BB pathway signaling enhances inflammatory response and promotes pulmonary fibrosis induced by crystalline silica.", {"entities": [[92, 110, "DISEASE"]]}], ["The findings here provide novel insights into the molecular events that control crystalline silica-induced lung inflammation and fibrosis through regulating Th responses and the recruitment of fibrocytes in crystalline silica-exposed lung.", {"entities": []}], ["To explore the function of miR-34a in promotion of apoptosis by SYB.", {"entities": [[27, 34, "GENE"]]}], ["In this study, the most effective concentration of SYB was determined by measuring cell proliferation.", {"entities": []}], ["Relative miR-34a mRNA levels were detected by quantitative RT-PCR.", {"entities": [[9, 16, "GENE"]]}], ["Apoptosis was assessed using Annexin-V/PI assays, whereas protein levels of p53, caspase 3, caspase 9, caspase 8 and Bcl2 were evaluated by western blotting.", {"entities": [[117, 121, "GENE"]]}], ["Minimum HepG2 cell growth was observed after 36h of exposure to 150 nmol/L SYB.", {"entities": []}], ["miR-34a expression was highest 40min after the addition of SYB.", {"entities": [[0, 7, "GENE"]]}], ["SYB slightly decreased the abundance of Bcl-2, but increased the abundance of p53, caspase 3, caspase 9 and caspase 8.", {"entities": []}], ["SYB failed to alter miR-34a expression when p53 was inhibited.", {"entities": [[20, 27, "GENE"]]}], ["Bcl-2 abundance remained low over time, whereas the abundance of caspase 3, caspase 9 and caspase 8 gradually increased.", {"entities": []}], ["Inhibition of p53 promoted HepG2 cell growth in comparison with that of the control group.", {"entities": []}], ["miR-34a was silenced to assess the role of miR-34a in the inhibitory effect of SYB on HepG2 cell growth.", {"entities": [[0, 7, "GENE"], [43, 50, "GENE"], [0, 7, "GENE"], [43, 50, "GENE"]]}], ["When p53 was silenced, protein abundance of Bcl2, caspase 3, caspase 8 and caspase 9 remained unchanged following the addition of SYB; moreover, HepG2 cell growth was increased.", {"entities": [[44, 48, "GENE"]]}], ["SYB represents a promising therapeutic approach for liver cancer patients.", {"entities": [[52, 64, "DISEASE"], [58, 64, "DISEASE"]]}], ["The obesity epidemic is a threat to the health of millions and to the economic viability of healthcare systems, governments, businesses, and nations.", {"entities": [[4, 11, "DISEASE"]]}], ["A range of answers come to mind if and when we ask, \u201cWhat can we, health professionals (physicians, nurses, nutritionists, behavioral psychologists), do about this epidemic?\u201d In this paper, we describe the Common-Sense Model of Self-Regulation as a framework for organizing existent tools and creating new tools to improve control of the obesity epidemic.", {"entities": [[338, 345, "DISEASE"]]}], ["Further, we explain how the Common-Sense Model can augment existing behavior-change models, with particular attention to the strength of the Common-Sense Model in addressing assessment and weight maintenance beyond initial weight loss.", {"entities": []}], ["Daily diaries are often used to collect data on disease activity, but are burdensome and compliance may be poor.", {"entities": []}], ["Their use in chronic obstructive pulmonary disease (COPD) and impact on the prevention and treatment of exacerbations is poorly researched.", {"entities": [[13, 50, "DISEASE"]]}], ["We investigated diary-keeping in COPD and ascertained items that best predicted emergency attendances for exacerbations.", {"entities": []}], ["Participants in the active limb of a clinical trial in COPD kept daily diaries rating breathlessness, cough, sputum, physical activity, and use of reliever medication.", {"entities": []}], ["Data on 55 participants, 67% of whom were female, showed that overall compliance with diary-keeping was 62%.", {"entities": []}], ["Participants educated to primary school level only had lower compliance ( P = 0.05).", {"entities": []}], ["Twenty patients had at least one emergency attendance, in whom the relative risk of an acute exacerbation for an increase in item score rose from six days prior to hospitalization, most sharply in the last two days.", {"entities": []}], ["Even for optimal combinations of items, the positive predictive value was poor, the best combination being cough, activity level, and inhaler use.", {"entities": []}], ["Good compliance can be achieved using daily diaries in COPD, although this is worse in those with a poor educational level.", {"entities": []}], ["Diary-keeping is not accurate in predicting acute exacerbations, but could be substantially simplified without loss of efficiency.", {"entities": []}], ["Objective To determine whether higher past exposure to particulate air pollution is associated with prevalent high symptoms of anxiety.", {"entities": []}], ["Design Observational cohort study.", {"entities": []}], ["Setting Nurses\u2019 Health Study.", {"entities": []}], ["Participants 71\u2009271 women enrolled in the Nurses\u2019 Health Study residing throughout the contiguous United States who had valid estimates on exposure to particulate matter for at least one exposure period of interest and data on anxiety symptoms.", {"entities": []}], ["Main outcome measures Meaningfully high symptoms of anxiety, defined as a score of 6 points or greater on the phobic anxiety subscale of the Crown-Crisp index, administered in 2004.", {"entities": []}], ["Results The 71\u2009271 eligible women were aged between 57 and 85 years (mean 70 years) at the time of assessment of anxiety symptoms, with a prevalence of high anxiety symptoms of 15%.", {"entities": []}], ["Exposure to particulate matter was characterized using estimated average exposure to particulate matter <2.5 \u03bcm in diameter (PM 2.5 ) and 2.5 to 10 \u03bcm in diameter (PM 2.5-10 ) in the one month, three months, six months, one year, and 15 years prior to assessment of anxiety symptoms, and residential distance to the nearest major road two years prior to assessment.", {"entities": []}], ["Significantly increased odds of high anxiety symptoms were observed with higher exposure to PM 2.5 for multiple averaging periods (for example, odds ratio per 10 \u00b5g/m 2.5 : 1.12, 95% confidence interval 1.06 to 1.19; in prior 12 month average PM 2.5 : 1.15, 1.06 to 1.26).", {"entities": []}], ["Models including multiple exposure windows suggested short term averaging periods were more relevant than long term averaging periods.", {"entities": []}], ["There was no association between anxiety and exposure to PM 2.5-10 .", {"entities": []}], ["Residential proximity to major roads was not related to anxiety symptoms in a dose dependent manner.", {"entities": []}], ["Conclusions Exposure to fine particulate matter (PM 2.5 ) was associated with high symptoms of anxiety, with more recent exposures potentially more relevant than more distant exposures.", {"entities": []}], ["Research evaluating whether reductions in exposure to ambient PM 2.5 would reduce the population level burden of clinically relevant symptoms of anxiety is warranted.", {"entities": []}], ["Patients suffering from atopic dermatitis often describe food hypersensitivity.", {"entities": [[24, 41, "DISEASE"], [31, 41, "DISEASE"]]}], ["Rising prevalence of food hypersensitivity and severe allergic reactions to foods have been reported, but the data are scarce.", {"entities": []}], ["Evaluation of food hypersensitivity reactions in patients suffering from atopic dermatitis.", {"entities": [[73, 90, "DISEASE"], [80, 90, "DISEASE"]]}], ["The dermatological examination was performed in patients of age 14 years and above and the detailed history was taken concerning the food hypersensitivity.", {"entities": []}], ["A total of 228 patients were examined-72 men, 156 women, average age 26.2 (SD 9.5) years.", {"entities": []}], ["The food hypersensitivity reactions were recorded in 196 patients from 228 (86%), no reactions were recorded in 32 patients (24%).", {"entities": []}], ["Foods with the most often recorded reactions are: Nuts (in 35% of patients), tomatoes (in 20%), and kiwi (in 17, 5%), apples and spices (in 16%), tangerines and oranges (in 15%), capsicum (in 13%), fishes (in 12%), celery (in 9%), and chocolate (in 7%).", {"entities": []}], ["Food hypersensitivity reactions are recorded in 86% of patients suffering from atopic dermatitis.", {"entities": [[79, 96, "DISEASE"], [86, 96, "DISEASE"]]}], ["Nuts, tomatoes, and pollen\u2013associated foods play a role in the majority of patients suffering from atopic dermatitis.", {"entities": [[99, 116, "DISEASE"], [106, 116, "DISEASE"]]}], ["To evaluate the mRNA and protein expressions of NLRP3 inflammasome and its downstream inflammatory factors in human dry eye.", {"entities": [[48, 53, "GENE"]]}], ["We recruited 54 patients with Sj\u00f6gren\u2019s syndrome dry eye (SSDE), 50 patients with non-Sj\u00f6gren\u2019s syndrome dry eye (NSSDE), and 46 healthy controls.", {"entities": [[40, 48, "DISEASE"], [96, 104, "DISEASE"]]}], ["Tear film breakup time (TBUT), Schirmer I test, and fluorescein staining (FL) were performed on all subjects.", {"entities": []}], ["Tear samples were obtained to analyze the inflammatory cytokine levels of IL-1\u03b2 and IL-18 via enzyme-linked immunosorbent (ELISA).", {"entities": []}], ["Conjunctival impression cytology (CIC) specimens were collected to detect the mRNA expression of NLRP3, caspase-1, IL-1\u03b2, and IL-18 using quantitative RT-PCR, and the protein expression of NLRP3 and caspase-1 by Western blotting.", {"entities": [[34, 37, "GENE"], [97, 102, "GENE"], [189, 194, "GENE"], [97, 102, "GENE"], [189, 194, "GENE"]]}], ["NLRP3 mRNA expression showed higher levels in both dry eye groups compared with controls, with a comparably significant elevation in the SSDE group (relative 2.47-fold upregulation, p <0.05).", {"entities": [[0, 5, "GENE"]]}], ["NLRP3 protein expression was also increased in SSDE group (relative1.94-fold upregulation) compared with the controls.", {"entities": [[0, 5, "GENE"]]}], ["mRNA expression of caspase-1 was significantly upregulated in both SSDE (relative 1.44-fold upregulation, p <0.05) and NSSDE (relative 1.32-fold upregulation, p <0.05).", {"entities": []}], ["Procaspase-1 protein level was increased in SSDE (relative 1.84-fold upregulation) and NSSDE (relative 1.12-fold upregulation) versus controls; and caspase-1 protein expression was also increased in SSDE (relative 1.49-fold upregulation) and NSSDE (relative 1.17-fold upregulation) compared with the controls.", {"entities": []}], ["The patients with SSDE and NSSDE had higher IL-1\u03b2 and IL-18 mRNA values and protein expressions than the controls did.", {"entities": []}], ["The relative mRNA expression of IL-1\u03b2 upregulated 3.59-fold ( p <0.001) in SSDE and 2.13-fold ( p <0.01) in NSSDE compared with the controls.", {"entities": []}], ["IL-1\u03b2 protein level also showed significant upregulation in SSDE ( p =0.01; vs. controls groups).", {"entities": []}], ["IL-18 mRNA expression levels were significantly upregulated in the SSDE (relative 2.97-fold upregulation, p =0.001) and NSSDE (relative 2.05-fold upregulation, p =0.001) groups compared with the controls; tear IL-18 concentrations were also significantly increased in the SSDE ( p <0.001) and NSSDE ( p <0.05) groups.", {"entities": []}], ["In the current study, we found that mRNA and protein expressions of NLRP3 inflammasome were upregulated in human dry eyes, especially in SSDE; the downstream inflammatory factors caspase-1, IL-1\u03b2, and IL-18 were also elevated in dry eye patients.", {"entities": [[68, 73, "GENE"]]}], ["These observations suggest the involvement of NLRP3 inflammasome in the onset and development of the inflammation in dry eye.", {"entities": [[46, 51, "GENE"]]}], ["Myocardial bridging is a common coronary anomaly, which is generally described as a benign phenomenon.", {"entities": []}], ["However, a growing number of studies consider this anomaly a relevant pathophysiological phenomenon with serious pathological consequences.", {"entities": []}], ["Here we report on the case of an 88-year-old woman suffering from myocardial infarction and ventricular septal rupture, lacking any recognizable coronary disease except for a myocardial bridge causing the systolic compression of the left anterior descending coronary artery.", {"entities": [[66, 87, "DISEASE"]]}], ["A wide range of diagnostic procedures, including coronarography, echocardiography, and magnetic resonance imaging were used.", {"entities": []}], ["The septal rupture was finally closed by using a percutaneous closure device.", {"entities": []}], ["This event indicates that myocardial bridges \u2013 at least in some cases \u2013 may have notable clinical relevance.", {"entities": []}], ["Self-control problems commonly manifest as temper outbursts and repetitive/rigid/impulsive behaviors, in children with autism spectrum disorders (ASD), which often contributes to learning difficulties and caregiver burden.", {"entities": []}], ["The present study aims to compare the effect of a traditional Chinese Chan -based mind-body exercise, Nei Yang Gong , with that of the conventional Progressive Muscle Relaxation (PMR) technique in enhancing the self-control of children with ASD.", {"entities": []}], ["Forty-six age- and IQ-matched ASD children were randomly assigned to receive group training in Nei Yang Gong (experimental group) or PMR (control group) twice per week for four weeks.", {"entities": []}], ["The participants\u2019 self-control was measured by three neuropsychological tests and parental rating on standardized questionnaires, and the underlying neural mechanism was assessed by the participants\u2019 brain EEG activity during an inhibitory-control task before and after intervention.", {"entities": []}], ["The results show that the experimental group demonstrated significantly greater improvement in self-control than the control group, which concurs with the parental reports of reduced autistic symptoms and increased control of temper and behaviors.", {"entities": []}], ["In addition, the experimental group showed enhanced EEG activity in the anterior cingulate cortex, a region that mediates self-control, whereas the PMR group did not.", {"entities": []}], ["The present findings support the potential application of Chinese Chan -based mind-body exercises as a form of neuropsychological rehabilitation for patients with self-control problems.", {"entities": []}], ["Chinese Clinical Trial Registry; Registration No.", {"entities": []}], [": ChiCTR-TRC-12002561; URL: www.chictr.org .", {"entities": []}], ["Peripheral arterial disease (PAD) is an increasingly recognized disorder that is associated with functional impairment, quality-of-life deterioration, increased risk of cardiovascular ischemic events, and increased risk of total and cardiovascular mortality.", {"entities": []}], ["Although earlier studies suggested that PAD was more common in men, recent reports based on more sensitive tests have shown that the prevalence of PAD in women is at least the same as in men, if not higher.", {"entities": []}], ["PAD tends to present itself asymptomatically or with atypical symptoms more frequently in women than in men, and is associated with comorbidities or situations particularly or exclusively found in the female sex, such as osteoporosis, hypothyroidism, the use of oral contraceptives, and a history of complications during pregnancy.", {"entities": [[235, 249, "DISEASE"], [221, 233, "DISEASE"]]}], ["Fat-distribution patterns and differential vascular characteristics in women may influence the interpretation of diagnostic methods, whereas sex-related vulnerability to drugs typically used in subjects with PAD, differences in risk-factor distribution among sexes, and distinct responses to revascularization procedures in men and women must be taken into account for proper disease management.", {"entities": []}], ["All these issues pose important challenges associated with PAD in women.", {"entities": []}], ["Of note, this group has classically been underrepresented in research studies.", {"entities": []}], ["As a consequence, several sex-related challenges regarding diagnosis and management issues should be acknowledged, and research gaps should be addressed in order to successfully deal with this major health issue.", {"entities": []}], ["Silicosis is an occupational lung disease caused by inhalation of silica dust and characterized by lung inflammation and fibrosis.", {"entities": [[0, 9, "DISEASE"], [29, 41, "DISEASE"]]}], ["Previous study showed that Tregs regulate the process of silicosis by modulating the maintenance of immune homeostasis in the lung.", {"entities": [[57, 66, "DISEASE"]]}], ["Th17 cells share reciprocal developmental pathway with Tregs and play a pivotal role in the immunopathogenesis of many lung diseases by recruiting and activating neutrophils, but the regulatory function of Tregs on Th17 response in silica induced lung fibrosis remains to be explored.", {"entities": []}], ["To evaluate the role of Th17 and IL-17 in the development of silicosis and their interaction with Tregs, Treg-depleted mice model was generated and exposed to silica to establish experimental model of silica-induced lung fibrosis.", {"entities": [[61, 70, "DISEASE"]]}], ["Here we showed that silica increased Th17 response in lung fibrosis.", {"entities": []}], ["Tregs depletion enhanced the neutrophils accumulation and attenuated Th17 response in silica induced lung fibrosis.", {"entities": []}], ["Both mRNA and protein results showed that Tregs exerted its modulatory function on Th17 cells and IL-17 by regulating TGF-\u03b21 and IL-1\u03b2.", {"entities": []}], ["Our study suggested that Tregs could promote Th17 cells differentiation by regulating TGF-\u03b21 and IL-1\u03b2 in silica induced lung fibrosis of mice, which further the understanding of the progress of silicosis and provide a new insight in the regulatory mechanism of Th17 by Tregs in lung inflammation.", {"entities": [[195, 204, "DISEASE"]]}], ["Following independence from the Soviet Union in 1991, Estonia introduced a national insurance system, consolidated the number of health care providers, and introduced family medicine centred primary health care (PHC) to strengthen the health system.", {"entities": []}], ["Using routinely collected health billing records for 2005\u20132012, we examine health system utilisation for seven ambulatory care sensitive conditions (ACSCs) (asthma, chronic obstructive pulmonary disease [COPD], depression, Type 2 diabetes, heart failure, hypertension, and ischemic heart disease [IHD]), and by patient characteristics (gender, age, and number of co\u2013morbidities).", {"entities": [[255, 267, "DISEASE"], [273, 295, "DISEASE"], [282, 295, "DISEASE"], [165, 202, "DISEASE"], [157, 163, "DISEASE"]]}], ["The data set contained 552\u2009822 individuals.", {"entities": []}], ["We use patient level data to test the significance of trends, and employ multivariate regression analysis to evaluate the probability of inpatient admission while controlling for patient characteristics, health system supply\u2013side variables, and PHC use.", {"entities": []}], ["Over the study period, utilisation of PHC increased, whilst inpatient admissions fell.", {"entities": []}], ["Service mix in PHC changed with increases in phone, email, nurse, and follow\u2013up (vs initial) consultations.", {"entities": []}], ["Healthcare utilisation for diabetes, depression, IHD and hypertension shifted to PHC, whilst for COPD, heart failure and asthma utilisation in outpatient and inpatient settings increased.", {"entities": [[57, 69, "DISEASE"], [121, 127, "DISEASE"]]}], ["Multivariate regression indicates higher probability of inpatient admission for males, older patient and especially those with multimorbidity, but protective effect for PHC, with significantly lower hospital admission for those utilising PHC services.", {"entities": []}], ["Our findings suggest health system reforms in Estonia have influenced the shift of ACSCs from secondary to primary care, with PHC having a protective effect in reducing hospital admissions.", {"entities": []}], ["Atopic dermatitis is a chronic inflammatory skin disease with a high prevalence rate and a large socioeconomic cost.", {"entities": [[0, 17, "DISEASE"], [44, 56, "DISEASE"], [7, 17, "DISEASE"]]}], ["There are many treatments for atopic dermatitis, such as antihistamine, tacrolimus and corticosteroids.", {"entities": [[30, 47, "DISEASE"], [37, 47, "DISEASE"]]}], ["However, due to concern about the adverse effects, many patients seek alternative treatments.", {"entities": []}], ["In this context, natural products are gaining interest.", {"entities": []}], ["KM110329 is a functional food consisting of four herbs that are beneficial to skin health.", {"entities": []}], ["The purpose of this study is to assess the efficacy and safety of KM110329 for atopic dermatitis.", {"entities": [[79, 96, "DISEASE"], [86, 96, "DISEASE"]]}], ["This study is a randomised, double-blind, placebo-controlled and multicentre trial of KM110329.", {"entities": []}], ["For this study, we will recruit 66 atopic dermatitis patients of both sexes, with ages ranging from 18 to 65, from three university hospitals.", {"entities": [[35, 52, "DISEASE"], [42, 52, "DISEASE"]]}], ["The participants will receive either KM110329 or a placebo twice a day for 8\u00a0weeks.", {"entities": []}], ["The primary end point will be a change in the scoring atopic dermatitis (SCORAD) index.", {"entities": [[54, 71, "DISEASE"], [61, 71, "DISEASE"]]}], ["The secondary end points will include changes to the dermatology life quality index (DLQI) and transepidermal water loss (TEWL), among others.", {"entities": []}], ["The outcomes will be measured at every visit.", {"entities": []}], ["The study will be continued for 8\u00a0weeks and will include five visits with each subject (at screening and at 0, 1, 4 and 8\u00a0weeks).", {"entities": []}], ["This trial will provide research methodologies for evaluate clinical efficacy and safety of KM110329 in adult patients with atopic dermatitis.", {"entities": [[124, 141, "DISEASE"], [131, 141, "DISEASE"]]}], ["In addition, we will evaluate the changes in the general skin health status and quality of life.", {"entities": []}], ["ClinicalTrials.gov NCT01692093 .", {"entities": []}], ["Campylobacter fetus subsp.", {"entities": []}], ["testudinum subsp.", {"entities": []}], ["nov. is a newly proposed subspecies of C. fetus with markers of reptile origin.", {"entities": []}], ["We summarize epidemiologic information for 9 humans infected with this bacterium.", {"entities": []}], ["All cases were in men, most of whom were of Asian origin.", {"entities": []}], ["Infection might have been related to exposure to Asian foods or reptiles.", {"entities": []}], ["There is extensive evidence supporting the interference of inflammatory activation with metabolism.", {"entities": []}], ["Obesity, mainly visceral obesity, is associated with a low-grade inflammatory state, triggered by metabolic surplus where specialized metabolic cells such as adipocytes activate cellular stress initiating and sustaining the inflammatory program.", {"entities": [[0, 7, "DISEASE"], [25, 32, "DISEASE"]]}], ["The increasing prevalence of obesity, resulting in increased cardiometabolic risk and precipitating illness such as cardiovascular disease, type 2 diabetes, fatty liver, cirrhosis, and certain types of cancer, constitutes a good example of this association.", {"entities": [[29, 36, "DISEASE"], [202, 208, "DISEASE"]]}], ["The metabolic actions of estrogens have been studied extensively and there is also accumulating evidence that estrogens influence immune processes.", {"entities": []}], ["However, the connection between these two fields of estrogen actions has been underacknowledged since little attention has been drawn towards the possible action of estrogens on the modulation of metabolism through their anti-inflammatory properties.", {"entities": []}], ["In the present paper, we summarize knowledge on the modification inflammatory processes by estrogens with impact on metabolism and highlight major research questions on the field.", {"entities": []}], ["Understanding the regulation of metabolic inflammation by estrogens may provide the basis for the development of therapeutic strategies to the management of metabolic dysfunctions.", {"entities": []}], ["Chronic inflammation is implicated in the development of several human cancers, including lung cancer.", {"entities": [[90, 101, "DISEASE"], [95, 101, "DISEASE"]]}], ["Certain particulate hexavalent chromium [Cr(VI)] compounds are well-documented human respiratory carcinogens that release genotoxic soluble chromate and are associated with fibrosis, fibrosarcomas, adenocarcinomas, and squamous cell carcinomas of the lung.", {"entities": []}], ["Despite this, little is known about the pathologic injury and immune responses after repetitive exposure to particulate chromates.", {"entities": []}], ["In this study we investigated the lung injury, inflammation, proliferation, and survival signaling responses after repetitive exposure to particulate chromate.", {"entities": []}], ["BALB/c mice were repetitively treated with particulate basic zinc chromate or saline using an intranasal exposure regimen.", {"entities": []}], ["We assessed lungs for Cr(VI)-induced changes by bronchoalveolar lavage, histologic examination, and immunohistochemistry.", {"entities": []}], ["Single exposure to Cr(VI) resulted in inflammation of lung tissue that persists for up to 21 days.", {"entities": []}], ["Repetitive Cr(VI) exposure induced a neutrophilic inflammatory airway response 24 hr after each treatment.", {"entities": [[82, 84, "GENE"]]}], ["Neutrophils were subsequently replaced by increasing numbers of macrophages by 5 days after treatment.", {"entities": []}], ["Repetitive Cr(VI) exposure induced chronic peribronchial inflammation with alveolar and interstitial pneumonitis dominated by lymphocytes and macrophages.", {"entities": []}], ["Moreover, chronic toxic mucosal injury was observed and accompanied by increased airway pro-matrix metalloprotease-9.", {"entities": []}], ["Injury and inflammation correlated with airways becoming immunoreactive for phosphorylation of the survival signaling protein Akt and the proliferation marker Ki-67.", {"entities": []}], ["We observed a reactive proliferative response in epithelial cells lining airways of chromate-exposed animals.", {"entities": []}], ["These data illustrate that repetitive exposure to particulate chromate induces chronic injury and an inflammatory microenvironment that may promote Cr(VI) carcinogenesis.", {"entities": []}], ["Previous studies suggest that caesarean section (CS) may increase the risk of asthma in children, but none of them could preclude potential confounding effects of underlying medical indications for CS.", {"entities": [[78, 84, "DISEASE"], [49, 51, "GENE"], [198, 200, "GENE"], [49, 51, "GENE"], [198, 200, "GENE"]]}], ["We aim to assess the association between CS itself (without medical indications) and risk of childhood asthma.", {"entities": [[103, 109, "DISEASE"], [41, 43, "GENE"]]}], ["We conducted a hospital-based case-control study on childhood asthma with 573 cases and 812 controls in Shanghai.", {"entities": [[62, 68, "DISEASE"]]}], ["Unconditional logistic regression models in SAS were employed to control for potential confounders.", {"entities": []}], ["Our study found that CS without medical indication was significantly associated with elevated asthma risk (adjusted OR = 1.58 [95% CI 1.17\u20132.13]).", {"entities": [[94, 100, "DISEASE"], [21, 23, "GENE"]]}], ["However, this risk was attenuated in children fed by exclusive breastfeeding in the first six months after birth (adjusted OR = 1.39 [95% CI 0.92\u20132.10]).", {"entities": []}], ["In contrast, the risk was more prominent in children with non-exclusive breastfeeding or bottle feeding (adjusted OR = 1.91 [95% CI 1.22\u20132.99]).", {"entities": []}], ["CS without medical indication was associated with an increased risk of childhood asthma.", {"entities": [[81, 87, "DISEASE"], [0, 2, "GENE"]]}], ["Exclusive breastfeeding in infancy may attenuate this risk.", {"entities": []}], ["Congaplex Immortalized CEM and Jurkat T lymphocytes and primary peripheral mononuclear blood cells (PBMCs) were treated with the aqueous extracts from Congaplex Congaplex In vitro treatment of PBMCs from 10 healthy donors with Congaplex While the effects of Congaplex", {"entities": []}], ["Colic is an important cause of mortality and morbidity in domesticated horses yet many questions about this condition remain to be answered.", {"entities": []}], ["One such question is: does season have an effect on the occurrence of colic?", {"entities": []}], ["Time-series analysis provides a rigorous statistical approach to this question but until now, to our knowledge, it has not been used in this context.", {"entities": []}], ["Traditional time-series modelling approaches have limited applicability in the case of relatively rare diseases, such as specific types of equine colic.", {"entities": []}], ["In this paper we present a modelling approach that respects the discrete nature of the count data and, using a regression model with a correlated latent variable and one with a linear trend, we explored the seasonality of specific types of colic occurring at a UK referral hospital between January 1995\u2013December 2004.", {"entities": []}], ["Six- and twelve-month cyclical patterns were identified for all colics, all medical colics, epiploic foramen entrapment (EFE), equine grass sickness (EGS), surgically treated and large colon displacement/torsion colic groups.", {"entities": []}], ["A twelve-month cyclical pattern only was seen in the large colon impaction colic group.", {"entities": []}], ["There was no evidence of any cyclical pattern in the pedunculated lipoma group.", {"entities": [[66, 72, "DISEASE"]]}], ["These results were consistent irrespective of whether we were using a model including latent correlation or trend.", {"entities": []}], ["Problems were encountered in attempting to include both trend and latent serial dependence in models simultaneously; this is likely to be a consequence of a lack of power to separate these two effects in the presence of small counts, yet in reality the underlying physical effect is likely to be a combination of both.", {"entities": []}], ["The use of a regression model with either an autocorrelated latent variable or a linear trend has allowed us to establish formally a seasonal component to certain types of colic presented to a UK referral hospital over a 10 year period.", {"entities": []}], ["These patterns appeared to coincide with either times of managemental change or periods when horses are more likely to be intensively managed.", {"entities": []}], ["Further studies are required to identify the determinants of the observed seasonality.", {"entities": []}], ["Importantly, this type of regression model has applications beyond the study of equine colic and it may be useful in the investigation of seasonal patterns in other, relatively rare, conditions in all species.", {"entities": []}], ["Pulmonary ailments are conventionally diagnosed by spirometry.", {"entities": []}], ["The complex forceful breathing maneuver as well as the extreme cost of spirometry renders it unsuitable in many situations.", {"entities": []}], ["This work is aimed to facilitate an emerging direction of tidal breathing-based pulmonary evaluation by designing a novel, equitable, precise and portable device for acquisition and analysis of directional tidal breathing patterns, in real time.", {"entities": []}], ["The proposed system primarily uses an in-house designed blow pipe, 40-kHz air-coupled ultrasound transreceivers, and a radio frequency (RF) phase-gain integrated circuit (IC).", {"entities": []}], ["Moreover, in order to achieve high sensitivity in a cost-effective design philosophy, we have exploited the phase measurement technique, instead of selecting the contemporary time-of-flight (TOF) measurement; since application of the TOF principle in tidal breathing assessments requires sub-micro to nanosecond time resolution.", {"entities": []}], ["This approach, which depends on accurate phase measurement, contributed to enhanced sensitivity using a simple electronics design.", {"entities": []}], ["The developed system has been calibrated using a standard 3-L calibration syringe.", {"entities": []}], ["The parameters of this system are validated against a standard spirometer, with maximum percentage error below 16%.", {"entities": []}], ["Further, the extracted respiratory parameters related to tidal breathing have been found to be comparable with relevant prior works.", {"entities": []}], ["The error in detecting respiration rate only is 3.9% compared to manual evaluation.", {"entities": []}], ["These encouraging insights reveal the definite potential of our tidal breathing pattern (TBP) prototype for measuring tidal breathing parameters in order to extend the reach of affordable healthcare in rural regions and developing areas.", {"entities": [[89, 92, "GENE"]]}], ["Tight junctions are the outermost structures of intercellular junctions and are classified as transmembrane proteins.", {"entities": []}], ["These factors form selective permeability barriers between cells, act as paracellular transporters and regulate structural and functional polarity of cells.", {"entities": []}], ["Although tight junctions have been previously studied, comparison of the transcriptional-translational levels of these molecules in canine organs remains to be investigated.", {"entities": []}], ["In the present study, organ-specific expression of the tight junction proteins, claudin, occludin, junction adhesion molecule A and zona occludens 1 was examined in the canine duodenum, lung, liver and kidney.", {"entities": []}], ["Results of immunohistochemistry analysis demonstrated that the tight junctions were localized in intestinal villi and glands of the duodenum, bronchiolar epithelia and alveolar walls of the lung, endometrium and myometrium of the hepatocytes, and the distal tubules and glomeruli of the kidney.", {"entities": []}], ["These results suggest that tight junctions are differently expressed in organs, and therefore may be involved in organ-specific functions to maintain physiological homeostasis.", {"entities": []}], ["Chronic rhinosinusitis with nasal polyposis is considered to be a multifactorial disease where different stimuli (mechanical, viral, bacterial, fungal infection, immunological disorders or dysreactivity, environmental pollution), acting on the mucosa of nasal cavities and paranasal sinuses, lead to epithelial damage and mucosal inflammation.", {"entities": []}], ["Inflammatory cell infiltration (predominantly eosinophils, but also neutrophils, mast cells, macrophages and lymphocytes), cytokine release and sub-epithelial oedema are the histological pictures that are associated, from the clinical point of view, with nasal congestion, secretion and/or post-nasal drip and facial pain/headache.", {"entities": []}], ["Recently, the importance of the HMG B-1 protein in the pathogenesis of several inflammatory diseases has been demonstrated.", {"entities": []}], ["This protein is released from necrotic/damaged cells or immune-activated cells, and by acting on specific membrane receptors causes the release of pro-inflammatory mediators, endothelial activation and the survival of inflammatory cells.", {"entities": []}], ["The objective of the present study was: i) to determine whether HMG B1 is augmented in chronic rhinosinusitis with nasal polyps; ii) if its expression is associated with eosinophils, TNF-\u03b1, IL 5 and IL 8 cytokines typically present in chronic inflammation of the nose and paranasal sinuses; iii) to investigate a hypothetical role of this protein in the pathogenesis of nasal polyposis.", {"entities": []}], ["Nasal polyps tissue from 21 patients affected by CRSwNP and nasal mucosa from 8 controls was collected at the ENT Department of the Chinese PLA General Hospital and underwent immunohistological staining for detection of HMG B1 protein and IL -5, IL -8 and TNF-\u03b1 inflammatory cytokines.", {"entities": []}], ["The degree of HMG B1 protein expression was evaluated by dividing the stained sections in 4 portions: 1) nucleus of epithelial cells, 2) cytoplasm of epithelial cells, 3) focal extracellular infiltration, 4) inflammatory cells.", {"entities": []}], ["HMG B1 was more expressed in the nucleus of epithelial cells of patients compared with controls.", {"entities": []}], ["In contrast, epithelial cytoplasm HMG B1 staining was significant lower in patients.", {"entities": []}], ["Sub-epithelial focal infiltration of HMG B1 protein expression was lower in controls, whereas the expression of HMG B1 in the inflammatory cells in patients was significantly increased in comparison with controls.", {"entities": []}], ["These data, together with the correlation we found between HMG B1 protein expression in different portions and the number of eosinophils infiltrating cells, or IL -5, IL -8 and TNF-\u03b1 positive cells in patients, suggest that HMG B1 may play a crucial role in the pathogenesis of chronic rhinosinusitis with nasal polyps.", {"entities": []}], ["Although studies have shown an association between air pollutants from anthropogenic sources and pregnancy outcomes, little is known regarding the association between low birth weight (LBW) and exposure to emissions of biomass burning.", {"entities": []}], ["This population-based retrospective cohort study assessed the effect of exposure to particulate matter and carbon monoxide (CO) from biomass burning in the Amazon and cerrado (Brazilian savanna) biomes on term LBW (<2500 g) in cities of Mato Grosso, Brazil.", {"entities": []}], ["Data on births were obtained from the Information System on Live Births of the Ministry of Health.", {"entities": []}], ["The exclusion criteria were a twin pregnancy, gestational age of less than 37 weeks, and congenital malformation diagnosed at birth.", {"entities": []}], ["For exposure variables, we used a historical series of daily average concentrations of particulate matter with a diameter less than 2.5 \u03bcm (PM 2.5 ) and CO provided by Coupled Aerosol and Trace Gases Transport Model for the Brazilian Development of the Regional Atmospheric Modeling System developed at the National Institute for Space National Center for Weather Forecasts and Climate Studies, National Institute for Space Research.", {"entities": []}], ["Maternal exposure was estimated by the average amount of pollutants for each trimester and for the entire period of gestation.", {"entities": []}], ["The association between air pollutants and LBW was analyzed by multiple logistic regression, adjusting for the newborn\u2019s sex, mother\u2019s age and education, and prenatal care.", {"entities": []}], ["A total of 6147 full-term singleton live births were included in the study and 193 (3.1%) were LBW.", {"entities": []}], ["In adjusted analysis, the number of prenatal visits and maternal education with 8 years or more were associated with LBW.", {"entities": []}], ["The association between exposure to air pollutants and the risk of LBW was significant for the 4 2.5 concentrations in the 2 This study provides further evidence of the effect of smoke from biomass burning on the occurrence of LBW in cities of the Brazilian Amazon.", {"entities": []}], ["Ozone is a strong oxidant that is globally used as disinfection agent for many purposes including indoor building air cleaning, during food preparation procedures, and for control and killing of bacteria such as E. coli and S. aureus .", {"entities": []}], ["However, it has been shown that effective ozone concentrations for controlling e.g., microbial growth need to be higher than 5\u2005ppm, thereby exceeding the recommended U.S. EPA threshold more than 10 times.", {"entities": []}], ["Consequently, real-time monitoring of such ozone concentration levels is essential.", {"entities": []}], ["Here, we describe the first online gas sensing system combining a compact Fourier transform infrared (FTIR) spectrometer with a new generation of gas cells, a so-called substrate-integrated hollow waveguide (iHWG).", {"entities": []}], ["The sensor was calibrated using an UV lamp for the controlled generation of ozone in synthetic air.", {"entities": []}], ["A calibration function was established in the concentration range of 0.3\u20135.4\u2005mmol m", {"entities": []}], ["Obesity is a global epidemic with major healthcare implications and costs.", {"entities": []}], ["Mobile technologies are potential interventions to promote weight loss.", {"entities": []}], ["An early systematic review of this rapidly growing area of research was conducted.", {"entities": []}], ["Electronic databases were searched for articles published between January 1998 and October 2011.", {"entities": []}], ["Data sources included Medline, Embase and the Cochrane Central Register of Controlled Trials.", {"entities": []}], ["Ongoing research was searched for using clinical trials databases and registers.", {"entities": []}], ["Out of 174 articles retrieved, 21 met the inclusion criteria of randomized controlled trials (RCTs) on mobile technology interventions facilitating weight loss in overweight and obese adults with any other comparator.", {"entities": []}], ["A narrative synthesis was undertaken.", {"entities": []}], ["Seven articles were included and appraised using the Cochrane risk of bias tool: four presented a low risk of bias and three presented a high risk of bias.", {"entities": []}], ["There is consistent strong evidence across the included multiple high-quality RCTs that weight loss occurs in the short-term because of mobile technology interventions, with moderate evidence for the medium-term.", {"entities": []}], ["Recommendations for improving the reporting and quality of future trials are made including reporting weight loss in percent to meet clinical standards, and including features such as long-term follow-up, cost-effectiveness and patient acceptability.", {"entities": []}], ["The pathophysiology of cystic fibrosis (CF) lung disease remains incompletely understood.", {"entities": [[23, 38, "DISEASE"], [44, 56, "DISEASE"]]}], ["New explanations for the pathogenesis of CF lung disease may be discovered by studying the patterns of protein expression in cultured human nasal epithelial cells (HNEC).", {"entities": [[44, 56, "DISEASE"]]}], ["To that aim, we compared the level of protein expressions in primary cultures of HNEC from nasal polyps secondary to CF (CFNP, n\u200a=\u200a4), primary nasal polyps (NP, n\u200a=\u200a8) and control mucosa (CTRL, n\u200a=\u200a4) using isobaric tag for relative and absolute quantification (iTRAQ) labeling coupled with liquid chromatography (LC)-MS-MS.", {"entities": [[188, 192, "GENE"]]}], ["The analysis of the data revealed 42 deregulated protein expressions in CFNP compared to NP and CTRL, suggesting that these alterations are related to CF.", {"entities": [[96, 100, "GENE"]]}], ["Overall, AmiGo analysis highlighted six major pathways important for cell functions that seem to be impaired: metabolism, G protein process, inflammation and oxidative stress response, protein folding, proteolysis and structural proteins.", {"entities": []}], ["Among them, glucose and fatty acid metabolic pathways could be impaired in CF with nine deregulated proteins.", {"entities": []}], ["Our proteomic study provides a reproducible set of differentially expressed proteins in airway epithelial cells from CF patients and reveals many novel deregulated proteins that could lead to further studies aiming to clarify the involvement of such proteins in CF pathophysiology.", {"entities": []}], ["Various beta-blockers with distinct pharmacological profiles are approved in heart failure, yet they remain underused and underdosed.", {"entities": []}], ["Although potentially of major public health importance, whether one agent is superior in terms of tolerability and optimal dosing has not been investigated.", {"entities": []}], ["The aim of this study was therefore to compare the tolerability and clinical effects of two proven beta-blockers in elderly patients with heart failure.", {"entities": []}], ["We performed a double-blind superiority trial of bisoprolol vs. carvedilol in 883 elderly heart failure patients with reduced or preserved left ventricular ejection fraction in 41 European centres.", {"entities": []}], ["The primary endpoint was tolerability, defined as reaching and maintaining guideline-recommended target doses after 12 weeks treatment.", {"entities": []}], ["Adverse events and clinical parameters of patient status were secondary endpoints.", {"entities": []}], ["None of the beta-blockers was superior with regards to tolerability: 24% [95% confidence interval (CI) 20\u201328] of patients in the bisoprolol arm and 25% (95% CI 21\u201329) of patients in the carvedilol arm achieved the primary endpoint ( P = 0.64).", {"entities": []}], ["The use of bisoprolol resulted in greater reduction of heart rate (adjusted mean difference 2.1 b.p.m., 95% CI 0.5\u20133.6, P = 0.008) and more, dose-limiting, bradycardic adverse events (16 vs. 11%; P = 0.02).", {"entities": []}], ["The use of carvedilol led to a reduction of forced expiratory volume (adjusted mean difference 50 mL, 95% CI 4\u201395, P = 0.03) and more, non-dose-limiting, pulmonary adverse events (10 vs. 4%; P < 0.001).", {"entities": []}], ["Overall tolerability to target doses was comparable.", {"entities": []}], ["The pattern of intolerance, however, was different: bradycardia occurred more often in the bisoprolol group, whereas pulmonary adverse events occurred more often in the carvedilol group.", {"entities": []}], ["This study is registered with controlled-trials.com, number ISRCTN34827306.", {"entities": []}], ["To systematically review the literature for evidence of smoking and alcohol intake as independent risk factors for invasive pneumococcal disease (IPD).", {"entities": []}], ["Systematic review.", {"entities": []}], ["MEDLINE (1946\u2014May 2012) and EMBASE (1947\u2014May 2012) were searched for studies investigating alcohol or smoking as risk factors for acquiring IPD and which reported results as relative risk.", {"entities": []}], ["Studies conducted exclusively in clinical risk groups, those assessing risk factors for outcomes other than acquisition of IPD and studies describing risk factors without quantifying a relative risk were excluded.", {"entities": []}], ["Seven observational studies were identified and reviewed; owing to the heterogeneity of study design, meta-analysis was not attempted.", {"entities": []}], ["Five of six studies investigating smoking reported an increased risk of IPD in the range 2.2\u20134.1.", {"entities": []}], ["Four of the six studies investigating alcohol intake reported a significant increased risk for IPD ranging from 2.9 to 11.4, while one reported a significant protective effect.", {"entities": []}], ["Overall, these observational data suggest that smoking and alcohol misuse may increase the risk of IPD in adults, but the magnitude of this risk remains unclear and should be explored with further research.", {"entities": []}], ["The findings of this review will contribute to the debate on whether pneumococcal vaccine should be offered to smokers and people who misuse alcohol in addition to other clinically defined risk groups.", {"entities": []}], ["The present study uses simulated data to find what the optimal number of response categories is to achieve adequate power in ordinal logistic regression (OLR) model for differential item functioning (DIF) analysis in psychometric research.", {"entities": [[200, 203, "GENE"]]}], ["A hypothetical ten-item quality of life scale with three, four, and five response categories was simulated.", {"entities": []}], ["The power and type I error rates of OLR model for detecting uniform DIF were investigated under different combinations of ability distribution ( \u03b8 ), sample size, sample size ratio, and the magnitude of uniform DIF across reference and focal groups.", {"entities": [[68, 71, "GENE"], [211, 214, "GENE"], [68, 71, "GENE"], [211, 214, "GENE"]]}], ["When \u03b8 was distributed identically in the reference and focal groups, increasing the number of response categories from 3 to 5 resulted in an increase of approximately 8% in power of OLR model for detecting uniform DIF.", {"entities": [[215, 218, "GENE"]]}], ["The power of OLR was less than 0.36 when ability distribution in the reference and focal groups was highly skewed to the left and right, respectively.", {"entities": []}], ["Conclusions.", {"entities": []}], ["The clearest conclusion from this research is that the minimum number of response categories for DIF analysis using OLR is five.", {"entities": [[97, 100, "GENE"]]}], ["However, the impact of the number of response categories in detecting DIF was lower than might be expected.", {"entities": [[70, 73, "GENE"]]}], ["Muckle-Wells syndrome (MWS) is a rare auto-inflammatory disease characterized by the presence of recurrent urticaria, deafness and amyloidosis.", {"entities": [[107, 116, "DISEASE"], [131, 142, "DISEASE"], [13, 21, "DISEASE"]]}], ["Progressive sensorineural hearing loss (SNHL) is reported to occur in up to 85% of patients occurring in the second and third decades and as early as the first decade in patients with a more severe phenotype, thus potentially having a significant impact on a child\u2019s development.", {"entities": [[12, 38, "DISEASE"]]}], ["IL-1 inhibitors, such as Anakinra, have been described to improve systemic inflammation, and stabilize or improve hearing status as well.", {"entities": []}], ["However, complete resolution of hearing loss has been rarely reported.", {"entities": []}], ["The objective of this article is to highlight the clinical presentation of a pediatric patient with a severe form of MWS and report on the complete resolution of SNHL with the use of Anakinra.", {"entities": []}], ["A 3-year-old boy was referred to our hospital to assess for the possibility of MWS given a history of hives and recurrent episodes of fever with a family history of MWS in his mother.", {"entities": []}], ["Of note, the patient\u2019s history was significant for conductive hearing loss, speech delay, as well as recurrent acute otitis media episodes.", {"entities": [[117, 129, "DISEASE"]]}], ["Genetic analysis was performed and diagnosis of MWS was confirmed due to the presence of a NLRP3 gene mutation.", {"entities": [[91, 96, "GENE"]]}], ["Further work-up demonstrated the presence of papilledema and elevation of systemic inflammatory markers for which Canakinumab was initiated.", {"entities": [[45, 56, "DISEASE"]]}], ["Despite initiation of this treatment, audiogram evaluation demonstrated a new right-sided SNHL.", {"entities": []}], ["Lumbar puncture also revealed aseptic meningitis.", {"entities": [[30, 48, "DISEASE"], [38, 48, "DISEASE"]]}], ["Canakinumab was eventually discontinued and Anakinra initiated.", {"entities": []}], ["Within 7\u00a0months of treatment with Anakinra at 5\u00a0mg/kg sc daily, resolution of the SNHL was observed.", {"entities": []}], ["With further escalation of the Anakinra dose, there was also complete resolution of the aseptic meningitis.", {"entities": [[88, 106, "DISEASE"], [96, 106, "DISEASE"]]}], ["Progressive hearing loss is a significant finding in patients with MWS.", {"entities": []}], ["Early screening as well as initiation of Anakinra can lead to complete resolution of SNHL even in a patient with a severe spectrum of MWS.", {"entities": []}], ["However, as this case demonstrates, longer treatment duration and higher doses of Anakinra may be required to achieve this.", {"entities": []}], ["Infections occurred exclusively among personnel who had close contact with MERS-CoV patients.", {"entities": []}], ["Healthcare settings can amplify transmission of Middle East respiratory syndrome coronavirus (MERS-CoV), but knowledge gaps about the epidemiology of transmission remain.", {"entities": [[72, 80, "DISEASE"]]}], ["We conducted a retrospective cohort study among healthcare personnel in hospital units that treated MERS-CoV patients.", {"entities": []}], ["Participants were interviewed about exposures to MERS-CoV patients, use of personal protective equipment, and signs and symptoms of illness after exposure.", {"entities": []}], ["Infection status was determined by the presence of antibodies against MERS-CoV.", {"entities": []}], ["To assess risk factors, we compared infected and uninfected participants.", {"entities": []}], ["Healthcare personnel caring for MERS-CoV patients were at high risk for infection, but infection most often resulted in a relatively mild illness that might be unrecognized.", {"entities": []}], ["In the healthcare personnel cohort reported here, infections occurred exclusively among those who had close contact with MERS-CoV patients.", {"entities": []}], ["The economic impact and ease of measurement of all-cause hospital readmission rates (HRR) have led to the current debate as to whether they are reducible, and whether they should be used as a publicly reported quality indicators of medical care.", {"entities": []}], ["To assess the efficacy of broad clinical interventions in preventing HRR of patients with chronic diseases A meta-review of published systematic reviews of randomized controlled trials (RCTs) of clinical interventions that have included HRR among the patients' outcomes of interest.", {"entities": []}], ["Meta-analyses of RCTs have consistently found that, in the community, disease management programs significantly reduced HRR in patients with heart failure, coronary heart disease and bronchial asthma, but not in patients with stroke and in unselected patients with chronic disorders.", {"entities": [[165, 178, "DISEASE"], [156, 178, "DISEASE"], [193, 199, "DISEASE"]]}], ["Inhospital interventions, such as discharge planning, pharmacological consultations and multidisciplinary care, and community interventions in patients with chronic obstructive pulmonary diseases had an inconsistent effect on HRR.", {"entities": []}], ["Despite their economic impact and ease of measurement, HRR are not the most important outcome of patient care, and efforts aimed at their reduction may compromise patients' health by reducing also justified re-admissions.", {"entities": []}], ["The efficacy of inhospital interventions in reducing HRR is in need of further study.", {"entities": []}], ["In patients with heart diseases and bronchial asthma, HRR may be considered as a publicly reported quality indicator of community care , provided that future research confirms that efforts to reduce HRR do not adversely affect other patients\u2019 outcomes, such as mortality, functional capacity and quality of life.", {"entities": [[46, 52, "DISEASE"]]}], ["Future research should also focus on the reasons for the higher efficacy of community interventions in patients with heart diseases and bronchial asthma than in those with other chronic diseases.", {"entities": [[146, 152, "DISEASE"]]}], ["Glucocorticoid therapy, especially at higher doses, is associated with significant adverse side effects including osteoporosis.", {"entities": [[114, 126, "DISEASE"]]}], ["Leptin, secreted from adipose tissue, has diverse effects on bone tissue regulation.", {"entities": []}], ["As glucocorticoids stimulate leptin synthesis and secretion directly in adipose tissue we hypothesised that dexamethasone (DEX) induced osteoporosis may, in part, be mediated by an osteoblast dependent leptin-leptin receptor pathway.", {"entities": [[136, 148, "DISEASE"]]}], ["Human bone cells expressed leptin and leptin receptors (Ob-Ra and Ob-Rb).", {"entities": []}], ["DEX increased leptin, Ob-Ra and Ob-Rb expression in a dose-dependent manner while decreasing expression of osteocalcin.", {"entities": []}], ["In the presence of leptin, Cbfa1 and osteonectin expression showed no significant change, whereas osteocalcin expression was decreased.", {"entities": []}], ["Recombinant human quadruple antagonist leptin suppressed DEX-induced osteocalcin downregulation.", {"entities": []}], ["The signaling pathway involved up-regulation of JAK2.", {"entities": [[48, 52, "GENE"]]}], ["In conclusion, upregulation of leptin and Ob-Rb in human bone cells by DEX is associated with down-regulation of osteocalcin expression.", {"entities": []}], ["The down regulation of osteocalcin by DEX was partially through a leptin autocrine/paracrine loop.", {"entities": []}], ["Adverse effects of DEX on the skeleton may be modified by targeting leptin signaling pathways.", {"entities": []}], ["Various amines, such as triethylamine and N,N-dimethylethylamine, have been reported to cause glaucopsia in workers employed in epoxy, foundry, and polyurethane foam industries.", {"entities": []}], ["This symptom has been related to corneal edema and vesicular collection of fluid within the corneal subepithelial cells.", {"entities": [[33, 46, "DISEASE"]]}], ["Exposure to amine vapors for 30 min to several hours leads to blurring of vision, a blue-grey appearance of objects, and halos around lights, that are probably reversible.", {"entities": []}], ["Concentration-effect relationships have been established.", {"entities": []}], ["The visual disturbance is considered a nuisance, as it could cause onsite accidents, impair work efficiency, and create difficulties in driving back home.", {"entities": []}], ["Occupational exposure limits have been established for some amines, but there is shortage of criteria.", {"entities": []}], ["Volatility factors, such as vapor pressure, should be considered in industrial settings to prevent human ocular risks, while trying to reduce levels of hazardous amines in the atmosphere.", {"entities": []}], ["About organ transplant, immunosuppressive medications adherence is a critical issue, because non-adherence to these medications causes rejection, reduces quality of life and increases treatment cost and mortality rate.", {"entities": []}], ["Among these, the quality of life is deemed very important to evaluate treatment result and also it can be useful for discovering non adherence.", {"entities": []}], ["The aim this study was to assess the relationship between medication adherence and quality of life and some patient factors in renal transplant patients.", {"entities": []}], ["The study was a descriptive-correlational design and was done on renal transplant patients over 18 who had undergone surgery for over 3 months, and were inclined to participate.", {"entities": []}], ["Sample size was 230 people and sampling was convenience.", {"entities": []}], ["Quality of life questionnaire in renal transplant patients and Immunosuppressant Therapy Adherence Scale were filled by patients and the data was analyzed by SPSS15 software.", {"entities": []}], ["It showed that the mean score of quality of life in renal transplant patients was 21.65\u00b14.03 and 57.8% of them did not adhere to immunosuppressive medications.", {"entities": []}], ["Results of correlation between scores of immunosuppressive medication adherence and Quality of life showed that there were significant correlation in 3 dimensions of 4: health performance (p\u22640.0001 & rETA=0.23), social-economic (p=0.001 & rETA=0.15), psychological-spiritual (p=0.011 & rETA=0.15), also logistic test showed significant relationship between immunosuppressive medication adherence and number of transplantation (\u03b2=1.04, p= 0.048).", {"entities": []}], ["According to the results, health care providers i.e.", {"entities": []}], ["nurses must note to medication adherence as a health enhancement factor while treating and educating to these patients.", {"entities": []}], ["Respiratory syncytial virus (RSV) is responsible for severe respiratory infections and higher costs in medical care.", {"entities": []}], ["The two aims of this work were to assess the performances of SOFIA In study 1, fresh nasopharyngeal swabs from patients of all ages were sampled in 1.5 ml of Universal virological Transport Medium (UTM) and prospectively tested using SOFIA The sensitivities of SOFIA SOFIA The online version of this article (doi:10.1186/s12879-017-2557-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To determine the characteristics of undiagnosed chronic obstructive pulmonary disease (COPD) in a senior community center.", {"entities": [[48, 85, "DISEASE"]]}], ["We performed a cross-sectional, observational study with the following procedures: questionnaire to record demographic and health status data, anthropometry, questionnaire about COPD risk factors and symptoms, spirometry, and socioeconomic evaluation.", {"entities": []}], ["Simple logistic regression and multiple analyses were carried out to assess associations.", {"entities": []}], ["The studied variables were tested for associations with previous COPD diagnosis.", {"entities": []}], ["Three hundred and thirty-five subjects aged 50 years or older were recruited and 318 completed the protocol.", {"entities": []}], ["Seventy-one (22%) had presumptive COPD.", {"entities": []}], ["Among them, 57 (80%) did not have a previous physician-made diagnosis of COPD.", {"entities": []}], ["We found no associations between previous diagnosis and socioeconomic status, anthropometric data, or risk factors.", {"entities": []}], ["Regarding respiratory symptoms, there was an association between previous COPD diagnosis and wheezing ( P =0.011).", {"entities": []}], ["FEV 1 and FVC values were lower in the previous diagnosis group compared to the group without a previous diagnosis ( P <0.001, Student\u2019s t -test).", {"entities": [[0, 3, "GENE"]]}], ["We found an association of lower FEV 1 (<50% predicted value) with a previous diagnosis ( P =0.028).", {"entities": [[33, 36, "GENE"]]}], ["Our results showed a high prevalence of undiagnosed obstructive ventilatory defects in a senior community center.", {"entities": []}], ["Previous COPD diagnosis was associated with more severe disease and more frequent wheezing.", {"entities": []}], ["This study highlights the potential of these centers to increase COPD diagnosis and to reduce its risks.", {"entities": []}], ["Knowledge on the role of genetic polymorphisms in the etiology of pediatric brain tumors (PBTs) is limited.", {"entities": []}], ["Therefore, we investigated the association between single nucleotide polymorphisms (SNPs), identified by candidate gene-association studies on adult brain tumors, and PBT risk.", {"entities": []}], ["The study is based on the largest series of PBT cases to date.", {"entities": []}], ["Saliva DNA from 245 cases and 489 controls, aged 7\u201319 years at diagnosis/reference date, was genotyped for 68 SNPs.", {"entities": []}], ["Data were analyzed using unconditional logistic regression.", {"entities": []}], ["The results showed EGFR rs730437 and EGFR rs11506105 may decrease susceptibility to PBTs, whereas ERCC1 rs3212986 may increase risk of these tumors.", {"entities": [[19, 23, "GENE"], [37, 41, "GENE"], [19, 23, "GENE"], [37, 41, "GENE"], [98, 103, "GENE"]]}], ["Moreover, stratified analyses indicated CHAF1A rs243341, CHAF1A rs2992, and XRCC1 rs25487 were associated with a decreased risk of astrocytoma subtype.", {"entities": [[131, 142, "DISEASE"], [40, 46, "GENE"], [57, 63, "GENE"], [40, 46, "GENE"], [57, 63, "GENE"], [76, 81, "GENE"]]}], ["Furthermore, an increased risk of non-astrocytoma subtype associated with EGFR rs9642393, EME1 rs12450550, ATM rs170548, and GLTSCR rs1035938 as well as a decreased risk of this subtype associated with XRCC4 rs7721416 and XRCC4 rs2662242 were detected.", {"entities": [[38, 49, "DISEASE"], [74, 78, "GENE"], [90, 94, "GENE"], [107, 110, "GENE"], [202, 207, "GENE"], [222, 227, "GENE"], [202, 207, "GENE"], [222, 227, "GENE"]]}], ["This study indicates SNPs in EGFR , ERCC1 , CHAF1A , XRCC1 , EME1 , ATM , GLTSCR1 , and XRCC4 may be associated with the risk of PBTs.", {"entities": [[29, 33, "GENE"], [36, 41, "GENE"], [44, 50, "GENE"], [53, 58, "GENE"], [61, 65, "GENE"], [68, 71, "GENE"], [74, 81, "GENE"], [88, 93, "GENE"]]}], ["Therefore, cell cycle and DNA repair pathways variations associated with susceptibility to adult brain tumors also seem to be associated with PBT risk, suggesting pediatric and adult brain tumors might share similar etiological pathways.", {"entities": []}], ["Internet-based self-management has shown to improve asthma control and asthma related quality of life, but the improvements were only marginally clinically relevant for the group as a whole.", {"entities": [[52, 58, "DISEASE"], [71, 77, "DISEASE"]]}], ["We hypothesized that self-management guided by weekly monitoring of asthma control tailors pharmacological therapy to individual needs and improves asthma control for patients with partly controlled or uncontrolled asthma.", {"entities": [[68, 74, "DISEASE"], [148, 154, "DISEASE"], [215, 221, "DISEASE"]]}], ["In a 1-year randomised controlled trial involving 200 adults (18-50 years) with mild to moderate persistent asthma we evaluated the adherence with weekly monitoring and effect on asthma control and pharmacological treatment of a self-management algorithm based on the Asthma Control Questionnaire (ACQ).", {"entities": [[108, 114, "DISEASE"], [179, 185, "DISEASE"], [268, 274, "DISEASE"]]}], ["Participants were assigned either to the Internet group (n = 101) that monitored asthma control weekly with the ACQ on the Internet and adjusted treatment using a self-management algorithm supervised by an asthma nurse specialist or to the usual care group (UC) (n = 99).", {"entities": [[81, 87, "DISEASE"], [206, 212, "DISEASE"]]}], ["We analysed 3 subgroups: patients with well controlled (ACQ \u2264 0.75), partly controlled (0.75>ACQ \u2264 1.5) or uncontrolled (ACQ>1.5) asthma at baseline.", {"entities": [[130, 136, "DISEASE"]]}], ["Overall monitoring adherence was 67% (95% CI, 60% to 74%).", {"entities": []}], ["Improvements in ACQ score after 12 months were -0.14 (p = 0.23), -0.52 (p < 0.001) and -0.82 (p < 0.001) in the Internet group compared to usual care for patients with well, partly and uncontrolled asthma at baseline, respectively.", {"entities": [[198, 204, "DISEASE"]]}], ["Daily inhaled corticosteroid dose significantly increased in the Internet group compared to usual care in the first 3 months in patients with uncontrolled asthma (+278 \u03bcg, p = 0.001), but not in patients with well or partly controlled asthma.", {"entities": [[155, 161, "DISEASE"], [235, 241, "DISEASE"]]}], ["After one year there were no differences in daily inhaled corticosteroid use or long-acting \u03b2 2 -agonists between the Internet group and usual care.", {"entities": []}], ["Weekly self-monitoring and subsequent treatment adjustment leads to improved asthma control in patients with partly and uncontrolled asthma at baseline and tailors asthma medication to individual patients' needs.", {"entities": [[77, 83, "DISEASE"], [133, 139, "DISEASE"], [164, 170, "DISEASE"]]}], ["Current Controlled Trials ISRCTN79864465", {"entities": []}], ["The Australian Government Department of Veterans\u2019 Affairs (DVA) funds an ongoing health promotion based program to improve use of medicines and related health services, which implements interventions that include audit and feedback in the form of patient-specific feedback generated from administrative claims records.", {"entities": []}], ["We aimed to determine changes in medicine use as a result of the program.", {"entities": []}], ["The program provides targeted patient-specific feedback to medical practitioners.", {"entities": []}], ["The feedback is supported with educational material developed by a clinical panel, subject to peer review and overseen by a national editorial committee.", {"entities": []}], ["Veterans who meet target criteria also receive educational brochures.", {"entities": []}], ["The program is supported by a national call centre and ongoing national consultation.", {"entities": []}], ["Segmented regression analyses (interrupted time series) were undertaken to assess changes in medication use in targeted veterans pre and post each intervention.", {"entities": []}], ["12 interventions were included; three to increase medicine use, seven which aimed to reduce use, and two which had combination of messages to change use.", {"entities": []}], ["All programs that aimed to increase medicine use were effective, with relative effect sizes at the time of the intervention ranging from 1% to 8%.", {"entities": []}], ["Mixed results were seen with programs aiming to reduce inappropriate medicine use.", {"entities": []}], ["Highly specific programs were effective, with relative effect sizes at the time of the intervention of 10% decline in use of NSAIDs in high risk groups and 14% decline in use of antipsychotics in dementia.", {"entities": [[196, 204, "DISEASE"]]}], ["Interventions targeting combinations of medicines, including medicine interactions and potentially inappropriate medicines in the elderly did not change practice significantly.", {"entities": []}], ["Interventions with combinations of messages targeting multiple components of practice had an impact on one component, but not all components targeted.", {"entities": []}], ["The Veterans\u2019 MATES program showed positive practice change over time, with interventions increasing use of appropriate medicines where under-use was evident and reduced use of inappropriate medicines when single medicines were targeted.", {"entities": []}], ["Combinations of messages were less effective, suggesting specific messages focusing on single medicines are required to maximise effect.", {"entities": []}], ["The program provides a model that could be replicated in other settings.", {"entities": []}], ["There is growing evidence that many diseases develop, progress, and respond to therapy differently in men and women.", {"entities": []}], ["This variability may manifest as a result of sex-specific structures in gene regulatory networks that influence how those networks operate.", {"entities": []}], ["However, there are few methods to identify and characterize differences in network structure, slowing progress in understanding mechanisms driving sexual dimorphism.", {"entities": []}], ["Here we apply an integrative network inference method, PANDA ( P assing A ttributes between N etworks for D ata A ssimilation), to model sex-specific networks in blood and sputum samples from subjects with Chronic Obstructive Pulmonary Disease (COPD).", {"entities": []}], ["We used a jack-knifing approach to build an ensemble of likely networks for each sex.", {"entities": []}], ["By adapting statistical methods to compare these network ensembles, we were able to identify strong differential-targeting patterns associated with functionally-related sets of genes, including those involved in mitochondrial function and energy metabolism.", {"entities": []}], ["Network analysis also identified several potential sex- and disease-specific transcriptional regulators of these pathways.", {"entities": []}], ["Network analysis yielded insight into potential mechanisms driving sexual dimorphism in COPD that were not evident from gene expression analysis alone.", {"entities": []}], ["We believe our ensemble approach to network analysis provides a principled way to capture sex-specific regulatory relationships and could be applied to identify differences in gene regulatory patterns in a wide variety of diseases and contexts.", {"entities": []}], ["The online version of this article (doi:10.1186/s12918-014-0118-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The management of osteoarthritis (OA) is unsatisfactory, as most treatments are not clinically effective over placebo and most drugs have considerable side effects.", {"entities": [[18, 32, "DISEASE"]]}], ["On average, 75 % of the analgesic effect from OA treatments in clinical trials can be attributed to a placebo response, and this response varies greatly from patient to patient.", {"entities": []}], ["This individual patient data (IPD) meta-analysis aims to identify placebo responders and the potential determinants of the placebo response in OA.", {"entities": []}], ["This study is undertaken in conjunction with the OA Trial Bank, an ongoing international consortium aiming to collect IPD from randomised controlled trials (RCTs) for all treatments of OA.", {"entities": []}], ["RCTs for each treatment of OA have been systematically searched for, and authors of the relevant trials have been contacted to request the IPD.", {"entities": []}], ["We will use the IPD of placebo-controlled RCTs held by the OA Trial Bank for this project.", {"entities": []}], ["The IPD in placebo groups will be used to investigate the placebo response according to the minimum clinically important difference (MCID) threshold (e.g.", {"entities": []}], ["20 % pain reduction).", {"entities": []}], ["Responders to placebo will be compared with non-responders to identify predictors of response.", {"entities": []}], ["The quality of the trials will be assessed and potential determinants will be examined using multilevel logistic regression analyses.", {"entities": []}], ["This study explores the varying magnitude of the placebo response and the proportion of participants that experience a clinically important placebo effect in OA RCTs.", {"entities": []}], ["Potential determinants of the placebo response will also be investigated.", {"entities": []}], ["These determinants may be useful for future studies as it may allow participants to be stratified into groups based on their likely response to placebo.", {"entities": []}], ["The results of this study may also be useful for pharmaceutical companies, who could improve the design of their studies in order to separate the specific treatment from the non-specific contextual (i.e.", {"entities": []}], ["placebo) effects.", {"entities": []}], ["PROSPERO CRD42016033212 The online version of this article (doi:10.1186/s13643-016-0362-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cymbopogon species are widely used as herbal remedies by the traditional healers living in Nkonkobe Municipality for the treatment and management of skin and respiratory infections.", {"entities": []}], ["According to our survey, the plants seem to be very important because of the higher demands.", {"entities": []}], ["The leaves of C. validis and C. plurinodis were hydro-distilled and the resulted extracted oils were analyzed by GC/MS.", {"entities": []}], ["Minimum inhibitory concentrations (MICs) ranging from 7.8 to 500.0\u00a0\u03bcg/ml of the extracted oils were tested against eight bacterial strains, using micro-well dilution method.", {"entities": []}], ["The human Chang liver cell viability was determined using the CellTiter-Blue cell assay.", {"entities": []}], ["GC-MS analysis of the C. validis essential oil amounted to 87.03%, major components identified were Linalyl alcohol (18.9%), 2-Nephthalenemethanol (6.67%), Longifolene (6.53%), Cubedol (6.08%).", {"entities": []}], ["Total oil percentage of C. plurinodis was 81.47% and the main components were characterized as 3-Cyclohexane-1-ol (13.58%), Nerolidol (13.6%) and 2-Carene (12.6%).", {"entities": []}], ["The essential oils from both plants were found to be active against the growth of Gram positive than the Gram negative bacterial tested.", {"entities": []}], ["Lethal dose at 50 (LD 50 ) of both plants showed 74.87\u00a0\u00b1\u00a01.41 and 81.66\u00a0\u00b1\u00a01.40 degree of toxicity at 24\u00a0h. Both plants extracts were toxic to human Chang liver cell lines.", {"entities": []}], ["To examine which interventions healthcare professionals use to support patients with taking medicines and their perceptions about the effectiveness of those actions.", {"entities": []}], ["Cross-sectional multinational study.", {"entities": []}], ["Online survey in Austria, Belgium, England, France, Germany, Hungary, The Netherlands, Poland, Portugal and Switzerland.", {"entities": []}], ["A total of 3196 healthcare professionals comprising doctors (855), nurses (1047) and pharmacists (1294) currently registered and practising in primary care and community settings.", {"entities": []}], ["Primary outcome: Responses to the question \u2018I ask patients if they have missed any doses of their medication\u2019 for each profession and in each country.", {"entities": []}], ["Secondary outcome: Responses to 50 items concerning healthcare professional behaviour to support patients with medication-taking for each profession and in each country.", {"entities": []}], ["Approximately half of the healthcare professionals in the survey ask patients with long-term conditions whether they have missed any doses of their medication on a regular basis.", {"entities": []}], ["Pharmacists persistently report that they intervene less than the other two professions to support patients with medicines.", {"entities": []}], ["No country effects were found for the primary outcome.", {"entities": []}], ["Healthcare professionals in Europe are limited in the extent to which they intervene to assist patients having long-term conditions with medication adherence.", {"entities": []}], ["This represents a missed opportunity to support people with prescribed treatment.", {"entities": []}], ["These conclusions are based on the largest international survey to date of healthcare professionals\u2019 management of medication adherence.", {"entities": []}], ["Abediterol is a once\u2010daily, long\u2010acting \u03b2 2 \u2010adrenergic agonist in development for the treatment of asthma and chronic obstructive pulmonary disease.", {"entities": [[111, 148, "DISEASE"], [100, 106, "DISEASE"]]}], ["We assessed the efficacy, safety, and tolerability of three dose levels of abediterol, given once daily for 7\u00a0days in patients with stable, persistent asthma.", {"entities": [[151, 157, "DISEASE"]]}], ["This was an ascending\u2010dose, three\u2010period incomplete crossover study design investigating three dose levels of abediterol versus placebo (Eudra CT No.", {"entities": []}], ["2008\u2010003732\u201038).", {"entities": []}], ["Twenty\u2010eight male patients (25\u201359\u00a0years) were randomized to one of four treatment sequences (1:1:1:1).", {"entities": []}], ["Follow\u2010up was 7\u00a0days after final treatment.", {"entities": []}], ["Spirometry was performed regularly up to 24\u00a0h postdose Day 1, up to 36\u00a0h postdose Day 7, and at follow\u2010up.", {"entities": []}], ["Vital signs, 12\u2010lead electrocardiogram, and clinical laboratory tests were recorded throughout.", {"entities": []}], ["Abediterol 2.5, 5, and 10\u00a0 \u03bc g provided clinically and statistically significant improvements from baseline (predose, Day 1) in trough forced expiratory volume in 1\u00a0sec ( FEV 1 ) versus placebo on Day\u00a07 (primary endpoint) of 334, 365, and 294\u00a0 mL , respectively (all P\u00a0 < \u00a0 0.01), and peak FEV 1 versus placebo on Day\u00a07 of 364 ( P\u00a0 < \u00a0 0.001), 403 ( P\u00a0 < \u00a0 0.001), and 375\u00a0 mL ( P\u00a0 < \u00a0 0.01), respectively.", {"entities": [[171, 174, "GENE"], [290, 293, "GENE"], [171, 174, "GENE"], [290, 293, "GENE"]]}], ["Days 1 and 7 area under the curve ( AUC ) parameters within each abediterol group were similar for AUC 0\u20136 , AUC 0\u201312 , AUC 0\u201324 , and AUC 12\u201324 , with dose\u2010dependent effects observed on Day 1.", {"entities": []}], ["Abediterol (2.5\u201310\u00a0 \u03bc g) demonstrated a good safety and tolerability profile.", {"entities": []}], ["Abediterol 2.5, 5, and 10\u00a0 \u03bc g once daily achieved statistically and clinically significant improvements in pulmonary function versus placebo over 7\u00a0days and demonstrated a safety and tolerability profile comparable with placebo.", {"entities": []}], ["Obesity/metabolic syndrome are common risk factors for overactive bladder.", {"entities": [[18, 26, "DISEASE"]]}], ["This study aimed to investigate the functional and molecular changes of detrusor smooth muscle (DSM) in high-fat insulin resistant obese mice, focusing on the role of protein kinase C (PKC) and Ca v 1.2 in causing bladder dysfunction.", {"entities": []}], ["Male C57BL/6 mice were fed with high-fat diet for 10 weeks.", {"entities": []}], ["In vitro functional responses and cystometry, as well as PKC and Ca v 1.2 expression in bladder were evaluated.", {"entities": []}], ["Obese mice exhibited higher body weight, epididymal fat mass, fasting glucose and insulin resistance.", {"entities": []}], ["Carbachol (0.001\u2013100 \u00b5M), \u03b1,\u03b2-methylene ATP (1\u201310 \u00b5M), KCl (1\u2013300 mM), extracellular Ca v 1.2 blocker amlodipine.", {"entities": []}], ["Cystometry evidenced augmented frequency, non-void contractions and post-void pressure in obese mice that were also prevented by amlodipine.", {"entities": []}], ["Metformin treatment improved the insulin sensitivity, and normalized the in vitro bladder hypercontractility and cystometric dysfunction in obese mice.", {"entities": []}], ["The PKC inhibitor GF109203X (1 \u00b5M) also reduced the carbachol induced contractions.", {"entities": []}], ["PKC protein expression was markedly higher in bladder tissues from obese mice, which was normalized by metformin treatment.", {"entities": []}], ["The Ca v 1.2 channel protein expression was not modified in any experimental group.", {"entities": []}], ["Our findings show that Ca v 1.2 blockade and improvement of insulin sensitization restores the enhanced PKC protein expression in bladder tissues and normalizes the overactive detrusor.", {"entities": []}], ["It is likely that insulin resistance importantly contributes for the pathophysiology of this urological disorder in obese mice.", {"entities": []}], ["Nicotine plays an important role in cigarette-smoke-associated airway disease.", {"entities": []}], ["The present study was designed to examine if nicotine could induce airway hyperresponsiveness through kinin receptors, and if so, explore the underlying mechanisms involved.", {"entities": []}], ["Murine tracheal segments were cultured for 1, 2 or 4 days in serum-free DMEM medium in presence of nicotine (1 and 10 \u03bcM) or vehicle (DMSO).", {"entities": []}], ["Contractile responses induced by kinin B 1 receptor agonist, des-Arg 2 receptor agonist, bradykinin, were monitored with myographs.", {"entities": []}], ["The B 1 and B 2 receptor mRNA expressions were semi-quantified using real-time PCR and their corresponding protein expressions assessed with confocal-microscopy-based immunohistochemistry.", {"entities": []}], ["Various pharmacological inhibitors were used for studying intracellular signaling pathways.", {"entities": []}], ["Four days of organ culture with nicotine concentration-dependently increased kinin B 1 and B 2 receptor-mediated airway contractions, without altering the kinin receptor-mediated relaxations.", {"entities": []}], ["No such increase was seen at day 1 or day 2.", {"entities": []}], ["The airway contractile responses to 5-HT, acetylcholine and endothelin receptor agonists remained unaffected by nicotine.", {"entities": []}], ["Two different neuronal nicotinic receptor antagonists MG624 and hexamethonium blocked the nicotine-induced effects.", {"entities": []}], ["The enhanced contractile responses were accompanied by increased mRNA and protein expression for both kinin receptors, suggesting the involvement of transcriptional mechanisms.", {"entities": []}], ["Confocal-microscopy-based immunohistochemistry showed that 4 days of nicotine treatment induced activation (phosphorylation) of c-Jun N-terminal kinase (JNK), but not extracellular signal-regulated kinase 1 and 2 (ERK1/2) and p38.", {"entities": []}], ["Inhibition of JNK with its specific inhibitor SP600125 abolished the nicotine-induced effects on kinin receptor-mediated contractions and reverted the enhanced receptor mRNA expression.", {"entities": []}], ["Administration of phosphodiesterase inhibitors (YM976 and theophylline), glucocorticoid (dexamethasone) or adenylcyclase activator (forskolin) suppressed the nicotine-enhanced airway contractile response to des-Arg Nicotine induces airway hyperresponsiveness via transcriptional up-regulation of airway kinin B 1 and B 2 receptors, an effect mediated via neuronal nicotinic receptors.", {"entities": []}], ["The underlying molecular mechanisms involve activation of JNK- and PDE4-mediated intracellular inflammatory signal pathways.", {"entities": []}], ["Our results might be relevant to active and passive smokers suffering from airway hyperresponsiveness, and suggest new therapeutic targets for the treatment of smoke-associated airway disease.", {"entities": []}], ["Chondroitin sulphate (CS) is a natural glycosaminoglycan present in the extracellular matrix and is formed by the 1\u20133 linkage of D-glucuronic acid to N-acetylgalactosamine.", {"entities": [[22, 24, "GENE"]]}], ["In chondrocytes, CS diminishes interleukin-1 p (IL-1p)-induced increases in p38 mitogen-activated protein kinase (p38MAPK) and signal-regulated kinase 1/2 (Erk1/2) phosphorylation, and decreases nuclear factor-KB (NF-kB) nuclear translocation and as a consequence, reduces the formation of pro-inflammatory cytokines, IL-1 p and TNF-a, and pro-inflammatory enzymes, such as phospholipase A2 (PLA2), cyclooxygenase 2 (COX-2) and nitric oxide synthase-2 (NOS-2).", {"entities": [[17, 19, "GENE"]]}], ["The mechanism of action of CS explains its beneficial effect on the cartilage, synovial membrane and subchondral bone.", {"entities": [[27, 29, "GENE"]]}], ["On the other hand, in vivo , CS given orally prevents hepatic NF-\u03baB nuclear translocation, suggesting that systemic CS may elicit an anti-inflammatory effect in many tissues besides the articulation.", {"entities": [[29, 31, "GENE"], [116, 118, "GENE"], [29, 31, "GENE"], [116, 118, "GENE"]]}], ["There is preliminary evidence showing that in human beings, CS may be of benefit in other diseases where inflammation is an essential marker, such as psoriasis and atherosclerosis.", {"entities": [[164, 179, "DISEASE"], [150, 159, "DISEASE"], [60, 62, "GENE"]]}], ["The review of the literature suggest that CS might also be of interest for the treatment of other diseases with an inflammatory and/or autoimmune character, such as inflammatory bowel disease, degenerative diseases of the central nervous system and stroke, multiple sclerosis and other autoimmune diseases.", {"entities": [[165, 191, "DISEASE"], [257, 275, "DISEASE"], [42, 44, "GENE"]]}], ["To establish patient and professional user satisfaction with the Advice & Interactive Messaging (AIM) for Health programme delivered using a mobile phone-based, simple telehealth intervention, \u2018Florence\u2019.", {"entities": []}], ["A service evaluation using data extracted from Florence and from a professional user electronic survey.", {"entities": []}], ["425 primary care practices across 31 Clinical Commissioning Groups in England.", {"entities": []}], ["3381 patients registered on 1 of 10 AIM protocols between March 2013 and January 2014 and 77 professional users.", {"entities": []}], ["The AIM programme offered 10 clinical protocols, in three broad groups: (1) hypertension diagnosis/monitoring, (2) medication reminders and (3) smoking cessation.", {"entities": [[76, 88, "DISEASE"]]}], ["Florence sent patients prompts to submit clinical information, educational messages and user satisfaction questions.", {"entities": []}], ["Patient responses were reviewed by their primary healthcare providers.", {"entities": []}], ["Patients and professional user experiences of using AIM, and within this, Florence.", {"entities": []}], ["Patient activity using Florence was generally good at month 1 for the hypertension protocols (71\u201380%), but reduced over 2\u20133\u2005months (31\u201360%).", {"entities": [[70, 82, "DISEASE"]]}], ["For the other protocols, patient activity was 0\u201339% at 3\u2005months.", {"entities": []}], ["Minimum target days of texting were met for half the hypertension protocols.", {"entities": [[53, 65, "DISEASE"]]}], ["1707/2304 (74%) patients sent evaluative texts responded at least once.", {"entities": []}], ["Among responders, agreement with the adapted friends and family statement generally exceeded preproject aspirations.", {"entities": []}], ["Professional responders were generally positive or equivocal about the programme.", {"entities": []}], ["Satisfaction with AIM appeared optimal when patients were carefully selected for the protocol; professional users were familiar with the system, the programme addressed a problem with the previous service delivery that was identified by users and users took an active approach to achieve clinical goals.", {"entities": []}], ["However, there was a significant decrease in patients\u2019 use of Florence over time.", {"entities": []}], ["Future applications may be optimised by identifying and addressing reasons for the waning use of the service and enhancing support during implementation of the service.", {"entities": []}], ["Persons with cystic fibrosis (CF) are at-risk for health effects from ambient air pollution but little is known about the interaction of nanoparticles (NP) with CF lungs.", {"entities": [[13, 28, "DISEASE"]]}], ["Here we study the distribution of inhaled NP in a murine CF model and aim to reveal mechanisms contributing to adverse effects of inhaled particles in susceptible populations.", {"entities": []}], ["Chloride channel defective Cftr Cftr mutant females had moderately reduced lung compliance and slightly increased airway resistance compared to wild type mice.", {"entities": [[27, 31, "GENE"], [32, 36, "GENE"], [27, 31, "GENE"], [32, 36, "GENE"]]}], ["We found no genotype dependent differences in total, regional and head deposition or in secondary-organ translocation of inhaled iridium NP.", {"entities": []}], ["Titanium dioxide inhalation resulted in higher NP uptake by alveolar epithelial cells in Cftr mutants.", {"entities": [[89, 93, "GENE"]]}], ["Instillation of carbon NP induced a comparable acute and transient inflammatory response in both genotypes.", {"entities": []}], ["The twofold increase of bronchoalveolar lavage (BAL) neutrophils in Cftr mutant compared to wild type mice at day\u00a03 but not at days\u00a01 and 7, indicated an impaired capacity in inflammation resolution in Cftr mutants.", {"entities": [[68, 72, "GENE"], [202, 206, "GENE"], [68, 72, "GENE"], [202, 206, "GENE"]]}], ["Concomitant to the delayed decline of neutrophils, BAL granulocyte-colony stimulating factor was augmented in Cftr mutant mice.", {"entities": [[110, 114, "GENE"]]}], ["Anti-inflammatory 15-hydroxyeicosatetraenoic acid was generally significantly lower in BAL of Cftr mutant than in wild type mice.", {"entities": [[94, 98, "GENE"]]}], ["Despite lacking alterations in lung deposition and biokinetics of inhaled NP, and absence of significant differences in lung function, higher uptake of NP by alveolar epithelial cells and prolonged, acute inflammatory responses to NP exposure indicate a moderately increased susceptibility of lungs to adverse effects of inhaled NP in Cftr mutant mice and provides potential mechanisms for the increased susceptibility of CF patients to air pollution.", {"entities": [[335, 339, "GENE"]]}], ["To determine and compare hospitalization costs of bacterial community-acquired pneumonia cases via different costing methods under the Brazilian Public Unified Health System perspective.", {"entities": [[79, 88, "DISEASE"]]}], ["Cost-of-illness study based on primary data collected from a sample of 59 children aged between 28 days and 35 months and hospitalized due to bacterial pneumonia.", {"entities": [[152, 161, "DISEASE"], [142, 161, "DISEASE"]]}], ["Direct medical and non-medical costs were considered and three costing methods employed: micro-costing based on medical record review, micro-costing based on therapeutic guidelines and gross-costing based on the Brazilian Public Unified Health System reimbursement rates.", {"entities": []}], ["Costs estimates obtained via different methods were compared using the Friedman test.", {"entities": []}], ["Cost estimates of inpatient cases of severe pneumonia amounted to R$ 780,70/$Int.", {"entities": [[44, 53, "DISEASE"]]}], ["858.7 (medical record review), R$ 641,90/$Int.", {"entities": []}], ["706.90 (therapeutic guidelines) and R$ 594,80/$Int.", {"entities": []}], ["654.28 (Brazilian Public Unified Health System reimbursement rates).", {"entities": []}], ["Costs estimated via micro-costing (medical record review or therapeutic guidelines) did not differ significantly (p=0.405), while estimates based on reimbursement rates were significantly lower compared to estimates based on therapeutic guidelines (p<0.001) or record review (p=0.006).", {"entities": []}], ["Brazilian Public Unified Health System costs estimated via different costing methods differ significantly, with gross-costing yielding lower cost estimates.", {"entities": []}], ["Given costs estimated by different micro-costing methods are similar and costing methods based on therapeutic guidelines are easier to apply and less expensive, this method may be a valuable alternative for estimation of hospitalization costs of bacterial community-acquired pneumonia in children.", {"entities": [[275, 284, "DISEASE"]]}], ["The objective of this study was to prepare and characterize etoposide (VP16)-loaded solid lipid nanoparticles (SLNs) and evaluate their antitumor activity in vitro.", {"entities": []}], ["VP16-SLNs were prepared using emulsification and low-temperature solidification methods.", {"entities": []}], ["The physicochemical properties of the VP16-SLNs were investigated by particle-size analysis, zeta potential measurement, drug loading, drug entrapment efficiency, stability, and in vitro drug-release behavior.", {"entities": []}], ["In contrast to free VP16, the VP16-SLNs were well dispersed in aqueous medium, showing a narrow size distribution at 30\u201350 nm, a zeta potential value of \u221228.4 mV, high drug loading (36.91%), and an ideal drug entrapment efficiency (75.42%).", {"entities": []}], ["The drug release of VP16-SLNs could last up to 60 hours and exhibited a sustained profile, which made it a promising vehicle for drug delivery.", {"entities": []}], ["Furthermore, VP16-SLNs could significantly enhance in vitro cytotoxicity against SGC7901 cells compared to the free drug.", {"entities": []}], ["Furthermore, VP16-SLNs could induce higher apoptotic rates, more significant cell cycle arrest effects, and greater cellular uptake in SGC7901 cells than free VP16.", {"entities": []}], ["Moreover, results demonstrated that the mechanisms of VP16-SLNs were similar to those claimed for free VP16, including induction of cellular apoptosis by activation of p53, release of cytochrome c, loss of membrane potential, and activation of caspases.", {"entities": []}], ["Thus, these results suggested that the SLNs might be a promising nanocarrier for VP16 to treat gastric carcinoma.", {"entities": [[103, 112, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by airway obstruction and inflammation but also accompanied by several extrapulmonary consequences, such as skeletal muscle weakness and osteoporosis.", {"entities": [[214, 226, "DISEASE"], [50, 62, "DISEASE"]]}], ["Skeletal muscle weakness is of major concern, since it leads to poor functional capacity, impaired health status, increased healthcare utilization, and even mortality, independently of lung function.", {"entities": []}], ["Osteoporosis leads to fractures and is associated with increased mortality, functional decline, loss of quality of life, and need for institutionalization.", {"entities": [[0, 12, "DISEASE"]]}], ["Therefore, the presence of the combination of these comorbidities will have a negative impact on daily life in patients with COPD.", {"entities": []}], ["In this review, we will focus on these two comorbidities, their prevalence in COPD, combined risk factors, and pathogenesis.", {"entities": []}], ["We will try to prove the clustering of these comorbidities and discuss possible preventive or therapeutic strategies.", {"entities": []}], ["To elucidate the presence and potential involvement of brain inflammation and cell death in neurological morbidity and intractable seizures in childhood epilepsy, we quantified cell death, astrocyte proliferation, microglial activation and cytokine release in brain tissue from patients who underwent epilepsy surgery.", {"entities": []}], ["Cortical tissue was collected from thirteen patients with intractable epilepsy due to focal cortical dysplasia (6), encephalomalacia (5), Rasmussen's encephalitis (1) or mesial temporal lobe epilepsy (1).", {"entities": [[116, 132, "DISEASE"], [150, 162, "DISEASE"], [177, 199, "DISEASE"]]}], ["Sections were processed for immunohistochemistry using markers for neuron, astrocyte, microglia or cellular injury.", {"entities": []}], ["Cytokine assay was performed on frozen cortices.", {"entities": []}], ["Controls were autopsy brains from eight patients without history of neurological diseases.", {"entities": []}], ["Marked activation of microglia and astrocytes and diffuse cell death were observed in epileptogenic tissue.", {"entities": []}], ["Numerous fibrillary astrocytes and their processes covered the entire cortex and converged on to blood vessels, neurons and microglia.", {"entities": []}], ["An overwhelming number of neurons and astrocytes showed DNA fragmentation and its magnitude significantly correlated with seizure frequency.", {"entities": []}], ["Majority of our patients with abundant cell death in the cortex have mental retardation.", {"entities": []}], ["IL-1beta, IL-8, IL-12p70 and MIP-1beta were significantly increased in the epileptogenic cortex; IL-6 and MCP-1 were significantly higher in patients with family history of epilepsy.", {"entities": []}], ["Our results suggest that active neuroinflammation and marked cellular injury occur in pediatric epilepsy and may play a common pathogenic role or consequences in childhood epilepsy of diverse etiologies.", {"entities": []}], ["Our findings support the concept that immunomodulation targeting activated microglia and astrocytes may be a novel therapeutic strategy to reduce neurological morbidity and prevent intractable epilepsy.", {"entities": []}], ["Cancer survivors remain at life-long risk of developing oral complications.", {"entities": [[0, 6, "DISEASE"]]}], ["This study investigated the oral health status and behavior among cancer survivors in comparison to subjects without a history of cancer using a nationwide survey.", {"entities": [[66, 72, "DISEASE"], [130, 136, "DISEASE"]]}], ["Cancer survivors and control subjects were selected from the sixth Korean National Health and Nutrition Examination Survey (2013\u20132015).", {"entities": [[0, 6, "DISEASE"]]}], ["Survivors reported chewing (34.8%) and speaking difficulties (15.3%) resulting from oral health problems.", {"entities": []}], ["More than 36% of survivors had periodontal disease and 15.9% needed dentures.", {"entities": [[31, 50, "DISEASE"]]}], ["In multiple logistic regression analysis, age, household income, education level, smoking status, cancer site, and current cancer status were associated with oral health status.", {"entities": [[98, 104, "DISEASE"], [123, 129, "DISEASE"]]}], ["Approximately 43.3% of cancer survivors brushed their teeth more than three times a day.", {"entities": [[23, 29, "DISEASE"]]}], ["In addition, 44.9% of survivors used secondary oral products, and 30.8% had been screened for oral health problems over the past year.", {"entities": []}], ["Age, household income and education level were associated with oral health behavior.", {"entities": []}], ["The oral health status and behavior excepting periodontal disease and the use of secondary oral products were not significantly different between cancer survivors and controls.", {"entities": [[46, 65, "DISEASE"], [146, 152, "DISEASE"]]}], ["Although oral health status of cancer survivors was not worse than that of controls, more than half of the survivors maintained unhealthy oral practices.", {"entities": [[31, 37, "DISEASE"]]}], ["A physically active lifestyle is important for cancer survivors.", {"entities": [[47, 53, "DISEASE"]]}], ["Therefore, this study was conducted to 1) provide population-based estimates of the prevalence of physical activity and sitting time, and 2) their correlates in Korean cancer survivors.", {"entities": [[168, 174, "DISEASE"]]}], ["This study analyzed a cancer survivor subsample (N=1,482) from 2008-2013 Korea National Health and Nutrition Examination Survey (KNHANES), data selected with a complex sampling design.", {"entities": [[22, 28, "DISEASE"]]}], ["Overall and subgroup-specific prevalences of physical activity and sitting time were estimated.", {"entities": []}], ["Correlates of moderate- to vigorous-intensity physical activity (MVPA) and sitting time were tested using age-group-specific hierarchical multiple regression models.", {"entities": []}], ["Overall adherence rate to physical activity guidelines was 34.9% (95% CI=31.5-38.4).", {"entities": []}], ["Age-group-specific adherence rates were 41.1% (95% CI=36.3-45.9) in adults (30-64 years old), and 25.3% (95% CI=21.0-25.3) in older adults (65 years or older).", {"entities": []}], ["Adults spent 213.33 minutes (95% CI=172.4-254.3) per week on MVPA and 55.3 minutes (95% CI=36.4-64.6) on sitting time per day.", {"entities": []}], ["In adults, sitting time was significantly associated with employed status (B=28.0, p=0.046), smoking (B=-47.4, p=0.020), and number of comorbidity conditions (B=-13, p=.037).", {"entities": []}], ["MVPA was significantly associated with marital status (B=134.9, p<0.001), employment status (B=98.12, p=.046), and years since cancer diagnosis (B=104.7, p=0.015).", {"entities": [[127, 133, "DISEASE"]]}], ["Older adults spent 162.2 minutes (95% CI=119.5-204.8) per week on MVPA and 63.0 minutes (95% CI=45.0-89.5) on sitting time per day.", {"entities": []}], ["Their significant correlates were sex (B= -45.2, p=0.014), smoking (B=-70.14, p<0.001), and years since cancer diagnosis (B=37.0, p=0.024).", {"entities": [[104, 110, "DISEASE"]]}], ["Age (B=5.8, p=0.042) and marital status (B=83.8, p=0.033) were also significantly associated with MVPA in older adults.", {"entities": []}], ["A majority of Korean cancer survivors do not sufficiently participate in physical activity.", {"entities": [[21, 27, "DISEASE"]]}], ["In general, older, unhealthier, non-working, and being unmarried were risk factors for physical inactivity.", {"entities": []}], ["While this study informs public health policy makers and practitioners about physical activity intervention demand for cancer survivors, future investigations should address psychosocial mediators to better inform intervention programs.", {"entities": [[119, 125, "DISEASE"]]}], ["Human nasopharynx is often colonized by potentially pathogenic bacteria.", {"entities": []}], ["Gene polymorphisms in mannose-binding lectin (MBL), toll-like receptor (TLR) 2 and TLR4 have been reported.", {"entities": [[83, 87, "GENE"]]}], ["The present study aimed to investigate possible association between nasopharyngeal bacterial colonization and gene polymorphisms of MBL, TLR2 and TLR4 in healthy infants.", {"entities": [[137, 141, "GENE"], [146, 150, "GENE"]]}], ["From August 2008 to June 2010, 489 nasopharyngeal swabs and 412 blood samples were taken from 3-month-old healthy Finnish infants.", {"entities": []}], ["Semi-quantitative culture was performed and pyrosequencing was used for detection of polymorphisms in MBL structural gene at codons 52, 54, and 57, TLR2 Arg753Gln and TLR4 Asp299Gly.", {"entities": [[148, 152, "GENE"], [167, 171, "GENE"]]}], ["Fifty-nine percent of subjects were culture positive for at least one of the four species: 11% for Streptococcus pneumoniae , 23% for Moraxella catarrhalis , 1% for Haemophilus influenzae and 25% for Staphylococcus aureus .", {"entities": []}], ["Thirty-two percent of subjects had variant types in MBL, 5% had polymorphism of TLR2, and 18% had polymorphism of TLR4.", {"entities": [[80, 84, "GENE"], [114, 118, "GENE"]]}], ["Colonization rates of S. pneumoniae and S. aureus were significantly higher in infants with variant types of MBL than those with wild type (p\u200a=\u200a.011 and p\u200a=\u200a.024).", {"entities": []}], ["Colonization rates of S. aureus and M. catarrhalis were significantly higher in infants with polymorphisms of TLR2 and of TLR4 than those without (p\u200a=\u200a.027 and p\u200a=\u200a.002).", {"entities": [[110, 114, "GENE"], [122, 126, "GENE"]]}], ["Our study suggests that there is an association between nasopharyngeal bacterial colonization and genetic variation of MBL, TLR2 and TLR4 in young infants.", {"entities": [[124, 128, "GENE"], [133, 137, "GENE"]]}], ["This finding supports a role for these genetic variations in susceptibility of children to respiratory infections.", {"entities": []}], ["Herein, we proposed planning of wide transdisciplinary actions, which bring a solution for economic activity such as transportation, strongly related to pollution output with possible repercussions on climate change and public health.", {"entities": []}], ["To solve logistics problem by introduction of common intermodal policy, and creation of more friendly transport solution, it is possible to obtain sustainable development, climate change prevention, government policy, and regulation which are all related to human health and creation of health-supportive environment.", {"entities": []}], ["This approach permits environmental and biological monitoring same as economic results measurement by key performance indicators.", {"entities": []}], ["This approach implementing emerging scientific knowledge in environmental health science such as genetic epidemiology aimed at understanding how genomic variation impacts phenotypic expression and how genes interact with the environment at the population level with subsequent translation into practical information for clinicians as well as for public health policy creation.", {"entities": []}], ["Glycyrrhizic acid (GA), the major bioactive triterpene glycoside of glycyrrhiza, has been shown to possess a wide range of pharmacological properties, including anti-inflammatory and anti-viral properties.", {"entities": []}], ["However, few studies have examined the anti-allergic activity and exact mechanism of action of GA.", {"entities": []}], ["In the present work, the anti-allergic activity and possible mechanisms of action of GA on an immunoglobulin (Ig) E-mediated allergic reaction has been studied using three models of allergic reaction in vivo and in vitro .", {"entities": []}], ["Active systemic allergic reaction in Balb/c mice showed that GA can suppress the increased level of IL-4 to restore the immune balance of T H 1/T H 2 cells in a dose-dependent manner.", {"entities": []}], ["Additionally, GA attenuated significantly the B cells producing allergen-specific IgE and IgG 1 partly because of the low levels of T H 2 cytokines.", {"entities": []}], ["Both passive cutaneous anaphylaxis in vivo and an RBL-2H3 cell-based immunological assay in vitro indicated that GA acted as a \u201cmast cell stabilizer\u201d, as it inhibited mast cell degranulation and decreased vascular permeability by inhibiting the expression of Orai1, STIM1 and TRPC1, which blocked extracellular Ca", {"entities": [[259, 264, "GENE"], [266, 271, "GENE"], [276, 281, "GENE"]]}], ["A study in frog and chicken embryos, and reports of a high incidence of birth defects in regions of intensive GM-soy planting have raised concerns on the teratogenic potential of glyphosate-based herbicides.", {"entities": []}], ["These public concerns prompted us to conduct a systematic review of the epidemiological studies testing hypotheses of associations between glyphosate exposure and adverse pregnancy outcomes including birth defects.", {"entities": []}], ["A systematic and comprehensive literature search was performed in MEDLINE, TOXLINE, Bireme-BVS and SCOPUS databases using different combinations of exposure and outcome terms.", {"entities": []}], ["A case\u2013control study on the association between pesticides and congenital malformations in areas of extensive GM soy crops in South America, and reports on the occurrence of birth defects in these regions were reviewed as well.", {"entities": []}], ["The search found ten studies testing associations between glyphosate and birth defects, abortions, pre-term deliveries, small for gestational date births, childhood diseases or altered sex ratios.", {"entities": []}], ["Two additional studies examined changes of time-to-pregnancy in glyphosate-exposed populations.", {"entities": []}], ["Except for an excess of Attention Deficit Hyperactivity Disorder - ADHD (OR\u2009=\u20093.6, 1.3-9.6) among children born to glyphosate appliers, no significant associations between this herbicide and adverse pregnancy outcomes were described.", {"entities": []}], ["Evidence that in South American regions of intensive GM-soy planting incidence of birth defects is high remains elusive.", {"entities": []}], ["Current epidemiological evidence, albeit limited to a few studies using non-quantitative and indirect estimates and dichotomous analysis of exposures, does not lend support to public concerns that glyphosate-based pesticides might pose developmental risks to the unborn child.", {"entities": []}], ["Nonetheless, owing to methodological limitations of existing analytical observational studies, and particularly to a lack of a direct measurement (urine and/or blood levels), or an indirect estimation of exposure that has proven valid, these negative findings cannot be taken as definitive evidence that GLY, at current levels of occupational and environmental exposures, brings no risk for human development and reproduction.", {"entities": []}], ["Self-management is critical if people with diabetes are to minimise their risk of macrovascular and microvascular complications, yet adherence to self-management recommendations is suboptimal.", {"entities": []}], ["Understanding the predictors of optimal diabetes self-management in specific populations is needed to inform effective interventions.", {"entities": []}], ["This study investigated the role of demographic and clinical characteristics, illness perceptions, and self-efficacy in explaining adherence to self-management recommendations among people with poorly controlled diabetes in North West of England.", {"entities": []}], ["Illness perceptions and self-efficacy data were collected using validated questionnaires and clinical data were obtained from hospital records.", {"entities": []}], ["Correlations were used to investigate bivariate relationships between independent variables and self-management, and multiple regression techniques were used to determine demographic and psychosocial predictors of self-management.", {"entities": []}], ["Various demographic and clinical characteristics were associated with adherence to self-management recommendations.", {"entities": []}], ["In particular, employment status explained 11% of the variation in adherence to foot care whilst diabetes treatment category explained 9% of exercise and 21% of the variations in SMBG recommendations.", {"entities": []}], ["Also, 22% and 8% of the variations in overall self-management were explained by illness perceptions and self-efficacy beliefs, respectively.", {"entities": []}], ["Illness perceptions and self-efficacy beliefs of people with poorly controlled diabetes are important predictors of their self-management behaviours and could potentially guide effective interventions.", {"entities": []}], ["Desensitization protocols are being used worldwide to enable kidney transplantation across immunologic barriers, i.e.", {"entities": []}], ["antibody to donor HLA or ABO antigens, which were once thought to be absolute contraindications to transplantation.", {"entities": [[18, 21, "GENE"], [25, 28, "GENE"]]}], ["Desensitization protocols are also being applied to permit transplantation of HLA mismatched hematopoietic stem cells to patients with antibody to donor HLA, to enhance the opportunity for transplantation of non-renal organs, and to treat antibody-mediated rejection.", {"entities": [[78, 81, "GENE"], [153, 156, "GENE"], [78, 81, "GENE"], [153, 156, "GENE"]]}], ["Although desensitization for organ transplantation carries an increased risk of antibody-mediated rejection, ultimately these transplants extend and enhance the quality of life for solid organ recipients, and desensitization that permits transplantation of hematopoietic stem cells is life saving for patients with limited donor options.", {"entities": []}], ["Complex patient factors and variability in treatment protocols have made it difficult to identify, precisely, the mechanisms underlying the downregulation of donor-specific antibodies.", {"entities": []}], ["The mechanisms underlying desensitization may differ among the various protocols in use, although there are likely to be some common features.", {"entities": []}], ["However, it is likely that desensitization achieves a sort of immune detente by first reducing the immunologic barrier and then by creating an environment in which an autoregulatory process restricts the immune response to the allograft.", {"entities": []}]]